Citrus Sinensis ID: 002721
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 888 | 2.2.26 [Sep-21-2011] | |||||||
| O22938 | 890 | Leucine-rich repeat recep | yes | no | 0.998 | 0.996 | 0.777 | 0.0 | |
| Q9LVP0 | 1102 | Probable leucine-rich rep | no | no | 0.900 | 0.725 | 0.383 | 1e-140 | |
| Q9SHI2 | 1101 | Leucine-rich repeat recep | no | no | 0.885 | 0.713 | 0.378 | 1e-138 | |
| O49318 | 1124 | Probable leucine-rich rep | no | no | 0.885 | 0.699 | 0.385 | 1e-137 | |
| Q9FII5 | 1041 | Leucine-rich repeat recep | no | no | 0.895 | 0.763 | 0.353 | 1e-130 | |
| C0LGV1 | 1135 | LRR receptor-like serine/ | no | no | 0.854 | 0.668 | 0.339 | 1e-125 | |
| Q9LHP4 | 1141 | Receptor-like protein kin | no | no | 0.871 | 0.678 | 0.346 | 1e-123 | |
| Q9FIZ3 | 1252 | LRR receptor-like serine/ | no | no | 0.888 | 0.630 | 0.352 | 1e-122 | |
| Q9SSL9 | 1123 | Leucine-rich repeat recep | no | no | 0.894 | 0.707 | 0.337 | 1e-121 | |
| Q42371 | 976 | LRR receptor-like serine/ | no | no | 0.952 | 0.866 | 0.345 | 1e-121 |
| >sp|O22938|Y2182_ARATH Leucine-rich repeat receptor-like tyrosine-protein kinase At2g41820 OS=Arabidopsis thaliana GN=At2g41820 PE=1 SV=1 | Back alignment and function desciption |
|---|
Score = 1391 bits (3600), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 690/888 (77%), Positives = 775/888 (87%), Gaps = 1/888 (0%)
Query: 1 MAFLCFFSILLLGVLSKSQLVFAQLNDEPTLLAINKELIVPGWGVNGTNFCNWKGIDCDL 60
M F C +L++G LSKS+L AQL+DE TL+AIN+EL VPGW NGT++C W G+ C +
Sbjct: 1 MTFWCMSILLIVGFLSKSELCEAQLSDEATLVAINRELGVPGWSSNGTDYCTWVGLKCGV 60
Query: 61 NQAFVVKLDLSRLQLRGNITLVSELKALKRLDLSNNAFSGTIPSAFGNLSELEFLDLSLN 120
N +FV LDLS LQLRGN+TL+S+L++LK LDLS N F+G IP++FGNLSELEFLDLSLN
Sbjct: 61 NNSFVEMLDLSGLQLRGNVTLISDLRSLKHLDLSGNNFNGRIPTSFGNLSELEFLDLSLN 120
Query: 121 KFGGVIPRELGSLKDLRFFNISNNVLVGEIPDELKSLEKLEDFQVSSNKLNGSIPFWVGN 180
+F G IP E G L+ LR FNISNN+LVGEIPDELK LE+LE+FQVS N LNGSIP WVGN
Sbjct: 121 RFVGAIPVEFGKLRGLRAFNISNNLLVGEIPDELKVLERLEEFQVSGNGLNGSIPHWVGN 180
Query: 181 LTNLRVFTAYENQLVGEIPDNLGSVSELELLNLHSNQLEGPIPKSIFASGKLEVLVLTQN 240
L++LRVFTAYEN LVGEIP+ LG VSELELLNLHSNQLEG IPK IF GKL+VLVLTQN
Sbjct: 181 LSSLRVFTAYENDLVGEIPNGLGLVSELELLNLHSNQLEGKIPKGIFEKGKLKVLVLTQN 240
Query: 241 RLTGDIPELVGHCKSLSNIRIGNNDLVGVIPRAIGNVSGLTYFEADNNNLSGEIVPEFSQ 300
RLTG++PE VG C LS+IRIGNN+LVGVIPR IGN+SGLTYFEAD NNLSGEIV EFS+
Sbjct: 241 RLTGELPEAVGICSGLSSIRIGNNELVGVIPRTIGNISGLTYFEADKNNLSGEIVAEFSK 300
Query: 301 CSNLTLLNLASNGFTGVIPPELGQLINLQELILYENSLFGEIPKSILACKNLNKLDLSNN 360
CSNLTLLNLA+NGF G IP ELGQLINLQELIL NSLFGEIPKS L NLNKLDLSNN
Sbjct: 301 CSNLTLLNLAANGFAGTIPTELGQLINLQELILSGNSLFGEIPKSFLGSGNLNKLDLSNN 360
Query: 361 RFNGTIPNAICDMSRLQYLLLGQNSLKGEIPHEIGNCMKLLQLHIGSNYLTGSIPPEIGH 420
R NGTIP +C M RLQYLLL QNS++G+IPHEIGNC+KLLQL +G NYLTG+IPPEIG
Sbjct: 361 RLNGTIPKELCSMPRLQYLLLDQNSIRGDIPHEIGNCVKLLQLQLGRNYLTGTIPPEIGR 420
Query: 421 IRNLQIALNLSFNHLHGSLPPELGKLDKLVSFDVSNNQLSGTIPSALKGMLSLIEVNFSN 480
+RNLQIALNLSFNHLHGSLPPELGKLDKLVS DVSNN L+G+IP LKGM+SLIEVNFSN
Sbjct: 421 MRNLQIALNLSFNHLHGSLPPELGKLDKLVSLDVSNNLLTGSIPPLLKGMMSLIEVNFSN 480
Query: 481 NLLTGPVPSFVPFQKSPNSSFFGNKGLCGEPLSFSCGNANGPDSKNYRHRVSYRIILAVV 540
NLL GPVP FVPFQKSPNSSF GNK LCG PLS SCG + D Y HRVSYRI+LAV+
Sbjct: 481 NLLNGPVPVFVPFQKSPNSSFLGNKELCGAPLSSSCGYSEDLDHLRYNHRVSYRIVLAVI 540
Query: 541 GSGLAVFISVTVVVLLFMMRERQEK-ASKSADVADSGASSQPSIIAGNVLVENLRQAIDL 599
GSG+AVF+SVTVVVLLFMMRE+QEK A+K+ DV ++ QP+IIAGNV +ENL+Q IDL
Sbjct: 541 GSGVAVFVSVTVVVLLFMMREKQEKAAAKNVDVEENVEDEQPAIIAGNVFLENLKQGIDL 600
Query: 600 DAVVKATMKDSNMIYCGTFSTVYKAVMPSGLILSVKRLKSMDRTIIHHQNKMIRELEKLS 659
DAVVKATMK+SN + GTFS+VYKAVMPSG+I+SVK+LKSMDR I HHQNKMIRELE+LS
Sbjct: 601 DAVVKATMKESNKLSTGTFSSVYKAVMPSGMIVSVKKLKSMDRAISHHQNKMIRELERLS 660
Query: 660 KLCHDNLVRPIGFVIYEDVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVA 719
KLCHD+LVRPIGFVIYEDVALLLH +LPNG L QL+HESTK+P+Y+PDWP RLSIA+G A
Sbjct: 661 KLCHDHLVRPIGFVIYEDVALLLHQHLPNGNLTQLIHESTKKPEYQPDWPMRLSIAVGAA 720
Query: 720 EGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSKGTASISAVAGSFGYIP 779
EGLAFLH VAIIHLD+SS NVLLD+ +K +LGEIEISKLLDPS+GTASIS+VAGSFGYIP
Sbjct: 721 EGLAFLHQVAIIHLDVSSSNVLLDSGYKAVLGEIEISKLLDPSRGTASISSVAGSFGYIP 780
Query: 780 PEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQIL 839
PEYAYTMQVTAPGNVYSYGVVLLEILT+R PVEE+FGEGVDLVKWVHGA ARGETPEQIL
Sbjct: 781 PEYAYTMQVTAPGNVYSYGVVLLEILTSRAPVEEEFGEGVDLVKWVHGASARGETPEQIL 840
Query: 840 DARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEMLQEIKQ 887
DA+LSTVSF WR+EML ALKVALLCTD TPAKRPKMKKVVEMLQE+KQ
Sbjct: 841 DAKLSTVSFAWRREMLAALKVALLCTDITPAKRPKMKKVVEMLQEVKQ 888
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 0EC: .EC: 1 |
| >sp|Q9LVP0|Y5639_ARATH Probable leucine-rich repeat receptor-like protein kinase At5g63930 OS=Arabidopsis thaliana GN=At5g63930 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 498 bits (1283), Expect = e-140, Method: Compositional matrix adjust.
Identities = 321/836 (38%), Positives = 458/836 (54%), Gaps = 36/836 (4%)
Query: 68 LDLSRLQLRGNI-TLVSELKALKRLDLSNNAFSGTIPSAFGNLSELEFLDLSLNKFGGVI 126
L L + QL G I + +L++L+ L L N +GTIP GNLS +D S N G I
Sbjct: 270 LALYKNQLVGPIPKELGDLQSLEFLYLYRNGLNGTIPREIGNLSYAIEIDFSENALTGEI 329
Query: 127 PRELGSLKDLRFFNISNNVLVGEIPDELKSLEKLEDFQVSSNKLNGSIPFWVGNLTNLRV 186
P ELG+++ L + N L G IP EL +L+ L +S N L G IP L L +
Sbjct: 330 PLELGNIEGLELLYLFENQLTGTIPVELSTLKNLSKLDLSINALTGPIPLGFQYLRGLFM 389
Query: 187 FTAYENQLVGEIPDNLGSVSELELLNLHSNQLEGPIPKSIFASGKLEVLVLTQNRLTGDI 246
++N L G IP LG S+L +L++ N L G IP + + +L L N L+G+I
Sbjct: 390 LQLFQNSLSGTIPPKLGWYSDLWVLDMSDNHLSGRIPSYLCLHSNMIILNLGTNNLSGNI 449
Query: 247 PELVGHCKSLSNIRIGNNDLVGVIPRAIGNVSGLTYFEADNNNLSGEIVPEFSQCSNLTL 306
P + CK+L +R+ N+LVG P + +T E N G I E CS L
Sbjct: 450 PTGITTCKTLVQLRLARNNLVGRFPSNLCKQVNVTAIELGQNRFRGSIPREVGNCSALQR 509
Query: 307 LNLASNGFTGVIPPELGQLINLQELILYENSLFGEIPKSILACKNLNKLDLSNNRFNGTI 366
L LA NGFTG +P E+G L L L + N L GE+P I CK L +LD+ N F+GT+
Sbjct: 510 LQLADNGFTGELPREIGMLSQLGTLNISSNKLTGEVPSEIFNCKMLQRLDMCCNNFSGTL 569
Query: 367 PNAICDMSRLQYLLLGQNSLKGEIPHEIGNCMKLLQLHIGSNYLTGSIPPEIGHIRNLQI 426
P+ + + +L+ L L N+L G IP +GN +L +L +G N GSIP E+G + LQI
Sbjct: 570 PSEVGSLYQLELLKLSNNNLSGTIPVALGNLSRLTELQMGGNLFNGSIPRELGSLTGLQI 629
Query: 427 ALNLSFNHLHGSLPPELGKLDKLVSFDVSNNQLSGTIPSALKGMLSLIEVNFSNNLLTGP 486
ALNLS+N L G +PPEL L L ++NN LSG IPS+ + SL+ NFS N LTGP
Sbjct: 630 ALNLSYNKLTGEIPPELSNLVMLEFLLLNNNNLSGEIPSSFANLSSLLGYNFSYNSLTGP 689
Query: 487 VPSFVPFQKSPNSSFFGNKGLCGEPLS-------FSCGNANGPDSKNYRHRVSYRIILAV 539
+P + SSF GN+GLCG PL+ F+ + G ++ I AV
Sbjct: 690 IPL---LRNISMSSFIGNEGLCGPPLNQCIQTQPFAPSQSTGKPGGMRSSKI-IAITAAV 745
Query: 540 VGSGLAVFISVTVVVLLFMMRERQEKASKSADVADSGASSQPSIIAGNVLVENLRQAIDL 599
+G +S+ ++ L+ + R + VA S QPS ++ ++ ++
Sbjct: 746 IGG-----VSLMLIALIVYLMRRPVRT-----VASSAQDGQPSEMSLDIYFPP-KEGFTF 794
Query: 600 DAVVKAT--MKDSNMIYCGTFSTVYKAVMPSGLILSVKRLKSMDRTIIHH--QNKMIREL 655
+V AT +S ++ G TVYKAV+P+G L+VK+L S ++ N E+
Sbjct: 795 QDLVAATDNFDESFVVGRGACGTVYKAVLPAGYTLAVKKLASNHEGGNNNNVDNSFRAEI 854
Query: 656 EKLSKLCHDNLVRPIGFVIYEDVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIA 715
L + H N+V+ GF ++ LLL+ Y+P G+L ++LH+ P DW R IA
Sbjct: 855 LTLGNIRHRNIVKLHGFCNHQGSNLLLYEYMPKGSLGEILHD----PSCNLDWSKRFKIA 910
Query: 716 IGVAEGLAFLHHVA---IIHLDISSGNVLLDADFKPLLGEIEISKLLDPSKGTASISAVA 772
+G A+GLA+LHH I H DI S N+LLD F+ +G+ ++K++D + S+SA+A
Sbjct: 911 LGAAQGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPH-SKSMSAIA 969
Query: 773 GSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARG 832
GS+GYI PEYAYTM+VT ++YSYGVVLLE+LT + PV+ +G D+V WV R
Sbjct: 970 GSYGYIAPEYAYTMKVTEKSDIYSYGVVLLELLTGKAPVQP-IDQGGDVVNWVRSYIRRD 1028
Query: 833 ETPEQILDARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEMLQEIKQN 888
+LDARL+ MLT LK+ALLCT +P RP M++VV ML E +++
Sbjct: 1029 ALSSGVLDARLTLEDERIVSHMLTVLKIALLCTSVSPVARPSMRQVVLMLIESERS 1084
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SHI2|Y1723_ARATH Leucine-rich repeat receptor-like serine/threonine-protein kinase At1g17230 OS=Arabidopsis thaliana GN=At1g17230 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 494 bits (1273), Expect = e-138, Method: Compositional matrix adjust.
Identities = 309/817 (37%), Positives = 456/817 (55%), Gaps = 31/817 (3%)
Query: 82 VSELKALKRLDLSNNAFSGTIPSAFGNLSELEFLDLSLNKFGGVIPRELGSLKDLRFFNI 141
+ +L +KRL L N +G IP GNL + +D S N+ G IP+E G + +L+ ++
Sbjct: 279 IGKLTKMKRLYLYTNQLTGEIPREIGNLIDAAEIDFSENQLTGFIPKEFGHILNLKLLHL 338
Query: 142 SNNVLVGEIPDELKSLEKLEDFQVSSNKLNGSIPFWVGNLTNLRVFTAYENQLVGEIPDN 201
N+L+G IP EL L LE +S N+LNG+IP + L L ++NQL G+IP
Sbjct: 339 FENILLGPIPRELGELTLLEKLDLSINRLNGTIPQELQFLPYLVDLQLFDNQLEGKIPPL 398
Query: 202 LGSVSELELLNLHSNQLEGPIPKSIFASGKLEVLVLTQNRLTGDIPELVGHCKSLSNIRI 261
+G S +L++ +N L GPIP L +L L N+L+G+IP + CKSL+ + +
Sbjct: 399 IGFYSNFSVLDMSANSLSGPIPAHFCRFQTLILLSLGSNKLSGNIPRDLKTCKSLTKLML 458
Query: 262 GNNDLVGVIPRAIGNVSGLTYFEADNNNLSGEIVPEFSQCSNLTLLNLASNGFTGVIPPE 321
G+N L G +P + N+ LT E N LSG I + + NL L LA+N FTG IPPE
Sbjct: 459 GDNQLTGSLPIELFNLQNLTALELHQNWLSGNISADLGKLKNLERLRLANNNFTGEIPPE 518
Query: 322 LGQLINLQELILYENSLFGEIPKSILACKNLNKLDLSNNRFNGTIPNAICDMSRLQYLLL 381
+G L + + N L G IPK + +C + +LDLS N+F+G I + + L+ L L
Sbjct: 519 IGNLTKIVGFNISSNQLTGHIPKELGSCVTIQRLDLSGNKFSGYIAQELGQLVYLEILRL 578
Query: 382 GQNSLKGEIPHEIGNCMKLLQLHIGSNYLTGSIPPEIGHIRNLQIALNLSFNHLHGSLPP 441
N L GEIPH G+ +L++L +G N L+ +IP E+G + +LQI+LN+S N+L G++P
Sbjct: 579 SDNRLTGEIPHSFGDLTRLMELQLGGNLLSENIPVELGKLTSLQISLNISHNNLSGTIPD 638
Query: 442 ELGKLDKLVSFDVSNNQLSGTIPSALKGMLSLIEVNFSNNLLTGPVPSFVPFQKSPNSSF 501
LG L L +++N+LSG IP+++ ++SL+ N SNN L G VP FQ+ +S+F
Sbjct: 639 SLGNLQMLEILYLNDNKLSGEIPASIGNLMSLLICNISNNNLVGTVPDTAVFQRMDSSNF 698
Query: 502 FGNKGLCGEPLSFSCGNANGPDSK-NYRHRVSYR-----IILAVVGSGLAVFISVTVVVL 555
GN GLC S DSK N+ S R I V+GS VF+ +T + L
Sbjct: 699 AGNHGLCNSQRSHCQPLVPHSDSKLNWLINGSQRQKILTITCIVIGS---VFL-ITFLGL 754
Query: 556 LFMMRERQEKASKSADVADSGASSQPSIIAGNVLVENLRQAIDLDAVVKATMKDSNMIYC 615
+ ++ R+ D ++P ++ ++ +V AT S +
Sbjct: 755 CWTIKRREPAFVALED------QTKPDVMDSYYFP---KKGFTYQGLVDATRNFSEDVVL 805
Query: 616 --GTFSTVYKAVMPSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFV 673
G TVYKA M G +++VK+L S N E+ L K+ H N+V+ GF
Sbjct: 806 GRGACGTVYKAEMSGGEVIAVKKLNSRGEG-ASSDNSFRAEISTLGKIRHRNIVKLYGFC 864
Query: 674 IYEDVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVA---I 730
+++ LLL+ Y+ G+L + L K + DW R IA+G AEGL +LHH I
Sbjct: 865 YHQNSNLLLYEYMSKGSLGEQLQRGEK--NCLLDWNARYRIALGAAEGLCYLHHDCRPQI 922
Query: 731 IHLDISSGNVLLDADFKPLLGEIEISKLLDPSKGTASISAVAGSFGYIPPEYAYTMQVTA 790
+H DI S N+LLD F+ +G+ ++KL+D S + S+SAVAGS+GYI PEYAYTM+VT
Sbjct: 923 VHRDIKSNNILLDERFQAHVGDFGLAKLIDLSY-SKSMSAVAGSYGYIAPEYAYTMKVTE 981
Query: 791 PGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPE-QILDARLSTVSFG 849
++YS+GVVLLE++T + PV+ +G DLV WV + R P ++ DARL T
Sbjct: 982 KCDIYSFGVVLLELITGKPPVQP-LEQGGDLVNWVRRS-IRNMIPTIEMFDARLDTNDKR 1039
Query: 850 WRKEMLTALKVALLCTDSTPAKRPKMKKVVEMLQEIK 886
EM LK+AL CT ++PA RP M++VV M+ E +
Sbjct: 1040 TVHEMSLVLKIALFCTSNSPASRPTMREVVAMITEAR 1076
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O49318|Y2317_ARATH Probable leucine-rich repeat receptor-like protein kinase At2g33170 OS=Arabidopsis thaliana GN=At2g33170 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 489 bits (1259), Expect = e-137, Method: Compositional matrix adjust.
Identities = 317/822 (38%), Positives = 450/822 (54%), Gaps = 36/822 (4%)
Query: 82 VSELKALKRLDLSNNAFSGTIPSAFGNLSELEFLDLSLNKFGGVIPRELGSLKDLRFFNI 141
+ +K+LK+L L N +GTIP G LS++ +D S N G IP EL + +LR +
Sbjct: 297 IGNMKSLKKLYLYQNQLNGTIPKELGKLSKVMEIDFSENLLSGEIPVELSKISELRLLYL 356
Query: 142 SNNVLVGEIPDELKSLEKLEDFQVSSNKLNGSIPFWVGNLTNLRVFTAYENQLVGEIPDN 201
N L G IP+EL L L +S N L G IP NLT++R + N L G IP
Sbjct: 357 FQNKLTGIIPNELSKLRNLAKLDLSINSLTGPIPPGFQNLTSMRQLQLFHNSLSGVIPQG 416
Query: 202 LGSVSELELLNLHSNQLEGPIPKSIFASGKLEVLVLTQNRLTGDIPELVGHCKSLSNIRI 261
LG S L +++ NQL G IP I L +L L NR+ G+IP V CKSL +R+
Sbjct: 417 LGLYSPLWVVDFSENQLSGKIPPFICQQSNLILLNLGSNRIFGNIPPGVLRCKSLLQLRV 476
Query: 262 GNNDLVGVIPRAIGNVSGLTYFEADNNNLSGEIVPEFSQCSNLTLLNLASNGFTGVIPPE 321
N L G P + + L+ E D N SG + PE C L L+LA+N F+ +P E
Sbjct: 477 VGNRLTGQFPTELCKLVNLSAIELDQNRFSGPLPPEIGTCQKLQRLHLAANQFSSNLPNE 536
Query: 322 LGQLINLQELILYENSLFGEIPKSILACKNLNKLDLSNNRFNGTIPNAICDMSRLQYLLL 381
+ +L NL + NSL G IP I CK L +LDLS N F G++P + + +L+ L L
Sbjct: 537 ISKLSNLVTFNVSSNSLTGPIPSEIANCKMLQRLDLSRNSFIGSLPPELGSLHQLEILRL 596
Query: 382 GQNSLKGEIPHEIGNCMKLLQLHIGSNYLTGSIPPEIGHIRNLQIALNLSFNHLHGSLPP 441
+N G IP IGN L +L +G N +GSIPP++G + +LQIA+NLS+N G +PP
Sbjct: 597 SENRFSGNIPFTIGNLTHLTELQMGGNLFSGSIPPQLGLLSSLQIAMNLSYNDFSGEIPP 656
Query: 442 ELGKLDKLVSFDVSNNQLSGTIPSALKGMLSLIEVNFSNNLLTGPVPSFVPFQKSPNSSF 501
E+G L L+ ++NN LSG IP+ + + SL+ NFS N LTG +P FQ +SF
Sbjct: 657 EIGNLHLLMYLSLNNNHLSGEIPTTFENLSSLLGCNFSYNNLTGQLPHTQIFQNMTLTSF 716
Query: 502 FGNKGLCGEPLSFSCGNANGPDSKNYRHRVSYRIILAVVGSGLAVFIS-------VTVVV 554
GNKGLCG L SC P ++ H S + A G + + S + + +
Sbjct: 717 LGNKGLCGGHLR-SC----DPSHSSWPHISSLKAGSARRGRIIIIVSSVIGGISLLLIAI 771
Query: 555 LLFMMRERQEKASKSADVADSGASSQPSIIAGNVLVENLRQAIDLDAVVKAT--MKDSNM 612
++ +R E + V D Q S I V ++ + +++AT DS +
Sbjct: 772 VVHFLRNPVEPTAPY--VHDKEPFFQESDI---YFVP--KERFTVKDILEATKGFHDSYI 824
Query: 613 IYCGTFSTVYKAVMPSGLILSVKRLKSMDRTIIHHQNKMIR----ELEKLSKLCHDNLVR 668
+ G TVYKAVMPSG ++VK+L+S ++ N E+ L K+ H N+VR
Sbjct: 825 VGRGACGTVYKAVMPSGKTIAVKKLESNREGNNNNSNNTDNSFRAEILTLGKIRHRNIVR 884
Query: 669 PIGFVIYE--DVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLH 726
F ++ + LLL+ Y+ G+L +LLH + DWPTR +IA+G AEGLA+LH
Sbjct: 885 LYSFCYHQGSNSNLLLYEYMSRGSLGELLHGGK---SHSMDWPTRFAIALGAAEGLAYLH 941
Query: 727 HVA---IIHLDISSGNVLLDADFKPLLGEIEISKLLDPSKGTASISAVAGSFGYIPPEYA 783
H IIH DI S N+L+D +F+ +G+ ++K++D + S+SAVAGS+GYI PEYA
Sbjct: 942 HDCKPRIIHRDIKSNNILIDENFEAHVGDFGLAKVIDMPL-SKSVSAVAGSYGYIAPEYA 1000
Query: 784 YTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQILDARL 843
YTM+VT ++YS+GVVLLE+LT + PV+ +G DL W +ILD L
Sbjct: 1001 YTMKVTEKCDIYSFGVVLLELLTGKAPVQP-LEQGGDLATWTRNHIRDHSLTSEILDPYL 1059
Query: 844 STVSFG-WRKEMLTALKVALLCTDSTPAKRPKMKKVVEMLQE 884
+ V M+T K+A+LCT S+P+ RP M++VV ML E
Sbjct: 1060 TKVEDDVILNHMITVTKIAVLCTKSSPSDRPTMREVVLMLIE 1101
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FII5|TDR_ARATH Leucine-rich repeat receptor-like protein kinase TDR OS=Arabidopsis thaliana GN=TDR PE=1 SV=1 | Back alignment and function description |
|---|
Score = 466 bits (1199), Expect = e-130, Method: Compositional matrix adjust.
Identities = 297/839 (35%), Positives = 429/839 (51%), Gaps = 44/839 (5%)
Query: 82 VSELKALKRLDLSNNAFSGTIPSAFGNLSELEFLDLSLNKFGGVIPRELGSLKDLRFFNI 141
VS L+ L+ L+ + F G IP+A+G L L+F+ L+ N GG +P LG L +L+ I
Sbjct: 173 VSRLRFLEELNFGGSYFEGEIPAAYGGLQRLKFIHLAGNVLGGKLPPRLGLLTELQHMEI 232
Query: 142 SNNVLVGEIPDELKSLEKLEDFQVSSNKLNGSIPFWVGNLTNLRVFTAYENQLVGEIPDN 201
N G IP E L L+ F VS+ L+GS+P +GNL+NL ++N GEIP++
Sbjct: 233 GYNHFNGNIPSEFALLSNLKYFDVSNCSLSGSLPQELGNLSNLETLFLFQNGFTGEIPES 292
Query: 202 LGSVSELELLNLHSNQLEGPIPKSIFASGKLEVLVLTQNRLTGDIPELVGHCKSLSNIRI 261
++ L+LL+ SNQL G IP L L L N L+G++PE +G L+ + +
Sbjct: 293 YSNLKSLKLLDFSSNQLSGSIPSGFSTLKNLTWLSLISNNLSGEVPEGIGELPELTTLFL 352
Query: 262 GNNDLVGVIPRAIGNVSGLTYFEADNNNLSGEIVPEFSQCSNLTLLNLASNGFTGVIPPE 321
NN+ GV+P +G+ L + NN+ +G I + L L L SN F G +P
Sbjct: 353 WNNNFTGVLPHKLGSNGKLETMDVSNNSFTGTIPSSLCHGNKLYKLILFSNMFEGELPKS 412
Query: 322 LGQLINLQELILYENSLFGEIPKSILACKNLNKLDLSNNRFNGTIPNAICDMSRLQYLLL 381
L + +L N L G IP + +NL +DLSNNRF IP LQYL L
Sbjct: 413 LTRCESLWRFRSQNNRLNGTIPIGFGSLRNLTFVDLSNNRFTDQIPADFATAPVLQYLNL 472
Query: 382 GQN------------------------SLKGEIPHEIGNCMKLLQLHIGSNYLTGSIPPE 417
N +L GEIP+ +G C ++ + N L G+IP +
Sbjct: 473 STNFFHRKLPENIWKAPNLQIFSASFSNLIGEIPNYVG-CKSFYRIELQGNSLNGTIPWD 531
Query: 418 IGHIRNLQIALNLSFNHLHGSLPPELGKLDKLVSFDVSNNQLSGTIPSALKGMLSLIEVN 477
IGH L + LNLS NHL+G +P E+ L + D+S+N L+GTIPS ++ N
Sbjct: 532 IGHCEKL-LCLNLSQNHLNGIIPWEISTLPSIADVDLSHNLLTGTIPSDFGSSKTITTFN 590
Query: 478 FSNNLLTGPVPSFVPFQKSPNSSFFGNKGLCGEPLSFSCG----NANGPDSKNYRHRVSY 533
S N L GP+PS +P S F N+GLCG+ + C NA D +
Sbjct: 591 VSYNQLIGPIPSGSFAHLNP-SFFSSNEGLCGDLVGKPCNSDRFNAGNADIDGHHKEERP 649
Query: 534 RIILAVVGSGLAVFISVTVVVLLFMMRERQEKASKSADVADSGASSQPSIIAGNVLVENL 593
+ + LA I V VL+ R Q+ D L
Sbjct: 650 KKTAGAIVWILAAAIGVGFFVLVAATRCFQKSYGNRVDGGGRNGGDIGPW----KLTAFQ 705
Query: 594 RQAIDLDAVVKATMKDSNMIYCGTFSTVYKAVMPSGLILSVKRLKSMDR---TIIHHQNK 650
R D VV+ K N++ G+ TVYKA MP+G I++VK+L ++ I ++
Sbjct: 706 RLNFTADDVVECLSKTDNILGMGSTGTVYKAEMPNGEIIAVKKLWGKNKENGKIRRRKSG 765
Query: 651 MIRELEKLSKLCHDNLVRPIGFVIYEDVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPT 710
++ E++ L + H N+VR +G D +LL+ Y+PNG+L LLH K +W
Sbjct: 766 VLAEVDVLGNVRHRNIVRLLGCCTNRDCTMLLYEYMPNGSLDDLLHGGDKTMTAAAEWTA 825
Query: 711 RLSIAIGVAEGLAFLHHVA---IIHLDISSGNVLLDADFKPLLGEIEISKLLDPSKGTAS 767
IAIGVA+G+ +LHH I+H D+ N+LLDADF+ + + ++KL+ + S
Sbjct: 826 LYQIAIGVAQGICYLHHDCDPVIVHRDLKPSNILLDADFEARVADFGVAKLIQTDE---S 882
Query: 768 ISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHG 827
+S VAGS+GYI PEYAYT+QV ++YSYGV+LLEI+T + VE +FGEG +V WV
Sbjct: 883 MSVVAGSYGYIAPEYAYTLQVDKKSDIYSYGVILLEIITGKRSVEPEFGEGNSIVDWVRS 942
Query: 828 APARGETPEQILDARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEMLQEIK 886
E E++LD + R+EM L++ALLCT +P RP M+ V+ +LQE K
Sbjct: 943 KLKTKEDVEEVLDKSMGRSCSLIREEMKQMLRIALLCTSRSPTDRPPMRDVLLILQEAK 1001
|
Acts with CLE41p and CLE44p peptides as a ligand-receptor pair in a signal transduction pathway involved in the regulation of procambium maintenance and polarity during vascular-tissue development. Mediates repression of tracheary element differentiation and the promotion of procambial cells formation and polar division adjacent to phloem cells in the veins. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|C0LGV1|RCH1_ARATH LRR receptor-like serine/threonine-protein kinase RCH1 OS=Arabidopsis thaliana GN=RCH1 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 449 bits (1155), Expect = e-125, Method: Compositional matrix adjust.
Identities = 277/817 (33%), Positives = 441/817 (53%), Gaps = 58/817 (7%)
Query: 84 ELKALKRLDLSNNAFSGTIPSAFGNLSELEFLDLSLNKFGGVIPRELGSLKDLRFFNISN 143
+L+ L+++ L N G IP G + L +DLS+N F G IP+ G+L +L+ +S+
Sbjct: 297 KLQNLEKMLLWQNNLHGPIPEEIGFMKSLNAIDLSMNYFSGTIPKSFGNLSNLQELMLSS 356
Query: 144 NVLVGEIPDELKSLEKLEDFQVSSNKLNGSIPFWVGNLTNLRVFTAYENQLVGEIPDNLG 203
N + G IP L + KL FQ+ +N+++G IP +G L L +F ++N+L G IPD L
Sbjct: 357 NNITGSIPSILSNCTKLVQFQIDANQISGLIPPEIGLLKELNIFLGWQNKLEGNIPDELA 416
Query: 204 SVSELELLNLHSNQLEGPIPKSIFASGKLEVLVLTQNRLTGDIPELVGHCKSLSNIRIGN 263
L+ L+L N L G +P +F L L+L N ++G IP +G+C SL +R+ N
Sbjct: 417 GCQNLQALDLSQNYLTGSLPAGLFQLRNLTKLLLISNAISGVIPLEIGNCTSLVRLRLVN 476
Query: 264 NDLVGVIPRAIGNVSGLTYFEADNNNLSGEIVPEFSQCSNLTLLNLASNGFTGVIPPELG 323
N + G IP+ IG + L++ + NNLSG + E S C L +LNL++N G +P L
Sbjct: 477 NRITGEIPKGIGFLQNLSFLDLSENNLSGPVPLEISNCRQLQMLNLSNNTLQGYLPLSLS 536
Query: 324 QLINLQELILYENSLFGEIPKSILACKNLNKLDLSNNRFNGTIPNAICDMSRLQYLLLGQ 383
L LQ LD+S+N G IP+++ + L L+L +
Sbjct: 537 SLTKLQ------------------------VLDVSSNDLTGKIPDSLGHLISLNRLILSK 572
Query: 384 NSLKGEIPHEIGNCMKLLQLHIGSNYLTGSIPPEIGHIRNLQIALNLSFNHLHGSLPPEL 443
NS GEIP +G+C L L + SN ++G+IP E+ I++L IALNLS+N L G +P +
Sbjct: 573 NSFNGEIPSSLGHCTNLQLLDLSSNNISGTIPEELFDIQDLDIALNLSWNSLDGFIPERI 632
Query: 444 GKLDKLVSFDVSNNQLSGTIPSALKGMLSLIEVNFSNNLLTGPVPSFVPFQKSPNSSFFG 503
L++L D+S+N LSG + SAL G+ +L+ +N S+N +G +P F++ + G
Sbjct: 633 SALNRLSVLDISHNMLSGDL-SALSGLENLVSLNISHNRFSGYLPDSKVFRQLIGAEMEG 691
Query: 504 NKGLCGEPLSFSCGNANGPDSKNYRHRVSYRIILAVVGSGLAVFISVTVVVLLFMMRERQ 563
N GLC + SC +N R S+R+ +A+ GL + ++ + VL + R
Sbjct: 692 NNGLCSKGFR-SCFVSNSSQLTTQRGVHSHRLRIAI---GLLISVTAVLAVLGVLAVIRA 747
Query: 564 EKASKSADVADSGASSQPSIIAGNVLVENLRQAIDLDAVVKATMK---DSNMIYCGTFST 620
++ + + +++G N+ L+ V+ +K + N+I G
Sbjct: 748 KQMIRDDNDSETGE---------NLWTWQFTPFQKLNFTVEHVLKCLVEGNVIGKGCSGI 798
Query: 621 VYKAVMPSGLILSVKRLKSMDRTIIHHQNKM--IR-----ELEKLSKLCHDNLVRPIGFV 673
VYKA MP+ +++VK+L + ++ + K +R E++ L + H N+VR +G
Sbjct: 799 VYKAEMPNREVIAVKKLWPVTVPNLNEKTKSSGVRDSFSAEVKTLGSIRHKNIVRFLGCC 858
Query: 674 IYEDVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVA---I 730
++ LL+++Y+ NG+L LLHE + W R I +G A+GLA+LHH I
Sbjct: 859 WNKNTRLLMYDYMSNGSLGSLLHERSGVCSL--GWEVRYKIILGAAQGLAYLHHDCVPPI 916
Query: 731 IHLDISSGNVLLDADFKPLLGEIEISKLLDPSKGTASISAVAGSFGYIPPEYAYTMQVTA 790
+H DI + N+L+ DF+P +G+ ++KL+D S + +AGS+GYI PEY Y+M++T
Sbjct: 917 VHRDIKANNILIGPDFEPYIGDFGLAKLVDDGDFARSSNTIAGSYGYIAPEYGYSMKITE 976
Query: 791 PGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQILDARLSTVSFGW 850
+VYSYGVV+LE+LT + P++ +G+ +V WV + Q++D L
Sbjct: 977 KSDVYSYGVVVLEVLTGKQPIDPTIPDGLHIVDWV-----KKIRDIQVIDQGLQARPESE 1031
Query: 851 RKEMLTALKVALLCTDSTPAKRPKMKKVVEMLQEIKQ 887
+EM+ L VALLC + P RP MK V ML EI Q
Sbjct: 1032 VEEMMQTLGVALLCINPIPEDRPTMKDVAAMLSEICQ 1068
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9LHP4|RCH2_ARATH Receptor-like protein kinase 2 OS=Arabidopsis thaliana GN=RCH2 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 443 bits (1140), Expect = e-123, Method: Compositional matrix adjust.
Identities = 280/809 (34%), Positives = 434/809 (53%), Gaps = 35/809 (4%)
Query: 93 LSNNAFSGTIPSAFGNLSELEFLDLSLNKFGGVIPRELGSLKDLRFFNISNNVLVGEIPD 152
L N+ SG+IP G L++LE L L N G IP E+G+ +L+ ++S N+L G IP
Sbjct: 281 LYENSLSGSIPREIGQLTKLEQLFLWQNSLVGGIPEEIGNCSNLKMIDLSLNLLSGSIPS 340
Query: 153 ELKSLEKLEDFQVSSNKLNGSIPFWVGNLTNLRVFTAYENQLVGEIPDNLGSVSELELLN 212
+ L LE+F +S NK +GSIP + N ++L +NQ+ G IP LG++++L L
Sbjct: 341 SIGRLSFLEEFMISDNKFSGSIPTTISNCSSLVQLQLDKNQISGLIPSELGTLTKLTLFF 400
Query: 213 LHSNQLEGPIPKSIFASGKLEVLVLTQNRLTGDIPELVGHCKSLSNIRIGNNDLVGVIPR 272
SNQLEG IP + L+ L L++N LTG IP + ++L+ + + +N L G IP+
Sbjct: 401 AWSNQLEGSIPPGLADCTDLQALDLSRNSLTGTIPSGLFMLRNLTKLLLISNSLSGFIPQ 460
Query: 273 AIGNVSGLTYFEADNNNLSGEIVPEFSQCSNLTLLNLASNGFTGVIPPELGQLINLQELI 332
IGN S L N ++GEI + L+ +SN G +P E+G LQ +
Sbjct: 461 EIGNCSSLVRLRLGFNRITGEIPSGIGSLKKINFLDFSSNRLHGKVPDEIGSCSELQMID 520
Query: 333 LYENSLFGEIPKSILACKNLNKLDLSNNRFNGTIPNAICDMSRLQYLLLGQNSLKGEIPH 392
L NSL G +P + + L LD+S N+F+G IP ++ + L L+L +N G IP
Sbjct: 521 LSNNSLEGSLPNPVSSLSGLQVLDVSANQFSGKIPASLGRLVSLNKLILSKNLFSGSIPT 580
Query: 393 EIGNCMKLLQLHIGSNYLTGSIPPEIGHIRNLQIALNLSFNHLHGSLPPELGKLDKLVSF 452
+G C L L +GSN L+G IP E+G I NL+IALNLS N L G +P ++ L+KL
Sbjct: 581 SLGMCSGLQLLDLGSNELSGEIPSELGDIENLEIALNLSSNRLTGKIPSKIASLNKLSIL 640
Query: 453 DVSNNQLSGTIPSALKGMLSLIEVNFSNNLLTGPVPSFVPFQKSPNSSFFGNKGLCGEP- 511
D+S+N L G + + L + +L+ +N S N +G +P F++ GNK LC
Sbjct: 641 DLSHNMLEGDL-APLANIENLVSLNISYNSFSGYLPDNKLFRQLSPQDLEGNKKLCSSTQ 699
Query: 512 ----LSFSCGNANGPDSKNYRHRVSYRIILAVVGSGLAVFISVTVVVLLFMMRERQEKAS 567
L++ GN G D R R + ++ + + I V V+ R +
Sbjct: 700 DSCFLTYRKGNGLGDDGDASRTRKLRLTLALLITLTVVLMILGAVAVI------RARRNI 753
Query: 568 KSADVADSGASSQPSIIAGNVLVENLRQAIDLDAVVKATMKDSNMIYCGTFSTVYKAVMP 627
+ ++ G + + L +D +++ + + N+I G VY+A +
Sbjct: 754 DNERDSELGETYKWQFTPFQKL------NFSVDQIIRC-LVEPNVIGKGCSGVVYRADVD 806
Query: 628 SGLILSVKRL------KSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVALL 681
+G +++VK+L D + ++ E++ L + H N+VR +G + LL
Sbjct: 807 NGEVIAVKKLWPAMVNGGHDEKTKNVRDSFSAEVKTLGTIRHKNIVRFLGCCWNRNTRLL 866
Query: 682 LHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVA---IIHLDISSG 738
+++Y+PNG+L LLHE + DW R I +G A+GLA+LHH I+H DI +
Sbjct: 867 MYDYMPNGSLGSLLHE---RRGSSLDWDLRYRILLGAAQGLAYLHHDCLPPIVHRDIKAN 923
Query: 739 NVLLDADFKPLLGEIEISKLLDPSKGTASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYG 798
N+L+ DF+P + + ++KL+D + VAGS+GYI PEY Y+M++T +VYSYG
Sbjct: 924 NILIGLDFEPYIADFGLAKLVDEGDIGRCSNTVAGSYGYIAPEYGYSMKITEKSDVYSYG 983
Query: 799 VVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQILDARLSTVSFGWRKEMLTAL 858
VV+LE+LT + P++ EG+ LV WV RG ++LD+ L + + EM+ L
Sbjct: 984 VVVLEVLTGKQPIDPTVPEGIHLVDWVR--QNRGSL--EVLDSTLRSRTEAEADEMMQVL 1039
Query: 859 KVALLCTDSTPAKRPKMKKVVEMLQEIKQ 887
ALLC +S+P +RP MK V ML+EIKQ
Sbjct: 1040 GTALLCVNSSPDERPTMKDVAAMLKEIKQ 1068
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FIZ3|GSO2_ARATH LRR receptor-like serine/threonine-protein kinase GSO2 OS=Arabidopsis thaliana GN=GSO2 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 441 bits (1133), Expect = e-122, Method: Compositional matrix adjust.
Identities = 290/822 (35%), Positives = 441/822 (53%), Gaps = 33/822 (4%)
Query: 85 LKALKRLDLSNNAFSGTIPSAFGNLSELEFLDLSLNKFGGVIPRELGSLKDLRFFNISNN 144
L L+ + L N FSG +P GN + L+ +D N+ G IP +G LKDL ++ N
Sbjct: 432 LGKLEIMYLYENRFSGEMPVEIGNCTRLQEIDWYGNRLSGEIPSSIGRLKDLTRLHLREN 491
Query: 145 VLVGEIPDELKSLEKLEDFQVSSNKLNGSIPFWVGNLTNLRVFTAYENQLVGEIPDNLGS 204
LVG IP L + ++ ++ N+L+GSIP G LT L +F Y N L G +PD+L +
Sbjct: 492 ELVGNIPASLGNCHQMTVIDLADNQLSGSIPSSFGFLTALELFMIYNNSLQGNLPDSLIN 551
Query: 205 VSELELLNLHSNQLEGPIPKSIFASGKLEVLVLTQNRLTGDIPELVGHCKSLSNIRIGNN 264
+ L +N SN+ G I +S L V T+N GDIP +G +L +R+G N
Sbjct: 552 LKNLTRINFSSNKFNGSISPLCGSSSYLSFDV-TENGFEGDIPLELGKSTNLDRLRLGKN 610
Query: 265 DLVGVIPRAIGNVSGLTYFEADNNNLSGEIVPEFSQCSNLTLLNLASNGFTGVIPPELGQ 324
G IPR G +S L+ + N+LSG I E C LT ++L +N +GVIP LG+
Sbjct: 611 QFTGRIPRTFGKISELSLLDISRNSLSGIIPVELGLCKKLTHIDLNNNYLSGVIPTWLGK 670
Query: 325 LINLQELILYENSLFGEIPKSILACKNLNKLDLSNNRFNGTIPNAICDMSRLQYLLLGQN 384
L L EL L N G +P I + N+ L L N NG+IP I ++ L L L +N
Sbjct: 671 LPLLGELKLSSNKFVGSLPTEIFSLTNILTLFLDGNSLNGSIPQEIGNLQALNALNLEEN 730
Query: 385 SLKGEIPHEIGNCMKLLQLHIGSNYLTGSIPPEIGHIRNLQIALNLSFNHLHGSLPPELG 444
L G +P IG KL +L + N LTG IP EIG +++LQ AL+LS+N+ G +P +
Sbjct: 731 QLSGPLPSTIGKLSKLFELRLSRNALTGEIPVEIGQLQDLQSALDLSYNNFTGRIPSTIS 790
Query: 445 KLDKLVSFDVSNNQLSGTIPSALKGMLSLIEVNFSNNLLTGPVPSFVPFQKSPNSSFFGN 504
L KL S D+S+NQL G +P + M SL +N S N L G + F + +F GN
Sbjct: 791 TLPKLESLDLSHNQLVGEVPGQIGDMKSLGYLNLSYNNLEGKLKK--QFSRWQADAFVGN 848
Query: 505 KGLCGEPLSFSCGNANGPDSKNYRHRVSYRIILAVVGSGLAVFISVTVVVLLFMMRE--- 561
GLCG PLS + N SKN R +++ S LA + +V++LF +
Sbjct: 849 AGLCGSPLS----HCNRAGSKNQRSLSPKTVVIISAISSLAAIALMVLVIILFFKQNHDL 904
Query: 562 -RQEKASKSADVADSGASSQPSIIAGNVLVENLRQAIDLDAVVKAT--MKDSNMIYCGTF 618
++ + SA ++S +S P G + I D +++AT + + MI G
Sbjct: 905 FKKVRGGNSAFSSNSSSSQAPLFSNGGA-----KSDIKWDDIMEATHYLNEEFMIGSGGS 959
Query: 619 STVYKAVMPSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVI--YE 676
VYKA + +G ++VK++ D + RE++ L + H +LV+ +G+ +
Sbjct: 960 GKVYKAELKNGETIAVKKILWKDD--LMSNKSFNREVKTLGTIRHRHLVKLMGYCSSKAD 1017
Query: 677 DVALLLHNYLPNGTLAQLLH--ESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVA---II 731
+ LL++ Y+ NG++ LH E+TK+ + W TRL IA+G+A+G+ +LH+ I+
Sbjct: 1018 GLNLLIYEYMANGSVWDWLHANENTKKKEVL-GWETRLKIALGLAQGVEYLHYDCVPPIV 1076
Query: 732 HLDISSGNVLLDADFKPLLGEIEISKLL--DPSKGTASISAVAGSFGYIPPEYAYTMQVT 789
H DI S NVLLD++ + LG+ ++K+L + T S + AGS+GYI PEYAY+++ T
Sbjct: 1077 HRDIKSSNVLLDSNIEAHLGDFGLAKILTGNYDTNTESNTMFAGSYGYIAPEYAYSLKAT 1136
Query: 790 APGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVH---GAPARGETPEQILDARLSTV 846
+VYS G+VL+EI+T ++P E F E D+V+WV P E E+++D+ L ++
Sbjct: 1137 EKSDVYSMGIVLMEIVTGKMPTEAMFDEETDMVRWVETVLDTPPGSEAREKLIDSELKSL 1196
Query: 847 SFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEMLQEIKQN 888
+ L++AL CT S P +RP ++ E L + N
Sbjct: 1197 LPCEEEAAYQVLEIALQCTKSYPQERPSSRQASEYLLNVFNN 1238
|
Together with GSO1, receptor-like serine/threonine-kinase required during the development of the epidermal surface in embryos and cotyledons. Involved in the nuclear division phase of megagametogenesis. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9SSL9|PEPR1_ARATH Leucine-rich repeat receptor-like protein kinase PEPR1 OS=Arabidopsis thaliana GN=PEPR1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 435 bits (1119), Expect = e-121, Method: Compositional matrix adjust.
Identities = 295/873 (33%), Positives = 452/873 (51%), Gaps = 79/873 (9%)
Query: 65 VVKLDLSRLQLRGNIT-LVSELKALKRLDLSNNAFSGTIPSAFGNLSELEFLDLSLNKFG 123
++ LDLS + G + + +L L + + SGTIPS+ G L L L+LS N+
Sbjct: 269 LLTLDLSYNEFEGGVPPALGNCSSLDALVIVSGNLSGTIPSSLGMLKNLTILNLSENRLS 328
Query: 124 GVIPRELGSLKDLRFFNISNNVLVGEIPDELKSLEKLEDFQVSSNKLNGSIPFWVGNLTN 183
G IP ELG+ L +++N LVG IP L L KLE ++ N+ +G IP + +
Sbjct: 329 GSIPAELGNCSSLNLLKLNDNQLVGGIPSALGKLRKLESLELFENRFSGEIPIEIWKSQS 388
Query: 184 LRVFTAYENQLVGEIPDNLGSVSELELLNLHSNQLEGPIPKSIFASGKLEVLVLTQNRLT 243
L Y+N L GE+P + + +L++ L +N G IP + + LE + N+LT
Sbjct: 389 LTQLLVYQNNLTGELPVEMTEMKKLKIATLFNNSFYGAIPPGLGVNSSLEEVDFIGNKLT 448
Query: 244 GDIPELVGHCKSLSNIRIGNNDLVGVIPRAIGNVSGLTYFEADNNNLSGEIVPEFSQ--- 300
G+IP + H + L + +G+N L G IP +IG+ + F NNLSG ++PEFSQ
Sbjct: 449 GEIPPNLCHGRKLRILNLGSNLLHGTIPASIGHCKTIRRFILRENNLSG-LLPEFSQDHS 507
Query: 301 ---------------------CSNLTLLNLASNGFTGVIPPELGQLINLQELILYENSLF 339
C NL+ +NL+ N FTG IPP+LG L NL + L N L
Sbjct: 508 LSFLDFNSNNFEGPIPGSLGSCKNLSSINLSRNRFTGQIPPQLGNLQNLGYMNLSRNLLE 567
Query: 340 GEIPKSILACKNLNKLDLSNNRFNGTIPNAICDMSRLQYLLLGQNSLKGEIPHEIGNCMK 399
G +P + C +L + D+ N NG++P+ + L L+L +N G IP + K
Sbjct: 568 GSLPAQLSNCVSLERFDVGFNSLNGSVPSNFSNWKGLTTLVLSENRFSGGIPQFLPELKK 627
Query: 400 LLQLHIGSNYLTGSIPPEIGHIRNLQIALNLSFNHLHGSLPPELGKLDKLVSFDVSNNQL 459
L L I N G IP IG I +L L+LS N L G +P +LG L KL ++SNN L
Sbjct: 628 LSTLQIARNAFGGEIPSSIGLIEDLIYDLDLSGNGLTGEIPAKLGDLIKLTRLNISNNNL 687
Query: 460 SGTIPSALKGMLSLIEVNFSNNLLTGPVPSFVPFQ-KSPNSSFFGNKGLCGEPLSFSCGN 518
+G++ S LKG+ SL+ V+ SNN TGP+P + Q S SSF GN LC P SFS N
Sbjct: 688 TGSL-SVLKGLTSLLHVDVSNNQFTGPIPDNLEGQLLSEPSSFSGNPNLC-IPHSFSASN 745
Query: 519 AN-------GPDSKNYRHRVSYRIILAVVGSGLAVFISVTVVVLLFMMRERQEKASKSAD 571
+ SK+ + +S I+ + + + V + ++ +R R+ + K A
Sbjct: 746 NSRSALKYCKDQSKSRKSGLSTWQIVLIAVLSSLLVLVVVLALVFICLRRRKGRPEKDAY 805
Query: 572 VADSGASSQPSIIAGNVLVENLRQAIDLDAVVKATMKDSNMIYCGTFSTVYKAVMPSGLI 631
V PS++ VL A D + + I G VY+A + SG +
Sbjct: 806 VFTQ--EEGPSLLLNKVLA-----ATD-------NLNEKYTIGRGAHGIVYRASLGSGKV 851
Query: 632 LSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVALLLHNYLPNGTL 691
+VKRL + + I M+RE++ + K+ H NL++ GF + +D L+L+ Y+P G+L
Sbjct: 852 YAVKRL--VFASHIRANQSMMREIDTIGKVRHRNLIKLEGFWLRKDDGLMLYRYMPKGSL 909
Query: 692 AQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLH---HVAIIHLDISSGNVLLDADFKP 748
+LH + + + DW R ++A+GVA GLA+LH H I+H DI N+L+D+D +P
Sbjct: 910 YDVLHGVSPKENVL-DWSARYNVALGVAHGLAYLHYDCHPPIVHRDIKPENILMDSDLEP 968
Query: 749 LLGEIEISKLLDPSKGTASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILTTR 808
+G+ +++LLD S T S + V G+ GYI PE A+ +VYSYGVVLLE++T +
Sbjct: 969 HIGDFGLARLLDDS--TVSTATVTGTTGYIAPENAFKTVRGRESDVYSYGVVLLELVTRK 1026
Query: 809 LPVEEDFGEGVDLVKWVHGAPARGETP--------------EQILDARLSTVSFGWRKEM 854
V++ F E D+V WV A + +++LD+ L R+++
Sbjct: 1027 RAVDKSFPESTDIVSWVRSALSSSNNNVEDMVTTIVDPILVDELLDSSL-------REQV 1079
Query: 855 LTALKVALLCTDSTPAKRPKMKKVVEMLQEIKQ 887
+ ++AL CT PA RP M+ V++L+++K
Sbjct: 1080 MQVTELALSCTQQDPAMRPTMRDAVKLLEDVKH 1112
|
Acts as a receptor for PEP defense peptides. Unlike typical immune receptors, senses an endogenous elicitor that potentiates PAMP-inducible plant responses. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q42371|ERECT_ARATH LRR receptor-like serine/threonine-protein kinase ERECTA OS=Arabidopsis thaliana GN=ERECTA PE=1 SV=1 | Back alignment and function description |
|---|
Score = 435 bits (1119), Expect = e-121, Method: Compositional matrix adjust.
Identities = 325/942 (34%), Positives = 473/942 (50%), Gaps = 96/942 (10%)
Query: 6 FFSILLLGVLSKSQLVFAQLNDE-PTLLAINKEL-----IVPGWGVN-GTNFCNWKGIDC 58
F I+LLG L LV ++E TLL I K ++ W + +++C W+G+ C
Sbjct: 4 FRDIVLLGFLFCLSLVATVTSEEGATLLEIKKSFKDVNNVLYDWTTSPSSDYCVWRGVSC 63
Query: 59 DLNQAFVVKLDLSRLQLRGNIT-LVSELKALKRLDLSNNAFSGTIPSAFGNLSELEFLDL 117
+ VV L+LS L L G I+ + +LK+L +DL N SG IP G+ S L+ LDL
Sbjct: 64 ENVTFNVVALNLSDLNLDGEISPAIGDLKSLLSIDLRGNRLSGQIPDEIGDCSSLQNLDL 123
Query: 118 SLNKFGGVIPRELGSLKDLRFFNISNNVLVGEIPDELKSLEKLEDFQVSSNKLNGSIP-- 175
S N+ G IP + LK L + NN L+G IP L + L+ ++ NKL+G IP
Sbjct: 124 SFNELSGDIPFSISKLKQLEQLILKNNQLIGPIPSTLSQIPNLKILDLAQNKLSGEIPRL 183
Query: 176 -FW--------------VGN-------LTNLRVFTAYENQLVGEIPDNLGSVSELELLNL 213
+W VGN LT L F N L G IP+ +G+ + ++L+L
Sbjct: 184 IYWNEVLQYLGLRGNNLVGNISPDLCQLTGLWYFDVRNNSLTGSIPETIGNCTAFQVLDL 243
Query: 214 HSNQLEGPIPKSIFASGKLEV--LVLTQNRLTGDIPELVGHCKSLSNIRIGNNDLVGVIP 271
NQL G IP F G L+V L L N+L+G IP ++G ++L+ + + N L G IP
Sbjct: 244 SYNQLTGEIP---FDIGFLQVATLSLQGNQLSGKIPSVIGLMQALAVLDLSGNLLSGSIP 300
Query: 272 RAIGNVSGLTYFEADNNNLSGEIVPEFSQCSNLTLLNLASNGFTGVIPPELGQLINLQEL 331
+GN++ +N L+G I PE S L L L N TG IPPELG+L +L +L
Sbjct: 301 PILGNLTFTEKLYLHSNKLTGSIPPELGNMSKLHYLELNDNHLTGHIPPELGKLTDLFDL 360
Query: 332 ILYENSLFGEIPKSILACKNLNKLDLSNNRFNGTIPNAICDMSRLQYLLLGQNSLKGEIP 391
+ N L G IP + +C NLN L++ N+F+GTIP A + + YL L N++KG IP
Sbjct: 361 NVANNDLEGPIPDHLSSCTNLNSLNVHGNKFSGTIPRAFQKLESMTYLNLSSNNIKGPIP 420
Query: 392 HEIGNCMKLLQLHIGSNYLTGSIPPEIGHIRNLQIALNLSFNHLHGSLPPELGKLDKLVS 451
E+ L L + +N + G IP +G + +L + +NLS NH+ G +P + G L ++
Sbjct: 421 VELSRIGNLDTLDLSNNKINGIIPSSLGDLEHL-LKMNLSRNHITGVVPGDFGNLRSIME 479
Query: 452 FDVSNNQLSGTIPS-----------------------ALKGMLSLIEVNFSNNLLTGPVP 488
D+SNN +SG IP +L LSL +N S+N L G +P
Sbjct: 480 IDLSNNDISGPIPEELNQLQNIILLRLENNNLTGNVGSLANCLSLTVLNVSHNNLVGDIP 539
Query: 489 SFVPFQKSPNSSFFGNKGLCGEPLSFSCGNANGPDSKNYRHRVSYRIILAVVGSGLAVFI 548
F + SF GN GLCG L+ C ++ + R +S IL + GL + +
Sbjct: 540 KNNNFSRFSPDSFIGNPGLCGSWLNSPCHDSR----RTVRVSISRAAILGIAIGGLVILL 595
Query: 549 SVTVVVLLFMMRERQEKASKSADVADSGASSQPSIIAGNVLVENLRQAIDLDAV-VKATM 607
+VL+ R + S P ++ +L N+ + D + + +
Sbjct: 596 ----MVLIAACRPHNPPPFLDGSLDKPVTYSTPKLV---ILHMNMALHVYEDIMRMTENL 648
Query: 608 KDSNMIYCGTFSTVYKAVMPSGLILSVKRLKSMDRTIIHHQNKMIR---ELEKLSKLCHD 664
+ +I G STVYK V+ + +++KRL S H+ M + ELE LS + H
Sbjct: 649 SEKYIIGHGASSTVYKCVLKNCKPVAIKRLYS------HNPQSMKQFETELEMLSSIKHR 702
Query: 665 NLVRPIGFVIYEDVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAF 724
NLV + + +LL ++YL NG+L LLH TK+ DW TRL IA G A+GLA+
Sbjct: 703 NLVSLQAYSLSHLGSLLFYDYLENGSLWDLLHGPTKKKTL--DWDTRLKIAYGAAQGLAY 760
Query: 725 LHHVA---IIHLDISSGNVLLDADFKPLLGEIEISKLLDPSKGTASISAVAGSFGYIPPE 781
LHH IIH D+ S N+LLD D + L + I+K L SK S + V G+ GYI PE
Sbjct: 761 LHHDCSPRIIHRDVKSSNILLDKDLEARLTDFGIAKSLCVSKSHTS-TYVMGTIGYIDPE 819
Query: 782 YAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQILDA 841
YA T ++T +VYSYG+VLLE+LT R V+++ +L + E E
Sbjct: 820 YARTSRLTEKSDVYSYGIVLLELLTRRKAVDDE----SNLHHLIMSKTGNNEVMEMADPD 875
Query: 842 RLSTV-SFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEML 882
ST G K++ ++ALLCT P RP M +V +L
Sbjct: 876 ITSTCKDLGVVKKV---FQLALLCTKRQPNDRPTMHQVTRVL 914
|
Receptor kinase that, together with ERL1 and ERL2, regulates aerial architecture, including inflorescence (e.g. shoot apical meristem-originating organ shape, elongation of the internode and pedicels, and adaxial-abaxial polarity), and stomatal patterning (e.g. density and clustering), probably by tuning cell division and expansion. Modulates plant transpiration efficiency by controlling stomatal density, leaf photosynthetic capacity, epidermal cell expansion, mesophyll cell proliferation and cell-cell contact. Probable major trait regulating canalization (maintenance of phenotype despite varying environment) in many aspect of the plant physiology (e.g. plant morphology, light-dependent leaves number, branch number, flowering time, phytate and mineral concentrations) by transducing microenvironmental variation into phenotypic differentiation (ecological amplifier). May maintain development integrity in heat stress conditions. Regulates cell wall composition and structure. Confers resistance to the pathogenic bacteria Ralstonia solanacearum and to the necrotrophic fungi Plectosphaerella cucumerina and Pythium irregulare, and required for callose deposition upon infection. Resistance to P.cucumerina seems cell wall-mediated. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 888 | ||||||
| 224139868 | 888 | predicted protein [Populus trichocarpa] | 0.998 | 0.998 | 0.824 | 0.0 | |
| 224087022 | 887 | predicted protein [Populus trichocarpa] | 0.998 | 1.0 | 0.820 | 0.0 | |
| 225441817 | 887 | PREDICTED: leucine-rich repeat receptor- | 0.998 | 1.0 | 0.816 | 0.0 | |
| 356572038 | 887 | PREDICTED: leucine-rich repeat receptor- | 0.997 | 0.998 | 0.766 | 0.0 | |
| 15227441 | 890 | Leucine-rich repeat protein kinase-like | 0.998 | 0.996 | 0.777 | 0.0 | |
| 297824143 | 891 | hypothetical protein ARALYDRAFT_483263 [ | 0.998 | 0.995 | 0.777 | 0.0 | |
| 110736557 | 890 | putative receptor-like protein kinase [A | 0.998 | 0.996 | 0.774 | 0.0 | |
| 356504789 | 888 | PREDICTED: leucine-rich repeat receptor- | 0.997 | 0.997 | 0.761 | 0.0 | |
| 449463364 | 892 | PREDICTED: leucine-rich repeat receptor- | 1.0 | 0.995 | 0.746 | 0.0 | |
| 449510553 | 892 | PREDICTED: LOW QUALITY PROTEIN: leucine- | 1.0 | 0.995 | 0.746 | 0.0 |
| >gi|224139868|ref|XP_002323316.1| predicted protein [Populus trichocarpa] gi|222867946|gb|EEF05077.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1504 bits (3894), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 731/887 (82%), Positives = 807/887 (90%)
Query: 1 MAFLCFFSILLLGVLSKSQLVFAQLNDEPTLLAINKELIVPGWGVNGTNFCNWKGIDCDL 60
M F CF + L+G LSKSQLV AQL+++ LLAI +EL VPGWG N T++CNW GI+C L
Sbjct: 1 MTFFCFVCLFLVGFLSKSQLVTAQLDEQAILLAIKRELGVPGWGANNTDYCNWAGINCGL 60
Query: 61 NQAFVVKLDLSRLQLRGNITLVSELKALKRLDLSNNAFSGTIPSAFGNLSELEFLDLSLN 120
N + V LDLSRL LRGN+TLVSELKALK+LDLS+N+F G IPSAFGNLS+LEFLDLSLN
Sbjct: 61 NHSMVEGLDLSRLGLRGNVTLVSELKALKQLDLSSNSFHGEIPSAFGNLSQLEFLDLSLN 120
Query: 121 KFGGVIPRELGSLKDLRFFNISNNVLVGEIPDELKSLEKLEDFQVSSNKLNGSIPFWVGN 180
KFGGVIP ELGSL++L+ N+SNN+L G IPDE + LEKLEDFQ+SSNKLNGSIP WVGN
Sbjct: 121 KFGGVIPMELGSLRNLKSLNLSNNMLGGWIPDEFQGLEKLEDFQISSNKLNGSIPSWVGN 180
Query: 181 LTNLRVFTAYENQLVGEIPDNLGSVSELELLNLHSNQLEGPIPKSIFASGKLEVLVLTQN 240
LTNLRVFTAYEN+L GEIPDNLGSVSEL +LNLHSN LEGPIPKSIFA GKLEVL+LT N
Sbjct: 181 LTNLRVFTAYENELGGEIPDNLGSVSELRVLNLHSNMLEGPIPKSIFAMGKLEVLILTMN 240
Query: 241 RLTGDIPELVGHCKSLSNIRIGNNDLVGVIPRAIGNVSGLTYFEADNNNLSGEIVPEFSQ 300
R G++PE VG+C+ LSNIRIGNNDLVGVIP+AIGNVS LTYFE NN++SGEIV EF++
Sbjct: 241 RFNGELPESVGNCRGLSNIRIGNNDLVGVIPKAIGNVSSLTYFEVANNHISGEIVSEFAR 300
Query: 301 CSNLTLLNLASNGFTGVIPPELGQLINLQELILYENSLFGEIPKSILACKNLNKLDLSNN 360
CSNLTLLNLASNGFTGVIPPELGQL+NLQELIL NSL+G+IPKSIL K+LNKLDLSNN
Sbjct: 301 CSNLTLLNLASNGFTGVIPPELGQLVNLQELILSGNSLYGDIPKSILGWKSLNKLDLSNN 360
Query: 361 RFNGTIPNAICDMSRLQYLLLGQNSLKGEIPHEIGNCMKLLQLHIGSNYLTGSIPPEIGH 420
RFNGT+PN IC+MSRLQ+LLLGQNS+KGEIPHEIGNCMKLL+L +GSNYLTGSIPPEIGH
Sbjct: 361 RFNGTVPNDICNMSRLQFLLLGQNSIKGEIPHEIGNCMKLLELQMGSNYLTGSIPPEIGH 420
Query: 421 IRNLQIALNLSFNHLHGSLPPELGKLDKLVSFDVSNNQLSGTIPSALKGMLSLIEVNFSN 480
IRNLQIALNLSFNHLHG+LPPELGKLDKLVS DVSNNQLSGTIP + KGMLSLIEVNFSN
Sbjct: 421 IRNLQIALNLSFNHLHGALPPELGKLDKLVSLDVSNNQLSGTIPPSFKGMLSLIEVNFSN 480
Query: 481 NLLTGPVPSFVPFQKSPNSSFFGNKGLCGEPLSFSCGNANGPDSKNYRHRVSYRIILAVV 540
NL +GPVP+FVPFQKS NSSFFGNKGLCGEPLS SCGN+ KNY H+VSYRIILAV+
Sbjct: 481 NLFSGPVPTFVPFQKSLNSSFFGNKGLCGEPLSLSCGNSYPSGRKNYHHKVSYRIILAVI 540
Query: 541 GSGLAVFISVTVVVLLFMMRERQEKASKSADVADSGASSQPSIIAGNVLVENLRQAIDLD 600
GSGLAVF+SVT+VVLLFM+RE QEKA+K+A + D + QP+IIAGNV VENLRQAIDLD
Sbjct: 541 GSGLAVFVSVTIVVLLFMLRESQEKAAKTAGIDDDKINDQPAIIAGNVFVENLRQAIDLD 600
Query: 601 AVVKATMKDSNMIYCGTFSTVYKAVMPSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSK 660
AVVKAT+KDSN I GTFS VYKAVMPSG++L +RLKSMDRTIIHHQNKMIRELE+LSK
Sbjct: 601 AVVKATLKDSNKISSGTFSAVYKAVMPSGMVLMARRLKSMDRTIIHHQNKMIRELERLSK 660
Query: 661 LCHDNLVRPIGFVIYEDVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAE 720
LCHDNLVRP+GFVIYED+ LLLHNYLPNGTLAQLLHES+K+ +Y PDWPTRLSIAIGVAE
Sbjct: 661 LCHDNLVRPVGFVIYEDIVLLLHNYLPNGTLAQLLHESSKKSEYEPDWPTRLSIAIGVAE 720
Query: 721 GLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSKGTASISAVAGSFGYIPP 780
GLAFLHHVAIIHLDISS NVLLDADF+PL+GE+EISKLLDPS+GTASISAVAGSFGYIPP
Sbjct: 721 GLAFLHHVAIIHLDISSCNVLLDADFRPLVGEVEISKLLDPSRGTASISAVAGSFGYIPP 780
Query: 781 EYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQILD 840
EYAYTMQVTAPGNVYSYGVVLLEILTTR+PV+EDFGEGVDLVKWVHGAPARGETPEQILD
Sbjct: 781 EYAYTMQVTAPGNVYSYGVVLLEILTTRIPVDEDFGEGVDLVKWVHGAPARGETPEQILD 840
Query: 841 ARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEMLQEIKQ 887
ARLSTVSFGWR+EML ALKVALLCTDSTPAKRPKMKKVVEMLQEIKQ
Sbjct: 841 ARLSTVSFGWRREMLAALKVALLCTDSTPAKRPKMKKVVEMLQEIKQ 887
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224087022|ref|XP_002308032.1| predicted protein [Populus trichocarpa] gi|222854008|gb|EEE91555.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 1497 bits (3875), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 729/888 (82%), Positives = 804/888 (90%), Gaps = 1/888 (0%)
Query: 1 MAFLCFFSILLLGVLSKSQLVFAQLNDEPTLLAINKELIVPGWGVNGTNFCNWKGIDCDL 60
MAF C L LG LSKS LV AQL+D+ LLAIN+EL VPGWG N TN+C W GI C L
Sbjct: 1 MAFSCLV-YLFLGFLSKSLLVTAQLDDQAILLAINRELGVPGWGANNTNYCKWAGISCGL 59
Query: 61 NQAFVVKLDLSRLQLRGNITLVSELKALKRLDLSNNAFSGTIPSAFGNLSELEFLDLSLN 120
N + V LDLSRL LRGN+TL+SELKALK+LDLS+N+F G IPSA GNLS+LEFLDLSLN
Sbjct: 60 NHSMVEGLDLSRLGLRGNVTLISELKALKQLDLSSNSFHGEIPSAIGNLSQLEFLDLSLN 119
Query: 121 KFGGVIPRELGSLKDLRFFNISNNVLVGEIPDELKSLEKLEDFQVSSNKLNGSIPFWVGN 180
KFGGVIP ELGSLK+L+ N+SNN+LVG+IPDE + LEKLEDFQ+SSNKLNGSIP WVGN
Sbjct: 120 KFGGVIPMELGSLKNLKSLNLSNNMLVGQIPDEFQGLEKLEDFQISSNKLNGSIPSWVGN 179
Query: 181 LTNLRVFTAYENQLVGEIPDNLGSVSELELLNLHSNQLEGPIPKSIFASGKLEVLVLTQN 240
LTNLRVFTAYEN L G IPDNLGSVSEL++LNLHSN LEGPIPKSIF+ GKLEVL+LT N
Sbjct: 180 LTNLRVFTAYENDLGGAIPDNLGSVSELKVLNLHSNMLEGPIPKSIFSMGKLEVLILTLN 239
Query: 241 RLTGDIPELVGHCKSLSNIRIGNNDLVGVIPRAIGNVSGLTYFEADNNNLSGEIVPEFSQ 300
RL G++PE VG+C+ LSNIRIGNNDLVGVIP+AIGNVS LTYFE NN++SGEIV EF+Q
Sbjct: 240 RLKGELPESVGNCRGLSNIRIGNNDLVGVIPKAIGNVSSLTYFEVANNHMSGEIVSEFAQ 299
Query: 301 CSNLTLLNLASNGFTGVIPPELGQLINLQELILYENSLFGEIPKSILACKNLNKLDLSNN 360
CSNL LLNLASNGFTGVIP ELGQL+NLQELIL NSL G+IP SI+ CK+LNKLDLSNN
Sbjct: 300 CSNLILLNLASNGFTGVIPAELGQLVNLQELILSGNSLIGDIPISIIGCKSLNKLDLSNN 359
Query: 361 RFNGTIPNAICDMSRLQYLLLGQNSLKGEIPHEIGNCMKLLQLHIGSNYLTGSIPPEIGH 420
RFNGT+PN IC+MSRLQYLLLGQNS+KGEIPHEIGNC+KLL+L +GSNYLTG+IPPEIGH
Sbjct: 360 RFNGTVPNGICNMSRLQYLLLGQNSIKGEIPHEIGNCLKLLELQMGSNYLTGNIPPEIGH 419
Query: 421 IRNLQIALNLSFNHLHGSLPPELGKLDKLVSFDVSNNQLSGTIPSALKGMLSLIEVNFSN 480
IRNLQIALNLSFNHLHG LPPELGKLDKLVS DVSNNQLSGTIP KGMLSLIE+NFSN
Sbjct: 420 IRNLQIALNLSFNHLHGPLPPELGKLDKLVSLDVSNNQLSGTIPPLFKGMLSLIEINFSN 479
Query: 481 NLLTGPVPSFVPFQKSPNSSFFGNKGLCGEPLSFSCGNANGPDSKNYRHRVSYRIILAVV 540
NLL+GPVP+FVPFQKSPNSSFFGNKGLCGEPLS SCGN+ +NY H+VSYRIILAV+
Sbjct: 480 NLLSGPVPTFVPFQKSPNSSFFGNKGLCGEPLSLSCGNSYPSGRENYHHKVSYRIILAVI 539
Query: 541 GSGLAVFISVTVVVLLFMMRERQEKASKSADVADSGASSQPSIIAGNVLVENLRQAIDLD 600
GSGLAVF+SVT+VVLLFMMRERQEKA+K+A +AD + QP+IIAGNV VENL+QAIDLD
Sbjct: 540 GSGLAVFVSVTIVVLLFMMRERQEKAAKTAGIADEKTNDQPAIIAGNVFVENLKQAIDLD 599
Query: 601 AVVKATMKDSNMIYCGTFSTVYKAVMPSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSK 660
AVVKAT+KDSN + GTFSTVYKAVMPSG++L +RLKSMDRTIIHHQNKMIRELE+LSK
Sbjct: 600 AVVKATLKDSNKLSIGTFSTVYKAVMPSGMVLMARRLKSMDRTIIHHQNKMIRELERLSK 659
Query: 661 LCHDNLVRPIGFVIYEDVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAE 720
LCHDNLVRP+GFVIYEDV LLLH+YLPNGTLAQLLHES+K+ +Y PDWP RLSIAIGVAE
Sbjct: 660 LCHDNLVRPVGFVIYEDVVLLLHHYLPNGTLAQLLHESSKKSEYEPDWPMRLSIAIGVAE 719
Query: 721 GLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSKGTASISAVAGSFGYIPP 780
GLAFLHHVA IHLDISS NVLLDADF+PL+GE+EISKLLDPS+GTASISAVAGSFGYIPP
Sbjct: 720 GLAFLHHVATIHLDISSFNVLLDADFQPLVGEVEISKLLDPSRGTASISAVAGSFGYIPP 779
Query: 781 EYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQILD 840
EYAYTMQVTAPGNVYSYGVVLLEILTTRLPV+EDFGEG+DLVKWVHGAPARGETPEQILD
Sbjct: 780 EYAYTMQVTAPGNVYSYGVVLLEILTTRLPVDEDFGEGLDLVKWVHGAPARGETPEQILD 839
Query: 841 ARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEMLQEIKQN 888
ARLSTVSFGWR+EML ALKVALLCTDSTPAKRPKMKKVVEMLQEIKQ+
Sbjct: 840 ARLSTVSFGWRREMLAALKVALLCTDSTPAKRPKMKKVVEMLQEIKQS 887
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225441817|ref|XP_002278051.1| PREDICTED: leucine-rich repeat receptor-like tyrosine-protein kinase At2g41820 [Vitis vinifera] gi|147777287|emb|CAN69090.1| hypothetical protein VITISV_009158 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 1452 bits (3760), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 725/888 (81%), Positives = 803/888 (90%), Gaps = 1/888 (0%)
Query: 1 MAFLCFFSILLLGVLSKSQLVFAQLNDEPTLLAINKELIVPGWGVNGTNFCNWKGIDCDL 60
MAF+C S++L+G LS SQ+V AQL+D+ TLLAINKEL VPGW VN +++C+W+GI C
Sbjct: 1 MAFVCLLSLVLMGSLSISQVVDAQLHDQATLLAINKELGVPGWDVNNSDYCSWRGIGCAA 60
Query: 61 NQAFVVKLDLSRLQLRGNITLVSELKALKRLDLSNNAFSGTIPSAFGNLSELEFLDLSLN 120
++ V +LDLS LRGN+TL+S LK+LK LDLS+N F G+IPS FGNLSEL FLDLS N
Sbjct: 61 DELIVERLDLSHRGLRGNLTLISGLKSLKSLDLSDNNFHGSIPSIFGNLSELVFLDLSWN 120
Query: 121 KFGGVIPRELGSLKDLRFFNISNNVLVGEIPDELKSLEKLEDFQVSSNKLNGSIPFWVGN 180
KFG IP ELGSL++LR N+SNN+L+GEIPDEL+SLEKL++FQ+S NK NGSIP WVGN
Sbjct: 121 KFGNSIPIELGSLRNLRSLNLSNNLLIGEIPDELQSLEKLQEFQISGNKFNGSIPIWVGN 180
Query: 181 LTNLRVFTAYENQLVGEIPDNLGSVSELELLNLHSNQLEGPIPKSIFASGKLEVLVLTQN 240
LTNLRVFTAYEN+L G+IPDNLGS SEL+LLNLHSNQLEG IP +IFASGKLEVLVLTQN
Sbjct: 181 LTNLRVFTAYENELAGKIPDNLGSHSELQLLNLHSNQLEGAIPDTIFASGKLEVLVLTQN 240
Query: 241 RLTGDIPELVGHCKSLSNIRIGNNDLVGVIPRAIGNVSGLTYFEADNNNLSGEIVPEFSQ 300
LTG++PELVG CK LSNIRIGNN+L+G IPR+IGNVS LTYFEADNNNLSGEIVPEF+Q
Sbjct: 241 ELTGNLPELVGKCKGLSNIRIGNNNLIGNIPRSIGNVSSLTYFEADNNNLSGEIVPEFAQ 300
Query: 301 CSNLTLLNLASNGFTGVIPPELGQLINLQELILYENSLFGEIPKSILACKNLNKLDLSNN 360
CSNLTLLNLASNGFTG+IPP LGQL NLQELI+ NSLFG+IP+SIL CKNLNKLDLSNN
Sbjct: 301 CSNLTLLNLASNGFTGMIPPGLGQLTNLQELIVSGNSLFGDIPESILRCKNLNKLDLSNN 360
Query: 361 RFNGTIPNAICDMSRLQYLLLGQNSLKGEIPHEIGNCMKLLQLHIGSNYLTGSIPPEIGH 420
RFNGTIP +C+ SRLQYLLL QNS++GEIPHEIGNC+KLL+L +GSNYLTGSIPPEIGH
Sbjct: 361 RFNGTIPGDLCNTSRLQYLLLSQNSIRGEIPHEIGNCVKLLELQMGSNYLTGSIPPEIGH 420
Query: 421 IRNLQIALNLSFNHLHGSLPPELGKLDKLVSFDVSNNQLSGTIPSALKGMLSLIEVNFSN 480
I+NLQIALNLSFNHLHG LP ELGKLDKLVS D+SNNQLSG IPSALKGMLSLIEVNFSN
Sbjct: 421 IKNLQIALNLSFNHLHGLLPLELGKLDKLVSLDLSNNQLSGNIPSALKGMLSLIEVNFSN 480
Query: 481 NLLTGPVPSFVPFQKSPNSSFFGNKGLCGEPLSFSCGNANGPDSKNYRHRVSYRIILAVV 540
NL TGPVP+FVPFQKSPNSSF GNKGLCGEPLS SCG NG D ++Y H+VSYRIILAV+
Sbjct: 481 NLFTGPVPTFVPFQKSPNSSFLGNKGLCGEPLSSSCG-TNGSDHESYHHKVSYRIILAVI 539
Query: 541 GSGLAVFISVTVVVLLFMMRERQEKASKSADVADSGASSQPSIIAGNVLVENLRQAIDLD 600
GSGLAVF+SVTVVVLLFMMRERQEKA+K+ VAD G +++ IIAGNV V+NLRQAID D
Sbjct: 540 GSGLAVFVSVTVVVLLFMMRERQEKAAKAGGVADDGINNRAVIIAGNVFVDNLRQAIDFD 599
Query: 601 AVVKATMKDSNMIYCGTFSTVYKAVMPSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSK 660
AVVKAT+KDSN + GTFSTVYKAVMPSGLILSVK L+SMDRTIIHHQNKMIRELE+LSK
Sbjct: 600 AVVKATLKDSNKLNSGTFSTVYKAVMPSGLILSVKSLRSMDRTIIHHQNKMIRELERLSK 659
Query: 661 LCHDNLVRPIGFVIYEDVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAE 720
LCHDNL+RPIGFVIYEDVALLLHNYLPNGTLAQ LH+ TK +Y PDWPTRL+IA GVAE
Sbjct: 660 LCHDNLMRPIGFVIYEDVALLLHNYLPNGTLAQFLHDPTKISEYEPDWPTRLNIATGVAE 719
Query: 721 GLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSKGTASISAVAGSFGYIPP 780
GLAFLHHVAIIHLDISSGN+LLDADFKPL+GEIEISKLLDPSKGTASISAVAGSFGYIPP
Sbjct: 720 GLAFLHHVAIIHLDISSGNILLDADFKPLVGEIEISKLLDPSKGTASISAVAGSFGYIPP 779
Query: 781 EYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQILD 840
EYAYTMQVTAPGNVYSYGVVLLEILTTRLPV+E FGEG+DLVKWVH APARGETPEQILD
Sbjct: 780 EYAYTMQVTAPGNVYSYGVVLLEILTTRLPVDEAFGEGIDLVKWVHTAPARGETPEQILD 839
Query: 841 ARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEMLQEIKQN 888
ARLSTVSF WRKEML+ALKVALLCTD+TPAKRPKMKKVVEMLQEIKQN
Sbjct: 840 ARLSTVSFAWRKEMLSALKVALLCTDNTPAKRPKMKKVVEMLQEIKQN 887
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356572038|ref|XP_003554177.1| PREDICTED: leucine-rich repeat receptor-like tyrosine-protein kinase At2g41820-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1397 bits (3615), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 681/889 (76%), Positives = 780/889 (87%), Gaps = 3/889 (0%)
Query: 1 MAFLCFFSILLLGVLSKSQLVFAQLNDEPTLLAINKELIVPGWG-VNGTNFCNWKGIDCD 59
M F+C ILL LS S+LV A+L D+ L AIN+EL VPGWG N +N+C W+G+ C
Sbjct: 1 MEFVCLLYILLAWCLSSSELVGAELQDQDILNAINQELRVPGWGDANNSNYCTWQGVSCG 60
Query: 60 LNQAFVVKLDLSRLQLRGNITLVSELKALKRLDLSNNAFSGTIPSAFGNLSELEFLDLSL 119
N + V LDLS LRGN+TL+SELKALKRLDLSNN F G+IP AFGNLS+LE LDLS
Sbjct: 61 -NHSMVEGLDLSHRNLRGNVTLMSELKALKRLDLSNNNFDGSIPPAFGNLSDLEVLDLSS 119
Query: 120 NKFGGVIPRELGSLKDLRFFNISNNVLVGEIPDELKSLEKLEDFQVSSNKLNGSIPFWVG 179
NKF G IP +LG L +L+ N+SNNVLVGEIP EL+ LEKL+DFQ+SSN L+G +P WVG
Sbjct: 120 NKFQGSIPPQLGGLTNLKSLNLSNNVLVGEIPIELQGLEKLQDFQISSNHLSGLVPSWVG 179
Query: 180 NLTNLRVFTAYENQLVGEIPDNLGSVSELELLNLHSNQLEGPIPKSIFASGKLEVLVLTQ 239
NLTNLR+FTAYEN+L G IPD+LG +S+L++LNLHSNQLEGPIP SIF GKLEVLVLTQ
Sbjct: 180 NLTNLRLFTAYENRLDGRIPDDLGLISDLQILNLHSNQLEGPIPASIFVPGKLEVLVLTQ 239
Query: 240 NRLTGDIPELVGHCKSLSNIRIGNNDLVGVIPRAIGNVSGLTYFEADNNNLSGEIVPEFS 299
N +G++P+ +G+CK+LS+IRIGNN LVG IP+ IGN+S LTYFEADNNNLSGE+V EF+
Sbjct: 240 NNFSGELPKEIGNCKALSSIRIGNNHLVGTIPKTIGNLSSLTYFEADNNNLSGEVVSEFA 299
Query: 300 QCSNLTLLNLASNGFTGVIPPELGQLINLQELILYENSLFGEIPKSILACKNLNKLDLSN 359
QCSNLTLLNLASNGFTG IP + GQL+NLQELIL NSLFG+IP SIL+CK+LNKLD+SN
Sbjct: 300 QCSNLTLLNLASNGFTGTIPQDFGQLMNLQELILSGNSLFGDIPTSILSCKSLNKLDISN 359
Query: 360 NRFNGTIPNAICDMSRLQYLLLGQNSLKGEIPHEIGNCMKLLQLHIGSNYLTGSIPPEIG 419
NRFNGTIPN IC++SRLQYLLL QN + GEIPHEIGNC KLL+L +GSN LTG+IPPEIG
Sbjct: 360 NRFNGTIPNEICNISRLQYLLLDQNFITGEIPHEIGNCAKLLELQLGSNILTGTIPPEIG 419
Query: 420 HIRNLQIALNLSFNHLHGSLPPELGKLDKLVSFDVSNNQLSGTIPSALKGMLSLIEVNFS 479
IRNLQIALNLSFNHLHGSLPPELGKLDKLVS DVSNN+LSG IP LKGMLSLIEVNFS
Sbjct: 420 RIRNLQIALNLSFNHLHGSLPPELGKLDKLVSLDVSNNRLSGNIPPELKGMLSLIEVNFS 479
Query: 480 NNLLTGPVPSFVPFQKSPNSSFFGNKGLCGEPLSFSCGNANGPDSKNYRHRVSYRIILAV 539
NNL GPVP+FVPFQKSP+SS+ GNKGLCGEPL+ SCG+ D K Y HRVSYRIILAV
Sbjct: 480 NNLFGGPVPTFVPFQKSPSSSYLGNKGLCGEPLNSSCGDLYD-DHKAYHHRVSYRIILAV 538
Query: 540 VGSGLAVFISVTVVVLLFMMRERQEKASKSADVADSGASSQPSIIAGNVLVENLRQAIDL 599
+GSGLAVF+SVT+VVLLFM+RERQEK +K A + + G++ P+IIAG V V+NL+QA+DL
Sbjct: 539 IGSGLAVFMSVTIVVLLFMIRERQEKVAKDAGIVEDGSNDNPTIIAGTVFVDNLKQAVDL 598
Query: 600 DAVVKATMKDSNMIYCGTFSTVYKAVMPSGLILSVKRLKSMDRTIIHHQNKMIRELEKLS 659
D V+KAT+KDSN + GTFSTVYKAVMPSG++LSV+RLKS+D+TIIHHQNKMIRELE+LS
Sbjct: 599 DTVIKATLKDSNKLSSGTFSTVYKAVMPSGVVLSVRRLKSVDKTIIHHQNKMIRELERLS 658
Query: 660 KLCHDNLVRPIGFVIYEDVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVA 719
K+CHDNLVRPIG+VIYEDVALLLH+Y PNGTLAQLLHEST++P+Y+PDWP+RLSIAIGVA
Sbjct: 659 KVCHDNLVRPIGYVIYEDVALLLHHYFPNGTLAQLLHESTRKPEYQPDWPSRLSIAIGVA 718
Query: 720 EGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSKGTASISAVAGSFGYIP 779
EGLAFLHHVAIIHLDISSGNVLLDA+ KPL+ EIEISKLLDP+KGTASISAVAGSFGYIP
Sbjct: 719 EGLAFLHHVAIIHLDISSGNVLLDANSKPLVAEIEISKLLDPTKGTASISAVAGSFGYIP 778
Query: 780 PEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQIL 839
PEYAYTMQVTAPGNVYSYGVVLLEILTTRLPV+EDFGEGVDLVKWVH AP RG+TPEQIL
Sbjct: 779 PEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVDEDFGEGVDLVKWVHNAPVRGDTPEQIL 838
Query: 840 DARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEMLQEIKQN 888
DA+LSTVSFGWRKEML ALKVA+LCTD+TPAKRPKMK VVEML+EI QN
Sbjct: 839 DAKLSTVSFGWRKEMLAALKVAMLCTDNTPAKRPKMKNVVEMLREITQN 887
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|15227441|ref|NP_181713.1| Leucine-rich repeat protein kinase-like protein [Arabidopsis thaliana] gi|75097645|sp|O22938.1|Y2182_ARATH RecName: Full=Leucine-rich repeat receptor-like tyrosine-protein kinase At2g41820; Flags: Precursor gi|2335097|gb|AAC02766.1| putative receptor-like protein kinase [Arabidopsis thaliana] gi|224589547|gb|ACN59307.1| leucine-rich repeat receptor-like protein kinase [Arabidopsis thaliana] gi|330254942|gb|AEC10036.1| Leucine-rich repeat protein kinase-like protein [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 1391 bits (3600), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 690/888 (77%), Positives = 775/888 (87%), Gaps = 1/888 (0%)
Query: 1 MAFLCFFSILLLGVLSKSQLVFAQLNDEPTLLAINKELIVPGWGVNGTNFCNWKGIDCDL 60
M F C +L++G LSKS+L AQL+DE TL+AIN+EL VPGW NGT++C W G+ C +
Sbjct: 1 MTFWCMSILLIVGFLSKSELCEAQLSDEATLVAINRELGVPGWSSNGTDYCTWVGLKCGV 60
Query: 61 NQAFVVKLDLSRLQLRGNITLVSELKALKRLDLSNNAFSGTIPSAFGNLSELEFLDLSLN 120
N +FV LDLS LQLRGN+TL+S+L++LK LDLS N F+G IP++FGNLSELEFLDLSLN
Sbjct: 61 NNSFVEMLDLSGLQLRGNVTLISDLRSLKHLDLSGNNFNGRIPTSFGNLSELEFLDLSLN 120
Query: 121 KFGGVIPRELGSLKDLRFFNISNNVLVGEIPDELKSLEKLEDFQVSSNKLNGSIPFWVGN 180
+F G IP E G L+ LR FNISNN+LVGEIPDELK LE+LE+FQVS N LNGSIP WVGN
Sbjct: 121 RFVGAIPVEFGKLRGLRAFNISNNLLVGEIPDELKVLERLEEFQVSGNGLNGSIPHWVGN 180
Query: 181 LTNLRVFTAYENQLVGEIPDNLGSVSELELLNLHSNQLEGPIPKSIFASGKLEVLVLTQN 240
L++LRVFTAYEN LVGEIP+ LG VSELELLNLHSNQLEG IPK IF GKL+VLVLTQN
Sbjct: 181 LSSLRVFTAYENDLVGEIPNGLGLVSELELLNLHSNQLEGKIPKGIFEKGKLKVLVLTQN 240
Query: 241 RLTGDIPELVGHCKSLSNIRIGNNDLVGVIPRAIGNVSGLTYFEADNNNLSGEIVPEFSQ 300
RLTG++PE VG C LS+IRIGNN+LVGVIPR IGN+SGLTYFEAD NNLSGEIV EFS+
Sbjct: 241 RLTGELPEAVGICSGLSSIRIGNNELVGVIPRTIGNISGLTYFEADKNNLSGEIVAEFSK 300
Query: 301 CSNLTLLNLASNGFTGVIPPELGQLINLQELILYENSLFGEIPKSILACKNLNKLDLSNN 360
CSNLTLLNLA+NGF G IP ELGQLINLQELIL NSLFGEIPKS L NLNKLDLSNN
Sbjct: 301 CSNLTLLNLAANGFAGTIPTELGQLINLQELILSGNSLFGEIPKSFLGSGNLNKLDLSNN 360
Query: 361 RFNGTIPNAICDMSRLQYLLLGQNSLKGEIPHEIGNCMKLLQLHIGSNYLTGSIPPEIGH 420
R NGTIP +C M RLQYLLL QNS++G+IPHEIGNC+KLLQL +G NYLTG+IPPEIG
Sbjct: 361 RLNGTIPKELCSMPRLQYLLLDQNSIRGDIPHEIGNCVKLLQLQLGRNYLTGTIPPEIGR 420
Query: 421 IRNLQIALNLSFNHLHGSLPPELGKLDKLVSFDVSNNQLSGTIPSALKGMLSLIEVNFSN 480
+RNLQIALNLSFNHLHGSLPPELGKLDKLVS DVSNN L+G+IP LKGM+SLIEVNFSN
Sbjct: 421 MRNLQIALNLSFNHLHGSLPPELGKLDKLVSLDVSNNLLTGSIPPLLKGMMSLIEVNFSN 480
Query: 481 NLLTGPVPSFVPFQKSPNSSFFGNKGLCGEPLSFSCGNANGPDSKNYRHRVSYRIILAVV 540
NLL GPVP FVPFQKSPNSSF GNK LCG PLS SCG + D Y HRVSYRI+LAV+
Sbjct: 481 NLLNGPVPVFVPFQKSPNSSFLGNKELCGAPLSSSCGYSEDLDHLRYNHRVSYRIVLAVI 540
Query: 541 GSGLAVFISVTVVVLLFMMRERQEK-ASKSADVADSGASSQPSIIAGNVLVENLRQAIDL 599
GSG+AVF+SVTVVVLLFMMRE+QEK A+K+ DV ++ QP+IIAGNV +ENL+Q IDL
Sbjct: 541 GSGVAVFVSVTVVVLLFMMREKQEKAAAKNVDVEENVEDEQPAIIAGNVFLENLKQGIDL 600
Query: 600 DAVVKATMKDSNMIYCGTFSTVYKAVMPSGLILSVKRLKSMDRTIIHHQNKMIRELEKLS 659
DAVVKATMK+SN + GTFS+VYKAVMPSG+I+SVK+LKSMDR I HHQNKMIRELE+LS
Sbjct: 601 DAVVKATMKESNKLSTGTFSSVYKAVMPSGMIVSVKKLKSMDRAISHHQNKMIRELERLS 660
Query: 660 KLCHDNLVRPIGFVIYEDVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVA 719
KLCHD+LVRPIGFVIYEDVALLLH +LPNG L QL+HESTK+P+Y+PDWP RLSIA+G A
Sbjct: 661 KLCHDHLVRPIGFVIYEDVALLLHQHLPNGNLTQLIHESTKKPEYQPDWPMRLSIAVGAA 720
Query: 720 EGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSKGTASISAVAGSFGYIP 779
EGLAFLH VAIIHLD+SS NVLLD+ +K +LGEIEISKLLDPS+GTASIS+VAGSFGYIP
Sbjct: 721 EGLAFLHQVAIIHLDVSSSNVLLDSGYKAVLGEIEISKLLDPSRGTASISSVAGSFGYIP 780
Query: 780 PEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQIL 839
PEYAYTMQVTAPGNVYSYGVVLLEILT+R PVEE+FGEGVDLVKWVHGA ARGETPEQIL
Sbjct: 781 PEYAYTMQVTAPGNVYSYGVVLLEILTSRAPVEEEFGEGVDLVKWVHGASARGETPEQIL 840
Query: 840 DARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEMLQEIKQ 887
DA+LSTVSF WR+EML ALKVALLCTD TPAKRPKMKKVVEMLQE+KQ
Sbjct: 841 DAKLSTVSFAWRREMLAALKVALLCTDITPAKRPKMKKVVEMLQEVKQ 888
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297824143|ref|XP_002879954.1| hypothetical protein ARALYDRAFT_483263 [Arabidopsis lyrata subsp. lyrata] gi|297325793|gb|EFH56213.1| hypothetical protein ARALYDRAFT_483263 [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 1389 bits (3594), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 691/889 (77%), Positives = 778/889 (87%), Gaps = 2/889 (0%)
Query: 1 MAFLCFFSILLL-GVLSKSQLVFAQLNDEPTLLAINKELIVPGWGVNGTNFCNWKGIDCD 59
MAF C +L+L LSKS+ AQL+DE TL+AIN+EL VPGW NGT++C W G+ C
Sbjct: 1 MAFWCMSILLILVAFLSKSEFCEAQLSDEATLVAINRELGVPGWSSNGTDYCTWVGLKCG 60
Query: 60 LNQAFVVKLDLSRLQLRGNITLVSELKALKRLDLSNNAFSGTIPSAFGNLSELEFLDLSL 119
LN +FV LDLS LQLRGN+TL+S+L++LK LDLS+N F+G IP++FGNLSELEFLDLSL
Sbjct: 61 LNNSFVEMLDLSGLQLRGNVTLISDLRSLKHLDLSSNNFNGPIPASFGNLSELEFLDLSL 120
Query: 120 NKFGGVIPRELGSLKDLRFFNISNNVLVGEIPDELKSLEKLEDFQVSSNKLNGSIPFWVG 179
N+F G IP E G L+ L+ FNISNN+LVGEIPDELK LE+LE+FQVS N LNGSIP WVG
Sbjct: 121 NRFVGAIPVEFGKLRGLKAFNISNNLLVGEIPDELKVLERLEEFQVSGNGLNGSIPHWVG 180
Query: 180 NLTNLRVFTAYENQLVGEIPDNLGSVSELELLNLHSNQLEGPIPKSIFASGKLEVLVLTQ 239
NL+NLRVFTAYEN LVGEIP+ LGSVSELELLNLHSNQLEG IPK +F GKL+VLVLTQ
Sbjct: 181 NLSNLRVFTAYENDLVGEIPNGLGSVSELELLNLHSNQLEGKIPKGVFEKGKLKVLVLTQ 240
Query: 240 NRLTGDIPELVGHCKSLSNIRIGNNDLVGVIPRAIGNVSGLTYFEADNNNLSGEIVPEFS 299
NRLTG++PE VG C LS+IRIGNN+LVGVIP+ IGN+SGLTYFEADNNNLSGEIV EFS
Sbjct: 241 NRLTGELPEAVGICSGLSSIRIGNNELVGVIPKTIGNISGLTYFEADNNNLSGEIVAEFS 300
Query: 300 QCSNLTLLNLASNGFTGVIPPELGQLINLQELILYENSLFGEIPKSILACKNLNKLDLSN 359
CSNLTLLNLA+NGF G IP ELGQLINLQELIL NSLFGEIPKS L NLNKLDLSN
Sbjct: 301 NCSNLTLLNLAANGFAGTIPTELGQLINLQELILSGNSLFGEIPKSFLGSGNLNKLDLSN 360
Query: 360 NRFNGTIPNAICDMSRLQYLLLGQNSLKGEIPHEIGNCMKLLQLHIGSNYLTGSIPPEIG 419
NR NGTIP +C M RLQYLLL QNS++G+IPHEIGNC+KLLQL +G NYLTG+IPPEIG
Sbjct: 361 NRLNGTIPKELCIMPRLQYLLLDQNSIRGDIPHEIGNCVKLLQLQLGRNYLTGTIPPEIG 420
Query: 420 HIRNLQIALNLSFNHLHGSLPPELGKLDKLVSFDVSNNQLSGTIPSALKGMLSLIEVNFS 479
+RNLQIALNLSFNHLHGSLPPELGKLDKLVS DVSNN L+G+IP LKGM+SLIEVNFS
Sbjct: 421 RMRNLQIALNLSFNHLHGSLPPELGKLDKLVSLDVSNNLLTGSIPQLLKGMMSLIEVNFS 480
Query: 480 NNLLTGPVPSFVPFQKSPNSSFFGNKGLCGEPLSFSCGNANGPDSKNYRHRVSYRIILAV 539
NNLL GPVP FVPFQKSPNSSF GNK LCG PLS SCGN+ + Y HRVSYRI+LAV
Sbjct: 481 NNLLNGPVPVFVPFQKSPNSSFSGNKELCGAPLSSSCGNSEDLEHLRYNHRVSYRIVLAV 540
Query: 540 VGSGLAVFISVTVVVLLFMMRERQEK-ASKSADVADSGASSQPSIIAGNVLVENLRQAID 598
+GSG+AVF+SVTVVVLLFMMRE+QEK A+K+ DV ++ QP+IIAGNV +ENL+Q ID
Sbjct: 541 IGSGVAVFVSVTVVVLLFMMREKQEKAAAKNVDVEENVEDEQPAIIAGNVFLENLKQGID 600
Query: 599 LDAVVKATMKDSNMIYCGTFSTVYKAVMPSGLILSVKRLKSMDRTIIHHQNKMIRELEKL 658
LDAVVKATMK+SN + GTFS+VYKAVMPSG+I+SVK+LKSMDR I HHQNKMIRELE+L
Sbjct: 601 LDAVVKATMKESNKLSTGTFSSVYKAVMPSGMIVSVKKLKSMDRAITHHQNKMIRELERL 660
Query: 659 SKLCHDNLVRPIGFVIYEDVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGV 718
SKLCHD+LVRPIGFVIYEDVALLLH +LPNG L QL+HESTK+P+Y+PDWP RLSIA+GV
Sbjct: 661 SKLCHDHLVRPIGFVIYEDVALLLHQHLPNGNLTQLIHESTKKPEYQPDWPMRLSIAVGV 720
Query: 719 AEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSKGTASISAVAGSFGYI 778
AEGLAFLH VAIIHLD+SS NVL+D+ +K +LGEIEISKLLDPS+GTASIS+VAGSFGYI
Sbjct: 721 AEGLAFLHQVAIIHLDVSSSNVLIDSGYKAVLGEIEISKLLDPSRGTASISSVAGSFGYI 780
Query: 779 PPEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQI 838
PPEYAYTMQVTAPGNVYSYGVVLLEILT+R PVEE+FGEGVDLVKWVHGA ARGETPEQI
Sbjct: 781 PPEYAYTMQVTAPGNVYSYGVVLLEILTSRAPVEEEFGEGVDLVKWVHGASARGETPEQI 840
Query: 839 LDARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEMLQEIKQ 887
LDA+LSTVSF WR+EML ALKVALLCTD TPAKRPKMKKVVEMLQE+KQ
Sbjct: 841 LDAKLSTVSFAWRREMLAALKVALLCTDITPAKRPKMKKVVEMLQEVKQ 889
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|110736557|dbj|BAF00244.1| putative receptor-like protein kinase [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 1385 bits (3586), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 688/888 (77%), Positives = 774/888 (87%), Gaps = 1/888 (0%)
Query: 1 MAFLCFFSILLLGVLSKSQLVFAQLNDEPTLLAINKELIVPGWGVNGTNFCNWKGIDCDL 60
M F C +L++G LSKS+L AQL+DE TL+AIN+EL VPGW NGT++C W G+ C +
Sbjct: 1 MTFWCMSILLIVGFLSKSELCEAQLSDEATLVAINRELGVPGWSSNGTDYCTWVGLKCGV 60
Query: 61 NQAFVVKLDLSRLQLRGNITLVSELKALKRLDLSNNAFSGTIPSAFGNLSELEFLDLSLN 120
N +FV LDLS LQLRGN+TL+S+L++LK LDLS N F+G IP++FGNLSELEFLDLSLN
Sbjct: 61 NNSFVEMLDLSGLQLRGNVTLISDLRSLKHLDLSGNNFNGRIPTSFGNLSELEFLDLSLN 120
Query: 121 KFGGVIPRELGSLKDLRFFNISNNVLVGEIPDELKSLEKLEDFQVSSNKLNGSIPFWVGN 180
+F G IP E G L+ LR FNISNN+LVGEIPDELK LE+LE+FQVS N LNGSIP WVGN
Sbjct: 121 RFVGAIPVEFGKLRGLRAFNISNNLLVGEIPDELKVLERLEEFQVSGNGLNGSIPHWVGN 180
Query: 181 LTNLRVFTAYENQLVGEIPDNLGSVSELELLNLHSNQLEGPIPKSIFASGKLEVLVLTQN 240
L++LRVFTAYEN LVGEIP+ LG VSELELLNLHSNQLEG IPK IF GKL+VLVLTQ+
Sbjct: 181 LSSLRVFTAYENDLVGEIPNGLGLVSELELLNLHSNQLEGKIPKGIFEKGKLKVLVLTQS 240
Query: 241 RLTGDIPELVGHCKSLSNIRIGNNDLVGVIPRAIGNVSGLTYFEADNNNLSGEIVPEFSQ 300
RLTG++PE VG C LS+IRIGNN+LVGVIPR IGN+SGLTYFEAD NNLSGEIV EFS+
Sbjct: 241 RLTGELPEAVGICSGLSSIRIGNNELVGVIPRTIGNISGLTYFEADKNNLSGEIVAEFSK 300
Query: 301 CSNLTLLNLASNGFTGVIPPELGQLINLQELILYENSLFGEIPKSILACKNLNKLDLSNN 360
CSNLTLLNLA+NGF G IP ELGQLINLQELIL NSLFGEIPKS L NLNKLDLSNN
Sbjct: 301 CSNLTLLNLAANGFAGTIPTELGQLINLQELILSGNSLFGEIPKSFLGSGNLNKLDLSNN 360
Query: 361 RFNGTIPNAICDMSRLQYLLLGQNSLKGEIPHEIGNCMKLLQLHIGSNYLTGSIPPEIGH 420
R NGTIP +C M RLQYLLL QNS++G+IPHEIGNC+KLLQL +G NYLTG+IPPEIG
Sbjct: 361 RLNGTIPKELCSMPRLQYLLLDQNSIRGDIPHEIGNCVKLLQLQLGRNYLTGTIPPEIGR 420
Query: 421 IRNLQIALNLSFNHLHGSLPPELGKLDKLVSFDVSNNQLSGTIPSALKGMLSLIEVNFSN 480
+RNLQIALNLSFNHLHGSLPPELGKLDKLVS DVSNN L+G+IP LKGM+SLIEVNFSN
Sbjct: 421 MRNLQIALNLSFNHLHGSLPPELGKLDKLVSLDVSNNLLTGSIPPLLKGMMSLIEVNFSN 480
Query: 481 NLLTGPVPSFVPFQKSPNSSFFGNKGLCGEPLSFSCGNANGPDSKNYRHRVSYRIILAVV 540
NLL GPVP FVPFQKSPNSSF GNK LCG PLS SCG + D Y HRVSYRI+LAV+
Sbjct: 481 NLLNGPVPVFVPFQKSPNSSFLGNKELCGAPLSSSCGYSEDLDHLRYNHRVSYRIVLAVI 540
Query: 541 GSGLAVFISVTVVVLLFMMRERQEK-ASKSADVADSGASSQPSIIAGNVLVENLRQAIDL 599
GSG+AVF+SVTVVVLLFMMRE+QEK A+K+ DV ++ QP+IIAGNV +ENL+Q IDL
Sbjct: 541 GSGVAVFVSVTVVVLLFMMREKQEKAAAKNVDVEENVEDEQPAIIAGNVFLENLKQGIDL 600
Query: 600 DAVVKATMKDSNMIYCGTFSTVYKAVMPSGLILSVKRLKSMDRTIIHHQNKMIRELEKLS 659
DAVVKATMK+SN + GTFS+VYKAVMPSG+I+SVK+LKSMDR I HHQNKMIRELE+LS
Sbjct: 601 DAVVKATMKESNKLSTGTFSSVYKAVMPSGMIVSVKKLKSMDRAISHHQNKMIRELERLS 660
Query: 660 KLCHDNLVRPIGFVIYEDVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVA 719
KLCHD+LVRPIGFVIYEDVALLLH +LPNG L QL+HESTK+P+Y+PDWP RLSIA+G A
Sbjct: 661 KLCHDHLVRPIGFVIYEDVALLLHQHLPNGNLTQLIHESTKKPEYQPDWPMRLSIAVGAA 720
Query: 720 EGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSKGTASISAVAGSFGYIP 779
EGLAFLH VAIIHLD+SS NVLLD+ +K +LGEIEISKLLDPS+GTASIS+VAGSFGYIP
Sbjct: 721 EGLAFLHQVAIIHLDVSSSNVLLDSGYKAVLGEIEISKLLDPSRGTASISSVAGSFGYIP 780
Query: 780 PEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQIL 839
PEYAYTMQVTAPGNVYSYGVVLLEILT+R PVEE+FG GVDLVKWVHGA ARGETPEQIL
Sbjct: 781 PEYAYTMQVTAPGNVYSYGVVLLEILTSRAPVEEEFGGGVDLVKWVHGASARGETPEQIL 840
Query: 840 DARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEMLQEIKQ 887
DA+LSTVSF WR+EML ALKVALLCTD TPAKRPKMKKVVEMLQE+KQ
Sbjct: 841 DAKLSTVSFAWRREMLAALKVALLCTDITPAKRPKMKKVVEMLQEVKQ 888
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356504789|ref|XP_003521177.1| PREDICTED: leucine-rich repeat receptor-like tyrosine-protein kinase At2g41820-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 1384 bits (3582), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 678/890 (76%), Positives = 779/890 (87%), Gaps = 4/890 (0%)
Query: 1 MAFLCFF-SILLLGVLSKSQLVFAQLNDEPTLLAINKELIVPGWGV-NGTNFCNWKGIDC 58
M FLC IL+ LS S+LV A+L D+ L AIN+EL VPGWG N +++CNW+G+ C
Sbjct: 1 MEFLCLLLYILVAWCLSSSELVGAELQDQDILHAINQELRVPGWGDGNNSDYCNWQGVSC 60
Query: 59 DLNQAFVVKLDLSRLQLRGNITLVSELKALKRLDLSNNAFSGTIPSAFGNLSELEFLDLS 118
N + V LDLS LRGN+TL+SELKALKRLDLSNN F G+IP+AFGNLS+LE LDL+
Sbjct: 61 G-NNSMVEGLDLSHRNLRGNVTLMSELKALKRLDLSNNNFDGSIPTAFGNLSDLEVLDLT 119
Query: 119 LNKFGGVIPRELGSLKDLRFFNISNNVLVGEIPDELKSLEKLEDFQVSSNKLNGSIPFWV 178
NKF G IP +LG L +L+ N+SNNVLVGEIP EL+ LEKL+DFQ+SSN L+G IP WV
Sbjct: 120 SNKFQGSIPPQLGGLTNLKSLNLSNNVLVGEIPMELQGLEKLQDFQISSNHLSGLIPSWV 179
Query: 179 GNLTNLRVFTAYENQLVGEIPDNLGSVSELELLNLHSNQLEGPIPKSIFASGKLEVLVLT 238
GNLTNLR+FTAYEN+L G IPD+LG +S+L++LNLHSNQLEGPIP SIF GKLEVLVLT
Sbjct: 180 GNLTNLRLFTAYENRLDGRIPDDLGLISDLQILNLHSNQLEGPIPASIFVPGKLEVLVLT 239
Query: 239 QNRLTGDIPELVGHCKSLSNIRIGNNDLVGVIPRAIGNVSGLTYFEADNNNLSGEIVPEF 298
QN +G +P+ +G+CK+LS+IRIGNN LVG IP+ IGN+S LTYFEADNNNLSGE+V EF
Sbjct: 240 QNNFSGALPKEIGNCKALSSIRIGNNHLVGTIPKTIGNLSSLTYFEADNNNLSGEVVSEF 299
Query: 299 SQCSNLTLLNLASNGFTGVIPPELGQLINLQELILYENSLFGEIPKSILACKNLNKLDLS 358
+QCSNLTLLNLASNGFTG IP + GQL+NLQELIL NSLFG+IP SIL+CK+LNKLD+S
Sbjct: 300 AQCSNLTLLNLASNGFTGTIPQDFGQLMNLQELILSGNSLFGDIPTSILSCKSLNKLDIS 359
Query: 359 NNRFNGTIPNAICDMSRLQYLLLGQNSLKGEIPHEIGNCMKLLQLHIGSNYLTGSIPPEI 418
NNRFNGTIPN IC++SRLQY+LL QN + GEIPHEIGNC KLL+L +GSN LTG IPPEI
Sbjct: 360 NNRFNGTIPNEICNISRLQYMLLDQNFITGEIPHEIGNCAKLLELQLGSNILTGGIPPEI 419
Query: 419 GHIRNLQIALNLSFNHLHGSLPPELGKLDKLVSFDVSNNQLSGTIPSALKGMLSLIEVNF 478
G IRNLQIALNLSFNHLHG LPPELGKLDKLVS DVSNN+LSG IP LKGMLSLIEVNF
Sbjct: 420 GRIRNLQIALNLSFNHLHGPLPPELGKLDKLVSLDVSNNRLSGNIPPELKGMLSLIEVNF 479
Query: 479 SNNLLTGPVPSFVPFQKSPNSSFFGNKGLCGEPLSFSCGNANGPDSKNYRHRVSYRIILA 538
SNNL GPVP+FVPFQKSP+SS+ GNKGLCGEPL+ SCG+ D K Y HRVSYRIILA
Sbjct: 480 SNNLFGGPVPTFVPFQKSPSSSYLGNKGLCGEPLNSSCGDLYD-DHKAYHHRVSYRIILA 538
Query: 539 VVGSGLAVFISVTVVVLLFMMRERQEKASKSADVADSGASSQPSIIAGNVLVENLRQAID 598
V+GSGLAVF+SVT+VVLLFM+RERQEK +K A + + G + P+IIAG + V+NL+QA+D
Sbjct: 539 VIGSGLAVFMSVTIVVLLFMIRERQEKVAKDAGIVEDGTNDNPTIIAGTIFVDNLKQAVD 598
Query: 599 LDAVVKATMKDSNMIYCGTFSTVYKAVMPSGLILSVKRLKSMDRTIIHHQNKMIRELEKL 658
LD VVKAT+KDSN + GTFSTVYKA+MPSG++LSV+RLKS+D+TIIHHQNKMIRELE+L
Sbjct: 599 LDVVVKATLKDSNKLSSGTFSTVYKAIMPSGVVLSVRRLKSVDKTIIHHQNKMIRELERL 658
Query: 659 SKLCHDNLVRPIGFVIYEDVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGV 718
SK+CH+NLVRPIG+VIYEDVALLLH+Y PNGTLAQLLHEST++P+Y+PDWP+RLSIAIGV
Sbjct: 659 SKVCHENLVRPIGYVIYEDVALLLHHYFPNGTLAQLLHESTRKPEYQPDWPSRLSIAIGV 718
Query: 719 AEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSKGTASISAVAGSFGYI 778
AEGLAFLHHVAIIHLDISSGNVLLDA+ KP++ EIEISKLLDP+KGTASISAVAGSFGYI
Sbjct: 719 AEGLAFLHHVAIIHLDISSGNVLLDANSKPVVAEIEISKLLDPTKGTASISAVAGSFGYI 778
Query: 779 PPEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQI 838
PPEYAYTMQVTAPGNVYSYGVVLLEILTTRLPV+EDFGEGVDLVKWVH AP RGETPEQI
Sbjct: 779 PPEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVDEDFGEGVDLVKWVHSAPVRGETPEQI 838
Query: 839 LDARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEMLQEIKQN 888
LDA+LSTVSFGWRKEML ALKVALLCTD+TPAKRPKMK VVEML+EIK+N
Sbjct: 839 LDAKLSTVSFGWRKEMLAALKVALLCTDNTPAKRPKMKNVVEMLREIKEN 888
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449463364|ref|XP_004149404.1| PREDICTED: leucine-rich repeat receptor-like tyrosine-protein kinase At2g41820-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 1363 bits (3529), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 666/892 (74%), Positives = 778/892 (87%), Gaps = 4/892 (0%)
Query: 1 MAFLCFFSI---LLLGVLSKSQLVFAQLNDEPTLLAINKELIVPGWGVNGTNFCNWKGID 57
MAFLCF S+ L++G+LS SQ + AQL+D+ T+ I +EL VPGW + + +C+WKG+
Sbjct: 1 MAFLCFCSLSIFLVVGLLSNSQFLGAQLDDQITMSTIREELQVPGWSSSISEYCSWKGVH 60
Query: 58 CDLNQAFVVKLDLSRLQLRGNITLVSELKALKRLDLSNNAFSGTIPSAFGNLSELEFLDL 117
C LN + V LDLS LR N+T++SELKALK LDLS N F G IP +F L ELEFLDL
Sbjct: 61 CGLNHSMVETLDLSGRSLRANLTMISELKALKWLDLSYNDFHGEIPLSFAKLPELEFLDL 120
Query: 118 SLNKFGGVIPRELGSLKDLRFFNISNNVLVGEIPDELKSLEKLEDFQVSSNKLNGSIPFW 177
S NKF G IP + G LK+L+ N+SNN+LVGEIPDEL+ LEKL+DFQ+SSN+LNGSIP W
Sbjct: 121 SSNKFDGSIPPQFGDLKNLKSLNLSNNLLVGEIPDELQGLEKLQDFQISSNRLNGSIPSW 180
Query: 178 VGNLTNLRVFTAYENQLVGEIPDNLGSVSELELLNLHSNQLEGPIPKSIFASGKLEVLVL 237
VGNL++LR+FTAYEN G IPDNLGSVS L++LNLH+N+LEG IP+SIFASGKLE+LVL
Sbjct: 181 VGNLSHLRLFTAYENNFDGMIPDNLGSVSALQVLNLHTNRLEGSIPRSIFASGKLEILVL 240
Query: 238 TQNRLTGDIPELVGHCKSLSNIRIGNNDLVGVIPRAIGNVSGLTYFEADNNNLSGEIVPE 297
TQNRLTG++PE +G+C+ L+++RIGNN+LVGVIP AIGNV+ L YFE DNN+LSG+I +
Sbjct: 241 TQNRLTGNLPEEIGNCQRLTSVRIGNNNLVGVIPPAIGNVTSLAYFEVDNNHLSGDIASQ 300
Query: 298 FSQCSNLTLLNLASNGFTGVIPPELGQLINLQELILYENSLFGEIPKSILACKNLNKLDL 357
FS+CSNLTLLNLASNGFTG+IPPELG+L+NLQELIL NSL+G+IP S+L CKNLNKLDL
Sbjct: 301 FSRCSNLTLLNLASNGFTGMIPPELGELMNLQELILSGNSLYGDIPGSMLECKNLNKLDL 360
Query: 358 SNNRFNGTIPNAICDMSRLQYLLLGQNSLKGEIPHEIGNCMKLLQLHIGSNYLTGSIPPE 417
S+NRFNGTIP+ IC++SRLQYLLL QNS+KGEIP+EIG C KLL L +GSNYLTGSIP E
Sbjct: 361 SSNRFNGTIPSDICNISRLQYLLLEQNSIKGEIPNEIGKCTKLLDLRLGSNYLTGSIPSE 420
Query: 418 IGHIRNLQIALNLSFNHLHGSLPPELGKLDKLVSFDVSNNQLSGTIPSALKGMLSLIEVN 477
IG I+NLQIALNLSFNHL+G +PPELG+LDKLV+ D+SNN LSG IPS LKGMLSLIEVN
Sbjct: 421 IGRIKNLQIALNLSFNHLNGPVPPELGRLDKLVTLDLSNNHLSGDIPSELKGMLSLIEVN 480
Query: 478 FSNNLLTGPVPSFVPFQKSPNSSFFGNKGLCGEPLSFSCGNANGPDSKNYRHRVSYRIIL 537
FSNNLLTG +P FVPFQKS NSSF GN+GLCG PLS +C N+ GP +++Y H+VSY+IIL
Sbjct: 481 FSNNLLTGSIPFFVPFQKSANSSFLGNEGLCGAPLSITCKNSIGPYNQDYHHKVSYKIIL 540
Query: 538 AVVGSGLAVFISVTVVVLLFMMRERQEKASKSADVADSGA-SSQPSIIAGNVLVENLRQA 596
AV+GSGLAVF+SVT+VVLLF+M+E+QEKA+KS+ AD + QP IIAGNV +NL+Q
Sbjct: 541 AVIGSGLAVFVSVTIVVLLFVMKEKQEKAAKSSGTADDETINDQPPIIAGNVFDDNLQQE 600
Query: 597 IDLDAVVKATMKDSNMIYCGTFSTVYKAVMPSGLILSVKRLKSMDRTIIHHQNKMIRELE 656
IDLDAVVKAT+KDSN + GTFSTVYKA+MPSG+I+SVKRLKSMD+TIIHHQ+KMIRELE
Sbjct: 601 IDLDAVVKATLKDSNKLIFGTFSTVYKAIMPSGMIISVKRLKSMDKTIIHHQSKMIRELE 660
Query: 657 KLSKLCHDNLVRPIGFVIYEDVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAI 716
+L KL H NL++ IG+VIYEDVALLLHNYL NGTLAQLLHESTKQP+Y PDWPTR SIAI
Sbjct: 661 RLGKLNHANLLQLIGYVIYEDVALLLHNYLTNGTLAQLLHESTKQPEYDPDWPTRFSIAI 720
Query: 717 GVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSKGTASISAVAGSFG 776
G AEGLAFLHHVAIIHLDISS NV LDA+FKPL+GE+EISKLLDPS+GTASISAVAGSFG
Sbjct: 721 GAAEGLAFLHHVAIIHLDISSSNVFLDANFKPLVGEVEISKLLDPSRGTASISAVAGSFG 780
Query: 777 YIPPEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPE 836
YIPPEYAYTMQVTAPGNVYSYGV+LLEILTTRLPV+E+FGEGVDLVKWVH AP+RGETPE
Sbjct: 781 YIPPEYAYTMQVTAPGNVYSYGVILLEILTTRLPVDEEFGEGVDLVKWVHTAPSRGETPE 840
Query: 837 QILDARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEMLQEIKQN 888
QILD+RLSTVSFGWRKEML ALK+ALLCTDS PAKRPKMKKVVEML EIKQN
Sbjct: 841 QILDSRLSTVSFGWRKEMLAALKIALLCTDSIPAKRPKMKKVVEMLSEIKQN 892
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|449510553|ref|XP_004163697.1| PREDICTED: LOW QUALITY PROTEIN: leucine-rich repeat receptor-like tyrosine-protein kinase At2g41820-like [Cucumis sativus] | Back alignment and taxonomy information |
|---|
Score = 1362 bits (3526), Expect = 0.0, Method: Compositional matrix adjust.
Identities = 666/892 (74%), Positives = 777/892 (87%), Gaps = 4/892 (0%)
Query: 1 MAFLCF---FSILLLGVLSKSQLVFAQLNDEPTLLAINKELIVPGWGVNGTNFCNWKGID 57
MAFLCF F L++G+LS SQ + AQL+D+ T+ I +EL VPGW + + +C+WKG+
Sbjct: 1 MAFLCFCSLFIFLVVGLLSNSQFLGAQLDDQITMSTIREELQVPGWSSSISEYCSWKGVH 60
Query: 58 CDLNQAFVVKLDLSRLQLRGNITLVSELKALKRLDLSNNAFSGTIPSAFGNLSELEFLDL 117
C LN + V LDLS LRGN+T++SELKALK LDLS N F G IP +F L ELEFLDL
Sbjct: 61 CGLNHSMVETLDLSGRSLRGNLTMISELKALKWLDLSYNDFHGEIPLSFAKLPELEFLDL 120
Query: 118 SLNKFGGVIPRELGSLKDLRFFNISNNVLVGEIPDELKSLEKLEDFQVSSNKLNGSIPFW 177
S NKF G IP + LK+L+ N+SNN+LVGEIPDEL+ LEKL+DFQ+SSN+LNGSIP W
Sbjct: 121 SSNKFDGSIPPQFXDLKNLKSLNLSNNLLVGEIPDELQGLEKLQDFQISSNRLNGSIPSW 180
Query: 178 VGNLTNLRVFTAYENQLVGEIPDNLGSVSELELLNLHSNQLEGPIPKSIFASGKLEVLVL 237
VGNL++LR+FTAYEN G IPDNLGSVS L++LNLH+N+LEG IP+SIFASGKLE+LVL
Sbjct: 181 VGNLSHLRLFTAYENNFDGMIPDNLGSVSALQVLNLHTNRLEGSIPRSIFASGKLEILVL 240
Query: 238 TQNRLTGDIPELVGHCKSLSNIRIGNNDLVGVIPRAIGNVSGLTYFEADNNNLSGEIVPE 297
TQNRLTG++PE +G+C+ L+++RIGNN+LVGVIP AIGNV+ L YFE DNN+LSG+I +
Sbjct: 241 TQNRLTGNLPEEIGNCQRLTSVRIGNNNLVGVIPPAIGNVTSLAYFEVDNNHLSGDIASQ 300
Query: 298 FSQCSNLTLLNLASNGFTGVIPPELGQLINLQELILYENSLFGEIPKSILACKNLNKLDL 357
FS+CSNLTLLNLASNGFTG+IPPELG+L+NLQELIL NSL+G+IP S+L CKNLNKLDL
Sbjct: 301 FSRCSNLTLLNLASNGFTGMIPPELGELMNLQELILSGNSLYGDIPGSMLECKNLNKLDL 360
Query: 358 SNNRFNGTIPNAICDMSRLQYLLLGQNSLKGEIPHEIGNCMKLLQLHIGSNYLTGSIPPE 417
S+NRFNGTIP+ IC++SRLQYLLL QNS+KGEIP+EIG C KLL L +GSNYLTGSIP E
Sbjct: 361 SSNRFNGTIPSDICNISRLQYLLLEQNSIKGEIPNEIGKCTKLLDLRLGSNYLTGSIPSE 420
Query: 418 IGHIRNLQIALNLSFNHLHGSLPPELGKLDKLVSFDVSNNQLSGTIPSALKGMLSLIEVN 477
IG I+NLQIALNLSFNHL+G +PPELG+LDKLV+ D+SNN LSG IPS LKGMLSLIEVN
Sbjct: 421 IGRIKNLQIALNLSFNHLNGPVPPELGRLDKLVTLDLSNNHLSGDIPSELKGMLSLIEVN 480
Query: 478 FSNNLLTGPVPSFVPFQKSPNSSFFGNKGLCGEPLSFSCGNANGPDSKNYRHRVSYRIIL 537
FSNNLLTG +P FVPFQKS NSSF GN+GLCG PLS +C N+ GP +++Y H+VSY+IIL
Sbjct: 481 FSNNLLTGSIPFFVPFQKSANSSFLGNEGLCGAPLSITCKNSIGPYNQDYHHKVSYKIIL 540
Query: 538 AVVGSGLAVFISVTVVVLLFMMRERQEKASKSADVADSGA-SSQPSIIAGNVLVENLRQA 596
AV+GSGLAVF+SVT+VVLLF+M+E+QEKA+KS+ AD + QP IIAGNV +NL+Q
Sbjct: 541 AVIGSGLAVFVSVTIVVLLFVMKEKQEKAAKSSGTADDETINDQPPIIAGNVFDDNLQQE 600
Query: 597 IDLDAVVKATMKDSNMIYCGTFSTVYKAVMPSGLILSVKRLKSMDRTIIHHQNKMIRELE 656
IDLDAVVKAT+KDSN + GTFSTVYKA+MPSG+I+SVKRLKSMD+TIIHHQ+KMIRELE
Sbjct: 601 IDLDAVVKATLKDSNKLIFGTFSTVYKAIMPSGMIISVKRLKSMDKTIIHHQSKMIRELE 660
Query: 657 KLSKLCHDNLVRPIGFVIYEDVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAI 716
+L KL H NL++ IG+VIYEDVALLLHNYL NGTLAQLLHESTKQP+Y PDWPTR SIAI
Sbjct: 661 RLGKLNHANLLQLIGYVIYEDVALLLHNYLTNGTLAQLLHESTKQPEYDPDWPTRFSIAI 720
Query: 717 GVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSKGTASISAVAGSFG 776
G AEGLAFLHHVAIIHLDISS NV LDA+FKPL+GE+EISKLLDPS+GTASISAVAGSFG
Sbjct: 721 GAAEGLAFLHHVAIIHLDISSSNVFLDANFKPLVGEVEISKLLDPSRGTASISAVAGSFG 780
Query: 777 YIPPEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPE 836
YIPPEYAYTMQVTAPGNVYSYGV+LLEILTTRLPV+E+FGEGVDLVKWVH AP+RGETPE
Sbjct: 781 YIPPEYAYTMQVTAPGNVYSYGVILLEILTTRLPVDEEFGEGVDLVKWVHTAPSRGETPE 840
Query: 837 QILDARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEMLQEIKQN 888
QILD+RLSTVSFGWRKEML ALK+ALLCTDS PAKRPKMKKVVEML EIKQN
Sbjct: 841 QILDSRLSTVSFGWRKEMLAALKIALLCTDSIPAKRPKMKKVVEMLSEIKQN 892
|
Source: Cucumis sativus Species: Cucumis sativus Genus: Cucumis Family: Cucurbitaceae Order: Cucurbitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 888 | ||||||
| TAIR|locus:2054421 | 890 | AT2G41820 [Arabidopsis thalian | 0.998 | 0.996 | 0.777 | 0.0 | |
| TAIR|locus:2160791 | 1102 | AT5G63930 [Arabidopsis thalian | 0.959 | 0.773 | 0.375 | 2.8e-137 | |
| TAIR|locus:2046525 | 1124 | AT2G33170 [Arabidopsis thalian | 0.889 | 0.702 | 0.388 | 2.3e-135 | |
| TAIR|locus:2020417 | 1101 | AT1G17230 [Arabidopsis thalian | 0.885 | 0.713 | 0.380 | 4.8e-133 | |
| TAIR|locus:2009288 | 966 | AT1G34420 [Arabidopsis thalian | 0.894 | 0.821 | 0.381 | 1e-130 | |
| TAIR|locus:2156349 | 1252 | GSO2 "GASSHO 2" [Arabidopsis t | 0.897 | 0.636 | 0.355 | 2.8e-121 | |
| TAIR|locus:2032697 | 1123 | PEPR1 "PEP1 receptor 1" [Arabi | 0.886 | 0.700 | 0.356 | 3.2e-120 | |
| TAIR|locus:2085949 | 1141 | AT3G24240 [Arabidopsis thalian | 0.870 | 0.677 | 0.357 | 1.4e-119 | |
| TAIR|locus:2161158 | 1041 | PXY "PHLOEM INTERCALATED WITH | 0.929 | 0.792 | 0.341 | 4.7e-119 | |
| TAIR|locus:2097310 | 1002 | BAM2 "BARELY ANY MERISTEM 2" [ | 0.547 | 0.485 | 0.344 | 5.6e-119 |
| TAIR|locus:2054421 AT2G41820 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 3572 (1262.5 bits), Expect = 0., P = 0.
Identities = 690/888 (77%), Positives = 775/888 (87%)
Query: 1 MAFLCFFSILLLGVLSKSQLVFAQLNDEPTLLAINKELIVPGWGVNGTNFCNWKGIDCDL 60
M F C +L++G LSKS+L AQL+DE TL+AIN+EL VPGW NGT++C W G+ C +
Sbjct: 1 MTFWCMSILLIVGFLSKSELCEAQLSDEATLVAINRELGVPGWSSNGTDYCTWVGLKCGV 60
Query: 61 NQAFVVKLDLSRLQLRGNITLVSELKALKRLDLSNNAFSGTIPSAFGNLSELEFLDLSLN 120
N +FV LDLS LQLRGN+TL+S+L++LK LDLS N F+G IP++FGNLSELEFLDLSLN
Sbjct: 61 NNSFVEMLDLSGLQLRGNVTLISDLRSLKHLDLSGNNFNGRIPTSFGNLSELEFLDLSLN 120
Query: 121 KFGGVIPRELGSLKDLRFFNISNNVLVGEIPDELKSLEKLEDFQVSSNKLNGSIPFWVGN 180
+F G IP E G L+ LR FNISNN+LVGEIPDELK LE+LE+FQVS N LNGSIP WVGN
Sbjct: 121 RFVGAIPVEFGKLRGLRAFNISNNLLVGEIPDELKVLERLEEFQVSGNGLNGSIPHWVGN 180
Query: 181 LTNLRVFTAYENQLVGEIPDNLGSVSELELLNLHSNQLEGPIPKSIFASGKLEVLVLTQN 240
L++LRVFTAYEN LVGEIP+ LG VSELELLNLHSNQLEG IPK IF GKL+VLVLTQN
Sbjct: 181 LSSLRVFTAYENDLVGEIPNGLGLVSELELLNLHSNQLEGKIPKGIFEKGKLKVLVLTQN 240
Query: 241 RLTGDIPELVGHCKSLSNIRIGNNDLVGVIPRAIGNVSGLTYFEADNNNLSGEIVPEFSQ 300
RLTG++PE VG C LS+IRIGNN+LVGVIPR IGN+SGLTYFEAD NNLSGEIV EFS+
Sbjct: 241 RLTGELPEAVGICSGLSSIRIGNNELVGVIPRTIGNISGLTYFEADKNNLSGEIVAEFSK 300
Query: 301 CSNLTLLNLASNGFTGVIPPELGQLINLQELILYENSLFGEIPKSILACKNLNKLDLSNN 360
CSNLTLLNLA+NGF G IP ELGQLINLQELIL NSLFGEIPKS L NLNKLDLSNN
Sbjct: 301 CSNLTLLNLAANGFAGTIPTELGQLINLQELILSGNSLFGEIPKSFLGSGNLNKLDLSNN 360
Query: 361 RFNGTIPNAICDMSRLQYLLLGQNSLKGEIPHEIGNCMKLLQLHIGSNYLTGSIPPEIGH 420
R NGTIP +C M RLQYLLL QNS++G+IPHEIGNC+KLLQL +G NYLTG+IPPEIG
Sbjct: 361 RLNGTIPKELCSMPRLQYLLLDQNSIRGDIPHEIGNCVKLLQLQLGRNYLTGTIPPEIGR 420
Query: 421 IRNLQIALNLSFNHLHGSLPPELGKLDKLVSFDVSNNQLSGTIPSALKGMLSLIEVNFSN 480
+RNLQIALNLSFNHLHGSLPPELGKLDKLVS DVSNN L+G+IP LKGM+SLIEVNFSN
Sbjct: 421 MRNLQIALNLSFNHLHGSLPPELGKLDKLVSLDVSNNLLTGSIPPLLKGMMSLIEVNFSN 480
Query: 481 NLLTGPVPSFVPFQKSPNSSFFGNKGLCGEPLSFSCGNANGPDSKNYRHRVSYRIILAVV 540
NLL GPVP FVPFQKSPNSSF GNK LCG PLS SCG + D Y HRVSYRI+LAV+
Sbjct: 481 NLLNGPVPVFVPFQKSPNSSFLGNKELCGAPLSSSCGYSEDLDHLRYNHRVSYRIVLAVI 540
Query: 541 GSGLAVFISVTVVVLLFMMRERQEKAS-KSADVADSGASSQPSIIAGNVLVENLRQAIDL 599
GSG+AVF+SVTVVVLLFMMRE+QEKA+ K+ DV ++ QP+IIAGNV +ENL+Q IDL
Sbjct: 541 GSGVAVFVSVTVVVLLFMMREKQEKAAAKNVDVEENVEDEQPAIIAGNVFLENLKQGIDL 600
Query: 600 DAVVKATMKDSNMIYCGTFSTVYKAVMPSGLILSVKRLKSMDRTIIHHQNKMIRELEKLS 659
DAVVKATMK+SN + GTFS+VYKAVMPSG+I+SVK+LKSMDR I HHQNKMIRELE+LS
Sbjct: 601 DAVVKATMKESNKLSTGTFSSVYKAVMPSGMIVSVKKLKSMDRAISHHQNKMIRELERLS 660
Query: 660 KLCHDNLVRPIGFVIYEDVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVA 719
KLCHD+LVRPIGFVIYEDVALLLH +LPNG L QL+HESTK+P+Y+PDWP RLSIA+G A
Sbjct: 661 KLCHDHLVRPIGFVIYEDVALLLHQHLPNGNLTQLIHESTKKPEYQPDWPMRLSIAVGAA 720
Query: 720 EGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSKGTASISAVAGSFGYIP 779
EGLAFLH VAIIHLD+SS NVLLD+ +K +LGEIEISKLLDPS+GTASIS+VAGSFGYIP
Sbjct: 721 EGLAFLHQVAIIHLDVSSSNVLLDSGYKAVLGEIEISKLLDPSRGTASISSVAGSFGYIP 780
Query: 780 PEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQIL 839
PEYAYTMQVTAPGNVYSYGVVLLEILT+R PVEE+FGEGVDLVKWVHGA ARGETPEQIL
Sbjct: 781 PEYAYTMQVTAPGNVYSYGVVLLEILTSRAPVEEEFGEGVDLVKWVHGASARGETPEQIL 840
Query: 840 DARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEMLQEIKQ 887
DA+LSTVSF WR+EML ALKVALLCTD TPAKRPKMKKVVEMLQE+KQ
Sbjct: 841 DAKLSTVSFAWRREMLAALKVALLCTDITPAKRPKMKKVVEMLQEVKQ 888
|
|
| TAIR|locus:2160791 AT5G63930 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1344 (478.2 bits), Expect = 2.8e-137, P = 2.8e-137
Identities = 336/896 (37%), Positives = 490/896 (54%)
Query: 8 SILLLGVLSKSQLVFAQLNDEPTLLAINKELIVPGWGVNGTNFCNWKGIDCDLNQAFVVK 67
S+++LG L+++QL +L E +L ++I+ W + F + +C +
Sbjct: 218 SLVMLG-LAQNQLS-GELPKEIGMLKKLSQVIL--WENEFSGFIPREISNCTSLET---- 269
Query: 68 LDLSRLQLRGNITL-VSELKALKRLDLSNNAFSGTIPSAFGNLSELEFLDLSLNKFGGVI 126
L L + QL G I + +L++L+ L L N +GTIP GNLS +D S N G I
Sbjct: 270 LALYKNQLVGPIPKELGDLQSLEFLYLYRNGLNGTIPREIGNLSYAIEIDFSENALTGEI 329
Query: 127 PRELGSLKDLRFFNISNNVLVGEIPDELKSLEKLEDFQVSSNKLNGSIPFWVGNLTNLRV 186
P ELG+++ L + N L G IP EL +L+ L +S N L G IP L L +
Sbjct: 330 PLELGNIEGLELLYLFENQLTGTIPVELSTLKNLSKLDLSINALTGPIPLGFQYLRGLFM 389
Query: 187 FTAYENQLVGEIPDNLGSVSELELLNLHSNQLEGPIPKSIFASGKLEVLVLTQNRLTGDI 246
++N L G IP LG S+L +L++ N L G IP + + +L L N L+G+I
Sbjct: 390 LQLFQNSLSGTIPPKLGWYSDLWVLDMSDNHLSGRIPSYLCLHSNMIILNLGTNNLSGNI 449
Query: 247 PELVGHCKSLSNIRIGNNDLVGVIPRAIGNVSGLTYFEADNNNLSGEIVPEFSQCSNLTL 306
P + CK+L +R+ N+LVG P + +T E N G I E CS L
Sbjct: 450 PTGITTCKTLVQLRLARNNLVGRFPSNLCKQVNVTAIELGQNRFRGSIPREVGNCSALQR 509
Query: 307 LNLASNGFTGVIPPELGQLINLQELILYENSLFGEIPKSILACKNLNKLDLSNNRFNGTI 366
L LA NGFTG +P E+G L L L + N L GE+P I CK L +LD+ N F+GT+
Sbjct: 510 LQLADNGFTGELPREIGMLSQLGTLNISSNKLTGEVPSEIFNCKMLQRLDMCCNNFSGTL 569
Query: 367 PNAICDMSRLQYLLLGQNSLKGEIPHEIGNCMKLLQLHIGSNYLTGSIPPEIGHIRNLQI 426
P+ + + +L+ L L N+L G IP +GN +L +L +G N GSIP E+G + LQI
Sbjct: 570 PSEVGSLYQLELLKLSNNNLSGTIPVALGNLSRLTELQMGGNLFNGSIPRELGSLTGLQI 629
Query: 427 ALNLSFNHLHGSLPPELGKLDKLVSFDVSNNQLSGTIPSALKGMLSLIEVNFSNNLLTGP 486
ALNLS+N L G +PPEL L L ++NN LSG IPS+ + SL+ NFS N LTGP
Sbjct: 630 ALNLSYNKLTGEIPPELSNLVMLEFLLLNNNNLSGEIPSSFANLSSLLGYNFSYNSLTGP 689
Query: 487 VPSFVPFQKSPNSSFFGNKGLCGEPLS-------FSCGNANGPDSKNYRHRVSYRIILAV 539
+P + SSF GN+GLCG PL+ F+ + G R I AV
Sbjct: 690 IPLL---RNISMSSFIGNEGLCGPPLNQCIQTQPFAPSQSTGKPG-GMRSSKIIAITAAV 745
Query: 540 VGSGLAVFISVTVVVLLFMMRERQEKASKSADVADSGASSQPSIIAGNVLVENLRQAIDL 599
+G G+++ + + +++++MR R + VA S QPS ++ ++ ++
Sbjct: 746 IG-GVSLML---IALIVYLMR-RPVRT-----VASSAQDGQPSEMSLDIYFPP-KEGFTF 794
Query: 600 DAVVKAT--MKDSNMIYCGTFSTVYKAVMPSGLILSVKRLKSMDRTIIHHQ--NKMIREL 655
+V AT +S ++ G TVYKAV+P+G L+VK+L S ++ N E+
Sbjct: 795 QDLVAATDNFDESFVVGRGACGTVYKAVLPAGYTLAVKKLASNHEGGNNNNVDNSFRAEI 854
Query: 656 EKLSKLCHDNLVRPIGFVIYEDVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIA 715
L + H N+V+ GF ++ LLL+ Y+P G+L ++LH+ P DW R IA
Sbjct: 855 LTLGNIRHRNIVKLHGFCNHQGSNLLLYEYMPKGSLGEILHD----PSCNLDWSKRFKIA 910
Query: 716 IGVAEGLAFLHHVA---IIHLDISSGNVLLDADFKPLLGEIEISKLLDPSKGTASISAVA 772
+G A+GLA+LHH I H DI S N+LLD F+ +G+ ++K++D + S+SA+A
Sbjct: 911 LGAAQGLAYLHHDCKPRIFHRDIKSNNILLDDKFEAHVGDFGLAKVIDMPH-SKSMSAIA 969
Query: 773 GSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARG 832
GS+GYI PEYAYTM+VT ++YSYGVVLLE+LT + PV+ +G D+V WV R
Sbjct: 970 GSYGYIAPEYAYTMKVTEKSDIYSYGVVLLELLTGKAPVQP-IDQGGDVVNWVRSYIRRD 1028
Query: 833 ETPEQILDARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEMLQEIKQN 888
+LDARL+ MLT LK+ALLCT +P RP M++VV ML E +++
Sbjct: 1029 ALSSGVLDARLTLEDERIVSHMLTVLKIALLCTSVSPVARPSMRQVVLMLIESERS 1084
|
|
| TAIR|locus:2046525 AT2G33170 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1326 (471.8 bits), Expect = 2.3e-135, P = 2.3e-135
Identities = 318/818 (38%), Positives = 453/818 (55%)
Query: 82 VSELKALKRLDLSNNAFSGTIPSAFGNLSELEFLDLSLNKFGGVIPRELGSLKDLRFFNI 141
+ +K+LK+L L N +GTIP G LS++ +D S N G IP EL + +LR +
Sbjct: 297 IGNMKSLKKLYLYQNQLNGTIPKELGKLSKVMEIDFSENLLSGEIPVELSKISELRLLYL 356
Query: 142 SNNVLVGEIPDELKSLEKLEDFQVSSNKLNGSIPFWVGNLTNLRVFTAYENQLVGEIPDN 201
N L G IP+EL L L +S N L G IP NLT++R + N L G IP
Sbjct: 357 FQNKLTGIIPNELSKLRNLAKLDLSINSLTGPIPPGFQNLTSMRQLQLFHNSLSGVIPQG 416
Query: 202 LGSVSELELLNLHSNQLEGPIPKSIFASGKLEVLVLTQNRLTGDIPELVGHCKSLSNIRI 261
LG S L +++ NQL G IP I L +L L NR+ G+IP V CKSL +R+
Sbjct: 417 LGLYSPLWVVDFSENQLSGKIPPFICQQSNLILLNLGSNRIFGNIPPGVLRCKSLLQLRV 476
Query: 262 GNNDLVGVIPRAIGNVSGLTYFEADNNNLSGEIVPEFSQCSNLTLLNLASNGFTGVIPPE 321
N L G P + + L+ E D N SG + PE C L L+LA+N F+ +P E
Sbjct: 477 VGNRLTGQFPTELCKLVNLSAIELDQNRFSGPLPPEIGTCQKLQRLHLAANQFSSNLPNE 536
Query: 322 LGQLINLQELILYENSLFGEIPKSILACKNLNKLDLSNNRFNGTIPNAICDMSRLQYLLL 381
+ +L NL + NSL G IP I CK L +LDLS N F G++P + + +L+ L L
Sbjct: 537 ISKLSNLVTFNVSSNSLTGPIPSEIANCKMLQRLDLSRNSFIGSLPPELGSLHQLEILRL 596
Query: 382 GQNSLKGEIPHEIGNCMKLLQLHIGSNYLTGSIPPEIGHIRNLQIALNLSFNHLHGSLPP 441
+N G IP IGN L +L +G N +GSIPP++G + +LQIA+NLS+N G +PP
Sbjct: 597 SENRFSGNIPFTIGNLTHLTELQMGGNLFSGSIPPQLGLLSSLQIAMNLSYNDFSGEIPP 656
Query: 442 ELGKLDKLVSFDVSNNQLSGTIPSALKGMLSLIEVNFSNNLLTGPVPSFVPFQKSPNSSF 501
E+G L L+ ++NN LSG IP+ + + SL+ NFS N LTG +P FQ +SF
Sbjct: 657 EIGNLHLLMYLSLNNNHLSGEIPTTFENLSSLLGCNFSYNNLTGQLPHTQIFQNMTLTSF 716
Query: 502 FGNKGLCGEPLSFSC--GNANGPDSKNYRHRVSYR-IILAVVGSGLAVFISVTVVVLLFM 558
GNKGLCG L SC +++ P + + + R I+ +V S + + + +++
Sbjct: 717 LGNKGLCGGHLR-SCDPSHSSWPHISSLKAGSARRGRIIIIVSSVIGGISLLLIAIVVHF 775
Query: 559 MRERQEKASKSADVADSGASSQPSIIAGNVLVENLRQAIDLDAVVKAT--MKDSNMIYCG 616
+R E + V D Q S I V R + D +++AT DS ++ G
Sbjct: 776 LRNPVEPTAPY--VHDKEPFFQESDI---YFVPKERFTVK-D-ILEATKGFHDSYIVGRG 828
Query: 617 TFSTVYKAVMPSGLILSVKRLKSM----DRTIIHHQNKMIRELEKLSKLCHDNLVRPIGF 672
TVYKAVMPSG ++VK+L+S + + N E+ L K+ H N+VR F
Sbjct: 829 ACGTVYKAVMPSGKTIAVKKLESNREGNNNNSNNTDNSFRAEILTLGKIRHRNIVRLYSF 888
Query: 673 VIYE--DVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVA- 729
++ + LLL+ Y+ G+L +LLH + DWPTR +IA+G AEGLA+LHH
Sbjct: 889 CYHQGSNSNLLLYEYMSRGSLGELLHGGKS---HSMDWPTRFAIALGAAEGLAYLHHDCK 945
Query: 730 --IIHLDISSGNVLLDADFKPLLGEIEISKLLDPSKGTASISAVAGSFGYIPPEYAYTMQ 787
IIH DI S N+L+D +F+ +G+ ++K++D + S+SAVAGS+GYI PEYAYTM+
Sbjct: 946 PRIIHRDIKSNNILIDENFEAHVGDFGLAKVIDMPL-SKSVSAVAGSYGYIAPEYAYTMK 1004
Query: 788 VTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQILDARLSTVS 847
VT ++YS+GVVLLE+LT + PV+ +G DL W +ILD L+ V
Sbjct: 1005 VTEKCDIYSFGVVLLELLTGKAPVQP-LEQGGDLATWTRNHIRDHSLTSEILDPYLTKVE 1063
Query: 848 FGW-RKEMLTALKVALLCTDSTPAKRPKMKKVVEMLQE 884
M+T K+A+LCT S+P+ RP M++VV ML E
Sbjct: 1064 DDVILNHMITVTKIAVLCTKSSPSDRPTMREVVLMLIE 1101
|
|
| TAIR|locus:2020417 AT1G17230 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1304 (464.1 bits), Expect = 4.8e-133, P = 4.8e-133
Identities = 311/817 (38%), Positives = 460/817 (56%)
Query: 82 VSELKALKRLDLSNNAFSGTIPSAFGNLSELEFLDLSLNKFGGVIPRELGSLKDLRFFNI 141
+ +L +KRL L N +G IP GNL + +D S N+ G IP+E G + +L+ ++
Sbjct: 279 IGKLTKMKRLYLYTNQLTGEIPREIGNLIDAAEIDFSENQLTGFIPKEFGHILNLKLLHL 338
Query: 142 SNNVLVGEIPDELKSLEKLEDFQVSSNKLNGSIPFWVGNLTNLRVFTAYENQLVGEIPDN 201
N+L+G IP EL L LE +S N+LNG+IP + L L ++NQL G+IP
Sbjct: 339 FENILLGPIPRELGELTLLEKLDLSINRLNGTIPQELQFLPYLVDLQLFDNQLEGKIPPL 398
Query: 202 LGSVSELELLNLHSNQLEGPIPKSIFASGKLEVLVLTQNRLTGDIPELVGHCKSLSNIRI 261
+G S +L++ +N L GPIP L +L L N+L+G+IP + CKSL+ + +
Sbjct: 399 IGFYSNFSVLDMSANSLSGPIPAHFCRFQTLILLSLGSNKLSGNIPRDLKTCKSLTKLML 458
Query: 262 GNNDLVGVIPRAIGNVSGLTYFEADNNNLSGEIVPEFSQCSNLTLLNLASNGFTGVIPPE 321
G+N L G +P + N+ LT E N LSG I + + NL L LA+N FTG IPPE
Sbjct: 459 GDNQLTGSLPIELFNLQNLTALELHQNWLSGNISADLGKLKNLERLRLANNNFTGEIPPE 518
Query: 322 LGQLINLQELILYENSLFGEIPKSILACKNLNKLDLSNNRFNGTIPNAICDMSRLQYLLL 381
+G L + + N L G IPK + +C + +LDLS N+F+G I + + L+ L L
Sbjct: 519 IGNLTKIVGFNISSNQLTGHIPKELGSCVTIQRLDLSGNKFSGYIAQELGQLVYLEILRL 578
Query: 382 GQNSLKGEIPHEIGNCMKLLQLHIGSNYLTGSIPPEIGHIRNLQIALNLSFNHLHGSLPP 441
N L GEIPH G+ +L++L +G N L+ +IP E+G + +LQI+LN+S N+L G++P
Sbjct: 579 SDNRLTGEIPHSFGDLTRLMELQLGGNLLSENIPVELGKLTSLQISLNISHNNLSGTIPD 638
Query: 442 ELGKLDKLVSFDVSNNQLSGTIPSALKGMLSLIEVNFSNNLLTGPVPSFVPFQKSPNSSF 501
LG L L +++N+LSG IP+++ ++SL+ N SNN L G VP FQ+ +S+F
Sbjct: 639 SLGNLQMLEILYLNDNKLSGEIPASIGNLMSLLICNISNNNLVGTVPDTAVFQRMDSSNF 698
Query: 502 FGNKGLCGEPLSFSCGNANGPDSK-NYRHRVSYR-----IILAVVGSGLAVFISVTVVVL 555
GN GLC S DSK N+ S R I V+GS VF+ +T + L
Sbjct: 699 AGNHGLCNSQRSHCQPLVPHSDSKLNWLINGSQRQKILTITCIVIGS---VFL-ITFLGL 754
Query: 556 LFMMRERQEKASKSADVADSGASSQPSIIAGNVLVENLRQAIDLDAVVKATMKDSNMIYC 615
+ ++ R+E A + + D ++P ++ ++ +V AT S +
Sbjct: 755 CWTIK-RREPAFVALE--DQ---TKPDVMDSYYFP---KKGFTYQGLVDATRNFSEDVVL 805
Query: 616 G--TFSTVYKAVMPSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFV 673
G TVYKA M G +++VK+L S N E+ L K+ H N+V+ GF
Sbjct: 806 GRGACGTVYKAEMSGGEVIAVKKLNSRGEGA-SSDNSFRAEISTLGKIRHRNIVKLYGFC 864
Query: 674 IYEDVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVA---I 730
+++ LLL+ Y+ G+L + L K + DW R IA+G AEGL +LHH I
Sbjct: 865 YHQNSNLLLYEYMSKGSLGEQLQRGEK--NCLLDWNARYRIALGAAEGLCYLHHDCRPQI 922
Query: 731 IHLDISSGNVLLDADFKPLLGEIEISKLLDPSKGTASISAVAGSFGYIPPEYAYTMQVTA 790
+H DI S N+LLD F+ +G+ ++KL+D S + S+SAVAGS+GYI PEYAYTM+VT
Sbjct: 923 VHRDIKSNNILLDERFQAHVGDFGLAKLIDLSY-SKSMSAVAGSYGYIAPEYAYTMKVTE 981
Query: 791 PGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPE-QILDARLSTVSFG 849
++YS+GVVLLE++T + PV+ +G DLV WV + R P ++ DARL T
Sbjct: 982 KCDIYSFGVVLLELITGKPPVQP-LEQGGDLVNWVRRS-IRNMIPTIEMFDARLDTNDKR 1039
Query: 850 WRKEMLTALKVALLCTDSTPAKRPKMKKVVEMLQEIK 886
EM LK+AL CT ++PA RP M++VV M+ E +
Sbjct: 1040 TVHEMSLVLKIALFCTSNSPASRPTMREVVAMITEAR 1076
|
|
| TAIR|locus:2009288 AT1G34420 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1282 (456.3 bits), Expect = 1.0e-130, P = 1.0e-130
Identities = 317/830 (38%), Positives = 462/830 (55%)
Query: 68 LDLSRLQLRGNITLVS--ELKALKRLDLSNNAFSGTIPSAFGNLSELEFLDLSLNKFGGV 125
LD S L GN+ L L+ L+LS N +G++P LE L++S N G
Sbjct: 161 LDFSHNVLSGNVGDYGFDGLVQLRSLNLSFNRLTGSVPVHL--TKSLEKLEVSDNSLSGT 218
Query: 126 IPRELGSLKDLRFFNISNNVLVGEIPDELKSLEKLEDFQVSSNKLNGSIPFWVGNLTNLR 185
IP + ++L ++S+N L G IP L +L KLE +S+N L+G IP + ++ LR
Sbjct: 219 IPEGIKDYQELTLIDLSDNQLNGSIPSSLGNLSKLESLLLSNNYLSGLIPESLSSIQTLR 278
Query: 186 VFTAYENQLVGEIPDNLGSVSELELLNLHSNQLEGPIPKSIFASGKLEVLVLTQNRLTGD 245
F A N+ GEIP L LE L+L N L G IP + + KL + L+ N+L G
Sbjct: 279 RFAANRNRFTGEIPSGL--TKHLENLDLSFNSLAGSIPGDLLSQLKLVSVDLSSNQLVGW 336
Query: 246 IPELVGHCKSLSNIRIGNNDLVGVIPR-AIGNVSGLTYFEADNNNLSGEIVPEFSQCSNL 304
IP+ + SL +R+G+N L G +P A ++ LTY E DNN+L+G I P F +L
Sbjct: 337 IPQSIS--SSLVRLRLGSNKLTGSVPSVAFESLQLLTYLEMDNNSLTGFIPPSFGNLVSL 394
Query: 305 TLLNLASNGFTGVIPPELGQLINLQELILYENSLFGEIPKSILACKNLNKLDLSNNRFNG 364
LLNLA N FTG++PP G L LQ + L +N L GEIP +I NL L++S N +G
Sbjct: 395 NLLNLAMNEFTGILPPAFGNLSRLQVIKLQQNKLTGEIPDTIAFLSNLLILNISCNSLSG 454
Query: 365 TIPNAICDMSRLQYLLLGQNSLKGEIPHEIGNCMKLLQLHIGSNYLTGSIPPEIGHIRNL 424
+IP ++ + RL + L N+L G IP I N L++L +G N L G IP R L
Sbjct: 455 SIPPSLSQLKRLSNMNLQGNNLNGTIPDNIQNLEDLIELQLGQNQLRGRIPVMP---RKL 511
Query: 425 QIALNLSFNHLHGSLPPELGKLDKLVSFDVSNNQLSGTIPSALKGMLSLIEVNFSNNLLT 484
QI+LNLS+N GS+P L +LD+L D+SNN SG IP+ L ++SL ++ SNN LT
Sbjct: 512 QISLNLSYNLFEGSIPTTLSELDRLEVLDLSNNNFSGEIPNFLSRLMSLTQLILSNNQLT 571
Query: 485 GPVPSFVPFQKSPNSSFFGNKGLCGEPLSFSCGNANGPDSKNYRHRVSYRIILAVVGSGL 544
G +P F + + GN G+ + + N P K+ ++ +I +G L
Sbjct: 572 GNIPRFT---HNVSVDVRGNPGVKLKTENEVSIQRN-PSGKS---KLVMIVIFVSLGV-L 623
Query: 545 AVFISVTVVVLLFMMRERQEKASKSADVADSGASSQPSIIAGNVLVENL--RQAIDLDAV 602
A+ + V +L R + + D + G++ P +I G +L N R I+
Sbjct: 624 ALLTGIITVTVLKFSRRCKGINNMQVDPDEEGSTVLPEVIHGKLLTSNALHRSNINFAKA 683
Query: 603 VKATMKDSNMIYCGTFSTVYKAVMPSGLILSVKRLKSMDRTIIHHQNKMIR-ELEKLSKL 661
V+A + ++ F + Y+ VMPSG +K+L + DR ++ + ELE L KL
Sbjct: 684 VEAVAHPEHGLHQTMFWSYYRVVMPSGSSYFIKKLNTRDRVFQQASSEQLEVELEMLGKL 743
Query: 662 CHDNLVRPIGFVIYEDVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEG 721
H N++ P+ +V+Y + LL++++ TL ++LH + DW +R SIA+G+A+G
Sbjct: 744 HHTNVMVPLAYVLYSEGCLLIYDFSHTCTLYEILHNHSSGV---VDWTSRYSIAVGIAQG 800
Query: 722 LAFLH------HVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSKGTASISAVAGSF 775
+++LH I+ D+SS +LL + +PL+G+IE+ K++DPSK +S+SAVAG+
Sbjct: 801 ISYLHGSESSGRDPILLPDLSSKKILLKSLTEPLVGDIELFKVIDPSKSNSSLSAVAGTI 860
Query: 776 GYIPPEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETP 835
GYIPPEYAYTM+VT GNVYS+GV+LLE+LT R V E G DL KWV + E
Sbjct: 861 GYIPPEYAYTMRVTMAGNVYSFGVILLELLTGRPAVSE----GRDLAKWVQSHSSHQEQQ 916
Query: 836 EQILDARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEMLQEI 885
ILD R+S S K+ML AL VAL C + +P RPKMK V+ ML +
Sbjct: 917 NNILDLRVSKTSTVATKQMLRALGVALACINISPGARPKMKTVLRMLTRL 966
|
|
| TAIR|locus:2156349 GSO2 "GASSHO 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1193 (425.0 bits), Expect = 2.8e-121, P = 2.8e-121
Identities = 297/835 (35%), Positives = 451/835 (54%)
Query: 75 LRGNITL-VSELKALKRLDLSNNAFSGTIPSAFGNLSELEFLDLSLNKFGGVIPRELGSL 133
L G + + L L+ + L N FSG +P GN + L+ +D N+ G IP +G L
Sbjct: 421 LEGKVPKEIGFLGKLEIMYLYENRFSGEMPVEIGNCTRLQEIDWYGNRLSGEIPSSIGRL 480
Query: 134 KDLRFFNISNNVLVGEIPDELKSLEKLEDFQVSSNKLNGSIPFWVGNLTNLRVFTAYENQ 193
KDL ++ N LVG IP L + ++ ++ N+L+GSIP G LT L +F Y N
Sbjct: 481 KDLTRLHLRENELVGNIPASLGNCHQMTVIDLADNQLSGSIPSSFGFLTALELFMIYNNS 540
Query: 194 LVGEIPDNLGSVSELELLNLHSNQLEGPIPKSIFASGKLEVLVLTQNRLTGDIPELVGHC 253
L G +PD+L ++ L +N SN+ G I +S L V T+N GDIP +G
Sbjct: 541 LQGNLPDSLINLKNLTRINFSSNKFNGSISPLCGSSSYLSFDV-TENGFEGDIPLELGKS 599
Query: 254 KSLSNIRIGNNDLVGVIPRAIGNVSGLTYFEADNNNLSGEIVPEFSQCSNLTLLNLASNG 313
+L +R+G N G IPR G +S L+ + N+LSG I E C LT ++L +N
Sbjct: 600 TNLDRLRLGKNQFTGRIPRTFGKISELSLLDISRNSLSGIIPVELGLCKKLTHIDLNNNY 659
Query: 314 FTGVIPPELGQLINLQELILYENSLFGEIPKSILACKNLNKLDLSNNRFNGTIPNAICDM 373
+GVIP LG+L L EL L N G +P I + N+ L L N NG+IP I ++
Sbjct: 660 LSGVIPTWLGKLPLLGELKLSSNKFVGSLPTEIFSLTNILTLFLDGNSLNGSIPQEIGNL 719
Query: 374 SRLQYLLLGQNSLKGEIPHEIGNCMKLLQLHIGSNYLTGSIPPEIGHIRNLQIALNLSFN 433
L L L +N L G +P IG KL +L + N LTG IP EIG +++LQ AL+LS+N
Sbjct: 720 QALNALNLEENQLSGPLPSTIGKLSKLFELRLSRNALTGEIPVEIGQLQDLQSALDLSYN 779
Query: 434 HLHGSLPPELGKLDKLVSFDVSNNQLSGTIPSALKGMLSLIEVNFSNNLLTGPVPSFVPF 493
+ G +P + L KL S D+S+NQL G +P + M SL +N S N L G + F
Sbjct: 780 NFTGRIPSTISTLPKLESLDLSHNQLVGEVPGQIGDMKSLGYLNLSYNNLEGKLKK--QF 837
Query: 494 QKSPNSSFFGNKGLCGEPLSFSCGNANGPDSKNYRHRVSYR--IILAVVGSGLAVFISVT 551
+ +F GN GLCG PLS C A SKN R +S + +I++ + S A+ + V
Sbjct: 838 SRWQADAFVGNAGLCGSPLSH-CNRAG---SKNQRS-LSPKTVVIISAISSLAAIALMVL 892
Query: 552 VVVLLFMMRE---RQEKASKSADVADSGASSQPSIIAGNVLVENLRQAIDLDAVVKAT-- 606
V++L F ++ + SA ++S +S P G + I D +++AT
Sbjct: 893 VIILFFKQNHDLFKKVRGGNSAFSSNSSSSQAPLFSNGGA-----KSDIKWDDIMEATHY 947
Query: 607 MKDSNMIYCGTFSTVYKAVMPSGLILSVKRLKSMDRTIIHHQNKMI-RELEKLSKLCHDN 665
+ + MI G VYKA + +G ++VK++ D + NK RE++ L + H +
Sbjct: 948 LNEEFMIGSGGSGKVYKAELKNGETIAVKKILWKDDLM---SNKSFNREVKTLGTIRHRH 1004
Query: 666 LVRPIGFVIY--EDVALLLHNYLPNGTLAQLLH--ESTKQPDYRPDWPTRLSIAIGVAEG 721
LV+ +G+ + + LL++ Y+ NG++ LH E+TK+ + W TRL IA+G+A+G
Sbjct: 1005 LVKLMGYCSSKADGLNLLIYEYMANGSVWDWLHANENTKKKEVL-GWETRLKIALGLAQG 1063
Query: 722 LAFLHHVA---IIHLDISSGNVLLDADFKPLLGEIEISKLLDPS--KGTASISAVAGSFG 776
+ +LH+ I+H DI S NVLLD++ + LG+ ++K+L + T S + AGS+G
Sbjct: 1064 VEYLHYDCVPPIVHRDIKSSNVLLDSNIEAHLGDFGLAKILTGNYDTNTESNTMFAGSYG 1123
Query: 777 YIPPEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVH---GAPARGE 833
YI PEYAY+++ T +VYS G+VL+EI+T ++P E F E D+V+WV P E
Sbjct: 1124 YIAPEYAYSLKATEKSDVYSMGIVLMEIVTGKMPTEAMFDEETDMVRWVETVLDTPPGSE 1183
Query: 834 TPEQILDARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEMLQEIKQN 888
E+++D+ L ++ + L++AL CT S P +RP ++ E L + N
Sbjct: 1184 AREKLIDSELKSLLPCEEEAAYQVLEIALQCTKSYPQERPSSRQASEYLLNVFNN 1238
|
|
| TAIR|locus:2032697 PEPR1 "PEP1 receptor 1" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1183 (421.5 bits), Expect = 3.2e-120, P = 3.2e-120
Identities = 297/834 (35%), Positives = 442/834 (52%)
Query: 77 GNI--TLVSELKALKRL---DLSNNAFSGTIPSAFGNLSELEFLDLSLNKFGGVIPRELG 131
GN+ T+ S L LK L +LS N SG+IP+ GN S L L L+ N+ G IP LG
Sbjct: 301 GNLSGTIPSSLGMLKNLTILNLSENRLSGSIPAELGNCSSLNLLKLNDNQLVGGIPSALG 360
Query: 132 SLKDLRFFNISNNVLVGEIPDELKSLEKLEDFQVSSNKLNGSIPFWVGNLTNLRVFTAYE 191
L+ L + N GEIP E+ + L V N L G +P + + L++ T +
Sbjct: 361 KLRKLESLELFENRFSGEIPIEIWKSQSLTQLLVYQNNLTGELPVEMTEMKKLKIATLFN 420
Query: 192 NQLVGEIPDNLGSVSELELLNLHSNQLEGPIPKSIFASGKLEVLVLTQNRLTGDIPELVG 251
N G IP LG S LE ++ N+L G IP ++ KL +L L N L G IP +G
Sbjct: 421 NSFYGAIPPGLGVNSSLEEVDFIGNKLTGEIPPNLCHGRKLRILNLGSNLLHGTIPASIG 480
Query: 252 HCKSLSNIRIGNNDLVGVIPRAIGNVSGLTYFEADNNNLSGEIVPEFSQCSNLTLLNLAS 311
HCK++ + N+L G++P + S L++ + ++NN G I C NL+ +NL+
Sbjct: 481 HCKTIRRFILRENNLSGLLPEFSQDHS-LSFLDFNSNNFEGPIPGSLGSCKNLSSINLSR 539
Query: 312 NGFTGVIPPELGQLINLQELILYENSLFGEIPKSILACKNLNKLDLSNNRFNGTIPNAIC 371
N FTG IPP+LG L NL + L N L G +P + C +L + D+ N NG++P+
Sbjct: 540 NRFTGQIPPQLGNLQNLGYMNLSRNLLEGSLPAQLSNCVSLERFDVGFNSLNGSVPSNFS 599
Query: 372 DMSRLQYLLLGQNSLKGEIPHEIGNCMKLLQLHIGSNYLTGSIPPEIGHIRNLQIALNLS 431
+ L L+L +N G IP + KL L I N G IP IG I +L L+LS
Sbjct: 600 NWKGLTTLVLSENRFSGGIPQFLPELKKLSTLQIARNAFGGEIPSSIGLIEDLIYDLDLS 659
Query: 432 FNHLHGSLPPELGKLDKLVSFDVSNNQLSGTIPSALKGMLSLIEVNFSNNLLTGPVPSFV 491
N L G +P +LG L KL ++SNN L+G++ S LKG+ SL+ V+ SNN TGP+P +
Sbjct: 660 GNGLTGEIPAKLGDLIKLTRLNISNNNLTGSL-SVLKGLTSLLHVDVSNNQFTGPIPDNL 718
Query: 492 PFQK-SPNSSFFGNKGLCGEPLSFSCGNANGP-------DSKNYRHRVS-YRIILAVVGS 542
Q S SSF GN LC P SFS N + SK+ + +S ++I+L V S
Sbjct: 719 EGQLLSEPSSFSGNPNLC-IPHSFSASNNSRSALKYCKDQSKSRKSGLSTWQIVLIAVLS 777
Query: 543 GLAVFISVTVVVLLFMMRERQEKASKSADVADSGASSQPSIIAGNVLVENLRQAIDLDAV 602
L V + V +V + +R R+ + K A V PS++ VL A D
Sbjct: 778 SLLVLVVVLALVFI-CLRRRKGRPEKDAYVFTQ--EEGPSLLLNKVLA-----ATD---- 825
Query: 603 VKATMKDSNMIYCGTFSTVYKAVMPSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLC 662
+ + I G VY+A + SG + +VKRL I M+RE++ + K+
Sbjct: 826 ---NLNEKYTIGRGAHGIVYRASLGSGKVYAVKRLVFASH--IRANQSMMREIDTIGKVR 880
Query: 663 HDNLVRPIGFVIYEDVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGL 722
H NL++ GF + +D L+L+ Y+P G+L +LH + + + DW R ++A+GVA GL
Sbjct: 881 HRNLIKLEGFWLRKDDGLMLYRYMPKGSLYDVLHGVSPKENVL-DWSARYNVALGVAHGL 939
Query: 723 AFLH---HVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSKGTASISAVAGSFGYIP 779
A+LH H I+H DI N+L+D+D +P +G+ +++LLD S T S + V G+ GYI
Sbjct: 940 AYLHYDCHPPIVHRDIKPENILMDSDLEPHIGDFGLARLLDDS--TVSTATVTGTTGYIA 997
Query: 780 PEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQ-- 837
PE A+ +VYSYGVVLLE++T + V++ F E D+V WV A + +
Sbjct: 998 PENAFKTVRGRESDVYSYGVVLLELVTRKRAVDKSFPESTDIVSWVRSALSSSNNNVEDM 1057
Query: 838 ---ILDARL--STVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEMLQEIK 886
I+D L + R++++ ++AL CT PA RP M+ V++L+++K
Sbjct: 1058 VTTIVDPILVDELLDSSLREQVMQVTELALSCTQQDPAMRPTMRDAVKLLEDVK 1111
|
|
| TAIR|locus:2085949 AT3G24240 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1177 (419.4 bits), Expect = 1.4e-119, P = 1.4e-119
Identities = 291/814 (35%), Positives = 447/814 (54%)
Query: 91 LDLSNNAFSGTIPSAFGNLSELEFLDLSLNKFGGVIPRELGSLKDLRFFNISNNVLVGEI 150
L L N+ SG+IP G L++LE L L N G IP E+G+ +L+ ++S N+L G I
Sbjct: 279 LFLYENSLSGSIPREIGQLTKLEQLFLWQNSLVGGIPEEIGNCSNLKMIDLSLNLLSGSI 338
Query: 151 PDELKSLEKLEDFQVSSNKLNGSIPFWVGNLTNLRVFTAYENQLVGEIPDNLGSVSELEL 210
P + L LE+F +S NK +GSIP + N ++L +NQ+ G IP LG++++L L
Sbjct: 339 PSSIGRLSFLEEFMISDNKFSGSIPTTISNCSSLVQLQLDKNQISGLIPSELGTLTKLTL 398
Query: 211 LNLHSNQLEGPIPKSIFASGKLEVLVLTQNRLTGDIPELVGHCKSLSNIRIGNNDLVGVI 270
SNQLEG IP + L+ L L++N LTG IP + ++L+ + + +N L G I
Sbjct: 399 FFAWSNQLEGSIPPGLADCTDLQALDLSRNSLTGTIPSGLFMLRNLTKLLLISNSLSGFI 458
Query: 271 PRAIGNVSGLTYFEADNNNLSGEIVPEFSQCSNLTLLNLASNGFTGVIPPELGQLINLQE 330
P+ IGN S L N ++GEI + L+ +SN G +P E+G LQ
Sbjct: 459 PQEIGNCSSLVRLRLGFNRITGEIPSGIGSLKKINFLDFSSNRLHGKVPDEIGSCSELQM 518
Query: 331 LILYENSLFGEIPKSILACKNLNKLDLSNNRFNGTIPNAICDMSRLQYLLLGQNSLKGEI 390
+ L NSL G +P + + L LD+S N+F+G IP ++ + L L+L +N G I
Sbjct: 519 IDLSNNSLEGSLPNPVSSLSGLQVLDVSANQFSGKIPASLGRLVSLNKLILSKNLFSGSI 578
Query: 391 PHEIGNCMKLLQLHIGSNYLTGSIPPEIGHIRNLQIALNLSFNHLHGSLPPELGKLDKLV 450
P +G C L L +GSN L+G IP E+G I NL+IALNLS N L G +P ++ L+KL
Sbjct: 579 PTSLGMCSGLQLLDLGSNELSGEIPSELGDIENLEIALNLSSNRLTGKIPSKIASLNKLS 638
Query: 451 SFDVSNNQLSGTIPSALKGMLSLIEVNFSNNLLTGPVPSFVPFQKSPNSSFFGNKGLCGE 510
D+S+N L G + + L + +L+ +N S N +G +P F++ GNK LC
Sbjct: 639 ILDLSHNMLEGDL-APLANIENLVSLNISYNSFSGYLPDNKLFRQLSPQDLEGNKKLCSS 697
Query: 511 P-----LSFSCGNANGPDSKNYRHRVSYRIILAVVGSGLAVFISVTVVVL--LFMMRERQ 563
L++ GN G D R R R+ LA L + ++V +++L + ++R R+
Sbjct: 698 TQDSCFLTYRKGNGLGDDGDASRTR-KLRLTLA-----LLITLTVVLMILGAVAVIRARR 751
Query: 564 EKASKSADVADSGASSQPSIIAGNVLVENLRQAIDLDAVVKATMKDSNMIYCGTFSTVYK 623
D ++ G + + L N +D +++ + + N+I G VY+
Sbjct: 752 N-IDNERD-SELGETYKWQFTPFQKL--NF----SVDQIIRCLV-EPNVIGKGCSGVVYR 802
Query: 624 AVMPSGLILSVKRL-KSMDRTIIHHQNKMIR-----ELEKLSKLCHDNLVRPIGFVIYED 677
A + +G +++VK+L +M + K +R E++ L + H N+VR +G +
Sbjct: 803 ADVDNGEVIAVKKLWPAMVNGGHDEKTKNVRDSFSAEVKTLGTIRHKNIVRFLGCCWNRN 862
Query: 678 VALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVA---IIHLD 734
LL+++Y+PNG+L LLHE DW R I +G A+GLA+LHH I+H D
Sbjct: 863 TRLLMYDYMPNGSLGSLLHERRGSS---LDWDLRYRILLGAAQGLAYLHHDCLPPIVHRD 919
Query: 735 ISSGNVLLDADFKPLLGEIEISKLLDPSK-GTASISAVAGSFGYIPPEYAYTMQVTAPGN 793
I + N+L+ DF+P + + ++KL+D G S + VAGS+GYI PEY Y+M++T +
Sbjct: 920 IKANNILIGLDFEPYIADFGLAKLVDEGDIGRCS-NTVAGSYGYIAPEYGYSMKITEKSD 978
Query: 794 VYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQILDARLSTVSFGWRKE 853
VYSYGVV+LE+LT + P++ EG+ LV WV RG ++LD+ L + + E
Sbjct: 979 VYSYGVVVLEVLTGKQPIDPTVPEGIHLVDWVR--QNRGSL--EVLDSTLRSRTEAEADE 1034
Query: 854 MLTALKVALLCTDSTPAKRPKMKKVVEMLQEIKQ 887
M+ L ALLC +S+P +RP MK V ML+EIKQ
Sbjct: 1035 MMQVLGTALLCVNSSPDERPTMKDVAAMLKEIKQ 1068
|
|
| TAIR|locus:2161158 PXY "PHLOEM INTERCALATED WITH XYLEM" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 1172 (417.6 bits), Expect = 4.7e-119, P = 4.7e-119
Identities = 290/848 (34%), Positives = 429/848 (50%)
Query: 52 NWKGI-DCDLNQA-FVVKLDLSRLQLRGNITLV-SELKALKRLDLSNNAFSGTIPSAFGN 108
N++G+ D+++ F+ +L+ G I L+ LK + L+ N G +P G
Sbjct: 164 NFEGLLPSDVSRLRFLEELNFGGSYFEGEIPAAYGGLQRLKFIHLAGNVLGGKLPPRLGL 223
Query: 109 LSELEFLDLSLNKFGGVIPRELGSLKDLRFFNISNNVLVGEIPDELKSLEKLEDFQVSSN 168
L+EL+ +++ N F G IP E L +L++F++SN L G +P EL +L LE + N
Sbjct: 224 LTELQHMEIGYNHFNGNIPSEFALLSNLKYFDVSNCSLSGSLPQELGNLSNLETLFLFQN 283
Query: 169 KLNGSIPFWVGNLTNLRVFTAYENQLVGEIPDNLGSVSELELLNLHSNQLEGPIPKSIFA 228
G IP NL +L++ NQL G IP ++ L L+L SN L G +P+ I
Sbjct: 284 GFTGEIPESYSNLKSLKLLDFSSNQLSGSIPSGFSTLKNLTWLSLISNNLSGEVPEGIGE 343
Query: 229 SGKLEVLVLTQNRLTGDIPELVGHCKSLSNIRIGNNDLVGVIPRAIGNVSGLTYFEADNN 288
+L L L N TG +P +G L + + NN G IP ++ + + L +N
Sbjct: 344 LPELTTLFLWNNNFTGVLPHKLGSNGKLETMDVSNNSFTGTIPSSLCHGNKLYKLILFSN 403
Query: 289 NLSGEIVPEFSQCSNLTLLNLASNGFTGVIPPELGQLINLQELILYENSLFGEIPKSILA 348
GE+ ++C +L +N G IP G L NL + L N +IP
Sbjct: 404 MFEGELPKSLTRCESLWRFRSQNNRLNGTIPIGFGSLRNLTFVDLSNNRFTDQIPADFAT 463
Query: 349 CKNLNKLDLSNNRFNGTIPNAICDMSRLQYLLLGQNSLKGEIPHEIGNCMKLLQLHIGSN 408
L L+LS N F+ +P I LQ ++L GEIP+ +G C ++ + N
Sbjct: 464 APVLQYLNLSTNFFHRKLPENIWKAPNLQIFSASFSNLIGEIPNYVG-CKSFYRIELQGN 522
Query: 409 YLTGSIPPEIGHIRNLQIALNLSFNHLHGSLPPELGKLDKLVSFDVSNNQLSGTIPSALK 468
L G+IP +IGH L + LNLS NHL+G +P E+ L + D+S+N L+GTIPS
Sbjct: 523 SLNGTIPWDIGHCEKL-LCLNLSQNHLNGIIPWEISTLPSIADVDLSHNLLTGTIPSDFG 581
Query: 469 GMLSLIEVNFSNNLLTGPVPSFVPFQKSPNSSFFGNKGLCGEPLSFSCG----NANGPDS 524
++ N S N L GP+PS +P S F N+GLCG+ + C NA D
Sbjct: 582 SSKTITTFNVSYNQLIGPIPSGSFAHLNP-SFFSSNEGLCGDLVGKPCNSDRFNAGNADI 640
Query: 525 KNYRHRVSYRIILAVVGSGLAVFISVTVVVLLFMMRERQEKASKSADVADSGASSQPSII 584
+ + + LA I V VL+ R Q+ D G I
Sbjct: 641 DGHHKEERPKKTAGAIVWILAAAIGVGFFVLVAATRCFQKSYGNRVD----GGGRNGGDI 696
Query: 585 AGNVLVENLRQAIDLDAVVKATMKDSNMIYCGTFSTVYKAVMPSGLILSVKRL--KSMDR 642
L R D VV+ K N++ G+ TVYKA MP+G I++VK+L K+ +
Sbjct: 697 GPWKLTAFQRLNFTADDVVECLSKTDNILGMGSTGTVYKAEMPNGEIIAVKKLWGKNKEN 756
Query: 643 TIIHHQNK-MIRELEKLSKLCHDNLVRPIGFVIYEDVALLLHNYLPNGTLAQLLHESTKQ 701
I + ++ E++ L + H N+VR +G D +LL+ Y+PNG+L LLH K
Sbjct: 757 GKIRRRKSGVLAEVDVLGNVRHRNIVRLLGCCTNRDCTMLLYEYMPNGSLDDLLHGGDKT 816
Query: 702 PDYRPDWPTRLSIAIGVAEGLAFLHH---VAIIHLDISSGNVLLDADFKPLLGEIEISKL 758
+W IAIGVA+G+ +LHH I+H D+ N+LLDADF+ + + ++KL
Sbjct: 817 MTAAAEWTALYQIAIGVAQGICYLHHDCDPVIVHRDLKPSNILLDADFEARVADFGVAKL 876
Query: 759 LDPSKGTASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEG 818
+ + S+S VAGS+GYI PEYAYT+QV ++YSYGV+LLEI+T + VE +FGEG
Sbjct: 877 IQTDE---SMSVVAGSYGYIAPEYAYTLQVDKKSDIYSYGVILLEIITGKRSVEPEFGEG 933
Query: 819 VDLVKWVHGAPARGETPEQILDARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKV 878
+V WV E E++LD + R+EM L++ALLCT +P RP M+ V
Sbjct: 934 NSIVDWVRSKLKTKEDVEEVLDKSMGRSCSLIREEMKQMLRIALLCTSRSPTDRPPMRDV 993
Query: 879 VEMLQEIK 886
+ +LQE K
Sbjct: 994 LLILQEAK 1001
|
|
| TAIR|locus:2097310 BAM2 "BARELY ANY MERISTEM 2" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 686 (246.5 bits), Expect = 5.6e-119, Sum P(2) = 5.6e-119
Identities = 172/499 (34%), Positives = 255/499 (51%)
Query: 1 MAFLCFFSILLLGVLSKSQLVFAQLNDEPTLLAINKELIV----P---GWGVNGTNFCNW 53
M L +LLL +S S V + + LL++ + P W ++ T FC+W
Sbjct: 1 MKLLLLLLLLLLLHISHSFTVAKPITELHALLSLKSSFTIDEHSPLLTSWNLS-TTFCSW 59
Query: 54 KGIDCDLNQAFVVKLDLSRLQLRGNITL-VSELKALKRLDLSNNAFSGTIPSAFGNLSEL 112
G+ CD++ V LDLS L L G ++ V+ L L+ L L+ N SG IP NL EL
Sbjct: 60 TGVTCDVSLRHVTSLDLSGLNLSGTLSSDVAHLPLLQNLSLAANQISGPIPPQISNLYEL 119
Query: 113 EFLDLSLNKFGGVIPRELGS-LKDLRFFNISNNVLVGEIPDELKSLEKLEDFQVSSNKLN 171
L+LS N F G P EL S L +LR ++ NN L G++P L +L +L + N +
Sbjct: 120 RHLNLSNNVFNGSFPDELSSGLVNLRVLDLYNNNLTGDLPVSLTNLTQLRHLHLGGNYFS 179
Query: 172 GSIPFWVGNLTNLRVFTAYENQLVGEIPDNLGSVSELELLNL-HSNQLEGPIPKSIFASG 230
G IP G L N+L G+IP +G+++ L L + + N E +P I
Sbjct: 180 GKIPATYGTWPVLEYLAVSGNELTGKIPPEIGNLTTLRELYIGYYNAFENGLPPEIGNLS 239
Query: 231 KLEVLVLTQNRLTGDIPELVGHCKSLSNIRIGNNDLVGVIPRAIGNVSGLTYFEADNNNL 290
+L LTG+IP +G + L + + N G I + +G +S L + NN
Sbjct: 240 ELVRFDAANCGLTGEIPPEIGKLQKLDTLFLQVNAFTGTITQELGLISSLKSMDLSNNMF 299
Query: 291 SGEIVPEFSQCSNLTLLNLASNGFTGVIPPELGQLINLQELILYENSLFGEIPKSILACK 350
+GEI FSQ NLTLLNL N G IP +G++ L+ L L+EN+ G IP+ +
Sbjct: 300 TGEIPTSFSQLKNLTLLNLFRNKLYGAIPEFIGEMPELEVLQLWENNFTGSIPQKLGENG 359
Query: 351 NLNKLDLSNNRFNGTIPNAICDMSRLQYLLLGQNSLKGEIPHEIGNCMKLLQLHIGSNYL 410
L LDLS+N+ GT+P +C +RL L+ N L G IP +G C L ++ +G N+L
Sbjct: 360 RLVILDLSSNKLTGTLPPNMCSGNRLMTLITLGNFLFGSIPDSLGKCESLTRIRMGENFL 419
Query: 411 TGSIPPEIGHIRNLQIALNLSFNHLHGSLPPELGKLD-KLVSFDVSNNQLSGTIPSALKG 469
GSIP E+ + L + L N+L G LP G + L +SNNQLSG++P+A+
Sbjct: 420 NGSIPKELFGLPKLS-QVELQDNYLTGELPISGGGVSGDLGQISLSNNQLSGSLPAAIGN 478
Query: 470 MLSLIEVNFSNNLLTGPVP 488
+ + ++ N +G +P
Sbjct: 479 LSGVQKLLLDGNKFSGSIP 497
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
| ID | Name | Annotated EC number | Identity | Query coverage | Hit coverage | RBH(Q2H) | RBH(H2Q) |
| O22938 | Y2182_ARATH | 2, ., 7, ., 1, 0, ., 1 | 0.7770 | 0.9988 | 0.9966 | yes | no |
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 3rd Layer | 2.7.10 | 0.983 |
| 3rd Layer | 2.7.11 | 0.766 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
Fail to connect to STRING server
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 888 | |||
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 1e-105 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 2e-28 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 1e-23 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 4e-20 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-18 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 1e-18 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 2e-17 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 3e-17 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 5e-17 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 1e-16 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-16 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 3e-16 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 1e-15 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 7e-15 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-14 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 1e-14 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 3e-14 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 3e-14 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 5e-13 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 6e-13 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 1e-12 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 2e-12 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 3e-12 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 4e-12 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-11 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-11 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 2e-11 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 3e-11 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 6e-11 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 7e-11 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 7e-11 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 8e-11 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 1e-10 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 1e-10 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 3e-10 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 3e-10 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 4e-10 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 5e-10 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 6e-10 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 7e-10 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 8e-10 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-09 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 1e-09 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 1e-09 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 1e-09 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 1e-09 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 3e-09 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 5e-09 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 6e-09 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 7e-09 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 8e-09 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 9e-09 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-08 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 1e-08 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 1e-08 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 1e-08 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 1e-08 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 1e-08 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 2e-08 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 2e-08 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 4e-08 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 4e-08 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 5e-08 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 5e-08 | |
| COG4886 | 394 | COG4886, COG4886, Leucine-rich repeat (LRR) protei | 6e-08 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 7e-08 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 8e-08 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 8e-08 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 9e-08 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 9e-08 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 9e-08 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 9e-08 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 1e-07 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 1e-07 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 2e-07 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 2e-07 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 2e-07 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 3e-07 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 3e-07 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 4e-07 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 4e-07 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 4e-07 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 4e-07 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 4e-07 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 5e-07 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 6e-07 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 6e-07 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 7e-07 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 8e-07 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 1e-06 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 1e-06 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 1e-06 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 1e-06 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 1e-06 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 1e-06 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 2e-06 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 2e-06 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 2e-06 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 2e-06 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 2e-06 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 2e-06 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 3e-06 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 4e-06 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 6e-06 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 6e-06 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 6e-06 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 7e-06 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 7e-06 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 7e-06 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 9e-06 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 9e-06 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 1e-05 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 1e-05 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 1e-05 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 1e-05 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 1e-05 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 1e-05 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 2e-05 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 2e-05 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 2e-05 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 2e-05 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 3e-05 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 3e-05 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 5e-05 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 5e-05 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 5e-05 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 5e-05 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 6e-05 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 7e-05 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 8e-05 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 8e-05 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 8e-05 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 8e-05 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 8e-05 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 9e-05 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 1e-04 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 1e-04 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 1e-04 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 1e-04 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 1e-04 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 1e-04 | |
| PLN03150 | 623 | PLN03150, PLN03150, hypothetical protein; Provisio | 2e-04 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 2e-04 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 2e-04 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 2e-04 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 2e-04 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 2e-04 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 2e-04 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 3e-04 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 3e-04 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 3e-04 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 3e-04 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 4e-04 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 4e-04 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 4e-04 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 4e-04 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 5e-04 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 5e-04 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 5e-04 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 5e-04 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 7e-04 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 7e-04 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 8e-04 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 9e-04 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 0.001 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 0.001 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 0.001 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 0.001 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 0.002 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 0.002 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 0.002 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 0.002 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 0.002 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 0.002 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 0.003 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 0.003 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 0.003 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 0.003 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 0.004 | |
| pfam13855 | 60 | pfam13855, LRR_8, Leucine rich repeat | 0.004 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 0.004 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 0.004 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 0.004 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 0.004 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 347 bits (892), Expect = e-105
Identities = 280/937 (29%), Positives = 436/937 (46%), Gaps = 145/937 (15%)
Query: 49 NFCNWKGIDCDLNQAFVVKLDLSRLQLRGNI----------------------------- 79
+ C W+GI C+ N + VV +DLS + G I
Sbjct: 56 DVCLWQGITCN-NSSRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQLSGPIPDDIF 114
Query: 80 TLVSELK-------------------ALKRLDLSNNAFSGTIPSAFGNLSELEFLDLSLN 120
T S L+ L+ LDLSNN SG IP+ G+ S L+ LDL N
Sbjct: 115 TTSSSLRYLNLSNNNFTGSIPRGSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGN 174
Query: 121 KFGGVIPRELGSLKDLRFFNISNNVLVGEIPDELKSLEKLEDFQVSSNKLNGSIPFWVGN 180
G IP L +L L F +++N LVG+IP EL ++ L+ + N L+G IP+ +G
Sbjct: 175 VLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGG 234
Query: 181 LTNLRVFTAYENQLVGEIPDNLGSVSELELLNLHSNQLEGPIPKSIFASGKLEVLVLTQN 240
LT+L N L G IP +LG++ L+ L L+ N+L GPIP SIF+ KL L L+ N
Sbjct: 235 LTSLNHLDLVYNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDN 294
Query: 241 RLTGDIPELVGHCKSLSNIRIGNNDLVGVIPRAIGNVSGLTYFEADNNNLSGEIVPEFSQ 300
L+G+IPELV ++L + + +N+ G IP A+ ++ L + +N SGEI +
Sbjct: 295 SLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKFSGEIPKNLGK 354
Query: 301 CSNLTLLNLASNGFTGVIPPELGQLINLQELILYENSLFGEIPKSILACKNLNK------ 354
+NLT+L+L++N TG IP L NL +LIL+ NSL GEIPKS+ AC++L +
Sbjct: 355 HNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDN 414
Query: 355 ------------------LDLSNNRFNGTIPNAICDMSRLQYLLLGQNSLKGEIPHEIGN 396
LD+SNN G I + DM LQ L L +N G +P G+
Sbjct: 415 SFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFGS 474
Query: 397 CMKLLQLHIGSNYLTGSIPPEIGHIRNLQIALNLSFNHLHGSLPPELGKLDKLVSFDVSN 456
+L L + N +G++P ++G + L + L LS N L G +P EL KLVS D+S+
Sbjct: 475 -KRLENLDLSRNQFSGAVPRKLGSLSEL-MQLKLSENKLSGEIPDELSSCKKLVSLDLSH 532
Query: 457 NQLSGTIPSA------------------------LKGMLSLIEVNFSNNLLTGPVPSFVP 492
NQLSG IP++ L + SL++VN S+N L G +PS
Sbjct: 533 NQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHLHGSLPSTGA 592
Query: 493 FQKSPNSSFFGNKGLCGEPLSFSCGNANG-PDSKNYRHRVSYRIILAVVGSGLAVFISVT 551
F S+ GN LCG +G P K R S+ + L F+ +
Sbjct: 593 FLAINASAVAGNIDLCGG------DTTSGLPPCKRVRKTPSWWFYIT---CTLGAFLVLA 643
Query: 552 VVVLLFM-MRERQEKASKSADVADSGASSQPSIIAGNVLVENLRQAIDLDAVVKATMKDS 610
+V F+ +R R K + D Q + ++I ++ ++ +++K+
Sbjct: 644 LVAFGFVFIRGRNNLELKRVENEDGTWELQ-------FFDSKVSKSITINDIL-SSLKEE 695
Query: 611 NMIYCGTFSTVYKA-VMPSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRP 669
N+I G YK + +G+ VK + ++ E+ + KL H N+V+
Sbjct: 696 NVISRGKKGASYKGKSIKNGMQFVVKEINDVNSI-------PSSEIADMGKLQHPNIVKL 748
Query: 670 IGFVIYEDVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLH--- 726
IG E A L+H Y+ L+++L + W R IAIG+A+ L FLH
Sbjct: 749 IGLCRSEKGAYLIHEYIEGKNLSEVLRNLS--------WERRRKIAIGIAKALRFLHCRC 800
Query: 727 HVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSKGTASISAVAGSFGYIPPEYAYTM 786
A++ ++S +++D +P L L + + S Y+ PE T
Sbjct: 801 SPAVVVGNLSPEKIIIDGKDEPHL-------RLSLPGLLCTDTKCFISSAYVAPETRETK 853
Query: 787 QVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQILDARLSTV 846
+T ++Y +G++L+E+LT + P + +FG +V+W + I + V
Sbjct: 854 DITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDV 913
Query: 847 SFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEMLQ 883
S + E++ + +AL CT + P RP V++ L+
Sbjct: 914 SVN-QNEIVEVMNLALHCTATDPTARPCANDVLKTLE 949
|
Length = 968 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 113 bits (285), Expect = 2e-28
Identities = 60/192 (31%), Positives = 96/192 (50%), Gaps = 11/192 (5%)
Query: 616 GTFSTVYKAV-MPSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVI 674
G F TVY A +G +++K +K D + + + ++RE+E L KL H N+V+ G
Sbjct: 4 GGFGTVYLARDKKTGKKVAIKIIKKEDSSSLLEE--LLREIEILKKLNHPNIVKLYGVFE 61
Query: 675 YEDVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLD 734
E+ L+ Y G+L LL K+ + + L I + + EGL +LH IIH D
Sbjct: 62 DENHLYLVMEYCEGGSLKDLL----KENEGKLSEDEILRILLQILEGLEYLHSNGIIHRD 117
Query: 735 ISSGNVLLDAD-FKPLLGEIEISKLLDPSKGTASISAVAGSFGYIPPE-YAYTMQVTAPG 792
+ N+LLD+D K L + +SKLL K + G+ Y+ PE +
Sbjct: 118 LKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKT--IVGTPAYMAPEVLLGKGYYSEKS 175
Query: 793 NVYSYGVVLLEI 804
+++S GV+L E+
Sbjct: 176 DIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 1e-23
Identities = 70/262 (26%), Positives = 102/262 (38%), Gaps = 26/262 (9%)
Query: 616 GTFSTVYKAVMPS-GLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVI 674
G+F TVYKA G I++VK LK Q RE+ L +L H N+VR I
Sbjct: 10 GSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTA-RREIRILRRLSHPNIVRLIDAFE 68
Query: 675 YEDVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLD 734
+D L+ Y G L L IA+ + GL +LH IIH D
Sbjct: 69 DKDHLYLVMEYCEGGDLFDYLSRGGPL-----SEDEAKKIALQILRGLEYLHSNGIIHRD 123
Query: 735 ISSGNVLLDADFKPLLGEIEISKLLDPSKGTASISAVAGSFGYIPPE-YAYTMQVTAPGN 793
+ N+LLD + + + ++K L S + + G+ Y+ PE +
Sbjct: 124 LKPENILLDENGVVKIADFGLAKKLLKSSSSL--TTFVGTPWYMAPEVLLGGNGYGPKVD 181
Query: 794 VYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQILDARLSTVSFGWRKE 853
V+S GV+L E+LT + P + + +IL L W
Sbjct: 182 VWSLGVILYELLTGKPPFSGENILDQL------------QLIRRILGPPLEFDEPKWSSG 229
Query: 854 MLTALKVA--LLCTDSTPAKRP 873
A + L D P+KRP
Sbjct: 230 SEEAKDLIKKCLNKD--PSKRP 249
|
Length = 260 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 90.7 bits (226), Expect = 4e-20
Identities = 65/298 (21%), Positives = 106/298 (35%), Gaps = 71/298 (23%)
Query: 616 GTFSTVYKAVMPSGLILS----VKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIG 671
G F VYK + + VK LK + ++E + KL H N+VR +G
Sbjct: 6 GAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE--ERKDFLKEARVMKKLGHPNVVRLLG 63
Query: 672 FVIYEDVALLLHNYLPNGTLAQLLHESTKQ----PDYRPDWPTRLSIAIGVAEGLAFLHH 727
E+ L+ Y+ G L L +S LS AI +A+G+ +L
Sbjct: 64 VCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLAS 123
Query: 728 VAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSKGTASISAVAGSFGYIP-----PEY 782
+H D+++ N L+ D + + +S+ + + G +P PE
Sbjct: 124 KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDD-----YYRKKTGGKLPIRWMAPES 178
Query: 783 AYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQILDAR 842
T+ +V+S+GV+L EI T G TP
Sbjct: 179 LKDGIFTSKSDVWSFGVLLWEIFT------------------------LGATP------- 207
Query: 843 LSTVSFGWRKEMLTALK-----------------VALLCTDSTPAKRPKMKKVVEMLQ 883
+S +E+L L+ + L C P RP ++VE L+
Sbjct: 208 YPGLSN---EEVLEYLRKGYRLPKPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 86.4 bits (215), Expect = 1e-18
Identities = 56/207 (27%), Positives = 93/207 (44%), Gaps = 25/207 (12%)
Query: 616 GTFSTVYKAVM-PSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVI 674
G+F VY A +G ++++K +K + I + +++RE++ L KL H N+VR
Sbjct: 10 GSFGKVYLARDKKTGKLVAIKVIKK--KKIKKDRERILREIKILKKLKHPNIVRLYDVFE 67
Query: 675 YEDVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLD 734
ED L+ Y G L LL + + + + L +LH I+H D
Sbjct: 68 DEDKLYLVMEYCEGGDLFDLLKKRGRLSEDE-----ARFYLRQILSALEYLHSKGIVHRD 122
Query: 735 ISSGNVLLD-------ADFKPLLGEIEISKLLDPSKGTASISAVAGSFGYIPPEYAYTMQ 787
+ N+LLD ADF G +++ LDP + + G+ Y+ PE
Sbjct: 123 LKPENILLDEDGHVKLADF----G---LARQLDPGEKLTT---FVGTPEYMAPEVLLGKG 172
Query: 788 VTAPGNVYSYGVVLLEILTTRLPVEED 814
+++S GV+L E+LT + P D
Sbjct: 173 YGKAVDIWSLGVILYELLTGKPPFPGD 199
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 86.0 bits (213), Expect = 1e-18
Identities = 59/207 (28%), Positives = 97/207 (46%), Gaps = 11/207 (5%)
Query: 611 NMIYCGTFSTVYKAVMPS-GLILSVKR--LKSMDRTIIHHQNKMIRELEKLSKLCHDNLV 667
N I G+F V+K V + + ++K+ L M+R + + I E L+KL ++
Sbjct: 6 NKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRR---EREEAIDEARVLAKLDSSYII 62
Query: 668 RPIGFVIYEDVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHH 727
R + + ++ Y NG L +LL +P D R I I + GLA LH
Sbjct: 63 RYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRP-LPEDQVWRFFIQILL--GLAHLHS 119
Query: 728 VAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSKGTASISAVAGSFGYIPPEYAYTMQ 787
I+H DI S N+ LDA +G++ ++KLL + A + + G+ Y+ PE
Sbjct: 120 KKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFA--NTIVGTPYYLSPELCEDKP 177
Query: 788 VTAPGNVYSYGVVLLEILTTRLPVEED 814
+V++ GVVL E T + P + +
Sbjct: 178 YNEKSDVWALGVVLYECCTGKHPFDAN 204
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 82.9 bits (206), Expect = 2e-17
Identities = 64/288 (22%), Positives = 114/288 (39%), Gaps = 60/288 (20%)
Query: 616 GTFSTVYKAVM-----PSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPI 670
G F VYK + + ++VK LK + + + + E + KL H N+VR +
Sbjct: 10 GAFGEVYKGTLKGDGEGTETKVAVKTLK--EGASEEEREEFLEEASIMKKLSHPNIVRLL 67
Query: 671 GFVIYEDVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAI 730
G + ++ Y+P G L L + + L +A+ +A+G+ +L
Sbjct: 68 GVCTQGEPLYIVTEYMPGGDLLDFLR----KHGEKLTLKDLLQMALQIAKGMEYLESKNF 123
Query: 731 IHLDISSGNVLLD-------ADFKPLLGEIEISKLLDPS----KGTASISAVAGSFGYIP 779
+H D+++ N L+ +DF G +S+ + K + ++
Sbjct: 124 VHRDLAARNCLVTENLVVKISDF----G---LSRDIYEDDYYRKRGGGKLPIK----WMA 172
Query: 780 PEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQIL 839
PE + T+ +V+S+GV+L EI T GE P G + E++L
Sbjct: 173 PESLKDGKFTSKSDVWSFGVLLWEIFT--------LGE----------QPYPGMSNEEVL 214
Query: 840 DA-----RLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEML 882
+ RL E+ ++ L C P RP ++VE L
Sbjct: 215 ELLEDGYRLPR-PENCPDEL---YELMLQCWAYDPEDRPTFSELVEDL 258
|
Length = 258 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 82.2 bits (204), Expect = 3e-17
Identities = 52/219 (23%), Positives = 97/219 (44%), Gaps = 41/219 (18%)
Query: 611 NMIYCGTFSTVYKAVMP-SGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRP 669
++ G+F +VY A+ +G +++VK ++ + + RE+ LS L H N+VR
Sbjct: 6 ELLGRGSFGSVYLALDKDTGELMAVKSVE-LSGDSEEELEALEREIRILSSLQHPNIVRY 64
Query: 670 IGFVI--YEDVALLLHNYLPNGTLAQL------LHES-----TKQPDYRPDWPTRLSIAI 716
G ++ + Y+ G+L+ L L E T+Q
Sbjct: 65 YGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQ--------------- 109
Query: 717 GVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEI-----SKLLDPSKGTASISAV 771
+ EGLA+LH I+H DI N+L+D+D G +++ +K L + +V
Sbjct: 110 -ILEGLAYLHSNGIVHRDIKGANILVDSD-----GVVKLADFGCAKRLGDIETGEGTGSV 163
Query: 772 AGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILTTRLP 810
G+ ++ PE + +++S G ++E+ T + P
Sbjct: 164 RGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPP 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 84.0 bits (206), Expect = 5e-17
Identities = 57/209 (27%), Positives = 94/209 (44%), Gaps = 13/209 (6%)
Query: 613 IYCGTFSTVYKAVMPSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKL-CHDNLVRPIG 671
+ G+F VY A ++++K L + + +RE++ L+ L N+V+
Sbjct: 8 LGEGSFGEVYLAR--DRKLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYD 65
Query: 672 FVIYEDVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAII 731
F E L+ Y+ G+L LL + ++ L I + L +LH II
Sbjct: 66 FFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESE--ALFILAQILSALEYLHSKGII 123
Query: 732 HLDISSGNVLLDAD-FKPLLGEIEISKLLDPSKGTASI----SAVAGSFGYIPPEYAYTM 786
H DI N+LLD D L + ++KLL T+SI S G+ GY+ PE +
Sbjct: 124 HRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGL 183
Query: 787 ---QVTAPGNVYSYGVVLLEILTTRLPVE 812
++ +++S G+ L E+LT P E
Sbjct: 184 SLAYASSSSDIWSLGITLYELLTGLPPFE 212
|
Length = 384 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 80.3 bits (199), Expect = 1e-16
Identities = 62/294 (21%), Positives = 111/294 (37%), Gaps = 71/294 (24%)
Query: 615 CGTFSTVYKAV-----MPSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRP 669
G F VYK + ++VK LK + + +RE + KL H N+V+
Sbjct: 9 EGAFGEVYKGKLKGKGGKKKVEVAVKTLK--EDASEQQIEEFLREARIMRKLDHPNVVKL 66
Query: 670 IGFVIYEDVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVA 729
+G E+ ++ Y+ G L L ++ + LS A+ +A G+ +L
Sbjct: 67 LGVCTEEEPLYIVMEYMEGGDLLSYL----RKNRPKLSLSDLLSFALQIARGMEYLESKN 122
Query: 730 IIHLDISSGNVLLD-------ADFKPLLGEIEISKLLDPSKGTASISA---VAGSFGYIP 779
IH D+++ N L+ +DF G +S+ L + ++
Sbjct: 123 FIHRDLAARNCLVGENLVVKISDF----G---LSRDLYDDDYYRKRGGKLPIR----WMA 171
Query: 780 PE----YAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGE-------GVDLVKWVHGA 828
PE +T + +V+S+GV+L EI T GE ++++++
Sbjct: 172 PESLKEGKFTSKS----DVWSFGVLLWEIFT--------LGEQPYPGMSNEEVLEYL--- 216
Query: 829 PARGETPEQILDARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEML 882
G Q + E+ + L C P RP ++VE+L
Sbjct: 217 -KNGYRLPQPPNC---------PPEL---YDLMLQCWAEDPEDRPTFSELVEIL 257
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 83.7 bits (207), Expect = 2e-16
Identities = 43/107 (40%), Positives = 59/107 (55%), Gaps = 5/107 (4%)
Query: 53 WKGIDCDLNQA----FVVKLDLSRLQLRGNI-TLVSELKALKRLDLSNNAFSGTIPSAFG 107
W G DC + F+ L L LRG I +S+L+ L+ ++LS N+ G IP + G
Sbjct: 404 WSGADCQFDSTKGKWFIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLG 463
Query: 108 NLSELEFLDLSLNKFGGVIPRELGSLKDLRFFNISNNVLVGEIPDEL 154
+++ LE LDLS N F G IP LG L LR N++ N L G +P L
Sbjct: 464 SITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAAL 510
|
Length = 623 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 79.1 bits (196), Expect = 3e-16
Identities = 65/291 (22%), Positives = 111/291 (38%), Gaps = 64/291 (21%)
Query: 615 CGTFSTVYKAVMPSGLILS-----VKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRP 669
G F VYK + VK LK + + +RE + KL H N+V+
Sbjct: 9 EGAFGEVYKGTLKGKGDGKEVEVAVKTLK--EDASEQQIEEFLREARIMRKLDHPNIVKL 66
Query: 670 IGFVIYEDVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVA 729
+G E+ +++ Y+P G L L K LS A+ +A G+ +L
Sbjct: 67 LGVCTEEEPLMIVMEYMPGGDLLDYLR---KNRPKELSLSDLLSFALQIARGMEYLESKN 123
Query: 730 IIHLDISSGNVLLDADFKPLLGEIEISKLLDP--SKGTASISAVAGSFGYIP-----PE- 781
IH D+++ N L+ + ++IS D S+ G +P PE
Sbjct: 124 FIHRDLAARNCLVGENLV-----VKIS---DFGLSRDLYDDDYYKVKGGKLPIRWMAPES 175
Query: 782 ---YAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGE-------GVDLVKWVHGAPAR 831
+T + +V+S+GV+L EI T GE ++++++ +
Sbjct: 176 LKEGKFTSKS----DVWSFGVLLWEIFT--------LGEEPYPGMSNAEVLEYL----KK 219
Query: 832 GETPEQILDARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEML 882
G + + E+ K+ L C P RP ++VE+L
Sbjct: 220 GYRLPKPPNC---------PPEL---YKLMLQCWAEDPEDRPTFSELVEIL 258
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 77.6 bits (192), Expect = 1e-15
Identities = 58/210 (27%), Positives = 101/210 (48%), Gaps = 37/210 (17%)
Query: 616 GTFSTVYKAV-MPSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVI 674
G+ VYK P+G I ++K++ Q ++REL+ L +V+ G
Sbjct: 12 GSSGVVYKVRHKPTGKIYALKKIHVDGDEEFRKQ--LLRELKTLRSCESPYVVKCYG-AF 68
Query: 675 YED--VALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVA-II 731
Y++ ++++L Y+ G+LA LL + K P+ P IA + +GL +LH II
Sbjct: 69 YKEGEISIVLE-YMDGGSLADLLKKVGKIPE-----PVLAYIARQILKGLDYLHTKRHII 122
Query: 732 HLDISSGNVLLDADFKPLLGEIEI-----SKLLDPSKGTASISAVAGSFGYIPPE----- 781
H DI N+L+++ GE++I SK+L+ + + + V G+ Y+ PE
Sbjct: 123 HRDIKPSNLLINSK-----GEVKIADFGISKVLENTLDQCN-TFV-GTVTYMSPERIQGE 175
Query: 782 -YAYTMQVTAPGNVYSYGVVLLEILTTRLP 810
Y+Y +++S G+ LLE + P
Sbjct: 176 SYSY------AADIWSLGLTLLECALGKFP 199
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 7e-15
Identities = 69/231 (29%), Positives = 105/231 (45%), Gaps = 9/231 (3%)
Query: 245 DIPELVGHCKSLSNIRIGNNDLVGVIPRAIGNVSGLTYFEADNNNLSGEIVPEFSQCSNL 304
D E + + L ++ + N L I + ++ LT + DNNN++ SNL
Sbjct: 84 DGSENLLNLLPLPSLDLNLNRLRSNISE-LLELTNLTSLDLDNNNITDIPPLIGLLKSNL 142
Query: 305 TLLNLASNGFTGVIPPELGQLINLQELILYENSLFGEIPKSILACKNLNKLDLSNNRFNG 364
L+L+ N +P L L NL+ L L N L ++PK + NLN LDLS N+ +
Sbjct: 143 KELDLSDNKIE-SLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKIS- 199
Query: 365 TIPNAICDMSRLQYLLLGQNSLKGEIPHEIGNCMKLLQLHIGSNYLTGSIPPEIGHIRNL 424
+P I +S L+ L L NS+ E+ + N L L + +N L IG++ NL
Sbjct: 200 DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLEDLPES-IGNLSNL 257
Query: 425 QIALNLSFNHLHGSLPPELGKLDKLVSFDVSNNQLSGTIPSALKGMLSLIE 475
+ L ++ S LG L L D+S N LS +P +L L
Sbjct: 258 ET---LDLSNNQISSISSLGSLTNLRELDLSGNSLSNALPLIALLLLLLEL 305
|
Length = 394 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 77.9 bits (192), Expect = 1e-14
Identities = 36/89 (40%), Positives = 54/89 (60%)
Query: 307 LNLASNGFTGVIPPELGQLINLQELILYENSLFGEIPKSILACKNLNKLDLSNNRFNGTI 366
L L + G G IP ++ +L +LQ + L NS+ G IP S+ + +L LDLS N FNG+I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 367 PNAICDMSRLQYLLLGQNSLKGEIPHEIG 395
P ++ ++ L+ L L NSL G +P +G
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 74.6 bits (184), Expect = 1e-14
Identities = 48/206 (23%), Positives = 89/206 (43%), Gaps = 23/206 (11%)
Query: 616 GTFSTVYKA-VMPSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVI 674
G F VYKA +G +++K + + K+I E++ L K H N+V+ G +
Sbjct: 11 GGFGEVYKARHKRTGKEVAIKV---IKLESKEKKEKIINEIQILKKCKHPNIVKYYGSYL 67
Query: 675 YEDVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLS------IAIGVAEGLAFLHHV 728
+D ++ + G+L LL L+ + + +GL +LH
Sbjct: 68 KKDELWIVMEFCSGGSLKDLLKS----------TNQTLTESQIAYVCKELLKGLEYLHSN 117
Query: 729 AIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSKGTASISAVAGSFGYIPPEYAYTMQV 788
IIH DI + N+LL +D + L + +S L +K ++ G+ ++ PE
Sbjct: 118 GIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTM---VGTPYWMAPEVINGKPY 174
Query: 789 TAPGNVYSYGVVLLEILTTRLPVEED 814
+++S G+ +E+ + P E
Sbjct: 175 DYKADIWSLGITAIELAEGKPPYSEL 200
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 76.4 bits (188), Expect = 3e-14
Identities = 42/111 (37%), Positives = 66/111 (59%), Gaps = 5/111 (4%)
Query: 410 LTGSIPPEIGHIRNLQIALNLSFNHLHGSLPPELGKLDKLVSFDVSNNQLSGTIPSALKG 469
L G IP +I +R+LQ ++NLS N + G++PP LG + L D+S N +G+IP +L
Sbjct: 430 LRGFIPNDISKLRHLQ-SINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQ 488
Query: 470 MLSLIEVNFSNNLLTGPVPSFV---PFQKSPNSSFFGNKGLCGEPLSFSCG 517
+ SL +N + N L+G VP+ + ++ + +F N GLCG P +CG
Sbjct: 489 LTSLRILNLNGNSLSGRVPAALGGRLLHRA-SFNFTDNAGLCGIPGLRACG 538
|
Length = 623 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 73.6 bits (181), Expect = 3e-14
Identities = 50/213 (23%), Positives = 91/213 (42%), Gaps = 24/213 (11%)
Query: 607 MKDSNMIYCGTFSTVYKAVMP-----SGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKL 661
+K + G F V +G ++VK L H++ RE+E L L
Sbjct: 6 LKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHS--GEEQHRSDFEREIEILRTL 63
Query: 662 CHDNLVRPIGFVIYEDVA---LLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGV 718
H+N+V+ G V + L+ YLP+G+L L Q + L + +
Sbjct: 64 DHENIVKYKG-VCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINL----KRLLLFSSQI 118
Query: 719 AEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSKGTASISAVAGSFGYI 778
+G+ +L IH D+++ N+L++++ + + ++K+L K G
Sbjct: 119 CKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDY----YYVKEPGES 174
Query: 779 P-----PEYAYTMQVTAPGNVYSYGVVLLEILT 806
P PE T + ++ +V+S+GV L E+ T
Sbjct: 175 PIFWYAPECLRTSKFSSASDVWSFGVTLYELFT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 5e-13
Identities = 40/104 (38%), Positives = 57/104 (54%), Gaps = 2/104 (1%)
Query: 355 LDLSNNRFNGTIPNAICDMSRLQYLLLGQNSLKGEIPHEIGNCMKLLQLHIGSNYLTGSI 414
L L N G IPN I + LQ + L NS++G IP +G+ L L + N GSI
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 415 PPEIGHIRNLQIALNLSFNHLHGSLPPELG-KLDKLVSFDVSNN 457
P +G + +L+I LNL+ N L G +P LG +L SF+ ++N
Sbjct: 483 PESLGQLTSLRI-LNLNGNSLSGRVPAALGGRLLHRASFNFTDN 525
|
Length = 623 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 69.7 bits (171), Expect = 6e-13
Identities = 66/277 (23%), Positives = 117/277 (42%), Gaps = 42/277 (15%)
Query: 616 GTFSTVYKAV-MPSGLILSVKRLK-SMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFV 673
G V K + P+G I++VK ++ ++ I Q +++REL+ L K +V G
Sbjct: 12 GNSGVVSKVLHRPTGKIMAVKTIRLEINEAI---QKQILRELDILHKCNSPYIVGFYGAF 68
Query: 674 IYEDVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLS-IAIGVAEGLAFLHHV-AII 731
+ Y+ G+L ++L E + R L IA+ V +GL +LH II
Sbjct: 69 YNNGDISICMEYMDGGSLDKILKEVQGRIPERI-----LGKIAVAVLKGLTYLHEKHKII 123
Query: 732 HLDISSGNVLLDADFKPLLGEIEISKLLDPSKGTASISAVAGSF----GYIPPEYAYTMQ 787
H D+ N+L+++ G+I KL D ++++A +F Y+ PE
Sbjct: 124 HRDVKPSNILVNS-----RGQI---KLCDFGVSGQLVNSLAKTFVGTSSYMAPERIQGND 175
Query: 788 VTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQILDA---RLS 844
+ +++S G+ L+E+ T R P E + I++ RL
Sbjct: 176 YSVKSDIWSLGLSLIELATGRFPYP----------PENDPPDGIFELLQYIVNEPPPRLP 225
Query: 845 TVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEM 881
S + + + LC P +RP K+++E
Sbjct: 226 --SGKFSPDFQDFVN---LCLIKDPRERPSYKELLEH 257
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 69.0 bits (169), Expect = 1e-12
Identities = 53/209 (25%), Positives = 96/209 (45%), Gaps = 12/209 (5%)
Query: 612 MIYCGTFSTVYKAV-MPSGLILSVKR--LKSMDRTIIHHQNKMIRELEKLSKLCHDNLVR 668
++ G+F +VY+ + + G +VK L +T ++ +E+ LSKL H N+V+
Sbjct: 7 LLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQ 66
Query: 669 PIGFVIYEDVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHV 728
+G ED + +P G+LA+LL + P+ TR + GL +LH
Sbjct: 67 YLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILL-----GLEYLHDR 121
Query: 729 AIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSKGTASISAVAGSFGYIPPEY-AYTMQ 787
+H DI N+L+D + L + ++K + + + GS ++ PE A
Sbjct: 122 NTVHRDIKGANILVDTNGVVKLADFGMAKQV---VEFSFAKSFKGSPYWMAPEVIAQQGG 178
Query: 788 VTAPGNVYSYGVVLLEILTTRLPVEEDFG 816
+++S G +LE+ T + P + G
Sbjct: 179 YGLAADIWSLGCTVLEMATGKPPWSQLEG 207
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 68.1 bits (167), Expect = 2e-12
Identities = 62/214 (28%), Positives = 96/214 (44%), Gaps = 20/214 (9%)
Query: 610 SNMIYCGTFSTVYKAV-MPSGLILSVK--RLKSMDRTIIHHQNKMI-RELEKLSKLCHDN 665
N I GTF VY AV + +G +++VK R++ D I K I E++ L L H N
Sbjct: 5 GNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDNDPKTI----KEIADEMKVLELLKHPN 60
Query: 666 LVRPIGFVIYEDVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFL 725
LV+ G ++ + + Y GTL +LL ++ R+ + + EGLA+L
Sbjct: 61 LVKYYGVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHV----IRV-YTLQLLEGLAYL 115
Query: 726 HHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSKGTASISAVAGSFG---YIPPE- 781
H I+H DI N+ LD + LG+ + L + T V G Y+ PE
Sbjct: 116 HSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNN-TTTMGEEVQSLAGTPAYMAPEV 174
Query: 782 YAYTMQVTAPG--NVYSYGVVLLEILTTRLPVEE 813
+++S G V+LE+ T + P E
Sbjct: 175 ITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSE 208
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 67.3 bits (165), Expect = 3e-12
Identities = 55/205 (26%), Positives = 99/205 (48%), Gaps = 27/205 (13%)
Query: 616 GTFSTVYKAV-MPSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVI 674
G F VYK + + +G +++K++ ++ M +E++ L L H N+V+ IG +
Sbjct: 11 GAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIM-QEIDLLKNLKHPNIVKYIGSIE 69
Query: 675 YEDVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVA---EGLAFLHHVAII 731
D ++ Y NG+L Q++ + P+ +A+ V +GLA+LH +I
Sbjct: 70 TSDSLYIILEYAENGSLRQIIKKFGPFPE--------SLVAVYVYQVLQGLAYLHEQGVI 121
Query: 732 HLDISSGNVLLDADFKPLLGEIEIS------KLLDPSKGTASISAVAGSFGYIPPEYAYT 785
H DI + N+L D G ++++ KL D SK AS V G+ ++ PE
Sbjct: 122 HRDIKAANILTTKD-----GVVKLADFGVATKLNDVSKDDAS---VVGTPYWMAPEVIEM 173
Query: 786 MQVTAPGNVYSYGVVLLEILTTRLP 810
+ +++S G ++E+LT P
Sbjct: 174 SGASTASDIWSLGCTVIELLTGNPP 198
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 4e-12
Identities = 56/210 (26%), Positives = 102/210 (48%), Gaps = 17/210 (8%)
Query: 612 MIYCGTFSTVYKAV-MPSGLILSVKRLKSMDRTIIHHQNKMIR--------ELEKLSKLC 662
+I GT+ VY A+ + +G +++VK+++ + TI + + E+E L L
Sbjct: 8 LIGKGTYGRVYLALNVTTGEMMAVKQVE-LPATIAGRHDSRQKDMVKALRSEIETLKDLD 66
Query: 663 HDNLVRPIGFVIYEDVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGL 722
H N+V+ +GF E+ + Y+P G++ L + + + V EGL
Sbjct: 67 HLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGR---FEEQLVRFFTEQ--VLEGL 121
Query: 723 AFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSKGTASISAVAGSFGYIPPEY 782
A+LH I+H D+ + N+L+DAD + + ISK D ++ GS ++ PE
Sbjct: 122 AYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEV 181
Query: 783 AYTMQ--VTAPGNVYSYGVVLLEILTTRLP 810
++ +A +++S G V+LE+ R P
Sbjct: 182 IHSYSQGYSAKVDIWSLGCVVLEMFAGRRP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 67.9 bits (166), Expect = 1e-11
Identities = 39/102 (38%), Positives = 54/102 (52%), Gaps = 3/102 (2%)
Query: 105 AFGNLSELEFLD-LSLNKFG--GVIPRELGSLKDLRFFNISNNVLVGEIPDELKSLEKLE 161
F + F+D L L+ G G IP ++ L+ L+ N+S N + G IP L S+ LE
Sbjct: 410 QFDSTKGKWFIDGLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLE 469
Query: 162 DFQVSSNKLNGSIPFWVGNLTNLRVFTAYENQLVGEIPDNLG 203
+S N NGSIP +G LT+LR+ N L G +P LG
Sbjct: 470 VLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 67.5 bits (165), Expect = 2e-11
Identities = 30/87 (34%), Positives = 51/87 (58%)
Query: 140 NISNNVLVGEIPDELKSLEKLEDFQVSSNKLNGSIPFWVGNLTNLRVFTAYENQLVGEIP 199
+ N L G IP+++ L L+ +S N + G+IP +G++T+L V N G IP
Sbjct: 424 GLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIP 483
Query: 200 DNLGSVSELELLNLHSNQLEGPIPKSI 226
++LG ++ L +LNL+ N L G +P ++
Sbjct: 484 ESLGQLTSLRILNLNGNSLSGRVPAAL 510
|
Length = 623 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 2e-11
Identities = 48/200 (24%), Positives = 95/200 (47%), Gaps = 4/200 (2%)
Query: 616 GTFSTVYKAV-MPSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVI 674
G FS VYKA+ + G ++++K+++ + + ++E++ L +L H N+++ + I
Sbjct: 13 GQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFI 72
Query: 675 YEDVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLD 734
+ ++ G L++++ KQ P+ T + + L +H I+H D
Sbjct: 73 ENNELNIVLELADAGDLSRMIKHFKKQKRLIPE-RTIWKYFVQLCSALEHMHSKRIMHRD 131
Query: 735 ISSGNVLLDADFKPLLGEIEISKLLDPSKGTASISAVAGSFGYIPPEYAYTMQVTAPGNV 794
I NV + A LG++ + + SK TA+ S V G+ Y+ PE + ++
Sbjct: 132 IKPANVFITATGVVKLGDLGLGRFFS-SKTTAAHSLV-GTPYYMSPERIHENGYNFKSDI 189
Query: 795 YSYGVVLLEILTTRLPVEED 814
+S G +L E+ + P D
Sbjct: 190 WSLGCLLYEMAALQSPFYGD 209
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 64.8 bits (158), Expect = 3e-11
Identities = 64/283 (22%), Positives = 114/283 (40%), Gaps = 43/283 (15%)
Query: 627 PSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIG-FVIYEDVAL-LLHN 684
+G+I ++K + + + Q ++RELE +V+ G F+ ++ +
Sbjct: 24 NTGMIFALKTITTDPNPDLQKQ--ILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAME 81
Query: 685 YLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDA 744
Y G+L + + K+ + IA V +GL++LH IIH DI N+LL
Sbjct: 82 YCEGGSLDSIYKKVKKRGGRIGEKVL-GKIAESVLKGLSYLHSRKIIHRDIKPSNILLTR 140
Query: 745 DFKPLLGEIEISKLLDPSKGTASISAVAGSFG----YIPPEYAYTMQVTAPGNVYSYGVV 800
G++ KL D ++++AG+F Y+ PE + +V+S G+
Sbjct: 141 K-----GQV---KLCDFGVSGELVNSLAGTFTGTSFYMAPERIQGKPYSITSDVWSLGLT 192
Query: 801 LLEILTTRLPVEEDFGEGV---DLVKWVHGAPARGETPEQILDARLSTVSFGWRKEMLTA 857
LLE+ R P + + +L+ ++ PE + W +E
Sbjct: 193 LLEVAQNRFPFPPEGEPPLGPIELLSYI----VNMPNPELKDEPGNGIK---WSEEFKDF 245
Query: 858 LKVALLCTDSTPAKRPK-------------MKKVVEMLQEIKQ 887
+K C + P +RP MKK V M + + Q
Sbjct: 246 IKQ---CLEKDPTRRPTPWDMLEHPWIKAQMKKKVNMAKFVAQ 285
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 63.6 bits (155), Expect = 6e-11
Identities = 53/210 (25%), Positives = 87/210 (41%), Gaps = 25/210 (11%)
Query: 616 GTFSTVYKAVMPSGL------ILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRP 669
G F V+ +++VK LK RE E L+ H+N+V+
Sbjct: 16 GAFGKVFLGECYHLEPENDKELVAVKTLKETASNDARKD--FEREAELLTNFQHENIVKF 73
Query: 670 IGFVIYEDVALLLHNYLPNGTLAQLLHE------STKQPDYRPDWPTR---LSIAIGVAE 720
G D +++ Y+ +G L + L K PD T L IA+ +A
Sbjct: 74 YGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIAS 133
Query: 721 GLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSKGTASISAVAGS----FG 776
G+ +L +H D+++ N L+ D +G+ +S+ + T V G
Sbjct: 134 GMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDV----YTTDYYRVGGHTMLPIR 189
Query: 777 YIPPEYAYTMQVTAPGNVYSYGVVLLEILT 806
++PPE + T +V+S+GVVL EI T
Sbjct: 190 WMPPESIMYRKFTTESDVWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 7e-11
Identities = 56/217 (25%), Positives = 95/217 (43%), Gaps = 45/217 (20%)
Query: 616 GTFSTVYKAVMPSGLILSVKR--------LKSMDRTIIHHQNKM--IRELEKLSKLCHDN 665
G++ +VYK VKR LK +D + + + + E+ L+ + H N
Sbjct: 11 GSYGSVYK----------VKRLSDNQFYALKEVDLGSMSQKEREDAVNEIRILASVNHPN 60
Query: 666 LVRPIGFVIYEDVALLLHN-------YLPNGTLAQLLHESTKQPDYRPD---WPTRLSIA 715
++ Y++ A L N Y P G L++ + + K+ P+ W I
Sbjct: 61 IIS------YKE-AFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIW----RIF 109
Query: 716 IGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSKGTASISAVAGSF 775
I + GL LH I+H D+ S N+LL A+ +G++ ISK+L K + G+
Sbjct: 110 IQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVL---KKNMA-KTQIGTP 165
Query: 776 GYIPPEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVE 812
Y+ PE + +++S G +L E+ T P E
Sbjct: 166 HYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFE 202
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 7e-11
Identities = 56/211 (26%), Positives = 101/211 (47%), Gaps = 18/211 (8%)
Query: 612 MIYCGTFSTVYKAV-MPSGLILSVKR--LKSMDRTIIHHQNKMI----RELEKLSKLCHD 664
+I G+F +VY + SG +++VK+ L S+ + + M+ RE+ L +L H+
Sbjct: 7 LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66
Query: 665 NLVRPIGFVIYEDVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAF 724
N+V+ +G + D + Y+P G++A LL+ + + + +GL +
Sbjct: 67 NIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEE-----TLVRNFVRQILKGLNY 121
Query: 725 LHHVAIIHLDISSGNVLLDADFKPLLGEIEISK-----LLDPSKGTASISAVAGSFGYIP 779
LH+ IIH DI N+L+D + + ISK L A S + GS ++
Sbjct: 122 LHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPS-LQGSVFWMA 180
Query: 780 PEYAYTMQVTAPGNVYSYGVVLLEILTTRLP 810
PE T +++S G +++E+LT + P
Sbjct: 181 PEVVKQTSYTRKADIWSLGCLVVEMLTGKHP 211
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 8e-11
Identities = 63/284 (22%), Positives = 119/284 (41%), Gaps = 47/284 (16%)
Query: 616 GTFSTVYKA--VMPSGLILSVKRLKSMDRTIIHHQNKMIRELEK----LSKLCHDNLVRP 669
G FS+ Y+A V +G +++VK++ + R Q +++ L K +++L H +++R
Sbjct: 11 GAFSSCYQARDVK-TGTLMAVKQV-TYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRM 68
Query: 670 IGFVIYEDVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIA--IGVAEGLAFLHH 727
+G + L ++ G+++ LL Y + + I + GL++LH
Sbjct: 69 LGATCEDSHFNLFVEWMAGGSVSHLLS------KYGA-FKEAVIINYTEQLLRGLSYLHE 121
Query: 728 VAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSKGTASISAVA-------GSFGYIPP 780
IIH D+ N+L+D+ + + I+ ++ A + G+ ++ P
Sbjct: 122 NQIIHRDVKGANLLIDSTGQ----RLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAP 177
Query: 781 EYAYTMQVTAPGNVYSYGVVLLEILTTRLPVE-EDFGEGVDLVKWVHGAPARGETPEQIL 839
E Q +V+S G V++E+ T + P E + L+ + A PE +
Sbjct: 178 EVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAPSIPEHL- 236
Query: 840 DARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEMLQ 883
S G R V L C + P RP E+L+
Sbjct: 237 -------SPGLR-------DVTLRCLELQPEDRP---PSRELLK 263
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 1e-10
Identities = 72/301 (23%), Positives = 114/301 (37%), Gaps = 62/301 (20%)
Query: 601 AVVKATMKDSNMIYCGTFSTVYKAVMPSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSK 660
A+ +K I G F V G ++VK LK + E ++
Sbjct: 2 AINSKELKLGATIGKGEFGDVMLGDY-RGQKVAVKCLKDDSTAA----QAFLAEASVMTT 56
Query: 661 LCHDNLVRPIGFVIYEDVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAE 720
L H NLV+ +G V+ + ++ Y+ G+L L + +L A+ V E
Sbjct: 57 LRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQ---QLGFALDVCE 113
Query: 721 GLAFLHHVAIIHLDISSGNVLLD-------ADF---KPLLGEIEISKLLDPSKGTASISA 770
G+ +L +H D+++ NVL+ +DF K + KL P K TA
Sbjct: 114 GMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQDSGKL--PVKWTA---- 167
Query: 771 VAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILT------TRLPVEEDFGEGVDLVKW 824
PE + + +V+S+G++L EI + R+P++ D+V
Sbjct: 168 ---------PEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK-------DVVPH 211
Query: 825 VHGAPARGETPEQILDARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEMLQE 884
V R E PE KV C + PAKRP K++ E L
Sbjct: 212 VEKG-YRMEAPEGCPPE---------------VYKVMKDCWELDPAKRPTFKQLREQLAL 255
Query: 885 I 885
I
Sbjct: 256 I 256
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 62.8 bits (153), Expect = 1e-10
Identities = 66/282 (23%), Positives = 111/282 (39%), Gaps = 43/282 (15%)
Query: 616 GTFSTVYKA--VMPSGLILSV--KRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIG 671
G+F V + G ++ V K LKS + I + ++E + L H+NL+R G
Sbjct: 6 GSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDI--MDDFLKEAAIMHSLDHENLIRLYG 63
Query: 672 FVIYEDVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAII 731
V+ +++ P G+L L + + T A+ +A G+ +L I
Sbjct: 64 -VVLTHPLMMVTELAPLGSLLDRLRKD--ALGHFL-ISTLCDYAVQIANGMRYLESKRFI 119
Query: 732 HLDISSGNVLLDADFKPLLGEIEISKLLDPSKGTASISA-VAGSFGYIPPEYAYTMQVTA 790
H D+++ N+LL +D K +G+ + + L ++ + + F + PE T +
Sbjct: 120 HRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTFSH 179
Query: 791 PGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQILDARLSTVSFGW 850
+V+ +GV L E+ T +GE P G + QIL
Sbjct: 180 ASDVWMFGVTLWEMFT--------YGE----------EPWAGLSGSQILKK------IDK 215
Query: 851 RKEMLTALK--------VALLCTDSTPAKRPKMKKVVEMLQE 884
E L + V L C PA RP + E L E
Sbjct: 216 EGERLERPEACPQDIYNVMLQCWAHNPADRPTFAALREFLPE 257
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 3e-10
Identities = 48/207 (23%), Positives = 90/207 (43%), Gaps = 19/207 (9%)
Query: 616 GTFSTVYKA----VMPSG--LILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRP 669
G F V+ A ++P ++++VK LK + + RE E L+ L H ++VR
Sbjct: 16 GAFGKVFLAECHNLLPEQDKMLVAVKALKEASESA---RQDFQREAELLTVLQHQHIVRF 72
Query: 670 IGFVIYEDVALLLHNYLPNGTL----------AQLLHESTKQPDYRPDWPTRLSIAIGVA 719
G L++ Y+ +G L A++L + L+IA +A
Sbjct: 73 YGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIA 132
Query: 720 EGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSKGTASISAVAGSFGYIP 779
G+ +L + +H D+++ N L+ +G+ +S+ + + ++P
Sbjct: 133 SGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMP 192
Query: 780 PEYAYTMQVTAPGNVYSYGVVLLEILT 806
PE + T +++S+GVVL EI T
Sbjct: 193 PESILYRKFTTESDIWSFGVVLWEIFT 219
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 61.5 bits (149), Expect = 3e-10
Identities = 41/198 (20%), Positives = 96/198 (48%), Gaps = 7/198 (3%)
Query: 612 MIYCGTFSTVYKAVMP-SGLILSVKRLKSMDRTIIHHQ-NKMIRELEKLSKLCHDNLVRP 669
+I G F V++ ++ G +K++ Q + E + + H N++R
Sbjct: 12 VIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTEKQRQDFLSEASIMGQFSHHNIIRL 71
Query: 670 IGFVIYEDVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVA 729
G V A+++ Y+ NG L + L + ++ + + G+A G+ +L +
Sbjct: 72 EGVVTKFKPAMIITEYMENGALDKYLRD--HDGEFSS--YQLVGMLRGIAAGMKYLSDMN 127
Query: 730 IIHLDISSGNVLLDADFKPLLGEIEISKLL-DPSKGTASISAVAGSFGYIPPEYAYTMQV 788
+H D+++ N+L++++ + + + +S++L D +GT + S + PE +
Sbjct: 128 YVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKF 187
Query: 789 TAPGNVYSYGVVLLEILT 806
T+ +V+S+G+V+ E+++
Sbjct: 188 TSASDVWSFGIVMWEVMS 205
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 62.9 bits (153), Expect = 4e-10
Identities = 37/109 (33%), Positives = 50/109 (45%), Gaps = 6/109 (5%)
Query: 263 NNDLVGVIPRAIGNVSGLTYFEADNNNLSGEIVPEFSQCSNLTLLNLASNGFTGVIPPEL 322
N L G IP I + L N++ G I P ++L +L+L+ N F G IP L
Sbjct: 427 NQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESL 486
Query: 323 GQLINLQELILYENSLFGEIPKSILACKNLNKLDLSNNRFNGTIPNAIC 371
GQL +L+ L L NSL G +P + L L FN T +C
Sbjct: 487 GQLTSLRILNLNGNSLSGRVPAA------LGGRLLHRASFNFTDNAGLC 529
|
Length = 623 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 62.5 bits (152), Expect = 5e-10
Identities = 39/114 (34%), Positives = 59/114 (51%), Gaps = 5/114 (4%)
Query: 191 ENQ-LVGEIPDNLGSVSELELLNLHSNQLEGPIPKSIFASGKLEVLVLTQNRLTGDIPEL 249
+NQ L G IP+++ + L+ +NL N + G IP S+ + LEVL L+ N G IPE
Sbjct: 426 DNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPES 485
Query: 250 VGHCKSLSNIRIGNNDLVGVIPRAIGN--VSGLTYFEADNNNLSGEIVPEFSQC 301
+G SL + + N L G +P A+G + ++ DN L G +P C
Sbjct: 486 LGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDNAGLCG--IPGLRAC 537
|
Length = 623 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 6e-10
Identities = 55/240 (22%), Positives = 109/240 (45%), Gaps = 15/240 (6%)
Query: 616 GTFSTVYKAVMPSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIY 675
G F V+ +++K LK + ++E + + KL H+ LV+ + V+
Sbjct: 17 GCFGEVWMGTWNGTTRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQ-LYAVVS 71
Query: 676 EDVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDI 735
E+ ++ Y+ G+L L + P + +A +A G+A++ + +H D+
Sbjct: 72 EEPIYIVTEYMSKGSLLDFLKGEMGK---YLRLPQLVDMAAQIASGMAYVERMNYVHRDL 128
Query: 736 SSGNVLLDADFKPLLGEIEISKLLDPSKGTASISAVAGSFGYIPPEYAYTMQVTAPGNVY 795
+ N+L+ + + + +++L++ ++ TA A + PE A + T +V+
Sbjct: 129 RAANILVGENLVCKVADFGLARLIEDNEYTARQGA-KFPIKWTAPEAALYGRFTIKSDVW 187
Query: 796 SYGVVLLEILTT-RLPVEEDFG-EGVDLVKWVHGAPARGETPEQILDARLSTVSFGWRKE 853
S+G++L E+ T R+P E +D V+ + P E PE + D WRKE
Sbjct: 188 SFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPCPPECPESLHDLMCQC----WRKE 243
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 7e-10
Identities = 58/204 (28%), Positives = 99/204 (48%), Gaps = 23/204 (11%)
Query: 616 GTFSTVYKAVMP-SGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVI 674
G+F VY A + +++VK++ + +I+E++ L +L H N + G +
Sbjct: 32 GSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYL 91
Query: 675 YEDVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLD 734
E A L+ Y G+ + LL E K+P + +I G +GLA+LH +IH D
Sbjct: 92 KEHTAWLVMEYCL-GSASDLL-EVHKKPLQEVEIA---AITHGALQGLAYLHSHNMIHRD 146
Query: 735 ISSGNVLLDADFKPLLGEIEISKLLDPSKGTASISAVAGSFGYIP----PEYAYTM---Q 787
I +GN+LL +P G+++++ G+AS S+ A SF P PE M Q
Sbjct: 147 IKAGNILLT---EP--GQVKLADF-----GSASKSSPANSFVGTPYWMAPEVILAMDEGQ 196
Query: 788 VTAPGNVYSYGVVLLEILTTRLPV 811
+V+S G+ +E+ + P+
Sbjct: 197 YDGKVDVWSLGITCIELAERKPPL 220
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 8e-10
Identities = 40/160 (25%), Positives = 85/160 (53%), Gaps = 6/160 (3%)
Query: 652 IRELEKLSKLCHDNLVRPIGFVIYEDVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTR 711
++E + + KL HD LV P+ V+ E+ ++ ++ G+L L E + P
Sbjct: 49 LQEAQIMKKLRHDKLV-PLYAVVSEEPIYIVTEFMGKGSLLDFLKEGDGK---YLKLPQL 104
Query: 712 LSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSKGTASISAV 771
+ +A +A+G+A++ + IH D+ + N+L+ + + + +++L++ ++ TA A
Sbjct: 105 VDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYTARQGA- 163
Query: 772 AGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILTT-RLP 810
+ PE A + T +V+S+G++L E++T R+P
Sbjct: 164 KFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 61.4 bits (149), Expect = 1e-09
Identities = 28/82 (34%), Positives = 43/82 (52%)
Query: 338 LFGEIPKSILACKNLNKLDLSNNRFNGTIPNAICDMSRLQYLLLGQNSLKGEIPHEIGNC 397
L G IP I ++L ++LS N G IP ++ ++ L+ L L NS G IP +G
Sbjct: 430 LRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQL 489
Query: 398 MKLLQLHIGSNYLTGSIPPEIG 419
L L++ N L+G +P +G
Sbjct: 490 TSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 59.7 bits (144), Expect = 1e-09
Identities = 47/200 (23%), Positives = 93/200 (46%), Gaps = 4/200 (2%)
Query: 616 GTFSTVYKAV-MPSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVI 674
G FS VY+A + G+ +++K+++ D + I+E++ L +L H N+++ I
Sbjct: 13 GQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFI 72
Query: 675 YEDVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLD 734
++ ++ G L++++ KQ P+ T + + L +H ++H D
Sbjct: 73 EDNELNIVLELADAGDLSRMIKHFKKQKRLIPE-KTVWKYFVQLCSALEHMHSRRVMHRD 131
Query: 735 ISSGNVLLDADFKPLLGEIEISKLLDPSKGTASISAVAGSFGYIPPEYAYTMQVTAPGNV 794
I NV + A LG++ + + SK TA+ S V + Y+ PE + ++
Sbjct: 132 IKPANVFITATGVVKLGDLGLGRFFS-SKTTAAHSLVGTPY-YMSPERIHENGYNFKSDI 189
Query: 795 YSYGVVLLEILTTRLPVEED 814
+S G +L E+ + P D
Sbjct: 190 WSLGCLLYEMAALQSPFYGD 209
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 60.1 bits (145), Expect = 1e-09
Identities = 56/204 (27%), Positives = 94/204 (46%), Gaps = 23/204 (11%)
Query: 616 GTFSTVYKAV-MPSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVI 674
G+F VY A + + ++++K++ + +I+E+ L KL H N ++ G +
Sbjct: 26 GSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYL 85
Query: 675 YEDVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLD 734
E A L+ Y G+ + LL E K+P + ++ G +GLA+LH +IH D
Sbjct: 86 REHTAWLVMEYCL-GSASDLL-EVHKKPLQEVEIA---AVTHGALQGLAYLHSHNMIHRD 140
Query: 735 ISSGNVLLDADFKPLLGEIEISKLLDPSKGTASISAVAGSFGYIP----PEYAYTM---Q 787
+ +GN+LL LG+ G+ASI A A F P PE M Q
Sbjct: 141 VKAGNILLSEPGLVKLGDF----------GSASIMAPANXFVGTPYWMAPEVILAMDEGQ 190
Query: 788 VTAPGNVYSYGVVLLEILTTRLPV 811
+V+S G+ +E+ + P+
Sbjct: 191 YDGKVDVWSLGITCIELAERKPPL 214
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 59.4 bits (145), Expect = 1e-09
Identities = 49/198 (24%), Positives = 85/198 (42%), Gaps = 9/198 (4%)
Query: 616 GTFSTVYKAV-MPSGLILSVKR--LKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGF 672
G+F VY G + +K L +M + + E++ L KL H N+++
Sbjct: 11 GSFGKVYLVRRKSDGKLYVLKEIDLSNMSEK---EREDALNEVKILKKLNHPNIIKYYES 67
Query: 673 VIYEDVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIH 732
+ ++ Y G L+Q + + K+ P+ L + + L +LH I+H
Sbjct: 68 FEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPE-EQILDWFVQLCLALKYLHSRKILH 126
Query: 733 LDISSGNVLLDADFKPLLGEIEISKLLDPSKGTASISAVAGSFGYIPPEYAYTMQVTAPG 792
DI N+ L ++ LG+ ISK+L + A V G+ Y+ PE
Sbjct: 127 RDIKPQNIFLTSNGLVKLGDFGISKVLSSTVDLA--KTVVGTPYYLSPELCQNKPYNYKS 184
Query: 793 NVYSYGVVLLEILTTRLP 810
+++S G VL E+ T + P
Sbjct: 185 DIWSLGCVLYELCTLKHP 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 59.5 bits (144), Expect = 1e-09
Identities = 52/205 (25%), Positives = 91/205 (44%), Gaps = 17/205 (8%)
Query: 616 GTFSTVYKAV-MPSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVI 674
GT+ VY A + + + +++K + D + + E+ S L H N+V+ +G
Sbjct: 19 GTYGIVYAARDLSTQVRIAIKEIPERDS---RYVQPLHEEIALHSYLKHRNIVQYLGSDS 75
Query: 675 YEDVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLD 734
+ +P G+L+ LL +K + + T + + EGL +LH I+H D
Sbjct: 76 ENGFFKIFMEQVPGGSLSALLR--SKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRD 133
Query: 735 ISSGNVLLDADFKPLLGEIEISKLLDPSKGTASISAVAGSFG----YIPPEYAYTMQ--V 788
I NVL++ G ++IS SK A I+ +F Y+ PE
Sbjct: 134 IKGDNVLVNT----YSGVVKISD-FGTSKRLAGINPCTETFTGTLQYMAPEVIDKGPRGY 188
Query: 789 TAPGNVYSYGVVLLEILTTRLPVEE 813
AP +++S G ++E+ T + P E
Sbjct: 189 GAPADIWSLGCTIVEMATGKPPFIE 213
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 60.2 bits (146), Expect = 3e-09
Identities = 32/85 (37%), Positives = 48/85 (56%)
Query: 286 DNNNLSGEIVPEFSQCSNLTLLNLASNGFTGVIPPELGQLINLQELILYENSLFGEIPKS 345
DN L G I + S+ +L +NL+ N G IPP LG + +L+ L L NS G IP+S
Sbjct: 426 DNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPES 485
Query: 346 ILACKNLNKLDLSNNRFNGTIPNAI 370
+ +L L+L+ N +G +P A+
Sbjct: 486 LGQLTSLRILNLNGNSLSGRVPAAL 510
|
Length = 623 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 57.5 bits (139), Expect = 5e-09
Identities = 59/278 (21%), Positives = 112/278 (40%), Gaps = 43/278 (15%)
Query: 616 GTFSTVYKAVMPSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIY 675
G F VYK V+ ++VK +S + + K ++E E L + H N+V+ IG +
Sbjct: 6 GNFGDVYKGVLKGNTEVAVKTCRSTLPPDL--KRKFLQEAEILKQYDHPNIVKLIGVCVQ 63
Query: 676 EDVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDI 735
+ ++ +P G+L L + + + L +++ A G+ +L IH D+
Sbjct: 64 KQPIYIVMELVPGGSLLTFLRKKKNRLTVK----KLLQMSLDAAAGMEYLESKNCIHRDL 119
Query: 736 SSGNVLLDADFKPLLGEIEISKLLDPSKGTASISAVAGSFGYIP-----PEYAYTMQVTA 790
++ N L+ + ++IS + I V+ IP PE + T+
Sbjct: 120 AARNCLVGEN-----NVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTS 174
Query: 791 PGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQILDARLSTVSFGW 850
+V+SYG++L E + G+ P G + +Q + + G+
Sbjct: 175 ESDVWSYGILLWETFS--------LGDT----------PYPGMSNQQTRE----RIESGY 212
Query: 851 R----KEMLTAL-KVALLCTDSTPAKRPKMKKVVEMLQ 883
R + + ++ L C P RP ++ LQ
Sbjct: 213 RMPAPQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 58.2 bits (140), Expect = 6e-09
Identities = 56/204 (27%), Positives = 101/204 (49%), Gaps = 23/204 (11%)
Query: 616 GTFSTVYKAV-MPSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVI 674
G+F VY A + + ++++K++ + +I+E++ L ++ H N + G +
Sbjct: 36 GSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYL 95
Query: 675 YEDVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLD 734
E A L+ Y G+ + LL E K+P + +I G +GLA+LH +IH D
Sbjct: 96 REHTAWLVMEYCL-GSASDLL-EVHKKPLQEVEIA---AITHGALQGLAYLHSHNMIHRD 150
Query: 735 ISSGNVLLDADFKPLLGEIEISKLLDPSKGTASISAVAGSFGYIP----PEYAYTM---Q 787
I +GN+LL +P G+++++ G+ASI++ A SF P PE M Q
Sbjct: 151 IKAGNILLT---EP--GQVKLADF-----GSASIASPANSFVGTPYWMAPEVILAMDEGQ 200
Query: 788 VTAPGNVYSYGVVLLEILTTRLPV 811
+V+S G+ +E+ + P+
Sbjct: 201 YDGKVDVWSLGITCIELAERKPPL 224
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 7e-09
Identities = 47/184 (25%), Positives = 95/184 (51%), Gaps = 13/184 (7%)
Query: 628 SGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVA---LLLHN 684
+G ++VK LK +H + +E+E L L H+N+V+ G + ED L+
Sbjct: 32 TGEQVAVKSLKPESGG--NHIADLKKEIEILRNLYHENIVKYKG-ICTEDGGNGIKLIME 88
Query: 685 YLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDA 744
+LP+G+L + L + + + + +L A+ + +G+ +L +H D+++ NVL+++
Sbjct: 89 FLPSGSLKEYLPRNKNKINLK----QQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVES 144
Query: 745 DFKPLLGEIEISKLLDPSKGTASISAVAGS--FGYIPPEYAYTMQVTAPGNVYSYGVVLL 802
+ + +G+ ++K ++ K ++ S F Y PE + +V+S+GV L
Sbjct: 145 EHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWY-APECLIQSKFYIASDVWSFGVTLY 203
Query: 803 EILT 806
E+LT
Sbjct: 204 ELLT 207
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 8e-09
Identities = 44/191 (23%), Positives = 84/191 (43%), Gaps = 8/191 (4%)
Query: 616 GTFSTVYKAVMPSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIY 675
G F V+ + ++VK LK ++ + E + L HD LVR V
Sbjct: 17 GQFGEVWMGYYNNSTKVAVKTLKPGTMSV----QAFLEEANLMKTLQHDKLVRLYAVVTK 72
Query: 676 EDVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDI 735
E+ ++ Y+ G+L L + P + + +AEG+A++ IH D+
Sbjct: 73 EEPIYIITEYMAKGSLLDFLKS---DEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDL 129
Query: 736 SSGNVLLDADFKPLLGEIEISKLLDPSKGTASISAVAGSFGYIPPEYAYTMQVTAPGNVY 795
+ NVL+ + + ++++++ ++ TA A + PE T +V+
Sbjct: 130 RAANVLVSESLMCKIADFGLARVIEDNEYTAREGA-KFPIKWTAPEAINFGSFTIKSDVW 188
Query: 796 SYGVVLLEILT 806
S+G++L EI+T
Sbjct: 189 SFGILLYEIVT 199
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 57.0 bits (137), Expect = 9e-09
Identities = 49/212 (23%), Positives = 101/212 (47%), Gaps = 14/212 (6%)
Query: 602 VVKATMKDSNMIYCGTFSTVYKAVMPSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKL 661
+ + ++K + G F V+ A ++VK +K ++ + E + L
Sbjct: 3 IPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSMSV----EAFLAEANVMKTL 58
Query: 662 CHDNLVRPIGFVIYEDVALLLHNYLPNGTLAQLL--HESTKQPDYRPDWPTRLSIAIGVA 719
HD LV+ + V+ ++ ++ ++ G+L L E +KQP P + + +A
Sbjct: 59 QHDKLVK-LHAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQP-----LPKLIDFSAQIA 112
Query: 720 EGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSKGTASISAVAGSFGYIP 779
EG+AF+ IH D+ + N+L+ A + + ++++++ ++ TA A +
Sbjct: 113 EGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREGA-KFPIKWTA 171
Query: 780 PEYAYTMQVTAPGNVYSYGVVLLEILT-TRLP 810
PE T +V+S+G++L+EI+T R+P
Sbjct: 172 PEAINFGSFTIKSDVWSFGILLMEIVTYGRIP 203
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 58.3 bits (141), Expect = 1e-08
Identities = 31/89 (34%), Positives = 44/89 (49%)
Query: 91 LDLSNNAFSGTIPSAFGNLSELEFLDLSLNKFGGVIPRELGSLKDLRFFNISNNVLVGEI 150
L L N G IP+ L L+ ++LS N G IP LGS+ L ++S N G I
Sbjct: 423 LGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSI 482
Query: 151 PDELKSLEKLEDFQVSSNKLNGSIPFWVG 179
P+ L L L ++ N L+G +P +G
Sbjct: 483 PESLGQLTSLRILNLNGNSLSGRVPAALG 511
|
Length = 623 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 57.7 bits (139), Expect = 1e-08
Identities = 86/296 (29%), Positives = 131/296 (44%), Gaps = 17/296 (5%)
Query: 67 KLDLSRLQLRGNITLVSELKALKRLDLSNNAFSGTIPSAFGNLSELEFLDLSLNKFGGVI 126
LDL+ +LR NI+ + EL L LDL NN + P S L+ LDLS NK +
Sbjct: 97 SLDLNLNRLRSNISELLELTNLTSLDLDNNNITDIPPLIGLLKSNLKELDLSDNKI-ESL 155
Query: 127 PRELGSLKDLRFFNISNNVLVGEIPDELKSLEKLEDFQVSSNKLNGSIPFWVGNLTNLRV 186
P L +L +L+ ++S N L ++P L +L L + +S NK++ +P + L+ L
Sbjct: 156 PSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEE 213
Query: 187 FTAYENQLVGEIPDNLGSVSELELLNLHSNQLEGPIPKSIFASGKLEVLVLTQNRLTGDI 246
N ++ E+ +L ++ L L L +N+LE +P+SI LE L L+ N+++ I
Sbjct: 214 LDLSNNSII-ELLSSLSNLKNLSGLELSNNKLE-DLPESIGNLSNLETLDLSNNQIS-SI 270
Query: 247 PELVGHCKSLSNIRIGNNDLVGVIPRAIGNVSGLTYFEADNNNLSGEIVPEFSQCSNLTL 306
L SL+N+R + + L E N L E S L
Sbjct: 271 SSL----GSLTNLRELDLSGNSLSNALPLIALLLLLLELLLNLLLTLKALELKLNSILLN 326
Query: 307 LNLASNGFTGVI--PPELGQLINLQEL-----ILYENSLFGEIPKSILACKNLNKL 355
N+ SNG T L L NL L N + P +I + +L K
Sbjct: 327 NNILSNGETSSPEALSILESLNNLWTLDNALDESNLNRYIVKNPNAIGSLLDLVKK 382
|
Length = 394 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 56.7 bits (137), Expect = 1e-08
Identities = 37/157 (23%), Positives = 68/157 (43%), Gaps = 9/157 (5%)
Query: 654 ELEKLSKLCHDNLVRPIGFVIYEDVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLS 713
E+ LS L H N++ + ++ L+ Y GTL + Q + +
Sbjct: 49 EIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQL-----FEEEMV 103
Query: 714 IA--IGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSKGTASISAV 771
+ + ++++H I+H DI + N+ L LG+ ISK+L A V
Sbjct: 104 LWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMA--ETV 161
Query: 772 AGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILTTR 808
G+ Y+ PE ++ ++++ G VL E+LT +
Sbjct: 162 VGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLK 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 56.6 bits (137), Expect = 1e-08
Identities = 69/282 (24%), Positives = 108/282 (38%), Gaps = 73/282 (25%)
Query: 616 GTFSTVYKAVMPSGLILSVKRLK--SMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFV 673
G F V+ ++VK LK +M ++E + + KL HD LV+
Sbjct: 17 GQFGEVWMGTWNGTTKVAVKTLKPGTMSPE------AFLQEAQIMKKLRHDKLVQLYAVC 70
Query: 674 IYEDVALLLHNYLPNGTLAQLLHEST--KQPDYRPDWPTRLSIAIGVAEGLAFLHHVAII 731
E+ ++ Y+ G+L L K P + +A +AEG+A+L I
Sbjct: 71 SEEEPIYIVTEYMSKGSLLDFLKSGEGKKLR-----LPQLVDMAAQIAEGMAYLESRNYI 125
Query: 732 HLDISSGNVLLD-------ADFKPLLGEIEI--------SKLLDPSKGTASISAVAGSFG 776
H D+++ N+L+ ADF L IE +K P K TA +A G F
Sbjct: 126 HRDLAARNILVGENLVCKIADFG-LARLIEDDEYTAREGAKF--PIKWTAPEAANYGRF- 181
Query: 777 YIPPEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPE 836
T +V+S+G++L EI+T +G P G T
Sbjct: 182 ------------TIKSDVWSFGILLTEIVT--------YGR----------VPYPGMTNR 211
Query: 837 QILDARLSTVSFGWRKEMLTAL-----KVALLCTDSTPAKRP 873
++L+ V G+R + L C D P +RP
Sbjct: 212 EVLEQ----VERGYRMPRPPNCPEELYDLMLQCWDKDPEERP 249
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 56.6 bits (137), Expect = 1e-08
Identities = 63/280 (22%), Positives = 127/280 (45%), Gaps = 43/280 (15%)
Query: 616 GTFSTVYKAV-MPSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVI 674
G + VY A+ +P+ +++KR+ +++ +++ +E++ +S+ H N+V+ +
Sbjct: 12 GATAVVYAAICLPNNEKVAIKRI-DLEKCQTS-VDELRKEVQAMSQCNHPNVVKYYTSFV 69
Query: 675 YEDVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLD 734
D L+ YL G+L ++ + P D ++ V +GL +LH IH D
Sbjct: 70 VGDELWLVMPYLSGGSLLDIM--KSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRD 127
Query: 735 ISSGNVLLDADFKPLLGEIEI------SKLLDPSKGTASISA---VAGSFGYIPPE---- 781
I +GN+LL D G ++I + L D G + G+ ++ PE
Sbjct: 128 IKAGNILLGED-----GSVKIADFGVSASLADG--GDRTRKVRKTFVGTPCWMAPEVMEQ 180
Query: 782 -YAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQILD 840
+ Y + +++S+G+ +E+ T P + V L+ + P ET D
Sbjct: 181 VHGYDFKA----DIWSFGITAIELATGAAPYSKYPPMKV-LMLTLQNDPPSLETGA---D 232
Query: 841 ARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVE 880
+ + SF ++M++ LC P+KRP +++++
Sbjct: 233 YKKYSKSF---RKMIS------LCLQKDPSKRPTAEELLK 263
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 1e-08
Identities = 43/169 (25%), Positives = 81/169 (47%), Gaps = 12/169 (7%)
Query: 648 QNKMIRELEKLSKLCHDNLVRPIGFVIYEDVALLLHNYLPNGTLAQLLHESTKQPDYRPD 707
+++ I E + + KL H+ LV+ G + ++ Y+ NG L L E K R
Sbjct: 43 EDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGK----RFQ 98
Query: 708 WPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISK-LLDPSKGTA 766
L + V EG+A+L IH D+++ N L+D + + +S+ +LD
Sbjct: 99 PSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDE---- 154
Query: 767 SISAVAGSF--GYIPPEYAYTMQVTAPGNVYSYGVVLLEILTT-RLPVE 812
S+V F + PPE + ++ +V+++GV++ E+ + ++P E
Sbjct: 155 YTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYE 203
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 56.4 bits (136), Expect = 2e-08
Identities = 52/217 (23%), Positives = 92/217 (42%), Gaps = 31/217 (14%)
Query: 616 GTFSTVYKAVMPSGL------ILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRP 669
G F V++A P L +++VK LK + Q RE +++ H N+V+
Sbjct: 16 GAFGRVFQARAPGLLPYEPFTMVAVKMLK--EEASADMQADFQREAALMAEFDHPNIVKL 73
Query: 670 IGFVIYEDVALLLHNYLPNGTLAQLL------------HESTKQPDYRPDWP-----TRL 712
+G LL Y+ G L + L H ++ + +L
Sbjct: 74 LGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQL 133
Query: 713 SIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISK---LLDPSKGTASIS 769
IA VA G+A+L +H D+++ N L+ + + + +S+ D K + +
Sbjct: 134 CIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKASEN-- 191
Query: 770 AVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILT 806
A ++PPE + + T +V++YGVVL EI +
Sbjct: 192 -DAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFS 227
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 2e-08
Identities = 50/197 (25%), Positives = 94/197 (47%), Gaps = 12/197 (6%)
Query: 616 GTFSTVYKAVMPSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIY 675
G F V+ ++VK LK + + E + + KL HD LV+ + V+
Sbjct: 17 GQFGEVWMGTWNGNTKVAVKTLKPGTMS----PESFLEEAQIMKKLRHDKLVQ-LYAVVS 71
Query: 676 EDVALLLHNYLPNGTLAQLLHESTKQPDYRP-DWPTRLSIAIGVAEGLAFLHHVAIIHLD 734
E+ ++ Y+ G+L L K + R P + +A VA G+A++ + IH D
Sbjct: 72 EEPIYIVTEYMSKGSLLDFL----KDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRD 127
Query: 735 ISSGNVLLDADFKPLLGEIEISKLLDPSKGTASISAVAGSFGYIPPEYAYTMQVTAPGNV 794
+ S N+L+ + + +++L++ ++ TA A + PE A + T +V
Sbjct: 128 LRSANILVGDGLVCKIADFGLARLIEDNEYTARQGA-KFPIKWTAPEAALYGRFTIKSDV 186
Query: 795 YSYGVVLLEILTT-RLP 810
+S+G++L E++T R+P
Sbjct: 187 WSFGILLTELVTKGRVP 203
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 55.5 bits (134), Expect = 4e-08
Identities = 54/211 (25%), Positives = 89/211 (42%), Gaps = 29/211 (13%)
Query: 616 GTFSTVYK------AVMPSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRP 669
G F VYK S +++K LK + Q + +E E +S L H N+V
Sbjct: 16 GAFGKVYKGELTGPNERLSATSVAIKTLK--ENAEPKVQQEFRQEAELMSDLQHPNIVCL 73
Query: 670 IGFVIYEDVALLLHNYLPNGTLAQLL--------------HESTKQPDYRPDWPTRLSIA 715
+G E +L YL +G L + L E+ K D+ L IA
Sbjct: 74 LGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDF---LHIA 130
Query: 716 IGVAEGLAFL--HHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSKGTASISAVAG 773
I +A G+ +L HH +H D+++ N L+ + + +S+ + + S
Sbjct: 131 IQIAAGMEYLSSHH--FVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLL 188
Query: 774 SFGYIPPEYAYTMQVTAPGNVYSYGVVLLEI 804
++PPE + T +++S+GVVL EI
Sbjct: 189 PVRWMPPEAILYGKFTTESDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 4e-08
Identities = 58/280 (20%), Positives = 112/280 (40%), Gaps = 40/280 (14%)
Query: 618 FSTVYKAV-----MPSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGF 672
F +YK M ++++K LK D + +E +++L H N+V +G
Sbjct: 18 FGKIYKGHLYLPGMDHAQLVAIKTLK--DINNPQQWGEFQQEASLMAELHHPNIVCLLGV 75
Query: 673 VIYEDVALLLHNYLPNGTLAQLLHESTKQPDY------------RPDWPTRLSIAIGVAE 720
V E +L YL G L + L + D D L IAI +A
Sbjct: 76 VTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAA 135
Query: 721 GLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSKGTASISAVAGSFGYIPP 780
G+ +L +H D+++ N+L+ + ++ +S+ + + ++PP
Sbjct: 136 GMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPP 195
Query: 781 EYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFG--EGVDLVKWVHGAPARGETPEQI 838
E + ++ +++S+GVVL EI + L F E +++V+ P + P ++
Sbjct: 196 EAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVRKRQLLPCSEDCPPRM 255
Query: 839 LDARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKV 878
++T C P++RP+ K +
Sbjct: 256 Y-------------SLMTE------CWQEGPSRRPRFKDI 276
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 55.1 bits (133), Expect = 5e-08
Identities = 52/231 (22%), Positives = 102/231 (44%), Gaps = 25/231 (10%)
Query: 616 GTFSTVYKAV-MPSG----LILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPI 670
G F TVYK V +P G + +++K L+ + T +++ E ++ + H ++VR +
Sbjct: 18 GAFGTVYKGVWIPEGEKVKIPVAIKVLR--EETSPKANKEILDEAYVMASVDHPHVVRLL 75
Query: 671 GFVIYEDVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAI 730
G + V L+ +P G L + + L+ + +A+G+++L +
Sbjct: 76 GICLSSQVQLITQ-LMPLGCLLDYVRNHKDNIGSQ----YLLNWCVQIAKGMSYLEEKRL 130
Query: 731 IHLDISSGNVLLDADFKPLLGEIEISKLLDPSKGTASISAVAGSFGYIPPEYAYTMQVTA 790
+H D+++ NVL+ + + ++KLLD + ++ E T
Sbjct: 131 VHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTH 190
Query: 791 PGNVYSYGVVLLEILTTRLPVEEDFG----EGVDLVKWVHGAPARGETPEQ 837
+V+SYGV + E++T FG EG+ V+ + +GE Q
Sbjct: 191 KSDVWSYGVTVWELMT--------FGAKPYEGIPAVE-IPDLLEKGERLPQ 232
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 5e-08
Identities = 44/210 (20%), Positives = 88/210 (41%), Gaps = 16/210 (7%)
Query: 616 GTFSTVYKAVMPSG------LILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRP 669
G F V+ A ++ VK L+ + Q++ REL+ KL H N+VR
Sbjct: 16 GEFGEVFLAKAKGIEEEGGETLVLVKALQKTKDE--NLQSEFRRELDMFRKLSHKNVVRL 73
Query: 670 IGFVIYEDVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPT----RLSIAIGVAEGLAFL 725
+G + ++ Y G L Q L + + + P ++++ +A G+ L
Sbjct: 74 LGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHL 133
Query: 726 HHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDP-SKGTASISAVAGSFGYIPPEYAY 784
+ +H D+++ N L+ + + + + +SK D + + ++ PE
Sbjct: 134 SNARFVHRDLAARNCLVSSQREVKVSLLSLSK--DVYNSEYYKLRNALIPLRWLAPEAVQ 191
Query: 785 TMQVTAPGNVYSYGVVLLEILT-TRLPVEE 813
+ +V+S+GV++ E+ T LP
Sbjct: 192 EDDFSTKSDVWSFGVLMWEVFTQGELPFYG 221
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|227223 COG4886, COG4886, Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Score = 55.7 bits (134), Expect = 6e-08
Identities = 57/168 (33%), Positives = 87/168 (51%), Gaps = 6/168 (3%)
Query: 59 DLNQAFVVKLDLSRLQLRGNITLVSELKALKRLDLSNNAFSGTIPSAFGNLSELEFLDLS 118
L ++ + +LDLS ++ + + L LK LDLS N S +P NLS L LDLS
Sbjct: 136 GLLKSNLKELDLSDNKIESLPSPLRNLPNLKNLDLSFNDLS-DLPKLLSNLSNLNNLDLS 194
Query: 119 LNKFGGVIPRELGSLKDLRFFNISNNVLVGEIPDELKSLEKLEDFQVSSNKLNGSIPFWV 178
NK +P E+ L L ++SNN ++ E+ L +L+ L ++S+NKL +P +
Sbjct: 195 GNKI-SDLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLE-DLPESI 251
Query: 179 GNLTNLRVFTAYENQLVGEIPDNLGSVSELELLNLHSNQLEGPIPKSI 226
GNL+NL NQ+ +LGS++ L L+L N L +P
Sbjct: 252 GNLSNLETLDLSNNQI--SSISSLGSLTNLRELDLSGNSLSNALPLIA 297
|
Length = 394 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 7e-08
Identities = 65/277 (23%), Positives = 118/277 (42%), Gaps = 43/277 (15%)
Query: 616 GTFSTVYKAV-MPSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVI 674
G F VYKA +G + + K +++ + ++ M+ E+E L+ H +V+ +G
Sbjct: 23 GAFGKVYKAKNKETGALAAAKVIETKSEEEL--EDYMV-EIEILATCNHPYIVKLLGAFY 79
Query: 675 YEDVALLLHNYLPNGTLAQLLHE---STKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAII 731
++ ++ + P G + ++ E +P + I + E L +LH + II
Sbjct: 80 WDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQ-------VICRQMLEALQYLHSMKII 132
Query: 732 HLDISSGNVLLDADFKPLLGEIEISKLLDPSKGTASIS---AVAGSFGYIPPEYAY--TM 786
H D+ +GNVLL D G+I+++ +K ++ + G+ ++ PE TM
Sbjct: 133 HRDLKAGNVLLTLD-----GDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCETM 187
Query: 787 QVTA---PGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQILDARL 843
+ T +++S G+ L+E+ P E V L+K P P +
Sbjct: 188 KDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRV-LLKIAKSEPPTLSQPSK------ 240
Query: 844 STVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVE 880
W E LK AL D P RP +++E
Sbjct: 241 ------WSMEFRDFLKTAL---DKHPETRPSAAQLLE 268
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 8e-08
Identities = 46/209 (22%), Positives = 102/209 (48%), Gaps = 9/209 (4%)
Query: 602 VVKAT-MKDSNMIYCGTFSTVYKAV-MPSGLILSVK-RLKSMDRTIIHHQN-KMIRELEK 657
++K T +K ++ G F TVYK + +P G + + +K ++ T N + + E
Sbjct: 3 ILKETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGPKANVEFMDEALI 62
Query: 658 LSKLCHDNLVRPIGFVIYEDVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIG 717
++ + H +LVR +G + + L+ +P+G L +HE + L+ +
Sbjct: 63 MASMDHPHLVRLLGVCLSPTIQLVTQ-LMPHGCLLDYVHEHKDNIGSQ----LLLNWCVQ 117
Query: 718 VAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSKGTASISAVAGSFGY 777
+A+G+ +L ++H D+++ NVL+ + + + +++LL+ + + +
Sbjct: 118 IAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKW 177
Query: 778 IPPEYAYTMQVTAPGNVYSYGVVLLEILT 806
+ E + + T +V+SYGV + E++T
Sbjct: 178 MALECIHYRKFTHQSDVWSYGVTIWELMT 206
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 54.6 bits (131), Expect = 8e-08
Identities = 50/208 (24%), Positives = 94/208 (45%), Gaps = 20/208 (9%)
Query: 616 GTFSTVYKA----VMPSG--LILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRP 669
G F V+ A + P+ ++++VK LK D T+ ++ RE E L+ L H+++V+
Sbjct: 16 GAFGKVFLAECYNLSPTKDKMLVAVKALK--DPTLAARKD-FQREAELLTNLQHEHIVKF 72
Query: 670 IGFVIYEDVALLLHNYLPNGTLAQLLHE-----------STKQPDYRPDWPTRLSIAIGV 718
G D +++ Y+ +G L + L +Q L IA +
Sbjct: 73 YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 132
Query: 719 AEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSKGTASISAVAGSFGYI 778
A G+ +L +H D+++ N L+ A+ +G+ +S+ + + ++
Sbjct: 133 ASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWM 192
Query: 779 PPEYAYTMQVTAPGNVYSYGVVLLEILT 806
PPE + T +V+S+GV+L EI T
Sbjct: 193 PPESIMYRKFTTESDVWSFGVILWEIFT 220
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 54.4 bits (131), Expect = 9e-08
Identities = 51/184 (27%), Positives = 91/184 (49%), Gaps = 14/184 (7%)
Query: 628 SGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVAL---LLHN 684
+G +++VK+L+ + H RE+E L L HDN+V+ G V Y L+
Sbjct: 32 TGEVVAVKKLQ---HSTAEHLRDFEREIEILKSLQHDNIVKYKG-VCYSAGRRNLRLVME 87
Query: 685 YLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDA 744
YLP G+L L + + R D L A + +G+ +L +H D+++ N+L+++
Sbjct: 88 YLPYGSLRDYLQKHRE----RLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVES 143
Query: 745 DFKPLLGEIEISKLLDPSKGTASISAVAGS--FGYIPPEYAYTMQVTAPGNVYSYGVVLL 802
+ + +G+ ++K+L K + S F Y PE + + +V+S+GVVL
Sbjct: 144 ENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWY-APESLTESKFSVASDVWSFGVVLY 202
Query: 803 EILT 806
E+ T
Sbjct: 203 ELFT 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 53.9 bits (130), Expect = 9e-08
Identities = 60/291 (20%), Positives = 127/291 (43%), Gaps = 55/291 (18%)
Query: 611 NMIYCGTFSTVYKAVM--PSG--LILSVKRLKSMDRTIIHHQNKM----IRELEKLSKLC 662
+I G F V + + P + +++K LK+ +K + E + +
Sbjct: 10 KVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKA------GSSDKQRLDFLTEASIMGQFD 63
Query: 663 HDNLVRPIGFVIYEDVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGL 722
H N++R G V +++ Y+ NG+L + L E+ D + + + G+A G+
Sbjct: 64 HPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLREN----DGKFTVGQLVGMLRGIASGM 119
Query: 723 AFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSKGTASISAVAGSFGYIP--- 779
+L + +H D+++ N+L++++ + + +S+ L+ S+ T + G IP
Sbjct: 120 KYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKG-----GKIPIRW 174
Query: 780 --PEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQ 837
PE + T+ +V+S+G+V+ E+++ +GE P + +
Sbjct: 175 TAPEAIAYRKFTSASDVWSFGIVMWEVMS--------YGE----------RPYWDMSNQD 216
Query: 838 ILDARLSTVSFGWR----KEMLTAL-KVALLCTDSTPAKRPKMKKVVEMLQ 883
++ A V G+R + +AL ++ L C +RP ++V L
Sbjct: 217 VIKA----VEDGYRLPPPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLD 263
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 54.7 bits (131), Expect = 9e-08
Identities = 54/193 (27%), Positives = 95/193 (49%), Gaps = 26/193 (13%)
Query: 627 PSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGF--VIYEDVAL-LLH 683
PSGLI++ K + + I +N++IREL+ L + C+ + +GF Y D + +
Sbjct: 28 PSGLIMARKLIHLEIKPAI--RNQIIRELQVLHE-CNSPYI--VGFYGAFYSDGEISICM 82
Query: 684 NYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHV-AIIHLDISSGNVLL 742
++ G+L Q+L E+ + P+ ++I V GLA+L I+H D+ N+L+
Sbjct: 83 EHMDGGSLDQVLKEAKRIPE-----EILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILV 137
Query: 743 DADFKPLLGEIEISKLLDPSKGTASISAVAGSF----GYIPPEYAYTMQVTAPGNVYSYG 798
++ GEI KL D I ++A SF Y+ PE + +++S G
Sbjct: 138 NSR-----GEI---KLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMG 189
Query: 799 VVLLEILTTRLPV 811
+ L+E+ R P+
Sbjct: 190 LSLVELAIGRYPI 202
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 53.9 bits (130), Expect = 9e-08
Identities = 57/203 (28%), Positives = 93/203 (45%), Gaps = 25/203 (12%)
Query: 615 CGTFSTVYKAV--MPSG--LILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPI 670
G F +V K V M SG + ++VK LK I + + +RE +++L H +VR I
Sbjct: 5 HGNFGSVVKGVYLMKSGKEVEVAVKTLK--QEHIAAGKKEFLREASVMAQLDHPCIVRLI 62
Query: 671 GFVIYEDVALLLHNYLPNGTLAQLLHESTKQPDYRPDWP--TRLSIAIGVAEGLAFLHHV 728
G V + +L+ P G L + L + R + P +A VA G+A+L
Sbjct: 63 G-VCKGEPLMLVMELAPLGPLLKYLKK-------RREIPVSDLKELAHQVAMGMAYLESK 114
Query: 729 AIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSKGTASISAVAGSFGYIP-----PEYA 783
+H D+++ NVLL + + + +S+ L G S A + G P PE
Sbjct: 115 HFVHRDLAARNVLLVNRHQAKISDFGMSRAL----GAGSDYYRATTAGRWPLKWYAPECI 170
Query: 784 YTMQVTAPGNVYSYGVVLLEILT 806
+ ++ +V+SYGV L E +
Sbjct: 171 NYGKFSSKSDVWSYGVTLWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 1e-07
Identities = 53/243 (21%), Positives = 101/243 (41%), Gaps = 46/243 (18%)
Query: 652 IRELEKLSKLCHDNLVRPIGFVIYEDVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTR 711
+ E ++KL H NLVR +G +++ + +++ + G L L +
Sbjct: 47 LEETAVMTKLHHKNLVRLLGVILHNGLYIVME-LMSKGNLVNFLRTRGR---ALVSVIQL 102
Query: 712 LSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSKGTASISAV 771
L ++ VAEG+ +L ++H D+++ N+L+ D ++K+ D G A + ++
Sbjct: 103 LQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDG--------VAKVSD--FGLARVGSM 152
Query: 772 AGSFGYIP-----PEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVH 826
+P PE + ++ +V+SYGV+L E+ + +G
Sbjct: 153 GVDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFS--------YG---------- 194
Query: 827 GAPARGETPEQILDARLSTVSFGWRKE-----MLTALKVALLCTDSTPAKRPKMKKVVEM 881
R P+ L V G+R E + C ++ P KRP K+ E
Sbjct: 195 ----RAPYPKMSLKEVKECVEKGYRMEPPEGCPADVYVLMTSCWETEPKKRPSFHKLREK 250
Query: 882 LQE 884
L++
Sbjct: 251 LEK 253
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 1e-07
Identities = 49/183 (26%), Positives = 84/183 (45%), Gaps = 13/183 (7%)
Query: 628 SGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIY--EDVALLLHNY 685
+G +++VK LK + + +E+ L L H+N+V+ G L+ Y
Sbjct: 32 TGEMVAVKTLKRECGQ--QNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIMEY 89
Query: 686 LPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDAD 745
+P G+L L P ++ + L A + EG+A+LH IH D+++ NVLLD D
Sbjct: 90 VPLGSLRDYL------PKHKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDND 143
Query: 746 FKPLLGEIEISKLLDPSKGTASISAVAGS--FGYIPPEYAYTMQVTAPGNVYSYGVVLLE 803
+G+ ++K + + S F Y E + + +V+S+GV L E
Sbjct: 144 RLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWY-AVECLKENKFSYASDVWSFGVTLYE 202
Query: 804 ILT 806
+LT
Sbjct: 203 LLT 205
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 2e-07
Identities = 43/187 (22%), Positives = 85/187 (45%), Gaps = 15/187 (8%)
Query: 630 LILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVALLLHNYLPNG 689
++++VK LK + + RE E L+ L H+++V+ G + D +++ Y+ +G
Sbjct: 36 ILVAVKTLKDASD---NARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHG 92
Query: 690 TLAQLLH----ESTKQPDYRPDWPTRLS------IAIGVAEGLAFLHHVAIIHLDISSGN 739
L + L ++ + P L+ IA +A G+ +L +H D+++ N
Sbjct: 93 DLNKFLRAHGPDAVLMAEGNR--PAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRN 150
Query: 740 VLLDADFKPLLGEIEISKLLDPSKGTASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGV 799
L+ + +G+ +S+ + + ++PPE + T +V+S GV
Sbjct: 151 CLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGV 210
Query: 800 VLLEILT 806
VL EI T
Sbjct: 211 VLWEIFT 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 2e-07
Identities = 59/220 (26%), Positives = 108/220 (49%), Gaps = 30/220 (13%)
Query: 627 PSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGF--VIYED--VALLL 682
PSGLI++ K + + I +N++IREL+ L + C+ + +GF Y D +++ +
Sbjct: 28 PSGLIMARKLIHLEIKPAI--RNQIIRELQVLHE-CNSPYI--VGFYGAFYSDGEISICM 82
Query: 683 HNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHV-AIIHLDISSGNVL 741
+ + G+L Q+L ++ + P+ ++I V +GL +L I+H D+ N+L
Sbjct: 83 EH-MDGGSLDQVLKKAGRIPE-----QILGKVSIAVIKGLTYLREKHKIMHRDVKPSNIL 136
Query: 742 LDADFKPLLGEIEISKLLDPSKGTASISAVAGSF----GYIPPEYAYTMQVTAPGNVYSY 797
+++ GEI KL D I ++A SF Y+ PE + +++S
Sbjct: 137 VNSR-----GEI---KLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSM 188
Query: 798 GVVLLEILTTRLPVEEDFGEGVDLV--KWVHGAPARGETP 835
G+ L+E+ R P+ + ++L+ V G PA ET
Sbjct: 189 GLSLVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETS 228
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 53.3 bits (128), Expect = 2e-07
Identities = 57/203 (28%), Positives = 93/203 (45%), Gaps = 23/203 (11%)
Query: 616 GTFSTVYKAV-MPSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVI 674
G+F VY A + + ++++K++ + +I+E+ L +L H N + G +
Sbjct: 26 GSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYL 85
Query: 675 YEDVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLD 734
E A L+ Y G+ + +L E K+P + +I G +GLA+LH IH D
Sbjct: 86 REHTAWLVMEYCL-GSASDIL-EVHKKPLQEVEIA---AICHGALQGLAYLHSHERIHRD 140
Query: 735 ISSGNVLLDADFKPLLGEIEISKLLDPSKGTASISAVAGSFGYIP----PEYAYTM---Q 787
I +GN+LL E KL D G+AS+ + A SF P PE M Q
Sbjct: 141 IKAGNILLT--------EPGTVKLAD--FGSASLVSPANSFVGTPYWMAPEVILAMDEGQ 190
Query: 788 VTAPGNVYSYGVVLLEILTTRLP 810
+V+S G+ +E+ + P
Sbjct: 191 YDGKVDVWSLGITCIELAERKPP 213
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.5 bits (127), Expect = 3e-07
Identities = 44/163 (26%), Positives = 71/163 (43%), Gaps = 54/163 (33%)
Query: 613 IYCGTFSTVYKAV-MPSGLILSVKRLKSMDR-------TIIHHQNKMIRELEKLSKLCHD 664
I GT+ VYKA +G ++++K+++ M+ T IRE++ L KL H
Sbjct: 7 IGEGTYGQVYKARNKKTGELVALKKIR-MENEKEGFPIT-------AIREIKLLQKLRHP 58
Query: 665 NLVR--------PIG--FVIYE----DVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPT 710
N+VR G ++++E D+ LL + T +Q+ KQ
Sbjct: 59 NIVRLKEIVTSKGKGSIYMVFEYMDHDLTGLLDSPEVKFTESQIKC-YMKQ--------- 108
Query: 711 RLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLD-------ADF 746
+ EGL +LH I+H DI N+L++ ADF
Sbjct: 109 -------LLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADF 144
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 52.7 bits (126), Expect = 3e-07
Identities = 42/198 (21%), Positives = 90/198 (45%), Gaps = 16/198 (8%)
Query: 616 GTFSTVYKAV-MPSG----LILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPI 670
G F TV+K + +P G + +++K ++ DR+ ++ + + L H +VR +
Sbjct: 18 GVFGTVHKGIWIPEGDSIKIPVAIKTIQ--DRSGRQTFQEITDHMLAMGSLDHAYIVRLL 75
Query: 671 GFVIYEDVALLLHNYLPNGTLAQLL--HESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHV 728
G + L+ P G+L + H + P +W + +A+G+ +L
Sbjct: 76 GICPGASLQLVTQ-LSPLGSLLDHVRQHRDSLDPQRLLNW------CVQIAKGMYYLEEH 128
Query: 729 AIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSKGTASISAVAGSFGYIPPEYAYTMQV 788
++H ++++ N+LL +D + + ++ LL P S ++ E +
Sbjct: 129 RMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRY 188
Query: 789 TAPGNVYSYGVVLLEILT 806
T +V+SYGV + E+++
Sbjct: 189 THQSDVWSYGVTVWEMMS 206
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.1 bits (126), Expect = 4e-07
Identities = 51/187 (27%), Positives = 82/187 (43%), Gaps = 30/187 (16%)
Query: 637 LKSMD-RTII--HHQNKMIRELEKLSKLCHDNLVRPI-GFVIYEDVALLLHNYLPNGTLA 692
+K + + II + E LS++ H +V+ F E + L+L Y P G L
Sbjct: 23 MKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVL-EYAPGGELF 81
Query: 693 QLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGE 752
L + + + R R A + L +LH + II+ D+ N+LLDAD G
Sbjct: 82 SHLSKEGRFSEER----ARFYAA-EIVLALEYLHSLGIIYRDLKPENILLDAD-----GH 131
Query: 753 IEI-----SKLLDPSKGTASISAVAGSFGYIPPEY----AYTMQVTAPGNVYSYGVVLLE 803
I++ +K L S + + G+ Y+ PE Y V + +S GV+L E
Sbjct: 132 IKLTDFGLAKEL--SSEGSRTNTFCGTPEYLAPEVLLGKGYGKAV----DWWSLGVLLYE 185
Query: 804 ILTTRLP 810
+LT + P
Sbjct: 186 MLTGKPP 192
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 4e-07
Identities = 58/273 (21%), Positives = 118/273 (43%), Gaps = 31/273 (11%)
Query: 616 GTFSTVYKAVMPSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIY 675
G F V++ + + + +++K LKS D Q +E++ L +L H +L+
Sbjct: 17 GYFGEVWEGLWKNRVRVAIKILKSDDLL---KQQDFQKEVQALKRLRHKHLISLFAVCSV 73
Query: 676 EDVALLLHNYLPNGTLAQLLHESTKQPDYRP-DWPTRLSIAIGVAEGLAFLHHVAIIHLD 734
+ ++ + G+L L + P+ + + + +A VAEG+A+L IH D
Sbjct: 74 GEPVYIITELMEKGSLLAFL----RSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRD 129
Query: 735 ISSGNVLLDADFKPLLGEIEISKLLDPSKGTASISAVAGSFGYIPPEYAYTMQVTAPGNV 794
+++ N+L+ D + + +++L+ +S + + + PE A + +V
Sbjct: 130 LAARNILVGEDLVCKVADFGLARLIKEDVYLSSDKKI--PYKWTAPEAASHGTFSTKSDV 187
Query: 795 YSYGVVLLEILTT-RLPVE-EDFGEGVDLVKWVHGAPARGETPEQILDARLSTVSFGWRK 852
+S+G++L E+ T ++P + E D + + P + P++I
Sbjct: 188 WSFGILLYEMFTYGQVPYPGMNNHEVYDQITAGYRMPCPAKCPQEI-------------- 233
Query: 853 EMLTALKVALLCTDSTPAKRPKMKKVVEMLQEI 885
K+ L C + P RP K + E L I
Sbjct: 234 -----YKIMLECWAAEPEDRPSFKALREELDNI 261
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 4e-07
Identities = 31/130 (23%), Positives = 66/130 (50%), Gaps = 8/130 (6%)
Query: 616 GTFSTVYKAVMPSGLILSVKR--LKSMDRTIIHHQ-NKMIRELEKLSKLCHDNLVRPIGF 672
G + TVY + G +++VK+ L + + + K+ E++ L L H N+V+ +G
Sbjct: 11 GAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGT 70
Query: 673 VIYEDVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIH 732
+ ++ + ++P G+++ +L+ P+ P + +G+A+LH+ ++H
Sbjct: 71 CLDDNTISIFMEFVPGGSISSILNRFGPLPE-----PVFCKYTKQILDGVAYLHNNCVVH 125
Query: 733 LDISSGNVLL 742
DI NV+L
Sbjct: 126 RDIKGNNVML 135
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.1 bits (125), Expect = 4e-07
Identities = 51/200 (25%), Positives = 89/200 (44%), Gaps = 11/200 (5%)
Query: 616 GTFSTVYKAV-MPSGLILSVKRLK--SMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGF 672
G F VY + +G L+VK++ N + E++ L L H+ +V+ G
Sbjct: 13 GAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGC 72
Query: 673 VIYEDVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIH 732
+ ++ + Y+P G++ + K + TR + EG+ +LH I+H
Sbjct: 73 LRDDETLSIFMEYMPGGSV----KDQLKAYGALTETVTR-KYTRQILEGVEYLHSNMIVH 127
Query: 733 LDISSGNVLLDADFKPLLGEIEISKLLDP--SKGTASISAVAGSFGYIPPEYAYTMQVTA 790
DI N+L D+ LG+ SK L S GT + +V G+ ++ PE
Sbjct: 128 RDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTG-MKSVTGTPYWMSPEVISGEGYGR 186
Query: 791 PGNVYSYGVVLLEILTTRLP 810
+V+S G ++E+LT + P
Sbjct: 187 KADVWSVGCTVVEMLTEKPP 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 51.9 bits (125), Expect = 4e-07
Identities = 52/208 (25%), Positives = 90/208 (43%), Gaps = 16/208 (7%)
Query: 613 IYCGTFSTVYKAV-MPSGLILSVKRLK--SMDRTIIHHQNKMIRELEKLSKLCHDNLVRP 669
I G+F TV K G IL K + +M + +++ E+ L +L H N+VR
Sbjct: 8 IGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTE---KEKQQLVSEVNILRELKHPNIVRY 64
Query: 670 IGFVIYEDVALL--LHNYLPNGTLAQLLHESTKQPDYRPD---WP--TRLSIAIGVAEGL 722
+I L + Y G LAQL+ + K+ Y + W T+L +A+
Sbjct: 65 YDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNR 124
Query: 723 AFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSKGTASISAVAGSFGYIPPEY 782
+ + ++H D+ N+ LDA+ LG+ ++K+L A G+ Y+ PE
Sbjct: 125 SDPGNT-VLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSFA--KTYVGTPYYMSPEQ 181
Query: 783 AYTMQVTAPGNVYSYGVVLLEILTTRLP 810
M +++S G ++ E+ P
Sbjct: 182 LNHMSYDEKSDIWSLGCLIYELCALSPP 209
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 52.4 bits (126), Expect = 5e-07
Identities = 56/199 (28%), Positives = 93/199 (46%), Gaps = 38/199 (19%)
Query: 627 PSGLILSVKRLKSMDRTIIHHQ------NKMIRELEKLSKLCHDNLVRPIGF--VIYEDV 678
PSGLI M R +IH + N++IREL+ L + C+ + +GF Y D
Sbjct: 24 PSGLI--------MARKLIHLEIKPAIRNQIIRELKVLHE-CNSPYI--VGFYGAFYSDG 72
Query: 679 AL-LLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHV-AIIHLDIS 736
+ + ++ G+L Q+L ++ + P+ I+I V GL +L I+H D+
Sbjct: 73 EISICMEHMDGGSLDQVLKKAGRIPE-----NILGKISIAVLRGLTYLREKHKIMHRDVK 127
Query: 737 SGNVLLDADFKPLLGEIEISKLLDPSKGTASISAVAGSF----GYIPPEYAYTMQVTAPG 792
N+L+++ GEI KL D I ++A SF Y+ PE T
Sbjct: 128 PSNILVNSR-----GEI---KLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHYTVQS 179
Query: 793 NVYSYGVVLLEILTTRLPV 811
+++S G+ L+E+ R P+
Sbjct: 180 DIWSLGLSLVEMAIGRYPI 198
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 6e-07
Identities = 48/202 (23%), Positives = 91/202 (45%), Gaps = 11/202 (5%)
Query: 606 TMKDSNMIYCGTFSTVYKAVMPS-GLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHD 664
TMK + + G + VY+ V L ++VK LK D + + ++E + ++ H
Sbjct: 9 TMK--HKLGGGQYGEVYEGVWKKYSLTVAVKTLKE-DTMEVE---EFLKEAAVMKEIKHP 62
Query: 665 NLVRPIGFVIYEDVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAF 724
NLV+ +G E ++ ++ G L L E +Q + L +A ++ + +
Sbjct: 63 NLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQ---EVNAVVLLYMATQISSAMEY 119
Query: 725 LHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSKGTASISAVAGSFGYIPPEYAY 784
L IH D+++ N L+ + + + +S+L+ TA A P AY
Sbjct: 120 LEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAY 179
Query: 785 TMQVTAPGNVYSYGVVLLEILT 806
+ + +V+++GV+L EI T
Sbjct: 180 N-KFSIKSDVWAFGVLLWEIAT 200
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 51.5 bits (124), Expect = 6e-07
Identities = 70/285 (24%), Positives = 113/285 (39%), Gaps = 45/285 (15%)
Query: 616 GTFSTVYKAVMPS-GLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVI 674
G + V+ A S G I ++K +K D + ++++ E + LS+ +V+
Sbjct: 4 GAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQ 63
Query: 675 YEDVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLD 734
+ L+ YLP G LA LL + R+ IA + L +LH IIH D
Sbjct: 64 GKKNLYLVMEYLPGGDLASLLE----NVGSLDEDVARIYIA-EIVLALEYLHSNGIIHRD 118
Query: 735 ISSGNVLLDADFKPLLGEIEISKL------LDPSKGTASISAVAGSFGYIPPEYAYTMQV 788
+ N+L+D++ L + +SK+ ++ + + G+ YI PE
Sbjct: 119 LKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGH 178
Query: 789 TAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQILDARLSTVSF 848
+ + +S G +L E L G+ P GETPE+I L+
Sbjct: 179 SKTVDWWSLGCILYEFLV-----------GI--------PPFHGETPEEIFQNILNGK-I 218
Query: 849 GWRKEMLTALKVA------LLCTDSTPAKRPKMKKVVEMLQEIKQ 887
W E + A LL D P KR K + +EIK
Sbjct: 219 EW-PEDVEVSDEAIDLISKLLVPD--PEKRLGAKSI----EEIKN 256
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 7e-07
Identities = 43/182 (23%), Positives = 72/182 (39%), Gaps = 13/182 (7%)
Query: 634 VKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVALLLHNYLPNGTLAQ 693
VK L+ Q ++E++ +L H N+++ +G I LL+ + P G L
Sbjct: 27 VKELR--ASATPDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGDLKN 84
Query: 694 LLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGE- 752
L + +A VA GL +LH IH D++ N L AD +G+
Sbjct: 85 YLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDY 144
Query: 753 -IEISKLLDPSKGTASISAVAGSFGYIPPEYA-------YTMQVTAPGNVYSYGVVLLEI 804
+ + + + T AV ++ PE T N++S GV + E+
Sbjct: 145 GLALEQYPEDYYITKDCHAV--PLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWEL 202
Query: 805 LT 806
T
Sbjct: 203 FT 204
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 46.4 bits (111), Expect = 8e-07
Identities = 24/59 (40%), Positives = 29/59 (49%)
Query: 88 LKRLDLSNNAFSGTIPSAFGNLSELEFLDLSLNKFGGVIPRELGSLKDLRFFNISNNVL 146
LK LDLSNN + AF L L+ LDLS N + P L LR ++S N L
Sbjct: 2 LKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 51.7 bits (124), Expect = 1e-06
Identities = 32/86 (37%), Positives = 50/86 (58%), Gaps = 2/86 (2%)
Query: 68 LDLSRLQLRGNITL-VSELKALKRLDLSNNAFSGTIPSAFGNLSELEFLDLSLNKFGGVI 126
++LS +RGNI + + +L+ LDLS N+F+G+IP + G L+ L L+L+ N G +
Sbjct: 447 INLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRV 506
Query: 127 PRELGSLKDLR-FFNISNNVLVGEIP 151
P LG R FN ++N + IP
Sbjct: 507 PAALGGRLLHRASFNFTDNAGLCGIP 532
|
Length = 623 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 1e-06
Identities = 50/199 (25%), Positives = 90/199 (45%), Gaps = 16/199 (8%)
Query: 616 GTFSTVYKAVMPSGLILSVKRLK--SMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFV 673
G F V+ +++K LK SM + E + +L H LVR V
Sbjct: 17 GQFGEVWMGYYNGHTKVAIKSLKQGSMS------PEAFLAEANLMKQLQHPRLVRLYAVV 70
Query: 674 IYEDVALLLHNYLPNGTLAQLLHESTKQPD-YRPDWPTRLSIAIGVAEGLAFLHHVAIIH 732
E + ++ Y+ NG+L L K P+ + + +A +AEG+AF+ IH
Sbjct: 71 TQEPI-YIITEYMENGSLVDFL----KTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIH 125
Query: 733 LDISSGNVLLDADFKPLLGEIEISKLLDPSKGTASISAVAGSFGYIPPEYAYTMQVTAPG 792
D+ + N+L+ + + +++L++ ++ TA A + PE T
Sbjct: 126 RDLRAANILVSETLCCKIADFGLARLIEDNEYTAREGA-KFPIKWTAPEAINYGTFTIKS 184
Query: 793 NVYSYGVVLLEILT-TRLP 810
+V+S+G++L EI+T R+P
Sbjct: 185 DVWSFGILLTEIVTYGRIP 203
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 50.8 bits (121), Expect = 1e-06
Identities = 55/272 (20%), Positives = 118/272 (43%), Gaps = 19/272 (6%)
Query: 616 GTFSTVYKAV-MPSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVI 674
G FS VY+A + +++K+++ + + ++E++ L +L H N+++ + I
Sbjct: 13 GQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFI 72
Query: 675 YEDVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLD 734
++ ++ G L+Q++ KQ P+ T + + + +H ++H D
Sbjct: 73 EDNELNIVLELADAGDLSQMIKYFKKQKRLIPE-RTVWKYFVQLCSAVEHMHSRRVMHRD 131
Query: 735 ISSGNVLLDADFKPLLGEIEISKLLDPSKGTASISAVAGSFGYIPPEYAYTMQVTAPGNV 794
I NV + A LG++ + + SK TA+ S V + Y+ PE + ++
Sbjct: 132 IKPANVFITATGVVKLGDLGLGRFFS-SKTTAAHSLVGTPY-YMSPERIHENGYNFKSDI 189
Query: 795 YSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQILDARLSTVSFGWRKEM 854
+S G +L E+ + P +G+ ++L EQ L T + +
Sbjct: 190 WSLGCLLYEMAALQSPF---YGDKMNLFSLCQKI-------EQCDYPPLPTEHYSEKLRE 239
Query: 855 LTALKVALLCTDSTPAKRPKMKKVVEMLQEIK 886
L + +C P +RP + V ++ +++
Sbjct: 240 LVS-----MCIYPDPDQRPDIGYVHQIAKQMH 266
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 1e-06
Identities = 52/200 (26%), Positives = 91/200 (45%), Gaps = 24/200 (12%)
Query: 616 GTFSTVYKA-VMPSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVI 674
G TVYKA + + IL+VK + +D T+ Q +++ ELE L K ++ G
Sbjct: 12 GNGGTVYKAYHLLTRRILAVKVI-PLDITV-ELQKQIMSELEILYKCDSPYIIGFYGAFF 69
Query: 675 YEDVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLD 734
E+ + ++ G+L K P+ IA+ V +GL +L + I+H D
Sbjct: 70 VENRISICTEFMDGGSLDVY----RKIPE-----HVLGRIAVAVVKGLTYLWSLKILHRD 120
Query: 735 ISSGNVLLDADFKPLLGEIEISKLLDPSKGTASISAVA----GSFGYIPPEYAYTMQVTA 790
+ N+L++ G++ KL D T ++++A G+ Y+ PE Q
Sbjct: 121 VKPSNMLVNTR-----GQV---KLCDFGVSTQLVNSIAKTYVGTNAYMAPERISGEQYGI 172
Query: 791 PGNVYSYGVVLLEILTTRLP 810
+V+S G+ +E+ R P
Sbjct: 173 HSDVWSLGISFMELALGRFP 192
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 1e-06
Identities = 46/200 (23%), Positives = 93/200 (46%), Gaps = 35/200 (17%)
Query: 629 GLILSVKRLKS---MDRTIIH------HQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVA 679
G + VK + + M + ++H + +++REL+ + + +V G + E+
Sbjct: 19 GSVSKVKHIPTGTVMAKKVVHIGAKSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNI 78
Query: 680 LLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLS----IAIGVAEGLAFLHHV-AIIHLD 734
+ ++ G+L ++ Y+ P + IA+ V EGL +L++V I+H D
Sbjct: 79 CMCMEFMDCGSLDRI---------YKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRD 129
Query: 735 ISSGNVLLDADFKPLLGEIEISKLLDPSKGTASISAVAGSF----GYIPPEYAYTMQVTA 790
I N+L+++ G+I KL D I+++A +F Y+ PE + T
Sbjct: 130 IKPSNILVNSR-----GQI---KLCDFGVSGELINSIADTFVGTSTYMSPERIQGGKYTV 181
Query: 791 PGNVYSYGVVLLEILTTRLP 810
+V+S G+ ++E+ + P
Sbjct: 182 KSDVWSLGISIIELALGKFP 201
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 1e-06
Identities = 50/210 (23%), Positives = 97/210 (46%), Gaps = 28/210 (13%)
Query: 630 LILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVALLLHNYLPNG 689
L+++VK L+ D + +N ++E++ LS+L N++R +G + ED ++ Y+ NG
Sbjct: 47 LLVAVKILRP-DANK-NARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENG 104
Query: 690 TLAQLLH-------ESTKQPDYRPD-------WPTRLSIAIGVAEGLAFLHHVAIIHLDI 735
L Q L E P + + L +A+ +A G+ +L + +H D+
Sbjct: 105 DLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDL 164
Query: 736 SSGNVLLDADFKPLLGEIEISKLLDPS-----KGTASISAVAGSFGYIPPEYAYTMQVTA 790
++ N L+ + + + +S+ L +G A + ++ E + T
Sbjct: 165 ATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVL-----PIRWMAWECILMGKFTT 219
Query: 791 PGNVYSYGVVLLEILTTRLPVEEDFGEGVD 820
+V+++GV L EIL L E+ +GE D
Sbjct: 220 ASDVWAFGVTLWEILM--LCKEQPYGELTD 247
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 50.4 bits (120), Expect = 2e-06
Identities = 41/164 (25%), Positives = 73/164 (44%), Gaps = 10/164 (6%)
Query: 654 ELEKLSKLCHDNLVRPIGFV--IYEDVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTR 711
E++ L L H+ +V+ G + E + ++P G++ L + TR
Sbjct: 54 EIQLLKNLLHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTR 113
Query: 712 LSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPS--KGTASIS 769
+ EG+++LH I+H DI N+L D+ LG+ SK L GT +
Sbjct: 114 -----QILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTG-MK 167
Query: 770 AVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEE 813
+V G+ ++ PE +++S G ++E+LT + P E
Sbjct: 168 SVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAE 211
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 50.7 bits (121), Expect = 2e-06
Identities = 63/261 (24%), Positives = 102/261 (39%), Gaps = 57/261 (21%)
Query: 651 MIRELEKLSKLC--HDNLVRPIGFVIYEDVALLLHNYLPNGTLAQLLH-ESTKQPDYRPD 707
+I E+E L KL H N++ +G E ++ Y G L + L PDY D
Sbjct: 64 LISEME-LMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFD 122
Query: 708 ----------WPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLD-------ADFKPLL 750
+ +S A VA G+ +L IH D+++ NVL+ ADF
Sbjct: 123 ITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLAR 182
Query: 751 GEIEISKLLDPSKGTASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILT---- 806
G +I S G + +A PE + T +V+S+G+++ EI T
Sbjct: 183 GVHDIDYYKKTSNGRLPVKWMA-------PEALFDRVYTHQSDVWSFGILMWEIFTLGGS 235
Query: 807 --TRLPVEEDFGEGVDLVKWVHGAPARGETPEQILDARLSTVSFGWRKEMLTALKVALLC 864
+PVEE F L++ H ++ + +E C
Sbjct: 236 PYPGIPVEELF----KLLREGHRMDKPSNCTHEL---------YMLMRE----------C 272
Query: 865 TDSTPAKRPKMKKVVEMLQEI 885
+ P +RP K++VE L ++
Sbjct: 273 WHAVPTQRPTFKQLVEALDKV 293
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 2e-06
Identities = 35/169 (20%), Positives = 77/169 (45%), Gaps = 15/169 (8%)
Query: 652 IRELEKLSKLCHDNLVRPIGFVIYEDVAL-LLHNYLPNGTLAQLLHESTKQPDYRPDWPT 710
+ E +++L H NLV+ +G ++ E L ++ Y+ G+L L +
Sbjct: 47 LAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSV---LGGDC 103
Query: 711 RLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSKGTASISA 770
L ++ V E + +L +H D+++ NVL+ D + + ++K ++ T +
Sbjct: 104 LLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKLPV 163
Query: 771 VAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILT------TRLPVEE 813
+ PE + + +V+S+G++L EI + R+P+++
Sbjct: 164 -----KWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD 207
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 49.9 bits (119), Expect = 2e-06
Identities = 36/162 (22%), Positives = 79/162 (48%), Gaps = 17/162 (10%)
Query: 652 IRELEKLSKLCHDNLVRPIGFVIYEDVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTR 711
+ E + + H N++ G V +++ Y+ NG+L L ++ D +
Sbjct: 53 LSEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFL----RKHDGQFTVIQL 108
Query: 712 LSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLL--DPSKGTASIS 769
+ + G+A G+ +L + +H D+++ N+L++++ + + +S++L DP +
Sbjct: 109 VGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPE------A 162
Query: 770 AVAGSFGYIP-----PEYAYTMQVTAPGNVYSYGVVLLEILT 806
A G IP PE + T+ +V+SYG+V+ E+++
Sbjct: 163 AYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMS 204
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 2e-06
Identities = 42/160 (26%), Positives = 73/160 (45%), Gaps = 7/160 (4%)
Query: 648 QNKMIRELEKLSKLCHDNLVRPIGFVIYEDVALLLHNYLPNGTLAQLLHESTKQPDYRPD 707
+ E + L L H N++ + + +++ Y P GTLA+ + K+ + D
Sbjct: 43 RLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQ---KRCNSLLD 99
Query: 708 WPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPL-LGEIEISKLLDPSKGTA 766
T L + + L +H I+H D+ + N+LLD + +G+ ISK+L SK A
Sbjct: 100 EDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILS-SKSKA 158
Query: 767 SISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILT 806
V G+ YI PE ++++ G VL E+ +
Sbjct: 159 --YTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELAS 196
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 49.6 bits (119), Expect = 2e-06
Identities = 44/146 (30%), Positives = 64/146 (43%), Gaps = 29/146 (19%)
Query: 616 GTFSTVYKAVM-PSGLILSVKRLK---SMDRTIIHHQNKMIRELEKLSKLC-HDNLVRPI 670
GT+ VYKA +G ++++K +K D II + M++E C H N+V
Sbjct: 14 GTYGDVYKARDIATGELVAIKVIKLEPGDDFEIIQQEISMLKE-------CRHPNIVAYF 66
Query: 671 GFVIYEDVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAE---GLAFLHH 727
G + D ++ Y G+L + T+ P + L IA E GLA+LH
Sbjct: 67 GSYLRRDKLWIVMEYCGGGSLQDIYQV-TRGP------LSELQIAYVCRETLKGLAYLHE 119
Query: 728 VAIIHLDISSGNVLLD-------ADF 746
IH DI N+LL ADF
Sbjct: 120 TGKIHRDIKGANILLTEDGDVKLADF 145
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 49.8 bits (119), Expect = 3e-06
Identities = 40/132 (30%), Positives = 59/132 (44%), Gaps = 19/132 (14%)
Query: 718 VAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISK-LLDPSKGTASISAVAGSFG 776
+A L LH + II+ D+ N+LLD + L + +SK +D K S G+
Sbjct: 107 LALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSF---CGTVE 163
Query: 777 YIPPEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPE 836
Y+ PE T + +S+GV++ E+LT LP +G D R ET
Sbjct: 164 YMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPF-----QGKD----------RKETMT 208
Query: 837 QILDARLSTVSF 848
IL A+L F
Sbjct: 209 MILKAKLGMPQF 220
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 4e-06
Identities = 65/289 (22%), Positives = 115/289 (39%), Gaps = 45/289 (15%)
Query: 616 GTFSTVYKAVM--PSGLILSVKRLKSMDRTIIHHQN--KMIRELEKLSKLCHDNLVRPIG 671
G F +V + + G L V +K+M I + + + E + H N+++ IG
Sbjct: 10 GEFGSVMEGQLSQDDGSQLKVA-VKTMKLDIHTYSEIEEFLSEAACMKDFDHPNVMKLIG 68
Query: 672 FVIYED------VALLLHNYLPNGTLAQLLHES--TKQPDYRPDWPTRLSIAIGVAEGLA 723
+++ ++ +G L L S P+ P T L + +A G+
Sbjct: 69 VCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLP-LQTLLKFMVDIALGME 127
Query: 724 FLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPS----KGTASISAVAGSFGYIP 779
+L + IH D+++ N +L D + + +SK + +G + V +I
Sbjct: 128 YLSNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVK----WIA 183
Query: 780 PEYAYTMQVTAPGNVYSYGVVLLEILT---TRLPVEEDFGEGVDLVKWVHGAPARGETPE 836
E T+ +V+++GV + EI T T P E+ E D ++ HG R + PE
Sbjct: 184 IESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVEN-HEIYDYLR--HG--NRLKQPE 238
Query: 837 QILDARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEMLQEI 885
LD + WR + P RP K+ E+L+ I
Sbjct: 239 DCLDELYDLMYSCWRAD---------------PKDRPTFTKLREVLENI 272
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 6e-06
Identities = 54/216 (25%), Positives = 101/216 (46%), Gaps = 39/216 (18%)
Query: 611 NMIYCGTFSTVYKAV-MPSGLILSVKRL-KSMDRTIIHHQNKMIRELEKLSKLCHDNLVR 668
N I G TVYK + P+G + ++K + + + T+ + ++ RE+E L + H N+V+
Sbjct: 80 NRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHEDTV---RRQICREIEILRDVNHPNVVK 136
Query: 669 PIGFVIYE---DVALLLHNYLPNGTL--AQLLHESTKQPDYRPDWPTRLSIAIGVAEGLA 723
++ ++ +LL ++ G+L + E + D +A + G+A
Sbjct: 137 CHDM--FDHNGEIQVLLE-FMDGGSLEGTHIADEQ-----FLAD------VARQILSGIA 182
Query: 724 FLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLL----DPSKGTASISAVAGSFGYIP 779
+LH I+H DI N+L+++ + + +S++L DP S+V G+ Y+
Sbjct: 183 YLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMDPCN-----SSV-GTIAYMS 236
Query: 780 PEYAYT-----MQVTAPGNVYSYGVVLLEILTTRLP 810
PE T G+++S GV +LE R P
Sbjct: 237 PERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFP 272
|
Length = 353 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 48.5 bits (115), Expect = 6e-06
Identities = 44/164 (26%), Positives = 73/164 (44%), Gaps = 10/164 (6%)
Query: 654 ELEKLSKLCHDNLVRPIGFVI--YEDVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTR 711
E++ L L H+ +V+ G + E + Y+P G++ L + TR
Sbjct: 54 EIQLLKNLQHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTR 113
Query: 712 LSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDP--SKGTASIS 769
+ EG+++LH I+H DI N+L D+ LG+ SK L GT I
Sbjct: 114 -----QILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTG-IR 167
Query: 770 AVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEE 813
+V G+ ++ PE +V+S G ++E+LT + P E
Sbjct: 168 SVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAE 211
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 6e-06
Identities = 65/277 (23%), Positives = 111/277 (40%), Gaps = 68/277 (24%)
Query: 632 LSVKRLKSMDRTIIHHQNKMIRELEKLSKL-CHDNLVRPIGFVIYEDVALLLHNYLPNGT 690
++VK LK + + ++ EL+ +S L H+N+V +G L++ Y G
Sbjct: 68 VAVKMLKPTAHS--SEREALMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGD 125
Query: 691 LAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLL 750
L L ++ + LS + VA+G+AFL IH D+++ NVLL
Sbjct: 126 LLNFLR---RKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLT------- 175
Query: 751 GEIEISKLLD-------------PSKGTASISAVAGSFGYIPPEYAYTMQVTAPGNVYSY 797
+I K+ D KG A + ++ PE + T +V+SY
Sbjct: 176 -HGKIVKICDFGLARDIMNDSNYVVKGNARLPV-----KWMAPESIFNCVYTFESDVWSY 229
Query: 798 GVVLLEILT------TRLPVEEDF----GEGVDLVKWVHGAPARGETPEQILDARLSTVS 847
G++L EI + +PV+ F EG + + H P +I D +
Sbjct: 230 GILLWEIFSLGSNPYPGMPVDSKFYKLIKEGYRMAQPEHA-------PAEIYDIMKT--- 279
Query: 848 FGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEMLQE 884
C D+ P KRP K++V+++ +
Sbjct: 280 ----------------CWDADPLKRPTFKQIVQLIGK 300
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.2 bits (115), Expect = 7e-06
Identities = 58/217 (26%), Positives = 79/217 (36%), Gaps = 44/217 (20%)
Query: 677 DVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDIS 736
D L+ YL G A L+ P+ DW + IA V G+ LH IIH DI
Sbjct: 70 DYLYLVMEYLNGGDCASLIKTLGGLPE---DW-AKQYIA-EVVLGVEDLHQRGIIHRDIK 124
Query: 737 SGNVLLDADFKPLLGEIEISKLLDPSKGTASISAVAGSFGYIPPEYAYTMQVTAPGNVYS 796
N+L+D L + +S+ +K G+ Y+ PE + + +S
Sbjct: 125 PENLLIDQTGHLKLTDFGLSRNGLENK------KFVGTPDYLAPETILGVGDDKMSDWWS 178
Query: 797 YGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQILDARLSTVSFGWRKEMLT 856
G V+ E L P ETP+ + D LS W +E+
Sbjct: 179 LGCVIFEFLFGYPPFH-------------------AETPDAVFDNILSRR-INWPEEVKE 218
Query: 857 AL-KVA------LLCTDSTPAKRPKMKKVVEMLQEIK 886
A LLC D PAKR QEIK
Sbjct: 219 FCSPEAVDLINRLLCMD--PAKRLGANGY----QEIK 249
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 7e-06
Identities = 34/167 (20%), Positives = 79/167 (47%), Gaps = 13/167 (7%)
Query: 646 HHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVALLLHNYLPNGTLAQLLHESTKQPDYR 705
+ + E + + H N++ G V +++ ++ NG L L ++ Q
Sbjct: 47 KQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFT-- 104
Query: 706 PDWPTRL-SIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSKG 764
+L + G+A G+ +L + +H D+++ N+L++++ + + +S+ L+
Sbjct: 105 ---VIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTS 161
Query: 765 TASISAVAGSFGYIP-----PEYAYTMQVTAPGNVYSYGVVLLEILT 806
+ ++ G G IP PE + T+ +V+SYG+V+ E+++
Sbjct: 162 DPTYTSSLG--GKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMS 206
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 47.9 bits (114), Expect = 7e-06
Identities = 42/170 (24%), Positives = 78/170 (45%), Gaps = 22/170 (12%)
Query: 652 IRELEKLSKLCHDNLVRPIGFVIYEDVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTR 711
I E + + KL H LV+ G + ++ ++ NG L L + +Q D
Sbjct: 47 IEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQ--RQGKLSKD--ML 102
Query: 712 LSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISK------LLDPSKGT 765
LS+ V EG+ +L + IH D+++ N L+ + G +++S +LD
Sbjct: 103 LSMCQDVCEGMEYLERNSFIHRDLAARNCLVSS-----TGVVKVSDFGMTRYVLDDE--- 154
Query: 766 ASISAVAGSF--GYIPPEYAYTMQVTAPGNVYSYGVVLLEILTT-RLPVE 812
S+ F + PPE + ++ +V+S+GV++ E+ T ++P E
Sbjct: 155 -YTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFE 203
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 9e-06
Identities = 47/170 (27%), Positives = 76/170 (44%), Gaps = 27/170 (15%)
Query: 721 GLAFL------HHV---AIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSKGTASISAV 771
GL F+ HHV +IH DI S N+LL ++ LG+ SK+ +
Sbjct: 146 GLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTF 205
Query: 772 AGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPAR 831
G+ Y+ PE + +++S GV+L E+LT + P +G ++ + +H A
Sbjct: 206 CGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPF-----DGENMEEVMHKTLA- 259
Query: 832 GETPEQILDARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEM 881
G D ++S EM + ALL +D P +RP K++ M
Sbjct: 260 GR-----YDPLPPSIS----PEMQEIVT-ALLSSD--PKRRPSSSKLLNM 297
|
Length = 496 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 48.1 bits (115), Expect = 9e-06
Identities = 28/93 (30%), Positives = 41/93 (44%), Gaps = 3/93 (3%)
Query: 718 VAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSKGTASISAVAGSFGY 777
+ L +LH IIH DI N+LLD + + I+ + P T S S G+ GY
Sbjct: 109 IVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTSTS---GTPGY 165
Query: 778 IPPEYAYTMQVTAPGNVYSYGVVLLEILTTRLP 810
+ PE + + +S GV E L + P
Sbjct: 166 MAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRP 198
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 47.8 bits (114), Expect = 1e-05
Identities = 52/218 (23%), Positives = 89/218 (40%), Gaps = 53/218 (24%)
Query: 616 GTFSTVYKAVMPSGLILSVKRLK--SMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFV 673
G F V++ + + ++VK LK +MD + E + + KL H L++
Sbjct: 17 GQFGEVWEGLWNNTTPVAVKTLKPGTMD------PKDFLAEAQIMKKLRHPKLIQLYAVC 70
Query: 674 IYEDVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHL 733
E+ ++ + G+L + L + P + +A VA G+A+L IH
Sbjct: 71 TLEEPIYIVTELMKYGSLLEYLQGGAGR---ALKLPQLIDMAAQVASGMAYLEAQNYIHR 127
Query: 734 DISSGNVLLDADFKPLLGEIEISKLLD--------------------PSKGTASISAVAG 773
D+++ NV L+GE I K+ D P K TA
Sbjct: 128 DLAARNV--------LVGENNICKVADFGLARVIKEDIYEAREGAKFPIKWTA------- 172
Query: 774 SFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILT-TRLP 810
PE A + + +V+S+G++L EI+T R+P
Sbjct: 173 ------PEAALYNRFSIKSDVWSFGILLTEIVTYGRMP 204
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 47.8 bits (114), Expect = 1e-05
Identities = 54/225 (24%), Positives = 102/225 (45%), Gaps = 30/225 (13%)
Query: 597 IDLDAVVKATMKDSNMIYCGTFSTVYKAVMPSGLILSVKRLKSMDRTIIHHQNKMIRELE 656
ID V D N IY G F+ K V +I + K+ + +I E++
Sbjct: 20 IDKYTSVLIKENDQNSIYKGIFNN--KEV----IIRTFKKFHKGHKVLIDITEN---EIK 70
Query: 657 KLSKLCHDNLVRPIGFVIYEDVAL----LLHNYLPNGTLAQLLHESTKQPDYRPDWPTRL 712
L ++ +N+++ GF+I L L+ Y G L ++L + K ++ T+L
Sbjct: 71 NLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDKE-KDLSFK----TKL 125
Query: 713 SIAIGVAEGLAFLH-HVAIIHLDISSGNVLLDADFKPLLGEIEISKLLD--PSKGTASIS 769
+AI +GL L+ + + +++S + L+ ++K + + K+L P K +++
Sbjct: 126 DMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPPFK---NVN 182
Query: 770 AVAGSFGYIPPEYAYTM--QVTAPGNVYSYGVVLLEILTTRLPVE 812
+ Y + + + T ++YS GVVL EI T ++P E
Sbjct: 183 FMV----YFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFE 223
|
Length = 283 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 47.6 bits (114), Expect = 1e-05
Identities = 32/142 (22%), Positives = 65/142 (45%), Gaps = 23/142 (16%)
Query: 616 GTFSTVYKAV-MPSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVI 674
G++ +VYKA+ +G ++++K + ++ + ++I+E+ L + +V+ G
Sbjct: 14 GSYGSVYKAIHKETGQVVAIKVV-PVEEDL----QEIIKEISILKQCDSPYIVKYYGSYF 68
Query: 675 YEDVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAI---GVAEGLAFLHHVAII 731
++ Y G+++ ++ + K IA +GL +LH I
Sbjct: 69 KNTDLWIVMEYCGAGSVSDIMKITNKTLTEE-------EIAAILYQTLKGLEYLHSNKKI 121
Query: 732 HLDISSGNVLLD-------ADF 746
H DI +GN+LL+ ADF
Sbjct: 122 HRDIKAGNILLNEEGQAKLADF 143
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 47.6 bits (114), Expect = 1e-05
Identities = 54/226 (23%), Positives = 89/226 (39%), Gaps = 47/226 (20%)
Query: 616 GTFSTVYKAV-MPSGLILSVKRLKSMDRTIIHHQNKM---IRELEKLSKL-CHDNLVRPI 670
G+FSTV A + ++K L D+ + + K+ E E L++L H +++
Sbjct: 12 GSFSTVVLAKEKETNKEYAIKIL---DKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLY 68
Query: 671 G--------FVIYEDVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGL 722
+ + E Y PNG L Q + K TR A + L
Sbjct: 69 YTFQDEENLYFVLE--------YAPNGELLQYIR---KYGSLDEKC-TRFYAA-EILLAL 115
Query: 723 AFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSKGTASISAVA---------- 772
+LH IIH D+ N+LLD D + + +K+LDP+ S A
Sbjct: 116 EYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKN 175
Query: 773 ----GSF-G---YIPPEYAYTMQVTAPGNVYSYGVVLLEILTTRLP 810
SF G Y+ PE ++++ G ++ ++LT + P
Sbjct: 176 RRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPP 221
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 1e-05
Identities = 56/211 (26%), Positives = 87/211 (41%), Gaps = 30/211 (14%)
Query: 616 GTFSTVYKA-VMPSGLIL--SVKRLKSMDRTIIHHQNKMIRELEKLSKLC-HDNLVRPIG 671
G F V KA + GL + ++KR+K H ELE L KL H N++ +G
Sbjct: 18 GNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRD--FAGELEVLCKLGHHPNIINLLG 75
Query: 672 FVIYEDVALLLHNYLPNGTLAQLLHES---TKQPDYRPDWPTR--------LSIAIGVAE 720
+ L Y P+G L L +S P + T L A VA
Sbjct: 76 ACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVAR 135
Query: 721 GLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSKGTASISAVAGSFGYIPP 780
G+ +L IH D+++ N+ L+GE ++K+ D V + G +P
Sbjct: 136 GMDYLSQKQFIHRDLAARNI--------LVGENYVAKIADFGLSRGQEVYVKKTMGRLPV 187
Query: 781 EYAYTMQV-----TAPGNVYSYGVVLLEILT 806
+ + T +V+SYGV+L EI++
Sbjct: 188 RWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 218
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 47.2 bits (113), Expect = 1e-05
Identities = 55/207 (26%), Positives = 88/207 (42%), Gaps = 23/207 (11%)
Query: 616 GTFSTVYKA-VMPSGLILSVKRLKSMDRTIIHH-QNKMI-RELEKLSKLCHDNLVRPI-G 671
G F V V ++K +K R I+ Q + I E E L + H +V+
Sbjct: 4 GGFGRVELVKVKSKNRTFALKCVKK--RHIVETGQQEHIFSEKEILEECNHPFIVKLYRT 61
Query: 672 FVIYEDVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAII 731
F + + +L+ Y G L +L + +Y R IA V +LH+ II
Sbjct: 62 FKDKKYIYMLM-EYCLGGELWTILRDRGLFDEYT----ARFYIA-CVVLAFEYLHNRGII 115
Query: 732 HLDISSGNVLLDADFKPLLGEIEISKLLDPSKGTASISAVAGSFGYIPPEY----AYTMQ 787
+ D+ N+LLD++ L + +K L + T + G+ Y+ PE Y
Sbjct: 116 YRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTWTF---CGTPEYVAPEIILNKGYDFS 172
Query: 788 VTAPGNVYSYGVVLLEILTTRLPVEED 814
V + +S G++L E+LT R P ED
Sbjct: 173 V----DYWSLGILLYELLTGRPPFGED 195
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 46.8 bits (112), Expect = 2e-05
Identities = 38/174 (21%), Positives = 75/174 (43%), Gaps = 38/174 (21%)
Query: 648 QNKMIRELEKLSKLCHDNLVRPIGFVIYEDVALLLHNYLPNGTLAQLLHESTKQPDYRPD 707
+ +I E+ + H N+V + D ++ Y+ G+L ++ ++
Sbjct: 59 KELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQN--------- 109
Query: 708 WPTRLS------IAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLD- 760
R++ + V +GL +LH +IH DI S N+LL D G + KL D
Sbjct: 110 -FVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKD-----GSV---KLADF 160
Query: 761 -----PSKGTASISAVAGSFGYIPPE----YAYTMQVTAPGNVYSYGVVLLEIL 805
+K + ++V G+ ++ PE Y +V +++S G++ +E+
Sbjct: 161 GFAAQLTKEKSKRNSVVGTPYWMAPEVIKRKDYGPKV----DIWSLGIMCIEMA 210
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 2e-05
Identities = 39/164 (23%), Positives = 76/164 (46%), Gaps = 10/164 (6%)
Query: 652 IRELEKLSKLCHDNLVRPIGFVIYEDVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTR 711
I E + + KL H NLV+ G + ++ Y+ NG L L E + +W
Sbjct: 47 IEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGK--LGTEW--L 102
Query: 712 LSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSKGTASISAV 771
L + V E + +L IH D+++ N L+ D + + +++ + + T+S
Sbjct: 103 LDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYTSSQGT- 161
Query: 772 AGSF--GYIPPEYAYTMQVTAPGNVYSYGVVLLEILTT-RLPVE 812
F + PPE + ++ +V+S+GV++ E+ + ++P E
Sbjct: 162 --KFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYE 203
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 2e-05
Identities = 62/295 (21%), Positives = 131/295 (44%), Gaps = 34/295 (11%)
Query: 602 VVKAT-MKDSNMIYCGTFSTVYKAV-MPSG----LILSVKRLKSMDRTIIHHQNKMIREL 655
++K T +K ++ G F TVYK + +P G + +++K L+ + T +++ E
Sbjct: 3 ILKETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLR--ENTSPKANKEILDEA 60
Query: 656 EKLSKLCHDNLVRPIGFVIYEDVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIA 715
++ + + R +G + V L+ +P G L + E+ + + L+
Sbjct: 61 YVMAGVGSPYVCRLLGICLTSTVQLVTQ-LMPYGCLLDYVRENKDRIGSQ----DLLNWC 115
Query: 716 IGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSKGTASISAVAGSF 775
+ +A+G+++L V ++H D+++ NVL+ + + + +++LLD +
Sbjct: 116 VQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPI 175
Query: 776 GYIPPEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETP 835
++ E + T +V+SYGV + E++T FG K G PAR E P
Sbjct: 176 KWMALESILHRRFTHQSDVWSYGVTVWELMT--------FG-----AKPYDGIPAR-EIP 221
Query: 836 EQILDA--RLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEMLQEIKQN 888
+ +L+ RL + +K C RP+ +++V+ + ++
Sbjct: 222 D-LLEKGERLPQPPICTIDVYMIMVK----CWMIDSECRPRFRELVDEFSRMARD 271
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.7 bits (111), Expect = 2e-05
Identities = 34/136 (25%), Positives = 56/136 (41%), Gaps = 18/136 (13%)
Query: 616 GTFSTVYKAVMPSGLILSVKRLKSMDRTIIHHQNKM---IRELEKLSKLCHDNLVRPIGF 672
G F VYKA + I + ++ + E++ LS+ H N+V
Sbjct: 16 GAFGKVYKAQHKE-----TGLFAAAKIIQIESEEELEDFMVEIDILSECKHPNIVGLYEA 70
Query: 673 VIYEDVALLLHNYLPNGTLAQLLHESTK---QPDYRPDWPTRLSIAIGVAEGLAFLHHVA 729
YE+ +L + G L ++ E + +P R + + E L FLH
Sbjct: 71 YFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRY-------VCRQMLEALNFLHSHK 123
Query: 730 IIHLDISSGNVLLDAD 745
+IH D+ +GN+LL D
Sbjct: 124 VIHRDLKAGNILLTLD 139
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 3e-05
Identities = 44/217 (20%), Positives = 93/217 (42%), Gaps = 18/217 (8%)
Query: 616 GTFSTVYKAVMPSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIY 675
G F V+ +++K + R + I E + + KL H LV+ G
Sbjct: 15 GQFGLVWLGYWLEKRKVAIKTI----REGAMSEEDFIEEAQVMMKLSHPKLVQLYGVCTE 70
Query: 676 EDVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDI 735
L+ ++ +G L+ L ++ + + T L + + V EG+A+L +IH D+
Sbjct: 71 RSPICLVFEFMEHGCLSDYLR--AQRGKFSQE--TLLGMCLDVCEGMAYLESSNVIHRDL 126
Query: 736 SSGNVLLDADFKPLLGEIEISKLLDPSKGTASISAVAGSFGYIPPEYAYTMQVTAPGNVY 795
++ N L+ + + + +++ + + T+S + + PE + ++ +V+
Sbjct: 127 AARNCLVGENQVVKVSDFGMTRFVLDDQYTSS-TGTKFPVKWSSPEVFSFSKYSSKSDVW 185
Query: 796 SYGVVLLEILTT-RLPVE--------EDFGEGVDLVK 823
S+GV++ E+ + + P E E G L K
Sbjct: 186 SFGVLMWEVFSEGKTPYENRSNSEVVETINAGFRLYK 222
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 3e-05
Identities = 70/297 (23%), Positives = 114/297 (38%), Gaps = 66/297 (22%)
Query: 616 GTFSTVYKAVM------PSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRP 669
G F VY+ + L ++VK L ++ + E +SK H N+VR
Sbjct: 17 GAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSE--QDESDFLMEALIMSKFNHQNIVRL 74
Query: 670 IGFVIYEDVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLS------IAIGVAEGLA 723
IG +L + G L L E+ +P RP+ P+ L+ A VA+G
Sbjct: 75 IGVSFERLPRFILLELMAGGDLKSFLREN--RP--RPERPSSLTMKDLLFCARDVAKGCK 130
Query: 724 FLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLD------------PSKGTASISAV 771
+L IH DI++ N LL G ++K+ D KG ++ +
Sbjct: 131 YLEENHFIHRDIAARNCLLTCK-----GPGRVAKIADFGMARDIYRASYYRKGGRAMLPI 185
Query: 772 AGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPAR 831
++PPE T+ +V+S+GV+L EI F G P
Sbjct: 186 K----WMPPEAFLDGIFTSKTDVWSFGVLLWEI----------FSLGY--------MPYP 223
Query: 832 GETPEQILDARLSTVSFGWRKEMLTALKVALL-----CTDSTPAKRPKMKKVVEMLQ 883
G T +++++ V+ G R + + C TP RP ++E +Q
Sbjct: 224 GRTNQEVME----FVTGGGRLDPPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 5e-05
Identities = 66/307 (21%), Positives = 114/307 (37%), Gaps = 68/307 (22%)
Query: 616 GTFSTVYKAV------MPSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRP 669
G F V KA ++VK LK + ++ E L ++ H ++++
Sbjct: 11 GEFGKVVKATAFRLKGRAGYTTVAVKMLKENASSS--ELRDLLSEFNLLKQVNHPHVIKL 68
Query: 670 IGFVIYEDVALLLHNYLPNGTLAQLLHESTK------------------QPDYRP-DWPT 710
G + LL+ Y G+L L ES K PD R
Sbjct: 69 YGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGD 128
Query: 711 RLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLD-------ADFKPLLGEIEISKLLDPSK 763
+S A ++ G+ +L + ++H D+++ NVL+ +DF E + SK
Sbjct: 129 LISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSK 188
Query: 764 GTASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVK 823
G + +A E + T +V+S+GV+L EI+T
Sbjct: 189 GRIPVKWMA-------IESLFDHIYTTQSDVWSFGVLLWEIVT----------------- 224
Query: 824 WVHGAPARGETPEQILDARLSTVSFGWRKEM-----LTALKVALLCTDSTPAKRPKMKKV 878
+ G P G PE++ + + G+R E + L C P KRP +
Sbjct: 225 -LGGNPYPGIAPERL----FNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPTFADI 279
Query: 879 VEMLQEI 885
+ L+++
Sbjct: 280 SKELEKM 286
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 5e-05
Identities = 40/183 (21%), Positives = 88/183 (48%), Gaps = 9/183 (4%)
Query: 631 ILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVALLLHNYLPNGT 690
+++VK L++ D T +N ++E++ +S+L + N++R +G + +D ++ Y+ NG
Sbjct: 46 LVAVKMLRA-DVTK-TARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGD 103
Query: 691 LAQLL--HESTKQPDYRPDWPT-----RLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLD 743
L Q L E + + P+ L +A+ +A G+ +L + +H D+++ N L+
Sbjct: 104 LNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVG 163
Query: 744 ADFKPLLGEIEISKLLDPSKGTASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLE 803
+ + + +S+ L ++ E + T +V+++GV L E
Sbjct: 164 NHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWE 223
Query: 804 ILT 806
+ T
Sbjct: 224 MFT 226
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 45.8 bits (109), Expect = 5e-05
Identities = 58/214 (27%), Positives = 96/214 (44%), Gaps = 41/214 (19%)
Query: 616 GTFSTVYKA-VMPSGLILSVKRLKSMDRTIIHHQNKMI-RELEKLSKLCHD--NLVRPIG 671
GT VYK +G +++VK+ M RT +NK I +L+ + K HD +V+ G
Sbjct: 26 GTCGQVYKMRFKKTGHVMAVKQ---MRRTGNKEENKRILMDLDVVLK-SHDCPYIVKCYG 81
Query: 672 FVIYE-DVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRL--SIAIGVAEGLAFL--H 726
+ I + DV + + T L + + P P + + + + + L +L
Sbjct: 82 YFITDSDVFICMELM---STCLDKLLKRIQGP-----IPEDILGKMTVAIVKALHYLKEK 133
Query: 727 HVAIIHLDISSGNVLLDADFKPLLGEIEIS-KLLDPSKGTASISAVAGSFGYIPPEYAYT 785
H +IH D+ N+LLDA L + IS +L+D T S AG Y+ PE
Sbjct: 134 H-GVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAKTRS----AGCAAYMAPE---- 184
Query: 786 MQVTAP---------GNVYSYGVVLLEILTTRLP 810
++ P +V+S G+ L+E+ T + P
Sbjct: 185 -RIDPPDPNPKYDIRADVWSLGISLVELATGQFP 217
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 46.2 bits (109), Expect = 5e-05
Identities = 65/282 (23%), Positives = 117/282 (41%), Gaps = 59/282 (20%)
Query: 630 LILSVKRLKSMDRTIIHHQNKMIRELEKLSKLC-HDNLVRPIGFVIYEDVALLLHNYLPN 688
+ ++VK LK D + ++ E+E + + H N++ +G + +L Y
Sbjct: 45 VTVAVKMLK--DDATDKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASK 102
Query: 689 GTLAQLLH-----------ESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISS 737
G L + L ++ K P+ + + +S A VA G+ +L IH D+++
Sbjct: 103 GNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAA 162
Query: 738 GNVLLDADFKPLLGEIEISK---LLDPSKGTASISAVAGSFGYIP-----PEYAYTMQVT 789
NVL+ D + + +++ +D K T + G +P PE + T
Sbjct: 163 RNVLVTEDNVMKIADFGLARDVHNIDYYKKTTN--------GRLPVKWMAPEALFDRVYT 214
Query: 790 APGNVYSYGVVLLEILT------TRLPVEEDFGEGVDLVKWVHGAPARGETPEQILDARL 843
+V+S+GV+L EI T +PVEE F L+K H R + P
Sbjct: 215 HQSDVWSFGVLLWEIFTLGGSPYPGIPVEELF----KLLKEGH----RMDKPANC----- 261
Query: 844 STVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEMLQEI 885
E+ ++ C + P++RP K++VE L +
Sbjct: 262 -------THELYMIMRE---CWHAVPSQRPTFKQLVEDLDRV 293
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 6e-05
Identities = 32/97 (32%), Positives = 47/97 (48%), Gaps = 8/97 (8%)
Query: 721 GLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKL---LDPSKGTASISAVAGSFGY 777
GL FLH II+ D+ NV+LD D G I+I+ + G S G+ Y
Sbjct: 108 GLQFLHSKGIIYRDLKLDNVMLDRD-----GHIKIADFGMCKENVFGDNRASTFCGTPDY 162
Query: 778 IPPEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEED 814
I PE ++ T + +S+GV+L E+L + P D
Sbjct: 163 IAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGD 199
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 7e-05
Identities = 69/280 (24%), Positives = 117/280 (41%), Gaps = 59/280 (21%)
Query: 632 LSVKRLKSMDRTIIHHQNKMIRELEKLSKLC-HDNLVRPIGFVIYEDVALLLHNYLPNGT 690
++VK LKS D T + +I E+E + + H N++ +G + ++ Y G
Sbjct: 53 VAVKMLKS-DATE-KDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGN 110
Query: 691 LAQLLH-------ESTKQPDYRPD----WPTRLSIAIGVAEGLAFLHHVAIIHLDISSGN 739
L + L E P P+ + +S A VA G+ +L IH D+++ N
Sbjct: 111 LREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARN 170
Query: 740 VLLDADFKPLLGEIEISK---LLDPSKGTASISAVAGSFGYIP-----PEYAYTMQVTAP 791
VL+ D + + +++ +D K T + G +P PE + T
Sbjct: 171 VLVTEDNVMKIADFGLARDIHHIDYYKKTTN--------GRLPVKWMAPEALFDRIYTHQ 222
Query: 792 GNVYSYGVVLLEILT------TRLPVEEDFGEGVDLVKWVHGAPARGETPEQILDARLST 845
+V+S+GV+L EI T +PVEE F L+K H R + P +
Sbjct: 223 SDVWSFGVLLWEIFTLGGSPYPGVPVEELF----KLLKEGH----RMDKPSNCTN----- 269
Query: 846 VSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEMLQEI 885
E+ ++ C + P++RP K++VE L I
Sbjct: 270 -------ELYMMMRD---CWHAVPSQRPTFKQLVEDLDRI 299
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 8e-05
Identities = 52/236 (22%), Positives = 99/236 (41%), Gaps = 39/236 (16%)
Query: 662 CHDNLVRPIGFVIYEDVALLLHNYLPNGTLAQLLHE---STKQPDYRPDWPT---RLSIA 715
CH ++VR +G V L++ + +G L L + RP PT + +A
Sbjct: 68 CH-HVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPP-PTLQEMIQMA 125
Query: 716 IGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPS----KGTASISAV 771
+A+G+A+L+ +H D+++ N ++ DF +G+ +++ + + KG + V
Sbjct: 126 AEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV 185
Query: 772 AGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPAR 831
+ PE T +++S+GVVL EI + + P +
Sbjct: 186 RW----MAPESLKDGVFTTSSDMWSFGVVLWEITS------------------LAEQPYQ 223
Query: 832 GETPEQILDARLSTVSFGWRK---EMLTALKVALLCTDSTPAKRPKMKKVVEMLQE 884
G + EQ+L + E +T L +C P RP ++V +L++
Sbjct: 224 GLSNEQVLKFVMDGGYLDQPDNCPERVTDL--MRMCWQFNPKMRPTFLEIVNLLKD 277
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 46.4 bits (110), Expect = 8e-05
Identities = 54/229 (23%), Positives = 94/229 (41%), Gaps = 27/229 (11%)
Query: 632 LSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVALL-LHNYLPNGT 690
+++K L++ H + + RE ++L H N+V + L + Y+P T
Sbjct: 6 VAIKLLRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVPGRT 65
Query: 691 LAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLL 750
L ++L P RL + V + LA H+ I+H D+ N+++
Sbjct: 66 LREVLAADGALP---AGETGRLMLQ--VLDALACAHNQGIVHRDLKPQNIMVSQT----- 115
Query: 751 GEIEISKLLDPSKGT----------ASISA---VAGSFGYIPPEYAYTMQVTAPGNVYSY 797
G +K+LD GT A+++ V G+ Y PE VT ++Y++
Sbjct: 116 GVRPHAKVLDFGIGTLLPGVRDADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAW 175
Query: 798 GVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQILDARLSTV 846
G++ LE LT + V+ G V + + +P P I L V
Sbjct: 176 GLIFLECLTGQRVVQ---GASVAEILYQQLSPVDVSLPPWIAGHPLGQV 221
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 45.4 bits (108), Expect = 8e-05
Identities = 40/190 (21%), Positives = 80/190 (42%), Gaps = 30/190 (15%)
Query: 634 VKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVALLLHNYLPNGTLAQ 693
VK L+ + + ++E++ LS+L N+ R +G + ++ Y+ NG L Q
Sbjct: 51 VKVLR--PDASDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQ 108
Query: 694 LLHESTKQPDYRPDWPTRLS------IAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFK 747
L + + LS +A +A G+ +L + +H D+++ N L+ ++
Sbjct: 109 FLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVGKNYT 168
Query: 748 PLLGEIEISKLLDPSKGTASISAVAGSFGYI---PP--------EYAYTMQVTAPGNVYS 796
I+I+ G + + + + + P E + T +V++
Sbjct: 169 -----IKIADF-----GMSR-NLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWA 217
Query: 797 YGVVLLEILT 806
+GV L EILT
Sbjct: 218 FGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 45.4 bits (108), Expect = 8e-05
Identities = 58/242 (23%), Positives = 89/242 (36%), Gaps = 85/242 (35%)
Query: 616 GTFSTVYKAVMPSGLILSVKRLKSMDRTIIHHQNK-----MIRELEKLSKLCHDNLVRPI 670
GTF VYKA + R+ ++ + ++H++ +RE++ L KL H N+V I
Sbjct: 19 GTFGEVYKARQ-----IKTGRVVALKKILMHNEKDGFPITALREIKILKKLKHPNVVPLI 73
Query: 671 GFVIYE--------------------DVALLLHNYLPNGTLA---------QLLHESTKQ 701
+ D++ LL N P+ L QLL
Sbjct: 74 DMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLEN--PSVKLTESQIKCYMLQLL------ 125
Query: 702 PDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLD-------ADF---KPLLG 751
EG+ +LH I+H DI + N+L+D ADF +P G
Sbjct: 126 ------------------EGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYDG 167
Query: 752 EIEISKLLDPSKGTASISAVAGSFGYIPPEYA-----YTMQVTAPGNVYSYGVVLLEILT 806
K GT + + + Y PPE YT V +++ G V E+ T
Sbjct: 168 PPPNPK-GGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAV----DIWGIGCVFAEMFT 222
Query: 807 TR 808
R
Sbjct: 223 RR 224
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 8e-05
Identities = 30/106 (28%), Positives = 45/106 (42%), Gaps = 10/106 (9%)
Query: 718 VAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKL---LDPSKGTASISAVAGS 774
+ GL LH I++ D+ NVLLD G + IS L ++ G I AG+
Sbjct: 104 IICGLEHLHQRRIVYRDLKPENVLLDDH-----GNVRISDLGLAVELKGGK-KIKGRAGT 157
Query: 775 FGYIPPEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVD 820
GY+ PE + ++ G L E++ R P E V+
Sbjct: 158 PGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPF-RQRKEKVE 202
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 45.0 bits (107), Expect = 9e-05
Identities = 43/195 (22%), Positives = 90/195 (46%), Gaps = 15/195 (7%)
Query: 616 GTFSTVYKA-VMPSGLILSVKRLKSMDRT--IIHHQNKMIRELEKLSKLCHDNLVRPIG- 671
G V+KA +G +++K++ I N+ +RE++ L H +V+ +
Sbjct: 11 GAHGIVFKAKDRETGETVALKKVALRRLEGGI---PNQALREIKALQACQHPYVVKLLDV 67
Query: 672 FVIYEDVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAII 731
F L++ Y+P L+++L + + P+ + S + +G+A++H I+
Sbjct: 68 FPHGSGFVLVME-YMP-SDLSEVLRDEERPL---PEAQVK-SYMRMLLKGVAYMHANGIM 121
Query: 732 HLDISSGNVLLDADFKPLLGEIEISKLLDPSKGTASISAVAGSFGYIPPEYAYTMQVTAP 791
H D+ N+L+ AD + + +++L + VA + Y PE Y + P
Sbjct: 122 HRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVA-TRWYRAPELLYGARKYDP 180
Query: 792 G-NVYSYGVVLLEIL 805
G ++++ G + E+L
Sbjct: 181 GVDLWAVGCIFAELL 195
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 1e-04
Identities = 47/187 (25%), Positives = 80/187 (42%), Gaps = 44/187 (23%)
Query: 712 LSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSKG----TAS 767
LS + VA+G++FL IH D+++ N+LL I+K+ D S
Sbjct: 217 LSFSYQVAKGMSFLASKNCIHRDLAARNILLTHG--------RITKICDFGLARDIRNDS 268
Query: 768 ISAVAGS----FGYIPPEYAYTMQVTAPGNVYSYGVVLLEILT------TRLPVEEDFGE 817
V G+ ++ PE + T +V+SYG++L EI + +PV+ F
Sbjct: 269 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKF-- 326
Query: 818 GVDLVKWVHGAPARGETPEQILDARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKK 877
++K R +PE EM +K C D+ P KRP K+
Sbjct: 327 -YKMIK----EGYRMLSPECA------------PSEMYDIMKS---CWDADPLKRPTFKQ 366
Query: 878 VVEMLQE 884
+V+++++
Sbjct: 367 IVQLIEQ 373
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.8 bits (107), Expect = 1e-04
Identities = 36/146 (24%), Positives = 64/146 (43%), Gaps = 28/146 (19%)
Query: 616 GTFSTVYKAV-MPSGLILSVKRLKSMDRTIIHHQNK-----MIRELEKLSKLCHDNLVRP 669
GT+ VYKA +G I+++K+++ + ++ + +RE+ L +L H N+V+
Sbjct: 10 GTYGVVYKARDKKTGEIVALKKIR------LDNEEEGIPSTALREISLLKELKHPNIVKL 63
Query: 670 IGFVIYEDVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRL--SIAIGVAEGLAFLHH 727
+ + E L+ Y L + L L SI + GLA+ H
Sbjct: 64 LDVIHTERKLYLVFEYCDM-DLKKYLD------KRPGPLSPNLIKSIMYQLLRGLAYCHS 116
Query: 728 VAIIHLDISSGNVLLD-------ADF 746
I+H D+ N+L++ ADF
Sbjct: 117 HRILHRDLKPQNILINRDGVLKLADF 142
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 44.6 bits (106), Expect = 1e-04
Identities = 46/197 (23%), Positives = 87/197 (44%), Gaps = 14/197 (7%)
Query: 616 GTFSTVYKAV-MPSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVI 674
GT+ VYKA +G I+++K++K + +RE++ L +L H N+++ + V
Sbjct: 10 GTYGVVYKARDKLTGEIVAIKKIKLRFESEGI-PKTALREIKLLKELNHPNIIK-LLDVF 67
Query: 675 YEDVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRL--SIAIGVAEGLAFLHHVAIIH 732
L L + L +L+ D + P L S + +GLAF H I+H
Sbjct: 68 RHKGDLYLVFEFMDTDLYKLIK------DRQRGLPESLIKSYLYQLLQGLAFCHSHGILH 121
Query: 733 LDISSGNVLLDADFKPLLGEIEISKLLDPSKGTASISAVAGSFGYIPPEYAYTM-QVTAP 791
D+ N+L++ + L + +++ + V + Y PE + P
Sbjct: 122 RDLKPENLLINTEGVLKLADFGLARSFGSPVRPYT-HYVVTRW-YRAPELLLGDKGYSTP 179
Query: 792 GNVYSYGVVLLEILTTR 808
+++S G + E+L+ R
Sbjct: 180 VDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 1e-04
Identities = 43/175 (24%), Positives = 84/175 (48%), Gaps = 23/175 (13%)
Query: 616 GTFSTVYKAV-MPSGLILSVKRLK---SMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIG 671
GT+ VYKA + +G + +VK +K D ++I + M++E + H N+V G
Sbjct: 20 GTYGDVYKARNLHTGELAAVKIIKLEPGDDFSLIQQEIFMVKECK------HCNIVAYFG 73
Query: 672 FVIYEDVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAII 731
+ + + Y G+L + H + + + + R ++ +GLA+LH +
Sbjct: 74 SYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETL-----QGLAYLHSKGKM 128
Query: 732 HLDISSGNVLLDADFKPLLGEIEISKLLDPSKGTASIS---AVAGSFGYIPPEYA 783
H DI N+LL + G+++++ +K TA+I+ + G+ ++ PE A
Sbjct: 129 HRDIKGANILLTDN-----GDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVA 178
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 1e-04
Identities = 33/113 (29%), Positives = 51/113 (45%), Gaps = 8/113 (7%)
Query: 701 QPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKL-- 758
Q ++ D P A + GL FLH I++ D+ N+LLD D G I+I+
Sbjct: 88 QSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTD-----GHIKIADFGM 142
Query: 759 -LDPSKGTASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILTTRLP 810
+ G A G+ YI PE + + +S+GV+L E+L + P
Sbjct: 143 CKENMLGDAKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 45.5 bits (108), Expect = 1e-04
Identities = 42/190 (22%), Positives = 78/190 (41%), Gaps = 32/190 (16%)
Query: 648 QNKMIRELEKLSKLCHDNLVRPIGFVIYEDVALLLHN--YLPNGTLAQLLHESTKQPDYR 705
+ + +RE + + L H +V P+ + I D + + Y+ TL LL +S Q +
Sbjct: 46 KKRFLREAKIAADLIHPGIV-PV-YSICSDGDPVYYTMPYIEGYTLKSLL-KSVWQKESL 102
Query: 706 P-------DWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLD------------ADF 746
LSI + + ++H ++H D+ N+LL A F
Sbjct: 103 SKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIF 162
Query: 747 KPLLGEIEISKLLDPSKGTASISA------VAGSFGYIPPEYAYTMQVTAPGNVYSYGVV 800
K L E + +D + S+ + G+ Y+ PE + + ++Y+ GV+
Sbjct: 163 KKLEEEDLLD--IDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVI 220
Query: 801 LLEILTTRLP 810
L ++LT P
Sbjct: 221 LYQMLTLSFP 230
|
Length = 932 |
| >gnl|CDD|178695 PLN03150, PLN03150, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 2e-04
Identities = 21/62 (33%), Positives = 32/62 (51%)
Query: 427 ALNLSFNHLHGSLPPELGKLDKLVSFDVSNNQLSGTIPSALKGMLSLIEVNFSNNLLTGP 486
L L L G +P ++ KL L S ++S N + G IP +L + SL ++ S N G
Sbjct: 422 GLGLDNQGLRGFIPNDISKLRHLQSINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGS 481
Query: 487 VP 488
+P
Sbjct: 482 IP 483
|
Length = 623 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 44.3 bits (105), Expect = 2e-04
Identities = 37/156 (23%), Positives = 70/156 (44%), Gaps = 18/156 (11%)
Query: 662 CHDNLVRPIGFVIYEDVALLLHNYLPNGTLAQLLHESTKQPDYR----PDWPTRLSI--- 714
CH ++VR +G V L++ + G L L ++P+ PT
Sbjct: 68 CH-HVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRS--RRPEAENNPGLGPPTLQKFIQM 124
Query: 715 AIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPS----KGTASISA 770
A +A+G+A+L +H D+++ N ++ D +G+ +++ + + KG +
Sbjct: 125 AAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLP 184
Query: 771 VAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILT 806
V ++ PE T +V+S+GVVL E+ T
Sbjct: 185 VR----WMAPESLKDGVFTTKSDVWSFGVVLWEMAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 43.8 bits (103), Expect = 2e-04
Identities = 26/92 (28%), Positives = 45/92 (48%), Gaps = 2/92 (2%)
Query: 721 GLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSKGTASISAVAGSFGYIPP 780
G+ +H ++H DI S N+ L + K LG+ ++LL + A G+ Y+PP
Sbjct: 112 GVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLL--TSPGAYACTYVGTPYYVPP 169
Query: 781 EYAYTMQVTAPGNVYSYGVVLLEILTTRLPVE 812
E M +++S G +L E+ T + P +
Sbjct: 170 EIWENMPYNNKSDIWSLGCILYELCTLKHPFQ 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 44.1 bits (104), Expect = 2e-04
Identities = 57/231 (24%), Positives = 95/231 (41%), Gaps = 28/231 (12%)
Query: 616 GTFSTVYKAV-MPSGLILSVKRLK-SMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFV 673
G + +VYK + P+G+ +++K ++ +D + N++I EL+ L K +V G
Sbjct: 12 GNYGSVYKVLHRPTGVTMAMKEIRLELDESKF---NQIIMELDILHKAVSPYIVDFYGAF 68
Query: 674 IYEDVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFL-HHVAIIH 732
E + Y+ G+L +L I V +GL FL IIH
Sbjct: 69 FIEGAVYMCMEYMDAGSLDKLYAGGVATE--GIPEDVLRRITYAVVKGLKFLKEEHNIIH 126
Query: 733 LDISSGNVLLDADFKPLLGEIEISKLLDPSKGTASISAVAGSFGYIPPEY---------- 782
D+ NVL++ + + L + +S L S +I G Y+ PE
Sbjct: 127 RDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAKTNI----GCQSYMAPERIKSGGPNQNP 182
Query: 783 AYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGV--DLVKWVHGAPAR 831
YT+Q +V+S G+ +LE+ R P + + L V G P
Sbjct: 183 TYTVQ----SDVWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPT 229
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 2e-04
Identities = 49/197 (24%), Positives = 87/197 (44%), Gaps = 12/197 (6%)
Query: 649 NKMIRELEKLSKLCHDNLVRPIGFVI-YEDVAL-LLHNYLPNGTLAQLLHESTKQPDYRP 706
N + E++ L L HD +V+ G + E+ L + Y+P G++ L +
Sbjct: 49 NALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVT 108
Query: 707 DWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDP--SKG 764
TR + +G+++LH I+H DI N+L D+ LG+ SK + G
Sbjct: 109 RRYTR-----QILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSG 163
Query: 765 TASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKW 824
T I +V G+ ++ PE +V+S ++E+LT + P E E + +
Sbjct: 164 TG-IKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAE--YEAMAAIFK 220
Query: 825 VHGAPARGETPEQILDA 841
+ P + P+ + DA
Sbjct: 221 IATQPTKPMLPDGVSDA 237
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 2e-04
Identities = 47/227 (20%), Positives = 85/227 (37%), Gaps = 50/227 (22%)
Query: 611 NMIYCGTFSTVYKAVMP------SGLI-LSVKRLKSMDRTIIHHQNKMIRELEKLSKLCH 663
N + G F VY+ SG I ++VK L+ + + ++E +S H
Sbjct: 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRK--GATDQEKKEFLKEAHLMSNFNH 58
Query: 664 DNLVRPIGFVIYEDVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTR--LSIAIGVAEG 721
N+V+ +G + + ++ + G L L ++ + P + L I + VA+G
Sbjct: 59 PNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKG 118
Query: 722 LAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSKGTASISAVAGSFG----- 776
+L + IH D+++ N L+ A G FG
Sbjct: 119 CVYLEQMHFIHRDLAARNCLVSE-----------------KGYDADRVVKIGDFGLARDI 161
Query: 777 -----------------YIPPEYAYTMQVTAPGNVYSYGVVLLEILT 806
++ PE + T +V+S+GV++ EILT
Sbjct: 162 YKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILT 208
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 2e-04
Identities = 40/170 (23%), Positives = 81/170 (47%), Gaps = 16/170 (9%)
Query: 648 QNKMIRELEKLSKLCHDNLVRPIGFVIYEDVALLLHNYLPNGTLAQLL--HESTKQPDYR 705
+N ++E++ +S+L N++R + I D ++ Y+ NG L Q L HE + +
Sbjct: 63 RNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKA 122
Query: 706 P----DWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDP 761
+ T + +A +A G+ +L + +H D+++ N L+ ++ + + +S+ L
Sbjct: 123 DVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYS 182
Query: 762 S-----KGTASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILT 806
+G A + S+ E + T +V+++GV L EILT
Sbjct: 183 GDYYRIQGRAVLPIRWMSW-----ESILLGKFTTASDVWAFGVTLWEILT 227
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 39.4 bits (93), Expect = 3e-04
Identities = 21/61 (34%), Positives = 26/61 (42%), Gaps = 2/61 (3%)
Query: 327 NLQELILYENSLFGEIPKSILA-CKNLNKLDLSNNRFNGTIPNAICDMSRLQYLLLGQNS 385
NL+ L L N+ IP NL LDLS N P A + L+ L L N+
Sbjct: 1 NLKSLDL-SNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNN 59
Query: 386 L 386
L
Sbjct: 60 L 60
|
Length = 60 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 43.4 bits (102), Expect = 3e-04
Identities = 28/103 (27%), Positives = 50/103 (48%), Gaps = 4/103 (3%)
Query: 718 VAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSKGTASISAVAGSFGY 777
+ G+ LH + I++ D+ NVLLD L ++ ++ L K +I+ AG+ GY
Sbjct: 104 ITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVEL---KDGKTITQRAGTNGY 160
Query: 778 IPPEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVD 820
+ PE + P + ++ G + E++ R P +D E V
Sbjct: 161 MAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPF-KDHKEKVA 202
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 3e-04
Identities = 50/209 (23%), Positives = 89/209 (42%), Gaps = 25/209 (11%)
Query: 616 GTFSTVYKAVMPSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIY 675
G F VYKA +L+ K +D + E++ L+ H N+V+ + Y
Sbjct: 16 GAFGKVYKAQNKETGVLAAA--KVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYY 73
Query: 676 EDVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIG-VAEGLAFLHHVAIIHLD 734
E+ +L + G + ++ E RP ++ + E L +LH IIH D
Sbjct: 74 ENNLWILIEFCAGGAVDAVMLELE-----RPLTEPQIRVVCKQTLEALNYLHENKIIHRD 128
Query: 735 ISSGNVLLDADFKPLLGEIEISKLLDPSKGTASIS---AVAGSFGYIPPEYAYTMQVTA- 790
+ +GN+L D G+I+++ +K T +I + G+ ++ PE M T+
Sbjct: 129 LKAGNILFTLD-----GDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPE--VVMCETSK 181
Query: 791 ------PGNVYSYGVVLLEILTTRLPVEE 813
+V+S G+ L+E+ P E
Sbjct: 182 DRPYDYKADVWSLGITLIEMAQIEPPHHE 210
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 3e-04
Identities = 62/279 (22%), Positives = 110/279 (39%), Gaps = 57/279 (20%)
Query: 632 LSVKRLKSMDRTIIHHQNKMIRELEKLSKLC-HDNLVRPIGFVIYEDVALLLHNYLPNGT 690
++VK LK D + ++ E+E + + H N++ +G + ++ Y G
Sbjct: 50 VAVKMLK--DDATEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGN 107
Query: 691 LAQLL-----------HESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGN 739
L + L ++ + PD + + +S VA G+ +L IH D+++ N
Sbjct: 108 LREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARN 167
Query: 740 VLLD-------ADFKPLLGEIEISKLLDPSKGTASISAVAGSFGYIPPEYAYTMQVTAPG 792
VL+ ADF I + G + ++ PE + T
Sbjct: 168 VLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVK-------WMAPEALFDRVYTHQS 220
Query: 793 NVYSYGVVLLEILT------TRLPVEEDFGEGVDLVKWVHGAPARGETPEQILDARLSTV 846
+V+S+GV++ EI T +PVEE F L+K H R + P +
Sbjct: 221 DVWSFGVLMWEIFTLGGSPYPGIPVEELF----KLLKEGH----RMDKPANCTN------ 266
Query: 847 SFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEMLQEI 885
E+ ++ C + P+ RP K++VE L I
Sbjct: 267 ------ELYMMMRD---CWHAIPSHRPTFKQLVEDLDRI 296
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 4e-04
Identities = 33/107 (30%), Positives = 51/107 (47%), Gaps = 15/107 (14%)
Query: 715 AIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKL------LDPSKGTASI 768
A +A GL FLH II+ D+ NV+LDA+ G I+I+ + K T +
Sbjct: 107 AAEIAIGLFFLHSKGIIYRDLKLDNVMLDAE-----GHIKIADFGMCKENIFGGKTTRTF 161
Query: 769 SAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVE-ED 814
G+ YI PE + +++GV+L E+L + P + ED
Sbjct: 162 ---CGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGED 205
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 43.1 bits (101), Expect = 4e-04
Identities = 57/220 (25%), Positives = 89/220 (40%), Gaps = 30/220 (13%)
Query: 607 MKDSNMIYCGTFSTVYKA-VMPSGLILS--VKRLKSMDRTIIHHQNKMIRELEKLSKLC- 662
+K ++I G F V +A + GL ++ +K LK H ELE L KL
Sbjct: 4 IKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASENDHRD--FAGELEVLCKLGH 61
Query: 663 HDNLVRPIGFVIYEDVALLLHNYLPNGTLAQLLHES---TKQPDYRPDWPTR-------- 711
H N++ +G + Y P G L L +S P + + T
Sbjct: 62 HPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQL 121
Query: 712 LSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSKGTASISAV 771
L A VA G+ +L IH D+++ NV L+GE SK+ D V
Sbjct: 122 LQFASDVATGMQYLSEKQFIHRDLAARNV--------LVGENLASKIADFGLSRGEEVYV 173
Query: 772 AGSFGYIPPEYAYTMQV-----TAPGNVYSYGVVLLEILT 806
+ G +P + + T +V+S+GV+L EI++
Sbjct: 174 KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVS 213
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 42.8 bits (101), Expect = 4e-04
Identities = 71/309 (22%), Positives = 115/309 (37%), Gaps = 79/309 (25%)
Query: 616 GTFSTVYKA------VMPSGLILSVKRLKS--MDRTIIHHQNKMIRELEKLSKLC-HDNL 666
G F V KA ++VK LK ++ + ++ E+E + + H N+
Sbjct: 23 GAFGQVVKAEAVGLDNPNETSTVAVKMLKDDATEKDLS----DLVSEMEMMKMIGKHKNI 78
Query: 667 VRPIGFVIYEDVALLLHNYLPNGTLAQLLHES-TKQPDYRPDWPTRL----------SIA 715
+ +G E ++ Y +G L L PD P S A
Sbjct: 79 INLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFA 138
Query: 716 IGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKL--------LDPSKGTAS 767
VA G+ FL IH D+++ NVL+ D ++I+ +D + T +
Sbjct: 139 YQVARGMEFLASKKCIHRDLAARNVLVTEDH-----VMKIADFGLARDIHHIDYYRKTTN 193
Query: 768 ISAVAGSFGYIP-----PEYAYTMQVTAPGNVYSYGVVLLEILT------TRLPVEEDFG 816
G +P PE + T +V+S+GV+L EI T +PVEE F
Sbjct: 194 --------GRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELF- 244
Query: 817 EGVDLVKWVHGAPARGETPEQILDARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMK 876
L+K + R E P+ E+ + C P++RP K
Sbjct: 245 ---KLLKEGY----RMEKPQNCTQ------------ELYHLM---RDCWHEVPSQRPTFK 282
Query: 877 KVVEMLQEI 885
++VE L +
Sbjct: 283 QLVEDLDRM 291
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 4e-04
Identities = 50/262 (19%), Positives = 98/262 (37%), Gaps = 60/262 (22%)
Query: 639 SMDRTIIHHQNKMIRELEKLSKLCHDNLV--RPIGFVIYEDVALLLHNYLPNGTLAQLLH 696
S D I + K IR S D V RP+ + +
Sbjct: 154 SSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVS--------------SSSSQSSDSKD 199
Query: 697 ESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEIS 756
E + + D L + VA+G+ FL IH D+++ NVLL + + ++
Sbjct: 200 EEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLA 259
Query: 757 K-LLDPS----KGTASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILTTRLPV 811
+ +++ S KG A + ++ PE + T +V+SYG++L EI +
Sbjct: 260 RDIMNDSNYVVKGNARLPV-----KWMAPESIFDCVYTVQSDVWSYGILLWEIFSL---- 310
Query: 812 EEDFGEGVDLVKWVHGAPARGETPEQILDARL-STVSFGWR--------KEMLTALKVAL 862
+ P +++++ V G++ E+ + +K
Sbjct: 311 ------------------GKSPYPGILVNSKFYKMVKRGYQMSRPDFAPPEIYSIMK--- 349
Query: 863 LCTDSTPAKRPKMKKVVEMLQE 884
+C + P +RP ++ +++Q
Sbjct: 350 MCWNLEPTERPTFSQISQLIQR 371
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 5e-04
Identities = 36/177 (20%), Positives = 78/177 (44%), Gaps = 14/177 (7%)
Query: 637 LKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVALLLHNYLPNGTLAQLLH 696
+K MD + + E+ + H+N+V + D ++ +L G L ++
Sbjct: 52 VKKMDLRKQQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALTDIVT 111
Query: 697 ESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEIS 756
+ R + ++ + V L++LH+ +IH DI S ++LL +D G I++S
Sbjct: 112 HT------RMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSD-----GRIKLS 160
Query: 757 KL---LDPSKGTASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILTTRLP 810
SK ++ G+ ++ PE + +++S G++++E++ P
Sbjct: 161 DFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPP 217
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.7 bits (101), Expect = 5e-04
Identities = 36/132 (27%), Positives = 59/132 (44%), Gaps = 13/132 (9%)
Query: 616 GTFSTVYKA-VMPSGLILSVKRLK-SMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFV 673
G + V K +G I+++K+ K S D + +RE++ L +L H+N+V
Sbjct: 12 GAYGVVLKCRNKATGEIVAIKKFKESEDDEDVK--KTALREVKVLRQLRHENIVNLKEAF 69
Query: 674 IYEDVALLLHNYLPNGTLAQLLHESTK--QPDYRPDWPTRLSIAIGVAEGLAFLHHVAII 731
+ L+ Y+ TL +LL S PD R I + + +A+ H II
Sbjct: 70 RRKGRLYLVFEYVER-TLLELLEASPGGLPPDA-----VRSYI-WQLLQAIAYCHSHNII 122
Query: 732 HLDISSGNVLLD 743
H DI N+L+
Sbjct: 123 HRDIKPENILVS 134
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 5e-04
Identities = 47/179 (26%), Positives = 70/179 (39%), Gaps = 9/179 (5%)
Query: 634 VKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVALLLHNYLPNGTLAQ 693
VK L+ + Q K + E + L H NL++ +G LL+ + P G L
Sbjct: 27 VKELRV--SASVQEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGDLKG 84
Query: 694 LLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEI 753
L K PD T +A +A GL LH IH D++ N LL AD +G+
Sbjct: 85 YLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDY 144
Query: 754 EISKLLDPSKGTASISAVAGSFGYIPPEYA-------YTMQVTAPGNVYSYGVVLLEIL 805
+S + + +I PE + T NV+S GV + E+
Sbjct: 145 GLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELF 203
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 5e-04
Identities = 46/198 (23%), Positives = 82/198 (41%), Gaps = 6/198 (3%)
Query: 616 GTFSTVYKAVMPSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIY 675
G+F +Y A S V + + + + + +E+ L+K+ H N+V
Sbjct: 11 GSFGKIYLAKAKSDSEHCVIKEIDLTKMPVKEKEASKKEVILLAKMKHPNIVTFFASFQE 70
Query: 676 EDVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDI 735
++ Y G L + ++ +Q LS + ++ GL +H I+H DI
Sbjct: 71 NGRLFIVMEYCDGGDLMKRIN---RQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDI 127
Query: 736 SSGNVLLDADFK-PLLGEIEISKLLDPSKGTASISAVAGSFGYIPPEYAYTMQVTAPGNV 794
S N+ L + LG+ I++ L+ S A G+ Y+ PE ++
Sbjct: 128 KSQNIFLSKNGMVAKLGDFGIARQLNDSMELA--YTCVGTPYYLSPEICQNRPYNNKTDI 185
Query: 795 YSYGVVLLEILTTRLPVE 812
+S G VL E+ T + P E
Sbjct: 186 WSLGCVLYELCTLKHPFE 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 7e-04
Identities = 48/210 (22%), Positives = 97/210 (46%), Gaps = 29/210 (13%)
Query: 616 GTFSTVYKAVMPSGLILSVKRLKSMDRTIIHHQNKMIRE-LEKLSKL-------CHDNLV 667
G+F VY+ + G++ + +T+ ++ +RE +E L++ CH ++V
Sbjct: 17 GSFGMVYEGI-AKGVVKDEPETRVAIKTV--NEAASMRERIEFLNEASVMKEFNCH-HVV 72
Query: 668 RPIGFVIYEDVALLLHNYLPNGTLAQLLHESTKQPDYR-------PDWPTRLSIAIGVAE 720
R +G V L++ + G L L + +P+ P + +A +A+
Sbjct: 73 RLLGVVSQGQPTLVIMELMTRGDLKSYLR--SLRPEMENNPVQAPPSLKKMIQMAGEIAD 130
Query: 721 GLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPS----KGTASISAVAGSFG 776
G+A+L+ +H D+++ N ++ DF +G+ +++ + + KG + V
Sbjct: 131 GMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVR---- 186
Query: 777 YIPPEYAYTMQVTAPGNVYSYGVVLLEILT 806
++ PE T +V+S+GVVL EI T
Sbjct: 187 WMSPESLKDGVFTTYSDVWSFGVVLWEIAT 216
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 7e-04
Identities = 49/215 (22%), Positives = 89/215 (41%), Gaps = 49/215 (22%)
Query: 615 CGTFSTVYKAV--MPSGLI-LSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIG 671
G F V K V M I +++K LK+ + + +++M+RE E + +L + +VR IG
Sbjct: 5 SGNFGCVKKGVYKMRKKQIDVAIKVLKNENEKSV--RDEMMREAEIMHQLDNPYIVRMIG 62
Query: 672 FVIYEDVALL--------LHNYL-------PNGTLAQLLHESTKQPDYRPDWPTRLSIAI 716
E + L+ L+ +L + +L+H+
Sbjct: 63 VCEAEALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQ------------------- 103
Query: 717 GVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSKGTASISAVAGSFG 776
V+ G+ +L +H D+++ NVLL + + +SK L G A S G
Sbjct: 104 -VSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKAL----GADDSYYKARSAG 158
Query: 777 YIP-----PEYAYTMQVTAPGNVYSYGVVLLEILT 806
P PE + ++ +V+SYG+ + E +
Sbjct: 159 KWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFS 193
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 42.1 bits (99), Expect = 8e-04
Identities = 30/90 (33%), Positives = 44/90 (48%), Gaps = 2/90 (2%)
Query: 721 GLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSKGTASISAVAGSFGYIPP 780
GL FLH II+ D+ NVLLD D + + + K +G A S G+ YI P
Sbjct: 108 GLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKA--STFCGTPDYIAP 165
Query: 781 EYAYTMQVTAPGNVYSYGVVLLEILTTRLP 810
E + + +S+GV+L E+L + P
Sbjct: 166 EILKGQKYNESVDWWSFGVLLYEMLIGQSP 195
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 41.6 bits (98), Expect = 9e-04
Identities = 68/297 (22%), Positives = 114/297 (38%), Gaps = 63/297 (21%)
Query: 612 MIYCGTFSTVYKAVM----PSGLILSVKRLK---SMDRTIIHHQNKMIRELEKLSKLCHD 664
I G F VY+ V + ++VK K S K ++E + + H
Sbjct: 13 CIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTSPSVR-----EKFLQEAYIMRQFDHP 67
Query: 665 NLVRPIGFVIYEDVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAF 724
++V+ IG VI E+ ++ P G L L + Y D + + + ++ LA+
Sbjct: 68 HIVKLIG-VITENPVWIVMELAPLGELRSYL----QVNKYSLDLASLILYSYQLSTALAY 122
Query: 725 LHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLD------PSKGTASISAVAGSFGYI 778
L +H DI++ NVL+ + LG+ +S+ L+ SKG I +A
Sbjct: 123 LESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMA------ 176
Query: 779 PPEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVH-----GAPARGE 833
PE + T+ +V+ +GV + EIL GV + V G GE
Sbjct: 177 -PESINFRRFTSASDVWMFGVCMWEILML----------GVKPFQGVKNNDVIGRIENGE 225
Query: 834 ---TPEQILDARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEMLQEIKQ 887
P S ++ W + P+KRP+ ++ L +I Q
Sbjct: 226 RLPMPPNCPPTLYSLMTKCWAYD---------------PSKRPRFTELKAQLSDILQ 267
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 0.001
Identities = 48/192 (25%), Positives = 79/192 (41%), Gaps = 48/192 (25%)
Query: 712 LSIAIGVAEGLAFLHHVAIIHLDISSGNVLLD-------ADFKPLLGEIEISKLLDPS-- 762
+S + VA G+ FL IH D+++ N+LL DF L +I K DP
Sbjct: 176 ISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFG--LAR-DIYK--DPDYV 230
Query: 763 -KGTASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILT------TRLPVEEDF 815
KG A + ++ PE + T +V+S+GV+L EI + + ++E+F
Sbjct: 231 RKGDARL-----PLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEF 285
Query: 816 GEGVDLVKWVHGAPARGETPEQILDARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKM 875
+ G R PE E+ + + L C + P RP
Sbjct: 286 CR-----RLKEG--TRMRAPEYATP------------EIYSIM---LDCWHNNPEDRPTF 323
Query: 876 KKVVEMLQEIKQ 887
++VE+L ++ Q
Sbjct: 324 SELVEILGDLLQ 335
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 41.6 bits (98), Expect = 0.001
Identities = 52/234 (22%), Positives = 107/234 (45%), Gaps = 34/234 (14%)
Query: 601 AVVKATMKDSNMIYCGTFSTVYKAVMPSGLILSVKRLKSMD---RTIIHHQ-----NKMI 652
A+ + + S+++ GTF ++ G+++ K K + +T+ H ++
Sbjct: 2 AISRDRVTLSDLLQEGTFGRIFY-----GILIDEKPGKEEEVFVKTVKDHASEIQVTLLL 56
Query: 653 RELEKLSKLCHDNLVRPIGFVIYE-DVALLLHNYLPNGTLAQLLHESTKQPDYRP-DWPT 710
+E L L H N++ + I + + +L+ Y+ G L L +Q + P
Sbjct: 57 QESCLLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFL----QQCRLGEANNPQ 112
Query: 711 RLS------IAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSK- 763
LS +AI +A G+++LH +IH DI++ N ++D + + + + +S+ L P
Sbjct: 113 ALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDY 172
Query: 764 ---GTASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILT-TRLPVEE 813
G V ++ E + ++ +V+S+GV+L E++T + P E
Sbjct: 173 HCLGDNENRPVK----WMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVE 222
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 41.3 bits (97), Expect = 0.001
Identities = 49/211 (23%), Positives = 99/211 (46%), Gaps = 28/211 (13%)
Query: 616 GTFSTVYKAV-MPSGLILSVKRLKSMDRTI-IHHQNKMIRELE-KLSKLCHDNLVRPIGF 672
G + V K +P+G I++VKR+++ T+ Q +++ +L+ + + V G
Sbjct: 12 GAYGVVDKMRHVPTGTIMAVKRIRA---TVNSQEQKRLLMDLDISMRSVDCPYTVTFYGA 68
Query: 673 VIYE-DVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLH-HVAI 730
+ E DV + + + + +L + + + P+ IA+ + + L +LH +++
Sbjct: 69 LFREGDVWICME--VMDTSLDKFYKKVYDKGLTIPE-DILGKIAVSIVKALEYLHSKLSV 125
Query: 731 IHLDISSGNVLLDADFKPLLGEIEIS-KLLDPSKGTASISAVAGSFGYIPPE-------- 781
IH D+ NVL++ + + L + IS L+D T AG Y+ PE
Sbjct: 126 IHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTID----AGCKPYMAPERINPELNQ 181
Query: 782 YAYTMQVTAPGNVYSYGVVLLEILTTRLPVE 812
Y ++ +V+S G+ ++E+ T R P +
Sbjct: 182 KGYDVK----SDVWSLGITMIELATGRFPYD 208
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 41.4 bits (97), Expect = 0.001
Identities = 31/100 (31%), Positives = 46/100 (46%), Gaps = 16/100 (16%)
Query: 718 VAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKL---LDPSKGTASISAVAGS 774
+ GL LH II+ D+ NVLLD D G + IS L ++ G + AG+
Sbjct: 106 IISGLEHLHQRRIIYRDLKPENVLLDND-----GNVRISDLGLAVELKDGQSKTKGYAGT 160
Query: 775 FGYIPPEY----AYTMQVTAPGNVYSYGVVLLEILTTRLP 810
G++ PE Y V + ++ GV L E++ R P
Sbjct: 161 PGFMAPELLQGEEYDFSV----DYFALGVTLYEMIAARGP 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 0.002
Identities = 65/278 (23%), Positives = 102/278 (36%), Gaps = 54/278 (19%)
Query: 616 GTFSTVYKAVMPSGLILSVKRLKS---MDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGF 672
G F V+K + ++VK K + I K + E L + H N+V+ IG
Sbjct: 6 GNFGEVFKGTLKDKTPVAVKTCKEDLPQELKI-----KFLSEARILKQYDHPNIVKLIGV 60
Query: 673 VIYEDVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIH 732
++ +P G L + + + + A+ A G+A+L IH
Sbjct: 61 CTQRQPIYIVMELVPGGDFLSFLRKKKDELKTK----QLVKFALDAAAGMAYLESKNCIH 116
Query: 733 LDISSGNVLLDADFKPLLGEIEISKLLDPSKGTASISAVAGSFGY--IP-----PEYAYT 785
D+++ N L+GE + K+ D + S G IP PE
Sbjct: 117 RDLAARNC--------LVGENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNY 168
Query: 786 MQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQILDARLST 845
+ ++ +V+SYG++L E F GV P G T +Q AR
Sbjct: 169 GRYSSESDVWSYGILLWET----------FSLGV--------CPYPGMTNQQ---AR-EQ 206
Query: 846 VSFGWRKEMLT-----ALKVALLCTDSTPAKRPKMKKV 878
V G+R KV C D P RPK ++
Sbjct: 207 VEKGYRMSCPQKCPDDVYKVMQRCWDYKPENRPKFSEL 244
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 0.002
Identities = 56/247 (22%), Positives = 97/247 (39%), Gaps = 34/247 (13%)
Query: 654 ELEKLSKLCHDNLVRPIGFVIYEDVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRL- 712
EL L+ H +V+ +D LL+ Y G L + + + K+ ++ L
Sbjct: 115 ELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLL 174
Query: 713 --SIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSKGTASISA 770
I + + E +H ++H D+ S N+ L LG+ SK S S+
Sbjct: 175 FYQIVLALDE----VHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASS 230
Query: 771 VAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPA 830
G+ Y+ PE + + +++S GV+L E+LT P + P+
Sbjct: 231 FCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFK---------------GPS 275
Query: 831 RGETPEQILDARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPK---------MKKVVEM 881
+ E +Q+L + M AL LL + PA RP +K V +
Sbjct: 276 QREIMQQVLYGKYDPFPCPVSSGM-KALLDPLLSKN--PALRPTTQQLLHTEFLKYVANL 332
Query: 882 LQEIKQN 888
Q+I ++
Sbjct: 333 FQDIVRH 339
|
Length = 478 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 0.002
Identities = 26/116 (22%), Positives = 52/116 (44%), Gaps = 14/116 (12%)
Query: 722 LAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSKGTASISAVAGSFGYIPPE 781
L ++H V +IH DI + N+L+ L + ++ LL ++ ++ S G+ ++ PE
Sbjct: 114 LKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALL--NQNSSKRSTFVGTPYWMAPE 171
Query: 782 Y-----AYTMQVTAPGNVYSYGVVLLEILTTRLPV-EEDFGEGVDLVKWVHGAPAR 831
Y + +++S G+ + E+ T P + D + L+ P R
Sbjct: 172 VITEGKYYDTKA----DIWSLGITIYEMATGNPPYSDVDAFRAMMLI--PKSKPPR 221
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 40.8 bits (96), Expect = 0.002
Identities = 75/294 (25%), Positives = 124/294 (42%), Gaps = 51/294 (17%)
Query: 607 MKDSNMIYCGTFSTVYKAVM-PSGLILSVKRLKSMDRTIIHHQNKMIRELE--KLSKLCH 663
+KD I G F TV K + PSG I++VKR++S Q +++ +L+ S C
Sbjct: 6 LKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRST--VDEKEQKRLLMDLDVVMRSSDC- 62
Query: 664 DNLVRPIGFVIYEDVAL----LLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVA 719
+V+ G + E L+ L + ++E K P + I VA
Sbjct: 63 PYIVKFYGALFREGDCWICMELMDISLDK--FYKYVYEVLKS-----VIPEEILGKIAVA 115
Query: 720 EGLAFLHHVA----IIHLDISSGNVLLDADFKPLLGEIEIS-KLLDPSKGTASISAV--A 772
A L+++ IIH D+ N+LLD + L + IS +L+D SI+ A
Sbjct: 116 TVKA-LNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVD------SIAKTRDA 168
Query: 773 GSFGYIPPEYAYTMQVTAPG-----NVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHG 827
G Y+ PE G +V+S G+ L E+ T + P + + D + V
Sbjct: 169 GCRPYMAPERIDPSA--RDGYDVRSDVWSLGITLYEVATGKFPYPK-WNSVFDQLTQV-- 223
Query: 828 APARGETPEQILDARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEM 881
+G+ P IL ++ + + + LC +KRPK K+++E
Sbjct: 224 --VKGDPP--ILS---NSEEREFSPSFVNFIN---LCLIKDESKRPKYKELLEH 267
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 0.002
Identities = 30/110 (27%), Positives = 50/110 (45%), Gaps = 3/110 (2%)
Query: 710 TRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSKGTASIS 769
++I + E LA+LH IIH D+ + N+ LD +LG+ + LD T
Sbjct: 186 QAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCY 245
Query: 770 AVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGV 819
+G+ PE A +++S G+VL E+ + + FG+ V
Sbjct: 246 GWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTL---FGKQV 292
|
Length = 392 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 0.002
Identities = 39/192 (20%), Positives = 88/192 (45%), Gaps = 23/192 (11%)
Query: 625 VMPSGLILSVKRL---KSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVALL 681
V SG +++VK++ K R ++ ++ ++R+ + H+N+V + D +
Sbjct: 41 VKSSGKLVAVKKMDLRKQQRRELLFNEVVIMRDYQ------HENVVEMYNSYLVGDELWV 94
Query: 682 LHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVL 741
+ +L G L ++ + R + ++ + V + L+ LH +IH DI S ++L
Sbjct: 95 VMEFLEGGALTDIVTHT------RMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSIL 148
Query: 742 LDADFKPLLGEIEISKL---LDPSKGTASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYG 798
L D G +++S SK ++ G+ ++ PE + +++S G
Sbjct: 149 LTHD-----GRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLG 203
Query: 799 VVLLEILTTRLP 810
++++E++ P
Sbjct: 204 IMVIEMVDGEPP 215
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 0.003
Identities = 42/196 (21%), Positives = 85/196 (43%), Gaps = 12/196 (6%)
Query: 616 GTFSTVYKAV-MPSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVI 674
G TVY A+ + +G +++K++ + + +I E+ + + H N+V + +
Sbjct: 30 GASGTVYTAIDVATGQEVAIKQMNLQQQP---KKELIINEILVMRENKHPNIVNYLDSYL 86
Query: 675 YEDVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLD 734
D ++ YL G+L ++ E+ D ++ + L FLH +IH D
Sbjct: 87 VGDELWVVMEYLAGGSLTDVVTETCM------DEGQIAAVCRECLQALEFLHSNQVIHRD 140
Query: 735 ISSGNVLLDADFKPLLGEIEISKLLDPSKGTASISAVAGSFGYIPPEYAYTMQVTAPGNV 794
I S N+LL D L + + P + S + G+ ++ PE ++
Sbjct: 141 IKSDNILLGMDGSVKLTDFGFCAQITPEQSKR--STMVGTPYWMAPEVVTRKAYGPKVDI 198
Query: 795 YSYGVVLLEILTTRLP 810
+S G++ +E++ P
Sbjct: 199 WSLGIMAIEMVEGEPP 214
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 0.003
Identities = 50/204 (24%), Positives = 91/204 (44%), Gaps = 15/204 (7%)
Query: 616 GTFSTVYKAVMPSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVR-PIGFVI 674
GT+ VYKA G LK ++ T I RE+ L +L H N++ F+
Sbjct: 12 GTYGHVYKAKRKDGKDEKEYALKQIEGTGI--SMSACREIALLRELKHPNVIALQKVFLS 69
Query: 675 YEDVAL-LLHNYLPNGTLAQL-LHESTKQPDYRPDWPTRL--SIAIGVAEGLAFLHHVAI 730
+ D + LL +Y + + H ++K P + S+ + +G+ +LH +
Sbjct: 70 HSDRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWV 129
Query: 731 IHLDISSGNVLLDADFKPLLGEIEI-----SKLLD-PSKGTASISAVAGSFGYIPPEYAY 784
+H D+ N+L+ + P G ++I ++L + P K A + V +F Y PE
Sbjct: 130 LHRDLKPANILVMGE-GPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLL 188
Query: 785 -TMQVTAPGNVYSYGVVLLEILTT 807
T ++++ G + E+LT+
Sbjct: 189 GARHYTKAIDIWAIGCIFAELLTS 212
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 40.1 bits (94), Expect = 0.003
Identities = 34/106 (32%), Positives = 48/106 (45%), Gaps = 14/106 (13%)
Query: 715 AIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLD--PSK----GTASI 768
A + GL FLH II+ D+ NVLLD++ G I K+ D K G +
Sbjct: 102 AAEIVLGLQFLHERGIIYRDLKLDNVLLDSE-----GHI---KIADFGMCKEGILGGVTT 153
Query: 769 SAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEED 814
S G+ YI PE + ++ GV+L E+L + P E D
Sbjct: 154 STFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGD 199
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.003
Identities = 48/195 (24%), Positives = 85/195 (43%), Gaps = 31/195 (15%)
Query: 632 LSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVALLLHNYLPNGTL 691
+++K LK D+ + + E S+L H N+V +G V E ++ +Y + L
Sbjct: 38 VAIKTLK--DKAEGPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDL 95
Query: 692 AQLL-------------HESTKQPDYRPDWPTRLSIAIGVAEGLAFL--HHVAIIHLDIS 736
+ L + T + P + I +A G+ FL HHV +H D++
Sbjct: 96 HEFLVMRSPHSDVGSTDDDKTVKSTLEP--ADFVHIVTQIAAGMEFLSSHHV--VHKDLA 151
Query: 737 SGNVLLDADFKPLLGEIEISKL-LDPSKGTASISAVAGS----FGYIPPEYAYTMQVTAP 791
+ NVL+ F L ++IS L L A + G+ ++ PE + +
Sbjct: 152 TRNVLV---FDKL--NVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSID 206
Query: 792 GNVYSYGVVLLEILT 806
+++SYGVVL E+ +
Sbjct: 207 SDIWSYGVVLWEVFS 221
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 36.0 bits (84), Expect = 0.004
Identities = 20/60 (33%), Positives = 24/60 (40%)
Query: 351 NLNKLDLSNNRFNGTIPNAICDMSRLQYLLLGQNSLKGEIPHEIGNCMKLLQLHIGSNYL 410
NL LDLSNNR A + L+ L L N+L P L L + N L
Sbjct: 1 NLKSLDLSNNRLTVIPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|206026 pfam13855, LRR_8, Leucine rich repeat | Back alignment and domain information |
|---|
Score = 36.0 bits (84), Expect = 0.004
Identities = 21/60 (35%), Positives = 31/60 (51%), Gaps = 2/60 (3%)
Query: 208 LELLNLHSNQLEGPIPKSIFAS-GKLEVLVLTQNRLTGDIPELVGHCKSLSNIRIGNNDL 266
L+ L+L +N+L IP F L+VL L+ N LT PE SL ++ + N+L
Sbjct: 2 LKSLDLSNNRLTV-IPDGAFKGLPNLKVLDLSGNNLTSISPEAFSGLPSLRSLDLSGNNL 60
|
Length = 60 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 0.004
Identities = 32/114 (28%), Positives = 47/114 (41%), Gaps = 2/114 (1%)
Query: 701 QPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLD 760
Q R D A + L FLH II+ D+ NVLLD + L + + K +
Sbjct: 88 QKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCK--E 145
Query: 761 PSKGTASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEED 814
+ S G+ YI PE M + ++ GV+L E+L P E +
Sbjct: 146 GIFNGKTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAE 199
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 0.004
Identities = 46/207 (22%), Positives = 92/207 (44%), Gaps = 34/207 (16%)
Query: 616 GTFSTVYKAV-MPSG----LILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPI 670
G F TVYK + +P G + +++K L+ + T +++ E ++ + + ++ R +
Sbjct: 18 GAFGTVYKGLWIPEGEKVKIPVAIKELR--EATSPKANKEILDEAYVMASVDNPHVCRLL 75
Query: 671 GFVIYEDVALLLHNYLPNGTLAQLLHESTKQ--PDYRPDWPTRLSIAIGVAEGLAFLHHV 728
G + V L+ +P G L + E Y +W + +A+G+ +L
Sbjct: 76 GICLTSTVQLITQ-LMPFGCLLDYVREHKDNIGSQYLLNW------CVQIAKGMNYLEER 128
Query: 729 AIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSKGTASISAVAGSFGYIPPEY------ 782
++H D+++ NVL+ + + ++KLL A G +P ++
Sbjct: 129 RLVHRDLAARNVLVKTPQHVKITDFGLAKLL-----GADEKEYHAEGGKVPIKWMALESI 183
Query: 783 ---AYTMQVTAPGNVYSYGVVLLEILT 806
YT Q +V+SYGV + E++T
Sbjct: 184 LHRIYTHQ----SDVWSYGVTVWELMT 206
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 40.0 bits (94), Expect = 0.004
Identities = 47/210 (22%), Positives = 81/210 (38%), Gaps = 24/210 (11%)
Query: 616 GTFSTVYKAVM---PSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGF 672
GT+ VYKA G ++K+ K RE+ L +L H+N+V +
Sbjct: 11 GTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVE- 69
Query: 673 VIYEDVAL---LLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVA 729
V E LL +Y + + + P S+ + G+ +LH
Sbjct: 70 VFLEHADKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPP-SMVKSLLWQILNGVHYLHSNW 128
Query: 730 IIHLDISSGNVLLDADFKPLLGEIEISKL------LDPSKGTASISAVAGSFGYIPPEYA 783
++H D+ N+L+ + P G ++I L P K A + V + Y PE
Sbjct: 129 VLHRDLKPANILVMGE-GPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELL 187
Query: 784 -----YTMQVTAPGNVYSYGVVLLEILTTR 808
YT + ++++ G + E+LT
Sbjct: 188 LGARHYTKAI----DIWAIGCIFAELLTLE 213
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 39.8 bits (93), Expect = 0.004
Identities = 51/213 (23%), Positives = 93/213 (43%), Gaps = 45/213 (21%)
Query: 616 GTFSTVYKAV-MPSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVI 674
GT+ VYKA +G ++++K+++ +D + IRE+ L +L H N+V+ + +
Sbjct: 11 GTYGVVYKARNKLTGEVVALKKIR-LDTETEGVPSTAIREISLLKELNHPNIVKLLDVIH 69
Query: 675 YEDVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRL--SIAIGVAEGLAFLHHVAIIH 732
E+ L+ +L + L + + S P L S + +GLAF H ++H
Sbjct: 70 TENKLYLVFEFL-HQDLKKFMDASPLS-----GIPLPLIKSYLFQLLQGLAFCHSHRVLH 123
Query: 733 LDISSGNVLLDADFKPLLGEIEISKLLDPSKGTASISAVAGSFGYIPPEYAYTMQV---- 788
D+ N+L++ + G I KL D +A +FG P YT +V
Sbjct: 124 RDLKPQNLLINTE-----GAI---KLAD--------FGLARAFGV--PVRTYTHEVVTLW 165
Query: 789 -------------TAPGNVYSYGVVLLEILTTR 808
+ +++S G + E++T R
Sbjct: 166 YRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 888 | |||
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG4194 | 873 | consensus Membrane glycoprotein LIG-1 [Signal tran | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 100.0 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0472 | 565 | consensus Leucine-rich repeat protein [Function un | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| KOG0444 | 1255 | consensus Cytoskeletal regulator Flightless-I (con | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.98 | |
| KOG0618 | 1081 | consensus Serine/threonine phosphatase 2C containi | 99.98 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.98 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.98 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.97 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.97 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.97 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.97 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.97 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.97 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.97 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.97 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.96 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.96 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.96 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.96 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.96 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.95 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.95 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.95 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.95 | |
| KOG4237 | 498 | consensus Extracellular matrix protein slit, conta | 99.94 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.94 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.93 | |
| PLN03210 | 1153 | Resistant to P. syringae 6; Provisional | 99.93 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.92 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.92 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.92 | |
| PRK15387 | 788 | E3 ubiquitin-protein ligase SspH2; Provisional | 99.91 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.9 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.89 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.89 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.89 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.88 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.88 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.87 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.87 | |
| PRK15370 | 754 | E3 ubiquitin-protein ligase SlrP; Provisional | 99.87 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.87 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.85 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.84 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.83 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.82 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.81 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.81 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.81 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.79 | |
| cd00116 | 319 | LRR_RI Leucine-rich repeats (LRRs), ribonuclease i | 99.79 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.78 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.78 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.78 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.77 | |
| KOG0617 | 264 | consensus Ras suppressor protein (contains leucine | 99.76 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.73 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.73 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.72 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.7 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.7 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.68 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.67 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.64 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.64 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.62 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.6 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.59 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.55 | |
| PLN03150 | 623 | hypothetical protein; Provisional | 99.53 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.48 | |
| COG4886 | 394 | Leucine-rich repeat (LRR) protein [Function unknow | 99.45 | |
| KOG0532 | 722 | consensus Leucine-rich repeat (LRR) protein, conta | 99.45 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.44 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.38 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.37 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.34 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.26 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.23 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.22 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 99.2 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.19 | |
| KOG0531 | 414 | consensus Protein phosphatase 1, regulatory subuni | 99.17 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.15 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.13 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.13 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.12 | |
| KOG1259 | 490 | consensus Nischarin, modulator of integrin alpha5 | 99.11 | |
| PF14580 | 175 | LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQ | 99.11 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.09 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 99.09 | |
| KOG3207 | 505 | consensus Beta-tubulin folding cofactor E [Posttra | 99.07 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 99.04 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 98.99 | |
| KOG1909 | 382 | consensus Ran GTPase-activating protein [RNA proce | 98.98 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 98.96 | |
| KOG4658 | 889 | consensus Apoptotic ATPase [Signal transduction me | 98.93 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.92 | |
| PF13855 | 61 | LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RF | 98.91 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 98.91 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.88 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.86 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.79 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.77 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.58 | |
| KOG2982 | 418 | consensus Uncharacterized conserved protein [Funct | 98.55 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.52 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 98.51 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.5 | |
| KOG4579 | 177 | consensus Leucine-rich repeat (LRR) protein associ | 98.49 | |
| KOG1859 | 1096 | consensus Leucine-rich repeat proteins [General fu | 98.45 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.45 |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-107 Score=1015.85 Aligned_cols=820 Identities=31% Similarity=0.540 Sum_probs=543.7
Q ss_pred CCCCHHHHHHHhhhcc-----CCCCCCCCCCCCCceeeEecCCCCeEEEEEcCCCCcccccc-cccCCCCCCEEeCCCCc
Q 002721 24 QLNDEPTLLAINKELI-----VPGWGVNGTNFCNWKGIDCDLNQAFVVKLDLSRLQLRGNIT-LVSELKALKRLDLSNNA 97 (888)
Q Consensus 24 ~~~~~~~ll~~~~~~~-----~~~w~~~~~~~c~w~gv~C~~~~~~v~~l~l~~~~l~~~~~-~~~~l~~L~~L~Ls~n~ 97 (888)
+++|++||++||+++. +.+|. .+.+||.|+||+|+. .++|+.|||+++.++|.++ .+..+++|++|+|++|+
T Consensus 27 ~~~~~~~l~~~~~~~~~~~~~~~~w~-~~~~~c~w~gv~c~~-~~~v~~L~L~~~~i~~~~~~~~~~l~~L~~L~Ls~n~ 104 (968)
T PLN00113 27 HAEELELLLSFKSSINDPLKYLSNWN-SSADVCLWQGITCNN-SSRVVSIDLSGKNISGKISSAIFRLPYIQTINLSNNQ 104 (968)
T ss_pred CHHHHHHHHHHHHhCCCCcccCCCCC-CCCCCCcCcceecCC-CCcEEEEEecCCCccccCChHHhCCCCCCEEECCCCc
Confidence 5678999999999982 56785 367999999999986 4689999999999888766 67778888888888888
Q ss_pred CcccCCCCCC-CCCCCCEEECcCCCCCC----------------------CCCCCCCCCCcceEEEcCCCccccccCccc
Q 002721 98 FSGTIPSAFG-NLSELEFLDLSLNKFGG----------------------VIPRELGSLKDLRFFNISNNVLVGEIPDEL 154 (888)
Q Consensus 98 l~~~~p~~~~-~l~~L~~L~Ls~N~l~~----------------------~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~ 154 (888)
+++.+|..+. ++++|++|+|++|++++ .+|..++.+++|++|+|++|.+.+.+|..|
T Consensus 105 ~~~~ip~~~~~~l~~L~~L~Ls~n~l~~~~p~~~l~~L~~L~Ls~n~~~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~~ 184 (968)
T PLN00113 105 LSGPIPDDIFTTSSSLRYLNLSNNNFTGSIPRGSIPNLETLDLSNNMLSGEIPNDIGSFSSLKVLDLGGNVLVGKIPNSL 184 (968)
T ss_pred cCCcCChHHhccCCCCCEEECcCCccccccCccccCCCCEEECcCCcccccCChHHhcCCCCCEEECccCcccccCChhh
Confidence 7766665533 55555555555555543 444455555555555555555555555555
Q ss_pred cccccccEEEecCCCCCCCCCccccccccccEEecccccccCCCCCCCCCcccccceeeccccCCCCCCCCccCCCCcce
Q 002721 155 KSLEKLEDFQVSSNKLNGSIPFWVGNLTNLRVFTAYENQLVGEIPDNLGSVSELELLNLHSNQLEGPIPKSIFASGKLEV 234 (888)
Q Consensus 155 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~ 234 (888)
.++++|++|+|++|.+++.+|..++++++|+.|+|++|++++.+|..|+++++|++|+|++|++++.+|..+.++++|++
T Consensus 185 ~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~ 264 (968)
T PLN00113 185 TNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLVYNNLTGPIPSSLGNLKNLQY 264 (968)
T ss_pred hhCcCCCeeeccCCCCcCcCChHHcCcCCccEEECcCCccCCcCChhHhcCCCCCEEECcCceeccccChhHhCCCCCCE
Confidence 55555555555555555555555555555555555555555555555555555555555555555555555555555555
Q ss_pred EEecCccCCCCchhhhccCCccceeeccCCccccccCCccccCCCccEEEeeccCCCCCCCccccCCCCCcEEEeecCcc
Q 002721 235 LVLTQNRLTGDIPELVGHCKSLSNIRIGNNDLVGVIPRAIGNVSGLTYFEADNNNLSGEIVPEFSQCSNLTLLNLASNGF 314 (888)
Q Consensus 235 L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l 314 (888)
|+|++|++++..|..+.++++|++|+|++|.+.+.+|..+.++++|++|++++|.+++..|..+..+++|+.|++++|.+
T Consensus 265 L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~~~~~~~l~~L~~L~L~~n~l 344 (968)
T PLN00113 265 LFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKIPVALTSLPRLQVLQLWSNKF 344 (968)
T ss_pred EECcCCeeeccCchhHhhccCcCEEECcCCeeccCCChhHcCCCCCcEEECCCCccCCcCChhHhcCCCCCEEECcCCCC
Confidence 55555555555555555555555555555555555555555555555555555555554444455555555555555555
Q ss_pred cccCCccccCCCCccEEEecccccc------------------------CcCcccccccCcceEEEccCCcCCCCCCchh
Q 002721 315 TGVIPPELGQLINLQELILYENSLF------------------------GEIPKSILACKNLNKLDLSNNRFNGTIPNAI 370 (888)
Q Consensus 315 ~~~~p~~~~~l~~L~~L~L~~N~l~------------------------~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~ 370 (888)
.+.+|..+..+++|+.|++++|++. +.+|..+..+++|+.|++++|++++.+|..|
T Consensus 345 ~~~~p~~l~~~~~L~~L~Ls~n~l~~~~p~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~~L~~L~L~~n~l~~~~p~~~ 424 (968)
T PLN00113 345 SGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACRSLRRVRLQDNSFSGELPSEF 424 (968)
T ss_pred cCcCChHHhCCCCCcEEECCCCeeEeeCChhHhCcCCCCEEECcCCEecccCCHHHhCCCCCCEEECcCCEeeeECChhH
Confidence 5444444444444444444444443 3444445555566666666666655555544
Q ss_pred ccccCcceec-----------------------------------------------ccCCccccccCCCccccccceEE
Q 002721 371 CDMSRLQYLL-----------------------------------------------LGQNSLKGEIPHEIGNCMKLLQL 403 (888)
Q Consensus 371 ~~l~~L~~L~-----------------------------------------------L~~N~l~~~~p~~~~~l~~L~~L 403 (888)
..++.|++|+ +++|++++.+|..+.++++|+.|
T Consensus 425 ~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~~~~~L~~L~ls~n~l~~~~~~~~~~l~~L~~L 504 (968)
T PLN00113 425 TKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSFGSKRLENLDLSRNQFSGAVPRKLGSLSELMQL 504 (968)
T ss_pred hcCCCCCEEECcCCcccCccChhhccCCCCcEEECcCceeeeecCcccccccceEEECcCCccCCccChhhhhhhccCEE
Confidence 4444333333 33333444444455556667777
Q ss_pred EeecccccccCCCccccccchhhhhhccCccccccCCccccCCCCccEEEeeCCccccCCchhhcccccceEEEccCCcC
Q 002721 404 HIGSNYLTGSIPPEIGHIRNLQIALNLSFNHLHGSLPPELGKLDKLVSFDVSNNQLSGTIPSALKGMLSLIEVNFSNNLL 483 (888)
Q Consensus 404 ~L~~N~l~~~~p~~~~~l~~L~~~L~ls~N~l~~~~p~~~~~l~~L~~LdLs~N~l~~~~p~~~~~l~~L~~L~ls~N~l 483 (888)
+|++|.+++.+|..+.++++|+ .|+|++|.+++.+|..|..+++|+.|||++|++++.+|..+..+++|++|++++|++
T Consensus 505 ~Ls~N~l~~~~p~~~~~l~~L~-~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~l~~l~~L~~l~ls~N~l 583 (968)
T PLN00113 505 KLSENKLSGEIPDELSSCKKLV-SLDLSHNQLSGQIPASFSEMPVLSQLDLSQNQLSGEIPKNLGNVESLVQVNISHNHL 583 (968)
T ss_pred ECcCCcceeeCChHHcCccCCC-EEECCCCcccccCChhHhCcccCCEEECCCCcccccCChhHhcCcccCEEeccCCcc
Confidence 7777777777777777777887 688888888888888888888899999999999888899898899999999999999
Q ss_pred cccCCCCCCCCCCCCCcccCCCCCCCCCCC---CCCCCCCCCCCCCcccccceeeeeeehhhhhHHHHHHHHHHHhhhhh
Q 002721 484 TGPVPSFVPFQKSPNSSFFGNKGLCGEPLS---FSCGNANGPDSKNYRHRVSYRIILAVVGSGLAVFISVTVVVLLFMMR 560 (888)
Q Consensus 484 ~~~~p~~~~~~~~~~~~~~~n~~lc~~~~~---~~c~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r 560 (888)
+|.+|+..++..+...+|.||+++||.+.. ..|.. ..+.. .+++ ++++++++++++++++++++++|
T Consensus 584 ~~~~p~~~~~~~~~~~~~~~n~~lc~~~~~~~~~~c~~--------~~~~~-~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 653 (968)
T PLN00113 584 HGSLPSTGAFLAINASAVAGNIDLCGGDTTSGLPPCKR--------VRKTP-SWWF-YITCTLGAFLVLALVAFGFVFIR 653 (968)
T ss_pred eeeCCCcchhcccChhhhcCCccccCCccccCCCCCcc--------ccccc-eeee-ehhHHHHHHHHHHHHHHHHHHHH
Confidence 999998888888888899999999986532 12321 11111 1122 22222222222222222223333
Q ss_pred hhhhcccccccccCCCCCCCcccccccchhcccccccCHHHHHHHhcCCcceeeecccceEEEEEe-CCCcEEEEEEeec
Q 002721 561 ERQEKASKSADVADSGASSQPSIIAGNVLVENLRQAIDLDAVVKATMKDSNMIYCGTFSTVYKAVM-PSGLILSVKRLKS 639 (888)
Q Consensus 561 ~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~ 639 (888)
+|+++..+... ...+. . ............++.+++. ..|+..+.||+|+||.||+|+. .++..||||+++.
T Consensus 654 ~~~~~~~~~~~-~~~~~--~----~~~~~~~~~~~~~~~~~~~-~~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~ 725 (968)
T PLN00113 654 GRNNLELKRVE-NEDGT--W----ELQFFDSKVSKSITINDIL-SSLKEENVISRGKKGASYKGKSIKNGMQFVVKEIND 725 (968)
T ss_pred hhhcccccccc-ccccc--c----cccccccccchhhhHHHHH-hhCCcccEEccCCCeeEEEEEECCCCcEEEEEEccC
Confidence 32221111100 00000 0 0000011111233444433 4588889999999999999995 5799999999874
Q ss_pred cChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCCeeEEEEecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHH
Q 002721 640 MDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVA 719 (888)
Q Consensus 640 ~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~ 719 (888)
... ...+|++++++++|||||+++|++.+++..|+||||+++|+|.++++ .++|.++.+++.||+
T Consensus 726 ~~~-------~~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~--------~l~~~~~~~i~~~ia 790 (968)
T PLN00113 726 VNS-------IPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLR--------NLSWERRRKIAIGIA 790 (968)
T ss_pred Ccc-------ccHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcHHHHHh--------cCCHHHHHHHHHHHH
Confidence 332 12356888999999999999999999999999999999999999996 367899999999999
Q ss_pred HHHhhcc---cCCeeecCCCCCCeEeCCCCCceEeccccccccCCCCCcccccccccccceecccccccCCcCccccchh
Q 002721 720 EGLAFLH---HVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSKGTASISAVAGSFGYIPPEYAYTMQVTAPGNVYS 796 (888)
Q Consensus 720 ~aL~~LH---~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwS 796 (888)
+||+||| +.+|+||||||+||+++.++.+++. ||.+...... ....+++.|+|||++.+..++.++||||
T Consensus 791 ~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~~------~~~~~t~~y~aPE~~~~~~~~~~sDv~S 863 (968)
T PLN00113 791 KALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTD------TKCFISSAYVAPETRETKDITEKSDIYG 863 (968)
T ss_pred HHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-eccccccccC------CCccccccccCcccccCCCCCcccchhh
Confidence 9999999 6799999999999999999888875 5554432211 1235789999999999999999999999
Q ss_pred HHHHHHHHHhCCCCCCCCCCCccchhhhccccCCCCCCcccccccccccCCcCcHHHHHHHHHHHhhccCCCCCCCCCHH
Q 002721 797 YGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQILDARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMK 876 (888)
Q Consensus 797 lG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ 876 (888)
|||++|||+||+.||...........+|....... .....+.++.+........++..++.+++.+||+.||++||||+
T Consensus 864 ~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~ 942 (968)
T PLN00113 864 FGLILIELLTGKSPADAEFGVHGSIVEWARYCYSD-CHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCAN 942 (968)
T ss_pred HHHHHHHHHhCCCCCCcccCCCCcHHHHHHHhcCc-cchhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHH
Confidence 99999999999999976555555555555433222 22333445444333333456677888999999999999999999
Q ss_pred HHHHHHHHhhh
Q 002721 877 KVVEMLQEIKQ 887 (888)
Q Consensus 877 evl~~L~~i~~ 887 (888)
||++.|+++.+
T Consensus 943 evl~~L~~~~~ 953 (968)
T PLN00113 943 DVLKTLESASR 953 (968)
T ss_pred HHHHHHHHhhc
Confidence 99999998854
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-51 Score=516.74 Aligned_cols=417 Identities=35% Similarity=0.596 Sum_probs=342.9
Q ss_pred eEEEEEcCCCCcccccc-cccCCCCCCEEeCCCCcCcccCCCCCCCCCCCCEEECcCCCCCCCCCCCCCCCCcceEEEcC
Q 002721 64 FVVKLDLSRLQLRGNIT-LVSELKALKRLDLSNNAFSGTIPSAFGNLSELEFLDLSLNKFGGVIPRELGSLKDLRFFNIS 142 (888)
Q Consensus 64 ~v~~l~l~~~~l~~~~~-~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 142 (888)
++..|||++|.+.+.++ .++++++|++|+|++|++++.+|..|+++++|++|+|++|++++.+|..|+.+++|++|+|+
T Consensus 165 ~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~L~ 244 (968)
T PLN00113 165 SLKVLDLGGNVLVGKIPNSLTNLTSLEFLTLASNQLVGQIPRELGQMKSLKWIYLGYNNLSGEIPYEIGGLTSLNHLDLV 244 (968)
T ss_pred CCCEEECccCcccccCChhhhhCcCCCeeeccCCCCcCcCChHHcCcCCccEEECcCCccCCcCChhHhcCCCCCEEECc
Confidence 57789999999888766 78899999999999999988889999999999999999999998889999999999999999
Q ss_pred CCccccccCccccccccccEEEecCCCCCCCCCccccccccccEEecccccccCCCCCCCCCcccccceeeccccCCCCC
Q 002721 143 NNVLVGEIPDELKSLEKLEDFQVSSNKLNGSIPFWVGNLTNLRVFTAYENQLVGEIPDNLGSVSELELLNLHSNQLEGPI 222 (888)
Q Consensus 143 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~ 222 (888)
+|.+++.+|..|+++++|++|++++|++++.+|..+.++++|+.|++++|++++.+|..+.++++|++|++++|.+++.+
T Consensus 245 ~n~l~~~~p~~l~~l~~L~~L~L~~n~l~~~~p~~l~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~l~~n~~~~~~ 324 (968)
T PLN00113 245 YNNLTGPIPSSLGNLKNLQYLFLYQNKLSGPIPPSIFSLQKLISLDLSDNSLSGEIPELVIQLQNLEILHLFSNNFTGKI 324 (968)
T ss_pred CceeccccChhHhCCCCCCEEECcCCeeeccCchhHhhccCcCEEECcCCeeccCCChhHcCCCCCcEEECCCCccCCcC
Confidence 99998888888999999999999999998888888888889999999988888888888888888888888888888888
Q ss_pred CCCccCCCCcceEEecCccCCCCchhhhccCCccceeeccCCccccccCCccccCCCccEEEeeccCCCCCCCccccCCC
Q 002721 223 PKSIFASGKLEVLVLTQNRLTGDIPELVGHCKSLSNIRIGNNDLVGVIPRAIGNVSGLTYFEADNNNLSGEIVPEFSQCS 302 (888)
Q Consensus 223 p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~ 302 (888)
|..+..+++|+.|+|++|++++..|..+..+++|+.|++++|++.+.+|..+..+++|+.|++++|++.+..|..+..++
T Consensus 325 ~~~~~~l~~L~~L~L~~n~l~~~~p~~l~~~~~L~~L~Ls~n~l~~~~p~~~~~~~~L~~L~l~~n~l~~~~p~~~~~~~ 404 (968)
T PLN00113 325 PVALTSLPRLQVLQLWSNKFSGEIPKNLGKHNNLTVLDLSTNNLTGEIPEGLCSSGNLFKLILFSNSLEGEIPKSLGACR 404 (968)
T ss_pred ChhHhcCCCCCEEECcCCCCcCcCChHHhCCCCCcEEECCCCeeEeeCChhHhCcCCCCEEECcCCEecccCCHHHhCCC
Confidence 88888888888888888888888888888888888888888877776666666555555555555555555555555555
Q ss_pred CCcEEEeecCcccccCCcc------------------------ccCCCCccEEEeccccccCcCcccccccCcceEEEcc
Q 002721 303 NLTLLNLASNGFTGVIPPE------------------------LGQLINLQELILYENSLFGEIPKSILACKNLNKLDLS 358 (888)
Q Consensus 303 ~L~~L~L~~N~l~~~~p~~------------------------~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls 358 (888)
+|+.|++++|++++.+|.. +..+++|+.|+|++|++.+.+|..+ ..++|+.|+++
T Consensus 405 ~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~n~~~~~~p~~~-~~~~L~~L~ls 483 (968)
T PLN00113 405 SLRRVRLQDNSFSGELPSEFTKLPLVYFLDISNNNLQGRINSRKWDMPSLQMLSLARNKFFGGLPDSF-GSKRLENLDLS 483 (968)
T ss_pred CCCEEECcCCEeeeECChhHhcCCCCCEEECcCCcccCccChhhccCCCCcEEECcCceeeeecCccc-ccccceEEECc
Confidence 5555555555555444444 4445555555555555555555443 34678888888
Q ss_pred CCcCCCCCCchhccccCcceecccCCccccccCCCccccccceEEEeecccccccCCCccccccchhhhhhccCcccccc
Q 002721 359 NNRFNGTIPNAICDMSRLQYLLLGQNSLKGEIPHEIGNCMKLLQLHIGSNYLTGSIPPEIGHIRNLQIALNLSFNHLHGS 438 (888)
Q Consensus 359 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~~L~ls~N~l~~~ 438 (888)
+|++++..|..|.++++|++|+|++|.+.+.+|..+.++++|+.|+|++|.+++.+|..+..+++|+ .|+|++|+++|.
T Consensus 484 ~n~l~~~~~~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~-~L~Ls~N~l~~~ 562 (968)
T PLN00113 484 RNQFSGAVPRKLGSLSELMQLKLSENKLSGEIPDELSSCKKLVSLDLSHNQLSGQIPASFSEMPVLS-QLDLSQNQLSGE 562 (968)
T ss_pred CCccCCccChhhhhhhccCEEECcCCcceeeCChHHcCccCCCEEECCCCcccccCChhHhCcccCC-EEECCCCccccc
Confidence 8888888999999999999999999999999999999999999999999999999999999999999 799999999999
Q ss_pred CCccccCCCCccEEEeeCCccccCCchhhcccccceEEEccCCcC
Q 002721 439 LPPELGKLDKLVSFDVSNNQLSGTIPSALKGMLSLIEVNFSNNLL 483 (888)
Q Consensus 439 ~p~~~~~l~~L~~LdLs~N~l~~~~p~~~~~l~~L~~L~ls~N~l 483 (888)
+|..+..+.+|+.|++++|+++|.+|.. +.+..+....+.+|..
T Consensus 563 ~p~~l~~l~~L~~l~ls~N~l~~~~p~~-~~~~~~~~~~~~~n~~ 606 (968)
T PLN00113 563 IPKNLGNVESLVQVNISHNHLHGSLPST-GAFLAINASAVAGNID 606 (968)
T ss_pred CChhHhcCcccCEEeccCCcceeeCCCc-chhcccChhhhcCCcc
Confidence 9999999999999999999999999964 3344455566777763
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-47 Score=390.20 Aligned_cols=254 Identities=24% Similarity=0.317 Sum_probs=210.9
Q ss_pred HHhcCCcceeeecccceEEEEEe-CCCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCC-eeEE
Q 002721 604 KATMKDSNMIYCGTFSTVYKAVM-PSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYED-VALL 681 (888)
Q Consensus 604 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~~l 681 (888)
..+.+..+.||+|..|+||++++ .+++.+|+|++.... ....++++.+|+++++.++||+||++||.|..++ ..++
T Consensus 78 ~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~~--~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI 155 (364)
T KOG0581|consen 78 LSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLNI--DPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISI 155 (364)
T ss_pred HHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeecccC--CHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEe
Confidence 44667788999999999999995 479999999995332 3345568999999999999999999999999998 5999
Q ss_pred EEecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhccc-CCeeecCCCCCCeEeCCCCCceEeccccccccC
Q 002721 682 LHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHH-VAIIHLDISSGNVLLDADFKPLLGEIEISKLLD 760 (888)
Q Consensus 682 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~~ 760 (888)
+||||++|+|+++++..+ ++++...-+|+.+|++||.|||+ ++||||||||+||||+..|.+||+|||.++.+.
T Consensus 156 ~mEYMDgGSLd~~~k~~g-----~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lv 230 (364)
T KOG0581|consen 156 CMEYMDGGSLDDILKRVG-----RIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILV 230 (364)
T ss_pred ehhhcCCCCHHHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhh
Confidence 999999999999998764 57788999999999999999995 999999999999999999999999999999876
Q ss_pred CCCCcccccccccccceecccccccCCcCccccchhHHHHHHHHHhCCCCCCCCCCCccchhhhccccCCCCCCcccccc
Q 002721 761 PSKGTASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQILD 840 (888)
Q Consensus 761 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 840 (888)
.+ ....++||..|||||.+.+..|+.++||||||++++|+++|+.||........+..+ ....+.+
T Consensus 231 nS----~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~----------Ll~~Iv~ 296 (364)
T KOG0581|consen 231 NS----IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFE----------LLCAIVD 296 (364)
T ss_pred hh----hcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHH----------HHHHHhc
Confidence 54 235689999999999999999999999999999999999999999765222222111 1112222
Q ss_pred cccccCCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002721 841 ARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVE 880 (888)
Q Consensus 841 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 880 (888)
...+..+.. ..++++.+++..|+++||.+|||++|+++
T Consensus 297 ~ppP~lP~~--~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~ 334 (364)
T KOG0581|consen 297 EPPPRLPEG--EFSPEFRSFVSCCLRKDPSERPSAKQLLQ 334 (364)
T ss_pred CCCCCCCcc--cCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 222222111 35677889999999999999999999985
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-48 Score=395.24 Aligned_cols=256 Identities=22% Similarity=0.314 Sum_probs=218.7
Q ss_pred HHHhcCCcceeeecccceEEEEE-eCCCcEEEEEEeeccChhh----hHHHHHHHHHHHHHhccCCCceeeeeeEEEeCC
Q 002721 603 VKATMKDSNMIYCGTFSTVYKAV-MPSGLILSVKRLKSMDRTI----IHHQNKMIRELEKLSKLCHDNLVRPIGFVIYED 677 (888)
Q Consensus 603 ~~~~~~~~~~ig~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~----~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 677 (888)
..+.|...+.+|+|+||.|-+|. .++|+.||||.+++..... ........+|+++|++++|||||+++++|+.++
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~d 249 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPD 249 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCC
Confidence 56778899999999999999999 5689999999997543322 112234679999999999999999999999999
Q ss_pred eeEEEEecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCC---CCceEeccc
Q 002721 678 VALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDAD---FKPLLGEIE 754 (888)
Q Consensus 678 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~---~~~kl~Dfg 754 (888)
..|+||||++||+|.+.+-.+.. +.+..-..+++|++.|+.|||++||+||||||+|||+..+ ..+||+|||
T Consensus 250 s~YmVlE~v~GGeLfd~vv~nk~-----l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNILl~~~~e~~llKItDFG 324 (475)
T KOG0615|consen 250 SSYMVLEYVEGGELFDKVVANKY-----LREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENILLSNDAEDCLLKITDFG 324 (475)
T ss_pred ceEEEEEEecCccHHHHHHhccc-----cccchhHHHHHHHHHHHHHHHHcCcccccCCcceEEeccCCcceEEEecccc
Confidence 99999999999999999987653 4556678899999999999999999999999999999765 789999999
Q ss_pred cccccCCCCCcccccccccccceecccccccCC---cCccccchhHHHHHHHHHhCCCCCCCCCCCccchhhhccccCCC
Q 002721 755 ISKLLDPSKGTASISAVAGSFGYIPPEYAYTMQ---VTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPAR 831 (888)
Q Consensus 755 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~ 831 (888)
+|+..... ..+...+||+.|.|||++.+.. +..++||||+||++|-+++|.+||.+.....
T Consensus 325 lAK~~g~~---sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~~------------- 388 (475)
T KOG0615|consen 325 LAKVSGEG---SFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTDP------------- 388 (475)
T ss_pred hhhccccc---eehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCCc-------------
Confidence 99987632 2356789999999999997664 3348899999999999999999998754331
Q ss_pred CCCcccccccccccCCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002721 832 GETPEQILDARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVE 880 (888)
Q Consensus 832 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 880 (888)
...+++..+++...+..|.+..+++.++|.+||..||++|||++|+++
T Consensus 389 -sl~eQI~~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~ 436 (475)
T KOG0615|consen 389 -SLKEQILKGRYAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALN 436 (475)
T ss_pred -cHHHHHhcCcccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhc
Confidence 134567777777778889999999999999999999999999999986
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-47 Score=406.18 Aligned_cols=250 Identities=22% Similarity=0.311 Sum_probs=216.0
Q ss_pred HhcCCcceeeecccceEEEEEe-CCCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCCeeEEEE
Q 002721 605 ATMKDSNMIYCGTFSTVYKAVM-PSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVALLLH 683 (888)
Q Consensus 605 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 683 (888)
.+|+..+.||+|||+.||+++. .+|+.||+|++.+.........+++.+|++|.++++|||||+++++|++.+++|+|.
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivL 97 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVL 97 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEE
Confidence 5799999999999999999996 789999999998766666667779999999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccccccccCCCC
Q 002721 684 NYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSK 763 (888)
Q Consensus 684 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 763 (888)
|+|+.++|..+++.+. .+++.++..+++||+.||.|||+++|+|||||..|++++++.++||+|||+|..+....
T Consensus 98 ELC~~~sL~el~Krrk-----~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~ 172 (592)
T KOG0575|consen 98 ELCHRGSLMELLKRRK-----PLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDG 172 (592)
T ss_pred EecCCccHHHHHHhcC-----CCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecCcc
Confidence 9999999999998543 57889999999999999999999999999999999999999999999999999987542
Q ss_pred CcccccccccccceecccccccCCcCccccchhHHHHHHHHHhCCCCCCCCCCCccchhhhccccCCCCCCccccccccc
Q 002721 764 GTASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQILDARL 843 (888)
Q Consensus 764 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 843 (888)
. .....+|||.|+|||++....++..+||||+|||||-|++|++||+...-. ++...+....
T Consensus 173 E--rk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vk---------------ety~~Ik~~~- 234 (592)
T KOG0575|consen 173 E--RKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVK---------------ETYNKIKLNE- 234 (592)
T ss_pred c--ccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHH---------------HHHHHHHhcC-
Confidence 2 234689999999999999999999999999999999999999999864211 1111111111
Q ss_pred ccCCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002721 844 STVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVE 880 (888)
Q Consensus 844 ~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 880 (888)
...+.....++.++|.++|++||.+|||+++|+.
T Consensus 235 ---Y~~P~~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~ 268 (592)
T KOG0575|consen 235 ---YSMPSHLSAEAKDLIRKLLRPNPSERPSLDEVLD 268 (592)
T ss_pred ---cccccccCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 1122245567889999999999999999999986
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-46 Score=403.42 Aligned_cols=282 Identities=39% Similarity=0.646 Sum_probs=235.4
Q ss_pred ccCHHHH--HHHhcCCcceeeecccceEEEEEeCCCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEE
Q 002721 596 AIDLDAV--VKATMKDSNMIYCGTFSTVYKAVMPSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFV 673 (888)
Q Consensus 596 ~~~~~~~--~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~ 673 (888)
.|+++++ +++.|...++||+|+||.||+|...+|+.||||++....... .++|.+|++++.+++|||+|+++|||
T Consensus 64 ~fs~~el~~AT~~Fs~~~~ig~Ggfg~VYkG~l~~~~~vAVK~~~~~~~~~---~~eF~~Ei~~ls~l~H~Nlv~LlGyC 140 (361)
T KOG1187|consen 64 SFSYDELRKATNNFSESNLIGEGGFGTVYKGVLSDGTVVAVKRLSSNSGQG---EREFLNEVEILSRLRHPNLVKLLGYC 140 (361)
T ss_pred eeeHHHHHHHHhCCchhcceecCCCeEEEEEEECCCCEEEEEEecCCCCcc---hhHHHHHHHHHhcCCCcCcccEEEEE
Confidence 5677775 456788899999999999999999899999999887544321 23699999999999999999999999
Q ss_pred EeCC-eeEEEEecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccC---CeeecCCCCCCeEeCCCCCce
Q 002721 674 IYED-VALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHV---AIIHLDISSGNVLLDADFKPL 749 (888)
Q Consensus 674 ~~~~-~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~k 749 (888)
.+.+ +.++|||||++|+|.+++...... .++|.++++||.++|+||+|||+. .||||||||+|||+|+++.+|
T Consensus 141 ~e~~~~~~LVYEym~nGsL~d~L~~~~~~---~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aK 217 (361)
T KOG1187|consen 141 LEGGEHRLLVYEYMPNGSLEDHLHGKKGE---PLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAK 217 (361)
T ss_pred ecCCceEEEEEEccCCCCHHHHhCCCCCC---CCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEE
Confidence 9998 599999999999999999986543 579999999999999999999983 599999999999999999999
Q ss_pred EeccccccccCCCCCccccccc-ccccceecccccccCCcCccccchhHHHHHHHHHhCCCCCCCCC-CCccchhhhccc
Q 002721 750 LGEIEISKLLDPSKGTASISAV-AGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDF-GEGVDLVKWVHG 827 (888)
Q Consensus 750 l~Dfg~a~~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~-~~~~~~~~~~~~ 827 (888)
|+|||+|+........ .... .||.+|+|||++..+..+.|+|||||||++.|++||+.|.+... .....++.|+..
T Consensus 218 lsDFGLa~~~~~~~~~--~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~ 295 (361)
T KOG1187|consen 218 LSDFGLAKLGPEGDTS--VSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKP 295 (361)
T ss_pred ccCccCcccCCccccc--eeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHH
Confidence 9999999665431111 1112 79999999999999999999999999999999999999887654 233347777755
Q ss_pred cCCCCCCcccccccccccCCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhh
Q 002721 828 APARGETPEQILDARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEMLQEIK 886 (888)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~i~ 886 (888)
....+ ...+++|+.+........+....+..++.+|++.+|++||+|.||+++|+.+.
T Consensus 296 ~~~~~-~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~~L~~~~ 353 (361)
T KOG1187|consen 296 LLEEG-KLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVKELEGIL 353 (361)
T ss_pred HHHCc-chhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHHHHHhhc
Confidence 55554 66778898876422222267888999999999999999999999999997764
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-46 Score=398.68 Aligned_cols=259 Identities=27% Similarity=0.396 Sum_probs=212.1
Q ss_pred hcCCcceeeecccceEEEEEeCCCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCC-eeEEEEe
Q 002721 606 TMKDSNMIYCGTFSTVYKAVMPSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYED-VALLLHN 684 (888)
Q Consensus 606 ~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-~~~lv~e 684 (888)
.+...+.||+|+||+||+|.+.....||||++...+..... .+.|.+|+.+|.+++|||||+++|++.... ..++|||
T Consensus 42 ~l~~~~~iG~G~~g~V~~~~~~g~~~vavK~~~~~~~~~~~-~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtE 120 (362)
T KOG0192|consen 42 ELPIEEVLGSGSFGTVYKGKWRGTDVVAVKIISDPDFDDES-RKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTE 120 (362)
T ss_pred HhhhhhhcccCCceeEEEEEeCCceeEEEEEecchhcChHH-HHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEE
Confidence 44555669999999999999855555999999865544433 678999999999999999999999999887 7999999
Q ss_pred cCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCC-eeecCCCCCCeEeCCCC-CceEeccccccccCCC
Q 002721 685 YLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVA-IIHLDISSGNVLLDADF-KPLLGEIEISKLLDPS 762 (888)
Q Consensus 685 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~-ivHrDlkp~NIll~~~~-~~kl~Dfg~a~~~~~~ 762 (888)
|+++|+|.+++.... ...+++..++.++.|||+|+.|||+++ ||||||||+|||++.++ ++||+|||+++.....
T Consensus 121 y~~~GsL~~~l~~~~---~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~ 197 (362)
T KOG0192|consen 121 YMPGGSLSVLLHKKR---KRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVIS 197 (362)
T ss_pred eCCCCcHHHHHhhcc---cCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChhhEEEcCCCCEEEECCCccceeeccc
Confidence 999999999998751 227899999999999999999999999 99999999999999997 9999999999876543
Q ss_pred CCcccccccccccceecccccc--cCCcCccccchhHHHHHHHHHhCCCCCCCCCCCccchhhhccccCCCCCCcccccc
Q 002721 763 KGTASISAVAGSFGYIPPEYAY--TMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQILD 840 (888)
Q Consensus 763 ~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 840 (888)
. ...+...||+.|||||++. ...|+.|+|||||||++|||+||+.||.+.... +....+.. .
T Consensus 198 ~--~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~--~~~~~v~~------------~ 261 (362)
T KOG0192|consen 198 K--TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPV--QVASAVVV------------G 261 (362)
T ss_pred c--ccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHH--HHHHHHHh------------c
Confidence 2 2233478999999999999 558999999999999999999999999875431 11111110 0
Q ss_pred cccccCCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhhh
Q 002721 841 ARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEMLQEIKQ 887 (888)
Q Consensus 841 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 887 (888)
...... .....+.+..+|.+||+.||++||++.+++..|+.+..
T Consensus 262 ~~Rp~~---p~~~~~~l~~l~~~CW~~dp~~RP~f~ei~~~l~~~~~ 305 (362)
T KOG0192|consen 262 GLRPPI---PKECPPHLSSLMERCWLVDPSRRPSFLEIVSRLESIMS 305 (362)
T ss_pred CCCCCC---CccCCHHHHHHHHHhCCCCCCcCCCHHHHHHHHHHHHH
Confidence 011111 11244567789999999999999999999999998864
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-47 Score=368.75 Aligned_cols=260 Identities=20% Similarity=0.285 Sum_probs=213.0
Q ss_pred HHHhcCCcceeeecccceEEEEE-eCCCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeee-EEEeCCe-e
Q 002721 603 VKATMKDSNMIYCGTFSTVYKAV-MPSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIG-FVIYEDV-A 679 (888)
Q Consensus 603 ~~~~~~~~~~ig~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~-~~~~~~~-~ 679 (888)
..++|++.+.||+|+||+||+++ ..+|..+|.|.++ .+.-+....+....|+.+|++++|||||++++ -+.++.. .
T Consensus 17 ~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~-f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evl 95 (375)
T KOG0591|consen 17 TLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQ-FGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVL 95 (375)
T ss_pred cHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcc-hhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhh
Confidence 34678999999999999999999 6689999999998 45555566678999999999999999999999 3444444 8
Q ss_pred EEEEecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhccc--CC--eeecCCCCCCeEeCCCCCceEecccc
Q 002721 680 LLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHH--VA--IIHLDISSGNVLLDADFKPLLGEIEI 755 (888)
Q Consensus 680 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~--~~--ivHrDlkp~NIll~~~~~~kl~Dfg~ 755 (888)
++|||||.+|||.++++....... .++++.+++++.|++.||.++|+ .+ |+||||||.||+++.+|.+|++|||+
T Consensus 96 nivmE~c~~GDLsqmIk~~K~qkr-~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL 174 (375)
T KOG0591|consen 96 NIVMELCDAGDLSQMIKHFKKQKR-LIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGL 174 (375)
T ss_pred HHHHHhhcccCHHHHHHHHHhccc-cCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchh
Confidence 999999999999999987655433 78999999999999999999999 56 99999999999999999999999999
Q ss_pred ccccCCCCCcccccccccccceecccccccCCcCccccchhHHHHHHHHHhCCCCCCCCCCCccchhhhccccCCCCCCc
Q 002721 756 SKLLDPSKGTASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETP 835 (888)
Q Consensus 756 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 835 (888)
++.+.... ......+|||.||+||.+.+.+|+.||||||+||++|||+.-++||.+.. ..++.+
T Consensus 175 ~r~l~s~~--tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n--~~~L~~------------ 238 (375)
T KOG0591|consen 175 GRFLSSKT--TFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDN--LLSLCK------------ 238 (375)
T ss_pred HhHhcchh--HHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCccccc--HHHHHH------------
Confidence 99987543 23457899999999999999999999999999999999999999998651 111111
Q ss_pred ccccccccccCCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 002721 836 EQILDARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEMLQ 883 (888)
Q Consensus 836 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~ 883 (888)
++.....+.. .....+..+..++..|+..||+.||+...++..+.
T Consensus 239 -KI~qgd~~~~--p~~~YS~~l~~li~~ci~vd~~~RP~t~~~v~di~ 283 (375)
T KOG0591|consen 239 -KIEQGDYPPL--PDEHYSTDLRELINMCIAVDPEQRPDTVPYVQDIQ 283 (375)
T ss_pred -HHHcCCCCCC--cHHHhhhHHHHHHHHHccCCcccCCCcchHHHHHH
Confidence 1112211111 12456677888999999999999998655555443
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-45 Score=378.60 Aligned_cols=204 Identities=25% Similarity=0.373 Sum_probs=181.5
Q ss_pred HHhcCCcceeeecccceEEEEEe-CCCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCCeeEEE
Q 002721 604 KATMKDSNMIYCGTFSTVYKAVM-PSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVALLL 682 (888)
Q Consensus 604 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 682 (888)
..+|...+.||+|+||+||+|++ .++..||||.+.+... ..+.++.+..|+++++.++|||||++++++..++..|+|
T Consensus 9 ~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l-~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lV 87 (429)
T KOG0595|consen 9 VGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKL-NKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLV 87 (429)
T ss_pred cccceehhhccCcceEEEEEeEeccCCceEEeeeehhhcc-CHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEE
Confidence 35788888999999999999994 4689999999975532 334556789999999999999999999999999999999
Q ss_pred EecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCC------CCceEeccccc
Q 002721 683 HNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDAD------FKPLLGEIEIS 756 (888)
Q Consensus 683 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~------~~~kl~Dfg~a 756 (888)
||||.||||.+|++..+ .+++..+..++.|+|.||++||+++||||||||+|||++.. -.+||+|||+|
T Consensus 88 MEyC~gGDLs~yi~~~~-----~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfA 162 (429)
T KOG0595|consen 88 MEYCNGGDLSDYIRRRG-----RLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFA 162 (429)
T ss_pred EEeCCCCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEeccCCCCCCCceEEecccchh
Confidence 99999999999999876 56779999999999999999999999999999999999764 45899999999
Q ss_pred cccCCCCCcccccccccccceecccccccCCcCccccchhHHHHHHHHHhCCCCCCCCCC
Q 002721 757 KLLDPSKGTASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFG 816 (888)
Q Consensus 757 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~ 816 (888)
+.+.... .....+|++.|||||++..++|+.|+|+||+|+|+|+|++|+.||...+.
T Consensus 163 R~L~~~~---~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~ 219 (429)
T KOG0595|consen 163 RFLQPGS---MAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETP 219 (429)
T ss_pred hhCCchh---HHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCH
Confidence 9987543 23567999999999999999999999999999999999999999986443
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-45 Score=372.93 Aligned_cols=245 Identities=22% Similarity=0.211 Sum_probs=207.4
Q ss_pred HHhcCCcceeeecccceEEEEEe-CCCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCCeeEEE
Q 002721 604 KATMKDSNMIYCGTFSTVYKAVM-PSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVALLL 682 (888)
Q Consensus 604 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 682 (888)
.++|+..++||+|+||+||.++. .+++.||+|++++.......+.+....|..++.+++||.||+++-.|++.+..|+|
T Consensus 24 ~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylV 103 (357)
T KOG0598|consen 24 PDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLV 103 (357)
T ss_pred hhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEE
Confidence 56899999999999999999994 46999999999977666666777899999999999999999999999999999999
Q ss_pred EecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccccccccCCC
Q 002721 683 HNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPS 762 (888)
Q Consensus 683 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 762 (888)
+||+.||.|...+++.+ .+++..+.-++.+|+.||.|||++|||||||||+|||+|.+|+++|+|||+++.....
T Consensus 104 ld~~~GGeLf~hL~~eg-----~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~ 178 (357)
T KOG0598|consen 104 LDYLNGGELFYHLQREG-----RFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKD 178 (357)
T ss_pred EeccCCccHHHHHHhcC-----CcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhcccC
Confidence 99999999999998765 5677889999999999999999999999999999999999999999999999965433
Q ss_pred CCcccccccccccceecccccccCCcCccccchhHHHHHHHHHhCCCCCCCCCCCccchhhhccccCCCCCCcccccccc
Q 002721 763 KGTASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQILDAR 842 (888)
Q Consensus 763 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 842 (888)
. .....++||+.|||||++.+..|+.++|.||+||++|||++|.+||...... +..+.+...+
T Consensus 179 ~--~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~---------------~~~~~I~~~k 241 (357)
T KOG0598|consen 179 G--DATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVK---------------KMYDKILKGK 241 (357)
T ss_pred C--CccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHH---------------HHHHHHhcCc
Confidence 2 2234589999999999999999999999999999999999999999764321 1122222222
Q ss_pred cccCCcCcHHHHHHHHHHHhhccCCCCCCCC
Q 002721 843 LSTVSFGWRKEMLTALKVALLCTDSTPAKRP 873 (888)
Q Consensus 843 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~RP 873 (888)
.... ..-...++.+++.+.+..||++|.
T Consensus 242 ~~~~---p~~ls~~ardll~~LL~rdp~~RL 269 (357)
T KOG0598|consen 242 LPLP---PGYLSEEARDLLKKLLKRDPRQRL 269 (357)
T ss_pred CCCC---CccCCHHHHHHHHHHhccCHHHhc
Confidence 1111 112345677889999999999996
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-44 Score=382.37 Aligned_cols=253 Identities=22% Similarity=0.258 Sum_probs=213.7
Q ss_pred HHhcCCcceeeecccceEEEEE-eCCCcEEEEEEeeccChhhhHHHHHHHHHHHHHhcc-CCCceeeeeeEEEeCCeeEE
Q 002721 604 KATMKDSNMIYCGTFSTVYKAV-MPSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKL-CHDNLVRPIGFVIYEDVALL 681 (888)
Q Consensus 604 ~~~~~~~~~ig~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~l 681 (888)
..+|.+++.||+|+|++||+|+ ..+++.||||++.+.........+.+.+|-.+|.+| .||.|+++|-.|.++...|+
T Consensus 72 ~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYF 151 (604)
T KOG0592|consen 72 PNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYF 151 (604)
T ss_pred hhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEE
Confidence 4579999999999999999999 557999999999876666666667788999999999 79999999999999999999
Q ss_pred EEecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccccccccCC
Q 002721 682 LHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDP 761 (888)
Q Consensus 682 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~~~ 761 (888)
|+||+++|+|.++|++.+ .+++.....++.||+.||+|||++|||||||||+|||+|+||++||+|||.|+.+.+
T Consensus 152 vLe~A~nGdll~~i~K~G-----sfde~caR~YAAeIldAleylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~ 226 (604)
T KOG0592|consen 152 VLEYAPNGDLLDLIKKYG-----SFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILSP 226 (604)
T ss_pred EEEecCCCcHHHHHHHhC-----cchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeEcCCCcEEEeeccccccCCh
Confidence 999999999999999875 567788999999999999999999999999999999999999999999999998865
Q ss_pred CCCc---------ccc--cccccccceecccccccCCcCccccchhHHHHHHHHHhCCCCCCCCCCCccchhhhccccCC
Q 002721 762 SKGT---------ASI--SAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPA 830 (888)
Q Consensus 762 ~~~~---------~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~ 830 (888)
.... ... ..++||..|.+||++.+...++++|||+||||+|+|+.|.+||......
T Consensus 227 ~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ney------------- 293 (604)
T KOG0592|consen 227 SQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEY------------- 293 (604)
T ss_pred hhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHH-------------
Confidence 3322 111 4589999999999999999999999999999999999999999864322
Q ss_pred CCCCcccccccccccCCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002721 831 RGETPEQILDARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVE 880 (888)
Q Consensus 831 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 880 (888)
...+++++-.+.. .....+.+.+++.+.|..||.+|+|++||-+
T Consensus 294 --liFqkI~~l~y~f----p~~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~ 337 (604)
T KOG0592|consen 294 --LIFQKIQALDYEF----PEGFPEDARDLIKKLLVRDPSDRLTSQQIKA 337 (604)
T ss_pred --HHHHHHHHhcccC----CCCCCHHHHHHHHHHHccCccccccHHHHhh
Confidence 1122222222211 1122356778999999999999999988754
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-44 Score=354.41 Aligned_cols=267 Identities=17% Similarity=0.185 Sum_probs=206.6
Q ss_pred HhcCCcceeeecccceEEEEEeC-CCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCCeeEEEE
Q 002721 605 ATMKDSNMIYCGTFSTVYKAVMP-SGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVALLLH 683 (888)
Q Consensus 605 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 683 (888)
+.|+...++|+|+||+||+++.+ +|+.||||++...+. +....+-..||++++++++|||+|.++++|......++|+
T Consensus 2 ekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Esed-d~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVF 80 (396)
T KOG0593|consen 2 EKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESED-DPVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVF 80 (396)
T ss_pred cHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCCc-cHHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEe
Confidence 46888899999999999999954 699999999984433 3344557889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccccccccCCCC
Q 002721 684 NYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSK 763 (888)
Q Consensus 684 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 763 (888)
|||+. ++.+-+..... .++...+..++.|++.|+.|+|++++|||||||+||||+.+|.+|+||||+|+.+..
T Consensus 81 E~~dh-TvL~eLe~~p~----G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~-- 153 (396)
T KOG0593|consen 81 EYCDH-TVLHELERYPN----GVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSA-- 153 (396)
T ss_pred eecch-HHHHHHHhccC----CCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEecCCcEEeccchhhHhhcC--
Confidence 99987 65555655433 467788999999999999999999999999999999999999999999999998874
Q ss_pred Ccccccccccccceeccccccc-CCcCccccchhHHHHHHHHHhCCCCCCCCCCCccchhhhccccCCCCCCccccc---
Q 002721 764 GTASISAVAGSFGYIPPEYAYT-MQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQIL--- 839 (888)
Q Consensus 764 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--- 839 (888)
....++..+.|.+|+|||.+.+ .+|+..+||||+||++.||++|.+.|.+..+-+. +...............+++
T Consensus 154 pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQ-Ly~I~ktLG~L~prhq~iF~~N 232 (396)
T KOG0593|consen 154 PGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQ-LYLIRKTLGNLIPRHQSIFSSN 232 (396)
T ss_pred CcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHH-HHHHHHHHcccCHHHHHHhccC
Confidence 2334567889999999999887 6899999999999999999999999976543211 1110000000000000000
Q ss_pred ---c----c---ccccCCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002721 840 ---D----A---RLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVE 880 (888)
Q Consensus 840 ---~----~---~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 880 (888)
. + ..............-++++++.|++.||++|++.+|++.
T Consensus 233 ~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~sc~qll~ 283 (396)
T KOG0593|consen 233 PFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLSCEQLLH 283 (396)
T ss_pred CceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCccccccHHHHhc
Confidence 0 0 011111123344556789999999999999999999874
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-44 Score=384.60 Aligned_cols=260 Identities=22% Similarity=0.349 Sum_probs=214.3
Q ss_pred HHHHhcCCcceeeecccceEEEEEeCCCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCCeeEE
Q 002721 602 VVKATMKDSNMIYCGTFSTVYKAVMPSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVALL 681 (888)
Q Consensus 602 ~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 681 (888)
+....++..+.||+|.||+||.|.+.....||+|.++...... +.|.+|+++|++++|++||+++|+|..++..||
T Consensus 203 i~r~~l~l~~~LG~G~FG~V~~g~~~~~~~vavk~ik~~~m~~----~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyI 278 (468)
T KOG0197|consen 203 IPREELKLIRELGSGQFGEVWLGKWNGSTKVAVKTIKEGSMSP----EAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYI 278 (468)
T ss_pred ecHHHHHHHHHhcCCccceEEEEEEcCCCcccceEEeccccCh----hHHHHHHHHHHhCcccCeEEEEEEEecCCceEE
Confidence 4456677889999999999999999788899999998654432 378899999999999999999999999889999
Q ss_pred EEecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccccccccCC
Q 002721 682 LHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDP 761 (888)
Q Consensus 682 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~~~ 761 (888)
|||||+.|+|.++++..... .+...+.+.++.|||+|++||+++++|||||.++||||+++..+||+|||+|+...+
T Consensus 279 VtE~m~~GsLl~yLr~~~~~---~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d 355 (468)
T KOG0197|consen 279 VTEYMPKGSLLDYLRTREGG---LLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARLIGD 355 (468)
T ss_pred EEEecccCcHHHHhhhcCCC---ccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhheeeccCceEEEcccccccccCC
Confidence 99999999999999973322 678899999999999999999999999999999999999999999999999996554
Q ss_pred CCCcccccccccccceecccccccCCcCccccchhHHHHHHHHHh-CCCCCCCCCCCccchhhhccccCCCCCCcccccc
Q 002721 762 SKGTASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILT-TRLPVEEDFGEGVDLVKWVHGAPARGETPEQILD 840 (888)
Q Consensus 762 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 840 (888)
+.... .....-+..|.|||.+....++.|||||||||+||||+| |+.||......+ .++.+....
T Consensus 356 ~~Y~~-~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~e--v~~~le~Gy----------- 421 (468)
T KOG0197|consen 356 DEYTA-SEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEE--VLELLERGY----------- 421 (468)
T ss_pred Cceee-cCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHH--HHHHHhccC-----------
Confidence 43222 222334568999999999999999999999999999999 899987653321 111111110
Q ss_pred cccccCCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhhh
Q 002721 841 ARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEMLQEIKQ 887 (888)
Q Consensus 841 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 887 (888)
.-. .+...+.++.++|..||+.+|++|||++.+...|+++..
T Consensus 422 --Rlp---~P~~CP~~vY~lM~~CW~~~P~~RPtF~~L~~~l~~~~~ 463 (468)
T KOG0197|consen 422 --RLP---RPEGCPDEVYELMKSCWHEDPEDRPTFETLREVLEDFFT 463 (468)
T ss_pred --cCC---CCCCCCHHHHHHHHHHhhCCcccCCCHHHHHHHHHHhhh
Confidence 000 122345678899999999999999999999999998753
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-43 Score=367.74 Aligned_cols=270 Identities=21% Similarity=0.296 Sum_probs=211.1
Q ss_pred HHHhcCCcceeeecccceEEEEE-eCCCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeC--Cee
Q 002721 603 VKATMKDSNMIYCGTFSTVYKAV-MPSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYE--DVA 679 (888)
Q Consensus 603 ~~~~~~~~~~ig~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~--~~~ 679 (888)
..+.|+..++||+|.||.||+|+ ..+|+.||+|++.... ..........|||.||+++.||||+++.+...+. ...
T Consensus 115 ~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~-~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~si 193 (560)
T KOG0600|consen 115 RADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDN-EKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSI 193 (560)
T ss_pred chHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeeccc-CCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceE
Confidence 45678899999999999999999 5689999999998433 2333445778999999999999999999998876 689
Q ss_pred EEEEecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEecccccccc
Q 002721 680 LLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLL 759 (888)
Q Consensus 680 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~ 759 (888)
|+|+|||+. ||.-++.... ..++..++..++.|++.||+|+|++||+|||||.+|||||.+|.+||+|||+|+++
T Consensus 194 YlVFeYMdh-DL~GLl~~p~----vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y 268 (560)
T KOG0600|consen 194 YLVFEYMDH-DLSGLLSSPG----VKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLARFY 268 (560)
T ss_pred EEEEecccc-hhhhhhcCCC----cccChHHHHHHHHHHHHHHHHHhhcCeeeccccccceEEcCCCCEEeccccceeec
Confidence 999999987 9988887543 37899999999999999999999999999999999999999999999999999988
Q ss_pred CCCCCcccccccccccceecccccccC-CcCccccchhHHHHHHHHHhCCCCCCCCCCCccchhh--hccccCCCCCCcc
Q 002721 760 DPSKGTASISAVAGSFGYIPPEYAYTM-QVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVK--WVHGAPARGETPE 836 (888)
Q Consensus 760 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~--~~~~~~~~~~~~~ 836 (888)
..... ..++..+-|.+|+|||.+.|. .|++++|+||.|||+.||++|++.|.+...- .++.. ..-+.+....+..
T Consensus 269 ~~~~~-~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEv-eQl~kIfklcGSP~e~~W~~ 346 (560)
T KOG0600|consen 269 TPSGS-APYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEV-EQLHKIFKLCGSPTEDYWPV 346 (560)
T ss_pred cCCCC-cccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHH-HHHHHHHHHhCCCChhcccc
Confidence 76543 336778899999999998876 5999999999999999999999999864321 11111 1222222222221
Q ss_pred cccc--cccccCCc-------CcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002721 837 QILD--ARLSTVSF-------GWRKEMLTALKVALLCTDSTPAKRPKMKKVVE 880 (888)
Q Consensus 837 ~~~~--~~~~~~~~-------~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 880 (888)
.-+. ..+..... ........+++++..+|..||++|.||.++++
T Consensus 347 ~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~tA~~aL~ 399 (560)
T KOG0600|consen 347 SKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRGTASSALQ 399 (560)
T ss_pred ccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccccHHHHhc
Confidence 0000 00000000 01122356788999999999999999999875
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-44 Score=379.34 Aligned_cols=396 Identities=22% Similarity=0.214 Sum_probs=229.1
Q ss_pred EEEEcCCCCcccccc-c-ccCC-CCCCEEeCCCCcCcccCCCCCCCCCCCCEEECcCCCCCCCCCCCCCCCCcceEEEcC
Q 002721 66 VKLDLSRLQLRGNIT-L-VSEL-KALKRLDLSNNAFSGTIPSAFGNLSELEFLDLSLNKFGGVIPRELGSLKDLRFFNIS 142 (888)
Q Consensus 66 ~~l~l~~~~l~~~~~-~-~~~l-~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 142 (888)
.-+|++++.|...-. . .+-| ..-+.||+|+|.+..+.+..|.++++|+.++|.+|.++ .+|...+...+|+.|+|.
T Consensus 55 ~lldcs~~~lea~~~~~l~g~lp~~t~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt-~IP~f~~~sghl~~L~L~ 133 (873)
T KOG4194|consen 55 RLLDCSDRELEAIDKSRLKGFLPSQTQTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELT-RIPRFGHESGHLEKLDLR 133 (873)
T ss_pred eeeecCccccccccccccCCcCccceeeeeccccccccCcHHHHhcCCcceeeeeccchhh-hcccccccccceeEEeee
Confidence 356666665543211 1 1111 23445777777777666666777777777777777776 556655555667777777
Q ss_pred CCccccccCccccccccccEEEecCCCCCCCCCccccccccccEEecccccccCCCCCCCCCcccccceeeccccCCCCC
Q 002721 143 NNVLVGEIPDELKSLEKLEDFQVSSNKLNGSIPFWVGNLTNLRVFTAYENQLVGEIPDNLGSVSELELLNLHSNQLEGPI 222 (888)
Q Consensus 143 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~ 222 (888)
+|.|+.+-.+++..++.|+.||||.|.|+.+.-.+|..-.++++|+|++|+|+..-.+.|.++.+|..|.|++|+|+...
T Consensus 134 ~N~I~sv~se~L~~l~alrslDLSrN~is~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL~tlkLsrNrittLp 213 (873)
T KOG4194|consen 134 HNLISSVTSEELSALPALRSLDLSRNLISEIPKPSFPAKVNIKKLNLASNRITTLETGHFDSLNSLLTLKLSRNRITTLP 213 (873)
T ss_pred ccccccccHHHHHhHhhhhhhhhhhchhhcccCCCCCCCCCceEEeeccccccccccccccccchheeeecccCcccccC
Confidence 77777666666677777777777777776555555655566666666666666666666666666666666666666555
Q ss_pred CCCccCCCCcceEEecCccCCCCchhhhccCCccceeeccCCccccccCCccccCCCccEEEeeccCCCCCCCccccCCC
Q 002721 223 PKSIFASGKLEVLVLTQNRLTGDIPELVGHCKSLSNIRIGNNDLVGVIPRAIGNVSGLTYFEADNNNLSGEIVPEFSQCS 302 (888)
Q Consensus 223 p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~ 302 (888)
+..|.++++|+.|+|..|+|.-..--.|.++++|+.|.|..|.+...-.++|..+.++++|+|+.|+++.....++.+++
T Consensus 214 ~r~Fk~L~~L~~LdLnrN~irive~ltFqgL~Sl~nlklqrN~I~kL~DG~Fy~l~kme~l~L~~N~l~~vn~g~lfgLt 293 (873)
T KOG4194|consen 214 QRSFKRLPKLESLDLNRNRIRIVEGLTFQGLPSLQNLKLQRNDISKLDDGAFYGLEKMEHLNLETNRLQAVNEGWLFGLT 293 (873)
T ss_pred HHHhhhcchhhhhhccccceeeehhhhhcCchhhhhhhhhhcCcccccCcceeeecccceeecccchhhhhhcccccccc
Confidence 55555566666666666666544344556666666666666666555555555555555555555555555555555555
Q ss_pred CCcEEEeecCcccccCCccccCCCCccEEEeccccccCcCcccccccCcceEEEccCCcCCCCCCchhccccCcceeccc
Q 002721 303 NLTLLNLASNGFTGVIPPELGQLINLQELILYENSLFGEIPKSILACKNLNKLDLSNNRFNGTIPNAICDMSRLQYLLLG 382 (888)
Q Consensus 303 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~ 382 (888)
.|+.|+||+|.|..+.++.+...++|++|+|++|+|+...+..|..+..|+.|+|++|+++..-..+|..+++|+.|||+
T Consensus 294 ~L~~L~lS~NaI~rih~d~WsftqkL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~lssL~~LdLr 373 (873)
T KOG4194|consen 294 SLEQLDLSYNAIQRIHIDSWSFTQKLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLAEGAFVGLSSLHKLDLR 373 (873)
T ss_pred hhhhhccchhhhheeecchhhhcccceeEeccccccccCChhHHHHHHHhhhhcccccchHHHHhhHHHHhhhhhhhcCc
Confidence 55555555555555555555555555555555555555555555555555555555555554444445555555555555
Q ss_pred CCccccccCCCccccccceEEEeecccccccCCCccccccchhhhhhccCccccccCCccccCCCCccEEEeeCCccccC
Q 002721 383 QNSLKGEIPHEIGNCMKLLQLHIGSNYLTGSIPPEIGHIRNLQIALNLSFNHLHGSLPPELGKLDKLVSFDVSNNQLSGT 462 (888)
Q Consensus 383 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~~L~ls~N~l~~~~p~~~~~l~~L~~LdLs~N~l~~~ 462 (888)
+|.++..+.+.- ..|..++.|+ .|.|.+|++..+.-.+|.++..|+.|||.+|.|...
T Consensus 374 ~N~ls~~IEDaa---------------------~~f~gl~~Lr-kL~l~gNqlk~I~krAfsgl~~LE~LdL~~NaiaSI 431 (873)
T KOG4194|consen 374 SNELSWCIEDAA---------------------VAFNGLPSLR-KLRLTGNQLKSIPKRAFSGLEALEHLDLGDNAIASI 431 (873)
T ss_pred CCeEEEEEecch---------------------hhhccchhhh-heeecCceeeecchhhhccCcccceecCCCCcceee
Confidence 555554333210 1133344444 455555555544445566666666666666666666
Q ss_pred CchhhcccccceEEEccCCcCcc
Q 002721 463 IPSALKGMLSLIEVNFSNNLLTG 485 (888)
Q Consensus 463 ~p~~~~~l~~L~~L~ls~N~l~~ 485 (888)
-|.+|..| .|++|-+..-.|-+
T Consensus 432 q~nAFe~m-~Lk~Lv~nSssflC 453 (873)
T KOG4194|consen 432 QPNAFEPM-ELKELVMNSSSFLC 453 (873)
T ss_pred cccccccc-hhhhhhhcccceEE
Confidence 66666666 66666555444433
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-44 Score=370.66 Aligned_cols=269 Identities=18% Similarity=0.255 Sum_probs=215.0
Q ss_pred HHHHhcCCcceeeecccceEEEEE-eCCCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccC-CCceeeeeeEEEeCC-e
Q 002721 602 VVKATMKDSNMIYCGTFSTVYKAV-MPSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLC-HDNLVRPIGFVIYED-V 678 (888)
Q Consensus 602 ~~~~~~~~~~~ig~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~-~ 678 (888)
.+-++|...++||.|.||.||+|+ ..+|..||||++++......+. .-.||++.++++. |||||++.+++.+.+ .
T Consensus 7 ~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~s~ee~--~nLREvksL~kln~hpniikL~Evi~d~~~~ 84 (538)
T KOG0661|consen 7 IFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFYSWEEC--MNLREVKSLRKLNPHPNIIKLKEVIRDNDRI 84 (538)
T ss_pred hHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhccHHHH--HHHHHHHHHHhcCCCCcchhhHHHhhccCce
Confidence 356789999999999999999999 5679999999998765554333 4569999999998 999999999999888 9
Q ss_pred eEEEEecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccccccc
Q 002721 679 ALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKL 758 (888)
Q Consensus 679 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~ 758 (888)
.|+|||||+. +|+++++.+.. .+++.++..|+.||++||+|+|.+|+.|||+||+|||+.....+||+|||+|+.
T Consensus 85 L~fVfE~Md~-NLYqLmK~R~r----~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARe 159 (538)
T KOG0661|consen 85 LYFVFEFMDC-NLYQLMKDRNR----LFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENILISGNDVIKIADFGLARE 159 (538)
T ss_pred EeeeHHhhhh-hHHHHHhhcCC----cCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheEecccceeEecccccccc
Confidence 9999999975 99999998743 689999999999999999999999999999999999999888999999999998
Q ss_pred cCCCCCcccccccccccceecccccc-cCCcCccccchhHHHHHHHHHhCCCCCCCCCCCccchhh--hccccCCCCCCc
Q 002721 759 LDPSKGTASISAVAGSFGYIPPEYAY-TMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVK--WVHGAPARGETP 835 (888)
Q Consensus 759 ~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~--~~~~~~~~~~~~ 835 (888)
..... .++..+.|.+|+|||++. ...|+.+.||||+|||++|+.+-++.|.+... -.++.+ .+.+.+......
T Consensus 160 v~Skp---PYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE-~Dqi~KIc~VLGtP~~~~~~ 235 (538)
T KOG0661|consen 160 VRSKP---PYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASE-IDQIYKICEVLGTPDKDSWP 235 (538)
T ss_pred cccCC---CcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcH-HHHHHHHHHHhCCCccccch
Confidence 76543 456778999999999875 55699999999999999999999998876432 222222 233444443333
Q ss_pred cc-ccccc----cccCCc-----CcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002721 836 EQ-ILDAR----LSTVSF-----GWRKEMLTALKVALLCTDSTPAKRPKMKKVVEM 881 (888)
Q Consensus 836 ~~-~~~~~----~~~~~~-----~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~ 881 (888)
+. .+... +..... -......++.+++.+|+++||++||||+|+++.
T Consensus 236 eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~al~~ 291 (538)
T KOG0661|consen 236 EGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQALQH 291 (538)
T ss_pred hHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHHHhcC
Confidence 31 11111 111110 011245778899999999999999999999863
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=357.92 Aligned_cols=263 Identities=20% Similarity=0.282 Sum_probs=212.2
Q ss_pred HHhcCCcceeeecccceEEEEE-eCCCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCCeeEEE
Q 002721 604 KATMKDSNMIYCGTFSTVYKAV-MPSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVALLL 682 (888)
Q Consensus 604 ~~~~~~~~~ig~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 682 (888)
.+.|+....||.|..++||+|+ .+.++.||||++.-..... ..+.+.+|+..|+.++||||++++..|..+...|+|
T Consensus 25 ~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~~--~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvV 102 (516)
T KOG0582|consen 25 AKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCNN--DLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVV 102 (516)
T ss_pred ccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhhh--hHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEe
Confidence 4579999999999999999999 6678999999998544433 256899999999999999999999999999999999
Q ss_pred EecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccccccccCCC
Q 002721 683 HNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPS 762 (888)
Q Consensus 683 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 762 (888)
|.||.+|++.++++..... .+.+..+..|.+++++||.|||.+|.||||||+.||||+.+|.+||+|||.+..+...
T Consensus 103 mpfMa~GS~ldIik~~~~~---Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~ 179 (516)
T KOG0582|consen 103 MPFMAGGSLLDIIKTYYPD---GLEEASIATILREVLKALDYLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDS 179 (516)
T ss_pred ehhhcCCcHHHHHHHHccc---cccHHHHHHHHHHHHHHHHHHHhcCceecccccccEEEcCCCcEEEcCceeeeeeccc
Confidence 9999999999999986554 5788999999999999999999999999999999999999999999999988776543
Q ss_pred CCccc--ccccccccceeccccccc--CCcCccccchhHHHHHHHHHhCCCCCCCCCCCccchhhhccccCCCCCCcccc
Q 002721 763 KGTAS--ISAVAGSFGYIPPEYAYT--MQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQI 838 (888)
Q Consensus 763 ~~~~~--~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 838 (888)
..... ...++||++|||||++.. ..|+.|+|||||||+..|+.+|..||....+-.+ +..-....+....+..
T Consensus 180 G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPmkv-Ll~tLqn~pp~~~t~~-- 256 (516)
T KOG0582|consen 180 GDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPMKV-LLLTLQNDPPTLLTSG-- 256 (516)
T ss_pred CceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChHHH-HHHHhcCCCCCccccc--
Confidence 32221 246789999999999543 3699999999999999999999999986433222 2222222222111000
Q ss_pred cccccccCCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002721 839 LDARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVE 880 (888)
Q Consensus 839 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 880 (888)
.+ ..........+.+++..|+++||++|||++++++
T Consensus 257 ~~------~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlk 292 (516)
T KOG0582|consen 257 LD------KDEDKKFSKSFREMIALCLVKDPSKRPTASKLLK 292 (516)
T ss_pred CC------hHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhc
Confidence 00 1112233457888999999999999999999985
|
|
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-43 Score=391.92 Aligned_cols=267 Identities=23% Similarity=0.323 Sum_probs=218.6
Q ss_pred HHHHHhcCCcceeeecccceEEEEEe------CCCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEE
Q 002721 601 AVVKATMKDSNMIYCGTFSTVYKAVM------PSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVI 674 (888)
Q Consensus 601 ~~~~~~~~~~~~ig~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~ 674 (888)
++...+.+..+.||+|.||+||+|+. .+.+.||||.++.... .+.+.+|+||+++++.++|||||+++|+|.
T Consensus 482 ~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~a~--~~~~~dF~REaeLla~l~H~nIVrLlGVC~ 559 (774)
T KOG1026|consen 482 EIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDKAE--NQARQDFRREAELLAELQHPNIVRLLGVCR 559 (774)
T ss_pred EechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhccccc--HHHHHHHHHHHHHHHhccCCCeEEEEEEEc
Confidence 35566777889999999999999983 2467899999985443 345669999999999999999999999999
Q ss_pred eCCeeEEEEecCCCCCHHHHhhccCCCCC---------CCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCC
Q 002721 675 YEDVALLLHNYLPNGTLAQLLHESTKQPD---------YRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDAD 745 (888)
Q Consensus 675 ~~~~~~lv~e~~~~g~L~~~l~~~~~~~~---------~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~ 745 (888)
+++..++|+|||..|||.++++....... ..++..+.+.||.|||.|++||-++.+|||||..+|+||.++
T Consensus 560 ~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge~ 639 (774)
T KOG1026|consen 560 EGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGEN 639 (774)
T ss_pred cCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhhhhceeccc
Confidence 99999999999999999999987644322 237889999999999999999999999999999999999999
Q ss_pred CCceEeccccccccCCCCCcccccccccccceecccccccCCcCccccchhHHHHHHHHHh-CCCCCCCCCCCccchhhh
Q 002721 746 FKPLLGEIEISKLLDPSKGTASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILT-TRLPVEEDFGEGVDLVKW 824 (888)
Q Consensus 746 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~~~~~~~~~~~~ 824 (888)
..|||+|||+++..-..+.........-..+|||||.+..++|+++||||||||++||+++ |+.||.+...+++
T Consensus 640 l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~EV----- 714 (774)
T KOG1026|consen 640 LVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEV----- 714 (774)
T ss_pred eEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHHH-----
Confidence 9999999999987654332211112234679999999999999999999999999999998 9999987544322
Q ss_pred ccccCCCCCCcccccccccccCCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhhh
Q 002721 825 VHGAPARGETPEQILDARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEMLQEIKQ 887 (888)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 887 (888)
.+.+.++.+ -..++..+.+++.+|..||+.+|++||+++||-.+|++..+
T Consensus 715 ----------Ie~i~~g~l---L~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~eI~~~L~~~~~ 764 (774)
T KOG1026|consen 715 ----------IECIRAGQL---LSCPENCPTEVYSLMLECWNENPKRRPSFKEIHSRLQAWAQ 764 (774)
T ss_pred ----------HHHHHcCCc---ccCCCCCCHHHHHHHHHHhhcCcccCCCHHHHHHHHHHHHh
Confidence 111122222 11334556788999999999999999999999999998643
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-42 Score=362.24 Aligned_cols=255 Identities=25% Similarity=0.357 Sum_probs=202.4
Q ss_pred HhcCCcceeeecccceEEEEEeC-CCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCC--eeEE
Q 002721 605 ATMKDSNMIYCGTFSTVYKAVMP-SGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYED--VALL 681 (888)
Q Consensus 605 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~--~~~l 681 (888)
.++...+.||+|+||+||++... +|...|||.+....... .+.+.+|+.+|++++|||||+++|.....+ .+++
T Consensus 17 ~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~~~~---~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i 93 (313)
T KOG0198|consen 17 SNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELEDSPT---SESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNI 93 (313)
T ss_pred chhhhhccccCccceEEEEEEecCCCcceeeeeeecccchh---HHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEe
Confidence 35777899999999999999954 49999999987553222 457899999999999999999999855544 6899
Q ss_pred EEecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCC-CCCceEeccccccccC
Q 002721 682 LHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDA-DFKPLLGEIEISKLLD 760 (888)
Q Consensus 682 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~-~~~~kl~Dfg~a~~~~ 760 (888)
+|||+++|+|.+++...+. .+++..+..+.+||++||+|||++|||||||||+|||++. ++.+||+|||.++...
T Consensus 94 ~mEy~~~GsL~~~~~~~g~----~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~ 169 (313)
T KOG0198|consen 94 FMEYAPGGSLSDLIKRYGG----KLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLE 169 (313)
T ss_pred eeeccCCCcHHHHHHHcCC----CCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEEeCCCCeEEeccCccccccc
Confidence 9999999999999998753 3788999999999999999999999999999999999999 7999999999999876
Q ss_pred CC-CCcccccccccccceecccccccC-CcCccccchhHHHHHHHHHhCCCCCCCCCCCccchhhhccccCCCCCCcccc
Q 002721 761 PS-KGTASISAVAGSFGYIPPEYAYTM-QVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQI 838 (888)
Q Consensus 761 ~~-~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 838 (888)
.. ..........||+.|||||++.++ ...+++||||+||++.||+||+.||.+............. ....
T Consensus 170 ~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~~~~~ig~----~~~~---- 241 (313)
T KOG0198|consen 170 SKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAEALLLIGR----EDSL---- 241 (313)
T ss_pred cccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHHHHHHHhc----cCCC----
Confidence 41 111223457899999999999853 3445999999999999999999999864111111111110 0000
Q ss_pred cccccccCCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 002721 839 LDARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEML 882 (888)
Q Consensus 839 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L 882 (888)
+......+.++.+++.+|+..||++||||+++++.-
T Consensus 242 --------P~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hp 277 (313)
T KOG0198|consen 242 --------PEIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHP 277 (313)
T ss_pred --------CCCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhCh
Confidence 112223456778899999999999999999998753
|
|
| >KOG4194 consensus Membrane glycoprotein LIG-1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-44 Score=375.94 Aligned_cols=360 Identities=22% Similarity=0.237 Sum_probs=328.7
Q ss_pred eEEEEEcCCCCcccccc-cccCCCCCCEEeCCCCcCcccCCCCCCCCCCCCEEECcCCCCCCCCCCCCCCCCcceEEEcC
Q 002721 64 FVVKLDLSRLQLRGNIT-LVSELKALKRLDLSNNAFSGTIPSAFGNLSELEFLDLSLNKFGGVIPRELGSLKDLRFFNIS 142 (888)
Q Consensus 64 ~v~~l~l~~~~l~~~~~-~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 142 (888)
.+..||+++|.|+..-. .+.+|++|+.++|.+|.++ .+|....-..+|+.|+|.+|.|+.+..+++..++.|++||||
T Consensus 79 ~t~~LdlsnNkl~~id~~~f~nl~nLq~v~l~~N~Lt-~IP~f~~~sghl~~L~L~~N~I~sv~se~L~~l~alrslDLS 157 (873)
T KOG4194|consen 79 QTQTLDLSNNKLSHIDFEFFYNLPNLQEVNLNKNELT-RIPRFGHESGHLEKLDLRHNLISSVTSEELSALPALRSLDLS 157 (873)
T ss_pred ceeeeeccccccccCcHHHHhcCCcceeeeeccchhh-hcccccccccceeEEeeeccccccccHHHHHhHhhhhhhhhh
Confidence 46789999999987543 7889999999999999997 788877777789999999999999999999999999999999
Q ss_pred CCccccccCccccccccccEEEecCCCCCCCCCccccccccccEEecccccccCCCCCCCCCcccccceeeccccCCCCC
Q 002721 143 NNVLVGEIPDELKSLEKLEDFQVSSNKLNGSIPFWVGNLTNLRVFTAYENQLVGEIPDNLGSVSELELLNLHSNQLEGPI 222 (888)
Q Consensus 143 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~ 222 (888)
.|.|+.+.-..|..-.++++|+|++|.|+..-.+.|.++.+|..|.|++|+++...+..|.+|++|+.|+|..|+|.-..
T Consensus 158 rN~is~i~~~sfp~~~ni~~L~La~N~It~l~~~~F~~lnsL~tlkLsrNrittLp~r~Fk~L~~L~~LdLnrN~irive 237 (873)
T KOG4194|consen 158 RNLISEIPKPSFPAKVNIKKLNLASNRITTLETGHFDSLNSLLTLKLSRNRITTLPQRSFKRLPKLESLDLNRNRIRIVE 237 (873)
T ss_pred hchhhcccCCCCCCCCCceEEeeccccccccccccccccchheeeecccCcccccCHHHhhhcchhhhhhccccceeeeh
Confidence 99999666677888899999999999999999999999999999999999999888889999999999999999998555
Q ss_pred CCCccCCCCcceEEecCccCCCCchhhhccCCccceeeccCCccccccCCccccCCCccEEEeeccCCCCCCCccccCCC
Q 002721 223 PKSIFASGKLEVLVLTQNRLTGDIPELVGHCKSLSNIRIGNNDLVGVIPRAIGNVSGLTYFEADNNNLSGEIVPEFSQCS 302 (888)
Q Consensus 223 p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~ 302 (888)
--+|.++.+|+.|.|..|++.......|..|.++++|+|+.|+++.+-..++-+++.|+.|+||+|.|..+.++.+.-.+
T Consensus 238 ~ltFqgL~Sl~nlklqrN~I~kL~DG~Fy~l~kme~l~L~~N~l~~vn~g~lfgLt~L~~L~lS~NaI~rih~d~Wsftq 317 (873)
T KOG4194|consen 238 GLTFQGLPSLQNLKLQRNDISKLDDGAFYGLEKMEHLNLETNRLQAVNEGWLFGLTSLEQLDLSYNAIQRIHIDSWSFTQ 317 (873)
T ss_pred hhhhcCchhhhhhhhhhcCcccccCcceeeecccceeecccchhhhhhcccccccchhhhhccchhhhheeecchhhhcc
Confidence 67899999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCcEEEeecCcccccCCccccCCCCccEEEeccccccCcCcccccccCcceEEEccCCcCCCCCCc---hhccccCccee
Q 002721 303 NLTLLNLASNGFTGVIPPELGQLINLQELILYENSLFGEIPKSILACKNLNKLDLSNNRFNGTIPN---AICDMSRLQYL 379 (888)
Q Consensus 303 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~---~~~~l~~L~~L 379 (888)
+|++|+|++|+|+...+.+|..|..|++|+|++|++...-...|..+++|+.|||++|.|+..+.+ .|.+|++|+.|
T Consensus 318 kL~~LdLs~N~i~~l~~~sf~~L~~Le~LnLs~Nsi~~l~e~af~~lssL~~LdLr~N~ls~~IEDaa~~f~gl~~LrkL 397 (873)
T KOG4194|consen 318 KLKELDLSSNRITRLDEGSFRVLSQLEELNLSHNSIDHLAEGAFVGLSSLHKLDLRSNELSWCIEDAAVAFNGLPSLRKL 397 (873)
T ss_pred cceeEeccccccccCChhHHHHHHHhhhhcccccchHHHHhhHHHHhhhhhhhcCcCCeEEEEEecchhhhccchhhhhe
Confidence 999999999999999999999999999999999999988888999999999999999999876654 57889999999
Q ss_pred cccCCccccccCCCccccccceEEEeecccccccCCCccccccchh
Q 002721 380 LLGQNSLKGEIPHEIGNCMKLLQLHIGSNYLTGSIPPEIGHIRNLQ 425 (888)
Q Consensus 380 ~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 425 (888)
+|.+|+++.+.-..|.++..|+.|||.+|.+...-|..|..+ .|+
T Consensus 398 ~l~gNqlk~I~krAfsgl~~LE~LdL~~NaiaSIq~nAFe~m-~Lk 442 (873)
T KOG4194|consen 398 RLTGNQLKSIPKRAFSGLEALEHLDLGDNAIASIQPNAFEPM-ELK 442 (873)
T ss_pred eecCceeeecchhhhccCcccceecCCCCcceeecccccccc-hhh
Confidence 999999996666778888888888888888886666666655 454
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=334.19 Aligned_cols=269 Identities=17% Similarity=0.233 Sum_probs=212.3
Q ss_pred HhcCCcceeeecccceEEEEE-eCCCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCCeeEEEE
Q 002721 605 ATMKDSNMIYCGTFSTVYKAV-MPSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVALLLH 683 (888)
Q Consensus 605 ~~~~~~~~ig~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 683 (888)
.+|...+++|+|.||.||+|+ ..+|+.||||+++.....+ .......||++.++.++||||+.++++|...+...+|+
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~kd-Gi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVf 80 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNAKD-GINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVF 80 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeecccccc-CccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEE
Confidence 468888999999999999999 5689999999998654332 22337889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccccccccCCCC
Q 002721 684 NYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSK 763 (888)
Q Consensus 684 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 763 (888)
|||+. ||+..++.... .++..++..++.++++|++|+|++.|+||||||.|+||+.+|.+|++|||+|+.+....
T Consensus 81 Efm~t-dLe~vIkd~~i----~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~ 155 (318)
T KOG0659|consen 81 EFMPT-DLEVVIKDKNI----ILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPN 155 (318)
T ss_pred Eeccc-cHHHHhccccc----ccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCCC
Confidence 99987 99999987654 57889999999999999999999999999999999999999999999999999987544
Q ss_pred CcccccccccccceecccccccC-CcCccccchhHHHHHHHHHhCCCCCCCCCCCc-cchhhhccccCCCCCCccccccc
Q 002721 764 GTASISAVAGSFGYIPPEYAYTM-QVTAPGNVYSYGVVLLEILTTRLPVEEDFGEG-VDLVKWVHGAPARGETPEQILDA 841 (888)
Q Consensus 764 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~P~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 841 (888)
.. .+..+-|.+|+|||.+.|. .|+..+||||.|||+.||+-|.+-|.+..+-+ ...+-.+.+.+..+.+++-..-+
T Consensus 156 ~~--~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lp 233 (318)
T KOG0659|consen 156 RI--QTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLP 233 (318)
T ss_pred cc--cccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccc
Confidence 33 2334789999999988765 59999999999999999999987776543321 11111233344444333311111
Q ss_pred c---cccCC-----cCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002721 842 R---LSTVS-----FGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEM 881 (888)
Q Consensus 842 ~---~~~~~-----~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~ 881 (888)
. +...+ ........++++++..|+..||.+|++++|++++
T Consensus 234 dY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~qaL~~ 281 (318)
T KOG0659|consen 234 DYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITASQALKH 281 (318)
T ss_pred cHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHHHHhcc
Confidence 0 00011 0123345667999999999999999999999864
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-42 Score=368.23 Aligned_cols=251 Identities=20% Similarity=0.245 Sum_probs=211.0
Q ss_pred HHHhcCCcceeeecccceEEEEE-eCCCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCCeeEE
Q 002721 603 VKATMKDSNMIYCGTFSTVYKAV-MPSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVALL 681 (888)
Q Consensus 603 ~~~~~~~~~~ig~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 681 (888)
....|....+||+|+.|.||.|+ ..+++.||||++....... .+-+..|+.+|+..+|+|||.+++.|..+++.|+
T Consensus 271 P~~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~~---keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWV 347 (550)
T KOG0578|consen 271 PRSKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQPK---KELLLNEILVMRDLHHPNIVNFLDSYLVGDELWV 347 (550)
T ss_pred hhhhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCCc---hhhhHHHHHHHHhccchHHHHHHHHhcccceeEE
Confidence 35578889999999999999999 5578999999997544432 3368899999999999999999999999999999
Q ss_pred EEecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccccccccCC
Q 002721 682 LHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDP 761 (888)
Q Consensus 682 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~~~ 761 (888)
|||||+||+|.+.+... .+++.++..|+++++.||+|||.+||+|||||.+|||++.+|.+||+|||++..+..
T Consensus 348 VMEym~ggsLTDvVt~~------~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~ 421 (550)
T KOG0578|consen 348 VMEYMEGGSLTDVVTKT------RMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISE 421 (550)
T ss_pred EEeecCCCchhhhhhcc------cccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeecccc
Confidence 99999999999999875 478899999999999999999999999999999999999999999999999998875
Q ss_pred CCCcccccccccccceecccccccCCcCccccchhHHHHHHHHHhCCCCCCCCCCCccchhhhccccCCCCCCccccccc
Q 002721 762 SKGTASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQILDA 841 (888)
Q Consensus 762 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 841 (888)
... .....+||+.|||||+.....|++|+||||||++++||+-|.+||-.+..-... ..+.+.
T Consensus 422 ~~~--KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAl---------------yLIa~n 484 (550)
T KOG0578|consen 422 EQS--KRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRAL---------------YLIATN 484 (550)
T ss_pred ccC--ccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHH---------------HHHhhc
Confidence 443 345789999999999999999999999999999999999999999753221110 000000
Q ss_pred ccccCCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002721 842 RLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVE 880 (888)
Q Consensus 842 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 880 (888)
.... -......++.+.+++.+||..||++||+|.|+++
T Consensus 485 g~P~-lk~~~klS~~~kdFL~~cL~~dv~~RasA~eLL~ 522 (550)
T KOG0578|consen 485 GTPK-LKNPEKLSPELKDFLDRCLVVDVEQRASAKELLE 522 (550)
T ss_pred CCCC-cCCccccCHHHHHHHHHHhhcchhcCCCHHHHhc
Confidence 0000 1123455678889999999999999999999986
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-42 Score=365.46 Aligned_cols=248 Identities=20% Similarity=0.183 Sum_probs=207.5
Q ss_pred HHhcCCcceeeecccceEEEEEe-CCCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCCeeEEE
Q 002721 604 KATMKDSNMIYCGTFSTVYKAVM-PSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVALLL 682 (888)
Q Consensus 604 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 682 (888)
.++|+..+.||+|+||+||.|+. .+|..||+|++++.+.....+.+.++.|-.+|....+|.||++|-.|++.++.|+|
T Consensus 140 ~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLi 219 (550)
T KOG0605|consen 140 LDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLI 219 (550)
T ss_pred cccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEE
Confidence 45799999999999999999994 57999999999988888888888999999999999999999999999999999999
Q ss_pred EecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccccccccCC-
Q 002721 683 HNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDP- 761 (888)
Q Consensus 683 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~~~- 761 (888)
|||++|||+..+|...+ .+++..+..++.+++-|++.+|+.|+|||||||+|+|||..|++||+|||++.-+..
T Consensus 220 MEylPGGD~mTLL~~~~-----~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~ 294 (550)
T KOG0605|consen 220 MEYLPGGDMMTLLMRKD-----TLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKK 294 (550)
T ss_pred EEecCCccHHHHHHhcC-----cCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheeecCCCCEeeccccccchhhhh
Confidence 99999999999998765 567788999999999999999999999999999999999999999999999864321
Q ss_pred ---------------------CCCc-----cc------------------ccccccccceecccccccCCcCccccchhH
Q 002721 762 ---------------------SKGT-----AS------------------ISAVAGSFGYIPPEYAYTMQVTAPGNVYSY 797 (888)
Q Consensus 762 ---------------------~~~~-----~~------------------~~~~~gt~~y~aPE~~~~~~~~~~~DiwSl 797 (888)
.... .. ....+|||.|||||++.+..|+..+|+||+
T Consensus 295 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSL 374 (550)
T KOG0605|consen 295 HRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSL 374 (550)
T ss_pred hhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHH
Confidence 0000 00 114689999999999999999999999999
Q ss_pred HHHHHHHHhCCCCCCCCCCCcc--chhhhccccCCCCCCcccccccccccCCcCcHHHHHHHHHHHhhccCCCCCCCCC
Q 002721 798 GVVLLEILTTRLPVEEDFGEGV--DLVKWVHGAPARGETPEQILDARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPK 874 (888)
Q Consensus 798 G~il~elltg~~P~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs 874 (888)
|||+|||+.|.+||..+..... .++.|..... .+.......++.++|.+|+. ||++|.-
T Consensus 375 G~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~-----------------fP~~~~~s~eA~DLI~rll~-d~~~RLG 435 (550)
T KOG0605|consen 375 GCIMYEMLVGYPPFCSETPQETYRKIVNWRETLK-----------------FPEEVDLSDEAKDLITRLLC-DPENRLG 435 (550)
T ss_pred HHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhcc-----------------CCCcCcccHHHHHHHHHHhc-CHHHhcC
Confidence 9999999999999987654321 2222221111 11122233778899999999 9999975
|
|
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-42 Score=367.73 Aligned_cols=265 Identities=23% Similarity=0.331 Sum_probs=213.9
Q ss_pred HHHHHhcCCcceeeecccceEEEEEeCCCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCCeeE
Q 002721 601 AVVKATMKDSNMIYCGTFSTVYKAVMPSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVAL 680 (888)
Q Consensus 601 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 680 (888)
++..+.+.....||+|+||+||+|++.. .||||+++...... ++.+.|+.|+.++++-+|.||+-+.||+..+.. .
T Consensus 388 eIp~~ev~l~~rIGsGsFGtV~Rg~whG--dVAVK~Lnv~~pt~-~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-A 463 (678)
T KOG0193|consen 388 EIPPEEVLLGERIGSGSFGTVYRGRWHG--DVAVKLLNVDDPTP-EQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-A 463 (678)
T ss_pred ccCHHHhhccceeccccccceeeccccc--ceEEEEEecCCCCH-HHHHHHHHHHHHHhhcchhhheeeehhhcCCce-e
Confidence 3456677889999999999999999743 58999999655544 477899999999999999999999999998877 9
Q ss_pred EEEecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccccccccC
Q 002721 681 LLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLD 760 (888)
Q Consensus 681 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~~ 760 (888)
||+.+|+|-+|+.+++.... .++..+.+.|++|||+|+.|||.++|||||||..||++.++++|||+|||++..-.
T Consensus 464 IiTqwCeGsSLY~hlHv~et----kfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~ 539 (678)
T KOG0193|consen 464 IITQWCEGSSLYTHLHVQET----KFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKT 539 (678)
T ss_pred eeehhccCchhhhhccchhh----hhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccceEEccCCcEEEecccceeeee
Confidence 99999999999999987542 68889999999999999999999999999999999999999999999999987644
Q ss_pred CCCCcccccccccccceecccccccC---CcCccccchhHHHHHHHHHhCCCCCCCCCCCccchhhhccccCCCCCCccc
Q 002721 761 PSKGTASISAVAGSFGYIPPEYAYTM---QVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQ 837 (888)
Q Consensus 761 ~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 837 (888)
.-.+........|...|||||++..+ +|++.+||||||||+|||+||..||.....+. +-|.-+.... ..
T Consensus 540 ~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~dq---IifmVGrG~l---~p- 612 (678)
T KOG0193|consen 540 RWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNRDQ---IIFMVGRGYL---MP- 612 (678)
T ss_pred eeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCChhh---eEEEeccccc---Cc-
Confidence 33333344556788899999998744 69999999999999999999999998432221 1111111110 00
Q ss_pred ccccccccCCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhhh
Q 002721 838 ILDARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEMLQEIKQ 887 (888)
Q Consensus 838 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 887 (888)
.. ........+++.+++..||.+++++||.+.+|+..|+.+.+
T Consensus 613 ----d~---s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~~l~~l~~ 655 (678)
T KOG0193|consen 613 ----DL---SKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLSKLEELLP 655 (678)
T ss_pred ----cc---hhhhccCHHHHHHHHHHHHhcCcccCccHHHHHHHHHHhhh
Confidence 00 11123344577889999999999999999999999988754
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-42 Score=335.35 Aligned_cols=239 Identities=21% Similarity=0.237 Sum_probs=207.8
Q ss_pred HhcCCcceeeecccceEEEEE-eCCCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCCeeEEEE
Q 002721 605 ATMKDSNMIYCGTFSTVYKAV-MPSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVALLLH 683 (888)
Q Consensus 605 ~~~~~~~~ig~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 683 (888)
++|+..+.+|.|+||.|..++ ..+|..||+|++++......++.+...+|..+++.+.||.++++++.+.+.+..|+||
T Consensus 44 ~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvm 123 (355)
T KOG0616|consen 44 QDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVM 123 (355)
T ss_pred hhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEE
Confidence 478889999999999999999 4469999999998777666677778899999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccccccccCCCC
Q 002721 684 NYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSK 763 (888)
Q Consensus 684 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 763 (888)
||++||.|..++++.+ +++++.+..++.||+.||+|||+.+|++||+||+|||+|.+|.+||+|||+|+.....
T Consensus 124 eyv~GGElFS~Lrk~~-----rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r- 197 (355)
T KOG0616|consen 124 EYVPGGELFSYLRKSG-----RFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR- 197 (355)
T ss_pred eccCCccHHHHHHhcC-----CCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeeccCCcEEEEeccceEEecCc-
Confidence 9999999999999876 5677899999999999999999999999999999999999999999999999987543
Q ss_pred CcccccccccccceecccccccCCcCccccchhHHHHHHHHHhCCCCCCCCCCCccchhhhccccCCCCCCccccccccc
Q 002721 764 GTASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQILDARL 843 (888)
Q Consensus 764 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 843 (888)
....+||+.|+|||++....|..++|.|||||++|||+.|.+||.+.... ...++++...+
T Consensus 198 ----T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~---------------~iY~KI~~~~v 258 (355)
T KOG0616|consen 198 ----TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPI---------------QIYEKILEGKV 258 (355)
T ss_pred ----EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChH---------------HHHHHHHhCcc
Confidence 34678999999999999999999999999999999999999999875331 23344444444
Q ss_pred ccCCcCcHHHHHHHHHHHhhccCCCCCCC
Q 002721 844 STVSFGWRKEMLTALKVALLCTDSTPAKR 872 (888)
Q Consensus 844 ~~~~~~~~~~~~~~~~li~~cl~~dP~~R 872 (888)
.. ++....++.+++...++.|-.+|
T Consensus 259 ~f----P~~fs~~~kdLl~~LL~vD~t~R 283 (355)
T KOG0616|consen 259 KF----PSYFSSDAKDLLKKLLQVDLTKR 283 (355)
T ss_pred cC----CcccCHHHHHHHHHHHhhhhHhh
Confidence 32 23344567788888888888888
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-42 Score=363.79 Aligned_cols=248 Identities=19% Similarity=0.232 Sum_probs=209.6
Q ss_pred HhcCCcceeeecccceEEEEEe-CCCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCCeeEEEE
Q 002721 605 ATMKDSNMIYCGTFSTVYKAVM-PSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVALLLH 683 (888)
Q Consensus 605 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 683 (888)
++|.+.+.||+|+||.||+|+. .+.+.||+|.+.+..+ ..++.+.+.+|+++++.++|||||.++++|+...+.|+|+
T Consensus 2 e~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~gr-~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVt 80 (808)
T KOG0597|consen 2 EQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSGR-NEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVT 80 (808)
T ss_pred cchhHHHHhcCCccceeeecccccceeEEEEEEehhcCC-chHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEe
Confidence 4688889999999999999994 4689999999985444 3445668999999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccccccccCCCC
Q 002721 684 NYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSK 763 (888)
Q Consensus 684 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 763 (888)
||+.| +|..++.... .++++.+..++.|++.||.|||+.+|+|||+||+||+++..|++|++|||+|+.+...
T Consensus 81 e~a~g-~L~~il~~d~-----~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~- 153 (808)
T KOG0597|consen 81 EYAVG-DLFTILEQDG-----KLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTN- 153 (808)
T ss_pred hhhhh-hHHHHHHhcc-----CCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCCCceeechhhhhhhcccC-
Confidence 99987 9999998765 4677999999999999999999999999999999999999999999999999987653
Q ss_pred CcccccccccccceecccccccCCcCccccchhHHHHHHHHHhCCCCCCCCCCCccchhhhccccCCCCCCccccccccc
Q 002721 764 GTASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQILDARL 843 (888)
Q Consensus 764 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 843 (888)
..-.+...|||.|||||...+++|+..+|+||+|||+||+++|++||.... -.++++ ...
T Consensus 154 -t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~s--i~~Lv~-----------------~I~ 213 (808)
T KOG0597|consen 154 -TSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARS--ITQLVK-----------------SIL 213 (808)
T ss_pred -ceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHH--HHHHHH-----------------HHh
Confidence 233457789999999999999999999999999999999999999996421 111111 111
Q ss_pred ccCCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002721 844 STVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVE 880 (888)
Q Consensus 844 ~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 880 (888)
.............+..++...+.+||.+|.|..+++.
T Consensus 214 ~d~v~~p~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~ 250 (808)
T KOG0597|consen 214 KDPVKPPSTASSSFVNFLQGLLIKDPAQRLTWTDLLG 250 (808)
T ss_pred cCCCCCcccccHHHHHHHHHHhhcChhhcccHHHHhc
Confidence 1112223355677888999999999999999998864
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-41 Score=369.66 Aligned_cols=266 Identities=19% Similarity=0.289 Sum_probs=206.5
Q ss_pred HHHhcCCcceeeecccceEEEEEe------CCCcEEEEEEeeccChhhhHHHHHHHHHHHHHhcc-CCCceeeeeeEEEe
Q 002721 603 VKATMKDSNMIYCGTFSTVYKAVM------PSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKL-CHDNLVRPIGFVIY 675 (888)
Q Consensus 603 ~~~~~~~~~~ig~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~ 675 (888)
..++|++.+.||+|+||.||+|.. .+++.||+|+++.... ....+.+.+|++++.++ +||||+++++++..
T Consensus 5 ~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~ 82 (338)
T cd05102 5 PRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGAT--ASEHKALMSELKILIHIGNHLNVVNLLGACTK 82 (338)
T ss_pred chhHceeeeEeccCCcceEEEEEEeccCCcccchhhheeccccccc--hHHHHHHHHHHHHHHHhccCcceeeEEeEecC
Confidence 457899999999999999999973 2357899999874332 22345789999999999 89999999998876
Q ss_pred C-CeeEEEEecCCCCCHHHHhhccCCC-----------------------------------------------------
Q 002721 676 E-DVALLLHNYLPNGTLAQLLHESTKQ----------------------------------------------------- 701 (888)
Q Consensus 676 ~-~~~~lv~e~~~~g~L~~~l~~~~~~----------------------------------------------------- 701 (888)
. +..++||||+++|+|.+++......
T Consensus 83 ~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (338)
T cd05102 83 PNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQE 162 (338)
T ss_pred CCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchh
Confidence 4 4689999999999999999753210
Q ss_pred ----CCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccccccccCCCCCcccccccccccce
Q 002721 702 ----PDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSKGTASISAVAGSFGY 777 (888)
Q Consensus 702 ----~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y 777 (888)
....+++.++..++.||++||+|||++||+||||||+||+++.++.+||+|||+++...............++..|
T Consensus 163 ~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y 242 (338)
T cd05102 163 TDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKW 242 (338)
T ss_pred ccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccc
Confidence 0124778889999999999999999999999999999999999999999999999865433222222234466789
Q ss_pred ecccccccCCcCccccchhHHHHHHHHHh-CCCCCCCCCCCccchhhhccccCCCCCCcccccccccccCCcCcHHHHHH
Q 002721 778 IPPEYAYTMQVTAPGNVYSYGVVLLEILT-TRLPVEEDFGEGVDLVKWVHGAPARGETPEQILDARLSTVSFGWRKEMLT 856 (888)
Q Consensus 778 ~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 856 (888)
+|||++.+..++.++|||||||++|||++ |..||....... ........ ..... ......+.
T Consensus 243 ~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~-~~~~~~~~-------------~~~~~---~~~~~~~~ 305 (338)
T cd05102 243 MAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINE-EFCQRLKD-------------GTRMR---APENATPE 305 (338)
T ss_pred cCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccH-HHHHHHhc-------------CCCCC---CCCCCCHH
Confidence 99999999999999999999999999997 999997532211 11111100 00000 01122356
Q ss_pred HHHHHhhccCCCCCCCCCHHHHHHHHHHhhh
Q 002721 857 ALKVALLCTDSTPAKRPKMKKVVEMLQEIKQ 887 (888)
Q Consensus 857 ~~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 887 (888)
+.+++.+||+.||++|||+.|+++.|+++.+
T Consensus 306 l~~li~~cl~~dp~~RPs~~el~~~l~~~~~ 336 (338)
T cd05102 306 IYRIMLACWQGDPKERPTFSALVEILGDLLQ 336 (338)
T ss_pred HHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 7889999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-41 Score=365.58 Aligned_cols=253 Identities=18% Similarity=0.248 Sum_probs=206.4
Q ss_pred HHHHhcCCcceeeecccceEEEEE-eCCCcEEEEEEeeccChh-h-hHHHHHHHHHHHHHhccC-CCceeeeeeEEEeCC
Q 002721 602 VVKATMKDSNMIYCGTFSTVYKAV-MPSGLILSVKRLKSMDRT-I-IHHQNKMIRELEKLSKLC-HDNLVRPIGFVIYED 677 (888)
Q Consensus 602 ~~~~~~~~~~~ig~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~-~-~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~ 677 (888)
...+.|...+.||+|+||+|+.|. ..++..||+|++.+.... . ....+.+.+|+.++++++ ||||+++++++....
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 345689999999999999999998 457899999977653111 1 123446779999999998 999999999999999
Q ss_pred eeEEEEecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCC-CCceEeccccc
Q 002721 678 VALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDAD-FKPLLGEIEIS 756 (888)
Q Consensus 678 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~-~~~kl~Dfg~a 756 (888)
..|+||||+.||+|.+++...+ ++.+.++..++.|++.|++|+|++||+||||||+||+++.+ +.+||+|||++
T Consensus 94 ~~~ivmEy~~gGdL~~~i~~~g-----~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s 168 (370)
T KOG0583|consen 94 KIYIVMEYCSGGDLFDYIVNKG-----RLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLS 168 (370)
T ss_pred eEEEEEEecCCccHHHHHHHcC-----CCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEecCCCCCEEEeccccc
Confidence 9999999999999999999843 56778999999999999999999999999999999999999 99999999999
Q ss_pred cccCCCCCcccccccccccceecccccccCC-cC-ccccchhHHHHHHHHHhCCCCCCCCCCCccchhhhccccCCCCCC
Q 002721 757 KLLDPSKGTASISAVAGSFGYIPPEYAYTMQ-VT-APGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGET 834 (888)
Q Consensus 757 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~ 834 (888)
.... .........+||+.|+|||++.+.. |+ .++||||+||++|.|++|+.||.+......
T Consensus 169 ~~~~--~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l--------------- 231 (370)
T KOG0583|consen 169 AISP--GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNL--------------- 231 (370)
T ss_pred cccC--CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHH---------------
Confidence 9874 1122345789999999999999877 86 689999999999999999999987321110
Q ss_pred cccccccccccCCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHH
Q 002721 835 PEQILDARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVV 879 (888)
Q Consensus 835 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl 879 (888)
...+......-. .+.. ..++..++.+|+..||.+|+|+.+|+
T Consensus 232 ~~ki~~~~~~~p--~~~~-S~~~~~Li~~mL~~~P~~R~t~~~i~ 273 (370)
T KOG0583|consen 232 YRKIRKGEFKIP--SYLL-SPEARSLIEKMLVPDPSTRITLLEIL 273 (370)
T ss_pred HHHHhcCCccCC--CCcC-CHHHHHHHHHHcCCCcccCCCHHHHh
Confidence 111111111111 1111 67788999999999999999999998
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-42 Score=374.61 Aligned_cols=264 Identities=19% Similarity=0.336 Sum_probs=218.4
Q ss_pred HHHHHhcCCcceeeecccceEEEEEeC----CCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeC
Q 002721 601 AVVKATMKDSNMIYCGTFSTVYKAVMP----SGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYE 676 (888)
Q Consensus 601 ~~~~~~~~~~~~ig~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 676 (888)
|+.....++.++||.|.||+||+|+++ ....||||.+|... .++++..|+.|+.||.++.||||+++.|+....
T Consensus 625 EId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~Gy--tekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks 702 (996)
T KOG0196|consen 625 EIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAGY--TEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKS 702 (996)
T ss_pred hcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccCc--cHHHHhhhhhhhhhcccCCCCcEEEEEEEEecC
Confidence 344556788999999999999999954 35689999998554 344566899999999999999999999999999
Q ss_pred CeeEEEEecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccccc
Q 002721 677 DVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEIS 756 (888)
Q Consensus 677 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a 756 (888)
...+||+|||++|+|+.+++.+.. .+++.+...+.++||.|++||-+.++|||||.++||||+.+-.+|++|||++
T Consensus 703 ~PvMIiTEyMENGsLDsFLR~~DG----qftviQLVgMLrGIAsGMkYLsdm~YVHRDLAARNILVNsnLvCKVsDFGLS 778 (996)
T KOG0196|consen 703 KPVMIITEYMENGSLDSFLRQNDG----QFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAARNILVNSNLVCKVSDFGLS 778 (996)
T ss_pred ceeEEEhhhhhCCcHHHHHhhcCC----ceEeehHHHHHHHHHHHhHHHhhcCchhhhhhhhheeeccceEEEeccccce
Confidence 999999999999999999998765 5888999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCCcc-cccccccccceecccccccCCcCccccchhHHHHHHHHHh-CCCCCCCCCCCccchhhhccccCCCCCC
Q 002721 757 KLLDPSKGTA-SISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILT-TRLPVEEDFGEGVDLVKWVHGAPARGET 834 (888)
Q Consensus 757 ~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~ 834 (888)
+.++++.... ....-.-..+|.|||.+..++++.++|||||||+|||.++ |..||.+....++ ++.+.
T Consensus 779 Rvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmSNQdV--IkaIe-------- 848 (996)
T KOG0196|consen 779 RVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDV--IKAIE-------- 848 (996)
T ss_pred eecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccchHHH--HHHHH--------
Confidence 9886554221 1112233568999999999999999999999999999887 9999987644322 11111
Q ss_pred cccccccccccCCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhhhC
Q 002721 835 PEQILDARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEMLQEIKQN 888 (888)
Q Consensus 835 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 888 (888)
+... -+.+.+.+..+.++|+.||++|-.+||.+.||+..|.++.+|
T Consensus 849 -----~gyR---LPpPmDCP~aL~qLMldCWqkdR~~RP~F~qiV~~lDklIrn 894 (996)
T KOG0196|consen 849 -----QGYR---LPPPMDCPAALYQLMLDCWQKDRNRRPKFAQIVSTLDKLIRN 894 (996)
T ss_pred -----hccC---CCCCCCCcHHHHHHHHHHHHHHhhcCCCHHHHHHHHHHHhcC
Confidence 1000 112334556788999999999999999999999999998765
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=351.97 Aligned_cols=251 Identities=19% Similarity=0.252 Sum_probs=206.5
Q ss_pred HHhcCCcceeeecccceEEEEE-eCCCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCCeeEEE
Q 002721 604 KATMKDSNMIYCGTFSTVYKAV-MPSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVALLL 682 (888)
Q Consensus 604 ~~~~~~~~~ig~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 682 (888)
...|+..+.||+|+||.||+|. ..+++.||+|++.-.... ...+.+.+|+.++.+++++||.++||.+..+...|++
T Consensus 12 ~~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~~~--deIediqqei~~Ls~~~~~~it~yygsyl~g~~Lwii 89 (467)
T KOG0201|consen 12 ELLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEEAE--DEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWII 89 (467)
T ss_pred ccccccchhccccccceeeeeeeccccceEEEEEechhhcc--hhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHH
Confidence 3467788999999999999999 457999999999854333 2345788999999999999999999999999999999
Q ss_pred EecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccccccccCCC
Q 002721 683 HNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPS 762 (888)
Q Consensus 683 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 762 (888)
||||.||++.+.++.... +++..+..++++++.||.|+|+++.+|||||+.||++..+|.+|++|||.+......
T Consensus 90 Mey~~gGsv~~lL~~~~~-----~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~ 164 (467)
T KOG0201|consen 90 MEYCGGGSVLDLLKSGNI-----LDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNT 164 (467)
T ss_pred HHHhcCcchhhhhccCCC-----CccceeeeehHHHHHHhhhhhhcceecccccccceeEeccCcEEEEecceeeeeech
Confidence 999999999999987543 255667778999999999999999999999999999999999999999999887654
Q ss_pred CCcccccccccccceecccccccCCcCccccchhHHHHHHHHHhCCCCCCCCCCCccchhhhccccCCCCCCcccccccc
Q 002721 763 KGTASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQILDAR 842 (888)
Q Consensus 763 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 842 (888)
... ...++||+.|||||++.+..|+.|+||||||++.+||++|.+|+.+..+..+ ....+ ...
T Consensus 165 ~~r--r~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrv-----lflIp----------k~~ 227 (467)
T KOG0201|consen 165 VKR--RKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRV-----LFLIP----------KSA 227 (467)
T ss_pred hhc--cccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceE-----EEecc----------CCC
Confidence 322 2578999999999999998999999999999999999999999986543211 10011 000
Q ss_pred cccCCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002721 843 LSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEM 881 (888)
Q Consensus 843 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~ 881 (888)
.+.. .....+.+.+++..|+++||+.||+|.++++.
T Consensus 228 PP~L---~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh 263 (467)
T KOG0201|consen 228 PPRL---DGDFSPPFKEFVEACLDKNPEFRPSAKELLKH 263 (467)
T ss_pred CCcc---ccccCHHHHHHHHHHhhcCcccCcCHHHHhhh
Confidence 0111 11344567789999999999999999999863
|
|
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=322.63 Aligned_cols=253 Identities=23% Similarity=0.253 Sum_probs=214.0
Q ss_pred HHHhcCCcceeeecccceEEEEE-eCCCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCCeeEE
Q 002721 603 VKATMKDSNMIYCGTFSTVYKAV-MPSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVALL 681 (888)
Q Consensus 603 ~~~~~~~~~~ig~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 681 (888)
.-++|++.+.+|+|.||.||.|+ .+++-.||+|++.+..........++.+|++|.+.++||||+++|+||.+....|+
T Consensus 20 ~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyL 99 (281)
T KOG0580|consen 20 TLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYL 99 (281)
T ss_pred chhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEE
Confidence 34689999999999999999999 55789999999987665555666789999999999999999999999999999999
Q ss_pred EEecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccccccccCC
Q 002721 682 LHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDP 761 (888)
Q Consensus 682 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~~~ 761 (888)
++||.+.|.+...+++.... ++++.....++.|+|.||.|+|.++||||||||+|+|++..+..|++|||.+..-..
T Consensus 100 ilEya~~gel~k~L~~~~~~---~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p~ 176 (281)
T KOG0580|consen 100 ILEYAPRGELYKDLQEGRMK---RFDEQRAATYIKQLANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS 176 (281)
T ss_pred EEEecCCchHHHHHHhcccc---cccccchhHHHHHHHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCceeecCC
Confidence 99999999999999965443 567788889999999999999999999999999999999999999999999886542
Q ss_pred CCCcccccccccccceecccccccCCcCccccchhHHHHHHHHHhCCCCCCCCCCCccchhhhccccCCCCCCccccccc
Q 002721 762 SKGTASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQILDA 841 (888)
Q Consensus 762 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 841 (888)
. .....+||..|.|||+..+..++.++|+|++|+..||++.|.+||...... +...++..-
T Consensus 177 ~----kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~---------------etYkrI~k~ 237 (281)
T KOG0580|consen 177 N----KRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHS---------------ETYKRIRKV 237 (281)
T ss_pred C----CceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhH---------------HHHHHHHHc
Confidence 2 234678999999999999999999999999999999999999999875421 111112211
Q ss_pred ccccCCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002721 842 RLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEM 881 (888)
Q Consensus 842 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~ 881 (888)
.+. .+......+.++|.+|+..+|.+|.+..|+++.
T Consensus 238 ~~~----~p~~is~~a~dlI~~ll~~~p~~r~~l~~v~~h 273 (281)
T KOG0580|consen 238 DLK----FPSTISGGAADLISRLLVKNPIERLALTEVMDH 273 (281)
T ss_pred ccc----CCcccChhHHHHHHHHhccCccccccHHHHhhh
Confidence 111 113345667889999999999999999999864
|
|
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-44 Score=364.77 Aligned_cols=405 Identities=27% Similarity=0.445 Sum_probs=268.0
Q ss_pred EEEEEcCCCCcccccccccCCCCCCEEeCCCCcCcccCCCCCCCCCCCCEEECcCCCCCCCCCCCCCCCCcceEEEcCCC
Q 002721 65 VVKLDLSRLQLRGNITLVSELKALKRLDLSNNAFSGTIPSAFGNLSELEFLDLSLNKFGGVIPRELGSLKDLRFFNISNN 144 (888)
Q Consensus 65 v~~l~l~~~~l~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 144 (888)
..++++++|.+....+.+.+|..|++|++++|++. ..|++++.+..+..|+.++|+++ .+|++++.+.+|+.|+.++|
T Consensus 47 l~~lils~N~l~~l~~dl~nL~~l~vl~~~~n~l~-~lp~aig~l~~l~~l~vs~n~ls-~lp~~i~s~~~l~~l~~s~n 124 (565)
T KOG0472|consen 47 LQKLILSHNDLEVLREDLKNLACLTVLNVHDNKLS-QLPAAIGELEALKSLNVSHNKLS-ELPEQIGSLISLVKLDCSSN 124 (565)
T ss_pred hhhhhhccCchhhccHhhhcccceeEEEeccchhh-hCCHHHHHHHHHHHhhcccchHh-hccHHHhhhhhhhhhhcccc
Confidence 34566667766655556666666777777777765 55666666667777777777766 56666666777777777777
Q ss_pred ccccccCccccccccccEEEecCCCCCCCCCccccccccccEEecccccccCCCCCCCCCcccccceeeccccCCCCCCC
Q 002721 145 VLVGEIPDELKSLEKLEDFQVSSNKLNGSIPFWVGNLTNLRVFTAYENQLVGEIPDNLGSVSELELLNLHSNQLEGPIPK 224 (888)
Q Consensus 145 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~ 224 (888)
.+. ..|+.++.+..|+.|+..+|+++ ..|+.+.++.+|..|++.+|++....|+.+. ++.|++||.-+|-++ .+|.
T Consensus 125 ~~~-el~~~i~~~~~l~dl~~~~N~i~-slp~~~~~~~~l~~l~~~~n~l~~l~~~~i~-m~~L~~ld~~~N~L~-tlP~ 200 (565)
T KOG0472|consen 125 ELK-ELPDSIGRLLDLEDLDATNNQIS-SLPEDMVNLSKLSKLDLEGNKLKALPENHIA-MKRLKHLDCNSNLLE-TLPP 200 (565)
T ss_pred cee-ecCchHHHHhhhhhhhccccccc-cCchHHHHHHHHHHhhccccchhhCCHHHHH-HHHHHhcccchhhhh-cCCh
Confidence 666 55666666666666666666666 5566666666666666666666643333333 666666666666665 4566
Q ss_pred CccCCCCcceEEecCccCCCCchhhhccCCccceeeccCCccccccCCccccCCCccEEEeeccCCCCCCCccccCCCCC
Q 002721 225 SIFASGKLEVLVLTQNRLTGDIPELVGHCKSLSNIRIGNNDLVGVIPRAIGNVSGLTYFEADNNNLSGEIVPEFSQCSNL 304 (888)
Q Consensus 225 ~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L 304 (888)
.++.+.+|+.|+|.+|+|.. .| .|.++..|.+|+++.|+|.-.+.....+++++.+|||.+|+++ ..|+.+.-+++|
T Consensus 201 ~lg~l~~L~~LyL~~Nki~~-lP-ef~gcs~L~Elh~g~N~i~~lpae~~~~L~~l~vLDLRdNklk-e~Pde~clLrsL 277 (565)
T KOG0472|consen 201 ELGGLESLELLYLRRNKIRF-LP-EFPGCSLLKELHVGENQIEMLPAEHLKHLNSLLVLDLRDNKLK-EVPDEICLLRSL 277 (565)
T ss_pred hhcchhhhHHHHhhhccccc-CC-CCCccHHHHHHHhcccHHHhhHHHHhcccccceeeeccccccc-cCchHHHHhhhh
Confidence 66666666666666666663 33 5666666666666666665333333446666666666666666 345556666666
Q ss_pred cEEEeecCcccccCCccccCCCCccEEEeccccccC--------------------------------------------
Q 002721 305 TLLNLASNGFTGVIPPELGQLINLQELILYENSLFG-------------------------------------------- 340 (888)
Q Consensus 305 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~-------------------------------------------- 340 (888)
++||+|+|.|++ .|.+++++ .|+.|-+.+|.+..
T Consensus 278 ~rLDlSNN~is~-Lp~sLgnl-hL~~L~leGNPlrTiRr~ii~~gT~~vLKyLrs~~~~dglS~se~~~e~~~t~~~~~~ 355 (565)
T KOG0472|consen 278 ERLDLSNNDISS-LPYSLGNL-HLKFLALEGNPLRTIRREIISKGTQEVLKYLRSKIKDDGLSQSEGGTETAMTLPSESF 355 (565)
T ss_pred hhhcccCCcccc-CCcccccc-eeeehhhcCCchHHHHHHHHcccHHHHHHHHHHhhccCCCCCCcccccccCCCCCCcc
Confidence 666666666663 45556666 56666666654420
Q ss_pred --------------------cCcccccccCc---ceEEEccCCcCC-----------------------CCCCchhcccc
Q 002721 341 --------------------EIPKSILACKN---LNKLDLSNNRFN-----------------------GTIPNAICDMS 374 (888)
Q Consensus 341 --------------------~~p~~~~~l~~---L~~L~Ls~N~l~-----------------------~~~p~~~~~l~ 374 (888)
.+|...+.... .+..+++.|++. +.+|..++.++
T Consensus 356 ~~~~~~i~tkiL~~s~~qlt~VPdEVfea~~~~~Vt~VnfskNqL~elPk~L~~lkelvT~l~lsnn~isfv~~~l~~l~ 435 (565)
T KOG0472|consen 356 PDIYAIITTKILDVSDKQLTLVPDEVFEAAKSEIVTSVNFSKNQLCELPKRLVELKELVTDLVLSNNKISFVPLELSQLQ 435 (565)
T ss_pred cchhhhhhhhhhcccccccccCCHHHHHHhhhcceEEEecccchHhhhhhhhHHHHHHHHHHHhhcCccccchHHHHhhh
Confidence 11111111111 344555555544 24555667777
Q ss_pred CcceecccCCccccccCCCccccccceEEEeecccccccCCCccccccchhhhhhccCccccccCCccccCCCCccEEEe
Q 002721 375 RLQYLLLGQNSLKGEIPHEIGNCMKLLQLHIGSNYLTGSIPPEIGHIRNLQIALNLSFNHLHGSLPPELGKLDKLVSFDV 454 (888)
Q Consensus 375 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~~L~ls~N~l~~~~p~~~~~l~~L~~LdL 454 (888)
+|..|+|++|.+. .+|.+++.+..|+.|+++.|+|. .+|..+..+..++ .+-.++|++..+.|..+.++.+|..|||
T Consensus 436 kLt~L~L~NN~Ln-~LP~e~~~lv~Lq~LnlS~NrFr-~lP~~~y~lq~lE-tllas~nqi~~vd~~~l~nm~nL~tLDL 512 (565)
T KOG0472|consen 436 KLTFLDLSNNLLN-DLPEEMGSLVRLQTLNLSFNRFR-MLPECLYELQTLE-TLLASNNQIGSVDPSGLKNMRNLTTLDL 512 (565)
T ss_pred cceeeecccchhh-hcchhhhhhhhhheecccccccc-cchHHHhhHHHHH-HHHhccccccccChHHhhhhhhcceecc
Confidence 8888888888877 77888888888888888888887 7787777777776 4556668887666666899999999999
Q ss_pred eCCccccCCchhhcccccceEEEccCCcCc
Q 002721 455 SNNQLSGTIPSALKGMLSLIEVNFSNNLLT 484 (888)
Q Consensus 455 s~N~l~~~~p~~~~~l~~L~~L~ls~N~l~ 484 (888)
.+|.+. .+|..+++|++|++|+++||+|.
T Consensus 513 ~nNdlq-~IPp~LgnmtnL~hLeL~gNpfr 541 (565)
T KOG0472|consen 513 QNNDLQ-QIPPILGNMTNLRHLELDGNPFR 541 (565)
T ss_pred CCCchh-hCChhhccccceeEEEecCCccC
Confidence 999998 88889999999999999999997
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=330.92 Aligned_cols=269 Identities=19% Similarity=0.209 Sum_probs=206.8
Q ss_pred HHhcCCcceeeecccceEEEEEe-CCCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEe--CCeeE
Q 002721 604 KATMKDSNMIYCGTFSTVYKAVM-PSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIY--EDVAL 680 (888)
Q Consensus 604 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~--~~~~~ 680 (888)
.+.|+..+.|++|.||.||+|++ ++++.||+|+++.. .......-...||+.++.+++|||||.+-.+... -+..|
T Consensus 75 v~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kme-kek~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy 153 (419)
T KOG0663|consen 75 VEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKME-KEKEGFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIY 153 (419)
T ss_pred HHHHHHHhhcccCcceeEEEeccCCcceeEEeeecccc-cccCCCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceee
Confidence 34688899999999999999994 57999999999843 3333333367899999999999999999998875 35799
Q ss_pred EEEecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccccccccC
Q 002721 681 LLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLD 760 (888)
Q Consensus 681 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~~ 760 (888)
+|||||+. ||..++..... ++...++..++.|+++|++|||.+.|+||||||+|+|++..|.+||+|||+|+.+.
T Consensus 154 ~VMe~~Eh-DLksl~d~m~q----~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~yg 228 (419)
T KOG0663|consen 154 IVMEYVEH-DLKSLMETMKQ----PFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREYG 228 (419)
T ss_pred eeHHHHHh-hHHHHHHhccC----CCchHHHHHHHHHHHHHHHHHhhceeEecccchhheeeccCCcEEecccchhhhhc
Confidence 99999987 99999987652 67888999999999999999999999999999999999999999999999999886
Q ss_pred CCCCcccccccccccceecccccccC-CcCccccchhHHHHHHHHHhCCCCCCCCCCCc-cchhhhccccCCCCCCcccc
Q 002721 761 PSKGTASISAVAGSFGYIPPEYAYTM-QVTAPGNVYSYGVVLLEILTTRLPVEEDFGEG-VDLVKWVHGAPARGETPEQI 838 (888)
Q Consensus 761 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~P~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 838 (888)
.. ....+..+-|.+|+|||.+.+. .|+++.|+||+|||+.||+++++-|.+....+ .+.+-...+.+....++.--
T Consensus 229 sp--~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~ 306 (419)
T KOG0663|consen 229 SP--LKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYS 306 (419)
T ss_pred CC--cccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCcc
Confidence 53 3345677889999999998876 59999999999999999999999987643221 11111122222222111110
Q ss_pred ccc-----ccccCC-----c--CcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002721 839 LDA-----RLSTVS-----F--GWRKEMLTALKVALLCTDSTPAKRPKMKKVVE 880 (888)
Q Consensus 839 ~~~-----~~~~~~-----~--~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 880 (888)
.-+ .+...+ . .........++++..++.+||++|.||+|.++
T Consensus 307 ~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~ 360 (419)
T KOG0663|consen 307 ELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLK 360 (419)
T ss_pred ccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHHhhc
Confidence 000 000000 0 00112366789999999999999999999875
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=359.67 Aligned_cols=250 Identities=20% Similarity=0.247 Sum_probs=210.9
Q ss_pred HhcCCcceeeecccceEEEEE-eCCCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCCeeEEEE
Q 002721 605 ATMKDSNMIYCGTFSTVYKAV-MPSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVALLLH 683 (888)
Q Consensus 605 ~~~~~~~~ig~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 683 (888)
+-|+.++-||.|+.|.|..|+ ..+|+.+|||++.+...........+.+|+-+|+-+.||||+++|++|+...++|+|.
T Consensus 12 GpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvl 91 (786)
T KOG0588|consen 12 GPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVL 91 (786)
T ss_pred cceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEE
Confidence 357889999999999999999 5689999999998664444455568999999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccccccccCCCC
Q 002721 684 NYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSK 763 (888)
Q Consensus 684 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 763 (888)
||+++|-|.+++-..+. +++.++.+++.||+.|+.|+|..+|+|||+||+|+|+|..+.+||+|||+|..-.++.
T Consensus 92 Eyv~gGELFdylv~kG~-----l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gk 166 (786)
T KOG0588|consen 92 EYVPGGELFDYLVRKGP-----LPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLEVPGK 166 (786)
T ss_pred EecCCchhHHHHHhhCC-----CCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeecccCCc
Confidence 99999999999988764 5668999999999999999999999999999999999999999999999998755433
Q ss_pred CcccccccccccceecccccccCCcC-ccccchhHHHHHHHHHhCCCCCCCCCCCccchhhhccccCCCCCCcccccccc
Q 002721 764 GTASISAVAGSFGYIPPEYAYTMQVT-APGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQILDAR 842 (888)
Q Consensus 764 ~~~~~~~~~gt~~y~aPE~~~~~~~~-~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 842 (888)
-....+|++.|.|||++.|.+|+ .++||||+|||+|.++||+.||+++.- ..++...
T Consensus 167 ---lLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNi-------------------r~LLlKV 224 (786)
T KOG0588|consen 167 ---LLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNI-------------------RVLLLKV 224 (786)
T ss_pred ---cccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccH-------------------HHHHHHH
Confidence 24567999999999999999985 589999999999999999999985421 1111111
Q ss_pred cccCCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002721 843 LSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEM 881 (888)
Q Consensus 843 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~ 881 (888)
..+...-+.....++.+++.+|++.||++|.|++||++.
T Consensus 225 ~~G~f~MPs~Is~eaQdLLr~ml~VDp~~RiT~~eI~kH 263 (786)
T KOG0588|consen 225 QRGVFEMPSNISSEAQDLLRRMLDVDPSTRITTEEILKH 263 (786)
T ss_pred HcCcccCCCcCCHHHHHHHHHHhccCccccccHHHHhhC
Confidence 111111224455677889999999999999999999864
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=329.11 Aligned_cols=255 Identities=21% Similarity=0.252 Sum_probs=214.7
Q ss_pred HHHHhcCCcceeeecccceEEEEE-eCCCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCCeeE
Q 002721 602 VVKATMKDSNMIYCGTFSTVYKAV-MPSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVAL 680 (888)
Q Consensus 602 ~~~~~~~~~~~ig~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 680 (888)
.+.+.|++.+.||+|.|+.||++. .++|+.+|+|.+....-.. ...+++.+|++|.+.++||||+++.+.+.+.+..|
T Consensus 8 ~f~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~-~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~y 86 (355)
T KOG0033|consen 8 KFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSA-RDFQKLEREARICRKLQHPNIVRLHDSIQEESFHY 86 (355)
T ss_pred ccchhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhcc-ccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeE
Confidence 456788999999999999999998 5679999999887433322 24558999999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCC---CCCceEecccccc
Q 002721 681 LLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDA---DFKPLLGEIEISK 757 (888)
Q Consensus 681 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~---~~~~kl~Dfg~a~ 757 (888)
+|+|+|+|++|..-+-.+. .+++..+-.+++||++||+|+|.+||||||+||+|+++.. .--+|++|||+|.
T Consensus 87 lvFe~m~G~dl~~eIV~R~-----~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi 161 (355)
T KOG0033|consen 87 LVFDLVTGGELFEDIVARE-----FYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAI 161 (355)
T ss_pred EEEecccchHHHHHHHHHH-----HHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeeccCCCceeecccceEE
Confidence 9999999999876554431 4577888899999999999999999999999999999953 3458999999999
Q ss_pred ccCCCCCcccccccccccceecccccccCCcCccccchhHHHHHHHHHhCCCCCCCCCCCccchhhhccccCCCCCCccc
Q 002721 758 LLDPSKGTASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQ 837 (888)
Q Consensus 758 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 837 (888)
....+ ....+.+|||.|||||++...+|+..+|||+.|+|+|-++.|.+||.+.... ...++
T Consensus 162 ~l~~g---~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~---------------rlye~ 223 (355)
T KOG0033|consen 162 EVNDG---EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQH---------------RLYEQ 223 (355)
T ss_pred EeCCc---cccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHH---------------HHHHH
Confidence 88722 2345789999999999999999999999999999999999999999874322 23344
Q ss_pred ccccccccCCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002721 838 ILDARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVE 880 (888)
Q Consensus 838 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 880 (888)
+........++.|....+++.+++.+|+..||.+|.|+.|.++
T Consensus 224 I~~g~yd~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~ 266 (355)
T KOG0033|consen 224 IKAGAYDYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALK 266 (355)
T ss_pred HhccccCCCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhC
Confidence 5555555555677888899999999999999999999999875
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=350.09 Aligned_cols=272 Identities=21% Similarity=0.299 Sum_probs=218.5
Q ss_pred HHHHHHHhcCCcceeeecccceEEEEEeCCCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCCe
Q 002721 599 LDAVVKATMKDSNMIYCGTFSTVYKAVMPSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDV 678 (888)
Q Consensus 599 ~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 678 (888)
..++......+.++||+|.||+|..+....+..||||.++..... ....+|.+|+++|.+++|||||+++|+|..++.
T Consensus 532 l~EfPRs~L~~~ekiGeGqFGEVhLCeveg~lkVAVK~Lr~~a~~--~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DeP 609 (807)
T KOG1094|consen 532 LVEFPRSRLRFKEKIGEGQFGEVHLCEVEGPLKVAVKILRPDATK--NARNDFLKEIKILSRLKHPNIVELLGVCVQDDP 609 (807)
T ss_pred hhhcchhheehhhhhcCcccceeEEEEecCceEEEEeecCcccch--hHHHHHHHHHHHHhccCCCCeeEEEeeeecCCc
Confidence 445677778889999999999999999877899999999865543 335689999999999999999999999999999
Q ss_pred eEEEEecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccccccc
Q 002721 679 ALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKL 758 (888)
Q Consensus 679 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~ 758 (888)
.++|+|||++|+|.+++.+..... ..-....+|+.||+.|++||.+.++||||+.++|+|+|.++++||+|||+++-
T Consensus 610 icmI~EYmEnGDLnqFl~aheapt---~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~ 686 (807)
T KOG1094|consen 610 LCMITEYMENGDLNQFLSAHELPT---AETAPGVSICTQIASGMAYLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRN 686 (807)
T ss_pred hHHHHHHHhcCcHHHHHHhccCcc---cccchhHHHHHHHHHHHHHHHhhchhhccccccceeecCcccEEecCcccccc
Confidence 999999999999999999874431 23355678999999999999999999999999999999999999999999996
Q ss_pred cCCCCCcccccccccccceecccccccCCcCccccchhHHHHHHHHHh--CCCCCCCCCCCccchhhhccccCCCCCCcc
Q 002721 759 LDPSKGTASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILT--TRLPVEEDFGEGVDLVKWVHGAPARGETPE 836 (888)
Q Consensus 759 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt--g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 836 (888)
+-.+.........+-..+|||||.+..+++++++|||+||+++||+++ ...||.+..++.. ++........ ..
T Consensus 687 lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~v--ven~~~~~~~-~~-- 761 (807)
T KOG1094|consen 687 LYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQV--VENAGEFFRD-QG-- 761 (807)
T ss_pred cccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHHH--HHhhhhhcCC-CC--
Confidence 654443333334556789999999999999999999999999999876 7889987655422 1111111111 11
Q ss_pred cccccccccCCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhh
Q 002721 837 QILDARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEMLQEIK 886 (888)
Q Consensus 837 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~i~ 886 (888)
.+.....+.-....++++|.+||..|.++||+++++...|++..
T Consensus 762 ------~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~~lq~~~ 805 (807)
T KOG1094|consen 762 ------RQVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHLFLQEDA 805 (807)
T ss_pred ------cceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHHHHHHhc
Confidence 11111122334456789999999999999999999999988754
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-40 Score=352.01 Aligned_cols=254 Identities=16% Similarity=0.174 Sum_probs=202.1
Q ss_pred hcCCcceeeecccceEEEEEe-CCCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCCeeEEEEe
Q 002721 606 TMKDSNMIYCGTFSTVYKAVM-PSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVALLLHN 684 (888)
Q Consensus 606 ~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 684 (888)
.|+..+.||+|+||+||+|.. .+|+.||+|.+.............+.+|++++++++|++|+++++++.+++..++|||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEE
Confidence 377789999999999999994 5799999999875443333334467899999999999999999999999999999999
Q ss_pred cCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccccccccCCCCC
Q 002721 685 YLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSKG 764 (888)
Q Consensus 685 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 764 (888)
|+++|+|.+++...... .+++..+..++.|++.||+|||++||+||||||+||++++++.+||+|||++.......
T Consensus 81 ~~~~g~L~~~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~- 156 (285)
T cd05631 81 IMNGGDLKFHIYNMGNP---GFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE- 156 (285)
T ss_pred ecCCCcHHHHHHhhCCC---CCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC-
Confidence 99999999888654321 47889999999999999999999999999999999999999999999999998754322
Q ss_pred cccccccccccceecccccccCCcCccccchhHHHHHHHHHhCCCCCCCCCCCccchhhhccccCCCCCCcccccccccc
Q 002721 765 TASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQILDARLS 844 (888)
Q Consensus 765 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 844 (888)
......||..|+|||++.+..++.++||||+||++|||++|+.||......... ..... .+....
T Consensus 157 --~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~-~~~~~----------~~~~~~-- 221 (285)
T cd05631 157 --TVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKR-EEVDR----------RVKEDQ-- 221 (285)
T ss_pred --eecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhH-HHHHH----------Hhhccc--
Confidence 123457899999999999999999999999999999999999999754321100 00000 000000
Q ss_pred cCCcCcHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHH
Q 002721 845 TVSFGWRKEMLTALKVALLCTDSTPAKRPK-----MKKVVE 880 (888)
Q Consensus 845 ~~~~~~~~~~~~~~~li~~cl~~dP~~RPs-----~~evl~ 880 (888)
.........++.+++.+||+.||++||+ ++++++
T Consensus 222 --~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~ 260 (285)
T cd05631 222 --EEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQ 260 (285)
T ss_pred --ccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhc
Confidence 0011123456778999999999999997 788776
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=361.07 Aligned_cols=245 Identities=21% Similarity=0.213 Sum_probs=210.1
Q ss_pred HHhcCCcceeeecccceEEEEEe-CCCcEEEEEEeeccChhhhHHHHHHHHHHHHHhcc-CCCceeeeeeEEEeCCeeEE
Q 002721 604 KATMKDSNMIYCGTFSTVYKAVM-PSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKL-CHDNLVRPIGFVIYEDVALL 681 (888)
Q Consensus 604 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~l 681 (888)
-++|...++||+|.||+|++|.. .+++.||||++++......+..+....|.+|+... +||.++.++..|+..++.|+
T Consensus 367 l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~f 446 (694)
T KOG0694|consen 367 LDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFF 446 (694)
T ss_pred ccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEE
Confidence 45799999999999999999994 46899999999988777777778889999998877 59999999999999999999
Q ss_pred EEecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccccccccCC
Q 002721 682 LHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDP 761 (888)
Q Consensus 682 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~~~ 761 (888)
||||+.|||+..+.+.. .+++..+..|+..|+.||+|||++||||||||.+|||+|.+|++||+|||+++..-.
T Consensus 447 vmey~~Ggdm~~~~~~~------~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~ 520 (694)
T KOG0694|consen 447 VMEYVAGGDLMHHIHTD------VFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMG 520 (694)
T ss_pred EEEecCCCcEEEEEecc------cccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheEEcccCcEEecccccccccCC
Confidence 99999999955544432 678899999999999999999999999999999999999999999999999997432
Q ss_pred CCCcccccccccccceecccccccCCcCccccchhHHHHHHHHHhCCCCCCCCCCCccchhhhccccCCCCCCccccccc
Q 002721 762 SKGTASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQILDA 841 (888)
Q Consensus 762 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 841 (888)
. ......++||+.|||||++.+..|+.++|.|||||+||||+.|..||.++.. +++.+.
T Consensus 521 ~--g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddE-------------------ee~Fds 579 (694)
T KOG0694|consen 521 Q--GDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDE-------------------EEVFDS 579 (694)
T ss_pred C--CCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCH-------------------HHHHHH
Confidence 2 2235678999999999999999999999999999999999999999986432 234444
Q ss_pred ccccCCcCcHHHHHHHHHHHhhccCCCCCCCCCH
Q 002721 842 RLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKM 875 (888)
Q Consensus 842 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~ 875 (888)
.+...+..+.-.+.++++++.+++.++|++|.-+
T Consensus 580 I~~d~~~yP~~ls~ea~~il~~ll~k~p~kRLG~ 613 (694)
T KOG0694|consen 580 IVNDEVRYPRFLSKEAIAIMRRLLRKNPEKRLGS 613 (694)
T ss_pred HhcCCCCCCCcccHHHHHHHHHHhccCcccccCC
Confidence 4444444455566788899999999999999865
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-39 Score=348.58 Aligned_cols=250 Identities=20% Similarity=0.291 Sum_probs=202.0
Q ss_pred cceeeecccceEEEEEeCCCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEe----CCeeEEEEec
Q 002721 610 SNMIYCGTFSTVYKAVMPSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIY----EDVALLLHNY 685 (888)
Q Consensus 610 ~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~----~~~~~lv~e~ 685 (888)
...||+|++|.||+|.. +|+.||||+++..........+.+.+|++++++++||||++++|++.+ ....++||||
T Consensus 25 ~~~i~~g~~~~v~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey 103 (283)
T PHA02988 25 SVLIKENDQNSIYKGIF-NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEY 103 (283)
T ss_pred CeEEeeCCceEEEEEEE-CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEe
Confidence 47899999999999998 789999999986544444445678899999999999999999999877 3478999999
Q ss_pred CCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhccc-CCeeecCCCCCCeEeCCCCCceEeccccccccCCCCC
Q 002721 686 LPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHH-VAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSKG 764 (888)
Q Consensus 686 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 764 (888)
+++|+|.+++.... .+++.....++.|++.||+|||+ .+++||||||+||++++++.+|++|||+++......
T Consensus 104 ~~~g~L~~~l~~~~-----~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~- 177 (283)
T PHA02988 104 CTRGYLREVLDKEK-----DLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP- 177 (283)
T ss_pred CCCCcHHHHHhhCC-----CCChhHHHHHHHHHHHHHHHHHhcCCCCCCcCChhhEEECCCCcEEEcccchHhhhcccc-
Confidence 99999999998643 46788999999999999999998 599999999999999999999999999998654321
Q ss_pred cccccccccccceeccccccc--CCcCccccchhHHHHHHHHHhCCCCCCCCCCCccchhhhccccCCCCCCcccccccc
Q 002721 765 TASISAVAGSFGYIPPEYAYT--MQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQILDAR 842 (888)
Q Consensus 765 ~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 842 (888)
....|+..|+|||++.+ ..++.++|||||||++|||++|+.||...... +....+.. ....
T Consensus 178 ----~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~~--~~~~~i~~---~~~~-------- 240 (283)
T PHA02988 178 ----FKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTK--EIYDLIIN---KNNS-------- 240 (283)
T ss_pred ----ccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCHH--HHHHHHHh---cCCC--------
Confidence 23467889999999876 67999999999999999999999999754221 11111100 0000
Q ss_pred cccCCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhhh
Q 002721 843 LSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEMLQEIKQ 887 (888)
Q Consensus 843 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 887 (888)
. .. .......+.+++.+||+.||++|||++|+++.|+.++.
T Consensus 241 ~-~~---~~~~~~~l~~li~~cl~~dp~~Rps~~ell~~l~~~~~ 281 (283)
T PHA02988 241 L-KL---PLDCPLEIKCIVEACTSHDSIKRPNIKEILYNLSLYKF 281 (283)
T ss_pred C-CC---CCcCcHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHh
Confidence 0 00 01234567889999999999999999999999998763
|
|
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=351.20 Aligned_cols=245 Identities=21% Similarity=0.329 Sum_probs=200.3
Q ss_pred HhcCCcceeeecccceEEEEEeCCCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCCeeEEEEe
Q 002721 605 ATMKDSNMIYCGTFSTVYKAVMPSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVALLLHN 684 (888)
Q Consensus 605 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 684 (888)
+.....+.+|+|+.|.||+|+. .++.||||+++... ..+|+-|++++||||+.+.|+|.....+|||||
T Consensus 124 e~IsELeWlGSGaQGAVF~Grl-~netVAVKKV~elk----------ETdIKHLRkLkH~NII~FkGVCtqsPcyCIiME 192 (904)
T KOG4721|consen 124 EEISELEWLGSGAQGAVFLGRL-HNETVAVKKVRELK----------ETDIKHLRKLKHPNIITFKGVCTQSPCYCIIME 192 (904)
T ss_pred HHhhhhhhhccCcccceeeeec-cCceehhHHHhhhh----------hhhHHHHHhccCcceeeEeeeecCCceeEEeee
Confidence 3445577899999999999998 57789999876322 246788999999999999999999999999999
Q ss_pred cCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccccccccCCCCC
Q 002721 685 YLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSKG 764 (888)
Q Consensus 685 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 764 (888)
||..|-|+.+++... .++......|..+||.|+.|||.+.|||||||.-||||..+..+||+|||-++.....
T Consensus 193 fCa~GqL~~VLka~~-----~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~-- 265 (904)
T KOG4721|consen 193 FCAQGQLYEVLKAGR-----PITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDDVVKISDFGTSKELSDK-- 265 (904)
T ss_pred ccccccHHHHHhccC-----ccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccceEEeccccchHhhhhh--
Confidence 999999999999765 4566788899999999999999999999999999999999999999999999876543
Q ss_pred cccccccccccceecccccccCCcCccccchhHHHHHHHHHhCCCCCCCCCCCccchhhhccccCCCCCCcccccccccc
Q 002721 765 TASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQILDARLS 844 (888)
Q Consensus 765 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 844 (888)
.....++||..|||||++...+.+.|+||||||||+|||+||..||.+.... .++.+..... +.-
T Consensus 266 -STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdss-----AIIwGVGsNs------L~L--- 330 (904)
T KOG4721|consen 266 -STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSS-----AIIWGVGSNS------LHL--- 330 (904)
T ss_pred -hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchh-----eeEEeccCCc------ccc---
Confidence 2235689999999999999999999999999999999999999999864221 2222211110 000
Q ss_pred cCCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHh
Q 002721 845 TVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEMLQEI 885 (888)
Q Consensus 845 ~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~i 885 (888)
.+ ....+.-+.-++++||+..|..||++.+|+..|+-.
T Consensus 331 pv---PstcP~GfklL~Kqcw~sKpRNRPSFrqil~HldIa 368 (904)
T KOG4721|consen 331 PV---PSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHLDIA 368 (904)
T ss_pred cC---cccCchHHHHHHHHHHhcCCCCCccHHHHHHHHhhc
Confidence 01 122233455688899999999999999999988754
|
|
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-40 Score=354.66 Aligned_cols=247 Identities=21% Similarity=0.224 Sum_probs=201.9
Q ss_pred hcCCcceeeecccceEEEEEeC-CCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCCeeEEEEe
Q 002721 606 TMKDSNMIYCGTFSTVYKAVMP-SGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVALLLHN 684 (888)
Q Consensus 606 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 684 (888)
+|++.+.||+|+||.||+|... +++.||+|++...........+.+.+|++++++++||||+++++++.+++..|+|||
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e 81 (291)
T cd05612 2 DLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLME 81 (291)
T ss_pred CceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEe
Confidence 6888999999999999999954 689999999975443333344578899999999999999999999999999999999
Q ss_pred cCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccccccccCCCCC
Q 002721 685 YLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSKG 764 (888)
Q Consensus 685 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 764 (888)
|+++|+|.+++.... .+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||+++......
T Consensus 82 ~~~~~~L~~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~~- 155 (291)
T cd05612 82 YVPGGELFSYLRNSG-----RFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRT- 155 (291)
T ss_pred CCCCCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccCCc-
Confidence 999999999997653 46778899999999999999999999999999999999999999999999998754321
Q ss_pred cccccccccccceecccccccCCcCccccchhHHHHHHHHHhCCCCCCCCCCCccchhhhccccCCCCCCcccccccccc
Q 002721 765 TASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQILDARLS 844 (888)
Q Consensus 765 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 844 (888)
....|++.|+|||++.+..++.++||||+||++|||++|+.||....... ..+. +......
T Consensus 156 ----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~--~~~~-------------i~~~~~~ 216 (291)
T cd05612 156 ----WTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFG--IYEK-------------ILAGKLE 216 (291)
T ss_pred ----ccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHH-------------HHhCCcC
Confidence 23568999999999999899999999999999999999999997542211 1110 1110000
Q ss_pred cCCcCcHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHHH
Q 002721 845 TVSFGWRKEMLTALKVALLCTDSTPAKRPK-----MKKVVEM 881 (888)
Q Consensus 845 ~~~~~~~~~~~~~~~li~~cl~~dP~~RPs-----~~evl~~ 881 (888)
........+.+++.+||+.||.+||+ ++|+++.
T Consensus 217 ----~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h 254 (291)
T cd05612 217 ----FPRHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNH 254 (291)
T ss_pred ----CCccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcC
Confidence 01112456788999999999999995 8887653
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-40 Score=357.32 Aligned_cols=244 Identities=19% Similarity=0.175 Sum_probs=197.6
Q ss_pred ceeeecccceEEEEEe-CCCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCCeeEEEEecCCCC
Q 002721 611 NMIYCGTFSTVYKAVM-PSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVALLLHNYLPNG 689 (888)
Q Consensus 611 ~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~g 689 (888)
+.||+|+||.||+|+. .+|+.||+|+++............+.+|++++++++||||+++++++..++..|+||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~ 80 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCC
Confidence 4799999999999995 478999999998544333344457889999999999999999999999999999999999999
Q ss_pred CHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccccccccCCCCCccccc
Q 002721 690 TLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSKGTASIS 769 (888)
Q Consensus 690 ~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 769 (888)
+|.+++.... .+++.++..++.||+.||+|||++||+||||||+||+++.++.+||+|||+++...... ....
T Consensus 81 ~L~~~l~~~~-----~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~--~~~~ 153 (323)
T cd05571 81 ELFFHLSRER-----VFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG--ATMK 153 (323)
T ss_pred cHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC--Cccc
Confidence 9999987643 46788999999999999999999999999999999999999999999999987543221 1123
Q ss_pred ccccccceecccccccCCcCccccchhHHHHHHHHHhCCCCCCCCCCCccchhhhccccCCCCCCcccccccccccCCcC
Q 002721 770 AVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQILDARLSTVSFG 849 (888)
Q Consensus 770 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 849 (888)
...||+.|+|||++.+..++.++||||+||++|||++|+.||...... ....... ..... .
T Consensus 154 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~--~~~~~~~-------------~~~~~----~ 214 (323)
T cd05571 154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE--KLFELIL-------------MEEIR----F 214 (323)
T ss_pred ceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHH--HHHHHHH-------------cCCCC----C
Confidence 457999999999999999999999999999999999999999753211 1111100 00000 0
Q ss_pred cHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 002721 850 WRKEMLTALKVALLCTDSTPAKRP-----KMKKVVE 880 (888)
Q Consensus 850 ~~~~~~~~~~li~~cl~~dP~~RP-----s~~evl~ 880 (888)
......++.+++.+||+.||++|| ++.++++
T Consensus 215 p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 250 (323)
T cd05571 215 PRTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIME 250 (323)
T ss_pred CCCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHc
Confidence 112345677899999999999999 7888875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-40 Score=342.25 Aligned_cols=256 Identities=21% Similarity=0.220 Sum_probs=200.7
Q ss_pred HHHhcCCcceeeecccceEEEEEe-CCCcEEEEEEeeccChhhhH-----------HHHHHHHHHHHHhccCCCceeeee
Q 002721 603 VKATMKDSNMIYCGTFSTVYKAVM-PSGLILSVKRLKSMDRTIIH-----------HQNKMIRELEKLSKLCHDNLVRPI 670 (888)
Q Consensus 603 ~~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~-----------~~~~~~~E~~~l~~l~hpnIv~~~ 670 (888)
.-+.|++.+.||+|.||.|-+|+. .+++.||+|++.+....... ..++..+|+.+|++++|||||+++
T Consensus 95 ~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~Li 174 (576)
T KOG0585|consen 95 QLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLI 174 (576)
T ss_pred ehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEE
Confidence 456899999999999999999994 47999999999754332111 124789999999999999999999
Q ss_pred eEEEeC--CeeEEEEecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCc
Q 002721 671 GFVIYE--DVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKP 748 (888)
Q Consensus 671 ~~~~~~--~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~ 748 (888)
++..+. +..|+|+|||..|.+...-.. ...+++.+++.|+++++.||+|||.+|||||||||+|+|++++|++
T Consensus 175 EvLDDP~s~~~YlVley~s~G~v~w~p~d-----~~els~~~Ar~ylrDvv~GLEYLH~QgiiHRDIKPsNLLl~~~g~V 249 (576)
T KOG0585|consen 175 EVLDDPESDKLYLVLEYCSKGEVKWCPPD-----KPELSEQQARKYLRDVVLGLEYLHYQGIIHRDIKPSNLLLSSDGTV 249 (576)
T ss_pred EeecCcccCceEEEEEeccCCccccCCCC-----cccccHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEEcCCCcE
Confidence 998864 589999999998776432211 1127889999999999999999999999999999999999999999
Q ss_pred eEeccccccccCCC---CCcccccccccccceecccccccCC----cCccccchhHHHHHHHHHhCCCCCCCCCCCccch
Q 002721 749 LLGEIEISKLLDPS---KGTASISAVAGSFGYIPPEYAYTMQ----VTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDL 821 (888)
Q Consensus 749 kl~Dfg~a~~~~~~---~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~ 821 (888)
||+|||.+.....+ .........+||+.|+|||...++. .+.+.||||+||++|.|+.|+.||.+++.-
T Consensus 250 KIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~---- 325 (576)
T KOG0585|consen 250 KISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFEL---- 325 (576)
T ss_pred EeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHH----
Confidence 99999999876322 1122344578999999999887632 356889999999999999999999864321
Q ss_pred hhhccccCCCCCCcccccccccccCCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002721 822 VKWVHGAPARGETPEQILDARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVE 880 (888)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 880 (888)
...+++....+... ...++.+++.++++++|.+||++|.+..+|..
T Consensus 326 -----------~l~~KIvn~pL~fP--~~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~ 371 (576)
T KOG0585|consen 326 -----------ELFDKIVNDPLEFP--ENPEINEDLKDLIKRLLEKDPEQRITLPDIKL 371 (576)
T ss_pred -----------HHHHHHhcCcccCC--CcccccHHHHHHHHHHhhcChhheeehhhhee
Confidence 11222222222211 22345677889999999999999999998854
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=352.66 Aligned_cols=253 Identities=20% Similarity=0.242 Sum_probs=213.7
Q ss_pred HhcCCcceeeecccceEEEEEe-CCCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCCe-eEEE
Q 002721 605 ATMKDSNMIYCGTFSTVYKAVM-PSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDV-ALLL 682 (888)
Q Consensus 605 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~-~~lv 682 (888)
+.|...+++|+|+||.++.++. .+++.||+|.+.-..... ..++...+|+.++++++|||||.+++.|+.++. .+||
T Consensus 4 ~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t~-~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Iv 82 (426)
T KOG0589|consen 4 DNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLTE-PERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIV 82 (426)
T ss_pred chhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccCc-hhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEE
Confidence 4688899999999999999994 468899999998544433 334478899999999999999999999999887 9999
Q ss_pred EecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccccccccCCC
Q 002721 683 HNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPS 762 (888)
Q Consensus 683 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 762 (888)
|+||+||++.+.+.+.... .++++++..|+.|++.|++|||+++|+|||||+.||+++.++.|||+|||+|+.+...
T Consensus 83 m~Y~eGg~l~~~i~~~k~~---~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~ 159 (426)
T KOG0589|consen 83 MEYCEGGDLAQLIKEQKGV---LFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPE 159 (426)
T ss_pred EeecCCCCHHHHHHHHhhc---cccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhccccCceeecchhhhhhcCCc
Confidence 9999999999999987632 6789999999999999999999999999999999999999999999999999998765
Q ss_pred CCcccccccccccceecccccccCCcCccccchhHHHHHHHHHhCCCCCCCCCCCccchhhhccccCCCCCCcccccccc
Q 002721 763 KGTASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQILDAR 842 (888)
Q Consensus 763 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 842 (888)
... ....+||+.||.||.+.+.+|..|+||||+||++|||++-+++|...... ....++....
T Consensus 160 ~~~--a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~---------------~Li~ki~~~~ 222 (426)
T KOG0589|consen 160 DSL--ASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMS---------------ELILKINRGL 222 (426)
T ss_pred hhh--hheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchH---------------HHHHHHhhcc
Confidence 422 34678999999999999999999999999999999999999999764221 1111222222
Q ss_pred cccCCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002721 843 LSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEM 881 (888)
Q Consensus 843 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~ 881 (888)
... .......++..++..|++.+|+.||++.+++.+
T Consensus 223 ~~P---lp~~ys~el~~lv~~~l~~~P~~RPsa~~LL~~ 258 (426)
T KOG0589|consen 223 YSP---LPSMYSSELRSLVKSMLRKNPEHRPSALELLRR 258 (426)
T ss_pred CCC---CCccccHHHHHHHHHHhhcCCccCCCHHHHhhC
Confidence 222 234455677789999999999999999999875
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=357.98 Aligned_cols=248 Identities=19% Similarity=0.191 Sum_probs=202.1
Q ss_pred HHhcCCcceeeecccceEEEEEeC-CCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCCeeEEE
Q 002721 604 KATMKDSNMIYCGTFSTVYKAVMP-SGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVALLL 682 (888)
Q Consensus 604 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 682 (888)
..+|++.+.||+|+||.||+|+.. +++.||+|+++..........+.+.+|++++++++||||+++++++..++..|+|
T Consensus 17 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv 96 (329)
T PTZ00263 17 LSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFL 96 (329)
T ss_pred chheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEE
Confidence 357899999999999999999954 6899999999854433334456788999999999999999999999999999999
Q ss_pred EecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccccccccCCC
Q 002721 683 HNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPS 762 (888)
Q Consensus 683 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 762 (888)
|||+++|+|.+++.... .+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||++......
T Consensus 97 ~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~ 171 (329)
T PTZ00263 97 LEFVVGGELFTHLRKAG-----RFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR 171 (329)
T ss_pred EcCCCCChHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcCCC
Confidence 99999999999998653 4577888899999999999999999999999999999999999999999999876432
Q ss_pred CCcccccccccccceecccccccCCcCccccchhHHHHHHHHHhCCCCCCCCCCCccchhhhccccCCCCCCcccccccc
Q 002721 763 KGTASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQILDAR 842 (888)
Q Consensus 763 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 842 (888)
. ....||+.|+|||++.+..++.++|||||||++|||++|+.||...... ...+ .+....
T Consensus 172 ~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~--~~~~-------------~i~~~~ 231 (329)
T PTZ00263 172 T-----FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPF--RIYE-------------KILAGR 231 (329)
T ss_pred c-----ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHH--HHHH-------------HHhcCC
Confidence 2 2356899999999999999999999999999999999999999753211 1111 011111
Q ss_pred cccCCcCcHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHH
Q 002721 843 LSTVSFGWRKEMLTALKVALLCTDSTPAKRPK-----MKKVVE 880 (888)
Q Consensus 843 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs-----~~evl~ 880 (888)
.. . ......++.+++.+||+.||++||+ ++++++
T Consensus 232 ~~-~---p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~ 270 (329)
T PTZ00263 232 LK-F---PNWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKN 270 (329)
T ss_pred cC-C---CCCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhc
Confidence 00 0 0112345678999999999999997 577664
|
|
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=337.33 Aligned_cols=262 Identities=24% Similarity=0.292 Sum_probs=199.4
Q ss_pred hcCCcceeeecccceEEEEE-eCCCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCC-----ee
Q 002721 606 TMKDSNMIYCGTFSTVYKAV-MPSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYED-----VA 679 (888)
Q Consensus 606 ~~~~~~~ig~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-----~~ 679 (888)
.|...+++|+|+||.||+|. ..+++.||||++-..... --+|+++|+.+.|||||++.-+|.... +.
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~-------knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~l 97 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY-------KNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYL 97 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCc-------CcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHH
Confidence 57778999999999999999 446899999988644332 237999999999999999998887532 34
Q ss_pred EEEEecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCC-CCceEeccccccc
Q 002721 680 LLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDAD-FKPLLGEIEISKL 758 (888)
Q Consensus 680 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~-~~~kl~Dfg~a~~ 758 (888)
.+||||||. +|.++++...... .+++...++-+..||.+||+|||+.||+||||||+|+|+|.+ |.+||||||.|+.
T Consensus 98 nlVleymP~-tL~~~~r~~~~~~-~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~ 175 (364)
T KOG0658|consen 98 NLVLEYMPE-TLYRVIRHYTRAN-QRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLVDPDTGVLKICDFGSAKV 175 (364)
T ss_pred HHHHHhchH-HHHHHHHHHhhcC-CCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEEcCCCCeEEeccCCccee
Confidence 589999997 9999998632221 156667888999999999999999999999999999999977 9999999999999
Q ss_pred cCCCCCcccccccccccceecccccccC-CcCccccchhHHHHHHHHHhCCCCCCCCCCCccchhhh--ccccCCCCCCc
Q 002721 759 LDPSKGTASISAVAGSFGYIPPEYAYTM-QVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKW--VHGAPARGETP 835 (888)
Q Consensus 759 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~--~~~~~~~~~~~ 835 (888)
+..+... .....|..|+|||.+.+. .|+.+.||||.|||+.||+-|++-|.++... .+++.. +-+.+..+...
T Consensus 176 L~~~epn---iSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~-dQL~eIik~lG~Pt~e~I~ 251 (364)
T KOG0658|consen 176 LVKGEPN---ISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSV-DQLVEIIKVLGTPTREDIK 251 (364)
T ss_pred eccCCCc---eeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHH-HHHHHHHHHhCCCCHHHHh
Confidence 8766543 346678999999998876 5999999999999999999999999875332 122222 11222111100
Q ss_pred ------ccccccccccCC---cCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002721 836 ------EQILDARLSTVS---FGWRKEMLTALKVALLCTDSTPAKRPKMKKVVE 880 (888)
Q Consensus 836 ------~~~~~~~~~~~~---~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 880 (888)
.+...+.+...+ .......+++++++.+++.++|.+|.++.|++.
T Consensus 252 ~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~~~~~~l~ 305 (364)
T KOG0658|consen 252 SMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRLSALEALA 305 (364)
T ss_pred hcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcCCHHHHhc
Confidence 011111111111 122345678899999999999999999999875
|
|
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=360.72 Aligned_cols=264 Identities=21% Similarity=0.318 Sum_probs=206.4
Q ss_pred HHHhcCCcceeeecccceEEEEEe------CCCcEEEEEEeeccChhhhHHHHHHHHHHHHHhcc-CCCceeeeeeEEEe
Q 002721 603 VKATMKDSNMIYCGTFSTVYKAVM------PSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKL-CHDNLVRPIGFVIY 675 (888)
Q Consensus 603 ~~~~~~~~~~ig~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~ 675 (888)
..++|++.+.||+|+||.||+|+. .++..||||+++..... ...+.+.+|+++++.+ +||||+++++++..
T Consensus 33 ~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~~~--~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~ 110 (375)
T cd05104 33 PRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSAHL--TEREALMSELKVLSYLGNHINIVNLLGACTV 110 (375)
T ss_pred chHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCcCc--HHHHHHHHHHHHHHHhcCCcceeeeeeeecc
Confidence 356899999999999999999973 24668999999744322 2334788999999999 89999999999999
Q ss_pred CCeeEEEEecCCCCCHHHHhhccCCC------------------------------------------------------
Q 002721 676 EDVALLLHNYLPNGTLAQLLHESTKQ------------------------------------------------------ 701 (888)
Q Consensus 676 ~~~~~lv~e~~~~g~L~~~l~~~~~~------------------------------------------------------ 701 (888)
.+..++||||+++|+|.++++.....
T Consensus 111 ~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (375)
T cd05104 111 GGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVR 190 (375)
T ss_pred CCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccc
Confidence 99999999999999999999753210
Q ss_pred ----------------CCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccccccccCCCCCc
Q 002721 702 ----------------PDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSKGT 765 (888)
Q Consensus 702 ----------------~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 765 (888)
....+++..+..++.||++||+|||++||+||||||+||+++.++.+||+|||++.........
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~ 270 (375)
T cd05104 191 SGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY 270 (375)
T ss_pred cceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceeccCcccc
Confidence 0124688899999999999999999999999999999999999999999999999876543221
Q ss_pred ccccccccccceecccccccCCcCccccchhHHHHHHHHHh-CCCCCCCCCCCccchhhhccccCCCCCCcccccccccc
Q 002721 766 ASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILT-TRLPVEEDFGEGVDLVKWVHGAPARGETPEQILDARLS 844 (888)
Q Consensus 766 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 844 (888)
.......++..|+|||++.+..++.++|||||||++|||++ |..||....... ...+....... .
T Consensus 271 ~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~-~~~~~~~~~~~-------------~ 336 (375)
T cd05104 271 VVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDS-KFYKMIKEGYR-------------M 336 (375)
T ss_pred cccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchH-HHHHHHHhCcc-------------C
Confidence 11122345668999999999999999999999999999998 889986542221 11111111000 0
Q ss_pred cCCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHh
Q 002721 845 TVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEMLQEI 885 (888)
Q Consensus 845 ~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~i 885 (888)
. .......++.+++.+||+.||++|||++||++.|++.
T Consensus 337 ~---~~~~~~~~l~~li~~cl~~dP~~RPs~~eil~~l~~~ 374 (375)
T cd05104 337 L---SPECAPSEMYDIMKSCWDADPLKRPTFKQIVQLIEQQ 374 (375)
T ss_pred C---CCCCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHhh
Confidence 0 0011234678999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-40 Score=379.44 Aligned_cols=266 Identities=24% Similarity=0.351 Sum_probs=213.1
Q ss_pred HHHHhcCCcceeeecccceEEEEEeC--CCc----EEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEe
Q 002721 602 VVKATMKDSNMIYCGTFSTVYKAVMP--SGL----ILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIY 675 (888)
Q Consensus 602 ~~~~~~~~~~~ig~G~~g~Vy~~~~~--~~~----~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~ 675 (888)
+.....+..+.||+|.||.||+|... +|. .||+|.+++... .++...|.+|..+|++++|||||+++|++.+
T Consensus 689 v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~~~--~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~ 766 (1025)
T KOG1095|consen 689 VPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRLSS--EQEVSDFLKEALLMSKFDHPNIVSLIGVCLD 766 (1025)
T ss_pred CChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEeccccCC--HHHHHHHHHHHHHHhcCCCcceeeEEEeecC
Confidence 44567778899999999999999944 343 489998875433 3455699999999999999999999999999
Q ss_pred CCeeEEEEecCCCCCHHHHhhccCCCC--CCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEecc
Q 002721 676 EDVALLLHNYLPNGTLAQLLHESTKQP--DYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEI 753 (888)
Q Consensus 676 ~~~~~lv~e~~~~g~L~~~l~~~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Df 753 (888)
....++++|||++|||..||++.+..+ ...++..+.+.++.|||+|+.||+++++|||||..+|+|++....+||+||
T Consensus 767 ~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIaDF 846 (1025)
T KOG1095|consen 767 SGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIADF 846 (1025)
T ss_pred CCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEccc
Confidence 999999999999999999999874322 236788999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCCcccccccccccceecccccccCCcCccccchhHHHHHHHHHh-CCCCCCCCCCCccchhhhccccCCCC
Q 002721 754 EISKLLDPSKGTASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILT-TRLPVEEDFGEGVDLVKWVHGAPARG 832 (888)
Q Consensus 754 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~ 832 (888)
|+|+.+.............-...|||||.+.++.++.|+|||||||++||++| |..||........- ..+..+
T Consensus 847 GlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~PY~~~~n~~v~-~~~~~g----- 920 (1025)
T KOG1095|consen 847 GLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATPYPSRSNFEVL-LDVLEG----- 920 (1025)
T ss_pred chhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCCCCCcchHHHH-HHHHhC-----
Confidence 99995443332222112123468999999999999999999999999999999 89999765333211 001111
Q ss_pred CCcccccccccccCCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhhh
Q 002721 833 ETPEQILDARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEMLQEIKQ 887 (888)
Q Consensus 833 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 887 (888)
.++. .+......++++|..||+.+|++||++..+++++..+..
T Consensus 921 --------gRL~----~P~~CP~~ly~lM~~CW~~~pe~RP~F~~i~~q~~~i~~ 963 (1025)
T KOG1095|consen 921 --------GRLD----PPSYCPEKLYQLMLQCWKHDPEDRPSFRTIVEQDPAISN 963 (1025)
T ss_pred --------CccC----CCCCCChHHHHHHHHHccCChhhCccHHHHHhhhhhhhh
Confidence 1111 123344567899999999999999999999999988753
|
|
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=334.75 Aligned_cols=251 Identities=18% Similarity=0.236 Sum_probs=212.3
Q ss_pred HHHhcCCcceeeecccceEEEEE-eCCCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCCeeEE
Q 002721 603 VKATMKDSNMIYCGTFSTVYKAV-MPSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVALL 681 (888)
Q Consensus 603 ~~~~~~~~~~ig~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 681 (888)
.+-+|++.+.+|+|.||.|-+|+ ...|+.||||.+++....+.+..-.+.+|++||+.++||||+.+|++|+..+...+
T Consensus 51 lkHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvi 130 (668)
T KOG0611|consen 51 LKHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVI 130 (668)
T ss_pred hhhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEE
Confidence 35589999999999999999999 46899999999987666666666689999999999999999999999999999999
Q ss_pred EEecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccccccccCC
Q 002721 682 LHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDP 761 (888)
Q Consensus 682 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~~~ 761 (888)
||||..+|.|++|+.+.+ .+++.++..+++||+.|+.|+|.++++|||||.+|||+|+++.+||+|||++..+..
T Consensus 131 vMEYaS~GeLYDYiSer~-----~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~~ 205 (668)
T KOG0611|consen 131 VMEYASGGELYDYISERG-----SLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYAD 205 (668)
T ss_pred EEEecCCccHHHHHHHhc-----cccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCCCCeeeeccchhhhhcc
Confidence 999999999999999876 567899999999999999999999999999999999999999999999999998765
Q ss_pred CCCcccccccccccceecccccccCCc-CccccchhHHHHHHHHHhCCCCCCCCCCCccchhhhccccCCCCCCcccccc
Q 002721 762 SKGTASISAVAGSFGYIPPEYAYTMQV-TAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQILD 840 (888)
Q Consensus 762 ~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 840 (888)
.. ....++|++-|.+||++.+.+| ++.+|-||+||++|.++.|..||++... ..+++.+......
T Consensus 206 ~k---fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dh--k~lvrQIs~GaYr--------- 271 (668)
T KOG0611|consen 206 KK---FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDH--KRLVRQISRGAYR--------- 271 (668)
T ss_pred cc---HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchH--HHHHHHhhccccc---------
Confidence 44 3457899999999999999887 5689999999999999999999986421 1222222111111
Q ss_pred cccccCCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002721 841 ARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEM 881 (888)
Q Consensus 841 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~ 881 (888)
..+.+..+.-+|.+|+..||++|-|+.+|...
T Consensus 272 ---------EP~~PSdA~gLIRwmLmVNP~RRATieDiAsH 303 (668)
T KOG0611|consen 272 ---------EPETPSDASGLIRWMLMVNPERRATIEDIASH 303 (668)
T ss_pred ---------CCCCCchHHHHHHHHHhcCcccchhHHHHhhh
Confidence 01112245678999999999999999998753
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=360.31 Aligned_cols=265 Identities=21% Similarity=0.320 Sum_probs=207.1
Q ss_pred HHHhcCCcceeeecccceEEEEEeC------CCcEEEEEEeeccChhhhHHHHHHHHHHHHHhcc-CCCceeeeeeEEEe
Q 002721 603 VKATMKDSNMIYCGTFSTVYKAVMP------SGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKL-CHDNLVRPIGFVIY 675 (888)
Q Consensus 603 ~~~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~ 675 (888)
..++|++.+.||+|+||.||+|+.. ++..||+|+++..... .....+.+|+++++.+ +||||+++++++..
T Consensus 36 ~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~ 113 (374)
T cd05106 36 PRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASAHT--DEREALMSELKILSHLGQHKNIVNLLGACTH 113 (374)
T ss_pred cHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCCCH--HHHHHHHHHHHHHHhhccCCceeeEeeEecC
Confidence 4568999999999999999999831 2458999999754332 2345788999999999 89999999999999
Q ss_pred CCeeEEEEecCCCCCHHHHhhccCC-------------------------------------------------------
Q 002721 676 EDVALLLHNYLPNGTLAQLLHESTK------------------------------------------------------- 700 (888)
Q Consensus 676 ~~~~~lv~e~~~~g~L~~~l~~~~~------------------------------------------------------- 700 (888)
.+..++||||+++|+|.+++.....
T Consensus 114 ~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (374)
T cd05106 114 GGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQ 193 (374)
T ss_pred CCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccccc
Confidence 9999999999999999999864321
Q ss_pred ----------CCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccccccccCCCCCcccccc
Q 002721 701 ----------QPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSKGTASISA 770 (888)
Q Consensus 701 ----------~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 770 (888)
.....+++.++.+++.||++||+|||++||+||||||+||++++++.+||+|||+++.............
T Consensus 194 ~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~ 273 (374)
T cd05106 194 SSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGN 273 (374)
T ss_pred cccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccC
Confidence 0112468889999999999999999999999999999999999999999999999986543322111122
Q ss_pred cccccceecccccccCCcCccccchhHHHHHHHHHh-CCCCCCCCCCCccchhhhccccCCCCCCcccccccccccCCcC
Q 002721 771 VAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILT-TRLPVEEDFGEGVDLVKWVHGAPARGETPEQILDARLSTVSFG 849 (888)
Q Consensus 771 ~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 849 (888)
..++..|+|||++.+..++.++|||||||++|||++ |+.||....... .......... ... .
T Consensus 274 ~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~-~~~~~~~~~~--------------~~~--~ 336 (374)
T cd05106 274 ARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNS-KFYKMVKRGY--------------QMS--R 336 (374)
T ss_pred CCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccH-HHHHHHHccc--------------Ccc--C
Confidence 345668999999988899999999999999999997 999997643221 1111111000 000 0
Q ss_pred cHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhh
Q 002721 850 WRKEMLTALKVALLCTDSTPAKRPKMKKVVEMLQEIK 886 (888)
Q Consensus 850 ~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~i~ 886 (888)
......++.+++.+||+.||++|||+.++++.|+++.
T Consensus 337 ~~~~~~~l~~li~~cl~~dp~~RPs~~~l~~~l~~~~ 373 (374)
T cd05106 337 PDFAPPEIYSIMKMCWNLEPTERPTFSQISQLIQRQL 373 (374)
T ss_pred CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHh
Confidence 0112356788999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-39 Score=347.38 Aligned_cols=268 Identities=20% Similarity=0.282 Sum_probs=203.7
Q ss_pred HHhcCCcceeeecccceEEEEEeC-----------------CCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCce
Q 002721 604 KATMKDSNMIYCGTFSTVYKAVMP-----------------SGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNL 666 (888)
Q Consensus 604 ~~~~~~~~~ig~G~~g~Vy~~~~~-----------------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnI 666 (888)
.++|++.+.||+|+||.||+|... ++..||+|.++.... ......+.+|++++++++||||
T Consensus 4 ~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~ni 81 (304)
T cd05096 4 RGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDAN--KNARNDFLKEVKILSRLKDPNI 81 (304)
T ss_pred hhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCCC--HHHHHHHHHHHHHHhhcCCCCe
Confidence 568999999999999999999743 234799999875432 2234578999999999999999
Q ss_pred eeeeeEEEeCCeeEEEEecCCCCCHHHHhhccCCC--------------CCCCCCHHHHHHHHHHHHHHHhhcccCCeee
Q 002721 667 VRPIGFVIYEDVALLLHNYLPNGTLAQLLHESTKQ--------------PDYRPDWPTRLSIAIGVAEGLAFLHHVAIIH 732 (888)
Q Consensus 667 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~--------------~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH 732 (888)
+++++++.+.+..++||||+++|+|.+++...... ....+++.++..++.||+.||+|||+.||+|
T Consensus 82 v~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~ivH 161 (304)
T cd05096 82 IRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVH 161 (304)
T ss_pred eEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCccc
Confidence 99999999999999999999999999998654211 1124678889999999999999999999999
Q ss_pred cCCCCCCeEeCCCCCceEeccccccccCCCCCcccccccccccceecccccccCCcCccccchhHHHHHHHHHh--CCCC
Q 002721 733 LDISSGNVLLDADFKPLLGEIEISKLLDPSKGTASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILT--TRLP 810 (888)
Q Consensus 733 rDlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt--g~~P 810 (888)
|||||+||+++.++.+||+|||+++...............++..|+|||++.+..++.++||||||+++|||++ +..|
T Consensus 162 ~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p 241 (304)
T cd05096 162 RDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQP 241 (304)
T ss_pred cCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCC
Confidence 99999999999999999999999986544322222223456788999999988899999999999999999987 5677
Q ss_pred CCCCCCCccchhhhccccCCCCCCcccccccccccCCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 002721 811 VEEDFGEGVDLVKWVHGAPARGETPEQILDARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEMLQE 884 (888)
Q Consensus 811 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~ 884 (888)
|....... ............. .... .. ........+.+++.+||+.||++|||+.||.+.|++
T Consensus 242 ~~~~~~~~--~~~~~~~~~~~~~--~~~~----~~---~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~~~l~~ 304 (304)
T cd05096 242 YGELTDEQ--VIENAGEFFRDQG--RQVY----LF---RPPPCPQGLYELMLQCWSRDCRERPSFSDIHAFLTE 304 (304)
T ss_pred CCcCCHHH--HHHHHHHHhhhcc--cccc----cc---CCCCCCHHHHHHHHHHccCCchhCcCHHHHHHHHhC
Confidence 76532211 1111100000000 0000 00 011223567889999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-39 Score=330.73 Aligned_cols=256 Identities=20% Similarity=0.227 Sum_probs=213.5
Q ss_pred HHhcCCcceeeecccceEEEEEeC-CCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCCeeEEE
Q 002721 604 KATMKDSNMIYCGTFSTVYKAVMP-SGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVALLL 682 (888)
Q Consensus 604 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 682 (888)
-..|+..+.||+|.-|+||+|+.. ++..+|+|++.+......+...+...|-+||+.++||.++.+|+.++.++..|+|
T Consensus 76 l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~ 155 (459)
T KOG0610|consen 76 LRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLV 155 (459)
T ss_pred HHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEE
Confidence 457888999999999999999965 4699999999987777777777899999999999999999999999999999999
Q ss_pred EecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccccccccCC-
Q 002721 683 HNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDP- 761 (888)
Q Consensus 683 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~~~- 761 (888)
||||+||+|....+++.. ..+++..+..++.+|+-||+|||-.|||+|||||+||||.++|++-|+||.++.....
T Consensus 156 meyCpGGdL~~LrqkQp~---~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENILvredGHIMLsDFDLS~~~~~~ 232 (459)
T KOG0610|consen 156 MEYCPGGDLHSLRQKQPG---KRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVS 232 (459)
T ss_pred EecCCCccHHHHHhhCCC---CccchhhHHHHHHHHHHHHHHHHhhceeeccCCcceeEEecCCcEEeeeccccccCCCC
Confidence 999999999999887544 3789999999999999999999999999999999999999999999999998654310
Q ss_pred --------------------------------C-CC--------------------cccccccccccceecccccccCCc
Q 002721 762 --------------------------------S-KG--------------------TASISAVAGSFGYIPPEYAYTMQV 788 (888)
Q Consensus 762 --------------------------------~-~~--------------------~~~~~~~~gt~~y~aPE~~~~~~~ 788 (888)
. .. ......++||-.|.|||++.+...
T Consensus 233 Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GH 312 (459)
T KOG0610|consen 233 PTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGH 312 (459)
T ss_pred CeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCC
Confidence 0 00 011235789999999999999999
Q ss_pred CccccchhHHHHHHHHHhCCCCCCCCCCCccchhhhccccCCCCCCcccccccccccCCcCcHHHHHHHHHHHhhccCCC
Q 002721 789 TAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQILDARLSTVSFGWRKEMLTALKVALLCTDST 868 (888)
Q Consensus 789 ~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~d 868 (888)
+.++|+|+|||++|||+.|..||.+...+ ++...++...+... .....+..+.++|++.|.+|
T Consensus 313 gsAVDWWtfGIflYEmLyG~TPFKG~~~~---------------~Tl~NIv~~~l~Fp--~~~~vs~~akDLIr~LLvKd 375 (459)
T KOG0610|consen 313 GSAVDWWTFGIFLYEMLYGTTPFKGSNNK---------------ETLRNIVGQPLKFP--EEPEVSSAAKDLIRKLLVKD 375 (459)
T ss_pred CchhhHHHHHHHHHHHHhCCCCcCCCCch---------------hhHHHHhcCCCcCC--CCCcchhHHHHHHHHHhccC
Confidence 99999999999999999999999876443 22333333322221 12255677889999999999
Q ss_pred CCCCCC----HHHHH
Q 002721 869 PAKRPK----MKKVV 879 (888)
Q Consensus 869 P~~RPs----~~evl 879 (888)
|.+|.. |+||-
T Consensus 376 P~kRlg~~rGA~eIK 390 (459)
T KOG0610|consen 376 PSKRLGSKRGAAEIK 390 (459)
T ss_pred hhhhhccccchHHhh
Confidence 999997 66653
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=336.95 Aligned_cols=268 Identities=24% Similarity=0.348 Sum_probs=206.8
Q ss_pred hcCCcceeeecccceEEEEEeCCCcEEEEEEeeccChhhhHHHHHHHHHHHHHhc--cCCCceeeeeeEEEeCC----ee
Q 002721 606 TMKDSNMIYCGTFSTVYKAVMPSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSK--LCHDNLVRPIGFVIYED----VA 679 (888)
Q Consensus 606 ~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~--l~hpnIv~~~~~~~~~~----~~ 679 (888)
.....++||+|+||.||+|+. +++.||||++...+. +.+..|-+|++. ++|+||++++++-.... ++
T Consensus 211 pl~l~eli~~Grfg~V~KaqL-~~~~VAVKifp~~~k------qs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~ey 283 (534)
T KOG3653|consen 211 PLQLLELIGRGRFGCVWKAQL-DNRLVAVKIFPEQEK------QSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEY 283 (534)
T ss_pred chhhHHHhhcCccceeehhhc-cCceeEEEecCHHHH------HHHHhHHHHHhccCccchhHHHhhchhccCCccccce
Confidence 345577899999999999998 569999999974332 367777777664 58999999999877655 89
Q ss_pred EEEEecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhccc---------CCeeecCCCCCCeEeCCCCCceE
Q 002721 680 LLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHH---------VAIIHLDISSGNVLLDADFKPLL 750 (888)
Q Consensus 680 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---------~~ivHrDlkp~NIll~~~~~~kl 750 (888)
++|+||.+.|+|.+|++.+ .++|....+|+..+++||+|||+ .+|+|||||++||||..|+++.|
T Consensus 284 wLVt~fh~kGsL~dyL~~n------tisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccI 357 (534)
T KOG3653|consen 284 WLVTEFHPKGSLCDYLKAN------TISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCI 357 (534)
T ss_pred eEEeeeccCCcHHHHHHhc------cccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEe
Confidence 9999999999999999976 57999999999999999999997 47999999999999999999999
Q ss_pred eccccccccCCCCCcccccccccccceecccccccCC-cC-----ccccchhHHHHHHHHHhCCCCCC-CCCCC-ccchh
Q 002721 751 GEIEISKLLDPSKGTASISAVAGSFGYIPPEYAYTMQ-VT-----APGNVYSYGVVLLEILTTRLPVE-EDFGE-GVDLV 822 (888)
Q Consensus 751 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~-----~~~DiwSlG~il~elltg~~P~~-~~~~~-~~~~~ 822 (888)
+|||+|..+..+.........+||.+|||||++.+.. +. .+.||||+|.|+|||+++..-+. +..++ ...+.
T Consensus 358 aDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe 437 (534)
T KOG3653|consen 358 ADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFE 437 (534)
T ss_pred eccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchh
Confidence 9999999998776665566789999999999987653 22 36899999999999999765543 22111 22223
Q ss_pred hhccccCCCCCCcccccccccc-cCCcCcH--HHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhh
Q 002721 823 KWVHGAPARGETPEQILDARLS-TVSFGWR--KEMLTALKVALLCTDSTPAKRPKMKKVVEMLQEIK 886 (888)
Q Consensus 823 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~--~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~i~ 886 (888)
..+...|..++..+.++..+.+ ..+..|. ..+..+.+.+..||+.||+.|.|+.=+-+++.++.
T Consensus 438 ~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA~Cv~eR~~~l~ 504 (534)
T KOG3653|consen 438 AEVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTAGCVEERMAELM 504 (534)
T ss_pred HHhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhhHHHHHHHHHHh
Confidence 3333333333222222222221 1222222 35667789999999999999999999999988774
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-40 Score=332.40 Aligned_cols=269 Identities=18% Similarity=0.222 Sum_probs=206.5
Q ss_pred HHhcCCcceeeecccceEEEEE-eCCCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEe-----CC
Q 002721 604 KATMKDSNMIYCGTFSTVYKAV-MPSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIY-----ED 677 (888)
Q Consensus 604 ~~~~~~~~~ig~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~-----~~ 677 (888)
...|...+.||+|+||.|+.|. ..+|+.||+|++...... ....++..||+++++.++|+||+.+++.+.. -.
T Consensus 21 ~~~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~F~~-~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~ 99 (359)
T KOG0660|consen 21 PRYYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNPFEN-QIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFN 99 (359)
T ss_pred cceecccccccCcceeeEEEEEEcCCCCEeehhhhhhhhhc-hHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccc
Confidence 4466668999999999999999 457999999998743322 2345688999999999999999999999875 34
Q ss_pred eeEEEEecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEecccccc
Q 002721 678 VALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISK 757 (888)
Q Consensus 678 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~ 757 (888)
..|+|+|+|+. ||.+.++... .++...+..+++|+++||.|+|+.+|+|||+||+|++++.+...||+|||+|+
T Consensus 100 DvYiV~elMet-DL~~iik~~~-----~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR 173 (359)
T KOG0660|consen 100 DVYLVFELMET-DLHQIIKSQQ-----DLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLLNADCDLKICDFGLAR 173 (359)
T ss_pred eeEEehhHHhh-HHHHHHHcCc-----cccHHHHHHHHHHHHHhcchhhcccccccccchhheeeccCCCEEecccccee
Confidence 78999999964 9999998764 36778999999999999999999999999999999999999999999999999
Q ss_pred ccCCCCCcccccccccccceecccccc-cCCcCccccchhHHHHHHHHHhCCCCCCCCCC-CccchhhhccccCCCCCCc
Q 002721 758 LLDPSKGTASISAVAGSFGYIPPEYAY-TMQVTAPGNVYSYGVVLLEILTTRLPVEEDFG-EGVDLVKWVHGAPARGETP 835 (888)
Q Consensus 758 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwSlG~il~elltg~~P~~~~~~-~~~~~~~~~~~~~~~~~~~ 835 (888)
..+........+..+.|.+|+|||++. ...|+.+.||||.|||+.||++|++-|.+... +...++-...+.+.. ...
T Consensus 174 ~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~-e~l 252 (359)
T KOG0660|consen 174 YLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQLILELLGTPSE-EDL 252 (359)
T ss_pred eccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCH-HHH
Confidence 886542333456788999999999875 45799999999999999999999999976422 112222222222211 111
Q ss_pred cccc--------ccccccCCcC----cHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002721 836 EQIL--------DARLSTVSFG----WRKEMLTALKVALLCTDSTPAKRPKMKKVVE 880 (888)
Q Consensus 836 ~~~~--------~~~~~~~~~~----~~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 880 (888)
..+. .......... .....+.+++++.+|+..||.+|+|++|+++
T Consensus 253 ~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRita~eAL~ 309 (359)
T KOG0660|consen 253 QKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRITAEEALA 309 (359)
T ss_pred HHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccCCHHHHhc
Confidence 1111 0000000011 1233467889999999999999999999986
|
|
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=352.31 Aligned_cols=242 Identities=19% Similarity=0.176 Sum_probs=194.5
Q ss_pred eeecccceEEEEEeC-CCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCCeeEEEEecCCCCCH
Q 002721 613 IYCGTFSTVYKAVMP-SGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVALLLHNYLPNGTL 691 (888)
Q Consensus 613 ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L 691 (888)
||+|+||.||+|+.. +++.||+|+++............+.+|++++++++||||+++++++..++..|+||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L 80 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGEL 80 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcH
Confidence 699999999999954 6889999999754333334455788999999999999999999999999999999999999999
Q ss_pred HHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccccccccCCCCCccccccc
Q 002721 692 AQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSKGTASISAV 771 (888)
Q Consensus 692 ~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~ 771 (888)
.+++.... .+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||+++....... .....
T Consensus 81 ~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~--~~~~~ 153 (312)
T cd05585 81 FHHLQREG-----RFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDD--KTNTF 153 (312)
T ss_pred HHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCC--ccccc
Confidence 99997643 467889999999999999999999999999999999999999999999999886432221 22345
Q ss_pred ccccceecccccccCCcCccccchhHHHHHHHHHhCCCCCCCCCCCccchhhhccccCCCCCCcccccccccccCCcCcH
Q 002721 772 AGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQILDARLSTVSFGWR 851 (888)
Q Consensus 772 ~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 851 (888)
.||+.|+|||++.+..++.++||||+||++|||++|+.||....... .... +..... ....
T Consensus 154 ~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~--~~~~-------------~~~~~~----~~~~ 214 (312)
T cd05585 154 CGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNE--MYRK-------------ILQEPL----RFPD 214 (312)
T ss_pred cCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHH--HHHH-------------HHcCCC----CCCC
Confidence 78999999999999999999999999999999999999997532211 1110 000000 0111
Q ss_pred HHHHHHHHHHhhccCCCCCCCCC---HHHHHH
Q 002721 852 KEMLTALKVALLCTDSTPAKRPK---MKKVVE 880 (888)
Q Consensus 852 ~~~~~~~~li~~cl~~dP~~RPs---~~evl~ 880 (888)
....++.+++.+||+.||++||+ +.|+++
T Consensus 215 ~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~ 246 (312)
T cd05585 215 GFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKN 246 (312)
T ss_pred cCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHc
Confidence 23356778999999999999985 556553
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=354.67 Aligned_cols=261 Identities=21% Similarity=0.287 Sum_probs=208.8
Q ss_pred HHhcCCcceeeecccceEEEEEeCC--C---cEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCCe
Q 002721 604 KATMKDSNMIYCGTFSTVYKAVMPS--G---LILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDV 678 (888)
Q Consensus 604 ~~~~~~~~~ig~G~~g~Vy~~~~~~--~---~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 678 (888)
.++....++||+|+||+||+|+... + ..||||..+...........++.+|+++|++++|||||++||+......
T Consensus 156 H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~P 235 (474)
T KOG0194|consen 156 HSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEP 235 (474)
T ss_pred ccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCc
Confidence 4455566999999999999999432 2 2389999886444555667799999999999999999999999999999
Q ss_pred eEEEEecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccccccc
Q 002721 679 ALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKL 758 (888)
Q Consensus 679 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~ 758 (888)
.|+|||+|.||+|.+++++... .++..++..++.+.|.||+|||++++|||||.++|+|++.++.+||+|||+++.
T Consensus 236 l~ivmEl~~gGsL~~~L~k~~~----~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAARNcL~~~~~~vKISDFGLs~~ 311 (474)
T KOG0194|consen 236 LMLVMELCNGGSLDDYLKKNKK----SLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAARNCLYSKKGVVKISDFGLSRA 311 (474)
T ss_pred cEEEEEecCCCcHHHHHHhCCC----CCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhHHHheecCCCeEEeCccccccC
Confidence 9999999999999999998754 478899999999999999999999999999999999999999999999999886
Q ss_pred cCCCCCcccccccccccceecccccccCCcCccccchhHHHHHHHHHh-CCCCCCCCCCCccchhhhccccCCCCCCccc
Q 002721 759 LDPSKGTASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILT-TRLPVEEDFGEGVDLVKWVHGAPARGETPEQ 837 (888)
Q Consensus 759 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 837 (888)
..... .......-...|+|||.+....|++++|||||||++||+++ |..||.+.... +...++.
T Consensus 312 ~~~~~--~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~--~v~~kI~----------- 376 (474)
T KOG0194|consen 312 GSQYV--MKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNY--EVKAKIV----------- 376 (474)
T ss_pred Cccee--eccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHH--HHHHHHH-----------
Confidence 54111 11111234578999999999999999999999999999999 88899865322 1111110
Q ss_pred ccccccccCCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhhh
Q 002721 838 ILDARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEMLQEIKQ 887 (888)
Q Consensus 838 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 887 (888)
........+ ...+..+..++.+||..||++||+|.++.+.++.+..
T Consensus 377 -~~~~r~~~~---~~~p~~~~~~~~~c~~~~p~~R~tm~~i~~~l~~~~~ 422 (474)
T KOG0194|consen 377 -KNGYRMPIP---SKTPKELAKVMKQCWKKDPEDRPTMSTIKKKLEALEK 422 (474)
T ss_pred -hcCccCCCC---CCCHHHHHHHHHHhccCChhhccCHHHHHHHHHHHHh
Confidence 001111111 1334556678889999999999999999999998753
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=312.59 Aligned_cols=264 Identities=19% Similarity=0.281 Sum_probs=211.8
Q ss_pred HHhcCCcceeeecccceEEEEE-eCCCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCC-----
Q 002721 604 KATMKDSNMIYCGTFSTVYKAV-MPSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYED----- 677 (888)
Q Consensus 604 ~~~~~~~~~ig~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~----- 677 (888)
.++|++.+.+|+|||+-||.++ ..+++.||+|++..... +..+...+|++..++++||||++++++...+.
T Consensus 20 ~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~~~---~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~ 96 (302)
T KOG2345|consen 20 NKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCHSQ---EDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKH 96 (302)
T ss_pred CceEEEeeeecCCCceeeeeecccCcccchhhheeeccch---HHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCce
Confidence 5689999999999999999999 67899999999986553 34458899999999999999999999876543
Q ss_pred eeEEEEecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCC--eeecCCCCCCeEeCCCCCceEecccc
Q 002721 678 VALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVA--IIHLDISSGNVLLDADFKPLLGEIEI 755 (888)
Q Consensus 678 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~~~~kl~Dfg~ 755 (888)
..|++++|+..|+|.+.+........ .+++.+++.|+.+|++||++||+.. ++||||||.||++.+++.+++.|||.
T Consensus 97 ~~yll~Pyy~~Gsl~d~i~~~k~kg~-~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D~GS 175 (302)
T KOG2345|consen 97 EAYLLLPYYKRGSLLDEIERLKIKGN-FVSEAQILWIFLGICRGLEALHEKEPPYAHRDIKPANILLSDSGLPVLMDLGS 175 (302)
T ss_pred eEEEEeehhccccHHHHHHHHhhcCC-ccCHHHHHHHHHHHHHHHHHHhccCCcccccCCCcceeEecCCCceEEEeccC
Confidence 58999999999999999987655443 6899999999999999999999987 99999999999999999999999999
Q ss_pred ccccCCCCC-------cccccccccccceecccccc---cCCcCccccchhHHHHHHHHHhCCCCCCCCCCCccchhhhc
Q 002721 756 SKLLDPSKG-------TASISAVAGSFGYIPPEYAY---TMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWV 825 (888)
Q Consensus 756 a~~~~~~~~-------~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~ 825 (888)
+....-.-. .+.......|..|+|||.+. +...+.++|||||||++|+|+.|..||+.....+..+.-
T Consensus 176 ~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaL-- 253 (302)
T KOG2345|consen 176 ATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLAL-- 253 (302)
T ss_pred ccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEE--
Confidence 886542110 11123456789999999875 345788999999999999999999999865443322211
Q ss_pred cccCCCCCCcccccccccccCCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhh
Q 002721 826 HGAPARGETPEQILDARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEMLQEIK 886 (888)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~i~ 886 (888)
.+..+.+... .....+..+.+++++|++.||.+||++.+++..++.+.
T Consensus 254 -----------Av~n~q~s~P--~~~~yse~l~~lik~mlqvdP~qRP~i~~ll~~~d~Li 301 (302)
T KOG2345|consen 254 -----------AVQNAQISIP--NSSRYSEALHQLIKSMLQVDPNQRPTIPELLSKLDDLI 301 (302)
T ss_pred -----------eeeccccccC--CCCCccHHHHHHHHHHhcCCcccCCCHHHHHHHHHhhc
Confidence 1111111111 11225667889999999999999999999999988764
|
|
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=354.42 Aligned_cols=249 Identities=17% Similarity=0.171 Sum_probs=201.6
Q ss_pred HHhcCCcceeeecccceEEEEEeC-C-CcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCCeeEE
Q 002721 604 KATMKDSNMIYCGTFSTVYKAVMP-S-GLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVALL 681 (888)
Q Consensus 604 ~~~~~~~~~ig~G~~g~Vy~~~~~-~-~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 681 (888)
.++|++.+.||+|+||.||+|... + +..||+|++...........+.+.+|+++++.++||||+++++++.+++..|+
T Consensus 29 ~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~l 108 (340)
T PTZ00426 29 YEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYL 108 (340)
T ss_pred hhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEE
Confidence 457999999999999999999843 3 46899999975433333445578899999999999999999999999999999
Q ss_pred EEecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccccccccCC
Q 002721 682 LHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDP 761 (888)
Q Consensus 682 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~~~ 761 (888)
||||+++|+|.+++.... .+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||++.....
T Consensus 109 v~Ey~~~g~L~~~i~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~ 183 (340)
T PTZ00426 109 VLEFVIGGEFFTFLRRNK-----RFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDT 183 (340)
T ss_pred EEeCCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEecCCCCeecCC
Confidence 999999999999997653 467889999999999999999999999999999999999999999999999987643
Q ss_pred CCCcccccccccccceecccccccCCcCccccchhHHHHHHHHHhCCCCCCCCCCCccchhhhccccCCCCCCccccccc
Q 002721 762 SKGTASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQILDA 841 (888)
Q Consensus 762 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 841 (888)
. .....||+.|+|||++.+..++.++||||+||++|||++|+.||....... .... +...
T Consensus 184 ~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~--~~~~-------------i~~~ 243 (340)
T PTZ00426 184 R-----TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLL--IYQK-------------ILEG 243 (340)
T ss_pred C-----cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHH--HHHH-------------HhcC
Confidence 2 124578999999999998889999999999999999999999997542210 0000 1111
Q ss_pred ccccCCcCcHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 002721 842 RLSTVSFGWRKEMLTALKVALLCTDSTPAKRP-----KMKKVVEM 881 (888)
Q Consensus 842 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RP-----s~~evl~~ 881 (888)
... .+ ......+.+++.+|++.||++|+ +++|+++.
T Consensus 244 ~~~-~p---~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h 284 (340)
T PTZ00426 244 IIY-FP---KFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEH 284 (340)
T ss_pred CCC-CC---CCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcC
Confidence 000 00 11224567899999999999995 88888753
|
|
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=328.86 Aligned_cols=272 Identities=20% Similarity=0.241 Sum_probs=210.3
Q ss_pred HHhcCCcceeeecccceEEEEE-eCCCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCc-eeeeeeEEEeCC----
Q 002721 604 KATMKDSNMIYCGTFSTVYKAV-MPSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDN-LVRPIGFVIYED---- 677 (888)
Q Consensus 604 ~~~~~~~~~ig~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpn-Iv~~~~~~~~~~---- 677 (888)
...|...++||+|.||+||+|+ ..+|+.||+|++.-.... +.......+|+.+++.++|+| |+++++++...+
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~~-EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~ 88 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFEE-EGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRG 88 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEeccccc-cCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccc
Confidence 4567778889999999999999 557999999999754332 222336789999999999999 999999999877
Q ss_pred --eeEEEEecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEecccc
Q 002721 678 --VALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEI 755 (888)
Q Consensus 678 --~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~ 755 (888)
..++|+||++. +|.+++....... ..++...++.++.||+.||+|||++||+||||||+||+|+++|.+||+|||+
T Consensus 89 ~~~l~lvfe~~d~-DL~~ymd~~~~~~-~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFGl 166 (323)
T KOG0594|consen 89 IGKLYLVFEFLDR-DLKKYMDSLPKKP-QGLPPRLIKSFMRQLLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFGL 166 (323)
T ss_pred cceEEEEEEeecc-cHHHHHHhccccc-cCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccch
Confidence 78999999976 9999998866432 2456678999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCcccccccccccceecccccccC-CcCccccchhHHHHHHHHHhCCCCCCCCCCCccchhhh--ccccCCCC
Q 002721 756 SKLLDPSKGTASISAVAGSFGYIPPEYAYTM-QVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKW--VHGAPARG 832 (888)
Q Consensus 756 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~--~~~~~~~~ 832 (888)
|+...-.. ...+..++|..|+|||++.+. .|++..||||+|||++||++++.-|.+.... .++.+. ..+.+...
T Consensus 167 Ara~~ip~--~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~-~ql~~If~~lGtP~e~ 243 (323)
T KOG0594|consen 167 ARAFSIPM--RTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEI-DQLFRIFRLLGTPNEK 243 (323)
T ss_pred HHHhcCCc--ccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHH-HHHHHHHHHcCCCCcc
Confidence 99765322 235677899999999999887 6999999999999999999999988765442 222221 22333333
Q ss_pred CCcccccccccccCCc------CcH----HHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002721 833 ETPEQILDARLSTVSF------GWR----KEMLTALKVALLCTDSTPAKRPKMKKVVEM 881 (888)
Q Consensus 833 ~~~~~~~~~~~~~~~~------~~~----~~~~~~~~li~~cl~~dP~~RPs~~evl~~ 881 (888)
.++....-+....... ... ...+...+++.+|++++|.+|.|++.++..
T Consensus 244 ~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~Sa~~al~h 302 (323)
T KOG0594|consen 244 DWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRISAKGALTH 302 (323)
T ss_pred CCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCcCHHHHhcC
Confidence 3333222111111000 111 112467899999999999999999999875
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=355.35 Aligned_cols=255 Identities=18% Similarity=0.167 Sum_probs=204.7
Q ss_pred hcCCcceeeecccceEEEEEeC-CCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCCeeEEEEe
Q 002721 606 TMKDSNMIYCGTFSTVYKAVMP-SGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVALLLHN 684 (888)
Q Consensus 606 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 684 (888)
+|++.+.||+|+||.||+|+.. +++.||+|+++............+.+|++++..++||||+++++++..++..|+|||
T Consensus 2 ~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e 81 (333)
T cd05600 2 DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAME 81 (333)
T ss_pred CcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEe
Confidence 6888999999999999999965 589999999985443333445578899999999999999999999999999999999
Q ss_pred cCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccccccccCCCCC
Q 002721 685 YLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSKG 764 (888)
Q Consensus 685 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 764 (888)
|+++|+|.+++.... .+++.++..++.||+.||+|||++||+||||||+||+++.++.+||+|||++.....
T Consensus 82 ~~~g~~L~~~l~~~~-----~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~--- 153 (333)
T cd05600 82 YVPGGDFRTLLNNLG-----VLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT--- 153 (333)
T ss_pred CCCCCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEEEeCcCCccccc---
Confidence 999999999997643 467789999999999999999999999999999999999999999999999986543
Q ss_pred cccccccccccceecccccccCCcCccccchhHHHHHHHHHhCCCCCCCCCCCccchhhhccccCCCCCCcccccccccc
Q 002721 765 TASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQILDARLS 844 (888)
Q Consensus 765 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 844 (888)
......||+.|+|||++.+..++.++||||+||++|||++|+.||........ ...+..... . ...+...
T Consensus 154 --~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~--~~~i~~~~~---~---~~~~~~~ 223 (333)
T cd05600 154 --YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNET--WENLKYWKE---T---LQRPVYD 223 (333)
T ss_pred --ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHH--HHHHHhccc---c---ccCCCCC
Confidence 12345789999999999999999999999999999999999999975432211 110000000 0 0000000
Q ss_pred cCCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002721 845 TVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEM 881 (888)
Q Consensus 845 ~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~ 881 (888)
. .......++.+++.+|+..+|++||+++|+++.
T Consensus 224 ~---~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h 257 (333)
T cd05600 224 D---PRFNLSDEAWDLITKLINDPSRRFGSLEDIKNH 257 (333)
T ss_pred c---cccccCHHHHHHHHHHhhChhhhcCCHHHHHhC
Confidence 0 001234567889999999999999999999864
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-39 Score=343.22 Aligned_cols=262 Identities=23% Similarity=0.347 Sum_probs=208.6
Q ss_pred HHhcCCcceeeecccceEEEEEeCC------CcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCC
Q 002721 604 KATMKDSNMIYCGTFSTVYKAVMPS------GLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYED 677 (888)
Q Consensus 604 ~~~~~~~~~ig~G~~g~Vy~~~~~~------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 677 (888)
..+|++.+.||+|+||.||+|.... ...||+|.++.... ......+.+|++++++++||||+++++++...+
T Consensus 4 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~~--~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~ 81 (283)
T cd05048 4 LSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAE--PKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQ 81 (283)
T ss_pred hHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCCC--HHHHHHHHHHHHHHHhcCCcccceEEEEEcCCC
Confidence 3578999999999999999998532 26799999874432 233457899999999999999999999999989
Q ss_pred eeEEEEecCCCCCHHHHhhccCCCCC-----------CCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCC
Q 002721 678 VALLLHNYLPNGTLAQLLHESTKQPD-----------YRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADF 746 (888)
Q Consensus 678 ~~~lv~e~~~~g~L~~~l~~~~~~~~-----------~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~ 746 (888)
..+++|||+++++|.+++.......+ ..+++.++..++.|++.||+|||++|++||||||+||++++++
T Consensus 82 ~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~~ 161 (283)
T cd05048 82 PTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGL 161 (283)
T ss_pred ceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCCC
Confidence 99999999999999999986533221 3578889999999999999999999999999999999999999
Q ss_pred CceEeccccccccCCCCCcccccccccccceecccccccCCcCccccchhHHHHHHHHHh-CCCCCCCCCCCccchhhhc
Q 002721 747 KPLLGEIEISKLLDPSKGTASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILT-TRLPVEEDFGEGVDLVKWV 825 (888)
Q Consensus 747 ~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~~~~~~~~~~~~~ 825 (888)
.+||+|||++................+++.|+|||.+.+..++.++|||||||++|||++ |..||...... +....+
T Consensus 162 ~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~~~~--~~~~~i 239 (283)
T cd05048 162 TVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQ--EVIEMI 239 (283)
T ss_pred cEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCCCHH--HHHHHH
Confidence 999999999986543322222234456788999999988899999999999999999998 99999754322 111111
Q ss_pred cccCCCCCCcccccccccccCCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHh
Q 002721 826 HGAPARGETPEQILDARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEMLQEI 885 (888)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~i 885 (888)
. ...... .....+.++.+++.+||+.||++||+++||++.|+++
T Consensus 240 ~-------------~~~~~~---~~~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~l~~~ 283 (283)
T cd05048 240 R-------------SRQLLP---CPEDCPARVYALMIECWNEIPARRPRFKDIHTRLRSW 283 (283)
T ss_pred H-------------cCCcCC---CcccCCHHHHHHHHHHccCChhhCcCHHHHHHHHhcC
Confidence 1 011111 1123346788999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-39 Score=350.69 Aligned_cols=245 Identities=20% Similarity=0.168 Sum_probs=197.7
Q ss_pred ceeeecccceEEEEEe-CCCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCCeeEEEEecCCCC
Q 002721 611 NMIYCGTFSTVYKAVM-PSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVALLLHNYLPNG 689 (888)
Q Consensus 611 ~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~g 689 (888)
+.||+|+||.||+|+. .+++.||+|++++...........+.+|+++++.++||||+++++++..++..|+||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g 80 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGG 80 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999995 468999999998544333344557889999999999999999999999999999999999999
Q ss_pred CHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccccccccCCCCCccccc
Q 002721 690 TLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSKGTASIS 769 (888)
Q Consensus 690 ~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 769 (888)
+|.+++.... .+++.++..++.||+.||+|||++||+||||||+||+++.++.+||+|||+++...... ....
T Consensus 81 ~L~~~l~~~~-----~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~--~~~~ 153 (328)
T cd05593 81 ELFFHLSRER-----VFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA--ATMK 153 (328)
T ss_pred CHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCcc--cccc
Confidence 9999887543 46888999999999999999999999999999999999999999999999987643221 1223
Q ss_pred ccccccceecccccccCCcCccccchhHHHHHHHHHhCCCCCCCCCCCccchhhhccccCCCCCCcccccccccccCCcC
Q 002721 770 AVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQILDARLSTVSFG 849 (888)
Q Consensus 770 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 849 (888)
...||+.|+|||++.+..++.++||||+||++|||++|+.||...... ....... .... . .
T Consensus 154 ~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~--~~~~~~~-------------~~~~-~---~ 214 (328)
T cd05593 154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE--KLFELIL-------------MEDI-K---F 214 (328)
T ss_pred cccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHH--HHHHHhc-------------cCCc-c---C
Confidence 457899999999999889999999999999999999999999753221 1111000 0000 0 0
Q ss_pred cHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 002721 850 WRKEMLTALKVALLCTDSTPAKRP-----KMKKVVEM 881 (888)
Q Consensus 850 ~~~~~~~~~~li~~cl~~dP~~RP-----s~~evl~~ 881 (888)
......++.+++.+||+.||++|| ++.|+++.
T Consensus 215 p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h 251 (328)
T cd05593 215 PRTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRH 251 (328)
T ss_pred CCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcC
Confidence 112235677899999999999997 88988753
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-39 Score=350.56 Aligned_cols=244 Identities=20% Similarity=0.187 Sum_probs=196.4
Q ss_pred ceeeecccceEEEEEe-CCCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCCeeEEEEecCCCC
Q 002721 611 NMIYCGTFSTVYKAVM-PSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVALLLHNYLPNG 689 (888)
Q Consensus 611 ~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~g 689 (888)
+.||+|+||.||+|+. .+|+.||+|+++............+.+|+++++.++||||+++++++...+..|+||||+++|
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGG 80 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCC
Confidence 4799999999999995 468999999998543333334457788999999999999999999999999999999999999
Q ss_pred CHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccccccccCCCCCccccc
Q 002721 690 TLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSKGTASIS 769 (888)
Q Consensus 690 ~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 769 (888)
+|.+++.... .+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||+++...... ....
T Consensus 81 ~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~--~~~~ 153 (323)
T cd05595 81 ELFFHLSRER-----VFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG--ATMK 153 (323)
T ss_pred cHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCC--Cccc
Confidence 9999887643 46788999999999999999999999999999999999999999999999987532221 1223
Q ss_pred ccccccceecccccccCCcCccccchhHHHHHHHHHhCCCCCCCCCCCccchhhhccccCCCCCCcccccccccccCCcC
Q 002721 770 AVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQILDARLSTVSFG 849 (888)
Q Consensus 770 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 849 (888)
...||+.|+|||++.+..++.++|||||||++|||++|+.||....... ..... ...... .
T Consensus 154 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~--~~~~~-------------~~~~~~-~--- 214 (323)
T cd05595 154 TFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER--LFELI-------------LMEEIR-F--- 214 (323)
T ss_pred cccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHH--HHHHH-------------hcCCCC-C---
Confidence 4578999999999999999999999999999999999999997532211 11100 000000 0
Q ss_pred cHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 002721 850 WRKEMLTALKVALLCTDSTPAKRP-----KMKKVVE 880 (888)
Q Consensus 850 ~~~~~~~~~~li~~cl~~dP~~RP-----s~~evl~ 880 (888)
.....+++.+++.+||+.||++|| ++.++++
T Consensus 215 p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~ 250 (323)
T cd05595 215 PRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 250 (323)
T ss_pred CCCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHc
Confidence 112235677899999999999998 7888765
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=336.20 Aligned_cols=264 Identities=17% Similarity=0.271 Sum_probs=211.9
Q ss_pred HhcCCcceeeecccceEEEEEe-CCCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCCeeEEEE
Q 002721 605 ATMKDSNMIYCGTFSTVYKAVM-PSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVALLLH 683 (888)
Q Consensus 605 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 683 (888)
++|++.+.||+|+||.||+|+. .+++.||+|.++............+.+|+++++.++||||+++++++...+..++||
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVL 81 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEE
Confidence 4688999999999999999994 478999999887544444445567889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccccccccCCCC
Q 002721 684 NYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSK 763 (888)
Q Consensus 684 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 763 (888)
||+++++|.+++....... ..+++..+..++.|++.||+|||++|++||||||+||+++.++.++++|||.+.......
T Consensus 82 e~~~~~~L~~~~~~~~~~~-~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~ 160 (267)
T cd08228 82 ELADAGDLSQMIKYFKKQK-RLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT 160 (267)
T ss_pred EecCCCcHHHHHHHhhhcc-CCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceeccchh
Confidence 9999999999886533221 146788999999999999999999999999999999999999999999999988765322
Q ss_pred CcccccccccccceecccccccCCcCccccchhHHHHHHHHHhCCCCCCCCCCCccchhhhccccCCCCCCccccccccc
Q 002721 764 GTASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQILDARL 843 (888)
Q Consensus 764 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 843 (888)
. ......++..|+|||.+.+..++.++||||+|+++|||++|+.||.............+.... .
T Consensus 161 ~--~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~-------------~ 225 (267)
T cd08228 161 T--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKIEQCD-------------Y 225 (267)
T ss_pred H--HHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHHHhcCC-------------C
Confidence 1 122346888999999998888999999999999999999999999654322111111111000 0
Q ss_pred ccCCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhh
Q 002721 844 STVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEMLQEIK 886 (888)
Q Consensus 844 ~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~i~ 886 (888)
.. .........+.+++.+||+.+|++||++.+|++.+++++
T Consensus 226 ~~--~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~~~~~~ 266 (267)
T cd08228 226 PP--LPTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQIAKQMH 266 (267)
T ss_pred CC--CChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHHHHHhc
Confidence 00 011233466789999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=338.77 Aligned_cols=257 Identities=16% Similarity=0.295 Sum_probs=204.3
Q ss_pred HHhcCCcceeeecccceEEEEEeC----CCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCCee
Q 002721 604 KATMKDSNMIYCGTFSTVYKAVMP----SGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVA 679 (888)
Q Consensus 604 ~~~~~~~~~ig~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 679 (888)
..+|++.+.||+|+||.||+|... .+..||+|.++..... ...+.+.+|+.++++++||||+++++++..++..
T Consensus 4 ~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 81 (266)
T cd05064 4 NKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGCSD--KQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTM 81 (266)
T ss_pred hHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCCCH--HHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCc
Confidence 467899999999999999999742 4678999998854322 2345789999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEecccccccc
Q 002721 680 LLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLL 759 (888)
Q Consensus 680 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~ 759 (888)
++||||+++|+|.+++..... .+++.+++.++.|++.||+|||++|++||||||+||+++.++.+|++|||.+...
T Consensus 82 ~lv~e~~~~~~L~~~l~~~~~----~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~ 157 (266)
T cd05064 82 MIVTEYMSNGALDSFLRKHEG----QLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQED 157 (266)
T ss_pred EEEEEeCCCCcHHHHHHhCCC----CCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhhEEEcCCCcEEECCCcccccc
Confidence 999999999999999976432 5788999999999999999999999999999999999999999999999987654
Q ss_pred CCCCCcccccccccccceecccccccCCcCccccchhHHHHHHHHHh-CCCCCCCCCCCccchhhhccccCCCCCCcccc
Q 002721 760 DPSKGTASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILT-TRLPVEEDFGEGVDLVKWVHGAPARGETPEQI 838 (888)
Q Consensus 760 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 838 (888)
..... .......++..|+|||.+.+..++.++|||||||++||+++ |+.||....... ..+.....
T Consensus 158 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~--~~~~~~~~---------- 224 (266)
T cd05064 158 KSEAI-YTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQD--VIKAVEDG---------- 224 (266)
T ss_pred cccch-hcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH--HHHHHHCC----------
Confidence 32211 11112335678999999999999999999999999999775 999997543221 11111100
Q ss_pred cccccccCCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHh
Q 002721 839 LDARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEMLQEI 885 (888)
Q Consensus 839 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~i 885 (888)
.... ........+.+++.+||+.+|++||+++||.+.|+++
T Consensus 225 ---~~~~---~~~~~~~~~~~li~~c~~~~p~~RP~~~~i~~~l~~~ 265 (266)
T cd05064 225 ---FRLP---APRNCPNLLHQLMLDCWQKERGERPRFSQIHSILSKM 265 (266)
T ss_pred ---CCCC---CCCCCCHHHHHHHHHHcCCCchhCCCHHHHHHHHHhh
Confidence 0000 1112335677899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=357.04 Aligned_cols=256 Identities=18% Similarity=0.191 Sum_probs=198.7
Q ss_pred hcCCcceeeecccceEEEEEe-CCCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCCeeEEEEe
Q 002721 606 TMKDSNMIYCGTFSTVYKAVM-PSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVALLLHN 684 (888)
Q Consensus 606 ~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 684 (888)
.|+..+.||+|+||+||+|+. .+++.||+|+++..........+.+.+|++++++++||||+++++++.+.+..|+|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E 81 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEe
Confidence 578899999999999999984 4689999999986544444445678999999999999999999999999999999999
Q ss_pred cCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccccccccCCCCC
Q 002721 685 YLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSKG 764 (888)
Q Consensus 685 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 764 (888)
|+++|+|.+++.... .+++..+..++.||+.||+|||+.||+||||||+||+++.++++||+|||++........
T Consensus 82 ~~~gg~L~~~l~~~~-----~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~ 156 (381)
T cd05626 82 YIPGGDMMSLLIRME-----VFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHN 156 (381)
T ss_pred cCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCCEEEeeCcCCcccccccc
Confidence 999999999997643 467788899999999999999999999999999999999999999999999764321000
Q ss_pred c---------------------------------------------ccccccccccceecccccccCCcCccccchhHHH
Q 002721 765 T---------------------------------------------ASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGV 799 (888)
Q Consensus 765 ~---------------------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~ 799 (888)
. ......+||+.|+|||++.+..++.++||||+||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~ 236 (381)
T cd05626 157 SKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGV 236 (381)
T ss_pred cccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhh
Confidence 0 0012357999999999999889999999999999
Q ss_pred HHHHHHhCCCCCCCCCCCccchhhhccccCCCCCCcccccccccccCCcCcHHHHHHHHHHHhh--ccCCCCCCCCCHHH
Q 002721 800 VLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQILDARLSTVSFGWRKEMLTALKVALL--CTDSTPAKRPKMKK 877 (888)
Q Consensus 800 il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~--cl~~dP~~RPs~~e 877 (888)
++|||++|+.||......... ........ .. ... ......+++.+++.+ |+..+|..||+++|
T Consensus 237 il~elltG~~Pf~~~~~~~~~-~~i~~~~~----~~------~~~----~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~ 301 (381)
T cd05626 237 ILFEMLVGQPPFLAPTPTETQ-LKVINWEN----TL------HIP----PQVKLSPEAVDLITKLCCSAEERLGRNGADD 301 (381)
T ss_pred HHHHHHhCCCCCcCCCHHHHH-HHHHcccc----cc------CCC----CCCCCCHHHHHHHHHHccCcccccCCCCHHH
Confidence 999999999999764322111 01000000 00 000 011123456677766 66677777999999
Q ss_pred HHHH
Q 002721 878 VVEM 881 (888)
Q Consensus 878 vl~~ 881 (888)
+++.
T Consensus 302 ~l~h 305 (381)
T cd05626 302 IKAH 305 (381)
T ss_pred HhcC
Confidence 9763
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=342.60 Aligned_cols=268 Identities=15% Similarity=0.138 Sum_probs=200.6
Q ss_pred hcCCcceeeecccceEEEEEeC-CCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCCeeEEEEe
Q 002721 606 TMKDSNMIYCGTFSTVYKAVMP-SGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVALLLHN 684 (888)
Q Consensus 606 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 684 (888)
+|++.+.||+|+||.||+|+.. +++.||+|+++..... ....+.+.+|++++++++||||+++++++..++..|+|||
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (287)
T cd07848 2 KFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEEN-EEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFE 80 (287)
T ss_pred CceEEEEecccCCEEEEEEEECCCCcEEEEEEEeccccc-ccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEe
Confidence 6889999999999999999964 6889999999754322 2334578899999999999999999999999999999999
Q ss_pred cCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccccccccCCCCC
Q 002721 685 YLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSKG 764 (888)
Q Consensus 685 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 764 (888)
|++++.+..+..... .+++..+..++.|++.||+|||+.||+||||||+||+++.++.+||+|||++........
T Consensus 81 ~~~~~~l~~~~~~~~-----~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~ 155 (287)
T cd07848 81 YVEKNMLELLEEMPN-----GVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSN 155 (287)
T ss_pred cCCCCHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccCccccccccc
Confidence 999877665543221 468889999999999999999999999999999999999999999999999987643221
Q ss_pred cccccccccccceecccccccCCcCccccchhHHHHHHHHHhCCCCCCCCCCCcc--chhhhccccCC-------CCCCc
Q 002721 765 TASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGV--DLVKWVHGAPA-------RGETP 835 (888)
Q Consensus 765 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~--~~~~~~~~~~~-------~~~~~ 835 (888)
.......|++.|+|||++.+..++.++||||+||++|||++|+.||........ .........+. .....
T Consensus 156 -~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (287)
T cd07848 156 -ANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRF 234 (287)
T ss_pred -ccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchh
Confidence 122345689999999999988899999999999999999999999976432110 00000000000 00000
Q ss_pred ccccccccccC----CcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002721 836 EQILDARLSTV----SFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVE 880 (888)
Q Consensus 836 ~~~~~~~~~~~----~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 880 (888)
.....+..... .........++.+++.+|++.||++|||++|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~~~~l~ 283 (287)
T cd07848 235 HGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLTEQCLN 283 (287)
T ss_pred cccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 00000000000 0001123456889999999999999999999885
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=354.47 Aligned_cols=205 Identities=20% Similarity=0.221 Sum_probs=177.4
Q ss_pred HhcCCcceeeecccceEEEEEe-CCCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCCeeEEEE
Q 002721 605 ATMKDSNMIYCGTFSTVYKAVM-PSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVALLLH 683 (888)
Q Consensus 605 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 683 (888)
++|+..+.||+|+||+||+|+. .+++.||+|++++...........+.+|+.++.+++||||+++++++.+....|+||
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~ 80 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIM 80 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEE
Confidence 3688899999999999999985 468999999998544333444457889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccccccccCCCC
Q 002721 684 NYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSK 763 (888)
Q Consensus 684 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 763 (888)
||+++|+|.+++.... .+++.++..++.|++.||+|||++||+||||||+||+++.++.+||+|||+++......
T Consensus 81 E~~~gg~L~~~l~~~~-----~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~ 155 (363)
T cd05628 81 EFLPGGDMMTLLMKKD-----TLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAH 155 (363)
T ss_pred cCCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCCEEEeeccCcccccccc
Confidence 9999999999997643 56889999999999999999999999999999999999999999999999987653211
Q ss_pred Cc---------------------------------ccccccccccceecccccccCCcCccccchhHHHHHHHHHhCCCC
Q 002721 764 GT---------------------------------ASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILTTRLP 810 (888)
Q Consensus 764 ~~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P 810 (888)
.. ......+||+.|+|||++.+..++.++|||||||++|||++|+.|
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~P 235 (363)
T cd05628 156 RTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPP 235 (363)
T ss_pred cccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCC
Confidence 00 001235799999999999999999999999999999999999999
Q ss_pred CCCC
Q 002721 811 VEED 814 (888)
Q Consensus 811 ~~~~ 814 (888)
|...
T Consensus 236 f~~~ 239 (363)
T cd05628 236 FCSE 239 (363)
T ss_pred CCCC
Confidence 9754
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=346.17 Aligned_cols=265 Identities=21% Similarity=0.258 Sum_probs=204.3
Q ss_pred HHhcCCcceeeecccceEEEEEeC-CCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCCeeEEE
Q 002721 604 KATMKDSNMIYCGTFSTVYKAVMP-SGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVALLL 682 (888)
Q Consensus 604 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 682 (888)
.++|+..+.||+|+||.||+|+.. ++..||+|.++.... ....+++.+|++++++++||||+++++++..++..++|
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv 81 (331)
T cd06649 4 DDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEIK--PAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC 81 (331)
T ss_pred cccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeecccC--HHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEE
Confidence 468999999999999999999954 688999999875322 22345799999999999999999999999999999999
Q ss_pred EecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccC-CeeecCCCCCCeEeCCCCCceEeccccccccCC
Q 002721 683 HNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHV-AIIHLDISSGNVLLDADFKPLLGEIEISKLLDP 761 (888)
Q Consensus 683 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~~~ 761 (888)
|||+++++|.+++.... .+++..+..++.|++.||.|||++ +|+||||||+||+++.++.+||+|||++.....
T Consensus 82 ~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~ 156 (331)
T cd06649 82 MEHMDGGSLDQVLKEAK-----RIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 156 (331)
T ss_pred eecCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEcCCCcEEEccCcccccccc
Confidence 99999999999997643 467888999999999999999985 699999999999999999999999999876543
Q ss_pred CCCcccccccccccceecccccccCCcCccccchhHHHHHHHHHhCCCCCCCCCCCccchhhhccccCCC--CCCc----
Q 002721 762 SKGTASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPAR--GETP---- 835 (888)
Q Consensus 762 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~--~~~~---- 835 (888)
.. .....|+..|+|||++.+..++.++|||||||++|||++|+.||....... +.......... ....
T Consensus 157 ~~----~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 230 (331)
T cd06649 157 SM----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKE--LEAIFGRPVVDGEEGEPHSIS 230 (331)
T ss_pred cc----cccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHhcccccccccCCccccC
Confidence 22 234568999999999999899999999999999999999999996432211 11110000000 0000
Q ss_pred -----------------------cccccccccc--CCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002721 836 -----------------------EQILDARLST--VSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEM 881 (888)
Q Consensus 836 -----------------------~~~~~~~~~~--~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~ 881 (888)
....+..... ..........++.+++.+||+.||++|||++|+++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rpt~~ell~h 301 (331)
T cd06649 231 PRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERADLKMLMNH 301 (331)
T ss_pred cccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCCCHHHHhcC
Confidence 0000000000 000011234678899999999999999999999874
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=342.16 Aligned_cols=267 Identities=18% Similarity=0.222 Sum_probs=199.1
Q ss_pred HhcCCcceeeecccceEEEEEeC-CCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCCeeEEEE
Q 002721 605 ATMKDSNMIYCGTFSTVYKAVMP-SGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVALLLH 683 (888)
Q Consensus 605 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 683 (888)
++|+..+.||+|+||.||+|+.. +++.||+|+++..... .....+.+|++++++++||||+++++++..++..++||
T Consensus 5 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~ 82 (288)
T cd07871 5 ETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEHEE--GAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVF 82 (288)
T ss_pred ccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccccC--CcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEE
Confidence 46889999999999999999954 6899999998743322 12236779999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccccccccCCCC
Q 002721 684 NYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSK 763 (888)
Q Consensus 684 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 763 (888)
||+++ +|.+++..... .+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||+++......
T Consensus 83 e~~~~-~l~~~l~~~~~----~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~ 157 (288)
T cd07871 83 EYLDS-DLKQYLDNCGN----LMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPT 157 (288)
T ss_pred eCCCc-CHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCC
Confidence 99985 99998875432 46788999999999999999999999999999999999999999999999997654322
Q ss_pred Ccccccccccccceeccccccc-CCcCccccchhHHHHHHHHHhCCCCCCCCCCCcc-chhhhccccCCCCCCc------
Q 002721 764 GTASISAVAGSFGYIPPEYAYT-MQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGV-DLVKWVHGAPARGETP------ 835 (888)
Q Consensus 764 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~-~~~~~~~~~~~~~~~~------ 835 (888)
. ......+++.|+|||++.+ ..++.++||||+||++|||++|+.||........ .......+.+......
T Consensus 158 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (288)
T cd07871 158 K--TYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNE 235 (288)
T ss_pred c--cccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccch
Confidence 1 1234567899999998865 5689999999999999999999999975432111 0000000111000000
Q ss_pred --ccccccccccCC--cCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002721 836 --EQILDARLSTVS--FGWRKEMLTALKVALLCTDSTPAKRPKMKKVVE 880 (888)
Q Consensus 836 --~~~~~~~~~~~~--~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 880 (888)
.....+.....+ ........++.+++.+|+.+||.+|||++|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~l~ 284 (288)
T cd07871 236 EFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAALR 284 (288)
T ss_pred hhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHHhc
Confidence 000000000000 000112356789999999999999999999985
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=347.93 Aligned_cols=247 Identities=21% Similarity=0.225 Sum_probs=194.7
Q ss_pred cCCcceeeecccceEEEEEe-CCCcEEEEEEeeccChhhhHHHHHHHHHHHHH---hccCCCceeeeeeEEEeCCeeEEE
Q 002721 607 MKDSNMIYCGTFSTVYKAVM-PSGLILSVKRLKSMDRTIIHHQNKMIRELEKL---SKLCHDNLVRPIGFVIYEDVALLL 682 (888)
Q Consensus 607 ~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l---~~l~hpnIv~~~~~~~~~~~~~lv 682 (888)
|++.+.||+|+||.||+|.. .+++.||+|+++..........+.+.+|++++ +.++||||+++++++...+..|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 66788999999999999995 46899999999854433333345667776655 566799999999999999999999
Q ss_pred EecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccccccccCCC
Q 002721 683 HNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPS 762 (888)
Q Consensus 683 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 762 (888)
|||+++++|..++... .+++.++..++.||+.||+|||++||+||||||+||+++.++.+||+|||+++.....
T Consensus 81 ~E~~~~~~L~~~~~~~------~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~ 154 (324)
T cd05589 81 MEYAAGGDLMMHIHTD------VFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGF 154 (324)
T ss_pred EcCCCCCcHHHHhhcC------CCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCC
Confidence 9999999999888642 5788999999999999999999999999999999999999999999999998754322
Q ss_pred CCcccccccccccceecccccccCCcCccccchhHHHHHHHHHhCCCCCCCCCCCccchhhhccccCCCCCCcccccccc
Q 002721 763 KGTASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQILDAR 842 (888)
Q Consensus 763 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 842 (888)
.. ......|++.|+|||++.+..++.++|||||||++|||++|+.||....... .... +....
T Consensus 155 ~~--~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~--~~~~-------------i~~~~ 217 (324)
T cd05589 155 GD--RTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEE--VFDS-------------IVNDE 217 (324)
T ss_pred CC--cccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHH--HHHH-------------HHhCC
Confidence 21 1234678999999999999999999999999999999999999997532211 1110 00000
Q ss_pred cccCCcCcHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 002721 843 LSTVSFGWRKEMLTALKVALLCTDSTPAKRP-----KMKKVVE 880 (888)
Q Consensus 843 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~RP-----s~~evl~ 880 (888)
.. ........+.+++.+||+.||++|| ++.++++
T Consensus 218 ~~----~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~ 256 (324)
T cd05589 218 VR----YPRFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKK 256 (324)
T ss_pred CC----CCCCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhh
Confidence 00 0111235667899999999999999 4666554
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=338.87 Aligned_cols=250 Identities=18% Similarity=0.178 Sum_probs=196.9
Q ss_pred eeecccceEEEEEe-CCCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCCeeEEEEecCCCCCH
Q 002721 613 IYCGTFSTVYKAVM-PSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVALLLHNYLPNGTL 691 (888)
Q Consensus 613 ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L 691 (888)
||+|+||+||+|.. .+++.||+|.+...........+.+..|++++++++||||+++.+++..++..|+||||+++|+|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L 80 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDL 80 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCH
Confidence 69999999999995 47899999998754433333445678899999999999999999999999999999999999999
Q ss_pred HHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccccccccCCCCCccccccc
Q 002721 692 AQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSKGTASISAV 771 (888)
Q Consensus 692 ~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~ 771 (888)
.+++....... ..+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||.+........ .....
T Consensus 81 ~~~~~~~~~~~-~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~--~~~~~ 157 (280)
T cd05608 81 RYHIYNVDEEN-PGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS--KTKGY 157 (280)
T ss_pred HHHHHhccccC-CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc--ccccc
Confidence 98886433221 2578899999999999999999999999999999999999999999999999987644322 12345
Q ss_pred ccccceecccccccCCcCccccchhHHHHHHHHHhCCCCCCCCCCCccchhhhccccCCCCCCcccccccccccCCcCcH
Q 002721 772 AGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQILDARLSTVSFGWR 851 (888)
Q Consensus 772 ~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 851 (888)
.||+.|+|||++.+..++.++||||+||++|||++|+.||......... ..... .+.... .....
T Consensus 158 ~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~-~~~~~----------~~~~~~----~~~~~ 222 (280)
T cd05608 158 AGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVEN-KELKQ----------RILNDS----VTYPD 222 (280)
T ss_pred CCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhH-HHHHH----------hhcccC----CCCcc
Confidence 7899999999999999999999999999999999999999753221100 00000 000000 00112
Q ss_pred HHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 002721 852 KEMLTALKVALLCTDSTPAKRP-----KMKKVVE 880 (888)
Q Consensus 852 ~~~~~~~~li~~cl~~dP~~RP-----s~~evl~ 880 (888)
.....+.+++.+||+.||++|| +++++++
T Consensus 223 ~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~ 256 (280)
T cd05608 223 KFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRT 256 (280)
T ss_pred cCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhc
Confidence 2345678899999999999999 6777765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=344.71 Aligned_cols=256 Identities=19% Similarity=0.235 Sum_probs=219.6
Q ss_pred HHHHhcCCcceeeecccceEEEEEeC-CCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccC-CCceeeeeeEEEeCCee
Q 002721 602 VVKATMKDSNMIYCGTFSTVYKAVMP-SGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLC-HDNLVRPIGFVIYEDVA 679 (888)
Q Consensus 602 ~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~ 679 (888)
-....|++.+.||+|.||.||+++.+ +|+.+|+|.+++.........+.+.+|+++|+++. |||||.++++|++....
T Consensus 32 ~~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~ 111 (382)
T KOG0032|consen 32 DIKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSV 111 (382)
T ss_pred cccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeE
Confidence 34667999999999999999999955 59999999998665544444568999999999998 99999999999999999
Q ss_pred EEEEecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCC----CCceEecccc
Q 002721 680 LLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDAD----FKPLLGEIEI 755 (888)
Q Consensus 680 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~----~~~kl~Dfg~ 755 (888)
++|||++.||.|.+.+... .+++.++..++.||+.|++|||+.||+|||+||+|+|+... +.+|++|||+
T Consensus 112 ~lvmEL~~GGeLfd~i~~~------~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGl 185 (382)
T KOG0032|consen 112 YLVMELCEGGELFDRIVKK------HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGL 185 (382)
T ss_pred EEEEEecCCchHHHHHHHc------cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCC
Confidence 9999999999999999875 27889999999999999999999999999999999999633 5799999999
Q ss_pred ccccCCCCCcccccccccccceecccccccCCcCccccchhHHHHHHHHHhCCCCCCCCCCCccchhhhccccCCCCCCc
Q 002721 756 SKLLDPSKGTASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETP 835 (888)
Q Consensus 756 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 835 (888)
+..... .......+||+.|+|||++.+..|+..+||||+|+++|.|++|.+||........ .
T Consensus 186 a~~~~~---~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~---------------~ 247 (382)
T KOG0032|consen 186 AKFIKP---GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEI---------------F 247 (382)
T ss_pred ceEccC---CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHH---------------H
Confidence 999875 2234678999999999999999999999999999999999999999987654322 1
Q ss_pred ccccccccccCCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002721 836 EQILDARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEM 881 (888)
Q Consensus 836 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~ 881 (888)
..+...........|......+.+++..|+..||.+|+|+.++++.
T Consensus 248 ~~i~~~~~~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~H 293 (382)
T KOG0032|consen 248 LAILRGDFDFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQH 293 (382)
T ss_pred HHHHcCCCCCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcC
Confidence 1333333344445667778889999999999999999999999873
|
|
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=353.85 Aligned_cols=257 Identities=18% Similarity=0.165 Sum_probs=202.5
Q ss_pred HHHhcCCcceeeecccceEEEEEe-CCCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCCeeEE
Q 002721 603 VKATMKDSNMIYCGTFSTVYKAVM-PSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVALL 681 (888)
Q Consensus 603 ~~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 681 (888)
..++|++.+.||+|+||.||+|+. .+++.||+|++++.........+.+.+|+.+++.++||||+++++++.+++..|+
T Consensus 41 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~l 120 (370)
T cd05596 41 KAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYM 120 (370)
T ss_pred CHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEE
Confidence 356899999999999999999995 4689999999975433333334467889999999999999999999999999999
Q ss_pred EEecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccccccccCC
Q 002721 682 LHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDP 761 (888)
Q Consensus 682 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~~~ 761 (888)
||||+++|+|.+++... .++...+..++.||+.||+|||++||+||||||+||+++.++.+||+|||.+.....
T Consensus 121 v~Ey~~gg~L~~~l~~~------~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~ 194 (370)
T cd05596 121 VMEYMPGGDLVNLMSNY------DIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDA 194 (370)
T ss_pred EEcCCCCCcHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEcCCCCEEEEeccceeeccC
Confidence 99999999999998753 356778889999999999999999999999999999999999999999999987643
Q ss_pred CCCcccccccccccceecccccccC----CcCccccchhHHHHHHHHHhCCCCCCCCCCCccchhhhccccCCCCCCccc
Q 002721 762 SKGTASISAVAGSFGYIPPEYAYTM----QVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQ 837 (888)
Q Consensus 762 ~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 837 (888)
... .......||+.|+|||++.+. .++.++|||||||++|||++|+.||....... ....
T Consensus 195 ~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~-~~~~-------------- 258 (370)
T cd05596 195 NGM-VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG-TYSK-------------- 258 (370)
T ss_pred CCc-ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHH-HHHH--------------
Confidence 221 122345799999999988653 47889999999999999999999997643211 0111
Q ss_pred ccccccccCCcCcHHHHHHHHHHHhhccCCCCCC--CCCHHHHHHH
Q 002721 838 ILDARLSTVSFGWRKEMLTALKVALLCTDSTPAK--RPKMKKVVEM 881 (888)
Q Consensus 838 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~--RPs~~evl~~ 881 (888)
+...............+.++.+++.+|++.+|++ ||+++|+++.
T Consensus 259 i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h 304 (370)
T cd05596 259 IMDHKNSLTFPDDIEISKQAKDLICAFLTDREVRLGRNGVDEIKSH 304 (370)
T ss_pred HHcCCCcCCCCCcCCCCHHHHHHHHHHccChhhccCCCCHHHHhcC
Confidence 1110000000011123467788999999999988 9999999753
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=352.02 Aligned_cols=265 Identities=19% Similarity=0.293 Sum_probs=207.6
Q ss_pred HHhcCCcceeeecccceEEEEEeC------CCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccC-CCceeeeeeEEEeC
Q 002721 604 KATMKDSNMIYCGTFSTVYKAVMP------SGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLC-HDNLVRPIGFVIYE 676 (888)
Q Consensus 604 ~~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~ 676 (888)
.++|.+.++||+|+||.||+|+.. .+..||||+++..... ...+.+.+|+++++++. ||||+++++++...
T Consensus 36 ~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~--~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~ 113 (400)
T cd05105 36 RDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPTARS--SEKQALMSELKIMTHLGPHLNIVNLLGACTKS 113 (400)
T ss_pred ccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCCCCh--HHHHHHHHHHHHHHhcCCCCCeeeEEEEEccC
Confidence 568889999999999999999842 2357999999754332 23457899999999996 99999999999999
Q ss_pred CeeEEEEecCCCCCHHHHhhccCCC-------------------------------------------------------
Q 002721 677 DVALLLHNYLPNGTLAQLLHESTKQ------------------------------------------------------- 701 (888)
Q Consensus 677 ~~~~lv~e~~~~g~L~~~l~~~~~~------------------------------------------------------- 701 (888)
+..|+||||+++|+|.+++......
T Consensus 114 ~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 193 (400)
T cd05105 114 GPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLE 193 (400)
T ss_pred CceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccchhhh
Confidence 9999999999999999998753210
Q ss_pred ------------------------------------CCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCC
Q 002721 702 ------------------------------------PDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDAD 745 (888)
Q Consensus 702 ------------------------------------~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~ 745 (888)
....+++.++..++.||++||+|||+++|+||||||+||+++++
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill~~~ 273 (400)
T cd05105 194 IKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQG 273 (400)
T ss_pred hhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEEeCC
Confidence 01246788889999999999999999999999999999999999
Q ss_pred CCceEeccccccccCCCCCcccccccccccceecccccccCCcCccccchhHHHHHHHHHh-CCCCCCCCCCCccchhhh
Q 002721 746 FKPLLGEIEISKLLDPSKGTASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILT-TRLPVEEDFGEGVDLVKW 824 (888)
Q Consensus 746 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~~~~~~~~~~~~ 824 (888)
+.+|++|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||........ ....
T Consensus 274 ~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~-~~~~ 352 (400)
T cd05105 274 KIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDST-FYNK 352 (400)
T ss_pred CEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHH-HHHH
Confidence 9999999999987643322222233456788999999988899999999999999999997 9999875422111 1111
Q ss_pred ccccCCCCCCcccccccccccCCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhhh
Q 002721 825 VHGAPARGETPEQILDARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEMLQEIKQ 887 (888)
Q Consensus 825 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 887 (888)
..... .. . ........+.+++.+||+.||++||++.++.+.|+++.+
T Consensus 353 ~~~~~----~~---------~---~~~~~~~~l~~li~~cl~~dP~~RPt~~~l~~~l~~l~~ 399 (400)
T cd05105 353 IKSGY----RM---------A---KPDHATQEVYDIMVKCWNSEPEKRPSFLHLSDIVESLLP 399 (400)
T ss_pred HhcCC----CC---------C---CCccCCHHHHHHHHHHCccCHhHCcCHHHHHHHHHHHcC
Confidence 10000 00 0 011234567889999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-38 Score=338.17 Aligned_cols=261 Identities=23% Similarity=0.348 Sum_probs=207.2
Q ss_pred HHhcCCcceeeecccceEEEEEeC------CCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCC
Q 002721 604 KATMKDSNMIYCGTFSTVYKAVMP------SGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYED 677 (888)
Q Consensus 604 ~~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 677 (888)
.++|.+.+.||+|+||.||+|+.. +++.||+|.++..... +..+.+.+|++++++++||||+++++++...+
T Consensus 4 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 81 (280)
T cd05049 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETASN--DARKDFEREAELLTNFQHENIVKFYGVCTEGD 81 (280)
T ss_pred hHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccCCH--HHHHHHHHHHHHHHhcCCCCchheeeEEecCC
Confidence 457888999999999999999853 3578999998754332 23458899999999999999999999999999
Q ss_pred eeEEEEecCCCCCHHHHhhccCC---------CCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCc
Q 002721 678 VALLLHNYLPNGTLAQLLHESTK---------QPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKP 748 (888)
Q Consensus 678 ~~~lv~e~~~~g~L~~~l~~~~~---------~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~ 748 (888)
..++||||+++++|.+++..... .....+++.++..++.|++.|++|||++|++||||||+||+++.++.+
T Consensus 82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~ 161 (280)
T cd05049 82 PPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVV 161 (280)
T ss_pred CeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCeE
Confidence 99999999999999999986532 112357888999999999999999999999999999999999999999
Q ss_pred eEeccccccccCCCCCcccccccccccceecccccccCCcCccccchhHHHHHHHHHh-CCCCCCCCCCCccchhhhccc
Q 002721 749 LLGEIEISKLLDPSKGTASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILT-TRLPVEEDFGEGVDLVKWVHG 827 (888)
Q Consensus 749 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~~~~~~~~~~~~~~~ 827 (888)
|++|||.+................+++.|+|||++.+..++.++|||||||++|||++ |+.||.....+. ......
T Consensus 162 kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~~~--~~~~~~- 238 (280)
T cd05049 162 KIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEE--VIECIT- 238 (280)
T ss_pred EECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCHHH--HHHHHH-
Confidence 9999999876533221111223345788999999999999999999999999999998 999997543221 111111
Q ss_pred cCCCCCCcccccccccccCCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 002721 828 APARGETPEQILDARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEMLQE 884 (888)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~ 884 (888)
...... ........+.+++.+||+.||++||++.|+++.|++
T Consensus 239 ------------~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~~l~~ 280 (280)
T cd05049 239 ------------QGRLLQ---RPRTCPSEVYDIMLGCWKRDPQQRINIKDIHERLQK 280 (280)
T ss_pred ------------cCCcCC---CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhhC
Confidence 000100 011234567899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-38 Score=344.91 Aligned_cols=243 Identities=22% Similarity=0.220 Sum_probs=191.1
Q ss_pred ceeeecccceEEEEEe-CCCcEEEEEEeeccChhhhHHHHHHHHHHHHHhcc-CCCceeeeeeEEEeCCeeEEEEecCCC
Q 002721 611 NMIYCGTFSTVYKAVM-PSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKL-CHDNLVRPIGFVIYEDVALLLHNYLPN 688 (888)
Q Consensus 611 ~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~lv~e~~~~ 688 (888)
+.||+|+||.||+|+. .+++.||+|+++..........+.+..|..++... +||||+++++++..++..|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~g 80 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 4799999999999995 46889999999854322233334566777777654 899999999999999999999999999
Q ss_pred CCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccccccccCCCCCcccc
Q 002721 689 GTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSKGTASI 768 (888)
Q Consensus 689 g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~ 768 (888)
|+|.+++.... .+++.++..++.|++.||+|||++||+||||||+||+++.++.+||+|||+++...... ...
T Consensus 81 g~L~~~~~~~~-----~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~--~~~ 153 (316)
T cd05592 81 GDLMFHIQSSG-----RFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE--GKA 153 (316)
T ss_pred CcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC--Ccc
Confidence 99999987643 46788999999999999999999999999999999999999999999999998643322 122
Q ss_pred cccccccceecccccccCCcCccccchhHHHHHHHHHhCCCCCCCCCCCccchhhhccccCCCCCCcccccccccccCCc
Q 002721 769 SAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQILDARLSTVSF 848 (888)
Q Consensus 769 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 848 (888)
....||+.|+|||++.+..++.++||||+||++|||++|+.||...... +....+... . ..
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~--~~~~~i~~~-------------~-~~--- 214 (316)
T cd05592 154 STFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDED--ELFDSILND-------------R-PH--- 214 (316)
T ss_pred ccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHH--HHHHHHHcC-------------C-CC---
Confidence 3457899999999999989999999999999999999999999754221 111110000 0 00
Q ss_pred CcHHHHHHHHHHHhhccCCCCCCCCCHH-HHH
Q 002721 849 GWRKEMLTALKVALLCTDSTPAKRPKMK-KVV 879 (888)
Q Consensus 849 ~~~~~~~~~~~li~~cl~~dP~~RPs~~-evl 879 (888)
.......++.+++.+||+.||++||++. +++
T Consensus 215 ~~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05592 215 FPRWISKEAKDCLSKLFERDPTKRLGVDGDIR 246 (316)
T ss_pred CCCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 0111234567899999999999999875 443
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-38 Score=332.72 Aligned_cols=251 Identities=19% Similarity=0.328 Sum_probs=202.0
Q ss_pred HhcCCcceeeecccceEEEEEeCCCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCCeeEEEEe
Q 002721 605 ATMKDSNMIYCGTFSTVYKAVMPSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVALLLHN 684 (888)
Q Consensus 605 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 684 (888)
++|++.+.||+|+||.||+|...++..+|+|.++..... .+.+.+|++++++++||||+++++++..++..++|||
T Consensus 4 ~~~~~~~~lg~G~~~~vy~~~~~~~~~~a~K~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e 79 (256)
T cd05114 4 SELTFMKELGSGQFGVVHLGKWRAQIKVAIKAINEGAMS----EEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTE 79 (256)
T ss_pred HHcEEeeEecCCcCceEEEEEeccCceEEEEecccCCcc----HHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEE
Confidence 568889999999999999999888889999988744322 2368899999999999999999999999999999999
Q ss_pred cCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccccccccCCCCC
Q 002721 685 YLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSKG 764 (888)
Q Consensus 685 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 764 (888)
|+++|+|.++++.... .+++..+..++.|++.||+|||++||+||||||+||++++++.+|++|||.+........
T Consensus 80 ~~~~~~L~~~~~~~~~----~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~ 155 (256)
T cd05114 80 FMENGCLLNYLRQRQG----KLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEY 155 (256)
T ss_pred cCCCCcHHHHHHhCcc----CCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCCce
Confidence 9999999999975432 478899999999999999999999999999999999999999999999999886543221
Q ss_pred cccccccccccceecccccccCCcCccccchhHHHHHHHHHh-CCCCCCCCCCCccchhhhccccCCCCCCccccccccc
Q 002721 765 TASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILT-TRLPVEEDFGEGVDLVKWVHGAPARGETPEQILDARL 843 (888)
Q Consensus 765 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 843 (888)
. ......++..|+|||++.+..++.++||||||+++|||++ |+.||...... +....+..... .
T Consensus 156 ~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~--~~~~~i~~~~~-------~----- 220 (256)
T cd05114 156 T-SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNY--EVVEMISRGFR-------L----- 220 (256)
T ss_pred e-ccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHH--HHHHHHHCCCC-------C-----
Confidence 1 1122345668999999988889999999999999999999 89999654221 11111111000 0
Q ss_pred ccCCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 002721 844 STVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEML 882 (888)
Q Consensus 844 ~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L 882 (888)
. ........+.+++.+||+.+|++||+++|+++.|
T Consensus 221 -~---~~~~~~~~~~~li~~c~~~~p~~Rps~~~l~~~l 255 (256)
T cd05114 221 -Y---RPKLASMTVYEVMYSCWHEKPEGRPTFAELLRAI 255 (256)
T ss_pred -C---CCCCCCHHHHHHHHHHccCCcccCcCHHHHHHhh
Confidence 0 0011234678999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=355.13 Aligned_cols=254 Identities=20% Similarity=0.192 Sum_probs=199.7
Q ss_pred hcCCcceeeecccceEEEEEeC-CCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCCeeEEEEe
Q 002721 606 TMKDSNMIYCGTFSTVYKAVMP-SGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVALLLHN 684 (888)
Q Consensus 606 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 684 (888)
+|+..+.||+|+||+||+|+.. +++.||||+++............+.+|+++++.++||||+++++++.+++..|+|||
T Consensus 2 ~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E 81 (364)
T cd05599 2 DFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIME 81 (364)
T ss_pred CceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEEC
Confidence 6888999999999999999954 689999999985433333444578899999999999999999999999999999999
Q ss_pred cCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccccccccCCCCC
Q 002721 685 YLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSKG 764 (888)
Q Consensus 685 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 764 (888)
|+++|+|.+++.... .+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||++........
T Consensus 82 ~~~~g~L~~~l~~~~-----~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~ 156 (364)
T cd05599 82 YLPGGDMMTLLMKKD-----TFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHR 156 (364)
T ss_pred CCCCcHHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEeecccceecccccc
Confidence 999999999997643 467889999999999999999999999999999999999999999999999876432110
Q ss_pred cc------------------------------------cccccccccceecccccccCCcCccccchhHHHHHHHHHhCC
Q 002721 765 TA------------------------------------SISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILTTR 808 (888)
Q Consensus 765 ~~------------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~ 808 (888)
.. .....+||+.|+|||++.+..++.++|||||||++|||++|.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~ 236 (364)
T cd05599 157 TEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGY 236 (364)
T ss_pred ccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCC
Confidence 00 011246999999999999989999999999999999999999
Q ss_pred CCCCCCCCCccchhhhccccCCCCCCcccccccccccCCcCcHHHHHHHHHHHhhccCCCCCCCCC---HHHHHH
Q 002721 809 LPVEEDFGEGVDLVKWVHGAPARGETPEQILDARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPK---MKKVVE 880 (888)
Q Consensus 809 ~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs---~~evl~ 880 (888)
.||........ ........ .. ... .......+++.+++.+|+. +|.+|++ +.|+++
T Consensus 237 ~Pf~~~~~~~~-~~~i~~~~----~~--------~~~--~~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~ 295 (364)
T cd05599 237 PPFCSDNPQET-YRKIINWK----ET--------LQF--PDEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKS 295 (364)
T ss_pred CCCCCCCHHHH-HHHHHcCC----Cc--------cCC--CCCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhc
Confidence 99975432110 00000000 00 000 0001123466788888886 9999998 888875
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=339.09 Aligned_cols=254 Identities=17% Similarity=0.165 Sum_probs=201.9
Q ss_pred hcCCcceeeecccceEEEEEe-CCCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCCeeEEEEe
Q 002721 606 TMKDSNMIYCGTFSTVYKAVM-PSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVALLLHN 684 (888)
Q Consensus 606 ~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 684 (888)
+|+..+.||+|+||+||++.. .+++.||+|.+.............+.+|++++++++||||+++++++..++..++|||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 80 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEe
Confidence 478889999999999999995 4689999999975443333333467889999999999999999999999999999999
Q ss_pred cCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccccccccCCCCC
Q 002721 685 YLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSKG 764 (888)
Q Consensus 685 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 764 (888)
|+++|+|.+++..... ..+++..+..++.|++.||+|||+.|++||||||+||++++++.++|+|||++........
T Consensus 81 ~~~~~~L~~~~~~~~~---~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~ 157 (285)
T cd05605 81 LMNGGDLKFHIYNMGN---PGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET 157 (285)
T ss_pred ccCCCcHHHHHHhcCc---CCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCCc
Confidence 9999999988865432 1578899999999999999999999999999999999999999999999999987543221
Q ss_pred cccccccccccceecccccccCCcCccccchhHHHHHHHHHhCCCCCCCCCCCccchhhhccccCCCCCCcccccccccc
Q 002721 765 TASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQILDARLS 844 (888)
Q Consensus 765 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 844 (888)
.....|+..|+|||++.+..++.++||||+||++|||++|+.||........ .+.+... ...
T Consensus 158 ---~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~--~~~~~~~----------~~~--- 219 (285)
T cd05605 158 ---IRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVK--REEVERR----------VKE--- 219 (285)
T ss_pred ---cccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhH--HHHHHHH----------hhh---
Confidence 2345689999999999888899999999999999999999999975322110 0000000 000
Q ss_pred cCCcCcHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 002721 845 TVSFGWRKEMLTALKVALLCTDSTPAKRP-----KMKKVVE 880 (888)
Q Consensus 845 ~~~~~~~~~~~~~~~li~~cl~~dP~~RP-----s~~evl~ 880 (888)
............+.+++.+||+.||++|| +++++++
T Consensus 220 ~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05605 220 DQEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKA 260 (285)
T ss_pred cccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhc
Confidence 00001122345678899999999999999 8888865
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-38 Score=341.53 Aligned_cols=259 Identities=18% Similarity=0.311 Sum_probs=203.7
Q ss_pred HHhcCCcceeeecccceEEEEEeC-CCc----EEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCCe
Q 002721 604 KATMKDSNMIYCGTFSTVYKAVMP-SGL----ILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDV 678 (888)
Q Consensus 604 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 678 (888)
..+|+..+.||+|+||.||+|++. +++ .||+|.++.... ....+++.+|+.+++.++||||++++|++..+ .
T Consensus 6 ~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~ 82 (316)
T cd05108 6 ETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS--PKANKEILDEAYVMASVDNPHVCRLLGICLTS-T 82 (316)
T ss_pred hhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEeccccCC--HHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-C
Confidence 467999999999999999999843 333 489999874322 23345788999999999999999999998764 5
Q ss_pred eEEEEecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccccccc
Q 002721 679 ALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKL 758 (888)
Q Consensus 679 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~ 758 (888)
.++|+||+++|+|.+++..... .+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||+++.
T Consensus 83 ~~~v~e~~~~g~l~~~l~~~~~----~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~ 158 (316)
T cd05108 83 VQLITQLMPFGCLLDYVREHKD----NIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKL 158 (316)
T ss_pred ceeeeecCCCCCHHHHHHhccc----cCCHHHHHHHHHHHHHHHHHHHhcCeeccccchhheEecCCCcEEEcccccccc
Confidence 7899999999999999986532 467889999999999999999999999999999999999999999999999987
Q ss_pred cCCCCCcccccccccccceecccccccCCcCccccchhHHHHHHHHHh-CCCCCCCCCCCccchhhhccccCCCCCCccc
Q 002721 759 LDPSKGTASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILT-TRLPVEEDFGEGVDLVKWVHGAPARGETPEQ 837 (888)
Q Consensus 759 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 837 (888)
..............++..|+|||++.+..++.++||||||+++|||++ |+.||.+.... +.........
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~--~~~~~~~~~~-------- 228 (316)
T cd05108 159 LGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS--EISSILEKGE-------- 228 (316)
T ss_pred ccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH--HHHHHHhCCC--------
Confidence 654333222223344678999999999999999999999999999998 99999753221 1111111000
Q ss_pred ccccccccCCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhhh
Q 002721 838 ILDARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEMLQEIKQ 887 (888)
Q Consensus 838 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 887 (888)
... .......++.+++.+||..||++||++.+++..+.++.+
T Consensus 229 ----~~~----~~~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~l~~~~~ 270 (316)
T cd05108 229 ----RLP----QPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 270 (316)
T ss_pred ----CCC----CCCCCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHc
Confidence 000 001122456789999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-38 Score=334.73 Aligned_cols=256 Identities=19% Similarity=0.325 Sum_probs=207.3
Q ss_pred HHhcCCcceeeecccceEEEEEeCCCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCCeeEEEE
Q 002721 604 KATMKDSNMIYCGTFSTVYKAVMPSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVALLLH 683 (888)
Q Consensus 604 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 683 (888)
.++|++.++||+|+||.||+|...++..||+|.+..... ..+.+.+|+.++++++||||+++++++...+..++||
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 80 (261)
T cd05072 5 RESIKLVKKLGAGQFGEVWMGYYNNSTKVAVKTLKPGTM----SVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIIT 80 (261)
T ss_pred hHHeEEeeecCCcCCceEEEEEecCCceEEEEEccCCch----hHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEE
Confidence 568999999999999999999987888999998874332 2347889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccccccccCCCC
Q 002721 684 NYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSK 763 (888)
Q Consensus 684 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 763 (888)
||+++++|.++++..... .+++.++..++.|++.||+|||+.+++||||||+||+++.++.++++|||.+.......
T Consensus 81 e~~~~~~L~~~l~~~~~~---~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~ 157 (261)
T cd05072 81 EYMAKGSLLDFLKSDEGG---KVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNE 157 (261)
T ss_pred ecCCCCcHHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEecCCCcEEECCCccceecCCCc
Confidence 999999999999764322 56888999999999999999999999999999999999999999999999998765432
Q ss_pred CcccccccccccceecccccccCCcCccccchhHHHHHHHHHh-CCCCCCCCCCCccchhhhccccCCCCCCcccccccc
Q 002721 764 GTASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILT-TRLPVEEDFGEGVDLVKWVHGAPARGETPEQILDAR 842 (888)
Q Consensus 764 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 842 (888)
.. ......++..|+|||++.+..++.++|||||||++|+|+| |+.||....... ....+......
T Consensus 158 ~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~--~~~~~~~~~~~----------- 223 (261)
T cd05072 158 YT-AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSD--VMSALQRGYRM----------- 223 (261)
T ss_pred ee-ccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHH--HHHHHHcCCCC-----------
Confidence 11 1223345678999999988889999999999999999998 999997542221 11111110000
Q ss_pred cccCCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHh
Q 002721 843 LSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEMLQEI 885 (888)
Q Consensus 843 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~i 885 (888)
. .......++.+++.+||..+|++||+++++.+.|+++
T Consensus 224 -~----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 261 (261)
T cd05072 224 -P----RMENCPDELYDIMKTCWKEKAEERPTFDYLQSVLDDF 261 (261)
T ss_pred -C----CCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHhcC
Confidence 0 0111234677899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=342.53 Aligned_cols=268 Identities=16% Similarity=0.223 Sum_probs=199.1
Q ss_pred HHhcCCcceeeecccceEEEEEeC-CCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCCeeEEE
Q 002721 604 KATMKDSNMIYCGTFSTVYKAVMP-SGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVALLL 682 (888)
Q Consensus 604 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 682 (888)
.++|++.+.||+|+||+||+|+.. +++.||+|+++...... ....+.+|+++++.++||||+++++++..++..++|
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~--~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv 81 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEEEG--TPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLV 81 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccccc--cchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEE
Confidence 357999999999999999999954 68999999987443221 223677899999999999999999999999999999
Q ss_pred EecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccccccccCCC
Q 002721 683 HNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPS 762 (888)
Q Consensus 683 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 762 (888)
|||++ +++.+++..... .++...+..++.||+.||+|||++||+||||||+||++++++.+||+|||++......
T Consensus 82 ~e~~~-~~l~~~~~~~~~----~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~ 156 (303)
T cd07869 82 FEYVH-TDLCQYMDKHPG----GLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVP 156 (303)
T ss_pred EECCC-cCHHHHHHhCCC----CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccCC
Confidence 99996 588888865432 4677889999999999999999999999999999999999999999999998764322
Q ss_pred CCcccccccccccceeccccccc-CCcCccccchhHHHHHHHHHhCCCCCCCCCCCccchhhhc--cccCCCCCCcc---
Q 002721 763 KGTASISAVAGSFGYIPPEYAYT-MQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWV--HGAPARGETPE--- 836 (888)
Q Consensus 763 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~--~~~~~~~~~~~--- 836 (888)
. .......+++.|+|||++.+ ..++.++||||+||++|||++|+.||.+.......+.... .+.+.......
T Consensus 157 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (303)
T cd07869 157 S--HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHS 234 (303)
T ss_pred C--ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhh
Confidence 1 11234568899999998765 4588899999999999999999999976432211111110 01111000000
Q ss_pred --ccccccccc-CCcCcH------HHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002721 837 --QILDARLST-VSFGWR------KEMLTALKVALLCTDSTPAKRPKMKKVVE 880 (888)
Q Consensus 837 --~~~~~~~~~-~~~~~~------~~~~~~~~li~~cl~~dP~~RPs~~evl~ 880 (888)
......... .+.... .....+.+++.+|++.||++|||++|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~~~~l~ 287 (303)
T cd07869 235 LPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSAQAALS 287 (303)
T ss_pred ccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCHHHHhc
Confidence 000000000 000000 11245778999999999999999999985
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=346.00 Aligned_cols=239 Identities=23% Similarity=0.219 Sum_probs=191.7
Q ss_pred ceeeecccceEEEEEeC-CCcEEEEEEeeccChhhhHHHHHHHHHHHHHhcc-CCCceeeeeeEEEeCCeeEEEEecCCC
Q 002721 611 NMIYCGTFSTVYKAVMP-SGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKL-CHDNLVRPIGFVIYEDVALLLHNYLPN 688 (888)
Q Consensus 611 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~lv~e~~~~ 688 (888)
+.||+|+||+||+|+.. +++.||+|++++.........+.+.+|.+++... +||||+++++++...+..|+||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~ 80 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNG 80 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCC
Confidence 47999999999999954 6899999999754333333445677888888876 699999999999999999999999999
Q ss_pred CCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccccccccCCCCCcccc
Q 002721 689 GTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSKGTASI 768 (888)
Q Consensus 689 g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~ 768 (888)
|+|.+++.... .+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||+++...... ...
T Consensus 81 g~L~~~i~~~~-----~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~--~~~ 153 (320)
T cd05590 81 GDLMFHIQKSR-----RFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG--KTT 153 (320)
T ss_pred chHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC--Ccc
Confidence 99999987653 46788999999999999999999999999999999999999999999999987643221 112
Q ss_pred cccccccceecccccccCCcCccccchhHHHHHHHHHhCCCCCCCCCCCccchhhhccccCCCCCCcccccccccccCCc
Q 002721 769 SAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQILDARLSTVSF 848 (888)
Q Consensus 769 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 848 (888)
....||+.|+|||++.+..++.++||||+||++|||++|+.||...... .....+. .....
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~--~~~~~i~-------------~~~~~---- 214 (320)
T cd05590 154 STFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENED--DLFEAIL-------------NDEVV---- 214 (320)
T ss_pred cccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHH--HHHHHHh-------------cCCCC----
Confidence 3457899999999999989999999999999999999999999754221 1111110 00000
Q ss_pred CcHHHHHHHHHHHhhccCCCCCCCCCH
Q 002721 849 GWRKEMLTALKVALLCTDSTPAKRPKM 875 (888)
Q Consensus 849 ~~~~~~~~~~~li~~cl~~dP~~RPs~ 875 (888)
.......++.+++.+|++.||++||++
T Consensus 215 ~~~~~~~~~~~li~~~L~~dP~~R~~~ 241 (320)
T cd05590 215 YPTWLSQDAVDILKAFMTKNPTMRLGS 241 (320)
T ss_pred CCCCCCHHHHHHHHHHcccCHHHCCCC
Confidence 011123567889999999999999998
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-38 Score=332.24 Aligned_cols=258 Identities=19% Similarity=0.331 Sum_probs=206.5
Q ss_pred HHhcCCcceeeecccceEEEEEeC----CCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCCee
Q 002721 604 KATMKDSNMIYCGTFSTVYKAVMP----SGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVA 679 (888)
Q Consensus 604 ~~~~~~~~~ig~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 679 (888)
.++|+..+.||+|+||.||+|++. +...||+|.++.... ......+.+|+.++++++||||+++++++...+..
T Consensus 3 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 80 (266)
T cd05033 3 PSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGSS--DKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPV 80 (266)
T ss_pred hHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCCC--hHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCce
Confidence 467999999999999999999853 246899998874432 22345788999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEecccccccc
Q 002721 680 LLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLL 759 (888)
Q Consensus 680 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~ 759 (888)
++||||+++++|.+++..... .+++.++..++.|++.||+|||+++|+||||||+||++++++.++++|||.+...
T Consensus 81 ~iv~e~~~~~~L~~~~~~~~~----~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~ 156 (266)
T cd05033 81 MIITEYMENGSLDKFLRENDG----KFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRL 156 (266)
T ss_pred EEEEEcCCCCCHHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEEcCCCCEEECccchhhcc
Confidence 999999999999999976432 5788999999999999999999999999999999999999999999999999987
Q ss_pred CCCCCcccccccccccceecccccccCCcCccccchhHHHHHHHHHh-CCCCCCCCCCCccchhhhccccCCCCCCcccc
Q 002721 760 DPSKGTASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILT-TRLPVEEDFGEGVDLVKWVHGAPARGETPEQI 838 (888)
Q Consensus 760 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 838 (888)
.............++..|+|||.+.+..++.++||||||+++|||++ |..||...... ..........
T Consensus 157 ~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~--~~~~~~~~~~--------- 225 (266)
T cd05033 157 EDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQ--DVIKAVEDGY--------- 225 (266)
T ss_pred cccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHH--HHHHHHHcCC---------
Confidence 52222211222345678999999998899999999999999999998 99999653221 1111111000
Q ss_pred cccccccCCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHh
Q 002721 839 LDARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEMLQEI 885 (888)
Q Consensus 839 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~i 885 (888)
... .....+..+.+++.+||+.+|++||+++|+++.|+++
T Consensus 226 ----~~~---~~~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~l~~~ 265 (266)
T cd05033 226 ----RLP---PPMDCPSALYQLMLDCWQKDRNERPTFSQIVSTLDKM 265 (266)
T ss_pred ----CCC---CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 000 0112235678999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-38 Score=337.88 Aligned_cols=263 Identities=21% Similarity=0.335 Sum_probs=208.0
Q ss_pred HHhcCCcceeeecccceEEEEEe------CCCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCC
Q 002721 604 KATMKDSNMIYCGTFSTVYKAVM------PSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYED 677 (888)
Q Consensus 604 ~~~~~~~~~ig~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 677 (888)
..+|.+.+.||+|+||.||++.. .++..+|+|.+..... ...+.+.+|++++++++||||+++++++...+
T Consensus 4 ~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 80 (288)
T cd05093 4 RHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDASD---NARKDFHREAELLTNLQHEHIVKFYGVCVEGD 80 (288)
T ss_pred hHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCcCH---HHHHHHHHHHHHHHhCCCCCcceEEEEEecCC
Confidence 46789999999999999999983 2356789998874432 23347889999999999999999999999999
Q ss_pred eeEEEEecCCCCCHHHHhhccCC--------CCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCce
Q 002721 678 VALLLHNYLPNGTLAQLLHESTK--------QPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPL 749 (888)
Q Consensus 678 ~~~lv~e~~~~g~L~~~l~~~~~--------~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~k 749 (888)
..++||||+++++|.+++..... .....+++.++..++.|++.||+|||++|++||||||+||++++++.+|
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~~k 160 (288)
T cd05093 81 PLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVK 160 (288)
T ss_pred ccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcEE
Confidence 99999999999999999975432 1112478999999999999999999999999999999999999999999
Q ss_pred EeccccccccCCCCCcccccccccccceecccccccCCcCccccchhHHHHHHHHHh-CCCCCCCCCCCccchhhhcccc
Q 002721 750 LGEIEISKLLDPSKGTASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILT-TRLPVEEDFGEGVDLVKWVHGA 828 (888)
Q Consensus 750 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~~~~~~~~~~~~~~~~ 828 (888)
++|||.+................++..|+|||++.+..++.++|||||||++|||++ |..||....... ....+.
T Consensus 161 l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~~~--~~~~i~-- 236 (288)
T cd05093 161 IGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNE--VIECIT-- 236 (288)
T ss_pred eccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHHH--
Confidence 999999986543322112223445778999999998899999999999999999998 999986543211 111110
Q ss_pred CCCCCCcccccccccccCCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhhh
Q 002721 829 PARGETPEQILDARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEMLQEIKQ 887 (888)
Q Consensus 829 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 887 (888)
....... ......++.+++.+||+.||.+|||+.|+.+.|+++.+
T Consensus 237 -----------~~~~~~~---~~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~~l~~~~~ 281 (288)
T cd05093 237 -----------QGRVLQR---PRTCPKEVYDLMLGCWQREPHMRLNIKEIHSLLQNLAK 281 (288)
T ss_pred -----------cCCcCCC---CCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHHHHH
Confidence 0000000 11123467899999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=355.15 Aligned_cols=255 Identities=16% Similarity=0.150 Sum_probs=197.7
Q ss_pred hcCCcceeeecccceEEEEEe-CCCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCCeeEEEEe
Q 002721 606 TMKDSNMIYCGTFSTVYKAVM-PSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVALLLHN 684 (888)
Q Consensus 606 ~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 684 (888)
+|++.+.||+|+||+||+|+. .+++.||+|++.+.........+.+.+|++++++++||||+++++++.+++..|+|||
T Consensus 2 ~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E 81 (377)
T cd05629 2 DFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIME 81 (377)
T ss_pred CceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEEe
Confidence 688899999999999999984 4789999999875443334445678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccccccccCCCCC
Q 002721 685 YLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSKG 764 (888)
Q Consensus 685 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 764 (888)
|+++|+|.+++.... .+++..+..++.|++.||+|||+.||+||||||+||+++.++.+|++|||+++.+.....
T Consensus 82 ~~~gg~L~~~l~~~~-----~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~ 156 (377)
T cd05629 82 FLPGGDLMTMLIKYD-----TFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHD 156 (377)
T ss_pred CCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEEeecccccccccccc
Confidence 999999999997643 467788899999999999999999999999999999999999999999999864321100
Q ss_pred c------------c---------------------------------cccccccccceecccccccCCcCccccchhHHH
Q 002721 765 T------------A---------------------------------SISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGV 799 (888)
Q Consensus 765 ~------------~---------------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~ 799 (888)
. . .....+||+.|+|||++.+..++.++||||+||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGv 236 (377)
T cd05629 157 SAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGA 236 (377)
T ss_pred cccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecch
Confidence 0 0 001246999999999999989999999999999
Q ss_pred HHHHHHhCCCCCCCCCCCccchhhhccccCCCCCCcccccccccccCCcCcHHHHHHHHHHHhhccCCCCCCC---CCHH
Q 002721 800 VLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQILDARLSTVSFGWRKEMLTALKVALLCTDSTPAKR---PKMK 876 (888)
Q Consensus 800 il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~R---Ps~~ 876 (888)
++|||++|..||........ +....... .. + .. +.......++.+++.+|+. +|.+| +++.
T Consensus 237 il~elltG~~Pf~~~~~~~~-~~~i~~~~----~~---~---~~----p~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~ 300 (377)
T cd05629 237 IMFECLIGWPPFCSENSHET-YRKIINWR----ET---L---YF----PDDIHLSVEAEDLIRRLIT-NAENRLGRGGAH 300 (377)
T ss_pred hhhhhhcCCCCCCCCCHHHH-HHHHHccC----Cc---c---CC----CCCCCCCHHHHHHHHHHhc-CHhhcCCCCCHH
Confidence 99999999999975432110 11110000 00 0 00 0111223567788889997 66665 5999
Q ss_pred HHHHH
Q 002721 877 KVVEM 881 (888)
Q Consensus 877 evl~~ 881 (888)
|+++.
T Consensus 301 ~~l~h 305 (377)
T cd05629 301 EIKSH 305 (377)
T ss_pred HHhcC
Confidence 98764
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-38 Score=332.39 Aligned_cols=264 Identities=19% Similarity=0.303 Sum_probs=212.1
Q ss_pred HhcCCcceeeecccceEEEEEe-CCCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCCeeEEEE
Q 002721 605 ATMKDSNMIYCGTFSTVYKAVM-PSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVALLLH 683 (888)
Q Consensus 605 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 683 (888)
++|++.+.||+|+||.||+|+. .+++.||||.+...........+.+.+|+++++.++||||+++++++..++..+++|
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 81 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVL 81 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEE
Confidence 3688889999999999999994 579999999887554444445568889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccccccccCCCC
Q 002721 684 NYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSK 763 (888)
Q Consensus 684 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 763 (888)
||+++++|.+++...... ...+++.+++.++.||++||+|||++|++|+||||+||+++.++.++++|||.+.......
T Consensus 82 e~~~~~~L~~~~~~~~~~-~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~ 160 (267)
T cd08229 82 ELADAGDLSRMIKHFKKQ-KRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT 160 (267)
T ss_pred EecCCCCHHHHHHHhhcc-CCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhccccCC
Confidence 999999999998753322 1257889999999999999999999999999999999999999999999999988764322
Q ss_pred CcccccccccccceecccccccCCcCccccchhHHHHHHHHHhCCCCCCCCCCCccchhhhccccCCCCCCccccccccc
Q 002721 764 GTASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQILDARL 843 (888)
Q Consensus 764 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 843 (888)
. ......++..|+|||++.+..++.++||||||+++|+|++|..||...........+... ....
T Consensus 161 ~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-------------~~~~ 225 (267)
T cd08229 161 T--AAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIE-------------QCDY 225 (267)
T ss_pred c--ccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhhhh-------------cCCC
Confidence 1 123456888999999998888999999999999999999999999653222111111100 0000
Q ss_pred ccCCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhh
Q 002721 844 STVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEMLQEIK 886 (888)
Q Consensus 844 ~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~i~ 886 (888)
.. .........+.+++.+||+.||++|||+.+|++.++++.
T Consensus 226 ~~--~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~~~~~~~ 266 (267)
T cd08229 226 PP--LPSDHYSEELRQLVNMCINPDPEKRPDITYVYDVAKRMH 266 (267)
T ss_pred CC--CCcccccHHHHHHHHHhcCCCcccCCCHHHHHHHHhhhc
Confidence 00 011234557889999999999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=350.89 Aligned_cols=254 Identities=18% Similarity=0.122 Sum_probs=201.8
Q ss_pred hcCCcceeeecccceEEEEEe-CCCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCCeeEEEEe
Q 002721 606 TMKDSNMIYCGTFSTVYKAVM-PSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVALLLHN 684 (888)
Q Consensus 606 ~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 684 (888)
+|++.+.||+|+||+||+|+. .+++.||+|+++..........+.+.+|+.+++.++||||+++++++.+.+..|+|||
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (330)
T cd05601 2 DFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVME 81 (330)
T ss_pred CceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEEC
Confidence 688899999999999999995 4689999999986544334445578899999999999999999999999999999999
Q ss_pred cCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccccccccCCCCC
Q 002721 685 YLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSKG 764 (888)
Q Consensus 685 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 764 (888)
|+++|+|.+++..... .+++..+..++.||+.||+|||+.||+||||||+||+++.++.+||+|||++........
T Consensus 82 ~~~~~~L~~~l~~~~~----~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~ 157 (330)
T cd05601 82 YQPGGDLLSLLNRYED----QFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKM 157 (330)
T ss_pred CCCCCCHHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCCCc
Confidence 9999999999986532 578889999999999999999999999999999999999999999999999987654322
Q ss_pred cccccccccccceecccccc------cCCcCccccchhHHHHHHHHHhCCCCCCCCCCCccchhhhccccCCCCCCcccc
Q 002721 765 TASISAVAGSFGYIPPEYAY------TMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQI 838 (888)
Q Consensus 765 ~~~~~~~~gt~~y~aPE~~~------~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 838 (888)
. ......||+.|+|||++. ...++.++|||||||++|||++|+.||........ ....... . .
T Consensus 158 ~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~-~~~i~~~-~---~----- 226 (330)
T cd05601 158 V-NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKT-YNNIMNF-Q---R----- 226 (330)
T ss_pred e-eeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHH-HHHHHcC-C---C-----
Confidence 1 123356899999999886 45678999999999999999999999975432110 1110000 0 0
Q ss_pred cccccccCCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002721 839 LDARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVE 880 (888)
Q Consensus 839 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 880 (888)
.. .. ........++.+++..|+. +|++||+++++++
T Consensus 227 ---~~-~~-~~~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~ 262 (330)
T cd05601 227 ---FL-KF-PEDPKVSSDFLDLIQSLLC-GQKERLGYEGLCC 262 (330)
T ss_pred ---cc-CC-CCCCCCCHHHHHHHHHHcc-ChhhCCCHHHHhC
Confidence 00 00 0111234567788899998 9999999999875
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=350.79 Aligned_cols=257 Identities=18% Similarity=0.168 Sum_probs=200.0
Q ss_pred HHHhcCCcceeeecccceEEEEEeC-CCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCCeeEE
Q 002721 603 VKATMKDSNMIYCGTFSTVYKAVMP-SGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVALL 681 (888)
Q Consensus 603 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 681 (888)
..++|++.+.||+|+||.||+|+.. +++.||+|++.+...........+.+|+.+++.++||||+++++++..++..|+
T Consensus 41 ~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~l 120 (370)
T cd05621 41 KAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYM 120 (370)
T ss_pred CHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEE
Confidence 3568999999999999999999954 689999999975433333334468899999999999999999999999999999
Q ss_pred EEecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccccccccCC
Q 002721 682 LHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDP 761 (888)
Q Consensus 682 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~~~ 761 (888)
||||+++|+|.+++... .+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||++.....
T Consensus 121 v~Ey~~gg~L~~~l~~~------~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~ 194 (370)
T cd05621 121 VMEYMPGGDLVNLMSNY------DVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDE 194 (370)
T ss_pred EEcCCCCCcHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEEecccceeccc
Confidence 99999999999999753 357788999999999999999999999999999999999999999999999987643
Q ss_pred CCCcccccccccccceecccccccCC----cCccccchhHHHHHHHHHhCCCCCCCCCCCccchhhhccccCCCCCCccc
Q 002721 762 SKGTASISAVAGSFGYIPPEYAYTMQ----VTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQ 837 (888)
Q Consensus 762 ~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 837 (888)
.. ........||+.|+|||++.+.. ++.++||||+||++|||++|+.||....... ....
T Consensus 195 ~~-~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~-~~~~-------------- 258 (370)
T cd05621 195 TG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVG-TYSK-------------- 258 (370)
T ss_pred CC-ceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHH-HHHH--------------
Confidence 22 11223567999999999986543 7889999999999999999999997542211 0111
Q ss_pred ccccccccCCcCcHHHHHHHHHHHhhccCCCCCC--CCCHHHHHHH
Q 002721 838 ILDARLSTVSFGWRKEMLTALKVALLCTDSTPAK--RPKMKKVVEM 881 (888)
Q Consensus 838 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~--RPs~~evl~~ 881 (888)
+.+.......+........+.+++.+|+..+|.+ ||++.|+++.
T Consensus 259 i~~~~~~~~~p~~~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~h 304 (370)
T cd05621 259 IMDHKNSLNFPEDVEISKHAKNLICAFLTDREVRLGRNGVEEIKQH 304 (370)
T ss_pred HHhCCcccCCCCcccCCHHHHHHHHHHccCchhccCCCCHHHHhcC
Confidence 1110000000011123455677888888755544 8899998764
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=347.57 Aligned_cols=244 Identities=18% Similarity=0.168 Sum_probs=195.9
Q ss_pred ceeeecccceEEEEEe-CCCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCCeeEEEEecCCCC
Q 002721 611 NMIYCGTFSTVYKAVM-PSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVALLLHNYLPNG 689 (888)
Q Consensus 611 ~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~g 689 (888)
+.||+|+||.||+|+. .+|+.||+|+++............+.+|+++++.++||||+++++++...+..|+||||+++|
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~ 80 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGG 80 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCC
Confidence 4699999999999994 478999999998543333334457788999999999999999999999999999999999999
Q ss_pred CHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhccc-CCeeecCCCCCCeEeCCCCCceEeccccccccCCCCCcccc
Q 002721 690 TLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHH-VAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSKGTASI 768 (888)
Q Consensus 690 ~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~ 768 (888)
+|.+++.... .+++.++..++.||+.||+|||+ +||+||||||+||+++.++.+||+|||+++....... ..
T Consensus 81 ~L~~~l~~~~-----~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~--~~ 153 (325)
T cd05594 81 ELFFHLSRER-----VFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA--TM 153 (325)
T ss_pred cHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc--cc
Confidence 9999887543 46889999999999999999997 8999999999999999999999999999875432211 12
Q ss_pred cccccccceecccccccCCcCccccchhHHHHHHHHHhCCCCCCCCCCCccchhhhccccCCCCCCcccccccccccCCc
Q 002721 769 SAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQILDARLSTVSF 848 (888)
Q Consensus 769 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 848 (888)
....||+.|+|||++.+..++.++||||+||++|||++|+.||.....+. ...... ..... .
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~--~~~~i~-------------~~~~~-~-- 215 (325)
T cd05594 154 KTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK--LFELIL-------------MEEIR-F-- 215 (325)
T ss_pred ccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHH--HHHHHh-------------cCCCC-C--
Confidence 34569999999999999999999999999999999999999997532211 111100 00000 0
Q ss_pred CcHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 002721 849 GWRKEMLTALKVALLCTDSTPAKRP-----KMKKVVE 880 (888)
Q Consensus 849 ~~~~~~~~~~~li~~cl~~dP~~RP-----s~~evl~ 880 (888)
.....+++.+++.+||+.||++|+ ++.++++
T Consensus 216 -p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~ 251 (325)
T cd05594 216 -PRTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQ 251 (325)
T ss_pred -CCCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhc
Confidence 111235677899999999999997 8998875
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=354.20 Aligned_cols=255 Identities=21% Similarity=0.223 Sum_probs=204.3
Q ss_pred hcCCcceeeecccceEEEEEeC-CCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCCeeEEEEe
Q 002721 606 TMKDSNMIYCGTFSTVYKAVMP-SGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVALLLHN 684 (888)
Q Consensus 606 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 684 (888)
+|++.+.||+|+||+||+|+.. +++.||+|+++............+.+|++++..++||||+++++++.+++..|+|||
T Consensus 2 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (350)
T cd05573 2 DFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVME 81 (350)
T ss_pred CceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEEc
Confidence 6888999999999999999954 699999999985443333445578899999999999999999999999999999999
Q ss_pred cCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccccccccCCCC-
Q 002721 685 YLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSK- 763 (888)
Q Consensus 685 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~~~~~- 763 (888)
|+++++|.+++.... .+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||++.......
T Consensus 82 ~~~~~~L~~~l~~~~-----~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~ 156 (350)
T cd05573 82 YMPGGDLMNLLIRKD-----VFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKD 156 (350)
T ss_pred CCCCCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCc
Confidence 999999999998652 56788999999999999999999999999999999999999999999999998765332
Q ss_pred --------------------------CcccccccccccceecccccccCCcCccccchhHHHHHHHHHhCCCCCCCCCCC
Q 002721 764 --------------------------GTASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGE 817 (888)
Q Consensus 764 --------------------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~ 817 (888)
.........||+.|+|||++.+..++.++|||||||++|||++|+.||......
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~ 236 (350)
T cd05573 157 REYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQ 236 (350)
T ss_pred ccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHH
Confidence 001123456899999999999999999999999999999999999999764321
Q ss_pred ccchhhhccccCCCCCCcccccccccccCCcCcHHHHHHHHHHHhhccCCCCCCCCC-HHHHHHH
Q 002721 818 GVDLVKWVHGAPARGETPEQILDARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPK-MKKVVEM 881 (888)
Q Consensus 818 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs-~~evl~~ 881 (888)
.. ........ .. . ... ......+++.+++.+|+. ||++||+ ++|+++.
T Consensus 237 ~~-~~~i~~~~----~~---~---~~p----~~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~h 285 (350)
T cd05573 237 ET-YNKIINWK----ES---L---RFP----PDPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSH 285 (350)
T ss_pred HH-HHHHhccC----Cc---c---cCC----CCCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcC
Confidence 10 00000000 00 0 000 001134567789999997 9999999 9999863
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-39 Score=311.00 Aligned_cols=255 Identities=18% Similarity=0.279 Sum_probs=215.4
Q ss_pred HHHhcCCcceeeecccceEEEEE-eCCCcEEEEEEeeccC-----hhhhHHHHHHHHHHHHHhcc-CCCceeeeeeEEEe
Q 002721 603 VKATMKDSNMIYCGTFSTVYKAV-MPSGLILSVKRLKSMD-----RTIIHHQNKMIRELEKLSKL-CHDNLVRPIGFVIY 675 (888)
Q Consensus 603 ~~~~~~~~~~ig~G~~g~Vy~~~-~~~~~~vavK~~~~~~-----~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~ 675 (888)
.-+.|...+.+|.|..++|.++. .++|+.+|+|++.... ....+..+.-.+|+.|++++ .||+|+++.++|+.
T Consensus 15 fy~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes 94 (411)
T KOG0599|consen 15 FYAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYES 94 (411)
T ss_pred HHhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccC
Confidence 44578888999999999999998 5578999999986321 12333445677899999999 59999999999999
Q ss_pred CCeeEEEEecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEecccc
Q 002721 676 EDVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEI 755 (888)
Q Consensus 676 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~ 755 (888)
+...++|+|.|+.|.|.|++.+.- .+++++..+|++|+.+|++|||.++|||||+||+|||++++.++||+|||+
T Consensus 95 ~sF~FlVFdl~prGELFDyLts~V-----tlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENILlddn~~i~isDFGF 169 (411)
T KOG0599|consen 95 DAFVFLVFDLMPRGELFDYLTSKV-----TLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENILLDDNMNIKISDFGF 169 (411)
T ss_pred cchhhhhhhhcccchHHHHhhhhe-----eecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhheeeccccceEEeccce
Confidence 999999999999999999998754 578899999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCcccccccccccceeccccccc------CCcCccccchhHHHHHHHHHhCCCCCCCCCCCccchhhhccccC
Q 002721 756 SKLLDPSKGTASISAVAGSFGYIPPEYAYT------MQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAP 829 (888)
Q Consensus 756 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~ 829 (888)
++.+.++. +....+|||+|.|||.+.. ..|+..+|+||+|+|||.++.|.+||.... .+
T Consensus 170 a~~l~~Ge---kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRk--Qm---------- 234 (411)
T KOG0599|consen 170 ACQLEPGE---KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRK--QM---------- 234 (411)
T ss_pred eeccCCch---hHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHH--HH----------
Confidence 99987655 3456899999999998753 358889999999999999999999997421 00
Q ss_pred CCCCCcccccccccccCCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002721 830 ARGETPEQILDARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVE 880 (888)
Q Consensus 830 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 880 (888)
.....+..+......+.|.+......+++.+|++.||.+|.|++|+++
T Consensus 235 ---lMLR~ImeGkyqF~speWadis~~~KdLIsrlLqVdp~~Ritake~La 282 (411)
T KOG0599|consen 235 ---LMLRMIMEGKYQFRSPEWADISATVKDLISRLLQVDPTKRITAKEALA 282 (411)
T ss_pred ---HHHHHHHhcccccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhc
Confidence 112234455555666778888999999999999999999999999986
|
|
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-38 Score=344.27 Aligned_cols=244 Identities=20% Similarity=0.197 Sum_probs=194.2
Q ss_pred ceeeecccceEEEEEe----CCCcEEEEEEeeccChh-hhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCCeeEEEEec
Q 002721 611 NMIYCGTFSTVYKAVM----PSGLILSVKRLKSMDRT-IIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVALLLHNY 685 (888)
Q Consensus 611 ~~ig~G~~g~Vy~~~~----~~~~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 685 (888)
+.||+|+||.||+|+. .+++.||+|+++..... .......+.+|+++++.++||||+++++++..++..|+||||
T Consensus 2 ~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~ 81 (323)
T cd05584 2 KVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEY 81 (323)
T ss_pred ceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeC
Confidence 6899999999999984 35789999999753221 122334678899999999999999999999999999999999
Q ss_pred CCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccccccccCCCCCc
Q 002721 686 LPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSKGT 765 (888)
Q Consensus 686 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 765 (888)
+++++|.+++.... .+.+..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||+++.......
T Consensus 82 ~~~~~L~~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~- 155 (323)
T cd05584 82 LSGGELFMHLEREG-----IFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT- 155 (323)
T ss_pred CCCchHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC-
Confidence 99999999997643 456788889999999999999999999999999999999999999999999875432221
Q ss_pred ccccccccccceecccccccCCcCccccchhHHHHHHHHHhCCCCCCCCCCCccchhhhccccCCCCCCccccccccccc
Q 002721 766 ASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQILDARLST 845 (888)
Q Consensus 766 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 845 (888)
......||+.|+|||++.+..++.++|||||||++|||++|+.||....... ... .+......
T Consensus 156 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~--~~~-------------~~~~~~~~- 218 (323)
T cd05584 156 -VTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKK--TID-------------KILKGKLN- 218 (323)
T ss_pred -cccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHH--HHH-------------HHHcCCCC-
Confidence 1234568999999999998889999999999999999999999997532211 000 01111100
Q ss_pred CCcCcHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 002721 846 VSFGWRKEMLTALKVALLCTDSTPAKRP-----KMKKVVE 880 (888)
Q Consensus 846 ~~~~~~~~~~~~~~li~~cl~~dP~~RP-----s~~evl~ 880 (888)
. ......++.+++.+||++||++|| +++++++
T Consensus 219 ~---~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~ 255 (323)
T cd05584 219 L---PPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQS 255 (323)
T ss_pred C---CCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhc
Confidence 0 111235677899999999999999 7887765
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=345.40 Aligned_cols=244 Identities=20% Similarity=0.213 Sum_probs=194.3
Q ss_pred ceeeecccceEEEEEeC-CCcEEEEEEeeccChhhhHHHHHHHHHHHHHhcc-CCCceeeeeeEEEeCCeeEEEEecCCC
Q 002721 611 NMIYCGTFSTVYKAVMP-SGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKL-CHDNLVRPIGFVIYEDVALLLHNYLPN 688 (888)
Q Consensus 611 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~lv~e~~~~ 688 (888)
+.||+|+||.||+|+.. +++.||+|+++..........+.+..|.+++..+ +||||+++++++..++..|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~ 80 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNG 80 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCC
Confidence 46999999999999954 5889999999854333333445677899998866 799999999999999999999999999
Q ss_pred CCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccccccccCCCCCcccc
Q 002721 689 GTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSKGTASI 768 (888)
Q Consensus 689 g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~ 768 (888)
|+|.+++.... .+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||++........ ..
T Consensus 81 ~~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~--~~ 153 (321)
T cd05591 81 GDLMFQIQRSR-----KFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV--TT 153 (321)
T ss_pred CcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeecccceecccCCc--cc
Confidence 99999987643 467889999999999999999999999999999999999999999999999876432221 12
Q ss_pred cccccccceecccccccCCcCccccchhHHHHHHHHHhCCCCCCCCCCCccchhhhccccCCCCCCcccccccccccCCc
Q 002721 769 SAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQILDARLSTVSF 848 (888)
Q Consensus 769 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 848 (888)
....||+.|+|||++.+..++.++||||+||++|||++|+.||....... ....+ ......
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~--~~~~i-------------~~~~~~---- 214 (321)
T cd05591 154 TTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDD--LFESI-------------LHDDVL---- 214 (321)
T ss_pred cccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHH--HHHHH-------------HcCCCC----
Confidence 34568999999999998899999999999999999999999997543211 11110 000000
Q ss_pred CcHHHHHHHHHHHhhccCCCCCCCC-------CHHHHHH
Q 002721 849 GWRKEMLTALKVALLCTDSTPAKRP-------KMKKVVE 880 (888)
Q Consensus 849 ~~~~~~~~~~~li~~cl~~dP~~RP-------s~~evl~ 880 (888)
.......++.+++.+|++.||++|| +++++++
T Consensus 215 ~p~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~ 253 (321)
T cd05591 215 YPVWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQ 253 (321)
T ss_pred CCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhc
Confidence 0011234677899999999999999 7777764
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=344.89 Aligned_cols=244 Identities=20% Similarity=0.192 Sum_probs=194.2
Q ss_pred hcCCcceeeecccceEEEEEeC-CCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCC-CceeeeeeEEEeCCeeEEEE
Q 002721 606 TMKDSNMIYCGTFSTVYKAVMP-SGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCH-DNLVRPIGFVIYEDVALLLH 683 (888)
Q Consensus 606 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h-pnIv~~~~~~~~~~~~~lv~ 683 (888)
+|++.+.||+|+||.||+|+.. +++.||+|+++..........+.+..|.+++..+.| ++|+++++++...+..|+||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 4788999999999999999954 578999999985433233344578889999999975 56888999999999999999
Q ss_pred ecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccccccccCCCC
Q 002721 684 NYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSK 763 (888)
Q Consensus 684 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 763 (888)
||+++|+|.+++.... .+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||++.......
T Consensus 81 E~~~~g~L~~~~~~~~-----~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~ 155 (324)
T cd05587 81 EYVNGGDLMYHIQQVG-----KFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG 155 (324)
T ss_pred cCCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCC
Confidence 9999999999987643 46788999999999999999999999999999999999999999999999987533221
Q ss_pred CcccccccccccceecccccccCCcCccccchhHHHHHHHHHhCCCCCCCCCCCccchhhhccccCCCCCCccccccccc
Q 002721 764 GTASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQILDARL 843 (888)
Q Consensus 764 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 843 (888)
. ......||+.|+|||++.+..++.++||||+||++|||+||+.||...... +....+. ....
T Consensus 156 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~--~~~~~i~-------------~~~~ 218 (324)
T cd05587 156 K--TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDED--ELFQSIM-------------EHNV 218 (324)
T ss_pred C--ceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH--HHHHHHH-------------cCCC
Confidence 1 123457899999999999999999999999999999999999999753221 1111110 0000
Q ss_pred ccCCcCcHHHHHHHHHHHhhccCCCCCCCCCH
Q 002721 844 STVSFGWRKEMLTALKVALLCTDSTPAKRPKM 875 (888)
Q Consensus 844 ~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~ 875 (888)
. .......++.+++.+||+.||++||++
T Consensus 219 ~----~~~~~~~~~~~li~~~l~~~P~~R~~~ 246 (324)
T cd05587 219 S----YPKSLSKEAVSICKGLLTKHPAKRLGC 246 (324)
T ss_pred C----CCCCCCHHHHHHHHHHhhcCHHHcCCC
Confidence 0 011123467789999999999999976
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-38 Score=360.37 Aligned_cols=253 Identities=18% Similarity=0.175 Sum_probs=201.4
Q ss_pred hcCCcceeeecccceEEEEEeC-C-CcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCCeeEEEE
Q 002721 606 TMKDSNMIYCGTFSTVYKAVMP-S-GLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVALLLH 683 (888)
Q Consensus 606 ~~~~~~~ig~G~~g~Vy~~~~~-~-~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 683 (888)
.|...+.||+|+||.||+|... + ++.||+|.+..... .....+.+|+++++.++||||+++++++..++..|+||
T Consensus 68 ~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~~~---~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~ 144 (478)
T PTZ00267 68 MYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLNDE---RQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIM 144 (478)
T ss_pred eEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccCCH---HHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEE
Confidence 4889999999999999999843 3 67888887653332 23346788999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccccccccCCCC
Q 002721 684 NYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSK 763 (888)
Q Consensus 684 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 763 (888)
||+++|+|.+++...... ...+++.++..++.||+.||+|+|++||+||||||+||+++.++.+||+|||+++......
T Consensus 145 E~~~gg~L~~~l~~~~~~-~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~ 223 (478)
T PTZ00267 145 EYGSGGDLNKQIKQRLKE-HLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSV 223 (478)
T ss_pred ECCCCCCHHHHHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCcc
Confidence 999999999988753221 1257888999999999999999999999999999999999999999999999998765433
Q ss_pred CcccccccccccceecccccccCCcCccccchhHHHHHHHHHhCCCCCCCCCCCccchhhhccccCCCCCCccccccccc
Q 002721 764 GTASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQILDARL 843 (888)
Q Consensus 764 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 843 (888)
........+||+.|+|||++.+..++.++||||+||++|||++|+.||...... ..... +.....
T Consensus 224 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~--~~~~~-------------~~~~~~ 288 (478)
T PTZ00267 224 SLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQR--EIMQQ-------------VLYGKY 288 (478)
T ss_pred ccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHH-------------HHhCCC
Confidence 222234567999999999999999999999999999999999999999653211 11110 000111
Q ss_pred ccCCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002721 844 STVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVE 880 (888)
Q Consensus 844 ~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 880 (888)
... .......+.+++.+||+.||++||++.+++.
T Consensus 289 ~~~---~~~~s~~~~~li~~~L~~dP~~Rps~~~~l~ 322 (478)
T PTZ00267 289 DPF---PCPVSSGMKALLDPLLSKNPALRPTTQQLLH 322 (478)
T ss_pred CCC---CccCCHHHHHHHHHHhccChhhCcCHHHHHh
Confidence 000 1122356788999999999999999999875
|
|
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-38 Score=353.84 Aligned_cols=257 Identities=24% Similarity=0.285 Sum_probs=209.2
Q ss_pred HHhcCCcceeeecccceEEEEEeCCC-cEEEEEEeeccChhhhHHHHHHHHHHHHHhccC-CCceeeeeeE-EEe-----
Q 002721 604 KATMKDSNMIYCGTFSTVYKAVMPSG-LILSVKRLKSMDRTIIHHQNKMIRELEKLSKLC-HDNLVRPIGF-VIY----- 675 (888)
Q Consensus 604 ~~~~~~~~~ig~G~~g~Vy~~~~~~~-~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~-~~~----- 675 (888)
.-++++.+.|.+|||+.||.|+...+ ..||+|++-..+. ...+.+.+|+++|++|+ |+|||.|+|. ...
T Consensus 36 ~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~de---~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~ 112 (738)
T KOG1989|consen 36 SHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVNDE---EALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNN 112 (738)
T ss_pred CEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecCCH---HHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCC
Confidence 34677889999999999999996655 9999999875533 34558899999999997 9999999993 322
Q ss_pred -CCeeEEEEecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCC--eeecCCCCCCeEeCCCCCceEec
Q 002721 676 -EDVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVA--IIHLDISSGNVLLDADFKPLLGE 752 (888)
Q Consensus 676 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~--ivHrDlkp~NIll~~~~~~kl~D 752 (888)
.-++++.||||+||.|-|++..+... ++++.++++|+.|+++|+++||..+ |||||||-+||||+.+|..||||
T Consensus 113 ~~~EvllLmEyC~gg~Lvd~mn~Rlq~---~lte~eVLkIf~dv~~AVa~mH~~~pPiIHRDLKiENvLls~~g~~KLCD 189 (738)
T KOG1989|consen 113 GVWEVLLLMEYCKGGSLVDFMNTRLQT---RLTEDEVLKIFYDVCEAVAAMHYLKPPIIHRDLKIENVLLSADGNYKLCD 189 (738)
T ss_pred ceeEEEeehhhccCCcHHHHHHHHHhc---cCChHHHHHHHHHHHHHHHHHhcCCCccchhhhhhhheEEcCCCCEEeCc
Confidence 12678999999999999999876544 5899999999999999999999865 99999999999999999999999
Q ss_pred cccccccCCCCCcc-cc------cccccccceeccccc---ccCCcCccccchhHHHHHHHHHhCCCCCCCCCCCccchh
Q 002721 753 IEISKLLDPSKGTA-SI------SAVAGSFGYIPPEYA---YTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLV 822 (888)
Q Consensus 753 fg~a~~~~~~~~~~-~~------~~~~gt~~y~aPE~~---~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~ 822 (888)
||.|...-...... .. -....|+.|+|||++ .+...++|+|||||||++|.|+....||++.
T Consensus 190 FGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~s-------- 261 (738)
T KOG1989|consen 190 FGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEES-------- 261 (738)
T ss_pred ccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcC--------
Confidence 99987543222111 00 123578999999976 4668999999999999999999999999753
Q ss_pred hhccccCCCCCCcccccccccccCCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhhh
Q 002721 823 KWVHGAPARGETPEQILDARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEMLQEIKQ 887 (888)
Q Consensus 823 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 887 (888)
..-.|++..+... ........+.++|..||+.||++||++.+|+..+.++..
T Consensus 262 -----------g~laIlng~Y~~P--~~p~ys~~l~~LI~~mL~~nP~~RPnI~Qv~~~~~~l~~ 313 (738)
T KOG1989|consen 262 -----------GKLAILNGNYSFP--PFPNYSDRLKDLIRTMLQPNPDERPNIYQVLEEIFELAN 313 (738)
T ss_pred -----------cceeEEeccccCC--CCccHHHHHHHHHHHHhccCcccCCCHHHHHHHHHHHhc
Confidence 1223455544433 235677888999999999999999999999999988753
|
|
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-38 Score=332.13 Aligned_cols=257 Identities=19% Similarity=0.296 Sum_probs=206.6
Q ss_pred HHHhcCCcceeeecccceEEEEEeCCCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCCeeEEE
Q 002721 603 VKATMKDSNMIYCGTFSTVYKAVMPSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVALLL 682 (888)
Q Consensus 603 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 682 (888)
..++|++.+.||+|+||.||+|...+++.||+|.++..... .+.+.+|++++++++||||+++++++...+..|+|
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~v~iK~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 79 (261)
T cd05068 4 DRTSIQLLRKLGAGQFGEVWEGLWNNTTPVAVKTLKPGTMD----PKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIV 79 (261)
T ss_pred chhheeeEEEecccCCccEEEEEecCCeEEEEEeeCCCccc----HHHHHHHHHHHHHCCCCCccceeEEEecCCCeeee
Confidence 45679999999999999999999777889999998754321 34688999999999999999999999999999999
Q ss_pred EecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccccccccCCC
Q 002721 683 HNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPS 762 (888)
Q Consensus 683 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 762 (888)
|||+++++|.+++..... ..+++.++..++.|++.|+.|||++|++||||||+||++++++.+||+|||++......
T Consensus 80 ~e~~~~~~L~~~~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~ 156 (261)
T cd05068 80 TELMKYGSLLEYLQGGAG---RALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKED 156 (261)
T ss_pred eecccCCcHHHHHhccCC---CCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEccCC
Confidence 999999999999976542 25789999999999999999999999999999999999999999999999999876532
Q ss_pred CCcccccccccccceecccccccCCcCccccchhHHHHHHHHHh-CCCCCCCCCCCccchhhhccccCCCCCCccccccc
Q 002721 763 KGTASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILT-TRLPVEEDFGEGVDLVKWVHGAPARGETPEQILDA 841 (888)
Q Consensus 763 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 841 (888)
... .......+..|+|||+..+..++.++||||||+++|||++ |+.||....... ....+.....
T Consensus 157 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~--~~~~~~~~~~----------- 222 (261)
T cd05068 157 IYE-AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAE--VLQQVDQGYR----------- 222 (261)
T ss_pred ccc-ccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHH--HHHHHHcCCC-----------
Confidence 211 1112223457999999988899999999999999999999 999997542211 1111100000
Q ss_pred ccccCCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHh
Q 002721 842 RLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEMLQEI 885 (888)
Q Consensus 842 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~i 885 (888)
. . ........+.+++.+|++.+|++||+++++++.|+++
T Consensus 223 -~-~---~~~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~~l~~~ 261 (261)
T cd05068 223 -M-P---CPPGCPKELYDIMLDCWKEDPDDRPTFETLQWKLEDF 261 (261)
T ss_pred -C-C---CCCcCCHHHHHHHHHHhhcCcccCCCHHHHHHHHhcC
Confidence 0 0 0112235678899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-38 Score=344.03 Aligned_cols=250 Identities=18% Similarity=0.188 Sum_probs=195.5
Q ss_pred ceeeecccceEEEEEe-CCCcEEEEEEeeccChhhhHHHHHHHHHHHHHhcc-CCCceeeeeeEEEeCCeeEEEEecCCC
Q 002721 611 NMIYCGTFSTVYKAVM-PSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKL-CHDNLVRPIGFVIYEDVALLLHNYLPN 688 (888)
Q Consensus 611 ~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~lv~e~~~~ 688 (888)
+.||+|+||.||+|+. .+++.||+|++++.........+.+.+|..++.++ +||||+++++++..++..|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSG 80 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCC
Confidence 4799999999999995 46899999999865433334445788999999988 699999999999999999999999999
Q ss_pred CCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccccccccCCCCCcccc
Q 002721 689 GTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSKGTASI 768 (888)
Q Consensus 689 g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~ 768 (888)
|+|.+++.... .+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||+++...... ...
T Consensus 81 g~L~~~~~~~~-----~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~--~~~ 153 (329)
T cd05588 81 GDLMFHMQRQR-----KLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG--DTT 153 (329)
T ss_pred CCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECcCccccccccCC--Ccc
Confidence 99999887543 57889999999999999999999999999999999999999999999999987532211 112
Q ss_pred cccccccceecccccccCCcCccccchhHHHHHHHHHhCCCCCCCCCCCc---cchhhhccccCCCCCCccccccccccc
Q 002721 769 SAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEG---VDLVKWVHGAPARGETPEQILDARLST 845 (888)
Q Consensus 769 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~~ 845 (888)
....||+.|+|||++.+..++.++||||+||++|||++|+.||....... .....+. .+.+......
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~---------~~~~~~~~~~- 223 (329)
T cd05588 154 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYL---------FQVILEKQIR- 223 (329)
T ss_pred ccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHH---------HHHHHcCCCC-
Confidence 34578999999999999999999999999999999999999996421111 0000000 0001111110
Q ss_pred CCcCcHHHHHHHHHHHhhccCCCCCCCCC------HHHHHH
Q 002721 846 VSFGWRKEMLTALKVALLCTDSTPAKRPK------MKKVVE 880 (888)
Q Consensus 846 ~~~~~~~~~~~~~~li~~cl~~dP~~RPs------~~evl~ 880 (888)
. ......++.+++.+|++.||++||+ ++++++
T Consensus 224 ~---p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~ 261 (329)
T cd05588 224 I---PRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKS 261 (329)
T ss_pred C---CCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhc
Confidence 1 1122456788999999999999997 566653
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-38 Score=335.75 Aligned_cols=262 Identities=18% Similarity=0.310 Sum_probs=204.5
Q ss_pred HHHhcCCcceeeecccceEEEEEeC------CCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeC
Q 002721 603 VKATMKDSNMIYCGTFSTVYKAVMP------SGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYE 676 (888)
Q Consensus 603 ~~~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 676 (888)
..++|+..+.||+|+||.||+|... ++..||+|+++..... ....++.+|+.+++.++||||+++++++..+
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~--~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~ 81 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAASM--RERIEFLNEASVMKEFNCHHVVRLLGVVSQG 81 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccCCH--HHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence 4678999999999999999999742 3568999988643322 2334788999999999999999999999999
Q ss_pred CeeEEEEecCCCCCHHHHhhccCCCC-----CCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEe
Q 002721 677 DVALLLHNYLPNGTLAQLLHESTKQP-----DYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLG 751 (888)
Q Consensus 677 ~~~~lv~e~~~~g~L~~~l~~~~~~~-----~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~ 751 (888)
...++||||+++++|.+++....... ...+++..+..++.|++.||+|||+.|++||||||+||++++++.++++
T Consensus 82 ~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~~l~ 161 (277)
T cd05062 82 QPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIG 161 (277)
T ss_pred CCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCcchheEEEcCCCCEEEC
Confidence 99999999999999999997643211 1245788899999999999999999999999999999999999999999
Q ss_pred ccccccccCCCCCcccccccccccceecccccccCCcCccccchhHHHHHHHHHh-CCCCCCCCCCCccchhhhccccCC
Q 002721 752 EIEISKLLDPSKGTASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILT-TRLPVEEDFGEGVDLVKWVHGAPA 830 (888)
Q Consensus 752 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~ 830 (888)
|||++................++..|+|||++.+..++.++|||||||++|||++ |..||.....+ ...+.....
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~p~~~~~~~--~~~~~~~~~-- 237 (277)
T cd05062 162 DFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNE--QVLRFVMEG-- 237 (277)
T ss_pred CCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHH--HHHHHHHcC--
Confidence 9999876543322111122345778999999998889999999999999999999 78888654322 111111000
Q ss_pred CCCCcccccccccccCCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 002721 831 RGETPEQILDARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEMLQE 884 (888)
Q Consensus 831 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~ 884 (888)
..... .......+.+++.+||+.||++|||+.|+++.|++
T Consensus 238 -----------~~~~~---~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~l~~ 277 (277)
T cd05062 238 -----------GLLDK---PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKE 277 (277)
T ss_pred -----------CcCCC---CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHhhC
Confidence 00000 11123467889999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-38 Score=343.71 Aligned_cols=245 Identities=18% Similarity=0.183 Sum_probs=191.8
Q ss_pred ceeeecccceEEEEEe-CCCcEEEEEEeeccChhhhHHHHHHHHHHHHHhcc-CCCceeeeeeEEEeCCeeEEEEecCCC
Q 002721 611 NMIYCGTFSTVYKAVM-PSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKL-CHDNLVRPIGFVIYEDVALLLHNYLPN 688 (888)
Q Consensus 611 ~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~lv~e~~~~ 688 (888)
+.||+|+||.||+|+. .+++.||+|++++.........+.+.+|+.++.++ +||||+++++++..++..|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~ 80 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNG 80 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCC
Confidence 4799999999999995 46889999999865433334445688899988877 799999999999999999999999999
Q ss_pred CCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccccccccCCCCCcccc
Q 002721 689 GTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSKGTASI 768 (888)
Q Consensus 689 g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~ 768 (888)
|+|..++.... .+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||+++....... ..
T Consensus 81 ~~L~~~~~~~~-----~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~--~~ 153 (329)
T cd05618 81 GDLMFHMQRQR-----KLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD--TT 153 (329)
T ss_pred CCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCC--cc
Confidence 99998887543 467889999999999999999999999999999999999999999999999875332111 12
Q ss_pred cccccccceecccccccCCcCccccchhHHHHHHHHHhCCCCCCCCCCCcc---chhhhccccCCCCCCccccccccccc
Q 002721 769 SAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGV---DLVKWVHGAPARGETPEQILDARLST 845 (888)
Q Consensus 769 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~~~ 845 (888)
....||+.|+|||++.+..++.++|||||||++|||++|+.||........ ....+.. ..+......
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~---------~~i~~~~~~- 223 (329)
T cd05618 154 STFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLF---------QVILEKQIR- 223 (329)
T ss_pred ccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHH---------HHHhcCCCC-
Confidence 345789999999999999999999999999999999999999963211110 0000000 000111000
Q ss_pred CCcCcHHHHHHHHHHHhhccCCCCCCCCCH
Q 002721 846 VSFGWRKEMLTALKVALLCTDSTPAKRPKM 875 (888)
Q Consensus 846 ~~~~~~~~~~~~~~li~~cl~~dP~~RPs~ 875 (888)
.+......+.+++.+||+.||++||++
T Consensus 224 ---~p~~~~~~~~~ll~~~L~~dP~~R~~~ 250 (329)
T cd05618 224 ---IPRSLSVKAASVLKSFLNKDPKERLGC 250 (329)
T ss_pred ---CCCCCCHHHHHHHHHHhcCCHHHcCCC
Confidence 111234567789999999999999984
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=319.13 Aligned_cols=251 Identities=18% Similarity=0.268 Sum_probs=208.2
Q ss_pred HHhcCCcceeeecccceEEEEEe-CCCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCCeeEEE
Q 002721 604 KATMKDSNMIYCGTFSTVYKAVM-PSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVALLL 682 (888)
Q Consensus 604 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 682 (888)
.+-|.+..++|+|+||.||+|.+ .+|+.+|+|.+.... ...++.+|+.+|.+++.|+||++||.|......|+|
T Consensus 32 EEVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~s-----DLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIV 106 (502)
T KOG0574|consen 32 EEVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVDT-----DLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIV 106 (502)
T ss_pred HHHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCccc-----hHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEee
Confidence 45688889999999999999994 579999999987432 234789999999999999999999999988899999
Q ss_pred EecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccccccccCCC
Q 002721 683 HNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPS 762 (888)
Q Consensus 683 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 762 (888)
||||..|+..+.++.+.+ .+++.++..+++..++||+|||...-||||||+.|||++.+|.+|++|||.|..+.+.
T Consensus 107 MEYCGAGSiSDI~R~R~K----~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDT 182 (502)
T KOG0574|consen 107 MEYCGAGSISDIMRARRK----PLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDT 182 (502)
T ss_pred hhhcCCCcHHHHHHHhcC----CccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhhh
Confidence 999999999999987654 6889999999999999999999999999999999999999999999999999877542
Q ss_pred CCcccccccccccceecccccccCCcCccccchhHHHHHHHHHhCCCCCCCCCCCccchhhhccccCCCCCCcccccccc
Q 002721 763 KGTASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQILDAR 842 (888)
Q Consensus 763 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 842 (888)
..+...+.||+.|||||++..-.|+.++||||+|++..||..|++||.+..+-.. +. ++...
T Consensus 183 --MAKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRA-----IF-----------MIPT~ 244 (502)
T KOG0574|consen 183 --MAKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRA-----IF-----------MIPTK 244 (502)
T ss_pred --HHhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccce-----eE-----------eccCC
Confidence 3344578899999999999999999999999999999999999999986422110 00 00111
Q ss_pred cccCCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002721 843 LSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEM 881 (888)
Q Consensus 843 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~ 881 (888)
.+.....+..-+.++-+++++|+.+.|++|-|+.++++.
T Consensus 245 PPPTF~KPE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H 283 (502)
T KOG0574|consen 245 PPPTFKKPEEWSSEFNDFIRSCLIKKPEERKTALRLCEH 283 (502)
T ss_pred CCCCCCChHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhh
Confidence 111111223334567789999999999999999988764
|
|
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=328.81 Aligned_cols=264 Identities=20% Similarity=0.305 Sum_probs=212.4
Q ss_pred HhcCCcceeeecccceEEEEEeC-CCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCCeeEEEE
Q 002721 605 ATMKDSNMIYCGTFSTVYKAVMP-SGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVALLLH 683 (888)
Q Consensus 605 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 683 (888)
++|++.+.||+|+||.||+|... +|+.||+|.++..........+.+.+|++++++++|++|+++++++..++..++||
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 81 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVL 81 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEE
Confidence 47889999999999999999965 79999999987544443444568999999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccccccccCCCC
Q 002721 684 NYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSK 763 (888)
Q Consensus 684 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 763 (888)
||+++++|.+++...... ...+++.++..++.|++.||+|||+.|++||||||+||+++.++.++++|||.+.......
T Consensus 82 e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~ 160 (267)
T cd08224 82 ELADAGDLSRMIKHFKKQ-KRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT 160 (267)
T ss_pred ecCCCCCHHHHHHHhccc-CCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeeccCCC
Confidence 999999999998754322 2257889999999999999999999999999999999999999999999999988654322
Q ss_pred CcccccccccccceecccccccCCcCccccchhHHHHHHHHHhCCCCCCCCCCCccchhhhccccCCCCCCccccccccc
Q 002721 764 GTASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQILDARL 843 (888)
Q Consensus 764 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 843 (888)
.. .....++..|+|||.+.+..++.++||||||+++|+|++|+.||........+..+... ....
T Consensus 161 ~~--~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~-------------~~~~ 225 (267)
T cd08224 161 TA--AHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIE-------------KCDY 225 (267)
T ss_pred cc--cceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhhhh-------------cCCC
Confidence 11 22346788999999998888999999999999999999999999653221111111100 0001
Q ss_pred ccCCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhh
Q 002721 844 STVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEMLQEIK 886 (888)
Q Consensus 844 ~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~i~ 886 (888)
... ........+.+++.+||+.+|++|||+.+|++.|+++.
T Consensus 226 ~~~--~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~~~~~~~ 266 (267)
T cd08224 226 PPL--PADHYSEELRDLVSRCINPDPEKRPDISYVLQVAKEMH 266 (267)
T ss_pred CCC--ChhhcCHHHHHHHHHHcCCCcccCCCHHHHHHHHHHhc
Confidence 111 11234456789999999999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-38 Score=360.58 Aligned_cols=258 Identities=21% Similarity=0.217 Sum_probs=204.3
Q ss_pred HHhcCCcceeeecccceEEEEEe-CCCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCC-----
Q 002721 604 KATMKDSNMIYCGTFSTVYKAVM-PSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYED----- 677 (888)
Q Consensus 604 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~----- 677 (888)
.++|.+.+.||+|+||+||+|+. .+|+.||||++...... ......+.+|+..+..++|+||+++++.+...+
T Consensus 31 ~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~~-~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~ 109 (496)
T PTZ00283 31 AKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGMS-EADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPE 109 (496)
T ss_pred CCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccCC-HHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcc
Confidence 45899999999999999999984 57999999999754332 234457889999999999999999988775432
Q ss_pred ---eeEEEEecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccc
Q 002721 678 ---VALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIE 754 (888)
Q Consensus 678 ---~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg 754 (888)
..++||||+++|+|.++++...... ..+++..+..++.|++.||+|+|++||+||||||+||+++.++.+||+|||
T Consensus 110 ~~~~i~lV~Ey~~~gsL~~~l~~~~~~~-~~l~e~~~~~i~~qll~aL~~lH~~~IiHrDLKP~NILl~~~~~vkL~DFG 188 (496)
T PTZ00283 110 NVLMIALVLDYANAGDLRQEIKSRAKTN-RTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFG 188 (496)
T ss_pred cceEEEEEEeCCCCCcHHHHHHHhhccC-CCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEeCCCCEEEEecc
Confidence 3689999999999999997654322 257888999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCcccccccccccceecccccccCCcCccccchhHHHHHHHHHhCCCCCCCCCCCccchhhhccccCCCCCC
Q 002721 755 ISKLLDPSKGTASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGET 834 (888)
Q Consensus 755 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~ 834 (888)
+++...............||+.|+|||++.+..++.++|||||||++|||++|+.||...... .....
T Consensus 189 ls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~~--~~~~~---------- 256 (496)
T PTZ00283 189 FSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENME--EVMHK---------- 256 (496)
T ss_pred cCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHH--HHHHH----------
Confidence 998765432222234567999999999999999999999999999999999999999753211 01110
Q ss_pred cccccccccccCCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002721 835 PEQILDARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEM 881 (888)
Q Consensus 835 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~ 881 (888)
+........ .....+++.+++.+||+.||++||++.++++.
T Consensus 257 ---~~~~~~~~~---~~~~~~~l~~li~~~L~~dP~~RPs~~ell~~ 297 (496)
T PTZ00283 257 ---TLAGRYDPL---PPSISPEMQEIVTALLSSDPKRRPSSSKLLNM 297 (496)
T ss_pred ---HhcCCCCCC---CCCCCHHHHHHHHHHcccChhhCcCHHHHHhC
Confidence 011111111 11234567889999999999999999999863
|
|
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=353.52 Aligned_cols=254 Identities=18% Similarity=0.180 Sum_probs=196.3
Q ss_pred hcCCcceeeecccceEEEEEe-CCCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCCeeEEEEe
Q 002721 606 TMKDSNMIYCGTFSTVYKAVM-PSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVALLLHN 684 (888)
Q Consensus 606 ~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 684 (888)
.|+..+.||+|+||+||+|+. .+++.||+|++.............+.+|++++++++||||+++++++.+++..|+|||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E 81 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMD 81 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEe
Confidence 578899999999999999995 4689999999975544334455678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccccccccCCCCC
Q 002721 685 YLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSKG 764 (888)
Q Consensus 685 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 764 (888)
|+++|+|.+++.... .+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++........
T Consensus 82 ~~~gg~L~~~l~~~~-----~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~ 156 (382)
T cd05625 82 YIPGGDMMSLLIRMG-----IFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD 156 (382)
T ss_pred CCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEEeECCCCcccccccc
Confidence 999999999997643 457788899999999999999999999999999999999999999999999753211000
Q ss_pred ---------------------------------------------cccccccccccceecccccccCCcCccccchhHHH
Q 002721 765 ---------------------------------------------TASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGV 799 (888)
Q Consensus 765 ---------------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~ 799 (888)
.......+||+.|+|||++.+..++.++||||+||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGv 236 (382)
T cd05625 157 SKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGV 236 (382)
T ss_pred ccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechH
Confidence 00012346899999999999999999999999999
Q ss_pred HHHHHHhCCCCCCCCCCCccchhhhccccCCCCCCcccccccccccCCcCcHHHHHHHHHHHhhccCCCCCCCCC---HH
Q 002721 800 VLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQILDARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPK---MK 876 (888)
Q Consensus 800 il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs---~~ 876 (888)
++|||++|+.||........ ......... ... .+......+++.+++.+|+ .+|++|++ ++
T Consensus 237 il~elltG~~Pf~~~~~~~~-~~~i~~~~~------------~~~--~p~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ 300 (382)
T cd05625 237 ILYEMLVGQPPFLAQTPLET-QMKVINWQT------------SLH--IPPQAKLSPEASDLIIKLC-RGPEDRLGKNGAD 300 (382)
T ss_pred HHHHHHhCCCCCCCCCHHHH-HHHHHccCC------------CcC--CCCcccCCHHHHHHHHHHc-cCHhHcCCCCCHH
Confidence 99999999999975432111 011100000 000 0011122345666776665 49999997 77
Q ss_pred HHHH
Q 002721 877 KVVE 880 (888)
Q Consensus 877 evl~ 880 (888)
|+++
T Consensus 301 ei~~ 304 (382)
T cd05625 301 EIKA 304 (382)
T ss_pred HHhc
Confidence 7764
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-38 Score=345.52 Aligned_cols=254 Identities=17% Similarity=0.153 Sum_probs=197.5
Q ss_pred hcCCcceeeecccceEEEEEe----CCCcEEEEEEeeccChh-hhHHHHHHHHHHHHHhcc-CCCceeeeeeEEEeCCee
Q 002721 606 TMKDSNMIYCGTFSTVYKAVM----PSGLILSVKRLKSMDRT-IIHHQNKMIRELEKLSKL-CHDNLVRPIGFVIYEDVA 679 (888)
Q Consensus 606 ~~~~~~~ig~G~~g~Vy~~~~----~~~~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~ 679 (888)
+|++.+.||+|+||.||+|+. .+++.||+|++++.... .....+.+.+|+++++.+ +||+|+++++++..++..
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 478889999999999999984 35899999999743221 222344678899999999 599999999999999999
Q ss_pred EEEEecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEecccccccc
Q 002721 680 LLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLL 759 (888)
Q Consensus 680 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~ 759 (888)
++||||+++|+|.+++.... .+++.++..++.||+.||+|||++||+||||||+||+++.++.+||+|||+++..
T Consensus 81 ~lv~e~~~~g~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~ 155 (332)
T cd05614 81 HLILDYVSGGEMFTHLYQRD-----NFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEF 155 (332)
T ss_pred EEEEeCCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCccc
Confidence 99999999999999997643 4678899999999999999999999999999999999999999999999999865
Q ss_pred CCCCCcccccccccccceecccccccC-CcCccccchhHHHHHHHHHhCCCCCCCCCCCccchhhhccccCCCCCCcccc
Q 002721 760 DPSKGTASISAVAGSFGYIPPEYAYTM-QVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQI 838 (888)
Q Consensus 760 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 838 (888)
...... ......||+.|+|||++.+. .++.++|||||||++|||++|+.||......... ..... .+
T Consensus 156 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~-~~~~~----------~~ 223 (332)
T cd05614 156 LSEEKE-RTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQ-SEVSR----------RI 223 (332)
T ss_pred cccCCC-ccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCH-HHHHH----------HH
Confidence 432211 12345799999999998765 4788999999999999999999999643221110 00000 00
Q ss_pred cccccccCCcCcHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 002721 839 LDARLSTVSFGWRKEMLTALKVALLCTDSTPAKRP-----KMKKVVE 880 (888)
Q Consensus 839 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RP-----s~~evl~ 880 (888)
.. ..+.........+.+++.+||+.||++|| +++++++
T Consensus 224 ~~----~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~ 266 (332)
T cd05614 224 LK----CDPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKE 266 (332)
T ss_pred hc----CCCCCCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHc
Confidence 00 00001112345677899999999999999 6777764
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=341.81 Aligned_cols=265 Identities=20% Similarity=0.285 Sum_probs=205.8
Q ss_pred HHhcCCcceeeecccceEEEEEe------CCCcEEEEEEeeccChhhhHHHHHHHHHHHHHhcc-CCCceeeeeeEEEeC
Q 002721 604 KATMKDSNMIYCGTFSTVYKAVM------PSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKL-CHDNLVRPIGFVIYE 676 (888)
Q Consensus 604 ~~~~~~~~~ig~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~ 676 (888)
.++|++.+.||+|+||.||+|.. .+++.||+|+++.... ....+.+.+|++++.++ +||||+++++++...
T Consensus 6 ~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~~--~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~ 83 (337)
T cd05054 6 RDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGAT--ASEYKALMTELKILIHIGHHLNVVNLLGACTKP 83 (337)
T ss_pred HHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCCC--HHHHHHHHHHHHHHHhhccCcchhheeeeEecC
Confidence 46899999999999999999963 2357899999874322 22345688999999999 799999999988754
Q ss_pred -CeeEEEEecCCCCCHHHHhhccCCC------------------------------------------------------
Q 002721 677 -DVALLLHNYLPNGTLAQLLHESTKQ------------------------------------------------------ 701 (888)
Q Consensus 677 -~~~~lv~e~~~~g~L~~~l~~~~~~------------------------------------------------------ 701 (888)
...+++|||+++++|.+++......
T Consensus 84 ~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (337)
T cd05054 84 GGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGD 163 (337)
T ss_pred CCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhhh
Confidence 5688999999999999998653210
Q ss_pred --CCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccccccccCCCCCcccccccccccceec
Q 002721 702 --PDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSKGTASISAVAGSFGYIP 779 (888)
Q Consensus 702 --~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~a 779 (888)
....+++..+..++.||+.||+|||++||+||||||+||++++++.+||+|||++..+.............++..|+|
T Consensus 164 ~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~a 243 (337)
T cd05054 164 ELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMA 243 (337)
T ss_pred HHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccC
Confidence 012578999999999999999999999999999999999999999999999999987643322222233456778999
Q ss_pred ccccccCCcCccccchhHHHHHHHHHh-CCCCCCCCCCCccchhhhccccCCCCCCcccccccccccCCcCcHHHHHHHH
Q 002721 780 PEYAYTMQVTAPGNVYSYGVVLLEILT-TRLPVEEDFGEGVDLVKWVHGAPARGETPEQILDARLSTVSFGWRKEMLTAL 858 (888)
Q Consensus 780 PE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 858 (888)
||++.+..++.++||||+||++|||++ |..||....... .+........ . .. .......++.
T Consensus 244 PE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~-~~~~~~~~~~----~---------~~---~~~~~~~~~~ 306 (337)
T cd05054 244 PESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDE-EFCRRLKEGT----R---------MR---APEYATPEIY 306 (337)
T ss_pred cHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccH-HHHHHHhccC----C---------CC---CCccCCHHHH
Confidence 999999999999999999999999998 999997532111 1111110000 0 00 0112235678
Q ss_pred HHHhhccCCCCCCCCCHHHHHHHHHHhhh
Q 002721 859 KVALLCTDSTPAKRPKMKKVVEMLQEIKQ 887 (888)
Q Consensus 859 ~li~~cl~~dP~~RPs~~evl~~L~~i~~ 887 (888)
+++.+||+.+|++||++.|+++.|+++.+
T Consensus 307 ~l~~~cl~~~p~~RPs~~ell~~l~~~~~ 335 (337)
T cd05054 307 SIMLDCWHNNPEDRPTFSELVEILGDLLQ 335 (337)
T ss_pred HHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 99999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=355.07 Aligned_cols=255 Identities=18% Similarity=0.199 Sum_probs=196.9
Q ss_pred hcCCcceeeecccceEEEEEe-CCCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCCeeEEEEe
Q 002721 606 TMKDSNMIYCGTFSTVYKAVM-PSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVALLLHN 684 (888)
Q Consensus 606 ~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 684 (888)
+|++.+.||+|+||.||+|+. .+++.||+|++.............+.+|++++++++||||+++++.+.+++..|+|||
T Consensus 2 ~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E 81 (376)
T cd05598 2 MFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMD 81 (376)
T ss_pred CceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEe
Confidence 688999999999999999994 4689999999975433333344578899999999999999999999999999999999
Q ss_pred cCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccccccccCCCCC
Q 002721 685 YLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSKG 764 (888)
Q Consensus 685 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 764 (888)
|+++|+|.+++.... .+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||++..+.....
T Consensus 82 ~~~~g~L~~~i~~~~-----~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~ 156 (376)
T cd05598 82 YIPGGDMMSLLIRLG-----IFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD 156 (376)
T ss_pred CCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCcccccccc
Confidence 999999999997643 457788889999999999999999999999999999999999999999999753321000
Q ss_pred -----------------------------------------cccccccccccceecccccccCCcCccccchhHHHHHHH
Q 002721 765 -----------------------------------------TASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLE 803 (888)
Q Consensus 765 -----------------------------------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~e 803 (888)
........||+.|+|||++.+..++.++||||+||++||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilye 236 (376)
T cd05598 157 SKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYE 236 (376)
T ss_pred ccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeee
Confidence 000113479999999999999999999999999999999
Q ss_pred HHhCCCCCCCCCCCccchhhhccccCCCCCCcccccccccccCCcCcHHHHHHHHHHHhhccCCCCCCCC---CHHHHHH
Q 002721 804 ILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQILDARLSTVSFGWRKEMLTALKVALLCTDSTPAKRP---KMKKVVE 880 (888)
Q Consensus 804 lltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RP---s~~evl~ 880 (888)
|++|+.||......... ....... .. . .. ........++.+++.+|+ .+|.+|+ ++.|+++
T Consensus 237 ll~G~~Pf~~~~~~~~~-~~i~~~~----~~---~---~~----~~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~ 300 (376)
T cd05598 237 MLVGQPPFLADTPAETQ-LKVINWE----TT---L---HI----PSQAKLSREASDLILRLC-CGAEDRLGKNGADEIKA 300 (376)
T ss_pred hhhCCCCCCCCCHHHHH-HHHhccC----cc---c---cC----CCCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhC
Confidence 99999999764322110 0000000 00 0 00 001112345566777766 4999999 8888875
Q ss_pred H
Q 002721 881 M 881 (888)
Q Consensus 881 ~ 881 (888)
.
T Consensus 301 h 301 (376)
T cd05598 301 H 301 (376)
T ss_pred C
Confidence 3
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=330.49 Aligned_cols=260 Identities=17% Similarity=0.276 Sum_probs=202.3
Q ss_pred HHhcCCcceeeecccceEEEEEeC-CCc----EEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCCe
Q 002721 604 KATMKDSNMIYCGTFSTVYKAVMP-SGL----ILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDV 678 (888)
Q Consensus 604 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 678 (888)
.++|+..+.||+|+||+||+|.+. +++ .+++|.+.... ......++..|+.+++++.||||+++++++. +..
T Consensus 6 ~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~~~~~l~~l~h~~iv~~~~~~~-~~~ 82 (279)
T cd05111 6 ETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDRS--GRQTFQEITDHMLAMGSLDHAYIVRLLGICP-GAS 82 (279)
T ss_pred HhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeeccccc--chHHHHHHHHHHHHHhcCCCCCcceEEEEEC-CCc
Confidence 457888999999999999999953 454 47777765322 2233357888999999999999999999875 456
Q ss_pred eEEEEecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccccccc
Q 002721 679 ALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKL 758 (888)
Q Consensus 679 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~ 758 (888)
.++++||+++|+|.+++..... .+++..+..++.||+.||+|||++|++||||||+||++++++.+|++|||.++.
T Consensus 83 ~~~i~e~~~~gsL~~~l~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~ 158 (279)
T cd05111 83 LQLVTQLSPLGSLLDHVRQHRD----SLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVADL 158 (279)
T ss_pred cEEEEEeCCCCcHHHHHHhccc----CCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEEcCCcccee
Confidence 7899999999999999976432 578899999999999999999999999999999999999999999999999987
Q ss_pred cCCCCCcccccccccccceecccccccCCcCccccchhHHHHHHHHHh-CCCCCCCCCCCccchhhhccccCCCCCCccc
Q 002721 759 LDPSKGTASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILT-TRLPVEEDFGEGVDLVKWVHGAPARGETPEQ 837 (888)
Q Consensus 759 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 837 (888)
..............++..|+|||++.+..++.++|||||||++||+++ |+.||.+..... ..+..... ....
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~--~~~~~~~~----~~~~- 231 (279)
T cd05111 159 LYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPHE--VPDLLEKG----ERLA- 231 (279)
T ss_pred ccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH--HHHHHHCC----CcCC-
Confidence 644332222334557778999999988899999999999999999998 999997542211 11111100 0000
Q ss_pred ccccccccCCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhhhC
Q 002721 838 ILDARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEMLQEIKQN 888 (888)
Q Consensus 838 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~i~~~ 888 (888)
.+ ......+.+++.+||..||++|||+.|+++.|+.+.++
T Consensus 232 --~~---------~~~~~~~~~li~~c~~~~p~~Rps~~el~~~l~~~~~~ 271 (279)
T cd05111 232 --QP---------QICTIDVYMVMVKCWMIDENVRPTFKELANEFTRMARD 271 (279)
T ss_pred --CC---------CCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHhC
Confidence 00 01123567789999999999999999999999987653
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=335.43 Aligned_cols=263 Identities=21% Similarity=0.333 Sum_probs=208.0
Q ss_pred HHhcCCcceeeecccceEEEEEe------CCCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCC
Q 002721 604 KATMKDSNMIYCGTFSTVYKAVM------PSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYED 677 (888)
Q Consensus 604 ~~~~~~~~~ig~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 677 (888)
..+|...+.||+|+||.||+|+. .++..+++|.++.... ...+.+.+|++++++++||||+++++++...+
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 80 (291)
T cd05094 4 RRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTL---AARKDFQREAELLTNLQHEHIVKFYGVCGDGD 80 (291)
T ss_pred hHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCccH---HHHHHHHHHHHHHhcCCCCCcceEEEEEccCC
Confidence 45688899999999999999973 2356789998864332 22347889999999999999999999999999
Q ss_pred eeEEEEecCCCCCHHHHhhccCC-----------CCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCC
Q 002721 678 VALLLHNYLPNGTLAQLLHESTK-----------QPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADF 746 (888)
Q Consensus 678 ~~~lv~e~~~~g~L~~~l~~~~~-----------~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~ 746 (888)
..++||||+++++|.+++..... .....+++..++.++.||+.|++|||++||+||||||+||+++.++
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~~ 160 (291)
T cd05094 81 PLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANL 160 (291)
T ss_pred ceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCC
Confidence 99999999999999999976432 1122578999999999999999999999999999999999999999
Q ss_pred CceEeccccccccCCCCCcccccccccccceecccccccCCcCccccchhHHHHHHHHHh-CCCCCCCCCCCccchhhhc
Q 002721 747 KPLLGEIEISKLLDPSKGTASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILT-TRLPVEEDFGEGVDLVKWV 825 (888)
Q Consensus 747 ~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~~~~~~~~~~~~~ 825 (888)
.++++|||.+................++..|+|||++.+..++.++||||||+++|||+| |+.||....... ..+..
T Consensus 161 ~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~--~~~~~ 238 (291)
T cd05094 161 LVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNTE--VIECI 238 (291)
T ss_pred cEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHH
Confidence 999999999976543322112233456788999999999999999999999999999999 999986543221 11111
Q ss_pred cccCCCCCCcccccccccccCCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhhh
Q 002721 826 HGAPARGETPEQILDARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEMLQEIKQ 887 (888)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 887 (888)
. ...... .....+..+.+++.+||+.||++||+++++++.|+++.+
T Consensus 239 ~-------------~~~~~~---~~~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~~l~~~~~ 284 (291)
T cd05094 239 T-------------QGRVLE---RPRVCPKEVYDIMLGCWQREPQQRLNIKEIYKILHALGK 284 (291)
T ss_pred h-------------CCCCCC---CCccCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHh
Confidence 0 000000 011123567899999999999999999999999998853
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=344.70 Aligned_cols=240 Identities=22% Similarity=0.210 Sum_probs=189.7
Q ss_pred ceeeecccceEEEEEe-CCCcEEEEEEeeccChhhhHHHHHHHHHHH-HHhccCCCceeeeeeEEEeCCeeEEEEecCCC
Q 002721 611 NMIYCGTFSTVYKAVM-PSGLILSVKRLKSMDRTIIHHQNKMIRELE-KLSKLCHDNLVRPIGFVIYEDVALLLHNYLPN 688 (888)
Q Consensus 611 ~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~-~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~ 688 (888)
+.||+|+||+||+|+. .+|+.||+|++.............+.+|.. +++.++||||+++++++..++..|+||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNG 80 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCC
Confidence 4799999999999995 479999999997543333333345556655 46789999999999999999999999999999
Q ss_pred CCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccccccccCCCCCcccc
Q 002721 689 GTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSKGTASI 768 (888)
Q Consensus 689 g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~ 768 (888)
|+|.+++.... .+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||+++...... ...
T Consensus 81 g~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~--~~~ 153 (323)
T cd05575 81 GELFFHLQRER-----SFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS--KTT 153 (323)
T ss_pred CCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCC--Ccc
Confidence 99999987643 46778899999999999999999999999999999999999999999999987543221 122
Q ss_pred cccccccceecccccccCCcCccccchhHHHHHHHHHhCCCCCCCCCCCccchhhhccccCCCCCCcccccccccccCCc
Q 002721 769 SAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQILDARLSTVSF 848 (888)
Q Consensus 769 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 848 (888)
....||+.|+|||++.+..++.++|||||||++|||++|+.||...... +..+. +.......
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~--~~~~~-------------i~~~~~~~--- 215 (323)
T cd05575 154 STFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTA--EMYDN-------------ILNKPLRL--- 215 (323)
T ss_pred ccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHH--HHHHH-------------HHcCCCCC---
Confidence 3457899999999999999999999999999999999999999753211 11110 11100000
Q ss_pred CcHHHHHHHHHHHhhccCCCCCCCCCHH
Q 002721 849 GWRKEMLTALKVALLCTDSTPAKRPKMK 876 (888)
Q Consensus 849 ~~~~~~~~~~~li~~cl~~dP~~RPs~~ 876 (888)
.......+.+++.+|++.||++||++.
T Consensus 216 -~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (323)
T cd05575 216 -KPNISVSARHLLEGLLQKDRTKRLGAK 242 (323)
T ss_pred -CCCCCHHHHHHHHHHhhcCHHhCCCCC
Confidence 111245678899999999999999985
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-38 Score=340.73 Aligned_cols=243 Identities=21% Similarity=0.247 Sum_probs=191.8
Q ss_pred ceeeecccceEEEEEeC-CCcEEEEEEeeccChhhhHHHHHHHHHHHHHhcc-CCCceeeeeeEEEeCCeeEEEEecCCC
Q 002721 611 NMIYCGTFSTVYKAVMP-SGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKL-CHDNLVRPIGFVIYEDVALLLHNYLPN 688 (888)
Q Consensus 611 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~lv~e~~~~ 688 (888)
+.||+|+||+||+|+.. +++.||+|+++..........+....|..++... +||||+++++++.+++..|+||||+++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~ 80 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNG 80 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCC
Confidence 47999999999999954 5889999999854322223334567788888764 899999999999999999999999999
Q ss_pred CCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccccccccCCCCCcccc
Q 002721 689 GTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSKGTASI 768 (888)
Q Consensus 689 g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~ 768 (888)
|+|.+++.... .+++.++..++.|++.||+|||++||+||||||+||+++.++.+||+|||+++....... ..
T Consensus 81 g~L~~~l~~~~-----~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~ 153 (316)
T cd05619 81 GDLMFHIQSCH-----KFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDA--KT 153 (316)
T ss_pred CcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCCC--ce
Confidence 99999997643 467889999999999999999999999999999999999999999999999875432211 12
Q ss_pred cccccccceecccccccCCcCccccchhHHHHHHHHHhCCCCCCCCCCCccchhhhccccCCCCCCcccccccccccCCc
Q 002721 769 SAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQILDARLSTVSF 848 (888)
Q Consensus 769 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 848 (888)
....||+.|+|||++.+..++.++||||+||++|||++|+.||...... +..+.+... ...
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~--~~~~~i~~~-----------~~~------ 214 (316)
T cd05619 154 CTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEE--ELFQSIRMD-----------NPC------ 214 (316)
T ss_pred eeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHH--HHHHHHHhC-----------CCC------
Confidence 3457899999999999989999999999999999999999999753211 111111000 000
Q ss_pred CcHHHHHHHHHHHhhccCCCCCCCCCHH-HHH
Q 002721 849 GWRKEMLTALKVALLCTDSTPAKRPKMK-KVV 879 (888)
Q Consensus 849 ~~~~~~~~~~~li~~cl~~dP~~RPs~~-evl 879 (888)
.......++.+++.+||+.||++||++. ++.
T Consensus 215 ~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 246 (316)
T cd05619 215 YPRWLTREAKDILVKLFVREPERRLGVKGDIR 246 (316)
T ss_pred CCccCCHHHHHHHHHHhccCHhhcCCChHHHH
Confidence 0011234567899999999999999997 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-38 Score=347.04 Aligned_cols=269 Identities=16% Similarity=0.236 Sum_probs=196.5
Q ss_pred hcCCcceeeecccceEEEEEe-CCCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCC-----ee
Q 002721 606 TMKDSNMIYCGTFSTVYKAVM-PSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYED-----VA 679 (888)
Q Consensus 606 ~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-----~~ 679 (888)
+|++.+.||+|+||.||+|+. .+++.||+|+++..... .....++.+|++++++++||||+++++++.... ..
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~ 79 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVFEH-VSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDI 79 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhhcc-chhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceE
Confidence 478889999999999999995 46899999998743221 222346889999999999999999999886432 57
Q ss_pred EEEEecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEecccccccc
Q 002721 680 LLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLL 759 (888)
Q Consensus 680 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~ 759 (888)
|+||||++ ++|.+++.... .+++..+..++.||++||+|||++||+||||||+||+++.++.+||+|||+++..
T Consensus 80 ~lv~e~~~-~~L~~~l~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~ 153 (338)
T cd07859 80 YVVFELME-SDLHQVIKAND-----DLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVA 153 (338)
T ss_pred EEEEecCC-CCHHHHHHhcc-----cCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEccCcccccc
Confidence 99999996 69999987543 4688999999999999999999999999999999999999999999999999865
Q ss_pred CCCCC-cccccccccccceeccccccc--CCcCccccchhHHHHHHHHHhCCCCCCCCCCCcc-chhhhccccCCCC---
Q 002721 760 DPSKG-TASISAVAGSFGYIPPEYAYT--MQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGV-DLVKWVHGAPARG--- 832 (888)
Q Consensus 760 ~~~~~-~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~-~~~~~~~~~~~~~--- 832 (888)
..... ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||........ .......+.+...
T Consensus 154 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (338)
T cd07859 154 FNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETIS 233 (338)
T ss_pred ccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHH
Confidence 32221 111234578999999998865 5789999999999999999999999975322100 0000000000000
Q ss_pred ----CCcccccccccccCCcC----cHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002721 833 ----ETPEQILDARLSTVSFG----WRKEMLTALKVALLCTDSTPAKRPKMKKVVEM 881 (888)
Q Consensus 833 ----~~~~~~~~~~~~~~~~~----~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~ 881 (888)
..............+.. .....+.+.+++.+||+.||++|||++|+++.
T Consensus 234 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~e~l~h 290 (338)
T cd07859 234 RVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRPTAEEALAD 290 (338)
T ss_pred HhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCCCHHHHhcC
Confidence 00000000000000000 01123567899999999999999999999863
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=340.96 Aligned_cols=201 Identities=22% Similarity=0.318 Sum_probs=175.0
Q ss_pred HHHhcCCcceeeecccceEEEEEeC-CCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCCeeEE
Q 002721 603 VKATMKDSNMIYCGTFSTVYKAVMP-SGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVALL 681 (888)
Q Consensus 603 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 681 (888)
..++|+..+.||+|+||.||+|... ++..+|+|.++.... ......+.+|++++++++||||+++++++..++..++
T Consensus 3 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 80 (333)
T cd06650 3 KDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEIK--PAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISI 80 (333)
T ss_pred chhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeecccC--HHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEE
Confidence 3578999999999999999999954 688999998875422 2234578999999999999999999999999999999
Q ss_pred EEecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhccc-CCeeecCCCCCCeEeCCCCCceEeccccccccC
Q 002721 682 LHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHH-VAIIHLDISSGNVLLDADFKPLLGEIEISKLLD 760 (888)
Q Consensus 682 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~~ 760 (888)
||||+++++|.+++.... .+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||++....
T Consensus 81 v~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~ 155 (333)
T cd06650 81 CMEHMDGGSLDQVLKKAG-----RIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 155 (333)
T ss_pred EEecCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhh
Confidence 999999999999997643 45778889999999999999997 479999999999999999999999999987653
Q ss_pred CCCCcccccccccccceecccccccCCcCccccchhHHHHHHHHHhCCCCCCCC
Q 002721 761 PSKGTASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEED 814 (888)
Q Consensus 761 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~ 814 (888)
... .....|+..|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 156 ~~~----~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~ 205 (333)
T cd06650 156 DSM----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPP 205 (333)
T ss_pred hhc----cccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCc
Confidence 221 12356899999999999888999999999999999999999999753
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-38 Score=341.04 Aligned_cols=243 Identities=21% Similarity=0.223 Sum_probs=191.8
Q ss_pred ceeeecccceEEEEEeC-CCcEEEEEEeeccChhhhHHHHHHHHHHHHHhcc-CCCceeeeeeEEEeCCeeEEEEecCCC
Q 002721 611 NMIYCGTFSTVYKAVMP-SGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKL-CHDNLVRPIGFVIYEDVALLLHNYLPN 688 (888)
Q Consensus 611 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~lv~e~~~~ 688 (888)
+.||+|+||.||+|+.. +|+.||+|.++..........+....|..++... +||||+++++++.+++..|+||||+++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~ 80 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNG 80 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCC
Confidence 47999999999999954 6899999999854322222334667788888754 899999999999999999999999999
Q ss_pred CCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccccccccCCCCCcccc
Q 002721 689 GTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSKGTASI 768 (888)
Q Consensus 689 g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~ 768 (888)
|+|.+++.... .+++.++..++.|++.||+|||++||+||||||+||+++.++.+||+|||+++...... ...
T Consensus 81 g~L~~~i~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~ 153 (316)
T cd05620 81 GDLMFHIQDKG-----RFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD--NRA 153 (316)
T ss_pred CcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCC--Cce
Confidence 99999987643 46788999999999999999999999999999999999999999999999987533221 122
Q ss_pred cccccccceecccccccCCcCccccchhHHHHHHHHHhCCCCCCCCCCCccchhhhccccCCCCCCcccccccccccCCc
Q 002721 769 SAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQILDARLSTVSF 848 (888)
Q Consensus 769 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 848 (888)
....||+.|+|||++.+..++.++||||+||++|||++|+.||...... ...+.+.. .. ...
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~--~~~~~~~~-------------~~-~~~-- 215 (316)
T cd05620 154 STFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDED--ELFESIRV-------------DT-PHY-- 215 (316)
T ss_pred eccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHH--HHHHHHHh-------------CC-CCC--
Confidence 3467899999999999999999999999999999999999999754221 11111100 00 000
Q ss_pred CcHHHHHHHHHHHhhccCCCCCCCCCHH-HHH
Q 002721 849 GWRKEMLTALKVALLCTDSTPAKRPKMK-KVV 879 (888)
Q Consensus 849 ~~~~~~~~~~~li~~cl~~dP~~RPs~~-evl 879 (888)
......++.+++.+||+.||++||++. +++
T Consensus 216 -~~~~~~~~~~li~~~l~~dP~~R~~~~~~~~ 246 (316)
T cd05620 216 -PRWITKESKDILEKLFERDPTRRLGVVGNIR 246 (316)
T ss_pred -CCCCCHHHHHHHHHHccCCHHHcCCChHHHH
Confidence 011234577899999999999999985 554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-38 Score=341.54 Aligned_cols=244 Identities=23% Similarity=0.221 Sum_probs=195.3
Q ss_pred ceeeecccceEEEEEeC-CCcEEEEEEeeccChhhhHHHHHHHHHHHHHhcc-CCCceeeeeeEEEeCCeeEEEEecCCC
Q 002721 611 NMIYCGTFSTVYKAVMP-SGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKL-CHDNLVRPIGFVIYEDVALLLHNYLPN 688 (888)
Q Consensus 611 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~lv~e~~~~ 688 (888)
+.||+|+||+||+|+.. +++.||+|++++.........+.+.+|.+++..+ +||||+++++++...+..|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNG 80 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 47999999999999954 5889999999854333333445678899999888 699999999999999999999999999
Q ss_pred CCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccccccccCCCCCcccc
Q 002721 689 GTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSKGTASI 768 (888)
Q Consensus 689 g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~ 768 (888)
|+|.+++.... .+++.++..++.|++.||+|||++||+||||||+||+++.++.+||+|||++........ ..
T Consensus 81 ~~L~~~~~~~~-----~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~--~~ 153 (318)
T cd05570 81 GDLMFHIQRSG-----RFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV--TT 153 (318)
T ss_pred CCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCC--cc
Confidence 99999887653 478899999999999999999999999999999999999999999999999875322211 12
Q ss_pred cccccccceecccccccCCcCccccchhHHHHHHHHHhCCCCCCCCCCCccchhhhccccCCCCCCcccccccccccCCc
Q 002721 769 SAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQILDARLSTVSF 848 (888)
Q Consensus 769 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 848 (888)
....|++.|+|||++.+..++.++||||+||++|||++|+.||...... ....... .....
T Consensus 154 ~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~--~~~~~i~-------------~~~~~---- 214 (318)
T cd05570 154 STFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDED--ELFQSIL-------------EDEVR---- 214 (318)
T ss_pred cceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHH--HHHHHHH-------------cCCCC----
Confidence 3456899999999999999999999999999999999999999753211 1111110 00000
Q ss_pred CcHHHHHHHHHHHhhccCCCCCCCCCH-----HHHHH
Q 002721 849 GWRKEMLTALKVALLCTDSTPAKRPKM-----KKVVE 880 (888)
Q Consensus 849 ~~~~~~~~~~~li~~cl~~dP~~RPs~-----~evl~ 880 (888)
........+.+++.+||+.||++||++ .++++
T Consensus 215 ~~~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~ 251 (318)
T cd05570 215 YPRWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKG 251 (318)
T ss_pred CCCcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhc
Confidence 011123567889999999999999999 77764
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-38 Score=346.43 Aligned_cols=249 Identities=21% Similarity=0.300 Sum_probs=193.4
Q ss_pred HhcCCcceeeecccceEEEEEe-CCCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCCeeEEEE
Q 002721 605 ATMKDSNMIYCGTFSTVYKAVM-PSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVALLLH 683 (888)
Q Consensus 605 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 683 (888)
.+|+..+.||+|+||.||+|+. .+++.||+|++..... ....+.+.+|+++++.++|+||+++++++..++..|+||
T Consensus 74 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 151 (353)
T PLN00034 74 SELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNHE--DTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLL 151 (353)
T ss_pred HHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCCc--HHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEE
Confidence 4677889999999999999995 4689999999864432 233457899999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccccccccCCCC
Q 002721 684 NYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSK 763 (888)
Q Consensus 684 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 763 (888)
||+++++|.+.. ...+..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||+++......
T Consensus 152 e~~~~~~L~~~~---------~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~ 222 (353)
T PLN00034 152 EFMDGGSLEGTH---------IADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM 222 (353)
T ss_pred ecCCCCcccccc---------cCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEcccccceeccccc
Confidence 999999986532 23456788899999999999999999999999999999999999999999998764322
Q ss_pred Ccccccccccccceeccccccc-----CCcCccccchhHHHHHHHHHhCCCCCCCCCCCccchhhhccccCCCCCCcccc
Q 002721 764 GTASISAVAGSFGYIPPEYAYT-----MQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQI 838 (888)
Q Consensus 764 ~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 838 (888)
. ......||..|+|||++.. ...+.++|||||||++|||++|+.||....... .........
T Consensus 223 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~--~~~~~~~~~--------- 289 (353)
T PLN00034 223 D--PCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGD--WASLMCAIC--------- 289 (353)
T ss_pred c--cccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCcc--HHHHHHHHh---------
Confidence 1 1234578999999998743 234568999999999999999999997322111 111000000
Q ss_pred cccccccCCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002721 839 LDARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEM 881 (888)
Q Consensus 839 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~ 881 (888)
.. ...........++.+++.+||+.||++||++.|+++.
T Consensus 290 -~~---~~~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~h 328 (353)
T PLN00034 290 -MS---QPPEAPATASREFRHFISCCLQREPAKRWSAMQLLQH 328 (353)
T ss_pred -cc---CCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00 0000112234567899999999999999999999864
|
|
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-38 Score=342.28 Aligned_cols=244 Identities=20% Similarity=0.193 Sum_probs=195.0
Q ss_pred hcCCcceeeecccceEEEEEeC-CCcEEEEEEeeccChhhhHHHHHHHHHHHHHhcc-CCCceeeeeeEEEeCCeeEEEE
Q 002721 606 TMKDSNMIYCGTFSTVYKAVMP-SGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKL-CHDNLVRPIGFVIYEDVALLLH 683 (888)
Q Consensus 606 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~lv~ 683 (888)
+|++.+.||+|+||.||+|+.. +++.||+|++++.........+.+..|..++..+ +||+|+++++++...+..|+||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 4788899999999999999954 6789999999854333333344677788888877 5899999999999999999999
Q ss_pred ecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccccccccCCCC
Q 002721 684 NYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSK 763 (888)
Q Consensus 684 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 763 (888)
||+++|+|.+++.... .+++.++..++.||+.||+|||++||+||||||+||+++.++.+||+|||+++......
T Consensus 81 E~~~~g~L~~~~~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~ 155 (323)
T cd05616 81 EYVNGGDLMYQIQQVG-----RFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG 155 (323)
T ss_pred cCCCCCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCCCC
Confidence 9999999999987643 46788999999999999999999999999999999999999999999999987543221
Q ss_pred CcccccccccccceecccccccCCcCccccchhHHHHHHHHHhCCCCCCCCCCCccchhhhccccCCCCCCccccccccc
Q 002721 764 GTASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQILDARL 843 (888)
Q Consensus 764 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 843 (888)
. ......||+.|+|||++.+..++.++|||||||++|||++|+.||...... .....+ .....
T Consensus 156 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~--~~~~~i-------------~~~~~ 218 (323)
T cd05616 156 V--TTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED--ELFQSI-------------MEHNV 218 (323)
T ss_pred C--ccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHH--HHHHHH-------------HhCCC
Confidence 1 123457899999999999999999999999999999999999999754221 111111 00000
Q ss_pred ccCCcCcHHHHHHHHHHHhhccCCCCCCCCCH
Q 002721 844 STVSFGWRKEMLTALKVALLCTDSTPAKRPKM 875 (888)
Q Consensus 844 ~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~ 875 (888)
. .......++.+++.+|++.||++|+++
T Consensus 219 ~----~p~~~s~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05616 219 A----YPKSMSKEAVAICKGLMTKHPGKRLGC 246 (323)
T ss_pred C----CCCcCCHHHHHHHHHHcccCHHhcCCC
Confidence 0 011234567889999999999999984
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-38 Score=331.81 Aligned_cols=257 Identities=21% Similarity=0.328 Sum_probs=208.7
Q ss_pred HHHhcCCcceeeecccceEEEEEeCCCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCCeeEEE
Q 002721 603 VKATMKDSNMIYCGTFSTVYKAVMPSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVALLL 682 (888)
Q Consensus 603 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 682 (888)
...+|+..+.||.|+||.||+|...+++.+|+|.++..... ....+.+|+++++.++||||+++++++...+..++|
T Consensus 4 ~~~~y~~~~~ig~g~~~~vy~~~~~~~~~~~~k~~~~~~~~---~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (261)
T cd05148 4 PREEFTLERKLGSGYFGEVWEGLWKNRVRVAIKILKSDDLL---KQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYII 80 (261)
T ss_pred cHHHHHHhhhhccCCCccEEEeEecCCCcEEEEeccccchh---hHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEE
Confidence 35679999999999999999999878999999998754332 233688999999999999999999999999999999
Q ss_pred EecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccccccccCCC
Q 002721 683 HNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPS 762 (888)
Q Consensus 683 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 762 (888)
|||+++++|.++++..... .+++.++..++.|++.||+|||++|++||||||+||++++++.+|++|||.+......
T Consensus 81 ~e~~~~~~L~~~~~~~~~~---~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~ 157 (261)
T cd05148 81 TELMEKGSLLAFLRSPEGQ---VLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKED 157 (261)
T ss_pred EeecccCCHHHHHhcCCCC---CCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEcCCceEEEccccchhhcCCc
Confidence 9999999999999865332 5788999999999999999999999999999999999999999999999999876432
Q ss_pred CCcccccccccccceecccccccCCcCccccchhHHHHHHHHHh-CCCCCCCCCCCccchhhhccccCCCCCCccccccc
Q 002721 763 KGTASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILT-TRLPVEEDFGEGVDLVKWVHGAPARGETPEQILDA 841 (888)
Q Consensus 763 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 841 (888)
.. ......++..|+|||...+..++.++||||||+++|+|++ |+.||...... +..+......
T Consensus 158 ~~--~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~--~~~~~~~~~~------------ 221 (261)
T cd05148 158 VY--LSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNH--EVYDQITAGY------------ 221 (261)
T ss_pred cc--cccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHH--HHHHHHHhCC------------
Confidence 21 1123345678999999988889999999999999999998 89999654321 1111111000
Q ss_pred ccccCCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHh
Q 002721 842 RLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEMLQEI 885 (888)
Q Consensus 842 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~i 885 (888)
... ........+.+++.+||+.||++|||++++++.|+.+
T Consensus 222 -~~~---~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~~L~~~ 261 (261)
T cd05148 222 -RMP---CPAKCPQEIYKIMLECWAAEPEDRPSFKALREELDNI 261 (261)
T ss_pred -cCC---CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhcC
Confidence 000 1112335678999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=335.99 Aligned_cols=264 Identities=22% Similarity=0.287 Sum_probs=207.5
Q ss_pred HHHhcCCcceeeecccceEEEEEeC------CCcEEEEEEeeccChhhhHHHHHHHHHHHHHhcc-CCCceeeeeeEEEe
Q 002721 603 VKATMKDSNMIYCGTFSTVYKAVMP------SGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKL-CHDNLVRPIGFVIY 675 (888)
Q Consensus 603 ~~~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~ 675 (888)
..++|+..+.||+|+||.||+|... ....+|+|.++.... ......+.+|+++++++ +||||+++++++..
T Consensus 10 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~~--~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~ 87 (293)
T cd05053 10 PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDAT--EKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQ 87 (293)
T ss_pred CHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCCC--HHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcC
Confidence 3567899999999999999999853 236899999874322 22334688999999999 79999999999999
Q ss_pred CCeeEEEEecCCCCCHHHHhhccCC-----------CCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCC
Q 002721 676 EDVALLLHNYLPNGTLAQLLHESTK-----------QPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDA 744 (888)
Q Consensus 676 ~~~~~lv~e~~~~g~L~~~l~~~~~-----------~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~ 744 (888)
++..+++|||+++|+|.++++.... .....+++..++.++.|++.||+|||++||+||||||+||++++
T Consensus 88 ~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~~~ 167 (293)
T cd05053 88 EGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTE 167 (293)
T ss_pred CCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccceeeEEEcC
Confidence 9999999999999999999975421 12236789999999999999999999999999999999999999
Q ss_pred CCCceEeccccccccCCCCCcccccccccccceecccccccCCcCccccchhHHHHHHHHHh-CCCCCCCCCCCccchhh
Q 002721 745 DFKPLLGEIEISKLLDPSKGTASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILT-TRLPVEEDFGEGVDLVK 823 (888)
Q Consensus 745 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~~~~~~~~~~~ 823 (888)
++.+|++|||.++...............++..|+|||++.+..++.++|||||||++||+++ |..||.....+. ..+
T Consensus 168 ~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~--~~~ 245 (293)
T cd05053 168 DHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEE--LFK 245 (293)
T ss_pred CCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCHHH--HHH
Confidence 99999999999987654322111222335678999999988899999999999999999998 999986532211 111
Q ss_pred hccccCCCCCCcccccccccccCCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhh
Q 002721 824 WVHGAPARGETPEQILDARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEMLQEIK 886 (888)
Q Consensus 824 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~i~ 886 (888)
...... .. . ........+.+++.+||+.||++|||+.|+++.|+++.
T Consensus 246 ~~~~~~----~~---------~---~~~~~~~~~~~li~~~l~~~p~~Rps~~eil~~l~~~~ 292 (293)
T cd05053 246 LLKEGY----RM---------E---KPQNCTQELYHLMRDCWHEVPSQRPTFKQLVEDLDRML 292 (293)
T ss_pred HHHcCC----cC---------C---CCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHHHHhh
Confidence 111000 00 0 11122456788999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=332.09 Aligned_cols=270 Identities=21% Similarity=0.274 Sum_probs=203.7
Q ss_pred cCCcceeeecccceEEEEE-----eCCCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeC--Cee
Q 002721 607 MKDSNMIYCGTFSTVYKAV-----MPSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYE--DVA 679 (888)
Q Consensus 607 ~~~~~~ig~G~~g~Vy~~~-----~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~--~~~ 679 (888)
|+..+.||+|+||+||++. ..+++.||+|.++.... ....+.+.+|++++++++||||+++++++... ...
T Consensus 6 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 83 (283)
T cd05080 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECG--QQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGL 83 (283)
T ss_pred ceeceecccCCCcEEEEeeEccccCCCCceEEEEEeccccC--hHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceE
Confidence 4889999999999998865 23578999999875432 12334788999999999999999999988753 468
Q ss_pred EEEEecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEecccccccc
Q 002721 680 LLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLL 759 (888)
Q Consensus 680 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~ 759 (888)
++||||+++++|.+++... .+++.++..++.|++.||+|||++||+||||||+||++++++.+|++|||++...
T Consensus 84 ~lv~e~~~~~~l~~~~~~~------~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~ 157 (283)
T cd05080 84 QLIMEYVPLGSLRDYLPKH------KLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAV 157 (283)
T ss_pred EEEecCCCCCCHHHHHHHc------CCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheEEEcCCCcEEEeeccccccc
Confidence 9999999999999999753 4788999999999999999999999999999999999999999999999999876
Q ss_pred CCCCCccc-ccccccccceecccccccCCcCccccchhHHHHHHHHHhCCCCCCCCCCCccchhhhccccCCCCCCcccc
Q 002721 760 DPSKGTAS-ISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQI 838 (888)
Q Consensus 760 ~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 838 (888)
........ .....++..|+|||++.+..++.++||||||+++|||+||..||........+........... ......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~-~~~~~~ 236 (283)
T cd05080 158 PEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFEEMIGPKQGQMTV-VRLIEL 236 (283)
T ss_pred CCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhhhhhcccccccch-hhhhhh
Confidence 54322111 1123456679999999888899999999999999999999999865432211111111100000 000001
Q ss_pred cccccccCCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhhh
Q 002721 839 LDARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEMLQEIKQ 887 (888)
Q Consensus 839 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 887 (888)
.+..... ........++.+++.+||+.+|++|||++++++.|+++.+
T Consensus 237 ~~~~~~~--~~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~~l~~~~~ 283 (283)
T cd05080 237 LERGMRL--PCPKNCPQEVYILMKNCWETEAKFRPTFRSLIPILKEMHH 283 (283)
T ss_pred hhcCCCC--CCCCCCCHHHHHHHHHHhccChhhCCCHHHHHHHHHHhhC
Confidence 1111100 0112234678899999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=330.38 Aligned_cols=256 Identities=18% Similarity=0.287 Sum_probs=204.9
Q ss_pred HHhcCCcceeeecccceEEEEEeC-CCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCCeeEEE
Q 002721 604 KATMKDSNMIYCGTFSTVYKAVMP-SGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVALLL 682 (888)
Q Consensus 604 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 682 (888)
..+|.+.+.||+|+||.||+|... +++.||+|.++.... ..+.+.+|++++++++||||+++++++..++..++|
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (263)
T cd05052 5 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 80 (263)
T ss_pred hHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCCch----HHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEE
Confidence 456888999999999999999954 588999999874322 234788999999999999999999999999999999
Q ss_pred EecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccccccccCCC
Q 002721 683 HNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPS 762 (888)
Q Consensus 683 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 762 (888)
|||+++++|.+++...... .+++..++.++.|+++||+|||++|++||||||+||++++++.+|++|||.+......
T Consensus 81 ~e~~~~~~L~~~~~~~~~~---~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~ 157 (263)
T cd05052 81 TEFMTYGNLLDYLRECNRQ---EVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 157 (263)
T ss_pred EEeCCCCcHHHHHHhCCCC---CCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCcEEeCCCccccccccc
Confidence 9999999999999764322 5788899999999999999999999999999999999999999999999999876532
Q ss_pred CCcccccccccccceecccccccCCcCccccchhHHHHHHHHHh-CCCCCCCCCCCccchhhhccccCCCCCCccccccc
Q 002721 763 KGTASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILT-TRLPVEEDFGEGVDLVKWVHGAPARGETPEQILDA 841 (888)
Q Consensus 763 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 841 (888)
... ......++..|+|||.+.+..++.++|||||||++|||++ |..||.....+ +...........
T Consensus 158 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~--~~~~~~~~~~~~---------- 224 (263)
T cd05052 158 TYT-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS--QVYELLEKGYRM---------- 224 (263)
T ss_pred eee-ccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH--HHHHHHHCCCCC----------
Confidence 211 1112234567999999988899999999999999999998 99998653221 111111100000
Q ss_pred ccccCCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHh
Q 002721 842 RLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEMLQEI 885 (888)
Q Consensus 842 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~i 885 (888)
. .....+.++.+++.+||+.||++||++.++++.|+.+
T Consensus 225 ---~---~~~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~~l~~~ 262 (263)
T cd05052 225 ---E---RPEGCPPKVYELMRACWQWNPSDRPSFAEIHQAFETM 262 (263)
T ss_pred ---C---CCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHhh
Confidence 0 0112235678899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=334.44 Aligned_cols=251 Identities=28% Similarity=0.417 Sum_probs=193.3
Q ss_pred CcceeeecccceEEEEEeC-----CCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCCeeEEEE
Q 002721 609 DSNMIYCGTFSTVYKAVMP-----SGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVALLLH 683 (888)
Q Consensus 609 ~~~~ig~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 683 (888)
..+.||.|.||.||+|.+. .+..|+||.++.... ....+.+.+|++.+++++||||++++|++...+..++||
T Consensus 3 ~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~~~--~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~ 80 (259)
T PF07714_consen 3 LIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPSSS--EEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVM 80 (259)
T ss_dssp EEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTTSS--HHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEE
T ss_pred EeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccccc--cccceeeeecccccccccccccccccccccccccccccc
Confidence 4678999999999999965 367899999964322 233568999999999999999999999999888899999
Q ss_pred ecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccccccccCCCC
Q 002721 684 NYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSK 763 (888)
Q Consensus 684 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 763 (888)
||+++|+|.+++...... .+++.++..|+.||++||+|||+++++|+||+++||+++.++.+||+|||++.......
T Consensus 81 e~~~~g~L~~~L~~~~~~---~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~ 157 (259)
T PF07714_consen 81 EYCPGGSLDDYLKSKNKE---PLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKS 157 (259)
T ss_dssp E--TTEBHHHHHHHTCTT---TSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSS
T ss_pred cccccccccccccccccc---ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 999999999999986222 57899999999999999999999999999999999999999999999999998763322
Q ss_pred CcccccccccccceecccccccCCcCccccchhHHHHHHHHHh-CCCCCCCCCCCccchhhhccccCCCCCCcccccccc
Q 002721 764 GTASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILT-TRLPVEEDFGEGVDLVKWVHGAPARGETPEQILDAR 842 (888)
Q Consensus 764 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 842 (888)
.............|+|||.+.+..++.++||||||+++||+++ |+.||.+.... +....+ .+..
T Consensus 158 ~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~--~~~~~~-------------~~~~ 222 (259)
T PF07714_consen 158 KYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNE--EIIEKL-------------KQGQ 222 (259)
T ss_dssp SEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHH--HHHHHH-------------HTTE
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccc--cccccc-------------cccc
Confidence 2222234456788999999998889999999999999999999 78998654211 111111 1111
Q ss_pred cccCCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 002721 843 LSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEML 882 (888)
Q Consensus 843 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L 882 (888)
... ........+.+++.+||+.||++|||++++++.|
T Consensus 223 ~~~---~~~~~~~~~~~li~~C~~~~p~~RPs~~~i~~~L 259 (259)
T PF07714_consen 223 RLP---IPDNCPKDIYSLIQQCWSHDPEKRPSFQEILQEL 259 (259)
T ss_dssp ETT---SBTTSBHHHHHHHHHHT-SSGGGS--HHHHHHHH
T ss_pred cce---eccchhHHHHHHHHHHcCCChhhCcCHHHHHhcC
Confidence 100 1111234567899999999999999999999886
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=328.70 Aligned_cols=253 Identities=19% Similarity=0.287 Sum_probs=202.6
Q ss_pred HHhcCCcceeeecccceEEEEEeCCCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCCeeEEEE
Q 002721 604 KATMKDSNMIYCGTFSTVYKAVMPSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVALLLH 683 (888)
Q Consensus 604 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 683 (888)
.++|++.+.||+|+||+||+|...++..||+|.++..... .+.+.+|+.++++++||||+++++++...+..++||
T Consensus 3 ~~~~~~~~~lg~G~~~~vy~~~~~~~~~~aik~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 78 (256)
T cd05113 3 PKDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS----EDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVT 78 (256)
T ss_pred hHHeEEeeEecCcccceEEEEEecCCCcEEEEEcCCCccc----HHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEE
Confidence 3578889999999999999999777778999988744322 236889999999999999999999999888999999
Q ss_pred ecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccccccccCCCC
Q 002721 684 NYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSK 763 (888)
Q Consensus 684 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 763 (888)
||+++|+|.+++..... .+++.+++.++.||+.||+|||+.|++|+||||+||++++++.+|++|||.++......
T Consensus 79 e~~~~~~l~~~i~~~~~----~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~ 154 (256)
T cd05113 79 EYMSNGCLLNYLREHGK----RFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDE 154 (256)
T ss_pred EcCCCCcHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCCc
Confidence 99999999999976432 46889999999999999999999999999999999999999999999999988654322
Q ss_pred CcccccccccccceecccccccCCcCccccchhHHHHHHHHHh-CCCCCCCCCCCccchhhhccccCCCCCCcccccccc
Q 002721 764 GTASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILT-TRLPVEEDFGEGVDLVKWVHGAPARGETPEQILDAR 842 (888)
Q Consensus 764 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 842 (888)
. .......++..|+|||+..+..++.++|||||||++|||++ |+.||....... ........ .
T Consensus 155 ~-~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~--~~~~~~~~-------------~ 218 (256)
T cd05113 155 Y-TSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSE--TVEKVSQG-------------L 218 (256)
T ss_pred e-eecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHH--HHHHHhcC-------------C
Confidence 1 11122345678999999988889999999999999999999 999986532211 11111000 0
Q ss_pred cccCCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 002721 843 LSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEMLQ 883 (888)
Q Consensus 843 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~ 883 (888)
.... .......+.+++.+||+.||++||++.++++.++
T Consensus 219 ~~~~---~~~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~~~ 256 (256)
T cd05113 219 RLYR---PHLASEKVYAIMYSCWHEKAEERPTFQQLLSSIE 256 (256)
T ss_pred CCCC---CCCCCHHHHHHHHHHcCCCcccCCCHHHHHHhhC
Confidence 0000 0112356788999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=325.25 Aligned_cols=250 Identities=17% Similarity=0.233 Sum_probs=196.3
Q ss_pred ceeeecccceEEEEEe-CCCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCCeeEEEEecCCCC
Q 002721 611 NMIYCGTFSTVYKAVM-PSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVALLLHNYLPNG 689 (888)
Q Consensus 611 ~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~g 689 (888)
+.||+|+||.||+|+. .+++.||+|.+..... ......+.+|++++++++||||+++++++...+..++||||++++
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~ 78 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRETLP--PDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGG 78 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCccCC--HHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCC
Confidence 4699999999999995 4789999998764322 223357899999999999999999999999999999999999999
Q ss_pred CHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccccccccCCCCCccccc
Q 002721 690 TLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSKGTASIS 769 (888)
Q Consensus 690 ~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~ 769 (888)
+|.+++..... .+++.+++.++.|++.||+|||++|++||||||+||+++.++.+|++|||.+.............
T Consensus 79 ~L~~~~~~~~~----~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~ 154 (252)
T cd05084 79 DFLTFLRTEGP----RLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGG 154 (252)
T ss_pred cHHHHHHhCCC----CCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEECccccCcccccccccccCC
Confidence 99999975432 46889999999999999999999999999999999999999999999999987654321111111
Q ss_pred ccccccceecccccccCCcCccccchhHHHHHHHHHh-CCCCCCCCCCCccchhhhccccCCCCCCcccccccccccCCc
Q 002721 770 AVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILT-TRLPVEEDFGEGVDLVKWVHGAPARGETPEQILDARLSTVSF 848 (888)
Q Consensus 770 ~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 848 (888)
....+..|+|||.+.+..++.++||||+|+++|||++ |..||....... ......... ...
T Consensus 155 ~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~--~~~~~~~~~-------------~~~--- 216 (252)
T cd05084 155 MKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQ--TREAIEQGV-------------RLP--- 216 (252)
T ss_pred CCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHH--HHHHHHcCC-------------CCC---
Confidence 1223457999999988889999999999999999998 888886432211 011000000 000
Q ss_pred CcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 002721 849 GWRKEMLTALKVALLCTDSTPAKRPKMKKVVEMLQE 884 (888)
Q Consensus 849 ~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~ 884 (888)
........+.+++.+|++.+|++|||+.|+++.|++
T Consensus 217 ~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~ 252 (252)
T cd05084 217 CPELCPDAVYRLMERCWEYDPGQRPSFSTVHQELQS 252 (252)
T ss_pred CcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhC
Confidence 011223567889999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=333.22 Aligned_cols=249 Identities=18% Similarity=0.226 Sum_probs=194.8
Q ss_pred eeecccceEEEEEe-CCCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCCeeEEEEecCCCCCH
Q 002721 613 IYCGTFSTVYKAVM-PSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVALLLHNYLPNGTL 691 (888)
Q Consensus 613 ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L 691 (888)
||+|+||.||+++. .+|+.||+|++...........+.+..|++++++++||||+++++++..+...|+||||+++++|
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L 80 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDL 80 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCH
Confidence 69999999999995 46999999998743332222334566799999999999999999999999999999999999999
Q ss_pred HHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccccccccCCCCCccccccc
Q 002721 692 AQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSKGTASISAV 771 (888)
Q Consensus 692 ~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~ 771 (888)
.+++...... .+++..+..++.||+.||+|||+.||+||||||+||+++.++.++|+|||++....... .....
T Consensus 81 ~~~~~~~~~~---~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~---~~~~~ 154 (277)
T cd05607 81 KYHIYNVGER---GLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK---TITQR 154 (277)
T ss_pred HHHHHhcccc---CCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc---eeecc
Confidence 9988654332 46788999999999999999999999999999999999999999999999988764322 12345
Q ss_pred ccccceecccccccCCcCccccchhHHHHHHHHHhCCCCCCCCCCCccchhhhccccCCCCCCcccccccccccCCcCcH
Q 002721 772 AGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQILDARLSTVSFGWR 851 (888)
Q Consensus 772 ~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 851 (888)
.|+..|+|||++.+..++.++||||+||++|||++|+.||........ ....... ....... ....
T Consensus 155 ~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~-~~~~~~~----------~~~~~~~---~~~~ 220 (277)
T cd05607 155 AGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVA-KEELKRR----------TLEDEVK---FEHQ 220 (277)
T ss_pred CCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhh-HHHHHHH----------hhccccc---cccc
Confidence 688999999999888899999999999999999999999975322110 0000000 0000000 0111
Q ss_pred HHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002721 852 KEMLTALKVALLCTDSTPAKRPKMKKVVEM 881 (888)
Q Consensus 852 ~~~~~~~~li~~cl~~dP~~RPs~~evl~~ 881 (888)
....++.+++.+||+.||++||++.|+++.
T Consensus 221 ~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ 250 (277)
T cd05607 221 NFTEESKDICRLFLAKKPEDRLGSREKNDD 250 (277)
T ss_pred cCCHHHHHHHHHHhccCHhhCCCCccchhh
Confidence 234567899999999999999999776643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=332.34 Aligned_cols=260 Identities=20% Similarity=0.326 Sum_probs=204.1
Q ss_pred HhcCCcceeeecccceEEEEEe-----CCCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCCee
Q 002721 605 ATMKDSNMIYCGTFSTVYKAVM-----PSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVA 679 (888)
Q Consensus 605 ~~~~~~~~ig~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 679 (888)
.+|++.+.||+|+||.||+|.. .++..||+|.++.... ......+.+|++++++++||||+++++++..++..
T Consensus 5 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~ 82 (283)
T cd05090 5 SAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDINN--PQQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPV 82 (283)
T ss_pred hhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCCCC--HHHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCce
Confidence 4688889999999999999983 3468899999874332 23345788999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHhhccCCC------------CCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCC
Q 002721 680 LLLHNYLPNGTLAQLLHESTKQ------------PDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFK 747 (888)
Q Consensus 680 ~lv~e~~~~g~L~~~l~~~~~~------------~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~ 747 (888)
|+||||+++++|.+++...... ....+++.++..++.|++.||+|||++|++||||||+||++++++.
T Consensus 83 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~~~ 162 (283)
T cd05090 83 CMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLH 162 (283)
T ss_pred EEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCCCc
Confidence 9999999999999998643210 0124678889999999999999999999999999999999999999
Q ss_pred ceEeccccccccCCCCCcccccccccccceecccccccCCcCccccchhHHHHHHHHHh-CCCCCCCCCCCccchhhhcc
Q 002721 748 PLLGEIEISKLLDPSKGTASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILT-TRLPVEEDFGEGVDLVKWVH 826 (888)
Q Consensus 748 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~~~~~~~~~~~~~~ 826 (888)
+|++|||++................++..|+|||++.+..++.++||||||+++|||++ |..||...... .......
T Consensus 163 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~--~~~~~~~ 240 (283)
T cd05090 163 VKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQ--EVIEMVR 240 (283)
T ss_pred EEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH--HHHHHHH
Confidence 99999999987643322222233445678999999988889999999999999999998 99998653211 1111111
Q ss_pred ccCCCCCCcccccccccccCCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 002721 827 GAPARGETPEQILDARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEMLQE 884 (888)
Q Consensus 827 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~ 884 (888)
.... .. .......++.+++.+||+.||++||++.+|.+.|+.
T Consensus 241 ~~~~-------------~~---~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 282 (283)
T cd05090 241 KRQL-------------LP---CSEDCPPRMYSLMTECWQEGPSRRPRFKDIHTRLRS 282 (283)
T ss_pred cCCc-------------CC---CCCCCCHHHHHHHHHHcccCcccCcCHHHHHHHhhc
Confidence 1000 00 011123567789999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=363.44 Aligned_cols=266 Identities=18% Similarity=0.230 Sum_probs=207.2
Q ss_pred HhcCCcceeeecccceEEEEEeC-CCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCCeeEEEE
Q 002721 605 ATMKDSNMIYCGTFSTVYKAVMP-SGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVALLLH 683 (888)
Q Consensus 605 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 683 (888)
++|++.++||+|+||.||+|+.. +++.||+|+++..........+++.+|++++++++||||+++++++.+++..|+||
T Consensus 2 grYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVM 81 (932)
T PRK13184 2 QRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTM 81 (932)
T ss_pred CCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEE
Confidence 47889999999999999999954 68999999997543333344567999999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhhccCCC------CCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEecccccc
Q 002721 684 NYLPNGTLAQLLHESTKQ------PDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISK 757 (888)
Q Consensus 684 e~~~~g~L~~~l~~~~~~------~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~ 757 (888)
||++||+|.+++...... .....++..++.++.||++||+|||++||+||||||+||+++.++.+|++|||+++
T Consensus 82 EY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiDFGLAk 161 (932)
T PRK13184 82 PYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAI 161 (932)
T ss_pred EcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEecCcce
Confidence 999999999998753211 11245677889999999999999999999999999999999999999999999998
Q ss_pred ccCCCCC----------------cccccccccccceecccccccCCcCccccchhHHHHHHHHHhCCCCCCCCCCCccch
Q 002721 758 LLDPSKG----------------TASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDL 821 (888)
Q Consensus 758 ~~~~~~~----------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~ 821 (888)
....... .......+||+.|+|||++.+..++.++||||+||++|||+||+.||..........
T Consensus 162 ~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ki~~ 241 (932)
T PRK13184 162 FKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRKISY 241 (932)
T ss_pred ecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhhhhh
Confidence 7621110 001123569999999999999999999999999999999999999997532211100
Q ss_pred hhhccccCCCCCCcccccccccccCCcCcHHHHHHHHHHHhhccCCCCCCCC-CHHHHHHHHHHhh
Q 002721 822 VKWVHGAPARGETPEQILDARLSTVSFGWRKEMLTALKVALLCTDSTPAKRP-KMKKVVEMLQEIK 886 (888)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RP-s~~evl~~L~~i~ 886 (888)
.. .+..+.. .......+..+.+++.+|++.||++|| +++++++.|+...
T Consensus 242 ~~-------------~i~~P~~---~~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~~Le~~l 291 (932)
T PRK13184 242 RD-------------VILSPIE---VAPYREIPPFLSQIAMKALAVDPAERYSSVQELKQDLEPHL 291 (932)
T ss_pred hh-------------hccChhh---ccccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence 00 0000000 001123345677899999999999996 6778888887763
|
|
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=336.61 Aligned_cols=266 Identities=20% Similarity=0.258 Sum_probs=195.3
Q ss_pred hcCCcceeeecccceEEEEEe-C-CCcEEEEEEeeccChhhhHHHHHHHHHHHHHhcc---CCCceeeeeeEEEe-----
Q 002721 606 TMKDSNMIYCGTFSTVYKAVM-P-SGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKL---CHDNLVRPIGFVIY----- 675 (888)
Q Consensus 606 ~~~~~~~ig~G~~g~Vy~~~~-~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l---~hpnIv~~~~~~~~----- 675 (888)
+|++.+.||+|+||+||+|+. . +++.||+|+++...... .....+.+|+++++.+ +||||+++++++..
T Consensus 2 ~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~ 80 (290)
T cd07862 2 QYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE-GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDR 80 (290)
T ss_pred CcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCCC-CchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCC
Confidence 688999999999999999985 2 47889999987433221 1223556777777665 69999999998863
Q ss_pred CCeeEEEEecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEecccc
Q 002721 676 EDVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEI 755 (888)
Q Consensus 676 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~ 755 (888)
....++||||++ ++|.+++...... .+++.++..++.||+.||+|||++||+||||||+||+++.++.+||+|||+
T Consensus 81 ~~~~~lv~e~~~-~~l~~~~~~~~~~---~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~ 156 (290)
T cd07862 81 ETKLTLVFEHVD-QDLTTYLDKVPEP---GVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGL 156 (290)
T ss_pred CCcEEEEEccCC-CCHHHHHHhCCCC---CCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccc
Confidence 346899999997 5999998764322 578899999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCcccccccccccceecccccccCCcCccccchhHHHHHHHHHhCCCCCCCCCCCccchhhhcc--ccCCCCC
Q 002721 756 SKLLDPSKGTASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVH--GAPARGE 833 (888)
Q Consensus 756 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~--~~~~~~~ 833 (888)
+....... ......|++.|+|||++.+..++.++||||+||++|||++|++||........ +..... +.+....
T Consensus 157 ~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~-~~~i~~~~~~~~~~~ 232 (290)
T cd07862 157 ARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQ-LGKILDVIGLPGEED 232 (290)
T ss_pred eEeccCCc---ccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHHH-HHHHHHHhCCCChhh
Confidence 98754331 22345689999999999888999999999999999999999999976432211 111110 0010000
Q ss_pred Ccccc--cccccccCCcCc-----HHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002721 834 TPEQI--LDARLSTVSFGW-----RKEMLTALKVALLCTDSTPAKRPKMKKVVE 880 (888)
Q Consensus 834 ~~~~~--~~~~~~~~~~~~-----~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 880 (888)
.+... ............ ......+.+++.+|++.||++|||+.|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 286 (290)
T cd07862 233 WPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALS 286 (290)
T ss_pred chhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCCHHHHhc
Confidence 00000 000000000000 112355678999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=329.24 Aligned_cols=260 Identities=19% Similarity=0.278 Sum_probs=202.7
Q ss_pred cCCcceeeecccceEEEEEeC----CCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCCe----
Q 002721 607 MKDSNMIYCGTFSTVYKAVMP----SGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDV---- 678 (888)
Q Consensus 607 ~~~~~~ig~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~---- 678 (888)
|++.+.||+|+||.||+|... .+..||+|+++.... .....+.+.+|++.++.++||||+++++++...+.
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 79 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIH-TYSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKI 79 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCcC-CHHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccC
Confidence 567889999999999999853 247899999875332 23344578999999999999999999998876554
Q ss_pred --eEEEEecCCCCCHHHHhhccCC-CCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEecccc
Q 002721 679 --ALLLHNYLPNGTLAQLLHESTK-QPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEI 755 (888)
Q Consensus 679 --~~lv~e~~~~g~L~~~l~~~~~-~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~ 755 (888)
.+++|||+++|+|.+++..... .....+++..+..++.|++.||+|||+.+++||||||+||++++++.+||+|||.
T Consensus 80 ~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~ 159 (273)
T cd05035 80 PKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGL 159 (273)
T ss_pred cccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeeccccchheEEECCCCeEEECCccc
Confidence 7999999999999999865432 1223678899999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCcccccccccccceecccccccCCcCccccchhHHHHHHHHHh-CCCCCCCCCCCccchhhhccccCCCCCC
Q 002721 756 SKLLDPSKGTASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILT-TRLPVEEDFGEGVDLVKWVHGAPARGET 834 (888)
Q Consensus 756 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~ 834 (888)
++...............++..|+|||.+.+..++.++|||||||++|||++ |..||...... +..+.....
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~~~~~~--~~~~~~~~~------ 231 (273)
T cd05035 160 SKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENH--EIYDYLRHG------ 231 (273)
T ss_pred eeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHHcC------
Confidence 987654322211122335678999999988889999999999999999999 88998653221 111111110
Q ss_pred cccccccccccCCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHh
Q 002721 835 PEQILDARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEMLQEI 885 (888)
Q Consensus 835 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~i 885 (888)
.... .......++.+++.+||+.||++|||+.|+++.|+++
T Consensus 232 -------~~~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~l~~~ 272 (273)
T cd05035 232 -------NRLK---QPEDCLDELYDLMYSCWRADPKDRPTFTKLREVLENI 272 (273)
T ss_pred -------CCCC---CCcCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 0000 0112345678899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=336.65 Aligned_cols=265 Identities=22% Similarity=0.273 Sum_probs=206.7
Q ss_pred HHHhcCCcceeeecccceEEEEEeC--------CCcEEEEEEeeccChhhhHHHHHHHHHHHHHhcc-CCCceeeeeeEE
Q 002721 603 VKATMKDSNMIYCGTFSTVYKAVMP--------SGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKL-CHDNLVRPIGFV 673 (888)
Q Consensus 603 ~~~~~~~~~~ig~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~ 673 (888)
..++|.+.+.||+|+||.||+|+.. +...||+|.++.... ......+.+|+++++.+ +||||+++++++
T Consensus 16 ~~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~ 93 (307)
T cd05098 16 PRDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDAT--EKDLSDLISEMEMMKMIGKHKNIINLLGAC 93 (307)
T ss_pred ehHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCCC--hHHHHHHHHHHHHHHHhcCCCCEeeEEEEE
Confidence 3568999999999999999999742 235799999875422 22334788899999999 799999999999
Q ss_pred EeCCeeEEEEecCCCCCHHHHhhccCC-----------CCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEe
Q 002721 674 IYEDVALLLHNYLPNGTLAQLLHESTK-----------QPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLL 742 (888)
Q Consensus 674 ~~~~~~~lv~e~~~~g~L~~~l~~~~~-----------~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll 742 (888)
...+..|+||||+++|+|.+++..... .++..+++.+++.++.|++.||+|||++|++||||||+||++
T Consensus 94 ~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill 173 (307)
T cd05098 94 TQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLV 173 (307)
T ss_pred ecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHHheEE
Confidence 999999999999999999999986532 122357889999999999999999999999999999999999
Q ss_pred CCCCCceEeccccccccCCCCCcccccccccccceecccccccCCcCccccchhHHHHHHHHHh-CCCCCCCCCCCccch
Q 002721 743 DADFKPLLGEIEISKLLDPSKGTASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILT-TRLPVEEDFGEGVDL 821 (888)
Q Consensus 743 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~~~~~~~~~ 821 (888)
+.++.+||+|||.+................++..|+|||++.+..++.++||||+||++|||++ |..||.....+ +.
T Consensus 174 ~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~--~~ 251 (307)
T cd05098 174 TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE--EL 251 (307)
T ss_pred cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHH--HH
Confidence 9999999999999876543221111122234568999999988889999999999999999998 88888643211 11
Q ss_pred hhhccccCCCCCCcccccccccccCCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhhh
Q 002721 822 VKWVHGAPARGETPEQILDARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEMLQEIKQ 887 (888)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 887 (888)
........ ... .......++.+++.+||+.+|++|||+.++++.|+++.+
T Consensus 252 ~~~~~~~~-------------~~~---~~~~~~~~~~~li~~~l~~~p~~Rps~~evl~~l~~~~~ 301 (307)
T cd05098 252 FKLLKEGH-------------RMD---KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRILA 301 (307)
T ss_pred HHHHHcCC-------------CCC---CCCcCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHHH
Confidence 11111100 000 011223567789999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=331.99 Aligned_cols=262 Identities=18% Similarity=0.301 Sum_probs=206.7
Q ss_pred HHHhcCCcceeeecccceEEEEEeC------CCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeC
Q 002721 603 VKATMKDSNMIYCGTFSTVYKAVMP------SGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYE 676 (888)
Q Consensus 603 ~~~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 676 (888)
..++|++.+.||+|+||.||+|... ++..||+|.+...... .....+.+|+.+++.++||||+++++++...
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~~~--~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~ 81 (277)
T cd05032 4 PREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASM--RERIEFLNEASVMKEFNCHHVVRLLGVVSTG 81 (277)
T ss_pred chHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCccCH--HHHHHHHHHHHHHHhCCCCceeEEEEEEcCC
Confidence 4568999999999999999999853 2478999998644322 2334788999999999999999999999999
Q ss_pred CeeEEEEecCCCCCHHHHhhccCCCC-----CCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEe
Q 002721 677 DVALLLHNYLPNGTLAQLLHESTKQP-----DYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLG 751 (888)
Q Consensus 677 ~~~~lv~e~~~~g~L~~~l~~~~~~~-----~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~ 751 (888)
...++||||+++|+|.+++....... ...+++..+..++.|++.||+|||+.+++||||||+||+++.++.+||+
T Consensus 82 ~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~kl~ 161 (277)
T cd05032 82 QPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIG 161 (277)
T ss_pred CCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChheEEEcCCCCEEEC
Confidence 99999999999999999997643221 1246888999999999999999999999999999999999999999999
Q ss_pred ccccccccCCCCCcccccccccccceecccccccCCcCccccchhHHHHHHHHHh-CCCCCCCCCCCccchhhhccccCC
Q 002721 752 EIEISKLLDPSKGTASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILT-TRLPVEEDFGEGVDLVKWVHGAPA 830 (888)
Q Consensus 752 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~ 830 (888)
|||.++...............++..|+|||.+.+..++.++|||||||++||+++ |..||...... ........
T Consensus 162 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~--~~~~~~~~--- 236 (277)
T cd05032 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNE--EVLKFVID--- 236 (277)
T ss_pred CcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHH--HHHHHHhc---
Confidence 9999886544322222233456788999999988889999999999999999998 99998653221 11111110
Q ss_pred CCCCcccccccccccCCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 002721 831 RGETPEQILDARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEMLQE 884 (888)
Q Consensus 831 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~ 884 (888)
......+ .....++.+++.+||+.+|++|||+.++++.|++
T Consensus 237 ----------~~~~~~~---~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 277 (277)
T cd05032 237 ----------GGHLDLP---ENCPDKLLELMRMCWQYNPKMRPTFLEIVSSLKD 277 (277)
T ss_pred ----------CCCCCCC---CCCCHHHHHHHHHHcCCChhhCCCHHHHHHHhcC
Confidence 0000001 1124567899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=334.60 Aligned_cols=255 Identities=18% Similarity=0.269 Sum_probs=202.2
Q ss_pred HHhcCCcceeeecccceEEEEEeCCCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccC-CCceeeeeeEEEeCCeeEEE
Q 002721 604 KATMKDSNMIYCGTFSTVYKAVMPSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLC-HDNLVRPIGFVIYEDVALLL 682 (888)
Q Consensus 604 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~~lv 682 (888)
...|++.++||+||.+.||++...+.+.||+|++.... .+.....-|.+|+..|.+++ |.+||++|+|-..++..|+|
T Consensus 360 g~~Yeilk~iG~GGSSkV~kV~~s~~~iyalkkv~~~~-~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmv 438 (677)
T KOG0596|consen 360 GREYEILKQIGSGGSSKVFKVLNSDKQIYALKKVVLLE-ADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMV 438 (677)
T ss_pred cchhhHHHhhcCCCcceeeeeecCCCcchhhhHHHHhh-cCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEE
Confidence 45699999999999999999998888999999886333 33345568999999999995 99999999999999999999
Q ss_pred EecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccccccccCCC
Q 002721 683 HNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPS 762 (888)
Q Consensus 683 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 762 (888)
|||=+ .||.++++...... ..| .++.+..||+.|+.++|.+||||.||||.|+++- .|.+||+|||+|..+..+
T Consensus 439 mE~Gd-~DL~kiL~k~~~~~---~~~-~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~D 512 (677)
T KOG0596|consen 439 MECGD-IDLNKILKKKKSID---PDW-FLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLLV-KGRLKLIDFGIANAIQPD 512 (677)
T ss_pred eeccc-ccHHHHHHhccCCC---chH-HHHHHHHHHHHHHHHHHHhceeecCCCcccEEEE-eeeEEeeeechhcccCcc
Confidence 99864 59999999876532 234 7788999999999999999999999999999997 479999999999998876
Q ss_pred CCcccccccccccceecccccccCC-----------cCccccchhHHHHHHHHHhCCCCCCCCCCCccchhhhccccCCC
Q 002721 763 KGTASISAVAGSFGYIPPEYAYTMQ-----------VTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPAR 831 (888)
Q Consensus 763 ~~~~~~~~~~gt~~y~aPE~~~~~~-----------~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~ 831 (888)
.........+||+.||+||.+.... .++++||||+|||+|+|+.|++||........
T Consensus 513 TTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~n~~a------------ 580 (677)
T KOG0596|consen 513 TTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQIINQIA------------ 580 (677)
T ss_pred ccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHHHHHH------------
Confidence 6555556789999999999876432 56789999999999999999999975321111
Q ss_pred CCCcccccccccccCCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002721 832 GETPEQILDARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVE 880 (888)
Q Consensus 832 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 880 (888)
....+.++...- .+.......+++++|+.||.+||++|||+.|+++
T Consensus 581 --Kl~aI~~P~~~I-efp~~~~~~~li~~mK~CL~rdPkkR~si~eLLq 626 (677)
T KOG0596|consen 581 --KLHAITDPNHEI-EFPDIPENDELIDVMKCCLARDPKKRWSIPELLQ 626 (677)
T ss_pred --HHHhhcCCCccc-cccCCCCchHHHHHHHHHHhcCcccCCCcHHHhc
Confidence 111122221100 0001111123889999999999999999999986
|
|
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-38 Score=342.63 Aligned_cols=244 Identities=20% Similarity=0.175 Sum_probs=190.1
Q ss_pred ceeeecccceEEEEEeC-CCcEEEEEEeeccChhhhHHHHHHHHHHH-HHhccCCCceeeeeeEEEeCCeeEEEEecCCC
Q 002721 611 NMIYCGTFSTVYKAVMP-SGLILSVKRLKSMDRTIIHHQNKMIRELE-KLSKLCHDNLVRPIGFVIYEDVALLLHNYLPN 688 (888)
Q Consensus 611 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~-~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~ 688 (888)
+.||+|+||+||+|+.. +++.||+|++.............+.+|.. +++.++||||+++++++...+..|+||||+++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYING 80 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCC
Confidence 47999999999999954 67899999997543322223334455544 56788999999999999999999999999999
Q ss_pred CCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccccccccCCCCCcccc
Q 002721 689 GTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSKGTASI 768 (888)
Q Consensus 689 g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~ 768 (888)
|+|.+++.... .+++..+..++.||++||+|||++||+||||||+||+++.++.+||+|||+++....... ..
T Consensus 81 ~~L~~~~~~~~-----~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~--~~ 153 (325)
T cd05602 81 GELFYHLQRER-----CFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG--TT 153 (325)
T ss_pred CcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCC--Cc
Confidence 99999997643 456778888999999999999999999999999999999999999999999875432221 12
Q ss_pred cccccccceecccccccCCcCccccchhHHHHHHHHHhCCCCCCCCCCCccchhhhccccCCCCCCcccccccccccCCc
Q 002721 769 SAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQILDARLSTVSF 848 (888)
Q Consensus 769 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 848 (888)
....||+.|+|||++.+..++.++||||+||++|||++|+.||...... ....... .....
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--~~~~~i~-------------~~~~~---- 214 (325)
T cd05602 154 STFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTA--EMYDNIL-------------NKPLQ---- 214 (325)
T ss_pred ccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHH--HHHHHHH-------------hCCcC----
Confidence 3457999999999999999999999999999999999999999753221 1111110 00000
Q ss_pred CcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002721 849 GWRKEMLTALKVALLCTDSTPAKRPKMKKVVE 880 (888)
Q Consensus 849 ~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 880 (888)
........+.+++.+|++.||.+||++.+.+.
T Consensus 215 ~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~ 246 (325)
T cd05602 215 LKPNITNSARHLLEGLLQKDRTKRLGAKDDFM 246 (325)
T ss_pred CCCCCCHHHHHHHHHHcccCHHHCCCCCCCHH
Confidence 01122356778999999999999999875443
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-38 Score=343.89 Aligned_cols=240 Identities=21% Similarity=0.249 Sum_probs=192.5
Q ss_pred ceeeecccceEEEEEe----CCCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCCeeEEEEecC
Q 002721 611 NMIYCGTFSTVYKAVM----PSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVALLLHNYL 686 (888)
Q Consensus 611 ~~ig~G~~g~Vy~~~~----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~ 686 (888)
+.||+|+||.||+++. .+|+.||+|+++..... ......+.+|++++++++||||+++++++..++..|+||||+
T Consensus 2 ~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~ 80 (318)
T cd05582 2 KVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLK-VRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFL 80 (318)
T ss_pred ceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCC
Confidence 5799999999999974 36899999999753322 223346788999999999999999999999999999999999
Q ss_pred CCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccccccccCCCCCcc
Q 002721 687 PNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSKGTA 766 (888)
Q Consensus 687 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 766 (888)
++|+|.+++.... .+++..+..++.||++||+|||++||+||||||+||+++.++.+||+|||++........
T Consensus 81 ~~~~L~~~l~~~~-----~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~-- 153 (318)
T cd05582 81 RGGDLFTRLSKEV-----MFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK-- 153 (318)
T ss_pred CCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCC--
Confidence 9999999987543 468899999999999999999999999999999999999999999999999886543221
Q ss_pred cccccccccceecccccccCCcCccccchhHHHHHHHHHhCCCCCCCCCCCccchhhhccccCCCCCCcccccccccccC
Q 002721 767 SISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQILDARLSTV 846 (888)
Q Consensus 767 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 846 (888)
......|++.|+|||++.+..++.++|||||||++|||++|+.||...... .....+ ...... .
T Consensus 154 ~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~--~~~~~i-------------~~~~~~-~ 217 (318)
T cd05582 154 KAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRK--ETMTMI-------------LKAKLG-M 217 (318)
T ss_pred ceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHH--HHHHHH-------------HcCCCC-C
Confidence 123457899999999999888999999999999999999999999753211 111100 000000 0
Q ss_pred CcCcHHHHHHHHHHHhhccCCCCCCCCCHHH
Q 002721 847 SFGWRKEMLTALKVALLCTDSTPAKRPKMKK 877 (888)
Q Consensus 847 ~~~~~~~~~~~~~li~~cl~~dP~~RPs~~e 877 (888)
.......+.+++.+||+.||++||++.+
T Consensus 218 ---p~~~~~~~~~li~~~l~~~P~~R~~a~~ 245 (318)
T cd05582 218 ---PQFLSPEAQSLLRALFKRNPANRLGAGP 245 (318)
T ss_pred ---CCCCCHHHHHHHHHHhhcCHhHcCCCCC
Confidence 1112355778999999999999999554
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=331.21 Aligned_cols=260 Identities=18% Similarity=0.334 Sum_probs=204.5
Q ss_pred HHHhcCCcceeeecccceEEEEEe-CCCc----EEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCC
Q 002721 603 VKATMKDSNMIYCGTFSTVYKAVM-PSGL----ILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYED 677 (888)
Q Consensus 603 ~~~~~~~~~~ig~G~~g~Vy~~~~-~~~~----~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 677 (888)
...+|+..+.||+|+||+||+|++ .+++ .||+|+++..... ...+.+.+|+.+++.+.||||+++++++.. .
T Consensus 5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~~~--~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~-~ 81 (279)
T cd05109 5 KETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSP--KANKEILDEAYVMAGVGSPYVCRLLGICLT-S 81 (279)
T ss_pred chhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCCCH--HHHHHHHHHHHHHHhcCCCCCceEEEEEcC-C
Confidence 456899999999999999999984 3444 4899998744322 234578899999999999999999999875 4
Q ss_pred eeEEEEecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEecccccc
Q 002721 678 VALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISK 757 (888)
Q Consensus 678 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~ 757 (888)
..+++|||+++|+|.++++.... .+++..++.++.||+.||+|||++||+||||||+||++++++.+||+|||+++
T Consensus 82 ~~~l~~~~~~~g~l~~~l~~~~~----~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~ 157 (279)
T cd05109 82 TVQLVTQLMPYGCLLDYVRENKD----RIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLAR 157 (279)
T ss_pred CcEEEEEcCCCCCHHHHHhhccC----CCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCCCcee
Confidence 57899999999999999976432 57889999999999999999999999999999999999999999999999998
Q ss_pred ccCCCCCcccccccccccceecccccccCCcCccccchhHHHHHHHHHh-CCCCCCCCCCCccchhhhccccCCCCCCcc
Q 002721 758 LLDPSKGTASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILT-TRLPVEEDFGEGVDLVKWVHGAPARGETPE 836 (888)
Q Consensus 758 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 836 (888)
...............++..|+|||...+..++.++|||||||++|||++ |..||...... ....++.... ..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--~~~~~~~~~~----~~- 230 (279)
T cd05109 158 LLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAR--EIPDLLEKGE----RL- 230 (279)
T ss_pred ecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH--HHHHHHHCCC----cC-
Confidence 7654332222222345678999999988899999999999999999998 89998653221 1111111100 00
Q ss_pred cccccccccCCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhhh
Q 002721 837 QILDARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEMLQEIKQ 887 (888)
Q Consensus 837 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 887 (888)
. .......++.+++.+||+.||++||++.++++.|+++.+
T Consensus 231 --------~---~~~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05109 231 --------P---QPPICTIDVYMIMVKCWMIDSECRPRFRELVDEFSRMAR 270 (279)
T ss_pred --------C---CCccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHhhc
Confidence 0 011223567789999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-38 Score=343.35 Aligned_cols=243 Identities=21% Similarity=0.188 Sum_probs=190.9
Q ss_pred ceeeecccceEEEEEe-CCCcEEEEEEeeccChhhhHHHHHHHHHHH-HHhccCCCceeeeeeEEEeCCeeEEEEecCCC
Q 002721 611 NMIYCGTFSTVYKAVM-PSGLILSVKRLKSMDRTIIHHQNKMIRELE-KLSKLCHDNLVRPIGFVIYEDVALLLHNYLPN 688 (888)
Q Consensus 611 ~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~-~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~ 688 (888)
+.||+|+||+||+|+. .+|+.||+|++.............+.+|.. +++.++||||+++++++..++..|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~ 80 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNG 80 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCC
Confidence 4699999999999995 468999999997543333333445666665 46778999999999999999999999999999
Q ss_pred CCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccccccccCCCCCcccc
Q 002721 689 GTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSKGTASI 768 (888)
Q Consensus 689 g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~ 768 (888)
|+|..++.... .+++.++..++.||+.||+|||++||+||||||+||+++.++.+||+|||+++....... ..
T Consensus 81 ~~L~~~l~~~~-----~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~~--~~ 153 (325)
T cd05604 81 GELFFHLQRER-----SFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSD--TT 153 (325)
T ss_pred CCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCCC--Cc
Confidence 99998887543 467889999999999999999999999999999999999999999999999875432211 12
Q ss_pred cccccccceecccccccCCcCccccchhHHHHHHHHHhCCCCCCCCCCCccchhhhccccCCCCCCcccccccccccCCc
Q 002721 769 SAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQILDARLSTVSF 848 (888)
Q Consensus 769 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 848 (888)
....||+.|+|||++.+..++.++||||+||++|||++|+.||....... ..+. +.......
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~--~~~~-------------~~~~~~~~--- 215 (325)
T cd05604 154 TTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAE--MYDN-------------ILHKPLVL--- 215 (325)
T ss_pred ccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHH--HHHH-------------HHcCCccC---
Confidence 34578999999999999999999999999999999999999997532111 1110 11100000
Q ss_pred CcHHHHHHHHHHHhhccCCCCCCCCCHHHHH
Q 002721 849 GWRKEMLTALKVALLCTDSTPAKRPKMKKVV 879 (888)
Q Consensus 849 ~~~~~~~~~~~li~~cl~~dP~~RPs~~evl 879 (888)
.......+.+++.+|++.+|.+||++.+.+
T Consensus 216 -~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~ 245 (325)
T cd05604 216 -RPGASLTAWSILEELLEKDRQRRLGAKEDF 245 (325)
T ss_pred -CCCCCHHHHHHHHHHhccCHHhcCCCCCCH
Confidence 011234567899999999999999886433
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=345.72 Aligned_cols=258 Identities=17% Similarity=0.157 Sum_probs=199.7
Q ss_pred HHHHhcCCcceeeecccceEEEEEeC-CCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCCeeE
Q 002721 602 VVKATMKDSNMIYCGTFSTVYKAVMP-SGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVAL 680 (888)
Q Consensus 602 ~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 680 (888)
+..++|++.+.||+|+||.||+|+.. +++.||+|++...........+.+.+|+.+++.++||||+++++++..++..|
T Consensus 40 ~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~ 119 (371)
T cd05622 40 MKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLY 119 (371)
T ss_pred cchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEE
Confidence 34578999999999999999999954 68999999997543333334456788999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccccccccC
Q 002721 681 LLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLD 760 (888)
Q Consensus 681 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~~ 760 (888)
+||||+++|+|.+++... .++...+..++.||+.||+|||++||+||||||+||+++.++.+||+|||++....
T Consensus 120 lv~Ey~~gg~L~~~~~~~------~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~ 193 (371)
T cd05622 120 MVMEYMPGGDLVNLMSNY------DVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMN 193 (371)
T ss_pred EEEcCCCCCcHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcC
Confidence 999999999999998753 35678888999999999999999999999999999999999999999999998764
Q ss_pred CCCCcccccccccccceecccccccCC----cCccccchhHHHHHHHHHhCCCCCCCCCCCccchhhhccccCCCCCCcc
Q 002721 761 PSKGTASISAVAGSFGYIPPEYAYTMQ----VTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPE 836 (888)
Q Consensus 761 ~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 836 (888)
... ........||+.|+|||++.+.. ++.++||||+||++|||++|+.||....... ....
T Consensus 194 ~~~-~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~-~~~~------------- 258 (371)
T cd05622 194 KEG-MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVG-TYSK------------- 258 (371)
T ss_pred cCC-cccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHH-HHHH-------------
Confidence 322 11223567999999999986543 7889999999999999999999997532210 0011
Q ss_pred cccccccccCCcCcHHHHHHHHHHHhhccCCCCCC--CCCHHHHHHH
Q 002721 837 QILDARLSTVSFGWRKEMLTALKVALLCTDSTPAK--RPKMKKVVEM 881 (888)
Q Consensus 837 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~--RPs~~evl~~ 881 (888)
+.........+........+.+++.+|+..++.+ ||+++|+++.
T Consensus 259 -i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h 304 (371)
T cd05622 259 -IMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRNGVEEIKRH 304 (371)
T ss_pred -HHcCCCcccCCCcCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcC
Confidence 1100000000011223456778889999844433 7789988764
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=340.95 Aligned_cols=240 Identities=22% Similarity=0.210 Sum_probs=189.0
Q ss_pred ceeeecccceEEEEEeC-CCcEEEEEEeeccChhhhHHHHHHHHHHH-HHhccCCCceeeeeeEEEeCCeeEEEEecCCC
Q 002721 611 NMIYCGTFSTVYKAVMP-SGLILSVKRLKSMDRTIIHHQNKMIRELE-KLSKLCHDNLVRPIGFVIYEDVALLLHNYLPN 688 (888)
Q Consensus 611 ~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~-~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~ 688 (888)
+.||+|+||.||+|+.. +++.||+|++.+...........+.+|.. +++.++||||+++++++.+.+..|+||||+++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~ 80 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNG 80 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCC
Confidence 47999999999999954 68999999997543333333445666654 57889999999999999999999999999999
Q ss_pred CCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccccccccCCCCCcccc
Q 002721 689 GTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSKGTASI 768 (888)
Q Consensus 689 g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~ 768 (888)
++|.+.+.... .+++.++..++.||++||+|||++||+||||||+||+++.++.+||+|||+++...... ...
T Consensus 81 ~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~--~~~ 153 (321)
T cd05603 81 GELFFHLQRER-----CFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE--ETT 153 (321)
T ss_pred CCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCC--Ccc
Confidence 99998887543 46778889999999999999999999999999999999999999999999987532221 112
Q ss_pred cccccccceecccccccCCcCccccchhHHHHHHHHHhCCCCCCCCCCCccchhhhccccCCCCCCcccccccccccCCc
Q 002721 769 SAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQILDARLSTVSF 848 (888)
Q Consensus 769 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 848 (888)
....||+.|+|||++.+..++.++||||+||++|||++|+.||...... ..... +...... .
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~--~~~~~-------------i~~~~~~-~-- 215 (321)
T cd05603 154 STFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVS--QMYDN-------------ILHKPLQ-L-- 215 (321)
T ss_pred ccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHH--HHHHH-------------HhcCCCC-C--
Confidence 3457899999999999889999999999999999999999999754211 11111 1110000 0
Q ss_pred CcHHHHHHHHHHHhhccCCCCCCCCCHH
Q 002721 849 GWRKEMLTALKVALLCTDSTPAKRPKMK 876 (888)
Q Consensus 849 ~~~~~~~~~~~li~~cl~~dP~~RPs~~ 876 (888)
.......+.+++.+|++.||++||++.
T Consensus 216 -~~~~~~~~~~li~~~l~~~p~~R~~~~ 242 (321)
T cd05603 216 -PGGKTVAACDLLVGLLHKDQRRRLGAK 242 (321)
T ss_pred -CCCCCHHHHHHHHHHccCCHhhcCCCC
Confidence 112234677899999999999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=347.70 Aligned_cols=262 Identities=16% Similarity=0.163 Sum_probs=198.2
Q ss_pred HHHhcCCcceeeecccceEEEEEe-CCCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCCeeEE
Q 002721 603 VKATMKDSNMIYCGTFSTVYKAVM-PSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVALL 681 (888)
Q Consensus 603 ~~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 681 (888)
...+|++.+.||+|+||.||+|.. .+++.||+|.... ..+.+|++++++++||||+++++++..+...++
T Consensus 90 ~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~---------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~l 160 (391)
T PHA03212 90 EKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQR---------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCL 160 (391)
T ss_pred ccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhh---------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEE
Confidence 345799999999999999999995 4689999996431 256789999999999999999999999999999
Q ss_pred EEecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccccccccCC
Q 002721 682 LHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDP 761 (888)
Q Consensus 682 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~~~ 761 (888)
|||++. ++|.+++.... .+++.+++.++.||+.||+|||++||+||||||+||+++.++.+||+|||++.....
T Consensus 161 v~e~~~-~~L~~~l~~~~-----~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~ 234 (391)
T PHA03212 161 ILPRYK-TDLYCYLAAKR-----NIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVD 234 (391)
T ss_pred EEecCC-CCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEcCCCCEEEEeCCccccccc
Confidence 999996 68988887643 467889999999999999999999999999999999999999999999999975432
Q ss_pred CCCcccccccccccceecccccccCCcCccccchhHHHHHHHHHhCCCCCCCCCCCc------cchhhhcc--ccCCCCC
Q 002721 762 SKGTASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEG------VDLVKWVH--GAPARGE 833 (888)
Q Consensus 762 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~------~~~~~~~~--~~~~~~~ 833 (888)
.. ........||+.|+|||++.+..++.++||||+||++|||++|+.||....... ..+..... +......
T Consensus 235 ~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~ 313 (391)
T PHA03212 235 IN-ANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEF 313 (391)
T ss_pred cc-ccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhc
Confidence 21 112234579999999999999899999999999999999999998875432111 01111110 0000000
Q ss_pred --C----ccccc----cc--ccccCCcCc---HHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002721 834 --T----PEQIL----DA--RLSTVSFGW---RKEMLTALKVALLCTDSTPAKRPKMKKVVE 880 (888)
Q Consensus 834 --~----~~~~~----~~--~~~~~~~~~---~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 880 (888)
. ..... .. ........+ .....++.+++.+||+.||++|||++|+++
T Consensus 314 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rpta~elL~ 375 (391)
T PHA03212 314 PIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRPSAEALLD 375 (391)
T ss_pred CcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCCCHHHHhc
Confidence 0 00000 00 000000011 123457889999999999999999999985
|
|
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=326.51 Aligned_cols=256 Identities=20% Similarity=0.341 Sum_probs=205.4
Q ss_pred HHHHhcCCcceeeecccceEEEEEeCCCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCCeeEE
Q 002721 602 VVKATMKDSNMIYCGTFSTVYKAVMPSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVALL 681 (888)
Q Consensus 602 ~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 681 (888)
+..++|++.++||+|+||.||+|...+++.||+|.+...... .+.+.+|+.++++++||||+++++++. .+..++
T Consensus 3 ~~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~a~K~~~~~~~~----~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~ 77 (260)
T cd05067 3 VPRETLKLVKKLGAGQFGEVWMGYYNGHTKVAIKSLKQGSMS----PEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYI 77 (260)
T ss_pred cchHHceeeeeeccCccceEEeeecCCCceEEEEEecCCCCc----HHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEE
Confidence 456789999999999999999999888999999998754332 237889999999999999999999874 567899
Q ss_pred EEecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccccccccCC
Q 002721 682 LHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDP 761 (888)
Q Consensus 682 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~~~ 761 (888)
+|||+++++|.+++...... .+++.++..++.|++.||+|||+.|++||||||+||++++++.++++|||.+.....
T Consensus 78 v~e~~~~~~L~~~~~~~~~~---~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 154 (260)
T cd05067 78 ITEYMENGSLVDFLKTPEGI---KLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIED 154 (260)
T ss_pred EEEcCCCCCHHHHHHhcCCC---CCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEEcCCCCEEEccCcceeecCC
Confidence 99999999999998764322 578899999999999999999999999999999999999999999999999987653
Q ss_pred CCCcccccccccccceecccccccCCcCccccchhHHHHHHHHHh-CCCCCCCCCCCccchhhhccccCCCCCCcccccc
Q 002721 762 SKGTASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILT-TRLPVEEDFGEGVDLVKWVHGAPARGETPEQILD 840 (888)
Q Consensus 762 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 840 (888)
.... ......++..|+|||++.+..++.++||||||+++||+++ |+.||...... +...........
T Consensus 155 ~~~~-~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--~~~~~~~~~~~~--------- 222 (260)
T cd05067 155 NEYT-AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNP--EVIQNLERGYRM--------- 222 (260)
T ss_pred CCcc-cccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChH--HHHHHHHcCCCC---------
Confidence 2211 1123345678999999988889999999999999999999 99999754321 111111100000
Q ss_pred cccccCCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 002721 841 ARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEMLQE 884 (888)
Q Consensus 841 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~ 884 (888)
. .......++.+++.+||+.+|++||+++++++.|+.
T Consensus 223 ----~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 259 (260)
T cd05067 223 ----P---RPDNCPEELYELMRLCWKEKPEERPTFEYLRSVLED 259 (260)
T ss_pred ----C---CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHhhc
Confidence 0 011123468889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-38 Score=348.05 Aligned_cols=204 Identities=21% Similarity=0.239 Sum_probs=176.5
Q ss_pred hcCCcceeeecccceEEEEEe-CCCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCCeeEEEEe
Q 002721 606 TMKDSNMIYCGTFSTVYKAVM-PSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVALLLHN 684 (888)
Q Consensus 606 ~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 684 (888)
+|+..+.||+|+||+||+|+. .+++.||+|+++............+.+|+.++.+++||+|+++++++.+++..|+|||
T Consensus 2 ~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E 81 (360)
T cd05627 2 DFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIME 81 (360)
T ss_pred CceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEe
Confidence 688899999999999999995 4689999999985443334445678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccccccccCCCCC
Q 002721 685 YLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSKG 764 (888)
Q Consensus 685 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 764 (888)
|+++|+|.+++.... .+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||++........
T Consensus 82 ~~~gg~L~~~l~~~~-----~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~ 156 (360)
T cd05627 82 FLPGGDMMTLLMKKD-----TLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHR 156 (360)
T ss_pred CCCCccHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCCCEEEeeccCCcccccccc
Confidence 999999999997643 467889999999999999999999999999999999999999999999999875432110
Q ss_pred c---------------------------------ccccccccccceecccccccCCcCccccchhHHHHHHHHHhCCCCC
Q 002721 765 T---------------------------------ASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILTTRLPV 811 (888)
Q Consensus 765 ~---------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~ 811 (888)
. ......+||+.|+|||++.+..++.++||||+||++|||++|+.||
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf 236 (360)
T cd05627 157 TEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPF 236 (360)
T ss_pred cccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCC
Confidence 0 0011347999999999999999999999999999999999999999
Q ss_pred CCC
Q 002721 812 EED 814 (888)
Q Consensus 812 ~~~ 814 (888)
...
T Consensus 237 ~~~ 239 (360)
T cd05627 237 CSE 239 (360)
T ss_pred CCC
Confidence 754
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=343.41 Aligned_cols=266 Identities=19% Similarity=0.273 Sum_probs=207.1
Q ss_pred HHHHhcCCcceeeecccceEEEEEeC------CCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccC-CCceeeeeeEEE
Q 002721 602 VVKATMKDSNMIYCGTFSTVYKAVMP------SGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLC-HDNLVRPIGFVI 674 (888)
Q Consensus 602 ~~~~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~ 674 (888)
+..++|.+.+.||+|+||.||+|++. .+..||+|+++..... ...+.+.+|++++.++. ||||+++++++.
T Consensus 34 ~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~~~--~~~~~~~~E~~~l~~l~~H~niv~~~~~~~ 111 (401)
T cd05107 34 MPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTARS--SEKQALMSELKIMSHLGPHLNIVNLLGACT 111 (401)
T ss_pred ecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCCCh--hHHHHHHHHHHHHHhcCCCCCeEEEEEEEc
Confidence 45668889999999999999999843 3468999999754322 22346889999999997 999999999999
Q ss_pred eCCeeEEEEecCCCCCHHHHhhccCCC-----------------------------------------------------
Q 002721 675 YEDVALLLHNYLPNGTLAQLLHESTKQ----------------------------------------------------- 701 (888)
Q Consensus 675 ~~~~~~lv~e~~~~g~L~~~l~~~~~~----------------------------------------------------- 701 (888)
..+..++||||+++|+|.++++.....
T Consensus 112 ~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (401)
T cd05107 112 KGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVP 191 (401)
T ss_pred cCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCccc
Confidence 999999999999999999999754210
Q ss_pred ----------------------------------------CCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeE
Q 002721 702 ----------------------------------------PDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVL 741 (888)
Q Consensus 702 ----------------------------------------~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIl 741 (888)
....+++..+..++.||+.||+|||+++++||||||+||+
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~NiL 271 (401)
T cd05107 192 MQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVL 271 (401)
T ss_pred hhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceEE
Confidence 1124677788999999999999999999999999999999
Q ss_pred eCCCCCceEeccccccccCCCCCcccccccccccceecccccccCCcCccccchhHHHHHHHHHh-CCCCCCCCCCCccc
Q 002721 742 LDADFKPLLGEIEISKLLDPSKGTASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILT-TRLPVEEDFGEGVD 820 (888)
Q Consensus 742 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~~~~~~~~ 820 (888)
+++++.+|++|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||........
T Consensus 272 l~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~- 350 (401)
T cd05107 272 ICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQ- 350 (401)
T ss_pred EeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHH-
Confidence 99999999999999986543222111223456788999999988889999999999999999998 8899865321111
Q ss_pred hhhhccccCCCCCCcccccccccccCCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhh
Q 002721 821 LVKWVHGAPARGETPEQILDARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEMLQEIK 886 (888)
Q Consensus 821 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~i~ 886 (888)
....+... ... . .......++.+++.+||..+|++||+++||++.|+++.
T Consensus 351 ~~~~~~~~----~~~---------~---~p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~L~~~~ 400 (401)
T cd05107 351 FYNAIKRG----YRM---------A---KPAHASDEIYEIMQKCWEEKFEIRPDFSQLVHLVGDLL 400 (401)
T ss_pred HHHHHHcC----CCC---------C---CCCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHHHh
Confidence 11100000 000 0 01112356788999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-37 Score=328.39 Aligned_cols=260 Identities=16% Similarity=0.211 Sum_probs=198.7
Q ss_pred cCCcceeeecccceEEEEEeCC-Cc--EEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeC------C
Q 002721 607 MKDSNMIYCGTFSTVYKAVMPS-GL--ILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYE------D 677 (888)
Q Consensus 607 ~~~~~~ig~G~~g~Vy~~~~~~-~~--~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~------~ 677 (888)
|.+.+.||+|+||.||+|+..+ +. .||+|.++.... .....+.+.+|+++++.++||||+++++++... .
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 79 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAIC-TRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYP 79 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCcC-CHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCC
Confidence 3567899999999999999644 33 689998875422 223345788999999999999999999987532 2
Q ss_pred eeEEEEecCCCCCHHHHhhccCC-CCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccccc
Q 002721 678 VALLLHNYLPNGTLAQLLHESTK-QPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEIS 756 (888)
Q Consensus 678 ~~~lv~e~~~~g~L~~~l~~~~~-~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a 756 (888)
..+++|||+++|+|.+++..... .....+++..+..++.|++.||+|||++||+||||||+||++++++.+||+|||++
T Consensus 80 ~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~ 159 (272)
T cd05075 80 SPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLS 159 (272)
T ss_pred CcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhheEEcCCCCEEECCCCcc
Confidence 46899999999999998854321 11225789999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCCcccccccccccceecccccccCCcCccccchhHHHHHHHHHh-CCCCCCCCCCCccchhhhccccCCCCCCc
Q 002721 757 KLLDPSKGTASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILT-TRLPVEEDFGEGVDLVKWVHGAPARGETP 835 (888)
Q Consensus 757 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 835 (888)
+...............+++.|+|||...+..++.++||||||+++|||++ |+.||...... ......... ...
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~--~~~~~~~~~----~~~ 233 (272)
T cd05075 160 KKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENS--EIYDYLRQG----NRL 233 (272)
T ss_pred cccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHH--HHHHHHHcC----CCC
Confidence 87654322111122345678999999998899999999999999999999 88998653211 111111110 000
Q ss_pred ccccccccccCCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHh
Q 002721 836 EQILDARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEMLQEI 885 (888)
Q Consensus 836 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~i 885 (888)
.. .......+.+++.+||+.||++|||+.++++.|+++
T Consensus 234 ---------~~---~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~~~ 271 (272)
T cd05075 234 ---------KQ---PPDCLDGLYSLMSSCWLLNPKDRPSFETLRCELEKA 271 (272)
T ss_pred ---------CC---CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 00 111234578899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=333.86 Aligned_cols=265 Identities=20% Similarity=0.284 Sum_probs=207.8
Q ss_pred HHHHhcCCcceeeecccceEEEEEe--------CCCcEEEEEEeeccChhhhHHHHHHHHHHHHHhcc-CCCceeeeeeE
Q 002721 602 VVKATMKDSNMIYCGTFSTVYKAVM--------PSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKL-CHDNLVRPIGF 672 (888)
Q Consensus 602 ~~~~~~~~~~~ig~G~~g~Vy~~~~--------~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~ 672 (888)
+...+|++.+.||+|+||.||+|+. .++..||+|.++.... ....+.+.+|+.+++.+ +||||++++++
T Consensus 12 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~~~--~~~~~~~~~E~~~l~~l~~h~~i~~~~~~ 89 (304)
T cd05101 12 FSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDAT--EKDLSDLVSEMEMMKMIGKHKNIINLLGA 89 (304)
T ss_pred ccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccccc--hHHHHHHHHHHHHHHhhccCCCchheeEE
Confidence 3467899999999999999999973 1245799998874322 22345788999999999 79999999999
Q ss_pred EEeCCeeEEEEecCCCCCHHHHhhccCCC-----------CCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeE
Q 002721 673 VIYEDVALLLHNYLPNGTLAQLLHESTKQ-----------PDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVL 741 (888)
Q Consensus 673 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~-----------~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIl 741 (888)
+...+..|+||||+++|+|.+++...... +...+++.++..++.||++||+|||++|++||||||+||+
T Consensus 90 ~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nil 169 (304)
T cd05101 90 CTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVL 169 (304)
T ss_pred EecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeecccccceEE
Confidence 99999999999999999999999864321 1235788899999999999999999999999999999999
Q ss_pred eCCCCCceEeccccccccCCCCCcccccccccccceecccccccCCcCccccchhHHHHHHHHHh-CCCCCCCCCCCccc
Q 002721 742 LDADFKPLLGEIEISKLLDPSKGTASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILT-TRLPVEEDFGEGVD 820 (888)
Q Consensus 742 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~~~~~~~~ 820 (888)
+++++.+|++|||.++...............++..|+|||++.+..++.++||||||+++|||++ |..||...... +
T Consensus 170 i~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~--~ 247 (304)
T cd05101 170 VTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE--E 247 (304)
T ss_pred EcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH--H
Confidence 99999999999999987654322222223345678999999988889999999999999999998 78888643211 1
Q ss_pred hhhhccccCCCCCCcccccccccccCCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhh
Q 002721 821 LVKWVHGAPARGETPEQILDARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEMLQEIK 886 (888)
Q Consensus 821 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~i~ 886 (888)
.......... .. ........+.+++.+||+.+|++|||+.|+++.|+++.
T Consensus 248 ~~~~~~~~~~-------------~~---~~~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~l~~~~ 297 (304)
T cd05101 248 LFKLLKEGHR-------------MD---KPANCTNELYMMMRDCWHAIPSHRPTFKQLVEDLDRIL 297 (304)
T ss_pred HHHHHHcCCc-------------CC---CCCCCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHHH
Confidence 1111110000 00 01123456778999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=326.02 Aligned_cols=255 Identities=19% Similarity=0.321 Sum_probs=203.6
Q ss_pred HHhcCCcceeeecccceEEEEEeCCCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCCeeEEEE
Q 002721 604 KATMKDSNMIYCGTFSTVYKAVMPSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVALLLH 683 (888)
Q Consensus 604 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 683 (888)
.++|++.+.||+|+||.||+|+..++..||+|.++..... .+.+.+|++++++++||||+++++++. .+..++||
T Consensus 5 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~valK~~~~~~~~----~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv~ 79 (262)
T cd05071 5 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVT 79 (262)
T ss_pred hHHeeEeeecCCCCCCcEEEEEecCCceEEEEecccCccC----HHHHHHHHHHHHhCCCCCcceEEEEEC-CCCcEEEE
Confidence 4679999999999999999999777778999998753321 236889999999999999999999874 45689999
Q ss_pred ecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccccccccCCCC
Q 002721 684 NYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSK 763 (888)
Q Consensus 684 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 763 (888)
||+++|+|.+++..... ..+++..+..++.|+++||+|+|+.|++||||||+||++++++.+||+|||.+.......
T Consensus 80 e~~~~~~L~~~~~~~~~---~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~ 156 (262)
T cd05071 80 EYMSKGSLLDFLKGEMG---KYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 156 (262)
T ss_pred EcCCCCcHHHHHhhccc---cCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEEcCCCcEEeccCCceeeccccc
Confidence 99999999999976432 156889999999999999999999999999999999999999999999999998765332
Q ss_pred CcccccccccccceecccccccCCcCccccchhHHHHHHHHHh-CCCCCCCCCCCccchhhhccccCCCCCCcccccccc
Q 002721 764 GTASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILT-TRLPVEEDFGEGVDLVKWVHGAPARGETPEQILDAR 842 (888)
Q Consensus 764 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 842 (888)
.. ......++..|+|||+..+..++.++||||||+++|||+| |+.||........ ...... ..
T Consensus 157 ~~-~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~--~~~~~~-------------~~ 220 (262)
T cd05071 157 YT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV--LDQVER-------------GY 220 (262)
T ss_pred cc-cccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHH--HHHHhc-------------CC
Confidence 21 1123346678999999988889999999999999999999 8888865432211 110000 00
Q ss_pred cccCCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHh
Q 002721 843 LSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEMLQEI 885 (888)
Q Consensus 843 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~i 885 (888)
. ..........+.+++.+|++.||++||++.++++.|+..
T Consensus 221 ~---~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~~l~~~ 260 (262)
T cd05071 221 R---MPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDY 260 (262)
T ss_pred C---CCCccccCHHHHHHHHHHccCCcccCCCHHHHHHHHHHh
Confidence 0 001123345678999999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-37 Score=338.69 Aligned_cols=244 Identities=20% Similarity=0.199 Sum_probs=194.3
Q ss_pred hcCCcceeeecccceEEEEEe-CCCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccC-CCceeeeeeEEEeCCeeEEEE
Q 002721 606 TMKDSNMIYCGTFSTVYKAVM-PSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLC-HDNLVRPIGFVIYEDVALLLH 683 (888)
Q Consensus 606 ~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~~lv~ 683 (888)
+|+..+.||+|+||+||+|+. .+|+.||+|+++..........+.+..|.+++..+. |++|+++++++...+..|+||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 477889999999999999995 468999999998543333334456778999988885 677888999999999999999
Q ss_pred ecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccccccccCCCC
Q 002721 684 NYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSK 763 (888)
Q Consensus 684 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 763 (888)
||+++|+|.+++.... .+++.++..++.||+.||+|||++||+||||||+||+++.++.+||+|||+++......
T Consensus 81 Ey~~~g~L~~~i~~~~-----~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~ 155 (323)
T cd05615 81 EYVNGGDLMYHIQQVG-----KFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG 155 (323)
T ss_pred cCCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCCCC
Confidence 9999999999987643 47889999999999999999999999999999999999999999999999987543221
Q ss_pred CcccccccccccceecccccccCCcCccccchhHHHHHHHHHhCCCCCCCCCCCccchhhhccccCCCCCCccccccccc
Q 002721 764 GTASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQILDARL 843 (888)
Q Consensus 764 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 843 (888)
. ......||+.|+|||++.+..++.++||||+||++|||++|+.||...... ..... +.....
T Consensus 156 ~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~--~~~~~-------------i~~~~~ 218 (323)
T cd05615 156 V--TTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDED--ELFQS-------------IMEHNV 218 (323)
T ss_pred c--cccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHH--HHHHH-------------HHhCCC
Confidence 1 123456899999999999889999999999999999999999999754221 11111 111000
Q ss_pred ccCCcCcHHHHHHHHHHHhhccCCCCCCCCCH
Q 002721 844 STVSFGWRKEMLTALKVALLCTDSTPAKRPKM 875 (888)
Q Consensus 844 ~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~ 875 (888)
. .......++.+++.+|++.+|++|++.
T Consensus 219 ~----~p~~~~~~~~~li~~~l~~~p~~R~~~ 246 (323)
T cd05615 219 S----YPKSLSKEAVSICKGLMTKHPSKRLGC 246 (323)
T ss_pred C----CCccCCHHHHHHHHHHcccCHhhCCCC
Confidence 0 011123467789999999999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=331.50 Aligned_cols=262 Identities=21% Similarity=0.275 Sum_probs=204.8
Q ss_pred hcCCcceeeecccceEEEEEeC------CCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCCee
Q 002721 606 TMKDSNMIYCGTFSTVYKAVMP------SGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVA 679 (888)
Q Consensus 606 ~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 679 (888)
+|++.+.||+|+||.||+|+.. ....+|+|.+...... .....+.+|+.+++.++||||+++++.+..++..
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~ 78 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENASS--SELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPL 78 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCCCH--HHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCc
Confidence 4678899999999999999842 2357888888743322 2335788999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHhhccCCC-------------------CCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCe
Q 002721 680 LLLHNYLPNGTLAQLLHESTKQ-------------------PDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNV 740 (888)
Q Consensus 680 ~lv~e~~~~g~L~~~l~~~~~~-------------------~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NI 740 (888)
++||||+++++|.+++...... ....+++.+++.++.|++.||+|||++|++||||||+||
T Consensus 79 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~ni 158 (290)
T cd05045 79 LLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNV 158 (290)
T ss_pred EEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheE
Confidence 9999999999999998753211 122478899999999999999999999999999999999
Q ss_pred EeCCCCCceEeccccccccCCCCCcccccccccccceecccccccCCcCccccchhHHHHHHHHHh-CCCCCCCCCCCcc
Q 002721 741 LLDADFKPLLGEIEISKLLDPSKGTASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILT-TRLPVEEDFGEGV 819 (888)
Q Consensus 741 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~~~~~~~ 819 (888)
++++++.+||+|||++................++..|+|||++.+..++.++||||||+++|||++ |..||.....+
T Consensus 159 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~-- 236 (290)
T cd05045 159 LVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPE-- 236 (290)
T ss_pred EEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHH--
Confidence 999999999999999986543322212223345678999999988889999999999999999999 99999653222
Q ss_pred chhhhccccCCCCCCcccccccccccCCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhhh
Q 002721 820 DLVKWVHGAPARGETPEQILDARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEMLQEIKQ 887 (888)
Q Consensus 820 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 887 (888)
.+.......... . .......++.+++.+||+.+|++||+++|+++.|+++..
T Consensus 237 ~~~~~~~~~~~~-------------~---~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~~l~~~~~ 288 (290)
T cd05045 237 RLFNLLKTGYRM-------------E---RPENCSEEMYNLMLTCWKQEPDKRPTFADISKELEKMMV 288 (290)
T ss_pred HHHHHHhCCCCC-------------C---CCCCCCHHHHHHHHHHccCCcccCCCHHHHHHHHHHHHh
Confidence 111111100000 0 011223567789999999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-37 Score=325.99 Aligned_cols=251 Identities=20% Similarity=0.314 Sum_probs=201.2
Q ss_pred HhcCCcceeeecccceEEEEEeCCCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCCeeEEEEe
Q 002721 605 ATMKDSNMIYCGTFSTVYKAVMPSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVALLLHN 684 (888)
Q Consensus 605 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 684 (888)
.+|++.+.||+|+||.||+|...++..+|+|.+...... .+.+.+|++++++++||||+++++++...+..|+|||
T Consensus 4 ~~~~~~~~lg~G~~~~v~~~~~~~~~~~~iK~~~~~~~~----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd05059 4 SELTFLKELGSGQFGVVHLGKWRGKIDVAIKMIREGAMS----EDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTE 79 (256)
T ss_pred HHcchhhhhccCCCceEEEeEecCCccEEEEEeccCCCC----HHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEe
Confidence 468889999999999999999877788999998744332 2367889999999999999999999999999999999
Q ss_pred cCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccccccccCCCCC
Q 002721 685 YLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSKG 764 (888)
Q Consensus 685 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 764 (888)
|+++++|.+++..... .+++..+..++.|++.||+|||+.|++||||||+||++++++.+|++|||.++.......
T Consensus 80 ~~~~~~L~~~l~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~ 155 (256)
T cd05059 80 YMANGCLLNYLRERKG----KLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQY 155 (256)
T ss_pred cCCCCCHHHHHHhccc----CCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECCCCcEEECCcccceecccccc
Confidence 9999999999976432 578899999999999999999999999999999999999999999999999876543211
Q ss_pred cccccccccccceecccccccCCcCccccchhHHHHHHHHHh-CCCCCCCCCCCccchhhhccccCCCCCCccccccccc
Q 002721 765 TASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILT-TRLPVEEDFGEGVDLVKWVHGAPARGETPEQILDARL 843 (888)
Q Consensus 765 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 843 (888)
. ......++..|+|||.+.+..++.++||||||+++|||++ |+.||...... +..........
T Consensus 156 ~-~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--~~~~~~~~~~~------------- 219 (256)
T cd05059 156 T-SSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNS--EVVESVSAGYR------------- 219 (256)
T ss_pred c-ccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHH--HHHHHHHcCCc-------------
Confidence 1 1112234567999999988899999999999999999999 89999653221 11111110000
Q ss_pred ccCCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 002721 844 STVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEML 882 (888)
Q Consensus 844 ~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L 882 (888)
.. .....+.++.+++.+||..+|++|||+.|+++.|
T Consensus 220 ~~---~~~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~l 255 (256)
T cd05059 220 LY---RPKLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQL 255 (256)
T ss_pred CC---CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHh
Confidence 00 0112345688999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=333.17 Aligned_cols=261 Identities=21% Similarity=0.325 Sum_probs=206.5
Q ss_pred HHHhcCCcceeeecccceEEEEEe------CCCcEEEEEEeeccChhhhHHHHHHHHHHHHHhcc-CCCceeeeeeEEEe
Q 002721 603 VKATMKDSNMIYCGTFSTVYKAVM------PSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKL-CHDNLVRPIGFVIY 675 (888)
Q Consensus 603 ~~~~~~~~~~ig~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~ 675 (888)
..++|.+.+.||+|+||.||+|.. .++..||+|.++..... ...+.+.+|+++++++ +||||+++++++..
T Consensus 33 ~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~ 110 (302)
T cd05055 33 PRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTAHS--SEREALMSELKIMSHLGNHENIVNLLGACTI 110 (302)
T ss_pred cHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccCCh--HHHHHHHHHHHHHHhccCCCCcceEEEEEec
Confidence 456899999999999999999973 13568999988754322 2345789999999999 79999999999999
Q ss_pred CCeeEEEEecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEecccc
Q 002721 676 EDVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEI 755 (888)
Q Consensus 676 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~ 755 (888)
.+..|+||||+++|+|.++++..... .+++.++..++.|++.||+|||+++|+|+||||+||+++.++.++++|||.
T Consensus 111 ~~~~~lv~e~~~~~~L~~~i~~~~~~---~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Nil~~~~~~~~l~dfg~ 187 (302)
T cd05055 111 GGPILVITEYCCYGDLLNFLRRKRES---FLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGL 187 (302)
T ss_pred CCceEEEEEcCCCCcHHHHHHhCCCC---CCCHHHHHHHHHHHHHHHHHHHHCCeehhhhccceEEEcCCCeEEECCCcc
Confidence 99999999999999999999764321 378899999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCcccccccccccceecccccccCCcCccccchhHHHHHHHHHh-CCCCCCCCCCCccchhhhccccCCCCCC
Q 002721 756 SKLLDPSKGTASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILT-TRLPVEEDFGEGVDLVKWVHGAPARGET 834 (888)
Q Consensus 756 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~ 834 (888)
++...............++..|+|||++.+..++.++||||+||++|||++ |..||....... ...+.....
T Consensus 188 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~~~~~-~~~~~~~~~------ 260 (302)
T cd05055 188 ARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGMPVDS-KFYKLIKEG------ 260 (302)
T ss_pred cccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCCCchH-HHHHHHHcC------
Confidence 986543322111223345778999999988889999999999999999998 999987542211 111111100
Q ss_pred cccccccccccCCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHh
Q 002721 835 PEQILDARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEMLQEI 885 (888)
Q Consensus 835 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~i 885 (888)
.... .......++.+++.+|++++|++|||+.|+++.|+++
T Consensus 261 --------~~~~--~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~~l~~~ 301 (302)
T cd05055 261 --------YRMA--QPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQLIGKQ 301 (302)
T ss_pred --------CcCC--CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHHhh
Confidence 0000 0011235678899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=337.90 Aligned_cols=246 Identities=20% Similarity=0.191 Sum_probs=193.2
Q ss_pred ceeeecccceEEEEEe-CCCcEEEEEEeeccChhhhHHHHHHHHHHHHHhcc-CCCceeeeeeEEEeCCeeEEEEecCCC
Q 002721 611 NMIYCGTFSTVYKAVM-PSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKL-CHDNLVRPIGFVIYEDVALLLHNYLPN 688 (888)
Q Consensus 611 ~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~lv~e~~~~ 688 (888)
+.||+|+||+||+|+. .+++.||+|++++.........+.+.+|+.++.++ +||+|+++++++...+..|+||||+++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 80 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNG 80 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCC
Confidence 4799999999999995 46899999999865444444456788999999888 699999999999999999999999999
Q ss_pred CCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccccccccCCCCCcccc
Q 002721 689 GTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSKGTASI 768 (888)
Q Consensus 689 g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~ 768 (888)
|+|.+++.... .+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||+++...... ...
T Consensus 81 ~~L~~~~~~~~-----~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~~ 153 (327)
T cd05617 81 GDLMFHMQRQR-----KLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG--DTT 153 (327)
T ss_pred CcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCC--Cce
Confidence 99999887543 47889999999999999999999999999999999999999999999999987532211 112
Q ss_pred cccccccceecccccccCCcCccccchhHHHHHHHHHhCCCCCCCCCCCc-cchhhhccccCCCCCCcccccccccccCC
Q 002721 769 SAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEG-VDLVKWVHGAPARGETPEQILDARLSTVS 847 (888)
Q Consensus 769 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 847 (888)
....||+.|+|||++.+..++.++||||+||++|||++|+.||....... .....+.. ..+...... .
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~---------~~~~~~~~~-~- 222 (327)
T cd05617 154 STFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLF---------QVILEKPIR-I- 222 (327)
T ss_pred ecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHH---------HHHHhCCCC-C-
Confidence 34678999999999999999999999999999999999999996432211 00000000 000000000 0
Q ss_pred cCcHHHHHHHHHHHhhccCCCCCCCCCHH
Q 002721 848 FGWRKEMLTALKVALLCTDSTPAKRPKMK 876 (888)
Q Consensus 848 ~~~~~~~~~~~~li~~cl~~dP~~RPs~~ 876 (888)
.......+.+++.+||+.||++||++.
T Consensus 223 --p~~~~~~~~~li~~~L~~dP~~R~~~~ 249 (327)
T cd05617 223 --PRFLSVKASHVLKGFLNKDPKERLGCQ 249 (327)
T ss_pred --CCCCCHHHHHHHHHHhccCHHHcCCCC
Confidence 111234567899999999999999853
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=330.16 Aligned_cols=260 Identities=22% Similarity=0.316 Sum_probs=202.9
Q ss_pred HHhcCCcceeeecccceEEEEEeC------CCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCC
Q 002721 604 KATMKDSNMIYCGTFSTVYKAVMP------SGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYED 677 (888)
Q Consensus 604 ~~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 677 (888)
.+.|++.+.||+|+||.||+|... .+..||+|.+...... .....+.+|+.++++++||||+++++++.+.+
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~ 82 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSE--QDESDFLMEALIMSKFNHQNIVRLIGVSFERL 82 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCCCCH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCC
Confidence 567999999999999999999954 3678999988643322 22347889999999999999999999999999
Q ss_pred eeEEEEecCCCCCHHHHhhccCCCC--CCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCC---CceEec
Q 002721 678 VALLLHNYLPNGTLAQLLHESTKQP--DYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADF---KPLLGE 752 (888)
Q Consensus 678 ~~~lv~e~~~~g~L~~~l~~~~~~~--~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~---~~kl~D 752 (888)
..++||||+++++|.+++....... ...+++.++..++.||+.||+|||+++++||||||+||+++.++ .+|++|
T Consensus 83 ~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~d 162 (277)
T cd05036 83 PRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIAD 162 (277)
T ss_pred CcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchheEEEeccCCCcceEecc
Confidence 9999999999999999997654321 22578999999999999999999999999999999999998654 589999
Q ss_pred cccccccCCCCCcccccccccccceecccccccCCcCccccchhHHHHHHHHHh-CCCCCCCCCCCccchhhhccccCCC
Q 002721 753 IEISKLLDPSKGTASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILT-TRLPVEEDFGEGVDLVKWVHGAPAR 831 (888)
Q Consensus 753 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~ 831 (888)
||.++................+..|+|||++.+..++.++|||||||++|||++ |..||.....+. ....+......
T Consensus 163 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~~~--~~~~~~~~~~~ 240 (277)
T cd05036 163 FGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTNQE--VMEFVTGGGRL 240 (277)
T ss_pred CccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCHHH--HHHHHHcCCcC
Confidence 999987643221111112234568999999988899999999999999999997 999997543221 11111110000
Q ss_pred CCCcccccccccccCCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 002721 832 GETPEQILDARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEMLQ 883 (888)
Q Consensus 832 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~ 883 (888)
. ........+.+++.+|++.+|++||++.+|++.|+
T Consensus 241 -------------~---~~~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~l~ 276 (277)
T cd05036 241 -------------D---PPKGCPGPVYRIMTDCWQHTPEDRPNFATILERIQ 276 (277)
T ss_pred -------------C---CCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHhh
Confidence 0 01112356788999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=325.91 Aligned_cols=255 Identities=21% Similarity=0.364 Sum_probs=203.5
Q ss_pred HHHhcCCcceeeecccceEEEEEeCCCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCCeeEEE
Q 002721 603 VKATMKDSNMIYCGTFSTVYKAVMPSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVALLL 682 (888)
Q Consensus 603 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 682 (888)
..++|++.+.||+|+||.||+|...++..||+|.++..... .+.+.+|+.++++++||+|+++++++. .+..+++
T Consensus 4 ~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~k~~~~~~~~----~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~lv 78 (260)
T cd05070 4 PRESLQLIKKLGNGQFGEVWMGTWNGNTKVAVKTLKPGTMS----PESFLEEAQIMKKLRHDKLVQLYAVVS-EEPIYIV 78 (260)
T ss_pred chHHhhhhheeccccCceEEEEEecCCceeEEEEecCCCCC----HHHHHHHHHHHHhcCCCceEEEEeEEC-CCCcEEE
Confidence 35689999999999999999999888889999998754332 236889999999999999999999875 4568999
Q ss_pred EecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccccccccCCC
Q 002721 683 HNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPS 762 (888)
Q Consensus 683 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 762 (888)
|||+++++|.+++..... ..+++.++..++.|++.||+|||++|++||||||+||++++++.++++|||.+......
T Consensus 79 ~e~~~~~~L~~~~~~~~~---~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~ 155 (260)
T cd05070 79 TEYMSKGSLLDFLKDGEG---RALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDN 155 (260)
T ss_pred EEecCCCcHHHHHHhcCC---CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEEeCCceEEeCCceeeeeccCc
Confidence 999999999999976432 25788999999999999999999999999999999999999999999999999876432
Q ss_pred CCcccccccccccceecccccccCCcCccccchhHHHHHHHHHh-CCCCCCCCCCCccchhhhccccCCCCCCccccccc
Q 002721 763 KGTASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILT-TRLPVEEDFGEGVDLVKWVHGAPARGETPEQILDA 841 (888)
Q Consensus 763 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 841 (888)
... ......++..|+|||+..+..++.++||||||+++|||++ |..||...... +...........
T Consensus 156 ~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~--~~~~~~~~~~~~---------- 222 (260)
T cd05070 156 EYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNR--EVLEQVERGYRM---------- 222 (260)
T ss_pred ccc-cccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHH--HHHHHHHcCCCC----------
Confidence 211 1122335668999999988889999999999999999999 89999653221 111111100000
Q ss_pred ccccCCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 002721 842 RLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEMLQE 884 (888)
Q Consensus 842 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~ 884 (888)
. ........+.+++.+|++.+|++|||+.++.+.|++
T Consensus 223 ---~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~ 259 (260)
T cd05070 223 ---P---CPQDCPISLHELMLQCWKKDPEERPTFEYLQSFLED 259 (260)
T ss_pred ---C---CCCcCCHHHHHHHHHHcccCcccCcCHHHHHHHHhc
Confidence 0 111233567899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-37 Score=330.84 Aligned_cols=263 Identities=18% Similarity=0.301 Sum_probs=204.3
Q ss_pred HHHhcCCcceeeecccceEEEEEeC------CCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeC
Q 002721 603 VKATMKDSNMIYCGTFSTVYKAVMP------SGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYE 676 (888)
Q Consensus 603 ~~~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 676 (888)
..++|++.+.||+|+||.||+|... .+..||+|.++..... .....+.+|+.+++.++||||+++++++...
T Consensus 4 ~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~ 81 (288)
T cd05061 4 SREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASL--RERIEFLNEASVMKGFTCHHVVRLLGVVSKG 81 (288)
T ss_pred cHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcCCH--HHHHHHHHHHHHHHhCCCCCeeeEEEEEcCC
Confidence 4678999999999999999999742 2558999988644322 2234678899999999999999999999999
Q ss_pred CeeEEEEecCCCCCHHHHhhccCCCC-----CCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEe
Q 002721 677 DVALLLHNYLPNGTLAQLLHESTKQP-----DYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLG 751 (888)
Q Consensus 677 ~~~~lv~e~~~~g~L~~~l~~~~~~~-----~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~ 751 (888)
+..|+||||+++|+|.++++...... ....++..+..++.|++.||+|||+++|+||||||+||++++++.++++
T Consensus 82 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~nili~~~~~~~L~ 161 (288)
T cd05061 82 QPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIG 161 (288)
T ss_pred CCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChheEEEcCCCcEEEC
Confidence 99999999999999999997643211 1234677889999999999999999999999999999999999999999
Q ss_pred ccccccccCCCCCcccccccccccceecccccccCCcCccccchhHHHHHHHHHh-CCCCCCCCCCCccchhhhccccCC
Q 002721 752 EIEISKLLDPSKGTASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILT-TRLPVEEDFGEGVDLVKWVHGAPA 830 (888)
Q Consensus 752 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~ 830 (888)
|||+++...............++..|+|||.+.+..++.++|||||||++|||++ |..||.....+. ..+..
T Consensus 162 Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~~--~~~~~----- 234 (288)
T cd05061 162 DFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQ--VLKFV----- 234 (288)
T ss_pred cCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHH-----
Confidence 9999886543222111122345678999999988889999999999999999998 788886532211 11111
Q ss_pred CCCCcccccccccccCCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHh
Q 002721 831 RGETPEQILDARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEMLQEI 885 (888)
Q Consensus 831 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~i 885 (888)
.+...... .......+.+++.+|++.||++|||+.++++.|++.
T Consensus 235 --------~~~~~~~~---~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~ 278 (288)
T cd05061 235 --------MDGGYLDQ---PDNCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDD 278 (288)
T ss_pred --------HcCCCCCC---CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhh
Confidence 00000000 111235788999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-37 Score=333.07 Aligned_cols=261 Identities=22% Similarity=0.282 Sum_probs=202.0
Q ss_pred HHhcCCcceeeecccceEEEEEeC-CCc--EEEEEEeeccChhhhHHHHHHHHHHHHHhcc-CCCceeeeeeEEEeCCee
Q 002721 604 KATMKDSNMIYCGTFSTVYKAVMP-SGL--ILSVKRLKSMDRTIIHHQNKMIRELEKLSKL-CHDNLVRPIGFVIYEDVA 679 (888)
Q Consensus 604 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~--~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~ 679 (888)
-++|++.+.||+|+||.||+|... ++. .+|+|.++... .....+.+.+|++++.++ +||||+++++++..++..
T Consensus 6 ~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~ 83 (303)
T cd05088 6 WNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYA--SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYL 83 (303)
T ss_pred hhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEecccC--CHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCc
Confidence 357888999999999999999954 454 45777765332 223345788999999999 899999999999999999
Q ss_pred EEEEecCCCCCHHHHhhccCCC-----------CCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCc
Q 002721 680 LLLHNYLPNGTLAQLLHESTKQ-----------PDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKP 748 (888)
Q Consensus 680 ~lv~e~~~~g~L~~~l~~~~~~-----------~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~ 748 (888)
|+||||+++++|.++++..... ....+++.+++.++.|++.|++|||++|++||||||+||++++++.+
T Consensus 84 ~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~~~ 163 (303)
T cd05088 84 YLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVA 163 (303)
T ss_pred eEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCCcE
Confidence 9999999999999999765321 11257889999999999999999999999999999999999999999
Q ss_pred eEeccccccccCCCCCcccccccccccceecccccccCCcCccccchhHHHHHHHHHh-CCCCCCCCCCCccchhhhccc
Q 002721 749 LLGEIEISKLLDPSKGTASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILT-TRLPVEEDFGEGVDLVKWVHG 827 (888)
Q Consensus 749 kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~~~~~~~~~~~~~~~ 827 (888)
||+|||++....... ......++..|+|||++.+..++.++|||||||++|||+| |..||...... +..+....
T Consensus 164 kl~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~--~~~~~~~~ 238 (303)
T cd05088 164 KIADFGLSRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA--ELYEKLPQ 238 (303)
T ss_pred EeCccccCcccchhh---hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChH--HHHHHHhc
Confidence 999999986432111 1112234567999999988889999999999999999998 99999653221 11111100
Q ss_pred cCCCCCCcccccccccccCCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhhh
Q 002721 828 APARGETPEQILDARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEMLQEIKQ 887 (888)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 887 (888)
.. ... ........+.+++.+||+.+|++||++++++..|+++.+
T Consensus 239 ~~----~~~------------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~l~~~~~ 282 (303)
T cd05088 239 GY----RLE------------KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 282 (303)
T ss_pred CC----cCC------------CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 00 000 011123467889999999999999999999999988753
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-37 Score=332.06 Aligned_cols=268 Identities=19% Similarity=0.286 Sum_probs=205.8
Q ss_pred HHhcCCcceeeecccceEEEEEeCC-----------------CcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCce
Q 002721 604 KATMKDSNMIYCGTFSTVYKAVMPS-----------------GLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNL 666 (888)
Q Consensus 604 ~~~~~~~~~ig~G~~g~Vy~~~~~~-----------------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnI 666 (888)
..+|++.+.||+|+||.||+|+... +..||+|.+...... ...+.+.+|++++++++||||
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i 81 (296)
T cd05051 4 RQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASD--NAREDFLKEVKILSRLSDPNI 81 (296)
T ss_pred hhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCccCH--HHHHHHHHHHHHHHhcCCCCE
Confidence 4689999999999999999998432 246899998744322 334578999999999999999
Q ss_pred eeeeeEEEeCCeeEEEEecCCCCCHHHHhhccCCCCC------CCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCe
Q 002721 667 VRPIGFVIYEDVALLLHNYLPNGTLAQLLHESTKQPD------YRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNV 740 (888)
Q Consensus 667 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~------~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NI 740 (888)
+++++++..++..++||||+++++|.+++........ ..+++..++.++.|++.||+|||++|++||||||+||
T Consensus 82 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~LH~~~i~H~dlkp~Ni 161 (296)
T cd05051 82 ARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNC 161 (296)
T ss_pred eEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHHHHHHHcCccccccchhce
Confidence 9999999999999999999999999999987542221 2578899999999999999999999999999999999
Q ss_pred EeCCCCCceEeccccccccCCCCCcccccccccccceecccccccCCcCccccchhHHHHHHHHHh--CCCCCCCCCCCc
Q 002721 741 LLDADFKPLLGEIEISKLLDPSKGTASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILT--TRLPVEEDFGEG 818 (888)
Q Consensus 741 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt--g~~P~~~~~~~~ 818 (888)
+++.++.++++|||.+................++..|+|||++.+..++.++|||||||++|||++ |..||......
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~- 240 (296)
T cd05051 162 LVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPYEHLTDQ- 240 (296)
T ss_pred eecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHHHHHHHHhcCCCCCCCCcChH-
Confidence 999999999999999876543322222233456778999999988889999999999999999998 67788643221
Q ss_pred cchhhhccccCCCCCCcccccccccccCCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 002721 819 VDLVKWVHGAPARGETPEQILDARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEMLQE 884 (888)
Q Consensus 819 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~ 884 (888)
+..+............. .. ......+.++.+++.+||+.||++|||+.|+++.|++
T Consensus 241 -~~~~~~~~~~~~~~~~~-~~--------~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~~L~~ 296 (296)
T cd05051 241 -QVIENAGHFFRDDGRQI-YL--------PRPPNCPKDIYELMLECWRRDEEDRPTFREIHLFLQR 296 (296)
T ss_pred -HHHHHHHhccccccccc-cC--------CCccCCCHHHHHHHHHHhccChhcCCCHHHHHHHhcC
Confidence 11111111000000000 00 0011223578899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=330.63 Aligned_cols=260 Identities=18% Similarity=0.272 Sum_probs=203.1
Q ss_pred HhcCCcceeeecccceEEEEEeC------CCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCCe
Q 002721 605 ATMKDSNMIYCGTFSTVYKAVMP------SGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDV 678 (888)
Q Consensus 605 ~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 678 (888)
.+|++.+.||+|+||.||+|+.. +++.||+|+++.... ....+.+.+|+.++++++||||+++++++...+.
T Consensus 5 ~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~ 82 (283)
T cd05091 5 STVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKAE--GPLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQP 82 (283)
T ss_pred HHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCCC--HHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCc
Confidence 46788899999999999999843 357899999974432 2234578899999999999999999999999999
Q ss_pred eEEEEecCCCCCHHHHhhccCC-----------CCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCC
Q 002721 679 ALLLHNYLPNGTLAQLLHESTK-----------QPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFK 747 (888)
Q Consensus 679 ~~lv~e~~~~g~L~~~l~~~~~-----------~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~ 747 (888)
.++++||+++++|.+++..... .....+++..+..++.|++.||+|+|++||+||||||+||++++++.
T Consensus 83 ~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~~~ 162 (283)
T cd05091 83 LSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLN 162 (283)
T ss_pred eEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchhheEecCCCc
Confidence 9999999999999999864321 01124788889999999999999999999999999999999999999
Q ss_pred ceEeccccccccCCCCCcccccccccccceecccccccCCcCccccchhHHHHHHHHHh-CCCCCCCCCCCccchhhhcc
Q 002721 748 PLLGEIEISKLLDPSKGTASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILT-TRLPVEEDFGEGVDLVKWVH 826 (888)
Q Consensus 748 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~~~~~~~~~~~~~~ 826 (888)
+||+|||+++...............+++.|+|||++.+..++.++||||+||++|||++ |..||...... +..+.+.
T Consensus 163 ~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~--~~~~~i~ 240 (283)
T cd05091 163 VKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ--DVIEMIR 240 (283)
T ss_pred eEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHH--HHHHHHH
Confidence 99999999886543322222233456778999999988889999999999999999998 88888653221 1111111
Q ss_pred ccCCCCCCcccccccccccCCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 002721 827 GAPARGETPEQILDARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEMLQE 884 (888)
Q Consensus 827 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~ 884 (888)
+...... .......+.+++.+||+.+|++||++++|+..|+.
T Consensus 241 -------------~~~~~~~---~~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~l~~ 282 (283)
T cd05091 241 -------------NRQVLPC---PDDCPAWVYTLMLECWNEFPSRRPRFKDIHSRLRT 282 (283)
T ss_pred -------------cCCcCCC---CCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHhhC
Confidence 1111011 11223457789999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=328.73 Aligned_cols=265 Identities=19% Similarity=0.276 Sum_probs=209.4
Q ss_pred HHHhcCCcceeeecccceEEEEEeCC-----CcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEe-C
Q 002721 603 VKATMKDSNMIYCGTFSTVYKAVMPS-----GLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIY-E 676 (888)
Q Consensus 603 ~~~~~~~~~~ig~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~-~ 676 (888)
..++|++.+.||+|+||.||+|.... +..|++|+++.... ....+.+.+|+.++++++||||+++++++.. +
T Consensus 4 ~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~~~--~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~ 81 (280)
T cd05043 4 SRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHAS--EIQVTLLLQESCLLYGLSHQNILPILHVCIEDG 81 (280)
T ss_pred chhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCCCC--HHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCC
Confidence 35789999999999999999999654 78899998874332 2334578899999999999999999998776 4
Q ss_pred CeeEEEEecCCCCCHHHHhhccCCC---CCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEecc
Q 002721 677 DVALLLHNYLPNGTLAQLLHESTKQ---PDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEI 753 (888)
Q Consensus 677 ~~~~lv~e~~~~g~L~~~l~~~~~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Df 753 (888)
...++++||+++++|.+++...... ....+++.++..++.|++.||+|||+++++||||||+||++++++.+|++||
T Consensus 82 ~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~d~ 161 (280)
T cd05043 82 EPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDN 161 (280)
T ss_pred CCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCHhhEEEcCCCcEEECCC
Confidence 6789999999999999999764322 1125789999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCCcccccccccccceecccccccCCcCccccchhHHHHHHHHHh-CCCCCCCCCCCccchhhhccccCCCC
Q 002721 754 EISKLLDPSKGTASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILT-TRLPVEEDFGEGVDLVKWVHGAPARG 832 (888)
Q Consensus 754 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~ 832 (888)
|+++.+.............++..|+|||++.+..++.++||||||+++||+++ |+.||..... .+...+......
T Consensus 162 g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~--~~~~~~~~~~~~-- 237 (280)
T cd05043 162 ALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEIDP--FEMAAYLKDGYR-- 237 (280)
T ss_pred CCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCCH--HHHHHHHHcCCC--
Confidence 99986644332211223345778999999988889999999999999999999 9999975322 111221111100
Q ss_pred CCcccccccccccCCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhhh
Q 002721 833 ETPEQILDARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEMLQEIKQ 887 (888)
Q Consensus 833 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 887 (888)
. . .......++.+++.+||..||++|||+.++++.|+++.+
T Consensus 238 --~--------~----~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~~~~~ 278 (280)
T cd05043 238 --L--------A----QPINCPDELFAVMACCWALDPEERPSFSQLVQCLTDFHA 278 (280)
T ss_pred --C--------C----CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 0 0 011123467899999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=330.40 Aligned_cols=254 Identities=17% Similarity=0.173 Sum_probs=199.9
Q ss_pred hcCCcceeeecccceEEEEEe-CCCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCCeeEEEEe
Q 002721 606 TMKDSNMIYCGTFSTVYKAVM-PSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVALLLHN 684 (888)
Q Consensus 606 ~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 684 (888)
+|+..+.||+|+||+||+|.. .+++.||+|.+.............+.+|++++++++|++|+++++++..++..++|||
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLT 80 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEE
Confidence 366778999999999999995 4689999999875443333334467889999999999999999999999999999999
Q ss_pred cCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccccccccCCCCC
Q 002721 685 YLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSKG 764 (888)
Q Consensus 685 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 764 (888)
|+++++|.+++...... .+++..+..++.|++.||+|||++||+||||||+||++++++.+||+|||++.......
T Consensus 81 ~~~~~~L~~~~~~~~~~---~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~- 156 (285)
T cd05632 81 IMNGGDLKFHIYNMGNP---GFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE- 156 (285)
T ss_pred eccCccHHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCCCC-
Confidence 99999999888754322 57899999999999999999999999999999999999999999999999987654322
Q ss_pred cccccccccccceecccccccCCcCccccchhHHHHHHHHHhCCCCCCCCCCCccchhhhccccCCCCCCcccccccccc
Q 002721 765 TASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQILDARLS 844 (888)
Q Consensus 765 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 844 (888)
......|+..|+|||++.+..++.++||||+||++|||++|+.||........ ...... .... ..
T Consensus 157 --~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~-~~~~~~-~~~~---------~~-- 221 (285)
T cd05632 157 --SIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVK-REEVDR-RVLE---------TE-- 221 (285)
T ss_pred --cccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHH-hhhc---------cc--
Confidence 12345689999999999888999999999999999999999999975322110 000000 0000 00
Q ss_pred cCCcCcHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHH
Q 002721 845 TVSFGWRKEMLTALKVALLCTDSTPAKRPK-----MKKVVE 880 (888)
Q Consensus 845 ~~~~~~~~~~~~~~~li~~cl~~dP~~RPs-----~~evl~ 880 (888)
..........+.+++.+|++.||++||+ +.++++
T Consensus 222 --~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~ 260 (285)
T cd05632 222 --EVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKR 260 (285)
T ss_pred --cccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHc
Confidence 0011122345678999999999999999 666665
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=332.86 Aligned_cols=268 Identities=19% Similarity=0.266 Sum_probs=203.2
Q ss_pred HHhcCCcceeeecccceEEEEEeC-----------------CCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCce
Q 002721 604 KATMKDSNMIYCGTFSTVYKAVMP-----------------SGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNL 666 (888)
Q Consensus 604 ~~~~~~~~~ig~G~~g~Vy~~~~~-----------------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnI 666 (888)
.++|++.+.||+|+||.||+|... ++..||+|+++.... ......+.+|+++++.++||||
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~~--~~~~~~~~~E~~~l~~l~~~~i 81 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDAN--KNARNDFLKEIKIMSRLKDPNI 81 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccCC--HHHHHHHHHHHHHHHhCCCCCc
Confidence 467999999999999999998532 245789999874322 2234578899999999999999
Q ss_pred eeeeeEEEeCCeeEEEEecCCCCCHHHHhhccCCCC------CCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCe
Q 002721 667 VRPIGFVIYEDVALLLHNYLPNGTLAQLLHESTKQP------DYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNV 740 (888)
Q Consensus 667 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~------~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NI 740 (888)
+++++++..++..++||||+++++|.+++....... ...+++.++..++.|++.||+|||++|++||||||+||
T Consensus 82 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dlkp~Ni 161 (296)
T cd05095 82 IRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNC 161 (296)
T ss_pred ceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHHHHHHCCeecccCChheE
Confidence 999999999999999999999999999998654221 12467889999999999999999999999999999999
Q ss_pred EeCCCCCceEeccccccccCCCCCcccccccccccceecccccccCCcCccccchhHHHHHHHHHh--CCCCCCCCCCCc
Q 002721 741 LLDADFKPLLGEIEISKLLDPSKGTASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILT--TRLPVEEDFGEG 818 (888)
Q Consensus 741 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt--g~~P~~~~~~~~ 818 (888)
+++.++.++++|||.+................++..|+|||...+..++.++|||||||++|||++ |..||.......
T Consensus 162 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~~~p~~~~~~~~ 241 (296)
T cd05095 162 LVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQ 241 (296)
T ss_pred EEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCCCCCccccChHH
Confidence 999999999999999986543322111222344678999999888889999999999999999998 778886432211
Q ss_pred cchhhhccccCCCCCCcccccccccccCCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 002721 819 VDLVKWVHGAPARGETPEQILDARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEMLQE 884 (888)
Q Consensus 819 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~ 884 (888)
........... ........ ........+.+++.+||+.||++||++.||++.|++
T Consensus 242 --~~~~~~~~~~~------~~~~~~~~---~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~l~~ 296 (296)
T cd05095 242 --VIENTGEFFRD------QGRQVYLP---KPALCPDSLYKLMLSCWRRNAKERPSFQEIHATLLE 296 (296)
T ss_pred --HHHHHHHHHhh------ccccccCC---CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 11000000000 00000000 011123567899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=334.24 Aligned_cols=250 Identities=22% Similarity=0.328 Sum_probs=203.2
Q ss_pred HHhcCCcceeeecccceEEEEE-eCCCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCCeeEEE
Q 002721 604 KATMKDSNMIYCGTFSTVYKAV-MPSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVALLL 682 (888)
Q Consensus 604 ~~~~~~~~~ig~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 682 (888)
...|...+.||.|+||.||-|+ ..+.+.||||.+.-..+...+.-..+.+|+..+.+++|||+|.+.|+|..+...|+|
T Consensus 25 Eklf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLV 104 (948)
T KOG0577|consen 25 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLV 104 (948)
T ss_pred HHHHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHH
Confidence 4467888999999999999999 457899999999755555555556899999999999999999999999999999999
Q ss_pred EecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccccccccCCC
Q 002721 683 HNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPS 762 (888)
Q Consensus 683 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 762 (888)
||||-| +-.|++.-..+ .+.+.++..|+.+.+.||+|||+.+.||||||+.|||+++.|.||++|||.|....+.
T Consensus 105 MEYClG-SAsDlleVhkK----plqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~PA 179 (948)
T KOG0577|consen 105 MEYCLG-SASDLLEVHKK----PLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPGLVKLADFGSASIMAPA 179 (948)
T ss_pred HHHHhc-cHHHHHHHHhc----cchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCCeeeeccccchhhcCch
Confidence 999964 88888875543 5677889999999999999999999999999999999999999999999999886653
Q ss_pred CCcccccccccccceecccccc---cCCcCccccchhHHHHHHHHHhCCCCCCCCCCCccchhhhccccCCCCCCccccc
Q 002721 763 KGTASISAVAGSFGYIPPEYAY---TMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQIL 839 (888)
Q Consensus 763 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 839 (888)
..++|||.|||||++. .+.|+-|+||||+||+..|+...++|+..+..-. .+..++.. .
T Consensus 180 ------nsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMS-ALYHIAQN---e-------- 241 (948)
T KOG0577|consen 180 ------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-ALYHIAQN---E-------- 241 (948)
T ss_pred ------hcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHH-HHHHHHhc---C--------
Confidence 3678999999999875 4579999999999999999999999987643210 01111100 0
Q ss_pred ccccccCCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002721 840 DARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEM 881 (888)
Q Consensus 840 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~ 881 (888)
.+.+. ...| +..+.+++..|+++-|.+|||.+++++.
T Consensus 242 sPtLq--s~eW---S~~F~~Fvd~CLqKipqeRptse~ll~H 278 (948)
T KOG0577|consen 242 SPTLQ--SNEW---SDYFRNFVDSCLQKIPQERPTSEELLKH 278 (948)
T ss_pred CCCCC--Cchh---HHHHHHHHHHHHhhCcccCCcHHHHhhc
Confidence 01111 1123 3456678889999999999999988753
|
|
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-37 Score=329.87 Aligned_cols=254 Identities=18% Similarity=0.205 Sum_probs=201.1
Q ss_pred hcCCcceeeecccceEEEEEe-CCCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCCeeEEEEe
Q 002721 606 TMKDSNMIYCGTFSTVYKAVM-PSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVALLLHN 684 (888)
Q Consensus 606 ~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 684 (888)
+|+..+.||+|+||+||+|.. .+++.||+|.+...........+.+.+|+.++++++|++|+++++.+.+++..++|||
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e 80 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLT 80 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEE
Confidence 477789999999999999995 4689999999875443333334467789999999999999999999999999999999
Q ss_pred cCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccccccccCCCCC
Q 002721 685 YLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSKG 764 (888)
Q Consensus 685 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 764 (888)
|+++++|.+++...... .+++.++..++.|++.||.|||+.||+||||||+||+++.++.++++|||++.......
T Consensus 81 ~~~g~~L~~~l~~~~~~---~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~- 156 (285)
T cd05630 81 LMNGGDLKFHIYHMGEA---GFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ- 156 (285)
T ss_pred ecCCCcHHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCc-
Confidence 99999999998654322 57888999999999999999999999999999999999999999999999987654322
Q ss_pred cccccccccccceecccccccCCcCccccchhHHHHHHHHHhCCCCCCCCCCCccchhhhccccCCCCCCcccccccccc
Q 002721 765 TASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQILDARLS 844 (888)
Q Consensus 765 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 844 (888)
......|+..|+|||++.+..++.++||||+|+++|+|++|+.||......... ... ....+....
T Consensus 157 --~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~--~~~----------~~~~~~~~~ 222 (285)
T cd05630 157 --TIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKR--EEV----------ERLVKEVQE 222 (285)
T ss_pred --cccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchH--HHH----------Hhhhhhhhh
Confidence 122346899999999999889999999999999999999999999754221100 000 000000000
Q ss_pred cCCcCcHHHHHHHHHHHhhccCCCCCCCCC-----HHHHHH
Q 002721 845 TVSFGWRKEMLTALKVALLCTDSTPAKRPK-----MKKVVE 880 (888)
Q Consensus 845 ~~~~~~~~~~~~~~~li~~cl~~dP~~RPs-----~~evl~ 880 (888)
. .......++.+++.+||+.||++||| ++|+++
T Consensus 223 ~---~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~ 260 (285)
T cd05630 223 E---YSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKE 260 (285)
T ss_pred h---cCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHc
Confidence 0 01122345778999999999999999 888876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-37 Score=329.65 Aligned_cols=260 Identities=20% Similarity=0.289 Sum_probs=210.7
Q ss_pred HHHHhcCCcceeeecccceEEEEEeC---CC--cEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeC
Q 002721 602 VVKATMKDSNMIYCGTFSTVYKAVMP---SG--LILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYE 676 (888)
Q Consensus 602 ~~~~~~~~~~~ig~G~~g~Vy~~~~~---~~--~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 676 (888)
+.++.....+.||.|.||.||+|... .| -.||||..+.....+ ..+.|.+|+.+|+.++|||||+++|+|.+
T Consensus 386 l~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~t~d--~tekflqEa~iMrnfdHphIikLIGv~~e- 462 (974)
T KOG4257|consen 386 LRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDCTPD--DTEKFLQEASIMRNFDHPHIIKLIGVCVE- 462 (974)
T ss_pred eehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCCChh--hHHHHHHHHHHHHhCCCcchhheeeeeec-
Confidence 44556667789999999999999842 23 468899888543332 25689999999999999999999999975
Q ss_pred CeeEEEEecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccccc
Q 002721 677 DVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEIS 756 (888)
Q Consensus 677 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a 756 (888)
...|+|||.++-|.|+.|++.+.. .++......++.||+.||+|||++++|||||..+|||+....-+|++|||++
T Consensus 463 ~P~WivmEL~~~GELr~yLq~nk~----sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGLS 538 (974)
T KOG4257|consen 463 QPMWIVMELAPLGELREYLQQNKD----SLPLRTLTLYCYQICTALAYLESKRFVHRDIAARNILVSSPQCVKLADFGLS 538 (974)
T ss_pred cceeEEEecccchhHHHHHHhccc----cchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhhheeecCcceeeecccchh
Confidence 578999999999999999998654 6788889999999999999999999999999999999999999999999999
Q ss_pred cccCCCCCcccccccccccceecccccccCCcCccccchhHHHHHHHHHh-CCCCCCCCCCCccchhhhccccCCCCCCc
Q 002721 757 KLLDPSKGTASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILT-TRLPVEEDFGEGVDLVKWVHGAPARGETP 835 (888)
Q Consensus 757 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 835 (888)
+.+++..... .+...-...|||||.+.-.+++.++|||-|||.+||++. |..||.+....++ .
T Consensus 539 R~~ed~~yYk-aS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsDV---------------I 602 (974)
T KOG4257|consen 539 RYLEDDAYYK-ASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSDV---------------I 602 (974)
T ss_pred hhccccchhh-ccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccce---------------E
Confidence 9987654322 222333567999999999999999999999999999987 9999987533322 0
Q ss_pred ccccccccccCCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhhh
Q 002721 836 EQILDARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEMLQEIKQ 887 (888)
Q Consensus 836 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 887 (888)
..+-.+. ..+.+...++.++.+|.+||++||.+||.+.|+...|+++.+
T Consensus 603 ~~iEnGe---RlP~P~nCPp~LYslmskcWayeP~kRPrftei~~~lsdv~q 651 (974)
T KOG4257|consen 603 GHIENGE---RLPCPPNCPPALYSLMSKCWAYEPSKRPRFTEIKAILSDVLQ 651 (974)
T ss_pred EEecCCC---CCCCCCCCChHHHHHHHHHhccCcccCCcHHHHHHHHHHHHH
Confidence 1111111 111233456778899999999999999999999999998864
|
|
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-37 Score=337.69 Aligned_cols=265 Identities=19% Similarity=0.271 Sum_probs=203.9
Q ss_pred HHhcCCcceeeecccceEEEEEe------CCCcEEEEEEeeccChhhhHHHHHHHHHHHHHhcc-CCCceeeeeeEEEeC
Q 002721 604 KATMKDSNMIYCGTFSTVYKAVM------PSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKL-CHDNLVRPIGFVIYE 676 (888)
Q Consensus 604 ~~~~~~~~~ig~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~ 676 (888)
.++|++.+.||+|+||.||+|.. .+++.||||+++.... ......+.+|+.++.++ +||||+++++++...
T Consensus 6 ~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~ 83 (343)
T cd05103 6 RDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT--HSEHRALMSELKILIHIGHHLNVVNLLGACTKP 83 (343)
T ss_pred hhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCCC--hHHHHHHHHHHHHHHhccCCccHhhhcceeecC
Confidence 56899999999999999999973 3578999999974332 22344788999999999 689999999988654
Q ss_pred -CeeEEEEecCCCCCHHHHhhccCCC------------------------------------------------------
Q 002721 677 -DVALLLHNYLPNGTLAQLLHESTKQ------------------------------------------------------ 701 (888)
Q Consensus 677 -~~~~lv~e~~~~g~L~~~l~~~~~~------------------------------------------------------ 701 (888)
...++||||+++|+|.+++......
T Consensus 84 ~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 163 (343)
T cd05103 84 GGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEE 163 (343)
T ss_pred CCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccchh
Confidence 4678999999999999998753210
Q ss_pred --------CCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccccccccCCCCCccccccccc
Q 002721 702 --------PDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSKGTASISAVAG 773 (888)
Q Consensus 702 --------~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g 773 (888)
....+++.++..++.||++||+|||++||+||||||+||+++.++.+|++|||++................+
T Consensus 164 ~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 243 (343)
T cd05103 164 EEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARL 243 (343)
T ss_pred hhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCC
Confidence 011367888899999999999999999999999999999999999999999999987543222222223345
Q ss_pred ccceecccccccCCcCccccchhHHHHHHHHHh-CCCCCCCCCCCccchhhhccccCCCCCCcccccccccccCCcCcHH
Q 002721 774 SFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILT-TRLPVEEDFGEGVDLVKWVHGAPARGETPEQILDARLSTVSFGWRK 852 (888)
Q Consensus 774 t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 852 (888)
+..|+|||.+.+..++.++||||||+++|||++ |..||....... .......... ....+ ..
T Consensus 244 ~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~-~~~~~~~~~~-------------~~~~~---~~ 306 (343)
T cd05103 244 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDE-EFCRRLKEGT-------------RMRAP---DY 306 (343)
T ss_pred CcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccH-HHHHHHhccC-------------CCCCC---CC
Confidence 678999999988899999999999999999997 999986532211 1111110000 00000 01
Q ss_pred HHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhhh
Q 002721 853 EMLTALKVALLCTDSTPAKRPKMKKVVEMLQEIKQ 887 (888)
Q Consensus 853 ~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 887 (888)
..+++.+++.+||+.||++|||+.|+++.|+.+.+
T Consensus 307 ~~~~~~~~~~~cl~~~p~~Rps~~eil~~l~~~~~ 341 (343)
T cd05103 307 TTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 341 (343)
T ss_pred CCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHh
Confidence 22467889999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-37 Score=323.87 Aligned_cols=254 Identities=20% Similarity=0.346 Sum_probs=202.6
Q ss_pred HHhcCCcceeeecccceEEEEEeCCCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCCeeEEEE
Q 002721 604 KATMKDSNMIYCGTFSTVYKAVMPSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVALLLH 683 (888)
Q Consensus 604 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 683 (888)
.++|++.+.||+|+||.||+|....+..+|+|.+..... ..+.+.+|++++++++|||++++++++. .+..++||
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~lK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~ 79 (260)
T cd05069 5 RESLRLDVKLGQGCFGEVWMGTWNGTTKVAIKTLKPGTM----MPEAFLQEAQIMKKLRHDKLVPLYAVVS-EEPIYIVT 79 (260)
T ss_pred hHHeeeeeeecCcCCCeEEEEEEcCCceEEEEEcccCCc----cHHHHHHHHHHHHhCCCCCeeeEEEEEc-CCCcEEEE
Confidence 467899999999999999999987777899998864332 1236889999999999999999999875 45689999
Q ss_pred ecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccccccccCCCC
Q 002721 684 NYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSK 763 (888)
Q Consensus 684 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 763 (888)
||+++++|.++++..... .+++..+..++.|++.||+|||+.|++||||||+||++++++.++|+|||.+.......
T Consensus 80 e~~~~~~L~~~~~~~~~~---~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~ 156 (260)
T cd05069 80 EFMGKGSLLDFLKEGDGK---YLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNE 156 (260)
T ss_pred EcCCCCCHHHHHhhCCCC---CCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEcCCCeEEECCCccceEccCCc
Confidence 999999999999764321 46889999999999999999999999999999999999999999999999998764322
Q ss_pred CcccccccccccceecccccccCCcCccccchhHHHHHHHHHh-CCCCCCCCCCCccchhhhccccCCCCCCcccccccc
Q 002721 764 GTASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILT-TRLPVEEDFGEGVDLVKWVHGAPARGETPEQILDAR 842 (888)
Q Consensus 764 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 842 (888)
.. ......++..|+|||...+..++.++||||||+++|||++ |+.||.+..... ...+.......
T Consensus 157 ~~-~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~--~~~~~~~~~~~----------- 222 (260)
T cd05069 157 YT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNRE--VLEQVERGYRM----------- 222 (260)
T ss_pred cc-ccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHHHcCCCC-----------
Confidence 11 1122345678999999988889999999999999999999 899997543221 11111110000
Q ss_pred cccCCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 002721 843 LSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEMLQE 884 (888)
Q Consensus 843 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~ 884 (888)
.........+.+++.+||+.||++||+++++++.|++
T Consensus 223 -----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 259 (260)
T cd05069 223 -----PCPQGCPESLHELMKLCWKKDPDERPTFEYIQSFLED 259 (260)
T ss_pred -----CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHHHhc
Confidence 0111234567889999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-37 Score=332.81 Aligned_cols=265 Identities=21% Similarity=0.294 Sum_probs=206.2
Q ss_pred HHHhcCCcceeeecccceEEEEEeC--------CCcEEEEEEeeccChhhhHHHHHHHHHHHHHhcc-CCCceeeeeeEE
Q 002721 603 VKATMKDSNMIYCGTFSTVYKAVMP--------SGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKL-CHDNLVRPIGFV 673 (888)
Q Consensus 603 ~~~~~~~~~~ig~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~ 673 (888)
..++|.+.+.||+|+||.||+|+.. ....||+|.++.... ......+.+|+++++++ +||||+++++++
T Consensus 10 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 87 (314)
T cd05099 10 PRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNAT--DKDLADLISEMELMKLIGKHKNIINLLGVC 87 (314)
T ss_pred cHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCCC--hHHHHHHHHHHHHHHhccCCCCeeeEEEEE
Confidence 3568999999999999999999731 245799998874332 22345788999999999 699999999999
Q ss_pred EeCCeeEEEEecCCCCCHHHHhhccCC-----------CCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEe
Q 002721 674 IYEDVALLLHNYLPNGTLAQLLHESTK-----------QPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLL 742 (888)
Q Consensus 674 ~~~~~~~lv~e~~~~g~L~~~l~~~~~-----------~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll 742 (888)
...+..|+||||+++|+|.+++..... .....+++.++..++.|++.||+|||++|++||||||+||++
T Consensus 88 ~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill 167 (314)
T cd05099 88 TQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLV 167 (314)
T ss_pred ccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeeccccceeEEE
Confidence 998999999999999999999976432 112357889999999999999999999999999999999999
Q ss_pred CCCCCceEeccccccccCCCCCcccccccccccceecccccccCCcCccccchhHHHHHHHHHh-CCCCCCCCCCCccch
Q 002721 743 DADFKPLLGEIEISKLLDPSKGTASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILT-TRLPVEEDFGEGVDL 821 (888)
Q Consensus 743 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~~~~~~~~~ 821 (888)
+.++.+|++|||.++...............++..|+|||++.+..++.++||||||+++|||++ |..||...... +.
T Consensus 168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~--~~ 245 (314)
T cd05099 168 TEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIPVE--EL 245 (314)
T ss_pred cCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCCHH--HH
Confidence 9999999999999987643221111112234567999999988889999999999999999999 88998653221 11
Q ss_pred hhhccccCCCCCCcccccccccccCCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhhh
Q 002721 822 VKWVHGAPARGETPEQILDARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEMLQEIKQ 887 (888)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 887 (888)
....... .. ... ......++.+++.+||+.||++|||+.|+++.|+++..
T Consensus 246 ~~~~~~~----~~---------~~~---~~~~~~~l~~li~~cl~~~p~~Rps~~~ll~~l~~~~~ 295 (314)
T cd05099 246 FKLLREG----HR---------MDK---PSNCTHELYMLMRECWHAVPTQRPTFKQLVEALDKVLA 295 (314)
T ss_pred HHHHHcC----CC---------CCC---CCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHHHHH
Confidence 1111100 00 000 11123467789999999999999999999999998763
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-37 Score=328.36 Aligned_cols=268 Identities=20% Similarity=0.311 Sum_probs=203.8
Q ss_pred HhcCCcceeeecccceEEEEEe-----CCCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeC--C
Q 002721 605 ATMKDSNMIYCGTFSTVYKAVM-----PSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYE--D 677 (888)
Q Consensus 605 ~~~~~~~~ig~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~--~ 677 (888)
..|++.+.||+|+||.||+|+. .++..||+|.++.... ....+.+.+|++++++++||||+++++++... .
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPESG--GNHIADLKKEIEILRNLYHENIVKYKGICTEDGGN 81 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCcccc--HHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCC
Confidence 4578899999999999999973 3578999999874432 22345789999999999999999999998875 5
Q ss_pred eeEEEEecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEecccccc
Q 002721 678 VALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISK 757 (888)
Q Consensus 678 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~ 757 (888)
..++||||+++++|.+++.+... .+++.++..++.|++.||+|||++|++||||||+||+++.++.++++|||.+.
T Consensus 82 ~~~lv~e~~~g~~L~~~l~~~~~----~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~ 157 (284)
T cd05079 82 GIKLIMEFLPSGSLKEYLPRNKN----KINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTK 157 (284)
T ss_pred ceEEEEEccCCCCHHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHHCCeeecccchheEEEcCCCCEEECCCcccc
Confidence 68999999999999999975432 46889999999999999999999999999999999999999999999999998
Q ss_pred ccCCCCCcc-cccccccccceecccccccCCcCccccchhHHHHHHHHHhCCCCCCCCCCCccchhhhccccCCCCCCcc
Q 002721 758 LLDPSKGTA-SISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPE 836 (888)
Q Consensus 758 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 836 (888)
......... ......++..|+|||++.+..++.++||||||+++|||++++.|......... +..... .......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~~---~~~~~~-~~~~~~~ 233 (284)
T cd05079 158 AIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFL---KMIGPT-HGQMTVT 233 (284)
T ss_pred ccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchhh---hhcccc-cccccHH
Confidence 765432211 11234567789999999888899999999999999999998876543211100 000000 0000000
Q ss_pred cc----cccccccCCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHh
Q 002721 837 QI----LDARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEMLQEI 885 (888)
Q Consensus 837 ~~----~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~i 885 (888)
.. .+..... .....+..+.+++.+||+.||++|||++++++.|+++
T Consensus 234 ~~~~~~~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~~~ 283 (284)
T cd05079 234 RLVRVLEEGKRLP---RPPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEGFEAI 283 (284)
T ss_pred HHHHHHHcCccCC---CCCCCCHHHHHHHHHHccCCcccCcCHHHHHHHHHhh
Confidence 00 0000000 1122346788999999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-37 Score=322.49 Aligned_cols=252 Identities=22% Similarity=0.280 Sum_probs=204.0
Q ss_pred hcCCcceeeecccceEEEEEe-CCCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCCeeEEEEe
Q 002721 606 TMKDSNMIYCGTFSTVYKAVM-PSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVALLLHN 684 (888)
Q Consensus 606 ~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 684 (888)
+|+..+.||+|++|.||+|+. .+++.|++|.+...... ....+.+.+|++++++++||||+++++++..++..|+|||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMN-RREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVME 79 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhCC-HHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEE
Confidence 477789999999999999995 46899999998743322 3344578999999999999999999999999999999999
Q ss_pred cCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccccccccCCCCC
Q 002721 685 YLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSKG 764 (888)
Q Consensus 685 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 764 (888)
|+++++|.+++..... ..+++.++..++.|++.||.|||+.|++||||||+||+++.++.++++|||.+........
T Consensus 80 ~~~~~~L~~~l~~~~~---~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~ 156 (256)
T cd08529 80 YAENGDLHKLLKMQRG---RPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN 156 (256)
T ss_pred eCCCCcHHHHHHHhcC---CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCccc
Confidence 9999999999986532 2578889999999999999999999999999999999999999999999999887654322
Q ss_pred cccccccccccceecccccccCCcCccccchhHHHHHHHHHhCCCCCCCCCCCccchhhhccccCCCCCCcccccccccc
Q 002721 765 TASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQILDARLS 844 (888)
Q Consensus 765 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 844 (888)
. .....|++.|+|||+..+..++.++||||||+++|||++|+.||...... ..... +......
T Consensus 157 ~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~~~~-------------~~~~~~~ 219 (256)
T cd08529 157 F--ANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQG--ALILK-------------IIRGVFP 219 (256)
T ss_pred h--hhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH--HHHHH-------------HHcCCCC
Confidence 1 23346788999999999888999999999999999999999999754311 11110 0001111
Q ss_pred cCCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002721 845 TVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEM 881 (888)
Q Consensus 845 ~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~ 881 (888)
. .......++.+++.+||+.+|++||++.++++.
T Consensus 220 ~---~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~ 253 (256)
T cd08529 220 P---VSQMYSQQLAQLIDQCLTKDYRQRPDTFQLLRN 253 (256)
T ss_pred C---CccccCHHHHHHHHHHccCCcccCcCHHHHhhC
Confidence 1 111334567899999999999999999999863
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=324.86 Aligned_cols=257 Identities=25% Similarity=0.291 Sum_probs=192.1
Q ss_pred ceeeecccceEEEEEeC---CCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCCeeEEEEecCC
Q 002721 611 NMIYCGTFSTVYKAVMP---SGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVALLLHNYLP 687 (888)
Q Consensus 611 ~~ig~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~ 687 (888)
+.||+|+||.||+|... ++..+|+|.++..... .....+.+|+.++++++||||+++++++.+....++||||++
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~~~--~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 78 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSASV--QEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCP 78 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCCCh--HHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCC
Confidence 46899999999999853 3467999988754322 233478899999999999999999999999899999999999
Q ss_pred CCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccccccccCCCCCccc
Q 002721 688 NGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSKGTAS 767 (888)
Q Consensus 688 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~ 767 (888)
+|+|.+++...........++..+..++.|++.|++|||+.|++||||||+||+++.++.+|++|||.+...........
T Consensus 79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~ 158 (269)
T cd05087 79 LGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVT 158 (269)
T ss_pred CCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCcceeec
Confidence 99999999765433223456778889999999999999999999999999999999999999999999875433221111
Q ss_pred ccccccccceecccccccC-------CcCccccchhHHHHHHHHHh-CCCCCCCCCCCccchhhhccccCCCCCCccccc
Q 002721 768 ISAVAGSFGYIPPEYAYTM-------QVTAPGNVYSYGVVLLEILT-TRLPVEEDFGEGVDLVKWVHGAPARGETPEQIL 839 (888)
Q Consensus 768 ~~~~~gt~~y~aPE~~~~~-------~~~~~~DiwSlG~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 839 (888)
.....++..|+|||++.+. .++.++||||||+++|||++ |+.||........ ......... ....
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~-~~~~~~~~~------~~~~ 231 (269)
T cd05087 159 PDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQV-LTYTVREQQ------LKLP 231 (269)
T ss_pred CCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChHHH-HHHHhhccc------CCCC
Confidence 2234567889999987542 35789999999999999996 9999965332211 000000000 0001
Q ss_pred ccccccCCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 002721 840 DARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEMLQ 883 (888)
Q Consensus 840 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~ 883 (888)
++... ......+.+++..|| .+|++|||++||++.|+
T Consensus 232 ~~~~~------~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~~l~ 268 (269)
T cd05087 232 KPRLK------LPLSDRWYEVMQFCW-LQPEQRPSAEEVHLLLS 268 (269)
T ss_pred CCccC------CCCChHHHHHHHHHh-cCcccCCCHHHHHHHhc
Confidence 11110 112334667888999 58999999999999875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-37 Score=328.51 Aligned_cols=270 Identities=21% Similarity=0.318 Sum_probs=201.9
Q ss_pred HhcCCcceeeecccceEEEEEe-----CCCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEe--CC
Q 002721 605 ATMKDSNMIYCGTFSTVYKAVM-----PSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIY--ED 677 (888)
Q Consensus 605 ~~~~~~~~ig~G~~g~Vy~~~~-----~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~--~~ 677 (888)
.+|++.+.||+|+||.||+|.. .++..||+|.++.... ...+.+.+|++++++++||||+++++++.. ..
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~ 80 (284)
T cd05081 4 RHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHSTA---EHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRR 80 (284)
T ss_pred ccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccCCH---HHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCC
Confidence 4788899999999999999973 2578999999875432 233578899999999999999999998754 34
Q ss_pred eeEEEEecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEecccccc
Q 002721 678 VALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISK 757 (888)
Q Consensus 678 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~ 757 (888)
..++||||+++++|.+++..... .+++..+..++.|++.||+|||++|++||||||+||++++++.+||+|||++.
T Consensus 81 ~~~lv~e~~~~~~L~~~l~~~~~----~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~ 156 (284)
T cd05081 81 NLRLVMEYLPYGSLRDYLQKHRE----RLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTK 156 (284)
T ss_pred ceEEEEEecCCCCHHHHHHhcCc----CCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHhhEEECCCCeEEECCCcccc
Confidence 68999999999999999975432 46889999999999999999999999999999999999999999999999998
Q ss_pred ccCCCCCcccc-cccccccceecccccccCCcCccccchhHHHHHHHHHhCCCCCCCCCCCccchhhhccccCCCCCCcc
Q 002721 758 LLDPSKGTASI-SAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPE 836 (888)
Q Consensus 758 ~~~~~~~~~~~-~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 836 (888)
........... ....++..|+|||+..+..++.++||||||+++|||++|..|+...... ..+.............
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~ 233 (284)
T cd05081 157 VLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAE---FMRMMGNDKQGQMIVY 233 (284)
T ss_pred cccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchh---hhhhcccccccccchH
Confidence 76543221111 1122345699999998888999999999999999999998776532211 0000000000000000
Q ss_pred ---cccccccccCCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhh
Q 002721 837 ---QILDARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEMLQEIK 886 (888)
Q Consensus 837 ---~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~i~ 886 (888)
+....... .........++.+++.+||+.+|++|||++|+++.|++++
T Consensus 234 ~~~~~~~~~~~--~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~~~ 284 (284)
T cd05081 234 HLIELLKNNGR--LPAPPGCPAEIYAIMKECWNNDPSQRPSFSELALQVEAIR 284 (284)
T ss_pred HHHHHHhcCCc--CCCCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHHhcC
Confidence 00000000 0011123456889999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-37 Score=333.52 Aligned_cols=269 Identities=19% Similarity=0.283 Sum_probs=203.1
Q ss_pred HHHhcCCcceeeecccceEEEEEeCC---------------CcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCcee
Q 002721 603 VKATMKDSNMIYCGTFSTVYKAVMPS---------------GLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLV 667 (888)
Q Consensus 603 ~~~~~~~~~~ig~G~~g~Vy~~~~~~---------------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv 667 (888)
...+|++.+.||+|+||.||+|+... ...||+|.++.... ......+.+|++++++++||||+
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~ei~~l~~l~h~~i~ 80 (295)
T cd05097 3 PRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVT--KTARNDFLKEIKIMSRLKNPNII 80 (295)
T ss_pred chHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCCCC--HHHHHHHHHHHHHHHhCCCCCcC
Confidence 35689999999999999999997532 23589999875322 22344789999999999999999
Q ss_pred eeeeEEEeCCeeEEEEecCCCCCHHHHhhccCCC-------CCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCe
Q 002721 668 RPIGFVIYEDVALLLHNYLPNGTLAQLLHESTKQ-------PDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNV 740 (888)
Q Consensus 668 ~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~-------~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NI 740 (888)
++++++..++..++||||+++++|.+++...... ....+++.+++.++.|++.||+|||++|++||||||+||
T Consensus 81 ~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~Ni 160 (295)
T cd05097 81 RLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNC 160 (295)
T ss_pred eEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCeeccccChhhE
Confidence 9999999999999999999999999999654211 111367889999999999999999999999999999999
Q ss_pred EeCCCCCceEeccccccccCCCCCcccccccccccceecccccccCCcCccccchhHHHHHHHHHh--CCCCCCCCCCCc
Q 002721 741 LLDADFKPLLGEIEISKLLDPSKGTASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILT--TRLPVEEDFGEG 818 (888)
Q Consensus 741 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt--g~~P~~~~~~~~ 818 (888)
++++++.+|++|||++................++..|+|||+..+..++.++|||||||++|||++ |..||.......
T Consensus 161 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~~p~~~~~~~~ 240 (295)
T cd05097 161 LVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQ 240 (295)
T ss_pred EEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCCCCCcccChHH
Confidence 999999999999999976543322222223345778999999988889999999999999999998 667776432211
Q ss_pred cchhhhccccCCCCCCcccccccccccCCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 002721 819 VDLVKWVHGAPARGETPEQILDARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEMLQE 884 (888)
Q Consensus 819 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~ 884 (888)
............. .... .. ........+.+++.+||+.||++|||+++|++.|++
T Consensus 241 --~~~~~~~~~~~~~--~~~~----~~---~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~~l~~ 295 (295)
T cd05097 241 --VIENTGEFFRNQG--RQIY----LS---QTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHHFLRE 295 (295)
T ss_pred --HHHHHHHhhhhcc--cccc----CC---CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHhC
Confidence 1110000000000 0000 00 011123578899999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-40 Score=347.55 Aligned_cols=366 Identities=27% Similarity=0.394 Sum_probs=290.4
Q ss_pred CCCCCEEECcCCCCC-CCCCCCCCCCCcceEEEcCCCccccccCccccccccccEEEecCCCCCCCCCccccccccccEE
Q 002721 109 LSELEFLDLSLNKFG-GVIPRELGSLKDLRFFNISNNVLVGEIPDELKSLEKLEDFQVSSNKLNGSIPFWVGNLTNLRVF 187 (888)
Q Consensus 109 l~~L~~L~Ls~N~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 187 (888)
|+-.+-.|+++|.++ +..|.....++.+++|-|...++. .+|+.++.+.+|++|.+++|++. .+.+.+..|+.|+.+
T Consensus 6 LpFVrGvDfsgNDFsg~~FP~~v~qMt~~~WLkLnrt~L~-~vPeEL~~lqkLEHLs~~HN~L~-~vhGELs~Lp~LRsv 83 (1255)
T KOG0444|consen 6 LPFVRGVDFSGNDFSGDRFPHDVEQMTQMTWLKLNRTKLE-QVPEELSRLQKLEHLSMAHNQLI-SVHGELSDLPRLRSV 83 (1255)
T ss_pred cceeecccccCCcCCCCcCchhHHHhhheeEEEechhhhh-hChHHHHHHhhhhhhhhhhhhhH-hhhhhhccchhhHHH
Confidence 334555677777776 456777777777777777777776 67777778888888888888777 566677777888888
Q ss_pred ecccccccCC-CCCCCCCcccccceeeccccCCCCCCCCccCCCCcceEEecCccCCCCchhhhccCCccceeeccCCcc
Q 002721 188 TAYENQLVGE-IPDNLGSVSELELLNLHSNQLEGPIPKSIFASGKLEVLVLTQNRLTGDIPELVGHCKSLSNIRIGNNDL 266 (888)
Q Consensus 188 ~L~~N~l~~~-~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l 266 (888)
.+.+|++... +|+.+..|..|..||||+|+++ ..|..+..-+++-+|+||+|+|..++...|.+++.|-.||||+|++
T Consensus 84 ~~R~N~LKnsGiP~diF~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~IetIPn~lfinLtDLLfLDLS~NrL 162 (1255)
T KOG0444|consen 84 IVRDNNLKNSGIPTDIFRLKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIETIPNSLFINLTDLLFLDLSNNRL 162 (1255)
T ss_pred hhhccccccCCCCchhcccccceeeecchhhhh-hcchhhhhhcCcEEEEcccCccccCCchHHHhhHhHhhhccccchh
Confidence 8888877633 5777777888888888888887 6788888888888888888888877777788888888888888888
Q ss_pred ccccCCccccCCCccEEEeeccCCCCCCCccccCCCCCcEEEeecCccc-ccCCccccCCCCccEEEeccccccCcCccc
Q 002721 267 VGVIPRAIGNVSGLTYFEADNNNLSGEIVPEFSQCSNLTLLNLASNGFT-GVIPPELGQLINLQELILYENSLFGEIPKS 345 (888)
Q Consensus 267 ~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~-~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~ 345 (888)
.. +|..+..+..|++|+|++|.+...-...+..+++|++|.+++.+-+ ..+|.++..+.+|..+|||.|.+. .+|..
T Consensus 163 e~-LPPQ~RRL~~LqtL~Ls~NPL~hfQLrQLPsmtsL~vLhms~TqRTl~N~Ptsld~l~NL~dvDlS~N~Lp-~vPec 240 (1255)
T KOG0444|consen 163 EM-LPPQIRRLSMLQTLKLSNNPLNHFQLRQLPSMTSLSVLHMSNTQRTLDNIPTSLDDLHNLRDVDLSENNLP-IVPEC 240 (1255)
T ss_pred hh-cCHHHHHHhhhhhhhcCCChhhHHHHhcCccchhhhhhhcccccchhhcCCCchhhhhhhhhccccccCCC-cchHH
Confidence 74 4556777888888888888877655556667778888888887643 247888888888888888888885 77888
Q ss_pred ccccCcceEEEccCCcCCCCCCchhccccCcceecccCCccccccCCCccccccceEEEeeccccc-ccCCCccccccch
Q 002721 346 ILACKNLNKLDLSNNRFNGTIPNAICDMSRLQYLLLGQNSLKGEIPHEIGNCMKLLQLHIGSNYLT-GSIPPEIGHIRNL 424 (888)
Q Consensus 346 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~-~~~p~~~~~l~~L 424 (888)
+-++++|+.|+||+|+|+ .+.-..+.+.+|++|+||+|+++ .+|..+..+++|+.|++.+|+++ .-||+.++.+.+|
T Consensus 241 ly~l~~LrrLNLS~N~it-eL~~~~~~W~~lEtLNlSrNQLt-~LP~avcKL~kL~kLy~n~NkL~FeGiPSGIGKL~~L 318 (1255)
T KOG0444|consen 241 LYKLRNLRRLNLSGNKIT-ELNMTEGEWENLETLNLSRNQLT-VLPDAVCKLTKLTKLYANNNKLTFEGIPSGIGKLIQL 318 (1255)
T ss_pred HhhhhhhheeccCcCcee-eeeccHHHHhhhhhhccccchhc-cchHHHhhhHHHHHHHhccCcccccCCccchhhhhhh
Confidence 888888888888888887 45556677788888888888888 78888888888888888888875 2488889999888
Q ss_pred hhhhhccCccccccCCccccCCCCccEEEeeCCccccCCchhhcccccceEEEccCCcCc
Q 002721 425 QIALNLSFNHLHGSLPPELGKLDKLVSFDVSNNQLSGTIPSALKGMLSLIEVNFSNNLLT 484 (888)
Q Consensus 425 ~~~L~ls~N~l~~~~p~~~~~l~~L~~LdLs~N~l~~~~p~~~~~l~~L~~L~ls~N~l~ 484 (888)
+ .+..++|++. .+|..++.+..|+.|.|+.|+|- ++|.++.-++.|..||+..|+=-
T Consensus 319 e-vf~aanN~LE-lVPEglcRC~kL~kL~L~~NrLi-TLPeaIHlL~~l~vLDlreNpnL 375 (1255)
T KOG0444|consen 319 E-VFHAANNKLE-LVPEGLCRCVKLQKLKLDHNRLI-TLPEAIHLLPDLKVLDLRENPNL 375 (1255)
T ss_pred H-HHHhhccccc-cCchhhhhhHHHHHhccccccee-echhhhhhcCCcceeeccCCcCc
Confidence 8 6888888887 78888999999999999999987 78999999999999999988643
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-37 Score=318.45 Aligned_cols=262 Identities=22% Similarity=0.301 Sum_probs=203.2
Q ss_pred HHHHhcCCcceeeecccceEEEEEeCCCcEEEEEEeeccChhhhHHHHHHHHHHHHHhcc--CCCceeeeeeEEEeCC--
Q 002721 602 VVKATMKDSNMIYCGTFSTVYKAVMPSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKL--CHDNLVRPIGFVIYED-- 677 (888)
Q Consensus 602 ~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l--~hpnIv~~~~~~~~~~-- 677 (888)
.+..+....+.||+|.||+||+|.+ .|+.||||++...+.. .+.+|.+|++.. +|+||+.+++.-..+.
T Consensus 208 TiarqI~L~e~IGkGRyGEVwrG~w-rGe~VAVKiF~srdE~------SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs 280 (513)
T KOG2052|consen 208 TIARQIVLQEIIGKGRFGEVWRGRW-RGEDVAVKIFSSRDER------SWFRETEIYQTVMLRHENILGFIAADNKDNGS 280 (513)
T ss_pred hhhheeEEEEEecCccccceeeccc-cCCceEEEEecccchh------hhhhHHHHHHHHHhccchhhhhhhccccCCCc
Confidence 4556788899999999999999998 7889999999855432 677888888754 9999999998754432
Q ss_pred --eeEEEEecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhccc--------CCeeecCCCCCCeEeCCCCC
Q 002721 678 --VALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHH--------VAIIHLDISSGNVLLDADFK 747 (888)
Q Consensus 678 --~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~--------~~ivHrDlkp~NIll~~~~~ 747 (888)
..|+|++|.+.|+|+||+.+. .++....++++..+|.||+|||. ..|.|||||+.||||..++.
T Consensus 281 ~TQLwLvTdYHe~GSL~DyL~r~------tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~ 354 (513)
T KOG2052|consen 281 WTQLWLVTDYHEHGSLYDYLNRN------TVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGT 354 (513)
T ss_pred eEEEEEeeecccCCcHHHHHhhc------cCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCc
Confidence 689999999999999999874 56788999999999999999995 56999999999999999999
Q ss_pred ceEeccccccccCCCCCc--ccccccccccceecccccccCC----c--CccccchhHHHHHHHHHhC----------CC
Q 002721 748 PLLGEIEISKLLDPSKGT--ASISAVAGSFGYIPPEYAYTMQ----V--TAPGNVYSYGVVLLEILTT----------RL 809 (888)
Q Consensus 748 ~kl~Dfg~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~~----~--~~~~DiwSlG~il~elltg----------~~ 809 (888)
+.|+|+|+|......... ......+||.+|||||++...- + -..+||||||.|+||++-+ +.
T Consensus 355 C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~ 434 (513)
T KOG2052|consen 355 CCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQL 434 (513)
T ss_pred EEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcC
Confidence 999999999887654322 2234678999999999875432 1 2358999999999999864 45
Q ss_pred CCCCCCCCccchhhhccccCCCCCCcccccccccc-cCCc--CcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhh
Q 002721 810 PVEEDFGEGVDLVKWVHGAPARGETPEQILDARLS-TVSF--GWRKEMLTALKVALLCTDSTPAKRPKMKKVVEMLQEIK 886 (888)
Q Consensus 810 P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~--~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~i~ 886 (888)
||.+..+.+. ..++..+-+...++. ..+. ...+....+.++|+.||..+|..|-|+-.+-+.|.++.
T Consensus 435 Pyyd~Vp~DP----------s~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltALriKKtl~~l~ 504 (513)
T KOG2052|consen 435 PYYDVVPSDP----------SFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTALRIKKTLAKLS 504 (513)
T ss_pred CcccCCCCCC----------CHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHHHHHHHHHHHHh
Confidence 6655433322 222222222222222 2222 23456777889999999999999999999999988875
|
|
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-37 Score=327.87 Aligned_cols=260 Identities=21% Similarity=0.304 Sum_probs=203.4
Q ss_pred HHhcCCcceeeecccceEEEEEe------CCCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCC
Q 002721 604 KATMKDSNMIYCGTFSTVYKAVM------PSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYED 677 (888)
Q Consensus 604 ~~~~~~~~~ig~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 677 (888)
..+|...+.||+|+||.||+|.. .++..+|+|.++.... ...+.+.+|+++++.++||||+++++++...+
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 80 (280)
T cd05092 4 RRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASE---SARQDFQREAELLTVLQHQHIVRFYGVCTEGR 80 (280)
T ss_pred hHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcCCH---HHHHHHHHHHHHHhcCCCCCCceEEEEEecCC
Confidence 45688899999999999999963 2466899998874432 23347899999999999999999999999999
Q ss_pred eeEEEEecCCCCCHHHHhhccCCC----------CCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCC
Q 002721 678 VALLLHNYLPNGTLAQLLHESTKQ----------PDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFK 747 (888)
Q Consensus 678 ~~~lv~e~~~~g~L~~~l~~~~~~----------~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~ 747 (888)
..+++|||+++++|.+++...... ....+++.++..++.|++.|++|||++|++||||||+||++++++.
T Consensus 81 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~~ 160 (280)
T cd05092 81 PLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLV 160 (280)
T ss_pred ceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCCC
Confidence 999999999999999999764321 1125788999999999999999999999999999999999999999
Q ss_pred ceEeccccccccCCCCCcccccccccccceecccccccCCcCccccchhHHHHHHHHHh-CCCCCCCCCCCccchhhhcc
Q 002721 748 PLLGEIEISKLLDPSKGTASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILT-TRLPVEEDFGEGVDLVKWVH 826 (888)
Q Consensus 748 ~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~~~~~~~~~~~~~~ 826 (888)
+||+|||++................+++.|+|||++.+..++.++|||||||++|||++ |+.||....... ......
T Consensus 161 ~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~--~~~~~~ 238 (280)
T cd05092 161 VKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTE--AIECIT 238 (280)
T ss_pred EEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCccCCHHH--HHHHHH
Confidence 99999999876543221111123345678999999998999999999999999999998 999986532211 111000
Q ss_pred ccCCCCCCcccccccccccCCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 002721 827 GAPARGETPEQILDARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEMLQE 884 (888)
Q Consensus 827 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~ 884 (888)
...... .....+..+.+++.+||+.||++||+++||++.|++
T Consensus 239 -------------~~~~~~---~~~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~~l~~ 280 (280)
T cd05092 239 -------------QGRELE---RPRTCPPEVYAIMQGCWQREPQQRMVIKDIHSRLQA 280 (280)
T ss_pred -------------cCccCC---CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHHHhC
Confidence 000000 011223557789999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-37 Score=348.93 Aligned_cols=264 Identities=18% Similarity=0.207 Sum_probs=192.4
Q ss_pred HHhcCCcceeeecccceEEEEEe-CCCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeC------
Q 002721 604 KATMKDSNMIYCGTFSTVYKAVM-PSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYE------ 676 (888)
Q Consensus 604 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~------ 676 (888)
..+|+..+.||+|+||.||+|.. .+++.||||++..... ...+|+.+++.++||||+++++++...
T Consensus 65 ~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~-------~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~ 137 (440)
T PTZ00036 65 NKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQ-------YKNRELLIMKNLNHINIIFLKDYYYTECFKKNE 137 (440)
T ss_pred CCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCcc-------hHHHHHHHHHhcCCCCCcceeeeEeecccccCC
Confidence 45799999999999999999995 4689999998864321 345799999999999999999987532
Q ss_pred --CeeEEEEecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCC-CceEecc
Q 002721 677 --DVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADF-KPLLGEI 753 (888)
Q Consensus 677 --~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~-~~kl~Df 753 (888)
...++||||+++ ++.+++....... ..+++..+..++.||+.||+|||++||+||||||+||+++.++ .+||+||
T Consensus 138 ~~~~l~lvmE~~~~-~l~~~~~~~~~~~-~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLKp~NILl~~~~~~vkL~DF 215 (440)
T PTZ00036 138 KNIFLNVVMEFIPQ-TVHKYMKHYARNN-HALPLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDF 215 (440)
T ss_pred CceEEEEEEecCCc-cHHHHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcCHHHEEEcCCCCceeeecc
Confidence 246799999985 7887776432221 2578899999999999999999999999999999999998664 6999999
Q ss_pred ccccccCCCCCcccccccccccceecccccccC-CcCccccchhHHHHHHHHHhCCCCCCCCCCCccchhhhccc--cCC
Q 002721 754 EISKLLDPSKGTASISAVAGSFGYIPPEYAYTM-QVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHG--APA 830 (888)
Q Consensus 754 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~--~~~ 830 (888)
|+++....... .....||+.|+|||++.+. .++.++||||+||++|||++|.+||.+..... .+.+.... .+.
T Consensus 216 Gla~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~~-~~~~i~~~~~~p~ 291 (440)
T PTZ00036 216 GSAKNLLAGQR---SVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVD-QLVRIIQVLGTPT 291 (440)
T ss_pred ccchhccCCCC---cccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHHhCCCC
Confidence 99987653322 2245689999999987654 68999999999999999999999997643221 11111110 000
Q ss_pred CCCC---cccccccccccCC-cCc-----HHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002721 831 RGET---PEQILDARLSTVS-FGW-----RKEMLTALKVALLCTDSTPAKRPKMKKVVE 880 (888)
Q Consensus 831 ~~~~---~~~~~~~~~~~~~-~~~-----~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 880 (888)
.... .....+-.+.... ... .....++.+++.+||.+||.+|||+.|+++
T Consensus 292 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~ta~e~l~ 350 (440)
T PTZ00036 292 EDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRLNPIEALA 350 (440)
T ss_pred HHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCcCHHHHhC
Confidence 0000 0000000000000 000 112357889999999999999999999984
|
|
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-36 Score=323.09 Aligned_cols=257 Identities=21% Similarity=0.358 Sum_probs=206.6
Q ss_pred HHHHhcCCcceeeecccceEEEEEeCCCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCCeeEE
Q 002721 602 VVKATMKDSNMIYCGTFSTVYKAVMPSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVALL 681 (888)
Q Consensus 602 ~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 681 (888)
+..++|++.+.||+|+||.||+|...+++.||+|.+...... .+.+.+|+.++++++||||+++++++......++
T Consensus 3 ~~~~~~~i~~~ig~g~~~~v~~~~~~~~~~~~vK~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~ 78 (261)
T cd05034 3 IPRESLKLERKLGAGQFGEVWMGTWNGTTKVAVKTLKPGTMS----PEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYI 78 (261)
T ss_pred cchhheeeeeeeccCcceEEEEEEEcCCceEEEEEecCCccC----HHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEE
Confidence 346789999999999999999999878889999998754332 2468899999999999999999999998889999
Q ss_pred EEecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccccccccCC
Q 002721 682 LHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDP 761 (888)
Q Consensus 682 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~~~ 761 (888)
||||+++++|.+++...... .+++.++..++.|++.|++|||++|++||||||+||++++++.+|++|||.+.....
T Consensus 79 v~e~~~~~~L~~~i~~~~~~---~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~ 155 (261)
T cd05034 79 VTEYMSKGSLLDFLKSGEGK---KLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIED 155 (261)
T ss_pred EEeccCCCCHHHHHhccccC---CCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEEEcCCCCEEECccccceeccc
Confidence 99999999999999865322 578899999999999999999999999999999999999999999999999887653
Q ss_pred CCCcccccccccccceecccccccCCcCccccchhHHHHHHHHHh-CCCCCCCCCCCccchhhhccccCCCCCCcccccc
Q 002721 762 SKGTASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILT-TRLPVEEDFGEGVDLVKWVHGAPARGETPEQILD 840 (888)
Q Consensus 762 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 840 (888)
... .......++..|+|||.+.+..++.++||||+|+++||+++ |+.||....... ..........
T Consensus 156 ~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~--~~~~~~~~~~---------- 222 (261)
T cd05034 156 DEY-TAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNRE--VLEQVERGYR---------- 222 (261)
T ss_pred hhh-hhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHHHcCCC----------
Confidence 211 11122334568999999998889999999999999999999 999996532211 1111110000
Q ss_pred cccccCCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 002721 841 ARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEMLQE 884 (888)
Q Consensus 841 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~ 884 (888)
.. .......++.+++.+|+..+|++||+++++.+.|+.
T Consensus 223 ---~~---~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~l~~ 260 (261)
T cd05034 223 ---MP---RPPNCPEELYDLMLQCWDKDPEERPTFEYLQSFLED 260 (261)
T ss_pred ---CC---CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHHHhc
Confidence 00 001113567889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=334.47 Aligned_cols=264 Identities=21% Similarity=0.286 Sum_probs=206.4
Q ss_pred HHHhcCCcceeeecccceEEEEEeC--------CCcEEEEEEeeccChhhhHHHHHHHHHHHHHhcc-CCCceeeeeeEE
Q 002721 603 VKATMKDSNMIYCGTFSTVYKAVMP--------SGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKL-CHDNLVRPIGFV 673 (888)
Q Consensus 603 ~~~~~~~~~~ig~G~~g~Vy~~~~~--------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~ 673 (888)
...+|++.+.||+|+||.||+|+.. .+..||+|.++.... ....+.+.+|+++++++ +||||+++++++
T Consensus 10 ~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 87 (334)
T cd05100 10 SRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDAT--DKDLSDLVSEMEMMKMIGKHKNIINLLGAC 87 (334)
T ss_pred CHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccccC--HHHHHHHHHHHHHHHhhcCCCCeeeeeEEE
Confidence 3567999999999999999999732 124789998874322 22345789999999999 799999999999
Q ss_pred EeCCeeEEEEecCCCCCHHHHhhccCC-----------CCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEe
Q 002721 674 IYEDVALLLHNYLPNGTLAQLLHESTK-----------QPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLL 742 (888)
Q Consensus 674 ~~~~~~~lv~e~~~~g~L~~~l~~~~~-----------~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll 742 (888)
..++..+++|||+++|+|.+++..... .++..+++.++..++.|++.||+|||++|++||||||+||++
T Consensus 88 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlkp~Nill 167 (334)
T cd05100 88 TQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLV 167 (334)
T ss_pred ccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccccceEEE
Confidence 999999999999999999999976432 123357889999999999999999999999999999999999
Q ss_pred CCCCCceEeccccccccCCCCCcccccccccccceecccccccCCcCccccchhHHHHHHHHHh-CCCCCCCCCCCccch
Q 002721 743 DADFKPLLGEIEISKLLDPSKGTASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILT-TRLPVEEDFGEGVDL 821 (888)
Q Consensus 743 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~~~~~~~~~ 821 (888)
+.++.+||+|||.++...............++..|+|||++.+..++.++||||||+++|||++ |..||.....+ +.
T Consensus 168 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~--~~ 245 (334)
T cd05100 168 TEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPVE--EL 245 (334)
T ss_pred cCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCCHH--HH
Confidence 9999999999999987643322211222334567999999999899999999999999999998 88888653211 11
Q ss_pred hhhccccCCCCCCcccccccccccCCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhh
Q 002721 822 VKWVHGAPARGETPEQILDARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEMLQEIK 886 (888)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~i~ 886 (888)
....... ..... ......++.+++.+||+.+|++||++.|+++.|+++.
T Consensus 246 ~~~~~~~-------------~~~~~---~~~~~~~l~~li~~cl~~~p~~Rps~~ell~~l~~~~ 294 (334)
T cd05100 246 FKLLKEG-------------HRMDK---PANCTHELYMIMRECWHAVPSQRPTFKQLVEDLDRVL 294 (334)
T ss_pred HHHHHcC-------------CCCCC---CCCCCHHHHHHHHHHcccChhhCcCHHHHHHHHHHHh
Confidence 1111100 00000 1122346778999999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=322.93 Aligned_cols=255 Identities=18% Similarity=0.233 Sum_probs=200.5
Q ss_pred HHhcCCcceeeecccceEEEEEe-CCCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCCeeEEE
Q 002721 604 KATMKDSNMIYCGTFSTVYKAVM-PSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVALLL 682 (888)
Q Consensus 604 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 682 (888)
..+|++.+.||+|+||.||+|+. .+++.||+|++...... ..+.+.+|+.++++++||||+++++++..++..|+|
T Consensus 8 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~---~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv 84 (267)
T cd06646 8 QHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEPGD---DFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWIC 84 (267)
T ss_pred hhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCccc---hHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEE
Confidence 45799999999999999999995 57899999998744322 223678899999999999999999999999999999
Q ss_pred EecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccccccccCCC
Q 002721 683 HNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPS 762 (888)
Q Consensus 683 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 762 (888)
|||+++++|.+++.... .+++.++..++.|++.||+|||+.||+||||||+||+++.++.+|++|||++......
T Consensus 85 ~e~~~~~~L~~~~~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd06646 85 MEYCGGGSLQDIYHVTG-----PLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITAT 159 (267)
T ss_pred EeCCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCCEEECcCccceeeccc
Confidence 99999999999987543 4678899999999999999999999999999999999999999999999999876432
Q ss_pred CCcccccccccccceecccccc---cCCcCccccchhHHHHHHHHHhCCCCCCCCCCCccchhhhccccCCCCCCccccc
Q 002721 763 KGTASISAVAGSFGYIPPEYAY---TMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQIL 839 (888)
Q Consensus 763 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 839 (888)
.. ......++..|+|||.+. ...++.++||||+||++|||++|+.||........ ........ ..
T Consensus 160 ~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~-~~~~~~~~---------~~ 227 (267)
T cd06646 160 IA--KRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA-LFLMSKSN---------FQ 227 (267)
T ss_pred cc--ccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhh-heeeecCC---------CC
Confidence 21 122346888999999874 34578899999999999999999999964322111 00000000 00
Q ss_pred ccccccCCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 002721 840 DARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEML 882 (888)
Q Consensus 840 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L 882 (888)
.+... ........+.+++.+||..+|++||+++++++.+
T Consensus 228 ~~~~~----~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l 266 (267)
T cd06646 228 PPKLK----DKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHL 266 (267)
T ss_pred CCCCc----cccccCHHHHHHHHHHhhCChhhCcCHHHHhcCC
Confidence 00000 0112345778999999999999999999998753
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=329.11 Aligned_cols=260 Identities=21% Similarity=0.275 Sum_probs=201.0
Q ss_pred HhcCCcceeeecccceEEEEEeC-CC--cEEEEEEeeccChhhhHHHHHHHHHHHHHhcc-CCCceeeeeeEEEeCCeeE
Q 002721 605 ATMKDSNMIYCGTFSTVYKAVMP-SG--LILSVKRLKSMDRTIIHHQNKMIRELEKLSKL-CHDNLVRPIGFVIYEDVAL 680 (888)
Q Consensus 605 ~~~~~~~~ig~G~~g~Vy~~~~~-~~--~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~ 680 (888)
++|++.+.||+|+||.||+|... ++ ..+++|.++..... ...+.+.+|++++.++ +||||+++++++...+..|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~ 79 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEFASE--NDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLY 79 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEccccCCH--HHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcce
Confidence 46888999999999999999854 33 35788887743222 2234788999999999 7999999999999999999
Q ss_pred EEEecCCCCCHHHHhhccCCC-----------CCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCce
Q 002721 681 LLHNYLPNGTLAQLLHESTKQ-----------PDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPL 749 (888)
Q Consensus 681 lv~e~~~~g~L~~~l~~~~~~-----------~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~k 749 (888)
+||||+++++|.+++...... ....+++..+..++.|++.||+|||++||+||||||+||++++++.+|
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~k 159 (297)
T cd05089 80 IAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASK 159 (297)
T ss_pred EEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCeEE
Confidence 999999999999999764321 112478899999999999999999999999999999999999999999
Q ss_pred EeccccccccCCCCCcccccccccccceecccccccCCcCccccchhHHHHHHHHHh-CCCCCCCCCCCccchhhhcccc
Q 002721 750 LGEIEISKLLDPSKGTASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILT-TRLPVEEDFGEGVDLVKWVHGA 828 (888)
Q Consensus 750 l~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~~~~~~~~~~~~~~~~ 828 (888)
|+|||++....... .......+..|+|||+..+..++.++|||||||++|||++ |..||....... .....
T Consensus 160 l~dfg~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~--~~~~~--- 231 (297)
T cd05089 160 IADFGLSRGEEVYV---KKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAE--LYEKL--- 231 (297)
T ss_pred ECCcCCCcccccee---ccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHH--HHHHH---
Confidence 99999986432211 1111223457999999988889999999999999999997 999996542211 11100
Q ss_pred CCCCCCcccccccccccCCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhhh
Q 002721 829 PARGETPEQILDARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEMLQEIKQ 887 (888)
Q Consensus 829 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 887 (888)
........ .......+.+++.+||+.+|.+||+++++++.|+.+.+
T Consensus 232 ----------~~~~~~~~---~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~~~ 277 (297)
T cd05089 232 ----------PQGYRMEK---PRNCDDEVYELMRQCWRDRPYERPPFAQISVQLSRMLE 277 (297)
T ss_pred ----------hcCCCCCC---CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHH
Confidence 00000000 11223567889999999999999999999999988754
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-36 Score=337.68 Aligned_cols=266 Identities=17% Similarity=0.181 Sum_probs=197.7
Q ss_pred HHHhcCCcceeeecccceEEEEEe-CCCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCC----
Q 002721 603 VKATMKDSNMIYCGTFSTVYKAVM-PSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYED---- 677 (888)
Q Consensus 603 ~~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~---- 677 (888)
..++|+..+.||+|+||.||+|.. .+|+.||+|++..... .......+.+|+.+++.++||||+++++++...+
T Consensus 19 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 97 (359)
T cd07876 19 VLKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPFQ-NQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEE 97 (359)
T ss_pred hhhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEeccccc-chhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccc
Confidence 457899999999999999999995 4689999999974432 2233457889999999999999999999986543
Q ss_pred --eeEEEEecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEecccc
Q 002721 678 --VALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEI 755 (888)
Q Consensus 678 --~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~ 755 (888)
..|+||||+++ ++.+.+.. .+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||+
T Consensus 98 ~~~~~lv~e~~~~-~l~~~~~~-------~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~ 169 (359)
T cd07876 98 FQDVYLVMELMDA-NLCQVIHM-------ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGL 169 (359)
T ss_pred cceeEEEEeCCCc-CHHHHHhc-------cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEecCCC
Confidence 57999999975 67766643 356788899999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCcccccccccccceecccccccCCcCccccchhHHHHHHHHHhCCCCCCCCCCCccchhhhc----------
Q 002721 756 SKLLDPSKGTASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWV---------- 825 (888)
Q Consensus 756 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~---------- 825 (888)
++...... ......||+.|+|||++.+..++.++||||+||++|+|++|+.||....... .+....
T Consensus 170 a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~-~~~~~~~~~~~~~~~~ 245 (359)
T cd07876 170 ARTACTNF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHID-QWNKVIEQLGTPSAEF 245 (359)
T ss_pred ccccccCc---cCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHhcCCCcHHH
Confidence 97643321 1234568999999999999999999999999999999999999997542210 000000
Q ss_pred ------------cccCCCC-CCcccccccc-cccCCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002721 826 ------------HGAPARG-ETPEQILDAR-LSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEM 881 (888)
Q Consensus 826 ------------~~~~~~~-~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~ 881 (888)
...+... ....+..... .............++.+++.+||+.||++|||+.|+++.
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 315 (359)
T cd07876 246 MNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRISVDEALRH 315 (359)
T ss_pred HHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCCCHHHHhcC
Confidence 0000000 0000000000 000000111124567899999999999999999999863
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=333.70 Aligned_cols=246 Identities=23% Similarity=0.315 Sum_probs=201.2
Q ss_pred eeeecccceEEEEEe-CCCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCCeeEEEEecCCCCC
Q 002721 612 MIYCGTFSTVYKAVM-PSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVALLLHNYLPNGT 690 (888)
Q Consensus 612 ~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~g~ 690 (888)
++|+|.||+||.|++ .+...+|||.+...+.. ...-+..|+...++++|.|||+++|.+.++++.-|.||-++||+
T Consensus 582 VLGKGTYG~VYA~RD~~tqvrIaIKEIpekdsr---~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGS 658 (1226)
T KOG4279|consen 582 VLGKGTYGTVYAARDMDTQVRIAIKEIPEKDSR---EVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGS 658 (1226)
T ss_pred EeecCceeEEEeeccccceeEEEeeecccccch---hhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCc
Confidence 799999999999995 45778999998755432 23367889999999999999999999999999999999999999
Q ss_pred HHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeC-CCCCceEeccccccccCCCCCccccc
Q 002721 691 LAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLD-ADFKPLLGEIEISKLLDPSKGTASIS 769 (888)
Q Consensus 691 L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~-~~~~~kl~Dfg~a~~~~~~~~~~~~~ 769 (888)
|.++++..-+. ..-.+.++-.+.+||++||.|||+..|||||||-+|+||+ -.|.+||+|||-++.+..-. ....
T Consensus 659 LSsLLrskWGP--lKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgin--P~TE 734 (1226)
T KOG4279|consen 659 LSSLLRSKWGP--LKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGIN--PCTE 734 (1226)
T ss_pred HHHHHHhccCC--CccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceEEecccccchhhccCC--cccc
Confidence 99999875432 1225677888999999999999999999999999999996 56899999999999876433 2345
Q ss_pred ccccccceecccccccC--CcCccccchhHHHHHHHHHhCCCCCCCCCCCccchhhhccccCCCCCCcccccccccccCC
Q 002721 770 AVAGSFGYIPPEYAYTM--QVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQILDARLSTVS 847 (888)
Q Consensus 770 ~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 847 (888)
.+.||..|||||++..+ .|+.++|||||||++.||.||++||.+.......+.+ -+.++.-+
T Consensus 735 TFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFk----------------VGmyKvHP 798 (1226)
T KOG4279|consen 735 TFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFK----------------VGMYKVHP 798 (1226)
T ss_pred ccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhh----------------hcceecCC
Confidence 67899999999999765 4899999999999999999999999764333211110 01122223
Q ss_pred cCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002721 848 FGWRKEMLTALKVALLCTDSTPAKRPKMKKVVE 880 (888)
Q Consensus 848 ~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 880 (888)
+.+.+...++..++.+|+.+||.+||+|++++.
T Consensus 799 ~iPeelsaeak~FilrcFepd~~~R~sA~~LL~ 831 (1226)
T KOG4279|consen 799 PIPEELSAEAKNFILRCFEPDPCDRPSAKDLLQ 831 (1226)
T ss_pred CCcHHHHHHHHHHHHHHcCCCcccCccHHHhcc
Confidence 345667788899999999999999999999875
|
|
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=322.18 Aligned_cols=258 Identities=19% Similarity=0.353 Sum_probs=204.5
Q ss_pred HHhcCCcceeeecccceEEEEEeC----CCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCCee
Q 002721 604 KATMKDSNMIYCGTFSTVYKAVMP----SGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVA 679 (888)
Q Consensus 604 ~~~~~~~~~ig~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 679 (888)
.++|++.+.||+|+||.||+|+.. .+..+|+|.++.... ....+.+.+|+.++++++||||+++++++..++..
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 80 (267)
T cd05066 3 ASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGYT--EKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPV 80 (267)
T ss_pred HHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCCC--HHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCcc
Confidence 457889999999999999999853 234799998874332 23345789999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEecccccccc
Q 002721 680 LLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLL 759 (888)
Q Consensus 680 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~ 759 (888)
|+||||+++++|.+++..... .+++.++..++.|++.|++|||+.|++||||||+||+++.++.++++|||.+...
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~~----~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~ 156 (267)
T cd05066 81 MIVTEYMENGSLDAFLRKHDG----QFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVL 156 (267)
T ss_pred EEEEEcCCCCCHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcEEECCCCeEEeCCCCccccc
Confidence 999999999999999976432 4688999999999999999999999999999999999999999999999999876
Q ss_pred CCCCCcc-cccccccccceecccccccCCcCccccchhHHHHHHHHHh-CCCCCCCCCCCccchhhhccccCCCCCCccc
Q 002721 760 DPSKGTA-SISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILT-TRLPVEEDFGEGVDLVKWVHGAPARGETPEQ 837 (888)
Q Consensus 760 ~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 837 (888)
....... ......++..|+|||.+.+..++.++||||||+++||+++ |..||...... +..........
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~--~~~~~~~~~~~------- 227 (267)
T cd05066 157 EDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQ--DVIKAIEEGYR------- 227 (267)
T ss_pred ccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHH--HHHHHHhCCCc-------
Confidence 5432111 1112233568999999998889999999999999999887 99999754322 11111111000
Q ss_pred ccccccccCCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHh
Q 002721 838 ILDARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEMLQEI 885 (888)
Q Consensus 838 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~i 885 (888)
. . .....+..+.+++.+|++.+|++||++.++++.|+++
T Consensus 228 -----~-~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 266 (267)
T cd05066 228 -----L-P---APMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKL 266 (267)
T ss_pred -----C-C---CCCCCCHHHHHHHHHHcccCchhCCCHHHHHHHHHhh
Confidence 0 0 0112235677899999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=323.17 Aligned_cols=258 Identities=19% Similarity=0.378 Sum_probs=204.0
Q ss_pred HHhcCCcceeeecccceEEEEEeC-CC---cEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCCee
Q 002721 604 KATMKDSNMIYCGTFSTVYKAVMP-SG---LILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVA 679 (888)
Q Consensus 604 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~---~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 679 (888)
..+|+..+.||+|+||.||+|+.. ++ ..+|+|.++..... ...+.+.+|++++++++||||+++++++...+..
T Consensus 4 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~ 81 (268)
T cd05063 4 PSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYTE--KQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPA 81 (268)
T ss_pred hHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccCCH--HHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCc
Confidence 457888999999999999999954 33 37999988744322 2345788999999999999999999999999999
Q ss_pred EEEEecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEecccccccc
Q 002721 680 LLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLL 759 (888)
Q Consensus 680 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~ 759 (888)
|+||||+++++|.+++..... .+++.++..++.|++.|++|||+.|++||||||+||++++++.+|++|||++...
T Consensus 82 ~lv~e~~~~~~L~~~~~~~~~----~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~ 157 (268)
T cd05063 82 MIITEYMENGALDKYLRDHDG----EFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVL 157 (268)
T ss_pred EEEEEcCCCCCHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEEEcCCCcEEECCCccceec
Confidence 999999999999999976432 5788999999999999999999999999999999999999999999999998866
Q ss_pred CCCCCccc-ccccccccceecccccccCCcCccccchhHHHHHHHHHh-CCCCCCCCCCCccchhhhccccCCCCCCccc
Q 002721 760 DPSKGTAS-ISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILT-TRLPVEEDFGEGVDLVKWVHGAPARGETPEQ 837 (888)
Q Consensus 760 ~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 837 (888)
........ ......+..|+|||++.+..++.++|||||||++|||++ |+.||...... +....+.... ..
T Consensus 158 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~--~~~~~i~~~~---~~--- 229 (268)
T cd05063 158 EDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNH--EVMKAINDGF---RL--- 229 (268)
T ss_pred ccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHH--HHHHHHhcCC---CC---
Confidence 43321111 111223457999999988889999999999999999998 99999653221 1111111000 00
Q ss_pred ccccccccCCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHh
Q 002721 838 ILDARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEMLQEI 885 (888)
Q Consensus 838 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~i 885 (888)
........++.+++.+||+.+|++||++.+|++.|+++
T Consensus 230 ----------~~~~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~~l~~~ 267 (268)
T cd05063 230 ----------PAPMDCPSAVYQLMLQCWQQDRARRPRFVDIVNLLDKL 267 (268)
T ss_pred ----------CCCCCCCHHHHHHHHHHcCCCcccCcCHHHHHHHHHhh
Confidence 00112235678999999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-37 Score=334.68 Aligned_cols=202 Identities=22% Similarity=0.293 Sum_probs=175.7
Q ss_pred HHHHHHhcCCcceeeecccceEEEEE-eCCCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccC-C-----CceeeeeeE
Q 002721 600 DAVVKATMKDSNMIYCGTFSTVYKAV-MPSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLC-H-----DNLVRPIGF 672 (888)
Q Consensus 600 ~~~~~~~~~~~~~ig~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h-----pnIv~~~~~ 672 (888)
.+....+|++.+.||+|.||+|.+|. ..+++.||||+++.... ...+...|+.+|..++ | -|+|+++++
T Consensus 181 ~d~i~~rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~k~----f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~ 256 (586)
T KOG0667|consen 181 NDHIAYRYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNKKR----FLRQAQIEIRILELLNKHDPDDKYNIVRMLDY 256 (586)
T ss_pred cceeEEEEEEEEEecccccceeEEEEecCCCcEEEEEeeccChH----HHHHHHHHHHHHHHHhccCCCCCeeEEEeeec
Confidence 34445589999999999999999999 45799999999985443 2346778999999996 3 489999999
Q ss_pred EEeCCeeEEEEecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCC--CCceE
Q 002721 673 VIYEDVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDAD--FKPLL 750 (888)
Q Consensus 673 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~--~~~kl 750 (888)
|...++.|+|+|.+.. +|+++++.+... .++...+..++.||+.||.+||+.||||+||||+|||+.+. ..+||
T Consensus 257 F~fr~HlciVfELL~~-NLYellK~n~f~---Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKV 332 (586)
T KOG0667|consen 257 FYFRNHLCIVFELLST-NLYELLKNNKFR---GLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILLKDPKRSRIKV 332 (586)
T ss_pred cccccceeeeehhhhh-hHHHHHHhcCCC---CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheeeccCCcCceeE
Confidence 9999999999999965 999999988665 57899999999999999999999999999999999999644 46999
Q ss_pred eccccccccCCCCCcccccccccccceecccccccCCcCccccchhHHHHHHHHHhCCCCCCCC
Q 002721 751 GEIEISKLLDPSKGTASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEED 814 (888)
Q Consensus 751 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~ 814 (888)
+|||.+....... ...+-+..|+|||++.|.+|+.+.||||||||++||++|.+.|.++
T Consensus 333 IDFGSSc~~~q~v-----ytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ 391 (586)
T KOG0667|consen 333 IDFGSSCFESQRV-----YTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGD 391 (586)
T ss_pred EecccccccCCcc-----eeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCC
Confidence 9999999865432 2456788999999999999999999999999999999998887654
|
|
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-37 Score=329.06 Aligned_cols=261 Identities=23% Similarity=0.365 Sum_probs=204.1
Q ss_pred HHhcCCcceeeecccceEEEEEeC------CCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCC
Q 002721 604 KATMKDSNMIYCGTFSTVYKAVMP------SGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYED 677 (888)
Q Consensus 604 ~~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 677 (888)
.++|+..+.||+|+||.||+|... ++..||+|.+..... ....+.+.+|+++++++.||||+++++++..++
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~ 81 (288)
T cd05050 4 RNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEAS--ADMQADFQREAALMAEFDHPNIVKLLGVCAVGK 81 (288)
T ss_pred hHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCcC--HHHHHHHHHHHHHHHhcCCCchheEEEEEcCCC
Confidence 567999999999999999999853 468899999874432 223457889999999999999999999999999
Q ss_pred eeEEEEecCCCCCHHHHhhccCC-----------------CCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCe
Q 002721 678 VALLLHNYLPNGTLAQLLHESTK-----------------QPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNV 740 (888)
Q Consensus 678 ~~~lv~e~~~~g~L~~~l~~~~~-----------------~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NI 740 (888)
..++||||+++|+|.+++..... .....+++.+++.++.|++.||+|||++|++||||||+||
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~ni 161 (288)
T cd05050 82 PMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNC 161 (288)
T ss_pred ccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhhe
Confidence 99999999999999999975421 1112467888999999999999999999999999999999
Q ss_pred EeCCCCCceEeccccccccCCCCCcccccccccccceecccccccCCcCccccchhHHHHHHHHHh-CCCCCCCCCCCcc
Q 002721 741 LLDADFKPLLGEIEISKLLDPSKGTASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILT-TRLPVEEDFGEGV 819 (888)
Q Consensus 741 ll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~~~~~~~ 819 (888)
++++++.++++|||.+.................+..|+|||.+.+..++.++|||||||++|||++ |..||.....+
T Consensus 162 l~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~-- 239 (288)
T cd05050 162 LVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHE-- 239 (288)
T ss_pred EecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHH--
Confidence 999999999999999876543221111122334667999999988899999999999999999998 88888643221
Q ss_pred chhhhccccCCCCCCcccccccccccCCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 002721 820 DLVKWVHGAPARGETPEQILDARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEMLQE 884 (888)
Q Consensus 820 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~ 884 (888)
+...... +...... ......++.+++.+||+.+|++|||+.|+++.|++
T Consensus 240 ~~~~~~~-------------~~~~~~~---~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~~l~~ 288 (288)
T cd05050 240 EVIYYVR-------------DGNVLSC---PDNCPLELYNLMRLCWSKLPSDRPSFASINRILQR 288 (288)
T ss_pred HHHHHHh-------------cCCCCCC---CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhhC
Confidence 1111110 0000000 11223567889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >KOG0472 consensus Leucine-rich repeat protein [Function unknown] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-41 Score=339.13 Aligned_cols=388 Identities=27% Similarity=0.427 Sum_probs=291.2
Q ss_pred eEEEEEcCCCCcccccccccCCCCCCEEeCCCCcCcccCCCCCCCCCCCCEEECcCCCCCCCCCCCCCCCCcceEEEcCC
Q 002721 64 FVVKLDLSRLQLRGNITLVSELKALKRLDLSNNAFSGTIPSAFGNLSELEFLDLSLNKFGGVIPRELGSLKDLRFFNISN 143 (888)
Q Consensus 64 ~v~~l~l~~~~l~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 143 (888)
-.+.+++++|++...+++++++..++.|+.++|+++ .+|+.++.+.+|..|+.++|.+. ..|+.++.+-.|..|+..+
T Consensus 69 ~l~vl~~~~n~l~~lp~aig~l~~l~~l~vs~n~ls-~lp~~i~s~~~l~~l~~s~n~~~-el~~~i~~~~~l~dl~~~~ 146 (565)
T KOG0472|consen 69 CLTVLNVHDNKLSQLPAAIGELEALKSLNVSHNKLS-ELPEQIGSLISLVKLDCSSNELK-ELPDSIGRLLDLEDLDATN 146 (565)
T ss_pred ceeEEEeccchhhhCCHHHHHHHHHHHhhcccchHh-hccHHHhhhhhhhhhhcccccee-ecCchHHHHhhhhhhhccc
Confidence 367899999999998889999999999999999996 78888888889999999999888 5677888888888888888
Q ss_pred CccccccCccccccccccEEEecCCCCCCCCCccccccccccEEecccccccCCCCCCCCCcccccceeeccccCCCCCC
Q 002721 144 NVLVGEIPDELKSLEKLEDFQVSSNKLNGSIPFWVGNLTNLRVFTAYENQLVGEIPDNLGSVSELELLNLHSNQLEGPIP 223 (888)
Q Consensus 144 N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p 223 (888)
|+++ ..|+.+.++.+|..|++.+|+++...|..+. ++.|+.|++..|-++ .+|..++++.+|+-|||.+|+|. ..|
T Consensus 147 N~i~-slp~~~~~~~~l~~l~~~~n~l~~l~~~~i~-m~~L~~ld~~~N~L~-tlP~~lg~l~~L~~LyL~~Nki~-~lP 222 (565)
T KOG0472|consen 147 NQIS-SLPEDMVNLSKLSKLDLEGNKLKALPENHIA-MKRLKHLDCNSNLLE-TLPPELGGLESLELLYLRRNKIR-FLP 222 (565)
T ss_pred cccc-cCchHHHHHHHHHHhhccccchhhCCHHHHH-HHHHHhcccchhhhh-cCChhhcchhhhHHHHhhhcccc-cCC
Confidence 8888 6777788888888888888888755554444 777888888777776 67777777777777788777776 445
Q ss_pred CCccCCCCcceEEecCccCCCCchhhhccCCccceeeccCCccccccCCccccCCCccEEEeeccCCCCCCCccccCCCC
Q 002721 224 KSIFASGKLEVLVLTQNRLTGDIPELVGHCKSLSNIRIGNNDLVGVIPRAIGNVSGLTYFEADNNNLSGEIVPEFSQCSN 303 (888)
Q Consensus 224 ~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~ 303 (888)
.|.+++.|+.|+++.|+|.-.+.+...++.++..|||.+|++. ..|+.+.-+.+|.+||+++|.|++ .|..++++ .
T Consensus 223 -ef~gcs~L~Elh~g~N~i~~lpae~~~~L~~l~vLDLRdNklk-e~Pde~clLrsL~rLDlSNN~is~-Lp~sLgnl-h 298 (565)
T KOG0472|consen 223 -EFPGCSLLKELHVGENQIEMLPAEHLKHLNSLLVLDLRDNKLK-EVPDEICLLRSLERLDLSNNDISS-LPYSLGNL-H 298 (565)
T ss_pred -CCCccHHHHHHHhcccHHHhhHHHHhcccccceeeeccccccc-cCchHHHHhhhhhhhcccCCcccc-CCcccccc-e
Confidence 5666666666666666666433344446666666666666665 345555566666666666666663 34455555 5
Q ss_pred CcEEEeecCcccc-------------------------------------------------------------------
Q 002721 304 LTLLNLASNGFTG------------------------------------------------------------------- 316 (888)
Q Consensus 304 L~~L~L~~N~l~~------------------------------------------------------------------- 316 (888)
|+.|.+.+|.+..
T Consensus 299 L~~L~leGNPlrTiRr~ii~~gT~~vLKyLrs~~~~dglS~se~~~e~~~t~~~~~~~~~~~~i~tkiL~~s~~qlt~VP 378 (565)
T KOG0472|consen 299 LKFLALEGNPLRTIRREIISKGTQEVLKYLRSKIKDDGLSQSEGGTETAMTLPSESFPDIYAIITTKILDVSDKQLTLVP 378 (565)
T ss_pred eeehhhcCCchHHHHHHHHcccHHHHHHHHHHhhccCCCCCCcccccccCCCCCCcccchhhhhhhhhhcccccccccCC
Confidence 5555555554431
Q ss_pred -----------------------cCCccccCCCCcc-EEEeccccccCcCcccccccCcceEEEccCCcCCCCCCchhcc
Q 002721 317 -----------------------VIPPELGQLINLQ-ELILYENSLFGEIPKSILACKNLNKLDLSNNRFNGTIPNAICD 372 (888)
Q Consensus 317 -----------------------~~p~~~~~l~~L~-~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~ 372 (888)
.+|..+..+..+. .+.+++|.+ +.+|..++.+++|..|+|++|-+. .+|..++.
T Consensus 379 dEVfea~~~~~Vt~VnfskNqL~elPk~L~~lkelvT~l~lsnn~i-sfv~~~l~~l~kLt~L~L~NN~Ln-~LP~e~~~ 456 (565)
T KOG0472|consen 379 DEVFEAAKSEIVTSVNFSKNQLCELPKRLVELKELVTDLVLSNNKI-SFVPLELSQLQKLTFLDLSNNLLN-DLPEEMGS 456 (565)
T ss_pred HHHHHHhhhcceEEEecccchHhhhhhhhHHHHHHHHHHHhhcCcc-ccchHHHHhhhcceeeecccchhh-hcchhhhh
Confidence 1122222222211 123333333 467777888999999999999998 78999999
Q ss_pred ccCcceecccCCccccccCCCccccccceEEEeecccccccCCCccccccchhhhhhccCccccccCCccccCCCCccEE
Q 002721 373 MSRLQYLLLGQNSLKGEIPHEIGNCMKLLQLHIGSNYLTGSIPPEIGHIRNLQIALNLSFNHLHGSLPPELGKLDKLVSF 452 (888)
Q Consensus 373 l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~~L~ls~N~l~~~~p~~~~~l~~L~~L 452 (888)
+..||.|+++.|+|. .+|..+..+..++.+-.++|++...-|..+.++.+|. .|||.+|.+. .+|+.++++.+|+.|
T Consensus 457 lv~Lq~LnlS~NrFr-~lP~~~y~lq~lEtllas~nqi~~vd~~~l~nm~nL~-tLDL~nNdlq-~IPp~LgnmtnL~hL 533 (565)
T KOG0472|consen 457 LVRLQTLNLSFNRFR-MLPECLYELQTLETLLASNNQIGSVDPSGLKNMRNLT-TLDLQNNDLQ-QIPPILGNMTNLRHL 533 (565)
T ss_pred hhhhheecccccccc-cchHHHhhHHHHHHHHhccccccccChHHhhhhhhcc-eeccCCCchh-hCChhhccccceeEE
Confidence 999999999999998 8999998888899988899999866666699999999 7999999998 889999999999999
Q ss_pred EeeCCccccCCchhh
Q 002721 453 DVSNNQLSGTIPSAL 467 (888)
Q Consensus 453 dLs~N~l~~~~p~~~ 467 (888)
+|++|+|+ .++..+
T Consensus 534 eL~gNpfr-~Pr~~i 547 (565)
T KOG0472|consen 534 ELDGNPFR-QPRHQI 547 (565)
T ss_pred EecCCccC-CCHHHH
Confidence 99999998 555444
|
|
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=319.90 Aligned_cols=251 Identities=24% Similarity=0.345 Sum_probs=204.6
Q ss_pred HHhcCCcceeeecccceEEEEEeCCCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCCeeEEEE
Q 002721 604 KATMKDSNMIYCGTFSTVYKAVMPSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVALLLH 683 (888)
Q Consensus 604 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 683 (888)
.++|++.+.||+|+||.||+|.. .|+.||+|.++.... ..+++.+|+.++++++|+||+++++++...+..++||
T Consensus 5 ~~~~~~~~~ig~g~~g~v~~~~~-~~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~ 79 (256)
T cd05039 5 SKELKLGATIGKGEFGDVMLGDY-RGQKVAVKCLKDDST----AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVT 79 (256)
T ss_pred hhhccceeeeecCCCceEEEEEe-cCcEEEEEEeccchh----HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEE
Confidence 45788999999999999999986 478999999975433 3457899999999999999999999999889999999
Q ss_pred ecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccccccccCCCC
Q 002721 684 NYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSK 763 (888)
Q Consensus 684 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 763 (888)
||+++++|.++++..... .+++..+..++.|++.||.|||++|++||||||+||+++.++.+|++|||.+.......
T Consensus 80 e~~~~~~L~~~~~~~~~~---~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~ 156 (256)
T cd05039 80 EYMAKGSLVDYLRSRGRA---VITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ 156 (256)
T ss_pred EecCCCcHHHHHHhcCCC---CCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEEeCCCCEEEccccccccccccc
Confidence 999999999999865432 47889999999999999999999999999999999999999999999999998763322
Q ss_pred CcccccccccccceecccccccCCcCccccchhHHHHHHHHHh-CCCCCCCCCCCccchhhhccccCCCCCCcccccccc
Q 002721 764 GTASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILT-TRLPVEEDFGEGVDLVKWVHGAPARGETPEQILDAR 842 (888)
Q Consensus 764 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 842 (888)
. ....+..|+|||++.+..++.++||||||+++|||++ |..||....... ..........
T Consensus 157 ~-----~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~--~~~~~~~~~~------------ 217 (256)
T cd05039 157 D-----SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKD--VVPHVEKGYR------------ 217 (256)
T ss_pred c-----cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHH--HHHHHhcCCC------------
Confidence 1 2234567999999988889999999999999999997 999986532211 1111110000
Q ss_pred cccCCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHh
Q 002721 843 LSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEMLQEI 885 (888)
Q Consensus 843 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~i 885 (888)
.. .....+..+.+++.+||..+|++|||+.|+++.|+++
T Consensus 218 -~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~~ 256 (256)
T cd05039 218 -ME---APEGCPPEVYKVMKDCWELDPAKRPTFKQLREQLALI 256 (256)
T ss_pred -CC---CccCCCHHHHHHHHHHhccChhhCcCHHHHHHHHhcC
Confidence 00 0112245678899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-37 Score=335.10 Aligned_cols=205 Identities=20% Similarity=0.183 Sum_probs=175.2
Q ss_pred HhcCCcceeeecccceEEEEEe-CCCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCCeeEEEE
Q 002721 605 ATMKDSNMIYCGTFSTVYKAVM-PSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVALLLH 683 (888)
Q Consensus 605 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 683 (888)
++|++.+.||+|+||+||+|+. .+++.||+|++.+.........+.+.+|+.++..++||||+++++++.+++..|+||
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVM 80 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEE
Confidence 3688999999999999999995 468999999997544333344556889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccccccccCCCC
Q 002721 684 NYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSK 763 (888)
Q Consensus 684 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 763 (888)
||+++|+|.+++.+... .+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||++.......
T Consensus 81 e~~~g~~L~~~l~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 156 (331)
T cd05597 81 DYYVGGDLLTLLSKFED----RLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADG 156 (331)
T ss_pred ecCCCCcHHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCC
Confidence 99999999999976432 56788999999999999999999999999999999999999999999999987654332
Q ss_pred Ccccccccccccceeccccccc-----CCcCccccchhHHHHHHHHHhCCCCCCCC
Q 002721 764 GTASISAVAGSFGYIPPEYAYT-----MQVTAPGNVYSYGVVLLEILTTRLPVEED 814 (888)
Q Consensus 764 ~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwSlG~il~elltg~~P~~~~ 814 (888)
.. ......||+.|+|||++.. ..++.++||||+||++|||++|+.||...
T Consensus 157 ~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~ 211 (331)
T cd05597 157 TV-QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAE 211 (331)
T ss_pred Cc-cccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCC
Confidence 11 1223468999999999863 45788999999999999999999999753
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=320.63 Aligned_cols=251 Identities=18% Similarity=0.224 Sum_probs=201.0
Q ss_pred hcCCcceeeecccceEEEEEeC-CCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCCeeEEEEe
Q 002721 606 TMKDSNMIYCGTFSTVYKAVMP-SGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVALLLHN 684 (888)
Q Consensus 606 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 684 (888)
+|++.+.||+|+||.||++... +++.||+|.++..... ...+.+.+|+.++++++||||+++++++..++..|+|||
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 78 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPKSS--SAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVME 78 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCcch--HHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEe
Confidence 4778899999999999999954 6899999998643322 234578899999999999999999999999999999999
Q ss_pred cCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccccccccCCCCC
Q 002721 685 YLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSKG 764 (888)
Q Consensus 685 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 764 (888)
|+++++|.+++...... .++...+..++.|++.||+|||++|++|+||||+||++++++.++++|||.+........
T Consensus 79 ~~~~~~l~~~~~~~~~~---~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~ 155 (255)
T cd08219 79 YCDGGDLMQKIKLQRGK---LFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA 155 (255)
T ss_pred eCCCCcHHHHHHhccCC---CCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeeccccc
Confidence 99999999998754322 467889999999999999999999999999999999999999999999999876643221
Q ss_pred cccccccccccceecccccccCCcCccccchhHHHHHHHHHhCCCCCCCCCCCccchhhhccccCCCCCCcccccccccc
Q 002721 765 TASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQILDARLS 844 (888)
Q Consensus 765 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 844 (888)
......|+..|+|||++.+..++.++||||+|+++|+|++|+.||....... ..... ......
T Consensus 156 --~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~--~~~~~-------------~~~~~~ 218 (255)
T cd08219 156 --YACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKN--LILKV-------------CQGSYK 218 (255)
T ss_pred --ccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHH--HHHHH-------------hcCCCC
Confidence 1223568889999999988889999999999999999999999997532111 00000 000000
Q ss_pred cCCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002721 845 TVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEM 881 (888)
Q Consensus 845 ~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~ 881 (888)
.. .......+.+++.+||+.||++||++.|++.+
T Consensus 219 ~~---~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 219 PL---PSHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred CC---CcccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 01 11123457789999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=319.78 Aligned_cols=249 Identities=20% Similarity=0.280 Sum_probs=195.1
Q ss_pred eeeecccceEEEEEeC---CCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCCeeEEEEecCCC
Q 002721 612 MIYCGTFSTVYKAVMP---SGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVALLLHNYLPN 688 (888)
Q Consensus 612 ~ig~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~ 688 (888)
.||+|+||.||+|... ++..||+|++..... ....+.+.+|+.++++++||||+++++++. .+..++||||+++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~~--~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~-~~~~~lv~e~~~~ 78 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNENE--KSVRDEMMREAEIMHQLDNPYIVRMIGVCE-AEALMLVMEMASG 78 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEcccccC--hHHHHHHHHHHHHHHhcCCCCeEEEEEEEc-CCCeEEEEEeCCC
Confidence 3899999999999743 356799999875432 233457899999999999999999999885 4578999999999
Q ss_pred CCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccccccccCCCCCccc-
Q 002721 689 GTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSKGTAS- 767 (888)
Q Consensus 689 g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~- 767 (888)
++|.+++..... .+++.+++.++.|++.||+|||++|++||||||+||+++.++.+|++|||++...........
T Consensus 79 ~~L~~~l~~~~~----~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~ 154 (257)
T cd05115 79 GPLNKFLSGKKD----EITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKA 154 (257)
T ss_pred CCHHHHHHhCCC----CCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEeccCCccccccCCccceec
Confidence 999999875432 578899999999999999999999999999999999999999999999999986543322111
Q ss_pred ccccccccceecccccccCCcCccccchhHHHHHHHHHh-CCCCCCCCCCCccchhhhccccCCCCCCcccccccccccC
Q 002721 768 ISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILT-TRLPVEEDFGEGVDLVKWVHGAPARGETPEQILDARLSTV 846 (888)
Q Consensus 768 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 846 (888)
.....++..|+|||++.+..++.++||||||+++||+++ |..||....... ....+.... ...
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--~~~~~~~~~-------------~~~- 218 (257)
T cd05115 155 RSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPE--VMSFIEQGK-------------RLD- 218 (257)
T ss_pred cCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHH--HHHHHHCCC-------------CCC-
Confidence 112223568999999988889999999999999999996 999997543221 111111100 000
Q ss_pred CcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHh
Q 002721 847 SFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEMLQEI 885 (888)
Q Consensus 847 ~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~i 885 (888)
.......++.+++.+||..+|++||++.+|.+.|+.+
T Consensus 219 --~~~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~~l~~~ 255 (257)
T cd05115 219 --CPAECPPEMYALMKDCWIYKWEDRPNFAKVEERMRTY 255 (257)
T ss_pred --CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHhhh
Confidence 0112245677899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=322.63 Aligned_cols=257 Identities=19% Similarity=0.357 Sum_probs=202.7
Q ss_pred HhcCCcceeeecccceEEEEEeC-CC---cEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCCeeE
Q 002721 605 ATMKDSNMIYCGTFSTVYKAVMP-SG---LILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVAL 680 (888)
Q Consensus 605 ~~~~~~~~ig~G~~g~Vy~~~~~-~~---~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 680 (888)
.+|++.+.||+|+||.||+|... ++ ..||+|.++.... ......+..|+.++++++||||+++++++..++..+
T Consensus 4 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~ 81 (269)
T cd05065 4 SCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSGYT--EKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVM 81 (269)
T ss_pred HHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCCCC--HHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceE
Confidence 46888999999999999999954 33 3699999875422 233457999999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccccccccC
Q 002721 681 LLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLD 760 (888)
Q Consensus 681 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~~ 760 (888)
+||||+++++|.+++..... .+++.+++.++.|++.||+|||++|++||||||+||+++.++.+|++|||.+....
T Consensus 82 lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~ 157 (269)
T cd05065 82 IITEFMENGALDSFLRQNDG----QFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLE 157 (269)
T ss_pred EEEecCCCCcHHHHHhhCCC----CCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheEEEcCCCcEEECCCccccccc
Confidence 99999999999999976432 57889999999999999999999999999999999999999999999999988664
Q ss_pred CCCCcccccccc---cccceecccccccCCcCccccchhHHHHHHHHHh-CCCCCCCCCCCccchhhhccccCCCCCCcc
Q 002721 761 PSKGTASISAVA---GSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILT-TRLPVEEDFGEGVDLVKWVHGAPARGETPE 836 (888)
Q Consensus 761 ~~~~~~~~~~~~---gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 836 (888)
............ .+..|+|||++.+..++.++||||+||++|||++ |..||...... +...++.....
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~~--~~~~~i~~~~~------ 229 (269)
T cd05065 158 DDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQ--DVINAIEQDYR------ 229 (269)
T ss_pred cCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCHH--HHHHHHHcCCc------
Confidence 332211111111 2457999999998899999999999999999886 99999653221 11111110000
Q ss_pred cccccccccCCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHh
Q 002721 837 QILDARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEMLQEI 885 (888)
Q Consensus 837 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~i 885 (888)
.. .....+..+.+++.+||+.+|++||++.+++..|+++
T Consensus 230 ------~~----~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~~ 268 (269)
T cd05065 230 ------LP----PPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKM 268 (269)
T ss_pred ------CC----CcccCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 00 0112234567899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-37 Score=332.61 Aligned_cols=267 Identities=16% Similarity=0.227 Sum_probs=198.6
Q ss_pred HhcCCcceeeecccceEEEEEeC-CCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCCeeEEEE
Q 002721 605 ATMKDSNMIYCGTFSTVYKAVMP-SGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVALLLH 683 (888)
Q Consensus 605 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 683 (888)
++|...+.||+|+||.||+|+.. +++.||+|+++...... ....+.+|++++++++||||+++++++..++..++||
T Consensus 6 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 83 (309)
T cd07872 6 ETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHEEG--APCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVF 83 (309)
T ss_pred CceEEEEEecccCCEEEEEEEecCCCCeEEEEEeeccccCC--cchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEE
Confidence 46889999999999999999954 68899999987443221 2235778999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccccccccCCCC
Q 002721 684 NYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSK 763 (888)
Q Consensus 684 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 763 (888)
||+++ ++.+++..... .+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||++.......
T Consensus 84 e~~~~-~l~~~~~~~~~----~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~ 158 (309)
T cd07872 84 EYLDK-DLKQYMDDCGN----IMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPT 158 (309)
T ss_pred eCCCC-CHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECccccceecCCCc
Confidence 99975 88888875432 46788899999999999999999999999999999999999999999999987654322
Q ss_pred Ccccccccccccceeccccccc-CCcCccccchhHHHHHHHHHhCCCCCCCCCCCcc-chhhhccccCCCCCCc-----c
Q 002721 764 GTASISAVAGSFGYIPPEYAYT-MQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGV-DLVKWVHGAPARGETP-----E 836 (888)
Q Consensus 764 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~-~~~~~~~~~~~~~~~~-----~ 836 (888)
. ......++..|+|||++.+ ..++.++||||+||++|||+||+.||........ .......+.+...... .
T Consensus 159 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (309)
T cd07872 159 K--TYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSND 236 (309)
T ss_pred c--ccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchh
Confidence 1 1223467889999998765 4688999999999999999999999976432211 0000000000000000 0
Q ss_pred cccccccccC-C----cCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002721 837 QILDARLSTV-S----FGWRKEMLTALKVALLCTDSTPAKRPKMKKVVE 880 (888)
Q Consensus 837 ~~~~~~~~~~-~----~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 880 (888)
...+...... + ........++.+++.+|++.||++|||++|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~ 285 (309)
T cd07872 237 EFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMK 285 (309)
T ss_pred hhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHHhc
Confidence 0000000000 0 001123456789999999999999999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=319.70 Aligned_cols=249 Identities=21% Similarity=0.302 Sum_probs=199.3
Q ss_pred HhcCCcceeeecccceEEEEEeCCCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEE-eCCeeEEEE
Q 002721 605 ATMKDSNMIYCGTFSTVYKAVMPSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVI-YEDVALLLH 683 (888)
Q Consensus 605 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~-~~~~~~lv~ 683 (888)
.+|++.+.||+|+||.||+|.. .|..||+|.++.... .+.+.+|+.++++++|+|++++++++. .++..++||
T Consensus 6 ~~~~~~~~lg~g~~~~v~~~~~-~~~~~~~k~~~~~~~-----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~ 79 (256)
T cd05082 6 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDAT-----AQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT 79 (256)
T ss_pred HhCeeeeeecccCCCeEEEEEE-cCCcEEEEEeCCCch-----HHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEE
Confidence 4788999999999999999986 478899998864321 246889999999999999999999765 456789999
Q ss_pred ecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccccccccCCCC
Q 002721 684 NYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSK 763 (888)
Q Consensus 684 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 763 (888)
||+++++|.++++..... .+++..++.++.|++.||+|||++|++||||||+||++++++.+|++|||.+.......
T Consensus 80 e~~~~~~L~~~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~ 156 (256)
T cd05082 80 EYMAKGSLVDYLRSRGRS---VLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ 156 (256)
T ss_pred ECCCCCcHHHHHHhcCCC---CCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheEEEcCCCcEEecCCccceeccccC
Confidence 999999999999865432 46889999999999999999999999999999999999999999999999987654322
Q ss_pred CcccccccccccceecccccccCCcCccccchhHHHHHHHHHh-CCCCCCCCCCCccchhhhccccCCCCCCcccccccc
Q 002721 764 GTASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILT-TRLPVEEDFGEGVDLVKWVHGAPARGETPEQILDAR 842 (888)
Q Consensus 764 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 842 (888)
....++..|+|||++.+..++.++|||||||++|||++ |+.||...... +......... ..
T Consensus 157 -----~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~--~~~~~~~~~~----~~------- 218 (256)
T cd05082 157 -----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK--DVVPRVEKGY----KM------- 218 (256)
T ss_pred -----CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHhcCC----CC-------
Confidence 12334568999999988889999999999999999998 99998643211 1111111000 00
Q ss_pred cccCCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHh
Q 002721 843 LSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEMLQEI 885 (888)
Q Consensus 843 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~i 885 (888)
. ........+.+++.+||+.+|++|||+.++++.|+++
T Consensus 219 --~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~~l~~~ 256 (256)
T cd05082 219 --D---APDGCPPVVYDVMKQCWHLDAATRPSFLQLREQLEHI 256 (256)
T ss_pred --C---CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHhcC
Confidence 0 0112245677899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=318.59 Aligned_cols=248 Identities=21% Similarity=0.274 Sum_probs=197.3
Q ss_pred ceeeecccceEEEEEeCCCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCCeeEEEEecCCCCC
Q 002721 611 NMIYCGTFSTVYKAVMPSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVALLLHNYLPNGT 690 (888)
Q Consensus 611 ~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~g~ 690 (888)
+.||+|+||.||+|...+++.||+|.++..... .....+.+|++++++++||||+++++++...+..++||||+++++
T Consensus 1 ~~ig~g~~g~vy~~~~~~~~~~a~K~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~ 78 (250)
T cd05085 1 ELLGKGNFGEVFKGTLKDKTPVAVKTCKEDLPQ--ELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGD 78 (250)
T ss_pred CccCCCCCceEEEEEecCCcEEEEEecCCcCCH--HHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCc
Confidence 468999999999999878999999998744322 223468899999999999999999999999999999999999999
Q ss_pred HHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccccccccCCCCCcccccc
Q 002721 691 LAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSKGTASISA 770 (888)
Q Consensus 691 L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 770 (888)
|.+++..... .+++..+..++.|++.||.|+|++|++||||||+||+++.++.+|++|||++......... ....
T Consensus 79 L~~~~~~~~~----~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~-~~~~ 153 (250)
T cd05085 79 FLSFLRKKKD----ELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYS-SSGL 153 (250)
T ss_pred HHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEECCCccceeccccccc-cCCC
Confidence 9999875432 4678999999999999999999999999999999999999999999999998764432211 1112
Q ss_pred cccccceecccccccCCcCccccchhHHHHHHHHHh-CCCCCCCCCCCccchhhhccccCCCCCCcccccccccccCCcC
Q 002721 771 VAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILT-TRLPVEEDFGEGVDLVKWVHGAPARGETPEQILDARLSTVSFG 849 (888)
Q Consensus 771 ~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 849 (888)
..++..|+|||++.+..++.++||||||+++|++++ |..||........ ........ .. . .
T Consensus 154 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~--~~~~~~~~----~~---------~---~ 215 (250)
T cd05085 154 KQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQA--REQVEKGY----RM---------S---C 215 (250)
T ss_pred CCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHH--HHHHHcCC----CC---------C---C
Confidence 234567999999988889999999999999999998 9999975422211 11110000 00 0 0
Q ss_pred cHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 002721 850 WRKEMLTALKVALLCTDSTPAKRPKMKKVVEMLQ 883 (888)
Q Consensus 850 ~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~ 883 (888)
.......+.+++.+|+..+|++||++.|+++.|.
T Consensus 216 ~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~ 249 (250)
T cd05085 216 PQKCPDDVYKVMQRCWDYKPENRPKFSELQKELA 249 (250)
T ss_pred CCCCCHHHHHHHHHHcccCcccCCCHHHHHHHhc
Confidence 1112356788999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=319.93 Aligned_cols=255 Identities=21% Similarity=0.279 Sum_probs=202.1
Q ss_pred HhcCCcceeeecccceEEEEEe-CCCcEEEEEEeeccChh--hhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCCeeEE
Q 002721 605 ATMKDSNMIYCGTFSTVYKAVM-PSGLILSVKRLKSMDRT--IIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVALL 681 (888)
Q Consensus 605 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 681 (888)
+.|+..+.||+|++|.||+|.. .+++.||+|.+...... .....+.+.+|++++++++||||+++++++..++..++
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 81 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSI 81 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEE
Confidence 3688899999999999999995 46899999998743322 22334578899999999999999999999999999999
Q ss_pred EEecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccccccccCC
Q 002721 682 LHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDP 761 (888)
Q Consensus 682 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~~~ 761 (888)
||||+++++|.+++.... .+++..+..++.|++.||+|||+.|++||||||+||+++.++.++|+|||.++....
T Consensus 82 v~e~~~~~~l~~~~~~~~-----~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~ 156 (263)
T cd06625 82 FMEYMPGGSVKDQLKAYG-----ALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQT 156 (263)
T ss_pred EEEECCCCcHHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeecccceeccc
Confidence 999999999999997653 457788899999999999999999999999999999999999999999999876543
Q ss_pred CCCccc-ccccccccceecccccccCCcCccccchhHHHHHHHHHhCCCCCCCCCCCccchhhhccccCCCCCCcccccc
Q 002721 762 SKGTAS-ISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQILD 840 (888)
Q Consensus 762 ~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 840 (888)
...... .....++..|+|||++.+..++.++||||+|+++|||++|+.||....... ....... ....
T Consensus 157 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~-~~~~~~~-~~~~--------- 225 (263)
T cd06625 157 ICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMA-AIFKIAT-QPTN--------- 225 (263)
T ss_pred cccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHH-HHHHHhc-cCCC---------
Confidence 221111 123457889999999999889999999999999999999999997532110 0000000 0000
Q ss_pred cccccCCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002721 841 ARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEM 881 (888)
Q Consensus 841 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~ 881 (888)
.. ........+.+++.+||..+|++|||+.|+++.
T Consensus 226 ---~~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~ 260 (263)
T cd06625 226 ---PQ---LPSHVSPDARNFLRRTFVENAKKRPSAEELLRH 260 (263)
T ss_pred ---CC---CCccCCHHHHHHHHHHhhcCcccCCCHHHHhhC
Confidence 00 111233467789999999999999999999864
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=320.60 Aligned_cols=249 Identities=19% Similarity=0.275 Sum_probs=195.9
Q ss_pred eeeecccceEEEEEe---CCCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCCeeEEEEecCCC
Q 002721 612 MIYCGTFSTVYKAVM---PSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVALLLHNYLPN 688 (888)
Q Consensus 612 ~ig~G~~g~Vy~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~ 688 (888)
.||+|+||.||+|.+ .++..||+|+++.... .....+.+.+|+.+++.++||||+++++++. .+..++||||+++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~-~~~~~lv~e~~~~ 79 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNN-DPALKDELLREANVMQQLDNPYIVRMIGICE-AESWMLVMELAEL 79 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCCC-cHHHHHHHHHHHHHHHhCCCCCcceEEEEEc-CCCcEEEEecCCC
Confidence 589999999999964 3578999999874432 2334457899999999999999999999875 4567899999999
Q ss_pred CCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccccccccCCCCCccc-
Q 002721 689 GTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSKGTAS- 767 (888)
Q Consensus 689 g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~- 767 (888)
++|.+++.... .+++..+..++.|++.||+|+|++||+||||||+||+++.++.+|++|||.+...........
T Consensus 80 ~~L~~~l~~~~-----~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~ 154 (257)
T cd05116 80 GPLNKFLQKNK-----HVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKA 154 (257)
T ss_pred CcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeee
Confidence 99999997543 467889999999999999999999999999999999999999999999999987654322111
Q ss_pred ccccccccceecccccccCCcCccccchhHHHHHHHHHh-CCCCCCCCCCCccchhhhccccCCCCCCcccccccccccC
Q 002721 768 ISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILT-TRLPVEEDFGEGVDLVKWVHGAPARGETPEQILDARLSTV 846 (888)
Q Consensus 768 ~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 846 (888)
.....++..|+|||.+....++.++|||||||++|||++ |+.||...... ...+.+.... ....
T Consensus 155 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~--~~~~~i~~~~-------------~~~~ 219 (257)
T cd05116 155 KTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGN--EVTQMIESGE-------------RMEC 219 (257)
T ss_pred cCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHHCCC-------------CCCC
Confidence 112234578999999888889999999999999999998 99999753221 1111111100 0000
Q ss_pred CcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHh
Q 002721 847 SFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEMLQEI 885 (888)
Q Consensus 847 ~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~i 885 (888)
......++.+++.+||+.||++||++++|.+.|++.
T Consensus 220 ---~~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~~l~~~ 255 (257)
T cd05116 220 ---PQRCPPEMYDLMKLCWTYGVDERPGFAVVELRLRNY 255 (257)
T ss_pred ---CCCCCHHHHHHHHHHhccCchhCcCHHHHHHHHhcc
Confidence 112335677899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=322.65 Aligned_cols=257 Identities=23% Similarity=0.280 Sum_probs=189.4
Q ss_pred ceeeecccceEEEEEeCC---CcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCCeeEEEEecCC
Q 002721 611 NMIYCGTFSTVYKAVMPS---GLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVALLLHNYLP 687 (888)
Q Consensus 611 ~~ig~G~~g~Vy~~~~~~---~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~ 687 (888)
+.||+|+||+||+|...+ ...+|+|.+..... ......+.+|+++++.++||||+++++++......|+||||++
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~ 78 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASAT--PDEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCP 78 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccCC--hHHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCC
Confidence 368999999999997433 45788887753322 2334578899999999999999999999999999999999999
Q ss_pred CCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccccccccCCCCCccc
Q 002721 688 NGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSKGTAS 767 (888)
Q Consensus 688 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~ 767 (888)
+|+|.+++...........++.....++.||+.||+|||++||+||||||+||++++++.+|++|||++...........
T Consensus 79 ~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~ 158 (269)
T cd05042 79 LGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYIT 158 (269)
T ss_pred CCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccchheec
Confidence 99999999876543222456778889999999999999999999999999999999999999999999875433221111
Q ss_pred ccccccccceecccccc-------cCCcCccccchhHHHHHHHHHh-CCCCCCCCCCCccchhhhccccCCCCCCccccc
Q 002721 768 ISAVAGSFGYIPPEYAY-------TMQVTAPGNVYSYGVVLLEILT-TRLPVEEDFGEGVDLVKWVHGAPARGETPEQIL 839 (888)
Q Consensus 768 ~~~~~gt~~y~aPE~~~-------~~~~~~~~DiwSlG~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 839 (888)
.....++..|+|||++. ...++.++||||+||++|||++ |..||....... .+.......... ..
T Consensus 159 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~-~~~~~~~~~~~~------~~ 231 (269)
T cd05042 159 KDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQ-VLKQVVREQDIK------LP 231 (269)
T ss_pred cCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHHH-HHHHHhhccCcc------CC
Confidence 12334567899999864 3457889999999999999999 788886542211 111111110000 00
Q ss_pred ccccccCCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 002721 840 DARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEMLQ 883 (888)
Q Consensus 840 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~ 883 (888)
.+.. .......+.+++..|| .||++|||++||++.|.
T Consensus 232 ~~~~------~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~~l~ 268 (269)
T cd05042 232 KPQL------DLKYSDRWYEVMQFCW-LDPETRPTAEEVHELLT 268 (269)
T ss_pred CCcc------cccCCHHHHHHHHHHh-cCcccccCHHHHHHHhc
Confidence 0000 1122344556778888 49999999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=321.00 Aligned_cols=257 Identities=19% Similarity=0.348 Sum_probs=205.4
Q ss_pred HHHHhcCCcceeeecccceEEEEEeCCCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCCeeEE
Q 002721 602 VVKATMKDSNMIYCGTFSTVYKAVMPSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVALL 681 (888)
Q Consensus 602 ~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 681 (888)
+..++|++.+.||+|+||.||+|...++..+|+|.++.... ..+.+.+|++++++++|+||+++++++.. ...++
T Consensus 3 ~~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~ 77 (260)
T cd05073 3 IPRESLKLEKKLGAGQFGEVWMATYNKHTKVAVKTMKPGSM----SVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYI 77 (260)
T ss_pred ccccceeEEeEecCccceEEEEEEecCCccEEEEecCCChh----HHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEE
Confidence 34578999999999999999999977788899998874322 23478899999999999999999999887 77899
Q ss_pred EEecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccccccccCC
Q 002721 682 LHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDP 761 (888)
Q Consensus 682 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~~~ 761 (888)
+|||+++++|.+++...... ..++.++..++.|++.||+|||+.|++||||||+||+++.++.+|++|||.+.....
T Consensus 78 v~e~~~~~~L~~~~~~~~~~---~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~ 154 (260)
T cd05073 78 ITEFMAKGSLLDFLKSDEGS---KQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIED 154 (260)
T ss_pred EEEeCCCCcHHHHHHhCCcc---ccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCCcceeeccC
Confidence 99999999999999764322 568889999999999999999999999999999999999999999999999976543
Q ss_pred CCCcccccccccccceecccccccCCcCccccchhHHHHHHHHHh-CCCCCCCCCCCccchhhhccccCCCCCCcccccc
Q 002721 762 SKGTASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILT-TRLPVEEDFGEGVDLVKWVHGAPARGETPEQILD 840 (888)
Q Consensus 762 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 840 (888)
.... ......++..|+|||++.+..++.++||||||+++|++++ |+.||...... +...........
T Consensus 155 ~~~~-~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~--~~~~~~~~~~~~--------- 222 (260)
T cd05073 155 NEYT-AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNP--EVIRALERGYRM--------- 222 (260)
T ss_pred CCcc-cccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHH--HHHHHHhCCCCC---------
Confidence 2211 1123345678999999988889999999999999999999 99999753221 111111110000
Q ss_pred cccccCCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHh
Q 002721 841 ARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEMLQEI 885 (888)
Q Consensus 841 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~i 885 (888)
........++.+++.+||+.+|++||++.++.+.|+.+
T Consensus 223 -------~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~~L~~~ 260 (260)
T cd05073 223 -------PRPENCPEELYNIMMRCWKNRPEERPTFEYIQSVLDDF 260 (260)
T ss_pred -------CCcccCCHHHHHHHHHHcccCcccCcCHHHHHHHHhcC
Confidence 00112345678899999999999999999999999753
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=330.05 Aligned_cols=267 Identities=16% Similarity=0.190 Sum_probs=195.0
Q ss_pred Ccceeeec--ccceEEEEEe-CCCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCCeeEEEEec
Q 002721 609 DSNMIYCG--TFSTVYKAVM-PSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVALLLHNY 685 (888)
Q Consensus 609 ~~~~ig~G--~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 685 (888)
+.++||+| +|++||+++. .+|+.||+|+++..... ....+.+.+|+++++.++||||+++++++..++..|+||||
T Consensus 2 ~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~ 80 (327)
T cd08227 2 LLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEACT-NEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSF 80 (327)
T ss_pred hhhhccccccceEEEEEEeecccCcEEEEEEechhhcc-HHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEec
Confidence 45789999 6789999984 57999999999744322 23344677899999999999999999999999999999999
Q ss_pred CCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccccccccCCCCCc
Q 002721 686 LPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSKGT 765 (888)
Q Consensus 686 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 765 (888)
+++|+|.+++...... .+++..+..++.|++.||+|||++||+||||||+||+++.++.++++||+.+.........
T Consensus 81 ~~~~~l~~~~~~~~~~---~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~ 157 (327)
T cd08227 81 MAYGSAKDLICTHFMD---GMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQR 157 (327)
T ss_pred cCCCcHHHHHHhhccC---CCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecCCcEEEcccchhhcccccccc
Confidence 9999999999754322 4788999999999999999999999999999999999999999999999865443211110
Q ss_pred c-----cccccccccceeccccccc--CCcCccccchhHHHHHHHHHhCCCCCCCCCCCccchhhhccccCCC-------
Q 002721 766 A-----SISAVAGSFGYIPPEYAYT--MQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPAR------- 831 (888)
Q Consensus 766 ~-----~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~------- 831 (888)
. ......++..|+|||++.+ ..++.++||||+||++|||++|+.||......... ..........
T Consensus 158 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~-~~~~~~~~~~~~~~~~~ 236 (327)
T cd08227 158 LRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQML-LEKLNGTVPCLLDTTTI 236 (327)
T ss_pred ccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhHHH-HHHhcCCccccccccch
Confidence 0 0122356778999999876 45899999999999999999999999753322110 0000000000
Q ss_pred -----------CCCcccccccc-----c-----ccCCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002721 832 -----------GETPEQILDAR-----L-----STVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVE 880 (888)
Q Consensus 832 -----------~~~~~~~~~~~-----~-----~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 880 (888)
........... . ...........+.+.+++.+||+.||++|||++|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~ 306 (327)
T cd08227 237 PAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLN 306 (327)
T ss_pred hhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchhcCCHHHHhc
Confidence 00000000000 0 0000011233467889999999999999999999986
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-37 Score=358.95 Aligned_cols=258 Identities=15% Similarity=0.220 Sum_probs=199.4
Q ss_pred HHHHHHhcCCcceeeecccceEEEEEeC-CCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEe--C
Q 002721 600 DAVVKATMKDSNMIYCGTFSTVYKAVMP-SGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIY--E 676 (888)
Q Consensus 600 ~~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~--~ 676 (888)
.+....+|++.+.||+|+||+||+|+.. ++..||+|.+..... .......+.+|+.++++++|||||+++++|.. .
T Consensus 8 ge~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l-~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~ 86 (1021)
T PTZ00266 8 GESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGL-KEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKAN 86 (1021)
T ss_pred CccccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEecccc-CHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCC
Confidence 4455678999999999999999999954 578999999874432 22334578999999999999999999998865 3
Q ss_pred CeeEEEEecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccC-------CeeecCCCCCCeEeCC-----
Q 002721 677 DVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHV-------AIIHLDISSGNVLLDA----- 744 (888)
Q Consensus 677 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-------~ivHrDlkp~NIll~~----- 744 (888)
..+|+||||+++|+|.+++....... ..+++..++.|+.||+.||+|||+. +||||||||+|||++.
T Consensus 87 ~~lyIVMEY~~gGSL~~lL~k~~~~~-g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~l 165 (1021)
T PTZ00266 87 QKLYILMEFCDAGDLSRNIQKCYKMF-GKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHI 165 (1021)
T ss_pred CEEEEEEeCCCCCcHHHHHHHHhhcc-CCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCcccc
Confidence 57899999999999999997643221 2578899999999999999999984 5999999999999964
Q ss_pred ------------CCCceEeccccccccCCCCCcccccccccccceeccccccc--CCcCccccchhHHHHHHHHHhCCCC
Q 002721 745 ------------DFKPLLGEIEISKLLDPSKGTASISAVAGSFGYIPPEYAYT--MQVTAPGNVYSYGVVLLEILTTRLP 810 (888)
Q Consensus 745 ------------~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~elltg~~P 810 (888)
.+.+||+|||++....... ......||+.|+|||++.+ ..++.++|||||||++|||++|+.|
T Consensus 166 g~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s---~~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~P 242 (1021)
T PTZ00266 166 GKITAQANNLNGRPIAKIGDFGLSKNIGIES---MAHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTP 242 (1021)
T ss_pred ccccccccccCCCCceEEccCCccccccccc---cccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCC
Confidence 2348999999998764322 1234578999999998854 4588999999999999999999999
Q ss_pred CCCCCCCccchhhhccccCCCCCCcccccccccccCCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002721 811 VEEDFGEGVDLVKWVHGAPARGETPEQILDARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVE 880 (888)
Q Consensus 811 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 880 (888)
|...... ..+...+...+ .+ .......++.++|..||+.+|++||++.|++.
T Consensus 243 F~~~~~~-~qli~~lk~~p------------~l-----pi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~ 294 (1021)
T PTZ00266 243 FHKANNF-SQLISELKRGP------------DL-----PIKGKSKELNILIKNLLNLSAKERPSALQCLG 294 (1021)
T ss_pred CCcCCcH-HHHHHHHhcCC------------CC-----CcCCCCHHHHHHHHHHhcCChhHCcCHHHHhc
Confidence 9643211 11111111000 00 01112456788999999999999999999984
|
|
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=336.06 Aligned_cols=267 Identities=17% Similarity=0.198 Sum_probs=198.4
Q ss_pred HHHhcCCcceeeecccceEEEEEe-CCCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeC-----
Q 002721 603 VKATMKDSNMIYCGTFSTVYKAVM-PSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYE----- 676 (888)
Q Consensus 603 ~~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~----- 676 (888)
..++|+..+.||+|+||.||+|.. ..++.||+|++...... ......+.+|+.+++.++||||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~ 93 (355)
T cd07874 15 VLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQN-QTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEE 93 (355)
T ss_pred hhhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcccC-hHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccc
Confidence 457899999999999999999985 46899999998754322 23345778999999999999999999988643
Q ss_pred -CeeEEEEecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEecccc
Q 002721 677 -DVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEI 755 (888)
Q Consensus 677 -~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~ 755 (888)
...|+||||+++ ++.+.+.. .+++..+..++.|+++||+|||++||+||||||+||+++.++.+||+|||+
T Consensus 94 ~~~~~lv~e~~~~-~l~~~~~~-------~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~Nill~~~~~~kl~Dfg~ 165 (355)
T cd07874 94 FQDVYLVMELMDA-NLCQVIQM-------ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGL 165 (355)
T ss_pred cceeEEEhhhhcc-cHHHHHhh-------cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEECCCCCEEEeeCcc
Confidence 357999999975 77777653 357788899999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCcccccccccccceecccccccCCcCccccchhHHHHHHHHHhCCCCCCCCCCCcc--chh-----------
Q 002721 756 SKLLDPSKGTASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGV--DLV----------- 822 (888)
Q Consensus 756 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~--~~~----------- 822 (888)
++...... ......||..|+|||++.+..++.++|||||||++|||++|+.||........ ...
T Consensus 166 ~~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~ 242 (355)
T cd07874 166 ARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFM 242 (355)
T ss_pred cccCCCcc---ccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHH
Confidence 98654322 12345789999999999998999999999999999999999999975321100 000
Q ss_pred --------hhccccCCCCC-C-cccccccccccCCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002721 823 --------KWVHGAPARGE-T-PEQILDARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEM 881 (888)
Q Consensus 823 --------~~~~~~~~~~~-~-~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~ 881 (888)
.+....+.... . .....+...............++.+++.+|++.||++|||+.|+++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rps~~ell~h 311 (355)
T cd07874 243 KKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDEALQH 311 (355)
T ss_pred HhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcCCHHHHhcC
Confidence 00000000000 0 00000000000001111234567899999999999999999999874
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-36 Score=319.85 Aligned_cols=259 Identities=19% Similarity=0.297 Sum_probs=204.4
Q ss_pred HHhcCCcceeeecccceEEEEEeC-CCc----EEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCCe
Q 002721 604 KATMKDSNMIYCGTFSTVYKAVMP-SGL----ILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDV 678 (888)
Q Consensus 604 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 678 (888)
..+|+..+.||+|+||.||+|... +|. .||+|..+.... ......+.+|+.++++++||||+++++++.. ..
T Consensus 6 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~ 82 (279)
T cd05057 6 ETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETS--PKANKEILDEAYVMASVDHPHVVRLLGICLS-SQ 82 (279)
T ss_pred HHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCC--HHHHHHHHHHHHHHHhCCCCCcceEEEEEec-Cc
Confidence 467899999999999999999853 333 689998874433 2334578899999999999999999999987 78
Q ss_pred eEEEEecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccccccc
Q 002721 679 ALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKL 758 (888)
Q Consensus 679 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~ 758 (888)
.++||||+++|+|.+++..... .+++..+..++.||+.||+|||+.|++||||||+||++++++.+||+|||.++.
T Consensus 83 ~~~v~e~~~~g~L~~~l~~~~~----~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~ 158 (279)
T cd05057 83 VQLITQLMPLGCLLDYVRNHKD----NIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKL 158 (279)
T ss_pred eEEEEecCCCCcHHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcceEEEcCCCeEEECCCccccc
Confidence 8999999999999999976433 478899999999999999999999999999999999999999999999999987
Q ss_pred cCCCCCcccccccccccceecccccccCCcCccccchhHHHHHHHHHh-CCCCCCCCCCCccchhhhccccCCCCCCccc
Q 002721 759 LDPSKGTASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILT-TRLPVEEDFGEGVDLVKWVHGAPARGETPEQ 837 (888)
Q Consensus 759 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 837 (888)
..............++..|+|||.+....++.++||||||+++||+++ |+.||.....+. ....+..
T Consensus 159 ~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~--~~~~~~~---------- 226 (279)
T cd05057 159 LDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVE--IPDLLEK---------- 226 (279)
T ss_pred ccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHHH--HHHHHhC----------
Confidence 654332222222234568999999988889999999999999999999 999997542221 1111110
Q ss_pred ccccccccCCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhhh
Q 002721 838 ILDARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEMLQEIKQ 887 (888)
Q Consensus 838 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 887 (888)
...... .......+.+++.+||..||++||++.++++.|+++.+
T Consensus 227 ---~~~~~~---~~~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~~l~~~~~ 270 (279)
T cd05057 227 ---GERLPQ---PPICTIDVYMVLVKCWMIDAESRPTFKELINEFSKMAR 270 (279)
T ss_pred ---CCCCCC---CCCCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHHh
Confidence 000000 01122456789999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=319.35 Aligned_cols=253 Identities=23% Similarity=0.328 Sum_probs=203.4
Q ss_pred ceeeecccceEEEEEeCC----CcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCCeeEEEEecC
Q 002721 611 NMIYCGTFSTVYKAVMPS----GLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVALLLHNYL 686 (888)
Q Consensus 611 ~~ig~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~ 686 (888)
+.||+|+||.||+|.... +..||+|.++...... ..+.+.+|++.++.++|+||+++++++..+...++||||+
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~ 78 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDASEE--ERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYM 78 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccchh--HHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEec
Confidence 479999999999999543 8899999998554432 3458899999999999999999999999999999999999
Q ss_pred CCCCHHHHhhccCCC----CCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccccccccCCC
Q 002721 687 PNGTLAQLLHESTKQ----PDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPS 762 (888)
Q Consensus 687 ~~g~L~~~l~~~~~~----~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 762 (888)
++++|.+++...... ....+++.++..++.|++.||+|||++|++||||||+||+++.++.+|++|||.+......
T Consensus 79 ~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~ 158 (262)
T cd00192 79 EGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDD 158 (262)
T ss_pred cCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceEEECCCCcEEEcccccccccccc
Confidence 999999999875211 0126789999999999999999999999999999999999999999999999999887654
Q ss_pred CCcccccccccccceecccccccCCcCccccchhHHHHHHHHHh-CCCCCCCCCCCccchhhhccccCCCCCCccccccc
Q 002721 763 KGTASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILT-TRLPVEEDFGEGVDLVKWVHGAPARGETPEQILDA 841 (888)
Q Consensus 763 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 841 (888)
..........++..|+|||.+.+..++.++||||+|+++|||++ |..||...... +..+.... .
T Consensus 159 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~--~~~~~~~~-------------~ 223 (262)
T cd00192 159 DYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNE--EVLEYLRK-------------G 223 (262)
T ss_pred cccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHH--HHHHHHHc-------------C
Confidence 32222334567889999999988889999999999999999999 69999764211 11111111 0
Q ss_pred ccccCCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 002721 842 RLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEMLQ 883 (888)
Q Consensus 842 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~ 883 (888)
.... .......++.+++.+||+.||++|||+.|+++.|+
T Consensus 224 ~~~~---~~~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~l~ 262 (262)
T cd00192 224 YRLP---KPEYCPDELYELMLSCWQLDPEDRPTFSELVERLE 262 (262)
T ss_pred CCCC---CCccCChHHHHHHHHHccCCcccCcCHHHHHHhhC
Confidence 0000 11122467889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-36 Score=333.60 Aligned_cols=258 Identities=16% Similarity=0.103 Sum_probs=197.2
Q ss_pred HhcCCcceeeecccceEEEEEeC-CCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCCeeEEEE
Q 002721 605 ATMKDSNMIYCGTFSTVYKAVMP-SGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVALLLH 683 (888)
Q Consensus 605 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 683 (888)
++|++.+.||+|+||+||+++.. +++.||+|++.+...........+.+|+.++..++|++|+++++++.+++..|+||
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVM 80 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEE
Confidence 36888999999999999999954 58899999997544333334456888999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccccccccCCCC
Q 002721 684 NYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSK 763 (888)
Q Consensus 684 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 763 (888)
||+++|+|.+++..... .+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||++.......
T Consensus 81 ey~~~g~L~~~l~~~~~----~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~ 156 (332)
T cd05623 81 DYYVGGDLLTLLSKFED----RLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDG 156 (332)
T ss_pred eccCCCcHHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCCCCEEEeecchheecccCC
Confidence 99999999999976432 46788899999999999999999999999999999999999999999999987654322
Q ss_pred Ccccccccccccceecccccc-----cCCcCccccchhHHHHHHHHHhCCCCCCCCCCCccchhhhccccCCCCCCcccc
Q 002721 764 GTASISAVAGSFGYIPPEYAY-----TMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQI 838 (888)
Q Consensus 764 ~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 838 (888)
. .......||+.|+|||++. ...++.++|||||||++|||++|+.||....... ....+......
T Consensus 157 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~--~~~~i~~~~~~------- 226 (332)
T cd05623 157 T-VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVE--TYGKIMNHKER------- 226 (332)
T ss_pred c-ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHH--HHHHHhCCCcc-------
Confidence 1 1223457999999999886 3468899999999999999999999997532111 11100000000
Q ss_pred cccccccCCcCcHHHHHHHHHHHhhccCCCCC--CCCCHHHHHHH
Q 002721 839 LDARLSTVSFGWRKEMLTALKVALLCTDSTPA--KRPKMKKVVEM 881 (888)
Q Consensus 839 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~--~RPs~~evl~~ 881 (888)
. ..+........++.+++.+|+..+++ .|++++|+++.
T Consensus 227 ----~-~~p~~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h 266 (332)
T cd05623 227 ----F-QFPAQVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQH 266 (332)
T ss_pred ----c-cCCCccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCC
Confidence 0 00111122345667788887755444 47899988764
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=325.81 Aligned_cols=254 Identities=26% Similarity=0.382 Sum_probs=200.9
Q ss_pred cCCcceeeecccceEEEEEeC-CCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCCeeEEEEec
Q 002721 607 MKDSNMIYCGTFSTVYKAVMP-SGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVALLLHNY 685 (888)
Q Consensus 607 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 685 (888)
|+..+.||+|+||+||+|+.. +++.||+|++......... .....+|+.++++++||||+++++++...+..++||||
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~~~-~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~ 79 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEEEE-REENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEY 79 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHHHH-HHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccccc-cchhhhhhhccccccccccccccccccccccccccccc
Confidence 677899999999999999955 5679999999866544332 23446699999999999999999999999999999999
Q ss_pred CCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccccccccCCCCCc
Q 002721 686 LPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSKGT 765 (888)
Q Consensus 686 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 765 (888)
+++++|.+++.... .+++..+..++.|+++||+|||+.||+||||||+||+++.++.++|+|||.+..... ..
T Consensus 80 ~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~--~~ 152 (260)
T PF00069_consen 80 CPGGSLQDYLQKNK-----PLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSE--NN 152 (260)
T ss_dssp ETTEBHHHHHHHHS-----SBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEEEESSGTTTEESTS--TT
T ss_pred cccccccccccccc-----ccccccccccccccccccccccccccccccccccccccccccccccccccccccccc--cc
Confidence 99999999998332 568899999999999999999999999999999999999999999999999986421 12
Q ss_pred ccccccccccceecccccc-cCCcCccccchhHHHHHHHHHhCCCCCCCCCCCccchhhhccccCCCCCCcccccccccc
Q 002721 766 ASISAVAGSFGYIPPEYAY-TMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQILDARLS 844 (888)
Q Consensus 766 ~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 844 (888)
.......++..|+|||++. +..++.++||||+|+++|+|++|..||........ ... ..+.......
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~--~~~----------~~~~~~~~~~ 220 (260)
T PF00069_consen 153 ENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQ--LEI----------IEKILKRPLP 220 (260)
T ss_dssp SEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHH--HHH----------HHHHHHTHHH
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccchhh--hhh----------hhhccccccc
Confidence 2334567899999999988 78899999999999999999999999986411100 000 0000000000
Q ss_pred cCCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002721 845 TVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVE 880 (888)
Q Consensus 845 ~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 880 (888)
............+.+++.+||+.||++||++.++++
T Consensus 221 ~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~ 256 (260)
T PF00069_consen 221 SSSQQSREKSEELRDLIKKMLSKDPEQRPSAEELLK 256 (260)
T ss_dssp HHTTSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHT
T ss_pred ccccccchhHHHHHHHHHHHccCChhHCcCHHHHhc
Confidence 000011111367889999999999999999999975
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=317.28 Aligned_cols=251 Identities=18% Similarity=0.244 Sum_probs=214.2
Q ss_pred HHHhcCCcceeeecccceEEEEE-eCCCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCCeeEE
Q 002721 603 VKATMKDSNMIYCGTFSTVYKAV-MPSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVALL 681 (888)
Q Consensus 603 ~~~~~~~~~~ig~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 681 (888)
+.+-|...+.||+|.|+.|-.|+ .-+|.+||||++.+..... .....+.+|++-|+-++|||||++|++.......|+
T Consensus 16 IAGLYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKlD~-~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyL 94 (864)
T KOG4717|consen 16 IAGLYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKLDT-LSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYL 94 (864)
T ss_pred eeeeehhhhhhcCCceehhhhhhhhcccceeEEEEecccccch-hhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEE
Confidence 45668888999999999999998 3489999999998654433 233478899999999999999999999999999999
Q ss_pred EEecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEe-CCCCCceEeccccccccC
Q 002721 682 LHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLL-DADFKPLLGEIEISKLLD 760 (888)
Q Consensus 682 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll-~~~~~~kl~Dfg~a~~~~ 760 (888)
|.|.-++|+|.+||.+... .+.+....+++.||+.|+.|+|...+|||||||+|+.+ ..-|-+|+.|||++..+.
T Consensus 95 iLELGD~GDl~DyImKHe~----Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~ 170 (864)
T KOG4717|consen 95 ILELGDGGDLFDYIMKHEE----GLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQ 170 (864)
T ss_pred EEEecCCchHHHHHHhhhc----cccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCC
Confidence 9999999999999987654 57888899999999999999999999999999999877 456899999999999887
Q ss_pred CCCCcccccccccccceecccccccCCcCc-cccchhHHHHHHHHHhCCCCCCCCCCCccchhhhccccCCCCCCccccc
Q 002721 761 PSKGTASISAVAGSFGYIPPEYAYTMQVTA-PGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQIL 839 (888)
Q Consensus 761 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~-~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 839 (888)
++. +....+|+..|-|||++.+..|+. ++||||+|||+|-++.|++||+...+. ++...++
T Consensus 171 PG~---kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDS---------------ETLTmIm 232 (864)
T KOG4717|consen 171 PGK---KLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDS---------------ETLTMIM 232 (864)
T ss_pred Ccc---hhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccch---------------hhhhhhh
Confidence 655 356789999999999999999875 789999999999999999999865433 3334455
Q ss_pred ccccccCCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002721 840 DARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVE 880 (888)
Q Consensus 840 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 880 (888)
|..+. -+.....++.++|..|+..||++|-+.+||+.
T Consensus 233 DCKYt----vPshvS~eCrdLI~sMLvRdPkkRAslEeI~s 269 (864)
T KOG4717|consen 233 DCKYT----VPSHVSKECRDLIQSMLVRDPKKRASLEEIVS 269 (864)
T ss_pred ccccc----CchhhhHHHHHHHHHHHhcCchhhccHHHHhc
Confidence 55443 34566788899999999999999999999864
|
|
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-36 Score=324.20 Aligned_cols=250 Identities=20% Similarity=0.274 Sum_probs=201.6
Q ss_pred HhcCCcceeeecccceEEEEEe-CCCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCCeeEEEE
Q 002721 605 ATMKDSNMIYCGTFSTVYKAVM-PSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVALLLH 683 (888)
Q Consensus 605 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 683 (888)
.+|+..+.||+|+||.||+|.. .+++.||+|.+...... ..+.+.+|+.+++.++||||+++++++..+...|+||
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~---~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~ 96 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP---KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVM 96 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCcc---hHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEee
Confidence 5789999999999999999994 46899999998754332 2346889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccccccccCCCC
Q 002721 684 NYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSK 763 (888)
Q Consensus 684 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 763 (888)
||+++++|.+++... .+++.++..++.|++.||+|||+.||+||||||+||+++.++.+||+|||.+.......
T Consensus 97 e~~~~~~L~~~~~~~------~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~ 170 (296)
T cd06654 97 EYLAGGSLTDVVTET------CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ 170 (296)
T ss_pred cccCCCCHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCCCEEECccccchhccccc
Confidence 999999999998653 35788999999999999999999999999999999999999999999999988654322
Q ss_pred CcccccccccccceecccccccCCcCccccchhHHHHHHHHHhCCCCCCCCCCCccchhhhccccCCCCCCccccccccc
Q 002721 764 GTASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQILDARL 843 (888)
Q Consensus 764 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 843 (888)
. ......+++.|+|||.+.+..++.++|||||||++|+|++|+.||........ ........ .. ..
T Consensus 171 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~-~~~~~~~~-----~~------~~ 236 (296)
T cd06654 171 S--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRA-LYLIATNG-----TP------EL 236 (296)
T ss_pred c--ccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHh-HHHHhcCC-----CC------CC
Confidence 1 12234688899999999888899999999999999999999999975432111 11000000 00 00
Q ss_pred ccCCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002721 844 STVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEM 881 (888)
Q Consensus 844 ~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~ 881 (888)
.........+.+++.+||..||++||++.|+++.
T Consensus 237 ----~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~ 270 (296)
T cd06654 237 ----QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQH 270 (296)
T ss_pred ----CCccccCHHHHHHHHHHCcCCcccCcCHHHHhhC
Confidence 0112234567789999999999999999999873
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-36 Score=333.68 Aligned_cols=258 Identities=17% Similarity=0.125 Sum_probs=197.6
Q ss_pred HhcCCcceeeecccceEEEEEeC-CCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCCeeEEEE
Q 002721 605 ATMKDSNMIYCGTFSTVYKAVMP-SGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVALLLH 683 (888)
Q Consensus 605 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 683 (888)
++|++.+.||+|+||+||+++.. +++.||+|++.+...........+.+|..++..++|++|+++++++..++..|+||
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~ 80 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVM 80 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEE
Confidence 36888999999999999999954 68899999997543333334456888999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccccccccCCCC
Q 002721 684 NYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSK 763 (888)
Q Consensus 684 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 763 (888)
||+++|+|.+++..... .+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||++.......
T Consensus 81 Ey~~gg~L~~~l~~~~~----~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 156 (331)
T cd05624 81 DYYVGGDLLTLLSKFED----RLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDG 156 (331)
T ss_pred eCCCCCcHHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCC
Confidence 99999999999986432 56788899999999999999999999999999999999999999999999998765332
Q ss_pred Ccccccccccccceeccccccc-----CCcCccccchhHHHHHHHHHhCCCCCCCCCCCccchhhhccccCCCCCCcccc
Q 002721 764 GTASISAVAGSFGYIPPEYAYT-----MQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQI 838 (888)
Q Consensus 764 ~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 838 (888)
. .......||+.|+|||++.+ ..++.++||||+||++|||++|+.||....... ......... .
T Consensus 157 ~-~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~-~~~~i~~~~----~----- 225 (331)
T cd05624 157 T-VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVE-TYGKIMNHE----E----- 225 (331)
T ss_pred c-eeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHH-HHHHHHcCC----C-----
Confidence 1 11233568999999998865 467889999999999999999999997532111 000000000 0
Q ss_pred cccccccCCcCcHHHHHHHHHHHhhccCCCCCC--CCCHHHHHHH
Q 002721 839 LDARLSTVSFGWRKEMLTALKVALLCTDSTPAK--RPKMKKVVEM 881 (888)
Q Consensus 839 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~--RPs~~evl~~ 881 (888)
.. ..+........++.+++.+|+..++++ |++++++++.
T Consensus 226 ---~~-~~p~~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h 266 (331)
T cd05624 226 ---RF-QFPSHITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKH 266 (331)
T ss_pred ---cc-cCCCccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcC
Confidence 00 001111123456778888888865544 4678877653
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-36 Score=317.66 Aligned_cols=250 Identities=22% Similarity=0.311 Sum_probs=197.6
Q ss_pred ceeeecccceEEEEEeC-C---CcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCCeeEEEEecC
Q 002721 611 NMIYCGTFSTVYKAVMP-S---GLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVALLLHNYL 686 (888)
Q Consensus 611 ~~ig~G~~g~Vy~~~~~-~---~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~ 686 (888)
+.||+|+||.||+|+.. . +..||+|.++..... ...+.+.+|+++++++.||||+++++++. .+..++||||+
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~ 77 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA--AGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELA 77 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeC
Confidence 47999999999999742 2 378999998754433 33457899999999999999999999876 45689999999
Q ss_pred CCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccccccccCCCCCcc
Q 002721 687 PNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSKGTA 766 (888)
Q Consensus 687 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 766 (888)
++++|.+++.... .+++..+..++.|++.||+|||+.|++||||||+||+++.++.+|++|||.+..........
T Consensus 78 ~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~ 152 (257)
T cd05060 78 PLGPLLKYLKKRR-----EIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYY 152 (257)
T ss_pred CCCcHHHHHHhCC-----CCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCccc
Confidence 9999999998654 46789999999999999999999999999999999999999999999999998765432211
Q ss_pred c-ccccccccceecccccccCCcCccccchhHHHHHHHHHh-CCCCCCCCCCCccchhhhccccCCCCCCcccccccccc
Q 002721 767 S-ISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILT-TRLPVEEDFGEGVDLVKWVHGAPARGETPEQILDARLS 844 (888)
Q Consensus 767 ~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 844 (888)
. .....++..|+|||...+..++.++||||||+++|||++ |..||..... .+...........
T Consensus 153 ~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~--~~~~~~~~~~~~~------------- 217 (257)
T cd05060 153 RATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG--AEVIAMLESGERL------------- 217 (257)
T ss_pred ccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCH--HHHHHHHHcCCcC-------------
Confidence 1 112223567999999988899999999999999999998 9999975432 1222222111000
Q ss_pred cCCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhh
Q 002721 845 TVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEMLQEIK 886 (888)
Q Consensus 845 ~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~i~ 886 (888)
. .....+..+.+++.+||..+|++||++.++++.|+++.
T Consensus 218 ~---~~~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~~l~~~~ 256 (257)
T cd05060 218 P---RPEECPQEIYSIMLSCWKYRPEDRPTFSELESTFRRDP 256 (257)
T ss_pred C---CCCCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHhcc
Confidence 0 01112356788999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-36 Score=325.12 Aligned_cols=260 Identities=20% Similarity=0.334 Sum_probs=202.7
Q ss_pred HHHhcCCcceeeecccceEEEEEe-CCCc----EEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCC
Q 002721 603 VKATMKDSNMIYCGTFSTVYKAVM-PSGL----ILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYED 677 (888)
Q Consensus 603 ~~~~~~~~~~ig~G~~g~Vy~~~~-~~~~----~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 677 (888)
..++|+..+.||+|+||.||+|.. .++. .||+|.+...... .....+.+|+.++++++||||+++++++...
T Consensus 5 ~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~- 81 (303)
T cd05110 5 KETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETTGP--KANVEFMDEALIMASMDHPHLVRLLGVCLSP- 81 (303)
T ss_pred chhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccCCH--HHHHHHHHHHHHHHhCCCCCcccEEEEEcCC-
Confidence 356788999999999999999984 3444 5788888643322 2234688999999999999999999998754
Q ss_pred eeEEEEecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEecccccc
Q 002721 678 VALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISK 757 (888)
Q Consensus 678 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~ 757 (888)
..++++||+++|+|.+++..... .+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||.++
T Consensus 82 ~~~~v~e~~~~g~l~~~~~~~~~----~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~ 157 (303)
T cd05110 82 TIQLVTQLMPHGCLLDYVHEHKD----NIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLAR 157 (303)
T ss_pred CceeeehhcCCCCHHHHHHhccc----CCCHHHHHHHHHHHHHHHHHHhhcCeeccccccceeeecCCCceEEccccccc
Confidence 46799999999999999876432 46788999999999999999999999999999999999999999999999998
Q ss_pred ccCCCCCcccccccccccceecccccccCCcCccccchhHHHHHHHHHh-CCCCCCCCCCCccchhhhccccCCCCCCcc
Q 002721 758 LLDPSKGTASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILT-TRLPVEEDFGEGVDLVKWVHGAPARGETPE 836 (888)
Q Consensus 758 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 836 (888)
...............++..|+|||++.+..++.++||||||+++|||++ |+.||...... ....+......
T Consensus 158 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~--~~~~~~~~~~~------ 229 (303)
T cd05110 158 LLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTR--EIPDLLEKGER------ 229 (303)
T ss_pred cccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHHCCCC------
Confidence 7654332222223445678999999988899999999999999999997 89999653211 11111111000
Q ss_pred cccccccccCCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhhh
Q 002721 837 QILDARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEMLQEIKQ 887 (888)
Q Consensus 837 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 887 (888)
.. ........+.+++.+||..+|++||+++++++.|+++.+
T Consensus 230 ------~~----~~~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~l~~~~~ 270 (303)
T cd05110 230 ------LP----QPPICTIDVYMVMVKCWMIDADSRPKFKELAAEFSRMAR 270 (303)
T ss_pred ------CC----CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 00 001123467789999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=324.06 Aligned_cols=271 Identities=21% Similarity=0.302 Sum_probs=207.4
Q ss_pred HHhcCCcceeeecccceEEEEEeC-----CCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEe--C
Q 002721 604 KATMKDSNMIYCGTFSTVYKAVMP-----SGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIY--E 676 (888)
Q Consensus 604 ~~~~~~~~~ig~G~~g~Vy~~~~~-----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~--~ 676 (888)
.++|+..+.||+|+||.||+|+.. ++..||+|+++..... ...+.+.+|+++++++.||||+++++++.. +
T Consensus 3 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~ 80 (284)
T cd05038 3 KRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE--QHRSDFEREIEILRTLDHENIVKYKGVCEKPGG 80 (284)
T ss_pred hhhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch--HHHHHHHHHHHHHHhCCCCChheEEeeeecCCC
Confidence 356888899999999999999843 3789999999855443 344589999999999999999999999887 5
Q ss_pred CeeEEEEecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccccc
Q 002721 677 DVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEIS 756 (888)
Q Consensus 677 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a 756 (888)
...++||||+++++|.+++..... .+++..+..++.|++.||+|||++|++||||||+||+++.++.++++|||.+
T Consensus 81 ~~~~lv~e~~~~~~l~~~l~~~~~----~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~ 156 (284)
T cd05038 81 RSLRLIMEYLPSGSLRDYLQRHRD----QINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLA 156 (284)
T ss_pred CceEEEEecCCCCCHHHHHHhCcc----ccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccccc
Confidence 578999999999999999976542 4788999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCCccc-ccccccccceecccccccCCcCccccchhHHHHHHHHHhCCCCCCCCCCCccchhhhccccCCCCCCc
Q 002721 757 KLLDPSKGTAS-ISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETP 835 (888)
Q Consensus 757 ~~~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 835 (888)
........... .....++..|+|||...+..++.++||||||+++|||++|+.|+............ ... .....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~~~~~---~~~-~~~~~ 232 (284)
T cd05038 157 KVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAEFLRMIG---IAQ-GQMIV 232 (284)
T ss_pred cccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccchhccccc---ccc-ccccH
Confidence 87653322111 11233456799999998889999999999999999999999998653322111000 000 00000
Q ss_pred ccc---cccccccCCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhh
Q 002721 836 EQI---LDARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEMLQEIK 886 (888)
Q Consensus 836 ~~~---~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~i~ 886 (888)
..+ ....... ........++.+++.+||+.+|++|||+.||+++|+++.
T Consensus 233 ~~~~~~~~~~~~~--~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~~l~~i~ 284 (284)
T cd05038 233 TRLLELLKEGERL--PRPPSCPDEVYDLMKLCWEAEPQDRPSFADLILIVDRLR 284 (284)
T ss_pred HHHHHHHHcCCcC--CCCccCCHHHHHHHHHHhccChhhCCCHHHHHHHHhhcC
Confidence 000 0000000 011122356889999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-36 Score=337.53 Aligned_cols=268 Identities=17% Similarity=0.270 Sum_probs=197.8
Q ss_pred hcCCcceeeecccceEEEEEe-CCCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCC-----ee
Q 002721 606 TMKDSNMIYCGTFSTVYKAVM-PSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYED-----VA 679 (888)
Q Consensus 606 ~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-----~~ 679 (888)
+|+..+.||+|+||.||+|.. .+++.||+|++...... ....+++.+|+++++.++||||+++++++...+ ..
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~ 79 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVFQN-LVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEI 79 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccccc-hHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceE
Confidence 477889999999999999995 47999999998643222 223457889999999999999999999998776 78
Q ss_pred EEEEecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEecccccccc
Q 002721 680 LLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLL 759 (888)
Q Consensus 680 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~ 759 (888)
|+||||+. ++|.+++.... .+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||++...
T Consensus 80 ~lv~e~~~-~~l~~~~~~~~-----~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~ 153 (372)
T cd07853 80 YVVTELMQ-SDLHKIIVSPQ-----PLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVE 153 (372)
T ss_pred EEEeeccc-cCHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEECCCCCEEeccccceeec
Confidence 99999997 58888876532 5788999999999999999999999999999999999999999999999999875
Q ss_pred CCCCCcccccccccccceecccccccC-CcCccccchhHHHHHHHHHhCCCCCCCCCCCcc-chhhhccccCCCCCC---
Q 002721 760 DPSKGTASISAVAGSFGYIPPEYAYTM-QVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGV-DLVKWVHGAPARGET--- 834 (888)
Q Consensus 760 ~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~-~~~~~~~~~~~~~~~--- 834 (888)
..... .......++..|+|||++.+. .++.++||||+||++|||++|+.||........ .......+.+.....
T Consensus 154 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~ 232 (372)
T cd07853 154 EPDES-KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSA 232 (372)
T ss_pred ccCcc-ccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHh
Confidence 43321 122345678999999998774 478999999999999999999999975432110 000000000000000
Q ss_pred ---c-ccccccc-----cccCCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002721 835 ---P-EQILDAR-----LSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEM 881 (888)
Q Consensus 835 ---~-~~~~~~~-----~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~ 881 (888)
. ..+.... .............++.+++.+|++.||++|||++|+++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~t~~e~l~h 288 (372)
T cd07853 233 CEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRISAADALAH 288 (372)
T ss_pred hHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCcCHHHHhcC
Confidence 0 0000000 000000011124567899999999999999999999863
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=327.83 Aligned_cols=199 Identities=19% Similarity=0.288 Sum_probs=162.3
Q ss_pred cceeeecccceEEEEEeC---CCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEe--CCeeEEEEe
Q 002721 610 SNMIYCGTFSTVYKAVMP---SGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIY--EDVALLLHN 684 (888)
Q Consensus 610 ~~~ig~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~--~~~~~lv~e 684 (888)
.++||+|+||+||+|+.. +++.||+|.++..... ..+.+|++++++++||||+++++++.. +...|+|||
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e 80 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGIS-----MSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFD 80 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCCc-----HHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEe
Confidence 468999999999999854 5689999998743321 256789999999999999999998864 457899999
Q ss_pred cCCCCCHHHHhhccCCC----CCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEe----CCCCCceEeccccc
Q 002721 685 YLPNGTLAQLLHESTKQ----PDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLL----DADFKPLLGEIEIS 756 (888)
Q Consensus 685 ~~~~g~L~~~l~~~~~~----~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll----~~~~~~kl~Dfg~a 756 (888)
|+++ +|.+++...... ....+++..+..++.||+.||+|||++||+||||||+||++ +.++.+||+|||++
T Consensus 81 ~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07868 81 YAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred ccCC-CHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCce
Confidence 9864 898887643211 12257888999999999999999999999999999999999 45678999999999
Q ss_pred cccCCCCC-cccccccccccceecccccccC-CcCccccchhHHHHHHHHHhCCCCCCCC
Q 002721 757 KLLDPSKG-TASISAVAGSFGYIPPEYAYTM-QVTAPGNVYSYGVVLLEILTTRLPVEED 814 (888)
Q Consensus 757 ~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~P~~~~ 814 (888)
+....... ........||+.|+|||++.+. .++.++||||+||++|||++|++||...
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~ 219 (317)
T cd07868 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred eccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCC
Confidence 87653321 1123356789999999998764 5899999999999999999999999753
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-36 Score=320.17 Aligned_cols=249 Identities=21% Similarity=0.284 Sum_probs=197.3
Q ss_pred hcCCcceeeecccceEEEEEe-CCCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCCeeEEEEe
Q 002721 606 TMKDSNMIYCGTFSTVYKAVM-PSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVALLLHN 684 (888)
Q Consensus 606 ~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 684 (888)
+|+..+.||+|+||.||+|.. .+++.||+|.+..... ....+++.+|++++++++||||+++++++..++..++|||
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 79 (279)
T cd06619 2 DIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDIT--VELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTE 79 (279)
T ss_pred cchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCCC--hHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEe
Confidence 578889999999999999994 5789999999874322 2234578899999999999999999999999999999999
Q ss_pred cCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccccccccCCCCC
Q 002721 685 YLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSKG 764 (888)
Q Consensus 685 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 764 (888)
|+++++|..+. .+++..+..++.|++.||+|||+.||+|+||||+||+++.++.++|+|||++.......
T Consensus 80 ~~~~~~l~~~~---------~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~- 149 (279)
T cd06619 80 FMDGGSLDVYR---------KIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI- 149 (279)
T ss_pred cCCCCChHHhh---------cCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCCCEEEeeCCcceeccccc-
Confidence 99999987542 34677888999999999999999999999999999999999999999999998654322
Q ss_pred cccccccccccceecccccccCCcCccccchhHHHHHHHHHhCCCCCCCCCCCccch--hhhccccCCCCCCcccccccc
Q 002721 765 TASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDL--VKWVHGAPARGETPEQILDAR 842 (888)
Q Consensus 765 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 842 (888)
.....|+..|+|||++.+..++.++||||+|+++|+|++|+.||.......... .... ..+.+..
T Consensus 150 ---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~----------~~~~~~~ 216 (279)
T cd06619 150 ---AKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLL----------QCIVDED 216 (279)
T ss_pred ---ccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHH----------HHHhccC
Confidence 234578999999999998899999999999999999999999997532221100 0000 0000000
Q ss_pred cccCCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002721 843 LSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEM 881 (888)
Q Consensus 843 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~ 881 (888)
.... .......++.+++.+|++.+|++||+++|+++.
T Consensus 217 ~~~~--~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~ 253 (279)
T cd06619 217 PPVL--PVGQFSEKFVHFITQCMRKQPKERPAPENLMDH 253 (279)
T ss_pred CCCC--CCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcC
Confidence 0000 111234567899999999999999999999764
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-36 Score=320.34 Aligned_cols=258 Identities=22% Similarity=0.317 Sum_probs=202.8
Q ss_pred HHhcCCcceeeecccceEEEEEeCC----CcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCCee
Q 002721 604 KATMKDSNMIYCGTFSTVYKAVMPS----GLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVA 679 (888)
Q Consensus 604 ~~~~~~~~~ig~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 679 (888)
..+|...+.||+|+||.||+|...+ ...||+|....... ....+.+.+|+.++++++||||+++++++.. +..
T Consensus 5 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~~--~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~ 81 (270)
T cd05056 5 REDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCTS--PSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPV 81 (270)
T ss_pred hhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcCC--HHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCc
Confidence 4578889999999999999998533 35789998864432 2234578899999999999999999998875 567
Q ss_pred EEEEecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEecccccccc
Q 002721 680 LLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLL 759 (888)
Q Consensus 680 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~ 759 (888)
|+||||+++++|.+++..... .+++..+..++.|++.||+|||+.|++||||||+||+++.++.+|++|||.+...
T Consensus 82 ~lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~ 157 (270)
T cd05056 82 WIVMELAPLGELRSYLQVNKY----SLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYL 157 (270)
T ss_pred EEEEEcCCCCcHHHHHHhCCC----CCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheEEEecCCCeEEccCceeeec
Confidence 899999999999999976432 4788999999999999999999999999999999999999999999999998876
Q ss_pred CCCCCcccccccccccceecccccccCCcCccccchhHHHHHHHHHh-CCCCCCCCCCCccchhhhccccCCCCCCcccc
Q 002721 760 DPSKGTASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILT-TRLPVEEDFGEGVDLVKWVHGAPARGETPEQI 838 (888)
Q Consensus 760 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 838 (888)
...... ......++..|+|||.+....++.++||||||+++||+++ |..||........ ....... ..
T Consensus 158 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~--~~~~~~~----~~---- 226 (270)
T cd05056 158 EDESYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDV--IGRIENG----ER---- 226 (270)
T ss_pred ccccce-ecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHH--HHHHHcC----Cc----
Confidence 433211 1122234568999999888889999999999999999996 9999975432211 1111000 00
Q ss_pred cccccccCCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhhh
Q 002721 839 LDARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEMLQEIKQ 887 (888)
Q Consensus 839 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 887 (888)
. .. ......++.+++.+|+..+|++|||+.++++.|+++..
T Consensus 227 ----~-~~---~~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~l~~~~~ 267 (270)
T cd05056 227 ----L-PM---PPNCPPTLYSLMTKCWAYDPSKRPRFTELKAQLSDILQ 267 (270)
T ss_pred ----C-CC---CCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHHHHh
Confidence 0 00 11223567889999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.7e-37 Score=335.81 Aligned_cols=243 Identities=19% Similarity=0.157 Sum_probs=187.4
Q ss_pred eeecccceEEEEEe-CCCcEEEEEEeeccChhhhHHHHHHHHHHHHHhcc---CCCceeeeeeEEEeCCeeEEEEecCCC
Q 002721 613 IYCGTFSTVYKAVM-PSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKL---CHDNLVRPIGFVIYEDVALLLHNYLPN 688 (888)
Q Consensus 613 ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l---~hpnIv~~~~~~~~~~~~~lv~e~~~~ 688 (888)
||+|+||+||+|+. .+++.||+|++...............+|..++... +||||+++++++..++..|+||||+++
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~ 80 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSG 80 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCC
Confidence 69999999999995 46899999999754333333334556677777665 699999999999999999999999999
Q ss_pred CCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccccccccCCCCCcccc
Q 002721 689 GTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSKGTASI 768 (888)
Q Consensus 689 g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~ 768 (888)
|+|.+++.... .+++..+..++.||++||+|||++||+||||||+||+++.++.+||+|||++........ ..
T Consensus 81 g~L~~~l~~~~-----~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~--~~ 153 (330)
T cd05586 81 GELFWHLQKEG-----RFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNK--TT 153 (330)
T ss_pred ChHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCC--Cc
Confidence 99999987643 467889999999999999999999999999999999999999999999999876432221 12
Q ss_pred cccccccceecccccccC-CcCccccchhHHHHHHHHHhCCCCCCCCCCCccchhhhccccCCCCCCcccccccccccCC
Q 002721 769 SAVAGSFGYIPPEYAYTM-QVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQILDARLSTVS 847 (888)
Q Consensus 769 ~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 847 (888)
....||..|+|||++.+. .++.++||||+||++|||++|+.||....... ....+ .......
T Consensus 154 ~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~--~~~~i-------------~~~~~~~-- 216 (330)
T cd05586 154 NTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQ--MYRNI-------------AFGKVRF-- 216 (330)
T ss_pred cCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHH--HHHHH-------------HcCCCCC--
Confidence 345789999999998754 48999999999999999999999997532211 11100 0000000
Q ss_pred cCcHHHHHHHHHHHhhccCCCCCCCCC----HHHHHH
Q 002721 848 FGWRKEMLTALKVALLCTDSTPAKRPK----MKKVVE 880 (888)
Q Consensus 848 ~~~~~~~~~~~~li~~cl~~dP~~RPs----~~evl~ 880 (888)
.......++.+++.+||+.||++||+ +.++++
T Consensus 217 -~~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~ 252 (330)
T cd05586 217 -PKNVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKE 252 (330)
T ss_pred -CCccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhc
Confidence 00112345678999999999999994 555544
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >KOG0444 consensus Cytoskeletal regulator Flightless-I (contains leucine-rich and gelsolin repeats) [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=342.94 Aligned_cols=381 Identities=26% Similarity=0.368 Sum_probs=270.4
Q ss_pred eEEEEEcCCCCcccc--cccccCCCCCCEEeCCCCcCcccCCCCCCCCCCCCEEECcCCCCCCCCCCCCCCCCcceEEEc
Q 002721 64 FVVKLDLSRLQLRGN--ITLVSELKALKRLDLSNNAFSGTIPSAFGNLSELEFLDLSLNKFGGVIPRELGSLKDLRFFNI 141 (888)
Q Consensus 64 ~v~~l~l~~~~l~~~--~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L 141 (888)
.|..+|+++|.++|. ++.+..+++++.|.|...++. .+|+.++.|.+|++|.+++|++. .+-+.+..|+.|+.+++
T Consensus 8 FVrGvDfsgNDFsg~~FP~~v~qMt~~~WLkLnrt~L~-~vPeEL~~lqkLEHLs~~HN~L~-~vhGELs~Lp~LRsv~~ 85 (1255)
T KOG0444|consen 8 FVRGVDFSGNDFSGDRFPHDVEQMTQMTWLKLNRTKLE-QVPEELSRLQKLEHLSMAHNQLI-SVHGELSDLPRLRSVIV 85 (1255)
T ss_pred eeecccccCCcCCCCcCchhHHHhhheeEEEechhhhh-hChHHHHHHhhhhhhhhhhhhhH-hhhhhhccchhhHHHhh
Confidence 466777777777753 335666677777777766664 56777777777777777777766 34456666677777777
Q ss_pred CCCcccc-ccCccccccccccEEEecCCCCCCCCCccccccccccEEecccccccCCCCCCCCCcccccceeeccccCCC
Q 002721 142 SNNVLVG-EIPDELKSLEKLEDFQVSSNKLNGSIPFWVGNLTNLRVFTAYENQLVGEIPDNLGSVSELELLNLHSNQLEG 220 (888)
Q Consensus 142 s~N~l~~-~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 220 (888)
.+|++.. -+|..+..+..|+.||||+|+++ ..|..+..-+++-+|+|++|+|..+....|.+|+.|-.||||+|++.
T Consensus 86 R~N~LKnsGiP~diF~l~dLt~lDLShNqL~-EvP~~LE~AKn~iVLNLS~N~IetIPn~lfinLtDLLfLDLS~NrLe- 163 (1255)
T KOG0444|consen 86 RDNNLKNSGIPTDIFRLKDLTILDLSHNQLR-EVPTNLEYAKNSIVLNLSYNNIETIPNSLFINLTDLLFLDLSNNRLE- 163 (1255)
T ss_pred hccccccCCCCchhcccccceeeecchhhhh-hcchhhhhhcCcEEEEcccCccccCCchHHHhhHhHhhhccccchhh-
Confidence 7776642 35555666666666666666666 45555555555555666666555333333455555555555555555
Q ss_pred CCCCCccCCCCcceEEecCccCCCCchhhhccCCccceeeccCCccccccCCccccCCCccEEEeeccCCC-CCCCcccc
Q 002721 221 PIPKSIFASGKLEVLVLTQNRLTGDIPELVGHCKSLSNIRIGNNDLVGVIPRAIGNVSGLTYFEADNNNLS-GEIVPEFS 299 (888)
Q Consensus 221 ~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~-~~~~~~~~ 299 (888)
.+|..+..+..|++|+|++| .+....-..+..|++|++|.+++.+=+ ..+|.++.
T Consensus 164 ~LPPQ~RRL~~LqtL~Ls~N------------------------PL~hfQLrQLPsmtsL~vLhms~TqRTl~N~Ptsld 219 (1255)
T KOG0444|consen 164 MLPPQIRRLSMLQTLKLSNN------------------------PLNHFQLRQLPSMTSLSVLHMSNTQRTLDNIPTSLD 219 (1255)
T ss_pred hcCHHHHHHhhhhhhhcCCC------------------------hhhHHHHhcCccchhhhhhhcccccchhhcCCCchh
Confidence 23444444444555555544 443333333444555555555554322 34677788
Q ss_pred CCCCCcEEEeecCcccccCCccccCCCCccEEEeccccccCcCcccccccCcceEEEccCCcCCCCCCchhccccCccee
Q 002721 300 QCSNLTLLNLASNGFTGVIPPELGQLINLQELILYENSLFGEIPKSILACKNLNKLDLSNNRFNGTIPNAICDMSRLQYL 379 (888)
Q Consensus 300 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 379 (888)
.+.||..+|||.|++. ..|+.+.++.+|+.|+||+|+|+ .+........+|+.|+||.|+++ .+|++++.++.|+.|
T Consensus 220 ~l~NL~dvDlS~N~Lp-~vPecly~l~~LrrLNLS~N~it-eL~~~~~~W~~lEtLNlSrNQLt-~LP~avcKL~kL~kL 296 (1255)
T KOG0444|consen 220 DLHNLRDVDLSENNLP-IVPECLYKLRNLRRLNLSGNKIT-ELNMTEGEWENLETLNLSRNQLT-VLPDAVCKLTKLTKL 296 (1255)
T ss_pred hhhhhhhccccccCCC-cchHHHhhhhhhheeccCcCcee-eeeccHHHHhhhhhhccccchhc-cchHHHhhhHHHHHH
Confidence 8889999999999998 68999999999999999999987 55556677889999999999998 899999999999999
Q ss_pred cccCCcccc-ccCCCccccccceEEEeecccccccCCCccccccchhhhhhccCccccccCCccccCCCCccEEEeeCCc
Q 002721 380 LLGQNSLKG-EIPHEIGNCMKLLQLHIGSNYLTGSIPPEIGHIRNLQIALNLSFNHLHGSLPPELGKLDKLVSFDVSNNQ 458 (888)
Q Consensus 380 ~L~~N~l~~-~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~~L~ls~N~l~~~~p~~~~~l~~L~~LdLs~N~ 458 (888)
++.+|+++- -+|+.++.+.+|+.+..++|.+. ..|..++.+..|+ .|+|+.|++- .+|+.+.-|+.|+.|||..|.
T Consensus 297 y~n~NkL~FeGiPSGIGKL~~Levf~aanN~LE-lVPEglcRC~kL~-kL~L~~NrLi-TLPeaIHlL~~l~vLDlreNp 373 (1255)
T KOG0444|consen 297 YANNNKLTFEGIPSGIGKLIQLEVFHAANNKLE-LVPEGLCRCVKLQ-KLKLDHNRLI-TLPEAIHLLPDLKVLDLRENP 373 (1255)
T ss_pred HhccCcccccCCccchhhhhhhHHHHhhccccc-cCchhhhhhHHHH-Hhccccccee-echhhhhhcCCcceeeccCCc
Confidence 999999874 37999999999999999999998 8999999999999 7999999997 789999999999999999997
Q ss_pred cccCCchhhcccccceEEEc
Q 002721 459 LSGTIPSALKGMLSLIEVNF 478 (888)
Q Consensus 459 l~~~~p~~~~~l~~L~~L~l 478 (888)
=---+|..-..-+.|+.-|+
T Consensus 374 nLVMPPKP~da~~~lefYNI 393 (1255)
T KOG0444|consen 374 NLVMPPKPNDARKKLEFYNI 393 (1255)
T ss_pred CccCCCCcchhhhcceeeec
Confidence 55344443333345554433
|
|
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=317.96 Aligned_cols=253 Identities=20% Similarity=0.349 Sum_probs=193.0
Q ss_pred ceeeecccceEEEEEeC----CCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEE-eCCeeEEEEec
Q 002721 611 NMIYCGTFSTVYKAVMP----SGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVI-YEDVALLLHNY 685 (888)
Q Consensus 611 ~~ig~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~-~~~~~~lv~e~ 685 (888)
+.||+|+||.||+|... ++..||+|.+..... ....+.+.+|+.+++.++||||+++++++. .++..++||||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~ 78 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRITD--LEEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPY 78 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCccCC--HHHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEec
Confidence 46899999999999843 246799998864322 223457889999999999999999999876 45568999999
Q ss_pred CCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccccccccCCCCC-
Q 002721 686 LPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSKG- 764 (888)
Q Consensus 686 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~- 764 (888)
+++|+|.+++..... ..++..+..++.|+++||+|||+.+++||||||+||++++++.+|++|||++........
T Consensus 79 ~~~~~L~~~~~~~~~----~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~ 154 (262)
T cd05058 79 MKHGDLRNFIRSETH----NPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYY 154 (262)
T ss_pred CCCCCHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCcEEECCccccccccCCcce
Confidence 999999999976432 356778889999999999999999999999999999999999999999999876543211
Q ss_pred -cccccccccccceecccccccCCcCccccchhHHHHHHHHHhC-CCCCCCCCCCccchhhhccccCCCCCCcccccccc
Q 002721 765 -TASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILTT-RLPVEEDFGEGVDLVKWVHGAPARGETPEQILDAR 842 (888)
Q Consensus 765 -~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg-~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 842 (888)
........++..|+|||.+.+..++.++|||||||++|||++| .+||..... .+........ .
T Consensus 155 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~--~~~~~~~~~~-------------~ 219 (262)
T cd05058 155 SVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDS--FDITVYLLQG-------------R 219 (262)
T ss_pred eecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCH--HHHHHHHhcC-------------C
Confidence 0111233456789999999888899999999999999999995 555543211 1111111100 0
Q ss_pred cccCCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhhh
Q 002721 843 LSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEMLQEIKQ 887 (888)
Q Consensus 843 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 887 (888)
... .....+..+.+++.+||+.+|++||++.|+++.|+++..
T Consensus 220 ~~~---~~~~~~~~~~~li~~cl~~~p~~Rp~~~~il~~l~~~~~ 261 (262)
T cd05058 220 RLL---QPEYCPDPLYEVMLSCWHPKPEMRPTFSELVSRIEQIFS 261 (262)
T ss_pred CCC---CCCcCCHHHHHHHHHHcCCChhhCCCHHHHHHHHHHHhc
Confidence 000 011123467889999999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-36 Score=315.14 Aligned_cols=249 Identities=22% Similarity=0.313 Sum_probs=198.1
Q ss_pred ceeeecccceEEEEEeCCCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCCeeEEEEecCCCCC
Q 002721 611 NMIYCGTFSTVYKAVMPSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVALLLHNYLPNGT 690 (888)
Q Consensus 611 ~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~g~ 690 (888)
++||+|+||.||+|...+++.||+|.++..... .....+.+|++++++++||||+++++++......++||||+++++
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~v~~K~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~ 78 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKGNTEVAVKTCRSTLPP--DLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGS 78 (251)
T ss_pred CccccCCCceEEEEEEeCCCcEEEEeccccCCH--HHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCc
Confidence 469999999999999766999999988754332 334578999999999999999999999999999999999999999
Q ss_pred HHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccccccccCCCCCcccccc
Q 002721 691 LAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSKGTASISA 770 (888)
Q Consensus 691 L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~ 770 (888)
|.+++..... .+++..+..++.|++.||+|||+++++||||||+||+++.++.+|++|||.+..............
T Consensus 79 l~~~l~~~~~----~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~ 154 (251)
T cd05041 79 LLTFLRKKKN----RLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGL 154 (251)
T ss_pred HHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceecccc
Confidence 9999976432 467889999999999999999999999999999999999999999999999986542221111112
Q ss_pred cccccceecccccccCCcCccccchhHHHHHHHHHh-CCCCCCCCCCCccchhhhccccCCCCCCcccccccccccCCcC
Q 002721 771 VAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILT-TRLPVEEDFGEGVDLVKWVHGAPARGETPEQILDARLSTVSFG 849 (888)
Q Consensus 771 ~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 849 (888)
..++..|+|||.+.+..++.++||||||+++|||+| |..||....... ......... .. ..
T Consensus 155 ~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~--~~~~~~~~~------------~~----~~ 216 (251)
T cd05041 155 KQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQ--TRERIESGY------------RM----PA 216 (251)
T ss_pred CcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHH--HHHHHhcCC------------CC----CC
Confidence 234567999999988889999999999999999999 888886543211 111110000 00 01
Q ss_pred cHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 002721 850 WRKEMLTALKVALLCTDSTPAKRPKMKKVVEMLQ 883 (888)
Q Consensus 850 ~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~ 883 (888)
......++.+++.+||..+|++|||+.|+++.|+
T Consensus 217 ~~~~~~~~~~li~~~l~~~p~~Rp~~~ell~~l~ 250 (251)
T cd05041 217 PQLCPEEIYRLMLQCWAYDPENRPSFSEIYNELQ 250 (251)
T ss_pred CccCCHHHHHHHHHHhccChhhCcCHHHHHHHhh
Confidence 1122356788999999999999999999999986
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-36 Score=316.04 Aligned_cols=252 Identities=19% Similarity=0.242 Sum_probs=203.7
Q ss_pred hcCCcceeeecccceEEEEE-eCCCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCCeeEEEEe
Q 002721 606 TMKDSNMIYCGTFSTVYKAV-MPSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVALLLHN 684 (888)
Q Consensus 606 ~~~~~~~ig~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 684 (888)
+|+..+.||+|+||.||.++ ..+++.+++|.+...... ....+++.+|++++++++|+||+++++++.+.+..+++||
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~-~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e 79 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLS-EKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEME 79 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeecccc-hhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEE
Confidence 47889999999999999999 456899999998744322 2334578899999999999999999999999999999999
Q ss_pred cCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccccccccCCCCC
Q 002721 685 YLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSKG 764 (888)
Q Consensus 685 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 764 (888)
|+++++|.+++..... ..+++.++..++.|++.||+|||+.|++||||||+||++++++.+|++|||.+........
T Consensus 80 ~~~~~~L~~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~ 156 (256)
T cd08221 80 YANGGTLYDKIVRQKG---QLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS 156 (256)
T ss_pred ecCCCcHHHHHHhccc---cCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCCCCEEECcCcceEEcccccc
Confidence 9999999999986532 2578899999999999999999999999999999999999999999999999987644321
Q ss_pred cccccccccccceecccccccCCcCccccchhHHHHHHHHHhCCCCCCCCCCCccchhhhccccCCCCCCcccccccccc
Q 002721 765 TASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQILDARLS 844 (888)
Q Consensus 765 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 844 (888)
......+++.|+|||...+..++.++||||+|+++|||++|..||...... +.... +......
T Consensus 157 --~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~--~~~~~-------------~~~~~~~ 219 (256)
T cd08221 157 --MAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPL--NLVVK-------------IVQGNYT 219 (256)
T ss_pred --cccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHH--HHHHH-------------HHcCCCC
Confidence 223456889999999998888999999999999999999999999653211 11100 0001111
Q ss_pred cCCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002721 845 TVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEM 881 (888)
Q Consensus 845 ~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~ 881 (888)
. .......++.+++.+||..+|++||++.|+++.
T Consensus 220 ~---~~~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~ 253 (256)
T cd08221 220 P---VVSVYSSELISLVHSLLQQDPEKRPTADEVLDQ 253 (256)
T ss_pred C---CccccCHHHHHHHHHHcccCcccCCCHHHHhhC
Confidence 0 012234567789999999999999999999875
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-36 Score=318.56 Aligned_cols=252 Identities=23% Similarity=0.327 Sum_probs=200.0
Q ss_pred hcCCcceeeecccceEEEEEe-CCCcEEEEEEeeccChh------hhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCCe
Q 002721 606 TMKDSNMIYCGTFSTVYKAVM-PSGLILSVKRLKSMDRT------IIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDV 678 (888)
Q Consensus 606 ~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~------~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 678 (888)
+|.+.+.||+|+||.||+|.. .+++.||+|.+...... .....+.+.+|++++++++||||+++++++...+.
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~ 80 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADH 80 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCc
Confidence 467789999999999999985 46889999988643322 12233578899999999999999999999999999
Q ss_pred eEEEEecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccccccc
Q 002721 679 ALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKL 758 (888)
Q Consensus 679 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~ 758 (888)
.++||||+++++|.+++.... .+++..+..++.|++.||+|||+.|++||||+|+||++++++.++|+|||.++.
T Consensus 81 ~~lv~e~~~~~~L~~~l~~~~-----~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~ 155 (267)
T cd06628 81 LNIFLEYVPGGSVAALLNNYG-----AFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKK 155 (267)
T ss_pred cEEEEEecCCCCHHHHHHhcc-----CccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEEEcCCCCEEecccCCCcc
Confidence 999999999999999997653 467788999999999999999999999999999999999999999999999987
Q ss_pred cCCCCCc----ccccccccccceecccccccCCcCccccchhHHHHHHHHHhCCCCCCCCCCCccchhhhccccCCCCCC
Q 002721 759 LDPSKGT----ASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGET 834 (888)
Q Consensus 759 ~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~ 834 (888)
....... .......|+..|+|||.+.+..++.++||||+||++|+|++|+.||....... ....
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-~~~~----------- 223 (267)
T cd06628 156 LEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQ-AIFK----------- 223 (267)
T ss_pred cccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHHH-HHHH-----------
Confidence 6532111 11123457889999999988889999999999999999999999997532211 0000
Q ss_pred cccccccccccCCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002721 835 PEQILDARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVE 880 (888)
Q Consensus 835 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 880 (888)
+....... ........+.+++.+||++||++||++.|+++
T Consensus 224 ---~~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 263 (267)
T cd06628 224 ---IGENASPE---IPSNISSEAIDFLEKTFEIDHNKRPTAAELLK 263 (267)
T ss_pred ---HhccCCCc---CCcccCHHHHHHHHHHccCCchhCcCHHHHhh
Confidence 00000000 11123456778999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=323.03 Aligned_cols=263 Identities=22% Similarity=0.279 Sum_probs=201.5
Q ss_pred hcCCcceeeecccceEEEEEe-CCCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCCeeEEEEe
Q 002721 606 TMKDSNMIYCGTFSTVYKAVM-PSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVALLLHN 684 (888)
Q Consensus 606 ~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 684 (888)
+|++.+.||+|+||.||+|.. .++..||+|.++.... .....++.+|++++++++||||+++++++..++..++|||
T Consensus 2 ~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 79 (308)
T cd06615 2 DFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIK--PAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICME 79 (308)
T ss_pred CceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccccC--HHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEee
Confidence 688899999999999999995 4688999998874322 2234578899999999999999999999999999999999
Q ss_pred cCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhccc-CCeeecCCCCCCeEeCCCCCceEeccccccccCCCC
Q 002721 685 YLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHH-VAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSK 763 (888)
Q Consensus 685 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 763 (888)
|+++++|.++++... .+++..+..++.|+++||.|||+ .+++||||||+||++++++.+|++|||.+.......
T Consensus 80 y~~~~~L~~~l~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 154 (308)
T cd06615 80 HMDGGSLDQVLKKAG-----RIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM 154 (308)
T ss_pred ccCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecCCcEEEccCCCcccccccc
Confidence 999999999997653 46788899999999999999997 699999999999999999999999999987653221
Q ss_pred CcccccccccccceecccccccCCcCccccchhHHHHHHHHHhCCCCCCCCCCCccchhhhccccCCCCCCcc-------
Q 002721 764 GTASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPE------- 836 (888)
Q Consensus 764 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~------- 836 (888)
.....++..|+|||.+.+..++.++||||||+++|+|++|+.||....... ................
T Consensus 155 ----~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~ 228 (308)
T cd06615 155 ----ANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKE--LEAMFGRPVSEGEAKESHRPVSG 228 (308)
T ss_pred ----cccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhh--HHHhhcCccccccccCCcccccC
Confidence 234568899999999988889999999999999999999999996432211 1111111000000000
Q ss_pred ------------cccccccccCCc--CcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002721 837 ------------QILDARLSTVSF--GWRKEMLTALKVALLCTDSTPAKRPKMKKVVEM 881 (888)
Q Consensus 837 ------------~~~~~~~~~~~~--~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~ 881 (888)
...+........ .......++.+++.+||..||++||++.|+++.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 287 (308)
T cd06615 229 HPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERADLKELTKH 287 (308)
T ss_pred CCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000000000000 001134568899999999999999999999875
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-36 Score=317.44 Aligned_cols=239 Identities=15% Similarity=0.290 Sum_probs=186.7
Q ss_pred ceeeecccceEEEEEeCC-------------CcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCC
Q 002721 611 NMIYCGTFSTVYKAVMPS-------------GLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYED 677 (888)
Q Consensus 611 ~~ig~G~~g~Vy~~~~~~-------------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 677 (888)
+.||+|+||.||+|+..+ ...||+|.+..... .....+.+|+.+++.++||||+++++++..+.
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~---~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~ 77 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPSHR---DISLAFFETASMMRQVSHKHIVLLYGVCVRDV 77 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChhhh---hHHHHHHHHHHHHHhCCCCCEeeEEEEEecCC
Confidence 468999999999998432 23588888764322 23347888999999999999999999999999
Q ss_pred eeEEEEecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCC-------ceE
Q 002721 678 VALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFK-------PLL 750 (888)
Q Consensus 678 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~-------~kl 750 (888)
..++||||+++++|..++..... .+++..+..++.||++||+|||++||+||||||+||+++.++. +++
T Consensus 78 ~~~lv~e~~~~~~l~~~~~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l 153 (262)
T cd05077 78 ENIMVEEFVEFGPLDLFMHRKSD----VLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKL 153 (262)
T ss_pred CCEEEEecccCCCHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCcccEEEecCCccCCCCceeEe
Confidence 99999999999999998875432 4688899999999999999999999999999999999987654 899
Q ss_pred eccccccccCCCCCcccccccccccceecccccc-cCCcCccccchhHHHHHHHHH-hCCCCCCCCCCCccchhhhcccc
Q 002721 751 GEIEISKLLDPSKGTASISAVAGSFGYIPPEYAY-TMQVTAPGNVYSYGVVLLEIL-TTRLPVEEDFGEGVDLVKWVHGA 828 (888)
Q Consensus 751 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwSlG~il~ell-tg~~P~~~~~~~~~~~~~~~~~~ 828 (888)
+|||.+...... ....++..|+|||.+. +..++.++|||||||++|||+ +|..||........ ....
T Consensus 154 ~d~g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~~--~~~~--- 222 (262)
T cd05077 154 SDPGIPITVLSR------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLKDKTLAEK--ERFY--- 222 (262)
T ss_pred CCCCCCccccCc------ccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCcchhHH--HHHH---
Confidence 999998764321 2345788999999886 466899999999999999998 58888865321111 0000
Q ss_pred CCCCCCcccccccccccCCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 002721 829 PARGETPEQILDARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEML 882 (888)
Q Consensus 829 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L 882 (888)
...... ......++.+++.+||+.||++||++.+|++.+
T Consensus 223 -----------~~~~~~----~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~~ 261 (262)
T cd05077 223 -----------EGQCML----VTPSCKELADLMTHCMNYDPNQRPFFRAIMRDI 261 (262)
T ss_pred -----------hcCccC----CCCChHHHHHHHHHHcCCChhhCcCHHHHHHhc
Confidence 000000 011234678899999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=324.42 Aligned_cols=266 Identities=20% Similarity=0.269 Sum_probs=193.7
Q ss_pred hcCCcceeeecccceEEEEEeC-CCcEEEEEEeeccChhhhHHHHHHHHHHHHHhcc---CCCceeeeeeEEEe-----C
Q 002721 606 TMKDSNMIYCGTFSTVYKAVMP-SGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKL---CHDNLVRPIGFVIY-----E 676 (888)
Q Consensus 606 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l---~hpnIv~~~~~~~~-----~ 676 (888)
+|++.+.||+|+||+||+|+.. +++.||+|.++...... .....+.+|+++++.+ +||||+++++++.. .
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~ 79 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNED-GLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRE 79 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCCC-CCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCC
Confidence 4788899999999999999954 68999999987432211 1122455677777655 69999999998864 2
Q ss_pred CeeEEEEecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccccc
Q 002721 677 DVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEIS 756 (888)
Q Consensus 677 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a 756 (888)
...++||||+++ +|.+++...... .+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||++
T Consensus 80 ~~~~lv~e~~~~-~l~~~~~~~~~~---~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~ 155 (288)
T cd07863 80 TKVTLVFEHVDQ-DLRTYLDKVPPP---GLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLA 155 (288)
T ss_pred ceEEEEEccccc-CHHHHHHhcCCC---CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCcc
Confidence 457999999985 899988764322 4788999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCCcccccccccccceecccccccCCcCccccchhHHHHHHHHHhCCCCCCCCCCCccchhhhcc--ccCCCCCC
Q 002721 757 KLLDPSKGTASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVH--GAPARGET 834 (888)
Q Consensus 757 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~--~~~~~~~~ 834 (888)
....... ......|+..|+|||++.+..++.++||||+||++|||++|++||....... .+.+... ..+.....
T Consensus 156 ~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~-~~~~~~~~~~~~~~~~~ 231 (288)
T cd07863 156 RIYSCQM---ALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEAD-QLGKIFDLIGLPPEDDW 231 (288)
T ss_pred ccccCcc---cCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHH-HHHHHHHHhCCCChhhC
Confidence 8764322 1234567899999999998899999999999999999999999996542211 1111100 00000000
Q ss_pred ccc------cccccc-ccCCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002721 835 PEQ------ILDARL-STVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVE 880 (888)
Q Consensus 835 ~~~------~~~~~~-~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 880 (888)
... ...+.. .............+.+++.+|+++||++|||+.|++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~~~l~ 284 (288)
T cd07863 232 PRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQ 284 (288)
T ss_pred cccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 000 000000 0000001123456779999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-36 Score=317.97 Aligned_cols=254 Identities=17% Similarity=0.267 Sum_probs=201.5
Q ss_pred hcCCcceeeecccceEEEEEeCCCcEEEEEEeeccCh---hhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCCeeEEE
Q 002721 606 TMKDSNMIYCGTFSTVYKAVMPSGLILSVKRLKSMDR---TIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVALLL 682 (888)
Q Consensus 606 ~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~---~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 682 (888)
+|+..+.||+|+||+||+|...+++.+|+|.++.... ......+.+.+|++++++++|+||+++++++.+.+..++|
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 80 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLTNQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIF 80 (265)
T ss_pred CccccceEeccCCeEEEEEEEcCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEE
Confidence 4788899999999999999988899999998874321 2233345788999999999999999999999999999999
Q ss_pred EecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccccccccCCC
Q 002721 683 HNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPS 762 (888)
Q Consensus 683 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 762 (888)
|||+++++|.+++.... .+++..+..++.|++.||+|||+.+|+|+||||+||++++++.++++|||.+......
T Consensus 81 ~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~ 155 (265)
T cd06631 81 MEFVPGGSISSILNRFG-----PLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWV 155 (265)
T ss_pred EecCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhc
Confidence 99999999999997643 4577889999999999999999999999999999999999999999999998765321
Q ss_pred CC----cccccccccccceecccccccCCcCccccchhHHHHHHHHHhCCCCCCCCCCCccchhhhccccCCCCCCcccc
Q 002721 763 KG----TASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQI 838 (888)
Q Consensus 763 ~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 838 (888)
.. ........++..|+|||++.+..++.++||||+|+++|+|++|+.||........ ........
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~-~~~~~~~~---------- 224 (265)
T cd06631 156 GLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAA-MFYIGAHR---------- 224 (265)
T ss_pred cccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHH-HHHhhhcc----------
Confidence 11 1112245688899999999988899999999999999999999999975321111 00000000
Q ss_pred cccccccCCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002721 839 LDARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVE 880 (888)
Q Consensus 839 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 880 (888)
...... ......++.+++.+||+.+|++||++.|+++
T Consensus 225 --~~~~~~---~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~ 261 (265)
T cd06631 225 --GLMPRL---PDSFSAAAIDFVTSCLTRDQHERPSALQLLR 261 (265)
T ss_pred --CCCCCC---CCCCCHHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 000001 1123456788999999999999999999875
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-36 Score=339.70 Aligned_cols=264 Identities=17% Similarity=0.204 Sum_probs=197.7
Q ss_pred HHhcCCcceeeecccceEEEEEeC-CCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCCeeEEE
Q 002721 604 KATMKDSNMIYCGTFSTVYKAVMP-SGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVALLL 682 (888)
Q Consensus 604 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 682 (888)
...|.+.+.||+|+||.||+|... +++.||||.... ..+.+|++++++++|||||++++++..++..++|
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~---------~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv 238 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWY---------ASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLV 238 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEecccc---------cCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEE
Confidence 346889999999999999999954 588999996431 1456899999999999999999999999999999
Q ss_pred EecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccccccccCCC
Q 002721 683 HNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPS 762 (888)
Q Consensus 683 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 762 (888)
||++. ++|.+++..... .+++.+++.|+.||+.||+|||++||+||||||+||+++.++.+||+|||+++.....
T Consensus 239 ~e~~~-~~L~~~l~~~~~----~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~ 313 (461)
T PHA03211 239 LPKYR-SDLYTYLGARLR----PLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGS 313 (461)
T ss_pred EEccC-CCHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceecccc
Confidence 99995 699988875432 5789999999999999999999999999999999999999999999999999876433
Q ss_pred CCcccccccccccceecccccccCCcCccccchhHHHHHHHHHhCCCCCCCCCCC------ccchhhhccccCCC-CCCc
Q 002721 763 KGTASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGE------GVDLVKWVHGAPAR-GETP 835 (888)
Q Consensus 763 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~------~~~~~~~~~~~~~~-~~~~ 835 (888)
..........||..|+|||++.+..++.++|||||||++|||++|..|+...... ..++.+.+...... ....
T Consensus 314 ~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~ 393 (461)
T PHA03211 314 WSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHVDEFP 393 (461)
T ss_pred cccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhccccccCC
Confidence 2222223457999999999999999999999999999999999988766432211 01111111111000 0000
Q ss_pred c----ccc----c-----cccccCCcCcH---HHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002721 836 E----QIL----D-----ARLSTVSFGWR---KEMLTALKVALLCTDSTPAKRPKMKKVVEM 881 (888)
Q Consensus 836 ~----~~~----~-----~~~~~~~~~~~---~~~~~~~~li~~cl~~dP~~RPs~~evl~~ 881 (888)
. .+. . .........+. .....+.+++.+||+.||++|||+.|+++.
T Consensus 394 ~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RPsa~elL~h 455 (461)
T PHA03211 394 QHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRPSAAELLRL 455 (461)
T ss_pred CCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCcCHHHHhhC
Confidence 0 000 0 00000000111 223467789999999999999999999874
|
|
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=337.04 Aligned_cols=268 Identities=17% Similarity=0.192 Sum_probs=201.4
Q ss_pred HHHHHHhcCCcceeeecccceEEEEEeC---CCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeC
Q 002721 600 DAVVKATMKDSNMIYCGTFSTVYKAVMP---SGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYE 676 (888)
Q Consensus 600 ~~~~~~~~~~~~~ig~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~ 676 (888)
..+...+|++.+.||+|+||.||+|... .+..||+|.+.... ...+|++++++++||||+++++++...
T Consensus 87 ~~~~~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~~--------~~~~E~~il~~l~h~~iv~~~~~~~~~ 158 (392)
T PHA03207 87 ASVVRMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGK--------TPGREIDILKTISHRAIINLIHAYRWK 158 (392)
T ss_pred chhccCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEeccccc--------cHHHHHHHHHhcCCCCccceeeeEeeC
Confidence 3455678999999999999999999743 46789999886421 346899999999999999999999999
Q ss_pred CeeEEEEecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccccc
Q 002721 677 DVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEIS 756 (888)
Q Consensus 677 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a 756 (888)
...|+|||++. ++|.+++.... .+++.+++.++.||+.||+|||++||+||||||+||+++.++.+||+|||++
T Consensus 159 ~~~~lv~e~~~-~~l~~~l~~~~-----~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~~~~~~~l~DfG~a 232 (392)
T PHA03207 159 STVCMVMPKYK-CDLFTYVDRSG-----PLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAA 232 (392)
T ss_pred CEEEEEehhcC-CCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEccCccc
Confidence 99999999996 58988884432 5788999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCCcccccccccccceecccccccCCcCccccchhHHHHHHHHHhCCCCCCCCCCCcc--chhhhccc---cCCC
Q 002721 757 KLLDPSKGTASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGV--DLVKWVHG---APAR 831 (888)
Q Consensus 757 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~--~~~~~~~~---~~~~ 831 (888)
................||+.|+|||++.+..++.++||||+||++|||++|+.||........ .+...... .+..
T Consensus 233 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~ 312 (392)
T PHA03207 233 CKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLE 312 (392)
T ss_pred cccCcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccc
Confidence 876544333223356799999999999999999999999999999999999999976433211 11111000 0000
Q ss_pred -CC-Ccccc---c---cccccc-C--Cc--CcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002721 832 -GE-TPEQI---L---DARLST-V--SF--GWRKEMLTALKVALLCTDSTPAKRPKMKKVVEM 881 (888)
Q Consensus 832 -~~-~~~~~---~---~~~~~~-~--~~--~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~ 881 (888)
.. ....+ . ...... . +. .......++.+++.+|+..||++|||+.|++..
T Consensus 313 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rpsa~e~l~~ 375 (392)
T PHA03207 313 FPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRPSAQDILSL 375 (392)
T ss_pred cCCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCCCHHHHhhC
Confidence 00 00000 0 000000 0 00 000123456789999999999999999999864
|
|
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-36 Score=317.72 Aligned_cols=250 Identities=24% Similarity=0.339 Sum_probs=199.0
Q ss_pred ceeeecccceEEEEEeCC--C--cEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCCeeEEEEecC
Q 002721 611 NMIYCGTFSTVYKAVMPS--G--LILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVALLLHNYL 686 (888)
Q Consensus 611 ~~ig~G~~g~Vy~~~~~~--~--~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~ 686 (888)
+.||+|++|.||+|.+.+ + ..||+|.+...... ...+.+.+|++++++++||||+++++++.. ...++||||+
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~ 77 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS--DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELA 77 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH--HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEec
Confidence 468999999999998533 3 36999999755443 445689999999999999999999999988 8899999999
Q ss_pred CCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccccccccCCCCCcc
Q 002721 687 PNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSKGTA 766 (888)
Q Consensus 687 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 766 (888)
++++|.+++..... ..+++..+..++.|++.||+|||++|++||||||+||+++.++.+|++|||.+..........
T Consensus 78 ~~~~L~~~l~~~~~---~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~ 154 (257)
T cd05040 78 PLGSLLDRLRKDAL---GHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHY 154 (257)
T ss_pred CCCcHHHHHHhccc---ccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCEEEeccccccccccccccce
Confidence 99999999987543 257899999999999999999999999999999999999999999999999998765432211
Q ss_pred -cccccccccceecccccccCCcCccccchhHHHHHHHHHh-CCCCCCCCCCCccchhhhccccCCCCCCcccccccccc
Q 002721 767 -SISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILT-TRLPVEEDFGEGVDLVKWVHGAPARGETPEQILDARLS 844 (888)
Q Consensus 767 -~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 844 (888)
......++..|+|||++.+..++.++|||||||++|||++ |+.||....... ......... ...
T Consensus 155 ~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~--~~~~~~~~~---~~~--------- 220 (257)
T cd05040 155 VMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQ--ILKKIDKEG---ERL--------- 220 (257)
T ss_pred ecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHH--HHHHHHhcC---CcC---------
Confidence 1123456788999999988899999999999999999999 999996432221 111111000 000
Q ss_pred cCCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 002721 845 TVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEMLQ 883 (888)
Q Consensus 845 ~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~ 883 (888)
. .....+..+.+++.+||+.+|++||++.|+++.|.
T Consensus 221 ~---~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~~l~ 256 (257)
T cd05040 221 E---RPEACPQDIYNVMLQCWAHNPADRPTFAALREFLP 256 (257)
T ss_pred C---CCccCCHHHHHHHHHHCCCCcccCCCHHHHHHHhc
Confidence 0 01122356788999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=318.94 Aligned_cols=253 Identities=19% Similarity=0.249 Sum_probs=199.2
Q ss_pred HHhcCCcceeeecccceEEEEEe-CCCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCCeeEEE
Q 002721 604 KATMKDSNMIYCGTFSTVYKAVM-PSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVALLL 682 (888)
Q Consensus 604 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 682 (888)
.++|++.+.||+|+||.||+|+. .+++.||+|.++..... ....+.+|+.+++.++||||+++++++..++..|+|
T Consensus 8 ~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv 84 (267)
T cd06645 8 QEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGE---DFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWIC 84 (267)
T ss_pred HHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCchh---HHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEE
Confidence 45788889999999999999995 46899999998754322 234678899999999999999999999999999999
Q ss_pred EecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccccccccCCC
Q 002721 683 HNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPS 762 (888)
Q Consensus 683 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 762 (888)
|||+++++|.+++.... .+++.++..++.|++.|++|||+.|++|+||||+||+++.++.+||+|||.+......
T Consensus 85 ~e~~~~~~L~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~ 159 (267)
T cd06645 85 MEFCGGGSLQDIYHVTG-----PLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITAT 159 (267)
T ss_pred EeccCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEECcceeeeEccCc
Confidence 99999999999987643 4678999999999999999999999999999999999999999999999998765432
Q ss_pred CCcccccccccccceecccccc---cCCcCccccchhHHHHHHHHHhCCCCCCCCCCCccchhhhccccCCCCCCccccc
Q 002721 763 KGTASISAVAGSFGYIPPEYAY---TMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQIL 839 (888)
Q Consensus 763 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 839 (888)
. .......|+..|+|||++. ...++.++||||+||++|+|++|+.||........ ......... ..
T Consensus 160 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~-~~~~~~~~~----~~---- 228 (267)
T cd06645 160 I--AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRA-LFLMTKSNF----QP---- 228 (267)
T ss_pred c--cccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhh-HHhhhccCC----CC----
Confidence 2 1123456899999999874 45688999999999999999999999865322111 000000000 00
Q ss_pred ccccccCCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002721 840 DARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVE 880 (888)
Q Consensus 840 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 880 (888)
+.... .......+.+++.+|++.+|++||+++++++
T Consensus 229 -~~~~~----~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~ 264 (267)
T cd06645 229 -PKLKD----KMKWSNSFHHFVKMALTKNPKKRPTAEKLLQ 264 (267)
T ss_pred -Ccccc----cCCCCHHHHHHHHHHccCCchhCcCHHHHhc
Confidence 00000 0012345678999999999999999999875
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=333.52 Aligned_cols=257 Identities=21% Similarity=0.351 Sum_probs=209.7
Q ss_pred hcCCcceeeecccceEEEEEe-CCC----cEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCCeeE
Q 002721 606 TMKDSNMIYCGTFSTVYKAVM-PSG----LILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVAL 680 (888)
Q Consensus 606 ~~~~~~~ig~G~~g~Vy~~~~-~~~----~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 680 (888)
..+..++||+|+||+||+|.+ +.| -+||+|++..... .+...++..|+-+|.+++|||+++++|++.... ..
T Consensus 697 elkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~--~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~q 773 (1177)
T KOG1025|consen 697 ELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTS--PKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQ 773 (1177)
T ss_pred hhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCC--chhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HH
Confidence 455678999999999999983 443 5789998874432 233458999999999999999999999998776 88
Q ss_pred EEEecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccccccccC
Q 002721 681 LLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLD 760 (888)
Q Consensus 681 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~~ 760 (888)
+|++|++.|+|.++++..+. .+-.+..+.|..|||+|+.|||++++|||||..+||||..-..+|+.|||+++...
T Consensus 774 lvtq~mP~G~LlDyvr~hr~----~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~ 849 (1177)
T KOG1025|consen 774 LVTQLMPLGCLLDYVREHRD----NIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLA 849 (1177)
T ss_pred HHHHhcccchHHHHHHHhhc----cccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheeecCCCeEEEEecchhhccC
Confidence 99999999999999998654 46678899999999999999999999999999999999999999999999999988
Q ss_pred CCCCcccccccccccceecccccccCCcCccccchhHHHHHHHHHh-CCCCCCCCCCCccchhhhccccCCCCCCccccc
Q 002721 761 PSKGTASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILT-TRLPVEEDFGEGVDLVKWVHGAPARGETPEQIL 839 (888)
Q Consensus 761 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 839 (888)
.+..........-.+.|||=|.+....|+.++|||||||++||++| |..||.....++. +.-+-
T Consensus 850 ~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI---------------~dlle 914 (1177)
T KOG1025|consen 850 PDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEI---------------PDLLE 914 (1177)
T ss_pred cccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHh---------------hHHHh
Confidence 7665544444455678999999999999999999999999999999 9999976533211 11010
Q ss_pred ccccccCCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhhh
Q 002721 840 DARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEMLQEIKQ 887 (888)
Q Consensus 840 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~i~~ 887 (888)
++.. -..+.....++..+|.+||..|++.||+++++...+.++.+
T Consensus 915 ~geR---LsqPpiCtiDVy~~mvkCwmid~~~rp~fkel~~~fs~~ar 959 (1177)
T KOG1025|consen 915 KGER---LSQPPICTIDVYMVMVKCWMIDADSRPTFKELAEEFSRMAR 959 (1177)
T ss_pred cccc---CCCCCCccHHHHHHHHHHhccCcccCccHHHHHHHHHHHhc
Confidence 1100 11223345678889999999999999999999999998754
|
|
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-36 Score=334.11 Aligned_cols=266 Identities=15% Similarity=0.155 Sum_probs=198.2
Q ss_pred HHHhcCCcceeeecccceEEEEEe-CCCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeC-----
Q 002721 603 VKATMKDSNMIYCGTFSTVYKAVM-PSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYE----- 676 (888)
Q Consensus 603 ~~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~----- 676 (888)
..++|+..+.||+|+||.||+|.. ..++.||||++..... .......+.+|+.+++.++||||+++++++...
T Consensus 22 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~ 100 (364)
T cd07875 22 VLKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEE 100 (364)
T ss_pred hhcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCcccc-CchhHHHHHHHHHHHHhcCCCCccccceeecccccccc
Confidence 356899999999999999999995 4689999999874332 222344788999999999999999999987643
Q ss_pred -CeeEEEEecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEecccc
Q 002721 677 -DVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEI 755 (888)
Q Consensus 677 -~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~ 755 (888)
...|+||||+++ ++.+++.. .+++..+..++.|++.||+|||++||+||||||+||+++.++.+||+|||+
T Consensus 101 ~~~~~lv~e~~~~-~l~~~~~~-------~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~ 172 (364)
T cd07875 101 FQDVYIVMELMDA-NLCQVIQM-------ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGL 172 (364)
T ss_pred cCeEEEEEeCCCC-CHHHHHHh-------cCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHHEEECCCCcEEEEeCCC
Confidence 357999999975 78777753 357788999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCcccccccccccceecccccccCCcCccccchhHHHHHHHHHhCCCCCCCCCCCccchhhhcc---------
Q 002721 756 SKLLDPSKGTASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVH--------- 826 (888)
Q Consensus 756 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~--------- 826 (888)
++...... ......+|..|+|||++.+..++.++|||||||++|||++|+.||....... .......
T Consensus 173 a~~~~~~~---~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~ 248 (364)
T cd07875 173 ARTAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHID-QWNKVIEQLGTPCPEF 248 (364)
T ss_pred ccccCCCC---cccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHhcCCCCHHH
Confidence 98754322 1234568999999999999999999999999999999999999997532211 0000000
Q ss_pred -------------ccCCCC-CCccccccccc-ccCCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002721 827 -------------GAPARG-ETPEQILDARL-STVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEM 881 (888)
Q Consensus 827 -------------~~~~~~-~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~ 881 (888)
..+... ...+....... ............++.+++.+|++.||++|||+.|+++.
T Consensus 249 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~t~~e~L~h 318 (364)
T cd07875 249 MKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRISVDEALQH 318 (364)
T ss_pred HHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCCCHHHHhcC
Confidence 000000 00000000000 00000111123567899999999999999999999863
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-36 Score=317.46 Aligned_cols=253 Identities=23% Similarity=0.294 Sum_probs=195.0
Q ss_pred ceeeecccceEEEEEeC-CCc--EEEEEEeeccChhhhHHHHHHHHHHHHHhcc-CCCceeeeeeEEEeCCeeEEEEecC
Q 002721 611 NMIYCGTFSTVYKAVMP-SGL--ILSVKRLKSMDRTIIHHQNKMIRELEKLSKL-CHDNLVRPIGFVIYEDVALLLHNYL 686 (888)
Q Consensus 611 ~~ig~G~~g~Vy~~~~~-~~~--~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~lv~e~~ 686 (888)
+.||+|+||.||+|+.. ++. .+|+|.++.... ....+.+.+|++++.++ +||||+++++++...+..|+||||+
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~ 78 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYAS--KDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYA 78 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEccccCC--HHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeC
Confidence 46899999999999964 343 568888764322 12334788999999999 7999999999999999999999999
Q ss_pred CCCCHHHHhhccCCC-----------CCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEecccc
Q 002721 687 PNGTLAQLLHESTKQ-----------PDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEI 755 (888)
Q Consensus 687 ~~g~L~~~l~~~~~~-----------~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~ 755 (888)
++|+|.+++...... ....+++.++..++.|++.|++|||++|++||||||+||++++++.+|++|||+
T Consensus 79 ~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~dfgl 158 (270)
T cd05047 79 PHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGL 158 (270)
T ss_pred CCCcHHHHHHhccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECCCCC
Confidence 999999999764321 112478899999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCcccccccccccceecccccccCCcCccccchhHHHHHHHHHh-CCCCCCCCCCCccchhhhccccCCCCCC
Q 002721 756 SKLLDPSKGTASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILT-TRLPVEEDFGEGVDLVKWVHGAPARGET 834 (888)
Q Consensus 756 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~ 834 (888)
+....... .......+..|+|||++.+..++.++||||||+++|||++ |..||...... +..+..... ..
T Consensus 159 ~~~~~~~~---~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~--~~~~~~~~~----~~ 229 (270)
T cd05047 159 SRGQEVYV---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCA--ELYEKLPQG----YR 229 (270)
T ss_pred ccccchhh---hccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHH--HHHHHHhCC----CC
Confidence 86422111 1111233567999999988889999999999999999997 99999653221 111111000 00
Q ss_pred cccccccccccCCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhh
Q 002721 835 PEQILDARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEMLQEIK 886 (888)
Q Consensus 835 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~i~ 886 (888)
.. .......++.+++.+||+.||.+|||+.|+++.|+++.
T Consensus 230 ~~------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~~~~ 269 (270)
T cd05047 230 LE------------KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRML 269 (270)
T ss_pred CC------------CCCcCCHHHHHHHHHHcccChhhCCCHHHHHHHHHHhh
Confidence 00 01112346779999999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-36 Score=319.10 Aligned_cols=251 Identities=20% Similarity=0.302 Sum_probs=196.7
Q ss_pred HHhcCCcceeeecccceEEEEEe-CCCcEEEEEEeeccChhhhHHHHHHHHHHHHHhcc-CCCceeeeeeEEEeC-----
Q 002721 604 KATMKDSNMIYCGTFSTVYKAVM-PSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKL-CHDNLVRPIGFVIYE----- 676 (888)
Q Consensus 604 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~----- 676 (888)
.+.|+..+.||+|+||.||+|.. .+++.||+|++...... ...+.+|+.+++++ +||||+++++++...
T Consensus 5 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~~~----~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 80 (272)
T cd06637 5 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTGDE----EEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGM 80 (272)
T ss_pred hhhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCCcc----HHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCC
Confidence 56788899999999999999995 46899999998744321 23678899999998 699999999998753
Q ss_pred -CeeEEEEecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEecccc
Q 002721 677 -DVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEI 755 (888)
Q Consensus 677 -~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~ 755 (888)
...|+||||+++++|.+++...... .+++..+..++.|++.|++|||+++|+||||||+||++++++.++|+|||+
T Consensus 81 ~~~~~iv~e~~~~~~L~~~l~~~~~~---~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~ 157 (272)
T cd06637 81 DDQLWLVMEFCGAGSVTDLIKNTKGN---TLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGV 157 (272)
T ss_pred CcEEEEEEEcCCCCcHHHHHHhccCC---CCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHEEECCCCCEEEccCCC
Confidence 4689999999999999999864322 578899999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCcccccccccccceecccccc-----cCCcCccccchhHHHHHHHHHhCCCCCCCCCCCccchhhhccccCC
Q 002721 756 SKLLDPSKGTASISAVAGSFGYIPPEYAY-----TMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPA 830 (888)
Q Consensus 756 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~ 830 (888)
+........ ......|+..|+|||++. +..++.++||||+||++|||++|+.||........... . ..
T Consensus 158 ~~~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~~~~~~~~--~---~~ 230 (272)
T cd06637 158 SAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHPMRALFL--I---PR 230 (272)
T ss_pred ceecccccc--cCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccCHHHHHHH--H---hc
Confidence 886543221 123456889999999876 34588899999999999999999999965321111000 0 00
Q ss_pred CCCCcccccccccccCCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002721 831 RGETPEQILDARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVE 880 (888)
Q Consensus 831 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 880 (888)
. ... .. ........+.+++.+||..||.+|||+.|+++
T Consensus 231 ~--~~~-----~~-----~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 268 (272)
T cd06637 231 N--PAP-----RL-----KSKKWSKKFQSFIESCLVKNHSQRPTTEQLMK 268 (272)
T ss_pred C--CCC-----CC-----CCCCcCHHHHHHHHHHcCCChhhCCCHHHHhh
Confidence 0 000 00 01122346788999999999999999999975
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-36 Score=315.83 Aligned_cols=251 Identities=18% Similarity=0.325 Sum_probs=200.7
Q ss_pred HhcCCcceeeecccceEEEEEeCCCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCCeeEEEEe
Q 002721 605 ATMKDSNMIYCGTFSTVYKAVMPSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVALLLHN 684 (888)
Q Consensus 605 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 684 (888)
.+|++.+.||+|+||.||+|...++..+|+|.++..... ...+.+|++++++++||+|+++++++......++|||
T Consensus 4 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~k~~~~~~~~----~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 79 (256)
T cd05112 4 SELTLVQEIGSGQFGLVWLGYWLEKRKVAIKTIREGAMS----EEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFE 79 (256)
T ss_pred hHeEEEeeecCcccceEEEEEEeCCCeEEEEECCCCCCC----HHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEE
Confidence 468888999999999999999777889999988744332 2368899999999999999999999999999999999
Q ss_pred cCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccccccccCCCCC
Q 002721 685 YLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSKG 764 (888)
Q Consensus 685 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 764 (888)
|+++++|.+++..... .++++.+..++.|++.|++|||+.+++||||||+||+++.++.+|++|||.+........
T Consensus 80 ~~~~~~L~~~~~~~~~----~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~ 155 (256)
T cd05112 80 FMEHGCLSDYLRAQRG----KFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQY 155 (256)
T ss_pred cCCCCcHHHHHHhCcc----CCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEcCCCeEEECCCcceeecccCcc
Confidence 9999999999875432 467889999999999999999999999999999999999999999999999876543211
Q ss_pred cccccccccccceecccccccCCcCccccchhHHHHHHHHHh-CCCCCCCCCCCccchhhhccccCCCCCCccccccccc
Q 002721 765 TASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILT-TRLPVEEDFGEGVDLVKWVHGAPARGETPEQILDARL 843 (888)
Q Consensus 765 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 843 (888)
.......++..|+|||.+.+..++.++||||+|+++|||++ |+.||...... ...+..... . ....
T Consensus 156 -~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~--~~~~~~~~~----~---~~~~--- 222 (256)
T cd05112 156 -TSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNS--EVVETINAG----F---RLYK--- 222 (256)
T ss_pred -cccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHH--HHHHHHhCC----C---CCCC---
Confidence 11122335678999999988889999999999999999998 99999753221 111111000 0 0000
Q ss_pred ccCCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 002721 844 STVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEML 882 (888)
Q Consensus 844 ~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L 882 (888)
.......+.+++.+||+.+|++|||+.|+++.|
T Consensus 223 ------~~~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~l 255 (256)
T cd05112 223 ------PRLASQSVYELMQHCWKERPEDRPSFSLLLHQL 255 (256)
T ss_pred ------CCCCCHHHHHHHHHHcccChhhCCCHHHHHHhh
Confidence 011235688899999999999999999999887
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=319.35 Aligned_cols=254 Identities=20% Similarity=0.346 Sum_probs=197.8
Q ss_pred ceeeecccceEEEEEeCC-------CcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCCeeEEEE
Q 002721 611 NMIYCGTFSTVYKAVMPS-------GLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVALLLH 683 (888)
Q Consensus 611 ~~ig~G~~g~Vy~~~~~~-------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 683 (888)
+.||+|+||.||+|+..+ ++.||+|.+..... ......+.+|+++++.++||||+++++++...+..++||
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~ 78 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGAT--DQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIM 78 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhcccc--hhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEE
Confidence 468999999999998532 26799998864321 223447889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhhccCCC--CCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCC-----CceEeccccc
Q 002721 684 NYLPNGTLAQLLHESTKQ--PDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADF-----KPLLGEIEIS 756 (888)
Q Consensus 684 e~~~~g~L~~~l~~~~~~--~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~-----~~kl~Dfg~a 756 (888)
||+++++|.+++...... ....+++.++..++.|++.||+|||+.+++|+||||+||+++.++ .++++|||++
T Consensus 79 e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~ 158 (269)
T cd05044 79 ELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLA 158 (269)
T ss_pred eccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCcccc
Confidence 999999999999754321 222478899999999999999999999999999999999999877 8999999998
Q ss_pred cccCCCCCcccccccccccceecccccccCCcCccccchhHHHHHHHHHh-CCCCCCCCCCCccchhhhccccCCCCCCc
Q 002721 757 KLLDPSKGTASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILT-TRLPVEEDFGEGVDLVKWVHGAPARGETP 835 (888)
Q Consensus 757 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 835 (888)
................++..|+|||++.+..++.++|||||||++|||++ |+.||...... +........ .
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~~~--~~~~~~~~~----~-- 230 (269)
T cd05044 159 RDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQ--EVLQHVTAG----G-- 230 (269)
T ss_pred cccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccCHH--HHHHHHhcC----C--
Confidence 76543222112223345678999999999999999999999999999998 99999643221 111111100 0
Q ss_pred ccccccccccCCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 002721 836 EQILDARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEMLQE 884 (888)
Q Consensus 836 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~ 884 (888)
.. ......+..+.+++.+||..+|++||+++++++.|++
T Consensus 231 ------~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~l~~ 269 (269)
T cd05044 231 ------RL----QKPENCPDKIYQLMTNCWAQDPSERPTFDRIQEILQN 269 (269)
T ss_pred ------cc----CCcccchHHHHHHHHHHcCCCcccCCCHHHHHHHHhC
Confidence 00 0112234567899999999999999999999999863
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=320.61 Aligned_cols=250 Identities=19% Similarity=0.267 Sum_probs=201.7
Q ss_pred HHhcCCcceeeecccceEEEEEe-CCCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCCeeEEE
Q 002721 604 KATMKDSNMIYCGTFSTVYKAVM-PSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVALLL 682 (888)
Q Consensus 604 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 682 (888)
..+|+..+.||+|+||.||+|.. .+++.||+|.+...... ..+.+.+|+.+++.++||||+++++++..++..|+|
T Consensus 18 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~---~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 94 (297)
T cd06656 18 KKKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQP---KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVV 94 (297)
T ss_pred hhhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCccc---hHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEe
Confidence 36899999999999999999995 57999999998744332 234688999999999999999999999999999999
Q ss_pred EecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccccccccCCC
Q 002721 683 HNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPS 762 (888)
Q Consensus 683 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 762 (888)
|||+++++|.+++.+. .+++.++..++.|++.||.|||+.|++||||||+||+++.++.++++|||.+......
T Consensus 95 ~e~~~~~~L~~~~~~~------~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~ 168 (297)
T cd06656 95 MEYLAGGSLTDVVTET------CMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 168 (297)
T ss_pred ecccCCCCHHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccCC
Confidence 9999999999998653 4577899999999999999999999999999999999999999999999998875433
Q ss_pred CCcccccccccccceecccccccCCcCccccchhHHHHHHHHHhCCCCCCCCCCCccchhhhccccCCCCCCcccccccc
Q 002721 763 KGTASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQILDAR 842 (888)
Q Consensus 763 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 842 (888)
... .....+++.|+|||...+..++.++||||+|+++|+|++|+.||.................+ .
T Consensus 169 ~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~~~------------~ 234 (297)
T cd06656 169 QSK--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTP------------E 234 (297)
T ss_pred ccC--cCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCCCC------------C
Confidence 211 22346788999999998888999999999999999999999999653221110000000000 0
Q ss_pred cccCCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002721 843 LSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVE 880 (888)
Q Consensus 843 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 880 (888)
..........+.+++.+||+.+|++||++.++++
T Consensus 235 ----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (297)
T cd06656 235 ----LQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQ 268 (297)
T ss_pred ----CCCccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0011223355678999999999999999999987
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-36 Score=319.34 Aligned_cols=239 Identities=17% Similarity=0.270 Sum_probs=185.4
Q ss_pred eeeecccceEEEEEeCC-------------------------CcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCce
Q 002721 612 MIYCGTFSTVYKAVMPS-------------------------GLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNL 666 (888)
Q Consensus 612 ~ig~G~~g~Vy~~~~~~-------------------------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnI 666 (888)
.||+|+||.||+|.... ...||+|++..... .....+.+|+.++++++||||
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~---~~~~~~~~~~~~~~~l~h~ni 78 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSHR---DIALAFFETASLMSQVSHIHL 78 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHHH---HHHHHHHHHHHHHhcCCCCCe
Confidence 69999999999997321 24588888864322 233478889999999999999
Q ss_pred eeeeeEEEeCCeeEEEEecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCC
Q 002721 667 VRPIGFVIYEDVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADF 746 (888)
Q Consensus 667 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~ 746 (888)
+++++++..+...++||||+++|+|..++..... .+++..+..++.||++||+|||++||+||||||+||+++.++
T Consensus 79 v~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~----~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~Nill~~~~ 154 (274)
T cd05076 79 AFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKG----RVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLARLG 154 (274)
T ss_pred eeEEEEEEeCCceEEEEecCCCCcHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHcCCccCCCCCcccEEEeccC
Confidence 9999999999999999999999999999875432 567889999999999999999999999999999999997643
Q ss_pred -------CceEeccccccccCCCCCcccccccccccceeccccccc-CCcCccccchhHHHHHHHHH-hCCCCCCCCCCC
Q 002721 747 -------KPLLGEIEISKLLDPSKGTASISAVAGSFGYIPPEYAYT-MQVTAPGNVYSYGVVLLEIL-TTRLPVEEDFGE 817 (888)
Q Consensus 747 -------~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~ell-tg~~P~~~~~~~ 817 (888)
.+|++|||.+...... ....++..|+|||.+.+ ..++.++||||||+++||++ +|+.||......
T Consensus 155 ~~~~~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~ 228 (274)
T cd05076 155 LAEGTSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEICFDGEVPLKERTPS 228 (274)
T ss_pred cccCccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCccccChH
Confidence 3799999987653221 12346788999998865 56899999999999999985 799999754322
Q ss_pred ccchhhhccccCCCCCCcccccccccccCCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 002721 818 GVDLVKWVHGAPARGETPEQILDARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEMLQ 883 (888)
Q Consensus 818 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~ 883 (888)
.. ..... .... .+ ......+.+++.+||+.+|++|||+.++++.|+
T Consensus 229 ~~--~~~~~--------------~~~~-~~---~~~~~~~~~li~~cl~~~p~~Rps~~~il~~L~ 274 (274)
T cd05076 229 EK--ERFYE--------------KKHR-LP---EPSCKELATLISQCLTYEPTQRPSFRTILRDLT 274 (274)
T ss_pred HH--HHHHH--------------hccC-CC---CCCChHHHHHHHHHcccChhhCcCHHHHHHhhC
Confidence 11 11100 0000 00 011245788999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-36 Score=324.03 Aligned_cols=267 Identities=17% Similarity=0.209 Sum_probs=197.7
Q ss_pred HhcCCcceeeecccceEEEEEeC-CCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCCeeEEEE
Q 002721 605 ATMKDSNMIYCGTFSTVYKAVMP-SGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVALLLH 683 (888)
Q Consensus 605 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 683 (888)
++|...+.||+|+||.||+|+.. +++.||+|.++...... ....+.+|++++++++||||+++++++..++..++||
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~ 83 (301)
T cd07873 6 ETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHEEG--APCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVF 83 (301)
T ss_pred cceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccccC--chhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEE
Confidence 47889999999999999999854 68999999987433221 2235778999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccccccccCCCC
Q 002721 684 NYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSK 763 (888)
Q Consensus 684 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 763 (888)
||++ ++|.+++..... .+++..+..++.||++||+|||+.||+||||||+||+++.++.+|++|||++.......
T Consensus 84 e~~~-~~l~~~l~~~~~----~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~ 158 (301)
T cd07873 84 EYLD-KDLKQYLDDCGN----SINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPT 158 (301)
T ss_pred eccc-cCHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCC
Confidence 9997 599998876432 46788999999999999999999999999999999999999999999999987654322
Q ss_pred CcccccccccccceecccccccC-CcCccccchhHHHHHHHHHhCCCCCCCCCCCcc-chhhhccccCCCCCCcc-----
Q 002721 764 GTASISAVAGSFGYIPPEYAYTM-QVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGV-DLVKWVHGAPARGETPE----- 836 (888)
Q Consensus 764 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~-~~~~~~~~~~~~~~~~~----- 836 (888)
. ......+++.|+|||++.+. .++.++||||+||++|||++|+.||........ .........+.......
T Consensus 159 ~--~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (301)
T cd07873 159 K--TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNE 236 (301)
T ss_pred C--cccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccc
Confidence 1 12234578899999987654 578899999999999999999999975432110 00000000000000000
Q ss_pred cccccccccCCc-----CcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002721 837 QILDARLSTVSF-----GWRKEMLTALKVALLCTDSTPAKRPKMKKVVE 880 (888)
Q Consensus 837 ~~~~~~~~~~~~-----~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 880 (888)
............ ........+.+++.+|++.||.+|||++|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~eil~ 285 (301)
T cd07873 237 EFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEAMK 285 (301)
T ss_pred cccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 000000000000 00112345778999999999999999999986
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-36 Score=320.70 Aligned_cols=268 Identities=19% Similarity=0.227 Sum_probs=198.0
Q ss_pred hcCCcceeeecccceEEEEEeC-CCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCCeeEEEEe
Q 002721 606 TMKDSNMIYCGTFSTVYKAVMP-SGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVALLLHN 684 (888)
Q Consensus 606 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 684 (888)
+|+..+.||+|++|.||+|+.. +++.||+|.++..... ....+.+.+|+.++++++||||+++++++..++..|+|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESEE-EGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFE 79 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEecccccc-CCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEe
Confidence 4778899999999999999954 6899999998643221 2223467889999999999999999999999999999999
Q ss_pred cCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccccccccCCCCC
Q 002721 685 YLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSKG 764 (888)
Q Consensus 685 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 764 (888)
|++ ++|.+++...... ..+++..+..++.|+++||+|||++|++||||||+||+++.++.+||+|||++........
T Consensus 80 ~~~-~~l~~~~~~~~~~--~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~ 156 (285)
T cd07861 80 FLS-MDLKKYLDSLPKG--QYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR 156 (285)
T ss_pred cCC-CCHHHHHhcCCCC--CcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCcc
Confidence 997 5898888754321 2578899999999999999999999999999999999999999999999999876543221
Q ss_pred cccccccccccceecccccccC-CcCccccchhHHHHHHHHHhCCCCCCCCCCCccchhhhcccc--CCCCCC--cccc-
Q 002721 765 TASISAVAGSFGYIPPEYAYTM-QVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGA--PARGET--PEQI- 838 (888)
Q Consensus 765 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~--~~~~~~--~~~~- 838 (888)
......+++.|+|||++.+. .++.++||||+||++|||+||+.||........ ........ +..... ....
T Consensus 157 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 233 (285)
T cd07861 157 --VYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQ-LFRIFRILGTPTEDVWPGVTSLP 233 (285)
T ss_pred --cccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHH-HHHHHHHhCCCChhhhhcchhhH
Confidence 12234578899999987654 478899999999999999999999975432111 00000000 000000 0000
Q ss_pred -cccccccC-----CcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002721 839 -LDARLSTV-----SFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVE 880 (888)
Q Consensus 839 -~~~~~~~~-----~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 880 (888)
........ .........++.+++.+||+.||++|||+.++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ll~ 281 (285)
T cd07861 234 DYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALN 281 (285)
T ss_pred HHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHHHhc
Confidence 00000000 0001113456779999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=314.92 Aligned_cols=250 Identities=18% Similarity=0.230 Sum_probs=202.8
Q ss_pred HHhcCCcceeeecccceEEEEEeC-CCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCCeeEEE
Q 002721 604 KATMKDSNMIYCGTFSTVYKAVMP-SGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVALLL 682 (888)
Q Consensus 604 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 682 (888)
.+.|+..+.||.|+||.||+|... +++.||+|.++..... .....+.+|+++++++.||||+++++++..+...|+|
T Consensus 3 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (277)
T cd06640 3 EELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEEAE--DEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWII 80 (277)
T ss_pred HHhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccccH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEE
Confidence 356888899999999999999954 6899999998744322 2345789999999999999999999999999999999
Q ss_pred EecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccccccccCCC
Q 002721 683 HNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPS 762 (888)
Q Consensus 683 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 762 (888)
|||+++++|.+++... .+++.++..++.|++.||+|+|+.+++|+||+|+||+++.++.++++|||.+......
T Consensus 81 ~e~~~~~~L~~~i~~~------~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~ 154 (277)
T cd06640 81 MEYLGGGSALDLLRAG------PFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDT 154 (277)
T ss_pred EecCCCCcHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCC
Confidence 9999999999998753 4677889999999999999999999999999999999999999999999999776432
Q ss_pred CCcccccccccccceecccccccCCcCccccchhHHHHHHHHHhCCCCCCCCCCCccchhhhccccCCCCCCcccccccc
Q 002721 763 KGTASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQILDAR 842 (888)
Q Consensus 763 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 842 (888)
.. ......++..|+|||++.+..++.++|+||||+++|||++|+.||........ ... +....
T Consensus 155 ~~--~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~--~~~-------------~~~~~ 217 (277)
T cd06640 155 QI--KRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRV--LFL-------------IPKNN 217 (277)
T ss_pred cc--ccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhH--hhh-------------hhcCC
Confidence 21 12234678899999999888899999999999999999999999975432211 000 00000
Q ss_pred cccCCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002721 843 LSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEM 881 (888)
Q Consensus 843 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~ 881 (888)
.+.........+.+++.+||+.+|++||++.+++..
T Consensus 218 ---~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06640 218 ---PPTLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKH 253 (277)
T ss_pred ---CCCCchhhhHHHHHHHHHHcccCcccCcCHHHHHhC
Confidence 011123345678899999999999999999999764
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=313.81 Aligned_cols=249 Identities=18% Similarity=0.267 Sum_probs=202.2
Q ss_pred HhcCCcceeeecccceEEEEEeCC-CcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCCeeEEEE
Q 002721 605 ATMKDSNMIYCGTFSTVYKAVMPS-GLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVALLLH 683 (888)
Q Consensus 605 ~~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 683 (888)
++|+..+.||+|+||.||+|...+ ++.||+|.++.... .+.+.+|++++++++||||+++++++..++..|+++
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-----~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~ 77 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED-----LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVM 77 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH-----HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEE
Confidence 578899999999999999999654 89999999874322 457899999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccccccccCCCC
Q 002721 684 NYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSK 763 (888)
Q Consensus 684 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 763 (888)
||+++++|.+++..... .+++..+..++.|+++||.|||+.|++||||+|+||+++.++.+|++|||.+.......
T Consensus 78 e~~~~~~L~~~l~~~~~----~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~ 153 (256)
T cd06612 78 EYCGAGSVSDIMKITNK----TLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTM 153 (256)
T ss_pred ecCCCCcHHHHHHhCcc----CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccCc
Confidence 99999999999975432 57889999999999999999999999999999999999999999999999998765432
Q ss_pred CcccccccccccceecccccccCCcCccccchhHHHHHHHHHhCCCCCCCCCCCccchhhhccccCCCCCCccccccccc
Q 002721 764 GTASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQILDARL 843 (888)
Q Consensus 764 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 843 (888)
. ......++..|+|||++.+..++.++||||||+++|+|++|+.||......... .. +.....
T Consensus 154 ~--~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~-~~--------------~~~~~~ 216 (256)
T cd06612 154 A--KRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAI-FM--------------IPNKPP 216 (256)
T ss_pred c--ccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhh-hh--------------hccCCC
Confidence 1 122345788999999998889999999999999999999999999753221110 00 000000
Q ss_pred ccCCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002721 844 STVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVE 880 (888)
Q Consensus 844 ~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 880 (888)
............+.+++.+||+.||++|||+.|+++
T Consensus 217 -~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~ 252 (256)
T cd06612 217 -PTLSDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQ 252 (256)
T ss_pred -CCCCchhhcCHHHHHHHHHHHhcChhhCcCHHHHhc
Confidence 000011123356788999999999999999999986
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-35 Score=314.47 Aligned_cols=251 Identities=18% Similarity=0.234 Sum_probs=201.7
Q ss_pred hcCCcceeeecccceEEEEEe-CCCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCCeeEEEEe
Q 002721 606 TMKDSNMIYCGTFSTVYKAVM-PSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVALLLHN 684 (888)
Q Consensus 606 ~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 684 (888)
+|+..+.||+|+||.||+++. .+++.||+|++...... ....+.+.+|++++++++||||+++++++...+..++|||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKMS-PKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMD 79 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhCC-hHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEe
Confidence 478899999999999999994 46899999998743222 2334578999999999999999999999999999999999
Q ss_pred cCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccccccccCCCCC
Q 002721 685 YLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSKG 764 (888)
Q Consensus 685 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 764 (888)
|+++++|.+++...... .+++.++..++.|++.|++|||+.|++|+||+|+||+++.++.++++|||.+........
T Consensus 80 ~~~~~~l~~~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~ 156 (256)
T cd08218 80 YCEGGDLYKKINAQRGV---LFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE 156 (256)
T ss_pred cCCCCcHHHHHHhccCC---CCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchh
Confidence 99999999999764322 467889999999999999999999999999999999999999999999999987643221
Q ss_pred cccccccccccceecccccccCCcCccccchhHHHHHHHHHhCCCCCCCCCCCccchhhhccccCCCCCCcccccccccc
Q 002721 765 TASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQILDARLS 844 (888)
Q Consensus 765 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 844 (888)
......|+..|+|||+..+..++.++|+|||||++|+|++|+.||...... +... .+......
T Consensus 157 --~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~--~~~~-------------~~~~~~~~ 219 (256)
T cd08218 157 --LARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMK--NLVL-------------KIIRGSYP 219 (256)
T ss_pred --hhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHH--HHHH-------------HHhcCCCC
Confidence 122345788999999998888999999999999999999999999643211 1110 00001100
Q ss_pred cCCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002721 845 TVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVE 880 (888)
Q Consensus 845 ~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 880 (888)
. .......++.+++.+||+.+|++||++.||++
T Consensus 220 ~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~ 252 (256)
T cd08218 220 P---VSSHYSYDLRNLVSQLFKRNPRDRPSVNSILE 252 (256)
T ss_pred C---CcccCCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 0 11123456788999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=313.57 Aligned_cols=251 Identities=18% Similarity=0.224 Sum_probs=199.7
Q ss_pred hcCCcceeeecccceEEEEEeC-CCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEe-CCeeEEEE
Q 002721 606 TMKDSNMIYCGTFSTVYKAVMP-SGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIY-EDVALLLH 683 (888)
Q Consensus 606 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~-~~~~~lv~ 683 (888)
+|++.+.||+|++|.||++... +++.||+|.+..... .....+.+.+|++++++++|||++++++.+.. +...|+||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~ 79 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNA-SRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVM 79 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhc-CHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEe
Confidence 4788999999999999999954 578999999874332 22334578899999999999999999998764 44689999
Q ss_pred ecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccccccccCCCC
Q 002721 684 NYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSK 763 (888)
Q Consensus 684 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 763 (888)
||+++++|.+++...... .+++.++..++.|++.|++|||++|++||||||+||+++.++.++|+|||.+.......
T Consensus 80 e~~~~~~l~~~l~~~~~~---~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~ 156 (257)
T cd08223 80 GFCEGGDLYHKLKEQKGK---LLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC 156 (257)
T ss_pred cccCCCcHHHHHHHhcCC---CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEecCCcEEEecccceEEecccC
Confidence 999999999999864322 47889999999999999999999999999999999999999999999999998764322
Q ss_pred CcccccccccccceecccccccCCcCccccchhHHHHHHHHHhCCCCCCCCCCCccchhhhccccCCCCCCccccccccc
Q 002721 764 GTASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQILDARL 843 (888)
Q Consensus 764 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 843 (888)
. ......+++.|+|||+..+..++.++||||+|+++|+|++|+.||........ ..... ....
T Consensus 157 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~-~~~~~--------------~~~~ 219 (257)
T cd08223 157 D--MASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSL-VYRII--------------EGKL 219 (257)
T ss_pred C--ccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHH-HHHHH--------------hcCC
Confidence 1 12345688899999999998999999999999999999999999864321100 00000 0001
Q ss_pred ccCCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002721 844 STVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVE 880 (888)
Q Consensus 844 ~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 880 (888)
.. ........+.+++.+|++.||++||++.++++
T Consensus 220 ~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 253 (257)
T cd08223 220 PP---MPKDYSPELGELIATMLSKRPEKRPSVKSILR 253 (257)
T ss_pred CC---CccccCHHHHHHHHHHhccCcccCCCHHHHhc
Confidence 01 11234456789999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=315.91 Aligned_cols=256 Identities=20% Similarity=0.261 Sum_probs=186.1
Q ss_pred ceeeecccceEEEEEeCCC---cEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCCeeEEEEecCC
Q 002721 611 NMIYCGTFSTVYKAVMPSG---LILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVALLLHNYLP 687 (888)
Q Consensus 611 ~~ig~G~~g~Vy~~~~~~~---~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~ 687 (888)
+.||+|+||.||+|...++ ..+++|.++.... ....+.+.+|+.+++.++||||+++++++......|+||||++
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~ 78 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANAS--SKEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCE 78 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCCC--hHHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCC
Confidence 3699999999999985443 3455666553322 2234589999999999999999999999999999999999999
Q ss_pred CCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccccccccCCCCCccc
Q 002721 688 NGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSKGTAS 767 (888)
Q Consensus 688 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~ 767 (888)
+|+|.+++.+..... ...++..+..++.||+.||+|||+.+++||||||+||+++.++.+|++|||.+...........
T Consensus 79 ~~~L~~~l~~~~~~~-~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~ 157 (268)
T cd05086 79 LGDLKSYLSQEQWHR-RNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIET 157 (268)
T ss_pred CCcHHHHHHhhhccc-ccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcchhhhc
Confidence 999999998653221 1456677889999999999999999999999999999999999999999999864322111111
Q ss_pred ccccccccceeccccccc-------CCcCccccchhHHHHHHHHHh-CCCCCCCCCCCccchhhhccccCCCCCCccccc
Q 002721 768 ISAVAGSFGYIPPEYAYT-------MQVTAPGNVYSYGVVLLEILT-TRLPVEEDFGEGVDLVKWVHGAPARGETPEQIL 839 (888)
Q Consensus 768 ~~~~~gt~~y~aPE~~~~-------~~~~~~~DiwSlG~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 839 (888)
.....++..|+|||++.. ..++.++||||||+++|||++ |..||...... ........... ....
T Consensus 158 ~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~-~~~~~~~~~~~------~~~~ 230 (268)
T cd05086 158 EDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDR-EVLNHVIKDQQ------VKLF 230 (268)
T ss_pred ccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHH-HHHHHHHhhcc------cccC
Confidence 234567889999998743 245789999999999999997 56777543211 11111111100 0111
Q ss_pred ccccccCCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 002721 840 DARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEMLQ 883 (888)
Q Consensus 840 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~ 883 (888)
++... ......+.+++..|| .+|++||+++||++.|.
T Consensus 231 ~~~~~------~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~~l~ 267 (268)
T cd05086 231 KPQLE------LPYSERWYEVLQFCW-LSPEKRATAEEVHRLLT 267 (268)
T ss_pred CCccC------CCCcHHHHHHHHHHh-hCcccCCCHHHHHHHhc
Confidence 11111 112345667888899 57999999999998874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-36 Score=332.98 Aligned_cols=265 Identities=17% Similarity=0.224 Sum_probs=196.1
Q ss_pred HHHhcCCcceeeecccceEEEEEe-CCCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeC-----
Q 002721 603 VKATMKDSNMIYCGTFSTVYKAVM-PSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYE----- 676 (888)
Q Consensus 603 ~~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~----- 676 (888)
..++|+..+.||+|+||.||+|.. .+++.||+|.+...... ....+.+.+|++++++++||||+++++++...
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07878 13 VPERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQS-LIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIEN 91 (343)
T ss_pred hhhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhhh-hHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccc
Confidence 356899999999999999999994 46889999998754322 22344677999999999999999999987643
Q ss_pred -CeeEEEEecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEecccc
Q 002721 677 -DVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEI 755 (888)
Q Consensus 677 -~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~ 755 (888)
...|++||++ +++|.++++.. .+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||+
T Consensus 92 ~~~~~~~~~~~-~~~l~~~~~~~------~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~ 164 (343)
T cd07878 92 FNEVYLVTNLM-GADLNNIVKCQ------KLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGL 164 (343)
T ss_pred cCcEEEEeecC-CCCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhhEEECCCCCEEEcCCcc
Confidence 3568999988 67999887642 478899999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCcccccccccccceeccccccc-CCcCccccchhHHHHHHHHHhCCCCCCCCCCCccchhhhccccCCCC-C
Q 002721 756 SKLLDPSKGTASISAVAGSFGYIPPEYAYT-MQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARG-E 833 (888)
Q Consensus 756 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~-~ 833 (888)
+...... .....||..|+|||++.+ ..++.++||||+||++|+|++|+.||....... .+..+........ .
T Consensus 165 ~~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~ 238 (343)
T cd07878 165 ARQADDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYID-QLKRIMEVVGTPSPE 238 (343)
T ss_pred ceecCCC-----cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHH-HHHHHHHHhCCCCHH
Confidence 9875432 234568999999999876 568999999999999999999999996532110 0111100000000 0
Q ss_pred Cccccc-------ccccccCCcC-----cHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002721 834 TPEQIL-------DARLSTVSFG-----WRKEMLTALKVALLCTDSTPAKRPKMKKVVEM 881 (888)
Q Consensus 834 ~~~~~~-------~~~~~~~~~~-----~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~ 881 (888)
....+. ...+...+.. .....+.+.+++.+|++.||++|||++|+++.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~s~~ell~h 298 (343)
T cd07878 239 VLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRISASEALAH 298 (343)
T ss_pred HHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 000000 0000000000 00122456789999999999999999999853
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-35 Score=316.94 Aligned_cols=260 Identities=19% Similarity=0.281 Sum_probs=200.3
Q ss_pred cCCcceeeecccceEEEEEeC----CCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCC-----
Q 002721 607 MKDSNMIYCGTFSTVYKAVMP----SGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYED----- 677 (888)
Q Consensus 607 ~~~~~~ig~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~----- 677 (888)
|++.+.||+|+||.||+|... +++.||+|+++.... .....+++.+|++++++++||||+++++++...+
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 79 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIF-SSSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRL 79 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEeccccC-ChHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcc
Confidence 567889999999999999843 468999999975432 2233457889999999999999999999886542
Q ss_pred -eeEEEEecCCCCCHHHHhhccCC-CCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEecccc
Q 002721 678 -VALLLHNYLPNGTLAQLLHESTK-QPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEI 755 (888)
Q Consensus 678 -~~~lv~e~~~~g~L~~~l~~~~~-~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~ 755 (888)
..++++||+++|+|.+++..... .....+++..+..++.|++.||+|||++||+||||||+||+++.++.+|++|||.
T Consensus 80 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~nili~~~~~~kl~dfg~ 159 (273)
T cd05074 80 PIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGL 159 (273)
T ss_pred cceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchhhEEEcCCCCEEECcccc
Confidence 34789999999999988754321 1122578889999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCcccccccccccceecccccccCCcCccccchhHHHHHHHHHh-CCCCCCCCCCCccchhhhccccCCCCCC
Q 002721 756 SKLLDPSKGTASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILT-TRLPVEEDFGEGVDLVKWVHGAPARGET 834 (888)
Q Consensus 756 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~ 834 (888)
++...............++..|++||.+.+..++.++||||||+++|||++ |+.||...... +...+......
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~--~~~~~~~~~~~---- 233 (273)
T cd05074 160 SKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENS--EIYNYLIKGNR---- 233 (273)
T ss_pred cccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHH--HHHHHHHcCCc----
Confidence 987643322112223345678999999988889999999999999999999 88988653221 11111111000
Q ss_pred cccccccccccCCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHh
Q 002721 835 PEQILDARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEMLQEI 885 (888)
Q Consensus 835 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~i 885 (888)
.. ........+.+++.+||+.+|++|||+.|+++.|+++
T Consensus 234 --------~~----~~~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~l~~~ 272 (273)
T cd05074 234 --------LK----QPPDCLEDVYELMCQCWSPEPKCRPSFQHLRDQLELI 272 (273)
T ss_pred --------CC----CCCCCCHHHHHHHHHHcCCChhhCcCHHHHHHHHHhh
Confidence 00 0012235688899999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=320.80 Aligned_cols=246 Identities=20% Similarity=0.233 Sum_probs=200.7
Q ss_pred hcCCcceeeecccceEEEEEeC-CCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCCeeEEEEe
Q 002721 606 TMKDSNMIYCGTFSTVYKAVMP-SGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVALLLHN 684 (888)
Q Consensus 606 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 684 (888)
+|+..+.||+|+||.||+|... +++.||+|+++..........+.+.+|++++++++||||+++++++..++..|+|||
T Consensus 2 ~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 81 (290)
T cd05580 2 DFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVME 81 (290)
T ss_pred ceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEe
Confidence 6888999999999999999954 689999999975443334445678899999999999999999999999999999999
Q ss_pred cCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccccccccCCCCC
Q 002721 685 YLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSKG 764 (888)
Q Consensus 685 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 764 (888)
|+++++|.+++.... .+++..+..++.|++.||+|||+.|++||||+|+||+++.++.+||+|||++......
T Consensus 82 ~~~~~~L~~~~~~~~-----~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~-- 154 (290)
T cd05580 82 YVPGGELFSHLRKSG-----RFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR-- 154 (290)
T ss_pred cCCCCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC--
Confidence 999999999997653 5678899999999999999999999999999999999999999999999998876543
Q ss_pred cccccccccccceecccccccCCcCccccchhHHHHHHHHHhCCCCCCCCCCCccchhhhccccCCCCCCcccccccccc
Q 002721 765 TASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQILDARLS 844 (888)
Q Consensus 765 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 844 (888)
.....+++.|+|||.+.+..++.++||||||+++|+|++|+.||...... ...+. +......
T Consensus 155 ---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~--~~~~~-------------~~~~~~~ 216 (290)
T cd05580 155 ---TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPI--QIYEK-------------ILEGKVR 216 (290)
T ss_pred ---CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHH--HHHHH-------------HhcCCcc
Confidence 22346889999999998888899999999999999999999999754311 11110 0000000
Q ss_pred cCCcCcHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 002721 845 TVSFGWRKEMLTALKVALLCTDSTPAKRP-----KMKKVVE 880 (888)
Q Consensus 845 ~~~~~~~~~~~~~~~li~~cl~~dP~~RP-----s~~evl~ 880 (888)
. .......+.+++.+||..||++|| +++|+++
T Consensus 217 -~---~~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~ 253 (290)
T cd05580 217 -F---PSFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKN 253 (290)
T ss_pred -C---CccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHc
Confidence 0 111235677899999999999999 6777653
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-35 Score=323.32 Aligned_cols=257 Identities=18% Similarity=0.181 Sum_probs=200.3
Q ss_pred hcCCcceeeecccceEEEEEeC-CCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCCeeEEEEe
Q 002721 606 TMKDSNMIYCGTFSTVYKAVMP-SGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVALLLHN 684 (888)
Q Consensus 606 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 684 (888)
+|+..+.||+|+||.||+|... +++.||+|.++..........+.+.+|+++++.++||||+++++.+..++..++|||
T Consensus 2 ~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 81 (305)
T cd05609 2 DFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVME 81 (305)
T ss_pred CceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEe
Confidence 5888999999999999999954 588999999876544334445578899999999999999999999999999999999
Q ss_pred cCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccccccccCCCCC
Q 002721 685 YLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSKG 764 (888)
Q Consensus 685 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 764 (888)
|+++++|.+++.... .+++..+..++.|++.||+|||+.|++||||||+||+++.++.+|++|||.++.......
T Consensus 82 ~~~g~~L~~~l~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~ 156 (305)
T cd05609 82 YVEGGDCATLLKNIG-----ALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLT 156 (305)
T ss_pred cCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCcc
Confidence 999999999997643 467888999999999999999999999999999999999999999999999874211100
Q ss_pred -------------cccccccccccceecccccccCCcCccccchhHHHHHHHHHhCCCCCCCCCCCccchhhhccccCCC
Q 002721 765 -------------TASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPAR 831 (888)
Q Consensus 765 -------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~ 831 (888)
........++..|+|||.+.+..++.++|||||||++|||++|..||.+..... ....
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~~~--~~~~------- 227 (305)
T cd05609 157 TNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE--LFGQ------- 227 (305)
T ss_pred ccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHH-------
Confidence 001112457888999999988889999999999999999999999997532211 0000
Q ss_pred CCCcccccccccccCCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 002721 832 GETPEQILDARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEMLQ 883 (888)
Q Consensus 832 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~ 883 (888)
........ +.........+.+++.+||+.||++||++.++.+.|+
T Consensus 228 ------~~~~~~~~-~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~ 272 (305)
T cd05609 228 ------VISDDIEW-PEGDEALPADAQDLISRLLRQNPLERLGTGGAFEVKQ 272 (305)
T ss_pred ------HHhcccCC-CCccccCCHHHHHHHHHHhccChhhccCccCHHHHHh
Confidence 00000000 0000123456789999999999999999666655554
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-37 Score=302.42 Aligned_cols=260 Identities=19% Similarity=0.299 Sum_probs=211.3
Q ss_pred cceeeecccceEEEEE-eCCCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccC-CCceeeeeeEEEeCCeeEEEEecCC
Q 002721 610 SNMIYCGTFSTVYKAV-MPSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLC-HDNLVRPIGFVIYEDVALLLHNYLP 687 (888)
Q Consensus 610 ~~~ig~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~~lv~e~~~ 687 (888)
.+.+|+|+|+.|--+. ..+|..||||++.+... ..+.++.+|++++.+++ |+||+++++||+++..+|+|||-|.
T Consensus 83 ~e~LGeGAyasVqtcv~i~t~~EYAVKiidKq~g---HsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~ 159 (463)
T KOG0607|consen 83 SELLGEGAYASVQTCVSIQTGKEYAVKIIDKQPG---HSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMR 159 (463)
T ss_pred HHHhcCccceeeeeeeeeccchhhhhhhhhcCCc---hHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEeccc
Confidence 5689999999999998 67899999999986533 34458999999999995 9999999999999999999999999
Q ss_pred CCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCC---ceEeccccccccCCCC-
Q 002721 688 NGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFK---PLLGEIEISKLLDPSK- 763 (888)
Q Consensus 688 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~---~kl~Dfg~a~~~~~~~- 763 (888)
||+|...|+++. .+++.++.++.++|+.||.|||.+||.|||+||+|||...... +||+||.++.-+....
T Consensus 160 GGplLshI~~~~-----~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~ 234 (463)
T KOG0607|consen 160 GGPLLSHIQKRK-----HFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNND 234 (463)
T ss_pred CchHHHHHHHhh-----hccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCCC
Confidence 999999998865 4677899999999999999999999999999999999976544 8999998776443211
Q ss_pred ----Ccccccccccccceecccccc---c--CCcCccccchhHHHHHHHHHhCCCCCCCCCCCccchhhhccccCCC---
Q 002721 764 ----GTASISAVAGSFGYIPPEYAY---T--MQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPAR--- 831 (888)
Q Consensus 764 ----~~~~~~~~~gt~~y~aPE~~~---~--~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~--- 831 (888)
.+......+|+..|||||+.. + ..|+.++|.||+|+|+|-|+.|.+||.+..+++. .|-++.+-+
T Consensus 235 ~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dC---GWdrGe~Cr~CQ 311 (463)
T KOG0607|consen 235 CSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADC---GWDRGEVCRVCQ 311 (463)
T ss_pred CCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcC---CccCCCccHHHH
Confidence 122334678999999999753 2 2489999999999999999999999998766533 222222211
Q ss_pred CCCcccccccccccCCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002721 832 GETPEQILDARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVE 880 (888)
Q Consensus 832 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 880 (888)
....+.+.+.........|...+.++.+++...+..||.+|.++.++++
T Consensus 312 ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rlsa~~vln 360 (463)
T KOG0607|consen 312 NKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRLSAAQVLN 360 (463)
T ss_pred HHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhhhhhhccC
Confidence 1223445556666666678888899999999999999999999998875
|
|
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=316.66 Aligned_cols=251 Identities=19% Similarity=0.260 Sum_probs=197.6
Q ss_pred HhcCCcceeeecccceEEEEEeC-CCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCCeeEEEE
Q 002721 605 ATMKDSNMIYCGTFSTVYKAVMP-SGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVALLLH 683 (888)
Q Consensus 605 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 683 (888)
+-|++.+.||+|+||.||+|... ++..+|+|.+..... ...+.+.+|+++++.++||||+++++++..++..|+||
T Consensus 5 ~~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~ 81 (282)
T cd06643 5 EFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTKSE---EELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILI 81 (282)
T ss_pred HHHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCCCH---HHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEE
Confidence 34678899999999999999954 578899998864432 23447889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccccccccCCCC
Q 002721 684 NYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSK 763 (888)
Q Consensus 684 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 763 (888)
||+++++|..++..... .+++..+..++.|+++||+|||+.|++||||||+||+++.++.+|++|||++.......
T Consensus 82 e~~~~~~l~~~~~~~~~----~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~ 157 (282)
T cd06643 82 EFCAGGAVDAVMLELER----PLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI 157 (282)
T ss_pred EecCCCcHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCCCEEEccccccccccccc
Confidence 99999999988765322 57889999999999999999999999999999999999999999999999987654321
Q ss_pred Ccccccccccccceecccccc-----cCCcCccccchhHHHHHHHHHhCCCCCCCCCCCccchhhhccccCCCCCCcccc
Q 002721 764 GTASISAVAGSFGYIPPEYAY-----TMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQI 838 (888)
Q Consensus 764 ~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 838 (888)
.......++..|+|||++. +..++.++||||+||++|||++|+.||....... ........... . .
T Consensus 158 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~-~~~~~~~~~~~-----~-~ 228 (282)
T cd06643 158 --QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMR-VLLKIAKSEPP-----T-L 228 (282)
T ss_pred --cccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHH-HHHHHhhcCCC-----C-C
Confidence 1123456889999999874 4457889999999999999999999997532211 11111110000 0 0
Q ss_pred cccccccCCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002721 839 LDARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVE 880 (888)
Q Consensus 839 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 880 (888)
. .......++.+++.+||+.||++||++.++++
T Consensus 229 ~---------~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 261 (282)
T cd06643 229 A---------QPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQ 261 (282)
T ss_pred C---------CccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 0 01112356788999999999999999999875
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-35 Score=313.11 Aligned_cols=253 Identities=20% Similarity=0.251 Sum_probs=202.9
Q ss_pred HhcCCcceeeecccceEEEEEe-CCCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCCeeEEEE
Q 002721 605 ATMKDSNMIYCGTFSTVYKAVM-PSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVALLLH 683 (888)
Q Consensus 605 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 683 (888)
++|+..+.||+|+||.||+|.. .+++.+|+|.+...... ..+.+.+|++++++++||||+++++++...+..|++|
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~ 79 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEPGD---DFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVM 79 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCchh---hHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEE
Confidence 5788999999999999999995 46889999999754332 3457889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccccccccCCCC
Q 002721 684 NYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSK 763 (888)
Q Consensus 684 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 763 (888)
||+++++|.+++..... .+++.++..++.|++.||+|||+.|++||||||+||++++++.+|++|||.+.......
T Consensus 80 e~~~~~~l~~~~~~~~~----~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~ 155 (262)
T cd06613 80 EYCGGGSLQDIYQVTRG----PLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATI 155 (262)
T ss_pred eCCCCCcHHHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCCCCEEECccccchhhhhhh
Confidence 99999999999876422 56788999999999999999999999999999999999999999999999988754322
Q ss_pred CcccccccccccceecccccccC---CcCccccchhHHHHHHHHHhCCCCCCCCCCCccchhhhccccCCCCCCcccccc
Q 002721 764 GTASISAVAGSFGYIPPEYAYTM---QVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQILD 840 (888)
Q Consensus 764 ~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 840 (888)
. ......++..|+|||.+.+. .++.++||||+|+++|||++|+.||........ ......... ..
T Consensus 156 ~--~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~-~~~~~~~~~---------~~ 223 (262)
T cd06613 156 A--KRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRA-LFLISKSNF---------PP 223 (262)
T ss_pred h--ccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHhccC---------CC
Confidence 1 12345678899999998776 789999999999999999999999975332111 000000000 00
Q ss_pred cccccCCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002721 841 ARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVE 880 (888)
Q Consensus 841 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 880 (888)
.. .........++.+++.+||..+|.+|||++++++
T Consensus 224 ~~----~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 259 (262)
T cd06613 224 PK----LKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQ 259 (262)
T ss_pred cc----ccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 00 0012334567889999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=323.76 Aligned_cols=259 Identities=19% Similarity=0.291 Sum_probs=210.8
Q ss_pred HHHHhcCCcceeeecccceEEEEEeCC-CcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCCeeE
Q 002721 602 VVKATMKDSNMIYCGTFSTVYKAVMPS-GLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVAL 680 (888)
Q Consensus 602 ~~~~~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~ 680 (888)
+...+..-.++||-|.||.||.|.|+. .-.||||.++.... ..++|.+|+.+|+.++|||+|+++|+|..+..+|
T Consensus 264 meRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKEDtM----eveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFY 339 (1157)
T KOG4278|consen 264 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFY 339 (1157)
T ss_pred ccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhcch----hHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeE
Confidence 445566677899999999999999754 77899999985433 3458999999999999999999999999999999
Q ss_pred EEEecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccccccccC
Q 002721 681 LLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLD 760 (888)
Q Consensus 681 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~~ 760 (888)
||+|||..|+|.+|+++.... .++.-..+.++.||..|++||..+++|||||..+|+|+.++..+|++|||+++++.
T Consensus 340 IiTEfM~yGNLLdYLRecnr~---ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsRlMt 416 (1157)
T KOG4278|consen 340 IITEFMCYGNLLDYLRECNRS---EVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSRLMT 416 (1157)
T ss_pred EEEecccCccHHHHHHHhchh---hcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhccccccceEEeeccchhhhhc
Confidence 999999999999999987654 34556678899999999999999999999999999999999999999999999987
Q ss_pred CCCCcccccccccccceecccccccCCcCccccchhHHHHHHHHHh-CCCCCCCCCCCccchhhhccccCCCCCCccccc
Q 002721 761 PSKGTASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILT-TRLPVEEDFGEGVDLVKWVHGAPARGETPEQIL 839 (888)
Q Consensus 761 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 839 (888)
.+..+. .....-...|.|||-+....++.|+|||+|||++||+.| |..||.+..-..+ . .++
T Consensus 417 gDTYTA-HAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSqV--Y--------------~LL 479 (1157)
T KOG4278|consen 417 GDTYTA-HAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV--Y--------------GLL 479 (1157)
T ss_pred CCceec-ccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHHH--H--------------HHH
Confidence 654332 222334568999999999999999999999999999998 8888875321110 0 011
Q ss_pred ccccccCCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhh
Q 002721 840 DARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEMLQEIK 886 (888)
Q Consensus 840 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~i~ 886 (888)
...++.. ......+.++++|+.||+++|.+||++.|+-+.+|.+-
T Consensus 480 EkgyRM~--~PeGCPpkVYeLMraCW~WsPsDRPsFaeiHqafEtmf 524 (1157)
T KOG4278|consen 480 EKGYRMD--GPEGCPPKVYELMRACWNWSPSDRPSFAEIHQAFETMF 524 (1157)
T ss_pred hcccccc--CCCCCCHHHHHHHHHHhcCCcccCccHHHHHHHHHHHh
Confidence 1111111 12334567889999999999999999999999999774
|
|
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=313.16 Aligned_cols=252 Identities=21% Similarity=0.289 Sum_probs=194.7
Q ss_pred hcCCcceeeecccceEEEEEe-CCCcEEEEEEeeccCh--hhhHHHHHHHHHHHHHhccCCCceeeeeeEEEe--CCeeE
Q 002721 606 TMKDSNMIYCGTFSTVYKAVM-PSGLILSVKRLKSMDR--TIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIY--EDVAL 680 (888)
Q Consensus 606 ~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~--~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~--~~~~~ 680 (888)
.|+..+.||+|+||.||+|.. .++..||+|++..... ...+....+.+|++++++++||||+++++++.. +...+
T Consensus 3 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 82 (266)
T cd06651 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLT 82 (266)
T ss_pred CccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEE
Confidence 588899999999999999995 4689999998864322 222344578899999999999999999998875 35788
Q ss_pred EEEecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccccccccC
Q 002721 681 LLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLD 760 (888)
Q Consensus 681 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~~ 760 (888)
++|||+++++|.+++.... .+++..+..++.|++.||+|||+.+|+||||||+||+++.++.+||+|||++....
T Consensus 83 l~~e~~~~~~L~~~l~~~~-----~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~ 157 (266)
T cd06651 83 IFMEYMPGGSVKDQLKAYG-----ALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQ 157 (266)
T ss_pred EEEeCCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCCCccccc
Confidence 9999999999999997643 36778889999999999999999999999999999999999999999999987654
Q ss_pred CCCC-cccccccccccceecccccccCCcCccccchhHHHHHHHHHhCCCCCCCCCCCccchhhhccccCCCCCCccccc
Q 002721 761 PSKG-TASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQIL 839 (888)
Q Consensus 761 ~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 839 (888)
.... ........++..|+|||++.+..++.++||||+||++|||++|+.||........ ... ..... .
T Consensus 158 ~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~-~~~-~~~~~---~------ 226 (266)
T cd06651 158 TICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAA-IFK-IATQP---T------ 226 (266)
T ss_pred cccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHH-HHH-HhcCC---C------
Confidence 3111 1112234578899999999988899999999999999999999999975321110 000 00000 0
Q ss_pred ccccccCCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002721 840 DARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVE 880 (888)
Q Consensus 840 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 880 (888)
.+ . ........+.+++ +||..+|++||+++||++
T Consensus 227 ~~---~---~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~ 260 (266)
T cd06651 227 NP---Q---LPSHISEHARDFL-GCIFVEARHRPSAEELLR 260 (266)
T ss_pred CC---C---CchhcCHHHHHHH-HHhcCChhhCcCHHHHhc
Confidence 00 0 0112233445555 688899999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-36 Score=318.91 Aligned_cols=250 Identities=19% Similarity=0.244 Sum_probs=201.2
Q ss_pred HHhcCCcceeeecccceEEEEEe-CCCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCCeeEEE
Q 002721 604 KATMKDSNMIYCGTFSTVYKAVM-PSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVALLL 682 (888)
Q Consensus 604 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 682 (888)
.+.|+..+.||+|+||.||+|.. .+++.||+|.++..... ...+.+.+|++++++++||||+++++++..++..|+|
T Consensus 3 ~~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (277)
T cd06642 3 EELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEEAE--DEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWII 80 (277)
T ss_pred HHHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEeccccch--HHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEE
Confidence 35677788999999999999985 46889999988744322 2345789999999999999999999999999999999
Q ss_pred EecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccccccccCCC
Q 002721 683 HNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPS 762 (888)
Q Consensus 683 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 762 (888)
|||+++++|.+++... .+++..+..++.|+++|+.|||++|++|+||+|+||++++++.++++|||++......
T Consensus 81 ~e~~~~~~L~~~~~~~------~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~ 154 (277)
T cd06642 81 MEYLGGGSALDLLKPG------PLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDT 154 (277)
T ss_pred EEccCCCcHHHHhhcC------CCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCCCEEEccccccccccCc
Confidence 9999999999998642 4678899999999999999999999999999999999999999999999998876532
Q ss_pred CCcccccccccccceecccccccCCcCccccchhHHHHHHHHHhCCCCCCCCCCCccchhhhccccCCCCCCcccccccc
Q 002721 763 KGTASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQILDAR 842 (888)
Q Consensus 763 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 842 (888)
. .......++..|+|||++.+..++.++|||||||++|||++|+.||........ ... +....
T Consensus 155 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~--~~~-------------~~~~~ 217 (277)
T cd06642 155 Q--IKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRV--LFL-------------IPKNS 217 (277)
T ss_pred c--hhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhH--Hhh-------------hhcCC
Confidence 2 112234678899999999988899999999999999999999999875322211 000 00000
Q ss_pred cccCCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002721 843 LSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEM 881 (888)
Q Consensus 843 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~ 881 (888)
... .......++.+++.+||+.+|++||++.++++.
T Consensus 218 ~~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 253 (277)
T cd06642 218 PPT---LEGQYSKPFKEFVEACLNKDPRFRPTAKELLKH 253 (277)
T ss_pred CCC---CCcccCHHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 000 011234567889999999999999999999973
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-35 Score=313.54 Aligned_cols=259 Identities=22% Similarity=0.330 Sum_probs=204.8
Q ss_pred HhcCCcceeeecccceEEEEEe-CCCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCCeeEEEE
Q 002721 605 ATMKDSNMIYCGTFSTVYKAVM-PSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVALLLH 683 (888)
Q Consensus 605 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 683 (888)
++|++.+.||.|+||+||+|.. .++..+|+|++....... ..+.+.+|+++++.++|+||+++++.+..++..|+||
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~ 78 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT--SVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVM 78 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch--HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEE
Confidence 3688999999999999999994 468899999987433222 4457899999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccccccccCCCC
Q 002721 684 NYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSK 763 (888)
Q Consensus 684 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 763 (888)
||+++++|.++++..... ..+++..+..++.|++.||+|||+.|++||||||+||++++++.++++|||.+.......
T Consensus 79 e~~~~~~l~~~~~~~~~~--~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~ 156 (267)
T cd06610 79 PYLSGGSLLDIMKSSYPR--GGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGG 156 (267)
T ss_pred eccCCCcHHHHHHHhccc--CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCc
Confidence 999999999999764321 257888999999999999999999999999999999999999999999999988765433
Q ss_pred Ccc--cccccccccceecccccccC-CcCccccchhHHHHHHHHHhCCCCCCCCCCCccchhhhccccCCCCCCcccccc
Q 002721 764 GTA--SISAVAGSFGYIPPEYAYTM-QVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQILD 840 (888)
Q Consensus 764 ~~~--~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 840 (888)
... ......|+..|+|||++... .++.++|+||||+++|||++|+.||....... ...+.....+
T Consensus 157 ~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~-~~~~~~~~~~----------- 224 (267)
T cd06610 157 DRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMK-VLMLTLQNDP----------- 224 (267)
T ss_pred cccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhh-hHHHHhcCCC-----------
Confidence 221 12344688999999998776 78999999999999999999999997543221 1111111100
Q ss_pred cccccCCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002721 841 ARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVE 880 (888)
Q Consensus 841 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 880 (888)
...... .........+.+++.+||..||++||++.++++
T Consensus 225 ~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~ 263 (267)
T cd06610 225 PSLETG-ADYKKYSKSFRKMISLCLQKDPSKRPTAEELLK 263 (267)
T ss_pred CCcCCc-cccccccHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 000000 011233466789999999999999999999986
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=317.73 Aligned_cols=252 Identities=22% Similarity=0.310 Sum_probs=199.1
Q ss_pred HHhcCCcceeeecccceEEEEEeC-CCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCCeeEEE
Q 002721 604 KATMKDSNMIYCGTFSTVYKAVMP-SGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVALLL 682 (888)
Q Consensus 604 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 682 (888)
.+.|++.+.||+|+||.||+|+.. +++.||+|.+..... ...+.+.+|+++++.++||||+++++++..++..|+|
T Consensus 11 ~~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 87 (292)
T cd06644 11 NEVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETKSE---EELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIM 87 (292)
T ss_pred chhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccCCH---HHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEE
Confidence 457999999999999999999954 589999999875432 2345788999999999999999999999999999999
Q ss_pred EecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccccccccCCC
Q 002721 683 HNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPS 762 (888)
Q Consensus 683 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 762 (888)
|||++++++..++.+... .+++..+..++.|++.|++|||+.|++||||||+||+++.++.+||+|||.+......
T Consensus 88 ~e~~~~~~l~~~~~~~~~----~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~ 163 (292)
T cd06644 88 IEFCPGGAVDAIMLELDR----GLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKT 163 (292)
T ss_pred EecCCCCcHHHHHHhhcC----CCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCCCCEEEccCccceecccc
Confidence 999999999988765432 4788999999999999999999999999999999999999999999999988764322
Q ss_pred CCcccccccccccceecccccc-----cCCcCccccchhHHHHHHHHHhCCCCCCCCCCCccchhhhccccCCCCCCccc
Q 002721 763 KGTASISAVAGSFGYIPPEYAY-----TMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQ 837 (888)
Q Consensus 763 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 837 (888)
. .......++..|+|||++. ...++.++|||||||++|||++|+.||....... .......... +
T Consensus 164 ~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~-~~~~~~~~~~-----~-- 233 (292)
T cd06644 164 L--QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMR-VLLKIAKSEP-----P-- 233 (292)
T ss_pred c--cccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHH-HHHHHhcCCC-----c--
Confidence 1 1123456788999999874 3457889999999999999999999997532211 1111110000 0
Q ss_pred ccccccccCCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002721 838 ILDARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVE 880 (888)
Q Consensus 838 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 880 (888)
.. ........++.+++.+||+.||++||++.|+++
T Consensus 234 ----~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 268 (292)
T cd06644 234 ----TL----SQPSKWSMEFRDFLKTALDKHPETRPSAAQLLE 268 (292)
T ss_pred ----cC----CCCcccCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 00 011123346778999999999999999999976
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-35 Score=312.96 Aligned_cols=247 Identities=21% Similarity=0.332 Sum_probs=197.7
Q ss_pred HhcCCcceeeecccceEEEEEeCCCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCCeeEEEEe
Q 002721 605 ATMKDSNMIYCGTFSTVYKAVMPSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVALLLHN 684 (888)
Q Consensus 605 ~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 684 (888)
++|++.+.||+|+||.||++.. +++.||+|.++.... .+.+.+|+.++++++||||+++++++..+ ..++|||
T Consensus 6 ~~~~~~~~lg~g~~g~v~~~~~-~~~~~~iK~~~~~~~-----~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e 78 (254)
T cd05083 6 QKLTLGEIIGEGEFGAVLQGEY-TGQKVAVKNIKCDVT-----AQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVME 78 (254)
T ss_pred HHceeeeeeccCCCCceEeccc-CCCceEEEeecCcch-----HHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEE
Confidence 5789999999999999999975 678899999864321 23788999999999999999999998754 4799999
Q ss_pred cCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccccccccCCCCC
Q 002721 685 YLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSKG 764 (888)
Q Consensus 685 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 764 (888)
|+++++|.+++...... .+++..+..++.|++.||+|||+.|++||||||+||+++.++.+||+|||.+.......
T Consensus 79 ~~~~~~L~~~l~~~~~~---~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~- 154 (254)
T cd05083 79 LMSKGNLVNFLRTRGRA---LVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV- 154 (254)
T ss_pred CCCCCCHHHHHHhcCcC---CCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEcCCCcEEECCCccceeccccC-
Confidence 99999999999765322 56888999999999999999999999999999999999999999999999987643221
Q ss_pred cccccccccccceecccccccCCcCccccchhHHHHHHHHHh-CCCCCCCCCCCccchhhhccccCCCCCCccccccccc
Q 002721 765 TASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILT-TRLPVEEDFGEGVDLVKWVHGAPARGETPEQILDARL 843 (888)
Q Consensus 765 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 843 (888)
.....+..|+|||.+.+..++.++||||||+++|||++ |+.||....... ........ .
T Consensus 155 ----~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~--~~~~~~~~--------------~ 214 (254)
T cd05083 155 ----DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKE--VKECVEKG--------------Y 214 (254)
T ss_pred ----CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHH--HHHHHhCC--------------C
Confidence 12234568999999988899999999999999999998 999997542211 11111000 0
Q ss_pred ccCCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHH
Q 002721 844 STVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEMLQE 884 (888)
Q Consensus 844 ~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~ 884 (888)
... .....+..+.+++.+||+.+|++||+++++++.|++
T Consensus 215 ~~~--~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~l~~ 253 (254)
T cd05083 215 RME--PPEGCPADVYVLMTSCWETEPKKRPSFHKLREKLEK 253 (254)
T ss_pred CCC--CCCcCCHHHHHHHHHHcCCChhhCcCHHHHHHHHcc
Confidence 000 011234567789999999999999999999998864
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-37 Score=326.84 Aligned_cols=252 Identities=20% Similarity=0.271 Sum_probs=202.2
Q ss_pred HHhcCCcceeeecccceEEEEEeC-CCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCCeeEEE
Q 002721 604 KATMKDSNMIYCGTFSTVYKAVMP-SGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVALLL 682 (888)
Q Consensus 604 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 682 (888)
.+.|+++..+|.|+||.||+|..+ ++...|.|++.... .+..+.+.-|++||..+.||+||++++.|..++..|++
T Consensus 31 ~d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetks---eEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwil 107 (1187)
T KOG0579|consen 31 RDHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETKS---EEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWIL 107 (1187)
T ss_pred HHHHHHHhhhcCccchhhhhhhcccchhhhhhhhhcccc---hhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEE
Confidence 345777889999999999999954 45566777776433 34456899999999999999999999999999999999
Q ss_pred EecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccccccccCCC
Q 002721 683 HNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPS 762 (888)
Q Consensus 683 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 762 (888)
.|||.||....++-+-+. .+++.++..+++|++.||.|||+++|||||||+.|||++-+|.++++|||.+.....
T Consensus 108 iEFC~GGAVDaimlEL~r----~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~- 182 (1187)
T KOG0579|consen 108 IEFCGGGAVDAIMLELGR----VLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKS- 182 (1187)
T ss_pred EeecCCchHhHHHHHhcc----ccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecCcEeeecccccccchh-
Confidence 999999999998877654 678899999999999999999999999999999999999999999999999876432
Q ss_pred CCcccccccccccceecccccc-----cCCcCccccchhHHHHHHHHHhCCCCCCCCCCCccchhhhccccCCCCCCccc
Q 002721 763 KGTASISAVAGSFGYIPPEYAY-----TMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQ 837 (888)
Q Consensus 763 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 837 (888)
.......++|||+|||||+.. +.+|+.++|||||||++.||..+.+|..+...- .-+.+.....|+.
T Consensus 183 -t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpM-RVllKiaKSePPT------ 254 (1187)
T KOG0579|consen 183 -TRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPM-RVLLKIAKSEPPT------ 254 (1187)
T ss_pred -HHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchH-HHHHHHhhcCCCc------
Confidence 223345789999999999864 567999999999999999999999998753221 1112222111111
Q ss_pred ccccccccCCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002721 838 ILDARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVE 880 (888)
Q Consensus 838 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 880 (888)
++ .+..-...+.+++.+|+..||+.||++.++++
T Consensus 255 Ll---------qPS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~ 288 (1187)
T KOG0579|consen 255 LL---------QPSHWSRSFSDFLKRCLVKNPRNRPPAAQLLK 288 (1187)
T ss_pred cc---------CcchhhhHHHHHHHHHHhcCCccCCCHHHHhh
Confidence 11 12233445678899999999999999999886
|
|
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=321.41 Aligned_cols=199 Identities=19% Similarity=0.295 Sum_probs=161.7
Q ss_pred cceeeecccceEEEEEeC---CCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEe--CCeeEEEEe
Q 002721 610 SNMIYCGTFSTVYKAVMP---SGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIY--EDVALLLHN 684 (888)
Q Consensus 610 ~~~ig~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~--~~~~~lv~e 684 (888)
..+||+|+||+||+|+.. ++..||+|.++..... ..+.+|++++++++||||+++++++.. +...++|||
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~~-----~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e 80 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGIS-----MSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFD 80 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCCc-----HHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEe
Confidence 468999999999999954 4578999988744321 257789999999999999999998864 457899999
Q ss_pred cCCCCCHHHHhhccCC----CCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEe----CCCCCceEeccccc
Q 002721 685 YLPNGTLAQLLHESTK----QPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLL----DADFKPLLGEIEIS 756 (888)
Q Consensus 685 ~~~~g~L~~~l~~~~~----~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll----~~~~~~kl~Dfg~a 756 (888)
|+++ +|.+++..... .....+++..+..++.||+.||+|||++||+||||||+||++ +.++.+||+|||++
T Consensus 81 ~~~~-~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a 159 (317)
T cd07867 81 YAEH-DLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFA 159 (317)
T ss_pred eeCC-cHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccce
Confidence 9875 88888754321 112257888999999999999999999999999999999999 56678999999999
Q ss_pred cccCCCCC-cccccccccccceecccccccC-CcCccccchhHHHHHHHHHhCCCCCCCC
Q 002721 757 KLLDPSKG-TASISAVAGSFGYIPPEYAYTM-QVTAPGNVYSYGVVLLEILTTRLPVEED 814 (888)
Q Consensus 757 ~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~P~~~~ 814 (888)
+....... ........+|+.|+|||++.+. .++.++||||+||++|||+||++||...
T Consensus 160 ~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~ 219 (317)
T cd07867 160 RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219 (317)
T ss_pred eccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCcccc
Confidence 87654321 1122345789999999988764 5899999999999999999999999753
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-36 Score=330.48 Aligned_cols=193 Identities=18% Similarity=0.234 Sum_probs=165.6
Q ss_pred HHHhcCCcceeeecccceEEEEEeC-CCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCCeeEE
Q 002721 603 VKATMKDSNMIYCGTFSTVYKAVMP-SGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVALL 681 (888)
Q Consensus 603 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 681 (888)
...+|++.+.||+|+||.||+|+.. +++.||+|..... ....|+.++++++||||+++++++...+..++
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~---------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~l 134 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKG---------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCM 134 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCcc---------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEE
Confidence 3457999999999999999999954 5789999975422 33569999999999999999999999999999
Q ss_pred EEecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccccccccCC
Q 002721 682 LHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDP 761 (888)
Q Consensus 682 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~~~ 761 (888)
||||+. ++|.+++..... .+++..+..|+.||+.||+|||++||+||||||+||+++.++.+||+|||.++....
T Consensus 135 v~e~~~-~~l~~~l~~~~~----~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~ 209 (357)
T PHA03209 135 VLPHYS-SDLYTYLTKRSR----PLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVV 209 (357)
T ss_pred EEEccC-CcHHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEecCcccccccc
Confidence 999995 589888875432 578999999999999999999999999999999999999999999999999875432
Q ss_pred CCCcccccccccccceecccccccCCcCccccchhHHHHHHHHHhCCCCCC
Q 002721 762 SKGTASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVE 812 (888)
Q Consensus 762 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~ 812 (888)
.. ......||..|+|||++.+..++.++|||||||++|||+++..|+.
T Consensus 210 ~~---~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f 257 (357)
T PHA03209 210 AP---AFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIF 257 (357)
T ss_pred Cc---ccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccc
Confidence 21 1234568999999999999999999999999999999999665553
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-36 Score=297.30 Aligned_cols=253 Identities=16% Similarity=0.187 Sum_probs=209.0
Q ss_pred HHHhcCC-cceeeecccceEEEEE-eCCCcEEEEEEeeccChhhhHHHHHHHHHHHHHhcc-CCCceeeeeeEEEe----
Q 002721 603 VKATMKD-SNMIYCGTFSTVYKAV-MPSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKL-CHDNLVRPIGFVIY---- 675 (888)
Q Consensus 603 ~~~~~~~-~~~ig~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~---- 675 (888)
++++|++ .++||-|-.|.|..+. ..+|+.+|+|++.... +.++|++..-.. .|||||.++++|+.
T Consensus 59 itedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds~--------KARrEVeLHw~~s~h~~iV~IidVyeNs~~~ 130 (400)
T KOG0604|consen 59 ITEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDSP--------KARREVELHWMASGHPHIVSIIDVYENSYQG 130 (400)
T ss_pred chhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcCH--------HHHhHhhhhhhhcCCCceEEeehhhhhhccC
Confidence 3556665 4689999999999998 4579999999886321 567888876555 59999999999874
Q ss_pred CCeeEEEEecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCC---CCCceEec
Q 002721 676 EDVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDA---DFKPLLGE 752 (888)
Q Consensus 676 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~---~~~~kl~D 752 (888)
.....+|||.|+||.|...+++++.. .+++.++-.|+.||+.|++|||+.+|.||||||+|+|... +..+||+|
T Consensus 131 rkcLLiVmE~meGGeLfsriq~~g~~---afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtD 207 (400)
T KOG0604|consen 131 RKCLLIVMECMEGGELFSRIQDRGDQ---AFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTD 207 (400)
T ss_pred ceeeEeeeecccchHHHHHHHHcccc---cchHHHHHHHHHHHHHHHHHHHhcchhhccCChhheeeecCCCCcceEecc
Confidence 34678999999999999999987654 6789999999999999999999999999999999999964 45799999
Q ss_pred cccccccCCCCCcccccccccccceecccccccCCcCccccchhHHHHHHHHHhCCCCCCCCCCCccchhhhccccCCCC
Q 002721 753 IEISKLLDPSKGTASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARG 832 (888)
Q Consensus 753 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~ 832 (888)
||+|+.-... ......+-|+.|.|||++...+|+..+|+||+||++|-|+.|.+||....+... ..
T Consensus 208 fGFAK~t~~~---~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~ai-----------sp 273 (400)
T KOG0604|consen 208 FGFAKETQEP---GDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI-----------SP 273 (400)
T ss_pred cccccccCCC---ccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCccC-----------Ch
Confidence 9999975532 234567889999999999999999999999999999999999999987543211 11
Q ss_pred CCcccccccccccCCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002721 833 ETPEQILDARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVE 880 (888)
Q Consensus 833 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 880 (888)
....++.........+.|...++++.++|+.+++.+|.+|.|+.|+++
T Consensus 274 gMk~rI~~gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~ 321 (400)
T KOG0604|consen 274 GMKRRIRTGQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMD 321 (400)
T ss_pred hHHhHhhccCccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhc
Confidence 122334445555566788999999999999999999999999999875
|
|
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=355.63 Aligned_cols=253 Identities=25% Similarity=0.328 Sum_probs=204.0
Q ss_pred hcCCcceeeecccceEEEEE-eCCCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCCeeEEEEe
Q 002721 606 TMKDSNMIYCGTFSTVYKAV-MPSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVALLLHN 684 (888)
Q Consensus 606 ~~~~~~~ig~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 684 (888)
++.....||.|.||.||-|. ..+|...|+|.++..+.. ....+.+.+|..++..++|||+|++||+-.+++..+|.||
T Consensus 1236 rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~-~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFME 1314 (1509)
T KOG4645|consen 1236 RWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSD-HKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFME 1314 (1509)
T ss_pred eeccccccCCcceeeeEEeecCCccchhhhhhhhcCccc-cccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHH
Confidence 46678899999999999999 567999999988754433 4445578899999999999999999999999999999999
Q ss_pred cCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccccccccCCCCC
Q 002721 685 YLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSKG 764 (888)
Q Consensus 685 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 764 (888)
||++|+|.+.+...+. .++.....+..|++.|++|||++|||||||||.||+++.+|.+|++|||.|..+.....
T Consensus 1315 yC~~GsLa~ll~~gri-----~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~ 1389 (1509)
T KOG4645|consen 1315 YCEGGSLASLLEHGRI-----EDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQ 1389 (1509)
T ss_pred HhccCcHHHHHHhcch-----hhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCcEEeecccceeEecCchh
Confidence 9999999999987543 34455567888999999999999999999999999999999999999999998875432
Q ss_pred c--ccccccccccceecccccccCC---cCccccchhHHHHHHHHHhCCCCCCCCCCCccchhhhccccCCCCCCccccc
Q 002721 765 T--ASISAVAGSFGYIPPEYAYTMQ---VTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQIL 839 (888)
Q Consensus 765 ~--~~~~~~~gt~~y~aPE~~~~~~---~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 839 (888)
. .......||+.|||||++.+.. ...++||||+|||+.||+||+.||.....+..-+.+. .
T Consensus 1390 ~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy~V--------------~ 1455 (1509)
T KOG4645|consen 1390 TMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMYHV--------------A 1455 (1509)
T ss_pred cCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHhHH--------------h
Confidence 2 1234678999999999987643 5678999999999999999999998754442211111 1
Q ss_pred ccccccCCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002721 840 DARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEM 881 (888)
Q Consensus 840 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~ 881 (888)
....+. .+.....+..+++..|+..||++|.++.|+++.
T Consensus 1456 ~gh~Pq---~P~~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~ 1494 (1509)
T KOG4645|consen 1456 AGHKPQ---IPERLSSEGRDFLEHCLEQDPKMRWTASQLLEH 1494 (1509)
T ss_pred ccCCCC---CchhhhHhHHHHHHHHHhcCchhhhHHHHHHHh
Confidence 111111 122356677899999999999999999988763
|
|
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=317.32 Aligned_cols=268 Identities=18% Similarity=0.198 Sum_probs=200.0
Q ss_pred HhcCCcceeeecccceEEEEEeC-CCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCCeeEEEE
Q 002721 605 ATMKDSNMIYCGTFSTVYKAVMP-SGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVALLLH 683 (888)
Q Consensus 605 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 683 (888)
++|+..+.||+|+||.||+|+.. +++.||+|++...... ....+.+.+|++++++++||||+++++++..+...++||
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~ 79 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESEDD-PVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVF 79 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeecccC-ccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEE
Confidence 36888999999999999999965 6899999998743321 122346789999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccccccccCCCC
Q 002721 684 NYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSK 763 (888)
Q Consensus 684 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 763 (888)
||++++.+..++.... .+++..+..++.|++.||+|||+.|++||||||+||+++.++.++|+|||++.......
T Consensus 80 e~~~~~~l~~~~~~~~-----~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 154 (286)
T cd07847 80 EYCDHTVLNELEKNPR-----GVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPG 154 (286)
T ss_pred eccCccHHHHHHhCCC-----CCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCCcEEECccccceecCCCc
Confidence 9999988888765432 46889999999999999999999999999999999999999999999999998765432
Q ss_pred Ccccccccccccceeccccccc-CCcCccccchhHHHHHHHHHhCCCCCCCCCCCccc--hhhhccccCC-------CCC
Q 002721 764 GTASISAVAGSFGYIPPEYAYT-MQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVD--LVKWVHGAPA-------RGE 833 (888)
Q Consensus 764 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~--~~~~~~~~~~-------~~~ 833 (888)
. ......++..|+|||++.+ ..++.++||||+|+++|||++|+.||.+....... .......... ...
T Consensus 155 ~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (286)
T cd07847 155 D--DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQ 232 (286)
T ss_pred c--cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhccccc
Confidence 1 1223457889999998866 45789999999999999999999999754322110 0000000000 000
Q ss_pred CcccccccccccCC---cCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002721 834 TPEQILDARLSTVS---FGWRKEMLTALKVALLCTDSTPAKRPKMKKVVE 880 (888)
Q Consensus 834 ~~~~~~~~~~~~~~---~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 880 (888)
.......+...... .........+.+++.+||++||++||++.|++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 282 (286)
T cd07847 233 FFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEELLE 282 (286)
T ss_pred ccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHHhc
Confidence 00000000000000 001122466789999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=315.13 Aligned_cols=248 Identities=19% Similarity=0.269 Sum_probs=201.1
Q ss_pred hcCCcceeeecccceEEEEEeC-CCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCCeeEEEEe
Q 002721 606 TMKDSNMIYCGTFSTVYKAVMP-SGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVALLLHN 684 (888)
Q Consensus 606 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 684 (888)
+|+..+.||.|+||.||+|+.. +++.||+|.+..... ......+.+|+++++.++||||+++++++..+...|+|+|
T Consensus 2 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (274)
T cd06609 2 LFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEEA--EDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIME 79 (274)
T ss_pred hhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeecccc--chHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEE
Confidence 6888899999999999999954 689999999874432 2233478899999999999999999999999999999999
Q ss_pred cCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccccccccCCCCC
Q 002721 685 YLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSKG 764 (888)
Q Consensus 685 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 764 (888)
|+++++|.+++... .+++..+..++.|++.|+.|||+++++||||+|+||++++++.++++|||.+........
T Consensus 80 ~~~~~~L~~~~~~~------~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~ 153 (274)
T cd06609 80 YCGGGSCLDLLKPG------KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS 153 (274)
T ss_pred eeCCCcHHHHHhhc------CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcccccceeeccccc
Confidence 99999999999754 467899999999999999999999999999999999999999999999999987754321
Q ss_pred cccccccccccceecccccccCCcCccccchhHHHHHHHHHhCCCCCCCCCCCccchhhhccccCCCCCCcccccccccc
Q 002721 765 TASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQILDARLS 844 (888)
Q Consensus 765 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 844 (888)
......++..|+|||++.+..++.++||||||+++|+|++|+.||....... ...... .....
T Consensus 154 --~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~--~~~~~~-------------~~~~~ 216 (274)
T cd06609 154 --KRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMR--VLFLIP-------------KNNPP 216 (274)
T ss_pred --ccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHH--HHHHhh-------------hcCCC
Confidence 1234567889999999998889999999999999999999999997532111 000000 00000
Q ss_pred cCCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002721 845 TVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVE 880 (888)
Q Consensus 845 ~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 880 (888)
... .......+.+++.+||..+|++|||++++++
T Consensus 217 ~~~--~~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~ 250 (274)
T cd06609 217 SLE--GNKFSKPFKDFVSLCLNKDPKERPSAKELLK 250 (274)
T ss_pred CCc--ccccCHHHHHHHHHHhhCChhhCcCHHHHhh
Confidence 000 0013456778999999999999999999975
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=317.13 Aligned_cols=240 Identities=20% Similarity=0.319 Sum_probs=186.1
Q ss_pred ceeeecccceEEEEEeCC--------CcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCCeeEEE
Q 002721 611 NMIYCGTFSTVYKAVMPS--------GLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVALLL 682 (888)
Q Consensus 611 ~~ig~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 682 (888)
+.||+|+||.||+|.... ...||+|.+.... ....+.+.+|+.+++.++||||+++++++..++..++|
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv 77 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH---RNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMV 77 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchh---HHHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEE
Confidence 469999999999998532 2348888775332 23344788899999999999999999999999999999
Q ss_pred EecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCC--------ceEeccc
Q 002721 683 HNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFK--------PLLGEIE 754 (888)
Q Consensus 683 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~--------~kl~Dfg 754 (888)
|||+++|+|.++++.... .+++..+..++.||+.||+|||++||+||||||+||+++.++. ++++|||
T Consensus 78 ~e~~~~g~L~~~l~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g 153 (258)
T cd05078 78 QEYVKFGSLDTYLKKNKN----LINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPG 153 (258)
T ss_pred EecCCCCcHHHHHhcCCC----CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEecccccccCCCceEEecccc
Confidence 999999999999986543 4688899999999999999999999999999999999987765 5899999
Q ss_pred cccccCCCCCcccccccccccceecccccccC-CcCccccchhHHHHHHHHHhCC-CCCCCCCCCccchhhhccccCCCC
Q 002721 755 ISKLLDPSKGTASISAVAGSFGYIPPEYAYTM-QVTAPGNVYSYGVVLLEILTTR-LPVEEDFGEGVDLVKWVHGAPARG 832 (888)
Q Consensus 755 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~-~P~~~~~~~~~~~~~~~~~~~~~~ 832 (888)
.+...... ....++..|+|||++.+. .++.++||||||+++|||++|. .||........ .....
T Consensus 154 ~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~~~~--~~~~~------ 219 (258)
T cd05078 154 ISITVLPK------EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDSQKK--LQFYE------ 219 (258)
T ss_pred cccccCCc------hhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccHHHH--HHHHH------
Confidence 87654321 234578899999998764 5789999999999999999995 55543211100 00000
Q ss_pred CCcccccccccccCCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 002721 833 ETPEQILDARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEMLQ 883 (888)
Q Consensus 833 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~ 883 (888)
... .. ......++.+++.+||+.||++|||++++++.|+
T Consensus 220 --------~~~-~~---~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~l~ 258 (258)
T cd05078 220 --------DRH-QL---PAPKWTELANLINQCMDYEPDFRPSFRAIIRDLN 258 (258)
T ss_pred --------ccc-cC---CCCCcHHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 000 00 0112246789999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-36 Score=321.28 Aligned_cols=267 Identities=18% Similarity=0.203 Sum_probs=197.1
Q ss_pred hcCCcceeeecccceEEEEEe-CCCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCCeeEEEEe
Q 002721 606 TMKDSNMIYCGTFSTVYKAVM-PSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVALLLHN 684 (888)
Q Consensus 606 ~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 684 (888)
+|+..+.||+|+||.||+|+. .+|+.||+|+++.... .......+.+|++++++++||||+++++++.+.+..++|+|
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~-~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 79 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFE 79 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccc-cccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEe
Confidence 478889999999999999995 4689999999874322 12223467789999999999999999999999999999999
Q ss_pred cCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccccccccCCCCC
Q 002721 685 YLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSKG 764 (888)
Q Consensus 685 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 764 (888)
|++ ++|.+++..... .+++..+..++.||++||+|||++|++||||||+||+++.++.+||+|||.+........
T Consensus 80 ~~~-~~l~~~~~~~~~----~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~ 154 (284)
T cd07839 80 YCD-QDLKKYFDSCNG----DIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR 154 (284)
T ss_pred cCC-CCHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCC
Confidence 997 488888765432 578899999999999999999999999999999999999999999999999986543221
Q ss_pred cccccccccccceecccccccC-CcCccccchhHHHHHHHHHhCCCCCCCCCCCccchhhhccccC--CCCCC--ccccc
Q 002721 765 TASISAVAGSFGYIPPEYAYTM-QVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAP--ARGET--PEQIL 839 (888)
Q Consensus 765 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~--~~~~~--~~~~~ 839 (888)
......++..|+|||++.+. .++.++||||+||++|||+||..|+.........+........ ..... .....
T Consensus 155 --~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (284)
T cd07839 155 --CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLP 232 (284)
T ss_pred --CcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcc
Confidence 12334678899999988764 4789999999999999999999987543222111111100000 00000 00000
Q ss_pred c-cccccCC------cCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002721 840 D-ARLSTVS------FGWRKEMLTALKVALLCTDSTPAKRPKMKKVVE 880 (888)
Q Consensus 840 ~-~~~~~~~------~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 880 (888)
+ ....... ........++.+++.+||+.||++|||++|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~il~ 280 (284)
T cd07839 233 DYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEALQ 280 (284)
T ss_pred cccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHHhc
Confidence 0 0000000 001123456788999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=313.71 Aligned_cols=257 Identities=24% Similarity=0.328 Sum_probs=198.5
Q ss_pred hcCCcceeeecccceEEEEEe-CCCcEEEEEEeeccChh-------hhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCC
Q 002721 606 TMKDSNMIYCGTFSTVYKAVM-PSGLILSVKRLKSMDRT-------IIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYED 677 (888)
Q Consensus 606 ~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~-------~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 677 (888)
+|...+.||+|+||.||+|.. .+++.||+|.++..... .....+.+.+|++++++++||||+++++++...+
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~ 81 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEE 81 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCC
Confidence 467788999999999999984 46899999988632111 1122346888999999999999999999999999
Q ss_pred eeEEEEecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEecccccc
Q 002721 678 VALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISK 757 (888)
Q Consensus 678 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~ 757 (888)
..++||||+++++|.++++... .+++..+..++.||+.||.|||+++++||||+|+||+++.++.++++|||.+.
T Consensus 82 ~~~lv~e~~~~~~L~~~l~~~~-----~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~ 156 (272)
T cd06629 82 YLSIFLEYVPGGSIGSCLRTYG-----RFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISK 156 (272)
T ss_pred ceEEEEecCCCCcHHHHHhhcc-----CCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhEEEcCCCeEEEeeccccc
Confidence 9999999999999999997652 46778899999999999999999999999999999999999999999999998
Q ss_pred ccCCCCCcccccccccccceecccccccCC--cCccccchhHHHHHHHHHhCCCCCCCCCCCccchhhhccccCCCCCCc
Q 002721 758 LLDPSKGTASISAVAGSFGYIPPEYAYTMQ--VTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETP 835 (888)
Q Consensus 758 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 835 (888)
...............++..|+|||.+.... ++.++|+||+|+++||+++|..||...... ....+..... ..
T Consensus 157 ~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~-~~~~~~~~~~-~~---- 230 (272)
T cd06629 157 KSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAI-AAMFKLGNKR-SA---- 230 (272)
T ss_pred cccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchH-HHHHHhhccc-cC----
Confidence 654322222223456788999999887654 889999999999999999999999642211 0001100000 00
Q ss_pred ccccccccccCCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002721 836 EQILDARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVE 880 (888)
Q Consensus 836 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 880 (888)
. .... .........+.+++.+||.++|++||+++++++
T Consensus 231 ~-~~~~------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 268 (272)
T cd06629 231 P-PIPP------DVSMNLSPVALDFLNACFTINPDNRPTARELLQ 268 (272)
T ss_pred C-cCCc------cccccCCHHHHHHHHHHhcCChhhCCCHHHHhh
Confidence 0 0000 011123467788999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=317.67 Aligned_cols=249 Identities=20% Similarity=0.273 Sum_probs=200.6
Q ss_pred HhcCCcceeeecccceEEEEEe-CCCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCCeeEEEE
Q 002721 605 ATMKDSNMIYCGTFSTVYKAVM-PSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVALLLH 683 (888)
Q Consensus 605 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 683 (888)
.+|+..+.||.|+||.||+|.. .+++.||+|.+...... ..+.+.+|+++++.++||||+++++++..++..|+||
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ 95 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQKQP---KKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVM 95 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEecccCc---hHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEE
Confidence 4688999999999999999984 57899999998743322 2347889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccccccccCCCC
Q 002721 684 NYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSK 763 (888)
Q Consensus 684 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 763 (888)
||+++++|.+++... .+++.++..++.|++.|++|||+.|++||||||+||+++.++.+||+|||++.......
T Consensus 96 e~~~~~~L~~~~~~~------~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~ 169 (296)
T cd06655 96 EYLAGGSLTDVVTET------CMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQ 169 (296)
T ss_pred EecCCCcHHHHHHhc------CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccchhccccc
Confidence 999999999998653 46889999999999999999999999999999999999999999999999988654332
Q ss_pred CcccccccccccceecccccccCCcCccccchhHHHHHHHHHhCCCCCCCCCCCccchhhhccccCCCCCCccccccccc
Q 002721 764 GTASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQILDARL 843 (888)
Q Consensus 764 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 843 (888)
.. .....++..|+|||.+.+..++.++|||||||++|+|++|+.||........ ......... . ..
T Consensus 170 ~~--~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~-~~~~~~~~~-~----------~~ 235 (296)
T cd06655 170 SK--RSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA-LYLIATNGT-P----------EL 235 (296)
T ss_pred cc--CCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHhcCC-c----------cc
Confidence 11 2234688899999999888899999999999999999999999975432111 110000000 0 00
Q ss_pred ccCCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002721 844 STVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVE 880 (888)
Q Consensus 844 ~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 880 (888)
.........+.+++.+||..||++||++.++++
T Consensus 236 ----~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~ 268 (296)
T cd06655 236 ----QNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQ 268 (296)
T ss_pred ----CCcccCCHHHHHHHHHHhhcChhhCCCHHHHhh
Confidence 011123346778999999999999999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=322.60 Aligned_cols=255 Identities=20% Similarity=0.233 Sum_probs=203.5
Q ss_pred hcCCcceeeecccceEEEEEeC-CCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCCeeEEEEe
Q 002721 606 TMKDSNMIYCGTFSTVYKAVMP-SGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVALLLHN 684 (888)
Q Consensus 606 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 684 (888)
+|+..+.||+|+||.||+|... +++.||+|.+...........+.+.+|+++++.++||||+++++++..++..|+|||
T Consensus 2 ~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 81 (316)
T cd05574 2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMD 81 (316)
T ss_pred ceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEE
Confidence 6888999999999999999965 589999999986544433455678999999999999999999999999999999999
Q ss_pred cCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccccccccCCCCC
Q 002721 685 YLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSKG 764 (888)
Q Consensus 685 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 764 (888)
|+.+++|.+++..... ..+++..+..++.|++.||+|||+.|++||||||+||+++.++.++++|||++........
T Consensus 82 ~~~~~~L~~~~~~~~~---~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~ 158 (316)
T cd05574 82 YCPGGELFRLLQRQPG---KCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPP 158 (316)
T ss_pred ecCCCCHHHHHHhCCC---CccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcCCCCEEEeecchhhccccccc
Confidence 9999999999875432 2578889999999999999999999999999999999999999999999999876542211
Q ss_pred cc---------------------------cccccccccceecccccccCCcCccccchhHHHHHHHHHhCCCCCCCCCCC
Q 002721 765 TA---------------------------SISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGE 817 (888)
Q Consensus 765 ~~---------------------------~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~ 817 (888)
.. ......|+..|+|||++.+..++.++||||||+++|+|++|+.||......
T Consensus 159 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~ 238 (316)
T cd05574 159 PVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRD 238 (316)
T ss_pred ccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCchH
Confidence 00 111346788999999999888999999999999999999999999754322
Q ss_pred ccchhhhccccCCCCCCcccccccccccCCcCcHHHHHHHHHHHhhccCCCCCCCCC----HHHHHH
Q 002721 818 GVDLVKWVHGAPARGETPEQILDARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPK----MKKVVE 880 (888)
Q Consensus 818 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs----~~evl~ 880 (888)
. .+... ....... .........+.+++.+||..||++||+ ++|+++
T Consensus 239 ~-~~~~~--------------~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~ 288 (316)
T cd05574 239 E-TFSNI--------------LKKEVTF--PGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQ 288 (316)
T ss_pred H-HHHHH--------------hcCCccC--CCccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHc
Confidence 1 11111 1000000 011114567889999999999999999 666665
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-35 Score=339.14 Aligned_cols=263 Identities=13% Similarity=0.122 Sum_probs=189.8
Q ss_pred HHHhcCCcceeeecccceEEEEEe-CCCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCC------CceeeeeeEEEe
Q 002721 603 VKATMKDSNMIYCGTFSTVYKAVM-PSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCH------DNLVRPIGFVIY 675 (888)
Q Consensus 603 ~~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h------pnIv~~~~~~~~ 675 (888)
..++|++.+.||+|+||+||+|.. .+++.||||+++.... .......|+++++.++| ++++++++++..
T Consensus 127 ~~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~----~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~ 202 (467)
T PTZ00284 127 STQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPK----YTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQN 202 (467)
T ss_pred CCCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchh----hHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEc
Confidence 356899999999999999999995 4688999999974322 12245567777776654 568999998876
Q ss_pred C-CeeEEEEecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhccc-CCeeecCCCCCCeEeCCCC-------
Q 002721 676 E-DVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHH-VAIIHLDISSGNVLLDADF------- 746 (888)
Q Consensus 676 ~-~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlkp~NIll~~~~------- 746 (888)
+ ...|+|||++ +++|.+++.... .+++..+..|+.||+.||+|||+ .|||||||||+|||++.++
T Consensus 203 ~~~~~~iv~~~~-g~~l~~~l~~~~-----~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~ 276 (467)
T PTZ00284 203 ETGHMCIVMPKY-GPCLLDWIMKHG-----PFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVT 276 (467)
T ss_pred CCceEEEEEecc-CCCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEecCCccccccc
Confidence 4 4788999988 678999887643 46888999999999999999998 5999999999999998765
Q ss_pred ---------CceEeccccccccCCCCCcccccccccccceecccccccCCcCccccchhHHHHHHHHHhCCCCCCCCCCC
Q 002721 747 ---------KPLLGEIEISKLLDPSKGTASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGE 817 (888)
Q Consensus 747 ---------~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~ 817 (888)
.+||+|||.+...... ....+||+.|+|||++.+..|+.++|||||||++|||++|+.||......
T Consensus 277 ~~~~~~~~~~vkl~DfG~~~~~~~~-----~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~~ 351 (467)
T PTZ00284 277 NRALPPDPCRVRICDLGGCCDERHS-----RTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDNL 351 (467)
T ss_pred ccccCCCCceEEECCCCccccCccc-----cccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH
Confidence 4999999987643221 23467999999999999999999999999999999999999999754321
Q ss_pred c-cchhhhccccCCCC-------CCcccccc----------c-----ccccCCcCcHHHHHHHHHHHhhccCCCCCCCCC
Q 002721 818 G-VDLVKWVHGAPARG-------ETPEQILD----------A-----RLSTVSFGWRKEMLTALKVALLCTDSTPAKRPK 874 (888)
Q Consensus 818 ~-~~~~~~~~~~~~~~-------~~~~~~~~----------~-----~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs 874 (888)
. ........+..... .....+.+ + ...............+.+++.+||++||++|||
T Consensus 352 ~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t 431 (467)
T PTZ00284 352 EHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLN 431 (467)
T ss_pred HHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCC
Confidence 1 00000000000000 00000000 0 000000000112356779999999999999999
Q ss_pred HHHHHH
Q 002721 875 MKKVVE 880 (888)
Q Consensus 875 ~~evl~ 880 (888)
++|+++
T Consensus 432 a~e~L~ 437 (467)
T PTZ00284 432 ARQMTT 437 (467)
T ss_pred HHHHhc
Confidence 999986
|
|
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-35 Score=314.84 Aligned_cols=260 Identities=20% Similarity=0.315 Sum_probs=203.3
Q ss_pred HHhcCCcceeeecccceEEEEEeC------CCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCC
Q 002721 604 KATMKDSNMIYCGTFSTVYKAVMP------SGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYED 677 (888)
Q Consensus 604 ~~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 677 (888)
.++|+..+.||+|+||+||+|+.. +.+.|++|.+..... ....+.+.+|++++++++||||+++++++.+.+
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~ 81 (275)
T cd05046 4 RSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTKD--ENLQSEFRRELDMFRKLSHKNVVRLLGLCREAE 81 (275)
T ss_pred hHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCccc--hHHHHHHHHHHHHHHhcCCcceeeeEEEECCCC
Confidence 467899999999999999999953 346799998864332 223457899999999999999999999999989
Q ss_pred eeEEEEecCCCCCHHHHhhccCCCC----CCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEecc
Q 002721 678 VALLLHNYLPNGTLAQLLHESTKQP----DYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEI 753 (888)
Q Consensus 678 ~~~lv~e~~~~g~L~~~l~~~~~~~----~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Df 753 (888)
..|+||||+++|+|.+++....... ...+++..+..++.|++.||+|||+.+|+||||||+||+++.++.++++||
T Consensus 82 ~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~~~ 161 (275)
T cd05046 82 PHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLL 161 (275)
T ss_pred cceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcccCcCccceEEEeCCCcEEEccc
Confidence 9999999999999999997654211 114789999999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCCcccccccccccceecccccccCCcCccccchhHHHHHHHHHh-CCCCCCCCCCCccchhhhccccCCCC
Q 002721 754 EISKLLDPSKGTASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILT-TRLPVEEDFGEGVDLVKWVHGAPARG 832 (888)
Q Consensus 754 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~ 832 (888)
|.+....... ........++..|+|||.+.+..++.++||||||+++|+|++ |..||...... ..........
T Consensus 162 ~~~~~~~~~~-~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~~~~~~~--~~~~~~~~~~--- 235 (275)
T cd05046 162 SLSKDVYNSE-YYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLSDE--EVLNRLQAGK--- 235 (275)
T ss_pred ccccccCccc-ccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCccccchH--HHHHHHHcCC---
Confidence 9987543221 112233456778999999888888999999999999999999 88898643221 1111111000
Q ss_pred CCcccccccccccCCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 002721 833 ETPEQILDARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEMLQ 883 (888)
Q Consensus 833 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~ 883 (888)
.... ........+.+++.+||+.+|++||++.|+++.|+
T Consensus 236 ----------~~~~--~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~l~ 274 (275)
T cd05046 236 ----------LELP--VPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSALG 274 (275)
T ss_pred ----------cCCC--CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHHhc
Confidence 0000 00112346788999999999999999999999886
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-35 Score=310.77 Aligned_cols=238 Identities=21% Similarity=0.326 Sum_probs=188.3
Q ss_pred ceeeecccceEEEEEeCC-C----------cEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCCee
Q 002721 611 NMIYCGTFSTVYKAVMPS-G----------LILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVA 679 (888)
Q Consensus 611 ~~ig~G~~g~Vy~~~~~~-~----------~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~ 679 (888)
+.||+|+||.||+|...+ + ..|++|.+...... ...+.+|+.++++++||||+++++++.. +..
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~~~----~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~ 75 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDHRD----SLAFFETASLMSQLSHKHLVKLYGVCVR-DEN 75 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccchhh----HHHHHHHHHHHHcCCCcchhheeeEEec-CCc
Confidence 468999999999999653 3 25777876643321 3578899999999999999999999988 778
Q ss_pred EEEEecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCC-------CceEec
Q 002721 680 LLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADF-------KPLLGE 752 (888)
Q Consensus 680 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~-------~~kl~D 752 (888)
++||||+++|+|.+++..... .+++..+..++.||+.||+|||++||+||||||+||+++.++ .+|++|
T Consensus 76 ~lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~D 151 (259)
T cd05037 76 IMVEEYVKFGPLDVFLHREKN----NVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSD 151 (259)
T ss_pred EEEEEcCCCCcHHHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEEEecCccccCCceeEEeCC
Confidence 999999999999999987542 467889999999999999999999999999999999999887 799999
Q ss_pred cccccccCCCCCcccccccccccceecccccccC--CcCccccchhHHHHHHHHHh-CCCCCCCCCCCccchhhhccccC
Q 002721 753 IEISKLLDPSKGTASISAVAGSFGYIPPEYAYTM--QVTAPGNVYSYGVVLLEILT-TRLPVEEDFGEGVDLVKWVHGAP 829 (888)
Q Consensus 753 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~ 829 (888)
||.+...... ....++..|+|||++.+. .++.++||||||+++|||++ |..||....... ...+..
T Consensus 152 fg~a~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~~~~~~--~~~~~~--- 220 (259)
T cd05037 152 PGIPITVLSR------EERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTLSSSE--KERFYQ--- 220 (259)
T ss_pred CCcccccccc------cccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCcccCCchh--HHHHHh---
Confidence 9998875431 233466789999998776 78999999999999999999 577776542111 011000
Q ss_pred CCCCCcccccccccccCCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 002721 830 ARGETPEQILDARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEMLQ 883 (888)
Q Consensus 830 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~ 883 (888)
....... .....+.+++.+||..+|++|||+.|+++.|+
T Consensus 221 ----------~~~~~~~-----~~~~~~~~li~~~l~~~p~~Rpt~~~il~~l~ 259 (259)
T cd05037 221 ----------DQHRLPM-----PDCAELANLINQCWTYDPTKRPSFRAILRDLN 259 (259)
T ss_pred ----------cCCCCCC-----CCchHHHHHHHHHhccChhhCCCHHHHHHhcC
Confidence 0000000 01157789999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-35 Score=317.34 Aligned_cols=255 Identities=19% Similarity=0.270 Sum_probs=203.3
Q ss_pred HHhcCCcceeeecccceEEEEEe-CCCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCCeeEEE
Q 002721 604 KATMKDSNMIYCGTFSTVYKAVM-PSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVALLL 682 (888)
Q Consensus 604 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 682 (888)
..+|++.+.||+|+||+||+|.. .+++.||+|++..... ....+.+.+|+++++.++||||+++++++...+..++|
T Consensus 4 ~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv 81 (284)
T cd06620 4 NEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGAK--SSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMC 81 (284)
T ss_pred HHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecCc--chHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEE
Confidence 46788999999999999999995 4689999998874432 22345789999999999999999999999999999999
Q ss_pred EecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhccc-CCeeecCCCCCCeEeCCCCCceEeccccccccCC
Q 002721 683 HNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHH-VAIIHLDISSGNVLLDADFKPLLGEIEISKLLDP 761 (888)
Q Consensus 683 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~~~ 761 (888)
|||+++++|.+++...+ .+++..+..++.|++.||.|||+ ++++||||||+||++++++.++++|||++.....
T Consensus 82 ~e~~~~~~L~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~ 156 (284)
T cd06620 82 MEFMDCGSLDRIYKKGG-----PIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELIN 156 (284)
T ss_pred EecCCCCCHHHHHHhcc-----CCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhh
Confidence 99999999999987643 46888999999999999999997 6999999999999999999999999999875432
Q ss_pred CCCcccccccccccceecccccccCCcCccccchhHHHHHHHHHhCCCCCCCCCCCcc------chhhhccccCCCCCCc
Q 002721 762 SKGTASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGV------DLVKWVHGAPARGETP 835 (888)
Q Consensus 762 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~------~~~~~~~~~~~~~~~~ 835 (888)
.. .....|+..|+|||++.+..++.++|||||||++|++++|+.||........ .......
T Consensus 157 ~~----~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~--------- 223 (284)
T cd06620 157 SI----ADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPMGILDLLQ--------- 223 (284)
T ss_pred hc----cCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhhHHHHHHH---------
Confidence 21 1235689999999999888899999999999999999999999976433210 0001000
Q ss_pred ccccccccccCCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002721 836 EQILDARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEM 881 (888)
Q Consensus 836 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~ 881 (888)
.+........ ........+.+++.+|++.||++|||++|+++.
T Consensus 224 -~~~~~~~~~~--~~~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~ 266 (284)
T cd06620 224 -QIVQEPPPRL--PSSDFPEDLRDFVDACLLKDPTERPTPQQLCAM 266 (284)
T ss_pred -HHhhccCCCC--CchhcCHHHHHHHHHHhcCCcccCcCHHHHhcC
Confidence 0000000000 111234567889999999999999999999975
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=316.31 Aligned_cols=253 Identities=22% Similarity=0.286 Sum_probs=200.3
Q ss_pred HHhcCCcceeeecccceEEEEEe-CCCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCCeeEEE
Q 002721 604 KATMKDSNMIYCGTFSTVYKAVM-PSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVALLL 682 (888)
Q Consensus 604 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 682 (888)
.++|++.+.||+|+||.||+|.. .+++.||+|+++..... ..+.+.+|++++++++||||+++++++..++..|+|
T Consensus 4 ~~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (280)
T cd06611 4 NDIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIESEE---ELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWIL 80 (280)
T ss_pred hhHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeCCHH---HHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEE
Confidence 45789999999999999999995 46899999998754322 334788999999999999999999999999999999
Q ss_pred EecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccccccccCCC
Q 002721 683 HNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPS 762 (888)
Q Consensus 683 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 762 (888)
|||+++++|.+++..... .+++..+..++.|++.||.|||+.||+||||||+||+++.++.++++|||.+......
T Consensus 81 ~e~~~~~~L~~~~~~~~~----~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~ 156 (280)
T cd06611 81 IEFCDGGALDSIMLELER----GLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKST 156 (280)
T ss_pred eeccCCCcHHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCCCCEEEccCccchhhccc
Confidence 999999999999876432 4788999999999999999999999999999999999999999999999988765432
Q ss_pred CCcccccccccccceecccccc-----cCCcCccccchhHHHHHHHHHhCCCCCCCCCCCccchhhhccccCCCCCCccc
Q 002721 763 KGTASISAVAGSFGYIPPEYAY-----TMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQ 837 (888)
Q Consensus 763 ~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 837 (888)
.. ......++..|+|||++. +..++.++||||+|+++|||++|+.||....... ..........
T Consensus 157 ~~--~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~-~~~~~~~~~~-------- 225 (280)
T cd06611 157 LQ--KRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMR-VLLKILKSEP-------- 225 (280)
T ss_pred cc--ccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHH-HHHHHhcCCC--------
Confidence 21 123456888999999874 3457789999999999999999999997542211 0111100000
Q ss_pred ccccccccCCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002721 838 ILDARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEM 881 (888)
Q Consensus 838 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~ 881 (888)
+... .......++.+++.+||+.+|++||++.++++.
T Consensus 226 ---~~~~----~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 262 (280)
T cd06611 226 ---PTLD----QPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKH 262 (280)
T ss_pred ---CCcC----CcccCCHHHHHHHHHHhccChhhCcCHHHHhcC
Confidence 0000 011123457789999999999999999999864
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=313.31 Aligned_cols=257 Identities=19% Similarity=0.278 Sum_probs=201.6
Q ss_pred hcCCcceeeecccceEEEEEeCC--CcEEEEEEeeccCh-------hhhHHHHHHHHHHHHHhc-cCCCceeeeeeEEEe
Q 002721 606 TMKDSNMIYCGTFSTVYKAVMPS--GLILSVKRLKSMDR-------TIIHHQNKMIRELEKLSK-LCHDNLVRPIGFVIY 675 (888)
Q Consensus 606 ~~~~~~~ig~G~~g~Vy~~~~~~--~~~vavK~~~~~~~-------~~~~~~~~~~~E~~~l~~-l~hpnIv~~~~~~~~ 675 (888)
.|++.+.||+|+||.||+|.... ++.+|+|.+..... .......++.+|+.++.+ ++||||+++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 47788999999999999999654 78999998863221 222334467789988875 799999999999999
Q ss_pred CCeeEEEEecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhccc-CCeeecCCCCCCeEeCCCCCceEeccc
Q 002721 676 EDVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHH-VAIIHLDISSGNVLLDADFKPLLGEIE 754 (888)
Q Consensus 676 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlkp~NIll~~~~~~kl~Dfg 754 (888)
++..++||||+++++|.+++....... ..+++..++.++.|++.||.|||+ .|++||||||+||+++.++.+|++|||
T Consensus 81 ~~~~~lv~e~~~~~~l~~~l~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~dfg 159 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEHFNSLKEKK-QRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFG 159 (269)
T ss_pred CCeEEEEEecCCCCcHHHHHHHHHhcc-CCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHHHEEECCCCcEEEeccc
Confidence 999999999999999999986532221 257888999999999999999996 789999999999999999999999999
Q ss_pred cccccCCCCCcccccccccccceecccccccCCcCccccchhHHHHHHHHHhCCCCCCCCCCCccchhhhccccCCCCCC
Q 002721 755 ISKLLDPSKGTASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGET 834 (888)
Q Consensus 755 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~ 834 (888)
.+....... ......++..|+|||...+..++.++||||||+++|||++|+.||....... ....
T Consensus 160 ~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~--~~~~---------- 224 (269)
T cd08528 160 LAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLS--LATK---------- 224 (269)
T ss_pred ceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHH--HHHH----------
Confidence 998755432 2334568889999999998889999999999999999999999996432110 0000
Q ss_pred cccccccccccCCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 002721 835 PEQILDARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEMLQ 883 (888)
Q Consensus 835 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~ 883 (888)
+........ ........+.+++.+||+.||++||++.|+.++++
T Consensus 225 ---~~~~~~~~~--~~~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~~~ 268 (269)
T cd08528 225 ---IVEAVYEPL--PEGMYSEDVTDVITSCLTPDAEARPDIIQVSAMIS 268 (269)
T ss_pred ---HhhccCCcC--CcccCCHHHHHHHHHHCCCCCccCCCHHHHHHHhc
Confidence 000000000 01122356788999999999999999999999886
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-35 Score=310.91 Aligned_cols=252 Identities=22% Similarity=0.283 Sum_probs=194.5
Q ss_pred hcCCcceeeecccceEEEEEe-CCCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCCeeEEEEe
Q 002721 606 TMKDSNMIYCGTFSTVYKAVM-PSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVALLLHN 684 (888)
Q Consensus 606 ~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 684 (888)
.+.....||+|+||.||+|+. .++..||+|.+...... ..+.+.+|++++++++||||+++++++..++..++|||
T Consensus 9 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 85 (268)
T cd06624 9 ENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPERDSR---YVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFME 85 (268)
T ss_pred cCCceEEEecCCceEEEEeEecCCCcEEEEEEecCCCHH---HHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEe
Confidence 445567899999999999994 46889999988754332 23478899999999999999999999999999999999
Q ss_pred cCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCC-CCCceEeccccccccCCCC
Q 002721 685 YLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDA-DFKPLLGEIEISKLLDPSK 763 (888)
Q Consensus 685 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~-~~~~kl~Dfg~a~~~~~~~ 763 (888)
|+++++|.+++...... ...++..+..++.||+.||+|||++||+||||||+||+++. ++.++|+|||.+.......
T Consensus 86 ~~~~~~L~~~l~~~~~~--~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~ 163 (268)
T cd06624 86 QVPGGSLSALLRSKWGP--LKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGIN 163 (268)
T ss_pred cCCCCCHHHHHHHhccc--CCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheecccCC
Confidence 99999999999864221 02267788899999999999999999999999999999976 6799999999987654322
Q ss_pred CcccccccccccceecccccccCC--cCccccchhHHHHHHHHHhCCCCCCCCCCCccchhhhccccCCCCCCccccccc
Q 002721 764 GTASISAVAGSFGYIPPEYAYTMQ--VTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQILDA 841 (888)
Q Consensus 764 ~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 841 (888)
. ......++..|+|||++.+.. ++.++||||+|+++|+|++|+.||............ .. ...
T Consensus 164 ~--~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~~--~~-----------~~~ 228 (268)
T cd06624 164 P--CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMFK--VG-----------MFK 228 (268)
T ss_pred C--ccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHhh--hh-----------hhc
Confidence 1 122345788999999886543 788999999999999999999999653221110000 00 000
Q ss_pred ccccCCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002721 842 RLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVE 880 (888)
Q Consensus 842 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 880 (888)
.. +........++.+++.+||+.+|++|||+.|+++
T Consensus 229 ~~---~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 264 (268)
T cd06624 229 IH---PEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQ 264 (268)
T ss_pred cC---CCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHh
Confidence 00 0011123456778999999999999999999986
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-35 Score=309.92 Aligned_cols=250 Identities=20% Similarity=0.313 Sum_probs=200.4
Q ss_pred hcCCcceeeecccceEEEEEe-CCCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCCeeEEEEe
Q 002721 606 TMKDSNMIYCGTFSTVYKAVM-PSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVALLLHN 684 (888)
Q Consensus 606 ~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 684 (888)
+|+..+.||+|+||.||+|.. .+++.+|+|++...... ......+.+|++++++++||||+++++.+..++..++|||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 79 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMT-KDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVME 79 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEeccccc-cHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEe
Confidence 478889999999999999995 46899999998754322 2335678999999999999999999999999999999999
Q ss_pred cCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCC-CCceEeccccccccCCCC
Q 002721 685 YLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDAD-FKPLLGEIEISKLLDPSK 763 (888)
Q Consensus 685 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~-~~~kl~Dfg~a~~~~~~~ 763 (888)
|+++++|.+++...... .+++..+..++.|++.|++|||++|++||||||+||+++++ +.+|++|||.+.......
T Consensus 80 ~~~~~~L~~~~~~~~~~---~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (256)
T cd08220 80 YAPGGTLAEYIQKRCNS---LLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS 156 (256)
T ss_pred cCCCCCHHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc
Confidence 99999999999865322 46888999999999999999999999999999999999855 458999999998765332
Q ss_pred CcccccccccccceecccccccCCcCccccchhHHHHHHHHHhCCCCCCCCCCCccchhhhccccCCCCCCccccccccc
Q 002721 764 GTASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQILDARL 843 (888)
Q Consensus 764 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 843 (888)
. .....++..|+|||.+.+..++.++||||+|+++|+|++|+.||....... ..... .....
T Consensus 157 ~---~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~--~~~~~-------------~~~~~ 218 (256)
T cd08220 157 K---AYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPA--LVLKI-------------MSGTF 218 (256)
T ss_pred c---ccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHH--HHHHH-------------HhcCC
Confidence 1 123467889999999988889999999999999999999999996532211 11110 00000
Q ss_pred ccCCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002721 844 STVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVE 880 (888)
Q Consensus 844 ~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 880 (888)
... .......+.+++.+||+.+|++|||+.|+++
T Consensus 219 ~~~---~~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~ 252 (256)
T cd08220 219 API---SDRYSPDLRQLILSMLNLDPSKRPQLSQIMA 252 (256)
T ss_pred CCC---CCCcCHHHHHHHHHHccCChhhCCCHHHHhh
Confidence 000 1123456778999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=309.54 Aligned_cols=250 Identities=24% Similarity=0.313 Sum_probs=200.4
Q ss_pred hcCCcceeeecccceEEEEEeC-CCcEEEEEEeeccCh--hhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCCeeEEE
Q 002721 606 TMKDSNMIYCGTFSTVYKAVMP-SGLILSVKRLKSMDR--TIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVALLL 682 (888)
Q Consensus 606 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~--~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 682 (888)
+|+..+.||+|+||.||+|... +++.|++|.+..... ...+..+.+.+|+++++.++||||+++++++..++..++|
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIF 80 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEE
Confidence 4778899999999999999965 789999999865332 2233445789999999999999999999999999999999
Q ss_pred EecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccccccccCCC
Q 002721 683 HNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPS 762 (888)
Q Consensus 683 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 762 (888)
|||+++++|.+++.... .+++..+..++.|+++|++|||+.|++|+||+|+||+++.++.+||+|||.+......
T Consensus 81 ~e~~~~~~L~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~ 155 (258)
T cd06632 81 LELVPGGSLAKLLKKYG-----SFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEF 155 (258)
T ss_pred EEecCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEccCccceecccc
Confidence 99999999999997643 4678899999999999999999999999999999999999999999999998875433
Q ss_pred CCcccccccccccceecccccccCC-cCccccchhHHHHHHHHHhCCCCCCCCCCCccchhhhccccCCCCCCccccccc
Q 002721 763 KGTASISAVAGSFGYIPPEYAYTMQ-VTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQILDA 841 (888)
Q Consensus 763 ~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 841 (888)
. ......++..|+|||.+.... ++.++|+||||+++|+|++|+.||...... ........ . .
T Consensus 156 ~---~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~-~~~~~~~~-~------------~ 218 (258)
T cd06632 156 S---FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGV-AAVFKIGR-S------------K 218 (258)
T ss_pred c---cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHH-HHHHHHHh-c------------c
Confidence 2 123456888999999987766 899999999999999999999999754311 10111000 0 0
Q ss_pred ccccCCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002721 842 RLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVE 880 (888)
Q Consensus 842 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 880 (888)
.... ........+.+++.+||+.+|++||++.+++.
T Consensus 219 ~~~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 254 (258)
T cd06632 219 ELPP---IPDHLSDEAKDFILKCLQRDPSLRPTAAELLE 254 (258)
T ss_pred cCCC---cCCCcCHHHHHHHHHHhhcCcccCcCHHHHhc
Confidence 0000 11122456678999999999999999999975
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=312.27 Aligned_cols=250 Identities=19% Similarity=0.185 Sum_probs=206.6
Q ss_pred HHHhcCCcceeeecccceEEEEE-eCCCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCCeeEE
Q 002721 603 VKATMKDSNMIYCGTFSTVYKAV-MPSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVALL 681 (888)
Q Consensus 603 ~~~~~~~~~~ig~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 681 (888)
..+.|+.-++||+||||.||-++ ..+|+.||+|.+.+..........-...|-.++.++..+.||.+--.|+..+..++
T Consensus 183 t~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LCl 262 (591)
T KOG0986|consen 183 TKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCL 262 (591)
T ss_pred cccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEE
Confidence 35578889999999999999999 45799999999876554444444567889999999999999999999999999999
Q ss_pred EEecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccccccccCC
Q 002721 682 LHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDP 761 (888)
Q Consensus 682 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~~~ 761 (888)
|+..|.||||.-+|...+.. .++++.++.++.+|+.||++||+.+||+||+||+|||+|+.|+++|+|.|+|..+..
T Consensus 263 VLtlMNGGDLkfHiyn~g~~---gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~ 339 (591)
T KOG0986|consen 263 VLTLMNGGDLKFHIYNHGNP---GFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVEIPE 339 (591)
T ss_pred EEEeecCCceeEEeeccCCC---CCchHHHHHHHHHHHhhHHHHHhcceeeccCChhheeeccCCCeEeeccceEEecCC
Confidence 99999999999888876642 688999999999999999999999999999999999999999999999999998876
Q ss_pred CCCcccccccccccceecccccccCCcCccccchhHHHHHHHHHhCCCCCCCCCCCccchhhhccccCCCCCCccccccc
Q 002721 762 SKGTASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQILDA 841 (888)
Q Consensus 762 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 841 (888)
+.. ....+||.+|||||++.++.|+...|.||+||++|||+.|+.||...... ...+-+++
T Consensus 340 g~~---~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeK----------------vk~eEvdr 400 (591)
T KOG0986|consen 340 GKP---IRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEK----------------VKREEVDR 400 (591)
T ss_pred CCc---cccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhh----------------hhHHHHHH
Confidence 543 34568999999999999999999999999999999999999999753111 11111222
Q ss_pred cccc-CCcCcHHHHHHHHHHHhhccCCCCCCCCC
Q 002721 842 RLST-VSFGWRKEMLTALKVALLCTDSTPAKRPK 874 (888)
Q Consensus 842 ~~~~-~~~~~~~~~~~~~~li~~cl~~dP~~RPs 874 (888)
+... ........++++.++....+.+||++|.-
T Consensus 401 r~~~~~~ey~~kFS~eakslc~~LL~Kdp~~RLG 434 (591)
T KOG0986|consen 401 RTLEDPEEYSDKFSEEAKSLCEGLLTKDPEKRLG 434 (591)
T ss_pred HHhcchhhcccccCHHHHHHHHHHHccCHHHhcc
Confidence 2211 11222445667778888899999999974
|
|
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=314.89 Aligned_cols=256 Identities=21% Similarity=0.232 Sum_probs=196.6
Q ss_pred HHHhcCCcceeeecccceEEEEEe-CCCcEEEEEEeeccChhhhHHHHHHHHHHHHHhcc-CCCceeeeeeEEE-----e
Q 002721 603 VKATMKDSNMIYCGTFSTVYKAVM-PSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKL-CHDNLVRPIGFVI-----Y 675 (888)
Q Consensus 603 ~~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~-----~ 675 (888)
..++|++.+.||+|+||.||+|.. .+++.||+|+++..... ...+.+|+.+++++ +||||+++++++. .
T Consensus 16 ~~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~----~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~ 91 (286)
T cd06638 16 PSDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIHDI----DEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKN 91 (286)
T ss_pred cccceeeeeeeccCCCcEEEEEEECCCCceeEEEeeccccch----HHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCC
Confidence 456899999999999999999985 46889999987643221 23677899999999 6999999999874 3
Q ss_pred CCeeEEEEecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEecccc
Q 002721 676 EDVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEI 755 (888)
Q Consensus 676 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~ 755 (888)
++..++||||+++++|.+++...... ...+++..+..++.|++.||.|||+.+++||||||+||++++++.+|++|||.
T Consensus 92 ~~~~~lv~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~dfg~ 170 (286)
T cd06638 92 GDQLWLVLELCNGGSVTDLVKGFLKR-GERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGV 170 (286)
T ss_pred CCeEEEEEeecCCCCHHHHHHHhhcc-CccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhEEECCCCCEEEccCCc
Confidence 45789999999999999988643222 12578889999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCcccccccccccceeccccccc-----CCcCccccchhHHHHHHHHHhCCCCCCCCCCCccchhhhccccCC
Q 002721 756 SKLLDPSKGTASISAVAGSFGYIPPEYAYT-----MQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPA 830 (888)
Q Consensus 756 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~ 830 (888)
+........ ......|+..|+|||++.. ..++.++||||+||++|||++|+.||....... .........
T Consensus 171 ~~~~~~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~~-~~~~~~~~~-- 245 (286)
T cd06638 171 SAQLTSTRL--RRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPMR-ALFKIPRNP-- 245 (286)
T ss_pred eeecccCCC--ccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchhH-HHhhccccC--
Confidence 887643221 1233468899999998753 457889999999999999999999997532211 111100000
Q ss_pred CCCCcccccccccccCCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002721 831 RGETPEQILDARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEM 881 (888)
Q Consensus 831 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~ 881 (888)
...... .......+.+++.+||+.||++|||+.|+++.
T Consensus 246 ----~~~~~~---------~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 283 (286)
T cd06638 246 ----PPTLHQ---------PELWSNEFNDFIRKCLTKDYEKRPTVSDLLQH 283 (286)
T ss_pred ----CCcccC---------CCCcCHHHHHHHHHHccCCcccCCCHHHHhhc
Confidence 000000 01112457789999999999999999999875
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-35 Score=316.35 Aligned_cols=253 Identities=23% Similarity=0.303 Sum_probs=199.2
Q ss_pred hcCCcceeeecccceEEEEEeC-CCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCCeeEEEEe
Q 002721 606 TMKDSNMIYCGTFSTVYKAVMP-SGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVALLLHN 684 (888)
Q Consensus 606 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 684 (888)
+|++.+.||+|+||.||+|... +++.||+|.++.... ....+.+.+|++++++++||||+++++++..++..|+|||
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~~--~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 79 (286)
T cd06622 2 EIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLELD--ESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCME 79 (286)
T ss_pred hhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecccC--HHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEe
Confidence 6888999999999999999964 789999998874322 2233578899999999999999999999999999999999
Q ss_pred cCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhccc-CCeeecCCCCCCeEeCCCCCceEeccccccccCCCC
Q 002721 685 YLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHH-VAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSK 763 (888)
Q Consensus 685 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 763 (888)
|+++++|.+++..... ...+++..+..++.|++.||.|||+ .||+||||||+||+++.++.+|++|||.+.......
T Consensus 80 ~~~~~~l~~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~ 157 (286)
T cd06622 80 YMDAGSLDKLYAGGVA--TEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL 157 (286)
T ss_pred ecCCCCHHHHHHhccc--cCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCCc
Confidence 9999999999876421 1257889999999999999999996 699999999999999999999999999987654322
Q ss_pred CcccccccccccceecccccccC------CcCccccchhHHHHHHHHHhCCCCCCCCCCCccchhhhccccCCCCCCccc
Q 002721 764 GTASISAVAGSFGYIPPEYAYTM------QVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQ 837 (888)
Q Consensus 764 ~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 837 (888)
.....++..|+|||.+.+. .++.++||||+||++|+|++|+.||........ .... ..
T Consensus 158 ----~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~--~~~~----------~~ 221 (286)
T cd06622 158 ----AKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANI--FAQL----------SA 221 (286)
T ss_pred ----cccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhhH--HHHH----------HH
Confidence 1234578899999988554 358899999999999999999999965321110 0000 00
Q ss_pred ccccccccCCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002721 838 ILDARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEM 881 (888)
Q Consensus 838 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~ 881 (888)
+....... .......++.+++.+||..+|++||+++++++.
T Consensus 222 ~~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~ 262 (286)
T cd06622 222 IVDGDPPT---LPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEH 262 (286)
T ss_pred HhhcCCCC---CCcccCHHHHHHHHHHcccCcccCCCHHHHhcC
Confidence 11111111 112245667889999999999999999999873
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-35 Score=312.77 Aligned_cols=253 Identities=23% Similarity=0.310 Sum_probs=202.3
Q ss_pred hcCCcceeeecccceEEEEEeC-CCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCCeeEEEEe
Q 002721 606 TMKDSNMIYCGTFSTVYKAVMP-SGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVALLLHN 684 (888)
Q Consensus 606 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 684 (888)
+|+..+.||+|+||.||+|... +++.||+|++...... ...+++.+|++++++++||||+++++++..++..++++|
T Consensus 2 ~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e 79 (265)
T cd06605 2 DLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEINE--AIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICME 79 (265)
T ss_pred cchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEecccCh--HHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEE
Confidence 5778889999999999999965 6899999998754332 334578899999999999999999999999999999999
Q ss_pred cCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhccc-CCeeecCCCCCCeEeCCCCCceEeccccccccCCCC
Q 002721 685 YLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHH-VAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSK 763 (888)
Q Consensus 685 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 763 (888)
|+++++|.+++.... ..+++..+..++.|+++|++|+|+ .|++||||||+||++++++.++|+|||.+.......
T Consensus 80 ~~~~~~L~~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~ 155 (265)
T cd06605 80 YMDGGSLDKILKEVQ----GRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSL 155 (265)
T ss_pred ecCCCcHHHHHHHcc----CCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHH
Confidence 999999999998653 156788999999999999999999 999999999999999999999999999987654221
Q ss_pred CcccccccccccceecccccccCCcCccccchhHHHHHHHHHhCCCCCCCCCCCccchhhhccccCCCCCCccccccccc
Q 002721 764 GTASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQILDARL 843 (888)
Q Consensus 764 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 843 (888)
. ....++..|+|||.+.+..++.++||||+|+++|+|++|+.||................ +.....
T Consensus 156 ~----~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~----------~~~~~~ 221 (265)
T cd06605 156 A----KTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQY----------IVNEPP 221 (265)
T ss_pred h----hcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHHH----------HhcCCC
Confidence 1 12567889999999988899999999999999999999999997543211111111100 000000
Q ss_pred ccCCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002721 844 STVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVE 880 (888)
Q Consensus 844 ~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 880 (888)
... .......++.+++.+||..||++|||+.|++.
T Consensus 222 ~~~--~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~ 256 (265)
T cd06605 222 PRL--PSGKFSPDFQDFVNLCLIKDPRERPSYKELLE 256 (265)
T ss_pred CCC--ChhhcCHHHHHHHHHHcCCCchhCcCHHHHhh
Confidence 000 01114556789999999999999999999975
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-35 Score=316.26 Aligned_cols=250 Identities=22% Similarity=0.309 Sum_probs=198.8
Q ss_pred HHhcCCcceeeecccceEEEEEeC-CCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCCeeEEE
Q 002721 604 KATMKDSNMIYCGTFSTVYKAVMP-SGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVALLL 682 (888)
Q Consensus 604 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 682 (888)
...|+..+.||+|+||+||+|+.. +++.||+|.+...........+.+.+|+++++.++||||+++++++..++..|+|
T Consensus 14 ~~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv 93 (307)
T cd06607 14 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLV 93 (307)
T ss_pred chhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEE
Confidence 356899999999999999999954 6899999998754444444455788999999999999999999999999999999
Q ss_pred EecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccccccccCCC
Q 002721 683 HNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPS 762 (888)
Q Consensus 683 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 762 (888)
|||++ |++.+++..... .+++..+..++.|++.||.|||+.||+||||+|+||++++++.++|+|||.+......
T Consensus 94 ~e~~~-g~l~~~~~~~~~----~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~ 168 (307)
T cd06607 94 MEYCL-GSASDILEVHKK----PLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA 168 (307)
T ss_pred HHhhC-CCHHHHHHHccc----CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCCCCEEEeecCcceecCCC
Confidence 99997 578777764332 4788999999999999999999999999999999999999999999999998765432
Q ss_pred CCcccccccccccceecccccc---cCCcCccccchhHHHHHHHHHhCCCCCCCCCCCccchhhhccccCCCCCCccccc
Q 002721 763 KGTASISAVAGSFGYIPPEYAY---TMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQIL 839 (888)
Q Consensus 763 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 839 (888)
....++..|+|||++. ...++.++||||||+++|||++|+.||........ ....... ..
T Consensus 169 ------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~--~~~~~~~----~~----- 231 (307)
T cd06607 169 ------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA--LYHIAQN----DS----- 231 (307)
T ss_pred ------CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHH--HHHHhcC----CC-----
Confidence 2345788999999874 45688999999999999999999999965321110 0000000 00
Q ss_pred ccccccCCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002721 840 DARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEM 881 (888)
Q Consensus 840 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~ 881 (888)
.. .........+.+++.+||..+|++||++.+++..
T Consensus 232 ----~~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 267 (307)
T cd06607 232 ----PT--LSSNDWSDYFRNFVDSCLQKIPQDRPSSEELLKH 267 (307)
T ss_pred ----CC--CCchhhCHHHHHHHHHHhcCChhhCcCHHHHhcC
Confidence 00 0111234567899999999999999999999863
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-35 Score=315.72 Aligned_cols=267 Identities=19% Similarity=0.242 Sum_probs=196.6
Q ss_pred HhcCCcceeeecccceEEEEEeC-CCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCCeeEEEE
Q 002721 605 ATMKDSNMIYCGTFSTVYKAVMP-SGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVALLLH 683 (888)
Q Consensus 605 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 683 (888)
++|+..+.||+|++|.||+|+.. +++.||+|.+....... ....+.+|++++++++||||+++++++..++..++||
T Consensus 5 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~--~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 82 (291)
T cd07844 5 ETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHEEG--APFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVF 82 (291)
T ss_pred cceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccccC--CchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEE
Confidence 57888999999999999999954 68999999987433221 1225678999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccccccccCCCC
Q 002721 684 NYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSK 763 (888)
Q Consensus 684 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 763 (888)
||+++ +|.+++..... .+++..+..++.|+++||.|||++||+||||||+||+++.++.+|++|||.+.......
T Consensus 83 e~~~~-~L~~~~~~~~~----~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~ 157 (291)
T cd07844 83 EYLDT-DLKQYMDDCGG----GLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPS 157 (291)
T ss_pred ecCCC-CHHHHHHhCCC----CCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcCCCCEEECccccccccCCCC
Confidence 99985 99998876432 46788999999999999999999999999999999999999999999999987543211
Q ss_pred Ccccccccccccceeccccccc-CCcCccccchhHHHHHHHHHhCCCCCCCCCCCccchhhh--ccccCCCCCCccc---
Q 002721 764 GTASISAVAGSFGYIPPEYAYT-MQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKW--VHGAPARGETPEQ--- 837 (888)
Q Consensus 764 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~--~~~~~~~~~~~~~--- 837 (888)
. ......++..|+|||++.+ ..++.++||||+|+++|||++|+.||.........+... ....+........
T Consensus 158 ~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (291)
T cd07844 158 K--TYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSN 235 (291)
T ss_pred c--cccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhc
Confidence 1 1122346788999998865 458899999999999999999999997543211111100 0000000000000
Q ss_pred --ccccccccCC-----c--CcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002721 838 --ILDARLSTVS-----F--GWRKEMLTALKVALLCTDSTPAKRPKMKKVVE 880 (888)
Q Consensus 838 --~~~~~~~~~~-----~--~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 880 (888)
.......... . ........+.+++.+|++.+|++|||+.|+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~e~l~ 287 (291)
T cd07844 236 PEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAAEAMK 287 (291)
T ss_pred cccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHHHHhc
Confidence 0000000000 0 00011256778999999999999999999875
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-35 Score=308.85 Aligned_cols=252 Identities=23% Similarity=0.367 Sum_probs=199.9
Q ss_pred cCCcceeeecccceEEEEEeCC-----CcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCCeeEE
Q 002721 607 MKDSNMIYCGTFSTVYKAVMPS-----GLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVALL 681 (888)
Q Consensus 607 ~~~~~~ig~G~~g~Vy~~~~~~-----~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 681 (888)
+++.+.||+|+||.||+|+... +..||+|+++..... ...+.+.+|+++++.++||||+++++++.+.+..++
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~ 78 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDADE--QQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMI 78 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCCCh--HHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEE
Confidence 3567899999999999999543 488999999754332 134578899999999999999999999999999999
Q ss_pred EEecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccccccccCC
Q 002721 682 LHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDP 761 (888)
Q Consensus 682 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~~~ 761 (888)
+|||+++++|.+++...... .+++.++..++.|++.||+|||+.|++||||||+||++++++.++++|||.+.....
T Consensus 79 i~e~~~~~~l~~~~~~~~~~---~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~ 155 (258)
T smart00219 79 VMEYMEGGDLLDYLRKNRPK---ELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYD 155 (258)
T ss_pred EEeccCCCCHHHHHHhhhhc---cCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEEccCCeEEEcccCCceeccc
Confidence 99999999999999864321 278899999999999999999999999999999999999999999999999987654
Q ss_pred CCCcccccccccccceecccccccCCcCccccchhHHHHHHHHHh-CCCCCCCCCCCccchhhhccccCCCCCCcccccc
Q 002721 762 SKGTASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILT-TRLPVEEDFGEGVDLVKWVHGAPARGETPEQILD 840 (888)
Q Consensus 762 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 840 (888)
...... ....++..|+|||...+..++.++||||+|+++|+|++ |..||...... +..+......
T Consensus 156 ~~~~~~-~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~--~~~~~~~~~~----------- 221 (258)
T smart00219 156 DDYYKK-KGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNE--EVLEYLKKGY----------- 221 (258)
T ss_pred cccccc-ccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHH--HHHHHHhcCC-----------
Confidence 322111 12336789999999988889999999999999999998 78888653211 1111111000
Q ss_pred cccccCCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 002721 841 ARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEML 882 (888)
Q Consensus 841 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L 882 (888)
... .......++.+++.+|+..||++|||+.|+++.|
T Consensus 222 --~~~---~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~l 258 (258)
T smart00219 222 --RLP---KPENCPPEIYKLMLQCWAEDPEDRPTFSELVEIL 258 (258)
T ss_pred --CCC---CCCcCCHHHHHHHHHHCcCChhhCcCHHHHHhhC
Confidence 000 0111345678899999999999999999998764
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=298.01 Aligned_cols=276 Identities=20% Similarity=0.236 Sum_probs=207.9
Q ss_pred HHhcCCcceeeecccceEEEEEeC---C--CcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEe-CC
Q 002721 604 KATMKDSNMIYCGTFSTVYKAVMP---S--GLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIY-ED 677 (888)
Q Consensus 604 ~~~~~~~~~ig~G~~g~Vy~~~~~---~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~-~~ 677 (888)
...|+.+..||+|.||.||+|... + .+.+|+|.++.... .........||+..++.++||||+.+..++.. +.
T Consensus 23 l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd-~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~ 101 (438)
T KOG0666|consen 23 LFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKD-GTGISMSACREIALLRELKHPNVISLVKVFLSHDK 101 (438)
T ss_pred HHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCC-CCCcCHHHHHHHHHHHHhcCCcchhHHHHHhccCc
Confidence 347899999999999999999632 2 34799999985422 12222368899999999999999999999887 78
Q ss_pred eeEEEEecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCC----CCceEecc
Q 002721 678 VALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDAD----FKPLLGEI 753 (888)
Q Consensus 678 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~----~~~kl~Df 753 (888)
..|+++||.+. ||.++|+-........++...+..|+.||+.|+.|||++=|+||||||.||||..+ |.+||+|+
T Consensus 102 ~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDl 180 (438)
T KOG0666|consen 102 KVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADL 180 (438)
T ss_pred eEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeecc
Confidence 99999999987 99999987665555578888999999999999999999999999999999999887 99999999
Q ss_pred ccccccCCC-CCcccccccccccceecccccccC-CcCccccchhHHHHHHHHHhCCCCCCCCCCCc--------cchhh
Q 002721 754 EISKLLDPS-KGTASISAVAGSFGYIPPEYAYTM-QVTAPGNVYSYGVVLLEILTTRLPVEEDFGEG--------VDLVK 823 (888)
Q Consensus 754 g~a~~~~~~-~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~P~~~~~~~~--------~~~~~ 823 (888)
|+++.+... ........++-|.+|+|||.+.+. .|+++.||||.|||+.||+|-.+-|....... .++.+
T Consensus 181 GlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~r 260 (438)
T KOG0666|consen 181 GLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDR 260 (438)
T ss_pred cHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHH
Confidence 999987643 223345567889999999998876 49999999999999999999998886532210 01111
Q ss_pred --hccccCCCCCCccccccccc---------ccCCcC-c-------HHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002721 824 --WVHGAPARGETPEQILDARL---------STVSFG-W-------RKEMLTALKVALLCTDSTPAKRPKMKKVVEM 881 (888)
Q Consensus 824 --~~~~~~~~~~~~~~~~~~~~---------~~~~~~-~-------~~~~~~~~~li~~cl~~dP~~RPs~~evl~~ 881 (888)
.+.+.+....++.-..-+.. ...... . ....+..++++.+++..||.+|.|+++.++.
T Consensus 261 If~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh 337 (438)
T KOG0666|consen 261 IFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEH 337 (438)
T ss_pred HHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcc
Confidence 22333333332221111110 000000 0 0012347899999999999999999998864
|
|
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-35 Score=313.09 Aligned_cols=247 Identities=19% Similarity=0.181 Sum_probs=193.9
Q ss_pred eeecccceEEEEEe-CCCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCCeeEEEEecCCCCCH
Q 002721 613 IYCGTFSTVYKAVM-PSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVALLLHNYLPNGTL 691 (888)
Q Consensus 613 ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L 691 (888)
||+|+||+||+|.. .+|+.||+|.+.............+.+|++++++++||||+++++++...+..|+||||+++++|
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDL 80 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcH
Confidence 68999999999984 46899999998754333333344677899999999999999999999999999999999999999
Q ss_pred HHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccccccccCCCCCccccccc
Q 002721 692 AQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSKGTASISAV 771 (888)
Q Consensus 692 ~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~ 771 (888)
.+++...... .+++.++..++.|++.||.|||+.|++||||+|+||+++.++.++++|||.+....... .....
T Consensus 81 ~~~l~~~~~~---~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~---~~~~~ 154 (277)
T cd05577 81 KYHIYNVGEP---GFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK---KIKGR 154 (277)
T ss_pred HHHHHHcCcC---CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhccCC---ccccc
Confidence 9999765432 57889999999999999999999999999999999999999999999999987654321 12234
Q ss_pred ccccceecccccccCCcCccccchhHHHHHHHHHhCCCCCCCCCCCccchhhhccccCCCCCCcccccccccccCCcCcH
Q 002721 772 AGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQILDARLSTVSFGWR 851 (888)
Q Consensus 772 ~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 851 (888)
.++..|+|||++.+..++.++||||+|+++|+|++|+.||........ ... +.............
T Consensus 155 ~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~-~~~--------------~~~~~~~~~~~~~~ 219 (277)
T cd05577 155 AGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVE-KEE--------------LKRRTLEMAVEYPD 219 (277)
T ss_pred cCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCccccc-HHH--------------HHhccccccccCCc
Confidence 578899999999888899999999999999999999999965432110 000 00000000000111
Q ss_pred HHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 002721 852 KEMLTALKVALLCTDSTPAKRP-----KMKKVVE 880 (888)
Q Consensus 852 ~~~~~~~~li~~cl~~dP~~RP-----s~~evl~ 880 (888)
...+.+.+++.+||+.||++|| ++.++++
T Consensus 220 ~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 253 (277)
T cd05577 220 KFSPEAKDLCEALLQKDPEKRLGCRGGSADEVRE 253 (277)
T ss_pred cCCHHHHHHHHHHccCChhHccCCCcccHHHHHh
Confidence 2345678999999999999999 6666654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-35 Score=313.53 Aligned_cols=252 Identities=20% Similarity=0.271 Sum_probs=196.9
Q ss_pred HHHhcCCcceeeecccceEEEEEe-CCCcEEEEEEeeccChhhhHHHHHHHHHHHHHhcc-CCCceeeeeeEEEe-----
Q 002721 603 VKATMKDSNMIYCGTFSTVYKAVM-PSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKL-CHDNLVRPIGFVIY----- 675 (888)
Q Consensus 603 ~~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~----- 675 (888)
..+.|++.+.||+|+||.||+|+. .+++.||+|++..... ....+..|+.+++++ +||||+++++++..
T Consensus 14 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~~~----~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~ 89 (282)
T cd06636 14 PAGIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVTED----EEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPG 89 (282)
T ss_pred hhhhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecChH----HHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccC
Confidence 356899999999999999999995 4689999998864322 224678899999998 69999999999863
Q ss_pred -CCeeEEEEecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccc
Q 002721 676 -EDVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIE 754 (888)
Q Consensus 676 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg 754 (888)
.+..|++|||+++|+|.+++...... .+++..+..++.||++|++|||+.||+||||||+||++++++.++|+|||
T Consensus 90 ~~~~~~iv~e~~~~~~L~~~~~~~~~~---~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~nili~~~~~~~l~dfg 166 (282)
T cd06636 90 HDDQLWLVMEFCGAGSVTDLVKNTKGN---ALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFG 166 (282)
T ss_pred CCCEEEEEEEeCCCCcHHHHHHHccCC---CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCc
Confidence 45789999999999999999764432 46778889999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCcccccccccccceecccccc-----cCCcCccccchhHHHHHHHHHhCCCCCCCCCCCccchhhhccccC
Q 002721 755 ISKLLDPSKGTASISAVAGSFGYIPPEYAY-----TMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAP 829 (888)
Q Consensus 755 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~ 829 (888)
.+........ ......|+..|+|||.+. +..++.++|||||||++|||++|+.||........ ...
T Consensus 167 ~~~~~~~~~~--~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~~~~-~~~------ 237 (282)
T cd06636 167 VSAQLDRTVG--RRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHPMRA-LFL------ 237 (282)
T ss_pred chhhhhcccc--CCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCHHhh-hhh------
Confidence 9876543221 123456889999999875 34688899999999999999999999965321110 000
Q ss_pred CCCCCcccccccccccCCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002721 830 ARGETPEQILDARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVE 880 (888)
Q Consensus 830 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 880 (888)
+...... .........++.+++.+||+.||.+||++.|+++
T Consensus 238 --------~~~~~~~--~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~ 278 (282)
T cd06636 238 --------IPRNPPP--KLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLK 278 (282)
T ss_pred --------HhhCCCC--CCcccccCHHHHHHHHHHhCCChhhCcCHHHHhc
Confidence 0000000 0011123456889999999999999999999975
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-35 Score=309.46 Aligned_cols=256 Identities=19% Similarity=0.310 Sum_probs=200.9
Q ss_pred hcCCcceeeecccceEEEEEe-CCCcEEEEEEeeccCh---hhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCCeeEE
Q 002721 606 TMKDSNMIYCGTFSTVYKAVM-PSGLILSVKRLKSMDR---TIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVALL 681 (888)
Q Consensus 606 ~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~---~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 681 (888)
+|+..+.||+|+||.||+|.. .+++.||+|+++.... ......+.+.+|++++++++||||+++++++.+.+..++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~ 80 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNL 80 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEE
Confidence 477889999999999999994 5789999999874332 112234678999999999999999999999999999999
Q ss_pred EEecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCC-CceEeccccccccC
Q 002721 682 LHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADF-KPLLGEIEISKLLD 760 (888)
Q Consensus 682 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~-~~kl~Dfg~a~~~~ 760 (888)
||||+++++|.+++.... .+++..+..++.|++.||+|||++|++||||||+||+++.++ .+||+|||.+....
T Consensus 81 v~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~ 155 (268)
T cd06630 81 FVEWMAGGSVSHLLSKYG-----AFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLA 155 (268)
T ss_pred EEeccCCCcHHHHHHHhC-----CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEcccccccccc
Confidence 999999999999997643 467889999999999999999999999999999999998776 59999999988765
Q ss_pred CCCCc--ccccccccccceecccccccCCcCccccchhHHHHHHHHHhCCCCCCCCCCCccchhhhccccCCCCCCcccc
Q 002721 761 PSKGT--ASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQI 838 (888)
Q Consensus 761 ~~~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 838 (888)
..... .......++..|+|||.+.+..++.++||||+|+++|+|++|..||........ ...... .
T Consensus 156 ~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~--~~~~~~----------~ 223 (268)
T cd06630 156 AKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNH--LALIFK----------I 223 (268)
T ss_pred cccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcch--HHHHHH----------H
Confidence 33111 111234678899999999888899999999999999999999999964321110 000000 0
Q ss_pred cccccccCCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002721 839 LDARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVE 880 (888)
Q Consensus 839 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 880 (888)
... ...+........++.+++.+|+..+|++||++.|+++
T Consensus 224 ~~~--~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~ 263 (268)
T cd06630 224 ASA--TTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLK 263 (268)
T ss_pred hcc--CCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhc
Confidence 000 0001112234567788999999999999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=319.02 Aligned_cols=250 Identities=19% Similarity=0.231 Sum_probs=207.1
Q ss_pred HHhcCCcceeeecccceEEEEEe-CCCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCCeeEEE
Q 002721 604 KATMKDSNMIYCGTFSTVYKAVM-PSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVALLL 682 (888)
Q Consensus 604 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 682 (888)
...|.+.+.||+|.|++|..|+. .++..||+|.+++........+ .+.+|+++|+.++|||||+++.+.......|+|
T Consensus 55 vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~~~~-k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV 133 (596)
T KOG0586|consen 55 VGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPSKRQ-KLGREVDIMKSLNHPNIVKLFSVIETEATLYLV 133 (596)
T ss_pred ccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChHHHH-HHHHHHHHHHhcCCcceeeeeeeeeecceeEEE
Confidence 45788999999999999999994 4799999999987655544433 589999999999999999999999999999999
Q ss_pred EecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccccccccCCC
Q 002721 683 HNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPS 762 (888)
Q Consensus 683 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 762 (888)
|||+.+|.+.+++...+.. ....+..++.|+.+|++|+|+++|||||||++||+++.+..+||+|||++..+...
T Consensus 134 ~eya~~ge~~~yl~~~gr~-----~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~ 208 (596)
T KOG0586|consen 134 MEYASGGELFDYLVKHGRM-----KEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFDYG 208 (596)
T ss_pred EEeccCchhHHHHHhcccc-----hhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccccccceeeeccccceeeccc
Confidence 9999999999999987643 44788899999999999999999999999999999999999999999999998754
Q ss_pred CCcccccccccccceecccccccCCc-CccccchhHHHHHHHHHhCCCCCCCCCCCccchhhhccccCCCCCCccccccc
Q 002721 763 KGTASISAVAGSFGYIPPEYAYTMQV-TAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQILDA 841 (888)
Q Consensus 763 ~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 841 (888)
. .....+|++.|.|||++.+..| ++++|+||+|+++|-|+.|..||++..-.. ..+.++..
T Consensus 209 ~---~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~---------------Lr~rvl~g 270 (596)
T KOG0586|consen 209 L---MLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKE---------------LRPRVLRG 270 (596)
T ss_pred c---cccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCccccc---------------ccchheee
Confidence 3 2456889999999999998876 568999999999999999999998642111 01111111
Q ss_pred ccccCCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002721 842 RLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEM 881 (888)
Q Consensus 842 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~ 881 (888)
.+. .+.....++.+++++++..+|.+|++++++.+.
T Consensus 271 k~r----Ip~~ms~dce~lLrk~lvl~Pskr~~~dqim~~ 306 (596)
T KOG0586|consen 271 KYR----IPFYMSCDCEDLLRKFLVLNPSKRGPCDQIMKD 306 (596)
T ss_pred eec----ccceeechhHHHHHHhhccCccccCCHHHhhhh
Confidence 111 112233456678999999999999999998763
|
|
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=312.32 Aligned_cols=258 Identities=23% Similarity=0.300 Sum_probs=200.7
Q ss_pred hcCCcceeeecccceEEEEEe-CCCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeC--CeeEEE
Q 002721 606 TMKDSNMIYCGTFSTVYKAVM-PSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYE--DVALLL 682 (888)
Q Consensus 606 ~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~--~~~~lv 682 (888)
+|+..+.||.|++|.||+|.. .+++.||+|.+...... ....++.+|++++++++||||+++++++... +..|+|
T Consensus 2 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv 79 (287)
T cd06621 2 KIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDPNP--DLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIA 79 (287)
T ss_pred ceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCCch--HHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEE
Confidence 578889999999999999996 46899999998754332 3345789999999999999999999998653 478999
Q ss_pred EecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccccccccCCC
Q 002721 683 HNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPS 762 (888)
Q Consensus 683 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 762 (888)
|||+++++|.+++...... ...++...+..++.||+.||+|||+.|++|+||+|+||+++.++.++++|||++......
T Consensus 80 ~e~~~~~~L~~~l~~~~~~-~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~ 158 (287)
T cd06621 80 MEYCEGGSLDSIYKKVKKR-GGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNS 158 (287)
T ss_pred EEecCCCCHHHHHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEecCCeEEEeecccccccccc
Confidence 9999999999987653322 225788899999999999999999999999999999999999999999999998765432
Q ss_pred CCcccccccccccceecccccccCCcCccccchhHHHHHHHHHhCCCCCCCCCCC---ccchhhhccccCCCCCCccccc
Q 002721 763 KGTASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGE---GVDLVKWVHGAPARGETPEQIL 839 (888)
Q Consensus 763 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~ 839 (888)
.. ....++..|+|||.+.+..++.++||||+|+++|+|++|+.||...... ..+...+......
T Consensus 159 ~~----~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~--------- 225 (287)
T cd06621 159 LA----GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPN--------- 225 (287)
T ss_pred cc----ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCc---------
Confidence 21 2345788999999998889999999999999999999999999765321 1111111111000
Q ss_pred ccccccCCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002721 840 DARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVE 880 (888)
Q Consensus 840 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 880 (888)
..+.............+.+++.+||+.+|++|||+.|+++
T Consensus 226 -~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~ 265 (287)
T cd06621 226 -PELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLE 265 (287)
T ss_pred -hhhccCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHh
Confidence 0000000001123456789999999999999999999987
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=308.31 Aligned_cols=253 Identities=19% Similarity=0.223 Sum_probs=196.7
Q ss_pred HhcCCcceeeecccceEEEEEe-CCCcEEEEEEeeccC--hhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeC--Cee
Q 002721 605 ATMKDSNMIYCGTFSTVYKAVM-PSGLILSVKRLKSMD--RTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYE--DVA 679 (888)
Q Consensus 605 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~--~~~ 679 (888)
.+|+..+.||+|+||.||+|.. .++..||+|.+.... .......+.+.+|++++++++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTL 81 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceE
Confidence 3688899999999999999995 468999999886332 12223445788999999999999999999988764 467
Q ss_pred EEEEecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEecccccccc
Q 002721 680 LLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLL 759 (888)
Q Consensus 680 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~ 759 (888)
++||||+++++|.+++.... .+++..+..++.|++.||+|||+.+++|+||||+||+++.++.++|+|||.+...
T Consensus 82 ~~v~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~ 156 (265)
T cd06652 82 SIFMEHMPGGSIKDQLKSYG-----ALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRL 156 (265)
T ss_pred EEEEEecCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecCCCCEEECcCcccccc
Confidence 89999999999999987543 3577888999999999999999999999999999999999999999999998865
Q ss_pred CCCCC-cccccccccccceecccccccCCcCccccchhHHHHHHHHHhCCCCCCCCCCCccchhhhccccCCCCCCcccc
Q 002721 760 DPSKG-TASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQI 838 (888)
Q Consensus 760 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 838 (888)
..... ........++..|+|||++.+..++.++|||||||++|||++|+.||....... ...+. ...+
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~-~~~~~-~~~~--------- 225 (265)
T cd06652 157 QTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMA-AIFKI-ATQP--------- 225 (265)
T ss_pred ccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHH-HHHHH-hcCC---------
Confidence 42111 111223458889999999988889999999999999999999999997532111 01000 0000
Q ss_pred cccccccCCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002721 839 LDARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVE 880 (888)
Q Consensus 839 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 880 (888)
. .+.........+.+++.+|+. +|++||+++|+++
T Consensus 226 ---~---~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~ 260 (265)
T cd06652 226 ---T---NPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLR 260 (265)
T ss_pred ---C---CCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhc
Confidence 0 011123344567788888985 9999999999975
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-35 Score=313.77 Aligned_cols=267 Identities=16% Similarity=0.185 Sum_probs=195.3
Q ss_pred HhcCCcceeeecccceEEEEEe-CCCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCCeeEEEE
Q 002721 605 ATMKDSNMIYCGTFSTVYKAVM-PSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVALLLH 683 (888)
Q Consensus 605 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 683 (888)
++|.+.+.||+|+||.||+|.. .+++.||+|+++...... ....+.+|+++++.++|+||+++++++..++..|+||
T Consensus 5 ~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~--~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~ 82 (291)
T cd07870 5 TSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTEEG--VPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVF 82 (291)
T ss_pred ceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCcCC--CcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEE
Confidence 5788999999999999999985 468999999987443221 2235678999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccccccccCCCC
Q 002721 684 NYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSK 763 (888)
Q Consensus 684 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 763 (888)
||+. +++.+++..... .+++.++..++.|++.||+|||+.||+||||||+||+++.++.+||+|||.++......
T Consensus 83 e~~~-~~l~~~~~~~~~----~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~ 157 (291)
T cd07870 83 EYMH-TDLAQYMIQHPG----GLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPS 157 (291)
T ss_pred eccc-CCHHHHHHhCCC----CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCCCC
Confidence 9996 688777754322 45678888999999999999999999999999999999999999999999987643321
Q ss_pred CcccccccccccceecccccccC-CcCccccchhHHHHHHHHHhCCCCCCCCCCCccchhhhcc--ccCCCC--------
Q 002721 764 GTASISAVAGSFGYIPPEYAYTM-QVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVH--GAPARG-------- 832 (888)
Q Consensus 764 ~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~--~~~~~~-------- 832 (888)
. ......++..|+|||++.+. .++.++||||+|+++|||++|+.||.........+.+... +.+...
T Consensus 158 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 235 (291)
T cd07870 158 Q--TYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKL 235 (291)
T ss_pred C--CCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhc
Confidence 1 12234578899999988754 5788999999999999999999999754322111111100 000000
Q ss_pred -CCccccccccccc-C--CcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002721 833 -ETPEQILDARLST-V--SFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVE 880 (888)
Q Consensus 833 -~~~~~~~~~~~~~-~--~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 880 (888)
............. . ..........+.+++.+|++.||++|||++|++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~~~~l~ 287 (291)
T cd07870 236 PNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISAQDALL 287 (291)
T ss_pred ccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCHHHHhc
Confidence 0000000000000 0 0000012356778999999999999999999875
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-35 Score=317.80 Aligned_cols=250 Identities=17% Similarity=0.262 Sum_probs=198.0
Q ss_pred HhcCCcceeeecccceEEEEEe-CCCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCCeeEEEE
Q 002721 605 ATMKDSNMIYCGTFSTVYKAVM-PSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVALLLH 683 (888)
Q Consensus 605 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 683 (888)
+.|.....||+|+||.||++.. .++..||+|.+..... ...+.+.+|+.+++.++||||+++++.+..++..|+||
T Consensus 22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~ 98 (292)
T cd06658 22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLRKQ---QRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVM 98 (292)
T ss_pred HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecchH---HHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEE
Confidence 3455567799999999999995 4689999999864322 23446889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccccccccCCCC
Q 002721 684 NYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSK 763 (888)
Q Consensus 684 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 763 (888)
||+++++|.+++... .+++.++..++.||+.||+|||++||+||||||+||++++++.++|+|||++.......
T Consensus 99 e~~~~~~L~~~~~~~------~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~ 172 (292)
T cd06658 99 EFLEGGALTDIVTHT------RMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEV 172 (292)
T ss_pred eCCCCCcHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhccccc
Confidence 999999999988542 46788999999999999999999999999999999999999999999999987654322
Q ss_pred CcccccccccccceecccccccCCcCccccchhHHHHHHHHHhCCCCCCCCCCCccchhhhccccCCCCCCccccccccc
Q 002721 764 GTASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQILDARL 843 (888)
Q Consensus 764 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 843 (888)
. ......|+..|+|||...+..++.++||||+|+++|||++|+.||....... ....... ......
T Consensus 173 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~--~~~~~~~----------~~~~~~ 238 (292)
T cd06658 173 P--KRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQ--AMRRIRD----------NLPPRV 238 (292)
T ss_pred c--cCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHHh----------cCCCcc
Confidence 1 1233568899999999988889999999999999999999999997532211 0000000 000000
Q ss_pred ccCCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002721 844 STVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEM 881 (888)
Q Consensus 844 ~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~ 881 (888)
. ........+.+++.+||..||++|||++|+++.
T Consensus 239 ~----~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~ 272 (292)
T cd06658 239 K----DSHKVSSVLRGFLDLMLVREPSQRATAQELLQH 272 (292)
T ss_pred c----cccccCHHHHHHHHHHccCChhHCcCHHHHhhC
Confidence 0 111233456788999999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-35 Score=312.10 Aligned_cols=252 Identities=19% Similarity=0.244 Sum_probs=193.8
Q ss_pred hcCCcceeeecccceEEEEEeC-CCcEEEEEEeeccChhhhHHHHHHHHHHHH-HhccCCCceeeeeeEEEeCCeeEEEE
Q 002721 606 TMKDSNMIYCGTFSTVYKAVMP-SGLILSVKRLKSMDRTIIHHQNKMIRELEK-LSKLCHDNLVRPIGFVIYEDVALLLH 683 (888)
Q Consensus 606 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~-l~~l~hpnIv~~~~~~~~~~~~~lv~ 683 (888)
+|++.+.||+|+||.||+|+.. +|+.||+|+++...... ...++..|+.+ ++..+||||+++++++..++..|+||
T Consensus 2 ~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~~--~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~ 79 (283)
T cd06617 2 DLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVNSQ--EQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICM 79 (283)
T ss_pred CceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCCcH--HHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEh
Confidence 6888999999999999999954 69999999987543222 22356667665 56668999999999999999999999
Q ss_pred ecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccC-CeeecCCCCCCeEeCCCCCceEeccccccccCCC
Q 002721 684 NYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHV-AIIHLDISSGNVLLDADFKPLLGEIEISKLLDPS 762 (888)
Q Consensus 684 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 762 (888)
||++ |+|.+++....... ..+++..++.++.||+.||+|||++ +++||||||+||+++.++.+||+|||.+......
T Consensus 80 e~~~-~~l~~~l~~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~ 157 (283)
T cd06617 80 EVMD-TSLDKFYKKVYDKG-LTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDS 157 (283)
T ss_pred hhhc-ccHHHHHHHhccCC-CCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCCCCEEEeecccccccccc
Confidence 9997 58988887543222 3678999999999999999999997 9999999999999999999999999998865432
Q ss_pred CCcccccccccccceeccccccc----CCcCccccchhHHHHHHHHHhCCCCCCCCCCCccchhhhccccCCCCCCcccc
Q 002721 763 KGTASISAVAGSFGYIPPEYAYT----MQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQI 838 (888)
Q Consensus 763 ~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 838 (888)
. ......++..|+|||.+.+ ..++.++|+||+||++|||++|+.||................
T Consensus 158 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~----------- 223 (283)
T cd06617 158 V---AKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQVVEE----------- 223 (283)
T ss_pred c---ccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHHHHhc-----------
Confidence 1 1123457889999998764 456889999999999999999999996432111111111100
Q ss_pred cccccccCCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002721 839 LDARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVE 880 (888)
Q Consensus 839 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 880 (888)
..... .....+.++.+++.+||..+|++||+++++++
T Consensus 224 ---~~~~~--~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~ 260 (283)
T cd06617 224 ---PSPQL--PAEKFSPEFQDFVNKCLKKNYKERPNYPELLQ 260 (283)
T ss_pred ---CCCCC--CccccCHHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00000 01123456788999999999999999999986
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-36 Score=341.94 Aligned_cols=255 Identities=19% Similarity=0.310 Sum_probs=195.1
Q ss_pred HHHhcCCcceeeecccceEEEEEeC-CCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeC-----
Q 002721 603 VKATMKDSNMIYCGTFSTVYKAVMP-SGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYE----- 676 (888)
Q Consensus 603 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~----- 676 (888)
-..+|+..+.||+||||.||+++.+ ||+.||||++.-.. ......++.+|++.+++++|||||+||..|.+.
T Consensus 477 Y~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~--s~~~~skI~rEVk~LArLnHpNVVRYysAWVEs~~~~~ 554 (1351)
T KOG1035|consen 477 YLNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA--SDKLYSKILREVKLLARLNHPNVVRYYSAWVESTAELT 554 (1351)
T ss_pred HhhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch--HHHHHHHHHHHHHHHhhcCCcceeeeehhhhccCCccc
Confidence 4567888999999999999999944 89999999998554 344556899999999999999999998632110
Q ss_pred --------------------------------------------------------------------------------
Q 002721 677 -------------------------------------------------------------------------------- 676 (888)
Q Consensus 677 -------------------------------------------------------------------------------- 676 (888)
T Consensus 555 ~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS 634 (1351)
T KOG1035|consen 555 VLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTS 634 (1351)
T ss_pred cccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccc
Confidence
Q ss_pred ----------------------------------CeeEEEEecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHH
Q 002721 677 ----------------------------------DVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGL 722 (888)
Q Consensus 677 ----------------------------------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL 722 (888)
...||-||||+..+++++++.+.... .....+++++||++||
T Consensus 635 ~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~----~~d~~wrLFreIlEGL 710 (1351)
T KOG1035|consen 635 DSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNS----QRDEAWRLFREILEGL 710 (1351)
T ss_pred ccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccch----hhHHHHHHHHHHHHHH
Confidence 02478899999888888887654321 3467899999999999
Q ss_pred hhcccCCeeecCCCCCCeEeCCCCCceEeccccccccC----------------CCCCcccccccccccceecccccccC
Q 002721 723 AFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLD----------------PSKGTASISAVAGSFGYIPPEYAYTM 786 (888)
Q Consensus 723 ~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~~----------------~~~~~~~~~~~~gt~~y~aPE~~~~~ 786 (888)
.|+|++|||||||||.||++++++.|||+|||+|+... .+......+..+||.-|+|||++.+.
T Consensus 711 aYIH~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~ 790 (1351)
T KOG1035|consen 711 AYIHDQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDT 790 (1351)
T ss_pred HHHHhCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccc
Confidence 99999999999999999999999999999999998721 01112234578899999999998765
Q ss_pred C---cCccccchhHHHHHHHHHhCCCCCCCCCCCccchhhhccccCCCCCCcccccccccccCCcCcHHHHHHHHHHHhh
Q 002721 787 Q---VTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQILDARLSTVSFGWRKEMLTALKVALL 863 (888)
Q Consensus 787 ~---~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 863 (888)
. |+.|+|+||+|||++||+. ||... ++.+.... .+.++.++..+..+.+..+.-.++|.+
T Consensus 791 ~~~~Yn~KiDmYSLGIVlFEM~y---PF~Ts----MERa~iL~----------~LR~g~iP~~~~f~~~~~~~e~slI~~ 853 (1351)
T KOG1035|consen 791 SSNKYNSKIDMYSLGIVLFEMLY---PFGTS----MERASILT----------NLRKGSIPEPADFFDPEHPEEASLIRW 853 (1351)
T ss_pred ccccccchhhhHHHHHHHHHHhc---cCCch----HHHHHHHH----------hcccCCCCCCcccccccchHHHHHHHH
Confidence 4 9999999999999999986 56532 21111111 111122211112244556666789999
Q ss_pred ccCCCCCCCCCHHHHHH
Q 002721 864 CTDSTPAKRPKMKKVVE 880 (888)
Q Consensus 864 cl~~dP~~RPs~~evl~ 880 (888)
+++.||.+||||.|+++
T Consensus 854 Ll~hdP~kRPtA~eLL~ 870 (1351)
T KOG1035|consen 854 LLSHDPSKRPTATELLN 870 (1351)
T ss_pred HhcCCCccCCCHHHHhh
Confidence 99999999999999986
|
|
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-35 Score=311.81 Aligned_cols=250 Identities=19% Similarity=0.187 Sum_probs=202.5
Q ss_pred hcCCcceeeecccceEEEEEeC-CCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCCeeEEEEe
Q 002721 606 TMKDSNMIYCGTFSTVYKAVMP-SGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVALLLHN 684 (888)
Q Consensus 606 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 684 (888)
.|++.+.||+|+||.||+|... +++.||+|.+...........+.+.+|++++++++||||+++++++..++..++|||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 80 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVD 80 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEe
Confidence 3778899999999999999964 689999999985544443455689999999999999999999999999999999999
Q ss_pred cCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccccccccCCCCC
Q 002721 685 YLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSKG 764 (888)
Q Consensus 685 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 764 (888)
|+++++|.+++.... .+++.++..++.|+++||+|||+.|++|+||||+||++++++.++++|||.+.......
T Consensus 81 ~~~~~~L~~~l~~~~-----~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~- 154 (258)
T cd05578 81 LLLGGDLRYHLSQKV-----KFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT- 154 (258)
T ss_pred CCCCCCHHHHHHhcC-----CcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCc-
Confidence 999999999997652 46788999999999999999999999999999999999999999999999988764332
Q ss_pred cccccccccccceecccccccCCcCccccchhHHHHHHHHHhCCCCCCCCCCCccchhhhccccCCCCCCcccccccccc
Q 002721 765 TASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQILDARLS 844 (888)
Q Consensus 765 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 844 (888)
......|+..|+|||.+.+..++.++|+||+|+++|+|++|+.||............ .....
T Consensus 155 --~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~---~~~~~------------- 216 (258)
T cd05578 155 --LTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIR---AKQET------------- 216 (258)
T ss_pred --cccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHH---HHhcc-------------
Confidence 123456788999999998888999999999999999999999999765332111000 00000
Q ss_pred cCCcCcHHHHHHHHHHHhhccCCCCCCCCCH--HHHH
Q 002721 845 TVSFGWRKEMLTALKVALLCTDSTPAKRPKM--KKVV 879 (888)
Q Consensus 845 ~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~--~evl 879 (888)
............+.+++.+||+.||++||++ +|++
T Consensus 217 ~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~ 253 (258)
T cd05578 217 ADVLYPATWSTEAIDAINKLLERDPQKRLGDNLKDLK 253 (258)
T ss_pred ccccCcccCcHHHHHHHHHHccCChhHcCCccHHHHh
Confidence 0000111223677889999999999999999 6654
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-34 Score=309.47 Aligned_cols=248 Identities=18% Similarity=0.273 Sum_probs=197.6
Q ss_pred hcCCcceeeecccceEEEEEe-CCCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccC---CCceeeeeeEEEeCCeeEE
Q 002721 606 TMKDSNMIYCGTFSTVYKAVM-PSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLC---HDNLVRPIGFVIYEDVALL 681 (888)
Q Consensus 606 ~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~---hpnIv~~~~~~~~~~~~~l 681 (888)
.|+..+.||+|+||.||+|.. .+++.||+|.++..... ...+.+.+|++++++++ |||++++++++..+...|+
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~l 79 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDTPD--DDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWI 79 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCCCc--hhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEE
Confidence 477889999999999999995 57899999998743222 23346889999999996 9999999999999999999
Q ss_pred EEecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccccccccCC
Q 002721 682 LHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDP 761 (888)
Q Consensus 682 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~~~ 761 (888)
||||+++++|.++++.. .+++..+..++.|+++||.|||+.|++||||+|+||++++++.++++|||.+.....
T Consensus 80 v~e~~~~~~L~~~~~~~------~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~ 153 (277)
T cd06917 80 IMEYAEGGSVRTLMKAG------PIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQ 153 (277)
T ss_pred EEecCCCCcHHHHHHcc------CCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCC
Confidence 99999999999998653 467899999999999999999999999999999999999999999999999987654
Q ss_pred CCCcccccccccccceeccccccc-CCcCccccchhHHHHHHHHHhCCCCCCCCCCCccchhhhccccCCCCCCcccccc
Q 002721 762 SKGTASISAVAGSFGYIPPEYAYT-MQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQILD 840 (888)
Q Consensus 762 ~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 840 (888)
... ......|+..|+|||.+.+ ..++.++||||||+++|+|++|+.||........ ..... .
T Consensus 154 ~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~--~~~~~-------------~ 216 (277)
T cd06917 154 NSS--KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRA--MMLIP-------------K 216 (277)
T ss_pred Ccc--ccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhh--hhccc-------------c
Confidence 331 1234468889999998765 4578899999999999999999999975322110 00000 0
Q ss_pred cccccCCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002721 841 ARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVE 880 (888)
Q Consensus 841 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 880 (888)
...... .......++.+++.+||+.||++||++.|+++
T Consensus 217 ~~~~~~--~~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~ 254 (277)
T cd06917 217 SKPPRL--EDNGYSKLLREFVAACLDEEPKERLSAEELLK 254 (277)
T ss_pred CCCCCC--CcccCCHHHHHHHHHHcCCCcccCcCHHHHhh
Confidence 000000 01113456788999999999999999999976
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=308.61 Aligned_cols=254 Identities=21% Similarity=0.288 Sum_probs=202.7
Q ss_pred hcCCcceeeecccceEEEEEe-CCCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEe--CCeeEEE
Q 002721 606 TMKDSNMIYCGTFSTVYKAVM-PSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIY--EDVALLL 682 (888)
Q Consensus 606 ~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~--~~~~~lv 682 (888)
+|++.+.||.|+||.||+|.. .+++.||+|+++.... .....+++.+|++++++++||||+++++++.. +...+++
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 79 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNM-TEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIV 79 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccC-CHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEE
Confidence 477889999999999999984 4689999999875433 23344578899999999999999999998764 4467999
Q ss_pred EecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcc-----cCCeeecCCCCCCeEeCCCCCceEecccccc
Q 002721 683 HNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLH-----HVAIIHLDISSGNVLLDADFKPLLGEIEISK 757 (888)
Q Consensus 683 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH-----~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~ 757 (888)
|||+++++|.+++....... ..+++..++.++.||+.||+||| +.+++||||||+||+++.++.+|++|||.+.
T Consensus 80 ~e~~~~~~L~~~l~~~~~~~-~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~ 158 (265)
T cd08217 80 MEYCEGGDLAQLIQKCKKER-KYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAK 158 (265)
T ss_pred ehhccCCCHHHHHHHHhhcc-cCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccc
Confidence 99999999999997653222 26788999999999999999999 8999999999999999999999999999998
Q ss_pred ccCCCCCcccccccccccceecccccccCCcCccccchhHHHHHHHHHhCCCCCCCCCCCccchhhhccccCCCCCCccc
Q 002721 758 LLDPSKGTASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQ 837 (888)
Q Consensus 758 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 837 (888)
........ .....++..|+|||++.+..++.++||||||+++|+|++|+.||..... ....+...
T Consensus 159 ~~~~~~~~--~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~--~~~~~~~~----------- 223 (265)
T cd08217 159 ILGHDSSF--AKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQ--LQLASKIK----------- 223 (265)
T ss_pred cccCCccc--ccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCH--HHHHHHHh-----------
Confidence 76543321 2334688999999999888899999999999999999999999975431 11111111
Q ss_pred ccccccccCCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002721 838 ILDARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEM 881 (888)
Q Consensus 838 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~ 881 (888)
...... ........+.+++.+|++.+|++||++.+|++.
T Consensus 224 --~~~~~~---~~~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~ 262 (265)
T cd08217 224 --EGKFRR---IPYRYSSELNEVIKSMLNVDPDKRPSTEELLQL 262 (265)
T ss_pred --cCCCCC---CccccCHHHHHHHHHHccCCcccCCCHHHHhhC
Confidence 111111 112234567899999999999999999999863
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-35 Score=311.46 Aligned_cols=245 Identities=17% Similarity=0.139 Sum_probs=187.1
Q ss_pred eeeecccceEEEEEe-CCCcEEEEEEeeccChhhhHHHHHHHHHHHHH---hccCCCceeeeeeEEEeCCeeEEEEecCC
Q 002721 612 MIYCGTFSTVYKAVM-PSGLILSVKRLKSMDRTIIHHQNKMIRELEKL---SKLCHDNLVRPIGFVIYEDVALLLHNYLP 687 (888)
Q Consensus 612 ~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l---~~l~hpnIv~~~~~~~~~~~~~lv~e~~~ 687 (888)
.||+|+||.||+|.. .+++.||+|.+.+...........+.+|..++ ....||+|+.+++++..++..++||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 489999999999995 46899999998754332222222344444433 33479999999999999999999999999
Q ss_pred CCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccccccccCCCCCccc
Q 002721 688 NGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSKGTAS 767 (888)
Q Consensus 688 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~ 767 (888)
+++|.+++.... .+++..+..++.|++.||+|||++||+||||||+||++++++.++++|||++.......
T Consensus 81 ~~~L~~~i~~~~-----~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~---- 151 (279)
T cd05633 81 GGDLHYHLSQHG-----VFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---- 151 (279)
T ss_pred CCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceeccccC----
Confidence 999999987543 47889999999999999999999999999999999999999999999999987554322
Q ss_pred ccccccccceecccccc-cCCcCccccchhHHHHHHHHHhCCCCCCCCCCCccchhhhccccCCCCCCcccccccccccC
Q 002721 768 ISAVAGSFGYIPPEYAY-TMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQILDARLSTV 846 (888)
Q Consensus 768 ~~~~~gt~~y~aPE~~~-~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 846 (888)
.....|+..|+|||.+. +..++.++||||+||++|||++|..||............... . ...
T Consensus 152 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~--~--------------~~~ 215 (279)
T cd05633 152 PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMT--L--------------TVN 215 (279)
T ss_pred ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHh--h--------------cCC
Confidence 12346899999999886 456899999999999999999999999754322111110000 0 000
Q ss_pred CcCcHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHHH
Q 002721 847 SFGWRKEMLTALKVALLCTDSTPAKRP-----KMKKVVEM 881 (888)
Q Consensus 847 ~~~~~~~~~~~~~li~~cl~~dP~~RP-----s~~evl~~ 881 (888)
.........++.+++.+||+.||++|| +++|+++.
T Consensus 216 ~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h 255 (279)
T cd05633 216 VELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEH 255 (279)
T ss_pred cCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhC
Confidence 001112345678899999999999999 59888763
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=313.07 Aligned_cols=254 Identities=22% Similarity=0.249 Sum_probs=196.7
Q ss_pred HHhcCCcceeeecccceEEEEEe-CCCcEEEEEEeeccChhhhHHHHHHHHHHHHHhcc-CCCceeeeeeEEEeC-----
Q 002721 604 KATMKDSNMIYCGTFSTVYKAVM-PSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKL-CHDNLVRPIGFVIYE----- 676 (888)
Q Consensus 604 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~----- 676 (888)
.++|++.+.||+|+||.||+|.. .+++.+|+|++...... ...+.+|+.+++++ +|||++++++++...
T Consensus 21 ~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~~~----~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 96 (291)
T cd06639 21 TDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDV----DEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVG 96 (291)
T ss_pred CCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccccH----HHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCC
Confidence 56799999999999999999995 46899999998743322 23677899999998 799999999998754
Q ss_pred CeeEEEEecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccccc
Q 002721 677 DVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEIS 756 (888)
Q Consensus 677 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a 756 (888)
+..|+||||+++++|.++++...... ..+++..++.++.|++.||+|||+.|++||||||+||+++.++.+|++|||.+
T Consensus 97 ~~~~lv~ey~~~~sL~~~~~~~~~~~-~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~nili~~~~~~kl~dfg~~ 175 (291)
T cd06639 97 GQLWLVLELCNGGSVTELVKGLLICG-QRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVS 175 (291)
T ss_pred CeeEEEEEECCCCcHHHHHHHhhhcC-CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEeecccc
Confidence 35899999999999999987532221 25788999999999999999999999999999999999999999999999998
Q ss_pred cccCCCCCcccccccccccceecccccccC-----CcCccccchhHHHHHHHHHhCCCCCCCCCCCccchhhhccccCCC
Q 002721 757 KLLDPSKGTASISAVAGSFGYIPPEYAYTM-----QVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPAR 831 (888)
Q Consensus 757 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~ 831 (888)
......... .....|+..|+|||.+... .++.++||||+||++|||++|+.||...... ....++.....
T Consensus 176 ~~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~-~~~~~~~~~~~-- 250 (291)
T cd06639 176 AQLTSTRLR--RNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPV-KTLFKIPRNPP-- 250 (291)
T ss_pred hhccccccc--ccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHH-HHHHHHhcCCC--
Confidence 875432211 1234678899999987543 3688999999999999999999999754221 11111111000
Q ss_pred CCCcccccccccccCCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002721 832 GETPEQILDARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVE 880 (888)
Q Consensus 832 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 880 (888)
..+. ........+.+++.+||+.+|++||++.|+++
T Consensus 251 ----~~~~---------~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~ 286 (291)
T cd06639 251 ----PTLL---------HPEKWCRSFNHFISQCLIKDFEARPSVTHLLE 286 (291)
T ss_pred ----CCCC---------cccccCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 0000 01122346788999999999999999999986
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-34 Score=308.33 Aligned_cols=250 Identities=18% Similarity=0.250 Sum_probs=200.9
Q ss_pred HHhcCCcceeeecccceEEEEEe-CCCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCCeeEEE
Q 002721 604 KATMKDSNMIYCGTFSTVYKAVM-PSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVALLL 682 (888)
Q Consensus 604 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 682 (888)
.+-|+..+.||+|+||.||+|.. .+++.||+|.+..... ....+.+.+|++++++++||||+++++++..++..|+|
T Consensus 3 ~~~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 80 (277)
T cd06641 3 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWII 80 (277)
T ss_pred HHhhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEE
Confidence 34678889999999999999985 4689999998864332 23345788999999999999999999999999999999
Q ss_pred EecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccccccccCCC
Q 002721 683 HNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPS 762 (888)
Q Consensus 683 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 762 (888)
|||+++++|.+++... .+++..+..++.|++.|++|||+.|++|+||||+||+++.++.++++|||.+......
T Consensus 81 ~e~~~~~~l~~~i~~~------~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~ 154 (277)
T cd06641 81 MEYLGGGSALDLLEPG------PLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT 154 (277)
T ss_pred EEeCCCCcHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCCEEEeecccceecccc
Confidence 9999999999998642 4678999999999999999999999999999999999999999999999998765432
Q ss_pred CCcccccccccccceecccccccCCcCccccchhHHHHHHHHHhCCCCCCCCCCCccchhhhccccCCCCCCcccccccc
Q 002721 763 KGTASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQILDAR 842 (888)
Q Consensus 763 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 842 (888)
. .......++..|+|||.+.+..++.++||||+||++|+|++|..||....... ........ .
T Consensus 155 ~--~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~--~~~~~~~~----~--------- 217 (277)
T cd06641 155 Q--IKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMK--VLFLIPKN----N--------- 217 (277)
T ss_pred h--hhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHH--HHHHHhcC----C---------
Confidence 2 11223467889999999988888999999999999999999999997532211 01100000 0
Q ss_pred cccCCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002721 843 LSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEM 881 (888)
Q Consensus 843 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~ 881 (888)
... .......++.+++.+||+.+|++||++.++++.
T Consensus 218 ~~~---~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~ 253 (277)
T cd06641 218 PPT---LEGNYSKPLKEFVEACLNKEPSFRPTAKELLKH 253 (277)
T ss_pred CCC---CCcccCHHHHHHHHHHccCChhhCcCHHHHHhC
Confidence 000 011233567789999999999999999999984
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=313.86 Aligned_cols=268 Identities=18% Similarity=0.233 Sum_probs=199.9
Q ss_pred hcCCcceeeecccceEEEEEeC-CCcEEEEEEeeccChh--hhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCCeeEEE
Q 002721 606 TMKDSNMIYCGTFSTVYKAVMP-SGLILSVKRLKSMDRT--IIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVALLL 682 (888)
Q Consensus 606 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 682 (888)
+|+..+.||+|+||.||+|... +++.||+|.++..... .......+..|++++++++|+||+++++++.+.+..++|
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv 80 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLV 80 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEE
Confidence 4778889999999999999954 6899999999754332 122334677899999999999999999999999999999
Q ss_pred EecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccccccccCCC
Q 002721 683 HNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPS 762 (888)
Q Consensus 683 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 762 (888)
|||+ +++|.+++.... ..+++..+..++.||++||+|||++||+||||||+||+++.++.++|+|||++......
T Consensus 81 ~e~~-~~~L~~~i~~~~----~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~ 155 (298)
T cd07841 81 FEFM-ETDLEKVIKDKS----IVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSP 155 (298)
T ss_pred Eccc-CCCHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCC
Confidence 9999 889999997643 15788999999999999999999999999999999999999999999999999876543
Q ss_pred CCcccccccccccceeccccccc-CCcCccccchhHHHHHHHHHhCCCCCCCCCCCccchhhhccc--cCCCCCC-----
Q 002721 763 KGTASISAVAGSFGYIPPEYAYT-MQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHG--APARGET----- 834 (888)
Q Consensus 763 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~--~~~~~~~----- 834 (888)
.. ......++..|+|||.+.+ ..++.++|||||||++|||++|.+||....... .+...... .+.....
T Consensus 156 ~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 232 (298)
T cd07841 156 NR--KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDID-QLGKIFEALGTPTEENWPGVTS 232 (298)
T ss_pred Cc--cccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHH-HHHHHHHHcCCCchhhhhhccc
Confidence 21 1223456788999998754 457889999999999999999988776533211 11111000 0000000
Q ss_pred ccccccc-cccc--CCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002721 835 PEQILDA-RLST--VSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEM 881 (888)
Q Consensus 835 ~~~~~~~-~~~~--~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~ 881 (888)
....... .... ...........+.+++.+||++||++|||++|+++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l~~ 282 (298)
T cd07841 233 LPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQALEH 282 (298)
T ss_pred ccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 0000000 0000 000112234678899999999999999999999874
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-36 Score=321.79 Aligned_cols=244 Identities=22% Similarity=0.326 Sum_probs=195.2
Q ss_pred CCcceeeecccceEEEEEeC-CCcEEEEEEeeccCh-hhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCCe--eEEEE
Q 002721 608 KDSNMIYCGTFSTVYKAVMP-SGLILSVKRLKSMDR-TIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDV--ALLLH 683 (888)
Q Consensus 608 ~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~--~~lv~ 683 (888)
+...+||+|+|-+||+|.+. +|..||--.++..+. ......++|..|+.+|+.|+||||+++|++|.+... .-+|+
T Consensus 43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iT 122 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFIT 122 (632)
T ss_pred ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeee
Confidence 45678999999999999954 577777654432221 123334689999999999999999999999998654 77899
Q ss_pred ecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhccc--CCeeecCCCCCCeEeCCC-CCceEeccccccccC
Q 002721 684 NYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHH--VAIIHLDISSGNVLLDAD-FKPLLGEIEISKLLD 760 (888)
Q Consensus 684 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~--~~ivHrDlkp~NIll~~~-~~~kl~Dfg~a~~~~ 760 (888)
|.+..|+|..|.++.+ +++.+.++.|++||++||.|||+ ..|||||||-+||+|+.+ |.|||+|.|+|....
T Consensus 123 EL~TSGtLr~Y~kk~~-----~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r 197 (632)
T KOG0584|consen 123 ELFTSGTLREYRKKHR-----RVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLR 197 (632)
T ss_pred ecccCCcHHHHHHHhc-----cCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcCCcCceeecchhHHHHhh
Confidence 9999999999999876 45778999999999999999998 589999999999999865 899999999999876
Q ss_pred CCCCcccccccccccceecccccccCCcCccccchhHHHHHHHHHhCCCCCCCCCCCccchhhhccccCCCCCCcccccc
Q 002721 761 PSKGTASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQILD 840 (888)
Q Consensus 761 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 840 (888)
... ...++|||.|||||++. ..|+..+||||||+.|.||+|+.+||.+...... +..
T Consensus 198 ~s~----aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQ------------------IYK 254 (632)
T KOG0584|consen 198 KSH----AKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQ------------------IYK 254 (632)
T ss_pred ccc----cceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHH------------------HHH
Confidence 543 23578999999999765 8899999999999999999999999986533211 111
Q ss_pred cccccCCcC--cHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002721 841 ARLSTVSFG--WRKEMLTALKVALLCTDSTPAKRPKMKKVVE 880 (888)
Q Consensus 841 ~~~~~~~~~--~~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 880 (888)
....+..+. ..-..+++.++|.+|+.. .++|||+.|+++
T Consensus 255 KV~SGiKP~sl~kV~dPevr~fIekCl~~-~~~R~sa~eLL~ 295 (632)
T KOG0584|consen 255 KVTSGIKPAALSKVKDPEVREFIEKCLAT-KSERLSAKELLK 295 (632)
T ss_pred HHHcCCCHHHhhccCCHHHHHHHHHHhcC-chhccCHHHHhh
Confidence 111111111 111246788999999999 899999999986
|
|
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-35 Score=317.63 Aligned_cols=274 Identities=18% Similarity=0.242 Sum_probs=199.8
Q ss_pred hcCCcceeeecccceEEEEEeC---CCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeC--CeeE
Q 002721 606 TMKDSNMIYCGTFSTVYKAVMP---SGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYE--DVAL 680 (888)
Q Consensus 606 ~~~~~~~ig~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~--~~~~ 680 (888)
+|++.+.||+|+||.||+|... +++.||+|.+...........+.+.+|++++++++||||+++++++.+. +..+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 80 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVY 80 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEE
Confidence 4778899999999999999954 5899999999864322222334678899999999999999999999988 7899
Q ss_pred EEEecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCC----CCCceEeccccc
Q 002721 681 LLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDA----DFKPLLGEIEIS 756 (888)
Q Consensus 681 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~----~~~~kl~Dfg~a 756 (888)
+||||+++ ++.+++..........++...+..++.||+.||+|||+++|+||||||+||+++. ++.+|++|||++
T Consensus 81 lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~ 159 (316)
T cd07842 81 LLFDYAEH-DLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLA 159 (316)
T ss_pred EEEeCCCc-CHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCccc
Confidence 99999975 7877776543332235788899999999999999999999999999999999999 899999999999
Q ss_pred cccCCCCC-cccccccccccceecccccccC-CcCccccchhHHHHHHHHHhCCCCCCCCCCCcc--------chhhhcc
Q 002721 757 KLLDPSKG-TASISAVAGSFGYIPPEYAYTM-QVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGV--------DLVKWVH 826 (888)
Q Consensus 757 ~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~--------~~~~~~~ 826 (888)
........ ........++..|+|||++.+. .++.++|||||||++|+|++|+.||........ .+.+.+.
T Consensus 160 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (316)
T cd07842 160 RLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFE 239 (316)
T ss_pred cccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHHH
Confidence 87643322 1122345678899999987664 578999999999999999999999976543320 0000000
Q ss_pred ccCCCCC----------Cccccccc-ccccCC-cCc-------HHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002721 827 GAPARGE----------TPEQILDA-RLSTVS-FGW-------RKEMLTALKVALLCTDSTPAKRPKMKKVVE 880 (888)
Q Consensus 827 ~~~~~~~----------~~~~~~~~-~~~~~~-~~~-------~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 880 (888)
....... ......+. ...... ... .....++.+++.+|+++||++|||+.|+++
T Consensus 240 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~ 312 (316)
T cd07842 240 VLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALE 312 (316)
T ss_pred HhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhc
Confidence 0000000 00000000 000000 000 023356789999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-35 Score=316.79 Aligned_cols=249 Identities=18% Similarity=0.253 Sum_probs=197.7
Q ss_pred hcCCcceeeecccceEEEEEe-CCCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCCeeEEEEe
Q 002721 606 TMKDSNMIYCGTFSTVYKAVM-PSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVALLLHN 684 (888)
Q Consensus 606 ~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 684 (888)
.|+....||+|+||.||+|.. .+++.||+|.+...... ..+.+.+|+.+++.++||||+++++++..++..|+|||
T Consensus 22 ~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~---~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e 98 (297)
T cd06659 22 LLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQQ---RRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLME 98 (297)
T ss_pred hHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEecccc---hHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEe
Confidence 344556899999999999995 46899999998643322 23468899999999999999999999999999999999
Q ss_pred cCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccccccccCCCCC
Q 002721 685 YLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSKG 764 (888)
Q Consensus 685 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 764 (888)
|+++++|.+++... .+++.++..++.|++.||+|||+.|++||||||+||+++.++.+||+|||++.......
T Consensus 99 ~~~~~~L~~~~~~~------~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~- 171 (297)
T cd06659 99 FLQGGALTDIVSQT------RLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV- 171 (297)
T ss_pred cCCCCCHHHHHhhc------CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhccccc-
Confidence 99999999987642 46789999999999999999999999999999999999999999999999987654322
Q ss_pred cccccccccccceecccccccCCcCccccchhHHHHHHHHHhCCCCCCCCCCCccchhhhccccCCCCCCcccccccccc
Q 002721 765 TASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQILDARLS 844 (888)
Q Consensus 765 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 844 (888)
.......++..|+|||++.+..++.++|||||||++|||++|+.||...... ............ ..
T Consensus 172 -~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~--~~~~~~~~~~~~----------~~- 237 (297)
T cd06659 172 -PKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPV--QAMKRLRDSPPP----------KL- 237 (297)
T ss_pred -ccccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHhccCCC----------Cc-
Confidence 1123456889999999998888999999999999999999999999743211 111111110000 00
Q ss_pred cCCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002721 845 TVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEM 881 (888)
Q Consensus 845 ~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~ 881 (888)
.........+.+++.+||+.+|++||+++++++.
T Consensus 238 ---~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~ 271 (297)
T cd06659 238 ---KNAHKISPVLRDFLERMLTREPQERATAQELLDH 271 (297)
T ss_pred ---cccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhC
Confidence 0011123456789999999999999999999873
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=307.17 Aligned_cols=254 Identities=26% Similarity=0.360 Sum_probs=201.7
Q ss_pred hcCCcceeeecccceEEEEEe-CCCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCCeeEEEEe
Q 002721 606 TMKDSNMIYCGTFSTVYKAVM-PSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVALLLHN 684 (888)
Q Consensus 606 ~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 684 (888)
+|+..+.||+|+||.||+|.. .+++.||+|.++..... ....+.+.+|++++++++|+||+++++++...+..++|+|
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDND-PKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFME 79 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECcccc-hHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEe
Confidence 478889999999999999995 47899999999855443 3455689999999999999999999999999999999999
Q ss_pred cCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccccccccCCCCC
Q 002721 685 YLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSKG 764 (888)
Q Consensus 685 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 764 (888)
|+++++|.+++.... .+++..+..++.|++.||+|||+.|++|+||+|+||++++++.+||+|||.+........
T Consensus 80 ~~~~~~L~~~~~~~~-----~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~ 154 (264)
T cd06626 80 YCSGGTLEELLEHGR-----ILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTT 154 (264)
T ss_pred cCCCCcHHHHHhhcC-----CCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCC
Confidence 999999999997643 357788999999999999999999999999999999999999999999999887654322
Q ss_pred ccc--ccccccccceecccccccCC---cCccccchhHHHHHHHHHhCCCCCCCCCCCccchhhhccccCCCCCCccccc
Q 002721 765 TAS--ISAVAGSFGYIPPEYAYTMQ---VTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQIL 839 (888)
Q Consensus 765 ~~~--~~~~~gt~~y~aPE~~~~~~---~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 839 (888)
... .....++..|+|||++.+.. ++.++||||||+++||+++|+.||............ .... .
T Consensus 155 ~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~~-~~~~----~------ 223 (264)
T cd06626 155 TMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMFH-VGAG----H------ 223 (264)
T ss_pred cccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHHH-HhcC----C------
Confidence 111 12356788999999988766 889999999999999999999999753211111000 0000 0
Q ss_pred ccccccCCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002721 840 DARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVE 880 (888)
Q Consensus 840 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 880 (888)
.+.. +........+.+++.+||+.+|++||++.|++.
T Consensus 224 ~~~~----~~~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~ 260 (264)
T cd06626 224 KPPI----PDSLQLSPEGKDFLDRCLESDPKKRPTASELLQ 260 (264)
T ss_pred CCCC----CcccccCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 0000 011122456678999999999999999999875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-34 Score=311.85 Aligned_cols=267 Identities=17% Similarity=0.192 Sum_probs=200.7
Q ss_pred hcCCcceeeecccceEEEEEe-CCCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCCeeEEEEe
Q 002721 606 TMKDSNMIYCGTFSTVYKAVM-PSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVALLLHN 684 (888)
Q Consensus 606 ~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 684 (888)
+|++.+.||+|+||.||+|+. .+|+.||+|++...... ....+.+.+|+.++++++||||+++++++..+...++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e 79 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRLE-GGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVME 79 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEccccc-chhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEec
Confidence 478889999999999999995 46899999999754321 2234578899999999999999999999999999999999
Q ss_pred cCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccccccccCCCCC
Q 002721 685 YLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSKG 764 (888)
Q Consensus 685 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 764 (888)
|+ +++|.+++..... .+++.++..++.||++||+|||+.|++|+||||+||+++.++.++++|||.+........
T Consensus 80 ~~-~~~L~~~~~~~~~----~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~ 154 (286)
T cd07832 80 YM-PSDLSEVLRDEER----PLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEP 154 (286)
T ss_pred cc-CCCHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC
Confidence 99 9999999876442 578899999999999999999999999999999999999999999999999987654321
Q ss_pred cccccccccccceecccccccC-CcCccccchhHHHHHHHHHhCCCCCCCCCCCccchhhhcccc--CCCCC--------
Q 002721 765 TASISAVAGSFGYIPPEYAYTM-QVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGA--PARGE-------- 833 (888)
Q Consensus 765 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~--~~~~~-------- 833 (888)
.......++..|+|||++.+. .++.++||||+|+++|||++|.+||...... ..+....... +....
T Consensus 155 -~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (286)
T cd07832 155 -RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDI-EQLAIVFRTLGTPNEETWPGLTSLP 232 (286)
T ss_pred -CccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHH-HHHHHHHHHcCCCChHHHhhccCcc
Confidence 122345688999999988654 4688999999999999999998888653321 1111100000 00000
Q ss_pred Cccccccccccc--CCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002721 834 TPEQILDARLST--VSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVE 880 (888)
Q Consensus 834 ~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 880 (888)
....+....... ...........+.+++.+|++.||++||+++++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~l~ 281 (286)
T cd07832 233 DYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLSAAEALR 281 (286)
T ss_pred hhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCCHHHHhh
Confidence 000000000000 00001122367789999999999999999999986
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-35 Score=316.25 Aligned_cols=268 Identities=18% Similarity=0.255 Sum_probs=199.7
Q ss_pred HhcCCcceeeecccceEEEEEeC-CCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCCeeEEEE
Q 002721 605 ATMKDSNMIYCGTFSTVYKAVMP-SGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVALLLH 683 (888)
Q Consensus 605 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 683 (888)
++|+..+.||+|+||.||+|... +++.||+|++....... ...+.+.+|+++++.++||||+++++++..++..|+||
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 79 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDDK-MVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVF 79 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCcc-hhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEE
Confidence 36888999999999999999965 58999999987543322 33457889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccccccccCCCC
Q 002721 684 NYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSK 763 (888)
Q Consensus 684 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 763 (888)
||++++++.++..... .+++.++..++.||+.||+|||+.|++||||+|+||++++++.++++|||++.......
T Consensus 80 e~~~~~~l~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~ 154 (286)
T cd07846 80 EFVDHTVLDDLEKYPN-----GLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG 154 (286)
T ss_pred ecCCccHHHHHHhccC-----CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc
Confidence 9999988888765432 46889999999999999999999999999999999999999999999999988764432
Q ss_pred Ccccccccccccceeccccccc-CCcCccccchhHHHHHHHHHhCCCCCCCCCCCcc--chhhhccccCCCCC---Cccc
Q 002721 764 GTASISAVAGSFGYIPPEYAYT-MQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGV--DLVKWVHGAPARGE---TPEQ 837 (888)
Q Consensus 764 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~--~~~~~~~~~~~~~~---~~~~ 837 (888)
.......++..|+|||++.+ ..++.++||||||+++|||++|++||........ ....+......... ....
T Consensus 155 --~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (286)
T cd07846 155 --EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNP 232 (286)
T ss_pred --cccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccch
Confidence 12234567889999998765 3478899999999999999999999964321100 00000000000000 0000
Q ss_pred cc----cccccc---CCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002721 838 IL----DARLST---VSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVE 880 (888)
Q Consensus 838 ~~----~~~~~~---~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 880 (888)
+. .+.... ...........+.+++.+||+.+|++||++.++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 282 (286)
T cd07846 233 LFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQLLH 282 (286)
T ss_pred HhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHHHhc
Confidence 00 000000 00001123466889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=287.00 Aligned_cols=251 Identities=22% Similarity=0.301 Sum_probs=197.9
Q ss_pred hcCCcceeeecccceEEEEEe-CCCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccC-CCceeeeeeEEEeCCeeEEEE
Q 002721 606 TMKDSNMIYCGTFSTVYKAVM-PSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLC-HDNLVRPIGFVIYEDVALLLH 683 (888)
Q Consensus 606 ~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~~lv~ 683 (888)
+.+....||+|.-|+|++++. .+|..+|||.+.+.... ++.+++...++++...+ .|+||+.+|||..+..+++.|
T Consensus 93 dl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt~Nk--ee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcM 170 (391)
T KOG0983|consen 93 DLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRTGNK--EENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICM 170 (391)
T ss_pred HhhhHHhhcCCCccceEEEEEcccceEEEEEeecccCCH--HHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHH
Confidence 445677899999999999995 46999999999865543 34568889999887775 999999999999999999999
Q ss_pred ecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhccc-CCeeecCCCCCCeEeCCCCCceEeccccccccCCC
Q 002721 684 NYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHH-VAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPS 762 (888)
Q Consensus 684 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 762 (888)
|.|.. -.+.+++.... .+++.-+-++...+++||.||.+ +||+|||+||+|||+|+.|.+|+||||++..+.++
T Consensus 171 elMs~-C~ekLlkrik~----piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdS 245 (391)
T KOG0983|consen 171 ELMST-CAEKLLKRIKG----PIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDS 245 (391)
T ss_pred HHHHH-HHHHHHHHhcC----CchHHhhhhhHHHHHHHHHHHHHhcceeecccCccceEEccCCCEEeecccccceeecc
Confidence 99853 55566554432 35666667888899999999987 79999999999999999999999999999988765
Q ss_pred CCcccccccccccceeccccccc---CCcCccccchhHHHHHHHHHhCCCCCCCCCCCccchhhhccccCCCCCCccccc
Q 002721 763 KGTASISAVAGSFGYIPPEYAYT---MQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQIL 839 (888)
Q Consensus 763 ~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 839 (888)
... +...|.+.|||||.+.- ..|+.++||||||++++|+.||..||.....+...+.+.....+..
T Consensus 246 kAh---trsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdFe~ltkvln~ePP~-------- 314 (391)
T KOG0983|consen 246 KAH---TRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDFEVLTKVLNEEPPL-------- 314 (391)
T ss_pred ccc---ccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccHHHHHHHHhcCCCC--------
Confidence 433 34578899999998753 3689999999999999999999999987544433333332222111
Q ss_pred ccccccCCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002721 840 DARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEM 881 (888)
Q Consensus 840 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~ 881 (888)
+. .....++.+.+++..|+.+|+.+||...++++.
T Consensus 315 ---L~----~~~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h 349 (391)
T KOG0983|consen 315 ---LP----GHMGFSPDFQSFVKDCLTKDHRKRPKYNKLLEH 349 (391)
T ss_pred ---CC----cccCcCHHHHHHHHHHhhcCcccCcchHHHhcC
Confidence 11 111245778889999999999999999998763
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=320.55 Aligned_cols=257 Identities=20% Similarity=0.290 Sum_probs=205.9
Q ss_pred HHHHhcCCcceeeecccceEEEEEeC--CC--cEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCC
Q 002721 602 VVKATMKDSNMIYCGTFSTVYKAVMP--SG--LILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYED 677 (888)
Q Consensus 602 ~~~~~~~~~~~ig~G~~g~Vy~~~~~--~~--~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~ 677 (888)
|..+..+..++||+|.||.|++|.|. .| ..||||.++...... ....|.+|+.+|.+++|||++++||+..+ .
T Consensus 107 Ipee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~--~mddflrEas~M~~L~H~hliRLyGvVl~-q 183 (1039)
T KOG0199|consen 107 IPEEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA--IMDDFLREASHMLKLQHPHLIRLYGVVLD-Q 183 (1039)
T ss_pred ccHHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch--hHHHHHHHHHHHHhccCcceeEEeeeecc-c
Confidence 34556677889999999999999964 23 468999998544332 45689999999999999999999999887 7
Q ss_pred eeEEEEecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEecccccc
Q 002721 678 VALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISK 757 (888)
Q Consensus 678 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~ 757 (888)
...+|||.++.|+|.+.+++... ..+.......++.|||.|+.||.+++.|||||..+|+++.....+||+|||+.+
T Consensus 184 p~mMV~ELaplGSLldrLrka~~---~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAARNlllasprtVKI~DFGLmR 260 (1039)
T KOG0199|consen 184 PAMMVFELAPLGSLLDRLRKAKK---AILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAARNLLLASPRTVKICDFGLMR 260 (1039)
T ss_pred hhhHHhhhcccchHHHHHhhccc---cceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhhhheecccceeeeeccccee
Confidence 78899999999999999998322 256778888999999999999999999999999999999998999999999999
Q ss_pred ccCCCCCccccc-ccccccceecccccccCCcCccccchhHHHHHHHHHh-CCCCCCCCCCCccchhhhccccCCCCCCc
Q 002721 758 LLDPSKGTASIS-AVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILT-TRLPVEEDFGEGVDLVKWVHGAPARGETP 835 (888)
Q Consensus 758 ~~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 835 (888)
.+........+. ...-...|+|||.+....++.++|||+|||++|||+| |..||.+..+. ++.+.+
T Consensus 261 aLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~g~--qIL~~i---------- 328 (1039)
T KOG0199|consen 261 ALGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCRGI--QILKNI---------- 328 (1039)
T ss_pred ccCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCCHH--HHHHhc----------
Confidence 887655443322 2234568999999999999999999999999999999 88999764322 111111
Q ss_pred ccccccccccCCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 002721 836 EQILDARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEML 882 (888)
Q Consensus 836 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L 882 (888)
-+...- .......++++++|+.||..+|++|||+..|.+.+
T Consensus 329 ---D~~erL---pRPk~csedIY~imk~cWah~paDRptFsair~~~ 369 (1039)
T KOG0199|consen 329 ---DAGERL---PRPKYCSEDIYQIMKNCWAHNPADRPTFSAIREDL 369 (1039)
T ss_pred ---cccccC---CCCCCChHHHHHHHHHhccCCccccccHHHHHHhH
Confidence 111111 12234567789999999999999999999997543
|
|
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=314.54 Aligned_cols=251 Identities=21% Similarity=0.303 Sum_probs=199.2
Q ss_pred HHhcCCcceeeecccceEEEEEe-CCCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCCeeEEE
Q 002721 604 KATMKDSNMIYCGTFSTVYKAVM-PSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVALLL 682 (888)
Q Consensus 604 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 682 (888)
...|+..+.||+|+||.||+|+. .++..||+|.+........+..+.+.+|++++++++|||++++++++..++..|+|
T Consensus 24 ~~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv 103 (317)
T cd06635 24 EKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLV 103 (317)
T ss_pred hhhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEE
Confidence 44588899999999999999995 46899999998754443444455788999999999999999999999999999999
Q ss_pred EecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccccccccCCC
Q 002721 683 HNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPS 762 (888)
Q Consensus 683 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 762 (888)
|||+++ ++.+.+..... .+++.++..++.|++.|+.|||++||+||||+|+||+++.++.+|++|||.+......
T Consensus 104 ~e~~~g-~l~~~~~~~~~----~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~ 178 (317)
T cd06635 104 MEYCLG-SASDLLEVHKK----PLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPA 178 (317)
T ss_pred EeCCCC-CHHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCCCCEEEecCCCccccCCc
Confidence 999975 88887764322 4788999999999999999999999999999999999999999999999988764322
Q ss_pred CCcccccccccccceecccccc---cCCcCccccchhHHHHHHHHHhCCCCCCCCCCCccchhhhccccCCCCCCccccc
Q 002721 763 KGTASISAVAGSFGYIPPEYAY---TMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQIL 839 (888)
Q Consensus 763 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 839 (888)
....++..|+|||++. +..++.++|||||||++|||++|+.||........ ...+...
T Consensus 179 ------~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~-~~~~~~~------------ 239 (317)
T cd06635 179 ------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA-LYHIAQN------------ 239 (317)
T ss_pred ------ccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHH-HHHHHhc------------
Confidence 2345788999999874 45688999999999999999999999865321110 1111100
Q ss_pred ccccccCCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 002721 840 DARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEML 882 (888)
Q Consensus 840 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L 882 (888)
.... .........+.+++.+||+.+|.+||++.++++..
T Consensus 240 --~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~ 278 (317)
T cd06635 240 --ESPT--LQSNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHM 278 (317)
T ss_pred --cCCC--CCCccccHHHHHHHHHHccCCcccCcCHHHHHhCh
Confidence 0000 01112334678899999999999999999999754
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-34 Score=309.05 Aligned_cols=254 Identities=22% Similarity=0.267 Sum_probs=198.7
Q ss_pred HHhcCCcceeeecccceEEEEEeC-CCcEEEEEEeeccChhhhHHHHHHHHHHHHHhcc-CCCceeeeeeEEEeCC----
Q 002721 604 KATMKDSNMIYCGTFSTVYKAVMP-SGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKL-CHDNLVRPIGFVIYED---- 677 (888)
Q Consensus 604 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~---- 677 (888)
.++|++.+.||+|+||.||+|... +++.|++|++..... ..+.+.+|+++++++ .||||+++++++....
T Consensus 5 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~----~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 80 (275)
T cd06608 5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED----EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGN 80 (275)
T ss_pred hhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch----hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCc
Confidence 478999999999999999999964 688999999875433 234788999999999 6999999999997644
Q ss_pred --eeEEEEecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEecccc
Q 002721 678 --VALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEI 755 (888)
Q Consensus 678 --~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~ 755 (888)
..|+||||+++++|.+++....... ..+++..+..++.|+++||+|||+.|++||||+|+||++++++.+|++|||.
T Consensus 81 ~~~~~lv~e~~~~~~L~~~~~~~~~~~-~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~~~ 159 (275)
T cd06608 81 DDQLWLVMELCGGGSVTDLVKGLRKKG-KRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGV 159 (275)
T ss_pred ceEEEEEEEcCCCCcHHHHHHHHhhcC-CCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEEccCCeEEECCCcc
Confidence 4899999999999999987643211 2578899999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCcccccccccccceeccccccc-----CCcCccccchhHHHHHHHHHhCCCCCCCCCCCccchhhhccccCC
Q 002721 756 SKLLDPSKGTASISAVAGSFGYIPPEYAYT-----MQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPA 830 (888)
Q Consensus 756 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~ 830 (888)
+....... .......++..|+|||++.. ..++.++||||+|+++|+|++|+.||...... .........
T Consensus 160 ~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~-~~~~~~~~~--- 233 (275)
T cd06608 160 SAQLDSTL--GRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMHPM-RALFKIPRN--- 233 (275)
T ss_pred ceecccch--hhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccchH-HHHHHhhcc---
Confidence 87654322 11234568889999998753 34778999999999999999999999743211 111111100
Q ss_pred CCCCcccccccccccCCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002721 831 RGETPEQILDARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVE 880 (888)
Q Consensus 831 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 880 (888)
..... .........+.+++.+||..||++|||+.|+++
T Consensus 234 -----------~~~~~-~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~ 271 (275)
T cd06608 234 -----------PPPTL-KSPENWSKKFNDFISECLIKNYEQRPFMEELLE 271 (275)
T ss_pred -----------CCCCC-CchhhcCHHHHHHHHHHhhcChhhCcCHHHHhc
Confidence 00000 011123456778999999999999999999985
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-34 Score=305.74 Aligned_cols=245 Identities=21% Similarity=0.199 Sum_probs=197.1
Q ss_pred eeecccceEEEEEeC-CCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCCeeEEEEecCCCCCH
Q 002721 613 IYCGTFSTVYKAVMP-SGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVALLLHNYLPNGTL 691 (888)
Q Consensus 613 ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L 691 (888)
||.|+||.||+|+.. +++.||+|++...........+.+.+|+++++.++||||+++++++.++...++||||+++++|
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGEL 80 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcH
Confidence 689999999999964 5899999999765444444556899999999999999999999999999999999999999999
Q ss_pred HHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccccccccCCCCCccccccc
Q 002721 692 AQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSKGTASISAV 771 (888)
Q Consensus 692 ~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~ 771 (888)
.+++.... .+++..+..++.|++.||+|||++|++|+||||+||+++.++.++++|||.+....... .....
T Consensus 81 ~~~l~~~~-----~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~~~ 152 (262)
T cd05572 81 WTILRDRG-----LFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWTF 152 (262)
T ss_pred HHHHhhcC-----CCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---ccccc
Confidence 99997643 36778999999999999999999999999999999999999999999999998765432 12234
Q ss_pred ccccceecccccccCCcCccccchhHHHHHHHHHhCCCCCCCCCCCccchhhhccccCCCCCCcccccccccccCCcCcH
Q 002721 772 AGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQILDARLSTVSFGWR 851 (888)
Q Consensus 772 ~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 851 (888)
.++..|+|||.+.+..++.++|+||+|+++|+|++|..||.....+....... +....... ....
T Consensus 153 ~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~-------------~~~~~~~~--~~~~ 217 (262)
T cd05572 153 CGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYND-------------ILKGNGKL--EFPN 217 (262)
T ss_pred cCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHH-------------HhccCCCC--CCCc
Confidence 67889999999888889999999999999999999999997653211111111 01000000 0011
Q ss_pred HHHHHHHHHHhhccCCCCCCCCC-----HHHHHH
Q 002721 852 KEMLTALKVALLCTDSTPAKRPK-----MKKVVE 880 (888)
Q Consensus 852 ~~~~~~~~li~~cl~~dP~~RPs-----~~evl~ 880 (888)
....++.+++.+||+.+|++||+ ++|+++
T Consensus 218 ~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~ 251 (262)
T cd05572 218 YIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKK 251 (262)
T ss_pred ccCHHHHHHHHHHccCChhhCcCCcccCHHHHhc
Confidence 11457889999999999999999 777765
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-34 Score=312.86 Aligned_cols=268 Identities=18% Similarity=0.206 Sum_probs=199.9
Q ss_pred hcCCcceeeecccceEEEEEeC-CCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCCeeEEEEe
Q 002721 606 TMKDSNMIYCGTFSTVYKAVMP-SGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVALLLHN 684 (888)
Q Consensus 606 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 684 (888)
+|+..+.||+|+||.||+|... +++.||+|+++.... .....+.+.+|++++++++|+||+++++++..++..++|||
T Consensus 2 ~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e 80 (288)
T cd07833 2 KYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESED-DEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFE 80 (288)
T ss_pred ceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcc-cccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEe
Confidence 6888999999999999999954 688999999874332 22334578999999999999999999999999999999999
Q ss_pred cCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccccccccCCCCC
Q 002721 685 YLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSKG 764 (888)
Q Consensus 685 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 764 (888)
|++++.+..+..... .+++.++..++.||+.||+|||+.|++||||+|+||++++++.+||+|||.+........
T Consensus 81 ~~~~~~l~~~~~~~~-----~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~ 155 (288)
T cd07833 81 YVERTLLELLEASPG-----GLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPA 155 (288)
T ss_pred cCCCCHHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCcc
Confidence 999877766554322 468899999999999999999999999999999999999999999999999987654432
Q ss_pred cccccccccccceecccccccC-CcCccccchhHHHHHHHHHhCCCCCCCCCCCcc--chhhhccccCCCCC---Ccccc
Q 002721 765 TASISAVAGSFGYIPPEYAYTM-QVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGV--DLVKWVHGAPARGE---TPEQI 838 (888)
Q Consensus 765 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~--~~~~~~~~~~~~~~---~~~~~ 838 (888)
. ......++..|+|||++.+. .++.++||||+|+++|+|++|+.||........ .........+.... .....
T Consensus 156 ~-~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (288)
T cd07833 156 S-PLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPR 234 (288)
T ss_pred c-cccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCcc
Confidence 1 22345678899999999888 789999999999999999999999975322110 00000000000000 00000
Q ss_pred ccc-ccccCC-------cCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002721 839 LDA-RLSTVS-------FGWRKEMLTALKVALLCTDSTPAKRPKMKKVVE 880 (888)
Q Consensus 839 ~~~-~~~~~~-------~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 880 (888)
... ...... ........++.+++.+||..+|++||+++++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 284 (288)
T cd07833 235 FAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLTCDELLQ 284 (288)
T ss_pred ccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcccHHHHhc
Confidence 000 000000 000112567889999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-35 Score=308.26 Aligned_cols=251 Identities=20% Similarity=0.243 Sum_probs=199.5
Q ss_pred hcCCcceeeecccceEEEEEeC-CCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCCeeEEEEe
Q 002721 606 TMKDSNMIYCGTFSTVYKAVMP-SGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVALLLHN 684 (888)
Q Consensus 606 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 684 (888)
+|+..+.||+|+||.||+|... +|..||+|.+..... .....+.+.+|++++++++||||+++++++..++..++|+|
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e 79 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKM-PVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVME 79 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhc-cchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEe
Confidence 4778899999999999999954 688999999875322 12234578899999999999999999999999999999999
Q ss_pred cCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCC-CceEeccccccccCCCC
Q 002721 685 YLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADF-KPLLGEIEISKLLDPSK 763 (888)
Q Consensus 685 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~-~~kl~Dfg~a~~~~~~~ 763 (888)
|+++++|.+++...... .+++..+..++.|+++||+|||+.+++|+||||+||++++++ .+|++|||.+.......
T Consensus 80 ~~~~~~L~~~~~~~~~~---~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~ 156 (257)
T cd08225 80 YCDGGDLMKRINRQRGV---LFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSM 156 (257)
T ss_pred cCCCCcHHHHHHhccCC---CCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCCc
Confidence 99999999999764332 468899999999999999999999999999999999999875 46999999988765332
Q ss_pred CcccccccccccceecccccccCCcCccccchhHHHHHHHHHhCCCCCCCCCCCccchhhhccccCCCCCCccccccccc
Q 002721 764 GTASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQILDARL 843 (888)
Q Consensus 764 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 843 (888)
. ......|++.|+|||+..+..++.++|+||||+++|||++|..||....... .... ......
T Consensus 157 ~--~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~-----~~~~----------~~~~~~ 219 (257)
T cd08225 157 E--LAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQ-----LVLK----------ICQGYF 219 (257)
T ss_pred c--cccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHH-----HHHH----------HhcccC
Confidence 1 1223468889999999988889999999999999999999999996432111 1100 000001
Q ss_pred ccCCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002721 844 STVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVE 880 (888)
Q Consensus 844 ~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 880 (888)
... ......++.+++.+||..+|++|||+.|+++
T Consensus 220 ~~~---~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 253 (257)
T cd08225 220 API---SPNFSRDLRSLISQLFKVSPRDRPSITSILK 253 (257)
T ss_pred CCC---CCCCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 111 1122346778999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-35 Score=314.23 Aligned_cols=264 Identities=19% Similarity=0.250 Sum_probs=197.7
Q ss_pred hcCCcceeeecccceEEEEEeC-CCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCCeeEEEEe
Q 002721 606 TMKDSNMIYCGTFSTVYKAVMP-SGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVALLLHN 684 (888)
Q Consensus 606 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 684 (888)
.|+..+.||.|++|.||+|+.. +++.||+|+++.... .....+.+.+|++++++++||||+++++++.+++..++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e 79 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE-TEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFE 79 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEcccccc-ccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEee
Confidence 3788899999999999999954 689999998874332 22223478899999999999999999999999999999999
Q ss_pred cCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccccccccCCCCC
Q 002721 685 YLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSKG 764 (888)
Q Consensus 685 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 764 (888)
|+. ++|.+++...... .+++..+..++.|++.||+|||+.|++||||+|+||++++++.+|++|||.+........
T Consensus 80 ~~~-~~l~~~~~~~~~~---~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~ 155 (284)
T cd07860 80 FLH-QDLKKFMDASPLS---GIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR 155 (284)
T ss_pred ccc-cCHHHHHHhCCCC---CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCcc
Confidence 996 5899988764322 578899999999999999999999999999999999999999999999999876543221
Q ss_pred cccccccccccceecccccccCC-cCccccchhHHHHHHHHHhCCCCCCCCCCCccchhhhccccCCCCCC---------
Q 002721 765 TASISAVAGSFGYIPPEYAYTMQ-VTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGET--------- 834 (888)
Q Consensus 765 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~--------- 834 (888)
......++..|+|||++.+.. ++.++||||||+++|||+||+.||....... ...+...........
T Consensus 156 --~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 232 (284)
T cd07860 156 --TYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID-QLFRIFRTLGTPDEVVWPGVTSLP 232 (284)
T ss_pred --ccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHH-HHHHHHHHhCCCChhhhhhhhHHH
Confidence 122345688999999876644 6889999999999999999999997543211 111111110000000
Q ss_pred -----cccccccccccCCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002721 835 -----PEQILDARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVE 880 (888)
Q Consensus 835 -----~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 880 (888)
........... .......++.+++.+||+.||++|||++|+++
T Consensus 233 ~~~~~~~~~~~~~~~~---~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 280 (284)
T cd07860 233 DYKPSFPKWARQDFSK---VVPPLDEDGRDLLSQMLHYDPNKRISAKAALA 280 (284)
T ss_pred HHHhhcccccccCHHH---HcccCCHHHHHHHHHhcCCCcccCCCHHHHhc
Confidence 00000000000 00112355678999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=341.74 Aligned_cols=255 Identities=20% Similarity=0.137 Sum_probs=207.0
Q ss_pred HHHhcCCcceeeecccceEEEEEe-CCCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCCeeEE
Q 002721 603 VKATMKDSNMIYCGTFSTVYKAVM-PSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVALL 681 (888)
Q Consensus 603 ~~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 681 (888)
..++|++.++||+|+||.|..++. .++++||+|++.+.+........-|..|-.+|.....+-|+.++-.|.++.+.|+
T Consensus 73 ~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYl 152 (1317)
T KOG0612|consen 73 KAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYL 152 (1317)
T ss_pred CHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEE
Confidence 466899999999999999999995 5799999999987555544555578899999999999999999999999999999
Q ss_pred EEecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccccccccCC
Q 002721 682 LHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDP 761 (888)
Q Consensus 682 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~~~ 761 (888)
|||||+||||-.++.... ++++..+..++..|+-||+-+|+.|+|||||||+|||+|..|++||+|||.+-.+..
T Consensus 153 VMdY~pGGDlltLlSk~~-----~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~ 227 (1317)
T KOG0612|consen 153 VMDYMPGGDLLTLLSKFD-----RLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDA 227 (1317)
T ss_pred EEecccCchHHHHHhhcC-----CChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHHhcCC
Confidence 999999999999998765 467788889999999999999999999999999999999999999999999988875
Q ss_pred CCCcccccccccccceecccccc----c-CCcCccccchhHHHHHHHHHhCCCCCCCCCCCccchhhhccccCCCCCCcc
Q 002721 762 SKGTASISAVAGSFGYIPPEYAY----T-MQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPE 836 (888)
Q Consensus 762 ~~~~~~~~~~~gt~~y~aPE~~~----~-~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~ 836 (888)
+. .......+|||-|++||++. + +.|++.+|.||+||++|||+.|..||..+.-- .++.
T Consensus 228 dG-~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslv---------------eTY~ 291 (1317)
T KOG0612|consen 228 DG-TVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLV---------------ETYG 291 (1317)
T ss_pred CC-cEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHH---------------HHHH
Confidence 43 44456778999999999875 2 56999999999999999999999999754211 1222
Q ss_pred cccccccccCCcCcHHHHHHHHHHHhhccCCCCCCCCC---HHHHH
Q 002721 837 QILDARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPK---MKKVV 879 (888)
Q Consensus 837 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs---~~evl 879 (888)
+|++..-....+.....++++.++|.+.+. +|+.|.. ++++-
T Consensus 292 KIm~hk~~l~FP~~~~VSeeakdLI~~ll~-~~e~RLgrngiedik 336 (1317)
T KOG0612|consen 292 KIMNHKESLSFPDETDVSEEAKDLIEALLC-DREVRLGRNGIEDIK 336 (1317)
T ss_pred HHhchhhhcCCCcccccCHHHHHHHHHHhc-ChhhhcccccHHHHH
Confidence 233221111111223456777788877665 7888877 66654
|
|
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=310.01 Aligned_cols=251 Identities=20% Similarity=0.269 Sum_probs=201.2
Q ss_pred HHhcCCcceeeecccceEEEEEe-CCCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCCeeEEE
Q 002721 604 KATMKDSNMIYCGTFSTVYKAVM-PSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVALLL 682 (888)
Q Consensus 604 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 682 (888)
..+|++.+.||+|+||.||+|.. .+++.||+|.+...... ..+.+.+|+.++++++||||+++++++...+..|+|
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~---~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv 94 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQQP---KKELIINEILVMRENKHPNIVNYLDSYLVGDELWVV 94 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEeccccch---HHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEE
Confidence 36899999999999999999984 46889999998643222 234788999999999999999999999999999999
Q ss_pred EecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccccccccCCC
Q 002721 683 HNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPS 762 (888)
Q Consensus 683 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 762 (888)
+||+++++|.+++.+. .+++.++..++.|++.||.|||++|++||||||+||+++.++.++|+|||.+......
T Consensus 95 ~e~~~~~~L~~~~~~~------~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~ 168 (293)
T cd06647 95 MEYLAGGSLTDVVTET------CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 168 (293)
T ss_pred EecCCCCcHHHHHhhc------CCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCCCCEEEccCcceeccccc
Confidence 9999999999998753 4578899999999999999999999999999999999999999999999988765433
Q ss_pred CCcccccccccccceecccccccCCcCccccchhHHHHHHHHHhCCCCCCCCCCCccchhhhccccCCCCCCcccccccc
Q 002721 763 KGTASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQILDAR 842 (888)
Q Consensus 763 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 842 (888)
.. ......+++.|+|||.+.+..++.++||||||+++|++++|+.||........ .... ...+
T Consensus 169 ~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~-~~~~----~~~~---------- 231 (293)
T cd06647 169 QS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA-LYLI----ATNG---------- 231 (293)
T ss_pred cc--ccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhh-eeeh----hcCC----------
Confidence 22 12334688899999999888899999999999999999999999975322110 0000 0000
Q ss_pred cccCCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002721 843 LSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEM 881 (888)
Q Consensus 843 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~ 881 (888)
... ..........+.+++.+||+.+|++||++.+++..
T Consensus 232 ~~~-~~~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h 269 (293)
T cd06647 232 TPE-LQNPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQH 269 (293)
T ss_pred CCC-CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 000 00112234567789999999999999999999864
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-34 Score=313.70 Aligned_cols=270 Identities=19% Similarity=0.209 Sum_probs=196.6
Q ss_pred hcCCcceeeecccceEEEEEeC-CCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccC-CCceeeeeeEEEeCCe-----
Q 002721 606 TMKDSNMIYCGTFSTVYKAVMP-SGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLC-HDNLVRPIGFVIYEDV----- 678 (888)
Q Consensus 606 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~----- 678 (888)
+|+..+.||+|+||.||+|... +++.||+|.++.... .......+.+|+.+++++. ||||+++++++...+.
T Consensus 2 ~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~ 80 (295)
T cd07837 2 AYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMD-EEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPS 80 (295)
T ss_pred CceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhcc-ccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCce
Confidence 6888999999999999999954 689999998864322 1222346888999999995 6999999999987665
Q ss_pred eEEEEecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCC-CCCceEecccccc
Q 002721 679 ALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDA-DFKPLLGEIEISK 757 (888)
Q Consensus 679 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~-~~~~kl~Dfg~a~ 757 (888)
.|+||||+++ ++.+++..........+++..++.++.||+.||+|||++||+||||||+||+++. ++.+|++|||.+.
T Consensus 81 ~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~~ 159 (295)
T cd07837 81 LYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGR 159 (295)
T ss_pred EEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeecccce
Confidence 8999999985 8999887654332235789999999999999999999999999999999999998 8899999999988
Q ss_pred ccCCCCCcccccccccccceeccccccc-CCcCccccchhHHHHHHHHHhCCCCCCCCCCCccchhhhccc--cCCCCCC
Q 002721 758 LLDPSKGTASISAVAGSFGYIPPEYAYT-MQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHG--APARGET 834 (888)
Q Consensus 758 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~--~~~~~~~ 834 (888)
....... ......+++.|+|||++.+ ..++.++||||||+++|+|++|..||....... ...+.... .+.....
T Consensus 160 ~~~~~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~~~-~~~~~~~~~~~~~~~~~ 236 (295)
T cd07837 160 AFSIPVK--SYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQ-QLLHIFKLLGTPTEQVW 236 (295)
T ss_pred ecCCCcc--ccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCHHH-HHHHHHHHhCCCChhhC
Confidence 6543221 1223356788999998765 457899999999999999999999997532211 11111000 0000000
Q ss_pred cccccccc---ccc-----CCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002721 835 PEQILDAR---LST-----VSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVE 880 (888)
Q Consensus 835 ~~~~~~~~---~~~-----~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 880 (888)
........ ... ..........++.+++.+||++||++||+++|++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~~~~eil~ 290 (295)
T cd07837 237 PGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISAKAALT 290 (295)
T ss_pred cchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcCCHHHHhc
Confidence 00000000 000 00001123466789999999999999999999875
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-34 Score=307.15 Aligned_cols=246 Identities=20% Similarity=0.163 Sum_probs=189.3
Q ss_pred ceeeecccceEEEEEe-CCCcEEEEEEeeccChhhhHHHHHHHHHHHHH-hccCCCceeeeeeEEEeCCeeEEEEecCCC
Q 002721 611 NMIYCGTFSTVYKAVM-PSGLILSVKRLKSMDRTIIHHQNKMIRELEKL-SKLCHDNLVRPIGFVIYEDVALLLHNYLPN 688 (888)
Q Consensus 611 ~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l-~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~ 688 (888)
+.||+|+||.||+|.. .+++.||+|+++............+..|..++ ...+|||++++++++..++..|+||||+++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~ 81 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNG 81 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCC
Confidence 5689999999999995 46899999998754433333333455565544 455899999999999999999999999999
Q ss_pred CCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccccccccCCCCCcccc
Q 002721 689 GTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSKGTASI 768 (888)
Q Consensus 689 g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~ 768 (888)
++|.+++.... .+++..+..++.|++.||.|||+.+++||||+|+||+++.++.+|++|||.+..... .
T Consensus 82 ~~L~~~l~~~~-----~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------~ 150 (260)
T cd05611 82 GDCASLIKTLG-----GLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------N 150 (260)
T ss_pred CCHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEeecccceeccc------c
Confidence 99999997643 467789999999999999999999999999999999999999999999998876432 1
Q ss_pred cccccccceecccccccCCcCccccchhHHHHHHHHHhCCCCCCCCCCCccchhhhccccCCCCCCcccccccccccCCc
Q 002721 769 SAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQILDARLSTVSF 848 (888)
Q Consensus 769 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 848 (888)
....++..|+|||...+..++.++||||+|+++|||++|..||....... ...... .........
T Consensus 151 ~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~--~~~~~~-------------~~~~~~~~~ 215 (260)
T cd05611 151 KKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDA--VFDNIL-------------SRRINWPEE 215 (260)
T ss_pred ccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHH--HHHHHH-------------hcccCCCCc
Confidence 23457889999999988889999999999999999999999997542211 111000 000000000
Q ss_pred CcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 002721 849 GWRKEMLTALKVALLCTDSTPAKRPKMKKVVEML 882 (888)
Q Consensus 849 ~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L 882 (888)
........+.+++.+||+.||++||++.++.+.+
T Consensus 216 ~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l 249 (260)
T cd05611 216 VKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIK 249 (260)
T ss_pred ccccCCHHHHHHHHHHccCCHHHccCCCcHHHHH
Confidence 1112345678999999999999999776554433
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-36 Score=295.53 Aligned_cols=245 Identities=20% Similarity=0.147 Sum_probs=203.8
Q ss_pred HHHhcCCcceeeecccceEEEEE-eCCCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCCeeEE
Q 002721 603 VKATMKDSNMIYCGTFSTVYKAV-MPSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVALL 681 (888)
Q Consensus 603 ~~~~~~~~~~ig~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 681 (888)
.-++|+..+++|+|.||.|-.++ ..+++.||+|++++.-.....+.+.-..|-++++..+||.+..+.-.|+..+..|+
T Consensus 166 Tm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCF 245 (516)
T KOG0690|consen 166 TMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCF 245 (516)
T ss_pred ccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEE
Confidence 34578899999999999999999 55799999999987665555666677889999999999999999989999999999
Q ss_pred EEecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccccccccCC
Q 002721 682 LHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDP 761 (888)
Q Consensus 682 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~~~ 761 (888)
||||..||.|.-++.... .+++.....+...|+.||.|||+++||.||+|.+|.++|.||++||+|||+++.--.
T Consensus 246 VMeyanGGeLf~HLsrer-----~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~ 320 (516)
T KOG0690|consen 246 VMEYANGGELFFHLSRER-----VFSEDRTRFYGAEIVSALGYLHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIK 320 (516)
T ss_pred EEEEccCceEeeehhhhh-----cccchhhhhhhHHHHHHhhhhhhCCeeeeechhhhheeccCCceEeeecccchhccc
Confidence 999999999988887643 467778888999999999999999999999999999999999999999999986432
Q ss_pred CCCcccccccccccceecccccccCCcCccccchhHHHHHHHHHhCCCCCCCCCCCccchhhhccccCCCCCCccccccc
Q 002721 762 SKGTASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQILDA 841 (888)
Q Consensus 762 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 841 (888)
. ......++|||.|.|||++....|+.++|.|.+||+||||+.|+.||.....+ ...+-++-.
T Consensus 321 ~--g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~---------------kLFeLIl~e 383 (516)
T KOG0690|consen 321 Y--GDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHE---------------KLFELILME 383 (516)
T ss_pred c--cceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchh---------------HHHHHHHhh
Confidence 2 23356789999999999999999999999999999999999999999764322 111111111
Q ss_pred ccccCCcCcHHHHHHHHHHHhhccCCCCCCCC
Q 002721 842 RLSTVSFGWRKEMLTALKVALLCTDSTPAKRP 873 (888)
Q Consensus 842 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RP 873 (888)
.++ .++...+++..++...+.+||.+|.
T Consensus 384 d~k----FPr~ls~eAktLLsGLL~kdP~kRL 411 (516)
T KOG0690|consen 384 DLK----FPRTLSPEAKTLLSGLLKKDPKKRL 411 (516)
T ss_pred hcc----CCccCCHHHHHHHHHHhhcChHhhc
Confidence 111 2233456677888899999999996
|
|
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-34 Score=311.87 Aligned_cols=258 Identities=26% Similarity=0.308 Sum_probs=194.4
Q ss_pred HhcCCcceeeecccceEEEEEe-CCCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccC-CCceeeeeeEEEeCCeeEEE
Q 002721 605 ATMKDSNMIYCGTFSTVYKAVM-PSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLC-HDNLVRPIGFVIYEDVALLL 682 (888)
Q Consensus 605 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~~lv 682 (888)
++|+..+.||+|+||.||++.. .+++.||+|.+...... .....+.+|+.++.++. ||||+++++++..++..+++
T Consensus 4 ~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~ 81 (288)
T cd06616 4 EDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVDE--KEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWIC 81 (288)
T ss_pred HHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccCh--HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEE
Confidence 3566778999999999999995 46899999998754332 33457889999999996 99999999999999999999
Q ss_pred EecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhccc-CCeeecCCCCCCeEeCCCCCceEeccccccccCC
Q 002721 683 HNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHH-VAIIHLDISSGNVLLDADFKPLLGEIEISKLLDP 761 (888)
Q Consensus 683 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~~~ 761 (888)
|||++. ++.++...........+++..+..++.|++.||+|||+ .+++||||||+||+++.++.+||+|||++.....
T Consensus 82 ~e~~~~-~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~ 160 (288)
T cd06616 82 MELMDI-SLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVD 160 (288)
T ss_pred EecccC-CHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHhcc
Confidence 999864 66554432111111257889999999999999999997 5999999999999999999999999999876543
Q ss_pred CCCcccccccccccceecccccccC---CcCccccchhHHHHHHHHHhCCCCCCCCCCCccchhhhccccCCCCCCcccc
Q 002721 762 SKGTASISAVAGSFGYIPPEYAYTM---QVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQI 838 (888)
Q Consensus 762 ~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 838 (888)
... .....|+..|+|||++.+. .++.++||||+||++|||++|+.||...........+......
T Consensus 161 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~--------- 228 (288)
T cd06616 161 SIA---KTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLTQVVKGDP--------- 228 (288)
T ss_pred CCc---cccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHHhhhcCCCC---------
Confidence 221 1234578899999998766 6899999999999999999999999753211001111000000
Q ss_pred cccccccCCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002721 839 LDARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEM 881 (888)
Q Consensus 839 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~ 881 (888)
+.+.. ........++.+++.+||+.||++|||+++|++.
T Consensus 229 --~~~~~--~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~ 267 (288)
T cd06616 229 --PILSN--SEEREFSPSFVNFINLCLIKDESKRPKYKELLEH 267 (288)
T ss_pred --CcCCC--cCCCccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 00000 0112245578899999999999999999999864
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=304.06 Aligned_cols=251 Identities=22% Similarity=0.332 Sum_probs=204.9
Q ss_pred hcCCcceeeecccceEEEEEeC-CCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCCeeEEEEe
Q 002721 606 TMKDSNMIYCGTFSTVYKAVMP-SGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVALLLHN 684 (888)
Q Consensus 606 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 684 (888)
+|++.+.||+|++|.||+|+.. +++.||+|++...... .....+.+|++.+.+++||||+++++++..++..++|||
T Consensus 2 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e 79 (264)
T cd06623 2 DLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGDE--EFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLE 79 (264)
T ss_pred cceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEE
Confidence 5788899999999999999965 5999999998755432 334578999999999999999999999999999999999
Q ss_pred cCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhccc-CCeeecCCCCCCeEeCCCCCceEeccccccccCCCC
Q 002721 685 YLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHH-VAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSK 763 (888)
Q Consensus 685 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 763 (888)
|+++++|.+++.... .+++..+..++.|+++|++|||+ .|++||||+|+||+++.++.++++|||.+.......
T Consensus 80 ~~~~~~L~~~l~~~~-----~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~ 154 (264)
T cd06623 80 YMDGGSLADLLKKVG-----KIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTL 154 (264)
T ss_pred ecCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccCC
Confidence 999999999998652 56889999999999999999999 999999999999999999999999999998765432
Q ss_pred CcccccccccccceecccccccCCcCccccchhHHHHHHHHHhCCCCCCCCCC-CccchhhhccccCCCCCCcccccccc
Q 002721 764 GTASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFG-EGVDLVKWVHGAPARGETPEQILDAR 842 (888)
Q Consensus 764 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~ 842 (888)
.. .....++..|+|||.+.+..++.++||||||+++|+|++|+.||..... ...+....... ..
T Consensus 155 ~~--~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~-------------~~ 219 (264)
T cd06623 155 DQ--CNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICD-------------GP 219 (264)
T ss_pred Cc--ccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHhc-------------CC
Confidence 21 1234678899999999888899999999999999999999999976432 11111111110 00
Q ss_pred cccCCcCcHH-HHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002721 843 LSTVSFGWRK-EMLTALKVALLCTDSTPAKRPKMKKVVEM 881 (888)
Q Consensus 843 ~~~~~~~~~~-~~~~~~~li~~cl~~dP~~RPs~~evl~~ 881 (888)
.... ... ....+.+++.+||+++|++||++.|+++.
T Consensus 220 ~~~~---~~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~ 256 (264)
T cd06623 220 PPSL---PAEEFSPEFRDFISACLQKDPKKRPSAAELLQH 256 (264)
T ss_pred CCCC---CcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 0000 111 34577889999999999999999999874
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=311.66 Aligned_cols=265 Identities=19% Similarity=0.232 Sum_probs=198.7
Q ss_pred HhcCCcceeeecccceEEEEEeC-CCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeC--CeeEE
Q 002721 605 ATMKDSNMIYCGTFSTVYKAVMP-SGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYE--DVALL 681 (888)
Q Consensus 605 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~--~~~~l 681 (888)
++|+..+.||+|+||.||+|... +++.||+|.++..... ......+.+|++++++++||||+++++++... +..|+
T Consensus 5 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~l 83 (293)
T cd07843 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEK-EGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYM 83 (293)
T ss_pred hhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeecccc-ccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEE
Confidence 47888999999999999999965 6899999999754332 22334577899999999999999999999877 89999
Q ss_pred EEecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccccccccCC
Q 002721 682 LHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDP 761 (888)
Q Consensus 682 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~~~ 761 (888)
||||+++ +|.+++..... .+++.++..++.||+.||+|||++|++||||||+||+++.++.+|++|||.+.....
T Consensus 84 v~e~~~~-~L~~~~~~~~~----~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~ 158 (293)
T cd07843 84 VMEYVEH-DLKSLMETMKQ----PFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGS 158 (293)
T ss_pred EehhcCc-CHHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEECCCCcEEEeecCceeeccC
Confidence 9999975 99998876432 578899999999999999999999999999999999999999999999999887654
Q ss_pred CCCcccccccccccceecccccccC-CcCccccchhHHHHHHHHHhCCCCCCCCCCCcc--chhhhcc-----------c
Q 002721 762 SKGTASISAVAGSFGYIPPEYAYTM-QVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGV--DLVKWVH-----------G 827 (888)
Q Consensus 762 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~--~~~~~~~-----------~ 827 (888)
... ......++..|+|||.+.+. .++.++||||+|+++|||++|+.||........ ....... .
T Consensus 159 ~~~--~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 236 (293)
T cd07843 159 PLK--PYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSE 236 (293)
T ss_pred Ccc--ccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhc
Confidence 321 12334578899999988654 468899999999999999999999975432110 0000000 0
Q ss_pred cCCCC-CCcccccccccccCCcCcHH--HHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002721 828 APARG-ETPEQILDARLSTVSFGWRK--EMLTALKVALLCTDSTPAKRPKMKKVVE 880 (888)
Q Consensus 828 ~~~~~-~~~~~~~~~~~~~~~~~~~~--~~~~~~~li~~cl~~dP~~RPs~~evl~ 880 (888)
.+... ..........+. ..... ..+.+.+++.+||+.||++|||+.|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~li~~~l~~~p~~R~t~~ell~ 289 (293)
T cd07843 237 LPGAKKKTFTKYPYNQLR---KKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALK 289 (293)
T ss_pred cchhcccccccccchhhh---ccccccCCChHHHHHHHHHhccCccccCCHHHHhc
Confidence 00000 000000000000 00111 2556788999999999999999999985
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-35 Score=335.31 Aligned_cols=279 Identities=15% Similarity=0.202 Sum_probs=192.4
Q ss_pred HHHHHHhcCCcceeeecccceEEEEEeC--CCcEEEEEE--------------eeccChhhhHHHHHHHHHHHHHhccCC
Q 002721 600 DAVVKATMKDSNMIYCGTFSTVYKAVMP--SGLILSVKR--------------LKSMDRTIIHHQNKMIRELEKLSKLCH 663 (888)
Q Consensus 600 ~~~~~~~~~~~~~ig~G~~g~Vy~~~~~--~~~~vavK~--------------~~~~~~~~~~~~~~~~~E~~~l~~l~h 663 (888)
++...++|++.+.||+|+||+||+|..+ ++..++.|. +.+...........+.+|++++++++|
T Consensus 143 ~~~~~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~~l~H 222 (501)
T PHA03210 143 DDEFLAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALGRLNH 222 (501)
T ss_pred chhhhhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHHhCCC
Confidence 3456778999999999999999998743 222222221 111111112233468899999999999
Q ss_pred CceeeeeeEEEeCCeeEEEEecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeC
Q 002721 664 DNLVRPIGFVIYEDVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLD 743 (888)
Q Consensus 664 pnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~ 743 (888)
|||+++++++...+..|+|+|++. +++.+++..............++..++.||+.||+|||++|||||||||+|||++
T Consensus 223 pnIv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~~gIiHrDLKP~NILl~ 301 (501)
T PHA03210 223 ENILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLN 301 (501)
T ss_pred CCcCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEC
Confidence 999999999999999999999996 4788877644322112334567788999999999999999999999999999999
Q ss_pred CCCCceEeccccccccCCCCCcccccccccccceecccccccCCcCccccchhHHHHHHHHHhCCCC-CCCCCCC-ccch
Q 002721 744 ADFKPLLGEIEISKLLDPSKGTASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILTTRLP-VEEDFGE-GVDL 821 (888)
Q Consensus 744 ~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P-~~~~~~~-~~~~ 821 (888)
.++.+||+|||++..+...... ......||..|+|||++.+..++.++|||||||++|||++|..| |...... ..++
T Consensus 302 ~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p~~~~~~~~~~~~ 380 (501)
T PHA03210 302 CDGKIVLGDFGTAMPFEKEREA-FDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQL 380 (501)
T ss_pred CCCCEEEEeCCCceecCccccc-ccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCccCCCCCHHHHH
Confidence 9999999999999876543221 12345789999999999999999999999999999999998764 4332211 1111
Q ss_pred hhhccccCCCC-CCcc---ccc---c-cccccCCcCcH------HHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002721 822 VKWVHGAPARG-ETPE---QIL---D-ARLSTVSFGWR------KEMLTALKVALLCTDSTPAKRPKMKKVVE 880 (888)
Q Consensus 822 ~~~~~~~~~~~-~~~~---~~~---~-~~~~~~~~~~~------~~~~~~~~li~~cl~~dP~~RPs~~evl~ 880 (888)
.+......... ..+. .+. + ........... .....+.+++.+|++.||++|||+.|+++
T Consensus 381 ~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rpsa~elL~ 453 (501)
T PHA03210 381 LKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRPGAAELLA 453 (501)
T ss_pred HHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCcCHHHHhh
Confidence 11111110000 0000 000 0 00000000000 11234567889999999999999999986
|
|
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=308.72 Aligned_cols=249 Identities=17% Similarity=0.259 Sum_probs=198.7
Q ss_pred HhcCCcceeeecccceEEEEEe-CCCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCCeeEEEE
Q 002721 605 ATMKDSNMIYCGTFSTVYKAVM-PSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVALLLH 683 (888)
Q Consensus 605 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 683 (888)
..|...+.||+|++|.||+|.. .+++.||+|+++..... ..+.+.+|+.+++.++||||+++++++..++..++|+
T Consensus 19 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~~~---~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~ 95 (285)
T cd06648 19 SYLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQ---RRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVM 95 (285)
T ss_pred HhhhcceEeccCCCeEEEEEEECCCCCEEEEEEEeccchh---HHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEE
Confidence 4566678999999999999994 47899999988643322 2346889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccccccccCCCC
Q 002721 684 NYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSK 763 (888)
Q Consensus 684 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 763 (888)
||+++++|.+++... .+++.++..++.|++.||+|||++|++||||+|+||+++.++.++++|||.+.......
T Consensus 96 e~~~~~~L~~~~~~~------~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~ 169 (285)
T cd06648 96 EFLEGGALTDIVTHT------RMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEV 169 (285)
T ss_pred eccCCCCHHHHHHhC------CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccCC
Confidence 999999999998762 46788999999999999999999999999999999999999999999999887654322
Q ss_pred CcccccccccccceecccccccCCcCccccchhHHHHHHHHHhCCCCCCCCCCCccchhhhccccCCCCCCccccccccc
Q 002721 764 GTASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQILDARL 843 (888)
Q Consensus 764 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 843 (888)
. ......|+..|+|||...+..++.++||||+|+++|||++|+.||...... ...+....... +..
T Consensus 170 ~--~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~--~~~~~~~~~~~----------~~~ 235 (285)
T cd06648 170 P--RRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPL--QAMKRIRDNLP----------PKL 235 (285)
T ss_pred c--ccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHH--HHHHHHHhcCC----------CCC
Confidence 1 122346889999999998888999999999999999999999999653211 11111110000 000
Q ss_pred ccCCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002721 844 STVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVE 880 (888)
Q Consensus 844 ~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 880 (888)
. ........+.+++.+||+.+|++||++.++++
T Consensus 236 ~----~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 268 (285)
T cd06648 236 K----NLHKVSPRLRSFLDRMLVRDPAQRATAAELLN 268 (285)
T ss_pred c----ccccCCHHHHHHHHHHcccChhhCcCHHHHcc
Confidence 0 01113356789999999999999999999985
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-35 Score=318.74 Aligned_cols=274 Identities=21% Similarity=0.285 Sum_probs=203.3
Q ss_pred hcCCcceeeecccceEEEEE-eCCCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeC------Ce
Q 002721 606 TMKDSNMIYCGTFSTVYKAV-MPSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYE------DV 678 (888)
Q Consensus 606 ~~~~~~~ig~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~------~~ 678 (888)
.+...+.||+|+||.||+++ ..+|+.||||.++..... ...++..+|+++|++++|||||+++|+-++. +.
T Consensus 14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~~~--r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~ 91 (732)
T KOG4250|consen 14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKESSL--RPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRL 91 (732)
T ss_pred ceeehhhhcCCccceeeeecccccccchhHHhhhhhccc--chHHHHHHHHHHHHHcCchhhhhhcccCCccccCccccc
Confidence 34556789999999999999 668999999999864422 2345788999999999999999999986653 36
Q ss_pred eEEEEecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeC--CCC--CceEeccc
Q 002721 679 ALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLD--ADF--KPLLGEIE 754 (888)
Q Consensus 679 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~--~~~--~~kl~Dfg 754 (888)
..+|||||.+|||+..+.+.... ..+++.+.+.+..+++.||.|||++||+||||||.||++- .+| ..||+|||
T Consensus 92 ~vlvmEyC~gGsL~~~L~~PEN~--~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG 169 (732)
T KOG4250|consen 92 PVLVMEYCSGGSLRKVLNSPENA--YGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFG 169 (732)
T ss_pred ceEEEeecCCCcHHHHhcCcccc--cCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCCcEEEeecCCCceEEeeeccc
Confidence 78999999999999999865433 4689999999999999999999999999999999999984 333 47999999
Q ss_pred cccccCCCCCcccccccccccceecccccc-cCCcCccccchhHHHHHHHHHhCCCCCCCCCCCcc--chhhhccccCCC
Q 002721 755 ISKLLDPSKGTASISAVAGSFGYIPPEYAY-TMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGV--DLVKWVHGAPAR 831 (888)
Q Consensus 755 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~--~~~~~~~~~~~~ 831 (888)
.|+..++.. .....+||..|.+||.+. ...|+..+|.|||||++|+++||..||........ ..........+.
T Consensus 170 ~Arel~d~s---~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~ 246 (732)
T KOG4250|consen 170 AARELDDNS---LFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGGPKNNKEIMWHIITKKPS 246 (732)
T ss_pred ccccCCCCC---eeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCCccccchhhhhhhccCCC
Confidence 999987654 456789999999999988 47899999999999999999999999976443311 011100001111
Q ss_pred CCCccc--------ccccccccCCcCcHHHHHHHHHHHhhccCCCCCCCC--CHHHHHHHHHHhh
Q 002721 832 GETPEQ--------ILDARLSTVSFGWRKEMLTALKVALLCTDSTPAKRP--KMKKVVEMLQEIK 886 (888)
Q Consensus 832 ~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RP--s~~evl~~L~~i~ 886 (888)
+..... .....++......+.....+-+.+..++..+|++|- ...+.-..+..|.
T Consensus 247 ~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~~~~~~~Fa~~~dIL 311 (732)
T KOG4250|consen 247 GVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGHEGFDRFFAEVDDIL 311 (732)
T ss_pred ceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCCCCcchHHHHHHHHH
Confidence 000000 000111111112233444556777788899999998 6666655555554
|
|
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-34 Score=313.30 Aligned_cols=268 Identities=20% Similarity=0.259 Sum_probs=196.8
Q ss_pred HHhcCCcceeeecccceEEEEEe-CCCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeC--CeeE
Q 002721 604 KATMKDSNMIYCGTFSTVYKAVM-PSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYE--DVAL 680 (888)
Q Consensus 604 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~--~~~~ 680 (888)
.++|+..+.||+|+||.||+|.. .+|+.||+|+++...... .....+.+|++++++++|+||+++++++... +..+
T Consensus 6 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 84 (309)
T cd07845 6 VTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNERD-GIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIF 84 (309)
T ss_pred ccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCCC-CCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEE
Confidence 35789999999999999999995 469999999987433221 1222566899999999999999999998765 4689
Q ss_pred EEEecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccccccccC
Q 002721 681 LLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLD 760 (888)
Q Consensus 681 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~~ 760 (888)
+||||+++ +|.+++.... ..+++.++..++.||+.||+|||+.|++||||||+||++++++.+||+|||.+....
T Consensus 85 lv~e~~~~-~l~~~l~~~~----~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~ 159 (309)
T cd07845 85 LVMEYCEQ-DLASLLDNMP----TPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYG 159 (309)
T ss_pred EEEecCCC-CHHHHHHhcc----cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccceeeecC
Confidence 99999975 8988887543 257889999999999999999999999999999999999999999999999998765
Q ss_pred CCCCcccccccccccceeccccccc-CCcCccccchhHHHHHHHHHhCCCCCCCCCCCccchhhhcc--ccCCCCCCc--
Q 002721 761 PSKGTASISAVAGSFGYIPPEYAYT-MQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVH--GAPARGETP-- 835 (888)
Q Consensus 761 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~--~~~~~~~~~-- 835 (888)
.... ......++..|+|||.+.+ ..++.++||||+||++|||++|+.||........ +..... +.+......
T Consensus 160 ~~~~--~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 236 (309)
T cd07845 160 LPAK--PMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQ-LDLIIQLLGTPNESIWPGF 236 (309)
T ss_pred CccC--CCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHhcCCCChhhchhh
Confidence 3321 1223345788999998865 4578999999999999999999999975432110 000000 000000000
Q ss_pred ------cc--ccccccccCCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002721 836 ------EQ--ILDARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVE 880 (888)
Q Consensus 836 ------~~--~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 880 (888)
.. .................+.+.+++.+|+++||++|||++|+++
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~il~ 289 (309)
T cd07845 237 SDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEEALE 289 (309)
T ss_pred hcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 00 0000000000001113566788999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=306.73 Aligned_cols=248 Identities=22% Similarity=0.250 Sum_probs=196.8
Q ss_pred eeecccceEEEEEeC-CCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCCeeEEEEecCCCCCH
Q 002721 613 IYCGTFSTVYKAVMP-SGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVALLLHNYLPNGTL 691 (888)
Q Consensus 613 ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L 691 (888)
||+|+||.||+|+.. +|+.||+|++...........+.+.+|++++++++||||+++++.+..++..|+||||+++++|
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L 80 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDL 80 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcH
Confidence 689999999999965 5999999999765544445556889999999999999999999999999999999999999999
Q ss_pred HHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccccccccCCCCC------c
Q 002721 692 AQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSKG------T 765 (888)
Q Consensus 692 ~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~------~ 765 (888)
.+++.... .+++..+..++.||++||+|||+.|++||||+|+||++++++.++++|||++........ .
T Consensus 81 ~~~l~~~~-----~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~ 155 (265)
T cd05579 81 ASLLENVG-----SLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDE 155 (265)
T ss_pred HHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCccccccccc
Confidence 99998643 467889999999999999999999999999999999999999999999999876543211 1
Q ss_pred ccccccccccceecccccccCCcCccccchhHHHHHHHHHhCCCCCCCCCCCccchhhhccccCCCCCCccccccccccc
Q 002721 766 ASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQILDARLST 845 (888)
Q Consensus 766 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 845 (888)
.......++..|+|||...+..++.++||||||+++|++++|+.||....... ...... ......
T Consensus 156 ~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~--~~~~~~-------------~~~~~~ 220 (265)
T cd05579 156 KEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEE--IFQNIL-------------NGKIEW 220 (265)
T ss_pred ccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHH--HHHHHh-------------cCCcCC
Confidence 12234567889999999988889999999999999999999999997543211 111000 000000
Q ss_pred CCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 002721 846 VSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEML 882 (888)
Q Consensus 846 ~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L 882 (888)
.........+.+++.+||+.+|++|||+.++.+.|
T Consensus 221 --~~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l 255 (265)
T cd05579 221 --PEDVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIK 255 (265)
T ss_pred --CccccCCHHHHHHHHHHhcCCHhhcCCCccHHHHh
Confidence 00001246678999999999999999995555544
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-34 Score=316.21 Aligned_cols=267 Identities=17% Similarity=0.194 Sum_probs=198.7
Q ss_pred HHHHhcCCcceeeecccceEEEEEe-CCCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeC----
Q 002721 602 VVKATMKDSNMIYCGTFSTVYKAVM-PSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYE---- 676 (888)
Q Consensus 602 ~~~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~---- 676 (888)
....+|+..+.||+|+||.||+|+. .+++.||+|++..... .....+.+.+|+.++++++||||+++++++...
T Consensus 13 ~~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~ 91 (353)
T cd07850 13 TVLKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPFQ-NVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLE 91 (353)
T ss_pred hhhcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCcccc-ChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCcc
Confidence 3467899999999999999999995 4799999999864322 222334677899999999999999999988643
Q ss_pred --CeeEEEEecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccc
Q 002721 677 --DVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIE 754 (888)
Q Consensus 677 --~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg 754 (888)
...|+||||+.+ +|.+.+.. .++..++..++.|++.||+|||+.||+||||||+||+++.++.+||+|||
T Consensus 92 ~~~~~~lv~e~~~~-~l~~~~~~-------~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nil~~~~~~~kL~Dfg 163 (353)
T cd07850 92 EFQDVYLVMELMDA-NLCQVIQM-------DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFG 163 (353)
T ss_pred ccCcEEEEEeccCC-CHHHHHhh-------cCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCCCCEEEccCc
Confidence 357999999964 88888764 25678889999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCcccccccccccceecccccccCCcCccccchhHHHHHHHHHhCCCCCCCCCCCccchhh-----------
Q 002721 755 ISKLLDPSKGTASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVK----------- 823 (888)
Q Consensus 755 ~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~----------- 823 (888)
.+........ .....++..|+|||++.+..++.++||||+||++|+|++|+.||....... ....
T Consensus 164 ~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~ 239 (353)
T cd07850 164 LARTAGTSFM---MTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHID-QWNKIIEQLGTPSDE 239 (353)
T ss_pred cceeCCCCCC---CCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHH-HHHHHHHhcCCCCHH
Confidence 9987543221 233467889999999999999999999999999999999999997532110 0000
Q ss_pred -----------hccccCCC-CCCcccccccccc-cC-CcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002721 824 -----------WVHGAPAR-GETPEQILDARLS-TV-SFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEM 881 (888)
Q Consensus 824 -----------~~~~~~~~-~~~~~~~~~~~~~-~~-~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~ 881 (888)
+....+.. .....+....... .. ..........+.+++.+||+.||++|||+.|+++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~eiL~~ 311 (353)
T cd07850 240 FMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRISVDDALQH 311 (353)
T ss_pred HHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 00000000 0000011100000 00 00011235567899999999999999999999853
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-34 Score=299.30 Aligned_cols=249 Identities=22% Similarity=0.308 Sum_probs=201.8
Q ss_pred hcCCcceeeecccceEEEEEeC-CCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCCeeEEEEe
Q 002721 606 TMKDSNMIYCGTFSTVYKAVMP-SGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVALLLHN 684 (888)
Q Consensus 606 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 684 (888)
+|+..+.||+|++|.||+|... +++.+++|++..... ...+.+.+|++++++++||+|+++++++..++..++++|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e 77 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK---EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVME 77 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch---hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEe
Confidence 4778899999999999999965 689999999975443 234578899999999999999999999999999999999
Q ss_pred cCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccccccccCCCCC
Q 002721 685 YLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSKG 764 (888)
Q Consensus 685 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 764 (888)
|+++++|.+++.... ..+++..+..++.|++.||+|||++|++||||+|+||++++++.++|+|||.+........
T Consensus 78 ~~~~~~L~~~~~~~~----~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 153 (253)
T cd05122 78 FCSGGSLKDLLKSTN----QTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA 153 (253)
T ss_pred cCCCCcHHHHHhhcC----CCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCCeEEEeecccccccccccc
Confidence 999999999987653 2578899999999999999999999999999999999999999999999999887654331
Q ss_pred cccccccccccceecccccccCCcCccccchhHHHHHHHHHhCCCCCCCCCCCccchhhhccccCCCCCCcccccccccc
Q 002721 765 TASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQILDARLS 844 (888)
Q Consensus 765 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 844 (888)
.....++..|+|||.+.+..++.++||||||+++|+|++|+.||........ ...... .......
T Consensus 154 ---~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~--~~~~~~-----~~~~~~~----- 218 (253)
T cd05122 154 ---RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKA--LFKIAT-----NGPPGLR----- 218 (253)
T ss_pred ---ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHH--HHHHHh-----cCCCCcC-----
Confidence 2345688899999999888899999999999999999999999975321110 000000 0000000
Q ss_pred cCCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002721 845 TVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVE 880 (888)
Q Consensus 845 ~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 880 (888)
........+.+++.+||+.||++|||+.|+++
T Consensus 219 ----~~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~ 250 (253)
T cd05122 219 ----NPEKWSDEFKDFLKKCLQKNPEKRPTAEQLLK 250 (253)
T ss_pred ----cccccCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 01111456788999999999999999999975
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-34 Score=302.85 Aligned_cols=251 Identities=20% Similarity=0.246 Sum_probs=203.4
Q ss_pred hcCCcceeeecccceEEEEEe-CCCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCCeeEEEEe
Q 002721 606 TMKDSNMIYCGTFSTVYKAVM-PSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVALLLHN 684 (888)
Q Consensus 606 ~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 684 (888)
+|++.+.||+|+||.||+++. .+++.+|+|.+...... .....++.+|++++++++||||+++++++......|+|||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 79 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSMS-QKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVME 79 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhcc-HHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEeh
Confidence 477889999999999999984 47899999998754332 2334577899999999999999999999999999999999
Q ss_pred cCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccccccccCCCCC
Q 002721 685 YLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSKG 764 (888)
Q Consensus 685 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 764 (888)
|+++++|.+++....... ..+++..++.++.|++.||+|||+.|++||||+|+||++++++.+|++|||.+.......
T Consensus 80 ~~~~~~L~~~~~~~~~~~-~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~- 157 (256)
T cd08530 80 YAPFGDLSKAISKRKKKR-KLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKNM- 157 (256)
T ss_pred hcCCCCHHHHHHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhccCC-
Confidence 999999999987643222 257889999999999999999999999999999999999999999999999998765431
Q ss_pred cccccccccccceecccccccCCcCccccchhHHHHHHHHHhCCCCCCCCCCCccchhhhccccCCCCCCcccccccccc
Q 002721 765 TASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQILDARLS 844 (888)
Q Consensus 765 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 844 (888)
.....++..|+|||.+.+..++.++|+||+|+++|||++|+.||....... .... +......
T Consensus 158 ---~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~--~~~~-------------~~~~~~~ 219 (256)
T cd08530 158 ---AKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQD--LRYK-------------VQRGKYP 219 (256)
T ss_pred ---cccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH--HHHH-------------HhcCCCC
Confidence 123457889999999998889999999999999999999999997542211 1110 0001111
Q ss_pred cCCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002721 845 TVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVE 880 (888)
Q Consensus 845 ~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 880 (888)
. .......++.+++.+|+..+|++||++.|+++
T Consensus 220 ~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~ 252 (256)
T cd08530 220 P---IPPIYSQDLQNFIRSMLQVKPKLRPNCDKILA 252 (256)
T ss_pred C---CchhhCHHHHHHHHHHcCCCcccCCCHHHHhc
Confidence 1 11234566889999999999999999999975
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-34 Score=306.09 Aligned_cols=261 Identities=19% Similarity=0.190 Sum_probs=192.9
Q ss_pred cCCcceeeecccceEEEEEe-CCCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccC-CCceeeeeeEEEeC--CeeEEE
Q 002721 607 MKDSNMIYCGTFSTVYKAVM-PSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLC-HDNLVRPIGFVIYE--DVALLL 682 (888)
Q Consensus 607 ~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~--~~~~lv 682 (888)
|++.+.||+|+||.||+|.. .+++.||+|+++....... .....+|+.++.++. ||||+++++++.++ +..++|
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~~~--~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv 78 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFKSLE--QVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALV 78 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccCCch--hhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEE
Confidence 56788999999999999994 4689999999875432221 124457899999885 99999999999987 889999
Q ss_pred EecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccccccccCCC
Q 002721 683 HNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPS 762 (888)
Q Consensus 683 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 762 (888)
|||++ +++.+.+..... .+++.++..++.|++.||+|||+.|++||||||+||+++. +.+||+|||.+......
T Consensus 79 ~e~~~-~~l~~~l~~~~~----~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~ 152 (282)
T cd07831 79 FELMD-MNLYELIKGRKR----PLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSK 152 (282)
T ss_pred EecCC-ccHHHHHHhccC----CCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-CCeEEEecccccccccC
Confidence 99997 488888875432 5788999999999999999999999999999999999999 99999999999876433
Q ss_pred CCcccccccccccceeccccccc-CCcCccccchhHHHHHHHHHhCCCCCCCCCCCccchhhhccc---cCCC-------
Q 002721 763 KGTASISAVAGSFGYIPPEYAYT-MQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHG---APAR------- 831 (888)
Q Consensus 763 ~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~---~~~~------- 831 (888)
.. .....++..|+|||++.+ ..++.++||||+||++|||++|+.||....... ....... .+..
T Consensus 153 ~~---~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~ 227 (282)
T cd07831 153 PP---YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELD--QIAKIHDVLGTPDAEVLKKFR 227 (282)
T ss_pred CC---cCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHH--HHHHHHHHcCCCCHHHHHhhc
Confidence 22 123457889999997644 457889999999999999999999997543211 1111000 0000
Q ss_pred -CCCcc-cccccccccCCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002721 832 -GETPE-QILDARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVE 880 (888)
Q Consensus 832 -~~~~~-~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 880 (888)
..... ...+................+.+++.+||+++|++||+++++++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l~ 278 (282)
T cd07831 228 KSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQALR 278 (282)
T ss_pred ccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHhh
Confidence 00000 00000000000001123577889999999999999999999986
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-34 Score=310.18 Aligned_cols=266 Identities=15% Similarity=0.183 Sum_probs=188.1
Q ss_pred HHHHHHhcCCcceeeecccceEEEEEeCC----CcEEEEEEeeccChhhhHH--------HHHHHHHHHHHhccCCCcee
Q 002721 600 DAVVKATMKDSNMIYCGTFSTVYKAVMPS----GLILSVKRLKSMDRTIIHH--------QNKMIRELEKLSKLCHDNLV 667 (888)
Q Consensus 600 ~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~--------~~~~~~E~~~l~~l~hpnIv 667 (888)
.++...+|++.+.||+|+||+||+|...+ +..+|+|............ ......+...+..+.|++|+
T Consensus 7 ~~i~~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~h~~i~ 86 (294)
T PHA02882 7 IDITGKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNIHNIDHLGIP 86 (294)
T ss_pred eccCCCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHhccCCCCCCC
Confidence 34556789999999999999999999543 4566666543222111000 01122344456677899999
Q ss_pred eeeeEEEeCC----eeEEEEecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeC
Q 002721 668 RPIGFVIYED----VALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLD 743 (888)
Q Consensus 668 ~~~~~~~~~~----~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~ 743 (888)
++++++.... ..++++|++.. ++.+.+.... ..++..+..++.|++.||+|||+++|+||||||+||+++
T Consensus 87 ~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~-----~~~~~~~~~i~~qi~~~l~~lH~~~iiHrDiKp~Nill~ 160 (294)
T PHA02882 87 KYYGCGSFKRCRMYYRFILLEKLVE-NTKEIFKRIK-----CKNKKLIKNIMKDMLTTLEYIHEHGISHGDIKPENIMVD 160 (294)
T ss_pred cEEEeeeEecCCceEEEEEEehhcc-CHHHHHHhhc-----cCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEc
Confidence 9999776543 45788888754 7777765432 235678889999999999999999999999999999999
Q ss_pred CCCCceEeccccccccCCCCCc-----ccccccccccceecccccccCCcCccccchhHHHHHHHHHhCCCCCCCCCCCc
Q 002721 744 ADFKPLLGEIEISKLLDPSKGT-----ASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEG 818 (888)
Q Consensus 744 ~~~~~kl~Dfg~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~ 818 (888)
.++.++|+|||+++........ .......||+.|+|||+..+..++.++||||+||++|||++|+.||.......
T Consensus 161 ~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~~~~ 240 (294)
T PHA02882 161 GNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFGHNG 240 (294)
T ss_pred CCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccccch
Confidence 9999999999999876432211 11223469999999999999999999999999999999999999997653221
Q ss_pred cchhhhccccCCCCCCcccccccccccCCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHH
Q 002721 819 VDLVKWVHGAPARGETPEQILDARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEML 882 (888)
Q Consensus 819 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L 882 (888)
. ....... .....+...... .......+.+++..||+.+|++||+++++.+.+
T Consensus 241 ~-~~~~~~~-----~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~~~ 293 (294)
T PHA02882 241 N-LIHAAKC-----DFIKRLHEGKIK-----IKNANKFIYDFIECVTKLSYEEKPDYDALIKIF 293 (294)
T ss_pred H-HHHHhHH-----HHHHHhhhhhhc-----cCCCCHHHHHHHHHHHhCCCCCCCCHHHHHHhh
Confidence 1 1100000 000001111110 111235678899999999999999999999876
|
|
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-34 Score=311.86 Aligned_cols=263 Identities=19% Similarity=0.263 Sum_probs=192.8
Q ss_pred ceeeec--ccceEEEEEe-CCCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCCeeEEEEecCC
Q 002721 611 NMIYCG--TFSTVYKAVM-PSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVALLLHNYLP 687 (888)
Q Consensus 611 ~~ig~G--~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~ 687 (888)
..||+| +||+||+|+. .+|+.||+|++....... ...+.+.+|+.+++.++||||+++++++..++..++||||++
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~~~-~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~ 82 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENCTE-EHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMA 82 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccCCH-HHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEeccc
Confidence 356666 8999999995 479999999987543322 344688999999999999999999999999999999999999
Q ss_pred CCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccccccccCCCCCccc
Q 002721 688 NGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSKGTAS 767 (888)
Q Consensus 688 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~ 767 (888)
++++.+++...... .+++..+..++.|++.||+|||++|++||||||+||+++.++.++++||+.+...........
T Consensus 83 ~~~l~~~l~~~~~~---~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (328)
T cd08226 83 YGSANSLLKTYFPE---GMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAK 159 (328)
T ss_pred CCCHHHHHHhhccc---CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCcccc
Confidence 99999998875432 478889999999999999999999999999999999999999999999976543321111100
Q ss_pred -----ccccccccceecccccccC--CcCccccchhHHHHHHHHHhCCCCCCCCCCCccchhhhccccCCCCC-------
Q 002721 768 -----ISAVAGSFGYIPPEYAYTM--QVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGE------- 833 (888)
Q Consensus 768 -----~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~------- 833 (888)
.....++..|+|||++.+. .++.++||||+||++|||++|+.||........ ........+....
T Consensus 160 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~ 238 (328)
T cd08226 160 VVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQM-LLQKLKGPPYSPLDITTFPC 238 (328)
T ss_pred ccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHH-HHHHhcCCCCCCccccccch
Confidence 0112345679999998763 478999999999999999999999975432111 1111110000000
Q ss_pred ---------------Ccc---------cccccccccCCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002721 834 ---------------TPE---------QILDARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVE 880 (888)
Q Consensus 834 ---------------~~~---------~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 880 (888)
..+ .+...... ..........+.+++.+||..||++|||++|+++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~ 307 (328)
T cd08226 239 EESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLR--TPSSKTFSPAFQNLVELCLQQDPEKRPSASSLLS 307 (328)
T ss_pred hhhhhccchhhhhcccccchhcccccccccccccc--chhhhhhhHHHHHHHHHHccCCcccCCCHHHHhh
Confidence 000 00000000 0112234567889999999999999999999975
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-34 Score=306.53 Aligned_cols=266 Identities=19% Similarity=0.256 Sum_probs=198.6
Q ss_pred hcCCcceeeecccceEEEEEeC-CCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCCeeEEEEe
Q 002721 606 TMKDSNMIYCGTFSTVYKAVMP-SGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVALLLHN 684 (888)
Q Consensus 606 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 684 (888)
+|+..+.||+|++|.||+|+.. +|+.||+|+++..... ...+.+.+|++++++++||||+++++++...+..++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e 78 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAEE--GTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFE 78 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEecccccc--cchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEe
Confidence 4788999999999999999964 6899999998754322 223467789999999999999999999999999999999
Q ss_pred cCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccccccccCCCCC
Q 002721 685 YLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSKG 764 (888)
Q Consensus 685 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 764 (888)
|+++ +|.+++..... ...+++..+..++.|++.||+|||+.|++||||||+||++++++.++++|||.+........
T Consensus 79 ~~~~-~l~~~~~~~~~--~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~ 155 (284)
T cd07836 79 YMDK-DLKKYMDTHGV--RGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN 155 (284)
T ss_pred cCCc-cHHHHHHhcCC--CCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc
Confidence 9985 89998876442 12578999999999999999999999999999999999999999999999999976543221
Q ss_pred cccccccccccceecccccccC-CcCccccchhHHHHHHHHHhCCCCCCCCCCCccchhhhccc--cCCCCCCccccc--
Q 002721 765 TASISAVAGSFGYIPPEYAYTM-QVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHG--APARGETPEQIL-- 839 (888)
Q Consensus 765 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~-- 839 (888)
......++..|+|||++.+. .++.++||||+|+++|+|++|+.||........ ..+.... .+.. ...+.+.
T Consensus 156 --~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~-~~~~~~~~~~~~~-~~~~~~~~~ 231 (284)
T cd07836 156 --TFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQ-LLKIFRIMGTPTE-STWPGISQL 231 (284)
T ss_pred --ccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHH-HHHHHHHhCCCCh-hhHHHHhcC
Confidence 12234578899999987654 578899999999999999999999976432211 0110000 0000 0000000
Q ss_pred ---ccccccCC-----cCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002721 840 ---DARLSTVS-----FGWRKEMLTALKVALLCTDSTPAKRPKMKKVVE 880 (888)
Q Consensus 840 ---~~~~~~~~-----~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 880 (888)
........ .........+.+++.+|++.||++||++.|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 280 (284)
T cd07836 232 PEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHDALQ 280 (284)
T ss_pred chhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHHHhc
Confidence 00000000 001122456789999999999999999999875
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-34 Score=304.47 Aligned_cols=244 Identities=16% Similarity=0.144 Sum_probs=186.8
Q ss_pred eeeecccceEEEEEe-CCCcEEEEEEeeccChhhhHHHHHHHHHH---HHHhccCCCceeeeeeEEEeCCeeEEEEecCC
Q 002721 612 MIYCGTFSTVYKAVM-PSGLILSVKRLKSMDRTIIHHQNKMIREL---EKLSKLCHDNLVRPIGFVIYEDVALLLHNYLP 687 (888)
Q Consensus 612 ~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~---~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~ 687 (888)
.||+|+||.||+|.. .+++.||+|.+.............+..|. +.++...||+|+++++++..++..++||||++
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 489999999999995 46899999998754322222112233343 34455679999999999999999999999999
Q ss_pred CCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccccccccCCCCCccc
Q 002721 688 NGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSKGTAS 767 (888)
Q Consensus 688 ~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~ 767 (888)
+++|.+++.... .+++..+..++.|+++|++|||+.+|+||||||+||+++.++.+|++|||.+.......
T Consensus 81 g~~L~~~l~~~~-----~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~---- 151 (278)
T cd05606 81 GGDLHYHLSQHG-----VFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK---- 151 (278)
T ss_pred CCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEccCcCccccCccC----
Confidence 999999886542 57889999999999999999999999999999999999999999999999987654322
Q ss_pred ccccccccceecccccccC-CcCccccchhHHHHHHHHHhCCCCCCCCCCCccchhhhccccCCCCCCcccccccccccC
Q 002721 768 ISAVAGSFGYIPPEYAYTM-QVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQILDARLSTV 846 (888)
Q Consensus 768 ~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 846 (888)
.....|+..|+|||.+.+. .++.++||||+|+++|||++|+.||................. ... .
T Consensus 152 ~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~----------~~~---~- 217 (278)
T cd05606 152 PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLT----------MAV---E- 217 (278)
T ss_pred CcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhc----------cCC---C-
Confidence 1234689999999998754 689999999999999999999999976422211100000000 000 0
Q ss_pred CcCcHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 002721 847 SFGWRKEMLTALKVALLCTDSTPAKRP-----KMKKVVE 880 (888)
Q Consensus 847 ~~~~~~~~~~~~~li~~cl~~dP~~RP-----s~~evl~ 880 (888)
.......++.+++.+|+..+|++|| ++.++++
T Consensus 218 --~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~ 254 (278)
T cd05606 218 --LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 254 (278)
T ss_pred --CCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHh
Confidence 0111246778899999999999999 9999885
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-34 Score=305.40 Aligned_cols=251 Identities=21% Similarity=0.291 Sum_probs=202.6
Q ss_pred HHhcCCcceeeecccceEEEEEeC-CCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCCeeEEE
Q 002721 604 KATMKDSNMIYCGTFSTVYKAVMP-SGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVALLL 682 (888)
Q Consensus 604 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 682 (888)
.+.|+..+.||+|+||.||+|... ++..||+|+++.... ..+.+.+|++++++++|+||+++++++...+..|+|
T Consensus 18 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv 93 (286)
T cd06614 18 RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ----NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVV 93 (286)
T ss_pred cccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch----hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEE
Confidence 456888899999999999999965 689999999975443 234788999999999999999999999999999999
Q ss_pred EecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccccccccCCC
Q 002721 683 HNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPS 762 (888)
Q Consensus 683 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 762 (888)
+||+++++|.+++.... ..+++..+..++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||.+......
T Consensus 94 ~e~~~~~~L~~~l~~~~----~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 169 (286)
T cd06614 94 MEYMDGGSLTDIITQNF----VRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKE 169 (286)
T ss_pred EeccCCCcHHHHHHHhc----cCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhccc
Confidence 99999999999998754 15788999999999999999999999999999999999999999999999998765432
Q ss_pred CCcccccccccccceecccccccCCcCccccchhHHHHHHHHHhCCCCCCCCCCCccchhhhccccCCCCCCcccccccc
Q 002721 763 KGTASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQILDAR 842 (888)
Q Consensus 763 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 842 (888)
.. ......++..|+|||++.+..++.++||||||+++|+|++|+.||........ ....... .
T Consensus 170 ~~--~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~-~~~~~~~--------------~ 232 (286)
T cd06614 170 KS--KRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRA-LFLITTK--------------G 232 (286)
T ss_pred hh--hhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHhc--------------C
Confidence 21 12234578899999999888899999999999999999999999975322110 0100000 0
Q ss_pred cccCCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002721 843 LSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVE 880 (888)
Q Consensus 843 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 880 (888)
.... .........+.+++.+||+.+|.+||++.++++
T Consensus 233 ~~~~-~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~ 269 (286)
T cd06614 233 IPPL-KNPEKWSPEFKDFLNKCLVKDPEKRPSAEELLQ 269 (286)
T ss_pred CCCC-cchhhCCHHHHHHHHHHhccChhhCcCHHHHhh
Confidence 0000 011113356788999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=262.56 Aligned_cols=266 Identities=18% Similarity=0.257 Sum_probs=204.8
Q ss_pred hcCCcceeeecccceEEEEE-eCCCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCCeeEEEEe
Q 002721 606 TMKDSNMIYCGTFSTVYKAV-MPSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVALLLHN 684 (888)
Q Consensus 606 ~~~~~~~ig~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 684 (888)
.|+..++||+|.||+||+|+ ..+++.||+|+++-.+ .++.......+|+-+++.++|.|||++++....+....+|+|
T Consensus 3 ~ydkmekigegtygtvfkarn~~t~eivalkrvrldd-ddegvpssalreicllkelkhknivrl~dvlhsdkkltlvfe 81 (292)
T KOG0662|consen 3 KYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDD-DDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFE 81 (292)
T ss_pred chHHHHhhcCCcceeeEecccCCccceEEEEEEeccC-CCCCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHH
Confidence 46677899999999999999 5579999999998443 333344578999999999999999999999999999999999
Q ss_pred cCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccccccccCCCCC
Q 002721 685 YLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSKG 764 (888)
Q Consensus 685 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 764 (888)
||.. +|..+...... .++.+.+..++.|+++||.|+|++++.|||+||.|.+|+.+|..|++|||+++.+.-.
T Consensus 82 ~cdq-dlkkyfdslng----~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ngelkladfglarafgip-- 154 (292)
T KOG0662|consen 82 FCDQ-DLKKYFDSLNG----DLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIP-- 154 (292)
T ss_pred HhhH-HHHHHHHhcCC----cCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCCc--
Confidence 9964 89988876543 5778889999999999999999999999999999999999999999999999987532
Q ss_pred cccccccccccceecccccccCC-cCccccchhHHHHHHHHHh-CCCCCCCCCCCccchhh--hccccCCCCCCcccccc
Q 002721 765 TASISAVAGSFGYIPPEYAYTMQ-VTAPGNVYSYGVVLLEILT-TRLPVEEDFGEGVDLVK--WVHGAPARGETPEQILD 840 (888)
Q Consensus 765 ~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~ellt-g~~P~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~ 840 (888)
....+..+-|..|++|.++.+.. |++..|+||.|||+.|+.. |++.|.+ .+-..++.+ +..+.+..+.++.--.-
T Consensus 155 vrcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg-~dvddqlkrif~~lg~p~ed~wps~t~l 233 (292)
T KOG0662|consen 155 VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPG-NDVDDQLKRIFRLLGTPTEDQWPSMTKL 233 (292)
T ss_pred eEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCC-CcHHHHHHHHHHHhCCCccccCCccccC
Confidence 22345667899999999988875 8999999999999999997 4544543 222333333 23344444433332111
Q ss_pred cccccCC-----cCcHHHHHH----HHHHHhhccCCCCCCCCCHHHHHH
Q 002721 841 ARLSTVS-----FGWRKEMLT----ALKVALLCTDSTPAKRPKMKKVVE 880 (888)
Q Consensus 841 ~~~~~~~-----~~~~~~~~~----~~~li~~cl~~dP~~RPs~~evl~ 880 (888)
+.....+ ..+.+..+. -.+++.+.+.-+|.+|.++++.++
T Consensus 234 pdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaeaalq 282 (292)
T KOG0662|consen 234 PDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEAALQ 282 (292)
T ss_pred CCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHHHhc
Confidence 1111111 123344333 357888899999999999998875
|
|
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=309.12 Aligned_cols=266 Identities=21% Similarity=0.243 Sum_probs=197.5
Q ss_pred cCCcceeeecccceEEEEEe-CCCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCCeeEEEEec
Q 002721 607 MKDSNMIYCGTFSTVYKAVM-PSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVALLLHNY 685 (888)
Q Consensus 607 ~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 685 (888)
|+..+.||.|++|.||+|.. .+|+.||+|++..... .....+.+.+|++++++++|||++++++++..++..|++|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~ 79 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETE-DEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEF 79 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccc-cccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEec
Confidence 67788999999999999995 4799999999874432 122234678899999999999999999999999999999999
Q ss_pred CCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccccccccCCCCCc
Q 002721 686 LPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSKGT 765 (888)
Q Consensus 686 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 765 (888)
++ ++|.+++..... ..+++..+..++.|+++||+|||+++++||||+|+||+++.++.++++|||.+........
T Consensus 80 ~~-~~l~~~~~~~~~---~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~- 154 (283)
T cd07835 80 LD-LDLKKYMDSSPL---TGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR- 154 (283)
T ss_pred cC-cCHHHHHhhCCC---CCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc-
Confidence 95 699999876542 2578899999999999999999999999999999999999999999999999976543221
Q ss_pred ccccccccccceecccccccC-CcCccccchhHHHHHHHHHhCCCCCCCCCCCccchhhhccccCCCCCC-------ccc
Q 002721 766 ASISAVAGSFGYIPPEYAYTM-QVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGET-------PEQ 837 (888)
Q Consensus 766 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~-------~~~ 837 (888)
......++..|+|||++.+. .++.++||||+|+++|+|++|+.||....... ...+........... ...
T Consensus 155 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (283)
T cd07835 155 -TYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEID-QLFRIFRTLGTPDEDVWPGVTSLPD 232 (283)
T ss_pred -ccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCCChHHhhhhhhchh
Confidence 12233568899999987654 57889999999999999999999997542211 111111100000000 000
Q ss_pred cccc----ccccCCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002721 838 ILDA----RLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVE 880 (888)
Q Consensus 838 ~~~~----~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 880 (888)
.... ...............+.+++.+|++.||++|||++|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~ 279 (283)
T cd07835 233 YKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAALQ 279 (283)
T ss_pred hhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHHhc
Confidence 0000 000000001122356789999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-34 Score=309.80 Aligned_cols=265 Identities=15% Similarity=0.169 Sum_probs=191.6
Q ss_pred cceeeecccceEEEEEeCCCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCCeeEEEEecCCCC
Q 002721 610 SNMIYCGTFSTVYKAVMPSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVALLLHNYLPNG 689 (888)
Q Consensus 610 ~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~g 689 (888)
.+.+|.|+++.||++.. +++.||+|+++.... .....+.+.+|++++++++||||+++++++...+..+++|||++++
T Consensus 7 ~~~~~~~~~v~~~~~~~-~~~~~avK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~ 84 (314)
T cd08216 7 GKCFEDLMIVHLAKHKP-TNTLVAVKKINLDSC-SKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYG 84 (314)
T ss_pred hHhhcCCceEEEEEecC-CCCEEEEEEEecccc-chhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCC
Confidence 34444455555555444 799999999975422 2234568999999999999999999999999999999999999999
Q ss_pred CHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccccccccCCCCC-----
Q 002721 690 TLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSKG----- 764 (888)
Q Consensus 690 ~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~----- 764 (888)
++.+++...... .+++..+..++.|++.||+|||+++|+||||||+||+++.++.+|++|||.+........
T Consensus 85 ~l~~~l~~~~~~---~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~ 161 (314)
T cd08216 85 SCEDLLKTHFPE---GLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVV 161 (314)
T ss_pred CHHHHHHHhccc---CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceEEecCccceeecccccccccc
Confidence 999999865332 467888999999999999999999999999999999999999999999998875532211
Q ss_pred cccccccccccceeccccccc--CCcCccccchhHHHHHHHHHhCCCCCCCCCCCccchhhhccccCC----------CC
Q 002721 765 TASISAVAGSFGYIPPEYAYT--MQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPA----------RG 832 (888)
Q Consensus 765 ~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~----------~~ 832 (888)
........++..|+|||++.+ ..++.++||||+||++|||++|+.||........ ..+...+... ..
T Consensus 162 ~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 240 (314)
T cd08216 162 HDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQM-LLEKVRGTVPCLLDKSTYPLYE 240 (314)
T ss_pred ccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHhccCccccccCchhhhc
Confidence 111123456778999998865 3588999999999999999999999975432211 1111110000 00
Q ss_pred CCccc----ccccc--cccCCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002721 833 ETPEQ----ILDAR--LSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVE 880 (888)
Q Consensus 833 ~~~~~----~~~~~--~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 880 (888)
..... ..+.. .............++.+++.+||..||++|||++|+++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~ 294 (314)
T cd08216 241 DSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRPSASQLLN 294 (314)
T ss_pred CCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCcCHHHHhc
Confidence 00000 00000 00011112234567889999999999999999999986
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=311.15 Aligned_cols=270 Identities=19% Similarity=0.241 Sum_probs=194.6
Q ss_pred HhcCCcceeeecccceEEEEEeC-CCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCC------
Q 002721 605 ATMKDSNMIYCGTFSTVYKAVMP-SGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYED------ 677 (888)
Q Consensus 605 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~------ 677 (888)
++|+..+.||+|+||.||+|+.. +++.||+|.+...... ......+.+|++++++++||||+++++++...+
T Consensus 12 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~ 90 (310)
T cd07865 12 SKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENEK-EGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRY 90 (310)
T ss_pred hheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCCc-CCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCC
Confidence 46999999999999999999954 6899999998643322 122235678999999999999999999987654
Q ss_pred --eeEEEEecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEecccc
Q 002721 678 --VALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEI 755 (888)
Q Consensus 678 --~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~ 755 (888)
..++||||+.+ ++.+++..... .+++.++..++.||++||+|||++|++||||||+||+++.++.+||+|||.
T Consensus 91 ~~~~~lv~e~~~~-~l~~~l~~~~~----~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~ 165 (310)
T cd07865 91 KGSFYLVFEFCEH-DLAGLLSNKNV----KFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGL 165 (310)
T ss_pred CceEEEEEcCCCc-CHHHHHHhccc----CCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEECCCCcEEECcCCC
Confidence 45999999975 88888865432 478899999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCc--ccccccccccceecccccccC-CcCccccchhHHHHHHHHHhCCCCCCCCCCCc-cchhhhccccCCC
Q 002721 756 SKLLDPSKGT--ASISAVAGSFGYIPPEYAYTM-QVTAPGNVYSYGVVLLEILTTRLPVEEDFGEG-VDLVKWVHGAPAR 831 (888)
Q Consensus 756 a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~P~~~~~~~~-~~~~~~~~~~~~~ 831 (888)
+......... .......++..|+|||++.+. .++.++||||+|+++|||++|+.||....... ........+....
T Consensus 166 ~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~ 245 (310)
T cd07865 166 ARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITP 245 (310)
T ss_pred cccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCh
Confidence 9876432211 112234578889999987664 47889999999999999999999997543211 0011111110000
Q ss_pred CCCcc----ccccc-ccccCCc-------CcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002721 832 GETPE----QILDA-RLSTVSF-------GWRKEMLTALKVALLCTDSTPAKRPKMKKVVE 880 (888)
Q Consensus 832 ~~~~~----~~~~~-~~~~~~~-------~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 880 (888)
...+. ...+. ....... ........+.+++.+||..||++|||++|+++
T Consensus 246 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~t~~e~l~ 306 (310)
T cd07865 246 EVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALN 306 (310)
T ss_pred hhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhccCHHHHhc
Confidence 00000 00000 0000000 00012345678999999999999999999985
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=297.78 Aligned_cols=253 Identities=24% Similarity=0.311 Sum_probs=204.7
Q ss_pred hcCCcceeeecccceEEEEEeC-CCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeC--CeeEEE
Q 002721 606 TMKDSNMIYCGTFSTVYKAVMP-SGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYE--DVALLL 682 (888)
Q Consensus 606 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~--~~~~lv 682 (888)
+|+..+.||+|++|.||+|... +++.|++|++...... ....+.+.+|++++++++||||+++++++... +..++|
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv 79 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDS-EEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIF 79 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccc-hHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEE
Confidence 4778899999999999999965 6999999998754432 33456889999999999999999999999988 899999
Q ss_pred EecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccccccccCCC
Q 002721 683 HNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPS 762 (888)
Q Consensus 683 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 762 (888)
|||+++++|.+++.... .+++.++..++.|++.||+|||+.|++|+||+|+||+++.++.++|+|||.+......
T Consensus 80 ~e~~~~~~L~~~~~~~~-----~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~ 154 (260)
T cd06606 80 LEYVSGGSLSSLLKKFG-----KLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDI 154 (260)
T ss_pred EEecCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCCCCEEEcccccEEecccc
Confidence 99999999999998653 5688999999999999999999999999999999999999999999999999887654
Q ss_pred CCcccccccccccceecccccccCCcCccccchhHHHHHHHHHhCCCCCCCCCCCccchhhhccccCCCCCCcccccccc
Q 002721 763 KGTASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQILDAR 842 (888)
Q Consensus 763 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 842 (888)
..........++..|+|||...+..++.++||||+|+++|+|++|..||............... . ..
T Consensus 155 ~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~----~---------~~ 221 (260)
T cd06606 155 ETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGS----S---------GE 221 (260)
T ss_pred cccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhccc----c---------CC
Confidence 3211123456888999999998888999999999999999999999999764311111111000 0 00
Q ss_pred cccCCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002721 843 LSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVE 880 (888)
Q Consensus 843 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 880 (888)
... ........+.+++.+|++.||++||++.|+++
T Consensus 222 ~~~---~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~ 256 (260)
T cd06606 222 PPE---IPEHLSEEAKDFLRKCLRRDPKKRPTADELLQ 256 (260)
T ss_pred CcC---CCcccCHHHHHHHHHhCcCChhhCCCHHHHhh
Confidence 000 11122467788999999999999999999986
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=300.50 Aligned_cols=242 Identities=20% Similarity=0.207 Sum_probs=189.6
Q ss_pred HhcCCccee--eecccceEEEEEe-CCCcEEEEEEeeccChhhhHHHHHHHHHHHHHhcc-CCCceeeeeeEEEeCCeeE
Q 002721 605 ATMKDSNMI--YCGTFSTVYKAVM-PSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKL-CHDNLVRPIGFVIYEDVAL 680 (888)
Q Consensus 605 ~~~~~~~~i--g~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~ 680 (888)
+.|++.+.+ |+|+||.||+++. .++..+|+|.+....... .|+.....+ +||||+++++++..++..|
T Consensus 14 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~--------~e~~~~~~~~~h~~iv~~~~~~~~~~~~~ 85 (267)
T PHA03390 14 KNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA--------IEPMVHQLMKDNPNFIKLYYSVTTLKGHV 85 (267)
T ss_pred HhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch--------hhHHHHHHhhcCCCEEEEEEEEecCCeeE
Confidence 466666666 9999999999994 468899999987432211 122222222 6999999999999999999
Q ss_pred EEEecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCC-CceEecccccccc
Q 002721 681 LLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADF-KPLLGEIEISKLL 759 (888)
Q Consensus 681 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~-~~kl~Dfg~a~~~ 759 (888)
+||||+++++|.+++.... .+++.++..++.|+++||+|||+.|++||||||+||+++.++ .++++|||.+...
T Consensus 86 iv~e~~~~~~L~~~l~~~~-----~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~ 160 (267)
T PHA03390 86 LIMDYIKDGDLFDLLKKEG-----KLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIYLCDYGLCKII 160 (267)
T ss_pred EEEEcCCCCcHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeCCCCeEEEecCccceec
Confidence 9999999999999997653 578899999999999999999999999999999999999988 9999999998765
Q ss_pred CCCCCcccccccccccceecccccccCCcCccccchhHHHHHHHHHhCCCCCCCCCCCccchhhhccccCCCCCCccccc
Q 002721 760 DPSKGTASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQIL 839 (888)
Q Consensus 760 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 839 (888)
.... ...++..|+|||++.+..++.++||||+|+++|||++|+.||.....+..+...+....
T Consensus 161 ~~~~------~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~----------- 223 (267)
T PHA03390 161 GTPS------CYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLLKRQ----------- 223 (267)
T ss_pred CCCc------cCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHHHhh-----------
Confidence 4321 23578899999999988999999999999999999999999985433322222111111
Q ss_pred ccccccCCcCcHHHHHHHHHHHhhccCCCCCCCCC-HHHHHH
Q 002721 840 DARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPK-MKKVVE 880 (888)
Q Consensus 840 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs-~~evl~ 880 (888)
.............+.+++.+||+.+|.+||+ ++|+++
T Consensus 224 ----~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~ 261 (267)
T PHA03390 224 ----QKKLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIK 261 (267)
T ss_pred ----cccCCcccccCHHHHHHHHHHhccChhhCCchHHHHhc
Confidence 0000111234567889999999999999996 588874
|
|
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-34 Score=317.83 Aligned_cols=267 Identities=17% Similarity=0.298 Sum_probs=196.2
Q ss_pred HHhcCCcceeeecccceEEEEEe-CCCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCC-----
Q 002721 604 KATMKDSNMIYCGTFSTVYKAVM-PSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYED----- 677 (888)
Q Consensus 604 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~----- 677 (888)
.++|++.+.||+|+||.||+|+. .+|+.||+|+++..... ....++.+|+.++++++||||+++++++....
T Consensus 4 ~~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~ 81 (336)
T cd07849 4 GPRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQ--TFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFN 81 (336)
T ss_pred ccceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEecccccc--hhHHHHHHHHHHHHhCCCCCcCchhheeecccccccc
Confidence 45799999999999999999984 57899999998643222 23346788999999999999999999876543
Q ss_pred eeEEEEecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEecccccc
Q 002721 678 VALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISK 757 (888)
Q Consensus 678 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~ 757 (888)
..|+||||+++ ++.+++... .+++..+..++.|++.||+|||+.||+||||||+||+++.++.+|++|||++.
T Consensus 82 ~~~lv~e~~~~-~l~~~~~~~------~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~ 154 (336)
T cd07849 82 DVYIVQELMET-DLYKLIKTQ------HLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLAR 154 (336)
T ss_pred eEEEEehhccc-CHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCCCEEECccccee
Confidence 57999999975 888877643 57888999999999999999999999999999999999999999999999988
Q ss_pred ccCCCCCcc-cccccccccceeccccccc-CCcCccccchhHHHHHHHHHhCCCCCCCCCCCccchhhhc--cccCCCCC
Q 002721 758 LLDPSKGTA-SISAVAGSFGYIPPEYAYT-MQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWV--HGAPARGE 833 (888)
Q Consensus 758 ~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~--~~~~~~~~ 833 (888)
......... ......|+..|+|||.+.+ ..++.++||||+||++|+|++|+.||....... ....+. ...+.. .
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~-~~~~~~~~~~~~~~-~ 232 (336)
T cd07849 155 IADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLH-QLNLILGVLGTPSQ-E 232 (336)
T ss_pred eccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHcCCCCH-H
Confidence 754322111 1223568899999998654 468899999999999999999999996532110 000000 000000 0
Q ss_pred Ccccccccc-------ccc-CCcC----cHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002721 834 TPEQILDAR-------LST-VSFG----WRKEMLTALKVALLCTDSTPAKRPKMKKVVEM 881 (888)
Q Consensus 834 ~~~~~~~~~-------~~~-~~~~----~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~ 881 (888)
....+.... ... .... ......++.+++.+||+.||++|||+.|+++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~e~l~h 292 (336)
T cd07849 233 DLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRITVEEALAH 292 (336)
T ss_pred HHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCcCHHHHhcC
Confidence 000000000 000 0000 01234568899999999999999999999875
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-34 Score=299.05 Aligned_cols=249 Identities=22% Similarity=0.314 Sum_probs=202.2
Q ss_pred hcCCcceeeecccceEEEEEeC-CCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCCeeEEEEe
Q 002721 606 TMKDSNMIYCGTFSTVYKAVMP-SGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVALLLHN 684 (888)
Q Consensus 606 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 684 (888)
+|+..+.||+|++|.||+|+.. +++.|++|.+...... ....+.+.+|++++++++|||++++++++..++..++|||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e 79 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIK-EEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILE 79 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEecccccC-HHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEe
Confidence 4788899999999999999854 6889999999755432 2344589999999999999999999999999999999999
Q ss_pred cCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccccccccCCCCC
Q 002721 685 YLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSKG 764 (888)
Q Consensus 685 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 764 (888)
|+++++|.+++.... .+++..+..++.|++.||.|||+.|++||||||+||+++.++.++|+|||.+........
T Consensus 80 ~~~~~~L~~~~~~~~-----~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~ 154 (254)
T cd06627 80 YAENGSLRQIIKKFG-----PFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK 154 (254)
T ss_pred cCCCCcHHHHHHhcc-----CCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCcc
Confidence 999999999997652 578899999999999999999999999999999999999999999999999987764332
Q ss_pred cccccccccccceecccccccCCcCccccchhHHHHHHHHHhCCCCCCCCCCCccchhhhccccCCCCCCcccccccccc
Q 002721 765 TASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQILDARLS 844 (888)
Q Consensus 765 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 844 (888)
. .....++..|+|||...+..++.++||||+|+++|+|++|+.||...... ........ ....
T Consensus 155 ~--~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~-~~~~~~~~--------------~~~~ 217 (254)
T cd06627 155 D--DASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPM-AALFRIVQ--------------DDHP 217 (254)
T ss_pred c--ccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHH-HHHHHHhc--------------cCCC
Confidence 1 23456788999999988888899999999999999999999999753211 00101000 0000
Q ss_pred cCCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002721 845 TVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVE 880 (888)
Q Consensus 845 ~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 880 (888)
. ........+.+++.+||..+|++||++.|++.
T Consensus 218 ~---~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~ 250 (254)
T cd06627 218 P---LPEGISPELKDFLMQCFQKDPNLRPTAKQLLK 250 (254)
T ss_pred C---CCCCCCHHHHHHHHHHHhCChhhCcCHHHHhc
Confidence 0 01122456778999999999999999999875
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-34 Score=300.07 Aligned_cols=253 Identities=21% Similarity=0.296 Sum_probs=203.7
Q ss_pred hcCCcceeeecccceEEEEEeC-CCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCCeeEEEEe
Q 002721 606 TMKDSNMIYCGTFSTVYKAVMP-SGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVALLLHN 684 (888)
Q Consensus 606 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 684 (888)
+|+..+.||+|+||.||+|... +++.||+|++...... ....+.+.+|++++++++|||++++++.+..++..++|+|
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e 79 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNMS-EKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVME 79 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccCC-hHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEE
Confidence 4778899999999999999954 6899999999754332 2344578899999999999999999999999999999999
Q ss_pred cCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccccccccCCCCC
Q 002721 685 YLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSKG 764 (888)
Q Consensus 685 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 764 (888)
|+++++|.+++....... ..+++.++..++.|++.||+|||+.|++|+||+|+||+++.++.++++|||.+.......
T Consensus 80 ~~~~~~L~~~l~~~~~~~-~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~- 157 (258)
T cd08215 80 YADGGDLSQKIKKQKKEG-KPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV- 157 (258)
T ss_pred ecCCCcHHHHHHHhhccC-CCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeecccCc-
Confidence 999999999998753211 267899999999999999999999999999999999999999999999999998765432
Q ss_pred cccccccccccceecccccccCCcCccccchhHHHHHHHHHhCCCCCCCCCCCccchhhhccccCCCCCCcccccccccc
Q 002721 765 TASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQILDARLS 844 (888)
Q Consensus 765 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 844 (888)
.......|++.|+|||...+..++.++|+||+|+++|+|++|+.||...... ..... .......
T Consensus 158 -~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~--~~~~~-------------~~~~~~~ 221 (258)
T cd08215 158 -DLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLL--ELALK-------------ILKGQYP 221 (258)
T ss_pred -ceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHH--HHHHH-------------HhcCCCC
Confidence 1123346888999999988888999999999999999999999999653211 11110 0000011
Q ss_pred cCCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002721 845 TVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVE 880 (888)
Q Consensus 845 ~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 880 (888)
..+ ......+.+++.+||..+|++|||+.|+++
T Consensus 222 ~~~---~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~ 254 (258)
T cd08215 222 PIP---SQYSSELRNLVSSLLQKDPEERPSIAQILQ 254 (258)
T ss_pred CCC---CCCCHHHHHHHHHHcCCChhhCcCHHHHhc
Confidence 111 122356778999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-34 Score=308.52 Aligned_cols=251 Identities=22% Similarity=0.303 Sum_probs=197.0
Q ss_pred HHHhcCCcceeeecccceEEEEEeC-CCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCCeeEE
Q 002721 603 VKATMKDSNMIYCGTFSTVYKAVMP-SGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVALL 681 (888)
Q Consensus 603 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~l 681 (888)
....|+..+.||+|+||.||+|+.. +++.+|+|.+............++.+|+++++.++|||++++++++...+..++
T Consensus 13 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~l 92 (308)
T cd06634 13 PEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWL 92 (308)
T ss_pred cHHHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEE
Confidence 3456888899999999999999954 688999999874333333344578899999999999999999999999999999
Q ss_pred EEecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccccccccCC
Q 002721 682 LHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDP 761 (888)
Q Consensus 682 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~~~ 761 (888)
||||+. |++.+++..... .+++.++..++.|++.|+.|||+.+++||||||+||+++.++.++++|||.+.....
T Consensus 93 v~e~~~-~~l~~~~~~~~~----~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~ 167 (308)
T cd06634 93 VMEYCL-GSASDLLEVHKK----PLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP 167 (308)
T ss_pred EEEccC-CCHHHHHHHcCC----CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCCCcEEECCcccceeecC
Confidence 999997 588887764332 467889999999999999999999999999999999999999999999999876543
Q ss_pred CCCcccccccccccceecccccc---cCCcCccccchhHHHHHHHHHhCCCCCCCCCCCccchhhhccccCCCCCCcccc
Q 002721 762 SKGTASISAVAGSFGYIPPEYAY---TMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQI 838 (888)
Q Consensus 762 ~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 838 (888)
. ....++..|+|||++. ...++.++|||||||++|+|++|+.||........ ......
T Consensus 168 ~------~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~-~~~~~~------------ 228 (308)
T cd06634 168 A------NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA-LYHIAQ------------ 228 (308)
T ss_pred c------ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHH-HHHHhh------------
Confidence 2 2345788999999874 35678899999999999999999999865321110 000000
Q ss_pred cccccccCCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002721 839 LDARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEM 881 (888)
Q Consensus 839 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~ 881 (888)
...... ........+.+++.+||+.+|++||+++++++.
T Consensus 229 --~~~~~~--~~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~ 267 (308)
T cd06634 229 --NESPAL--QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKH 267 (308)
T ss_pred --cCCCCc--CcccccHHHHHHHHHHhhCCcccCCCHHHHhhC
Confidence 000000 111234567789999999999999999999865
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-34 Score=307.90 Aligned_cols=268 Identities=18% Similarity=0.242 Sum_probs=195.3
Q ss_pred HhcCCcceeeecccceEEEEEeC-CCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCCeeEEEE
Q 002721 605 ATMKDSNMIYCGTFSTVYKAVMP-SGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVALLLH 683 (888)
Q Consensus 605 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 683 (888)
++|+..+.||+|++|+||+|+.. +++.||+|.+...... ....+.+.+|++++++++||||+++++++..++..|+||
T Consensus 2 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~ 80 (294)
T PLN00009 2 DQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQED-EGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVF 80 (294)
T ss_pred CceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhcccc-ccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEE
Confidence 36888999999999999999954 6899999988643221 223346889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCC-CCCceEeccccccccCCC
Q 002721 684 NYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDA-DFKPLLGEIEISKLLDPS 762 (888)
Q Consensus 684 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~-~~~~kl~Dfg~a~~~~~~ 762 (888)
||++ +++.+++...... ..++..+..++.||+.||+|||++|++||||||+||+++. ++.+|++|||.+......
T Consensus 81 e~~~-~~l~~~~~~~~~~---~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~ 156 (294)
T PLN00009 81 EYLD-LDLKKHMDSSPDF---AKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP 156 (294)
T ss_pred eccc-ccHHHHHHhCCCC---CcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCC
Confidence 9996 5888887654322 3567888899999999999999999999999999999985 557999999999765432
Q ss_pred CCcccccccccccceecccccccC-CcCccccchhHHHHHHHHHhCCCCCCCCCCCccchhhhcc--ccCCCCCCc----
Q 002721 763 KGTASISAVAGSFGYIPPEYAYTM-QVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVH--GAPARGETP---- 835 (888)
Q Consensus 763 ~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~--~~~~~~~~~---- 835 (888)
. .......+++.|+|||++.+. .++.++||||+|+++|+|+||+.||........ ..+... ..+......
T Consensus 157 ~--~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~ 233 (294)
T PLN00009 157 V--RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDE-LFKIFRILGTPNEETWPGVTS 233 (294)
T ss_pred c--cccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHhCCCChhhcccccc
Confidence 1 112334578899999987654 578999999999999999999999975432111 111000 000000000
Q ss_pred -ccccc--cccccC--CcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002721 836 -EQILD--ARLSTV--SFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVE 880 (888)
Q Consensus 836 -~~~~~--~~~~~~--~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 880 (888)
..... +..... .........++.+++.+|++.+|++||++.++++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~~l~ 283 (294)
T PLN00009 234 LPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARAALE 283 (294)
T ss_pred chhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHHHhc
Confidence 00000 000000 0001123456788999999999999999999986
|
|
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-33 Score=298.90 Aligned_cols=253 Identities=20% Similarity=0.244 Sum_probs=197.3
Q ss_pred HhcCCcceeeecccceEEEEEe-CCCcEEEEEEeeccC--hhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeC--Cee
Q 002721 605 ATMKDSNMIYCGTFSTVYKAVM-PSGLILSVKRLKSMD--RTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYE--DVA 679 (888)
Q Consensus 605 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~--~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~--~~~ 679 (888)
.+|++.+.||+|+||.||+|+. .+++.||+|.+.... .........+.+|++++++++||||+++++++.+. ...
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~ 81 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKL 81 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEE
Confidence 3688899999999999999995 468999999875322 12233445788999999999999999999998764 468
Q ss_pred EEEEecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEecccccccc
Q 002721 680 LLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLL 759 (888)
Q Consensus 680 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~ 759 (888)
++||||+++++|.+++.... .+++..+..++.|++.||.|||+.|++||||||+||+++.++.++++|||.+...
T Consensus 82 ~~v~e~~~~~~L~~~~~~~~-----~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~ 156 (264)
T cd06653 82 SIFVEYMPGGSIKDQLKAYG-----ALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRI 156 (264)
T ss_pred EEEEEeCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcccccccc
Confidence 89999999999999987643 3577889999999999999999999999999999999999999999999999865
Q ss_pred CCCCC-cccccccccccceecccccccCCcCccccchhHHHHHHHHHhCCCCCCCCCCCccchhhhccccCCCCCCcccc
Q 002721 760 DPSKG-TASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQI 838 (888)
Q Consensus 760 ~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 838 (888)
..... ........++..|+|||++.+..++.++|||||||++|++++|+.||....... ...+.. ..+..
T Consensus 157 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~-~~~~~~-~~~~~------- 227 (264)
T cd06653 157 QTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMA-AIFKIA-TQPTK------- 227 (264)
T ss_pred ccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHH-HHHHHH-cCCCC-------
Confidence 42111 111223568889999999988889999999999999999999999997532111 111100 00000
Q ss_pred cccccccCCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002721 839 LDARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVE 880 (888)
Q Consensus 839 ~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 880 (888)
+.........+.+++.+||. +|.+||++.+++.
T Consensus 228 --------~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~ 260 (264)
T cd06653 228 --------PMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLR 260 (264)
T ss_pred --------CCCCcccCHHHHHHHHHHhc-CcccCccHHHHhc
Confidence 01122334567889999999 5799999998875
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-34 Score=307.67 Aligned_cols=251 Identities=22% Similarity=0.264 Sum_probs=202.2
Q ss_pred hcCCcceeeecccceEEEEEeC-CCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccC-CCceeeeeeEEEeCCeeEEEE
Q 002721 606 TMKDSNMIYCGTFSTVYKAVMP-SGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLC-HDNLVRPIGFVIYEDVALLLH 683 (888)
Q Consensus 606 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~~lv~ 683 (888)
+|...+.||+|+||.||+|+.. +++.||+|++...........+.+.+|+++++++. ||||+++++++..++..++||
T Consensus 2 ~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~ 81 (280)
T cd05581 2 DFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVL 81 (280)
T ss_pred CceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEE
Confidence 6888899999999999999954 79999999987543333344457889999999998 999999999999999999999
Q ss_pred ecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccccccccCCCC
Q 002721 684 NYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSK 763 (888)
Q Consensus 684 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 763 (888)
||+++++|.+++.... .+++..+..++.|++.||+|||+.|++|+||||+||+++.++.++++|||.+.......
T Consensus 82 e~~~~~~L~~~l~~~~-----~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~ 156 (280)
T cd05581 82 EYAPNGELLQYIRKYG-----SLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNS 156 (280)
T ss_pred cCCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCcc
Confidence 9999999999998653 57889999999999999999999999999999999999999999999999988764322
Q ss_pred Cc------------------ccccccccccceecccccccCCcCccccchhHHHHHHHHHhCCCCCCCCCCCccchhhhc
Q 002721 764 GT------------------ASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWV 825 (888)
Q Consensus 764 ~~------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~ 825 (888)
.. .......++..|+|||...+..++.++||||+|+++|++++|+.||...... ..+..
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~-~~~~~-- 233 (280)
T cd05581 157 SPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEY-LTFQK-- 233 (280)
T ss_pred ccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCccHH-HHHHH--
Confidence 11 1223446788999999988888999999999999999999999999754211 00000
Q ss_pred cccCCCCCCcccccccccccCCcCcHHHHHHHHHHHhhccCCCCCCCCCH----HHHHH
Q 002721 826 HGAPARGETPEQILDARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKM----KKVVE 880 (888)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~----~evl~ 880 (888)
+..... . ......+.+.+++.+||+.+|++||++ +++++
T Consensus 234 ------------~~~~~~-~---~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~ 276 (280)
T cd05581 234 ------------ILKLEY-S---FPPNFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKA 276 (280)
T ss_pred ------------HHhcCC-C---CCCccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhc
Confidence 000000 0 011224567899999999999999999 77664
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-34 Score=306.26 Aligned_cols=248 Identities=17% Similarity=0.265 Sum_probs=196.1
Q ss_pred hcCCcceeeecccceEEEEEe-CCCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCCeeEEEEe
Q 002721 606 TMKDSNMIYCGTFSTVYKAVM-PSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVALLLHN 684 (888)
Q Consensus 606 ~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 684 (888)
.|+....||+|+||.||+|.. .+++.||+|++..... ...+.+.+|+.+++.++||||+++++++..++..++|||
T Consensus 21 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 97 (292)
T cd06657 21 YLDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLRKQ---QRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVME 97 (292)
T ss_pred HhhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEecccch---hHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEe
Confidence 344457899999999999985 5789999998753322 234578899999999999999999999999999999999
Q ss_pred cCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccccccccCCCCC
Q 002721 685 YLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSKG 764 (888)
Q Consensus 685 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 764 (888)
|+++++|.+++... .+++..+..++.|++.||+|||+.|++||||||+||+++.++.++++|||.+........
T Consensus 98 ~~~~~~L~~~~~~~------~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~ 171 (292)
T cd06657 98 FLEGGALTDIVTHT------RMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP 171 (292)
T ss_pred cCCCCcHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCEEEcccccceecccccc
Confidence 99999999987542 467889999999999999999999999999999999999999999999998876543221
Q ss_pred cccccccccccceecccccccCCcCccccchhHHHHHHHHHhCCCCCCCCCCCccchhhhccccCCCCCCcccccccccc
Q 002721 765 TASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQILDARLS 844 (888)
Q Consensus 765 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 844 (888)
......++..|+|||++.+..++.++||||+|+++|+|++|..||...... .......... .....
T Consensus 172 --~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~--~~~~~~~~~~----------~~~~~ 237 (292)
T cd06657 172 --RRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPL--KAMKMIRDNL----------PPKLK 237 (292)
T ss_pred --cccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHH--HHHHHHHhhC----------CcccC
Confidence 123356788999999988888999999999999999999999999743211 1111110000 00000
Q ss_pred cCCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002721 845 TVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVE 880 (888)
Q Consensus 845 ~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 880 (888)
........+.+++.+||+.||.+||++.++++
T Consensus 238 ----~~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~ 269 (292)
T cd06657 238 ----NLHKVSPSLKGFLDRLLVRDPAQRATAAELLK 269 (292)
T ss_pred ----CcccCCHHHHHHHHHHHhCCcccCcCHHHHhc
Confidence 01122345678999999999999999999986
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-34 Score=315.62 Aligned_cols=270 Identities=17% Similarity=0.254 Sum_probs=198.5
Q ss_pred HHhcCCcceeeecccceEEEEEe-CCCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEe----CCe
Q 002721 604 KATMKDSNMIYCGTFSTVYKAVM-PSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIY----EDV 678 (888)
Q Consensus 604 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~----~~~ 678 (888)
..+|+..+.||+|+||.||+|.. .+|+.||+|++..... .....+.+.+|+.++++++||||+++++++.. ...
T Consensus 4 ~~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 82 (334)
T cd07855 4 GSRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFD-VPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKD 82 (334)
T ss_pred hhceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccc-cccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCce
Confidence 36899999999999999999994 4699999999875332 22234467889999999999999999998763 346
Q ss_pred eEEEEecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccccccc
Q 002721 679 ALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKL 758 (888)
Q Consensus 679 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~ 758 (888)
.|+||||+. ++|.+++.... .+++..+..++.||+.||+|||++||+||||||+||++++++.+||+|||.+..
T Consensus 83 ~~lv~e~~~-~~l~~~~~~~~-----~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~ 156 (334)
T cd07855 83 VYVVMDLME-SDLHHIIHSDQ-----PLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGMARG 156 (334)
T ss_pred EEEEEehhh-hhHHHHhccCC-----CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEeccccccee
Confidence 899999996 58999886543 468899999999999999999999999999999999999999999999999987
Q ss_pred cCCCCCc--ccccccccccceeccccccc-CCcCccccchhHHHHHHHHHhCCCCCCCCCCCc-cchhhhccccCCCC--
Q 002721 759 LDPSKGT--ASISAVAGSFGYIPPEYAYT-MQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEG-VDLVKWVHGAPARG-- 832 (888)
Q Consensus 759 ~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~-~~~~~~~~~~~~~~-- 832 (888)
....... .......++..|+|||.+.+ ..++.++||||+||++|||++|+.||....... ........+.+...
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~ 236 (334)
T cd07855 157 LSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVL 236 (334)
T ss_pred ecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhh
Confidence 5432211 11123468889999998765 458899999999999999999999996542210 00000000111000
Q ss_pred -----CCcccccccccccCCcC----cHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002721 833 -----ETPEQILDARLSTVSFG----WRKEMLTALKVALLCTDSTPAKRPKMKKVVE 880 (888)
Q Consensus 833 -----~~~~~~~~~~~~~~~~~----~~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 880 (888)
.......+......... ......++.+++.+||+.+|++||++++++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~l~ 293 (334)
T cd07855 237 NRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERITVEQALQ 293 (334)
T ss_pred hhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCcCHHHHHh
Confidence 00000000000000001 1123567889999999999999999999886
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-33 Score=304.67 Aligned_cols=248 Identities=22% Similarity=0.313 Sum_probs=194.8
Q ss_pred hcCCcceeeecccceEEEEEe-CCCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCCeeEEEEe
Q 002721 606 TMKDSNMIYCGTFSTVYKAVM-PSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVALLLHN 684 (888)
Q Consensus 606 ~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 684 (888)
.|...+.||+|+||+||+|+. .+++.||+|.+.............+.+|+++++.++|||++++++++.+.+..|+|||
T Consensus 22 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e 101 (313)
T cd06633 22 IFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVME 101 (313)
T ss_pred HhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEe
Confidence 477788899999999999995 4689999999875443333444578899999999999999999999999999999999
Q ss_pred cCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccccccccCCCCC
Q 002721 685 YLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSKG 764 (888)
Q Consensus 685 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 764 (888)
|+. |++.+++..... .+++.++..++.||+.|++|||++|++||||||+||+++.++.+||+|||.+.....
T Consensus 102 ~~~-~~l~~~l~~~~~----~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~--- 173 (313)
T cd06633 102 YCL-GSASDLLEVHKK----PLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSSP--- 173 (313)
T ss_pred cCC-CCHHHHHHhcCC----CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCCCEEEeecCCCcccCC---
Confidence 996 588888765432 468899999999999999999999999999999999999999999999998864322
Q ss_pred cccccccccccceecccccc---cCCcCccccchhHHHHHHHHHhCCCCCCCCCCCccchhhhccccCCCCCCccccccc
Q 002721 765 TASISAVAGSFGYIPPEYAY---TMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQILDA 841 (888)
Q Consensus 765 ~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 841 (888)
.....|+..|+|||++. ...++.++|||||||++|||++|..||........ ...... . ..+.
T Consensus 174 ---~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~--~~~~~~---~-~~~~----- 239 (313)
T cd06633 174 ---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSA--LYHIAQ---N-DSPT----- 239 (313)
T ss_pred ---CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHH--HHHHHh---c-CCCC-----
Confidence 12346888999999874 45688899999999999999999999975421110 000000 0 0000
Q ss_pred ccccCCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002721 842 RLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEM 881 (888)
Q Consensus 842 ~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~ 881 (888)
. ........+.+++.+||+++|++||++.+++..
T Consensus 240 ----~--~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~ 273 (313)
T cd06633 240 ----L--QSNEWTDSFRGFVDYCLQKIPQERPASAELLRH 273 (313)
T ss_pred ----C--CccccCHHHHHHHHHHccCChhhCcCHHHHhcC
Confidence 0 001122456789999999999999999999863
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=304.50 Aligned_cols=254 Identities=19% Similarity=0.180 Sum_probs=195.1
Q ss_pred hcCCcceeeecccceEEEEEe----CCCcEEEEEEeeccChh-hhHHHHHHHHHHHHHhcc-CCCceeeeeeEEEeCCee
Q 002721 606 TMKDSNMIYCGTFSTVYKAVM----PSGLILSVKRLKSMDRT-IIHHQNKMIRELEKLSKL-CHDNLVRPIGFVIYEDVA 679 (888)
Q Consensus 606 ~~~~~~~ig~G~~g~Vy~~~~----~~~~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~ 679 (888)
.|++.+.||+|+||.||+|+. .+|..||+|+++..... .....+.+.+|+++++++ +||+|+++++++..+...
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 377889999999999999985 36899999999753321 122334678899999999 599999999999999999
Q ss_pred EEEEecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEecccccccc
Q 002721 680 LLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLL 759 (888)
Q Consensus 680 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~ 759 (888)
|+||||+++++|.+++.... .+++..+..++.|+++||+|||+.|++||||||+||+++.++.+||+|||++...
T Consensus 81 ~lv~e~~~~~~L~~~l~~~~-----~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~ 155 (290)
T cd05613 81 HLILDYINGGELFTHLSQRE-----RFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEF 155 (290)
T ss_pred EEEEecCCCCcHHHHHHHcC-----CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEECCCCCEEEeeCccceec
Confidence 99999999999999997643 4677888899999999999999999999999999999999999999999999875
Q ss_pred CCCCCcccccccccccceecccccccC--CcCccccchhHHHHHHHHHhCCCCCCCCCCCccchhhhccccCCCCCCccc
Q 002721 760 DPSKGTASISAVAGSFGYIPPEYAYTM--QVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQ 837 (888)
Q Consensus 760 ~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 837 (888)
..... .......|+..|+|||.+.+. .++.++||||||+++|+|++|+.||....... .......
T Consensus 156 ~~~~~-~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~-~~~~~~~----------- 222 (290)
T cd05613 156 HEDEV-ERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKN-SQAEISR----------- 222 (290)
T ss_pred ccccc-cccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccc-cHHHHHH-----------
Confidence 43221 112235688899999988653 46789999999999999999999996422110 0111100
Q ss_pred ccccccccCCcCcHHHHHHHHHHHhhccCCCCCCCC-----CHHHHHH
Q 002721 838 ILDARLSTVSFGWRKEMLTALKVALLCTDSTPAKRP-----KMKKVVE 880 (888)
Q Consensus 838 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RP-----s~~evl~ 880 (888)
......+.........+.+++.+||+.||++|| +++++++
T Consensus 223 ---~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~ 267 (290)
T cd05613 223 ---RILKSEPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKK 267 (290)
T ss_pred ---HhhccCCCCCccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHc
Confidence 000000001112335667899999999999997 6676654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-34 Score=304.41 Aligned_cols=265 Identities=18% Similarity=0.228 Sum_probs=200.2
Q ss_pred cCCcceeeecccceEEEEEeC-CCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCCeeEEEEec
Q 002721 607 MKDSNMIYCGTFSTVYKAVMP-SGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVALLLHNY 685 (888)
Q Consensus 607 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 685 (888)
|+..+.||+|++|.||+|... +++.+|+|+++..... ......+.+|++++++++||||+++++++..++..++||||
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~ 79 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFES-EGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEF 79 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEecccccc-chhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEec
Confidence 567889999999999999954 6899999998754332 23345788999999999999999999999999999999999
Q ss_pred CCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccccccccCCCCCc
Q 002721 686 LPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSKGT 765 (888)
Q Consensus 686 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 765 (888)
+++ ++.+++..... .+++.++..++.|++.||+|||+.+|+|+||||+||+++.++.++++|||.+.......
T Consensus 80 ~~~-~l~~~l~~~~~----~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~-- 152 (283)
T cd05118 80 MDT-DLYKLIKDRQR----GLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPV-- 152 (283)
T ss_pred cCC-CHHHHHHhhcc----cCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc--
Confidence 975 88888876432 57889999999999999999999999999999999999999999999999998765432
Q ss_pred ccccccccccceecccccccC-CcCccccchhHHHHHHHHHhCCCCCCCCCCCccchhhhccccCC-CCCCccccc----
Q 002721 766 ASISAVAGSFGYIPPEYAYTM-QVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPA-RGETPEQIL---- 839 (888)
Q Consensus 766 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~---- 839 (888)
.......++..|+|||.+.+. .++.++||||+|+++|+|++|+.||........ .......... .........
T Consensus 153 ~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~ 231 (283)
T cd05118 153 RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQ-LFKIFRTLGTPDPEVWPKFTSLAR 231 (283)
T ss_pred ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHHHcCCCchHhcccchhhhh
Confidence 112234578899999998776 789999999999999999999999965432110 0000000000 000000000
Q ss_pred -------ccccccCCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002721 840 -------DARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVE 880 (888)
Q Consensus 840 -------~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 880 (888)
................++.+++.+||++||.+||++.+++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ll~ 279 (283)
T cd05118 232 NYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQALA 279 (283)
T ss_pred hhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHHHhh
Confidence 00000000111234567889999999999999999999985
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=304.09 Aligned_cols=266 Identities=21% Similarity=0.267 Sum_probs=198.1
Q ss_pred cCCcceeeecccceEEEEEeC-CCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeC--CeeEEEE
Q 002721 607 MKDSNMIYCGTFSTVYKAVMP-SGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYE--DVALLLH 683 (888)
Q Consensus 607 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~--~~~~lv~ 683 (888)
|++.+.||+|+||.||+|+.. +++.||+|++.... ........+.+|++++++++|||++++++++... +..++||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~ 79 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMEN-EKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVF 79 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEeccc-ccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEe
Confidence 567889999999999999965 58999999998553 2223334688999999999999999999999988 8999999
Q ss_pred ecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccccccccCCCC
Q 002721 684 NYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSK 763 (888)
Q Consensus 684 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 763 (888)
||+++ +|.+++.... ..+++.+++.++.||++||+|||+.|++|+||||+||++++++.+|++|||.+.......
T Consensus 80 e~~~~-~l~~~~~~~~----~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~ 154 (287)
T cd07840 80 EYMDH-DLTGLLDSPE----VKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRN 154 (287)
T ss_pred ccccc-cHHHHHhccC----CCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCC
Confidence 99975 8998887543 157889999999999999999999999999999999999999999999999998765433
Q ss_pred Ccccccccccccceeccccccc-CCcCccccchhHHHHHHHHHhCCCCCCCCCCCccchhhhcc--ccCCCCCC--cccc
Q 002721 764 GTASISAVAGSFGYIPPEYAYT-MQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVH--GAPARGET--PEQI 838 (888)
Q Consensus 764 ~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~--~~~~~~~~--~~~~ 838 (888)
. .......++..|+|||.+.+ ..++.++||||||+++|||++|+.||........ ...... ..+..... ...+
T Consensus 155 ~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~ 232 (287)
T cd07840 155 S-ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQ-LEKIFELCGSPTDENWPGVSKL 232 (287)
T ss_pred c-ccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHhCCCchhhccccccc
Confidence 1 11233456788999997765 4578999999999999999999999975432110 000000 00000000 0000
Q ss_pred -cccccccCC-------cCcHH-HHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002721 839 -LDARLSTVS-------FGWRK-EMLTALKVALLCTDSTPAKRPKMKKVVE 880 (888)
Q Consensus 839 -~~~~~~~~~-------~~~~~-~~~~~~~li~~cl~~dP~~RPs~~evl~ 880 (888)
......... ..... ....+.+++.+||..+|++||++.++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 283 (287)
T cd07840 233 PWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQALQ 283 (287)
T ss_pred hhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCcCHHHHhh
Confidence 000000000 00011 2567889999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-34 Score=312.97 Aligned_cols=270 Identities=18% Similarity=0.224 Sum_probs=198.5
Q ss_pred HHHhcCCcceeeecccceEEEEEeC-CCcEEEEEEeeccChhhhHHHHHHHHHHHHHhcc-CCCceeeeeeEEEeC--Ce
Q 002721 603 VKATMKDSNMIYCGTFSTVYKAVMP-SGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKL-CHDNLVRPIGFVIYE--DV 678 (888)
Q Consensus 603 ~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~--~~ 678 (888)
+.++|++.+.||+|+||.||+|... +++.||+|++....... .....+.+|+.+++++ +||||+++++++... ..
T Consensus 5 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~~~~-~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~ 83 (337)
T cd07852 5 ILRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAFRNA-TDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKD 83 (337)
T ss_pred hhhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeeccccCcc-hhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCce
Confidence 5678999999999999999999954 68899999886432222 2234677899999999 999999999998654 36
Q ss_pred eEEEEecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccccccc
Q 002721 679 ALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKL 758 (888)
Q Consensus 679 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~ 758 (888)
.|+||||++ ++|.+++... .+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||.+..
T Consensus 84 ~~lv~e~~~-~~L~~~~~~~------~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~ 156 (337)
T cd07852 84 IYLVFEYME-TDLHAVIRAN------ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARS 156 (337)
T ss_pred EEEEecccc-cCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCCcEEEeeccchhc
Confidence 899999997 4999988753 456788889999999999999999999999999999999999999999999987
Q ss_pred cCCCCCc---ccccccccccceeccccccc-CCcCccccchhHHHHHHHHHhCCCCCCCCCCCccchhhhccccCCCC--
Q 002721 759 LDPSKGT---ASISAVAGSFGYIPPEYAYT-MQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARG-- 832 (888)
Q Consensus 759 ~~~~~~~---~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~-- 832 (888)
....... .......|+..|+|||.+.+ ..++.++||||||+++|+|++|+.||........ ..+.........
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~~-~~~~~~~~~~~~~~ 235 (337)
T cd07852 157 LSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQ-LEKIIEVIGPPSAE 235 (337)
T ss_pred cccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHHH-HHHHHHHhCCCCHH
Confidence 6533221 12234568899999998755 4578899999999999999999999965322110 001000000000
Q ss_pred -------CCcccccc----cccccCCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002721 833 -------ETPEQILD----ARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEM 881 (888)
Q Consensus 833 -------~~~~~~~~----~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~ 881 (888)
.....+.+ ...............++.+++.+||+.||++|||+.++++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rps~~~il~~ 295 (337)
T cd07852 236 DIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRLTAEEALEH 295 (337)
T ss_pred HHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCcccccCHHHHhhC
Confidence 00000000 00000000011134667899999999999999999999864
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-34 Score=305.48 Aligned_cols=257 Identities=19% Similarity=0.167 Sum_probs=198.0
Q ss_pred hcCCcceeeecccceEEEEEe----CCCcEEEEEEeeccChh-hhHHHHHHHHHHHHHhcc-CCCceeeeeeEEEeCCee
Q 002721 606 TMKDSNMIYCGTFSTVYKAVM----PSGLILSVKRLKSMDRT-IIHHQNKMIRELEKLSKL-CHDNLVRPIGFVIYEDVA 679 (888)
Q Consensus 606 ~~~~~~~ig~G~~g~Vy~~~~----~~~~~vavK~~~~~~~~-~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~ 679 (888)
+|++.+.||+|+||.||+|+. .+++.||+|+++..... .....+.+.+|++++.++ +||||+++++.+..++..
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 367789999999999999984 35788999998743222 122345688999999999 599999999999999999
Q ss_pred EEEEecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEecccccccc
Q 002721 680 LLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLL 759 (888)
Q Consensus 680 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~ 759 (888)
++||||+++++|.+++.... .+++..+..++.|+++||+|||+.|++||||||+||+++.++.++++|||++...
T Consensus 81 ~lv~e~~~~~~L~~~~~~~~-----~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~ 155 (288)
T cd05583 81 HLILDYVNGGELFTHLYQRE-----HFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEF 155 (288)
T ss_pred EEEEecCCCCcHHHHHhhcC-----CcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEEECcccccc
Confidence 99999999999999987542 4678889999999999999999999999999999999999999999999998765
Q ss_pred CCCCCcccccccccccceecccccccCC--cCccccchhHHHHHHHHHhCCCCCCCCCCCccchhhhccccCCCCCCccc
Q 002721 760 DPSKGTASISAVAGSFGYIPPEYAYTMQ--VTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQ 837 (888)
Q Consensus 760 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 837 (888)
...... ......|+..|+|||...+.. .+.++||||+|+++|||++|..||........ .......
T Consensus 156 ~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~-~~~~~~~---------- 223 (288)
T cd05583 156 LAEEEE-RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNS-QSEISRR---------- 223 (288)
T ss_pred cccccc-ccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccch-HHHHHHH----------
Confidence 433211 112345788999999987655 78899999999999999999999964321100 0000000
Q ss_pred ccccccccCCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 002721 838 ILDARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEMLQ 883 (888)
Q Consensus 838 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~ 883 (888)
+.. ............+.+++.+||+.||++|||+.++.+.|+
T Consensus 224 ~~~----~~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~ 265 (288)
T cd05583 224 ILK----SKPPFPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKN 265 (288)
T ss_pred HHc----cCCCCCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhc
Confidence 000 000011123356778999999999999999888876654
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-33 Score=306.74 Aligned_cols=271 Identities=20% Similarity=0.267 Sum_probs=198.0
Q ss_pred HHHHhcCCcceeeecccceEEEEEeC-CCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCC---
Q 002721 602 VVKATMKDSNMIYCGTFSTVYKAVMP-SGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYED--- 677 (888)
Q Consensus 602 ~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~--- 677 (888)
...++|++.+.||+|+||.||+|... +++.||+|+++..... ......+.+|++++++++||||+++++++.+..
T Consensus 4 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~~-~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~ 82 (302)
T cd07864 4 RCVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNEK-EGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDAL 82 (302)
T ss_pred hhhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeecccc-cCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhh
Confidence 45678999999999999999999964 6899999999754322 122236778999999999999999999987654
Q ss_pred -------eeEEEEecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceE
Q 002721 678 -------VALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLL 750 (888)
Q Consensus 678 -------~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl 750 (888)
..++|+||+++ ++.+.+.... ..+++..+..++.||+.||+|||+.||+||||||+||++++++.+||
T Consensus 83 ~~~~~~~~~~lv~e~~~~-~l~~~l~~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili~~~~~~kl 157 (302)
T cd07864 83 DFKKDKGAFYLVFEYMDH-DLMGLLESGL----VHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKL 157 (302)
T ss_pred hccccCCcEEEEEcccCc-cHHHHHhcCC----CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCcEEe
Confidence 78999999986 7777776542 15788999999999999999999999999999999999999999999
Q ss_pred eccccccccCCCCCcccccccccccceeccccccc-CCcCccccchhHHHHHHHHHhCCCCCCCCCCCccchhhh--ccc
Q 002721 751 GEIEISKLLDPSKGTASISAVAGSFGYIPPEYAYT-MQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKW--VHG 827 (888)
Q Consensus 751 ~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~--~~~ 827 (888)
+|||.+........ .......++..|+|||++.+ ..++.++||||+||++|||++|++||...... ..+... ...
T Consensus 158 ~dfg~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~~~-~~~~~~~~~~~ 235 (302)
T cd07864 158 ADFGLARLYNSEES-RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQEL-AQLELISRLCG 235 (302)
T ss_pred CcccccccccCCcc-cccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCChH-HHHHHHHHHhC
Confidence 99999987654322 11223346778999998764 35788999999999999999999999753211 001000 000
Q ss_pred cCCCCCCcc--cc-----ccccc---ccCCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002721 828 APARGETPE--QI-----LDARL---STVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVE 880 (888)
Q Consensus 828 ~~~~~~~~~--~~-----~~~~~---~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 880 (888)
.+.....+. +. .+... .............+.+++.+||+.||++||++.++++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~ 298 (302)
T cd07864 236 SPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRCTAEEALN 298 (302)
T ss_pred CCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 000000000 00 00000 0000001112456789999999999999999999875
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-36 Score=289.39 Aligned_cols=258 Identities=23% Similarity=0.281 Sum_probs=196.2
Q ss_pred HhcCCcceeeecccceEEEEE-eCCCcEEEEEEeeccChhhhHHHHHHHHHHHHHhcc-CCCceeeeeeEEEeCCeeEEE
Q 002721 605 ATMKDSNMIYCGTFSTVYKAV-MPSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKL-CHDNLVRPIGFVIYEDVALLL 682 (888)
Q Consensus 605 ~~~~~~~~ig~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~lv 682 (888)
+..+....||.|+||+|++-. .+.|+..|||+++.... ...++++..|.+...+- +.||||++||.+..++..|+.
T Consensus 64 ~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n~--~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiC 141 (361)
T KOG1006|consen 64 DNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNNI--EKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWIC 141 (361)
T ss_pred chHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeeccc--hHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeee
Confidence 344556789999999999998 45799999999986544 34556899999765544 799999999999999999999
Q ss_pred EecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhccc-CCeeecCCCCCCeEeCCCCCceEeccccccccCC
Q 002721 683 HNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHH-VAIIHLDISSGNVLLDADFKPLLGEIEISKLLDP 761 (888)
Q Consensus 683 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~~~ 761 (888)
||.|.- ++..+.+........++++.-.-.|....+.||.||-+ ..|||||+||+|||++..|.+|+||||++..+..
T Consensus 142 MELMd~-SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~ 220 (361)
T KOG1006|consen 142 MELMDI-SLDKLYKRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVD 220 (361)
T ss_pred HHHHhh-hHHHHHHHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChhheEEecCCCEeeecccchHhHHH
Confidence 999964 77665543322222356777777788889999999986 7999999999999999999999999999987654
Q ss_pred CCCcccccccccccceeccccccc--CCcCccccchhHHHHHHHHHhCCCCCCCCCCCccchhhhccccCCCCCCccccc
Q 002721 762 SKGTASISAVAGSFGYIPPEYAYT--MQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQIL 839 (888)
Q Consensus 762 ~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 839 (888)
+- ..+...|...|||||.+.. ..|+-++||||+|+++||+.||+.||..-.....++...+.+.++.
T Consensus 221 Si---AkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~-------- 289 (361)
T KOG1006|consen 221 SI---AKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVFEQLCQVVIGDPPI-------- 289 (361)
T ss_pred HH---HhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHHHHHHHHHcCCCCe--------
Confidence 32 2244578889999998863 3489999999999999999999999975332222222222222211
Q ss_pred ccccccCCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002721 840 DARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVE 880 (888)
Q Consensus 840 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 880 (888)
-............+..++..|+.+|-.+||...++.+
T Consensus 290 ----l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~ 326 (361)
T KOG1006|consen 290 ----LLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKK 326 (361)
T ss_pred ----ecCcccccccCHHHHHHHHHHhhcccccCcchhhhhc
Confidence 0111122345667888999999999999999998764
|
|
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=300.35 Aligned_cols=265 Identities=19% Similarity=0.211 Sum_probs=196.8
Q ss_pred cCCcceeeecccceEEEEEeC-CCcEEEEEEeeccChhhhHHHHHHHHHHHHHhcc---CCCceeeeeeEEEeCCe----
Q 002721 607 MKDSNMIYCGTFSTVYKAVMP-SGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKL---CHDNLVRPIGFVIYEDV---- 678 (888)
Q Consensus 607 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l---~hpnIv~~~~~~~~~~~---- 678 (888)
|++.+.||+|+||.||+|+.. +++.||+|+++..... ......+.+|+.+++++ .||||+++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~ 79 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLSE-EGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDREL 79 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEecccccc-chhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCc
Confidence 567889999999999999965 5899999999744332 22233566788777666 59999999999988776
Q ss_pred -eEEEEecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEecccccc
Q 002721 679 -ALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISK 757 (888)
Q Consensus 679 -~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~ 757 (888)
.+++|||+.+ +|.+++...... .+++..+..++.|+++||+|||+.+++|+||+|+||++++++.+|++|||.+.
T Consensus 80 ~~~l~~e~~~~-~l~~~l~~~~~~---~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~ 155 (287)
T cd07838 80 KLTLVFEHVDQ-DLATYLSKCPKP---GLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLAR 155 (287)
T ss_pred eeEEEehhccc-CHHHHHHHccCC---CCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCcce
Confidence 8999999975 899988764321 57899999999999999999999999999999999999999999999999998
Q ss_pred ccCCCCCcccccccccccceecccccccCCcCccccchhHHHHHHHHHhCCCCCCCCCCCccchhhhccccCC--CCCCc
Q 002721 758 LLDPSKGTASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPA--RGETP 835 (888)
Q Consensus 758 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~--~~~~~ 835 (888)
....... .....++..|+|||++.+..++.++|||||||++|||++|++||...... ....++...... .....
T Consensus 156 ~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~ 231 (287)
T cd07838 156 IYSFEMA---LTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEA-DQLDKIFDVIGLPSEEEWP 231 (287)
T ss_pred eccCCcc---cccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChH-HHHHHHHHHcCCCChHhcC
Confidence 7653321 12345788999999999889999999999999999999999998754321 111111110000 00000
Q ss_pred c------ccccccccc-CCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002721 836 E------QILDARLST-VSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVE 880 (888)
Q Consensus 836 ~------~~~~~~~~~-~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 880 (888)
. ......... ...........+.+++.+||+.||++||++.|++.
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~~~~il~ 283 (287)
T cd07838 232 RNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQ 283 (287)
T ss_pred CCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCCHHHHhc
Confidence 0 000000000 00011233467789999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-33 Score=303.15 Aligned_cols=252 Identities=22% Similarity=0.316 Sum_probs=193.7
Q ss_pred HhcCCcceeeecccceEEEEEeC-CCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccC-CCceeeeeeEEEeCCeeEEE
Q 002721 605 ATMKDSNMIYCGTFSTVYKAVMP-SGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLC-HDNLVRPIGFVIYEDVALLL 682 (888)
Q Consensus 605 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~~lv 682 (888)
++|++.+.||+|+||.||+|... +++.||||.++...... ....+.+|+.++.+.. ||||+++++++.++...|+|
T Consensus 15 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~~~--~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v 92 (296)
T cd06618 15 NDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKE--ENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFIC 92 (296)
T ss_pred chheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCChH--HHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEE
Confidence 56888999999999999999965 49999999997543322 2335677887776664 99999999999999999999
Q ss_pred EecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhccc-CCeeecCCCCCCeEeCCCCCceEeccccccccCC
Q 002721 683 HNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHH-VAIIHLDISSGNVLLDADFKPLLGEIEISKLLDP 761 (888)
Q Consensus 683 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~~~ 761 (888)
|||+++ ++.+++..... .+++..+..++.|++.|++|||+ .||+||||+|+||++++++.+||+|||.+.....
T Consensus 93 ~e~~~~-~l~~l~~~~~~----~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~ 167 (296)
T cd06618 93 MELMST-CLDKLLKRIQG----PIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVD 167 (296)
T ss_pred eeccCc-CHHHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHEEEcCCCCEEECccccchhccC
Confidence 999864 78777765332 57888999999999999999997 6999999999999999999999999999876543
Q ss_pred CCCcccccccccccceecccccccCC----cCccccchhHHHHHHHHHhCCCCCCCCCCCccchhhhccccCCCCCCccc
Q 002721 762 SKGTASISAVAGSFGYIPPEYAYTMQ----VTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQ 837 (888)
Q Consensus 762 ~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 837 (888)
... .....++..|+|||.+.+.. ++.++||||||+++|+|++|+.||.........+........
T Consensus 168 ~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~-------- 236 (296)
T cd06618 168 SKA---KTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEP-------- 236 (296)
T ss_pred CCc---ccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHHHHHHHHhcCCC--------
Confidence 221 12335778999999987554 788999999999999999999999653221111111111100
Q ss_pred ccccccccCCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002721 838 ILDARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEM 881 (888)
Q Consensus 838 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~ 881 (888)
...+ .......++.+++.+||+.||++||++.++++.
T Consensus 237 ------~~~~-~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~ 273 (296)
T cd06618 237 ------PSLP-PNEGFSPDFCSFVDLCLTKDHRKRPKYRELLQH 273 (296)
T ss_pred ------CCCC-CCCCCCHHHHHHHHHHccCChhhCCCHHHHhcC
Confidence 0000 001233567889999999999999999999764
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-34 Score=312.54 Aligned_cols=269 Identities=14% Similarity=0.174 Sum_probs=197.5
Q ss_pred HHhcCCcceeeecccceEEEEEe-CCCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeC-----C
Q 002721 604 KATMKDSNMIYCGTFSTVYKAVM-PSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYE-----D 677 (888)
Q Consensus 604 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~-----~ 677 (888)
..+|++.+.||+|+||+||+|+. .+++.||+|.++..... ......+.+|+.+++.++||||+++++++... .
T Consensus 4 ~~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~ 82 (337)
T cd07858 4 DTKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFDN-RIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFN 82 (337)
T ss_pred ccceeEEEEeccCCCeEEEEEEecCCCCeEEEEEecccccc-cchhHHHHHHHHHHHhcCCCCccchHHheecccccccC
Confidence 35789999999999999999994 46899999998753222 22234677899999999999999999988654 3
Q ss_pred eeEEEEecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEecccccc
Q 002721 678 VALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISK 757 (888)
Q Consensus 678 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~ 757 (888)
..|+||||+. ++|.+++.... .+++..+..++.|++.||.|||+++++||||||+||+++.++.+||+|||++.
T Consensus 83 ~~~lv~e~~~-~~L~~~~~~~~-----~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~ 156 (337)
T cd07858 83 DVYIVYELMD-TDLHQIIRSSQ-----TLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR 156 (337)
T ss_pred cEEEEEeCCC-CCHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCCCCEEECcCcccc
Confidence 5799999996 68998887543 57889999999999999999999999999999999999999999999999998
Q ss_pred ccCCCCCcccccccccccceeccccccc-CCcCccccchhHHHHHHHHHhCCCCCCCCCCCcc-c-hhhhccccCCC---
Q 002721 758 LLDPSKGTASISAVAGSFGYIPPEYAYT-MQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGV-D-LVKWVHGAPAR--- 831 (888)
Q Consensus 758 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~-~-~~~~~~~~~~~--- 831 (888)
...... .......++..|+|||.+.+ ..++.++|||||||++|+|++|+.||........ . ...........
T Consensus 157 ~~~~~~--~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (337)
T cd07858 157 TTSEKG--DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLG 234 (337)
T ss_pred ccCCCc--ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhh
Confidence 764332 11233467889999998765 4688999999999999999999999965321100 0 00000000000
Q ss_pred ---CCCcccccccccc----cCCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002721 832 ---GETPEQILDARLS----TVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEM 881 (888)
Q Consensus 832 ---~~~~~~~~~~~~~----~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~ 881 (888)
............. ...........++.+++.+||+.+|++|||++|+++.
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rps~~ell~h 291 (337)
T cd07858 235 FIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRITVEEALAH 291 (337)
T ss_pred hcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhccCHHHHHcC
Confidence 0000000000000 0000011235667899999999999999999999876
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-35 Score=283.60 Aligned_cols=272 Identities=19% Similarity=0.254 Sum_probs=201.0
Q ss_pred HHhcCCcceeeecccceEEEEEe-CCCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEe-------
Q 002721 604 KATMKDSNMIYCGTFSTVYKAVM-PSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIY------- 675 (888)
Q Consensus 604 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~------- 675 (888)
...|+...+||+|.||+||+|+. .+|+.||+|++-- +...........+|++++..++|+|++.+++.|..
T Consensus 16 ~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlm-eneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r 94 (376)
T KOG0669|consen 16 VSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLM-ENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNR 94 (376)
T ss_pred chHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHH-hccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCccc
Confidence 34677788999999999999994 4688899886642 11112223367899999999999999999988764
Q ss_pred -CCeeEEEEecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccc
Q 002721 676 -EDVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIE 754 (888)
Q Consensus 676 -~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg 754 (888)
....|+|+++|+. +|..++..... +++..++.+++.++..||.|+|+..|+|||+||+|+||+.+|.+||+|||
T Consensus 95 ~r~t~ylVf~~ceh-DLaGlLsn~~v----r~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmKaaNvLIt~dgilklADFG 169 (376)
T KOG0669|consen 95 DRATFYLVFDFCEH-DLAGLLSNRKV----RFSLSEIKKVMKGLMNGLYYIHRNKILHRDMKAANVLITKDGILKLADFG 169 (376)
T ss_pred ccceeeeeHHHhhh-hHHHHhcCccc----cccHHHHHHHHHHHHHHHHHHHHhhHHhhcccHhhEEEcCCceEEeeccc
Confidence 2358999999987 99988876532 68889999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCc--ccccccccccceecccccccC-CcCccccchhHHHHHHHHHhCCCCCCCCCCCc-cchhhhccccCC
Q 002721 755 ISKLLDPSKGT--ASISAVAGSFGYIPPEYAYTM-QVTAPGNVYSYGVVLLEILTTRLPVEEDFGEG-VDLVKWVHGAPA 830 (888)
Q Consensus 755 ~a~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~P~~~~~~~~-~~~~~~~~~~~~ 830 (888)
+++.+...+.. ..++..+-|.+|++||.+.+. .|+++.|||..|||+.||+||.+-+++.+... ..+++...+...
T Consensus 170 lar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is~LcGs~t 249 (376)
T KOG0669|consen 170 LARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSIT 249 (376)
T ss_pred cccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHHHHhccCC
Confidence 99876543322 224556779999999988765 69999999999999999999998887654321 222332222222
Q ss_pred CCCCccccccccc-----ccCCc----CcHHH------HHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002721 831 RGETPEQILDARL-----STVSF----GWRKE------MLTALKVALLCTDSTPAKRPKMKKVVEM 881 (888)
Q Consensus 831 ~~~~~~~~~~~~~-----~~~~~----~~~~~------~~~~~~li~~cl~~dP~~RPs~~evl~~ 881 (888)
.+.++.-.--+.. .+.+. ..... .+++.+++.+++..||.+|++++++++.
T Consensus 250 kevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh 315 (376)
T KOG0669|consen 250 KEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNH 315 (376)
T ss_pred cccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhch
Confidence 2222211000000 00000 00111 2367889999999999999999998864
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-34 Score=300.84 Aligned_cols=245 Identities=20% Similarity=0.278 Sum_probs=206.1
Q ss_pred cceeeecccceEEEEE-eCCCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCCeeEEEEecCCC
Q 002721 610 SNMIYCGTFSTVYKAV-MPSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVALLLHNYLPN 688 (888)
Q Consensus 610 ~~~ig~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~ 688 (888)
.+.+|+|.||+||-|+ .++|+.||||++.+..-.. +....++.|++|+.+++||.||.+.-.|+..+..++|||-+.|
T Consensus 569 devLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~-kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~G 647 (888)
T KOG4236|consen 569 DEVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPT-KQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHG 647 (888)
T ss_pred HhhccCCcceeeecceecccCceeeeeeeecccCCC-chHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcc
Confidence 5789999999999999 5579999999998544332 3335899999999999999999999999999999999999965
Q ss_pred CCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCC---CCceEeccccccccCCCCCc
Q 002721 689 GTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDAD---FKPLLGEIEISKLLDPSKGT 765 (888)
Q Consensus 689 g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~---~~~kl~Dfg~a~~~~~~~~~ 765 (888)
|..++|-..... ++++.....++.||+.||.|||.++|+|+||||+|||+.+. -++||+|||+|+.+....
T Consensus 648 -DMLEMILSsEkg---RL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEks-- 721 (888)
T KOG4236|consen 648 -DMLEMILSSEKG---RLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKS-- 721 (888)
T ss_pred -hHHHHHHHhhcc---cchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCceeeccccceeecchhh--
Confidence 666665543332 67888888899999999999999999999999999999643 469999999999987543
Q ss_pred ccccccccccceecccccccCCcCccccchhHHHHHHHHHhCCCCCCCCCCCccchhhhccccCCCCCCccccccccccc
Q 002721 766 ASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQILDARLST 845 (888)
Q Consensus 766 ~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 845 (888)
....++||+.|.|||++....|...-|+||.|+|+|--++|..||.++. ...+++....+..
T Consensus 722 -FRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdE-----------------dIndQIQNAaFMy 783 (888)
T KOG4236|consen 722 -FRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDE-----------------DINDQIQNAAFMY 783 (888)
T ss_pred -hhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCcc-----------------chhHHhhcccccc
Confidence 2346789999999999999999999999999999999999999998642 2334455555556
Q ss_pred CCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHH
Q 002721 846 VSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVV 879 (888)
Q Consensus 846 ~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl 879 (888)
.+..|.+....++++|...++..-.+|.|.++.+
T Consensus 784 Pp~PW~eis~~AidlIn~LLqVkm~kRysvdk~l 817 (888)
T KOG4236|consen 784 PPNPWSEISPEAIDLINNLLQVKMRKRYSVDKSL 817 (888)
T ss_pred CCCchhhcCHHHHHHHHHHHHHHHHHhcchHhhc
Confidence 6678899999999999999999999999987654
|
|
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-33 Score=299.90 Aligned_cols=264 Identities=19% Similarity=0.271 Sum_probs=196.2
Q ss_pred cCCcceeeecccceEEEEEeC-CCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccC-CCceeeeeeEEEeCCeeEEEEe
Q 002721 607 MKDSNMIYCGTFSTVYKAVMP-SGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLC-HDNLVRPIGFVIYEDVALLLHN 684 (888)
Q Consensus 607 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~~lv~e 684 (888)
|++.+.||+|+||+||+|+.. +++.||+|++....... ......+|+..+++++ ||||+++++++..++..++|||
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e 78 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYSW--EECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFE 78 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccch--hHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEe
Confidence 567889999999999999965 58899999987543321 1224567999999998 9999999999999999999999
Q ss_pred cCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccccccccCCCCC
Q 002721 685 YLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSKG 764 (888)
Q Consensus 685 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 764 (888)
|+ +|++.+++..... ..+++.++..++.|++.||.|||++|++|+||+|+||++++++.++|+|||.+........
T Consensus 79 ~~-~~~l~~~~~~~~~---~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~ 154 (283)
T cd07830 79 YM-EGNLYQLMKDRKG---KPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPP 154 (283)
T ss_pred cC-CCCHHHHHHhccc---ccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCCEEEeecccceeccCCCC
Confidence 99 7799999876542 2578899999999999999999999999999999999999999999999999987643221
Q ss_pred cccccccccccceecccccc-cCCcCccccchhHHHHHHHHHhCCCCCCCCCCCccc--hhhhccccCCCCCCc-----c
Q 002721 765 TASISAVAGSFGYIPPEYAY-TMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVD--LVKWVHGAPARGETP-----E 836 (888)
Q Consensus 765 ~~~~~~~~gt~~y~aPE~~~-~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~--~~~~~~~~~~~~~~~-----~ 836 (888)
.....++..|+|||++. +..++.++||||||+++|||++|+.||......... ...... .+...... .
T Consensus 155 ---~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~ 230 (283)
T cd07830 155 ---YTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLG-TPTKQDWPEGYKLA 230 (283)
T ss_pred ---cCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHhcC-CCChhhhhhHhhhh
Confidence 22346788999999875 445789999999999999999999999654321110 000000 00000000 0
Q ss_pred cccccccccCCcC-----cHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002721 837 QILDARLSTVSFG-----WRKEMLTALKVALLCTDSTPAKRPKMKKVVE 880 (888)
Q Consensus 837 ~~~~~~~~~~~~~-----~~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 880 (888)
...+......... .......+.+++.+||+.||++|||++|++.
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 279 (283)
T cd07830 231 SKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQALQ 279 (283)
T ss_pred ccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHHHhh
Confidence 0000000000000 0112466889999999999999999999975
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-33 Score=307.30 Aligned_cols=270 Identities=20% Similarity=0.260 Sum_probs=193.9
Q ss_pred HHhcCCcceeeecccceEEEEEe-CCCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCC-----
Q 002721 604 KATMKDSNMIYCGTFSTVYKAVM-PSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYED----- 677 (888)
Q Consensus 604 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~----- 677 (888)
.++|+..+.||+|+||.||+|+. .+++.||+|++....... .....+.+|++++++++||||+++++++....
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~ 85 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEKD-GFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKR 85 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCCC-CcchhHHHHHHHHHhcCCCCccchhhheecccccccc
Confidence 46899999999999999999995 468999999986443221 11235678999999999999999999875433
Q ss_pred ---eeEEEEecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccc
Q 002721 678 ---VALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIE 754 (888)
Q Consensus 678 ---~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg 754 (888)
..++||||+++ ++.+.+.... ..+++.++..++.|+++||+|||++||+||||||+||++++++.++++|||
T Consensus 86 ~~~~~~lv~~~~~~-~l~~~~~~~~----~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg 160 (311)
T cd07866 86 KRGSVYMVTPYMDH-DLSGLLENPS----VKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFG 160 (311)
T ss_pred cCceEEEEEecCCc-CHHHHHhccc----cCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCCEEECcCc
Confidence 46999999975 7777776432 257899999999999999999999999999999999999999999999999
Q ss_pred cccccCCCCCc---------ccccccccccceecccccccC-CcCccccchhHHHHHHHHHhCCCCCCCCCCCcc--chh
Q 002721 755 ISKLLDPSKGT---------ASISAVAGSFGYIPPEYAYTM-QVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGV--DLV 822 (888)
Q Consensus 755 ~a~~~~~~~~~---------~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~--~~~ 822 (888)
++......... .......+++.|+|||.+.+. .++.++||||+||++|||++|++||........ ...
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~ 240 (311)
T cd07866 161 LARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIF 240 (311)
T ss_pred cchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 99865432211 112234578889999987654 588999999999999999999999975332110 000
Q ss_pred hhccccCCCCCCc-----ccccc-cccccCCc----CcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002721 823 KWVHGAPARGETP-----EQILD-ARLSTVSF----GWRKEMLTALKVALLCTDSTPAKRPKMKKVVE 880 (888)
Q Consensus 823 ~~~~~~~~~~~~~-----~~~~~-~~~~~~~~----~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 880 (888)
.... .+...... ....+ ......+. ........+.+++.+|+..||++|||+.|++.
T Consensus 241 ~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~t~~ell~ 307 (311)
T cd07866 241 KLCG-TPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRLTASDALE 307 (311)
T ss_pred HHhC-CCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCcCHHHHhc
Confidence 0000 00000000 00000 00000000 01112256789999999999999999999875
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=297.53 Aligned_cols=253 Identities=19% Similarity=0.180 Sum_probs=194.9
Q ss_pred hcCCcceeeecccceEEEEEeC-CCcEEEEEEeeccChh--hhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCCeeEEE
Q 002721 606 TMKDSNMIYCGTFSTVYKAVMP-SGLILSVKRLKSMDRT--IIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVALLL 682 (888)
Q Consensus 606 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 682 (888)
+|.+.+.||+|+||.||+++.. .+..+++|.++..... ......++.+|+.++++++||||+++++++.+.+..++|
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv 80 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCII 80 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEE
Confidence 5788899999999999999854 3555666666532221 112223577899999999999999999999999999999
Q ss_pred EecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccccccccCCC
Q 002721 683 HNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPS 762 (888)
Q Consensus 683 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 762 (888)
|||+++++|.+++....... ..+++.+++.++.|+++||+|||+.|++|+||||+||++++ +.++++|||.+......
T Consensus 81 ~e~~~~~~l~~~~~~~~~~~-~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~ 158 (260)
T cd08222 81 TEYCEGRDLDCKLEELKHTG-KTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGS 158 (260)
T ss_pred EEeCCCCCHHHHHHHHhhcc-cccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-CCEeecccCceeecCCC
Confidence 99999999999987543222 26789999999999999999999999999999999999975 57999999998776432
Q ss_pred CCcccccccccccceecccccccCCcCccccchhHHHHHHHHHhCCCCCCCCCCCccchhhhccccCCCCCCcccccccc
Q 002721 763 KGTASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQILDAR 842 (888)
Q Consensus 763 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 842 (888)
.. ......|+..|+|||...+..++.++|+||+|+++|+|++|..||...... ..... +....
T Consensus 159 ~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~--~~~~~-------------~~~~~ 221 (260)
T cd08222 159 CD--LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFL--SVVLR-------------IVEGP 221 (260)
T ss_pred cc--cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHH--HHHHH-------------HHcCC
Confidence 21 122345788999999988888899999999999999999999999643211 00000 00000
Q ss_pred cccCCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002721 843 LSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVE 880 (888)
Q Consensus 843 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 880 (888)
... .......++.+++.+||+.+|++||++.|+++
T Consensus 222 ~~~---~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~ 256 (260)
T cd08222 222 TPS---LPETYSRQLNSIMQSMLNKDPSLRPSAAEILR 256 (260)
T ss_pred CCC---CcchhcHHHHHHHHHHhcCChhhCcCHHHHhh
Confidence 000 11233457788999999999999999999986
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-33 Score=307.78 Aligned_cols=270 Identities=16% Similarity=0.217 Sum_probs=196.3
Q ss_pred HHhcC-CcceeeecccceEEEEEeC-CCcEEEEEEeeccChhhhH-----------HHHHHHHHHHHHhccCCCceeeee
Q 002721 604 KATMK-DSNMIYCGTFSTVYKAVMP-SGLILSVKRLKSMDRTIIH-----------HQNKMIRELEKLSKLCHDNLVRPI 670 (888)
Q Consensus 604 ~~~~~-~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~-----------~~~~~~~E~~~l~~l~hpnIv~~~ 670 (888)
.++|. ..+.||+|+||+||+|... +++.||+|.++........ ....+.+|++++++++||||++++
T Consensus 7 ~~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~ 86 (335)
T PTZ00024 7 SERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLV 86 (335)
T ss_pred ccchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeee
Confidence 34565 4578999999999999954 6999999998744322100 012477899999999999999999
Q ss_pred eEEEeCCeeEEEEecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceE
Q 002721 671 GFVIYEDVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLL 750 (888)
Q Consensus 671 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl 750 (888)
+++..++..++||||++ |+|.+++.... .+++..+..++.|++.||+|||++|++||||||+||+++.++.+++
T Consensus 87 ~~~~~~~~~~lv~e~~~-~~l~~~l~~~~-----~~~~~~~~~~~~ql~~aL~~LH~~~i~H~dl~~~nill~~~~~~kl 160 (335)
T PTZ00024 87 DVYVEGDFINLVMDIMA-SDLKKVVDRKI-----RLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKI 160 (335)
T ss_pred EEEecCCcEEEEEeccc-cCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHHeEECCCCCEEE
Confidence 99999999999999997 59999987533 4678899999999999999999999999999999999999999999
Q ss_pred eccccccccCCCC------------CcccccccccccceecccccccC-CcCccccchhHHHHHHHHHhCCCCCCCCCCC
Q 002721 751 GEIEISKLLDPSK------------GTASISAVAGSFGYIPPEYAYTM-QVTAPGNVYSYGVVLLEILTTRLPVEEDFGE 817 (888)
Q Consensus 751 ~Dfg~a~~~~~~~------------~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~P~~~~~~~ 817 (888)
+|||.+....... .........++..|+|||.+.+. .++.++||||+||++|||++|+.||......
T Consensus 161 ~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~~ 240 (335)
T PTZ00024 161 ADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEI 240 (335)
T ss_pred CCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 9999987654110 01112233567889999988764 4688999999999999999999999754322
Q ss_pred ccchhhhc--cccCCCCCCccccccc----ccccCCcC----cHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002721 818 GVDLVKWV--HGAPARGETPEQILDA----RLSTVSFG----WRKEMLTALKVALLCTDSTPAKRPKMKKVVE 880 (888)
Q Consensus 818 ~~~~~~~~--~~~~~~~~~~~~~~~~----~~~~~~~~----~~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 880 (888)
.. +.... .+.+.....+.....+ .....+.. ......++.+++.+|++.+|++|||++|++.
T Consensus 241 ~~-~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~~~l~ 312 (335)
T PTZ00024 241 DQ-LGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERISAKEALK 312 (335)
T ss_pred HH-HHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhccCHHHHhc
Confidence 11 10000 0011110000000000 00000000 1112456789999999999999999999985
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=285.98 Aligned_cols=265 Identities=21% Similarity=0.257 Sum_probs=210.2
Q ss_pred HHHHhcCCcceeeecccceEEEEEeC------CCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEe
Q 002721 602 VVKATMKDSNMIYCGTFSTVYKAVMP------SGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIY 675 (888)
Q Consensus 602 ~~~~~~~~~~~ig~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~ 675 (888)
+.+++++...++-+|.||.||+|.+. +.+.|-+|.++..... -+...+..|.-.+....|||+.++.+++.+
T Consensus 281 v~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~AS~--iQv~~~L~es~lly~~sH~nll~V~~V~ie 358 (563)
T KOG1024|consen 281 VQRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQHASQ--IQVNLLLQESMLLYGASHPNLLSVLGVSIE 358 (563)
T ss_pred hhhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhcccH--HHHHHHHHHHHHHhcCcCCCccceeEEEee
Confidence 55677888889999999999999643 3456777877644332 334578899999999999999999999876
Q ss_pred C-CeeEEEEecCCCCCHHHHhhccCCC---CCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEe
Q 002721 676 E-DVALLLHNYLPNGTLAQLLHESTKQ---PDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLG 751 (888)
Q Consensus 676 ~-~~~~lv~e~~~~g~L~~~l~~~~~~---~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~ 751 (888)
+ +..++++.++.-|+|..++...+.. ....++-.+...++.|++.|++|||++||||.||..+|.+||+.-++|++
T Consensus 359 ~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~ViHkDiAaRNCvIdd~LqVklt 438 (563)
T KOG1024|consen 359 DYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGVIHKDIAARNCVIDDQLQVKLT 438 (563)
T ss_pred ccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCcccchhhhhcceehhheeEEec
Confidence 4 5778999999999999999833221 12245667888999999999999999999999999999999999999999
Q ss_pred ccccccccCCCCCcccccccccccceecccccccCCcCccccchhHHHHHHHHHh-CCCCCCCCCCCccchhhhccccCC
Q 002721 752 EIEISKLLDPSKGTASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILT-TRLPVEEDFGEGVDLVKWVHGAPA 830 (888)
Q Consensus 752 Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~~~~~~~~~~~~~~~~~~ 830 (888)
|=.+++.+-+.+...-.........||+||.+....|+.++||||||+++|||+| |+.||.+..+.++. .+
T Consensus 439 DsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~PyaeIDPfEm~--~y------ 510 (563)
T KOG1024|consen 439 DSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKLPYAEIDPFEME--HY------ 510 (563)
T ss_pred cchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCCCccccCHHHHH--HH------
Confidence 9999998776655444444556778999999999999999999999999999999 99999875443221 11
Q ss_pred CCCCcccccccccccCCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhh
Q 002721 831 RGETPEQILDARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEMLQEIK 886 (888)
Q Consensus 831 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~i~ 886 (888)
+.|+..-. ++...+.+++.+|..||+..|++||+++|++..|.++.
T Consensus 511 -------lkdGyRla---QP~NCPDeLf~vMacCWallpeeRPsf~Qlv~cLseF~ 556 (563)
T KOG1024|consen 511 -------LKDGYRLA---QPFNCPDELFTVMACCWALLPEERPSFSQLVICLSEFH 556 (563)
T ss_pred -------Hhccceec---CCCCCcHHHHHHHHHHHhcCcccCCCHHHHHHHHHHHH
Confidence 11211111 12234567889999999999999999999999998763
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-33 Score=330.84 Aligned_cols=148 Identities=23% Similarity=0.227 Sum_probs=132.9
Q ss_pred HhcCCcceeeecccceEEEEEeC-CCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCCeeEEEE
Q 002721 605 ATMKDSNMIYCGTFSTVYKAVMP-SGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVALLLH 683 (888)
Q Consensus 605 ~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 683 (888)
++|.+.+.||+|+||+||+|... +++.||+|+++............+.+|+.+++.++||||+++++++...+..|+||
T Consensus 4 ~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVm 83 (669)
T cd05610 4 EEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVM 83 (669)
T ss_pred CCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEE
Confidence 47889999999999999999965 68999999998654444444567889999999999999999999999999999999
Q ss_pred ecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEecccccc
Q 002721 684 NYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISK 757 (888)
Q Consensus 684 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~ 757 (888)
||+++++|.+++.... .+++..++.|+.||+.||+|||++||+||||||+|||++.++.+||+|||+++
T Consensus 84 Ey~~g~~L~~li~~~~-----~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 84 EYLIGGDVKSLLHIYG-----YFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred eCCCCCCHHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 9999999999997643 46778899999999999999999999999999999999999999999999886
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-33 Score=309.72 Aligned_cols=264 Identities=17% Similarity=0.220 Sum_probs=195.7
Q ss_pred HHHhcCCcceeeecccceEEEEE-eCCCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCC----
Q 002721 603 VKATMKDSNMIYCGTFSTVYKAV-MPSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYED---- 677 (888)
Q Consensus 603 ~~~~~~~~~~ig~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~---- 677 (888)
..++|++.+.||+|+||.||+|. ..+++.||+|+++.... .......+.+|++++++++||||+++++++..+.
T Consensus 13 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07880 13 VPDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPFQ-SELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDR 91 (343)
T ss_pred cccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEeccccc-chHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccc
Confidence 45689999999999999999998 45799999999864322 2233446889999999999999999999987653
Q ss_pred --eeEEEEecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEecccc
Q 002721 678 --VALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEI 755 (888)
Q Consensus 678 --~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~ 755 (888)
..++||||+ +++|.+++... .+++..+..++.||++||+|||+.||+||||||+||+++.++.++++|||+
T Consensus 92 ~~~~~lv~e~~-~~~l~~~~~~~------~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~Nill~~~~~~kl~dfg~ 164 (343)
T cd07880 92 FHDFYLVMPFM-GTDLGKLMKHE------KLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGL 164 (343)
T ss_pred cceEEEEEecC-CCCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeccc
Confidence 458999999 67999888642 568899999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCcccccccccccceeccccccc-CCcCccccchhHHHHHHHHHhCCCCCCCCCCCccchhhhccccCCCC--
Q 002721 756 SKLLDPSKGTASISAVAGSFGYIPPEYAYT-MQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARG-- 832 (888)
Q Consensus 756 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~-- 832 (888)
+....... ....+++.|+|||.+.+ ..++.++||||+|+++|++++|+.||....... .............
T Consensus 165 ~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~ 238 (343)
T cd07880 165 ARQTDSEM-----TGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLD-QLMEIMKVTGTPSKE 238 (343)
T ss_pred ccccccCc-----cccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHhcCCCCHH
Confidence 88654321 23457889999998875 458889999999999999999999997542211 0111000000000
Q ss_pred -------CCcccccccc--cc--cCCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002721 833 -------ETPEQILDAR--LS--TVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVE 880 (888)
Q Consensus 833 -------~~~~~~~~~~--~~--~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 880 (888)
.......... .. ...........++.+++.+|++.||++|||+.++++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~t~~~~l~ 297 (343)
T cd07880 239 FVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRITAAEALA 297 (343)
T ss_pred HHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCCCHHHHhc
Confidence 0000000000 00 000001122345789999999999999999999983
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-33 Score=292.80 Aligned_cols=239 Identities=22% Similarity=0.223 Sum_probs=193.6
Q ss_pred eeecccceEEEEEeC-CCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCCeeEEEEecCCCCCH
Q 002721 613 IYCGTFSTVYKAVMP-SGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVALLLHNYLPNGTL 691 (888)
Q Consensus 613 ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L 691 (888)
||+|+||.||++... +++.||+|++...........+.+..|++++++++||||+++++.+..++..++||||+++++|
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L 80 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGEL 80 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcH
Confidence 689999999999954 5899999998765444334456788999999999999999999999999999999999999999
Q ss_pred HHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccccccccCCCCCccccccc
Q 002721 692 AQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSKGTASISAV 771 (888)
Q Consensus 692 ~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~ 771 (888)
.+++.... .+++..+..++.|++.|+.|+|+.+++|+||+|+||+++.++.++++|||.+....... ......
T Consensus 81 ~~~l~~~~-----~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~ 153 (250)
T cd05123 81 FSHLSKEG-----RFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG--SRTNTF 153 (250)
T ss_pred HHHHHhcC-----CCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCC--CcccCC
Confidence 99997653 46788999999999999999999999999999999999999999999999988765432 122345
Q ss_pred ccccceecccccccCCcCccccchhHHHHHHHHHhCCCCCCCCCCCccchhhhccccCCCCCCcccccccccccCCcCcH
Q 002721 772 AGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQILDARLSTVSFGWR 851 (888)
Q Consensus 772 ~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 851 (888)
.++..|+|||...+...+.++|+||||+++|++++|+.||..... ........ ..... ...
T Consensus 154 ~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~--~~~~~~~~-------------~~~~~----~~~ 214 (250)
T cd05123 154 CGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDR--KEIYEKIL-------------KDPLR----FPE 214 (250)
T ss_pred cCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCH--HHHHHHHh-------------cCCCC----CCC
Confidence 678899999999888889999999999999999999999965321 11111110 00000 011
Q ss_pred HHHHHHHHHHhhccCCCCCCCCCHHH
Q 002721 852 KEMLTALKVALLCTDSTPAKRPKMKK 877 (888)
Q Consensus 852 ~~~~~~~~li~~cl~~dP~~RPs~~e 877 (888)
.....+.+++.+||..||++||++.+
T Consensus 215 ~~~~~l~~~i~~~l~~~p~~R~~~~~ 240 (250)
T cd05123 215 FLSPEARDLISGLLQKDPTKRLGSGG 240 (250)
T ss_pred CCCHHHHHHHHHHhcCCHhhCCCccc
Confidence 11456778999999999999999944
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-33 Score=306.61 Aligned_cols=268 Identities=16% Similarity=0.237 Sum_probs=201.4
Q ss_pred hcCCcceeeecccceEEEEEeC-CCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCC-----ee
Q 002721 606 TMKDSNMIYCGTFSTVYKAVMP-SGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYED-----VA 679 (888)
Q Consensus 606 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-----~~ 679 (888)
+|++.+.||+|+||.||+|+.. +++.||+|++..... .....+.+.+|+++++.++||||+++++++...+ ..
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~ 79 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVFD-DLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDV 79 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeeccccc-cchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccce
Confidence 4788999999999999999964 589999999875432 1233457889999999999999999999988775 78
Q ss_pred EEEEecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEecccccccc
Q 002721 680 LLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLL 759 (888)
Q Consensus 680 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~ 759 (888)
|+||||+++ +|.+++.... .+++..+..++.|++.||+|||++||+||||||+||+++.++.++|+|||.+...
T Consensus 80 ~lv~e~~~~-~l~~~l~~~~-----~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~ 153 (330)
T cd07834 80 YIVTELMET-DLHKVIKSPQ-----PLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGV 153 (330)
T ss_pred EEEecchhh-hHHHHHhCCC-----CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEcccCceEee
Confidence 999999984 8998887543 5788999999999999999999999999999999999999999999999999876
Q ss_pred CCCCCc-ccccccccccceecccccccC-CcCccccchhHHHHHHHHHhCCCCCCCCCCCcc--chhhhccccCCCC---
Q 002721 760 DPSKGT-ASISAVAGSFGYIPPEYAYTM-QVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGV--DLVKWVHGAPARG--- 832 (888)
Q Consensus 760 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~--~~~~~~~~~~~~~--- 832 (888)
...... .......++..|+|||++.+. .++.++||||+|+++|+|++|+.||........ ...... +.+...
T Consensus 154 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~-~~~~~~~~~ 232 (330)
T cd07834 154 DPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLNLIVEVL-GTPSEEDLK 232 (330)
T ss_pred cccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHHhc-CCCChhHhh
Confidence 543210 112345678899999999887 789999999999999999999999976432110 000000 000000
Q ss_pred ----CCcccccccccccCCc----CcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002721 833 ----ETPEQILDARLSTVSF----GWRKEMLTALKVALLCTDSTPAKRPKMKKVVEM 881 (888)
Q Consensus 833 ----~~~~~~~~~~~~~~~~----~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~ 881 (888)
................ ........+.+++.+||+.+|++||+++++++.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~ll~~ 289 (330)
T cd07834 233 FITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRITADEALAH 289 (330)
T ss_pred hccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCCCHHHHHhC
Confidence 0000000000000000 011134667899999999999999999999874
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-33 Score=296.70 Aligned_cols=263 Identities=19% Similarity=0.230 Sum_probs=198.5
Q ss_pred cCCcceeeecccceEEEEEeC-CCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCCeeEEEEec
Q 002721 607 MKDSNMIYCGTFSTVYKAVMP-SGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVALLLHNY 685 (888)
Q Consensus 607 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 685 (888)
|+..+.||+|+||.||+|+.. +++.||+|.++... ......+.+.+|++++++++||||+++++++...+..++||||
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~ 79 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDN-EEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEY 79 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEecccc-ccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecC
Confidence 566788999999999999954 59999999998543 1222344778899999999999999999999999999999999
Q ss_pred CCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccccccccCCCCCc
Q 002721 686 LPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSKGT 765 (888)
Q Consensus 686 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 765 (888)
++ ++|.+++..... .+++..+..++.|++.||+|||+.||+||||+|+||++++++.++|+|||.+........
T Consensus 80 ~~-~~l~~~i~~~~~----~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~- 153 (282)
T cd07829 80 CD-MDLKKYLDKRPG----PLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR- 153 (282)
T ss_pred cC-cCHHHHHHhhcc----CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCCcc-
Confidence 98 599999987531 578899999999999999999999999999999999999999999999999987653321
Q ss_pred ccccccccccceecccccccC-CcCccccchhHHHHHHHHHhCCCCCCCCCCCcc--chhhhcc-----------ccCCC
Q 002721 766 ASISAVAGSFGYIPPEYAYTM-QVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGV--DLVKWVH-----------GAPAR 831 (888)
Q Consensus 766 ~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~--~~~~~~~-----------~~~~~ 831 (888)
......++..|+|||.+.+. .++.++||||+|+++||+++|+.||........ ....... .....
T Consensus 154 -~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 232 (282)
T cd07829 154 -TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDY 232 (282)
T ss_pred -ccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccc
Confidence 12234567789999988766 789999999999999999999999975432110 0000000 00000
Q ss_pred CCCcccccccccccCCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002721 832 GETPEQILDARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVE 880 (888)
Q Consensus 832 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 880 (888)
............. .........+.+++.+||+.||++||++.+++.
T Consensus 233 ~~~~~~~~~~~~~---~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~l~ 278 (282)
T cd07829 233 KPTFPKFPPKDLE---KVLPRLDPEGIDLLSKMLQYNPAKRISAKEALK 278 (282)
T ss_pred cccccccCccchH---HhcccccHHHHHHHHHhhccCcccCCCHHHHhh
Confidence 0000000000000 001112457889999999999999999999975
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-35 Score=303.76 Aligned_cols=246 Identities=20% Similarity=0.173 Sum_probs=205.7
Q ss_pred HHhcCCcceeeecccceEEEEEeCC-CcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCCeeEEE
Q 002721 604 KATMKDSNMIYCGTFSTVYKAVMPS-GLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVALLL 682 (888)
Q Consensus 604 ~~~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 682 (888)
-.+++.+..+|-|+||.|=.++... ...+|+|.+++.......+++.+..|-.+|.+++.|.||++|..|.+..+.|+.
T Consensus 419 l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmL 498 (732)
T KOG0614|consen 419 LSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYML 498 (732)
T ss_pred hhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhh
Confidence 4466778889999999999998544 335999999887777777778899999999999999999999999999999999
Q ss_pred EecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccccccccCCC
Q 002721 683 HNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPS 762 (888)
Q Consensus 683 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 762 (888)
||-|-||.++..++.++. ++......++..+++|++|||++|||+|||||+|.+++.+|-+||.|||+|+.+..+
T Consensus 499 mEaClGGElWTiLrdRg~-----Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g 573 (732)
T KOG0614|consen 499 MEACLGGELWTILRDRGS-----FDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSG 573 (732)
T ss_pred HHhhcCchhhhhhhhcCC-----cccchhhhhHHHHHHHHHHHHhcCceeccCChhheeeccCCceEEeehhhHHHhccC
Confidence 999999999999998764 556788889999999999999999999999999999999999999999999998765
Q ss_pred CCcccccccccccceecccccccCCcCccccchhHHHHHHHHHhCCCCCCCCCCCccchhhhccccCCCCCCcccccccc
Q 002721 763 KGTASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQILDAR 842 (888)
Q Consensus 763 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 842 (888)
.. .-.++||+.|.|||++.+...+.++|.||+|+++||+++|.+||....+- .+...++...
T Consensus 574 ~K---TwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpm---------------ktYn~ILkGi 635 (732)
T KOG0614|consen 574 RK---TWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPM---------------KTYNLILKGI 635 (732)
T ss_pred Cc---eeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchH---------------HHHHHHHhhh
Confidence 53 34689999999999999999999999999999999999999999864221 1111122111
Q ss_pred cccCCcCcHHHHHHHHHHHhhccCCCCCCCCC
Q 002721 843 LSTVSFGWRKEMLTALKVALLCTDSTPAKRPK 874 (888)
Q Consensus 843 ~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs 874 (888)
- ... .++.....+.++|++.++.+|.+|.-
T Consensus 636 d-~i~-~Pr~I~k~a~~Lik~LCr~~P~ERLG 665 (732)
T KOG0614|consen 636 D-KIE-FPRRITKTATDLIKKLCRDNPTERLG 665 (732)
T ss_pred h-hhh-cccccchhHHHHHHHHHhcCcHhhhc
Confidence 0 000 12345566778999999999999975
|
|
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-33 Score=307.55 Aligned_cols=267 Identities=16% Similarity=0.237 Sum_probs=194.3
Q ss_pred HHhcCCcceeeecccceEEEEEe-CCCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCC-----
Q 002721 604 KATMKDSNMIYCGTFSTVYKAVM-PSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYED----- 677 (888)
Q Consensus 604 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~----- 677 (888)
..+|...+.||+|+||.||+|+. .+|+.||+|+++..... ......+.+|++++++++||||+++++++....
T Consensus 14 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~ 92 (342)
T cd07879 14 PERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQS-EIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEF 92 (342)
T ss_pred ccceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCcccc-ccchhHHHHHHHHHHhcCCCCccchhheecccccCCCC
Confidence 45788999999999999999995 46899999998753222 222346789999999999999999999987543
Q ss_pred -eeEEEEecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccccc
Q 002721 678 -VALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEIS 756 (888)
Q Consensus 678 -~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a 756 (888)
..|+||||+.. ++.++... .+++..+..++.|++.||+|||++|++||||||+||+++.++.+|++|||++
T Consensus 93 ~~~~lv~e~~~~-~l~~~~~~-------~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~~ 164 (342)
T cd07879 93 QDFYLVMPYMQT-DLQKIMGH-------PLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLA 164 (342)
T ss_pred ceEEEEeccccc-CHHHHHcC-------CCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEEeeCCCC
Confidence 46999999964 77766531 4678899999999999999999999999999999999999999999999998
Q ss_pred cccCCCCCcccccccccccceeccccccc-CCcCccccchhHHHHHHHHHhCCCCCCCCCCCccchhhhccccCCCCC--
Q 002721 757 KLLDPSKGTASISAVAGSFGYIPPEYAYT-MQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGE-- 833 (888)
Q Consensus 757 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~-- 833 (888)
+..... .....++..|+|||.+.+ ..++.++|||||||++|||++|+.||....... .+............
T Consensus 165 ~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~ 238 (342)
T cd07879 165 RHADAE-----MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLD-QLTQILKVTGVPGPEF 238 (342)
T ss_pred cCCCCC-----CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHhcCCCCHHH
Confidence 765322 123467889999998866 468899999999999999999999997532110 01111100000000
Q ss_pred -------Cccccccc--cccc--CCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH--HHHh
Q 002721 834 -------TPEQILDA--RLST--VSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEM--LQEI 885 (888)
Q Consensus 834 -------~~~~~~~~--~~~~--~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~--L~~i 885 (888)
........ .... ...........+.+++.+||+.||++||+++|++.. ++.+
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~~~~e~l~h~~f~~~ 303 (342)
T cd07879 239 VQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLTATEALEHPYFDSF 303 (342)
T ss_pred HHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcchhhc
Confidence 00000000 0000 000001123567899999999999999999999854 4443
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-33 Score=307.96 Aligned_cols=265 Identities=18% Similarity=0.240 Sum_probs=194.4
Q ss_pred HHHhcCCcceeeecccceEEEEEe-CCCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeC-----
Q 002721 603 VKATMKDSNMIYCGTFSTVYKAVM-PSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYE----- 676 (888)
Q Consensus 603 ~~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~----- 676 (888)
..++|+..+.||+|+||.||+|.. .+++.||+|+++..... ....+.+.+|++++++++||||+++++++...
T Consensus 15 ~~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~ 93 (345)
T cd07877 15 VPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQS-IIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEE 93 (345)
T ss_pred ccCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcchh-hHHHHHHHHHHHHHHHcCCCcccceeeeeeecccccc
Confidence 457899999999999999999984 57899999998753322 22345688899999999999999999988643
Q ss_pred -CeeEEEEecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEecccc
Q 002721 677 -DVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEI 755 (888)
Q Consensus 677 -~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~ 755 (888)
...|++++++ +++|.+++... .+++..+..++.|+++||+|||+.||+||||||+||++++++.+|++|||+
T Consensus 94 ~~~~~lv~~~~-~~~L~~~~~~~------~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll~~~~~~kl~dfg~ 166 (345)
T cd07877 94 FNDVYLVTHLM-GADLNNIVKCQ------KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGL 166 (345)
T ss_pred cccEEEEehhc-ccCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHHEEEcCCCCEEEecccc
Confidence 3467888876 77998887642 468889999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCcccccccccccceeccccccc-CCcCccccchhHHHHHHHHHhCCCCCCCCCCCccchhhhccccCCCC-C
Q 002721 756 SKLLDPSKGTASISAVAGSFGYIPPEYAYT-MQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARG-E 833 (888)
Q Consensus 756 a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~-~ 833 (888)
+...... .....++..|+|||.+.+ ..++.++||||+||++|||++|+.||....... .+........... .
T Consensus 167 ~~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~-~~~~~~~~~~~~~~~ 240 (345)
T cd07877 167 ARHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID-QLKLILRLVGTPGAE 240 (345)
T ss_pred ccccccc-----ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHH-HHHHHHHHhCCCCHH
Confidence 8764322 123467889999998766 468889999999999999999999996432211 0111000000000 0
Q ss_pred Ccccccc-------cccccCCc-----CcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002721 834 TPEQILD-------ARLSTVSF-----GWRKEMLTALKVALLCTDSTPAKRPKMKKVVEM 881 (888)
Q Consensus 834 ~~~~~~~-------~~~~~~~~-----~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~ 881 (888)
....+.+ ......+. .......++.+++.+|++.||++||++.++++.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~l~h 300 (345)
T cd07877 241 LLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALAH 300 (345)
T ss_pred HHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcCCHHHHhcC
Confidence 0000000 00000000 000124567899999999999999999998753
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-32 Score=321.32 Aligned_cols=264 Identities=21% Similarity=0.327 Sum_probs=208.2
Q ss_pred HHHHhcCCcceeeecccceEEEEEeC----C----CcEEEEEEeeccChhhhHHHHHHHHHHHHHhcc-CCCceeeeeeE
Q 002721 602 VVKATMKDSNMIYCGTFSTVYKAVMP----S----GLILSVKRLKSMDRTIIHHQNKMIRELEKLSKL-CHDNLVRPIGF 672 (888)
Q Consensus 602 ~~~~~~~~~~~ig~G~~g~Vy~~~~~----~----~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~ 672 (888)
+..+..++.+.+|+|.||.|++|... . ...||||.++..... .+.+.+..|+++|+.+ +||||+.++|+
T Consensus 293 ~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~~~--~~~~~~~~El~~m~~~g~H~niv~llG~ 370 (609)
T KOG0200|consen 293 IPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENASS--SEKKDLMSELNVLKELGKHPNIVNLLGA 370 (609)
T ss_pred echhhccccceeecccccceEeEEEeecccccccceEEEEEEecccccCc--HHHHHHHHHHHHHHHhcCCcchhhheee
Confidence 34555667779999999999999822 1 468999999855443 4456899999999999 59999999999
Q ss_pred EEeCCeeEEEEecCCCCCHHHHhhccC---------CCCCC--CCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeE
Q 002721 673 VIYEDVALLLHNYLPNGTLAQLLHEST---------KQPDY--RPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVL 741 (888)
Q Consensus 673 ~~~~~~~~lv~e~~~~g~L~~~l~~~~---------~~~~~--~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIl 741 (888)
+..++..++|+||++.|+|.++++..+ ..... .++..+.+.++.|||.|++||++.++||||+.++|||
T Consensus 371 ~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVL 450 (609)
T KOG0200|consen 371 CTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHRDLAARNVL 450 (609)
T ss_pred eccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccchhhhhhhEE
Confidence 999999999999999999999999876 11112 2888999999999999999999999999999999999
Q ss_pred eCCCCCceEeccccccccCCCCCccccccccc--ccceecccccccCCcCccccchhHHHHHHHHHh-CCCCCCCCCCCc
Q 002721 742 LDADFKPLLGEIEISKLLDPSKGTASISAVAG--SFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILT-TRLPVEEDFGEG 818 (888)
Q Consensus 742 l~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~~~~~~ 818 (888)
+.++..+||+|||+|+......... .....+ ...|||||.+....|+.++|||||||++||++| |..||.+... .
T Consensus 451 i~~~~~~kIaDFGlar~~~~~~~y~-~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~-~ 528 (609)
T KOG0200|consen 451 ITKNKVIKIADFGLARDHYNKDYYR-TKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGIPP-T 528 (609)
T ss_pred ecCCCEEEEccccceeccCCCCceE-ecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCCCc-H
Confidence 9999999999999999654433221 111222 345999999999999999999999999999999 8899976211 1
Q ss_pred cchhhhccccCCCCCCcccccccccccCCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHh
Q 002721 819 VDLVKWVHGAPARGETPEQILDARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEMLQEI 885 (888)
Q Consensus 819 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~i 885 (888)
.++.++.... .... .+.....+++++|+.||+.+|++||++.|+.+.++..
T Consensus 529 ~~l~~~l~~G-------------~r~~---~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~~~~~~ 579 (609)
T KOG0200|consen 529 EELLEFLKEG-------------NRME---QPEHCSDEIYDLMKSCWNADPEDRPTFSECVEFFEKH 579 (609)
T ss_pred HHHHHHHhcC-------------CCCC---CCCCCCHHHHHHHHHHhCCCcccCCCHHHHHHHHHHH
Confidence 1122211111 1111 1122356778999999999999999999999999875
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-33 Score=304.65 Aligned_cols=266 Identities=18% Similarity=0.238 Sum_probs=191.6
Q ss_pred hcCCcceeeecccceEEEEEeC-C--CcEEEEEEeeccChhhhHHHHHHHHHHHHHhcc-CCCceeeeeeEEEeC----C
Q 002721 606 TMKDSNMIYCGTFSTVYKAVMP-S--GLILSVKRLKSMDRTIIHHQNKMIRELEKLSKL-CHDNLVRPIGFVIYE----D 677 (888)
Q Consensus 606 ~~~~~~~ig~G~~g~Vy~~~~~-~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~----~ 677 (888)
+|++.+.||+|+||.||+|+.. + +..||+|++...... ....+.+.+|+++++++ +||||+++++++... .
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~ 79 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSK-KILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFN 79 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEecccccc-chhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCC
Confidence 4778899999999999999953 4 789999998743221 22234678899999999 599999999975432 4
Q ss_pred eeEEEEecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEecccccc
Q 002721 678 VALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISK 757 (888)
Q Consensus 678 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~ 757 (888)
..|+++||+. ++|.+++.... .+++..+..++.||+.||+|||++||+||||||+||+++.++.+||+|||.+.
T Consensus 80 ~~~~~~e~~~-~~L~~~l~~~~-----~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~ 153 (332)
T cd07857 80 ELYLYEELME-ADLHQIIRSGQ-----PLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLAR 153 (332)
T ss_pred cEEEEEeccc-CCHHHHHhcCC-----CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeEEcCCCCEEeCcCCCce
Confidence 5788899886 59999886532 57889999999999999999999999999999999999999999999999998
Q ss_pred ccCCCCCc--ccccccccccceeccccccc-CCcCccccchhHHHHHHHHHhCCCCCCCCCCCccchhhhcc--ccCCCC
Q 002721 758 LLDPSKGT--ASISAVAGSFGYIPPEYAYT-MQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVH--GAPARG 832 (888)
Q Consensus 758 ~~~~~~~~--~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~--~~~~~~ 832 (888)
........ .......|+..|+|||+..+ ..++.++||||+|+++|+|++|+.||........ +...+. +.+..
T Consensus 154 ~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~~-~~~~~~~~~~~~~- 231 (332)
T cd07857 154 GFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQ-LNQILQVLGTPDE- 231 (332)
T ss_pred ecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHHH-HHHHHHHhCCCCH-
Confidence 75432211 11234568999999998765 4689999999999999999999999975321100 000000 00000
Q ss_pred CCccccccc-------cc-----ccCCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002721 833 ETPEQILDA-------RL-----STVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVE 880 (888)
Q Consensus 833 ~~~~~~~~~-------~~-----~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 880 (888)
.....+... .. .............+.+++.+|++.||++|||+.|+++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~ll~ 291 (332)
T cd07857 232 ETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRISVEEALE 291 (332)
T ss_pred HHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCCCHHHHhc
Confidence 000000000 00 0000001112456789999999999999999999874
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-34 Score=290.19 Aligned_cols=247 Identities=20% Similarity=0.187 Sum_probs=197.6
Q ss_pred HHHHhcCCcceeeecccceEEEEEeC-CCcEEEEEEeeccChhhhHHHHHHHHHHHHHhcc-CCCceeeeeeEEEeCCee
Q 002721 602 VVKATMKDSNMIYCGTFSTVYKAVMP-SGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKL-CHDNLVRPIGFVIYEDVA 679 (888)
Q Consensus 602 ~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~ 679 (888)
+...+|.+..+||+|+||.|.+|..+ +.+.||||++++.........+--..|-++|.-. +-|.+++++.+|+.-+..
T Consensus 346 i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRL 425 (683)
T KOG0696|consen 346 IKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRL 425 (683)
T ss_pred eeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhhe
Confidence 44568999999999999999999854 5789999999865433333333445677777666 578899999999999999
Q ss_pred EEEEecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEecccccccc
Q 002721 680 LLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLL 759 (888)
Q Consensus 680 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~ 759 (888)
|+||||+.||+|--.+++.+. +.++.+..++.+||-||-|||++|||+||||.+|||+|.+|++||+|||+++.-
T Consensus 426 yFVMEyvnGGDLMyhiQQ~Gk-----FKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEn 500 (683)
T KOG0696|consen 426 YFVMEYVNGGDLMYHIQQVGK-----FKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKEN 500 (683)
T ss_pred eeEEEEecCchhhhHHHHhcc-----cCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEeccCCceEeeeccccccc
Confidence 999999999999999988764 455788899999999999999999999999999999999999999999999864
Q ss_pred CCCCCcccccccccccceecccccccCCcCccccchhHHHHHHHHHhCCCCCCCCCCCccchhhhccccCCCCCCccccc
Q 002721 760 DPSKGTASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQIL 839 (888)
Q Consensus 760 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 839 (888)
-... .....++||+.|+|||++...+|+.++|.||+||++|||+.|++||+++..+. + ...+.
T Consensus 501 i~~~--~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~e--l-------------F~aI~ 563 (683)
T KOG0696|consen 501 IFDG--VTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE--L-------------FQAIM 563 (683)
T ss_pred ccCC--cceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHH--H-------------HHHHH
Confidence 3322 23457899999999999999999999999999999999999999998753221 1 11122
Q ss_pred ccccccCCcCcHHHHHHHHHHHhhccCCCCCCCCC
Q 002721 840 DARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPK 874 (888)
Q Consensus 840 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs 874 (888)
+... ..+...+.++..+....+.+.|.+|..
T Consensus 564 ehnv----syPKslSkEAv~ickg~ltK~P~kRLG 594 (683)
T KOG0696|consen 564 EHNV----SYPKSLSKEAVAICKGLLTKHPGKRLG 594 (683)
T ss_pred HccC----cCcccccHHHHHHHHHHhhcCCccccC
Confidence 2211 122344566777888888899999863
|
|
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-33 Score=303.03 Aligned_cols=264 Identities=16% Similarity=0.216 Sum_probs=195.2
Q ss_pred HHHhcCCcceeeecccceEEEEEe-CCCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEe-CCeeE
Q 002721 603 VKATMKDSNMIYCGTFSTVYKAVM-PSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIY-EDVAL 680 (888)
Q Consensus 603 ~~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~-~~~~~ 680 (888)
..++|+..+.||+|+||.||+|.. .+++.||+|++...... ....+.+.+|++++++++||||+++++++.. ....|
T Consensus 8 ~~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~ 86 (328)
T cd07856 8 ITNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFST-PVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIY 86 (328)
T ss_pred cccceEEEEeecccCCeEEEEEEECCCCCEEEEEEecccccc-cchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEE
Confidence 456899999999999999999984 47999999988643222 2233467899999999999999999999876 55789
Q ss_pred EEEecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccccccccC
Q 002721 681 LLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLD 760 (888)
Q Consensus 681 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~~ 760 (888)
+||||+ +++|.++++.. .+++..+..++.|+++||+|||++||+||||||+||++++++.++++|||.+....
T Consensus 87 lv~e~~-~~~L~~~~~~~------~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~ 159 (328)
T cd07856 87 FVTELL-GTDLHRLLTSR------PLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARIQD 159 (328)
T ss_pred EEeehh-ccCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECCCCCEEeCccccccccC
Confidence 999998 56899888643 35677888999999999999999999999999999999999999999999987643
Q ss_pred CCCCcccccccccccceeccccccc-CCcCccccchhHHHHHHHHHhCCCCCCCCCCCcc--chhhh--------ccccC
Q 002721 761 PSKGTASISAVAGSFGYIPPEYAYT-MQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGV--DLVKW--------VHGAP 829 (888)
Q Consensus 761 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~--~~~~~--------~~~~~ 829 (888)
... ....++..|+|||.+.+ ..++.++||||+|+++|+|++|+.||........ ...+. .....
T Consensus 160 ~~~-----~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 234 (328)
T cd07856 160 PQM-----TGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTIC 234 (328)
T ss_pred CCc-----CCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcc
Confidence 221 23457888999998765 5689999999999999999999999965322100 00000 00000
Q ss_pred CCCCCcccccccccccCCcCcH----HHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002721 830 ARGETPEQILDARLSTVSFGWR----KEMLTALKVALLCTDSTPAKRPKMKKVVEM 881 (888)
Q Consensus 830 ~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~li~~cl~~dP~~RPs~~evl~~ 881 (888)
.. .. ................ .....+.+++.+|++.+|++||++++++..
T Consensus 235 ~~-~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~ell~~ 288 (328)
T cd07856 235 SE-NT-LRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAEALAH 288 (328)
T ss_pred ch-hh-HHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHHHhcC
Confidence 00 00 0000000000000011 123677899999999999999999999764
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-33 Score=308.14 Aligned_cols=265 Identities=17% Similarity=0.252 Sum_probs=191.8
Q ss_pred HhcCCcceeeecccceEEEEEe-CCCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeC-------
Q 002721 605 ATMKDSNMIYCGTFSTVYKAVM-PSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYE------- 676 (888)
Q Consensus 605 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~------- 676 (888)
.+|+..+.||.|+||.||+|.. .+++.||+|.+..... ...+.+.+|++++++++||||+++++++...
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~~---~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~ 81 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTDP---QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTED 81 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCCC---chHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccc
Confidence 5799999999999999999995 4689999999875443 2334688999999999999999999876643
Q ss_pred -------CeeEEEEecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCC-CCCc
Q 002721 677 -------DVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDA-DFKP 748 (888)
Q Consensus 677 -------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~-~~~~ 748 (888)
...|+||||++ ++|.+++... .+++..+..++.||++||+|||+.||+||||||+||+++. ++.+
T Consensus 82 ~~~~~~~~~~~lv~e~~~-~~L~~~~~~~------~l~~~~~~~~~~qi~~aL~~LH~~givH~dikp~Nili~~~~~~~ 154 (342)
T cd07854 82 VGSLTELNSVYIVQEYME-TDLANVLEQG------PLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVL 154 (342)
T ss_pred cccccccceEEEEeeccc-ccHHHHHHcC------CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEcCCCceE
Confidence 35789999997 5998888642 4678899999999999999999999999999999999974 5678
Q ss_pred eEeccccccccCCCCCcc-cccccccccceeccccccc-CCcCccccchhHHHHHHHHHhCCCCCCCCCCCccchhhhcc
Q 002721 749 LLGEIEISKLLDPSKGTA-SISAVAGSFGYIPPEYAYT-MQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVH 826 (888)
Q Consensus 749 kl~Dfg~a~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~ 826 (888)
|++|||.+.......... ......++..|+|||.+.+ ..++.++|||||||++|||++|+.||........ ......
T Consensus 155 kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~-~~~~~~ 233 (342)
T cd07854 155 KIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELEQ-MQLILE 233 (342)
T ss_pred EECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH-HHHHHH
Confidence 999999997654321111 1123357889999997654 5688899999999999999999999975422110 111111
Q ss_pred ccCCCCC---------Ccccccc-cccccCC--cCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002721 827 GAPARGE---------TPEQILD-ARLSTVS--FGWRKEMLTALKVALLCTDSTPAKRPKMKKVVE 880 (888)
Q Consensus 827 ~~~~~~~---------~~~~~~~-~~~~~~~--~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 880 (888)
..+.... ....... ......+ ........++.+++.+|+..||++|||+.|++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ell~ 299 (342)
T cd07854 234 SVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRLTAEEALM 299 (342)
T ss_pred hcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhccCHHHHhC
Confidence 0000000 0000000 0000000 000112356788999999999999999999974
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-35 Score=327.60 Aligned_cols=404 Identities=27% Similarity=0.365 Sum_probs=253.7
Q ss_pred eEEEEEcCCCCcccccccccCCCCCCEEeCCCCcCcccCCCCCCCCCCCCEEECcCCCCCCCCCCCCCCCCcceEEEcCC
Q 002721 64 FVVKLDLSRLQLRGNITLVSELKALKRLDLSNNAFSGTIPSAFGNLSELEFLDLSLNKFGGVIPRELGSLKDLRFFNISN 143 (888)
Q Consensus 64 ~v~~l~l~~~~l~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 143 (888)
++..||+++|.+...+..+..+.+|+.|+++.|.|. ..|.+.+++.+|++|.|.+|++. ..|..+..+++|++|++|.
T Consensus 46 ~L~~l~lsnn~~~~fp~~it~l~~L~~ln~s~n~i~-~vp~s~~~~~~l~~lnL~~n~l~-~lP~~~~~lknl~~LdlS~ 123 (1081)
T KOG0618|consen 46 KLKSLDLSNNQISSFPIQITLLSHLRQLNLSRNYIR-SVPSSCSNMRNLQYLNLKNNRLQ-SLPASISELKNLQYLDLSF 123 (1081)
T ss_pred eeEEeeccccccccCCchhhhHHHHhhcccchhhHh-hCchhhhhhhcchhheeccchhh-cCchhHHhhhcccccccch
Confidence 366777877777776667777777788888887775 56677777777888888877777 5677777778888888888
Q ss_pred CccccccCccccccccccEEEecCC-------------------CCCCCCCccccccccccEEecccccccCCCCCCCCC
Q 002721 144 NVLVGEIPDELKSLEKLEDFQVSSN-------------------KLNGSIPFWVGNLTNLRVFTAYENQLVGEIPDNLGS 204 (888)
Q Consensus 144 N~l~~~~p~~~~~l~~L~~L~Ls~N-------------------~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~ 204 (888)
|.+. .+|..+..++.++.+..++| .+.+.++..+.+++. .|+|++|+++ . ..+..
T Consensus 124 N~f~-~~Pl~i~~lt~~~~~~~s~N~~~~~lg~~~ik~~~l~~n~l~~~~~~~i~~l~~--~ldLr~N~~~-~--~dls~ 197 (1081)
T KOG0618|consen 124 NHFG-PIPLVIEVLTAEEELAASNNEKIQRLGQTSIKKLDLRLNVLGGSFLIDIYNLTH--QLDLRYNEME-V--LDLSN 197 (1081)
T ss_pred hccC-CCchhHHhhhHHHHHhhhcchhhhhhccccchhhhhhhhhcccchhcchhhhhe--eeecccchhh-h--hhhhh
Confidence 8776 66666666655555555555 233333333333333 4555555554 1 12333
Q ss_pred cccccceeeccccCCCCCC------------------CCccCCCCcceEEecCccCCCCchhhhccCCccceeeccCCcc
Q 002721 205 VSELELLNLHSNQLEGPIP------------------KSIFASGKLEVLVLTQNRLTGDIPELVGHCKSLSNIRIGNNDL 266 (888)
Q Consensus 205 l~~L~~L~L~~N~l~~~~p------------------~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l 266 (888)
+.+|+.|....|+++...- ..-+.-.+|+++|+++|++++.+ +++..+.+|+.++..+|+|
T Consensus 198 ~~~l~~l~c~rn~ls~l~~~g~~l~~L~a~~n~l~~~~~~p~p~nl~~~dis~n~l~~lp-~wi~~~~nle~l~~n~N~l 276 (1081)
T KOG0618|consen 198 LANLEVLHCERNQLSELEISGPSLTALYADHNPLTTLDVHPVPLNLQYLDISHNNLSNLP-EWIGACANLEALNANHNRL 276 (1081)
T ss_pred ccchhhhhhhhcccceEEecCcchheeeeccCcceeeccccccccceeeecchhhhhcch-HHHHhcccceEecccchhH
Confidence 3444444444444331100 00011234555555555555333 5555555555555555555
Q ss_pred ccccCCccccCCCccEEEeeccCCCCCCCccccCCCCCcEEEeecCcccccCCccccCCCC-ccEEEeccccccCcCccc
Q 002721 267 VGVIPRAIGNVSGLTYFEADNNNLSGEIVPEFSQCSNLTLLNLASNGFTGVIPPELGQLIN-LQELILYENSLFGEIPKS 345 (888)
Q Consensus 267 ~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~-L~~L~L~~N~l~~~~p~~ 345 (888)
+ .+|..+..+++|++|.+.+|.++. +|+...+++.|++|+|..|+|....+..|..+.. |+.|+.+.|++.....-.
T Consensus 277 ~-~lp~ri~~~~~L~~l~~~~nel~y-ip~~le~~~sL~tLdL~~N~L~~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~ 354 (1081)
T KOG0618|consen 277 V-ALPLRISRITSLVSLSAAYNELEY-IPPFLEGLKSLRTLDLQSNNLPSLPDNFLAVLNASLNTLNVSSNKLSTLPSYE 354 (1081)
T ss_pred H-hhHHHHhhhhhHHHHHhhhhhhhh-CCCcccccceeeeeeehhccccccchHHHhhhhHHHHHHhhhhcccccccccc
Confidence 3 344445555555555555555553 3344445555666666666655333322222222 455555555554222111
Q ss_pred ccccCcceEEEccCCcCCCCCCchhccccCcceecccCCccccccCCCccccccceEEEeecccccccCCCccccccchh
Q 002721 346 ILACKNLNKLDLSNNRFNGTIPNAICDMSRLQYLLLGQNSLKGEIPHEIGNCMKLLQLHIGSNYLTGSIPPEIGHIRNLQ 425 (888)
Q Consensus 346 ~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 425 (888)
=..++.|+.|++.+|.++...-+.+.++.+|+.|+|++|++.......+.++..|++|+||+|+|+ .+|.++..+..|+
T Consensus 355 e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~~fpas~~~kle~LeeL~LSGNkL~-~Lp~tva~~~~L~ 433 (1081)
T KOG0618|consen 355 ENNHAALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLNSFPASKLRKLEELEELNLSGNKLT-TLPDTVANLGRLH 433 (1081)
T ss_pred chhhHHHHHHHHhcCcccccchhhhccccceeeeeecccccccCCHHHHhchHHhHHHhcccchhh-hhhHHHHhhhhhH
Confidence 123456888888888888777777888888999999999887444445678888888999999888 7888888888888
Q ss_pred hhhhccCccccccCCccccCCCCccEEEeeCCccccC-CchhhcccccceEEEccCCcC
Q 002721 426 IALNLSFNHLHGSLPPELGKLDKLVSFDVSNNQLSGT-IPSALKGMLSLIEVNFSNNLL 483 (888)
Q Consensus 426 ~~L~ls~N~l~~~~p~~~~~l~~L~~LdLs~N~l~~~-~p~~~~~l~~L~~L~ls~N~l 483 (888)
.|...+|++. ..| .+..+++|+.+|||.|+|+.. +|..... ++|++|||++|..
T Consensus 434 -tL~ahsN~l~-~fP-e~~~l~qL~~lDlS~N~L~~~~l~~~~p~-p~LkyLdlSGN~~ 488 (1081)
T KOG0618|consen 434 -TLRAHSNQLL-SFP-ELAQLPQLKVLDLSCNNLSEVTLPEALPS-PNLKYLDLSGNTR 488 (1081)
T ss_pred -HHhhcCCcee-ech-hhhhcCcceEEecccchhhhhhhhhhCCC-cccceeeccCCcc
Confidence 6888888887 666 788899999999999988743 3333332 7889999999973
|
|
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-33 Score=305.61 Aligned_cols=263 Identities=15% Similarity=0.227 Sum_probs=196.3
Q ss_pred HHhcCCcceeeecccceEEEEEeC-CCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCCe----
Q 002721 604 KATMKDSNMIYCGTFSTVYKAVMP-SGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDV---- 678 (888)
Q Consensus 604 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~---- 678 (888)
.++|+..+.||+|+||.||+|+.. +++.||+|++...... ....+.+.+|+.++++++||||+++++++..++.
T Consensus 14 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~ 92 (343)
T cd07851 14 PDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQS-AIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDF 92 (343)
T ss_pred cCceEEEEEeccCCceEEEEEEECCCCcEEEEEecccccch-hhHHHHHHHHHHHHHhccCCCHHHHHHHhhcccccccc
Confidence 457999999999999999999954 6889999998743222 2233567889999999999999999998876554
Q ss_pred --eEEEEecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccccc
Q 002721 679 --ALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEIS 756 (888)
Q Consensus 679 --~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a 756 (888)
.++|+||+ +++|.+++... .+++.++..++.|+++||+|||+.||+||||||+||++++++.++|+|||.+
T Consensus 93 ~~~~lv~e~~-~~~L~~~~~~~------~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~Nill~~~~~~kL~dfg~~ 165 (343)
T cd07851 93 QDVYLVTHLM-GADLNNIVKCQ------KLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLA 165 (343)
T ss_pred ccEEEEEecC-CCCHHHHHhcC------CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCCEEEcccccc
Confidence 89999998 56999998752 5788999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCCcccccccccccceeccccccc-CCcCccccchhHHHHHHHHHhCCCCCCCCCCCccchhhhccccCCCC-CC
Q 002721 757 KLLDPSKGTASISAVAGSFGYIPPEYAYT-MQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARG-ET 834 (888)
Q Consensus 757 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~-~~ 834 (888)
...... .....++..|+|||.+.+ ..++.++||||+||++|||++|+.||....... .+........... ..
T Consensus 166 ~~~~~~-----~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~-~~~~i~~~~~~~~~~~ 239 (343)
T cd07851 166 RHTDDE-----MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHID-QLKRIMNLVGTPDEEL 239 (343)
T ss_pred cccccc-----ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHH-HHHHHHHhcCCCCHHH
Confidence 875432 223467889999998765 367889999999999999999999997532211 0111100000000 00
Q ss_pred --------cccccccccccCCcC----cHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002721 835 --------PEQILDARLSTVSFG----WRKEMLTALKVALLCTDSTPAKRPKMKKVVE 880 (888)
Q Consensus 835 --------~~~~~~~~~~~~~~~----~~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 880 (888)
............... ......++.+++.+|+..||++|||+.|+++
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rpt~~ell~ 297 (343)
T cd07851 240 LQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRITAAEALA 297 (343)
T ss_pred HhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCCCHHHHhc
Confidence 000000000000000 0112567889999999999999999999875
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=303.50 Aligned_cols=240 Identities=19% Similarity=0.177 Sum_probs=195.1
Q ss_pred HHHhcCCcceeeecccceEEEEE-eCCCcEEEEEEeeccChhhhHHHHHHHHHHHHHhcc-CCCceeeeeeEEEeCCeeE
Q 002721 603 VKATMKDSNMIYCGTFSTVYKAV-MPSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKL-CHDNLVRPIGFVIYEDVAL 680 (888)
Q Consensus 603 ~~~~~~~~~~ig~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~ 680 (888)
+.+.|+....+|.|+|+.|-.+. ..+++..++|++.+... ...+|+.++... .||||+++.+.+.++.+.|
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~-------~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~ 392 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRAD-------DNQDEIPISLLVRDHPNIVKSHDVYEDGKEIY 392 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheecccccc-------ccccccchhhhhcCCCcceeecceecCCceee
Confidence 35678888889999999999998 55789999999975522 344677777666 6999999999999999999
Q ss_pred EEEecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEe-CCCCCceEecccccccc
Q 002721 681 LLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLL-DADFKPLLGEIEISKLL 759 (888)
Q Consensus 681 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll-~~~~~~kl~Dfg~a~~~ 759 (888)
+|||++.|+-+.+.+..... .. .++..|+.+|+.|+.|||++||||||+||+|||+ ++.++++|+|||.++..
T Consensus 393 ~v~e~l~g~ell~ri~~~~~-----~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~ 466 (612)
T KOG0603|consen 393 LVMELLDGGELLRRIRSKPE-----FC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSEL 466 (612)
T ss_pred eeehhccccHHHHHHHhcch-----hH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecCCCCcEEEEEechhhhC
Confidence 99999999988877765432 22 5677899999999999999999999999999999 58899999999999987
Q ss_pred CCCCCcccccccccccceecccccccCCcCccccchhHHHHHHHHHhCCCCCCCCCCCccchhhhccccCCCCCCccccc
Q 002721 760 DPSKGTASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQIL 839 (888)
Q Consensus 760 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 839 (888)
... ....+-|..|.|||+.....|++++||||||+++|+|++|+.||...... .++ ...+.
T Consensus 467 ~~~-----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~-~ei-------------~~~i~ 527 (612)
T KOG0603|consen 467 ERS-----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG-IEI-------------HTRIQ 527 (612)
T ss_pred chh-----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch-HHH-------------HHhhc
Confidence 654 23446688999999999999999999999999999999999999864332 111 11111
Q ss_pred ccccccCCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002721 840 DARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVE 880 (888)
Q Consensus 840 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 880 (888)
.+. .....+..+.+++.+||+.||.+||+|.++..
T Consensus 528 ~~~------~s~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~ 562 (612)
T KOG0603|consen 528 MPK------FSECVSDEAKDLLQQLLQVDPALRLGADEIGA 562 (612)
T ss_pred CCc------cccccCHHHHHHHHHhccCChhhCcChhhhcc
Confidence 111 11345677889999999999999999999864
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.98 E-value=1e-32 Score=294.40 Aligned_cols=211 Identities=20% Similarity=0.236 Sum_probs=183.1
Q ss_pred HHhcCCcceeeecccceEEEEE-eCCCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCCeeEEE
Q 002721 604 KATMKDSNMIYCGTFSTVYKAV-MPSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVALLL 682 (888)
Q Consensus 604 ~~~~~~~~~ig~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 682 (888)
+.-|..++.||-|+||+|.+++ ..+...||+|.+++.+............|-+||..-..+-||++|-.|.+++..|+|
T Consensus 628 KSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFV 707 (1034)
T KOG0608|consen 628 KSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFV 707 (1034)
T ss_pred ccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEE
Confidence 4457788999999999999998 445789999999988877777778899999999999999999999999999999999
Q ss_pred EecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccccccccCCC
Q 002721 683 HNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPS 762 (888)
Q Consensus 683 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 762 (888)
|||++|||+-.++-+.+ .+.+..+..++.++..|+++.|..|+|||||||+|||||.||++||.|||++.-+...
T Consensus 708 MdYIPGGDmMSLLIrmg-----IFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWT 782 (1034)
T KOG0608|consen 708 MDYIPGGDMMSLLIRMG-----IFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWT 782 (1034)
T ss_pred EeccCCccHHHHHHHhc-----cCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEEccCCceeeeeccccccceec
Confidence 99999999999988765 4566778889999999999999999999999999999999999999999998643210
Q ss_pred C--------Cc--------------------------------ccccccccccceecccccccCCcCccccchhHHHHHH
Q 002721 763 K--------GT--------------------------------ASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLL 802 (888)
Q Consensus 763 ~--------~~--------------------------------~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ 802 (888)
. .. ......+||+.|+|||++....|+..+|.||.|||+|
T Consensus 783 HdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~ 862 (1034)
T KOG0608|consen 783 HDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILY 862 (1034)
T ss_pred cccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHH
Confidence 0 00 0012457999999999999999999999999999999
Q ss_pred HHHhCCCCCCCCCCCcc
Q 002721 803 EILTTRLPVEEDFGEGV 819 (888)
Q Consensus 803 elltg~~P~~~~~~~~~ 819 (888)
||+.|+.||...+..+.
T Consensus 863 em~~g~~pf~~~tp~~t 879 (1034)
T KOG0608|consen 863 EMLVGQPPFLADTPGET 879 (1034)
T ss_pred HHhhCCCCccCCCCCcc
Confidence 99999999987765543
|
|
| >KOG0618 consensus Serine/threonine phosphatase 2C containing leucine-rich repeats, similar to SCN circadian oscillatory protein (SCOP) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.2e-35 Score=326.44 Aligned_cols=419 Identities=28% Similarity=0.379 Sum_probs=309.0
Q ss_pred eEEEEEcCCCCcccccc-cccCCCCCCEEeCCCCcCcccCCCCCCCCCCCCEEECcCCCCCCCCCCCCCCCCcceEEEcC
Q 002721 64 FVVKLDLSRLQLRGNIT-LVSELKALKRLDLSNNAFSGTIPSAFGNLSELEFLDLSLNKFGGVIPRELGSLKDLRFFNIS 142 (888)
Q Consensus 64 ~v~~l~l~~~~l~~~~~-~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 142 (888)
+++.|++++|-+...+- .+..--+|+.|||++|++. ..|..+..+.+|+.|+++.|.|. ..|.+..++.+|++|+|.
T Consensus 22 ~~~~ln~~~N~~l~~pl~~~~~~v~L~~l~lsnn~~~-~fp~~it~l~~L~~ln~s~n~i~-~vp~s~~~~~~l~~lnL~ 99 (1081)
T KOG0618|consen 22 ALQILNLRRNSLLSRPLEFVEKRVKLKSLDLSNNQIS-SFPIQITLLSHLRQLNLSRNYIR-SVPSSCSNMRNLQYLNLK 99 (1081)
T ss_pred HHHhhhccccccccCchHHhhheeeeEEeeccccccc-cCCchhhhHHHHhhcccchhhHh-hCchhhhhhhcchhheec
Confidence 47788888887765443 4444455999999999995 88999999999999999999999 578999999999999999
Q ss_pred CCccccccCccccccccccEEEecCCCCCCCCCccccccccccEEecccc-------------------cccCCCCCCCC
Q 002721 143 NNVLVGEIPDELKSLEKLEDFQVSSNKLNGSIPFWVGNLTNLRVFTAYEN-------------------QLVGEIPDNLG 203 (888)
Q Consensus 143 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N-------------------~l~~~~p~~~~ 203 (888)
+|++. ..|..+..+.+|+.||+|+|++. .+|..+..++.+..+..++| .+.+.++..+.
T Consensus 100 ~n~l~-~lP~~~~~lknl~~LdlS~N~f~-~~Pl~i~~lt~~~~~~~s~N~~~~~lg~~~ik~~~l~~n~l~~~~~~~i~ 177 (1081)
T KOG0618|consen 100 NNRLQ-SLPASISELKNLQYLDLSFNHFG-PIPLVIEVLTAEEELAASNNEKIQRLGQTSIKKLDLRLNVLGGSFLIDIY 177 (1081)
T ss_pred cchhh-cCchhHHhhhcccccccchhccC-CCchhHHhhhHHHHHhhhcchhhhhhccccchhhhhhhhhcccchhcchh
Confidence 99998 88999999999999999999998 77877777777777777766 22222333333
Q ss_pred CcccccceeeccccCCCCCCCCccCCCCcceEEecCccCCCCchhhhccCCccceeeccCCccccccCCccccCCCccEE
Q 002721 204 SVSELELLNLHSNQLEGPIPKSIFASGKLEVLVLTQNRLTGDIPELVGHCKSLSNIRIGNNDLVGVIPRAIGNVSGLTYF 283 (888)
Q Consensus 204 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L 283 (888)
.++. .|+|.+|++. --.+..+.+|+.|....|++.... -.-++|+.|+.++|.++...+.. --.+|+++
T Consensus 178 ~l~~--~ldLr~N~~~---~~dls~~~~l~~l~c~rn~ls~l~----~~g~~l~~L~a~~n~l~~~~~~p--~p~nl~~~ 246 (1081)
T KOG0618|consen 178 NLTH--QLDLRYNEME---VLDLSNLANLEVLHCERNQLSELE----ISGPSLTALYADHNPLTTLDVHP--VPLNLQYL 246 (1081)
T ss_pred hhhe--eeecccchhh---hhhhhhccchhhhhhhhcccceEE----ecCcchheeeeccCcceeecccc--ccccceee
Confidence 3222 3555555543 112233344444444444443211 12245666666666666332211 12367788
Q ss_pred EeeccCCCCCCCccccCCCCCcEEEeecCcccccCCccccCCCCccEEEeccccccCcCcccccccCcceEEEccCCcCC
Q 002721 284 EADNNNLSGEIVPEFSQCSNLTLLNLASNGFTGVIPPELGQLINLQELILYENSLFGEIPKSILACKNLNKLDLSNNRFN 363 (888)
Q Consensus 284 ~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 363 (888)
++++|++++.. .++..+.+|+.++..+|+|+ .+|..+...++|+.|+..+|.+. -+|....+++.|+.|+|..|+|.
T Consensus 247 dis~n~l~~lp-~wi~~~~nle~l~~n~N~l~-~lp~ri~~~~~L~~l~~~~nel~-yip~~le~~~sL~tLdL~~N~L~ 323 (1081)
T KOG0618|consen 247 DISHNNLSNLP-EWIGACANLEALNANHNRLV-ALPLRISRITSLVSLSAAYNELE-YIPPFLEGLKSLRTLDLQSNNLP 323 (1081)
T ss_pred ecchhhhhcch-HHHHhcccceEecccchhHH-hhHHHHhhhhhHHHHHhhhhhhh-hCCCcccccceeeeeeehhcccc
Confidence 88888887544 77777888888888888885 46777777777777777777775 55556666777777777777776
Q ss_pred CCCCchh--------------------------ccccCcceecccCCccccccCCCccccccceEEEeecccccccCCC-
Q 002721 364 GTIPNAI--------------------------CDMSRLQYLLLGQNSLKGEIPHEIGNCMKLLQLHIGSNYLTGSIPP- 416 (888)
Q Consensus 364 ~~~p~~~--------------------------~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~- 416 (888)
..|+.+ ..++.|+.|++.+|.++...-..+.+..+|+.|+|++|+|. ++|.
T Consensus 324 -~lp~~~l~v~~~~l~~ln~s~n~l~~lp~~~e~~~~~Lq~LylanN~Ltd~c~p~l~~~~hLKVLhLsyNrL~-~fpas 401 (1081)
T KOG0618|consen 324 -SLPDNFLAVLNASLNTLNVSSNKLSTLPSYEENNHAALQELYLANNHLTDSCFPVLVNFKHLKVLHLSYNRLN-SFPAS 401 (1081)
T ss_pred -ccchHHHhhhhHHHHHHhhhhccccccccccchhhHHHHHHHHhcCcccccchhhhccccceeeeeecccccc-cCCHH
Confidence 333221 12456889999999998776667888999999999999998 6665
Q ss_pred ccccccchhhhhhccCccccccCCccccCCCCccEEEeeCCccccCCchhhcccccceEEEccCCcCcc-cCCCCCCCCC
Q 002721 417 EIGHIRNLQIALNLSFNHLHGSLPPELGKLDKLVSFDVSNNQLSGTIPSALKGMLSLIEVNFSNNLLTG-PVPSFVPFQK 495 (888)
Q Consensus 417 ~~~~l~~L~~~L~ls~N~l~~~~p~~~~~l~~L~~LdLs~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~-~~p~~~~~~~ 495 (888)
.+.++..|+ .|+||+|+++ .+|..+..+..|++|...+|+|. ..| .+..+++|+.+|+|.|+|+- .+|.-.+..+
T Consensus 402 ~~~kle~Le-eL~LSGNkL~-~Lp~tva~~~~L~tL~ahsN~l~-~fP-e~~~l~qL~~lDlS~N~L~~~~l~~~~p~p~ 477 (1081)
T KOG0618|consen 402 KLRKLEELE-ELNLSGNKLT-TLPDTVANLGRLHTLRAHSNQLL-SFP-ELAQLPQLKVLDLSCNNLSEVTLPEALPSPN 477 (1081)
T ss_pred HHhchHHhH-HHhcccchhh-hhhHHHHhhhhhHHHhhcCCcee-ech-hhhhcCcceEEecccchhhhhhhhhhCCCcc
Confidence 567889998 7999999998 78899999999999999999999 667 89999999999999999984 5555444344
Q ss_pred CCCCcccCCCC
Q 002721 496 SPNSSFFGNKG 506 (888)
Q Consensus 496 ~~~~~~~~n~~ 506 (888)
.....+.||..
T Consensus 478 LkyLdlSGN~~ 488 (1081)
T KOG0618|consen 478 LKYLDLSGNTR 488 (1081)
T ss_pred cceeeccCCcc
Confidence 44556677774
|
|
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.7e-32 Score=301.11 Aligned_cols=252 Identities=20% Similarity=0.255 Sum_probs=204.8
Q ss_pred HHhcCCcceeeecccceEEEEE-eCCCcEEEEEEeeccChhhhHHHHHHHHHHHHHhcc-CCCceeeeeeEEEe-----C
Q 002721 604 KATMKDSNMIYCGTFSTVYKAV-MPSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKL-CHDNLVRPIGFVIY-----E 676 (888)
Q Consensus 604 ~~~~~~~~~ig~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~-----~ 676 (888)
.+.|++.+.||.|.+|.||+++ .++++..|+|+....... .+++..|.++++.. .|||++.+||+|.. +
T Consensus 18 ~d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~d~----deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~ 93 (953)
T KOG0587|consen 18 ADIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTEDE----EEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNG 93 (953)
T ss_pred CCccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCccc----cHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCC
Confidence 4578899999999999999999 567999999988744332 23677888898887 59999999999874 5
Q ss_pred CeeEEEEecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccccc
Q 002721 677 DVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEIS 756 (888)
Q Consensus 677 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a 756 (888)
+..|+|||||.+|+..|+++.... .++.|+.+..|++.++.|+.+||...++|||||-.|||++.++.+|++|||.+
T Consensus 94 DqLWLVMEfC~gGSVTDLVKn~~g---~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFGvS 170 (953)
T KOG0587|consen 94 DQLWLVMEFCGGGSVTDLVKNTKG---NRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFGVS 170 (953)
T ss_pred CeEEEEeeccCCccHHHHHhhhcc---cchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEEEeccCcEEEeeeeee
Confidence 689999999999999999998763 37899999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCCcccccccccccceecccccccC-----CcCccccchhHHHHHHHHHhCCCCCCCCCCCccchhhhccccCCC
Q 002721 757 KLLDPSKGTASISAVAGSFGYIPPEYAYTM-----QVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPAR 831 (888)
Q Consensus 757 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~ 831 (888)
...+..... ....+||+.|||||++... .|+.++|+||+|++..||.-|.+|+.+..+-.. .-..+
T Consensus 171 aQldsT~gr--RnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmra-----LF~Ip-- 241 (953)
T KOG0587|consen 171 AQLDSTVGR--RNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMRA-----LFLIP-- 241 (953)
T ss_pred eeeeccccc--ccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhhh-----hccCC--
Confidence 887654332 3467899999999998643 478899999999999999999999976532210 00000
Q ss_pred CCCcccccccccccCCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002721 832 GETPEQILDARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVE 880 (888)
Q Consensus 832 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 880 (888)
+..+.....+..-..++.++|..|+.+|.++||++.++++
T Consensus 242 ---------RNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~ 281 (953)
T KOG0587|consen 242 ---------RNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLK 281 (953)
T ss_pred ---------CCCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhcc
Confidence 0111111234555677888999999999999999998875
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.98 E-value=6.5e-32 Score=281.88 Aligned_cols=220 Identities=20% Similarity=0.148 Sum_probs=175.7
Q ss_pred cccceEEEEEe-CCCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCCeeEEEEecCCCCCHHHH
Q 002721 616 GTFSTVYKAVM-PSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVALLLHNYLPNGTLAQL 694 (888)
Q Consensus 616 G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~ 694 (888)
|.||.||+|+. .+++.||+|+++... .+.+|...+....||||+++++++...+..++||||+++|+|.++
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~--------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 75 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSS--------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSH 75 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchh--------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHH
Confidence 89999999995 468999999987532 233455555566799999999999999999999999999999999
Q ss_pred hhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccccccccCCCCCcccccccccc
Q 002721 695 LHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSKGTASISAVAGS 774 (888)
Q Consensus 695 l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt 774 (888)
+.... .+++..+..++.|+++||+|+|++||+||||||+||+++.++.++++|||.+....... ....++
T Consensus 76 l~~~~-----~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~-----~~~~~~ 145 (237)
T cd05576 76 ISKFL-----NIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC-----DGEAVE 145 (237)
T ss_pred HHHhc-----CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchhcccccc-----ccCCcC
Confidence 87643 46889999999999999999999999999999999999999999999999876654321 223456
Q ss_pred cceecccccccCCcCccccchhHHHHHHHHHhCCCCCCCCCCCccchhhhccccCCCCCCcccccccccccCCcCcHHHH
Q 002721 775 FGYIPPEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQILDARLSTVSFGWRKEM 854 (888)
Q Consensus 775 ~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 854 (888)
..|+|||...+..++.++||||+|+++|||++|+.|+........ ... . . .. .....
T Consensus 146 ~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~~~--------------~~~---~--~-~~---~~~~~ 202 (237)
T cd05576 146 NMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSGIN--------------THT---T--L-NI---PEWVS 202 (237)
T ss_pred ccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchhcc--------------ccc---c--c-CC---cccCC
Confidence 789999999888899999999999999999999988753211100 000 0 0 00 01123
Q ss_pred HHHHHHHhhccCCCCCCCCCHH
Q 002721 855 LTALKVALLCTDSTPAKRPKMK 876 (888)
Q Consensus 855 ~~~~~li~~cl~~dP~~RPs~~ 876 (888)
..+.+++.+|++.||++||++.
T Consensus 203 ~~~~~li~~~l~~dp~~R~~~~ 224 (237)
T cd05576 203 EEARSLLQQLLQFNPTERLGAG 224 (237)
T ss_pred HHHHHHHHHHccCCHHHhcCCC
Confidence 5678899999999999999973
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.6e-33 Score=282.89 Aligned_cols=272 Identities=16% Similarity=0.220 Sum_probs=208.0
Q ss_pred ccCHHHHHHHhcCCcceeeecccceEEEEEe-CCCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccC-C-C----ceee
Q 002721 596 AIDLDAVVKATMKDSNMIYCGTFSTVYKAVM-PSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLC-H-D----NLVR 668 (888)
Q Consensus 596 ~~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-h-p----nIv~ 668 (888)
.+...+....+|.+...+|+|.||.|-.+.. ..+..||+|+++.... +.+...-|++++.++. + | -+|+
T Consensus 80 v~~~gD~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V~k----YreAa~iEi~vLqki~~~DP~g~~rcv~ 155 (415)
T KOG0671|consen 80 VYQVGDILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNVDK----YREAALIEIEVLQKINESDPNGKFRCVQ 155 (415)
T ss_pred EEEeccccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHHHH----HhhHHHHHHHHHHHHHhcCCCCceEEEe
Confidence 3455677789999999999999999999984 4589999999985443 4457788999999994 2 2 4788
Q ss_pred eeeEEEeCCeeEEEEecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCC----
Q 002721 669 PIGFVIYEDVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDA---- 744 (888)
Q Consensus 669 ~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~---- 744 (888)
+.+||...++.++|+|.+ |-++.++++++... .++..++..++.|++++++|||+.+++|-||||+||++.+
T Consensus 156 m~~wFdyrghiCivfell-G~S~~dFlk~N~y~---~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLKPENILfvss~~~ 231 (415)
T KOG0671|consen 156 MRDWFDYRGHICIVFELL-GLSTFDFLKENNYI---PFPIDHIRHMGYQLLESVAFLHDLKLTHTDLKPENILFVSSEYF 231 (415)
T ss_pred eehhhhccCceEEEEecc-ChhHHHHhccCCcc---ccchHHHHHHHHHHHHHHHHHHhcceeecCCChheEEEeccceE
Confidence 899999999999999988 55999999987654 6788999999999999999999999999999999999941
Q ss_pred ----------------CCCceEeccccccccCCCCCcccccccccccceecccccccCCcCccccchhHHHHHHHHHhCC
Q 002721 745 ----------------DFKPLLGEIEISKLLDPSKGTASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILTTR 808 (888)
Q Consensus 745 ----------------~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~ 808 (888)
+..++++|||.|.+..... ...+.|..|+|||++.+-.++.++||||+|||++|+.||.
T Consensus 232 ~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h-----s~iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~ 306 (415)
T KOG0671|consen 232 KTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH-----STIVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGE 306 (415)
T ss_pred EEeccCCccceeccCCCcceEEEecCCcceeccCc-----ceeeeccccCCchheeccCcCCccCceeeeeEEEEeeccc
Confidence 2348999999998855433 4567899999999999999999999999999999999999
Q ss_pred CCCCCCCC-CccchhhhccccCCCCC----------------Cccccccccc----------ccCCcCcHHHHHHHHHHH
Q 002721 809 LPVEEDFG-EGVDLVKWVHGAPARGE----------------TPEQILDARL----------STVSFGWRKEMLTALKVA 861 (888)
Q Consensus 809 ~P~~~~~~-~~~~~~~~~~~~~~~~~----------------~~~~~~~~~~----------~~~~~~~~~~~~~~~~li 861 (888)
..|+.... +...+.+-+.+..+... +.+.-.++.. ...-.....+..++++++
T Consensus 307 ~LFqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl 386 (415)
T KOG0671|consen 307 TLFQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLL 386 (415)
T ss_pred eecccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCcHHHhHHHHHH
Confidence 99976432 11111121111111000 0000000000 000112234567789999
Q ss_pred hhccCCCCCCCCCHHHHHH
Q 002721 862 LLCTDSTPAKRPKMKKVVE 880 (888)
Q Consensus 862 ~~cl~~dP~~RPs~~evl~ 880 (888)
.+|+..||.+|+|+.|++.
T Consensus 387 ~~mL~fDP~~RiTl~EAL~ 405 (415)
T KOG0671|consen 387 RRMLEFDPARRITLREALS 405 (415)
T ss_pred HHHHccCccccccHHHHhc
Confidence 9999999999999999985
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-32 Score=255.58 Aligned_cols=214 Identities=21% Similarity=0.284 Sum_probs=174.3
Q ss_pred HHHhcCCcceeeecccceEEEEE-eCCCcEEEEEEeeccChhhhHHHHHHHHHHHHHhcc-CCCceeeeeeEEEeCCeeE
Q 002721 603 VKATMKDSNMIYCGTFSTVYKAV-MPSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKL-CHDNLVRPIGFVIYEDVAL 680 (888)
Q Consensus 603 ~~~~~~~~~~ig~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~ 680 (888)
..+.......||+|+||.|-+.+ ..+|+..|+|+++..-. .+.+++..+|+.+..+. .+|.+|.+||.+......|
T Consensus 44 ~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~tvn--~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvw 121 (282)
T KOG0984|consen 44 PADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRATVN--SQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVW 121 (282)
T ss_pred chhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhhcC--hHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEE
Confidence 34556667889999999998888 45899999999985433 34566889999887655 7999999999999999999
Q ss_pred EEEecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhccc-CCeeecCCCCCCeEeCCCCCceEecccccccc
Q 002721 681 LLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHH-VAIIHLDISSGNVLLDADFKPLLGEIEISKLL 759 (888)
Q Consensus 681 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~ 759 (888)
+.||.|.. +|..+-++.-.... .+++.-.-+|+..|++||.|||+ ..+||||+||+||||+.+|++|+||||++..+
T Consensus 122 IcME~M~t-Sldkfy~~v~~~g~-~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L 199 (282)
T KOG0984|consen 122 ICMELMDT-SLDKFYRKVLKKGG-TIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISGYL 199 (282)
T ss_pred EeHHHhhh-hHHHHHHHHHhcCC-cCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEccCCcEEEcccccceee
Confidence 99999965 88777665433322 67778888999999999999998 58999999999999999999999999999987
Q ss_pred CCCCCcccccccccccceeccccccc----CCcCccccchhHHHHHHHHHhCCCCCCCCCCCccchhh
Q 002721 760 DPSKGTASISAVAGSFGYIPPEYAYT----MQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVK 823 (888)
Q Consensus 760 ~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~ 823 (888)
.++-. .+...|...|||||.+.. ..|+-|+||||+|+++.||.+++.||..-..+..++.+
T Consensus 200 ~dSiA---kt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~qLkq 264 (282)
T KOG0984|consen 200 VDSIA---KTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQLKQ 264 (282)
T ss_pred hhhhH---HHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHHHHH
Confidence 65431 223467889999998753 36999999999999999999999999865444433333
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-32 Score=271.56 Aligned_cols=251 Identities=18% Similarity=0.156 Sum_probs=199.7
Q ss_pred HHhcCCcceeeecccceEEEEE-eCCCcEEEEEEeeccChhhhHHHHHHHHHHHHHhcc-CCCceeeeeeEEEeCCeeEE
Q 002721 604 KATMKDSNMIYCGTFSTVYKAV-MPSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKL-CHDNLVRPIGFVIYEDVALL 681 (888)
Q Consensus 604 ~~~~~~~~~ig~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~l 681 (888)
-.+|+..++||+|+|++|..++ .++.+.||+|++++.-....+..+....|-.+..+. +||.+|.++.+|..+...++
T Consensus 249 l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlff 328 (593)
T KOG0695|consen 249 LQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFF 328 (593)
T ss_pred cccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEE
Confidence 4578999999999999999999 557899999999875555555556777788888776 69999999999999999999
Q ss_pred EEecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccccccccCC
Q 002721 682 LHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDP 761 (888)
Q Consensus 682 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~~~ 761 (888)
|.||++||+|--.+++.+ .++++.+..+...|.-||.|||++|||.||+|.+|+++|..|++|+.|+|+++.--.
T Consensus 329 vieyv~ggdlmfhmqrqr-----klpeeharfys~ei~lal~flh~rgiiyrdlkldnvlldaeghikltdygmcke~l~ 403 (593)
T KOG0695|consen 329 VIEYVNGGDLMFHMQRQR-----KLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLG 403 (593)
T ss_pred EEEEecCcceeeehhhhh-----cCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccceEEccCCceeecccchhhcCCC
Confidence 999999999987777665 467788899999999999999999999999999999999999999999999986432
Q ss_pred CCCcccccccccccceecccccccCCcCccccchhHHHHHHHHHhCCCCCCCCCCC--ccchhhhccccCCCCCCccccc
Q 002721 762 SKGTASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGE--GVDLVKWVHGAPARGETPEQIL 839 (888)
Q Consensus 762 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~ 839 (888)
. ....+.++||+.|+|||++.+..|+..+|.|++|++|+||+.|+.||.-.... +....++ ..+-++
T Consensus 404 ~--gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~ntedy---------lfqvil 472 (593)
T KOG0695|consen 404 P--GDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMNTEDY---------LFQVIL 472 (593)
T ss_pred C--CcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccchhHH---------HHHHHh
Confidence 2 22345789999999999999999999999999999999999999999743211 1111111 111112
Q ss_pred ccccccCCcCcHHHHHHHHHHHhhccCCCCCCCCC
Q 002721 840 DARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPK 874 (888)
Q Consensus 840 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs 874 (888)
...+. .++..+..+..+++.-+.+||.+|..
T Consensus 473 ekqir----iprslsvkas~vlkgflnkdp~erlg 503 (593)
T KOG0695|consen 473 EKQIR----IPRSLSVKASHVLKGFLNKDPKERLG 503 (593)
T ss_pred hhccc----ccceeehhhHHHHHHhhcCCcHHhcC
Confidence 22211 12233445567788889999999863
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3e-32 Score=279.71 Aligned_cols=260 Identities=21% Similarity=0.249 Sum_probs=200.4
Q ss_pred HHHHhcCCcceeeecccceEEEEE-eCCCcEEEEEEeeccChhh----hHHHHHHHHHHHHHhccCCCceeeeeeEEEe-
Q 002721 602 VVKATMKDSNMIYCGTFSTVYKAV-MPSGLILSVKRLKSMDRTI----IHHQNKMIRELEKLSKLCHDNLVRPIGFVIY- 675 (888)
Q Consensus 602 ~~~~~~~~~~~ig~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~----~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~- 675 (888)
...++|-..+++|+|||++||+|. ....+.||||+-.....+. ..+.+...+|.+|.+.+.||.||++|+|+.-
T Consensus 460 tLn~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslD 539 (775)
T KOG1151|consen 460 TLNDRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLD 539 (775)
T ss_pred chHHHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeec
Confidence 567789999999999999999999 4568899999765433332 2334567899999999999999999999975
Q ss_pred CCeeEEEEecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhccc--CCeeecCCCCCCeEeC---CCCCceE
Q 002721 676 EDVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHH--VAIIHLDISSGNVLLD---ADFKPLL 750 (888)
Q Consensus 676 ~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~--~~ivHrDlkp~NIll~---~~~~~kl 750 (888)
.+.+|-|.|||+|.+|.-|++... .++++++..|+.||+.||.||.+ ..|||-||||.|||+. ..|.+||
T Consensus 540 tdsFCTVLEYceGNDLDFYLKQhk-----lmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgNILLv~GtacGeIKI 614 (775)
T KOG1151|consen 540 TDSFCTVLEYCEGNDLDFYLKQHK-----LMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGNILLVNGTACGEIKI 614 (775)
T ss_pred cccceeeeeecCCCchhHHHHhhh-----hhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCccEEEecCcccceeEe
Confidence 567899999999999999998765 46789999999999999999997 6899999999999995 3478999
Q ss_pred eccccccccCCCCCc-----ccccccccccceecccccccC----CcCccccchhHHHHHHHHHhCCCCCCCCCCCccch
Q 002721 751 GEIEISKLLDPSKGT-----ASISAVAGSFGYIPPEYAYTM----QVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDL 821 (888)
Q Consensus 751 ~Dfg~a~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~----~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~ 821 (888)
.|||+++.++.+... .-.....||.+|.+||.+.-+ ..+.|+||||+|||+|+++.|+.||........ +
T Consensus 615 TDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQQd-I 693 (775)
T KOG1151|consen 615 TDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQQD-I 693 (775)
T ss_pred eecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhHHH-H
Confidence 999999998754322 223456899999999987533 478899999999999999999999975432211 1
Q ss_pred hhhccccCCCCCCcccccccccccCCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHH
Q 002721 822 VKWVHGAPARGETPEQILDARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVV 879 (888)
Q Consensus 822 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl 879 (888)
... ..++...-...+ ..+....++..+|.+|+++.-++|....++.
T Consensus 694 Lqe-----------NTIlkAtEVqFP-~KPvVsseAkaFIRRCLaYRKeDR~DV~qLA 739 (775)
T KOG1151|consen 694 LQE-----------NTILKATEVQFP-PKPVVSSEAKAFIRRCLAYRKEDRIDVQQLA 739 (775)
T ss_pred Hhh-----------hchhcceeccCC-CCCccCHHHHHHHHHHHHhhhhhhhhHHHHc
Confidence 110 011111111111 1123345677899999999999898877764
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.4e-32 Score=258.30 Aligned_cols=260 Identities=18% Similarity=0.208 Sum_probs=201.6
Q ss_pred HHhcCCcceeeecccceEEEEE-eCCCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccC-CCceeeeeeEEEeCC--ee
Q 002721 604 KATMKDSNMIYCGTFSTVYKAV-MPSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLC-HDNLVRPIGFVIYED--VA 679 (888)
Q Consensus 604 ~~~~~~~~~ig~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~--~~ 679 (888)
.++|++.+++|+|.|++||.|. ..++++++||++++... +.+.+|++|+..++ ||||+++++...++. .+
T Consensus 37 ~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPVkk------kKIkREikIL~nL~gg~NIi~L~DiV~Dp~Sktp 110 (338)
T KOG0668|consen 37 QDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPVKK------KKIKREIKILQNLRGGPNIIKLLDIVKDPESKTP 110 (338)
T ss_pred cchHHHHHHHcCccHhhHhcccccCCCceEEEeeechHHH------HHHHHHHHHHHhccCCCCeeehhhhhcCccccCc
Confidence 4579999999999999999999 55789999999986543 37899999999997 999999999998754 57
Q ss_pred EEEEecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCC-CCceEeccccccc
Q 002721 680 LLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDAD-FKPLLGEIEISKL 758 (888)
Q Consensus 680 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~-~~~kl~Dfg~a~~ 758 (888)
.+|+||+.+.+...+.. .++..++..++.|+++||.|+|++||+|||+||.|++||.. -..+++|+|+|.+
T Consensus 111 aLiFE~v~n~Dfk~ly~--------tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEF 182 (338)
T KOG0668|consen 111 SLIFEYVNNTDFKQLYP--------TLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEF 182 (338)
T ss_pred hhHhhhhccccHHHHhh--------hhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhh
Confidence 89999999988877654 34556888999999999999999999999999999999965 4689999999999
Q ss_pred cCCCCCcccccccccccceecccccccC-CcCccccchhHHHHHHHHHhCCCCCCCCCCCccchhhhccccCCC------
Q 002721 759 LDPSKGTASISAVAGSFGYIPPEYAYTM-QVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPAR------ 831 (888)
Q Consensus 759 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~------ 831 (888)
+.++.. ....+.+..|.-||.+... .|+..-|+|||||++..|+..+.||....+...++++.+.-....
T Consensus 183 YHp~~e---YnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl 259 (338)
T KOG0668|consen 183 YHPGKE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYL 259 (338)
T ss_pred cCCCce---eeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHH
Confidence 876543 3345677889999988765 488899999999999999999999987666555555543222111
Q ss_pred -------CCCccccccccccc-----CCcCcH-HHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002721 832 -------GETPEQILDARLST-----VSFGWR-KEMLTALKVALLCTDSTPAKRPKMKKVVE 880 (888)
Q Consensus 832 -------~~~~~~~~~~~~~~-----~~~~~~-~~~~~~~~li~~cl~~dP~~RPs~~evl~ 880 (888)
+...+.++...... ...... -..+++++++.+.+..|..+||||+|.+.
T Consensus 260 ~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRlTakEam~ 321 (338)
T KOG0668|consen 260 NKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERLTAKEAMA 321 (338)
T ss_pred HHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhccccccchHHHhc
Confidence 11111111111100 000111 12478899999999999999999999875
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.8e-32 Score=298.65 Aligned_cols=247 Identities=21% Similarity=0.306 Sum_probs=190.8
Q ss_pred cCCcceeeecccc-eEEEEEeCCCcEEEEEEeeccChhhhHHHHHHHHHHHHHhcc-CCCceeeeeeEEEeCCeeEEEEe
Q 002721 607 MKDSNMIYCGTFS-TVYKAVMPSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKL-CHDNLVRPIGFVIYEDVALLLHN 684 (888)
Q Consensus 607 ~~~~~~ig~G~~g-~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~lv~e 684 (888)
|...+.+|.|+-| .||+|.. +|+.||||++-... .+...+|+..++.- +|||||++|+.-.++...||..|
T Consensus 511 ~~~~eilG~Gs~Gt~Vf~G~y-e~R~VAVKrll~e~------~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalE 583 (903)
T KOG1027|consen 511 FSPKEILGYGSNGTVVFRGVY-EGREVAVKRLLEEF------FDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALE 583 (903)
T ss_pred eccHHHcccCCCCcEEEEEee-CCceehHHHHhhHh------HHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEeh
Confidence 5556789999886 6899998 78899999986332 23677999999988 59999999999999999999999
Q ss_pred cCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCC---C--CCceEecccccccc
Q 002721 685 YLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDA---D--FKPLLGEIEISKLL 759 (888)
Q Consensus 685 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~---~--~~~kl~Dfg~a~~~ 759 (888)
.|.. +|.+++.......+ ...-...+.+..|+++||+|||+.+||||||||.||||+. + .+++|+|||+++.+
T Consensus 584 LC~~-sL~dlie~~~~d~~-~~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl 661 (903)
T KOG1027|consen 584 LCAC-SLQDLIESSGLDVE-MQSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKL 661 (903)
T ss_pred Hhhh-hHHHHHhccccchh-hcccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCCcceeEEeccccccccc
Confidence 9964 99999987411111 1111345778999999999999999999999999999975 3 56899999999998
Q ss_pred CCCCCccc-ccccccccceecccccccCCcCccccchhHHHHHHHHHhC-CCCCCCCCCCccchhhhccccCCCCCCccc
Q 002721 760 DPSKGTAS-ISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILTT-RLPVEEDFGEGVDLVKWVHGAPARGETPEQ 837 (888)
Q Consensus 760 ~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg-~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 837 (888)
..+..... .....||.+|+|||++....-+.++||||+||++|+.++| ..||.+....+..+.
T Consensus 662 ~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~~R~~NIl--------------- 726 (903)
T KOG1027|consen 662 AGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSLERQANIL--------------- 726 (903)
T ss_pred CCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchHHhhhhhh---------------
Confidence 76554332 3467799999999999988888899999999999999996 999986533222111
Q ss_pred ccccccccCCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002721 838 ILDARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVE 880 (888)
Q Consensus 838 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 880 (888)
.....-......... ++.++|.+|++++|..||+|.+|+.
T Consensus 727 --~~~~~L~~L~~~~d~-eA~dLI~~ml~~dP~~RPsa~~VL~ 766 (903)
T KOG1027|consen 727 --TGNYTLVHLEPLPDC-EAKDLISRMLNPDPQLRPSATDVLN 766 (903)
T ss_pred --cCccceeeeccCchH-HHHHHHHHhcCCCcccCCCHHHHhC
Confidence 111100000011111 7789999999999999999999974
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-30 Score=301.21 Aligned_cols=263 Identities=16% Similarity=0.140 Sum_probs=169.1
Q ss_pred HHhcCCcceeeecccceEEEEEeC-C----CcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeE------
Q 002721 604 KATMKDSNMIYCGTFSTVYKAVMP-S----GLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGF------ 672 (888)
Q Consensus 604 ~~~~~~~~~ig~G~~g~Vy~~~~~-~----~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~------ 672 (888)
.++|+..+.||+|+||.||+|+.. + +..||+|++....... ....| .+....+.+++.++..
T Consensus 131 ~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~~~e-----~~~~e--~l~~~~~~~~~~~~~~~~~~~~ 203 (566)
T PLN03225 131 KDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYGAVE-----IWMNE--RVRRACPNSCADFVYGFLEPVS 203 (566)
T ss_pred cCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccchhH-----HHHHH--HHHhhchhhHHHHHHhhhcccc
Confidence 467999999999999999999954 4 7899999876432211 11111 1112222222222211
Q ss_pred EEeCCeeEEEEecCCCCCHHHHhhccCCC---------------CCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCC
Q 002721 673 VIYEDVALLLHNYLPNGTLAQLLHESTKQ---------------PDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISS 737 (888)
Q Consensus 673 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~---------------~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp 737 (888)
...+...++||||+++++|.+++...... .........+..++.||+.||+|||++||+||||||
T Consensus 204 ~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLKP 283 (566)
T PLN03225 204 SKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKP 283 (566)
T ss_pred cccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCCH
Confidence 23456899999999999999998754210 000112334567999999999999999999999999
Q ss_pred CCeEeCC-CCCceEeccccccccCCCCCcccccccccccceecccccccC----------------------CcCccccc
Q 002721 738 GNVLLDA-DFKPLLGEIEISKLLDPSKGTASISAVAGSFGYIPPEYAYTM----------------------QVTAPGNV 794 (888)
Q Consensus 738 ~NIll~~-~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------------------~~~~~~Di 794 (888)
+|||++. ++.+||+|||+++........ ......+++.|+|||.+... .++.++||
T Consensus 284 ~NILl~~~~~~~KL~DFGlA~~l~~~~~~-~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DV 362 (566)
T PLN03225 284 QNIIFSEGSGSFKIIDLGAAADLRVGINY-IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDI 362 (566)
T ss_pred HHEEEeCCCCcEEEEeCCCcccccccccc-CCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCccc
Confidence 9999985 579999999999876433221 12346789999999965322 23456799
Q ss_pred hhHHHHHHHHHhCCCCCCCCCCC--------ccchhhhccccCCCCCCcccccccccccCCcCcHHHHHHHHHHHhhccC
Q 002721 795 YSYGVVLLEILTTRLPVEEDFGE--------GVDLVKWVHGAPARGETPEQILDARLSTVSFGWRKEMLTALKVALLCTD 866 (888)
Q Consensus 795 wSlG~il~elltg~~P~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~ 866 (888)
||+||++|||+++..|+...... +.+...|....... ....................+++.+|++
T Consensus 363 wSlGviL~el~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~-------~~~~~~~~~~~~d~~~~~~~dLi~~mL~ 435 (566)
T PLN03225 363 YSAGLIFLQMAFPNLRSDSNLIQFNRQLKRNDYDLVAWRKLVEPR-------ASPDLRRGFEVLDLDGGAGWELLKSMMR 435 (566)
T ss_pred HHHHHHHHHHHhCcCCCchHHHHHHHHHHhcCCcHHHHHHhhccc-------cchhhhhhhhhccccchHHHHHHHHHcc
Confidence 99999999999987765432100 01111111110000 0000000000000112345589999999
Q ss_pred CCCCCCCCHHHHHHH
Q 002721 867 STPAKRPKMKKVVEM 881 (888)
Q Consensus 867 ~dP~~RPs~~evl~~ 881 (888)
.||++|||++|+++.
T Consensus 436 ~dP~kR~ta~e~L~H 450 (566)
T PLN03225 436 FKGRQRISAKAALAH 450 (566)
T ss_pred CCcccCCCHHHHhCC
Confidence 999999999999863
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=4e-30 Score=269.04 Aligned_cols=239 Identities=26% Similarity=0.334 Sum_probs=191.4
Q ss_pred ccceEEEEEeC-CCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCCeeEEEEecCCCCCHHHHh
Q 002721 617 TFSTVYKAVMP-SGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVALLLHNYLPNGTLAQLL 695 (888)
Q Consensus 617 ~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l 695 (888)
+||.||+|... +++.+|+|++........ .+.+.+|++.+++++|+||+++++++..+...+++|||+++++|.+++
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~ 78 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK--RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLL 78 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccH--HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHH
Confidence 58999999965 589999999975443221 458899999999999999999999999999999999999999999998
Q ss_pred hccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccccccccCCCCCccccccccccc
Q 002721 696 HESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSKGTASISAVAGSF 775 (888)
Q Consensus 696 ~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~ 775 (888)
.... .+++..+..++.+++.+++|||+.+++|+||+|+||++++++.++++|||.+....... ......++.
T Consensus 79 ~~~~-----~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~ 150 (244)
T smart00220 79 KKRG-----RLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTP 150 (244)
T ss_pred Hhcc-----CCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCc
Confidence 7643 26788999999999999999999999999999999999999999999999998765432 223456788
Q ss_pred ceecccccccCCcCccccchhHHHHHHHHHhCCCCCCCCCCCccchhhhccccCCCCCCcccccccccccCCcCcHHHHH
Q 002721 776 GYIPPEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQILDARLSTVSFGWRKEML 855 (888)
Q Consensus 776 ~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 855 (888)
.|+|||...+..++.++||||+|+++|++++|..||...... ....+...... ... .........
T Consensus 151 ~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~-~~~~~~~~~~~-------------~~~-~~~~~~~~~ 215 (244)
T smart00220 151 EYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQL-LELFKKIGKPK-------------PPF-PPPEWKISP 215 (244)
T ss_pred CCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcH-HHHHHHHhccC-------------CCC-ccccccCCH
Confidence 999999998888999999999999999999999999652111 11111111000 000 000000335
Q ss_pred HHHHHHhhccCCCCCCCCCHHHHHH
Q 002721 856 TALKVALLCTDSTPAKRPKMKKVVE 880 (888)
Q Consensus 856 ~~~~li~~cl~~dP~~RPs~~evl~ 880 (888)
++.+++.+|+..+|++||++.++++
T Consensus 216 ~~~~~i~~~l~~~p~~Rp~~~~~~~ 240 (244)
T smart00220 216 EAKDLIRKLLVKDPEKRLTAEEALQ 240 (244)
T ss_pred HHHHHHHHHccCCchhccCHHHHhh
Confidence 6788999999999999999999986
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.4e-30 Score=287.77 Aligned_cols=271 Identities=15% Similarity=0.144 Sum_probs=182.0
Q ss_pred HHHhcCCcceeeecccceEEEEEe-----------------CCCcEEEEEEeeccChhhhH-----------HHHHHHHH
Q 002721 603 VKATMKDSNMIYCGTFSTVYKAVM-----------------PSGLILSVKRLKSMDRTIIH-----------HQNKMIRE 654 (888)
Q Consensus 603 ~~~~~~~~~~ig~G~~g~Vy~~~~-----------------~~~~~vavK~~~~~~~~~~~-----------~~~~~~~E 654 (888)
..++|++.++||+|+||.||+|.. ..++.||||+++........ ..+....|
T Consensus 143 ~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~vE 222 (507)
T PLN03224 143 SSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGMVE 222 (507)
T ss_pred cccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhHHH
Confidence 356899999999999999999963 23568999998643221111 11234457
Q ss_pred HHHHhccCCCce-----eeeeeEEEe--------CCeeEEEEecCCCCCHHHHhhccCCC-------------------C
Q 002721 655 LEKLSKLCHDNL-----VRPIGFVIY--------EDVALLLHNYLPNGTLAQLLHESTKQ-------------------P 702 (888)
Q Consensus 655 ~~~l~~l~hpnI-----v~~~~~~~~--------~~~~~lv~e~~~~g~L~~~l~~~~~~-------------------~ 702 (888)
+.++.+++|.++ ++++++|.. .+..|+||||+++++|.++++..... .
T Consensus 223 ~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~ 302 (507)
T PLN03224 223 AYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMP 302 (507)
T ss_pred HHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcc
Confidence 777777766554 677787753 35689999999999999998753210 1
Q ss_pred CCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccccccccCCCCCcccccccccccceecccc
Q 002721 703 DYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSKGTASISAVAGSFGYIPPEY 782 (888)
Q Consensus 703 ~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~ 782 (888)
....++..+..++.|++.||+|+|+.+|+||||||+||+++.++.+||+|||++......... ......+++.|+|||.
T Consensus 303 ~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~~-~~~~g~~tp~Y~aPE~ 381 (507)
T PLN03224 303 QDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGINF-NPLYGMLDPRYSPPEE 381 (507)
T ss_pred cccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCcc-CccccCCCcceeChhh
Confidence 123567788999999999999999999999999999999999999999999999765432211 1112234789999998
Q ss_pred cccCC--------------------c--CccccchhHHHHHHHHHhCCC-CCCCCCCCccchhhhccccCCCCCCccccc
Q 002721 783 AYTMQ--------------------V--TAPGNVYSYGVVLLEILTTRL-PVEEDFGEGVDLVKWVHGAPARGETPEQIL 839 (888)
Q Consensus 783 ~~~~~--------------------~--~~~~DiwSlG~il~elltg~~-P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 839 (888)
+.... + ..+.||||+||++|+|++|.. ||........+...+-.... ......
T Consensus 382 l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~----~~r~~~ 457 (507)
T PLN03224 382 LVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLN----RWRMYK 457 (507)
T ss_pred hcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHH----HHHhhc
Confidence 75432 1 124799999999999999875 66532111111000000000 000000
Q ss_pred ccccccCCcCcHHHHHHHHHHHhhccCCCC---CCCCCHHHHHH
Q 002721 840 DARLSTVSFGWRKEMLTALKVALLCTDSTP---AKRPKMKKVVE 880 (888)
Q Consensus 840 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP---~~RPs~~evl~ 880 (888)
..... ...+........+++.+++..+| .+|+|++|+++
T Consensus 458 ~~~~~--~~~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~ 499 (507)
T PLN03224 458 GQKYD--FSLLDRNKEAGWDLACKLITKRDQANRGRLSVGQALS 499 (507)
T ss_pred ccCCC--cccccccChHHHHHHHHHhccCCCCcccCCCHHHHhC
Confidence 00000 01123345667889999998765 78999999985
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.2e-31 Score=257.70 Aligned_cols=266 Identities=17% Similarity=0.301 Sum_probs=193.0
Q ss_pred cCCcceeeecccceEEEEEeC-CCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCC-----eeE
Q 002721 607 MKDSNMIYCGTFSTVYKAVMP-SGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYED-----VAL 680 (888)
Q Consensus 607 ~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~-----~~~ 680 (888)
.+..+-||.|+||.||.++++ +|+.||+|++...... -...+++.+|++++.-++|.|++..+++..-.. +.|
T Consensus 55 i~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnvfq~-L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiY 133 (449)
T KOG0664|consen 55 IQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNVFQN-LASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELY 133 (449)
T ss_pred CCCCCcccccceeEEEeccCCCCccchhHhhcchHHHH-HHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHH
Confidence 344578999999999999954 7999999988743322 233458999999999999999999998776433 568
Q ss_pred EEEecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccccccccC
Q 002721 681 LLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLD 760 (888)
Q Consensus 681 lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~~ 760 (888)
+++|.|.. +|..++-... .++...++-+.+||++||.|||+.+|.||||||.|.+++.+...||+|||+++..+
T Consensus 134 V~TELmQS-DLHKIIVSPQ-----~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee 207 (449)
T KOG0664|consen 134 VLTELMQS-DLHKIIVSPQ-----ALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLLVNSNCILKICDFGLARTWD 207 (449)
T ss_pred HHHHHHHh-hhhheeccCC-----CCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEEeccCceEEecccccccccc
Confidence 89999865 8887775432 46667888899999999999999999999999999999999999999999999876
Q ss_pred CCCCcccccccccccceecccccccC-CcCccccchhHHHHHHHHHhCCCCCCCCCCC-ccchhhhccccCCCCC-----
Q 002721 761 PSKGTASISAVAGSFGYIPPEYAYTM-QVTAPGNVYSYGVVLLEILTTRLPVEEDFGE-GVDLVKWVHGAPARGE----- 833 (888)
Q Consensus 761 ~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~P~~~~~~~-~~~~~~~~~~~~~~~~----- 833 (888)
.+.. ...+..+-|..|+|||++.+. .|+.+.||||.|||+.|++.++..|.....- ..+++....+.+..+.
T Consensus 208 ~d~~-~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~AC 286 (449)
T KOG0664|consen 208 QRDR-LNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYAC 286 (449)
T ss_pred hhhh-hhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHh
Confidence 5432 234556778899999998876 5999999999999999999999888754321 1122211112211100
Q ss_pred --Ccccccccccc--------cCCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002721 834 --TPEQILDARLS--------TVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEM 881 (888)
Q Consensus 834 --~~~~~~~~~~~--------~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~ 881 (888)
....++....+ ..... ...-.+...+.+.++.+||++|.+..+.+..
T Consensus 287 EGAk~H~LR~~~k~Ps~~vLYtlsS~-~~~~heav~~~~~~l~~d~dkris~~~A~~~ 343 (449)
T KOG0664|consen 287 EGAKNHVLRAGLRAPDTQRLYKIASP-DDKNHEAVDLLQKLLHFDPDKRISVEEALQH 343 (449)
T ss_pred hhhHHHhhccCCCCCCccceeeecCC-cccchHHHHHHHHHhCCCCcccccHhhhccc
Confidence 00001111100 01111 1122345567788999999999998887653
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.5e-29 Score=261.60 Aligned_cols=139 Identities=23% Similarity=0.304 Sum_probs=118.4
Q ss_pred cCHHHHHH-HhcCCcceeeecccceEEEEE-eCCCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccC--------CCce
Q 002721 597 IDLDAVVK-ATMKDSNMIYCGTFSTVYKAV-MPSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLC--------HDNL 666 (888)
Q Consensus 597 ~~~~~~~~-~~~~~~~~ig~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~--------hpnI 666 (888)
+.+++.+. ++|.+.++||.|.|++||+|. ..+.+.||+|+.+... .+.+....||++|++++ -.+|
T Consensus 69 V~IGD~F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq----hYtEaAlDEIklL~~v~~~Dp~~~~~~~V 144 (590)
T KOG1290|consen 69 VRIGDVFNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ----HYTEAALDEIKLLQQVREGDPNDPGKKCV 144 (590)
T ss_pred eeccccccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhh----HHHHHHHHHHHHHHHHHhcCCCCCCCcee
Confidence 45566666 899999999999999999999 4568899999998543 34457889999999984 2479
Q ss_pred eeeeeEEEe----CCeeEEEEecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhccc-CCeeecCCCCCCeE
Q 002721 667 VRPIGFVIY----EDVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHH-VAIIHLDISSGNVL 741 (888)
Q Consensus 667 v~~~~~~~~----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlkp~NIl 741 (888)
|+++++|.. +.++++|+|++ |.+|..+|...... .++...+..|++||+.||.|||+ .||||-||||+|||
T Consensus 145 V~LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~Yr---Glpl~~VK~I~~qvL~GLdYLH~ecgIIHTDlKPENvL 220 (590)
T KOG1290|consen 145 VQLLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYR---GLPLSCVKEICRQVLTGLDYLHRECGIIHTDLKPENVL 220 (590)
T ss_pred eeeeccceecCCCCcEEEEEehhh-hhHHHHHHHHhCCC---CCcHHHHHHHHHHHHHHHHHHHHhcCccccCCCcceee
Confidence 999999986 44899999999 56999999876554 57889999999999999999998 69999999999999
Q ss_pred eC
Q 002721 742 LD 743 (888)
Q Consensus 742 l~ 743 (888)
+.
T Consensus 221 l~ 222 (590)
T KOG1290|consen 221 LC 222 (590)
T ss_pred ee
Confidence 93
|
|
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-29 Score=269.03 Aligned_cols=200 Identities=19% Similarity=0.248 Sum_probs=170.8
Q ss_pred HHhcCCcceeeecccceEEEEEeC-CCcEEEEEEeeccChhhhH-----HHHHHHHHHHHHhccC---CCceeeeeeEEE
Q 002721 604 KATMKDSNMIYCGTFSTVYKAVMP-SGLILSVKRLKSMDRTIIH-----HQNKMIRELEKLSKLC---HDNLVRPIGFVI 674 (888)
Q Consensus 604 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~-----~~~~~~~E~~~l~~l~---hpnIv~~~~~~~ 674 (888)
..+|...+.+|.|+||.|+.|.++ +...|++|.+.+...-... ..-.+-.|++||..++ |+||++++++|+
T Consensus 560 ~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFE 639 (772)
T KOG1152|consen 560 FSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFE 639 (772)
T ss_pred cccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheee
Confidence 346899999999999999999954 5788999988753221111 1113557999999997 999999999999
Q ss_pred eCCeeEEEEecC-CCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEecc
Q 002721 675 YEDVALLLHNYL-PNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEI 753 (888)
Q Consensus 675 ~~~~~~lv~e~~-~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Df 753 (888)
+++++|++||-- ++.+|.++|.... ++++.++..|++||+.|+++||+.||||||||-+|+.++.+|-+|++||
T Consensus 640 ddd~yyl~te~hg~gIDLFd~IE~kp-----~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikdenvivd~~g~~klidf 714 (772)
T KOG1152|consen 640 DDDYYYLETEVHGEGIDLFDFIEFKP-----RMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLIDF 714 (772)
T ss_pred cCCeeEEEecCCCCCcchhhhhhccC-----ccchHHHHHHHHHHHhccccccccCceecccccccEEEecCCeEEEeec
Confidence 999999999964 5679999998764 5678899999999999999999999999999999999999999999999
Q ss_pred ccccccCCCCCcccccccccccceecccccccCCc-CccccchhHHHHHHHHHhCCCCCC
Q 002721 754 EISKLLDPSKGTASISAVAGSFGYIPPEYAYTMQV-TAPGNVYSYGVVLLEILTTRLPVE 812 (888)
Q Consensus 754 g~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DiwSlG~il~elltg~~P~~ 812 (888)
|.+.+...+. ...++||..|.|||++.|.+| +..-|||++|+++|.++....||.
T Consensus 715 gsaa~~ksgp----fd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyy 770 (772)
T KOG1152|consen 715 GSAAYTKSGP----FDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYY 770 (772)
T ss_pred cchhhhcCCC----cceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCc
Confidence 9998865432 567899999999999999887 456899999999999999998885
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-29 Score=253.18 Aligned_cols=264 Identities=18% Similarity=0.208 Sum_probs=196.5
Q ss_pred HHhcCCcceeeecccceEEEEEe-CCCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCC-----
Q 002721 604 KATMKDSNMIYCGTFSTVYKAVM-PSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYED----- 677 (888)
Q Consensus 604 ~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~----- 677 (888)
..+|...+.+|.|.- .|..|.+ -.++.||+|.+...... ....++..+|...+..+.|+||++++.+|.-..
T Consensus 16 ~~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~pf~n-~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~ 93 (369)
T KOG0665|consen 16 PKRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRPFQN-QTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEF 93 (369)
T ss_pred eeeeeeecccCCCCc-eEEecchhhccCceehhhhcCcccc-CccchhhhhhhhhhhhhcccceeeeeeccCccccHHHH
Confidence 346777788888887 6666653 36889999988654322 344568889999999999999999999987533
Q ss_pred -eeEEEEecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccccc
Q 002721 678 -VALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEIS 756 (888)
Q Consensus 678 -~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a 756 (888)
..|+|||||.. +|.+.+.. .++-.++..|..|++.|++|+|+.||+||||||+||++..+..+||.|||+|
T Consensus 94 ~e~y~v~e~m~~-nl~~vi~~-------elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsnivv~~~~~lKi~dfg~a 165 (369)
T KOG0665|consen 94 QEVYLVMELMDA-NLCQVILM-------ELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNIVVNSDCTLKILDFGLA 165 (369)
T ss_pred HhHHHHHHhhhh-HHHHHHHH-------hcchHHHHHHHHHHHHHHHHHHhcceeecccCcccceecchhheeeccchhh
Confidence 67999999964 99999884 3455788899999999999999999999999999999999999999999999
Q ss_pred cccCCCCCcccccccccccceecccccccCCcCccccchhHHHHHHHHHhCCCCCCCCCCC-------------ccchhh
Q 002721 757 KLLDPSKGTASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGE-------------GVDLVK 823 (888)
Q Consensus 757 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~-------------~~~~~~ 823 (888)
..-+.. ...+..+.|..|.|||++.+..|.+.+||||+||++.||++|+.-|.+...- +..+..
T Consensus 166 r~e~~~---~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~ 242 (369)
T KOG0665|consen 166 RTEDTD---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMK 242 (369)
T ss_pred cccCcc---cccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHH
Confidence 875433 2356678899999999999999999999999999999999999988743210 000000
Q ss_pred --------hccccCCCC--CCcccccccccccCCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002721 824 --------WVHGAPARG--ETPEQILDARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVE 880 (888)
Q Consensus 824 --------~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 880 (888)
++...+... ...+..-|..+.............+.+++.+||..||++|.|++++++
T Consensus 243 qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Risv~daL~ 309 (369)
T KOG0665|consen 243 QLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRISVDDALR 309 (369)
T ss_pred HhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcccHHHHhc
Confidence 000000000 000111111222222222344566788999999999999999999985
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.8e-31 Score=268.16 Aligned_cols=415 Identities=20% Similarity=0.218 Sum_probs=258.3
Q ss_pred eEecCCCCeEEEEEcCCCCcccccccccCCCCCCEEeCCCCcCcccCCCCCCCCCCCCEEECcCCCCCCCCCCCCCCCCc
Q 002721 56 IDCDLNQAFVVKLDLSRLQLRGNITLVSELKALKRLDLSNNAFSGTIPSAFGNLSELEFLDLSLNKFGGVIPRELGSLKD 135 (888)
Q Consensus 56 v~C~~~~~~v~~l~l~~~~l~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~ 135 (888)
.+|....| ...|.++-+|+..+..+- .....++|..|+|+.+.|.+|+.+.+|++||||+|+|+.+-|++|.++.+
T Consensus 41 C~Cs~~~g--~~VdCr~~GL~eVP~~LP--~~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~ 116 (498)
T KOG4237|consen 41 CTCSDVEG--GIVDCRGKGLTEVPANLP--PETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLAS 116 (498)
T ss_pred cccCCCCC--ceEEccCCCcccCcccCC--CcceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHh
Confidence 44544333 345556666665544221 34678999999999888899999999999999999999999999999999
Q ss_pred ceEEEcCC-CccccccCccccccccccEEEecCCCCCCCCCccccccccccEEecccccccCCCCCCCCCcccccceeec
Q 002721 136 LRFFNISN-NVLVGEIPDELKSLEKLEDFQVSSNKLNGSIPFWVGNLTNLRVFTAYENQLVGEIPDNLGSVSELELLNLH 214 (888)
Q Consensus 136 L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~ 214 (888)
|..|-+-+ |+|+....+.|++|..|+.|.+.-|++..+..++|..|++|..|.+.+|.+..+--.+|..+..++.+.+.
T Consensus 117 l~~Lvlyg~NkI~~l~k~~F~gL~slqrLllNan~i~Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA 196 (498)
T KOG4237|consen 117 LLSLVLYGNNKITDLPKGAFGGLSSLQRLLLNANHINCIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLA 196 (498)
T ss_pred hhHHHhhcCCchhhhhhhHhhhHHHHHHHhcChhhhcchhHHHHHHhhhcchhcccchhhhhhccccccchhccchHhhh
Confidence 88766555 99997777889999999999999999999999999999999999999999985555589999999999999
Q ss_pred cccCC------------CCCCCCccCCCCcceEEecCccCCCCchhhhccC-Cccc-eeeccCCccccccCCccccCCCc
Q 002721 215 SNQLE------------GPIPKSIFASGKLEVLVLTQNRLTGDIPELVGHC-KSLS-NIRIGNNDLVGVIPRAIGNVSGL 280 (888)
Q Consensus 215 ~N~l~------------~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l-~~L~-~L~L~~N~l~~~~~~~~~~l~~L 280 (888)
.|.+- ...|..+.+..-..-..|.++++..+.+..|... +++. .+....+.....+...|..+++|
T Consensus 197 ~np~icdCnL~wla~~~a~~~ietsgarc~~p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L 276 (498)
T KOG4237|consen 197 QNPFICDCNLPWLADDLAMNPIETSGARCVSPYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLPNL 276 (498)
T ss_pred cCccccccccchhhhHHhhchhhcccceecchHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcccc
Confidence 99832 2233344444444444444454444444333221 1111 11111122222222335555555
Q ss_pred cEEEeeccCCCCCCCccccCCCCCcEEEeecCcccccCCccccCCCCccEEEeccccccCcCcccccccCcceEEEccCC
Q 002721 281 TYFEADNNNLSGEIVPEFSQCSNLTLLNLASNGFTGVIPPELGQLINLQELILYENSLFGEIPKSILACKNLNKLDLSNN 360 (888)
Q Consensus 281 ~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N 360 (888)
+.|+|++|+|+++.+.+|.++..++.|.|..|+|..+....|.++..|+.|+|++|+|+..-|..|..+.+|..|+|-.|
T Consensus 277 ~~lnlsnN~i~~i~~~aFe~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~N 356 (498)
T KOG4237|consen 277 RKLNLSNNKITRIEDGAFEGAAELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLSN 356 (498)
T ss_pred eEeccCCCccchhhhhhhcchhhhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeeeeehccC
Confidence 55555555555555555555555555555555555444455555555555555555555555555555555555555555
Q ss_pred cCCCC-----CCchh-----------ccccCcceecccCCccc---cccCCCc---------cccccceEEEeecccccc
Q 002721 361 RFNGT-----IPNAI-----------CDMSRLQYLLLGQNSLK---GEIPHEI---------GNCMKLLQLHIGSNYLTG 412 (888)
Q Consensus 361 ~l~~~-----~p~~~-----------~~l~~L~~L~L~~N~l~---~~~p~~~---------~~l~~L~~L~L~~N~l~~ 412 (888)
.+.-. +-+++ +.-..++.+.++++.+. ...|++. ..++-+.+..=-+|+...
T Consensus 357 p~~CnC~l~wl~~Wlr~~~~~~~~~Cq~p~~~~~~~~~dv~~~~~~c~~~ee~~~~~s~~cP~~c~c~~tVvRcSnk~lk 436 (498)
T KOG4237|consen 357 PFNCNCRLAWLGEWLRKKSVVGNPRCQSPGFVRQIPISDVAFGDFRCGGPEELGCLTSSPCPPPCTCLDTVVRCSNKLLK 436 (498)
T ss_pred cccCccchHHHHHHHhhCCCCCCCCCCCCchhccccchhccccccccCCccccCCCCCCCCCCCcchhhhhHhhcccchh
Confidence 43200 00000 01112444444444332 1122221 122333332222333333
Q ss_pred cCCCccccccchhhhhhccCccccccCCccccCCCCccEEEeeCCccccCCchhhcccccceEEEccCC
Q 002721 413 SIPPEIGHIRNLQIALNLSFNHLHGSLPPELGKLDKLVSFDVSNNQLSGTIPSALKGMLSLIEVNFSNN 481 (888)
Q Consensus 413 ~~p~~~~~l~~L~~~L~ls~N~l~~~~p~~~~~l~~L~~LdLs~N~l~~~~p~~~~~l~~L~~L~ls~N 481 (888)
.+|..+-. . +..+++.+|.++ .+|.+ .+.+| .+|+|+|+++..--..|.+|++|.+|-+|+|
T Consensus 437 ~lp~~iP~--d-~telyl~gn~~~-~vp~~--~~~~l-~~dls~n~i~~Lsn~tf~n~tql~tlilsyn 498 (498)
T KOG4237|consen 437 LLPRGIPV--D-VTELYLDGNAIT-SVPDE--LLRSL-LLDLSNNRISSLSNYTFSNMTQLSTLILSYN 498 (498)
T ss_pred hcCCCCCc--h-hHHHhcccchhc-ccCHH--HHhhh-hcccccCceehhhcccccchhhhheeEEecC
Confidence 55543311 1 126889999998 66766 66778 8999999999777789999999999999987
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-29 Score=264.62 Aligned_cols=276 Identities=17% Similarity=0.164 Sum_probs=213.4
Q ss_pred ccccCHHHHHHHhcCCcceeeecccceEEEEEeC-CCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccC------CCce
Q 002721 594 RQAIDLDAVVKATMKDSNMIYCGTFSTVYKAVMP-SGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLC------HDNL 666 (888)
Q Consensus 594 ~~~~~~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~------hpnI 666 (888)
.+.+.+.++...+|.+....|+|-|++|.+|... .|+.||||++...+. ..+.-.+|+++|++|. --|+
T Consensus 421 YYrv~igE~LD~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~----M~KtGl~EleiLkKL~~AD~Edk~Hc 496 (752)
T KOG0670|consen 421 YYRVRIGELLDSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEV----MHKTGLKELEILKKLNDADPEDKFHC 496 (752)
T ss_pred eEEEehhhhhcceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchH----HhhhhhHHHHHHHHhhccCchhhhHH
Confidence 4466788999999999999999999999999954 588999999985432 3346778999999995 3589
Q ss_pred eeeeeEEEeCCeeEEEEecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCC-
Q 002721 667 VRPIGFVIYEDVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDAD- 745 (888)
Q Consensus 667 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~- 745 (888)
++++..|....+.|+|+|-+. .+|.++++..+..- .+....+..++.|+.-||..|-..||+|.||||+||||++.
T Consensus 497 lrl~r~F~hknHLClVFE~Ls-lNLRevLKKyG~nv--GL~ikaVRsYaqQLflALklLK~c~vlHaDIKPDNiLVNE~k 573 (752)
T KOG0670|consen 497 LRLFRHFKHKNHLCLVFEPLS-LNLREVLKKYGRNV--GLHIKAVRSYAQQLFLALKLLKKCGVLHADIKPDNILVNESK 573 (752)
T ss_pred HHHHHHhhhcceeEEEehhhh-chHHHHHHHhCccc--ceeehHHHHHHHHHHHHHHHHHhcCeeecccCccceEeccCc
Confidence 999999999999999999885 59999999876643 57778999999999999999999999999999999999865
Q ss_pred CCceEeccccccccCCCCCcccccccccccceecccccccCCcCccccchhHHHHHHHHHhCCCCCCCCCCCccc-hhhh
Q 002721 746 FKPLLGEIEISKLLDPSKGTASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVD-LVKW 824 (888)
Q Consensus 746 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~-~~~~ 824 (888)
..+||||||.|....... .+.+.-+..|.|||++.|-+|+...|+||+||++||+.||+..|.+.+...+- +.-.
T Consensus 574 ~iLKLCDfGSA~~~~ene----itPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~MLrl~me 649 (752)
T KOG0670|consen 574 NILKLCDFGSASFASENE----ITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQMLRLFME 649 (752)
T ss_pred ceeeeccCcccccccccc----ccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHHHHHHHHH
Confidence 568999999998865433 33455677899999999999999999999999999999999999875443220 0000
Q ss_pred cccc-----------------------------CCCCCC--ccccccc------cccc---CCcCcHHHHHHHHHHHhhc
Q 002721 825 VHGA-----------------------------PARGET--PEQILDA------RLST---VSFGWRKEMLTALKVALLC 864 (888)
Q Consensus 825 ~~~~-----------------------------~~~~~~--~~~~~~~------~~~~---~~~~~~~~~~~~~~li~~c 864 (888)
+.+. ...... +...+.+ .+.. .+........++.+++..|
T Consensus 650 ~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~rdLLdkm 729 (752)
T KOG0670|consen 650 LKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKM 729 (752)
T ss_pred hcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHHHHHHHHH
Confidence 0000 000000 0000000 1111 2233445677888999999
Q ss_pred cCCCCCCCCCHHHHHH
Q 002721 865 TDSTPAKRPKMKKVVE 880 (888)
Q Consensus 865 l~~dP~~RPs~~evl~ 880 (888)
+..||++|.|..++++
T Consensus 730 l~LdP~KRit~nqAL~ 745 (752)
T KOG0670|consen 730 LILDPEKRITVNQALK 745 (752)
T ss_pred hccChhhcCCHHHHhc
Confidence 9999999999999875
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-29 Score=273.98 Aligned_cols=253 Identities=20% Similarity=0.220 Sum_probs=198.6
Q ss_pred HHhcCCcceeeecccceEEEEE-eCCCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCCeeEEE
Q 002721 604 KATMKDSNMIYCGTFSTVYKAV-MPSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVALLL 682 (888)
Q Consensus 604 ~~~~~~~~~ig~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 682 (888)
+++|+...++|+|.||.||+|+ ..+++..|+|+++-..... .+-+.+|+-+++.++|||||.++|.+..++..|+.
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLep~dd---~~~iqqei~~~~dc~h~nivay~gsylr~dklwic 90 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLEPGDD---FSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWIC 90 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeeccCCcc---ccccccceeeeecCCCcChHHHHhhhhhhcCcEEE
Confidence 4579999999999999999999 4579999999998543332 33677899999999999999999999999999999
Q ss_pred EecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccccccccCCC
Q 002721 683 HNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPS 762 (888)
Q Consensus 683 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 762 (888)
||||.+|+|.+.-+-.+ .+++.++..+++..++||+|+|+.|-+|||||-.||++++.|.+|++|||.+..+...
T Consensus 91 MEycgggslQdiy~~Tg-----plselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~gDvklaDfgvsaqitat 165 (829)
T KOG0576|consen 91 MEYCGGGSLQDIYHVTG-----PLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDEGDVKLADFGVSAQITAT 165 (829)
T ss_pred EEecCCCcccceeeecc-----cchhHHHHHHHhhhhccchhhhcCCcccccccccceeecccCceeecccCchhhhhhh
Confidence 99999999999877654 5677888899999999999999999999999999999999999999999998876543
Q ss_pred CCcccccccccccceecccccc---cCCcCccccchhHHHHHHHHHhCCCCCCCCCCCccchhhhccccCCCCCCccccc
Q 002721 763 KGTASISAVAGSFGYIPPEYAY---TMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQIL 839 (888)
Q Consensus 763 ~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 839 (888)
- .+...+.||+.|||||+.. .+.|..++|||++|++..|+-.-++|-.+...-.. +.-.....+ .
T Consensus 166 i--~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~-l~LmTkS~~----q----- 233 (829)
T KOG0576|consen 166 I--AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRA-LFLMTKSGF----Q----- 233 (829)
T ss_pred h--hhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHH-HHHhhccCC----C-----
Confidence 2 3345789999999999764 45689999999999999999888877654211100 000000000 0
Q ss_pred ccccccCCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002721 840 DARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVE 880 (888)
Q Consensus 840 ~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 880 (888)
.+.+. . ...-.+.+-++++.|+.++|++||+++.++.
T Consensus 234 pp~lk-D---k~kws~~fh~fvK~altknpKkRptaeklL~ 270 (829)
T KOG0576|consen 234 PPTLK-D---KTKWSEFFHNFVKGALTKNPKKRPTAEKLLQ 270 (829)
T ss_pred CCccc-C---CccchHHHHHHHHHHhcCCCccCCChhhhee
Confidence 01111 1 1122345567888999999999999987664
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.3e-29 Score=240.33 Aligned_cols=253 Identities=15% Similarity=0.224 Sum_probs=188.0
Q ss_pred HHHhcCCcceeeecccceEEEEEe-CCCcEEEEEEeeccChhhhHHHHHHHHHHHHHhcc-CCCceeeeeeE-EEeCCee
Q 002721 603 VKATMKDSNMIYCGTFSTVYKAVM-PSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKL-CHDNLVRPIGF-VIYEDVA 679 (888)
Q Consensus 603 ~~~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~-~~~~~~~ 679 (888)
..+.|.+.+.+|+|.||.+-+|++ .+++.+|+|.+...... ++.|.+|...--.+ .|.||+.-|+. |+..+.+
T Consensus 22 l~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt----~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~Y 97 (378)
T KOG1345|consen 22 LEDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTT----QADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAY 97 (378)
T ss_pred hhhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhh----HHHHHHHhccceeeccchhhhHHHHHHhhcCceE
Confidence 456799999999999999999995 46889999998754332 34788998766666 49999987764 6777889
Q ss_pred EEEEecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeC--CCCCceEecccccc
Q 002721 680 LLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLD--ADFKPLLGEIEISK 757 (888)
Q Consensus 680 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~--~~~~~kl~Dfg~a~ 757 (888)
+++|||++.|+|..-+... .+-+....+++.|+++|+.|+|++++||||||.+||||- +..++|++|||...
T Consensus 98 vF~qE~aP~gdL~snv~~~------GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~ 171 (378)
T KOG1345|consen 98 VFVQEFAPRGDLRSNVEAA------GIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTR 171 (378)
T ss_pred EEeeccCccchhhhhcCcc------cccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEecCCccEEEeeeccccc
Confidence 9999999999999888764 345677889999999999999999999999999999993 34589999999987
Q ss_pred ccCCCCCcccccccccccceecccccccC-----CcCccccchhHHHHHHHHHhCCCCCCCCCCCccchhhhccccCCCC
Q 002721 758 LLDPSKGTASISAVAGSFGYIPPEYAYTM-----QVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARG 832 (888)
Q Consensus 758 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~ 832 (888)
..+.. ......+..|.|||..... ...+.+|||.|||++|.++||+.||+..........+|.....
T Consensus 172 k~g~t-----V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~--- 243 (378)
T KOG1345|consen 172 KVGTT-----VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLK--- 243 (378)
T ss_pred ccCce-----ehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchHHHHHHHhc---
Confidence 65432 1233356689999975432 3677899999999999999999999854433333333322211
Q ss_pred CCcccccccccccCCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002721 833 ETPEQILDARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEM 881 (888)
Q Consensus 833 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~ 881 (888)
+.....+.......+.+.++.++-+.++|++|--..++-++
T Consensus 244 --------rk~~~~P~~F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~ 284 (378)
T KOG1345|consen 244 --------RKNPALPKKFNPFSEKALRLFKKSLTPRFKDRCKIWTAKKM 284 (378)
T ss_pred --------ccCccCchhhcccCHHHHHHHHHhcCCcccccchhHHHHHH
Confidence 11112222233445667778888899999998544444433
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.9e-27 Score=241.36 Aligned_cols=211 Identities=31% Similarity=0.466 Sum_probs=182.5
Q ss_pred eeecccceEEEEEeC-CCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCCeeEEEEecCCCCCH
Q 002721 613 IYCGTFSTVYKAVMP-SGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVALLLHNYLPNGTL 691 (888)
Q Consensus 613 ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L 691 (888)
||+|++|.||++... +++.+++|++....... ..+.+.+|++.++.++|++|+++++++......+++|||+++++|
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~--~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l 78 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS--LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSL 78 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh--HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcH
Confidence 689999999999965 48999999998554322 234789999999999999999999999999999999999999999
Q ss_pred HHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCC-CCCceEeccccccccCCCCCcccccc
Q 002721 692 AQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDA-DFKPLLGEIEISKLLDPSKGTASISA 770 (888)
Q Consensus 692 ~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~-~~~~kl~Dfg~a~~~~~~~~~~~~~~ 770 (888)
.+++.... ..+++..+..++.+++++++|||+.|++|+||+|.||+++. ++.++++|||.+........ ....
T Consensus 79 ~~~~~~~~----~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~ 152 (215)
T cd00180 79 KDLLKENE----GKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKT 152 (215)
T ss_pred HHHHHhcc----CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhc
Confidence 99998653 14678899999999999999999999999999999999999 89999999999987654321 1233
Q ss_pred cccccceecccccccC-CcCccccchhHHHHHHHHHhCCCCCCCCCCCccchhhhccccCCCCCCcccccccccccCCcC
Q 002721 771 VAGSFGYIPPEYAYTM-QVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQILDARLSTVSFG 849 (888)
Q Consensus 771 ~~gt~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 849 (888)
..+...|++||..... .++.++|+|++|++++++
T Consensus 153 ~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l--------------------------------------------- 187 (215)
T cd00180 153 IVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL--------------------------------------------- 187 (215)
T ss_pred ccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH---------------------------------------------
Confidence 4577899999998777 788999999999999998
Q ss_pred cHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002721 850 WRKEMLTALKVALLCTDSTPAKRPKMKKVVEM 881 (888)
Q Consensus 850 ~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~ 881 (888)
..+.+++.+|++.||++||++.++++.
T Consensus 188 -----~~~~~~l~~~l~~~p~~R~~~~~l~~~ 214 (215)
T cd00180 188 -----PELKDLIRKMLQKDPEKRPSAKEILEH 214 (215)
T ss_pred -----HHHHHHHHHHhhCCcccCcCHHHHhhC
Confidence 456789999999999999999999874
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.9e-28 Score=250.03 Aligned_cols=265 Identities=22% Similarity=0.287 Sum_probs=196.2
Q ss_pred HHHhcCCcceeeecccceEEEEEeC----CCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccC-CCceeeeeeEEEeCC
Q 002721 603 VKATMKDSNMIYCGTFSTVYKAVMP----SGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLC-HDNLVRPIGFVIYED 677 (888)
Q Consensus 603 ~~~~~~~~~~ig~G~~g~Vy~~~~~----~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~ 677 (888)
....|...++||.|.|++||+|... ..+.||+|.+...... .++..|++.|..+. +.||+++.+++..++
T Consensus 34 ~~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts~p-----~ri~~El~~L~~~gG~~ni~~~~~~~rnnd 108 (418)
T KOG1167|consen 34 ISNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTSSP-----SRILNELEMLYRLGGSDNIIKLNGCFRNND 108 (418)
T ss_pred hhhhhhhhccccccchhhhhhhhHhhhccccceEeeeecccccCc-----hHHHHHHHHHHHhccchhhhcchhhhccCC
Confidence 4567899999999999999999833 4789999998754432 37889999999994 999999999999999
Q ss_pred eeEEEEecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCC-CCceEeccccc
Q 002721 678 VALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDAD-FKPLLGEIEIS 756 (888)
Q Consensus 678 ~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~-~~~kl~Dfg~a 756 (888)
...+|+||++..+..++... ++..++..+++.+..||+++|.+|||||||||+|++.+.. ++-.|.|||+|
T Consensus 109 ~v~ivlp~~~H~~f~~l~~~--------l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA 180 (418)
T KOG1167|consen 109 QVAIVLPYFEHDRFRDLYRS--------LSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLA 180 (418)
T ss_pred eeEEEecccCccCHHHHHhc--------CCHHHHHHHHHHHHHHhhhhhccCccccCCCccccccccccCCceEEechhH
Confidence 99999999999999998874 4568899999999999999999999999999999999754 67789999999
Q ss_pred cccCCCC------C------------------------------------cccccccccccceecccccccC-CcCcccc
Q 002721 757 KLLDPSK------G------------------------------------TASISAVAGSFGYIPPEYAYTM-QVTAPGN 793 (888)
Q Consensus 757 ~~~~~~~------~------------------------------------~~~~~~~~gt~~y~aPE~~~~~-~~~~~~D 793 (888)
...+... . ........||++|+|||++... .-++++|
T Consensus 181 ~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiD 260 (418)
T KOG1167|consen 181 QRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAID 260 (418)
T ss_pred HHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccc
Confidence 8321000 0 0001245799999999987654 4788999
Q ss_pred chhHHHHHHHHHhCCCCCCCCCCCccchhhh--------------cccc--CCC-C---CC------ccccc-ccccc--
Q 002721 794 VYSYGVVLLEILTTRLPVEEDFGEGVDLVKW--------------VHGA--PAR-G---ET------PEQIL-DARLS-- 844 (888)
Q Consensus 794 iwSlG~il~elltg~~P~~~~~~~~~~~~~~--------------~~~~--~~~-~---~~------~~~~~-~~~~~-- 844 (888)
|||.|+|+.-+++++.||.....+-..+.+. ..+. ... . .. .+.+. .....
T Consensus 261 iws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~ 340 (418)
T KOG1167|consen 261 IWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSR 340 (418)
T ss_pred eeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHHhchhccChhhccccc
Confidence 9999999999999999997654432221111 1111 000 0 00 00000 00000
Q ss_pred ---cCCcCcHHH-HHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002721 845 ---TVSFGWRKE-MLTALKVALLCTDSTPAKRPKMKKVVE 880 (888)
Q Consensus 845 ---~~~~~~~~~-~~~~~~li~~cl~~dP~~RPs~~evl~ 880 (888)
.....+.+. ...+++++.+|++.||.+|.|++|.++
T Consensus 341 q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALk 380 (418)
T KOG1167|consen 341 QPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALK 380 (418)
T ss_pred ccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhc
Confidence 011112222 236789999999999999999999885
|
|
| >KOG4237 consensus Extracellular matrix protein slit, contains leucine-rich and EGF-like repeats [Extracellular structures; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.2e-29 Score=255.50 Aligned_cols=394 Identities=21% Similarity=0.229 Sum_probs=305.2
Q ss_pred eEecCC---------CCeEEEEEcCCCCcccccc-cccCCCCCCEEeCCCCcCcccCCCCCCCCCCCCEEECcC-CCCCC
Q 002721 56 IDCDLN---------QAFVVKLDLSRLQLRGNIT-LVSELKALKRLDLSNNAFSGTIPSAFGNLSELEFLDLSL-NKFGG 124 (888)
Q Consensus 56 v~C~~~---------~~~v~~l~l~~~~l~~~~~-~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~-N~l~~ 124 (888)
|+|+.. ....|.++|..|+++..++ .|..+++|++||||+|+|+.+-|.+|.++.+|..|-+-+ |+|+.
T Consensus 51 VdCr~~GL~eVP~~LP~~tveirLdqN~I~~iP~~aF~~l~~LRrLdLS~N~Is~I~p~AF~GL~~l~~Lvlyg~NkI~~ 130 (498)
T KOG4237|consen 51 VDCRGKGLTEVPANLPPETVEIRLDQNQISSIPPGAFKTLHRLRRLDLSKNNISFIAPDAFKGLASLLSLVLYGNNKITD 130 (498)
T ss_pred EEccCCCcccCcccCCCcceEEEeccCCcccCChhhccchhhhceecccccchhhcChHhhhhhHhhhHHHhhcCCchhh
Confidence 778653 2358899999999998887 899999999999999999999999999999998886666 99999
Q ss_pred CCCCCCCCCCcceEEEcCCCccccccCccccccccccEEEecCCCCCCCCCccccccccccEEeccccc-----------
Q 002721 125 VIPRELGSLKDLRFFNISNNVLVGEIPDELKSLEKLEDFQVSSNKLNGSIPFWVGNLTNLRVFTAYENQ----------- 193 (888)
Q Consensus 125 ~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~----------- 193 (888)
+..++|++|..|+.|.+.-|++.-+..++|..+++|..|.+-.|.+..+.-.+|.++.+++.+.+..|.
T Consensus 131 l~k~~F~gL~slqrLllNan~i~Cir~~al~dL~~l~lLslyDn~~q~i~~~tf~~l~~i~tlhlA~np~icdCnL~wla 210 (498)
T KOG4237|consen 131 LPKGAFGGLSSLQRLLLNANHINCIRQDALRDLPSLSLLSLYDNKIQSICKGTFQGLAAIKTLHLAQNPFICDCNLPWLA 210 (498)
T ss_pred hhhhHhhhHHHHHHHhcChhhhcchhHHHHHHhhhcchhcccchhhhhhccccccchhccchHhhhcCccccccccchhh
Confidence 999999999999999999999998889999999999999999999996666699999999999999998
Q ss_pred -ccCCCCCCCCCcccccceeeccccCCCCCCCCccCC-CCc-ceEEecCccCCCCchhhhccCCccceeeccCCcccccc
Q 002721 194 -LVGEIPDNLGSVSELELLNLHSNQLEGPIPKSIFAS-GKL-EVLVLTQNRLTGDIPELVGHCKSLSNIRIGNNDLVGVI 270 (888)
Q Consensus 194 -l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l-~~L-~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~ 270 (888)
+....|-.+++..-..-..|.++++...-+..|.-. ..+ ..+....+-....+...|..+++|+.|+|++|+|+++-
T Consensus 211 ~~~a~~~ietsgarc~~p~rl~~~Ri~q~~a~kf~c~~esl~s~~~~~d~~d~~cP~~cf~~L~~L~~lnlsnN~i~~i~ 290 (498)
T KOG4237|consen 211 DDLAMNPIETSGARCVSPYRLYYKRINQEDARKFLCSLESLPSRLSSEDFPDSICPAKCFKKLPNLRKLNLSNNKITRIE 290 (498)
T ss_pred hHHhhchhhcccceecchHHHHHHHhcccchhhhhhhHHhHHHhhccccCcCCcChHHHHhhcccceEeccCCCccchhh
Confidence 333456677777777888888888876555554322 222 12222333333334456889999999999999999999
Q ss_pred CCccccCCCccEEEeeccCCCCCCCccccCCCCCcEEEeecCcccccCCccccCCCCccEEEeccccccC-----cCccc
Q 002721 271 PRAIGNVSGLTYFEADNNNLSGEIVPEFSQCSNLTLLNLASNGFTGVIPPELGQLINLQELILYENSLFG-----EIPKS 345 (888)
Q Consensus 271 ~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~-----~~p~~ 345 (888)
+.+|.++.+++.|.|..|+|.......|.++..|++|+|.+|+|+.+.|.+|..+..|.+|.|-.|.+.- .+-+|
T Consensus 291 ~~aFe~~a~l~eL~L~~N~l~~v~~~~f~~ls~L~tL~L~~N~it~~~~~aF~~~~~l~~l~l~~Np~~CnC~l~wl~~W 370 (498)
T KOG4237|consen 291 DGAFEGAAELQELYLTRNKLEFVSSGMFQGLSGLKTLSLYDNQITTVAPGAFQTLFSLSTLNLLSNPFNCNCRLAWLGEW 370 (498)
T ss_pred hhhhcchhhhhhhhcCcchHHHHHHHhhhccccceeeeecCCeeEEEecccccccceeeeeehccCcccCccchHHHHHH
Confidence 9999999999999999999988878889999999999999999998899999999999999998886531 00011
Q ss_pred c-----------cccCcceEEEccCCcCCC---CCCchhc---------cccCcc-eecccCCccccccCCCccccccce
Q 002721 346 I-----------LACKNLNKLDLSNNRFNG---TIPNAIC---------DMSRLQ-YLLLGQNSLKGEIPHEIGNCMKLL 401 (888)
Q Consensus 346 ~-----------~~l~~L~~L~Ls~N~l~~---~~p~~~~---------~l~~L~-~L~L~~N~l~~~~p~~~~~l~~L~ 401 (888)
+ .+-..++.++++.+.+.. ..|++.+ .++-+. +..-|++.++ .+|..+. ..-.
T Consensus 371 lr~~~~~~~~~Cq~p~~~~~~~~~dv~~~~~~c~~~ee~~~~~s~~cP~~c~c~~tVvRcSnk~lk-~lp~~iP--~d~t 447 (498)
T KOG4237|consen 371 LRKKSVVGNPRCQSPGFVRQIPISDVAFGDFRCGGPEELGCLTSSPCPPPCTCLDTVVRCSNKLLK-LLPRGIP--VDVT 447 (498)
T ss_pred HhhCCCCCCCCCCCCchhccccchhccccccccCCccccCCCCCCCCCCCcchhhhhHhhcccchh-hcCCCCC--chhH
Confidence 1 111245667777665532 1222221 122232 3334455554 5665543 3456
Q ss_pred EEEeecccccccCCCccccccchhhhhhccCccccccCCccccCCCCccEEEeeCC
Q 002721 402 QLHIGSNYLTGSIPPEIGHIRNLQIALNLSFNHLHGSLPPELGKLDKLVSFDVSNN 457 (888)
Q Consensus 402 ~L~L~~N~l~~~~p~~~~~l~~L~~~L~ls~N~l~~~~p~~~~~l~~L~~LdLs~N 457 (888)
+|++.+|.++ .+|.+ .+..+ .+++|+|+++..-...|.++.+|.+|-||+|
T Consensus 448 elyl~gn~~~-~vp~~--~~~~l--~~dls~n~i~~Lsn~tf~n~tql~tlilsyn 498 (498)
T KOG4237|consen 448 ELYLDGNAIT-SVPDE--LLRSL--LLDLSNNRISSLSNYTFSNMTQLSTLILSYN 498 (498)
T ss_pred HHhcccchhc-ccCHH--HHhhh--hcccccCceehhhcccccchhhhheeEEecC
Confidence 7899999998 78877 56666 4899999999777788999999999999987
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.5e-26 Score=237.48 Aligned_cols=200 Identities=24% Similarity=0.344 Sum_probs=172.1
Q ss_pred cCCcceeeecccceEEEEEeCC-CcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCCeeEEEEec
Q 002721 607 MKDSNMIYCGTFSTVYKAVMPS-GLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVALLLHNY 685 (888)
Q Consensus 607 ~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 685 (888)
|+..+.||+|++|.||+|...+ ++.+|+|.+...... ...+.+.+|++.+++++|+|++++++++......++++||
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~ 78 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE--KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEY 78 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch--HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEec
Confidence 5677899999999999999654 899999999754332 2345888999999999999999999999999999999999
Q ss_pred CCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccccccccCCCCCc
Q 002721 686 LPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSKGT 765 (888)
Q Consensus 686 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~ 765 (888)
+++++|.+++..... .+++..+..++.|++.++.|||+.+++|+|++|+||+++.++.++++|||.+.........
T Consensus 79 ~~~~~L~~~~~~~~~----~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~ 154 (225)
T smart00221 79 CEGGDLFDYLRKKGG----KLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAA 154 (225)
T ss_pred cCCCCHHHHHHhccc----CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccc
Confidence 999999999986542 1678899999999999999999999999999999999999999999999999876543211
Q ss_pred ccccccccccceeccccc-ccCCcCccccchhHHHHHHHHHhCCCCCCC
Q 002721 766 ASISAVAGSFGYIPPEYA-YTMQVTAPGNVYSYGVVLLEILTTRLPVEE 813 (888)
Q Consensus 766 ~~~~~~~gt~~y~aPE~~-~~~~~~~~~DiwSlG~il~elltg~~P~~~ 813 (888)
......++..|++||.. ....++.++|||+||++++||++|+.||..
T Consensus 155 -~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 155 -LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred -cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 12345677889999988 666788899999999999999999999965
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.4e-25 Score=279.48 Aligned_cols=345 Identities=23% Similarity=0.274 Sum_probs=171.0
Q ss_pred CCCCCCCCCCEEECcCCC------CCCCCCCCCCCCC-cceEEEcCCCccccccCccccccccccEEEecCCCCCCCCCc
Q 002721 104 SAFGNLSELEFLDLSLNK------FGGVIPRELGSLK-DLRFFNISNNVLVGEIPDELKSLEKLEDFQVSSNKLNGSIPF 176 (888)
Q Consensus 104 ~~~~~l~~L~~L~Ls~N~------l~~~~p~~~~~l~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~ 176 (888)
.+|.++++|+.|.+..+. +...+|..|..++ +|+.|++.+|.++ .+|..| ...+|++|+|++|++. .++.
T Consensus 552 ~aF~~m~~L~~L~~~~~~~~~~~~~~~~lp~~~~~lp~~Lr~L~~~~~~l~-~lP~~f-~~~~L~~L~L~~s~l~-~L~~ 628 (1153)
T PLN03210 552 NAFKGMRNLLFLKFYTKKWDQKKEVRWHLPEGFDYLPPKLRLLRWDKYPLR-CMPSNF-RPENLVKLQMQGSKLE-KLWD 628 (1153)
T ss_pred HHHhcCccccEEEEecccccccccceeecCcchhhcCcccEEEEecCCCCC-CCCCcC-CccCCcEEECcCcccc-cccc
Confidence 345555555555554432 2223344444442 3555555555554 344444 3455555555555554 3444
Q ss_pred cccccccccEEecccccccCCCCCCCCCcccccceeeccccCCCCCCCCccCCCCcceEEecCccCCCCchhhhccCCcc
Q 002721 177 WVGNLTNLRVFTAYENQLVGEIPDNLGSVSELELLNLHSNQLEGPIPKSIFASGKLEVLVLTQNRLTGDIPELVGHCKSL 256 (888)
Q Consensus 177 ~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L 256 (888)
.+..+++|+.|+|++|.....+|+ ++.+++|++|+|++|.....+|..+..+++|+.|++++|..-..+|..+ ++++|
T Consensus 629 ~~~~l~~Lk~L~Ls~~~~l~~ip~-ls~l~~Le~L~L~~c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~i-~l~sL 706 (1153)
T PLN03210 629 GVHSLTGLRNIDLRGSKNLKEIPD-LSMATNLETLKLSDCSSLVELPSSIQYLNKLEDLDMSRCENLEILPTGI-NLKSL 706 (1153)
T ss_pred ccccCCCCCEEECCCCCCcCcCCc-cccCCcccEEEecCCCCccccchhhhccCCCCEEeCCCCCCcCccCCcC-CCCCC
Confidence 445555555555555443334442 4445555555555544434455555555555555555543222333322 34445
Q ss_pred ceeeccCCccccccCCccccCCCccEEEeeccCCCCCCCccccCCCCCcEEEeecCcccccCCccccCCCCccEEEeccc
Q 002721 257 SNIRIGNNDLVGVIPRAIGNVSGLTYFEADNNNLSGEIVPEFSQCSNLTLLNLASNGFTGVIPPELGQLINLQELILYEN 336 (888)
Q Consensus 257 ~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N 336 (888)
+.|+|++|...+.+|.. .++|++|++++|.++. +|..+ .+++|+.|++.++.... +. +
T Consensus 707 ~~L~Lsgc~~L~~~p~~---~~nL~~L~L~~n~i~~-lP~~~-~l~~L~~L~l~~~~~~~-l~----------------~ 764 (1153)
T PLN03210 707 YRLNLSGCSRLKSFPDI---STNISWLDLDETAIEE-FPSNL-RLENLDELILCEMKSEK-LW----------------E 764 (1153)
T ss_pred CEEeCCCCCCccccccc---cCCcCeeecCCCcccc-ccccc-cccccccccccccchhh-cc----------------c
Confidence 55555444333233321 1234444444444432 22221 23344444433322110 00 0
Q ss_pred cccCcCcccccccCcceEEEccCCcCCCCCCchhccccCcceecccCCccccccCCCccccccceEEEeecccccccCCC
Q 002721 337 SLFGEIPKSILACKNLNKLDLSNNRFNGTIPNAICDMSRLQYLLLGQNSLKGEIPHEIGNCMKLLQLHIGSNYLTGSIPP 416 (888)
Q Consensus 337 ~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~ 416 (888)
.+....|..+...++|+.|+|++|...+.+|..++++++|+.|+|++|...+.+|..+ ++++|+.|++++|.....+|.
T Consensus 765 ~~~~l~~~~~~~~~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~~~-~L~sL~~L~Ls~c~~L~~~p~ 843 (1153)
T PLN03210 765 RVQPLTPLMTMLSPSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPTGI-NLESLESLDLSGCSRLRTFPD 843 (1153)
T ss_pred cccccchhhhhccccchheeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCCCC-CccccCEEECCCCCccccccc
Confidence 0111111122233566666666666555666666666666666666654333555554 566666666666554445554
Q ss_pred ccccccchhhhhhccCccccccCCccccCCCCccEEEeeC-CccccCCchhhcccccceEEEccCCc
Q 002721 417 EIGHIRNLQIALNLSFNHLHGSLPPELGKLDKLVSFDVSN-NQLSGTIPSALKGMLSLIEVNFSNNL 482 (888)
Q Consensus 417 ~~~~l~~L~~~L~ls~N~l~~~~p~~~~~l~~L~~LdLs~-N~l~~~~p~~~~~l~~L~~L~ls~N~ 482 (888)
.. .+++ .|+|++|.++ .+|.++..+++|+.|+|++ |+|. .+|..+..+++|+.++++++.
T Consensus 844 ~~---~nL~-~L~Ls~n~i~-~iP~si~~l~~L~~L~L~~C~~L~-~l~~~~~~L~~L~~L~l~~C~ 904 (1153)
T PLN03210 844 IS---TNIS-DLNLSRTGIE-EVPWWIEKFSNLSFLDMNGCNNLQ-RVSLNISKLKHLETVDFSDCG 904 (1153)
T ss_pred cc---cccC-EeECCCCCCc-cChHHHhcCCCCCEEECCCCCCcC-ccCcccccccCCCeeecCCCc
Confidence 32 3444 5667777776 5666777777777777777 3444 466667777777777777663
|
syringae 6; Provisional |
| >PLN03210 Resistant to P | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.9e-25 Score=276.01 Aligned_cols=290 Identities=19% Similarity=0.240 Sum_probs=183.4
Q ss_pred ccEEecccccccCCCCCCCCCcccccceeeccccCCCCCCCCccCCCCcceEEecCccCCCCchhhhccCCccceeeccC
Q 002721 184 LRVFTAYENQLVGEIPDNLGSVSELELLNLHSNQLEGPIPKSIFASGKLEVLVLTQNRLTGDIPELVGHCKSLSNIRIGN 263 (888)
Q Consensus 184 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~ 263 (888)
|+.|.+.+|.+. .+|..| ...+|++|+|++|++. .++..+..+++|+.|+|++|.....+|. +..+++|+.|+|++
T Consensus 591 Lr~L~~~~~~l~-~lP~~f-~~~~L~~L~L~~s~l~-~L~~~~~~l~~Lk~L~Ls~~~~l~~ip~-ls~l~~Le~L~L~~ 666 (1153)
T PLN03210 591 LRLLRWDKYPLR-CMPSNF-RPENLVKLQMQGSKLE-KLWDGVHSLTGLRNIDLRGSKNLKEIPD-LSMATNLETLKLSD 666 (1153)
T ss_pred cEEEEecCCCCC-CCCCcC-CccCCcEEECcCcccc-ccccccccCCCCCEEECCCCCCcCcCCc-cccCCcccEEEecC
Confidence 444444444443 344444 2345555555555554 3444444455555555554433223332 44455555555555
Q ss_pred CccccccCCccccCCCccEEEeeccCCCCCCCccccCCCCCcEEEeecCcccccCCccccCCCCccEEEeccccccCcCc
Q 002721 264 NDLVGVIPRAIGNVSGLTYFEADNNNLSGEIVPEFSQCSNLTLLNLASNGFTGVIPPELGQLINLQELILYENSLFGEIP 343 (888)
Q Consensus 264 N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p 343 (888)
|.....+|..+.++++|+.|++++|..-..+|..+ ++++|+.|++++|.....+|.. ..+|++|++++|.+. .+|
T Consensus 667 c~~L~~lp~si~~L~~L~~L~L~~c~~L~~Lp~~i-~l~sL~~L~Lsgc~~L~~~p~~---~~nL~~L~L~~n~i~-~lP 741 (1153)
T PLN03210 667 CSSLVELPSSIQYLNKLEDLDMSRCENLEILPTGI-NLKSLYRLNLSGCSRLKSFPDI---STNISWLDLDETAIE-EFP 741 (1153)
T ss_pred CCCccccchhhhccCCCCEEeCCCCCCcCccCCcC-CCCCCCEEeCCCCCCccccccc---cCCcCeeecCCCccc-ccc
Confidence 54444455555555555666655543333334333 4566666666666544344432 345666677776664 445
Q ss_pred ccccccCcceEEEccCCcC-------CCCCCchhccccCcceecccCCccccccCCCccccccceEEEeecccccccCCC
Q 002721 344 KSILACKNLNKLDLSNNRF-------NGTIPNAICDMSRLQYLLLGQNSLKGEIPHEIGNCMKLLQLHIGSNYLTGSIPP 416 (888)
Q Consensus 344 ~~~~~l~~L~~L~Ls~N~l-------~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~ 416 (888)
..+ .+++|+.|++.++.. ....|..+...++|+.|+|++|...+.+|..++++++|+.|++++|...+.+|.
T Consensus 742 ~~~-~l~~L~~L~l~~~~~~~l~~~~~~l~~~~~~~~~sL~~L~Ls~n~~l~~lP~si~~L~~L~~L~Ls~C~~L~~LP~ 820 (1153)
T PLN03210 742 SNL-RLENLDELILCEMKSEKLWERVQPLTPLMTMLSPSLTRLFLSDIPSLVELPSSIQNLHKLEHLEIENCINLETLPT 820 (1153)
T ss_pred ccc-cccccccccccccchhhccccccccchhhhhccccchheeCCCCCCccccChhhhCCCCCCEEECCCCCCcCeeCC
Confidence 443 456666666665332 222233344457899999999988889999999999999999999876668888
Q ss_pred ccccccchhhhhhccCccccccCCccccCCCCccEEEeeCCccccCCchhhcccccceEEEccC-CcCcccCCC
Q 002721 417 EIGHIRNLQIALNLSFNHLHGSLPPELGKLDKLVSFDVSNNQLSGTIPSALKGMLSLIEVNFSN-NLLTGPVPS 489 (888)
Q Consensus 417 ~~~~l~~L~~~L~ls~N~l~~~~p~~~~~l~~L~~LdLs~N~l~~~~p~~~~~l~~L~~L~ls~-N~l~~~~p~ 489 (888)
.+ ++++|+ .|++++|.....+|.. ..+|+.|+|++|.++ .+|.++..+++|++|+|++ |+|.+..+.
T Consensus 821 ~~-~L~sL~-~L~Ls~c~~L~~~p~~---~~nL~~L~Ls~n~i~-~iP~si~~l~~L~~L~L~~C~~L~~l~~~ 888 (1153)
T PLN03210 821 GI-NLESLE-SLDLSGCSRLRTFPDI---STNISDLNLSRTGIE-EVPWWIEKFSNLSFLDMNGCNNLQRVSLN 888 (1153)
T ss_pred CC-CccccC-EEECCCCCcccccccc---ccccCEeECCCCCCc-cChHHHhcCCCCCEEECCCCCCcCccCcc
Confidence 76 788898 7999998765566653 367999999999998 7899999999999999998 667764443
|
syringae 6; Provisional |
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.9e-26 Score=278.52 Aligned_cols=196 Identities=17% Similarity=0.154 Sum_probs=138.7
Q ss_pred ccCC-CceeeeeeEEE-------eCCeeEEEEecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCee
Q 002721 660 KLCH-DNLVRPIGFVI-------YEDVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAII 731 (888)
Q Consensus 660 ~l~h-pnIv~~~~~~~-------~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iv 731 (888)
.++| +||+++++++. ..+.++.++||+ +++|.+++.... ..+++.+++.++.||++||+|||++||+
T Consensus 28 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~----~~~~~~~~~~i~~qi~~al~~lH~~gIv 102 (793)
T PLN00181 28 SLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPD----RSVDAFECFHVFRQIVEIVNAAHSQGIV 102 (793)
T ss_pred hhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhccc----ccccHHHHHHHHHHHHHHHHHHHhCCee
Confidence 3445 57888888772 234567788887 559999997532 2578899999999999999999999999
Q ss_pred ecCCCCCCeEeCC-------------------CCCceEeccccccccCCCCC--------------ccccccccccccee
Q 002721 732 HLDISSGNVLLDA-------------------DFKPLLGEIEISKLLDPSKG--------------TASISAVAGSFGYI 778 (888)
Q Consensus 732 HrDlkp~NIll~~-------------------~~~~kl~Dfg~a~~~~~~~~--------------~~~~~~~~gt~~y~ 778 (888)
||||||+|||++. ++.+|++|||+++....... ........||+.||
T Consensus 103 HrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~ 182 (793)
T PLN00181 103 VHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYT 182 (793)
T ss_pred eccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceE
Confidence 9999999999954 44566666666654221000 00011245788999
Q ss_pred cccccccCCcCccccchhHHHHHHHHHhCCCCCCCCCCCccchhhhccccCCCCCCcccccccccccCCcCcHHHHHHHH
Q 002721 779 PPEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQILDARLSTVSFGWRKEMLTAL 858 (888)
Q Consensus 779 aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 858 (888)
|||++.+..|+.++|||||||++|||++|..|+...... ...... .... ........+..
T Consensus 183 APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~~~----~~~~~~---------~~~~-------~~~~~~~~~~~ 242 (793)
T PLN00181 183 SPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKSRT----MSSLRH---------RVLP-------PQILLNWPKEA 242 (793)
T ss_pred ChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHHHH----HHHHHH---------hhcC-------hhhhhcCHHHH
Confidence 999999999999999999999999999998887532110 000000 0000 01111234456
Q ss_pred HHHhhccCCCCCCCCCHHHHHH
Q 002721 859 KVALLCTDSTPAKRPKMKKVVE 880 (888)
Q Consensus 859 ~li~~cl~~dP~~RPs~~evl~ 880 (888)
+++.+||++||.+||++.|+++
T Consensus 243 ~~~~~~L~~~P~~Rps~~eil~ 264 (793)
T PLN00181 243 SFCLWLLHPEPSCRPSMSELLQ 264 (793)
T ss_pred HHHHHhCCCChhhCcChHHHhh
Confidence 7888999999999999999975
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.92 E-value=8.1e-25 Score=217.05 Aligned_cols=168 Identities=20% Similarity=0.225 Sum_probs=128.0
Q ss_pred CCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccccccccCCCCCcccc
Q 002721 689 GTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSKGTASI 768 (888)
Q Consensus 689 g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~ 768 (888)
|+|.++++.... .+++.+++.|+.||++||+|||+++ ||+||+++.++.+|+ ||.+.......
T Consensus 1 GsL~~~l~~~~~----~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~~----- 63 (176)
T smart00750 1 VSLADILEVRGR----PLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTPEQ----- 63 (176)
T ss_pred CcHHHHHHHhCC----CCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeecccc-----
Confidence 689999986432 5789999999999999999999998 999999999999999 99988754322
Q ss_pred cccccccceecccccccCCcCccccchhHHHHHHHHHhCCCCCCCCCCCccchhhhccccCCCCCCcccccccccccCCc
Q 002721 769 SAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQILDARLSTVSF 848 (888)
Q Consensus 769 ~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 848 (888)
..||+.|+|||++.+..++.++|||||||++|||+||+.||..................... . ....
T Consensus 64 --~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~-~----------~~~~ 130 (176)
T smart00750 64 --SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADD-P----------RDRS 130 (176)
T ss_pred --CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCC-c----------cccc
Confidence 25789999999999999999999999999999999999999754322211111111111000 0 0000
Q ss_pred CcHHHH--HHHHHHHhhccCCCCCCCCCHHHHHHHHHHhh
Q 002721 849 GWRKEM--LTALKVALLCTDSTPAKRPKMKKVVEMLQEIK 886 (888)
Q Consensus 849 ~~~~~~--~~~~~li~~cl~~dP~~RPs~~evl~~L~~i~ 886 (888)
...... .++.+++.+||+.||++||++.|+++.+..+.
T Consensus 131 ~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~~ 170 (176)
T smart00750 131 NLESVSAARSFADFMRVCASRLPQRREAANHYLAHCRALF 170 (176)
T ss_pred cHHHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHHH
Confidence 111222 26889999999999999999999999987664
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.5e-24 Score=252.28 Aligned_cols=265 Identities=25% Similarity=0.318 Sum_probs=151.8
Q ss_pred CCEEeCCCCcCcccCCCCCCCCCCCCEEECcCCCCCCCCCCCCCCCCcceEEEcCCCccccccCccccccccccEEEecC
Q 002721 88 LKRLDLSNNAFSGTIPSAFGNLSELEFLDLSLNKFGGVIPRELGSLKDLRFFNISNNVLVGEIPDELKSLEKLEDFQVSS 167 (888)
Q Consensus 88 L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 167 (888)
-..|||++|+|+ .+|..+. ++|+.|+|++|+|+. +|. .+++|++|+|++|+|+. +|.. .++|+.|++++
T Consensus 203 ~~~LdLs~~~Lt-sLP~~l~--~~L~~L~L~~N~Lt~-LP~---lp~~Lk~LdLs~N~Lts-LP~l---p~sL~~L~Ls~ 271 (788)
T PRK15387 203 NAVLNVGESGLT-TLPDCLP--AHITTLVIPDNNLTS-LPA---LPPELRTLEVSGNQLTS-LPVL---PPGLLELSIFS 271 (788)
T ss_pred CcEEEcCCCCCC-cCCcchh--cCCCEEEccCCcCCC-CCC---CCCCCcEEEecCCccCc-ccCc---ccccceeeccC
Confidence 456777777776 4565554 367777777777764 343 24566666666666663 3432 24566666666
Q ss_pred CCCCCCCCccccccccccEEecccccccCCCCCCCCCcccccceeeccccCCCCCCCCccCCCCcceEEecCccCCCCch
Q 002721 168 NKLNGSIPFWVGNLTNLRVFTAYENQLVGEIPDNLGSVSELELLNLHSNQLEGPIPKSIFASGKLEVLVLTQNRLTGDIP 247 (888)
Q Consensus 168 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~ 247 (888)
|.|+. +|..+ ++|+.|++++|+++. +|.. +++|++|+|++|+|++ +|..
T Consensus 272 N~L~~-Lp~lp---~~L~~L~Ls~N~Lt~-LP~~---p~~L~~LdLS~N~L~~-Lp~l---------------------- 320 (788)
T PRK15387 272 NPLTH-LPALP---SGLCKLWIFGNQLTS-LPVL---PPGLQELSVSDNQLAS-LPAL---------------------- 320 (788)
T ss_pred Cchhh-hhhch---hhcCEEECcCCcccc-cccc---ccccceeECCCCcccc-CCCC----------------------
Confidence 66652 33222 345555555555552 3321 2445555555555543 2221
Q ss_pred hhhccCCccceeeccCCccccccCCccccCCCccEEEeeccCCCCCCCccccCCCCCcEEEeecCcccccCCccccCCCC
Q 002721 248 ELVGHCKSLSNIRIGNNDLVGVIPRAIGNVSGLTYFEADNNNLSGEIVPEFSQCSNLTLLNLASNGFTGVIPPELGQLIN 327 (888)
Q Consensus 248 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~ 327 (888)
..+|+.|++++|.|+++ |.. ..+|++|+|++|+|++. |.. .++|+.|++++|+|++ +|.. ..+
T Consensus 321 -----p~~L~~L~Ls~N~L~~L-P~l---p~~Lq~LdLS~N~Ls~L-P~l---p~~L~~L~Ls~N~L~~-LP~l---~~~ 383 (788)
T PRK15387 321 -----PSELCKLWAYNNQLTSL-PTL---PSGLQELSVSDNQLASL-PTL---PSELYKLWAYNNRLTS-LPAL---PSG 383 (788)
T ss_pred -----cccccccccccCccccc-ccc---ccccceEecCCCccCCC-CCC---Ccccceehhhcccccc-Cccc---ccc
Confidence 12344445555555432 211 12455566666666542 221 2355666666666664 4432 245
Q ss_pred ccEEEeccccccCcCcccccccCcceEEEccCCcCCCCCCchhccccCcceecccCCccccccCCCccccccceEEEeec
Q 002721 328 LQELILYENSLFGEIPKSILACKNLNKLDLSNNRFNGTIPNAICDMSRLQYLLLGQNSLKGEIPHEIGNCMKLLQLHIGS 407 (888)
Q Consensus 328 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~ 407 (888)
|+.|+|++|+|.+ +|.. .++|+.|++++|+|++ +|... .+|+.|+|++|+|+ .+|..+.++++|+.|+|++
T Consensus 384 L~~LdLs~N~Lt~-LP~l---~s~L~~LdLS~N~Lss-IP~l~---~~L~~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~ 454 (788)
T PRK15387 384 LKELIVSGNRLTS-LPVL---PSELKELMVSGNRLTS-LPMLP---SGLLSLSVYRNQLT-RLPESLIHLSSETTVNLEG 454 (788)
T ss_pred cceEEecCCcccC-CCCc---ccCCCEEEccCCcCCC-CCcch---hhhhhhhhccCccc-ccChHHhhccCCCeEECCC
Confidence 7777777777763 4432 2567788888888874 55432 45677888888887 6788888888888888888
Q ss_pred ccccccCCCcccc
Q 002721 408 NYLTGSIPPEIGH 420 (888)
Q Consensus 408 N~l~~~~p~~~~~ 420 (888)
|+|++..|..+.+
T Consensus 455 N~Ls~~~~~~L~~ 467 (788)
T PRK15387 455 NPLSERTLQALRE 467 (788)
T ss_pred CCCCchHHHHHHH
Confidence 8888776665533
|
|
| >PRK15387 E3 ubiquitin-protein ligase SspH2; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.1e-24 Score=247.80 Aligned_cols=243 Identities=30% Similarity=0.357 Sum_probs=116.0
Q ss_pred cccEEecccccccCCCCCCCCCcccccceeeccccCCCCCCCCccCCCCcceEEecCccCCCCchhhhccCCccceeecc
Q 002721 183 NLRVFTAYENQLVGEIPDNLGSVSELELLNLHSNQLEGPIPKSIFASGKLEVLVLTQNRLTGDIPELVGHCKSLSNIRIG 262 (888)
Q Consensus 183 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~ 262 (888)
+|+.|++.+|+++. +|.. +++|++|+|++|+|+. +|.. .++|+.|+|++|.|+. +|..+ ++|+.|+++
T Consensus 223 ~L~~L~L~~N~Lt~-LP~l---p~~Lk~LdLs~N~Lts-LP~l---p~sL~~L~Ls~N~L~~-Lp~lp---~~L~~L~Ls 290 (788)
T PRK15387 223 HITTLVIPDNNLTS-LPAL---PPELRTLEVSGNQLTS-LPVL---PPGLLELSIFSNPLTH-LPALP---SGLCKLWIF 290 (788)
T ss_pred CCCEEEccCCcCCC-CCCC---CCCCcEEEecCCccCc-ccCc---ccccceeeccCCchhh-hhhch---hhcCEEECc
Confidence 34444444444442 3321 2445555555555552 2321 2345555555555543 22221 345555555
Q ss_pred CCccccccCCccccCCCccEEEeeccCCCCCCCccccCCCCCcEEEeecCcccccCCccccCCCCccEEEeccccccCcC
Q 002721 263 NNDLVGVIPRAIGNVSGLTYFEADNNNLSGEIVPEFSQCSNLTLLNLASNGFTGVIPPELGQLINLQELILYENSLFGEI 342 (888)
Q Consensus 263 ~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~ 342 (888)
+|+|+.+ |. ..++|++|++++|+|++. |.. ..+|+.|++++|+|++ +|.. ..+|+.|+|++|+|++ +
T Consensus 291 ~N~Lt~L-P~---~p~~L~~LdLS~N~L~~L-p~l---p~~L~~L~Ls~N~L~~-LP~l---p~~Lq~LdLS~N~Ls~-L 357 (788)
T PRK15387 291 GNQLTSL-PV---LPPGLQELSVSDNQLASL-PAL---PSELCKLWAYNNQLTS-LPTL---PSGLQELSVSDNQLAS-L 357 (788)
T ss_pred CCccccc-cc---cccccceeECCCCccccC-CCC---cccccccccccCcccc-cccc---ccccceEecCCCccCC-C
Confidence 5555532 22 124455555555555542 221 1245555566666653 3321 1345666666666653 3
Q ss_pred cccccccCcceEEEccCCcCCCCCCchhccccCcceecccCCccccccCCCccccccceEEEeecccccccCCCcccccc
Q 002721 343 PKSILACKNLNKLDLSNNRFNGTIPNAICDMSRLQYLLLGQNSLKGEIPHEIGNCMKLLQLHIGSNYLTGSIPPEIGHIR 422 (888)
Q Consensus 343 p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~ 422 (888)
|.. ..+|+.|++++|+|++ +|.. .++|+.|+|++|+|++ +|... .+|+.|++++|.++ .+|... .
T Consensus 358 P~l---p~~L~~L~Ls~N~L~~-LP~l---~~~L~~LdLs~N~Lt~-LP~l~---s~L~~LdLS~N~Ls-sIP~l~---~ 422 (788)
T PRK15387 358 PTL---PSELYKLWAYNNRLTS-LPAL---PSGLKELIVSGNRLTS-LPVLP---SELKELMVSGNRLT-SLPMLP---S 422 (788)
T ss_pred CCC---Ccccceehhhcccccc-Cccc---ccccceEEecCCcccC-CCCcc---cCCCEEEccCCcCC-CCCcch---h
Confidence 332 2345556666666653 4432 2345666666666652 34322 34555666666655 344322 2
Q ss_pred chhhhhhccCccccccCCccccCCCCccEEEeeCCccccCCchhh
Q 002721 423 NLQIALNLSFNHLHGSLPPELGKLDKLVSFDVSNNQLSGTIPSAL 467 (888)
Q Consensus 423 ~L~~~L~ls~N~l~~~~p~~~~~l~~L~~LdLs~N~l~~~~p~~~ 467 (888)
+|+ .|++++|+|+ .+|..++.+++|+.|+|++|+|++.+|..+
T Consensus 423 ~L~-~L~Ls~NqLt-~LP~sl~~L~~L~~LdLs~N~Ls~~~~~~L 465 (788)
T PRK15387 423 GLL-SLSVYRNQLT-RLPESLIHLSSETTVNLEGNPLSERTLQAL 465 (788)
T ss_pred hhh-hhhhccCccc-ccChHHhhccCCCeEECCCCCCCchHHHHH
Confidence 233 3555555554 445555555555555555555555555444
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=8.9e-24 Score=228.21 Aligned_cols=169 Identities=15% Similarity=0.132 Sum_probs=131.1
Q ss_pred HHHHhcCCcceeeecccceEEEEEeC--CCcEEEEEEeeccCh--hhhHHHHHHHHHHHHHhccCCCceee-eeeEEEeC
Q 002721 602 VVKATMKDSNMIYCGTFSTVYKAVMP--SGLILSVKRLKSMDR--TIIHHQNKMIRELEKLSKLCHDNLVR-PIGFVIYE 676 (888)
Q Consensus 602 ~~~~~~~~~~~ig~G~~g~Vy~~~~~--~~~~vavK~~~~~~~--~~~~~~~~~~~E~~~l~~l~hpnIv~-~~~~~~~~ 676 (888)
...++|...+.||+|+||+||+|+.. +++.||||++..... ......+.+.+|++++++++|+|+++ ++++
T Consensus 15 ~~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~---- 90 (365)
T PRK09188 15 ALSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLAT---- 90 (365)
T ss_pred cccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEc----
Confidence 34568999999999999999999854 578889998753211 12223457999999999999999985 4432
Q ss_pred CeeEEEEecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCC-CCCCeEeCCCCCceEecccc
Q 002721 677 DVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDI-SSGNVLLDADFKPLLGEIEI 755 (888)
Q Consensus 677 ~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDl-kp~NIll~~~~~~kl~Dfg~ 755 (888)
+..|+||||++|++|... .. . ....++.|+++||+|||++||+|||| ||+||+++.++.+||+|||+
T Consensus 91 ~~~~LVmE~~~G~~L~~~-~~---~--------~~~~~~~~i~~aL~~lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGl 158 (365)
T PRK09188 91 GKDGLVRGWTEGVPLHLA-RP---H--------GDPAWFRSAHRALRDLHRAGITHNDLAKPQNWLMGPDGEAAVIDFQL 158 (365)
T ss_pred CCcEEEEEccCCCCHHHh-Cc---c--------chHHHHHHHHHHHHHHHHCCCeeCCCCCcceEEEcCCCCEEEEECcc
Confidence 467999999999999732 11 0 01467889999999999999999999 99999999999999999999
Q ss_pred ccccCCCCCccc------ccccccccceecccccccC
Q 002721 756 SKLLDPSKGTAS------ISAVAGSFGYIPPEYAYTM 786 (888)
Q Consensus 756 a~~~~~~~~~~~------~~~~~gt~~y~aPE~~~~~ 786 (888)
++.+........ .....+++.|+|||.+...
T Consensus 159 A~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~ 195 (365)
T PRK09188 159 ASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR 195 (365)
T ss_pred ceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence 997754332211 2356788899999987643
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=9.4e-23 Score=221.89 Aligned_cols=260 Identities=19% Similarity=0.161 Sum_probs=190.5
Q ss_pred hcCCcceeeecccceEEEEEeCC--CcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCC----CceeeeeeEE-EeCCe
Q 002721 606 TMKDSNMIYCGTFSTVYKAVMPS--GLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCH----DNLVRPIGFV-IYEDV 678 (888)
Q Consensus 606 ~~~~~~~ig~G~~g~Vy~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h----pnIv~~~~~~-~~~~~ 678 (888)
+|++.+.||+|+||.||.|.... ...+|+|.......... ..+..|..++..+.. +++..+++.. ..+..
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~---~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~ 95 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKP---SVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDF 95 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCC---ccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCce
Confidence 89999999999999999999654 35789988764332211 156778888888863 6899999998 47778
Q ss_pred eEEEEecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCC-----CCceEecc
Q 002721 679 ALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDAD-----FKPLLGEI 753 (888)
Q Consensus 679 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~-----~~~kl~Df 753 (888)
.|+||+.+ |.+|.++..... ...++..++.+|+.|++.+|+++|+.|++||||||+|+.+... ..+.+.||
T Consensus 96 ~~iVM~l~-G~sL~dl~~~~~---~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDf 171 (322)
T KOG1164|consen 96 NFIVMSLL-GPSLEDLRKRNP---PGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDF 171 (322)
T ss_pred eEEEEecc-CccHHHHHHhCC---CCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEec
Confidence 99999988 679999886655 2278999999999999999999999999999999999999865 35899999
Q ss_pred cccc--ccCCCCCc----c-c-ccccccccceecccccccCCcCccccchhHHHHHHHHHhCCCCCCCCCCCccchhhhc
Q 002721 754 EISK--LLDPSKGT----A-S-ISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWV 825 (888)
Q Consensus 754 g~a~--~~~~~~~~----~-~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~ 825 (888)
|+++ .+...... . . .....||..|++++...+...+.+.|+||++.++.|+..|..||........ ...+
T Consensus 172 Glar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~--~~~~ 249 (322)
T KOG1164|consen 172 GLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEMTDL--KSKF 249 (322)
T ss_pred CCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccccch--HHHH
Confidence 9998 32222111 1 1 1345699999999999999999999999999999999999999965432111 0000
Q ss_pred cccCCCCCCcccccccccccCCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhh
Q 002721 826 HGAPARGETPEQILDARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEMLQEIK 886 (888)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~i~ 886 (888)
...... . .......... .++.++...+-..+..++|....+.+.++...
T Consensus 250 ~~~~~~------~---~~~~~~~~~~---~~~~~~~~~~~~~~~~~~Pdy~~~~~~l~~~~ 298 (322)
T KOG1164|consen 250 EKDPRK------L---LTDRFGDLKP---EEFAKILEYIDSLDYEDKPDYEKLAELLKDVF 298 (322)
T ss_pred HHHhhh------h---ccccccCCCh---HHHHHHHHHhhccCCcCCCCHHHHHHHHHHHH
Confidence 000000 0 0000111122 23334444444588999999999999887654
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.6e-23 Score=198.92 Aligned_cols=263 Identities=17% Similarity=0.184 Sum_probs=197.8
Q ss_pred HHHHhcCCcceeeecccceEEEEE-eCCCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccC-CCceeeeeeEEEeCCee
Q 002721 602 VVKATMKDSNMIYCGTFSTVYKAV-MPSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLC-HDNLVRPIGFVIYEDVA 679 (888)
Q Consensus 602 ~~~~~~~~~~~ig~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~ 679 (888)
+..+.|+..++||+|+||.+|.|. ..+|..||+|+-...... .++..|.++.+.++ ...|..+..|..+.++-
T Consensus 12 iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~h-----pqL~yEskvY~iL~~g~GiP~i~~y~~e~~yn 86 (341)
T KOG1163|consen 12 IVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKH-----PQLLYESKVYRILQGGVGIPHIRHYGTEKDYN 86 (341)
T ss_pred eeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCC-----cchhHHHHHHHHhccCCCCchhhhhccccccc
Confidence 456789999999999999999999 668999999987644332 26788999999996 46777888888888999
Q ss_pred EEEEecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCC---CCceEeccccc
Q 002721 680 LLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDAD---FKPLLGEIEIS 756 (888)
Q Consensus 680 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~---~~~kl~Dfg~a 756 (888)
.+|||.+ |.+|++++.-... +++..+++-++-|++.-++|+|.+++|||||||+|+|+.-+ ..+.++|||+|
T Consensus 87 vlVMdLL-GPsLEdLfnfC~R----~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLa 161 (341)
T KOG1163|consen 87 VLVMDLL-GPSLEDLFNFCSR----RFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLA 161 (341)
T ss_pred eeeeecc-CccHHHHHHHHhh----hhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceeeccccccceEEEEeccch
Confidence 9999988 7899999875443 67889999999999999999999999999999999999633 56889999999
Q ss_pred cccCCCCCcc-----cccccccccceecccccccCCcCccccchhHHHHHHHHHhCCCCCCCCCCCccchhhhccccCCC
Q 002721 757 KLLDPSKGTA-----SISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPAR 831 (888)
Q Consensus 757 ~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~ 831 (888)
+.+.+..... ......||.+|.+-....+..-+.+.|+-|+|.++.+.--|..||++.......
T Consensus 162 Kky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~tk~----------- 230 (341)
T KOG1163|consen 162 KKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAATKK----------- 230 (341)
T ss_pred hhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhhHH-----------
Confidence 9876543221 123457999999988877888889999999999999999999999875332110
Q ss_pred CCCcccccccccccCC-cCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhh
Q 002721 832 GETPEQILDARLSTVS-FGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEMLQEIK 886 (888)
Q Consensus 832 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~i~ 886 (888)
...+.+......... .-....+.++...+..|-..--++-|...-+.+.+.-+.
T Consensus 231 -QKyEkI~EkK~s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~ylrqlFriLf 285 (341)
T KOG1163|consen 231 -QKYEKISEKKMSTPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMYLRQLFRILF 285 (341)
T ss_pred -HHHHHHHHhhcCCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHHHHHHHHHHH
Confidence 111222221111100 001112345556667777777788888777666665543
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.89 E-value=6.5e-24 Score=244.57 Aligned_cols=258 Identities=15% Similarity=0.140 Sum_probs=191.5
Q ss_pred CCcceeeecccceEEEEEeC-CCcEEEEEEeec---cChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCCeeEEEE
Q 002721 608 KDSNMIYCGTFSTVYKAVMP-SGLILSVKRLKS---MDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVALLLH 683 (888)
Q Consensus 608 ~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~---~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 683 (888)
...+++|.|++|.|+.+... ....++.|.... ...........+..|..+-..+.|||++.....+.+....+-+|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 45789999999988888733 344444443331 12222223334677888888999999998888877766666669
Q ss_pred ecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccccccccCCCC
Q 002721 684 NYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSK 763 (888)
Q Consensus 684 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 763 (888)
|||++ ||..++.... .+...++..++.|++.|++|+|+.||.|||+||+|++++.+|.+|++|||.+..+....
T Consensus 401 E~~~~-Dlf~~~~~~~-----~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~ 474 (601)
T KOG0590|consen 401 EYCPY-DLFSLVMSNG-----KLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPW 474 (601)
T ss_pred hcccH-HHHHHHhccc-----ccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCceEEeecCcceeeccCc
Confidence 99999 9999998752 45667889999999999999999999999999999999999999999999998765433
Q ss_pred Cc--ccccccccccceecccccccCCcCc-cccchhHHHHHHHHHhCCCCCCCCCCCccchhhhccccCCCCCCcccccc
Q 002721 764 GT--ASISAVAGSFGYIPPEYAYTMQVTA-PGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQILD 840 (888)
Q Consensus 764 ~~--~~~~~~~gt~~y~aPE~~~~~~~~~-~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 840 (888)
.. ......+|+.+|+|||.+.+..|++ ..||||.|++++.|.+|+.||.....+...+...... ...
T Consensus 475 e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~~~~------~~~---- 544 (601)
T KOG0590|consen 475 EKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTNNYS------DQR---- 544 (601)
T ss_pred chhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhhccc------ccc----
Confidence 32 3445788999999999999999988 4799999999999999999998654443322000000 000
Q ss_pred cccccCCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002721 841 ARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEM 881 (888)
Q Consensus 841 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~ 881 (888)
....+..........+...++.+|++.||.+|.|+++|++.
T Consensus 545 ~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d 585 (601)
T KOG0590|consen 545 NIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILND 585 (601)
T ss_pred ccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhC
Confidence 00111111223344556789999999999999999999863
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.8e-22 Score=202.06 Aligned_cols=260 Identities=14% Similarity=0.126 Sum_probs=196.2
Q ss_pred HHhcCCcceeeecccceEEEEE-eCCCcEEEEEEeeccChhhhHHHHHHHHHHHHHhcc-CCCceeeeeeEEEeCCeeEE
Q 002721 604 KATMKDSNMIYCGTFSTVYKAV-MPSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKL-CHDNLVRPIGFVIYEDVALL 681 (888)
Q Consensus 604 ~~~~~~~~~ig~G~~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~~l 681 (888)
.-.|++.++||+|+||+++.|+ .-+++.||||.-..... ..++..|.+..+.+ ..+.|..+|-|..++.+-.+
T Consensus 27 G~hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS~-----APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiL 101 (449)
T KOG1165|consen 27 GPHYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKSE-----APQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNIL 101 (449)
T ss_pred cccceeccccccCcceeeecccccccCceEEEEeccccCC-----cchHHHHHHHHHHHcCCCCCCceeeeccccchhhh
Confidence 3479999999999999999999 56899999997653322 22677888888888 47999999998888889999
Q ss_pred EEecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCC-----CCceEeccccc
Q 002721 682 LHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDAD-----FKPLLGEIEIS 756 (888)
Q Consensus 682 v~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~-----~~~kl~Dfg~a 756 (888)
|||.+ |.+|+|++.-.+. +++.+++..+|.|++.-++|+|++..|.|||||+|+||... ..+.++|||+|
T Consensus 102 VidLL-GPSLEDLFD~CgR----~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmA 176 (449)
T KOG1165|consen 102 VIDLL-GPSLEDLFDLCGR----RFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMA 176 (449)
T ss_pred hhhhh-CcCHHHHHHHhcC----cccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCCCCCCceEEEEeccch
Confidence 99988 7799999886654 78999999999999999999999999999999999999744 35889999999
Q ss_pred cccCCCCCcc-----cccccccccceecccccccCCcCccccchhHHHHHHHHHhCCCCCCCCCCCccchhhhccccCCC
Q 002721 757 KLLDPSKGTA-----SISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPAR 831 (888)
Q Consensus 757 ~~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~ 831 (888)
+.+.+..... ......||.+||+-....+.+-+.+.|+-|+|-++.+.+-|..||.+-.... .
T Consensus 177 K~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA~t------------n 244 (449)
T KOG1165|consen 177 KEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKADT------------N 244 (449)
T ss_pred hhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccCcc------------h
Confidence 9876543322 1235679999999999999999999999999999999999999998743221 1
Q ss_pred CCCcccccccccccCC-cCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHh
Q 002721 832 GETPEQILDARLSTVS-FGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEMLQEI 885 (888)
Q Consensus 832 ~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~i 885 (888)
....++|-+.+..... .-....+.++..-+.-.-..+-.+-|..+-+...+.++
T Consensus 245 K~kYeKIGe~Kr~T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdylr~Lf~dv 299 (449)
T KOG1165|consen 245 KEKYEKIGETKRSTPIEVLCEGFPEEFATYLRYVRRLDFFETPDYDYLRKLFDDV 299 (449)
T ss_pred HHHHHHhccccccCCHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHHHHHHHHH
Confidence 1122222222211110 00111223444444444466777888877766666554
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.5e-23 Score=203.53 Aligned_cols=252 Identities=20% Similarity=0.296 Sum_probs=186.6
Q ss_pred hcCCcceeeecccceEEEEEeCCCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCCeeEEEEec
Q 002721 606 TMKDSNMIYCGTFSTVYKAVMPSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVALLLHNY 685 (888)
Q Consensus 606 ~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 685 (888)
......+|.+...|+.|+|+++ |..+++|+++..+.. ....+.|..|.-.++-+.||||..++|.|..+....++..|
T Consensus 191 ~lnl~tkl~e~hsgelwrgrwq-gndivakil~vr~~t-~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~ 268 (448)
T KOG0195|consen 191 SLNLITKLAESHSGELWRGRWQ-GNDIVAKILNVREVT-ARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQY 268 (448)
T ss_pred hhhhhhhhccCCCccccccccc-Ccchhhhhhhhhhcc-hhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeee
Confidence 3445567888899999999984 455667887744333 33334788899999999999999999999999999999999
Q ss_pred CCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccC-C-eeecCCCCCCeEeCCCCCceEeccccccccCCCC
Q 002721 686 LPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHV-A-IIHLDISSGNVLLDADFKPLLGEIEISKLLDPSK 763 (888)
Q Consensus 686 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~-~-ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~~~~~ 763 (888)
|+.|+|+.++++.... ..+-.++.+++.+||+|++|||+. . |..--+.+..++||++.+++|+- +-+++.-
T Consensus 269 mp~gslynvlhe~t~v---vvd~sqav~faldiargmaflhslep~ipr~~lns~hvmidedltarism-ad~kfsf--- 341 (448)
T KOG0195|consen 269 MPFGSLYNVLHEQTSV---VVDHSQAVRFALDIARGMAFLHSLEPMIPRFYLNSKHVMIDEDLTARISM-ADTKFSF--- 341 (448)
T ss_pred ccchHHHHHHhcCccE---EEecchHHHHHHHHHhhHHHHhhcchhhhhhhcccceEEecchhhhheec-ccceeee---
Confidence 9999999999986543 456678999999999999999983 3 44446889999999998887642 1112111
Q ss_pred CcccccccccccceecccccccCCcC---ccccchhHHHHHHHHHhCCCCCCCCCCCccchhhhccccCCCCCCcccccc
Q 002721 764 GTASISAVAGSFGYIPPEYAYTMQVT---APGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQILD 840 (888)
Q Consensus 764 ~~~~~~~~~gt~~y~aPE~~~~~~~~---~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 840 (888)
........+.||+||.+...+-+ .++|+|||++++||+.|...||.+-..-+.. ..-.+.
T Consensus 342 ---qe~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevpfadlspmecg--------------mkiale 404 (448)
T KOG0195|consen 342 ---QEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVPFADLSPMECG--------------MKIALE 404 (448)
T ss_pred ---eccccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccccccCCchhhh--------------hhhhhc
Confidence 11233457899999988766533 4789999999999999999999864322111 011111
Q ss_pred cccccCCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhh
Q 002721 841 ARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEMLQEIK 886 (888)
Q Consensus 841 ~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~i~ 886 (888)
......+ +.....+.++|.-|+..||.+||.++.|+-.||++.
T Consensus 405 glrv~ip---pgis~hm~klm~icmnedpgkrpkfdmivpilekm~ 447 (448)
T KOG0195|consen 405 GLRVHIP---PGISRHMNKLMNICMNEDPGKRPKFDMIVPILEKMI 447 (448)
T ss_pred cccccCC---CCccHHHHHHHHHHhcCCCCcCCCcceehhhHHHhc
Confidence 1111122 233455667888899999999999999999999875
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.6e-22 Score=237.23 Aligned_cols=263 Identities=21% Similarity=0.376 Sum_probs=145.2
Q ss_pred CCEEECcCCCCCCCCCCCCCCCCcceEEEcCCCccccccCccccccccccEEEecCCCCCCCCCccccccccccEEeccc
Q 002721 112 LEFLDLSLNKFGGVIPRELGSLKDLRFFNISNNVLVGEIPDELKSLEKLEDFQVSSNKLNGSIPFWVGNLTNLRVFTAYE 191 (888)
Q Consensus 112 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~ 191 (888)
...|+|++++++. +|..+. ++|+.|+|++|+|+ .+|..+. ++|+.|++++|+|+ .+|..+. ++|+.|+|++
T Consensus 180 ~~~L~L~~~~Lts-LP~~Ip--~~L~~L~Ls~N~Lt-sLP~~l~--~nL~~L~Ls~N~Lt-sLP~~l~--~~L~~L~Ls~ 250 (754)
T PRK15370 180 KTELRLKILGLTT-IPACIP--EQITTLILDNNELK-SLPENLQ--GNIKTLYANSNQLT-SIPATLP--DTIQEMELSI 250 (754)
T ss_pred ceEEEeCCCCcCc-CCcccc--cCCcEEEecCCCCC-cCChhhc--cCCCEEECCCCccc-cCChhhh--ccccEEECcC
Confidence 4445555555542 333331 34555555555554 2333222 24555555555554 2333322 2455555555
Q ss_pred ccccCCCCCCCCCcccccceeeccccCCCCCCCCccCCCCcceEEecCccCCCCchhhhccCCccceeeccCCccccccC
Q 002721 192 NQLVGEIPDNLGSVSELELLNLHSNQLEGPIPKSIFASGKLEVLVLTQNRLTGDIPELVGHCKSLSNIRIGNNDLVGVIP 271 (888)
Q Consensus 192 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~ 271 (888)
|+++ .+|..+. ++|+.|+|++|+|+ .+|..+. .+|+.|+|++|+|++.+ ..+. ++|+.|++++|.++.+ |
T Consensus 251 N~L~-~LP~~l~--s~L~~L~Ls~N~L~-~LP~~l~--~sL~~L~Ls~N~Lt~LP-~~lp--~sL~~L~Ls~N~Lt~L-P 320 (754)
T PRK15370 251 NRIT-ELPERLP--SALQSLDLFHNKIS-CLPENLP--EELRYLSVYDNSIRTLP-AHLP--SGITHLNVQSNSLTAL-P 320 (754)
T ss_pred CccC-cCChhHh--CCCCEEECcCCccC-ccccccC--CCCcEEECCCCccccCc-ccch--hhHHHHHhcCCccccC-C
Confidence 5555 3444432 35666666666665 3454443 35666666666666432 2221 3566677777777643 3
Q ss_pred CccccCCCccEEEeeccCCCCCCCccccCCCCCcEEEeecCcccccCCccccCCCCccEEEeccccccCcCcccccccCc
Q 002721 272 RAIGNVSGLTYFEADNNNLSGEIVPEFSQCSNLTLLNLASNGFTGVIPPELGQLINLQELILYENSLFGEIPKSILACKN 351 (888)
Q Consensus 272 ~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~ 351 (888)
..+ .++|++|++++|.+++ +|..+. ++|+.|++++|+|+ .+|..+. ++|+.|+|++|+|. .+|..+. .+
T Consensus 321 ~~l--~~sL~~L~Ls~N~Lt~-LP~~l~--~sL~~L~Ls~N~L~-~LP~~lp--~~L~~LdLs~N~Lt-~LP~~l~--~s 389 (754)
T PRK15370 321 ETL--PPGLKTLEAGENALTS-LPASLP--PELQVLDVSKNQIT-VLPETLP--PTITTLDVSRNALT-NLPENLP--AA 389 (754)
T ss_pred ccc--cccceeccccCCcccc-CChhhc--CcccEEECCCCCCC-cCChhhc--CCcCEEECCCCcCC-CCCHhHH--HH
Confidence 222 1467777777777765 344442 57788888888877 3555443 57888888888877 3454443 36
Q ss_pred ceEEEccCCcCCCCCCchh----ccccCcceecccCCccccccCCCccccccceEEEeecccccc
Q 002721 352 LNKLDLSNNRFNGTIPNAI----CDMSRLQYLLLGQNSLKGEIPHEIGNCMKLLQLHIGSNYLTG 412 (888)
Q Consensus 352 L~~L~Ls~N~l~~~~p~~~----~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 412 (888)
|+.|++++|+|+ .+|..+ ..++++..|+|.+|++.. ..+.+|+.| ++.+.+.|
T Consensus 390 L~~LdLs~N~L~-~LP~sl~~~~~~~~~l~~L~L~~Npls~------~tl~~L~~L-l~s~~~~g 446 (754)
T PRK15370 390 LQIMQASRNNLV-RLPESLPHFRGEGPQPTRIIVEYNPFSE------RTIQNMQRL-MSSVGYQG 446 (754)
T ss_pred HHHHhhccCCcc-cCchhHHHHhhcCCCccEEEeeCCCccH------HHHHHHHHh-hhcccccC
Confidence 788888888887 455443 334677888888888762 344455555 33444433
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.87 E-value=3.3e-21 Score=211.83 Aligned_cols=263 Identities=24% Similarity=0.302 Sum_probs=198.5
Q ss_pred cCCcceeeecccceEEEEEeCCCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCC-ceeeeeeEEEeCCeeEEEEec
Q 002721 607 MKDSNMIYCGTFSTVYKAVMPSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHD-NLVRPIGFVIYEDVALLLHNY 685 (888)
Q Consensus 607 ~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp-nIv~~~~~~~~~~~~~lv~e~ 685 (888)
|...+.||.|+||.||++... ..+++|.+.............+.+|+.+++.+.|+ +|+++++++......+++++|
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~--~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~ 79 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR--KLVALKVLAKKLESKSKEVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEY 79 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec--cEEEEEeechhhccchhHHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEec
Confidence 667789999999999999976 88999999865544333456899999999999988 799999999877778999999
Q ss_pred CCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCC-CceEeccccccccCCCCC
Q 002721 686 LPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADF-KPLLGEIEISKLLDPSKG 764 (888)
Q Consensus 686 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~-~~kl~Dfg~a~~~~~~~~ 764 (888)
+.++++.+++...... ..++......++.|++.+++|+|+.+++|||+||+||+++..+ .++++|||.+........
T Consensus 80 ~~~~~l~~~~~~~~~~--~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~ 157 (384)
T COG0515 80 VDGGSLEDLLKKIGRK--GPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGS 157 (384)
T ss_pred CCCCcHHHHHHhcccc--cCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCc
Confidence 9999999777765321 2467788999999999999999999999999999999999988 699999999986554332
Q ss_pred cc----cccccccccceeccccccc---CCcCccccchhHHHHHHHHHhCCCCCCCCCCC--ccchhhhccccCCCCCCc
Q 002721 765 TA----SISAVAGSFGYIPPEYAYT---MQVTAPGNVYSYGVVLLEILTTRLPVEEDFGE--GVDLVKWVHGAPARGETP 835 (888)
Q Consensus 765 ~~----~~~~~~gt~~y~aPE~~~~---~~~~~~~DiwSlG~il~elltg~~P~~~~~~~--~~~~~~~~~~~~~~~~~~ 835 (888)
.. ......|+..|+|||.+.+ ..++...|+||+|++++++++|..||...... .......+......
T Consensus 158 ~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~---- 233 (384)
T COG0515 158 TSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTP---- 233 (384)
T ss_pred cccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCc----
Confidence 21 2356789999999999887 57888999999999999999999997654321 11111111111110
Q ss_pred ccccccccccCCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHH
Q 002721 836 EQILDARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEM 881 (888)
Q Consensus 836 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~ 881 (888)
......... ........+.+++..|+..+|..|.++.+....
T Consensus 234 --~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~ 275 (384)
T COG0515 234 --SLASPLSPS--NPELISKAASDLLKKLLAKDPKNRLSSSSDLSH 275 (384)
T ss_pred --ccccccCcc--ccchhhHHHHHHHHHHHhcCchhcCCHHHHhhc
Confidence 000000000 001223456788889999999999998876653
|
|
| >PRK15370 E3 ubiquitin-protein ligase SlrP; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=2.7e-22 Score=235.30 Aligned_cols=281 Identities=22% Similarity=0.373 Sum_probs=199.3
Q ss_pred CcceEEEcCCCccccccCccccccccccEEEecCCCCCCCCCccccccccccEEecccccccCCCCCCCCCcccccceee
Q 002721 134 KDLRFFNISNNVLVGEIPDELKSLEKLEDFQVSSNKLNGSIPFWVGNLTNLRVFTAYENQLVGEIPDNLGSVSELELLNL 213 (888)
Q Consensus 134 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 213 (888)
.+...|+|+++.++ .+|..+. ++|+.|+|++|+|+. +|..+. ++|+.|++++|+++ .+|..+. ++|+.|+|
T Consensus 178 ~~~~~L~L~~~~Lt-sLP~~Ip--~~L~~L~Ls~N~Lts-LP~~l~--~nL~~L~Ls~N~Lt-sLP~~l~--~~L~~L~L 248 (754)
T PRK15370 178 NNKTELRLKILGLT-TIPACIP--EQITTLILDNNELKS-LPENLQ--GNIKTLYANSNQLT-SIPATLP--DTIQEMEL 248 (754)
T ss_pred cCceEEEeCCCCcC-cCCcccc--cCCcEEEecCCCCCc-CChhhc--cCCCEEECCCCccc-cCChhhh--ccccEEEC
Confidence 45678999999888 5666553 478899999999984 555443 58899999999988 4666553 47889999
Q ss_pred ccccCCCCCCCCccCCCCcceEEecCccCCCCchhhhccCCccceeeccCCccccccCCccccCCCccEEEeeccCCCCC
Q 002721 214 HSNQLEGPIPKSIFASGKLEVLVLTQNRLTGDIPELVGHCKSLSNIRIGNNDLVGVIPRAIGNVSGLTYFEADNNNLSGE 293 (888)
Q Consensus 214 ~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~ 293 (888)
++|+++ .+|..+. .+|+.|+|++|+|+. +|..+. ++|+.|+|++|+|++. |..+. ++|+.|++++|+++..
T Consensus 249 s~N~L~-~LP~~l~--s~L~~L~Ls~N~L~~-LP~~l~--~sL~~L~Ls~N~Lt~L-P~~lp--~sL~~L~Ls~N~Lt~L 319 (754)
T PRK15370 249 SINRIT-ELPERLP--SALQSLDLFHNKISC-LPENLP--EELRYLSVYDNSIRTL-PAHLP--SGITHLNVQSNSLTAL 319 (754)
T ss_pred cCCccC-cCChhHh--CCCCEEECcCCccCc-cccccC--CCCcEEECCCCccccC-cccch--hhHHHHHhcCCccccC
Confidence 999988 5676654 478999999999885 455443 5789999999998864 43332 4688889999998854
Q ss_pred CCccccCCCCCcEEEeecCcccccCCccccCCCCccEEEeccccccCcCcccccccCcceEEEccCCcCCCCCCchhccc
Q 002721 294 IVPEFSQCSNLTLLNLASNGFTGVIPPELGQLINLQELILYENSLFGEIPKSILACKNLNKLDLSNNRFNGTIPNAICDM 373 (888)
Q Consensus 294 ~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l 373 (888)
|..+. ++|+.|++++|.+++ +|..+. ++|+.|++++|+|. .+|..+. ++|+.|++++|+|+ .+|..+.
T Consensus 320 -P~~l~--~sL~~L~Ls~N~Lt~-LP~~l~--~sL~~L~Ls~N~L~-~LP~~lp--~~L~~LdLs~N~Lt-~LP~~l~-- 387 (754)
T PRK15370 320 -PETLP--PGLKTLEAGENALTS-LPASLP--PELQVLDVSKNQIT-VLPETLP--PTITTLDVSRNALT-NLPENLP-- 387 (754)
T ss_pred -Ccccc--ccceeccccCCcccc-CChhhc--CcccEEECCCCCCC-cCChhhc--CCcCEEECCCCcCC-CCCHhHH--
Confidence 43332 688899999999885 566554 58999999999887 4666553 68899999999988 4565554
Q ss_pred cCcceecccCCccccccCCCc----cccccceEEEeecccccccCCCccccccchhhhhhccCccccc-cCCccccCCCC
Q 002721 374 SRLQYLLLGQNSLKGEIPHEI----GNCMKLLQLHIGSNYLTGSIPPEIGHIRNLQIALNLSFNHLHG-SLPPELGKLDK 448 (888)
Q Consensus 374 ~~L~~L~L~~N~l~~~~p~~~----~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~~L~ls~N~l~~-~~p~~~~~l~~ 448 (888)
..|++|++++|+++ .+|..+ ..++++..|++.+|.++. ..+.+++ .+ ++.+.+.| .++...+.+.+
T Consensus 388 ~sL~~LdLs~N~L~-~LP~sl~~~~~~~~~l~~L~L~~Npls~------~tl~~L~-~L-l~s~~~~gp~i~~~~~~~~~ 458 (754)
T PRK15370 388 AALQIMQASRNNLV-RLPESLPHFRGEGPQPTRIIVEYNPFSE------RTIQNMQ-RL-MSSVGYQGPRVLFAMGDFSI 458 (754)
T ss_pred HHHHHHhhccCCcc-cCchhHHHHhhcCCCccEEEeeCCCccH------HHHHHHH-Hh-hhcccccCCccccccccccc
Confidence 36888999999988 556554 344778889999998862 3444454 34 44455544 23444444455
Q ss_pred ccEEE
Q 002721 449 LVSFD 453 (888)
Q Consensus 449 L~~Ld 453 (888)
++...
T Consensus 459 l~~~~ 463 (754)
T PRK15370 459 VRVTR 463 (754)
T ss_pred ccccc
Confidence 54433
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.87 E-value=3.1e-22 Score=200.50 Aligned_cols=178 Identities=10% Similarity=0.076 Sum_probs=140.4
Q ss_pred HHHHHHHhcCCcceeeecccceEEEEEeCCCcEEEEEEeeccChhhhHHHHH------HHHHHHHHhccCCCceeeeeeE
Q 002721 599 LDAVVKATMKDSNMIYCGTFSTVYKAVMPSGLILSVKRLKSMDRTIIHHQNK------MIRELEKLSKLCHDNLVRPIGF 672 (888)
Q Consensus 599 ~~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~------~~~E~~~l~~l~hpnIv~~~~~ 672 (888)
.+++..++|+..+++|.|+||.||.+.. ++..+|+|.+.+........... +.+|++.+.++.||+|..+.++
T Consensus 25 ~~~~l~~~y~~~~~l~~~~f~~v~l~~~-~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~rL~~~GI~~~~d~ 103 (232)
T PRK10359 25 FDDFLSYNIKTIKVFRNIDDTKVSLIDT-DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTDRVRSEGLASLNDF 103 (232)
T ss_pred HHHHhhCceEEEEEecCCCceEEEEEec-CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHHHHHHCCCCcceEe
Confidence 3567888999999999999999999765 57789999998655444443333 6799999999999999999998
Q ss_pred EEeC--------CeeEEEEecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCC
Q 002721 673 VIYE--------DVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDA 744 (888)
Q Consensus 673 ~~~~--------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~ 744 (888)
+... ...++||||++|.+|.++.. ++. ....+++.++..+|+.|++|||+||+||++++
T Consensus 104 ~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~---------~~~----~~~~~i~~~l~~lH~~gi~H~Dikp~Nili~~ 170 (232)
T PRK10359 104 YLLAERKTLRYAHTYIMLIEYIEGVELNDMPE---------ISE----DVKAKIKASIESLHQHGMVSGDPHKGNFIVSK 170 (232)
T ss_pred eeecccccccccCCeEEEEEEECCccHHHhhh---------ccH----HHHHHHHHHHHHHHHcCCccCCCChHHEEEeC
Confidence 6643 35789999999999988732 121 24569999999999999999999999999999
Q ss_pred CCCceEeccccccccCCCCCcccccccccccceecccccccCCcCccccchhHHHHHHHHH
Q 002721 745 DFKPLLGEIEISKLLDPSKGTASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEIL 805 (888)
Q Consensus 745 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell 805 (888)
+| ++++|||........... ..+.....|..++||||||+++....
T Consensus 171 ~g-i~liDfg~~~~~~e~~a~--------------d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 171 NG-LRIIDLSGKRCTAQRKAK--------------DRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred CC-EEEEECCCcccccchhhH--------------HHHHHHhHhcccccccceeEeehHHH
Confidence 88 999999988765322111 11344555778999999999887654
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.6e-22 Score=230.20 Aligned_cols=252 Identities=20% Similarity=0.242 Sum_probs=183.5
Q ss_pred hcCCcceeeecccceEEEEEeCCCcEEEEEEeeccCh-hhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCCeeEEEEe
Q 002721 606 TMKDSNMIYCGTFSTVYKAVMPSGLILSVKRLKSMDR-TIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVALLLHN 684 (888)
Q Consensus 606 ~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e 684 (888)
++...+.+|++.|=+|.+|+++.|. |+||++-+.+. ..-...++-.+|++ ...++|||++++.-+...+...|+|-+
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~eG~-vVvKVFvk~~p~~sL~~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRq 101 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDREGL-VVVKVFVKQDPTISLRPFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQ 101 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCCce-EEEEEEeccCCCCCchHHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHH
Confidence 5777889999999999999988887 88999865542 22222223344555 556689999999998888888999999
Q ss_pred cCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccccccccC-CCC
Q 002721 685 YLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLD-PSK 763 (888)
Q Consensus 685 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~~-~~~ 763 (888)
|... +|+|.+..+. -+...+.+-|+.|++.||..+|..||+|||||.+||||+.-..+.|+||..-+..- +.+
T Consensus 102 yvkh-nLyDRlSTRP-----FL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeD 175 (1431)
T KOG1240|consen 102 YVKH-NLYDRLSTRP-----FLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPED 175 (1431)
T ss_pred HHhh-hhhhhhccch-----HHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeechhhhhcccccCCccCCCC
Confidence 9976 9999987654 34567788899999999999999999999999999999999999999997655321 111
Q ss_pred Cccccc----ccccccceecccccccC----------C-cCccccchhHHHHHHHHHh-CCCCCCCCCCCccchhhhccc
Q 002721 764 GTASIS----AVAGSFGYIPPEYAYTM----------Q-VTAPGNVYSYGVVLLEILT-TRLPVEEDFGEGVDLVKWVHG 827 (888)
Q Consensus 764 ~~~~~~----~~~gt~~y~aPE~~~~~----------~-~~~~~DiwSlG~il~ellt-g~~P~~~~~~~~~~~~~~~~~ 827 (888)
...... ....-..|.|||.+... . .+++.||||+||+++|+++ |++||.- .++.++..+
T Consensus 176 NPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~L-----SQL~aYr~~ 250 (1431)
T KOG1240|consen 176 NPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTL-----SQLLAYRSG 250 (1431)
T ss_pred CcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccH-----HHHHhHhcc
Confidence 111222 22334479999976541 1 5788999999999999998 6888853 223333222
Q ss_pred cCCCCCCcccccccccccCCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 002721 828 APARGETPEQILDARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEMLQ 883 (888)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~ 883 (888)
. ...++..+... +...+.+++..|++.||++|.+|++.++.-.
T Consensus 251 ~---~~~~e~~Le~I----------ed~~~Rnlil~Mi~rdPs~RlSAedyL~~yr 293 (1431)
T KOG1240|consen 251 N---ADDPEQLLEKI----------EDVSLRNLILSMIQRDPSKRLSAEDYLQKYR 293 (1431)
T ss_pred C---ccCHHHHHHhC----------cCccHHHHHHHHHccCchhccCHHHHHHhhh
Confidence 1 11122222111 1124568899999999999999999998744
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.84 E-value=5.2e-21 Score=190.39 Aligned_cols=143 Identities=17% Similarity=0.201 Sum_probs=109.7
Q ss_pred cceeeecccceEEEEEeCCCcEEEEEEeeccChhhhH-----------------------HHHHHHHHHHHHhccCCCce
Q 002721 610 SNMIYCGTFSTVYKAVMPSGLILSVKRLKSMDRTIIH-----------------------HQNKMIRELEKLSKLCHDNL 666 (888)
Q Consensus 610 ~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~-----------------------~~~~~~~E~~~l~~l~hpnI 666 (888)
...||+|+||.||+|...+|+.||+|+++........ ......+|++.+.++.++++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~v 81 (190)
T cd05147 2 NGCISTGKEANVYHATTANGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKRLVTAGI 81 (190)
T ss_pred CCccccccceEEEEEECCCCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHHHHHCCC
Confidence 4689999999999999778999999999754221100 01223459999999988776
Q ss_pred eeeeeEEEeCCeeEEEEecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhc-ccCCeeecCCCCCCeEeCCC
Q 002721 667 VRPIGFVIYEDVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFL-HHVAIIHLDISSGNVLLDAD 745 (888)
Q Consensus 667 v~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~L-H~~~ivHrDlkp~NIll~~~ 745 (888)
.....+.. ...++||||++++++........ .++..++..++.|++.+|+|+ |+.||+||||||+||+++ +
T Consensus 82 ~~p~~~~~--~~~~iVmE~i~g~~l~~~~~~~~-----~~~~~~~~~i~~qi~~~L~~l~H~~giiHrDlkP~NIli~-~ 153 (190)
T cd05147 82 PCPEPILL--KSHVLVMEFIGDDGWAAPRLKDA-----PLSESKARELYLQVIQIMRILYQDCRLVHADLSEYNLLYH-D 153 (190)
T ss_pred CCCcEEEe--cCCEEEEEEeCCCCCcchhhhcC-----CCCHHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEE-C
Confidence 44333322 23489999999877665432221 467888999999999999999 799999999999999998 4
Q ss_pred CCceEeccccccccC
Q 002721 746 FKPLLGEIEISKLLD 760 (888)
Q Consensus 746 ~~~kl~Dfg~a~~~~ 760 (888)
+.++++|||++...+
T Consensus 154 ~~v~LiDFG~a~~~~ 168 (190)
T cd05147 154 GKLYIIDVSQSVEHD 168 (190)
T ss_pred CcEEEEEccccccCC
Confidence 789999999997643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.83 E-value=2.4e-20 Score=182.38 Aligned_cols=191 Identities=16% Similarity=0.092 Sum_probs=142.0
Q ss_pred CCcceeeecccceEEEEEeCCCcEEEEEEeeccChhhhHH-HHHHHHHHHHHhccC-CCceeeeeeEEEeCCeeEEEEec
Q 002721 608 KDSNMIYCGTFSTVYKAVMPSGLILSVKRLKSMDRTIIHH-QNKMIRELEKLSKLC-HDNLVRPIGFVIYEDVALLLHNY 685 (888)
Q Consensus 608 ~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~-~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~~lv~e~ 685 (888)
.+...|++|+||+||.+.. .+.+++.+.+.......... ...+.+|+++|+++. |++|++++++ +..+++|||
T Consensus 5 ~~~~~l~~~~f~~v~~~~~-~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmey 79 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG-GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRSY 79 (218)
T ss_pred ccceeecCCCcceEEEeec-CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEee
Confidence 3567899999999998776 78888888777444432211 225789999999995 5889999886 346999999
Q ss_pred CCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCC-CCCCeEeCCCCCceEeccccccccCCCCC
Q 002721 686 LPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDI-SSGNVLLDADFKPLLGEIEISKLLDPSKG 764 (888)
Q Consensus 686 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDl-kp~NIll~~~~~~kl~Dfg~a~~~~~~~~ 764 (888)
++|.+|.+.... ....++.|++.+|+++|++||+|||| ||+||+++.++.++|+|||++........
T Consensus 80 I~G~~L~~~~~~------------~~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~ 147 (218)
T PRK12274 80 LAGAAMYQRPPR------------GDLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRAR 147 (218)
T ss_pred ecCccHHhhhhh------------hhHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcch
Confidence 999998754321 11357889999999999999999999 79999999999999999999986553321
Q ss_pred c----c--c-----ccccccccceecccccccC-CcC-ccccchhHHHHHHHHHhCCCCCCCCC
Q 002721 765 T----A--S-----ISAVAGSFGYIPPEYAYTM-QVT-APGNVYSYGVVLLEILTTRLPVEEDF 815 (888)
Q Consensus 765 ~----~--~-----~~~~~gt~~y~aPE~~~~~-~~~-~~~DiwSlG~il~elltg~~P~~~~~ 815 (888)
. . . ......++.|++|+...-- ..+ .+.+.++-|+-+|.++|+..|..++.
T Consensus 148 ~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~~ 211 (218)
T PRK12274 148 WMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWEDN 211 (218)
T ss_pred HHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCccccC
Confidence 0 0 0 0112356677777743221 222 45688899999999999999887653
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.82 E-value=9.7e-20 Score=182.20 Aligned_cols=143 Identities=20% Similarity=0.220 Sum_probs=111.8
Q ss_pred cceeeecccceEEEEEeCCCcEEEEEEeeccChhh-----------------------hHHHHHHHHHHHHHhccCCCce
Q 002721 610 SNMIYCGTFSTVYKAVMPSGLILSVKRLKSMDRTI-----------------------IHHQNKMIRELEKLSKLCHDNL 666 (888)
Q Consensus 610 ~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~-----------------------~~~~~~~~~E~~~l~~l~hpnI 666 (888)
...||+|+||+||+|+..+|+.||||+++...... ......+.+|.+.+.++.|++|
T Consensus 2 ~~~ig~G~~~~Vy~a~~~~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i 81 (190)
T cd05145 2 NGCISTGKEANVYHARTGDGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLKRLYEAGV 81 (190)
T ss_pred CceeecCCCcEEEEEEcCCCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHHHHHhCCC
Confidence 46899999999999997789999999998542210 0011234689999999999987
Q ss_pred eeeeeEEEeCCeeEEEEecCCCCCHHHH-hhccCCCCCCCCCHHHHHHHHHHHHHHHhhccc-CCeeecCCCCCCeEeCC
Q 002721 667 VRPIGFVIYEDVALLLHNYLPNGTLAQL-LHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHH-VAIIHLDISSGNVLLDA 744 (888)
Q Consensus 667 v~~~~~~~~~~~~~lv~e~~~~g~L~~~-l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlkp~NIll~~ 744 (888)
.....+... ..|+||||++++++... +... .++..+...++.|++.++.++|+ .||+||||||+||+++
T Consensus 82 ~~p~~~~~~--~~~lVmE~~~g~~~~~~~l~~~------~~~~~~~~~i~~~l~~~l~~lH~~~givHrDlkP~NIll~- 152 (190)
T cd05145 82 PVPEPILLK--KNVLVMEFIGDDGSPAPRLKDV------PLEEEEAEELYEQVVEQMRRLYQEAGLVHGDLSEYNILYH- 152 (190)
T ss_pred CCceEEEec--CCEEEEEEecCCCchhhhhhhc------cCCHHHHHHHHHHHHHHHHHHHHhCCEecCCCChhhEEEE-
Confidence 554444333 34899999998755433 3321 45677889999999999999999 9999999999999999
Q ss_pred CCCceEeccccccccCC
Q 002721 745 DFKPLLGEIEISKLLDP 761 (888)
Q Consensus 745 ~~~~kl~Dfg~a~~~~~ 761 (888)
++.++++|||++.....
T Consensus 153 ~~~~~liDFG~a~~~~~ 169 (190)
T cd05145 153 DGKPYIIDVSQAVELDH 169 (190)
T ss_pred CCCEEEEEcccceecCC
Confidence 78999999999987643
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.81 E-value=4.5e-20 Score=190.59 Aligned_cols=237 Identities=20% Similarity=0.225 Sum_probs=151.9
Q ss_pred hcCCcceeeecccceEEEEEeC-CCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCC----------CceeeeeeEEE
Q 002721 606 TMKDSNMIYCGTFSTVYKAVMP-SGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCH----------DNLVRPIGFVI 674 (888)
Q Consensus 606 ~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h----------pnIv~~~~~~~ 674 (888)
.+...+.||.|+++.||.+++. +|+.+|+|+............+++.+|.-....+.+ -.++-.++...
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 4556789999999999999965 599999999875555555556677777755554322 22332233222
Q ss_pred e---------CC--------eeEEEEecCCCCCHHHHhhc---cCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecC
Q 002721 675 Y---------ED--------VALLLHNYLPNGTLAQLLHE---STKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLD 734 (888)
Q Consensus 675 ~---------~~--------~~~lv~e~~~~g~L~~~l~~---~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrD 734 (888)
. .. ..+++|+-+. +||.+++.. .... ........++.+..|+++.+++||+.|++|+|
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~~~~~~l~~~~~~-~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgd 170 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQDLVEALFSRAQT-HSPLAFAARLSLTVQMIRLVANLHSYGLVHGD 170 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE--S-EEHHHHHHHHHHHTTT-SHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST
T ss_pred EcCCCcceecCCCCccceeehhhhccchhh-hcHHHHHHHHhhcccc-cchhHHHHHHHHHHHHHHHHHHHhhcceEecc
Confidence 1 11 2366788775 588888653 2221 11233445567779999999999999999999
Q ss_pred CCCCCeEeCCCCCceEeccccccccCCCCCcccccccccccceeccccccc--------CCcCccccchhHHHHHHHHHh
Q 002721 735 ISSGNVLLDADFKPLLGEIEISKLLDPSKGTASISAVAGSFGYIPPEYAYT--------MQVTAPGNVYSYGVVLLEILT 806 (888)
Q Consensus 735 lkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~DiwSlG~il~ellt 806 (888)
|||+|++++.+|.++|+||+.....+... .....+..|.+||.... ..++.+.|.|++|+++|.|++
T Consensus 171 i~~~nfll~~~G~v~Lg~F~~~~r~g~~~-----~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC 245 (288)
T PF14531_consen 171 IKPENFLLDQDGGVFLGDFSSLVRAGTRY-----RCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWC 245 (288)
T ss_dssp -SGGGEEE-TTS-EEE--GGGEEETTEEE-----EGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHH
T ss_pred cceeeEEEcCCCCEEEcChHHHeecCcee-----eccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHH
Confidence 99999999999999999998877643211 11334577999997643 247889999999999999999
Q ss_pred CCCCCCCCCCCccchhhhccccCCCCCCcccccccccccCCcCcHHHHHHHHHHHhhccCCCCCCC
Q 002721 807 TRLPVEEDFGEGVDLVKWVHGAPARGETPEQILDARLSTVSFGWRKEMLTALKVALLCTDSTPAKR 872 (888)
Q Consensus 807 g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~R 872 (888)
|..||.....+... + ..+. ...+.++.+..+|..++++||++|
T Consensus 246 ~~lPf~~~~~~~~~---------------~----~~f~----~C~~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 246 GRLPFGLSSPEADP---------------E----WDFS----RCRDMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp SS-STCCCGGGSTS---------------G----GGGT----TSS---HHHHHHHHHHT-SSGGGS
T ss_pred ccCCCCCCCccccc---------------c----ccch----hcCCcCHHHHHHHHHHccCCcccC
Confidence 99999754322110 0 0111 112555667789999999999988
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=4e-21 Score=209.71 Aligned_cols=227 Identities=22% Similarity=0.200 Sum_probs=178.3
Q ss_pred eeeecccceEEEEE----eCCCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccC-CCceeeeeeEEEeCCeeEEEEecC
Q 002721 612 MIYCGTFSTVYKAV----MPSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLC-HDNLVRPIGFVIYEDVALLLHNYL 686 (888)
Q Consensus 612 ~ig~G~~g~Vy~~~----~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~~lv~e~~ 686 (888)
.+|+|.||.|+.++ ...|+.||+|+.++......... ....|..++..++ ||.+|++.-.++.+...+++++|.
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~-~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~ 79 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRT-HTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFL 79 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhccccccccccccc-ccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhc
Confidence 36899999999887 23478899998875433322222 4556888888887 999999999999999999999999
Q ss_pred CCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccccccccCCCCCcc
Q 002721 687 PNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSKGTA 766 (888)
Q Consensus 687 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~ 766 (888)
.+|++...+.... .+++.....+...++-|++++|+.+|+|||+|++||+++.+|++++.|||.++..-..+
T Consensus 80 rgg~lft~l~~~~-----~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~--- 151 (612)
T KOG0603|consen 80 RGGDLFTRLSKEV-----MFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEK--- 151 (612)
T ss_pred ccchhhhccccCC-----chHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhhh---
Confidence 9999988877654 34566777788899999999999999999999999999999999999999998754332
Q ss_pred cccccccccceecccccccCCcCccccchhHHHHHHHHHhCCCCCCCCCCCccchhhhccccCCCCCCcccccccccccC
Q 002721 767 SISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQILDARLSTV 846 (888)
Q Consensus 767 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 846 (888)
..+||..|||||++. ....++|.||||++++||+||..||..+ . ...+... .
T Consensus 152 ---~~cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~~------~-------------~~~Il~~----~ 203 (612)
T KOG0603|consen 152 ---IACGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGGD------T-------------MKRILKA----E 203 (612)
T ss_pred ---hcccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCchH------H-------------HHHHhhh----c
Confidence 228999999999987 5678999999999999999999999751 1 1111111 1
Q ss_pred CcCcHHHHHHHHHHHhhccCCCCCCCCCH
Q 002721 847 SFGWRKEMLTALKVALLCTDSTPAKRPKM 875 (888)
Q Consensus 847 ~~~~~~~~~~~~~li~~cl~~dP~~RPs~ 875 (888)
..........+.+++..+...+|..|--.
T Consensus 204 ~~~p~~l~~~a~~~~~~l~~r~p~nrLg~ 232 (612)
T KOG0603|consen 204 LEMPRELSAEARSLFRQLFKRNPENRLGA 232 (612)
T ss_pred cCCchhhhHHHHHHHHHHHhhCHHHHhcc
Confidence 11234455566677778888888888644
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.81 E-value=6.1e-20 Score=187.83 Aligned_cols=197 Identities=20% Similarity=0.194 Sum_probs=137.5
Q ss_pred CCCceeeeeeEEEe---------------------------CCeeEEEEecCCCCCHHHHhhccCCCCCCCCCHHHHHHH
Q 002721 662 CHDNLVRPIGFVIY---------------------------EDVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSI 714 (888)
Q Consensus 662 ~hpnIv~~~~~~~~---------------------------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i 714 (888)
+|||||++.++|.+ +...|+||..++. +|.+++..+. .+.....-+
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~-tLr~yl~~~~------~s~r~~~~~ 346 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQ-TLREYLWTRH------RSYRTGRVI 346 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchh-hHHHHHhcCC------CchHHHHHH
Confidence 49999999987754 1246999999875 9999998764 344566778
Q ss_pred HHHHHHHHhhcccCCeeecCCCCCCeEe--CCCCC--ceEeccccccccCCCCC----cccccccccccceecccccccC
Q 002721 715 AIGVAEGLAFLHHVAIIHLDISSGNVLL--DADFK--PLLGEIEISKLLDPSKG----TASISAVAGSFGYIPPEYAYTM 786 (888)
Q Consensus 715 ~~qi~~aL~~LH~~~ivHrDlkp~NIll--~~~~~--~kl~Dfg~a~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~ 786 (888)
+.|+++|+.|||.+||.|||+|++||++ |+|+. ..++|||++-..+...- ........|.-.-||||+....
T Consensus 347 laQlLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~ 426 (598)
T KOG4158|consen 347 LAQLLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAV 426 (598)
T ss_pred HHHHHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcC
Confidence 9999999999999999999999999999 44443 57899998764332110 0111233467789999987643
Q ss_pred C------cCccccchhHHHHHHHHHhCCCCCCCCCCCccchhhhccccCCCCCCcccccccccccCCcCcHHHHHHHHHH
Q 002721 787 Q------VTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQILDARLSTVSFGWRKEMLTALKV 860 (888)
Q Consensus 787 ~------~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 860 (888)
+ --.|+|.|+.|.+.||+++...||.....-..+.. . .....++. -.....+.+.++
T Consensus 427 PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r-----------~---Yqe~qLPa---lp~~vpp~~rql 489 (598)
T KOG4158|consen 427 PGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTR-----------T---YQESQLPA---LPSRVPPVARQL 489 (598)
T ss_pred CCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechh-----------h---hhhhhCCC---CcccCChHHHHH
Confidence 3 12478999999999999999999976211111000 0 11111111 123344566788
Q ss_pred HhhccCCCCCCCCCHHHHHHHH
Q 002721 861 ALLCTDSTPAKRPKMKKVVEML 882 (888)
Q Consensus 861 i~~cl~~dP~~RPs~~evl~~L 882 (888)
+...+++||.+|++..-..+.|
T Consensus 490 V~~lL~r~pskRvsp~iAANvl 511 (598)
T KOG4158|consen 490 VFDLLKRDPSKRVSPNIAANVL 511 (598)
T ss_pred HHHHhcCCccccCCccHHHhHH
Confidence 8999999999999976555544
|
|
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.79 E-value=2.1e-21 Score=212.49 Aligned_cols=276 Identities=22% Similarity=0.272 Sum_probs=133.6
Q ss_pred EEeCCCCcCc-ccCCCCCCCCCCCCEEECcCCCCCCC----CCCCCCCCCcceEEEcCCCcccc------ccCccccccc
Q 002721 90 RLDLSNNAFS-GTIPSAFGNLSELEFLDLSLNKFGGV----IPRELGSLKDLRFFNISNNVLVG------EIPDELKSLE 158 (888)
Q Consensus 90 ~L~Ls~n~l~-~~~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~------~~p~~~~~l~ 158 (888)
.|+|..+.++ +..+..|..+.+|++|+|+++.++.. ++..+...++|++|+++++.+.+ .++..+..++
T Consensus 2 ~l~L~~~~l~~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~ 81 (319)
T cd00116 2 QLSLKGELLKTERATELLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGC 81 (319)
T ss_pred ccccccCcccccchHHHHHHHhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCCcchHHHHHHHHHHhcC
Confidence 4677777776 33445566667778888887777532 34445566667777777776652 1233445555
Q ss_pred cccEEEecCCCCCCCCCcccccccc---ccEEecccccccCCCCCCCCCcccccceeeccccCCCCCCCCccCC-CCcce
Q 002721 159 KLEDFQVSSNKLNGSIPFWVGNLTN---LRVFTAYENQLVGEIPDNLGSVSELELLNLHSNQLEGPIPKSIFAS-GKLEV 234 (888)
Q Consensus 159 ~L~~L~Ls~N~l~~~~p~~~~~l~~---L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l-~~L~~ 234 (888)
+|+.|++++|.+.+..+..+..+.+ |+.|++++|++++... ..+...+..+ ++|+.
T Consensus 82 ~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~--------------------~~l~~~l~~~~~~L~~ 141 (319)
T cd00116 82 GLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGL--------------------RLLAKGLKDLPPALEK 141 (319)
T ss_pred ceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHH--------------------HHHHHHHHhCCCCceE
Confidence 6666666666655444444433333 4555554444431100 0111122223 44555
Q ss_pred EEecCccCCCC----chhhhccCCccceeeccCCccccc----cCCccccCCCccEEEeeccCCCCCC----CccccCCC
Q 002721 235 LVLTQNRLTGD----IPELVGHCKSLSNIRIGNNDLVGV----IPRAIGNVSGLTYFEADNNNLSGEI----VPEFSQCS 302 (888)
Q Consensus 235 L~Ls~N~l~~~----~~~~~~~l~~L~~L~L~~N~l~~~----~~~~~~~l~~L~~L~l~~N~l~~~~----~~~~~~l~ 302 (888)
|+|++|.+++. .+..+..+++|+.|++++|.+++. ++..+...++|++|++++|.+++.. ...+..++
T Consensus 142 L~L~~n~l~~~~~~~~~~~~~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~l~~~~~~~~ 221 (319)
T cd00116 142 LVLGRNRLEGASCEALAKALRANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASALAETLASLK 221 (319)
T ss_pred EEcCCCcCCchHHHHHHHHHHhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHHHHHHHhcccC
Confidence 55555554421 222334444555555555555421 1222333345555555555554322 12234455
Q ss_pred CCcEEEeecCcccccCCcccc-----CCCCccEEEeccccccC----cCcccccccCcceEEEccCCcCCCC----CCch
Q 002721 303 NLTLLNLASNGFTGVIPPELG-----QLINLQELILYENSLFG----EIPKSILACKNLNKLDLSNNRFNGT----IPNA 369 (888)
Q Consensus 303 ~L~~L~L~~N~l~~~~p~~~~-----~l~~L~~L~L~~N~l~~----~~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~ 369 (888)
+|++|++++|.+++.....+. ..+.|+.|++++|.++. .+...+..+++|+.+++++|.++.. ....
T Consensus 222 ~L~~L~ls~n~l~~~~~~~l~~~~~~~~~~L~~L~l~~n~i~~~~~~~l~~~~~~~~~L~~l~l~~N~l~~~~~~~~~~~ 301 (319)
T cd00116 222 SLEVLNLGDNNLTDAGAAALASALLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFGEEGAQLLAES 301 (319)
T ss_pred CCCEEecCCCcCchHHHHHHHHHHhccCCCceEEEccCCCCCcHHHHHHHHHHhcCCCccEEECCCCCCcHHHHHHHHHH
Confidence 566666666655532221111 12456666666665541 1223334445566666666666533 2222
Q ss_pred hccc-cCcceecccCCc
Q 002721 370 ICDM-SRLQYLLLGQNS 385 (888)
Q Consensus 370 ~~~l-~~L~~L~L~~N~ 385 (888)
+... +.|++|++.+|+
T Consensus 302 ~~~~~~~~~~~~~~~~~ 318 (319)
T cd00116 302 LLEPGNELESLWVKDDS 318 (319)
T ss_pred HhhcCCchhhcccCCCC
Confidence 2223 455555555554
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >cd00116 LRR_RI Leucine-rich repeats (LRRs), ribonuclease inhibitor (RI)-like subfamily | Back alignment and domain information |
|---|
Probab=99.79 E-value=2.3e-21 Score=212.04 Aligned_cols=276 Identities=25% Similarity=0.319 Sum_probs=173.4
Q ss_pred EEEcCCCCcccc--cccccCCCCCCEEeCCCCcCccc----CCCCCCCCCCCCEEECcCCCCCC------CCCCCCCCCC
Q 002721 67 KLDLSRLQLRGN--ITLVSELKALKRLDLSNNAFSGT----IPSAFGNLSELEFLDLSLNKFGG------VIPRELGSLK 134 (888)
Q Consensus 67 ~l~l~~~~l~~~--~~~~~~l~~L~~L~Ls~n~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~------~~p~~~~~l~ 134 (888)
.|+|.++.+++. ...+..+..|++|+++++.++.. ++..+...++|++|++++|.+.+ .++..+..++
T Consensus 2 ~l~L~~~~l~~~~~~~~~~~l~~L~~l~l~~~~l~~~~~~~i~~~l~~~~~l~~l~l~~~~~~~~~~~~~~~~~~l~~~~ 81 (319)
T cd00116 2 QLSLKGELLKTERATELLPKLLCLQVLRLEGNTLGEEAAKALASALRPQPSLKELCLSLNETGRIPRGLQSLLQGLTKGC 81 (319)
T ss_pred ccccccCcccccchHHHHHHHhhccEEeecCCCCcHHHHHHHHHHHhhCCCceEEeccccccCCcchHHHHHHHHHHhcC
Confidence 478888888743 23667788899999999999542 56667788899999999999873 2345677899
Q ss_pred cceEEEcCCCccccccCcccccccc---ccEEEecCCCCCC----CCCcccccc-ccccEEecccccccCC----CCCCC
Q 002721 135 DLRFFNISNNVLVGEIPDELKSLEK---LEDFQVSSNKLNG----SIPFWVGNL-TNLRVFTAYENQLVGE----IPDNL 202 (888)
Q Consensus 135 ~L~~L~Ls~N~l~~~~p~~~~~l~~---L~~L~Ls~N~l~~----~~p~~~~~l-~~L~~L~L~~N~l~~~----~p~~~ 202 (888)
+|+.|+|++|.+.+..+..+..+.+ |++|++++|++++ .+...+..+ ++|+.|++++|.+++. ++..+
T Consensus 82 ~L~~L~l~~~~~~~~~~~~~~~l~~~~~L~~L~ls~~~~~~~~~~~l~~~l~~~~~~L~~L~L~~n~l~~~~~~~~~~~~ 161 (319)
T cd00116 82 GLQELDLSDNALGPDGCGVLESLLRSSSLQELKLNNNGLGDRGLRLLAKGLKDLPPALEKLVLGRNRLEGASCEALAKAL 161 (319)
T ss_pred ceeEEEccCCCCChhHHHHHHHHhccCcccEEEeeCCccchHHHHHHHHHHHhCCCCceEEEcCCCcCCchHHHHHHHHH
Confidence 9999999999998777777776666 9999999999984 222334555 7778888888877742 22334
Q ss_pred CCcccccceeeccccCCCC----CCCCccCCCCcceEEecCccCCCCchhhhccCCccceeeccCCccccccCCccccCC
Q 002721 203 GSVSELELLNLHSNQLEGP----IPKSIFASGKLEVLVLTQNRLTGDIPELVGHCKSLSNIRIGNNDLVGVIPRAIGNVS 278 (888)
Q Consensus 203 ~~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~ 278 (888)
..+++|++|+|++|.+++. ++..+..+++|+.|+|++|.+++..... +...+..++
T Consensus 162 ~~~~~L~~L~l~~n~l~~~~~~~l~~~l~~~~~L~~L~L~~n~i~~~~~~~--------------------l~~~~~~~~ 221 (319)
T cd00116 162 RANRDLKELNLANNGIGDAGIRALAEGLKANCNLEVLDLNNNGLTDEGASA--------------------LAETLASLK 221 (319)
T ss_pred HhCCCcCEEECcCCCCchHHHHHHHHHHHhCCCCCEEeccCCccChHHHHH--------------------HHHHhcccC
Confidence 4555666666666666531 1222333345556666655554322111 112233344
Q ss_pred CccEEEeeccCCCCCCCcccc-----CCCCCcEEEeecCcccc----cCCccccCCCCccEEEeccccccCc----Cccc
Q 002721 279 GLTYFEADNNNLSGEIVPEFS-----QCSNLTLLNLASNGFTG----VIPPELGQLINLQELILYENSLFGE----IPKS 345 (888)
Q Consensus 279 ~L~~L~l~~N~l~~~~~~~~~-----~l~~L~~L~L~~N~l~~----~~p~~~~~l~~L~~L~L~~N~l~~~----~p~~ 345 (888)
+|++|++++|.+++.....+. ..+.|+.|++++|.++. .+...+..+++|+++++++|.+... ....
T Consensus 222 ~L~~L~ls~n~l~~~~~~~l~~~~~~~~~~L~~L~l~~n~i~~~~~~~l~~~~~~~~~L~~l~l~~N~l~~~~~~~~~~~ 301 (319)
T cd00116 222 SLEVLNLGDNNLTDAGAAALASALLSPNISLLTLSLSCNDITDDGAKDLAEVLAEKESLLELDLRGNKFGEEGAQLLAES 301 (319)
T ss_pred CCCEEecCCCcCchHHHHHHHHHHhccCCCceEEEccCCCCCcHHHHHHHHHHhcCCCccEEECCCCCCcHHHHHHHHHH
Confidence 455555555554432222111 13566777777776651 1223445556777777777777643 3333
Q ss_pred cccc-CcceEEEccCCcC
Q 002721 346 ILAC-KNLNKLDLSNNRF 362 (888)
Q Consensus 346 ~~~l-~~L~~L~Ls~N~l 362 (888)
+... +.|+.|++.+|.+
T Consensus 302 ~~~~~~~~~~~~~~~~~~ 319 (319)
T cd00116 302 LLEPGNELESLWVKDDSF 319 (319)
T ss_pred HhhcCCchhhcccCCCCC
Confidence 3333 5677777777653
|
LRRs are 20-29 residue sequence motifs present in many proteins that participate in protein-protein interactions and have different functions and cellular locations. LRRs correspond to structural units consisting of a beta strand (LxxLxLxxN/CxL conserved pattern) and an alpha helix. This alignment contains 12 strands corresponding to 11 full repeats, consistent with the extent observed in the subfamily acting as Ran GTPase Activating Proteins (RanGAP1). |
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=8.5e-21 Score=172.45 Aligned_cols=165 Identities=30% Similarity=0.508 Sum_probs=97.8
Q ss_pred cCCCCCCEEeCCCCcCcccCCCCCCCCCCCCEEECcCCCCCCCCCCCCCCCCcceEEEcCCCccccccCccccccccccE
Q 002721 83 SELKALKRLDLSNNAFSGTIPSAFGNLSELEFLDLSLNKFGGVIPRELGSLKDLRFFNISNNVLVGEIPDELKSLEKLED 162 (888)
Q Consensus 83 ~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 162 (888)
.++.+++.|-||+|.++ .+|+.+..+.+|+.|++++|+|+ ..|..++++++|+.|+++-|++. ..|..|+.++.|+.
T Consensus 30 f~~s~ITrLtLSHNKl~-~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~lev 106 (264)
T KOG0617|consen 30 FNMSNITRLTLSHNKLT-VVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEV 106 (264)
T ss_pred cchhhhhhhhcccCcee-ecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhhh
Confidence 34444555555555554 34444555555555555555555 34555555555555555555554 44555555555555
Q ss_pred EEecCCCCCCCCCccccccccccEEecccccccCCCCCCCCCcccccceeeccccCCCCCCCCccCCCCcceEEecCccC
Q 002721 163 FQVSSNKLNGSIPFWVGNLTNLRVFTAYENQLVGEIPDNLGSVSELELLNLHSNQLEGPIPKSIFASGKLEVLVLTQNRL 242 (888)
Q Consensus 163 L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 242 (888)
|||++|++.. ..+|+.|..++.|+.|+|++|.+. .+|..++.+++|+.|.+.+|.+
T Consensus 107 ldltynnl~e-----------------------~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdndl 162 (264)
T KOG0617|consen 107 LDLTYNNLNE-----------------------NSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDL 162 (264)
T ss_pred hhcccccccc-----------------------ccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCch
Confidence 5555555431 245667777777777777777776 5677777777777777777776
Q ss_pred CCCchhhhccCCccceeeccCCccccccCCcccc
Q 002721 243 TGDIPELVGHCKSLSNIRIGNNDLVGVIPRAIGN 276 (888)
Q Consensus 243 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~ 276 (888)
- ..|..++.++.|++|.+.+|+++ ++|..+++
T Consensus 163 l-~lpkeig~lt~lrelhiqgnrl~-vlppel~~ 194 (264)
T KOG0617|consen 163 L-SLPKEIGDLTRLRELHIQGNRLT-VLPPELAN 194 (264)
T ss_pred h-hCcHHHHHHHHHHHHhcccceee-ecChhhhh
Confidence 6 45666777777777777777776 33433433
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=6.1e-19 Score=193.52 Aligned_cols=215 Identities=23% Similarity=0.370 Sum_probs=162.3
Q ss_pred HhccCCCceeeeeeEEEeCCeeEEEEecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCe-eecCCC
Q 002721 658 LSKLCHDNLVRPIGFVIYEDVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAI-IHLDIS 736 (888)
Q Consensus 658 l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i-vHrDlk 736 (888)
|+.+.|.|+.+++|.+.++...++|.+||..|+|.+.+..... .+++.-...++++|++||+|+|...| .|+.++
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~----~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~ 76 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDI----KLDYFFILSFIRDISKGLAYLHNSPIGYHGALK 76 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhcccc----CccHHHHHHHHHHHHHHHHHHhcCcceeeeeec
Confidence 4578899999999999999999999999999999999987432 57888889999999999999999665 999999
Q ss_pred CCCeEeCCCCCceEeccccccccCCCCCcccccccccccceecccccccCC-------cCccccchhHHHHHHHHHhCCC
Q 002721 737 SGNVLLDADFKPLLGEIEISKLLDPSKGTASISAVAGSFGYIPPEYAYTMQ-------VTAPGNVYSYGVVLLEILTTRL 809 (888)
Q Consensus 737 p~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-------~~~~~DiwSlG~il~elltg~~ 809 (888)
++|.++|..+.+|++|||+.................-..-|.|||.+.+.. .+.+.||||||++++|+++.+.
T Consensus 77 s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~ 156 (484)
T KOG1023|consen 77 SSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSG 156 (484)
T ss_pred cccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccC
Confidence 999999999999999999988764311111112223455799999887641 4667999999999999999999
Q ss_pred CCCCCCCCcc--chhhhccccCCCCCCcccccccccccCCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHHHhh
Q 002721 810 PVEEDFGEGV--DLVKWVHGAPARGETPEQILDARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEMLQEIK 886 (888)
Q Consensus 810 P~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~~i~ 886 (888)
||........ +++..+... ......+.+.. ..+..+++..++..||..+|++||++++|-..++.+.
T Consensus 157 ~~~~~~~~~~~~eii~~~~~~------~~~~~rP~i~~----~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~~~~~~~ 225 (484)
T KOG1023|consen 157 PFDLRNLVEDPDEIILRVKKG------GSNPFRPSIEL----LNELPPELLLLVARCWEEIPEKRPSIEQIRSKLLTIN 225 (484)
T ss_pred ccccccccCChHHHHHHHHhc------CCCCcCcchhh----hhhcchHHHHHHHHhcccChhhCccHHHHHhhhhhhc
Confidence 9987433322 222221110 00011111110 0133346889999999999999999999998887664
|
|
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.78 E-value=6e-19 Score=206.56 Aligned_cols=196 Identities=18% Similarity=0.149 Sum_probs=161.7
Q ss_pred HHHhcCCcceeeecccceEEEEEeCCCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccC---CCceeeeeeEEEeCCee
Q 002721 603 VKATMKDSNMIYCGTFSTVYKAVMPSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLC---HDNLVRPIGFVIYEDVA 679 (888)
Q Consensus 603 ~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~---hpnIv~~~~~~~~~~~~ 679 (888)
-.+.|.+.+.||+|+||+||+|...+|+.||+|+-++...+. |.-=.+++.+|+ -+-|..+...+...+.-
T Consensus 696 ~~~~~~I~~e~G~g~y~~vy~a~~~~~~~~alK~e~P~~~WE------fYI~~q~~~RLk~~~~~~~~~~~~a~~~~~~S 769 (974)
T KOG1166|consen 696 GGEKFCISKEIGEGSYGSVYVATHSNGKLVALKVEKPPNPWE------FYICLQVMERLKPQMLPSIMHISSAHVFQNAS 769 (974)
T ss_pred cceeEEEEeeeccccceEEEEeecCCCcEEEEEeecCCCcee------eeehHHHHHhhchhhhcchHHHHHHHccCCcc
Confidence 355788999999999999999997789999999988766552 333334455554 23455566666667788
Q ss_pred EEEEecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCC-------CCCceEec
Q 002721 680 LLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDA-------DFKPLLGE 752 (888)
Q Consensus 680 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~-------~~~~kl~D 752 (888)
++|+||.+.|+|.+++.... .++|.-++.+..|++.-+++||..+|||+||||+|+|+.. ...++|+|
T Consensus 770 ~lv~ey~~~Gtlld~~N~~~-----~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~~~~~~~l~lID 844 (974)
T KOG1166|consen 770 VLVSEYSPYGTLLDLINTNK-----VMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICADSDSKGLYLID 844 (974)
T ss_pred eeeeeccccccHHHhhccCC-----CCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCCCCcccceEEEe
Confidence 99999999999999998433 5688889999999999999999999999999999999952 34589999
Q ss_pred cccccccCCCCCcccccccccccceecccccccCCcCccccchhHHHHHHHHHhCCC
Q 002721 753 IEISKLLDPSKGTASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILTTRL 809 (888)
Q Consensus 753 fg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~ 809 (888)
||.+-.+..-.........++|-.+-.+|+..|++++..+|.|.++.+++-|+.|++
T Consensus 845 fG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 845 FGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred cccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 999887654434455677888999999999999999999999999999999999975
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.77 E-value=2.3e-18 Score=172.73 Aligned_cols=137 Identities=15% Similarity=0.214 Sum_probs=105.3
Q ss_pred cCCcceeeecccceEEEEEeCCCcEEEEEEeeccChhhhHHHHHHHHHHHHHhcc-----CCCceeeeeeEEEeCC---e
Q 002721 607 MKDSNMIYCGTFSTVYKAVMPSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKL-----CHDNLVRPIGFVIYED---V 678 (888)
Q Consensus 607 ~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-----~hpnIv~~~~~~~~~~---~ 678 (888)
+...+.||+|+||.||. ++.....+||++...... ..+.+.+|+++++.+ .||||++++|++.++. .
T Consensus 4 L~~~~~LG~G~~~~Vy~--hp~~~~k~IKv~~~~~~~---~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~ 78 (210)
T PRK10345 4 LSEQSPLGTGRHRKCYA--HPEDAQRCIKIVYHRGDG---GDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGY 78 (210)
T ss_pred cCCcceecCCCceEEEE--CCCCcCeEEEEEeccccc---hHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeE
Confidence 45578999999999996 433333478888753222 234789999999999 5799999999999863 4
Q ss_pred -eEEEEec--CCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHH-hhcccCCeeecCCCCCCeEeCC----CCCceE
Q 002721 679 -ALLLHNY--LPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGL-AFLHHVAIIHLDISSGNVLLDA----DFKPLL 750 (888)
Q Consensus 679 -~~lv~e~--~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL-~~LH~~~ivHrDlkp~NIll~~----~~~~kl 750 (888)
+.+|||| +++|+|.+++++. .+++. ..++.|++.++ +|||+++|+||||||+||+++. ++.++|
T Consensus 79 v~~~I~e~~G~~~~tL~~~l~~~------~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~L 150 (210)
T PRK10345 79 VYDVIADFDGKPSITLTEFAEQC------RYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVV 150 (210)
T ss_pred EEEEEecCCCCcchhHHHHHHcc------cccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEE
Confidence 3478999 6689999999763 23333 35678888888 9999999999999999999974 347999
Q ss_pred eccccc
Q 002721 751 GEIEIS 756 (888)
Q Consensus 751 ~Dfg~a 756 (888)
+||+.+
T Consensus 151 iDg~G~ 156 (210)
T PRK10345 151 CDNIGE 156 (210)
T ss_pred EECCCC
Confidence 995433
|
|
| >KOG0617 consensus Ras suppressor protein (contains leucine-rich repeats) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.76 E-value=1.5e-20 Score=170.95 Aligned_cols=161 Identities=27% Similarity=0.534 Sum_probs=148.8
Q ss_pred CeEEEEEcCCCCcccccccccCCCCCCEEeCCCCcCcccCCCCCCCCCCCCEEECcCCCCCCCCCCCCCCCCcceEEEcC
Q 002721 63 AFVVKLDLSRLQLRGNITLVSELKALKRLDLSNNAFSGTIPSAFGNLSELEFLDLSLNKFGGVIPRELGSLKDLRFFNIS 142 (888)
Q Consensus 63 ~~v~~l~l~~~~l~~~~~~~~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 142 (888)
.+++.|.|++|.++-.++-+++|.+|+.|++++|+|+ .+|.+++.+++|+.|+++-|++. +.|..|+.++.|++|||.
T Consensus 33 s~ITrLtLSHNKl~~vppnia~l~nlevln~~nnqie-~lp~~issl~klr~lnvgmnrl~-~lprgfgs~p~levldlt 110 (264)
T KOG0617|consen 33 SNITRLTLSHNKLTVVPPNIAELKNLEVLNLSNNQIE-ELPTSISSLPKLRILNVGMNRLN-ILPRGFGSFPALEVLDLT 110 (264)
T ss_pred hhhhhhhcccCceeecCCcHHHhhhhhhhhcccchhh-hcChhhhhchhhhheecchhhhh-cCccccCCCchhhhhhcc
Confidence 3688999999999999999999999999999999997 78999999999999999999998 889999999999999999
Q ss_pred CCcccc-ccCccccccccccEEEecCCCCCCCCCccccccccccEEecccccccCCCCCCCCCcccccceeeccccCCCC
Q 002721 143 NNVLVG-EIPDELKSLEKLEDFQVSSNKLNGSIPFWVGNLTNLRVFTAYENQLVGEIPDNLGSVSELELLNLHSNQLEGP 221 (888)
Q Consensus 143 ~N~l~~-~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ 221 (888)
.|++.. ..|+.|..++.|+.|+|+.|.+. .+|..+++|++|+.|.+.+|.+. .+|..++.+++|++|.+.+|+++ .
T Consensus 111 ynnl~e~~lpgnff~m~tlralyl~dndfe-~lp~dvg~lt~lqil~lrdndll-~lpkeig~lt~lrelhiqgnrl~-v 187 (264)
T KOG0617|consen 111 YNNLNENSLPGNFFYMTTLRALYLGDNDFE-ILPPDVGKLTNLQILSLRDNDLL-SLPKEIGDLTRLRELHIQGNRLT-V 187 (264)
T ss_pred ccccccccCCcchhHHHHHHHHHhcCCCcc-cCChhhhhhcceeEEeeccCchh-hCcHHHHHHHHHHHHhcccceee-e
Confidence 999974 58999999999999999999998 88999999999999999999998 78999999999999999999998 4
Q ss_pred CCCCccC
Q 002721 222 IPKSIFA 228 (888)
Q Consensus 222 ~p~~~~~ 228 (888)
+|..+..
T Consensus 188 lppel~~ 194 (264)
T KOG0617|consen 188 LPPELAN 194 (264)
T ss_pred cChhhhh
Confidence 5554443
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.73 E-value=8.4e-19 Score=188.05 Aligned_cols=242 Identities=18% Similarity=0.186 Sum_probs=161.8
Q ss_pred cCCcceeeecccceEEEEEeCC----CcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeee-------EEEe
Q 002721 607 MKDSNMIYCGTFSTVYKAVMPS----GLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIG-------FVIY 675 (888)
Q Consensus 607 ~~~~~~ig~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~-------~~~~ 675 (888)
+.+.+..+..+++.++..+... ...++.|+.+.... .......+++-.+....|.+..-..+ .+..
T Consensus 246 ~~~~k~~~~~~~~~~~~~q~~~~~s~~E~~~s~~~~~d~~---~~~~~~~r~~~~l~~~~~~~~s~~~d~~~s~~~~~~~ 322 (516)
T KOG1033|consen 246 SSISKSSERVSSGIVFEKQGKNNSSLREWLKSKRADVDSL---CACKYTFRQLGVLVDSSHSNRSILEDLRPSLFESSKR 322 (516)
T ss_pred ccccccccccccCCchhhhhcccchhhhhccchhhhccch---hhhhhhhhhhhheeccccCCcccccCCCCchhhhccc
Confidence 4445566667777776665322 23444444432221 11223445555555444433333332 1111
Q ss_pred -----CCeeEEEEecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceE
Q 002721 676 -----EDVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLL 750 (888)
Q Consensus 676 -----~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl 750 (888)
..+.|+.|++|...+|.+++....... ..++...+.++.|++.|++| +|.+|||+||.||+...+..+||
T Consensus 323 ~~v~~~~~lyI~Mn~c~~~tledWl~rr~~~e--~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kI 397 (516)
T KOG1033|consen 323 NKVGKKVYLYIQMNLCEKETLEDWLRRRRTGE--ERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKI 397 (516)
T ss_pred cccccccchhhhhhhhhhhhHHHHhhCCCccc--ccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhh
Confidence 235789999999999999997654332 45777889999999999999 99999999999999999999999
Q ss_pred eccccccccCCCC----CcccccccccccceecccccccCCcCccccchhHHHHHHHHHh-CCCCCCCCCCCccchhhhc
Q 002721 751 GEIEISKLLDPSK----GTASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILT-TRLPVEEDFGEGVDLVKWV 825 (888)
Q Consensus 751 ~Dfg~a~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt-g~~P~~~~~~~~~~~~~~~ 825 (888)
+|||+........ ..+..+...||..||+||++.+..|+.|+||||||++++|+++ =..++...
T Consensus 398 gDFgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~er~----------- 466 (516)
T KOG1033|consen 398 GDFGLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFERI----------- 466 (516)
T ss_pred hhhhheeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHHHH-----------
Confidence 9999988765443 2334566789999999999999999999999999999999998 22222210
Q ss_pred cccCCCCCCcccccccccccCCcCcHHHHHHHHHHHhhccCCCCCCCCCHHH
Q 002721 826 HGAPARGETPEQILDARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKK 877 (888)
Q Consensus 826 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~e 877 (888)
.....+.+..++. .....-++-..++.+++.+.|.+||++.+
T Consensus 467 -------~t~~d~r~g~ip~---~~~~d~p~e~~ll~~lls~~p~~RP~~~~ 508 (516)
T KOG1033|consen 467 -------ATLTDIRDGIIPP---EFLQDYPEEYTLLQQLLSPSPEERPSAIE 508 (516)
T ss_pred -------HhhhhhhcCCCCh---HHhhcCcHHHHHHHHhcCCCcccCchHHH
Confidence 1112222222221 11222334467888999999999995444
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.73 E-value=1.7e-17 Score=170.94 Aligned_cols=144 Identities=20% Similarity=0.231 Sum_probs=111.4
Q ss_pred cCCcceeeecccceEEEEE--eCCCcEEEEEEeeccChhh---------------------hHHHHHHHHHHHHHhccCC
Q 002721 607 MKDSNMIYCGTFSTVYKAV--MPSGLILSVKRLKSMDRTI---------------------IHHQNKMIRELEKLSKLCH 663 (888)
Q Consensus 607 ~~~~~~ig~G~~g~Vy~~~--~~~~~~vavK~~~~~~~~~---------------------~~~~~~~~~E~~~l~~l~h 663 (888)
|++.+.||+|+||.||+|. ..+|+.||+|+++...... ......+.+|++.+.++.+
T Consensus 30 ~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~L~~ 109 (237)
T smart00090 30 SAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQRLYE 109 (237)
T ss_pred HHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHHHHh
Confidence 7889999999999999998 5689999999987532110 0012346789999999975
Q ss_pred C--ceeeeeeEEEeCCeeEEEEecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCC-eeecCCCCCCe
Q 002721 664 D--NLVRPIGFVIYEDVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVA-IIHLDISSGNV 740 (888)
Q Consensus 664 p--nIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~-ivHrDlkp~NI 740 (888)
. .+.+++++ ...++||||++++++........ .....+...++.||+.++++||+.| |+||||||+||
T Consensus 110 ~~i~~p~~~~~----~~~~lV~E~~~g~~L~~~~~~~~-----~~~~~~~~~i~~qi~~~l~~LH~~g~iiH~Dikp~NI 180 (237)
T smart00090 110 AGVPVPKPIAW----RRNVLVMEFIGGDGLPAPRLKDV-----EPEEEEEFELYDDILEEMRKLYKEGELVHGDLSEYNI 180 (237)
T ss_pred cCCCCCeeeEe----cCceEEEEEecCCcccccccccC-----CcchHHHHHHHHHHHHHHHHHHhcCCEEeCCCChhhE
Confidence 3 34444443 23589999999988876543221 2344567789999999999999999 99999999999
Q ss_pred EeCCCCCceEeccccccccC
Q 002721 741 LLDADFKPLLGEIEISKLLD 760 (888)
Q Consensus 741 ll~~~~~~kl~Dfg~a~~~~ 760 (888)
+++ ++.++++|||.+....
T Consensus 181 li~-~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 181 LVH-DGKVVIIDVSQSVELD 199 (237)
T ss_pred EEE-CCCEEEEEChhhhccC
Confidence 999 8899999999987644
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.72 E-value=2.2e-18 Score=197.08 Aligned_cols=210 Identities=22% Similarity=0.228 Sum_probs=145.1
Q ss_pred HHhcCCcceeeecccceEEEEEeC-CCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCCeeEEE
Q 002721 604 KATMKDSNMIYCGTFSTVYKAVMP-SGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVALLL 682 (888)
Q Consensus 604 ~~~~~~~~~ig~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv 682 (888)
..+|+.++.|..|+||.||.++++ +.+.+|+|.-+. . .+.|- ++.....|.+|
T Consensus 82 e~df~~IklisngAygavylvrh~~trqrfa~kiNkq-~--------lilRn--ilt~a~npfvv--------------- 135 (1205)
T KOG0606|consen 82 ESDFNTIKLISNGAYGAVYLVRHKETRQRFAMKINKQ-N--------LILRN--ILTFAGNPFVV--------------- 135 (1205)
T ss_pred ccccceeEeeccCCCCceeeeeccccccchhhccccc-c--------hhhhc--cccccCCccee---------------
Confidence 457899999999999999999965 477888854331 1 11121 33333344444
Q ss_pred EecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccccccccCCC
Q 002721 683 HNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPS 762 (888)
Q Consensus 683 ~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~~~~ 762 (888)
||=...++..+..+. +++.+++|+|+.||+|||+||+|.+|+.-|++|+.|||+.+..-..
T Consensus 136 ------gDc~tllk~~g~lPv-------------dmvla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms 196 (1205)
T KOG0606|consen 136 ------GDCATLLKNIGPLPV-------------DMVLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMS 196 (1205)
T ss_pred ------chhhhhcccCCCCcc-------------hhhHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhh
Confidence 344444444332211 2378999999999999999999999999999999999998764211
Q ss_pred CC-------------cccccccccccceecccccccCCcCccccchhHHHHHHHHHhCCCCCCCCCCCccchhhhccccC
Q 002721 763 KG-------------TASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAP 829 (888)
Q Consensus 763 ~~-------------~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~ 829 (888)
.. ...-...+||+.|+|||++..+.|+..+|+|++|+|+||.+.|+.||.+++.+.. ...+..
T Consensus 197 ~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeel--fg~vis-- 272 (1205)
T KOG0606|consen 197 LATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEEL--FGQVIS-- 272 (1205)
T ss_pred ccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHH--Hhhhhh--
Confidence 10 0112356899999999999999999999999999999999999999988754421 110000
Q ss_pred CCCCCcccccccccccCCcCcHHHHHHHHHHHhhccCCCCCCCCC
Q 002721 830 ARGETPEQILDARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPK 874 (888)
Q Consensus 830 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs 874 (888)
....+++ ......+++.+++.+.++.+|..|--
T Consensus 273 d~i~wpE------------~dea~p~Ea~dli~~LL~qnp~~Rlg 305 (1205)
T KOG0606|consen 273 DDIEWPE------------EDEALPPEAQDLIEQLLRQNPLCRLG 305 (1205)
T ss_pred hhccccc------------cCcCCCHHHHHHHHHHHHhChHhhcc
Confidence 0001111 12223456778888899999999963
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.70 E-value=5.8e-17 Score=163.63 Aligned_cols=140 Identities=21% Similarity=0.168 Sum_probs=110.5
Q ss_pred cCCcceeeecccceEEEEEeCCCcEEEEEEeeccChhhh-------------------HHHHHHHHHHHHHhccCCCc--
Q 002721 607 MKDSNMIYCGTFSTVYKAVMPSGLILSVKRLKSMDRTII-------------------HHQNKMIRELEKLSKLCHDN-- 665 (888)
Q Consensus 607 ~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~-------------------~~~~~~~~E~~~l~~l~hpn-- 665 (888)
|...+.||+|+||.||+|...+|+.||||+++....... .......+|..++..+.|++
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~ 96 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDPDGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKALYEEGFP 96 (198)
T ss_pred hhcCCccccCcceEEEEEEcCCCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHHHHHcCCC
Confidence 778899999999999999987899999998764321100 01123678899999998774
Q ss_pred eeeeeeEEEeCCeeEEEEecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCC
Q 002721 666 LVRPIGFVIYEDVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDAD 745 (888)
Q Consensus 666 Iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~ 745 (888)
+++.++ ....++||||+++++|.+.... .....++.+++.++.++|+.||+||||||+||+++++
T Consensus 97 v~~~~~----~~~~~lv~e~~~g~~L~~~~~~-----------~~~~~~~~~i~~~l~~lh~~gi~H~Dl~p~Nill~~~ 161 (198)
T cd05144 97 VPKPID----WNRHAVVMEYIDGVELYRVRVL-----------EDPEEVLDEILEEIVKAYKHGIIHGDLSEFNILVDDD 161 (198)
T ss_pred CCceee----cCCceEEEEEeCCcchhhcccc-----------ccHHHHHHHHHHHHHHHHHCCCCcCCCCcccEEEcCC
Confidence 444444 2456899999999998765431 2345788999999999999999999999999999999
Q ss_pred CCceEeccccccccCC
Q 002721 746 FKPLLGEIEISKLLDP 761 (888)
Q Consensus 746 ~~~kl~Dfg~a~~~~~ 761 (888)
+.++++|||.+.....
T Consensus 162 ~~~~liDfg~~~~~~~ 177 (198)
T cd05144 162 EKIYIIDWPQMVSTDH 177 (198)
T ss_pred CcEEEEECCccccCCC
Confidence 9999999999976544
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.70 E-value=8.8e-17 Score=164.39 Aligned_cols=137 Identities=17% Similarity=0.261 Sum_probs=114.8
Q ss_pred ceeeecccceEEEEEeCCCcEEEEEEeeccChh-----hhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCCeeEEEEec
Q 002721 611 NMIYCGTFSTVYKAVMPSGLILSVKRLKSMDRT-----IIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVALLLHNY 685 (888)
Q Consensus 611 ~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~-----~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 685 (888)
+.||+|++|.||+|.. +|..+++|+....... ......++.+|++++..+.|++|.....++...+..++||||
T Consensus 2 ~~l~~G~~~~vy~~~~-~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~ 80 (211)
T PRK14879 2 KLIKRGAEAEIYLGDF-LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEY 80 (211)
T ss_pred cccccCceEEEEEEee-CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEE
Confidence 5799999999999987 7778999976532211 111234688999999999999998877777777889999999
Q ss_pred CCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccccccc
Q 002721 686 LPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKL 758 (888)
Q Consensus 686 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~ 758 (888)
++|++|.+++.... . .+..++.+++.+|.++|+.|++|||++|+||+++ ++.++++|||.+..
T Consensus 81 ~~G~~L~~~~~~~~--------~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 81 IEGEPLKDLINSNG--------M-EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred eCCcCHHHHHHhcc--------H-HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 99999999986421 1 7788999999999999999999999999999999 78899999998875
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.68 E-value=1.6e-16 Score=160.77 Aligned_cols=134 Identities=18% Similarity=0.263 Sum_probs=108.9
Q ss_pred eeeecccceEEEEEeCCCcEEEEEEeeccCh-----hhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCCeeEEEEecC
Q 002721 612 MIYCGTFSTVYKAVMPSGLILSVKRLKSMDR-----TIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVALLLHNYL 686 (888)
Q Consensus 612 ~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~-----~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~ 686 (888)
.||+|+||.||+|.. ++..|++|+...... .......++.+|++++..++|+++.....++...+..++||||+
T Consensus 1 ~ig~G~~~~vy~~~~-~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~ 79 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF-LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYI 79 (199)
T ss_pred CCCCCceEEEEEeec-CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEE
Confidence 489999999999995 678899998653221 11122356789999999999887766666666677789999999
Q ss_pred CCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEecccccccc
Q 002721 687 PNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLL 759 (888)
Q Consensus 687 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~ 759 (888)
+|++|.+++.... . .++.|++.+|.++|+.|++|||++|+||+++ ++.++++|||.+...
T Consensus 80 ~g~~l~~~~~~~~----------~--~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~~ 139 (199)
T TIGR03724 80 EGKPLKDVIEEGN----------D--ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKYS 139 (199)
T ss_pred CCccHHHHHhhcH----------H--HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence 9999998875421 0 7899999999999999999999999999999 789999999988763
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.67 E-value=2.2e-16 Score=183.74 Aligned_cols=141 Identities=18% Similarity=0.191 Sum_probs=113.1
Q ss_pred HHhcCCcceeeecccceEEEEEeCCCcEEEEEE-eeccCh----hhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCCe
Q 002721 604 KATMKDSNMIYCGTFSTVYKAVMPSGLILSVKR-LKSMDR----TIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDV 678 (888)
Q Consensus 604 ~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~-~~~~~~----~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~ 678 (888)
...|...+.||+|+||+||+|...... +++|+ ..+... ......+++.+|+++++.++|++++..+.++.....
T Consensus 332 ~~~~~~~~~iG~G~~g~Vy~~~~~~~~-~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~ 410 (535)
T PRK09605 332 KRRKIPDHLIGKGAEADIKKGEYLGRD-AVIKERVPKGYRHPELDERLRTERTRAEARLLSEARRAGVPTPVIYDVDPEE 410 (535)
T ss_pred ccccCccceeccCCcEEEEEEeecCcc-ceeEEEecccccchhHHHHHHHHHHHHHHHHHHhhcccCCCeeEEEEEeCCC
Confidence 344567899999999999999875443 33443 221111 111223578899999999999999988888877778
Q ss_pred eEEEEecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccccccc
Q 002721 679 ALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKL 758 (888)
Q Consensus 679 ~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~ 758 (888)
.++||||+++++|.+++. ....++.|++++|.|||+.|++|||+||+||++ +++.++++|||+++.
T Consensus 411 ~~lv~E~~~g~~L~~~l~-------------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl-~~~~~~liDFGla~~ 476 (535)
T PRK09605 411 KTIVMEYIGGKDLKDVLE-------------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKY 476 (535)
T ss_pred CEEEEEecCCCcHHHHHH-------------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE-ECCcEEEEeCccccc
Confidence 899999999999998875 245689999999999999999999999999999 577999999999876
Q ss_pred c
Q 002721 759 L 759 (888)
Q Consensus 759 ~ 759 (888)
.
T Consensus 477 ~ 477 (535)
T PRK09605 477 S 477 (535)
T ss_pred C
Confidence 3
|
|
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.64 E-value=6.9e-16 Score=181.29 Aligned_cols=145 Identities=35% Similarity=0.664 Sum_probs=91.0
Q ss_pred cCCCCHHHHHHHhhhccC---CCCCCCCCCCC----CceeeEecCC--C--CeEEEEEcCCCCcccccc-cccCCCCCCE
Q 002721 23 AQLNDEPTLLAINKELIV---PGWGVNGTNFC----NWKGIDCDLN--Q--AFVVKLDLSRLQLRGNIT-LVSELKALKR 90 (888)
Q Consensus 23 ~~~~~~~~ll~~~~~~~~---~~w~~~~~~~c----~w~gv~C~~~--~--~~v~~l~l~~~~l~~~~~-~~~~l~~L~~ 90 (888)
..+.|.+||+++|+++.. .+|. +..|| .|.||.|+.. . .+|+.|+|+++++.|.++ .++.|++|+.
T Consensus 369 t~~~~~~aL~~~k~~~~~~~~~~W~--g~~C~p~~~~w~Gv~C~~~~~~~~~~v~~L~L~~n~L~g~ip~~i~~L~~L~~ 446 (623)
T PLN03150 369 TLLEEVSALQTLKSSLGLPLRFGWN--GDPCVPQQHPWSGADCQFDSTKGKWFIDGLGLDNQGLRGFIPNDISKLRHLQS 446 (623)
T ss_pred cCchHHHHHHHHHHhcCCcccCCCC--CCCCCCcccccccceeeccCCCCceEEEEEECCCCCccccCCHHHhCCCCCCE
Confidence 356689999999999843 2674 54443 7999999532 2 246666766666666554 5566666666
Q ss_pred EeCCCCcCcccCCCCCCCCCCCCEEECcCCCCCCCCCCCCCCCCcceEEEcCCCccccccCcccccc-ccccEEEecCCC
Q 002721 91 LDLSNNAFSGTIPSAFGNLSELEFLDLSLNKFGGVIPRELGSLKDLRFFNISNNVLVGEIPDELKSL-EKLEDFQVSSNK 169 (888)
Q Consensus 91 L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l-~~L~~L~Ls~N~ 169 (888)
|+|++|+++|.+|..++.+++|+.|+|++|++++.+|..++.+++|++|+|++|.+++.+|..+..+ .++..+++++|.
T Consensus 447 L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~l~~~~~~~~~l~~~~N~ 526 (623)
T PLN03150 447 INLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNLNGNSLSGRVPAALGGRLLHRASFNFTDNA 526 (623)
T ss_pred EECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEECcCCcccccCChHHhhccccCceEEecCCc
Confidence 6666666666666666666666666666666666666666666666666666666666666555442 244455555554
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.64 E-value=4.2e-17 Score=188.36 Aligned_cols=256 Identities=20% Similarity=0.199 Sum_probs=194.6
Q ss_pred HhcCCcceeeecccceEEEEEeC--CCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccC-CCceeeeeeEEEeCCeeEE
Q 002721 605 ATMKDSNMIYCGTFSTVYKAVMP--SGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLC-HDNLVRPIGFVIYEDVALL 681 (888)
Q Consensus 605 ~~~~~~~~ig~G~~g~Vy~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~~~~~~~~~~~l 681 (888)
..|...+.||+|+|+.|-.+... ....+|+|.+.... ...........|..+-..+. |+|++.+++.....+..++
T Consensus 20 ~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~-~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~ 98 (601)
T KOG0590|consen 20 SQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPP-KSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLL 98 (601)
T ss_pred ccccccccccccccchhhhhhhcCCCcceeeccCCCCCC-CccchhhhcCccccccccccccccccccCCccCCCccccc
Confidence 35777788999999999988853 35567777665433 22233345667888888886 9999999999999999999
Q ss_pred EEecCCCCCHHHHhh-ccCCCCCCCCCHHHHHHHHHHHHHHHhhcc-cCCeeecCCCCCCeEeCCCC-CceEeccccccc
Q 002721 682 LHNYLPNGTLAQLLH-ESTKQPDYRPDWPTRLSIAIGVAEGLAFLH-HVAIIHLDISSGNVLLDADF-KPLLGEIEISKL 758 (888)
Q Consensus 682 v~e~~~~g~L~~~l~-~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH-~~~ivHrDlkp~NIll~~~~-~~kl~Dfg~a~~ 758 (888)
+++|..++++.+.+. .... ..+......++.|+..++.|+| ..++.|||+||+|.+++..+ ..+++|||+|..
T Consensus 99 ~~~~s~g~~~f~~i~~~~~~----~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~ 174 (601)
T KOG0590|consen 99 SLSYSDGGSLFSKISHPDST----GTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATA 174 (601)
T ss_pred ccCcccccccccccccCCcc----CCCCcchhhhhhhhccCccccCcccccccCCCCCccchhccCCCcccCCCchhhcc
Confidence 999999999998883 3220 2344567789999999999999 99999999999999999999 999999999998
Q ss_pred cCC-CCCccccccccc-ccceecccccccC-CcCccccchhHHHHHHHHHhCCCCCCCCCCCccchhhhccccCCCCCCc
Q 002721 759 LDP-SKGTASISAVAG-SFGYIPPEYAYTM-QVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETP 835 (888)
Q Consensus 759 ~~~-~~~~~~~~~~~g-t~~y~aPE~~~~~-~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~ 835 (888)
+.. ..........+| ++.|+|||...+. ...+..|+||.|+++.-+++|..||............|.....
T Consensus 175 ~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~~~~~~~~~~~~~------ 248 (601)
T KOG0590|consen 175 YRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRKDGRYSSWKSNKG------ 248 (601)
T ss_pred ccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccccccceeeccccc------
Confidence 776 333444456678 9999999998874 4567899999999999999999999875544433333322211
Q ss_pred ccccccccccCCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHH
Q 002721 836 EQILDARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVV 879 (888)
Q Consensus 836 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl 879 (888)
......+........++..+++..+|..|.+.+++-
T Consensus 249 --------~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~ 284 (601)
T KOG0590|consen 249 --------RFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELK 284 (601)
T ss_pred --------ccccCccccCChhhhhcccccccCCchhcccccccc
Confidence 001112334445567788889989999999987764
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.62 E-value=2e-15 Score=151.19 Aligned_cols=140 Identities=19% Similarity=0.232 Sum_probs=100.5
Q ss_pred cceeeecccceEEEEEeCCCcEEEEEEeeccChhhhHHHH---------------------HHHHHHHHHhccCCCc--e
Q 002721 610 SNMIYCGTFSTVYKAVMPSGLILSVKRLKSMDRTIIHHQN---------------------KMIRELEKLSKLCHDN--L 666 (888)
Q Consensus 610 ~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~---------------------~~~~E~~~l~~l~hpn--I 666 (888)
.+.||+|+||+||+|...+++.||||+++........... ....|.+.+.++.+.. +
T Consensus 2 ~~~lg~G~~g~Vy~a~~~~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~~ 81 (187)
T cd05119 2 GGPIGTGKEADVYLALDGDGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVPV 81 (187)
T ss_pred CcccccccceeEEEEECCCCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCCC
Confidence 4689999999999999878999999998753322111111 1135666666664432 4
Q ss_pred eeeeeEEEeCCeeEEEEecCCCCCHHHH-hhccCCCCCCCCCHHHHHHHHHHHHHHHhhccc-CCeeecCCCCCCeEeCC
Q 002721 667 VRPIGFVIYEDVALLLHNYLPNGTLAQL-LHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHH-VAIIHLDISSGNVLLDA 744 (888)
Q Consensus 667 v~~~~~~~~~~~~~lv~e~~~~g~L~~~-l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~-~~ivHrDlkp~NIll~~ 744 (888)
.+.+++ ...++||||++++++... +.... .. .+...++.+++.++.++|. .||+||||||+||+++
T Consensus 82 ~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~------~~-~~~~~~~~~~~~~l~~lh~~~~ivH~Dl~p~Nili~- 149 (187)
T cd05119 82 PKPIDL----NRHVLVMEFIGGDGIPAPRLKDVR------LL-EDPEELYDQILELMRKLYREAGLVHGDLSEYNILVD- 149 (187)
T ss_pred CceEec----CCCEEEEEEeCCCCccChhhhhhh------hc-ccHHHHHHHHHHHHHHHhhccCcCcCCCChhhEEEE-
Confidence 444443 246899999998543211 11110 01 4577899999999999999 9999999999999999
Q ss_pred CCCceEeccccccccCC
Q 002721 745 DFKPLLGEIEISKLLDP 761 (888)
Q Consensus 745 ~~~~kl~Dfg~a~~~~~ 761 (888)
++.++++|||.+.....
T Consensus 150 ~~~~~liDfg~a~~~~~ 166 (187)
T cd05119 150 DGKVYIIDVPQAVEIDH 166 (187)
T ss_pred CCcEEEEECcccccccC
Confidence 88999999999976543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.60 E-value=5.6e-17 Score=173.74 Aligned_cols=180 Identities=33% Similarity=0.605 Sum_probs=162.9
Q ss_pred CCCCCcEEEeecCcccccCCccccCCCCccEEEeccccccCcCcccccccCcceEEEccCCcCCCCCCchhccccCccee
Q 002721 300 QCSNLTLLNLASNGFTGVIPPELGQLINLQELILYENSLFGEIPKSILACKNLNKLDLSNNRFNGTIPNAICDMSRLQYL 379 (888)
Q Consensus 300 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 379 (888)
.+..-...||+.|++. .+|..++.+..|+.+.|++|.+. .+|..+.++..|++|||+.|+++ .+|..+|.++ |+.|
T Consensus 73 ~ltdt~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS-~lp~~lC~lp-Lkvl 148 (722)
T KOG0532|consen 73 DLTDTVFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLS-HLPDGLCDLP-LKVL 148 (722)
T ss_pred cccchhhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhh-cCChhhhcCc-ceeE
Confidence 3455577899999998 68999999999999999999997 78889999999999999999998 7899999987 9999
Q ss_pred cccCCccccccCCCccccccceEEEeecccccccCCCccccccchhhhhhccCccccccCCccccCCCCccEEEeeCCcc
Q 002721 380 LLGQNSLKGEIPHEIGNCMKLLQLHIGSNYLTGSIPPEIGHIRNLQIALNLSFNHLHGSLPPELGKLDKLVSFDVSNNQL 459 (888)
Q Consensus 380 ~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~~L~ls~N~l~~~~p~~~~~l~~L~~LdLs~N~l 459 (888)
-+++|+++ .+|..++.+.+|..||.+.|.+. .+|..++++..|+ .|++..|++. .+|+++..|+ |..||+|.|++
T Consensus 149 i~sNNkl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr-~l~vrRn~l~-~lp~El~~Lp-Li~lDfScNki 223 (722)
T KOG0532|consen 149 IVSNNKLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLR-DLNVRRNHLE-DLPEELCSLP-LIRLDFSCNKI 223 (722)
T ss_pred EEecCccc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHH-HHHHhhhhhh-hCCHHHhCCc-eeeeecccCce
Confidence 99999998 88999999999999999999998 8999999999999 7999999998 6778888664 99999999999
Q ss_pred ccCCchhhcccccceEEEccCCcCcccCCC
Q 002721 460 SGTIPSALKGMLSLIEVNFSNNLLTGPVPS 489 (888)
Q Consensus 460 ~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~ 489 (888)
+ .+|-.|..|..|++|.|.+|+|+.++-+
T Consensus 224 s-~iPv~fr~m~~Lq~l~LenNPLqSPPAq 252 (722)
T KOG0532|consen 224 S-YLPVDFRKMRHLQVLQLENNPLQSPPAQ 252 (722)
T ss_pred e-ecchhhhhhhhheeeeeccCCCCCChHH
Confidence 9 8999999999999999999999876543
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.59 E-value=8e-15 Score=151.43 Aligned_cols=139 Identities=19% Similarity=0.218 Sum_probs=107.2
Q ss_pred cceee-ecccceEEEEEeCCCcEEEEEEeeccCh----------hhhHHHHHHHHHHHHHhccCCCce--eeeeeEEEeC
Q 002721 610 SNMIY-CGTFSTVYKAVMPSGLILSVKRLKSMDR----------TIIHHQNKMIRELEKLSKLCHDNL--VRPIGFVIYE 676 (888)
Q Consensus 610 ~~~ig-~G~~g~Vy~~~~~~~~~vavK~~~~~~~----------~~~~~~~~~~~E~~~l~~l~hpnI--v~~~~~~~~~ 676 (888)
...|| .||.|+||.+.. .+..+|||++..... .......++.+|++++.++.|++| ++.+++....
T Consensus 36 ~~~lg~~~g~gtv~~v~~-~~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~ 114 (239)
T PRK01723 36 ARVVGSAKGRGTTWFVQT-PGVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLAQLYEAGLPVPRPIAARVVR 114 (239)
T ss_pred CceeecCCCCccEEEEEe-CCceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHHHHHhCCCCCceeEeeeeee
Confidence 46787 899999999987 477899998864221 011233468899999999998775 6777765433
Q ss_pred C----eeEEEEecCCC-CCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEe
Q 002721 677 D----VALLLHNYLPN-GTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLG 751 (888)
Q Consensus 677 ~----~~~lv~e~~~~-g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~ 751 (888)
. ..++||||++| .+|.+++... .++.. .+.||+.++.+||++||+||||||+|||++.++.++++
T Consensus 115 ~~~~~~~~lV~e~l~G~~~L~~~l~~~------~l~~~----~~~~i~~~l~~lH~~GI~HrDlkp~NILv~~~~~v~LI 184 (239)
T PRK01723 115 HGLFYRADILIERIEGARDLVALLQEA------PLSEE----QWQAIGQLIARFHDAGVYHADLNAHNILLDPDGKFWLI 184 (239)
T ss_pred cCcceeeeEEEEecCCCCCHHHHHhcC------CCCHH----HHHHHHHHHHHHHHCCCCCCCCCchhEEEcCCCCEEEE
Confidence 2 23599999997 6999888642 22322 36789999999999999999999999999998899999
Q ss_pred cccccccc
Q 002721 752 EIEISKLL 759 (888)
Q Consensus 752 Dfg~a~~~ 759 (888)
|||.+...
T Consensus 185 Dfg~~~~~ 192 (239)
T PRK01723 185 DFDRGELR 192 (239)
T ss_pred ECCCcccC
Confidence 99988763
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.55 E-value=2.5e-14 Score=137.64 Aligned_cols=133 Identities=21% Similarity=0.172 Sum_probs=111.8
Q ss_pred CcceeeecccceEEEEEeCCCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCC--CceeeeeeEEEeCCeeEEEEecC
Q 002721 609 DSNMIYCGTFSTVYKAVMPSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCH--DNLVRPIGFVIYEDVALLLHNYL 686 (888)
Q Consensus 609 ~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h--pnIv~~~~~~~~~~~~~lv~e~~ 686 (888)
+.+.||+|.++.||++...+ ..+++|....... ...+.+|+.+++.++| +.+++++++....+..+++|||+
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~-~~~~iK~~~~~~~-----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~ 75 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD-EDYVLKINPSREK-----GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWI 75 (155)
T ss_pred cceecccccccceEEEEecC-CeEEEEecCCCCc-----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEec
Confidence 45789999999999999744 7899998865433 2368899999999976 58999999888888899999999
Q ss_pred CCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccC---CeeecCCCCCCeEeCCCCCceEecccccccc
Q 002721 687 PNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHV---AIIHLDISSGNVLLDADFKPLLGEIEISKLL 759 (888)
Q Consensus 687 ~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~---~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~ 759 (888)
+++.+..+ +......++.+++++++++|.. +++|+|++|+||++++++.+++.|||.+...
T Consensus 76 ~g~~~~~~------------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~~ 139 (155)
T cd05120 76 EGETLDEV------------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGYG 139 (155)
T ss_pred CCeecccC------------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcEEEEEecccccCC
Confidence 98776644 2356677899999999999984 7999999999999999899999999988753
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PLN03150 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.53 E-value=1.5e-14 Score=170.04 Aligned_cols=118 Identities=36% Similarity=0.602 Sum_probs=103.8
Q ss_pred cceEEEeecccccccCCCccccccchhhhhhccCccccccCCccccCCCCccEEEeeCCccccCCchhhcccccceEEEc
Q 002721 399 KLLQLHIGSNYLTGSIPPEIGHIRNLQIALNLSFNHLHGSLPPELGKLDKLVSFDVSNNQLSGTIPSALKGMLSLIEVNF 478 (888)
Q Consensus 399 ~L~~L~L~~N~l~~~~p~~~~~l~~L~~~L~ls~N~l~~~~p~~~~~l~~L~~LdLs~N~l~~~~p~~~~~l~~L~~L~l 478 (888)
.++.|+|++|.+.|.+|..++.+++|+ .|+|++|+++|.+|..++.+++|+.|||++|+++|.+|..++.+++|++|+|
T Consensus 419 ~v~~L~L~~n~L~g~ip~~i~~L~~L~-~L~Ls~N~l~g~iP~~~~~l~~L~~LdLs~N~lsg~iP~~l~~L~~L~~L~L 497 (623)
T PLN03150 419 FIDGLGLDNQGLRGFIPNDISKLRHLQ-SINLSGNSIRGNIPPSLGSITSLEVLDLSYNSFNGSIPESLGQLTSLRILNL 497 (623)
T ss_pred EEEEEECCCCCccccCCHHHhCCCCCC-EEECCCCcccCcCChHHhCCCCCCEEECCCCCCCCCCchHHhcCCCCCEEEC
Confidence 378899999999999999999999999 7999999999999999999999999999999999999999999999999999
Q ss_pred cCCcCcccCCCCCCC--CCCCCCcccCCCCCCCCCCCCCCC
Q 002721 479 SNNLLTGPVPSFVPF--QKSPNSSFFGNKGLCGEPLSFSCG 517 (888)
Q Consensus 479 s~N~l~~~~p~~~~~--~~~~~~~~~~n~~lc~~~~~~~c~ 517 (888)
++|+++|.+|..... .......+.+|+.+|+.|....|.
T Consensus 498 s~N~l~g~iP~~l~~~~~~~~~l~~~~N~~lc~~p~l~~C~ 538 (623)
T PLN03150 498 NGNSLSGRVPAALGGRLLHRASFNFTDNAGLCGIPGLRACG 538 (623)
T ss_pred cCCcccccCChHHhhccccCceEEecCCccccCCCCCCCCc
Confidence 999999999975432 222345688999999987555664
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.48 E-value=3e-14 Score=160.45 Aligned_cols=200 Identities=28% Similarity=0.452 Sum_probs=105.9
Q ss_pred EEeCCCCcCcccCCCCCCCCCCCCEEECcCCCCCCCCCCCCCCCC-cceEEEcCCCccccccCccccccccccEEEecCC
Q 002721 90 RLDLSNNAFSGTIPSAFGNLSELEFLDLSLNKFGGVIPRELGSLK-DLRFFNISNNVLVGEIPDELKSLEKLEDFQVSSN 168 (888)
Q Consensus 90 ~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 168 (888)
.|+++.|.+.. .+..+..++.++.|++.+|.++ .+|...+.++ +|+.|++++|.+. .+|..+..+++|+.|++++|
T Consensus 97 ~l~~~~~~~~~-~~~~~~~~~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~N 173 (394)
T COG4886 97 SLDLNLNRLRS-NISELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSFN 173 (394)
T ss_pred eeecccccccc-CchhhhcccceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCCc
Confidence 34455554421 1222333445555555555555 3344444442 5555555555555 33344555555555555555
Q ss_pred CCCCCCCccccccccccEEecccccccCCCCCCCCCcccccceeeccccCCCCCCCCccCCCCcceEEecCccCCCCchh
Q 002721 169 KLNGSIPFWVGNLTNLRVFTAYENQLVGEIPDNLGSVSELELLNLHSNQLEGPIPKSIFASGKLEVLVLTQNRLTGDIPE 248 (888)
Q Consensus 169 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~ 248 (888)
+++ .+|...+.+++|+.|++++|+++ .+|.....+..|++|++++|++. ..+..+..+.++..|.+.+|++.. .+.
T Consensus 174 ~l~-~l~~~~~~~~~L~~L~ls~N~i~-~l~~~~~~~~~L~~l~~~~N~~~-~~~~~~~~~~~l~~l~l~~n~~~~-~~~ 249 (394)
T COG4886 174 DLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLED-LPE 249 (394)
T ss_pred hhh-hhhhhhhhhhhhhheeccCCccc-cCchhhhhhhhhhhhhhcCCcce-ecchhhhhcccccccccCCceeee-ccc
Confidence 555 33333335555555555555555 34444444445666666666432 344555555666666666666552 255
Q ss_pred hhccCCccceeeccCCccccccCCccccCCCccEEEeeccCCCCCCCccc
Q 002721 249 LVGHCKSLSNIRIGNNDLVGVIPRAIGNVSGLTYFEADNNNLSGEIVPEF 298 (888)
Q Consensus 249 ~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~ 298 (888)
.++.++++++|++++|.++.+.+ ++.+.+++.|++++|.++...+...
T Consensus 250 ~~~~l~~l~~L~~s~n~i~~i~~--~~~~~~l~~L~~s~n~~~~~~~~~~ 297 (394)
T COG4886 250 SIGNLSNLETLDLSNNQISSISS--LGSLTNLRELDLSGNSLSNALPLIA 297 (394)
T ss_pred hhccccccceecccccccccccc--ccccCccCEEeccCccccccchhhh
Confidence 55666666666666666664433 6666667777777776665554443
|
|
| >COG4886 Leucine-rich repeat (LRR) protein [Function unknown] | Back alignment and domain information |
|---|
Probab=99.45 E-value=6.9e-14 Score=157.50 Aligned_cols=262 Identities=28% Similarity=0.382 Sum_probs=182.5
Q ss_pred CEEECcCCCCCCCCCCCCCCCCcceEEEcCCCccccccCccccccc-cccEEEecCCCCCCCCCccccccccccEEeccc
Q 002721 113 EFLDLSLNKFGGVIPRELGSLKDLRFFNISNNVLVGEIPDELKSLE-KLEDFQVSSNKLNGSIPFWVGNLTNLRVFTAYE 191 (888)
Q Consensus 113 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~-~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~ 191 (888)
..|+++.|.+.. ....+..++.++.|++.+|.++ .+|.....+. +|+.|++++|++. .+|..++++++|+.|++++
T Consensus 96 ~~l~~~~~~~~~-~~~~~~~~~~l~~L~l~~n~i~-~i~~~~~~~~~nL~~L~l~~N~i~-~l~~~~~~l~~L~~L~l~~ 172 (394)
T COG4886 96 PSLDLNLNRLRS-NISELLELTNLTSLDLDNNNIT-DIPPLIGLLKSNLKELDLSDNKIE-SLPSPLRNLPNLKNLDLSF 172 (394)
T ss_pred ceeecccccccc-CchhhhcccceeEEecCCcccc-cCccccccchhhcccccccccchh-hhhhhhhccccccccccCC
Confidence 468888888853 3445566688999999999998 6666667774 8999999999988 5566788899999999999
Q ss_pred ccccCCCCCCCCCcccccceeeccccCCCCCCCCccCCCCcceEEecCccCCCCchhhhccCCccceeeccCCccccccC
Q 002721 192 NQLVGEIPDNLGSVSELELLNLHSNQLEGPIPKSIFASGKLEVLVLTQNRLTGDIPELVGHCKSLSNIRIGNNDLVGVIP 271 (888)
Q Consensus 192 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~ 271 (888)
|+++ .+|...+.+++|+.|++++|+++ .+|........|++|++++|++. ..+..+.+++++..|.+.+|++... +
T Consensus 173 N~l~-~l~~~~~~~~~L~~L~ls~N~i~-~l~~~~~~~~~L~~l~~~~N~~~-~~~~~~~~~~~l~~l~l~~n~~~~~-~ 248 (394)
T COG4886 173 NDLS-DLPKLLSNLSNLNNLDLSGNKIS-DLPPEIELLSALEELDLSNNSII-ELLSSLSNLKNLSGLELSNNKLEDL-P 248 (394)
T ss_pred chhh-hhhhhhhhhhhhhheeccCCccc-cCchhhhhhhhhhhhhhcCCcce-ecchhhhhcccccccccCCceeeec-c
Confidence 9998 56666667888999999999998 56666666677899999999644 4566777888888888888888743 6
Q ss_pred CccccCCCccEEEeeccCCCCCCCccccCCCCCcEEEeecCcccccCCccccCCCCccEEEeccccccCcCcccccccCc
Q 002721 272 RAIGNVSGLTYFEADNNNLSGEIVPEFSQCSNLTLLNLASNGFTGVIPPELGQLINLQELILYENSLFGEIPKSILACKN 351 (888)
Q Consensus 272 ~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~ 351 (888)
..+++++++++|++++|.++.... +..+.+++.|++++|.+....|........... ... +.+. ..+........
T Consensus 249 ~~~~~l~~l~~L~~s~n~i~~i~~--~~~~~~l~~L~~s~n~~~~~~~~~~~~~~~~~~-~~~-~~~~-~~~~~~~~~~~ 323 (394)
T COG4886 249 ESIGNLSNLETLDLSNNQISSISS--LGSLTNLRELDLSGNSLSNALPLIALLLLLLEL-LLN-LLLT-LKALELKLNSI 323 (394)
T ss_pred chhccccccceecccccccccccc--ccccCccCEEeccCccccccchhhhccchhHHh-hhh-hhhh-ccccccccccc
Confidence 778888889999999999986544 888889999999999988766654433222221 111 2221 22222222333
Q ss_pred ceEEEccCCcCCCCCCchhccccCcceecccCCccc
Q 002721 352 LNKLDLSNNRFNGTIPNAICDMSRLQYLLLGQNSLK 387 (888)
Q Consensus 352 L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 387 (888)
+...++..+... ..+..+.....+..++...+...
T Consensus 324 ~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~ 358 (394)
T COG4886 324 LLNNNILSNGET-SSPEALSILESLNNLWTLDNALD 358 (394)
T ss_pred cccccccccccc-ccchhhcccccccCceecccccc
Confidence 344444444444 44455555555555555554443
|
|
| >KOG0532 consensus Leucine-rich repeat (LRR) protein, contains calponin homology domain [Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.45 E-value=5.3e-15 Score=158.76 Aligned_cols=170 Identities=25% Similarity=0.422 Sum_probs=85.3
Q ss_pred ceEEecCccCCCCchhhhccCCccceeeccCCccccccCCccccCCCccEEEeeccCCCCCCCccccCCCCCcEEEeecC
Q 002721 233 EVLVLTQNRLTGDIPELVGHCKSLSNIRIGNNDLVGVIPRAIGNVSGLTYFEADNNNLSGEIVPEFSQCSNLTLLNLASN 312 (888)
Q Consensus 233 ~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N 312 (888)
...||+.|++. .+|..+..+-.|+.+.|..|.+. .+|.++.++..|++|||+.|+++. .|..++.++ |+.|-+++|
T Consensus 78 ~~aDlsrNR~~-elp~~~~~f~~Le~liLy~n~~r-~ip~~i~~L~~lt~l~ls~NqlS~-lp~~lC~lp-Lkvli~sNN 153 (722)
T KOG0532|consen 78 VFADLSRNRFS-ELPEEACAFVSLESLILYHNCIR-TIPEAICNLEALTFLDLSSNQLSH-LPDGLCDLP-LKVLIVSNN 153 (722)
T ss_pred hhhhccccccc-cCchHHHHHHHHHHHHHHhccce-ecchhhhhhhHHHHhhhccchhhc-CChhhhcCc-ceeEEEecC
Confidence 34444444444 34444444445555555555554 344455555555555555555542 233333332 455555555
Q ss_pred cccccCCccccCCCCccEEEeccccccCcCcccccccCcceEEEccCCcCCCCCCchhccccCcceecccCCccccccCC
Q 002721 313 GFTGVIPPELGQLINLQELILYENSLFGEIPKSILACKNLNKLDLSNNRFNGTIPNAICDMSRLQYLLLGQNSLKGEIPH 392 (888)
Q Consensus 313 ~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~ 392 (888)
+++ .+|+.++.+.+|..||.+.|.+. .+|..++.+.+|+.|.+..|++. .+|..++.++ |..||+|.|++. .+|-
T Consensus 154 kl~-~lp~~ig~~~tl~~ld~s~nei~-slpsql~~l~slr~l~vrRn~l~-~lp~El~~Lp-Li~lDfScNkis-~iPv 228 (722)
T KOG0532|consen 154 KLT-SLPEEIGLLPTLAHLDVSKNEIQ-SLPSQLGYLTSLRDLNVRRNHLE-DLPEELCSLP-LIRLDFSCNKIS-YLPV 228 (722)
T ss_pred ccc-cCCcccccchhHHHhhhhhhhhh-hchHHhhhHHHHHHHHHhhhhhh-hCCHHHhCCc-eeeeecccCcee-ecch
Confidence 555 34555555555555555555554 34444555555555555555554 3444444332 555555555555 4555
Q ss_pred CccccccceEEEeeccccc
Q 002721 393 EIGNCMKLLQLHIGSNYLT 411 (888)
Q Consensus 393 ~~~~l~~L~~L~L~~N~l~ 411 (888)
.|..|+.|++|-|.+|.|.
T Consensus 229 ~fr~m~~Lq~l~LenNPLq 247 (722)
T KOG0532|consen 229 DFRKMRHLQVLQLENNPLQ 247 (722)
T ss_pred hhhhhhhheeeeeccCCCC
Confidence 5555555555555555554
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.44 E-value=3.7e-13 Score=151.25 Aligned_cols=144 Identities=17% Similarity=0.148 Sum_probs=103.4
Q ss_pred cceeeecccceEEEEEeCCCcEEEEEEeeccChhhhH-------------------------------HH------HHHH
Q 002721 610 SNMIYCGTFSTVYKAVMPSGLILSVKRLKSMDRTIIH-------------------------------HQ------NKMI 652 (888)
Q Consensus 610 ~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~-------------------------------~~------~~~~ 652 (888)
.+.||.|++|+||+|+..+|+.||||+.++....... .. -.+.
T Consensus 122 ~~plasaSigQVh~A~l~~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 122 EKPLAAASIAQVHRARLVDGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred CcceeeeehhheEEEEecCCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 4679999999999999989999999998754221110 00 0245
Q ss_pred HHHHHHhccC-----CCceeeeeeEE-EeCCeeEEEEecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHH-HHhhc
Q 002721 653 RELEKLSKLC-----HDNLVRPIGFV-IYEDVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAE-GLAFL 725 (888)
Q Consensus 653 ~E~~~l~~l~-----hpnIv~~~~~~-~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~-aL~~L 725 (888)
+|++.+.++. +++| .+-.++ ......++||||++|+++.++...... .. ....++.+++. .+..+
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v-~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~----~~---~~~~ia~~~~~~~l~ql 273 (437)
T TIGR01982 202 REAANASELGENFKNDPGV-YVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEA----GL---DRKALAENLARSFLNQV 273 (437)
T ss_pred HHHHHHHHHHHhcCCCCCE-EeCCEehhhcCCceEEEEeECCcccccHHHHHhc----CC---CHHHHHHHHHHHHHHHH
Confidence 5666666653 3433 322222 234467999999999999988654211 11 23456666666 47889
Q ss_pred ccCCeeecCCCCCCeEeCCCCCceEeccccccccCC
Q 002721 726 HHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDP 761 (888)
Q Consensus 726 H~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~~~ 761 (888)
|..|++|+|+||.||+++.+++++++|||++..+..
T Consensus 274 ~~~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 274 LRDGFFHADLHPGNIFVLKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred HhCCceeCCCCcccEEECCCCcEEEEeCCCeeECCH
Confidence 999999999999999999999999999999987653
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.38 E-value=5.4e-13 Score=134.44 Aligned_cols=202 Identities=18% Similarity=0.291 Sum_probs=138.3
Q ss_pred HHHhccCCCceeeeeeEEEeCC-----eeEEEEecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhccc--C
Q 002721 656 EKLSKLCHDNLVRPIGFVIYED-----VALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHH--V 728 (888)
Q Consensus 656 ~~l~~l~hpnIv~~~~~~~~~~-----~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~--~ 728 (888)
.-+-++.|.|+|+++.|+.+.. ...++.|||..|++.+++++...... .+......+|+.||..||.|||+ .
T Consensus 119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~-a~~~~~wkkw~tqIlsal~yLhs~~P 197 (458)
T KOG1266|consen 119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQK-ALFQKAWKKWCTQILSALSYLHSCDP 197 (458)
T ss_pred HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhh-hhhHHHHHHHHHHHHhhhhhhhccCC
Confidence 3455667999999999987643 56889999999999999997654332 56667778999999999999998 6
Q ss_pred CeeecCCCCCCeEeCCCCCceEeccccccccCCC---CCcccccccccccceecccccccCCcCccccchhHHHHHHHHH
Q 002721 729 AIIHLDISSGNVLLDADFKPLLGEIEISKLLDPS---KGTASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEIL 805 (888)
Q Consensus 729 ~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~~~~---~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell 805 (888)
.|+|+++.-+-|++..+|-+|++-- ........ ..........+-++|.|||.-.....+.++|||+||+...||.
T Consensus 198 piihgnlTc~tifiq~ngLIkig~~-ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlema 276 (458)
T KOG1266|consen 198 PIIHGNLTCDTIFIQHNGLIKIGSV-APDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMA 276 (458)
T ss_pred ccccCCcchhheeecCCceEEeccc-CccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHH
Confidence 8999999999999999988887432 11111111 1111122334678899999877677788999999999999999
Q ss_pred hCCCCCCCCCCCccchhhhccccCCCCCCcccccccccccCCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002721 806 TTRLPVEEDFGEGVDLVKWVHGAPARGETPEQILDARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVE 880 (888)
Q Consensus 806 tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 880 (888)
.+..--....... ..+.-....+..... ..-..++.+|++.+|..||+|.+++.
T Consensus 277 ilEiq~tnseS~~---------------~~ee~ia~~i~~len------~lqr~~i~kcl~~eP~~rp~ar~llf 330 (458)
T KOG1266|consen 277 ILEIQSTNSESKV---------------EVEENIANVIIGLEN------GLQRGSITKCLEGEPNGRPDARLLLF 330 (458)
T ss_pred HheeccCCCccee---------------ehhhhhhhheeeccC------ccccCcCcccccCCCCCCcchhhhhc
Confidence 8765322111000 000000000000000 00124678899999999999998764
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.37 E-value=1e-12 Score=144.68 Aligned_cols=259 Identities=16% Similarity=0.135 Sum_probs=183.3
Q ss_pred cCHHHHHHHhcCCcceeee--cccceEEEEEe---CCCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccC-CCceeeee
Q 002721 597 IDLDAVVKATMKDSNMIYC--GTFSTVYKAVM---PSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLC-HDNLVRPI 670 (888)
Q Consensus 597 ~~~~~~~~~~~~~~~~ig~--G~~g~Vy~~~~---~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~-hpnIv~~~ 670 (888)
-..++.....+...+.+|. |.+|.||.+.. .++..+|+|+-+..... .....+=.+|+...++++ |++.++.+
T Consensus 106 S~~~s~~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~s~-p~~~~~k~~~~~s~~~i~~~~~~v~~~ 184 (524)
T KOG0601|consen 106 SPFDSFFDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPFSP-PLDSKRKLREFLSHHKIDSHENPVRDS 184 (524)
T ss_pred CCccchhhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCCCC-ccccccccchhhcccccCccccccccC
Confidence 3445567778889999999 99999999985 46889999985422221 111123346777667774 99999999
Q ss_pred eEEEeCCeeEEEEecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHH----HHhhcccCCeeecCCCCCCeEeCCC-
Q 002721 671 GFVIYEDVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAE----GLAFLHHVAIIHLDISSGNVLLDAD- 745 (888)
Q Consensus 671 ~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~----aL~~LH~~~ivHrDlkp~NIll~~~- 745 (888)
..+...+..|+-+|++. .++.++...... .++....+.+..+... ||.++|+.+++|-|+||.||++..+
T Consensus 185 ~~~e~~~~lfiqtE~~~-~sl~~~~~~~~~----~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~kp~~i~~~~~~ 259 (524)
T KOG0601|consen 185 PAWEGSGILFIQTELCG-ESLQSYCHTPCN----FLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDLKPANIFTTSDW 259 (524)
T ss_pred cccccCCcceeeecccc-chhHHhhhcccc----cCCchhhhhHHhhhhhcccccccccCCCcccccccchhheeccccc
Confidence 99999999999999985 688888776554 2344566677777777 9999999999999999999999999
Q ss_pred CCceEeccccccccCCCCCcc--c-ccccccccceecccccccCCcCccccchhHHHHHHHHHhCCCCCCCCCCCccchh
Q 002721 746 FKPLLGEIEISKLLDPSKGTA--S-ISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLV 822 (888)
Q Consensus 746 ~~~kl~Dfg~a~~~~~~~~~~--~-~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~ 822 (888)
...+++|||....+....-.. . .....|...|++||.. ...++.++|||++|.++.+..++..+.......
T Consensus 260 ~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~-~~l~~~~~di~sl~ev~l~~~l~~~~~~~g~~~----- 333 (524)
T KOG0601|consen 260 TSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELL-NGLATFASDIFSLGEVILEAILGSHLPSVGKNS----- 333 (524)
T ss_pred ceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhh-ccccchHhhhcchhhhhHhhHhhcccccCCCCC-----
Confidence 889999999998876543111 1 1122567789999965 456789999999999999999987665432100
Q ss_pred hhccccCCCCCCcccccccccccCCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHH
Q 002721 823 KWVHGAPARGETPEQILDARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVE 880 (888)
Q Consensus 823 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~ 880 (888)
.|..-... ..+.+..+ ....++...+..+++.+|..|++++.+.+
T Consensus 334 ~W~~~r~~--~ip~e~~~-----------~~s~~l~~~~~~~~d~~~~~~~~~q~~~~ 378 (524)
T KOG0601|consen 334 SWSQLRQG--YIPLEFCE-----------GGSSSLRSVTSQMLDEDPRLRLTAQILTA 378 (524)
T ss_pred Cccccccc--cCchhhhc-----------CcchhhhhHHHHhcCcchhhhhHHHHHhc
Confidence 11100000 01111111 11223334777899999999999887754
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.34 E-value=1.2e-12 Score=148.38 Aligned_cols=148 Identities=12% Similarity=0.092 Sum_probs=96.7
Q ss_pred HhcCCcceeeecccceEEEEEeCC-CcEEEEEEeeccChhh-------------------------------hHHHHH--
Q 002721 605 ATMKDSNMIYCGTFSTVYKAVMPS-GLILSVKRLKSMDRTI-------------------------------IHHQNK-- 650 (888)
Q Consensus 605 ~~~~~~~~ig~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~-------------------------------~~~~~~-- 650 (888)
..|+. +.||+|++|+||+|+.++ |+.||||+.++.-... .+..+.
T Consensus 120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~ 198 (537)
T PRK04750 120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH 198 (537)
T ss_pred HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence 45666 789999999999999876 9999999997542110 011122
Q ss_pred ----HHHHHHHHhccC----CCceeeeeeEEEe-CCeeEEEEecCCCCCHHHHh--hccCCCCCCCCCHHHHHHHHHHHH
Q 002721 651 ----MIRELEKLSKLC----HDNLVRPIGFVIY-EDVALLLHNYLPNGTLAQLL--HESTKQPDYRPDWPTRLSIAIGVA 719 (888)
Q Consensus 651 ----~~~E~~~l~~l~----hpnIv~~~~~~~~-~~~~~lv~e~~~~g~L~~~l--~~~~~~~~~~l~~~~~~~i~~qi~ 719 (888)
+.+|+..+.+++ +...+.+-.++.+ ....++||||++|+++.++- ...+.. ...+....+..++.|+
T Consensus 199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~~~l~~~g~d-~~~la~~~v~~~~~Qi- 276 (537)
T PRK04750 199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDVAALRAAGTD-MKLLAERGVEVFFTQV- 276 (537)
T ss_pred HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhHHHHHhcCCC-HHHHHHHHHHHHHHHH-
Confidence 344554444442 3333333333332 44678999999999998753 222110 0012222233344444
Q ss_pred HHHhhcccCCeeecCCCCCCeEeCCCC----CceEeccccccccCC
Q 002721 720 EGLAFLHHVAIIHLDISSGNVLLDADF----KPLLGEIEISKLLDP 761 (888)
Q Consensus 720 ~aL~~LH~~~ivHrDlkp~NIll~~~~----~~kl~Dfg~a~~~~~ 761 (888)
+..|++|+|+||.||+++.++ ++++.|||++..++.
T Consensus 277 ------f~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l~~ 316 (537)
T PRK04750 277 ------FRDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSLNK 316 (537)
T ss_pred ------HhCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEECCH
Confidence 459999999999999999888 999999999988754
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.26 E-value=4.8e-12 Score=139.42 Aligned_cols=249 Identities=18% Similarity=0.129 Sum_probs=174.4
Q ss_pred HHHhcCCcceeeecccceEEEEEe--CCCcEEEEEEeeccChhhhHHHHHHHHHHHHHhcc-CCCceeeeeeEEEeCCee
Q 002721 603 VKATMKDSNMIYCGTFSTVYKAVM--PSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKL-CHDNLVRPIGFVIYEDVA 679 (888)
Q Consensus 603 ~~~~~~~~~~ig~G~~g~Vy~~~~--~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~~~~~~ 679 (888)
...+|..+..||.|.|+.||.... .++..|++|.+...-.....+ ..-..|+.+...+ .|.++++++..|...+..
T Consensus 263 ~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~d-i~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~ 341 (524)
T KOG0601|consen 263 KLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASD-IFSLGEVILEAILGSHLPSVGKNSSWSQLRQG 341 (524)
T ss_pred ecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhh-hcchhhhhHhhHhhcccccCCCCCCccccccc
Confidence 345788899999999999999873 468899999887544333222 1344677666666 499999998888888888
Q ss_pred EEEEecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCC-CCceEeccccccc
Q 002721 680 LLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDAD-FKPLLGEIEISKL 758 (888)
Q Consensus 680 ~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~-~~~kl~Dfg~a~~ 758 (888)
|+--|||++++....+.-.. .++...++++..|++.++.++|++.++|+|+||+||++..+ +..+++|||.+..
T Consensus 342 ~ip~e~~~~~s~~l~~~~~~-----~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~ 416 (524)
T KOG0601|consen 342 YIPLEFCEGGSSSLRSVTSQ-----MLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTR 416 (524)
T ss_pred cCchhhhcCcchhhhhHHHH-----hcCcchhhhhHHHHHhccccccchhhhcccccccceeeccchhhhhccccccccc
Confidence 89999999998876663322 34557788999999999999999999999999999999876 7889999999875
Q ss_pred cCCCCCcccccccccccce-ecccccccCCcCccccchhHHHHHHHHHhCCCCCCCCCCCccchhhhccccCCCCCCccc
Q 002721 759 LDPSKGTASISAVAGSFGY-IPPEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQ 837 (888)
Q Consensus 759 ~~~~~~~~~~~~~~gt~~y-~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~ 837 (888)
+...... ....+..| .+|+......+..+.|+||||..+.+.+++..--... . ....
T Consensus 417 ~~~~~~~----~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~-~-----------------~~~~ 474 (524)
T KOG0601|consen 417 LAFSSGV----FHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESG-V-----------------QSLT 474 (524)
T ss_pred cceeccc----ccccccccccchhhccccccccccccccccccccccccCcccCccc-c-----------------ccee
Confidence 3322111 11223334 3566666778889999999999999999986432210 0 0111
Q ss_pred ccccccccCCcCcHHHHHHHHHHHhhccCCCCCCCCCHHHHHHHHH
Q 002721 838 ILDARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEMLQ 883 (888)
Q Consensus 838 ~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~evl~~L~ 883 (888)
+........ .....++..+.+.+..+++..||.+.+.....+
T Consensus 475 i~~~~~p~~----~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~ 516 (524)
T KOG0601|consen 475 IRSGDTPNL----PGLKLQLQVLLKVMINPDRKRRPSAVELSLHSE 516 (524)
T ss_pred eecccccCC----CchHHhhhhhhhhhcCCccccchhhhhhcccch
Confidence 111111111 111133445566677899999999888765544
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.23 E-value=2.2e-11 Score=119.66 Aligned_cols=128 Identities=17% Similarity=0.151 Sum_probs=95.8
Q ss_pred cceeeecccceEEEEEeCCCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCce-eeeeeEEEeCCeeEEEEecCCC
Q 002721 610 SNMIYCGTFSTVYKAVMPSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNL-VRPIGFVIYEDVALLLHNYLPN 688 (888)
Q Consensus 610 ~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnI-v~~~~~~~~~~~~~lv~e~~~~ 688 (888)
.+.++.|.++.||+++.. +..|++|........ ...+.+|+++++.+.+.++ .+++++. ....++||||++|
T Consensus 3 ~~~l~~G~~~~vy~~~~~-~~~~~lK~~~~~~~~----~~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G 75 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA-NKKYVVRIPGNGTEL----LINRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEG 75 (170)
T ss_pred eeecCCcccCceEEEEEC-CeEEEEEeCCCCccc----ccCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCC
Confidence 456889999999999864 778999987643211 1245789999998865444 3455443 3346899999999
Q ss_pred CCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCe-----eecCCCCCCeEeCCCCCceEeccccccc
Q 002721 689 GTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAI-----IHLDISSGNVLLDADFKPLLGEIEISKL 758 (888)
Q Consensus 689 g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i-----vHrDlkp~NIll~~~~~~kl~Dfg~a~~ 758 (888)
.++.+. . .....++.+++++|+.||+.++ +|+|++|.||+++ ++.++++||+.+..
T Consensus 76 ~~l~~~--~-----------~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~~ 136 (170)
T cd05151 76 SELLTE--D-----------FSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAGM 136 (170)
T ss_pred Cccccc--c-----------ccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CCeEEEEecccccC
Confidence 877643 0 0112456799999999999875 9999999999999 66899999998765
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.22 E-value=8.3e-11 Score=130.63 Aligned_cols=167 Identities=16% Similarity=0.168 Sum_probs=127.5
Q ss_pred eCCCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCCeeEEEEecCCCCCHHHHhhccCCCCCCC
Q 002721 626 MPSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVALLLHNYLPNGTLAQLLHESTKQPDYR 705 (888)
Q Consensus 626 ~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~ 705 (888)
..++.+|.|.+.+.... .......+-++.++.++||+|+++++.++.++..|+|+|.+. .|..++++..
T Consensus 34 k~~~~~vsVF~~~~~~~---~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~--Pl~~~lk~l~------ 102 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNG---EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVR--PLETVLKELG------ 102 (690)
T ss_pred eccCCceEEEEEeCCCc---hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccc--cHHHHHHHhH------
Confidence 55788888888875544 233456778889999999999999999999999999999984 7888887654
Q ss_pred CCHHHHHHHHHHHHHHHhhcc-cCCeeecCCCCCCeEeCCCCCceEeccccccccCCCCCcccccccccccceecccccc
Q 002721 706 PDWPTRLSIAIGVAEGLAFLH-HVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSKGTASISAVAGSFGYIPPEYAY 784 (888)
Q Consensus 706 l~~~~~~~i~~qi~~aL~~LH-~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~ 784 (888)
...+...+.||+.||.||| +.+++|++|.-+.|+|+..|..||++|-.+......... .....--..|..|+.+.
T Consensus 103 --~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~~--~~~~~~~~s~~~P~~~~ 178 (690)
T KOG1243|consen 103 --KEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNAP--AKSLYLIESFDDPEEID 178 (690)
T ss_pred --HHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCcc--cccchhhhcccChhhcC
Confidence 3456667889999999997 589999999999999999999999999887654322210 01111222466676443
Q ss_pred cCCcCccccchhHHHHHHHHHhCCC
Q 002721 785 TMQVTAPGNVYSYGVVLLEILTTRL 809 (888)
Q Consensus 785 ~~~~~~~~DiwSlG~il~elltg~~ 809 (888)
... -..|.|-|||+++|++.|..
T Consensus 179 ~s~--~s~D~~~Lg~li~el~ng~~ 201 (690)
T KOG1243|consen 179 PSE--WSIDSWGLGCLIEELFNGSL 201 (690)
T ss_pred ccc--cchhhhhHHHHHHHHhCccc
Confidence 222 34599999999999999943
|
|
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.20 E-value=1.7e-12 Score=146.30 Aligned_cols=85 Identities=24% Similarity=0.202 Sum_probs=45.8
Q ss_pred CcEEEeecCcccccCCccccCCCCccEEEeccccccCcCcccccccCcceEEEccCCcCCCC---CCch-hccccCccee
Q 002721 304 LTLLNLASNGFTGVIPPELGQLINLQELILYENSLFGEIPKSILACKNLNKLDLSNNRFNGT---IPNA-ICDMSRLQYL 379 (888)
Q Consensus 304 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~---~p~~-~~~l~~L~~L 379 (888)
|+.+++++|.+.. .+..+..+.++..|++.+|++...- .+...+.+..+.+..|.+... .... ....+.++.+
T Consensus 234 L~~l~l~~n~i~~-~~~~~~~~~~l~~l~~~~n~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 310 (414)
T KOG0531|consen 234 LRELYLSGNRISR-SPEGLENLKNLPVLDLSSNRISNLE--GLERLPKLSELWLNDNKLALSEAISQEYITSAAPTLVTL 310 (414)
T ss_pred HHHHhcccCcccc-ccccccccccccccchhhccccccc--cccccchHHHhccCcchhcchhhhhcccccccccccccc
Confidence 5566666666652 2244555566666666666654321 233445555566666665421 1111 3455667777
Q ss_pred cccCCccccccC
Q 002721 380 LLGQNSLKGEIP 391 (888)
Q Consensus 380 ~L~~N~l~~~~p 391 (888)
.+..|.+....+
T Consensus 311 ~~~~~~~~~~~~ 322 (414)
T KOG0531|consen 311 TLELNPIRKISS 322 (414)
T ss_pred ccccCccccccc
Confidence 777777765444
|
|
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.19 E-value=9.8e-11 Score=115.25 Aligned_cols=140 Identities=16% Similarity=0.134 Sum_probs=99.6
Q ss_pred cceeeecccceEEEEEeCC-------CcEEEEEEeeccCh-------hh------------hHHHH----HHHHHHHHHh
Q 002721 610 SNMIYCGTFSTVYKAVMPS-------GLILSVKRLKSMDR-------TI------------IHHQN----KMIRELEKLS 659 (888)
Q Consensus 610 ~~~ig~G~~g~Vy~~~~~~-------~~~vavK~~~~~~~-------~~------------~~~~~----~~~~E~~~l~ 659 (888)
...||.|.-+.||.|...+ +..+|||+.+.... .. ....+ ...+|++.|+
T Consensus 2 ~g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~ 81 (197)
T cd05146 2 NGCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLK 81 (197)
T ss_pred CCccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHH
Confidence 3578999999999998543 47999998752110 00 00011 2348999999
Q ss_pred ccC--CCceeeeeeEEEeCCeeEEEEecCCCCCHHH-HhhccCCCCCCCCCHHHHHHHHHHHHHHHhhc-ccCCeeecCC
Q 002721 660 KLC--HDNLVRPIGFVIYEDVALLLHNYLPNGTLAQ-LLHESTKQPDYRPDWPTRLSIAIGVAEGLAFL-HHVAIIHLDI 735 (888)
Q Consensus 660 ~l~--hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~-~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~L-H~~~ivHrDl 735 (888)
++. .-++.+.+++ ...++||||+.+..+.. .++.. .++..+...+..|++.++..+ |+.|+||||+
T Consensus 82 rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~------~~~~~~~~~i~~~i~~~l~~l~H~~glVHGDL 151 (197)
T cd05146 82 RMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDA------KLNDEEMKNAYYQVLSMMKQLYKECNLVHADL 151 (197)
T ss_pred HHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhcc------ccCHHHHHHHHHHHHHHHHHHHHhCCeecCCC
Confidence 985 3466666664 46789999997643321 22211 233456677889999999999 8999999999
Q ss_pred CCCCeEeCCCCCceEeccccccccC
Q 002721 736 SSGNVLLDADFKPLLGEIEISKLLD 760 (888)
Q Consensus 736 kp~NIll~~~~~~kl~Dfg~a~~~~ 760 (888)
++.||+++ ++.+.++|||.+...+
T Consensus 152 s~~NIL~~-~~~v~iIDF~qav~~~ 175 (197)
T cd05146 152 SEYNMLWH-DGKVWFIDVSQSVEPT 175 (197)
T ss_pred CHHHEEEE-CCcEEEEECCCceeCC
Confidence 99999997 4689999999887654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG0531 consensus Protein phosphatase 1, regulatory subunit, and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.17 E-value=3.3e-12 Score=144.04 Aligned_cols=247 Identities=25% Similarity=0.264 Sum_probs=119.5
Q ss_pred CCCCCEEeCCCCcCcccCCCCCCCCCCCCEEECcCCCCCCCCCCCCCCCCcceEEEcCCCccccccCccccccccccEEE
Q 002721 85 LKALKRLDLSNNAFSGTIPSAFGNLSELEFLDLSLNKFGGVIPRELGSLKDLRFFNISNNVLVGEIPDELKSLEKLEDFQ 164 (888)
Q Consensus 85 l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 164 (888)
+..++.+++..|.+.. +-..+..+++|+.|+|.+|+|..+ ...+..+++|++|+|++|.|+.+. .+..++.|+.|+
T Consensus 71 l~~l~~l~l~~n~i~~-~~~~l~~~~~l~~l~l~~n~i~~i-~~~l~~~~~L~~L~ls~N~I~~i~--~l~~l~~L~~L~ 146 (414)
T KOG0531|consen 71 LTSLKELNLRQNLIAK-ILNHLSKLKSLEALDLYDNKIEKI-ENLLSSLVNLQVLDLSFNKITKLE--GLSTLTLLKELN 146 (414)
T ss_pred hHhHHhhccchhhhhh-hhcccccccceeeeeccccchhhc-ccchhhhhcchheecccccccccc--chhhccchhhhe
Confidence 4444555555555542 222345555555555555555532 222445555555555555555332 233444455555
Q ss_pred ecCCCCCCCCCccccccccccEEecccccccCCCC-CCCCCcccccceeeccccCCCCCCCCccCCCCcceEEecCccCC
Q 002721 165 VSSNKLNGSIPFWVGNLTNLRVFTAYENQLVGEIP-DNLGSVSELELLNLHSNQLEGPIPKSIFASGKLEVLVLTQNRLT 243 (888)
Q Consensus 165 Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 243 (888)
+++|.|+.. ..+..+++|+.+++++|++...-+ . ...+.+|+.+++++|.+.. ...+..
T Consensus 147 l~~N~i~~~--~~~~~l~~L~~l~l~~n~i~~ie~~~-~~~~~~l~~l~l~~n~i~~--i~~~~~--------------- 206 (414)
T KOG0531|consen 147 LSGNLISDI--SGLESLKSLKLLDLSYNRIVDIENDE-LSELISLEELDLGGNSIRE--IEGLDL--------------- 206 (414)
T ss_pred eccCcchhc--cCCccchhhhcccCCcchhhhhhhhh-hhhccchHHHhccCCchhc--ccchHH---------------
Confidence 555555421 123334445555555554443222 1 2344444444444444431 122222
Q ss_pred CCchhhhccCCccceeeccCCccccccCCccccCCCccEEEeeccCCCCCCCccccCCCCCcEEEeecCcccccCCcccc
Q 002721 244 GDIPELVGHCKSLSNIRIGNNDLVGVIPRAIGNVSGLTYFEADNNNLSGEIVPEFSQCSNLTLLNLASNGFTGVIPPELG 323 (888)
Q Consensus 244 ~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~ 323 (888)
+..+..+++..|.++.+-+-....+..|+.+++++|++... +..+..+.++..|++.+|++... ..+.
T Consensus 207 ---------~~~l~~~~l~~n~i~~~~~l~~~~~~~L~~l~l~~n~i~~~-~~~~~~~~~l~~l~~~~n~~~~~--~~~~ 274 (414)
T KOG0531|consen 207 ---------LKKLVLLSLLDNKISKLEGLNELVMLHLRELYLSGNRISRS-PEGLENLKNLPVLDLSSNRISNL--EGLE 274 (414)
T ss_pred ---------HHHHHHhhcccccceeccCcccchhHHHHHHhcccCccccc-cccccccccccccchhhcccccc--cccc
Confidence 23333334555554432211111011255666666666532 13445566677777777776643 2344
Q ss_pred CCCCccEEEeccccccCc---Cccc-ccccCcceEEEccCCcCCCCCC
Q 002721 324 QLINLQELILYENSLFGE---IPKS-ILACKNLNKLDLSNNRFNGTIP 367 (888)
Q Consensus 324 ~l~~L~~L~L~~N~l~~~---~p~~-~~~l~~L~~L~Ls~N~l~~~~p 367 (888)
....+..+.+..|.+... .... ....+.++.+.+..|.+....+
T Consensus 275 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (414)
T KOG0531|consen 275 RLPKLSELWLNDNKLALSEAISQEYITSAAPTLVTLTLELNPIRKISS 322 (414)
T ss_pred ccchHHHhccCcchhcchhhhhccccccccccccccccccCccccccc
Confidence 555666666666665421 1111 4456778888888888775544
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.15 E-value=9.6e-12 Score=143.48 Aligned_cols=251 Identities=20% Similarity=0.170 Sum_probs=174.3
Q ss_pred HhcCCcceeeecccceEEEEEe-CCCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCCeeEEEE
Q 002721 605 ATMKDSNMIYCGTFSTVYKAVM-PSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVALLLH 683 (888)
Q Consensus 605 ~~~~~~~~ig~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 683 (888)
+.+.+.+-+-+|.++.++.+.- ..|...+.|+............+...++-.+.-..+||-+++..--+......++++
T Consensus 804 d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~~ 883 (1205)
T KOG0606|consen 804 DGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLVG 883 (1205)
T ss_pred ccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchhh
Confidence 3566777888999999999883 346556666555433333322334445555555556777777666666677889999
Q ss_pred ecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccccccccCC--
Q 002721 684 NYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDP-- 761 (888)
Q Consensus 684 e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~~~-- 761 (888)
+|+.++++...++..... +..-.......+..+++|||...++|||++|.|+++..+++.++.|||.......
T Consensus 884 ~~~~~~~~~Skl~~~~~~-----saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~ 958 (1205)
T KOG0606|consen 884 HYLNGGDLPSKLHNSGCL-----SAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIP 958 (1205)
T ss_pred HHhccCCchhhhhcCCCc-----ccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCcccccccccccc
Confidence 999999999999876532 2233445666788999999999999999999999999999999999983332110
Q ss_pred -------------------CCC-----c---ccccccccccceecccccccCCcCccccchhHHHHHHHHHhCCCCCCCC
Q 002721 762 -------------------SKG-----T---ASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEED 814 (888)
Q Consensus 762 -------------------~~~-----~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~P~~~~ 814 (888)
... . .......||+.|.+||...+......+|+|+.|++++|.++|.+||...
T Consensus 959 p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~ 1038 (1205)
T KOG0606|consen 959 PTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAE 1038 (1205)
T ss_pred CcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCCc
Confidence 000 0 0122457899999999999999999999999999999999999999875
Q ss_pred CCCccchhhhccccCCCCCCcccccccccccCCcCcHHHHHHHHHHHhhccCCCCCCCCCHH
Q 002721 815 FGEGVDLVKWVHGAPARGETPEQILDARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMK 876 (888)
Q Consensus 815 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RPs~~ 876 (888)
..... .+.+...... .+........++.+++...+..+|.+|-.|.
T Consensus 1039 tpq~~---------------f~ni~~~~~~-~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1039 TPQQI---------------FENILNRDIP-WPEGPEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred chhhh---------------hhccccCCCC-CCCCccccChhhhhhhhhhhccCchhccCcc
Confidence 44321 1222211111 1112233444555667777788888887654
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.13 E-value=3.1e-11 Score=116.35 Aligned_cols=107 Identities=32% Similarity=0.440 Sum_probs=27.8
Q ss_pred CCCCCCEEeCCCCcCcccCCCCCC-CCCCCCEEECcCCCCCCCCCCCCCCCCcceEEEcCCCccccccCccc-ccccccc
Q 002721 84 ELKALKRLDLSNNAFSGTIPSAFG-NLSELEFLDLSLNKFGGVIPRELGSLKDLRFFNISNNVLVGEIPDEL-KSLEKLE 161 (888)
Q Consensus 84 ~l~~L~~L~Ls~n~l~~~~p~~~~-~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~-~~l~~L~ 161 (888)
+..++++|+|++|.|+. + +.++ .+.+|+.|||++|+|+.+. .+..+++|++|+|++|+|+. +++.+ ..+++|+
T Consensus 17 n~~~~~~L~L~~n~I~~-I-e~L~~~l~~L~~L~Ls~N~I~~l~--~l~~L~~L~~L~L~~N~I~~-i~~~l~~~lp~L~ 91 (175)
T PF14580_consen 17 NPVKLRELNLRGNQIST-I-ENLGATLDKLEVLDLSNNQITKLE--GLPGLPRLKTLDLSNNRISS-ISEGLDKNLPNLQ 91 (175)
T ss_dssp ---------------------S--TT-TT--EEE-TTS--S--T--T----TT--EEE--SS---S--CHHHHHH-TT--
T ss_pred ccccccccccccccccc-c-cchhhhhcCCCEEECCCCCCcccc--CccChhhhhhcccCCCCCCc-cccchHHhCCcCC
Confidence 33456666666666653 2 2344 4566666666666666432 35566666666666666663 32233 3456666
Q ss_pred EEEecCCCCCCCCC-ccccccccccEEeccccccc
Q 002721 162 DFQVSSNKLNGSIP-FWVGNLTNLRVFTAYENQLV 195 (888)
Q Consensus 162 ~L~Ls~N~l~~~~p-~~~~~l~~L~~L~L~~N~l~ 195 (888)
+|+|++|+|...-. ..+..+++|++|+|.+|.++
T Consensus 92 ~L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv~ 126 (175)
T PF14580_consen 92 ELYLSNNKISDLNELEPLSSLPKLRVLSLEGNPVC 126 (175)
T ss_dssp EEE-TTS---SCCCCGGGGG-TT--EEE-TT-GGG
T ss_pred EEECcCCcCCChHHhHHHHcCCCcceeeccCCccc
Confidence 66666666653211 23444555555555555544
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.13 E-value=3.9e-10 Score=106.47 Aligned_cols=134 Identities=22% Similarity=0.307 Sum_probs=100.6
Q ss_pred ceeeecccceEEEEEeCCCcEEEEEE-eeccChh----hhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCCeeEEEEec
Q 002721 611 NMIYCGTFSTVYKAVMPSGLILSVKR-LKSMDRT----IIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVALLLHNY 685 (888)
Q Consensus 611 ~~ig~G~~g~Vy~~~~~~~~~vavK~-~~~~~~~----~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~ 685 (888)
..+++|+-+.+|.+.+. |..+++|. +++.... ..-...+-.+|++++.+++--.|...+=|..+.+...++|||
T Consensus 2 ~~i~~GAEa~i~~~~~~-g~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~ 80 (204)
T COG3642 2 DLIKQGAEAIIYLTDFL-GLPAVVKERIPKRYRHPELDEKLRRERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEY 80 (204)
T ss_pred chhhCCcceeEEeeecc-CcceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEE
Confidence 45789999999999763 33455553 3322111 111234677899999999765665555566677888999999
Q ss_pred CCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccccccc
Q 002721 686 LPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKL 758 (888)
Q Consensus 686 ~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~ 758 (888)
++|..|.+++... ...++..+-.-+.-||..||+|+|+.++||++..++ +.++|||++..
T Consensus 81 I~G~~lkd~l~~~------------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 81 IEGELLKDALEEA------------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred eCChhHHHHHHhc------------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 9999999888764 134677777888889999999999999999998764 99999999875
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.12 E-value=1.4e-11 Score=122.62 Aligned_cols=128 Identities=27% Similarity=0.269 Sum_probs=74.3
Q ss_pred CccEEEeeccCCCCCCCccccCCCCCcEEEeecCcccccCCccccCCCCccEEEeccccccCcCcccccccCcceEEEcc
Q 002721 279 GLTYFEADNNNLSGEIVPEFSQCSNLTLLNLASNGFTGVIPPELGQLINLQELILYENSLFGEIPKSILACKNLNKLDLS 358 (888)
Q Consensus 279 ~L~~L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls 358 (888)
.|+.+||++|.|+ .+..+..-++.++.|++|+|.|..+ ..+..+++|+.||||+|.++ .+..+-.++-+.+.|.|+
T Consensus 285 ~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~~v--~nLa~L~~L~~LDLS~N~Ls-~~~Gwh~KLGNIKtL~La 360 (490)
T KOG1259|consen 285 ELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIRTV--QNLAELPQLQLLDLSGNLLA-ECVGWHLKLGNIKTLKLA 360 (490)
T ss_pred hhhhccccccchh-hhhhhhhhccceeEEeccccceeee--hhhhhcccceEeecccchhH-hhhhhHhhhcCEeeeehh
Confidence 4555555555554 2333444455666666666666533 23556666666666666664 344445556666666666
Q ss_pred CCcCCCCCCchhccccCcceecccCCcccccc-CCCccccccceEEEeecccccc
Q 002721 359 NNRFNGTIPNAICDMSRLQYLLLGQNSLKGEI-PHEIGNCMKLLQLHIGSNYLTG 412 (888)
Q Consensus 359 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~-p~~~~~l~~L~~L~L~~N~l~~ 412 (888)
+|.|... ..+..+-+|.+||+++|+|.... -..+++++-|+.+.|.+|.+.+
T Consensus 361 ~N~iE~L--SGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NPl~~ 413 (490)
T KOG1259|consen 361 QNKIETL--SGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNPLAG 413 (490)
T ss_pred hhhHhhh--hhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCCccc
Confidence 6666521 24555666667777777665221 2346777777777777777763
|
|
| >KOG1259 consensus Nischarin, modulator of integrin alpha5 subunit action [Signal transduction mechanisms; Cytoskeleton] | Back alignment and domain information |
|---|
Probab=99.11 E-value=1.4e-11 Score=122.53 Aligned_cols=132 Identities=27% Similarity=0.271 Sum_probs=75.7
Q ss_pred CCcccccceeeccccCCCCCCCCccCCCCcceEEecCccCCCCchhhhccCCccceeeccCCccccccCCccccCCCccE
Q 002721 203 GSVSELELLNLHSNQLEGPIPKSIFASGKLEVLVLTQNRLTGDIPELVGHCKSLSNIRIGNNDLVGVIPRAIGNVSGLTY 282 (888)
Q Consensus 203 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~ 282 (888)
.....|++||||+|.|+ .+..+..-.++++.|++|+|.|+.+.. +..+++|+.||||+|.++.
T Consensus 281 dTWq~LtelDLS~N~I~-~iDESvKL~Pkir~L~lS~N~i~~v~n--La~L~~L~~LDLS~N~Ls~-------------- 343 (490)
T KOG1259|consen 281 DTWQELTELDLSGNLIT-QIDESVKLAPKLRRLILSQNRIRTVQN--LAELPQLQLLDLSGNLLAE-------------- 343 (490)
T ss_pred chHhhhhhccccccchh-hhhhhhhhccceeEEeccccceeeehh--hhhcccceEeecccchhHh--------------
Confidence 34455666666666665 344444445555555555555553211 4444555555555554442
Q ss_pred EEeeccCCCCCCCccccCCCCCcEEEeecCcccccCCccccCCCCccEEEeccccccCc-CcccccccCcceEEEccCCc
Q 002721 283 FEADNNNLSGEIVPEFSQCSNLTLLNLASNGFTGVIPPELGQLINLQELILYENSLFGE-IPKSILACKNLNKLDLSNNR 361 (888)
Q Consensus 283 L~l~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~-~p~~~~~l~~L~~L~Ls~N~ 361 (888)
...+-..+-|+++|.|++|.|... ..+..+.+|..||+++|+|... --..++++|.|+.+.|.+|.
T Consensus 344 -----------~~Gwh~KLGNIKtL~La~N~iE~L--SGL~KLYSLvnLDl~~N~Ie~ldeV~~IG~LPCLE~l~L~~NP 410 (490)
T KOG1259|consen 344 -----------CVGWHLKLGNIKTLKLAQNKIETL--SGLRKLYSLVNLDLSSNQIEELDEVNHIGNLPCLETLRLTGNP 410 (490)
T ss_pred -----------hhhhHhhhcCEeeeehhhhhHhhh--hhhHhhhhheeccccccchhhHHHhcccccccHHHHHhhcCCC
Confidence 222333455666777777766532 3456666777777777776532 12356777888888888888
Q ss_pred CCC
Q 002721 362 FNG 364 (888)
Q Consensus 362 l~~ 364 (888)
+.+
T Consensus 411 l~~ 413 (490)
T KOG1259|consen 411 LAG 413 (490)
T ss_pred ccc
Confidence 874
|
|
| >PF14580 LRR_9: Leucine-rich repeat; PDB: 2JE1_D 2JE0_A 2JQD_A | Back alignment and domain information |
|---|
Probab=99.11 E-value=3.3e-11 Score=116.20 Aligned_cols=108 Identities=26% Similarity=0.403 Sum_probs=31.0
Q ss_pred CCCCCCCCEEECcCCCCCCCCCCCCC-CCCcceEEEcCCCccccccCccccccccccEEEecCCCCCCCCCccc-ccccc
Q 002721 106 FGNLSELEFLDLSLNKFGGVIPRELG-SLKDLRFFNISNNVLVGEIPDELKSLEKLEDFQVSSNKLNGSIPFWV-GNLTN 183 (888)
Q Consensus 106 ~~~l~~L~~L~Ls~N~l~~~~p~~~~-~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~-~~l~~ 183 (888)
+.+..++++|+|++|+|+.+ +.++ .+.+|+.|+|++|.|+.. + .+..+++|++|++++|+|+.. ++.+ ..+++
T Consensus 15 ~~n~~~~~~L~L~~n~I~~I--e~L~~~l~~L~~L~Ls~N~I~~l-~-~l~~L~~L~~L~L~~N~I~~i-~~~l~~~lp~ 89 (175)
T PF14580_consen 15 YNNPVKLRELNLRGNQISTI--ENLGATLDKLEVLDLSNNQITKL-E-GLPGLPRLKTLDLSNNRISSI-SEGLDKNLPN 89 (175)
T ss_dssp -----------------------S--TT-TT--EEE-TTS--S---T-T----TT--EEE--SS---S--CHHHHHH-TT
T ss_pred cccccccccccccccccccc--cchhhhhcCCCEEECCCCCCccc-c-CccChhhhhhcccCCCCCCcc-ccchHHhCCc
Confidence 45666788899999988854 2455 578888888888888843 2 477788888888888888743 3333 35677
Q ss_pred ccEEecccccccCCCC-CCCCCcccccceeeccccC
Q 002721 184 LRVFTAYENQLVGEIP-DNLGSVSELELLNLHSNQL 218 (888)
Q Consensus 184 L~~L~L~~N~l~~~~p-~~~~~l~~L~~L~L~~N~l 218 (888)
|++|+|++|+|...-. ..++.+++|+.|+|.+|.+
T Consensus 90 L~~L~L~~N~I~~l~~l~~L~~l~~L~~L~L~~NPv 125 (175)
T PF14580_consen 90 LQELYLSNNKISDLNELEPLSSLPKLRVLSLEGNPV 125 (175)
T ss_dssp --EEE-TTS---SCCCCGGGGG-TT--EEE-TT-GG
T ss_pred CCEEECcCCcCCChHHhHHHHcCCCcceeeccCCcc
Confidence 7777777777763211 2233444444444444444
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.09 E-value=9.5e-10 Score=103.07 Aligned_cols=146 Identities=19% Similarity=0.225 Sum_probs=107.1
Q ss_pred CcceeeecccceEEEEEeCCCcEEEEEE-eeccCh----hhhHHHHHHHHHHHHHhccCCCceeeeeeEEEeCCeeEEEE
Q 002721 609 DSNMIYCGTFSTVYKAVMPSGLILSVKR-LKSMDR----TIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVALLLH 683 (888)
Q Consensus 609 ~~~~ig~G~~g~Vy~~~~~~~~~vavK~-~~~~~~----~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~ 683 (888)
....+.+|+-+.|+++.+ .|+.+.||. +.+... +..-..++..+|++++.+++--.|.-..=++.+...-.++|
T Consensus 11 ~l~likQGAEArv~~~~~-~Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~M 89 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSF-SGEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYM 89 (229)
T ss_pred cceeeeccceeeEeeecc-CCceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEE
Confidence 567899999999999997 566666663 322211 11222346789999999997555555555566777778999
Q ss_pred ecCCC-CCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCC---CceEeccccccc
Q 002721 684 NYLPN-GTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADF---KPLLGEIEISKL 758 (888)
Q Consensus 684 e~~~~-g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~---~~kl~Dfg~a~~ 758 (888)
||++| .++.+++......+. ..+....++.+|-+.+.-||..+|+|+||..+||++..++ .+.++|||++..
T Consensus 90 E~~~g~~~vk~~i~~~~~~~~---~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 90 EFIDGASTVKDFILSTMEDES---EDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV 165 (229)
T ss_pred EeccchhHHHHHHHHHccCcc---cchhHHHHHHHHHHHHHHhhhCCeecccccccceEEecCCCcCceEEEeecchhc
Confidence 99986 488888877644321 1122367889999999999999999999999999997654 357999999764
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=99.09 E-value=1.1e-11 Score=129.78 Aligned_cols=210 Identities=22% Similarity=0.173 Sum_probs=113.3
Q ss_pred CCCCCCCEEECcCCCCCCCCC-CCCCCCCcceEEEcCCCcccccc--CccccccccccEEEecCCCCCCCCCc-cccccc
Q 002721 107 GNLSELEFLDLSLNKFGGVIP-RELGSLKDLRFFNISNNVLVGEI--PDELKSLEKLEDFQVSSNKLNGSIPF-WVGNLT 182 (888)
Q Consensus 107 ~~l~~L~~L~Ls~N~l~~~~p-~~~~~l~~L~~L~Ls~N~l~~~~--p~~~~~l~~L~~L~Ls~N~l~~~~p~-~~~~l~ 182 (888)
+++.+|+...|.+..+..... +....+++++.||||+|-+.... -.....|++|+.|+||.|++...... .-..++
T Consensus 118 sn~kkL~~IsLdn~~V~~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v~~i~eqLp~Le~LNls~Nrl~~~~~s~~~~~l~ 197 (505)
T KOG3207|consen 118 SNLKKLREISLDNYRVEDAGIEEYSKILPNVRDLDLSRNLFHNWFPVLKIAEQLPSLENLNLSSNRLSNFISSNTTLLLS 197 (505)
T ss_pred hhHHhhhheeecCccccccchhhhhhhCCcceeecchhhhHHhHHHHHHHHHhcccchhcccccccccCCccccchhhhh
Confidence 356677777777777652211 34566777777777777776332 22345677777777777777532211 122455
Q ss_pred cccEEecccccccCCC-CCCCCCcccccceeeccccCCCCCCCCccCCCCcceEEecCccCCCCc-hhhhccCCccceee
Q 002721 183 NLRVFTAYENQLVGEI-PDNLGSVSELELLNLHSNQLEGPIPKSIFASGKLEVLVLTQNRLTGDI-PELVGHCKSLSNIR 260 (888)
Q Consensus 183 ~L~~L~L~~N~l~~~~-p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~-~~~~~~l~~L~~L~ 260 (888)
+|+.|.|+.+.++..- -......++|+.|+|+.|...........-+..|+.|||++|++-... -...+.++.|..|.
T Consensus 198 ~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~N~li~~~~~~~~~~l~~L~~Ln 277 (505)
T KOG3207|consen 198 HLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSNNNLIDFDQGYKVGTLPGLNQLN 277 (505)
T ss_pred hhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccccCCcccccccccccccccchhhhh
Confidence 6666666666665211 112234556666666666422222233333445555555555554211 12334444444444
Q ss_pred ccCCccccccCCccccCCCccEEEeeccCCCCCCCcc------ccCCCCCcEEEeecCccccc-CCccccCCCCccEEEe
Q 002721 261 IGNNDLVGVIPRAIGNVSGLTYFEADNNNLSGEIVPE------FSQCSNLTLLNLASNGFTGV-IPPELGQLINLQELIL 333 (888)
Q Consensus 261 L~~N~l~~~~~~~~~~l~~L~~L~l~~N~l~~~~~~~------~~~l~~L~~L~L~~N~l~~~-~p~~~~~l~~L~~L~L 333 (888)
++.+.+ ..+-.+. ...+++|++|++..|+|... .-..+..+.+|+.|..
T Consensus 278 ls~tgi------------------------~si~~~d~~s~~kt~~f~kL~~L~i~~N~I~~w~sl~~l~~l~nlk~l~~ 333 (505)
T KOG3207|consen 278 LSSTGI------------------------ASIAEPDVESLDKTHTFPKLEYLNISENNIRDWRSLNHLRTLENLKHLRI 333 (505)
T ss_pred ccccCc------------------------chhcCCCccchhhhcccccceeeecccCccccccccchhhccchhhhhhc
Confidence 444444 3322221 24456777788888777421 1123455667777787
Q ss_pred ccccccC
Q 002721 334 YENSLFG 340 (888)
Q Consensus 334 ~~N~l~~ 340 (888)
..|.+..
T Consensus 334 ~~n~ln~ 340 (505)
T KOG3207|consen 334 TLNYLNK 340 (505)
T ss_pred ccccccc
Confidence 7887764
|
|
| >KOG3207 consensus Beta-tubulin folding cofactor E [Posttranslational modification, protein turnover, chaperones] | Back alignment and domain information |
|---|
Probab=99.07 E-value=2.9e-11 Score=126.73 Aligned_cols=163 Identities=24% Similarity=0.275 Sum_probs=94.5
Q ss_pred CCCcceEEEcCCCccccccC--ccccccccccEEEecCCCCCCCCCccccccccccEEecccccccCCCCCCCCCccccc
Q 002721 132 SLKDLRFFNISNNVLVGEIP--DELKSLEKLEDFQVSSNKLNGSIPFWVGNLTNLRVFTAYENQLVGEIPDNLGSVSELE 209 (888)
Q Consensus 132 ~l~~L~~L~Ls~N~l~~~~p--~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~ 209 (888)
++++|+...|.+.... ..+ .....++++++||||+|-+....|- -.-...|++|+
T Consensus 119 n~kkL~~IsLdn~~V~-~~~~~~~~k~~~~v~~LdLS~NL~~nw~~v----------------------~~i~eqLp~Le 175 (505)
T KOG3207|consen 119 NLKKLREISLDNYRVE-DAGIEEYSKILPNVRDLDLSRNLFHNWFPV----------------------LKIAEQLPSLE 175 (505)
T ss_pred hHHhhhheeecCcccc-ccchhhhhhhCCcceeecchhhhHHhHHHH----------------------HHHHHhcccch
Confidence 5566666666666654 222 2445566666666666665532221 01123455555
Q ss_pred ceeeccccCCCCCCCCc-cCCCCcceEEecCccCCCC-chhhhccCCccceeeccCCccccccCCccccCCCccEEEeec
Q 002721 210 LLNLHSNQLEGPIPKSI-FASGKLEVLVLTQNRLTGD-IPELVGHCKSLSNIRIGNNDLVGVIPRAIGNVSGLTYFEADN 287 (888)
Q Consensus 210 ~L~L~~N~l~~~~p~~~-~~l~~L~~L~Ls~N~l~~~-~~~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~ 287 (888)
.|+|+.|++........ ..++.|+.|.|+.|.|+.- +-.....+++|+.|+|..|............+..|+.|||++
T Consensus 176 ~LNls~Nrl~~~~~s~~~~~l~~lK~L~l~~CGls~k~V~~~~~~fPsl~~L~L~~N~~~~~~~~~~~i~~~L~~LdLs~ 255 (505)
T KOG3207|consen 176 NLNLSSNRLSNFISSNTTLLLSHLKQLVLNSCGLSWKDVQWILLTFPSLEVLYLEANEIILIKATSTKILQTLQELDLSN 255 (505)
T ss_pred hcccccccccCCccccchhhhhhhheEEeccCCCCHHHHHHHHHhCCcHHHhhhhcccccceecchhhhhhHHhhccccC
Confidence 56666665542221111 1456788888888888732 233345678888888888864444444555566777777777
Q ss_pred cCCCCCC-CccccCCCCCcEEEeecCccccc
Q 002721 288 NNLSGEI-VPEFSQCSNLTLLNLASNGFTGV 317 (888)
Q Consensus 288 N~l~~~~-~~~~~~l~~L~~L~L~~N~l~~~ 317 (888)
|++.... ......++.|+.|+++.+.|..+
T Consensus 256 N~li~~~~~~~~~~l~~L~~Lnls~tgi~si 286 (505)
T KOG3207|consen 256 NNLIDFDQGYKVGTLPGLNQLNLSSTGIASI 286 (505)
T ss_pred CcccccccccccccccchhhhhccccCcchh
Confidence 7765432 13345667777777777776643
|
|
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.04 E-value=7.8e-12 Score=127.71 Aligned_cols=39 Identities=31% Similarity=0.451 Sum_probs=24.1
Q ss_pred cccCCCCCCEEeCCCCcCcc----cCCCCCCCCCCCCEEECcC
Q 002721 81 LVSELKALKRLDLSNNAFSG----TIPSAFGNLSELEFLDLSL 119 (888)
Q Consensus 81 ~~~~l~~L~~L~Ls~n~l~~----~~p~~~~~l~~L~~L~Ls~ 119 (888)
.+.....+++|+||+|.|.. .+-..+.+.++|+.-++|+
T Consensus 25 ~~~~~~s~~~l~lsgnt~G~EAa~~i~~~L~~~~~L~~v~~sd 67 (382)
T KOG1909|consen 25 ELEPMDSLTKLDLSGNTFGTEAARAIAKVLASKKELREVNLSD 67 (382)
T ss_pred HhcccCceEEEeccCCchhHHHHHHHHHHHhhcccceeeehHh
Confidence 34556677777777777742 2334455666677777664
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=98.99 E-value=1.6e-09 Score=111.59 Aligned_cols=141 Identities=18% Similarity=0.180 Sum_probs=104.3
Q ss_pred cceeeecccceEEEEEeCCCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCC--CceeeeeeEEEeC---CeeEEEEe
Q 002721 610 SNMIYCGTFSTVYKAVMPSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCH--DNLVRPIGFVIYE---DVALLLHN 684 (888)
Q Consensus 610 ~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h--pnIv~~~~~~~~~---~~~~lv~e 684 (888)
.+.|+.|..+.||++...+|..+++|........ .....+.+|+++++.+.+ ..+.+++.+.... +..++|||
T Consensus 3 ~~~l~~G~~n~~~~v~~~~g~~~ilK~~~~~~~~--~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e 80 (223)
T cd05154 3 VRQLSGGQSNLTYLLTAGGGRRLVLRRPPPGALL--PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVME 80 (223)
T ss_pred ceecCCCccceEEEEEecCCcceEEEeCCCcccC--cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEE
Confidence 3578999999999999766789999987643321 112367899999999975 3456777776653 36789999
Q ss_pred cCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhccc-------------------------------------
Q 002721 685 YLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHH------------------------------------- 727 (888)
Q Consensus 685 ~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~------------------------------------- 727 (888)
|++|.++.+.+... .++..+...++.+++++|.+||+
T Consensus 81 ~i~G~~l~~~~~~~------~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 154 (223)
T cd05154 81 RVDGRVLRDRLLRP------ELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEP 154 (223)
T ss_pred EeCCEecCCCCCCC------CCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhccccc
Confidence 99998887655310 23455666677777777777763
Q ss_pred -------------------CCeeecCCCCCCeEeCC--CCCceEeccccccc
Q 002721 728 -------------------VAIIHLDISSGNVLLDA--DFKPLLGEIEISKL 758 (888)
Q Consensus 728 -------------------~~ivHrDlkp~NIll~~--~~~~kl~Dfg~a~~ 758 (888)
..++|+|++|.||+++. ++.+.++||+.+..
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~~ 206 (223)
T cd05154 155 PAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELATL 206 (223)
T ss_pred HHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEecccccc
Confidence 34699999999999998 56688999988765
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG1909 consensus Ran GTPase-activating protein [RNA processing and modification; Nuclear structure; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.98 E-value=2.5e-11 Score=124.04 Aligned_cols=38 Identities=42% Similarity=0.535 Sum_probs=18.9
Q ss_pred CCCCCCCCEEECcCCCCCCC----CCCCCCCCCcceEEEcCC
Q 002721 106 FGNLSELEFLDLSLNKFGGV----IPRELGSLKDLRFFNISN 143 (888)
Q Consensus 106 ~~~l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~Ls~ 143 (888)
+..+..++.|+||+|.|... +...+.+.++|+..++|+
T Consensus 26 ~~~~~s~~~l~lsgnt~G~EAa~~i~~~L~~~~~L~~v~~sd 67 (382)
T KOG1909|consen 26 LEPMDSLTKLDLSGNTFGTEAARAIAKVLASKKELREVNLSD 67 (382)
T ss_pred hcccCceEEEeccCCchhHHHHHHHHHHHhhcccceeeehHh
Confidence 33445566666666665421 223344445555555543
|
|
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.96 E-value=7.1e-10 Score=133.24 Aligned_cols=132 Identities=23% Similarity=0.310 Sum_probs=84.1
Q ss_pred cCCCCCCEEeCCCCcCcccCCCCCCCCCCCCEEECcCCC--CCCCCCCCCCCCCcceEEEcCCCccccccCccccccccc
Q 002721 83 SELKALKRLDLSNNAFSGTIPSAFGNLSELEFLDLSLNK--FGGVIPRELGSLKDLRFFNISNNVLVGEIPDELKSLEKL 160 (888)
Q Consensus 83 ~~l~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~--l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L 160 (888)
.+....+...+-+|.+. .++... ..++|++|-+..|. +..+.++.|..++.|++||||+|.=-+.+|..+++|-+|
T Consensus 520 ~~~~~~rr~s~~~~~~~-~~~~~~-~~~~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~L 597 (889)
T KOG4658|consen 520 KSWNSVRRMSLMNNKIE-HIAGSS-ENPKLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHL 597 (889)
T ss_pred cchhheeEEEEeccchh-hccCCC-CCCccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhh
Confidence 34455666666666664 333333 23367777777775 444444456667777777777765555677777777777
Q ss_pred cEEEecCCCCCCCCCccccccccccEEecccccccCCCCCCCCCcccccceeecccc
Q 002721 161 EDFQVSSNKLNGSIPFWVGNLTNLRVFTAYENQLVGEIPDNLGSVSELELLNLHSNQ 217 (888)
Q Consensus 161 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~ 217 (888)
++|+|++..++ .+|..+.+|.+|.+|++..+.-...+|.....|++|++|.+..-.
T Consensus 598 ryL~L~~t~I~-~LP~~l~~Lk~L~~Lnl~~~~~l~~~~~i~~~L~~Lr~L~l~~s~ 653 (889)
T KOG4658|consen 598 RYLDLSDTGIS-HLPSGLGNLKKLIYLNLEVTGRLESIPGILLELQSLRVLRLPRSA 653 (889)
T ss_pred hcccccCCCcc-ccchHHHHHHhhheeccccccccccccchhhhcccccEEEeeccc
Confidence 77777777776 666677777777777777666554555556667777777665543
|
|
| >KOG4658 consensus Apoptotic ATPase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.93 E-value=7.9e-10 Score=132.86 Aligned_cols=127 Identities=27% Similarity=0.315 Sum_probs=102.3
Q ss_pred EEEEEcCCCCcccccccccCCCCCCEEeCCCCc--CcccCCCCCCCCCCCCEEECcCCCCCCCCCCCCCCCCcceEEEcC
Q 002721 65 VVKLDLSRLQLRGNITLVSELKALKRLDLSNNA--FSGTIPSAFGNLSELEFLDLSLNKFGGVIPRELGSLKDLRFFNIS 142 (888)
Q Consensus 65 v~~l~l~~~~l~~~~~~~~~l~~L~~L~Ls~n~--l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls 142 (888)
+....+.+|...-.... .+.+.|++|-+..|. +....+..|..++.|++||||+|.=-+.+|..++.|-+|++|+|+
T Consensus 525 ~rr~s~~~~~~~~~~~~-~~~~~L~tLll~~n~~~l~~is~~ff~~m~~LrVLDLs~~~~l~~LP~~I~~Li~LryL~L~ 603 (889)
T KOG4658|consen 525 VRRMSLMNNKIEHIAGS-SENPKLRTLLLQRNSDWLLEISGEFFRSLPLLRVLDLSGNSSLSKLPSSIGELVHLRYLDLS 603 (889)
T ss_pred eeEEEEeccchhhccCC-CCCCccceEEEeecchhhhhcCHHHHhhCcceEEEECCCCCccCcCChHHhhhhhhhccccc
Confidence 33444444443322222 223479999999996 655556668899999999999988777899999999999999999
Q ss_pred CCccccccCccccccccccEEEecCCCCCCCCCccccccccccEEeccccc
Q 002721 143 NNVLVGEIPDELKSLEKLEDFQVSSNKLNGSIPFWVGNLTNLRVFTAYENQ 193 (888)
Q Consensus 143 ~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~ 193 (888)
+..++ .+|..+.+|.+|.+|++.++.-...+|.....|++|++|.+..-.
T Consensus 604 ~t~I~-~LP~~l~~Lk~L~~Lnl~~~~~l~~~~~i~~~L~~Lr~L~l~~s~ 653 (889)
T KOG4658|consen 604 DTGIS-HLPSGLGNLKKLIYLNLEVTGRLESIPGILLELQSLRVLRLPRSA 653 (889)
T ss_pred CCCcc-ccchHHHHHHhhheeccccccccccccchhhhcccccEEEeeccc
Confidence 99999 899999999999999999998776778888889999999998765
|
|
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.92 E-value=8.1e-10 Score=87.61 Aligned_cols=59 Identities=36% Similarity=0.515 Sum_probs=25.6
Q ss_pred CCCEEECcCCCCCCCCCCCCCCCCcceEEEcCCCccccccCccccccccccEEEecCCC
Q 002721 111 ELEFLDLSLNKFGGVIPRELGSLKDLRFFNISNNVLVGEIPDELKSLEKLEDFQVSSNK 169 (888)
Q Consensus 111 ~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~ 169 (888)
+|++|+|++|+|+.+.++.|.++++|++|++++|.|+...|+.|.++++|++|++++|+
T Consensus 2 ~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~ 60 (61)
T PF13855_consen 2 NLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNN 60 (61)
T ss_dssp TESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSS
T ss_pred cCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCc
Confidence 34444444444443333444444444444444444444444444444444444444443
|
... |
| >PF13855 LRR_8: Leucine rich repeat; PDB: 2O6S_A 3A79_B 3RFS_A 3G39_A 3VQ2_A 3VQ1_B 2Z64_A 2Z66_C 3FXI_A 2Z63_A | Back alignment and domain information |
|---|
Probab=98.91 E-value=7.9e-10 Score=87.67 Aligned_cols=61 Identities=43% Similarity=0.676 Sum_probs=57.6
Q ss_pred CCCCEEeCCCCcCcccCCCCCCCCCCCCEEECcCCCCCCCCCCCCCCCCcceEEEcCCCcc
Q 002721 86 KALKRLDLSNNAFSGTIPSAFGNLSELEFLDLSLNKFGGVIPRELGSLKDLRFFNISNNVL 146 (888)
Q Consensus 86 ~~L~~L~Ls~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 146 (888)
++|++|++++|+|+.+.+..|.++++|++|++++|+|+.+.|++|.++++|++|++++|+|
T Consensus 1 p~L~~L~l~~n~l~~i~~~~f~~l~~L~~L~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~l 61 (61)
T PF13855_consen 1 PNLESLDLSNNKLTEIPPDSFSNLPNLETLDLSNNNLTSIPPDAFSNLPNLRYLDLSNNNL 61 (61)
T ss_dssp TTESEEEETSSTESEECTTTTTTGTTESEEEETSSSESEEETTTTTTSTTESEEEETSSSB
T ss_pred CcCcEEECCCCCCCccCHHHHcCCCCCCEeEccCCccCccCHHHHcCCCCCCEEeCcCCcC
Confidence 4789999999999988888999999999999999999999999999999999999999986
|
... |
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=98.91 E-value=1.8e-08 Score=108.60 Aligned_cols=170 Identities=20% Similarity=0.243 Sum_probs=128.0
Q ss_pred cceEEEEE-eCCCcEEEEEEeeccChhhhHHHHHHHHHHHHHhccCCCceeeeeeEEEe----CCeeEEEEecCCC-CCH
Q 002721 618 FSTVYKAV-MPSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIY----EDVALLLHNYLPN-GTL 691 (888)
Q Consensus 618 ~g~Vy~~~-~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~----~~~~~lv~e~~~~-g~L 691 (888)
-.+.|++. ..||..|++|+++....... .....-+++++++.|+|||++.+++.. +...++||+|+++ ++|
T Consensus 289 ~~Ttyk~~s~~DG~~YvLkRlhg~r~~~~---nk~t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL 365 (655)
T KOG3741|consen 289 SITTYKATSNVDGNAYVLKRLHGDRDQST---NKDTSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTL 365 (655)
T ss_pred cceeEeeeeccCCceeeeeeeccccccCc---ccchHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchH
Confidence 36789998 55899999999953222111 123345788999999999999998873 4478999999986 467
Q ss_pred HHHhhccCCC----------CCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEeccccccccCC
Q 002721 692 AQLLHESTKQ----------PDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDP 761 (888)
Q Consensus 692 ~~~l~~~~~~----------~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~~~ 761 (888)
.++--..... .....++...|.++.|++.||.++|+.|..-+-+.|.+|+++++.+++++..|+......
T Consensus 366 ~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~ 445 (655)
T KOG3741|consen 366 YDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQE 445 (655)
T ss_pred HHHHccCCccccccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccceeeecC
Confidence 7764332111 123467889999999999999999999999999999999999999999998888777654
Q ss_pred CCCcccccccccccceecccccccCCcCccccchhHHHHHHHHHhCCC
Q 002721 762 SKGTASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILTTRL 809 (888)
Q Consensus 762 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~ 809 (888)
+.. +| +.+ -.+-|.=.||.++..+.||..
T Consensus 446 d~~--------------~~--le~---~Qq~D~~~lG~ll~aLAt~~~ 474 (655)
T KOG3741|consen 446 DPT--------------EP--LES---QQQNDLRDLGLLLLALATGTE 474 (655)
T ss_pred CCC--------------cc--hhH---HhhhhHHHHHHHHHHHhhccc
Confidence 331 11 111 235688999999999999864
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.88 E-value=1.1e-08 Score=100.60 Aligned_cols=129 Identities=19% Similarity=0.243 Sum_probs=84.9
Q ss_pred eEEEEEeCCCcEEEEEEeeccC-----------------------hhhhHHHHHHHHHHHHHhccCCC--ceeeeeeEEE
Q 002721 620 TVYKAVMPSGLILSVKRLKSMD-----------------------RTIIHHQNKMIRELEKLSKLCHD--NLVRPIGFVI 674 (888)
Q Consensus 620 ~Vy~~~~~~~~~vavK~~~~~~-----------------------~~~~~~~~~~~~E~~~l~~l~hp--nIv~~~~~~~ 674 (888)
.||.|...+|..+|+|..+... ...........+|.+.|.++..- ++.+.+++.
T Consensus 1 ~Vy~~~~~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~- 79 (188)
T PF01163_consen 1 DVYHAIDPDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN- 79 (188)
T ss_dssp EEEEEEECTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE-
T ss_pred CEEEEECCCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe-
Confidence 4899998899999999875210 01111224577899999999755 566776553
Q ss_pred eCCeeEEEEecCC--CCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhh-cccCCeeecCCCCCCeEeCCCCCceEe
Q 002721 675 YEDVALLLHNYLP--NGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAF-LHHVAIIHLDISSGNVLLDADFKPLLG 751 (888)
Q Consensus 675 ~~~~~~lv~e~~~--~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~-LH~~~ivHrDlkp~NIll~~~~~~kl~ 751 (888)
..++||||++ |..+..+.... ++......++.+++..+.. +|..|++|+|+.+.||+++++ .+.++
T Consensus 80 ---~~~ivME~I~~~G~~~~~l~~~~-------~~~~~~~~~~~~il~~~~~~~~~~givHGDLs~~NIlv~~~-~~~iI 148 (188)
T PF01163_consen 80 ---RNVIVMEYIGEDGVPLPRLKDVD-------LSPEEPKELLEEILEEIIKMLHKAGIVHGDLSEYNILVDDG-KVYII 148 (188)
T ss_dssp ---TTEEEEE--EETTEEGGCHHHCG-------GGGSTHHHHHHHHHHHHHHHHHCTTEEESS-STTSEEEETT-CEEE-
T ss_pred ---CCEEEEEecCCCccchhhHHhcc-------ccchhHHHHHHHHHHHHHHHHHhcCceecCCChhhEEeecc-eEEEE
Confidence 3579999998 65554433321 1123456678888886555 579999999999999999987 99999
Q ss_pred ccccccccC
Q 002721 752 EIEISKLLD 760 (888)
Q Consensus 752 Dfg~a~~~~ 760 (888)
|||.+....
T Consensus 149 Df~qav~~~ 157 (188)
T PF01163_consen 149 DFGQAVDSS 157 (188)
T ss_dssp -GTTEEETT
T ss_pred ecCcceecC
Confidence 999877643
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.86 E-value=3.1e-08 Score=103.51 Aligned_cols=145 Identities=14% Similarity=0.111 Sum_probs=101.0
Q ss_pred cceeeecccceEEEEEeCCCcEEEEEEeeccChhhh-H-------HHHHHHHHHHHHhccCCCce--eeeeeEEEe----
Q 002721 610 SNMIYCGTFSTVYKAVMPSGLILSVKRLKSMDRTII-H-------HQNKMIRELEKLSKLCHDNL--VRPIGFVIY---- 675 (888)
Q Consensus 610 ~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~-~-------~~~~~~~E~~~l~~l~hpnI--v~~~~~~~~---- 675 (888)
.+.+-......|+++.. +|+.|.||+......... . -...+.+|...+.++...+| ++.+++.+.
T Consensus 27 ~e~v~~~~~rrvvr~~~-~g~~~~vKr~~~~~~~~~~k~l~~~~~p~~~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~ 105 (268)
T PRK15123 27 GEVFRELEGRRTLRFEL-AGKSYFLKWHRGTGWGEIFKNLLSLRMPVLGADREWRAIHRLHEVGVDTMTGVAFGERGSNP 105 (268)
T ss_pred CcEEecCCCceEEEEEE-CCEEEEEEEecCCcHHHHhhhhcccccccHHHHHHHHHHHHHHHcCCCCCCeeEEEEecCCC
Confidence 34555455555777765 678899997753331110 0 00137789988888853333 344555543
Q ss_pred -CCeeEEEEecCCCC-CHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCC-------CC
Q 002721 676 -EDVALLLHNYLPNG-TLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDA-------DF 746 (888)
Q Consensus 676 -~~~~~lv~e~~~~g-~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~-------~~ 746 (888)
....++|||++++. +|.+++...... ..+...+..++.+++..+.-||..||+|+|++++|||++. ++
T Consensus 106 ~~~~s~LVte~l~~~~sL~~~~~~~~~~---~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~ 182 (268)
T PRK15123 106 ATRTSFIITEDLAPTISLEDYCADWATN---PPDPRLKRMLIKRVATMVRDMHAAGINHRDCYICHFLLHLPFPGREEDL 182 (268)
T ss_pred ccceeEEEEeeCCCCccHHHHHHhhccc---CCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChhhEEEeccccCCCCCc
Confidence 23578999999986 899998643211 2345667789999999999999999999999999999975 46
Q ss_pred CceEeccccccc
Q 002721 747 KPLLGEIEISKL 758 (888)
Q Consensus 747 ~~kl~Dfg~a~~ 758 (888)
.+.++||+.+..
T Consensus 183 ~~~LIDl~r~~~ 194 (268)
T PRK15123 183 KLSVIDLHRAQI 194 (268)
T ss_pred eEEEEECCcccc
Confidence 789999998754
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.79 E-value=1.9e-07 Score=98.14 Aligned_cols=267 Identities=16% Similarity=0.117 Sum_probs=158.6
Q ss_pred CCcceeeecccceEEEEEeCCCcEEEEEEeeccChhhhHHHHHHHHHHHHHhcc-CCCceeeeeeEEE------eCC-ee
Q 002721 608 KDSNMIYCGTFSTVYKAVMPSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKL-CHDNLVRPIGFVI------YED-VA 679 (888)
Q Consensus 608 ~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l-~hpnIv~~~~~~~------~~~-~~ 679 (888)
...+.+|+|+-+.+|-.-.-.+ .+-|++....... -.+.++.|... .||-+-.-+.|=. .+. ..
T Consensus 14 ~~gr~LgqGgea~ly~l~e~~d--~VAKIYh~Pppa~------~aqk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~i 85 (637)
T COG4248 14 PPGRPLGQGGEADLYTLGEVRD--QVAKIYHAPPPAA------QAQKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVI 85 (637)
T ss_pred CCCccccCCccceeeecchhhc--hhheeecCCCchH------HHHHHHHhccCCCCcchhhhhcccHHHhhCCCcccee
Confidence 3467899999999997652122 2446665332221 11223334333 4665443222211 122 35
Q ss_pred EEEEecCCCCC-HHHHhhcc-CCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCCceEecccccc
Q 002721 680 LLLHNYLPNGT-LAQLLHES-TKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISK 757 (888)
Q Consensus 680 ~lv~e~~~~g~-L~~~l~~~-~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~ 757 (888)
-+.|..+++.. ..++.... +...-....|+..++.++.++.+.+.||..|.+-+|+.++|+|+.+++.+.+.|-..-.
T Consensus 86 GflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfq 165 (637)
T COG4248 86 GFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSDSFQ 165 (637)
T ss_pred EEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEccccee
Confidence 67788776642 22332211 11112246899999999999999999999999999999999999999999998854333
Q ss_pred ccCCCCCcccccccccccceecccccc-----cCCcCccccchhHHHHHHHHHhC-CCCCCCCCCCcc---chh-hhccc
Q 002721 758 LLDPSKGTASISAVAGSFGYIPPEYAY-----TMQVTAPGNVYSYGVVLLEILTT-RLPVEEDFGEGV---DLV-KWVHG 827 (888)
Q Consensus 758 ~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DiwSlG~il~elltg-~~P~~~~~~~~~---~~~-~~~~~ 827 (888)
.... .......+|...|.+||.-. +..-+...|-|.+|+++++++.| +.||.+...... ... ++..+
T Consensus 166 i~~n---g~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~g 242 (637)
T COG4248 166 INAN---GTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAHG 242 (637)
T ss_pred eccC---CceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhcc
Confidence 2221 12234467889999999643 33456788999999999999986 999986432110 011 11111
Q ss_pred cCCCCCCcccccccccccCCcCcHHHHHHHHHHHhhccCC--CCCCCCCHHHHHHHHHHhhh
Q 002721 828 APARGETPEQILDARLSTVSFGWRKEMLTALKVALLCTDS--TPAKRPKMKKVVEMLQEIKQ 887 (888)
Q Consensus 828 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~--dP~~RPs~~evl~~L~~i~~ 887 (888)
...+... +-...+.......+.--.+.+-.+..+|+.. ++.-|||++..+..|.++..
T Consensus 243 ~f~ya~~--~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~aW~aAl~al~~ 302 (637)
T COG4248 243 RFAYASD--QRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKAWVAALDALRQ 302 (637)
T ss_pred eeeechh--ccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHHHHHHHHHHHH
Confidence 1111000 0000011111222333344555566677764 35689999999998887753
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.77 E-value=2.4e-08 Score=100.27 Aligned_cols=137 Identities=22% Similarity=0.204 Sum_probs=99.6
Q ss_pred cCCcceeeecccceEEEEEeCCCcEEEEEEeeccC-------------------hhhhHHHHHHHHHHHHHhccCCC--c
Q 002721 607 MKDSNMIYCGTFSTVYKAVMPSGLILSVKRLKSMD-------------------RTIIHHQNKMIRELEKLSKLCHD--N 665 (888)
Q Consensus 607 ~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~-------------------~~~~~~~~~~~~E~~~l~~l~hp--n 665 (888)
..+...||-|.-+.||.|..+.|.++|||.=+... .+.........+|.++|.++... .
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~~ 172 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDPKGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGVK 172 (304)
T ss_pred HhhccccccCccceEEEEECCCCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCCC
Confidence 45678999999999999999999999999542110 01111223567899999999644 6
Q ss_pred eeeeeeEEEeCCeeEEEEecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCC
Q 002721 666 LVRPIGFVIYEDVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDAD 745 (888)
Q Consensus 666 Iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~ 745 (888)
|.+.+++ +...+||||++|-.|...-- +....-.++..|++-+.-+-..||||+|+.+=||++++|
T Consensus 173 VP~P~~~----nRHaVvMe~ieG~eL~~~r~----------~~en~~~il~~il~~~~~~~~~GiVHGDlSefNIlV~~d 238 (304)
T COG0478 173 VPKPIAW----NRHAVVMEYIEGVELYRLRL----------DVENPDEILDKILEEVRKAYRRGIVHGDLSEFNILVTED 238 (304)
T ss_pred CCCcccc----ccceeeeehcccceeecccC----------cccCHHHHHHHHHHHHHHHHHcCccccCCchheEEEecC
Confidence 7777664 45689999999866654321 122334455566666666668999999999999999999
Q ss_pred CCceEecccccc
Q 002721 746 FKPLLGEIEISK 757 (888)
Q Consensus 746 ~~~kl~Dfg~a~ 757 (888)
|.+.++||--+.
T Consensus 239 g~~~vIDwPQ~v 250 (304)
T COG0478 239 GDIVVIDWPQAV 250 (304)
T ss_pred CCEEEEeCcccc
Confidence 999999995443
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.58 E-value=5.1e-07 Score=89.03 Aligned_cols=141 Identities=18% Similarity=0.084 Sum_probs=100.2
Q ss_pred eeecccceEEEEEeCCCcEEEEEEeeccChhh---hHHHHHHHHHHHHHhccCC--CceeeeeeEEEe---C--CeeEEE
Q 002721 613 IYCGTFSTVYKAVMPSGLILSVKRLKSMDRTI---IHHQNKMIRELEKLSKLCH--DNLVRPIGFVIY---E--DVALLL 682 (888)
Q Consensus 613 ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~---~~~~~~~~~E~~~l~~l~h--pnIv~~~~~~~~---~--~~~~lv 682 (888)
-|+||.+.|++... +|+.+-+|+-...-... ..-...|.+|...+.++.. -.+.+.. ++.. + ...++|
T Consensus 26 ~~rgG~SgV~r~~~-~g~~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LV 103 (216)
T PRK09902 26 YRRNGMSGVQCVER-NGKKLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLV 103 (216)
T ss_pred cCCCCcceEEEEEe-CCcEEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEE
Confidence 35689999999886 44468888764111111 1133479999999998853 2244444 3321 1 246899
Q ss_pred EecCCC-CCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCCCC--ceEeccccccc
Q 002721 683 HNYLPN-GTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFK--PLLGEIEISKL 758 (888)
Q Consensus 683 ~e~~~~-g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~--~kl~Dfg~a~~ 758 (888)
+|-+++ .+|.+++.+.... +.+...+..+..+++..++-||+.|+.|+|+-+.||+++.++. ++++||--++.
T Consensus 104 Te~L~g~~~L~~~l~~~~~~---~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 104 TEDMAGFISIADWYAQHAVS---PYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR 179 (216)
T ss_pred EEeCCCCccHHHHHhcCCcC---CcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence 997763 4898888654322 3456777899999999999999999999999999999986666 89999965543
|
|
| >KOG2982 consensus Uncharacterized conserved protein [Function unknown] | Back alignment and domain information |
|---|
Probab=98.55 E-value=1.5e-08 Score=101.46 Aligned_cols=186 Identities=23% Similarity=0.279 Sum_probs=92.1
Q ss_pred CCcceEEEcCCCcccc--ccCccccccccccEEEecCCCCCCCCCccccccccccEEecccccccCCCC-CCCCCccccc
Q 002721 133 LKDLRFFNISNNVLVG--EIPDELKSLEKLEDFQVSSNKLNGSIPFWVGNLTNLRVFTAYENQLVGEIP-DNLGSVSELE 209 (888)
Q Consensus 133 l~~L~~L~Ls~N~l~~--~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p-~~~~~l~~L~ 209 (888)
.+.++.|||.+|.|+. ++-..+.+++.|+.|+||.|++...+...-..+.+|++|-|.+..+...-- ..+..++.++
T Consensus 70 ~~~v~elDL~~N~iSdWseI~~ile~lP~l~~LNls~N~L~s~I~~lp~p~~nl~~lVLNgT~L~w~~~~s~l~~lP~vt 149 (418)
T KOG2982|consen 70 VTDVKELDLTGNLISDWSEIGAILEQLPALTTLNLSCNSLSSDIKSLPLPLKNLRVLVLNGTGLSWTQSTSSLDDLPKVT 149 (418)
T ss_pred hhhhhhhhcccchhccHHHHHHHHhcCccceEeeccCCcCCCccccCcccccceEEEEEcCCCCChhhhhhhhhcchhhh
Confidence 3456666666666652 233335666777777777777664333222455677777777766654332 3456777788
Q ss_pred ceeeccccCCCCCCCCccCCCCcceEEecCccCCCCchhh--hccCCccceeeccCCccccccCCccccCCCccEEEeec
Q 002721 210 LLNLHSNQLEGPIPKSIFASGKLEVLVLTQNRLTGDIPEL--VGHCKSLSNIRIGNNDLVGVIPRAIGNVSGLTYFEADN 287 (888)
Q Consensus 210 ~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~--~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~l~~ 287 (888)
+|.+|.|.+.. +.+..|-+....|+. +..++.+..++++-|++....| ++..+.+..
T Consensus 150 elHmS~N~~rq--------------~n~Dd~c~e~~s~~v~tlh~~~c~~~~w~~~~~l~r~Fp-------nv~sv~v~e 208 (418)
T KOG2982|consen 150 ELHMSDNSLRQ--------------LNLDDNCIEDWSTEVLTLHQLPCLEQLWLNKNKLSRIFP-------NVNSVFVCE 208 (418)
T ss_pred hhhhccchhhh--------------hccccccccccchhhhhhhcCCcHHHHHHHHHhHHhhcc-------cchheeeec
Confidence 88888775542 222222222221111 1122334444444455443332 233344444
Q ss_pred cCCCCCC-CccccCCCCCcEEEeecCcccccC-CccccCCCCccEEEecccccc
Q 002721 288 NNLSGEI-VPEFSQCSNLTLLNLASNGFTGVI-PPELGQLINLQELILYENSLF 339 (888)
Q Consensus 288 N~l~~~~-~~~~~~l~~L~~L~L~~N~l~~~~-p~~~~~l~~L~~L~L~~N~l~ 339 (888)
|.+.... ...+..++.+..|+|+.|+|..-- -+++.+++.|..|.+++|.+.
T Consensus 209 ~PlK~~s~ek~se~~p~~~~LnL~~~~idswasvD~Ln~f~~l~dlRv~~~Pl~ 262 (418)
T KOG2982|consen 209 GPLKTESSEKGSEPFPSLSCLNLGANNIDSWASVDALNGFPQLVDLRVSENPLS 262 (418)
T ss_pred CcccchhhcccCCCCCcchhhhhcccccccHHHHHHHcCCchhheeeccCCccc
Confidence 4443221 122344455555666666654211 123444555555555555543
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.52 E-value=4.4e-07 Score=89.71 Aligned_cols=144 Identities=16% Similarity=0.172 Sum_probs=97.3
Q ss_pred HHHHHHhcCCcceeeecccceEEEEEeCCCcEEEEEEeeccChhhhHHHHHH------HHHHHHHhccCC---Cceeeee
Q 002721 600 DAVVKATMKDSNMIYCGTFSTVYKAVMPSGLILSVKRLKSMDRTIIHHQNKM------IRELEKLSKLCH---DNLVRPI 670 (888)
Q Consensus 600 ~~~~~~~~~~~~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~------~~E~~~l~~l~h---pnIv~~~ 670 (888)
+++...+|+..+++.......|.+... +|+.+++|..+............| .+++..+.+++. ...+.++
T Consensus 26 ~~i~~~~~~~~kv~k~~~r~~ValIei-~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~y 104 (229)
T PF06176_consen 26 EKILDNNYKIIKVFKNTKRNYVALIEI-DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPY 104 (229)
T ss_pred HHHHhCCceEEEeecCCCccEEEEEEE-CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCccccccce
Confidence 457778899999998888777777765 678999998876544433322222 344444444432 2222322
Q ss_pred eEEE-----eCCeeEEEEecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHHhhcccCCeeecCCCCCCeEeCCC
Q 002721 671 GFVI-----YEDVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDAD 745 (888)
Q Consensus 671 ~~~~-----~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~ 745 (888)
.+.. .....+++|||++|..|.++.. ++. .++..+++++.-+|+.|++|+|..|.|++++++
T Consensus 105 l~~ekk~~~~~~~~~ll~EYIeG~~l~d~~~---------i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv~~~ 171 (229)
T PF06176_consen 105 LAAEKKIFRYTSSYVLLMEYIEGVELNDIED---------IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLVSNN 171 (229)
T ss_pred eeeeeeeccceeEEEEEEEEecCeecccchh---------cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEEECC
Confidence 2222 2235678999999988766532 111 255677888999999999999999999999865
Q ss_pred CCceEeccccccc
Q 002721 746 FKPLLGEIEISKL 758 (888)
Q Consensus 746 ~~~kl~Dfg~a~~ 758 (888)
.+++.||+..+.
T Consensus 172 -~i~iID~~~k~~ 183 (229)
T PF06176_consen 172 -GIRIIDTQGKRM 183 (229)
T ss_pred -cEEEEECccccc
Confidence 589999976653
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.51 E-value=3.6e-08 Score=110.54 Aligned_cols=149 Identities=18% Similarity=0.245 Sum_probs=100.2
Q ss_pred HHHHHHHHhhccc-CCeeecCCCCCCeEeCCCCCceEeccccccccCCCCCcc------cc-cccccccceecccccccC
Q 002721 715 AIGVAEGLAFLHH-VAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSKGTA------SI-SAVAGSFGYIPPEYAYTM 786 (888)
Q Consensus 715 ~~qi~~aL~~LH~-~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~------~~-~~~~gt~~y~aPE~~~~~ 786 (888)
+.+++.|+.|+|. .++||++|.|++|.++..+..|++.|+++.......... .. .-......|.|||++.+.
T Consensus 105 l~~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~ 184 (700)
T KOG2137|consen 105 LGNVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGT 184 (700)
T ss_pred hhcccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhccc
Confidence 3456699999997 799999999999999999999999999877654311110 00 112345579999999998
Q ss_pred CcCccccchhHHHHHHHHHh-CCCCCCCCCCCcc-chhhhccccCCCCCCcccccccccccCCcCcHHHHHHHHHHHhhc
Q 002721 787 QVTAPGNVYSYGVVLLEILT-TRLPVEEDFGEGV-DLVKWVHGAPARGETPEQILDARLSTVSFGWRKEMLTALKVALLC 864 (888)
Q Consensus 787 ~~~~~~DiwSlG~il~ellt-g~~P~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~c 864 (888)
..++++|+||+|+.+|.+.. |+.-+........ .... ...+..... .......++.+-+.++
T Consensus 185 ~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~-------------~~~~~~~~~---~s~~~p~el~~~l~k~ 248 (700)
T KOG2137|consen 185 TNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSR-------------NLLNAGAFG---YSNNLPSELRESLKKL 248 (700)
T ss_pred cccccccceeeeeEEEEEecCCcchhhccCCcchhhhhh-------------ccccccccc---ccccCcHHHHHHHHHH
Confidence 88999999999999999994 4444432211100 0000 001111111 1133445667778889
Q ss_pred cCCCCCCCCCHHHHH
Q 002721 865 TDSTPAKRPKMKKVV 879 (888)
Q Consensus 865 l~~dP~~RPs~~evl 879 (888)
+..++..||++.++.
T Consensus 249 l~~~~~~rp~~~~l~ 263 (700)
T KOG2137|consen 249 LNGDSAVRPTLDLLL 263 (700)
T ss_pred hcCCcccCcchhhhh
Confidence 999999999877664
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.50 E-value=5.1e-07 Score=91.33 Aligned_cols=105 Identities=24% Similarity=0.332 Sum_probs=82.3
Q ss_pred HHHHHHHHHhccCCC--ceeeeeeEEEeCC----eeEEEEecCCCC-CHHHHhhccCCCCCCCCCHHHHHHHHHHHHHHH
Q 002721 650 KMIRELEKLSKLCHD--NLVRPIGFVIYED----VALLLHNYLPNG-TLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGL 722 (888)
Q Consensus 650 ~~~~E~~~l~~l~hp--nIv~~~~~~~~~~----~~~lv~e~~~~g-~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~aL 722 (888)
+..+|...+..+... .+.+.+++..... ..++|+|++++. +|.+++..... .+......++.++++.+
T Consensus 57 ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~-----~~~~~~~~ll~~l~~~i 131 (206)
T PF06293_consen 57 RAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQ-----LDPSQRRELLRALARLI 131 (206)
T ss_pred HHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcc-----cchhhHHHHHHHHHHHH
Confidence 677888888877532 3455666665532 458999999874 79999886332 23456778999999999
Q ss_pred hhcccCCeeecCCCCCCeEeCCCC---CceEecccccccc
Q 002721 723 AFLHHVAIIHLDISSGNVLLDADF---KPLLGEIEISKLL 759 (888)
Q Consensus 723 ~~LH~~~ivHrDlkp~NIll~~~~---~~kl~Dfg~a~~~ 759 (888)
+-||+.||+|+|+++.|||++.++ .+.++||+-++..
T Consensus 132 ~~lH~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~~ 171 (206)
T PF06293_consen 132 AKLHDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRFR 171 (206)
T ss_pred HHHHHCcCCCCCCCcccEEEeCCCCceeEEEEcchhceeC
Confidence 999999999999999999999886 7899999877653
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >KOG4579 consensus Leucine-rich repeat (LRR) protein associated with apoptosis in muscle tissue [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.49 E-value=3.9e-09 Score=93.61 Aligned_cols=113 Identities=26% Similarity=0.276 Sum_probs=55.2
Q ss_pred CCCCCEEECcCCCCCCCCCCCCCCCCcceEEEcCCCccccccCccccccccccEEEecCCCCCCCCCccccccccccEEe
Q 002721 109 LSELEFLDLSLNKFGGVIPRELGSLKDLRFFNISNNVLVGEIPDELKSLEKLEDFQVSSNKLNGSIPFWVGNLTNLRVFT 188 (888)
Q Consensus 109 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ 188 (888)
..+|+..+|++|.+....+..-...+.++.|+|++|.|+ .+|..+..++.|+.|+++.|.+. ..|..+..|.+|-.|+
T Consensus 52 ~~el~~i~ls~N~fk~fp~kft~kf~t~t~lNl~~neis-dvPeE~Aam~aLr~lNl~~N~l~-~~p~vi~~L~~l~~Ld 129 (177)
T KOG4579|consen 52 GYELTKISLSDNGFKKFPKKFTIKFPTATTLNLANNEIS-DVPEELAAMPALRSLNLRFNPLN-AEPRVIAPLIKLDMLD 129 (177)
T ss_pred CceEEEEecccchhhhCCHHHhhccchhhhhhcchhhhh-hchHHHhhhHHhhhcccccCccc-cchHHHHHHHhHHHhc
Confidence 334444455555555322222233345555556666555 45555555566666666666555 4455555555555555
Q ss_pred cccccccCCCCCCCCCcccccceeeccccCCCCCCC
Q 002721 189 AYENQLVGEIPDNLGSVSELELLNLHSNQLEGPIPK 224 (888)
Q Consensus 189 L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~ 224 (888)
..+|.+. .+|-.+-.-+..-..++.++.+.+.-+.
T Consensus 130 s~~na~~-eid~dl~~s~~~al~~lgnepl~~~~~~ 164 (177)
T KOG4579|consen 130 SPENARA-EIDVDLFYSSLPALIKLGNEPLGDETKK 164 (177)
T ss_pred CCCCccc-cCcHHHhccccHHHHHhcCCcccccCcc
Confidence 5555555 3332222222223334455555544333
|
|
| >KOG1859 consensus Leucine-rich repeat proteins [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.45 E-value=6.8e-09 Score=115.19 Aligned_cols=179 Identities=25% Similarity=0.263 Sum_probs=111.9
Q ss_pred CCCCCCCCCCCEEECcCCCCCCCCCCCCCCC-CcceEEEcCCCccc----------cccCccccccccccEEEecCCCCC
Q 002721 103 PSAFGNLSELEFLDLSLNKFGGVIPRELGSL-KDLRFFNISNNVLV----------GEIPDELKSLEKLEDFQVSSNKLN 171 (888)
Q Consensus 103 p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l-~~L~~L~Ls~N~l~----------~~~p~~~~~l~~L~~L~Ls~N~l~ 171 (888)
|-.+..+..|++|.|.++.|+. ...+..+ ..|+.|.- +|.+. |.+.+++ ...+|...+.++|.+.
T Consensus 102 pi~ifpF~sLr~LElrg~~L~~--~~GL~~lr~qLe~LIC-~~Sl~Al~~v~ascggd~~ns~-~Wn~L~~a~fsyN~L~ 177 (1096)
T KOG1859|consen 102 PISIFPFRSLRVLELRGCDLST--AKGLQELRHQLEKLIC-HNSLDALRHVFASCGGDISNSP-VWNKLATASFSYNRLV 177 (1096)
T ss_pred CceeccccceeeEEecCcchhh--hhhhHHHHHhhhhhhh-hccHHHHHHHHHHhccccccch-hhhhHhhhhcchhhHH
Confidence 5567778889999998888863 1112112 23444422 22222 1111111 1245777788888887
Q ss_pred CCCCccccccccccEEecccccccCCCCCCCCCcccccceeeccccCCCCCCCCccCCCCcceEEecCccCCCCchhhhc
Q 002721 172 GSIPFWVGNLTNLRVFTAYENQLVGEIPDNLGSVSELELLNLHSNQLEGPIPKSIFASGKLEVLVLTQNRLTGDIPELVG 251 (888)
Q Consensus 172 ~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~~~~~~ 251 (888)
....++.-++.|+.|+|++|+++.. +.+..++.|++|||++|+++ .+|..-..--+|+.|.+++|.++.. ..+.
T Consensus 178 -~mD~SLqll~ale~LnLshNk~~~v--~~Lr~l~~LkhLDlsyN~L~-~vp~l~~~gc~L~~L~lrnN~l~tL--~gie 251 (1096)
T KOG1859|consen 178 -LMDESLQLLPALESLNLSHNKFTKV--DNLRRLPKLKHLDLSYNCLR-HVPQLSMVGCKLQLLNLRNNALTTL--RGIE 251 (1096)
T ss_pred -hHHHHHHHHHHhhhhccchhhhhhh--HHHHhcccccccccccchhc-cccccchhhhhheeeeecccHHHhh--hhHH
Confidence 6667777778888888888888743 37778888888888888887 4444322223488888888887643 3456
Q ss_pred cCCccceeeccCCccccccC-CccccCCCccEEEeeccCCC
Q 002721 252 HCKSLSNIRIGNNDLVGVIP-RAIGNVSGLTYFEADNNNLS 291 (888)
Q Consensus 252 ~l~~L~~L~L~~N~l~~~~~-~~~~~l~~L~~L~l~~N~l~ 291 (888)
++++|+.||+++|-|.+--. ..++.+..|+.|+|.+|.+-
T Consensus 252 ~LksL~~LDlsyNll~~hseL~pLwsLs~L~~L~LeGNPl~ 292 (1096)
T KOG1859|consen 252 NLKSLYGLDLSYNLLSEHSELEPLWSLSSLIVLWLEGNPLC 292 (1096)
T ss_pred hhhhhhccchhHhhhhcchhhhHHHHHHHHHHHhhcCCccc
Confidence 77788888888887764311 12445566777777777653
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.45 E-value=4.5e-07 Score=102.59 Aligned_cols=144 Identities=22% Similarity=0.256 Sum_probs=97.6
Q ss_pred ceeeecccceEEEEEeCCCcEEEEEEeeccChhhhHH-------------------------------HH------HHHH
Q 002721 611 NMIYCGTFSTVYKAVMPSGLILSVKRLKSMDRTIIHH-------------------------------QN------KMIR 653 (888)
Q Consensus 611 ~~ig~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~-------------------------------~~------~~~~ 653 (888)
+-|+.++-|+||+|+.++|+.||||+.++.-...... .+ .+.+
T Consensus 131 ~PiAsASIaQVH~A~L~sG~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~~ 210 (517)
T COG0661 131 EPIASASIAQVHRAVLKSGEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYRR 210 (517)
T ss_pred CchhhhhHhhheeEEecCCCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHHH
Confidence 6899999999999999999999999986432211100 01 2345
Q ss_pred HHHHHhccC-----CCceeeeeeEEEeCCeeEEEEecCCCCCHHHHhhccCCCCCCCCCHHHHHHHHHHHHHH-Hhhccc
Q 002721 654 ELEKLSKLC-----HDNLVRPIGFVIYEDVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEG-LAFLHH 727 (888)
Q Consensus 654 E~~~l~~l~-----hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~qi~~a-L~~LH~ 727 (888)
|+.-+.+++ .|++.--.=|++......++|||++|-.+.+...-... ..+ ...++..++++ +..+-.
T Consensus 211 EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~----g~d---~k~ia~~~~~~f~~q~~~ 283 (517)
T COG0661 211 EAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSA----GID---RKELAELLVRAFLRQLLR 283 (517)
T ss_pred HHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhc----CCC---HHHHHHHHHHHHHHHHHh
Confidence 666665553 34433222233345667899999999988888432221 122 23344443333 444445
Q ss_pred CCeeecCCCCCCeEeCCCCCceEeccccccccCC
Q 002721 728 VAIIHLDISSGNVLLDADFKPLLGEIEISKLLDP 761 (888)
Q Consensus 728 ~~ivHrDlkp~NIll~~~~~~kl~Dfg~a~~~~~ 761 (888)
.|++|.|..|.||+++.+|++.+.|||+...+++
T Consensus 284 dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 284 DGFFHADPHPGNILVRSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred cCccccCCCccceEEecCCcEEEEcCcceecCCH
Confidence 8999999999999999999999999999987764
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 888 | ||||
| 3rgx_A | 768 | Structural Insight Into Brassinosteroid Perception | 9e-49 | ||
| 3riz_A | 772 | Crystal Structure Of The Plant Steroid Receptor Bri | 9e-49 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 8e-39 | ||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 1e-38 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 6e-28 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 7e-28 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-25 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 6e-25 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 3e-24 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 4e-23 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 2e-20 | ||
| 1ogq_A | 313 | The Crystal Structure Of Pgip (Polygalacturonase In | 7e-19 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 2e-14 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 2e-14 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 3e-12 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 1e-11 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 9e-11 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 9e-11 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 2e-10 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 3e-10 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 3e-10 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 3e-10 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 3e-10 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 3e-10 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 3e-10 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 3e-10 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 3e-10 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 3e-10 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 3e-10 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 4e-10 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 4e-10 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 4e-10 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 4e-10 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 5e-10 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 6e-10 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 6e-10 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 6e-10 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 6e-10 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 7e-10 | ||
| 2omu_A | 462 | Crystal Structure Of Inla G194s+s Y369s/hec1 Comple | 1e-09 | ||
| 2omu_A | 462 | Crystal Structure Of Inla G194s+s Y369s/hec1 Comple | 1e-04 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 2e-09 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 3e-09 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 3e-09 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 3e-09 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 4e-09 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 4e-09 | ||
| 2omt_A | 462 | Crystal Structure Of Inla G194s+sHEC1 COMPLEX Lengt | 4e-09 | ||
| 2omt_A | 462 | Crystal Structure Of Inla G194s+sHEC1 COMPLEX Lengt | 1e-04 | ||
| 2omx_A | 462 | Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX | 4e-09 | ||
| 2omx_A | 462 | Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX | 2e-04 | ||
| 2omv_A | 461 | Crystal Structure Of Inla S192n Y369s/hec1 Complex | 4e-09 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 4e-09 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 5e-09 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 5e-09 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 5e-09 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 5e-09 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 5e-09 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 5e-09 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 6e-09 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 6e-09 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 6e-09 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 6e-09 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 7e-09 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 7e-09 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 7e-09 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 7e-09 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 8e-09 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 8e-09 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 8e-09 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 9e-09 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 9e-09 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 9e-09 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 9e-09 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 9e-09 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 1e-08 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 1e-08 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 1e-08 | ||
| 2omz_A | 466 | Crystal Structure Of Inla Y369a/hec1 Complex Length | 1e-08 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 1e-08 | ||
| 2omy_A | 461 | Crystal Structure Of Inla S192n/hec1 Complex Length | 1e-08 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 1e-08 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 1e-08 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 1e-08 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 1e-08 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-08 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 1e-08 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-08 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 1e-08 | ||
| 1o6s_A | 466 | Internalin (Listeria Monocytogenes) E-Cadherin (Hum | 1e-08 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 1e-08 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 1e-08 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 1e-08 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 2e-08 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 2e-08 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 2e-08 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 2e-08 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 2e-08 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 2e-08 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 2e-08 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 2e-08 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 2e-08 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 2e-08 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 2e-08 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 2e-08 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 2e-08 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 3e-08 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 3e-08 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 3e-08 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 3e-08 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 3e-08 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 3e-08 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-08 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 3e-08 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 4e-08 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 4e-08 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 4e-08 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 4e-08 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 4e-08 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 4e-08 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 4e-08 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 5e-08 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 5e-08 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 5e-08 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 5e-08 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 5e-08 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 6e-08 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 6e-08 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 6e-08 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 6e-08 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 7e-08 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 7e-08 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 8e-08 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 8e-08 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 8e-08 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 9e-08 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 9e-08 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 9e-08 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 9e-08 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 1e-07 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 1e-07 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 1e-07 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 1e-07 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 1e-07 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-07 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 1e-07 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-07 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 1e-07 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 1e-07 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 1e-07 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-07 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-07 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 1e-07 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 1e-07 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 1e-07 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-07 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 1e-07 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 1e-07 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 1e-07 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 1e-07 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 1e-07 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 1e-07 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 1e-07 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 1e-07 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 1e-07 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 1e-07 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 1e-07 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 2e-07 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 2e-07 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 2e-07 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 2e-07 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 2e-07 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 2e-07 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 2e-07 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 2e-07 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 2e-07 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 2e-07 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 2e-07 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 2e-07 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-07 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 3e-07 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 3e-07 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 3e-07 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 3e-07 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 3e-07 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 3e-07 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 3e-07 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 4e-07 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 4e-07 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 4e-07 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 4e-07 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 4e-07 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 5e-07 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 5e-07 | ||
| 2z7x_B | 520 | Crystal Structure Of The Tlr1-Tlr2 Heterodimer Indu | 5e-07 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 5e-07 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 5e-07 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 5e-07 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 6e-07 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 6e-07 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 6e-07 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 7e-07 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 7e-07 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 7e-07 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 7e-07 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 7e-07 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 7e-07 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 7e-07 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 8e-07 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 8e-07 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 8e-07 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 9e-07 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 9e-07 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 1e-06 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 1e-06 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 1e-06 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-06 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 1e-06 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 1e-06 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 1e-06 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 1e-06 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-06 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 1e-06 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 1e-06 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 1e-06 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 1e-06 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 2e-06 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 2e-06 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-06 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 2e-06 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 2e-06 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 2e-06 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 2e-06 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-06 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 2e-06 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 2e-06 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 2e-06 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 2e-06 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 2e-06 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 2e-06 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 2e-06 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 2e-06 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-06 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 3e-06 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 3e-06 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 3e-06 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 3e-06 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 3e-06 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 3e-06 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 3e-06 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-06 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 3e-06 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 3e-06 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 3e-06 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 3e-06 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-06 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 3e-06 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 3e-06 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 3e-06 | ||
| 4fvp_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain ( | 4e-06 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 6e-06 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 7e-06 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 8e-06 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 8e-06 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 8e-06 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 8e-06 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 8e-06 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 8e-06 | ||
| 3kmw_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 9e-06 | ||
| 3j0a_A | 844 | Homology Model Of Human Toll-Like Receptor 5 Fitted | 9e-06 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 1e-05 | ||
| 4fvr_A | 289 | Crystal Structure Of The Jak2 Pseudokinase Domain M | 1e-05 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 1e-05 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 1e-05 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-05 | ||
| 3g2f_A | 336 | Crystal Structure Of The Kinase Domain Of Bone Morp | 1e-05 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 1e-05 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 1e-05 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 1e-05 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-05 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 1e-05 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 1e-05 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 1e-05 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-05 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 2e-05 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 2e-05 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 2e-05 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 2e-05 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 2e-05 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 2e-05 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 2e-05 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 2e-05 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 2e-05 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-05 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-05 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-05 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 2e-05 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-05 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-05 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 2e-05 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 2e-05 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 2e-05 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-05 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-05 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-05 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 2e-05 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-05 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 2e-05 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-05 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-05 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 3e-05 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-05 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 3e-05 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 3e-05 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 3e-05 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 3e-05 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 3e-05 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 3e-05 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 4e-05 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 4e-05 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 4e-05 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 4e-05 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 4e-05 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 4e-05 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 4e-05 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 4e-05 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-05 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 4e-05 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 4e-05 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 4e-05 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 4e-05 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 4e-05 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 4e-05 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 4e-05 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 4e-05 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 4e-05 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 4e-05 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 4e-05 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 4e-05 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 5e-05 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 5e-05 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 5e-05 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 5e-05 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 6e-05 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 6e-05 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-05 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 6e-05 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 6e-05 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 6e-05 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 6e-05 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 6e-05 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 6e-05 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 6e-05 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 6e-05 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 6e-05 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 7e-05 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 7e-05 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 7e-05 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 7e-05 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 7e-05 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 7e-05 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 7e-05 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 8e-05 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 8e-05 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 8e-05 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 8e-05 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 8e-05 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 8e-05 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 9e-05 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 9e-05 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 9e-05 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 1e-04 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 1e-04 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 1e-04 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 1e-04 | ||
| 3kj4_A | 286 | Structure Of Rat Nogo Receptor Bound To 1d9 Antagon | 1e-04 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 1e-04 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 1e-04 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-04 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-04 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 1e-04 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-04 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 1e-04 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 1e-04 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 1e-04 | ||
| 1x8b_A | 289 | Structure Of Human Wee1a Kinase: Kinase Domain Comp | 1e-04 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 1e-04 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-04 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 1e-04 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 1e-04 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-04 | ||
| 3bi6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd352396 Length | 1e-04 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 1e-04 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 2e-04 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 2e-04 | ||
| 3v47_A | 455 | Crystal Structure Of The N-Tetminal Fragment Of Zeb | 2e-04 | ||
| 2in6_A | 287 | Wee1 Kinase Complex With Inhibitor Pd311839 Length | 2e-04 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 2e-04 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 2e-04 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 2e-04 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 2e-04 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 2e-04 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 2e-04 | ||
| 4b8c_D | 727 | Nuclease Module Of The Yeast Ccr4-Not Complex Lengt | 2e-04 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 2e-04 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-04 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 2e-04 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 2e-04 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 2e-04 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 2e-04 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 2e-04 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 2e-04 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 2e-04 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 2e-04 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 2e-04 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 2e-04 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 2e-04 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 2e-04 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 2e-04 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 2e-04 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 3e-04 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 3e-04 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 3e-04 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 3e-04 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-04 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-04 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 3e-04 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 3e-04 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 3e-04 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 3e-04 | ||
| 2wfh_A | 193 | The Human Slit 2 Dimerization Domain D4 Length = 19 | 3e-04 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 3e-04 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 3e-04 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 3e-04 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 3e-04 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 4e-04 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 4e-04 | ||
| 3rg1_A | 612 | Crystal Structure Of The Rp105MD-1 Complex Length = | 4e-04 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 5e-04 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 5e-04 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 5e-04 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 6e-04 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 6e-04 | ||
| 3rfj_A | 279 | Design Of A Binding Scaffold Based On Variable Lymp | 6e-04 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 6e-04 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 6e-04 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 6e-04 | ||
| 2o6q_A | 270 | Structural Diversity Of The Hagfish Variable Lympho | 6e-04 | ||
| 3kmu_A | 271 | Crystal Structure Of The IlkALPHA-Parvin Core Compl | 6e-04 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 7e-04 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 7e-04 | ||
| 4fho_A | 231 | Crystal Structure Of An Internalin C2 (Inlc2) From | 7e-04 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 7e-04 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 7e-04 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 7e-04 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 8e-04 | ||
| 2id5_A | 477 | Crystal Structure Of The Lingo-1 Ectodomain Length | 8e-04 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 9e-04 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 9e-04 |
| >pdb|3RGX|A Chain A, Structural Insight Into Brassinosteroid Perception By Bri1 Length = 768 | Back alignment and structure |
|
| >pdb|3RIZ|A Chain A, Crystal Structure Of The Plant Steroid Receptor Bri1 Ectodomain Length = 772 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|1OGQ|A Chain A, The Crystal Structure Of Pgip (Polygalacturonase Inhibiting Protein), A Leucine Rich Repeat Protein Involved In Plant Defense Length = 313 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|2OMU|A Chain A, Crystal Structure Of Inla G194s+s Y369s/hec1 Complex Length = 462 | Back alignment and structure |
|
| >pdb|2OMU|A Chain A, Crystal Structure Of Inla G194s+s Y369s/hec1 Complex Length = 462 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|2OMT|A Chain A, Crystal Structure Of Inla G194s+sHEC1 COMPLEX Length = 462 | Back alignment and structure |
|
| >pdb|2OMT|A Chain A, Crystal Structure Of Inla G194s+sHEC1 COMPLEX Length = 462 | Back alignment and structure |
|
| >pdb|2OMX|A Chain A, Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX Length = 462 | Back alignment and structure |
|
| >pdb|2OMX|A Chain A, Crystal Structure Of Inla S192n G194s+sHEC1 COMPLEX Length = 462 | Back alignment and structure |
|
| >pdb|2OMV|A Chain A, Crystal Structure Of Inla S192n Y369s/hec1 Complex Length = 461 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|2OMZ|A Chain A, Crystal Structure Of Inla Y369a/hec1 Complex Length = 466 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2OMY|A Chain A, Crystal Structure Of Inla S192n/hec1 Complex Length = 461 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1O6S|A Chain A, Internalin (Listeria Monocytogenes) E-Cadherin (Human) Recognition Complex Length = 466 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2Z7X|B Chain B, Crystal Structure Of The Tlr1-Tlr2 Heterodimer Induced By Binding Of A Tri-Acylated Lipopeptide Length = 520 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|4FVP|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain (Apo Form) Length = 289 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|3KMW|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Mgatp) Length = 271 | Back alignment and structure |
|
| >pdb|3J0A|A Chain A, Homology Model Of Human Toll-Like Receptor 5 Fitted Into An Electron Microscopy Single Particle Reconstruction Length = 844 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|4FVR|A Chain A, Crystal Structure Of The Jak2 Pseudokinase Domain Mutant V617f (Mg- Atp-Bound Form) Length = 289 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|3G2F|A Chain A, Crystal Structure Of The Kinase Domain Of Bone Morphogenetic Protein Receptor Type Ii (Bmpr2) At 2.35 A Resolution Length = 336 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3KJ4|A Chain A, Structure Of Rat Nogo Receptor Bound To 1d9 Antagonist Antibody Length = 286 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|1X8B|A Chain A, Structure Of Human Wee1a Kinase: Kinase Domain Complexed With Inhibitor Pd0407824 Length = 289 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3BI6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd352396 Length = 287 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3V47|A Chain A, Crystal Structure Of The N-Tetminal Fragment Of Zebrafish Tlr5 In Complex With Salmonella Flagellin Length = 455 | Back alignment and structure |
|
| >pdb|2IN6|A Chain A, Wee1 Kinase Complex With Inhibitor Pd311839 Length = 287 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|4B8C|D Chain D, Nuclease Module Of The Yeast Ccr4-Not Complex Length = 727 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|2WFH|A Chain A, The Human Slit 2 Dimerization Domain D4 Length = 193 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|3RG1|A Chain A, Crystal Structure Of The Rp105MD-1 Complex Length = 612 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|3RFJ|A Chain A, Design Of A Binding Scaffold Based On Variable Lymphocyte Receptors Of Jawless Vertebrates By Module Engineering Length = 279 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|2O6Q|A Chain A, Structural Diversity Of The Hagfish Variable Lymphocyte Receptors A29 Length = 270 | Back alignment and structure |
|
| >pdb|3KMU|A Chain A, Crystal Structure Of The IlkALPHA-Parvin Core Complex (Apo) Length = 271 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4FHO|A Chain A, Crystal Structure Of An Internalin C2 (Inlc2) From Listeria Monocytogenes Str. 4b F2365 At 1.90 A Resolution Length = 231 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2ID5|A Chain A, Crystal Structure Of The Lingo-1 Ectodomain Length = 477 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 436 bits (1123), Expect = e-141
Identities = 155/471 (32%), Positives = 222/471 (47%), Gaps = 13/471 (2%)
Query: 68 LDLSRLQLRGNI-TLVSELKALKRLDLSNNAFSGTIP-SAFGNLSELEFLDLSLNKFGGV 125
LDLS G + L+ L LS+N FSG +P + L+ LDLS N+F G
Sbjct: 299 LDLSGNHFYGAVPPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGE 358
Query: 126 IPRELGSLK-DLRFFNISNNVLVGEIPDEL--KSLEKLEDFQVSSNKLNGSIPFWVGNLT 182
+P L +L L ++S+N G I L L++ + +N G IP + N +
Sbjct: 359 LPESLTNLSASLLTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCS 418
Query: 183 NLRVFTAYENQLVGEIPDNLGSVSELELLNLHSNQLEGPIPKSIFASGKLEVLVLTQNRL 242
L N L G IP +LGS+S+L L L N LEG IP+ + LE L+L N L
Sbjct: 419 ELVSLHLSFNYLSGTIPSSLGSLSKLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDL 478
Query: 243 TGDIPELVGHCKSLSNIRIGNNDLVGVIPRAIGNVSGLTYFEADNNNLSGEIVPEFSQCS 302
TG+IP + +C +L+ I + NN L G IP+ IG + L + NN+ SG I E C
Sbjct: 479 TGEIPSGLSNCTNLNWISLSNNRLTGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCR 538
Query: 303 NLTLLNLASNGFTGVIPPELGQLINLQELILYENSLFGEIPKSILACKNLNKLDLSNN-- 360
+L L+L +N F G IP + + + N + G+ I + + N
Sbjct: 539 SLIWLDLNTNLFNGTIPAAMFKQSGK----IAANFIAGKRYVYIKNDGMKKECHGAGNLL 594
Query: 361 RFNGTIPNAICDMSRLQYLLLGQNSLKGEIPHEIGNCMKLLQLHIGSNYLTGSIPPEIGH 420
F G + +S + G N ++ L + N L+G IP EIG
Sbjct: 595 EFQGIRSEQLNRLSTRNPCNITSRVYGGHTSPTFDNNGSMMFLDMSYNMLSGYIPKEIGS 654
Query: 421 IRNLQIALNLSFNHLHGSLPPELGKLDKLVSFDVSNNQLSGTIPSALKGMLSLIEVNFSN 480
+ L I LNL N + GS+P E+G L L D+S+N+L G IP A+ + L E++ SN
Sbjct: 655 MPYLFI-LNLGHNDISGSIPDEVGDLRGLNILDLSSNKLDGRIPQAMSALTMLTEIDLSN 713
Query: 481 NLLTGPVPSFVPFQKSPNSSFFGNKGLCGEPLSFSC-GNANGPDSKNYRHR 530
N L+GP+P F+ P + F N GLCG PL NA+G H
Sbjct: 714 NNLSGPIPEMGQFETFPPAKFLNNPGLCGYPLPRCDPSNADGYAHHQRSHH 764
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 405 bits (1043), Expect = e-129
Identities = 146/501 (29%), Positives = 228/501 (45%), Gaps = 47/501 (9%)
Query: 31 LLAINKELIVPG----WGVNGTNFCNWKGIDCD-------------------------LN 61
L++ L W + N C + G+ C L+
Sbjct: 17 LISFKDVLPDKNLLPDWS-SNKNPCTFDGVTCRDDKVTSIDLSSKPLNVGFSAVSSSLLS 75
Query: 62 QAFVVKLDLSRLQLRGNITLVSELKALKRLDLSNNAFSGTIPSA--FGNLSELEFLDLSL 119
+ L LS + G+++ +L LDLS N+ SG + + G+ S L+FL++S
Sbjct: 76 LTGLESLFLSNSHINGSVSGFKCSASLTSLDLSRNSLSGPVTTLTSLGSCSGLKFLNVSS 135
Query: 120 NKFGGVIPRELG-SLKDLRFFNISNNVLVGEIPDELK---SLEKLEDFQVSSNKLNGSIP 175
N G L L ++S N + G +L+ +S NK++G +
Sbjct: 136 NTLDFPGKVSGGLKLNSLEVLDLSANSISGANVVGWVLSDGCGELKHLAISGNKISGDVD 195
Query: 176 FWVGNLTNLRVFTAYENQLVGEIPDNLGSVSELELLNLHSNQLEGPIPKSIFASGKLEVL 235
NL N IP LG S L+ L++ N+L G ++I +L++L
Sbjct: 196 V--SRCVNLEFLDVSSNNFSTGIPF-LGDCSALQHLDISGNKLSGDFSRAISTCTELKLL 252
Query: 236 VLTQNRLTGDIPELVGHCKSLSNIRIGNNDLVGVIPRAI-GNVSGLTYFEADNNNLSGEI 294
++ N+ G IP KSL + + N G IP + G LT + N+ G +
Sbjct: 253 NISSNQFVGPIPP--LPLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAV 310
Query: 295 VPEFSQCSNLTLLNLASNGFTGVIPPE-LGQLINLQELILYENSLFGEIPKSILACK-NL 352
P F CS L L L+SN F+G +P + L ++ L+ L L N GE+P+S+ +L
Sbjct: 311 PPFFGSCSLLESLALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASL 370
Query: 353 NKLDLSNNRFNGTIPNAICD--MSRLQYLLLGQNSLKGEIPHEIGNCMKLLQLHIGSNYL 410
LDLS+N F+G I +C + LQ L L N G+IP + NC +L+ LH+ NYL
Sbjct: 371 LTLDLSSNNFSGPILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYL 430
Query: 411 TGSIPPEIGHIRNLQIALNLSFNHLHGSLPPELGKLDKLVSFDVSNNQLSGTIPSALKGM 470
+G+IP +G + L+ L L N L G +P EL + L + + N L+G IPS L
Sbjct: 431 SGTIPSSLGSLSKLRD-LKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNC 489
Query: 471 LSLIEVNFSNNLLTGPVPSFV 491
+L ++ SNN LTG +P ++
Sbjct: 490 TNLNWISLSNNRLTGEIPKWI 510
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 401 bits (1034), Expect = e-128
Identities = 130/431 (30%), Positives = 192/431 (44%), Gaps = 14/431 (3%)
Query: 68 LDLSRLQLRGNITLVSELKALKRLDLSNNAFSGTIPSAFGNLSELEFLDLSLNKFGGVIP 127
LD+S I + + AL+ LD+S N SG A +EL+ L++S N+F G IP
Sbjct: 205 LDVSSNNFSTGIPFLGDCSALQHLDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIP 264
Query: 128 RELGSLKDLRFFNISNNVLVGEIPDELK-SLEKLEDFQVSSNKLNGSIPFWVGNLTNLRV 186
LK L++ +++ N GEIPD L + + L +S N G++P + G+ + L
Sbjct: 265 PL--PLKSLQYLSLAENKFTGEIPDFLSGACDTLTGLDLSGNHFYGAVPPFFGSCSLLES 322
Query: 187 FTAYENQLVGEIP-DNLGSVSELELLNLHSNQLEGPIPKSIF-ASGKLEVLVLTQNRLTG 244
N GE+P D L + L++L+L N+ G +P+S+ S L L L+ N +G
Sbjct: 323 LALSSNNFSGELPMDTLLKMRGLKVLDLSFNEFSGELPESLTNLSASLLTLDLSSNNFSG 382
Query: 245 DIPELVGHC--KSLSNIRIGNNDLVGVIPRAIGNVSGLTYFEADNNNLSGEIVPEFSQCS 302
I + +L + + NN G IP + N S L N LSG I S
Sbjct: 383 PILPNLCQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLS 442
Query: 303 NLTLLNLASNGFTGVIPPELGQLINLQELILYENSLFGEIPKSILACKNLNKLDLSNNRF 362
L L L N G IP EL + L+ LIL N L GEIP + C NLN + LSNNR
Sbjct: 443 KLRDLKLWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRL 502
Query: 363 NGTIPNAICDMSRLQYLLLGQNSLKGEIPHEIGNCMKLLQLHIGSNYLTGSIPPEIGHIR 422
G IP I + L L L NS G IP E+G+C L+ L + +N G+IP +
Sbjct: 503 TGEIPKWIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQS 562
Query: 423 NLQIALNLSFNHLHGSLPPELGKLDKLVSFDVSNN--QLSGTIPSALKGMLSLIEVNFSN 480
++ N + G + + N + G L + + N ++
Sbjct: 563 GK-----IAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITS 617
Query: 481 NLLTGPVPSFV 491
+ G
Sbjct: 618 RVYGGHTSPTF 628
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 302 bits (775), Expect = 3e-90
Identities = 105/337 (31%), Positives = 153/337 (45%), Gaps = 7/337 (2%)
Query: 58 CDLNQAFVVKLDLSRLQLRGNI-TLVSELKALKRLDLSNNAFSGTIPSAFGNLSELEFLD 116
C + + +L L G I +S L L LS N SGTIPS+ G+LS+L L
Sbjct: 389 CQNPKNTLQELYLQNNGFTGKIPPTLSNCSELVSLHLSFNYLSGTIPSSLGSLSKLRDLK 448
Query: 117 LSLNKFGGVIPRELGSLKDLRFFNISNNVLVGEIPDELKSLEKLEDFQVSSNKLNGSIPF 176
L LN G IP+EL +K L + N L GEIP L + L +S+N+L G IP
Sbjct: 449 LWLNMLEGEIPQELMYVKTLETLILDFNDLTGEIPSGLSNCTNLNWISLSNNRLTGEIPK 508
Query: 177 WVGNLTNLRVFTAYENQLVGEIPDNLGSVSELELLNLHSNQLEGPIPKSIFASGKLEVLV 236
W+G L NL + N G IP LG L L+L++N G IP ++F
Sbjct: 509 WIGRLENLAILKLSNNSFSGNIPAELGDCRSLIWLDLNTNLFNGTIPAAMFKQSGK---- 564
Query: 237 LTQNRLTGDIPELVGHCKSLSNIRIGNND--LVGVIPRAIGNVSGLTYFEADNNNLSGEI 294
+ N + G + + N G+ + +S + G
Sbjct: 565 IAANFIAGKRYVYIKNDGMKKECHGAGNLLEFQGIRSEQLNRLSTRNPCNITSRVYGGHT 624
Query: 295 VPEFSQCSNLTLLNLASNGFTGVIPPELGQLINLQELILYENSLFGEIPKSILACKNLNK 354
P F ++ L+++ N +G IP E+G + L L L N + G IP + + LN
Sbjct: 625 SPTFDNNGSMMFLDMSYNMLSGYIPKEIGSMPYLFILNLGHNDISGSIPDEVGDLRGLNI 684
Query: 355 LDLSNNRFNGTIPNAICDMSRLQYLLLGQNSLKGEIP 391
LDLS+N+ +G IP A+ ++ L + L N+L G IP
Sbjct: 685 LDLSSNKLDGRIPQAMSALTMLTEIDLSNNNLSGPIP 721
|
| >3rgz_A Protein brassinosteroid insensitive 1; phytohormone, leucine-rich RE receptor-like kinases, leucine-rich repeat; HET: NAG BLD; 2.28A {Arabidopsis thaliana} PDB: 3rgx_A* 3riz_A* 3rj0_A* Length = 768 | Back alignment and structure |
|---|
Score = 204 bits (521), Expect = 2e-55
Identities = 60/250 (24%), Positives = 107/250 (42%), Gaps = 13/250 (5%)
Query: 251 GHCKSLSNIRIGNNDLVGVIPRAIGNVSGLTYFEADNNNLSGEIVPEFSQCSNLTLLNLA 310
S+ N + ++ +++GL N++++G + F ++LT L+L+
Sbjct: 50 DKVTSIDLSSKPLNVGFSAVSSSLLSLTGLESLFLSNSHINGSV-SGFKCSASLTSLDLS 108
Query: 311 SNGFTGVIPP--ELGQLINLQELILYENSLFGEIPKSILA-CKNLNKLDLSNNRFNGTIP 367
N +G + LG L+ L + N+L S +L LDLS N +G
Sbjct: 109 RNSLSGPVTTLTSLGSCSGLKFLNVSSNTLDFPGKVSGGLKLNSLEVLDLSANSISGANV 168
Query: 368 NAICD---MSRLQYLLLGQNSLKGEIPHEIGNCMKLLQLHIGSNYLTGSIPPEIGHIRNL 424
L++L + N + G++ + C+ L L + SN + IP +G L
Sbjct: 169 VGWVLSDGCGELKHLAISGNKISGDVD--VSRCVNLEFLDVSSNNFSTGIP-FLGDCSAL 225
Query: 425 QIALNLSFNHLHGSLPPELGKLDKLVSFDVSNNQLSGTIPSALKGMLSLIEVNFSNNLLT 484
Q L++S N L G + +L ++S+NQ G IP + SL ++ + N T
Sbjct: 226 QH-LDISGNKLSGDFSRAISTCTELKLLNISSNQFVGPIPPLP--LKSLQYLSLAENKFT 282
Query: 485 GPVPSFVPFQ 494
G +P F+
Sbjct: 283 GEIPDFLSGA 292
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 291 bits (746), Expect = 1e-87
Identities = 58/462 (12%), Positives = 144/462 (31%), Gaps = 49/462 (10%)
Query: 68 LDLSRLQLRGNI------TLVSELKALKRLDLSNNAFSGTIPSAFGNLSELEFLDLSLNK 121
DL + + + ++ +N + + A L++L + +
Sbjct: 159 SDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSP 217
Query: 122 FGGVIPRELGSLKDLRFFNISNNVLVGEIPDELKSLEKLEDFQVSSNKLNGSIPFWVGNL 181
F E ++ + +L+ L D +V + +P ++ L
Sbjct: 218 FVAENICEAWENENS-----EYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKAL 272
Query: 182 TNLRVFTAYENQLV--------GEIPDNLGSVSELELLNLHSNQL-EGPIPKSIFASGKL 232
+++ N+ + + + +++++ + N L P+ S+ KL
Sbjct: 273 PEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKL 332
Query: 233 EVLVLTQNRLTGDIPELVGHCKSLSNIRIGNNDLVGVIPRAIGNVSGLTYFEADNNNLSG 292
+L N+L G +P G L+++ + N + + G + +N L
Sbjct: 333 GMLECLYNQLEGKLPAF-GSEIKLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLKY 391
Query: 293 -EIVPEFSQCSNLTLLNLASNGFTGV-------IPPELGQLINLQELILYENSLFGEIPK 344
+ + S ++ ++ + N V + P + IN+ + L N + +
Sbjct: 392 IPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKE 451
Query: 345 SILACKNLNKLDLSNNRFNG-------TIPNAICDMSRLQYLLLGQNSLKGEIPHEI--G 395
L+ ++L N + L + L N L + +
Sbjct: 452 LFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLRFNKLTK-LSDDFRAT 510
Query: 396 NCMKLLQLHIGSNYLTGSIPPEIGHIRNLQI-----ALNLSFNHLHGSLPPELGKLDKLV 450
L+ + + N + P + + L+ + N P + L
Sbjct: 511 TLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDAQGNRTLREWPEGITLCPSLT 569
Query: 451 SFDVSNNQLSGTIPSALKGMLSLIEVNFSNNLLTGPVPSFVP 492
+ +N + ++ ++ +N S+V
Sbjct: 570 QLQIGSNDIRKVNEKITP---NISVLDIKDNPNISIDLSYVC 608
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 280 bits (717), Expect = 2e-83
Identities = 71/458 (15%), Positives = 148/458 (32%), Gaps = 45/458 (9%)
Query: 68 LDLSRLQLRGNI---TLVSELKALKRLDLSNNAFSGTIPSAFGNLSELEFLDLSLNKFGG 124
R+ + + L + ++++ +I + + + N
Sbjct: 138 KQKMRMHYQKTFVDYDPREDFSDLIKDCINSDPQQKSIKKSSRITLKDTQIGQLSNNITF 197
Query: 125 VIPRELGSLKDLRFFNISNNVLVGEIPDELKSLEKLEDFQVSSNKLNGSIPFWVGNLTNL 184
+ + + L LR F + N+ V E E E E + + NL +L
Sbjct: 198 -VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSE-----YAQQYKTEDLKWDNLKDL 251
Query: 185 RVFTAYENQLVGEIPDNLGSVSELELLNLHSNQL--------EGPIPKSIFASGKLEVLV 236
Y + ++P L ++ E++L+N+ N+ + K++++
Sbjct: 252 TDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISGEQLKDDWQALADAPVGEKIQIIY 311
Query: 237 LTQNRL-TGDIPELVGHCKSLSNIRIGNNDLVGVIPRAIGNVSGLTYFEADNNNLSGEIV 295
+ N L T + + K L + N L G +P A G+ L N ++
Sbjct: 312 IGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLNLAYNQITEIPA 370
Query: 296 PEFSQCSNLTLLNLASNGFTGVIPP-ELGQLINLQELILYENSL-------FGEIPKSIL 347
+ L+ A N + + + + + N + F + +
Sbjct: 371 NFCGFTEQVENLSFAHNKLKYIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPF 430
Query: 348 ACKNLNKLDLSNNRFNGTIPNAICDMSRLQYLLLGQNSLKG-------EIPHEIGNCMKL 400
N++ ++LSNN+ + S L + L N L + N L
Sbjct: 431 KGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLL 490
Query: 401 LQLHIGSNYLTGSIPPEI--GHIRNLQIALNLSFNHLHGSLPPELGKLDKLVSFDVSN-- 456
+ + N LT + + + L ++LS+N P + L F + N
Sbjct: 491 TSIDLRFNKLT-KLSDDFRATTLPYLVG-IDLSYNSF-SKFPTQPLNSSTLKGFGIRNQR 547
Query: 457 ----NQLSGTIPSALKGMLSLIEVNFSNNLLTGPVPSF 490
N+ P + SL ++ +N +
Sbjct: 548 DAQGNRTLREWPEGITLCPSLTQLQIGSNDIRKVNEKI 585
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 267 bits (684), Expect = 9e-79
Identities = 66/436 (15%), Positives = 140/436 (32%), Gaps = 46/436 (10%)
Query: 70 LSRLQLRGN-ITLVSELKALKRLDLSNNAFSGTIPSAFGNLSELEFLDLSLNKFGGVIPR 128
L + + + + +A + + T + NL +L +++ +P
Sbjct: 208 LRQFYMGNSPFVAENICEAWENENSEYAQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPT 267
Query: 129 ELGSLKDLRFFNISNNVLVGEIPDELKSLEKLEDFQVSSNKLNGSIPFWVGNLTNLRVFT 188
L +L +++ N++ N + K + +++
Sbjct: 268 FLKALPEMQLINVACNRGIS----------------GEQLKDDWQALADAPVGEKIQIIY 311
Query: 189 AYENQL-VGEIPDNLGSVSELELLNLHSNQLEGPIPKSIFASGKLEVLVLTQNRLTGDIP 247
N L + +L + +L +L NQLEG +P + + KL L L N++T
Sbjct: 312 IGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLP-AFGSEIKLASLNLAYNQITEIPA 370
Query: 248 ELVGHCKSLSNIRIGNNDLVGVIPRA-IGNVSGLTYFEADNNNLSG-------EIVPEFS 299
G + + N+ +N L + +VS ++ + N + + P
Sbjct: 371 NFCGFTEQVENLSFAHNKLKYIPNIFDAKSVSVMSAIDFSYNEIGSVDGKNFDPLDPTPF 430
Query: 300 QCSNLTLLNLASNGFTGVIPPELGQLINLQELILYENSL-------FGEIPKSILACKNL 352
+ N++ +NL++N + L + L N L + ++ L
Sbjct: 431 KGINVSSINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLL 490
Query: 353 NKLDLSNNRFNGTIPN-AICDMSRLQYLLLGQNSLKGEIPHEIGNCMKLLQLHIG----- 406
+DL N+ + + L + L NS P + N L I
Sbjct: 491 TSIDLRFNKLTKLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQRDA 549
Query: 407 -SNYLTGSIPPEIGHIRNLQIALNLSFNHLHGSLPPELGKLDKLVSFDVSNNQLSGTIPS 465
N P I +L L + N + + ++ + D+ +N S
Sbjct: 550 QGNRTLREWPEGITLCPSLTQ-LQIGSNDIR-KVNEKI--TPNISVLDIKDNPNISIDLS 605
Query: 466 ALKGMLSLIEVNFSNN 481
+ + +
Sbjct: 606 YVCPYIEAGMYMLFYD 621
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 266 bits (682), Expect = 2e-78
Identities = 81/486 (16%), Positives = 145/486 (29%), Gaps = 68/486 (13%)
Query: 25 LNDEPTLLAINKELIVPGWGVNGTNF---CNWKGIDCDLNQAFVVKLDLSRLQLRGNITL 81
+ D L I L W G NW F +LD+ Q ++L
Sbjct: 29 IKDYLALKEIWDALNGKNWSQQGFGTQPGANWN---------FNKELDMWGAQP--GVSL 77
Query: 82 VSELKALKRLDLSNNAFSGTIPSAFGNLSELEFLDLSLNKFGG----VIPRELGSLKDLR 137
+ + L L SG +P A G L+ELE L L + P+ + +
Sbjct: 78 -NSNGRVTGLSLEGFGASGRVPDAIGQLTELEVLALGSHGEKVNERLFGPKGISANMSDE 136
Query: 138 FFNISNNVLVGEIPDELKSLEKLEDFQVSSNKLNGSIPFWVGNLTNLRVFTAYENQLVGE 197
D + + + +N +
Sbjct: 137 QKQKMRMHYQKTFVDYDPREDFS---DLIKDCINS-------------------DPQQKS 174
Query: 198 IPDNLGSVSELELLNLHSNQLEGPIPKSIFASGKLEVLVLTQNRLTGDIPELVGHCKSLS 257
I + + + SN + + K++ KL + + + ++
Sbjct: 175 IKKSSRITLKDTQIGQLSNNITF-VSKAVMRLTKLRQFYMGNSPFVAENICEAWENENSE 233
Query: 258 NIRIGNNDLVGVIPRAIGNVSGLTYFEADNNNLSGEIVPEFSQCSNLTLLNLASNGFTGV 317
N+ LT E N ++ + L+N+A N
Sbjct: 234 Y-----AQQYKTEDLKWDNLKDLTDVEVYNCPNLTKLPTFLKALPEMQLINVACNRGISG 288
Query: 318 --------IPPELGQLINLQELILYENSLF-GEIPKSILACKNLNKLDLSNNRFNGTIPN 368
+ +Q + + N+L + S+ K L L+ N+ G +P
Sbjct: 289 EQLKDDWQALADAPVGEKIQIIYIGYNNLKTFPVETSLQKMKKLGMLECLYNQLEGKLP- 347
Query: 369 AICDMSRLQYLLLGQNSLKGEIPHEIGNCMKLLQLHIGSNYLTGSIPP--EIGHIRNLQI 426
A +L L L N + + G ++ L N L IP + + +
Sbjct: 348 AFGSEIKLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLK-YIPNIFDAKSVSVMSA 406
Query: 427 ALNLSFNHLHG-------SLPPELGKLDKLVSFDVSNNQLSGTIPSALKGMLSLIEVNFS 479
++ S+N + L P K + S ++SNNQ+S L +N
Sbjct: 407 -IDFSYNEIGSVDGKNFDPLDPTPFKGINVSSINLSNNQISKFPKELFSTGSPLSSINLM 465
Query: 480 NNLLTG 485
N+LT
Sbjct: 466 GNMLTE 471
|
| >4eco_A Uncharacterized protein; leucine-rich repeats, protein binding, structural genomics, center for structural genomics, JCSG; 2.70A {Bacteroides eggerthii dsm 20697} Length = 636 | Back alignment and structure |
|---|
Score = 184 bits (468), Expect = 3e-49
Identities = 54/343 (15%), Positives = 101/343 (29%), Gaps = 53/343 (15%)
Query: 67 KLDLSRLQLRGNITLVSELKALKRLDLSNNAFSGTIPSAFGNLSELEFLDLSLNKFGGVI 126
L+ QL G + L L+L+ N + + G ++E L + NK +
Sbjct: 334 MLECLYNQLEGKLPAFGSEIKLASLNLAYNQITEIPANFCGFTEQVENLSFAHNKLKYIP 393
Query: 127 PR-ELGSLKDLRFFNISNNVLVGEIPDELKSLEKLEDFQVSSNKLNGSIPFWVGNLTNLR 185
+ S+ + + S N + + N+
Sbjct: 394 NIFDAKSVSVMSAIDFSYNEIGSVDGKNF-----------------DPLDPTPFKGINVS 436
Query: 186 VFTAYENQLVGEIPDNLGSVSELELLNLHSNQLEG-------PIPKSIFASGKLEVLVLT 238
NQ+ + + S L +NL N L ++ + L + L
Sbjct: 437 SINLSNNQISKFPKELFSTGSPLSSINLMGNMLTEIPKNSLKDENENFKNTYLLTSIDLR 496
Query: 239 QNRLTGDIPEL-VGHCKSLSNIRIGNNDLVGVIPRAIGNVSGLTYFEADNNNLSGEIVPE 297
N+LT + L I + N P N S L F N
Sbjct: 497 FNKLTKLSDDFRATTLPYLVGIDLSYNSFSK-FPTQPLNSSTLKGFGIRNQ--------- 546
Query: 298 FSQCSNLTLLNLASNGFTGVIPPELGQLINLQELILYENSLFGEIPKSILACKNLNKLDL 357
+ N P + +L +L + N + ++ + I N++ LD+
Sbjct: 547 ---------RDAQGNRTLREWPEGITLCPSLTQLQIGSNDI-RKVNEKIT--PNISVLDI 594
Query: 358 SNNRFNGTIPNAICDMSRLQYLLLGQNSLKGEIPHEIGNCMKL 400
+N + +C +L + + +I C L
Sbjct: 595 KDNPNISIDLSYVCPYIEAGMYMLFYDKTQ-----DIRGCDAL 632
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 261 bits (669), Expect = 2e-80
Identities = 84/326 (25%), Positives = 129/326 (39%), Gaps = 50/326 (15%)
Query: 192 NQLVGEIPDNLGSVSELELLNLHSNQLEGPIPKSIFASGKLEVLVLTQNRLTGDIPELVG 251
+G + D + L+L L IP +
Sbjct: 36 RTWLGVLCDTDTQTYRVNNLDLSGLNLPK----------------------PYPIPSSLA 73
Query: 252 HCKSLSNIRIGN-NDLVGVIPRAIGNVSGLTYFEADNNNLSGEIVPEFSQCSNLTLLNLA 310
+ L+ + IG N+LVG IP AI ++ L Y + N+SG I SQ L L+ +
Sbjct: 74 NLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFS 133
Query: 311 SNGFTGVIPPELGQLINLQELILYENSLFGEIPKSILACKNLNKLDLSNNRFNGTIPNAI 370
N +G +PP + L NL + N + G IP S + L
Sbjct: 134 YNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKL------------------ 175
Query: 371 CDMSRLQYLLLGQNSLKGEIPHEIGNCMKLLQLHIGSNYLTGSIPPEIGHIRNLQIALNL 430
+ + +N L G+IP N + L + + N L G G +N Q ++L
Sbjct: 176 -----FTSMTISRNRLTGKIPPTFAN-LNLAFVDLSRNMLEGDASVLFGSDKNTQK-IHL 228
Query: 431 SFNHLHGSLPPELGKLDKLVSFDVSNNQLSGTIPSALKGMLSLIEVNFSNNLLTGPVPSF 490
+ N L L ++G L D+ NN++ GT+P L + L +N S N L G +P
Sbjct: 229 AKNSLAFDL-GKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQG 287
Query: 491 VPFQKSPNSSFFGNKGLCGEPLSFSC 516
Q+ S++ NK LCG PL +C
Sbjct: 288 GNLQRFDVSAYANNKCLCGSPLP-AC 312
|
| >1ogq_A PGIP-2, polygalacturonase inhibiting protein; inhibitor; HET: NAG; 1.7A {Phaseolus vulgaris} SCOP: c.10.2.8 Length = 313 | Back alignment and structure |
|---|
Score = 244 bits (625), Expect = 5e-74
Identities = 86/299 (28%), Positives = 136/299 (45%), Gaps = 17/299 (5%)
Query: 27 DEPTLLAINKELIVPG----WGVNGTNFCN--WKGIDCDL--NQAFVVKLDLSRLQLRGN 78
D+ LL I K+L P W + T+ CN W G+ CD V LDLS L L
Sbjct: 7 DKQALLQIKKDLGNPTTLSSW-LPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKP 65
Query: 79 ITL---VSELKALKRLDLSN-NAFSGTIPSAFGNLSELEFLDLSLNKFGGVIPRELGSLK 134
+ ++ L L L + N G IP A L++L +L ++ G IP L +K
Sbjct: 66 YPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIK 125
Query: 135 DLRFFNISNNVLVGEIPDELKSLEKLEDFQVSSNKLNGSIPFWVGNLTNLRVF-TAYENQ 193
L + S N L G +P + SL L N+++G+IP G+ + L T N+
Sbjct: 126 TLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNR 185
Query: 194 LVGEIPDNLGSVSELELLNLHSNQLEGPIPKSIFASGKLEVLVLTQNRLTGDIPELVGHC 253
L G+IP +++ L ++L N LEG + + + L +N L D+ ++ G
Sbjct: 186 LTGKIPPTFANLN-LAFVDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKV-GLS 243
Query: 254 KSLSNIRIGNNDLVGVIPRAIGNVSGLTYFEADNNNLSGEIVPEFSQCSNLTLLNLASN 312
K+L+ + + NN + G +P+ + + L NNL GEI P+ + A+N
Sbjct: 244 KNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEI-PQGGNLQRFDVSAYANN 301
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 261 bits (670), Expect = 2e-76
Identities = 80/442 (18%), Positives = 151/442 (34%), Gaps = 30/442 (6%)
Query: 68 LDLSRLQLR---GNITLVSELKALKRLDLSNNAFSGTIPSAFGNLSELEFLDLSLNKFGG 124
D S L+L ++ + L+L++N + F S+L LD+ N
Sbjct: 9 ADCSHLKLTQVPDDL-----PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTISK 63
Query: 125 VIPRELGSLKDLRFFNISNNVLVGEIPDELKSLEKLEDFQVSSNKLNGSIPFWVGNLTNL 184
+ P L L+ N+ +N L L + + SN + NL
Sbjct: 64 LEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKNL 123
Query: 185 RVFTAYENQLVGEIPDNLGSVSELELLNLHSNQLEGPIPK--SIFASGKLEVLVLTQNRL 242
N L + L+ L L +N+++ + IFA+ L+ L L+ N++
Sbjct: 124 ITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKLELSSNQI 183
Query: 243 TGDIPELVGHCKSLSNIRIGNNDLVGVIPRAIG---NVSGLTYFEADNNNLSGEIVPEFS 299
P L + + N L + + + + N+ LS F
Sbjct: 184 KEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFL 243
Query: 300 QC--SNLTLLNLASNGFTGVIPPELGQLINLQELILYENSLFGEIPKSILACKNLNKLDL 357
+NLT+L+L+ N V L L+ L N++ S+ N+ L+L
Sbjct: 244 GLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNL 303
Query: 358 SNN---------RFNGTIPNAICDMSRLQYLLLGQNSLKGEIPHEIGNCMKLLQLHIGSN 408
+ + + L++L + N + G + + L L + ++
Sbjct: 304 KRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNS 363
Query: 409 YLTGSIPPEIG----HIRNLQIALNLSFNHLHGSLPPELGKLDKLVSFDVSNNQLSGTIP 464
+ + L I LNL+ N + L L D+ N++ +
Sbjct: 364 FTSLRTLTNETFVSLAHSPLHI-LNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELT 422
Query: 465 -SALKGMLSLIEVNFSNNLLTG 485
+G+ ++ E+ S N
Sbjct: 423 GQEWRGLENIFEIYLSYNKYLQ 444
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 238 bits (609), Expect = 8e-68
Identities = 89/444 (20%), Positives = 152/444 (34%), Gaps = 61/444 (13%)
Query: 67 KLDLSRLQLRGNIT----LVSELKALKRLDLSNNAFSGTIPSAFGNL--SELEFLDLSLN 120
L L+ +QL ++T L +++ L LSN+ S T + F L + L LDLS N
Sbjct: 199 GLFLNNVQLGPSLTEKLCLELANTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYN 258
Query: 121 KFGGVIPRELGSLKDLRFFNISNNVLVGEIPDELKSLEKLE---------DFQVSSNKLN 171
V L L +F + N + L L + +S L
Sbjct: 259 NLNVVGNDSFAWLPQLEYFFLEYNNIQHLFSHSLHGLFNVRYLNLKRSFTKQSISLASLP 318
Query: 172 GSIPFWVGNLTNLRVFTAYENQLVGEIPDNLGSVSELELLNLHSNQLE-GPIPKSIFAS- 229
F L L +N + G + + L+ L+L ++ + F S
Sbjct: 319 KIDDFSFQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSL 378
Query: 230 --GKLEVLVLTQNRLTGDIPELVGHCKSLSNIRIGNNDLVGVIPRAIGNVSGLTYFEADN 287
L +L LT+N+++ + L + +G N++ +
Sbjct: 379 AHSPLHILNLTKNKISKIESDAFSWLGHLEVLDLGLNEIGQELTGQ-------------- 424
Query: 288 NNLSGEIVPEFSQCSNLTLLNLASNGFTGVIPPELGQLINLQELILYENSL--FGEIPKS 345
E+ N+ + L+ N + + + +LQ L+L +L P
Sbjct: 425 ---------EWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVALKNVDSSPSP 475
Query: 346 ILACKNLNKLDLSNNRFNGTIPNAICDMSRLQYLLLGQNSLKGEIPHEIGNCMKLLQLHI 405
+NL LDLSNN + + + +L+ L L N+L +
Sbjct: 476 FQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLA----------------RL 519
Query: 406 GSNYLTGSIPPEIGHIRNLQIALNLSFNHLHGSLPPELGKLDKLVSFDVSNNQLSGTIPS 465
+ G + + +L I LNL N L +L D+ N L+ S
Sbjct: 520 WKHANPGGPIYFLKGLSHLHI-LNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPAS 578
Query: 466 ALKGMLSLIEVNFSNNLLTGPVPS 489
+SL +N NL+T
Sbjct: 579 VFNNQVSLKSLNLQKNLITSVEKK 602
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 231 bits (590), Expect = 3e-65
Identities = 66/418 (15%), Positives = 136/418 (32%), Gaps = 46/418 (11%)
Query: 88 LKRLDLSNNAFSGTIPSAFGNLSELEFLDLSLNKFGGVIPRELGSLKDLRFFNISNNVLV 147
+ D S+ + +P + + L+L+ N+ + L ++ N +
Sbjct: 6 HEVADCSHLKLT-QVPDDL--PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVGFNTIS 62
Query: 148 GEIPDELKSLEKLEDFQVSSNKLNGSIPFWVGNLTNLRVFTAYENQLVGEIPDNLGSVSE 207
P+ + L L+ + N+L+ TNL N + +
Sbjct: 63 KLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPFVKQKN 122
Query: 208 LELLNLHSNQLEGPIPKSIFASGKLEVLVLTQNRLTGDIPELVGHCKSLSNIRIGNNDLV 267
L L+L N L + L+ L+L+ N++ E + + S
Sbjct: 123 LITLDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSS---------- 172
Query: 268 GVIPRAIGNVSGLTYFEADNNNLSGEIVPEFSQCSNLTLLNLASNGFTGVIPPELG---Q 324
L E +N + F L L L + + +L
Sbjct: 173 ------------LKKLELSSNQIKEFSPGCFHAIGRLFGLFLNNVQLGPSLTEKLCLELA 220
Query: 325 LINLQELILYENSLFGEIPKSI--LACKNLNKLDLSNNRFNGTIPNAICDMSRLQYLLLG 382
+++ L L + L + L NL LDLS N N ++ + +L+Y L
Sbjct: 221 NTSIRNLSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLE 280
Query: 383 QNSLKGEIPHEIGNCMKLLQLHIGSNYLTGSIPPEIGHIRNLQIALNLSFNHLHGSLPPE 442
N+++ H + + L++ ++ ++S L
Sbjct: 281 YNNIQHLFSHSLHGLFNVRYLNLKRSFTK----------------QSISLASLPKIDDFS 324
Query: 443 LGKLDKLVSFDVSNNQLSGTIPSALKGMLSLIEVNFSNNLLTGPVPSFVPFQKSPNSS 500
L L ++ +N + G + G+++L ++ SN+ + + F +S
Sbjct: 325 FQWLKCLEHLNMEDNDIPGIKSNMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSP 382
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 227 bits (580), Expect = 6e-64
Identities = 92/445 (20%), Positives = 157/445 (35%), Gaps = 34/445 (7%)
Query: 68 LDLSRLQLRGNITLV---SELKALKRLDLSNNAFSGTIPSAFGNLSELEFLDLSLNKFGG 124
L LS QL + L LDLS N + +F L +LE+ L N
Sbjct: 227 LSLSNSQLSTTSNTTFLGLKWTNLTMLDLSYNNLNVVGNDSFAWLPQLEYFFLEYNNIQH 286
Query: 125 VIPRELGSLKDLRFFNISNNVLVGEI---------PDELKSLEKLEDFQVSSNKLNGSIP 175
+ L L ++R+ N+ + I + L+ LE + N + G
Sbjct: 287 LFSHSLHGLFNVRYLNLKRSFTKQSISLASLPKIDDFSFQWLKCLEHLNMEDNDIPGIKS 346
Query: 176 FWVGNLTNLRVFTAYENQLVGEIPDNLG----SVSELELLNLHSNQLEGPIPKSIFASGK 231
L NL+ + + N + S L +LNL N++ + G
Sbjct: 347 NMFTGLINLKYLSLSNSFTSLRTLTNETFVSLAHSPLHILNLTKNKISKIESDAFSWLGH 406
Query: 232 LEVLVLTQNRLTGDIPELV-GHCKSLSNIRIGNNDLVGVIPRAIGNVSGLTYFEADNNNL 290
LEVL L N + ++ +++ I + N + + + V L L
Sbjct: 407 LEVLDLGLNEIGQELTGQEWRGLENIFEIYLSYNKYLQLTRNSFALVPSLQRLMLRRVAL 466
Query: 291 SG--EIVPEFSQCSNLTLLNLASNGFTGVIPPELGQLINLQELILYENSL--------FG 340
F NLT+L+L++N + L L L+ L L N+L G
Sbjct: 467 KNVDSSPSPFQPLRNLTILDLSNNNIANINDDMLEGLEKLEILDLQHNNLARLWKHANPG 526
Query: 341 EIPKSILACKNLNKLDLSNNRFNGTIPNAICDMSRLQYLLLGQNSLKGEIPHEIGNCMKL 400
+ +L+ L+L +N F+ D+ L+ + LG N+L N + L
Sbjct: 527 GPIYFLKGLSHLHILNLESNGFDEIPVEVFKDLFELKIIDLGLNNLNTLPASVFNNQVSL 586
Query: 401 LQLHIGSNYLTGSIPPEIGHI-RNLQIALNLSFNHLHGSLPPELGKLDKLVSFDVSNNQL 459
L++ N +T G RNL L++ FN + ++ + + +L
Sbjct: 587 KSLNLQKNLITSVEKKVFGPAFRNLTE-LDMRFNPFDCTCESIAWFVNWINETHTNIPEL 645
Query: 460 SGTI----PSALKGMLSLIEVNFSN 480
S P G + + S+
Sbjct: 646 SSHYLCNTPPHYHGF-PVRLFDTSS 669
|
| >1ziw_A TOLL-like receptor 3; innate immunity, immune system; HET: NDG NAG; 2.10A {Homo sapiens} PDB: 2a0z_A* 3cig_A* 3ciy_A* Length = 680 | Back alignment and structure |
|---|
Score = 134 bits (339), Expect = 1e-32
Identities = 43/193 (22%), Positives = 72/193 (37%), Gaps = 7/193 (3%)
Query: 300 QCS-NLTLLNLASNGFTGVIPPELGQLINLQELILYENSLFGEIPKSILACKNLNKLDLS 358
+C+ + + + + T +P +L N+ L L N L + L LD+
Sbjct: 1 KCTVSHEVADCSHLKLTQ-VPDDL--PTNITVLNLTHNQLRRLPAANFTRYSQLTSLDVG 57
Query: 359 NNRFNGTIPNAICDMSRLQYLLLGQNSLKGEIPHEIGNCMKLLQLHIGSNYLTGSIPPEI 418
N + P + L+ L L N L C L +LH+ SN +
Sbjct: 58 FNTISKLEPELCQKLPMLKVLNLQHNELSQLSDKTFAFCTNLTELHLMSNSIQKIKNNPF 117
Query: 419 GHIRNLQIALNLSFNHLHGSLPPELGKLDKLVSFDVSNNQLSGTIPSALK--GMLSLIEV 476
+NL L+LS N L + +L+ L +SNN++ L SL ++
Sbjct: 118 VKQKNLIT-LDLSHNGLSSTKLGTQVQLENLQELLLSNNKIQALKSEELDIFANSSLKKL 176
Query: 477 NFSNNLLTGPVPS 489
S+N + P
Sbjct: 177 ELSSNQIKEFSPG 189
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 246 bits (630), Expect = 1e-74
Identities = 97/282 (34%), Positives = 154/282 (54%), Gaps = 17/282 (6%)
Query: 609 DSNMIYCGTFSTVYKAVMPSGLILSVKRLKSMDRTIIHHQNKM--IRELEKLSKLCHDNL 666
+ N++ G F VYK + G +++VKRLK ++ E+E +S H NL
Sbjct: 34 NKNILGRGGFGKVYKGRLADGTLVAVKRLKEER----TQGGELQFQTEVEMISMAVHRNL 89
Query: 667 VRPIGFVIYEDVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLH 726
+R GF + LL++ Y+ NG++A L E + DWP R IA+G A GLA+LH
Sbjct: 90 LRLRGFCMTPTERLLVYPYMANGSVASCLRERPES-QPPLDWPKRQRIALGSARGLAYLH 148
Query: 727 HVA---IIHLDISSGNVLLDADFKPLLGEIEISKLLDPSKGTASISAVAGSFGYIPPEYA 783
IIH D+ + N+LLD +F+ ++G+ ++KL+D + +AV G+ G+I PEY
Sbjct: 149 DHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHVT-TAVRGTIGHIAPEYL 207
Query: 784 YTMQVTAPGNVYSYGVVLLEILTTRLPVEEDF---GEGVDLVKWVHGAPARGETPEQILD 840
T + + +V+ YGV+LLE++T + + + V L+ WV G + E ++D
Sbjct: 208 STGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKL-EALVD 266
Query: 841 ARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEML 882
L +E+ ++VALLCT S+P +RPKM +VV ML
Sbjct: 267 VDLQ--GNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRML 306
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 252 bits (645), Expect = 1e-73
Identities = 86/453 (18%), Positives = 151/453 (33%), Gaps = 32/453 (7%)
Query: 67 KLDLSRLQLRGNI-TLVSELKALKRLDLSNNAF-SGTIPSAFGNLSELEFLDLSLNKFGG 124
KL L + LK LK L++++N S +P F NL+ LE LDLS NK
Sbjct: 104 KLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQS 163
Query: 125 VIPRELGSLKDLRFF----NISNNVLVGEIPDELKSLEKLEDFQVSSNKLNGSIP-FWVG 179
+ +L L + ++S N + P K + +L + +N + ++ +
Sbjct: 164 IYCTDLRVLHQMPLLNLSLDLSLNPMNFIQPGAFKEI-RLHKLTLRNNFDSLNVMKTCIQ 222
Query: 180 NLTNLRVFTAYENQLVGE------IPDNLGSVSELELLNLHSNQLE---GPIPKSIFASG 230
L L V + E L + L + L+ I
Sbjct: 223 GLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLT 282
Query: 231 KLEVLVLTQNRLTGDIPELVGHCKSLSNIRIGNNDLVGVIPRAIGNVSGLTYFEADNNNL 290
+ L + + ++ + N + ++ LT+ +
Sbjct: 283 NVSSFSLVSVTIERVKD--FSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTF-----TSN 335
Query: 291 SGEIVPEFSQCSNLTLLNLASNG--FTGVIPPELGQLINLQELILYENSLFGEIPKSILA 348
G +L L+L+ NG F G +L+ L L N + + + L
Sbjct: 336 KGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLG 394
Query: 349 CKNLNKLDLSNNRFNGTIP-NAICDMSRLQYLLLGQNSLKGEIPHEIGNCMKLLQLHIGS 407
+ L LD ++ + + L YL + + L L +
Sbjct: 395 LEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAG 454
Query: 408 NYLTGSIPPEI-GHIRNLQIALNLSFNHLHGSLPPELGKLDKLVSFDVSNNQLSGTIPSA 466
N + P+I +RNL L+LS L P L L ++S+N
Sbjct: 455 NSFQENFLPDIFTELRNLTF-LDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFP 513
Query: 467 LKGMLSLIEVNFSNNLLTGPVPSFVPFQKSPNS 499
K + SL +++S N + Q P+S
Sbjct: 514 YKCLNSLQVLDYSLNHIMTSKKQE--LQHFPSS 544
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 244 bits (626), Expect = 7e-71
Identities = 90/469 (19%), Positives = 151/469 (32%), Gaps = 54/469 (11%)
Query: 65 VVKLDLSRLQLRGNI-TLVSELKALKRLDLSNNAFSGTIPSAFGNLSELEFLDLSLNKFG 123
LDLS LR L+ LDLS A+ +LS L L L+ N
Sbjct: 30 TKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQ 89
Query: 124 GVIPRELGSLKDLRFFNISNNVLVGEIPDELKSLEKLEDFQVSSNKLNG-SIPFWVGNLT 182
+ L L+ L + L+ L++ V+ N + +P + NLT
Sbjct: 90 SLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLT 149
Query: 183 NLRVFTAYENQLVGEIPDNLGSVSELEL----LNLHSNQLEGPIPKSIFASGKLEVLVLT 238
NL N++ +L + ++ L L+L N + I F +L L L
Sbjct: 150 NLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNF-IQPGAFKEIRLHKLTLR 208
Query: 239 QNRLTGDIPELV----------------------------GHCKSLSNIRIGNNDL---- 266
N + ++ + + L N+ I L
Sbjct: 209 NNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLD 268
Query: 267 --VGVIPRAIGNVSGLTYFEADNNNLSGEIVPEFSQCSNLTLLNLASNGFTGVIPPELGQ 324
+ I ++ ++ F + + V +FS L L + F +L
Sbjct: 269 YYLDDIIDLFNCLTNVSSFSLVSVTIER--VKDFSYNFGWQHLELVNCKFGQFPTLKLKS 326
Query: 325 LINLQELILYENSLFGEIPKSILACKNLNKLDLSNNRFN--GTIPNAICDMSRLQYLLLG 382
L L S G S + +L LDLS N + G + + L+YL L
Sbjct: 327 LKR-----LTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLS 381
Query: 383 QNSLKGEIPHEIGNCMKLLQLHIGSNYLTGSIPPEI-GHIRNLQIALNLSFNHLHGSLPP 441
N + + +L L + L + +RNL L++S H +
Sbjct: 382 FNGVIT-MSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIY-LDISHTHTRVAFNG 439
Query: 442 ELGKLDKLVSFDVSNNQLSGTI-PSALKGMLSLIEVNFSNNLLTGPVPS 489
L L ++ N P + +L ++ S L P+
Sbjct: 440 IFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPT 488
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 227 bits (580), Expect = 2e-64
Identities = 84/434 (19%), Positives = 142/434 (32%), Gaps = 25/434 (5%)
Query: 62 QAFVVKLDLSRLQLRGNITLVSELKALKRLDLSNNAFSGTIPS-AFGNLSELEFLDLSLN 120
+ LDLS + + L +L L NN S + L+ LE L L
Sbjct: 176 PLLNLSLDLSLNPMNFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLG 235
Query: 121 KFGGVIPRE---LGSLKDLRFFNISNNVL------VGEIPDELKSLEKLEDFQVSSNKLN 171
+F E +L+ L I L + +I D L + F + S +
Sbjct: 236 EFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIE 295
Query: 172 GSIPFWVGNLTNLRVFTAYENQLVGEIPDNLGSVSELELLNLHSNQLEGPIPKSIFASGK 231
F + + L S+ L + S
Sbjct: 296 RVKDF--SYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGG-----NAFSEVDLPS 348
Query: 232 LEVLVLTQNRLT--GDIPELVGHCKSLSNIRIGNNDLVGVIPRAIGNVSGLTYFEADNNN 289
LE L L++N L+ G + SL + + N ++ + + L + + ++N
Sbjct: 349 LEFLDLSRNGLSFKGCCSQSDFGTTSLKYLDLSFNGVIT-MSSNFLGLEQLEHLDFQHSN 407
Query: 290 LSGEIVPE-FSQCSNLTLLNLASNGFTGVIPPELGQLINLQELILYENSLFGEIPKSILA 348
L F NL L+++ L +L+ L + NS I
Sbjct: 408 LKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFT 467
Query: 349 -CKNLNKLDLSNNRFNGTIPNAICDMSRLQYLLLGQNSLKGEIPHEIGNCMKLLQLHIGS 407
+NL LDLS + P A +S LQ L + N+ L L
Sbjct: 468 ELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNFFSLDTFPYKCLNSLQVLDYSL 527
Query: 408 NYLTGSIPPEIGHIRNLQIALNLSFNHLHGSLPPE--LGKLDKLVSFDVSNNQLSGTIPS 465
N++ S E+ H + LNL+ N + + L + V ++ PS
Sbjct: 528 NHIMTSKKQELQHFPSSLAFLNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECATPS 587
Query: 466 ALKGMLSLIEVNFS 479
+GM ++ +N +
Sbjct: 588 DKQGM-PVLSLNIT 600
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 171 bits (436), Expect = 3e-45
Identities = 59/336 (17%), Positives = 106/336 (31%), Gaps = 25/336 (7%)
Query: 166 SSNKLNGSIPFWVGNLTNLRVFTAYENQLVGEIPDNLGSVSELELLNLHSNQLEGPIPKS 225
IP + + N L + S EL++L+L +++ +
Sbjct: 15 MELNFY-KIPD--NLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGA 71
Query: 226 IFASGKLEVLVLTQNRLTGDIPELVGHCKSLSNIRIGNNDLVGVIPRAIGNVSGLTYFEA 285
+ L L+LT N + SL + +L + IG++ L
Sbjct: 72 YQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNV 131
Query: 286 DNNNL-SGEIVPEFSQCSNLTLLNLASNGFTGVIPPELGQLINLQ----ELILYENSLFG 340
+N + S ++ FS +NL L+L+SN + +L L + L L N +
Sbjct: 132 AHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPM-N 190
Query: 341 EIPKSILACKNLNKLDLSNNRFNGTIP-NAICDMSRLQYLLLGQNSLKGEI---PHEIGN 396
I L+KL L NN + + I ++ L+ L + E +
Sbjct: 191 FIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSA 250
Query: 397 CMKLLQLHIGSNYLT------GSIPPEIGHIRNLQIALNLSFNHLHGSLPPELGKLDKLV 450
L L I L I + N+ +L +
Sbjct: 251 LEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSS-FSLVSVTIERVKD--FSYNFGWQ 307
Query: 451 SFDVSNNQLSGTIPSALKGMLSLIEVNFSNNLLTGP 486
++ N + LK + L F++N
Sbjct: 308 HLELVNCKFGQFPTLKLKSLKRL---TFTSNKGGNA 340
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 6e-38
Identities = 46/253 (18%), Positives = 86/253 (33%), Gaps = 8/253 (3%)
Query: 278 SGLTYFEADNNNLSGEIVPEFSQCSNLTLLNLASNGFTGVIPPELGQLINLQELILYENS 337
+ N L F L +L+L+ + L +L LIL N
Sbjct: 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNP 87
Query: 338 LFGEIPKSILACKNLNKLDLSNNRFNGTIPNAICDMSRLQYLLLGQNSLKG-EIPHEIGN 396
+ + +L KL I + L+ L + N ++ ++P N
Sbjct: 88 IQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSN 147
Query: 397 CMKLLQLHIGSNYLTGSIPPEIGHIRNLQIA---LNLSFNHLHGSLPPELGKLDKLVSFD 453
L L + SN + ++ + + + L+LS N ++ + P K +L
Sbjct: 148 LTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNF-IQPGAFKEIRLHKLT 206
Query: 454 VSNNQLSGTIPSALKGMLSLIEVNFSNNLLTGPVPSFVPFQKSPNSSFFGNKGLCGEPLS 513
+ NN S + L+ +EV + L+ G + +K S+ G L E
Sbjct: 207 LRNNFDSLNVMKTCIQGLAGLEV---HRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFR 263
Query: 514 FSCGNANGPDSKN 526
+ + D +
Sbjct: 264 LAYLDYYLDDIID 276
|
| >3fxi_A TLR4, htoll, TOLL-like receptor 4; leucine rich repeat, glycoprotein, immune response, inflamma response, innate immunity, membrane, receptor; HET: PA1 KDO GMH FTT DAO MYR NAG GCS; 3.10A {Homo sapiens} Length = 605 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 1e-35
Identities = 39/273 (14%), Positives = 86/273 (31%), Gaps = 41/273 (15%)
Query: 255 SLSNIRIGNNDLVGVIPRAIGNVSGLTYFEADNNNLSGEIVPEFSQCSNLTLLNLASNGF 314
S N+ + N L + + + L + + + S+L+ L L N
Sbjct: 29 STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPI 88
Query: 315 TGVIPPELGQLINLQELILYENSLFGEIPKSILACKNLNKLDLSNNRFNGT-IPNAICDM 373
+ L +LQ+L+ E +L I K L +L++++N +P ++
Sbjct: 89 QSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNL 148
Query: 374 SRLQYLLLGQNSLKGEIPHEIGNCMKL----LQLHIGSNYLTGSIPPEIGHIRNLQIALN 429
+ L++L L N ++ ++ ++ L L + N + I P L L
Sbjct: 149 TNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNF-IQPGAFKEIRLHK-LT 206
Query: 430 LSFNHLHGSLPPEL----------------------------GKLDKLVSFDVSNNQLS- 460
L N ++ L+ L + + +L+
Sbjct: 207 LRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAY 266
Query: 461 -----GTIPSALKGMLSLIEVNFSNNLLTGPVP 488
I + ++ + + +
Sbjct: 267 LDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKD 299
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 237 bits (607), Expect = 2e-66
Identities = 64/460 (13%), Positives = 143/460 (31%), Gaps = 71/460 (15%)
Query: 70 LSRLQLRGN-ITLVSELKALKRLDLSNNAFSGTIPSAFGNLSELEFLDLSLNKFGGVIPR 128
L + + T + + + ++ NL +L ++L +P
Sbjct: 450 LQIIYFANSPFTYDNIAVDWEDANSDYAKQYENEELSWSNLKDLTDVELYNCPNMTQLPD 509
Query: 129 ELGSLKDLRFFNISNNVLVG---------EIPDELKSLEKLEDFQVSSNKLNG-SIPFWV 178
L L +L+ NI+ N + + D+ + K++ F + N L +
Sbjct: 510 FLYDLPELQSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLEEFPASASL 569
Query: 179 GNLTNLRVFTAYENQLVGEIPDNLGSVSELELLNLHSNQLEGPIPKSIFA-SGKLEVLVL 237
+ L + N++ + G+ +L L L NQ+E IP+ A + ++E L
Sbjct: 570 QKMVKLGLLDCVHNKV--RHLEAFGTNVKLTDLKLDYNQIEE-IPEDFCAFTDQVEGLGF 626
Query: 238 TQNRLTGDIPELV--GHCKSLSNIRIGNNDLVGVIPRAIGNVSGLTYFEADNNNLSGEIV 295
+ N+L IP + + ++ N + ++
Sbjct: 627 SHNKLKY-IPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDY--------------- 670
Query: 296 PEFSQCSNLTLLNLASNGFTGVIPPELGQLINLQELILYENSL-------FGEIPKSILA 348
+ N + + L+ N + +IL N + +
Sbjct: 671 ----KGINASTVTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLKPKDGNYKN 726
Query: 349 CKNLNKLDLSNNRFNGTIPNAI--CDMSRLQYLLLGQNSLKGEIPHEIGNCMKLLQLHIG 406
L +DL N+ ++ + + L + + N P + N +L I
Sbjct: 727 TYLLTTIDLRFNKLT-SLSDDFRATTLPYLSNMDVSYNCFS-SFPTQPLNSSQLKAFGIR 784
Query: 407 SNYLTGSIPPEIGHIRNLQIALNLSFNHLHGSLPPELGKLDKLVSFDVSNNQLSGTIPSA 466
+ N + P + L+ + +N + +
Sbjct: 785 HQ-------------------RDAEGNRILRQWPTGITTCPSLIQLQIGSNDIR-KVDEK 824
Query: 467 LKGMLSLIEVNFSNN-LLTGPVPSFVPFQKSPNSSFFGNK 505
L L ++ ++N ++ V S P+ ++ +K
Sbjct: 825 L--TPQLYILDIADNPNISIDVTSVCPYIEAGMYVLLYDK 862
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 231 bits (591), Expect = 3e-64
Identities = 72/517 (13%), Positives = 148/517 (28%), Gaps = 69/517 (13%)
Query: 23 AQLNDEPTLLAINKELIVPGWGVNG------TNFCNWK-GIDCDL--NQAFVVKLDLSRL 73
+ D L AI + L W + NW + D+ +Q V + R+
Sbjct: 266 EYIKDYKALKAIWEALDGKNWRYYSGTINNTIHSLNWNFNKELDMWGDQPGVDLDNNGRV 325
Query: 74 QLRGNITLVSELKALKRLDLSNNAFSGTIPSAFGNLSELEFLDLSLNKFGGVIPRELGSL 133
L L+ G +P A G L+EL+ L +
Sbjct: 326 T---------------GLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSGRLFGDEE 370
Query: 134 KDLRFFNISNNVLVGEIP----DELKSLEKLEDFQVSSNKLNGSIPFWVGNLTNLRV--F 187
+ + D + L + Q + N+ P + +L+
Sbjct: 371 LTPDMSEERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEMKPIKKDSRISLKDTQI 430
Query: 188 TAYENQLVGEIPDNLGSVSELELLNLHSNQLEGPIPKSIFASGKLEVLVLTQNRLTGDIP 247
N++ I + +++L+++ ++ E + +
Sbjct: 431 GNLTNRI-TFISKAIQRLTKLQIIYFANSPFTYDNIAVD-----WEDANSDYAKQYENEE 484
Query: 248 ELVGHCKSLSNIRIGNNDLVGVIPRAIGNVSGLTYFEADNNNLSG---------EIVPEF 298
+ K L+++ + N + +P + ++ L N + +
Sbjct: 485 LSWSNLKDLTDVELYNCPNMTQLPDFLYDLPELQSLNIACNRGISAAQLKADWTRLADDE 544
Query: 299 SQCSNLTLLNLASNGFTGVIPP-ELGQLINLQELILYENSLFGEIPKSILACKNLNKLDL 357
+ + + N L +++ L L N + ++ L L L
Sbjct: 545 DTGPKIQIFYMGYNNLEEFPASASLQKMVKLGLLDCVHNKV--RHLEAFGTNVKLTDLKL 602
Query: 358 SNNRFNGTIPNAIC-DMSRLQYLLLGQNSLKGEIPH--EIGNCMKLLQLHIGSNYLTGSI 414
N+ IP C +++ L N LK IP+ + + + N + S
Sbjct: 603 DYNQIE-EIPEDFCAFTDQVEGLGFSHNKLK-YIPNIFNAKSVYVMGSVDFSYNKIG-SE 659
Query: 415 PPEIG------HIRNLQIALNLSFNHLHGSLPPELGKLDKLVSFDVSNNQLS-------G 461
I N + LS+N + + + +SNN ++
Sbjct: 660 GRNISCSMDDYKGINAST-VTLSYNEIQKFPTELFATGSPISTIILSNNLMTSIPENSLK 718
Query: 462 TIPSALKGMLSLIEVNFSNNLLTGPVPSFVPFQKSPN 498
K L ++ N LT + P
Sbjct: 719 PKDGNYKNTYLLTTIDLRFNKLTS-LSDDFRATTLPY 754
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 170 bits (432), Expect = 7e-44
Identities = 54/365 (14%), Positives = 117/365 (32%), Gaps = 46/365 (12%)
Query: 66 VKLDLSRLQLRGNITLVSE----------LKALKRLDLSNNAFSGTIPSA-FGNLSELEF 114
L+++ + L ++ ++ + N SA + +L
Sbjct: 518 QSLNIACNRGISAAQLKADWTRLADDEDTGPKIQIFYMGYNNLEEFPASASLQKMVKLGL 577
Query: 115 LDLSLNKFGGVIPRELGSLKDLRFFNISNNVLVGEIPDEL-KSLEKLEDFQVSSNKLNGS 173
LD NK G+ L + N + EIP++ +++E S NKL
Sbjct: 578 LDCVHNKV--RHLEAFGTNVKLTDLKLDYNQIE-EIPEDFCAFTDQVEGLGFSHNKLK-Y 633
Query: 174 IP--FWVGNLTNLRVFTAYENQLVGEIPDNLGSVSE-----LELLNLHSNQLEGPIPKSI 226
IP F ++ + N++ E + S+ + + L N+++ +
Sbjct: 634 IPNIFNAKSVYVMGSVDFSYNKIGSEGRNISCSMDDYKGINASTVTLSYNEIQKFPTELF 693
Query: 227 FASGKLEVLVLTQNRLT-------GDIPELVGHCKSLSNIRIGNNDLVGVIPR-AIGNVS 278
+ ++L+ N +T + L+ I + N L + +
Sbjct: 694 ATGSPISTIILSNNLMTSIPENSLKPKDGNYKNTYLLTTIDLRFNKLTSLSDDFRATTLP 753
Query: 279 GLTYFEADNNNLSGEIVPEFSQCSNLTLLNL------ASNGFTGVIPPELGQLINLQELI 332
L+ + N S + S L + N P + +L +L
Sbjct: 754 YLSNMDVSYNCFS-SFPTQPLNSSQLKAFGIRHQRDAEGNRILRQWPTGITTCPSLIQLQ 812
Query: 333 LYENSLFGEIPKSILACKNLNKLDLSNNRFNGTIPNAICDMSRLQYLLLGQNSLKGEIPH 392
+ N + ++ + + L LD+++N ++C +L +
Sbjct: 813 IGSNDI-RKVDEKLT--PQLYILDIADNPNISIDVTSVCPYIEAGMYVLLYDKT-----Q 864
Query: 393 EIGNC 397
+I C
Sbjct: 865 DIRGC 869
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 64.1 bits (156), Expect = 2e-10
Identities = 27/248 (10%), Positives = 65/248 (26%), Gaps = 32/248 (12%)
Query: 255 SLSNIRIGNNDLVGVIPRAIGNVSGLTYFEADNNNLSGEIVPEFSQCSNLTL-------- 306
+ + + +V G ++ DN VP + + +
Sbjct: 217 QVVAYTTYSQSGIKRSELETQSVRGESFTVIDNKLTKDANVPIQLKETAEYIKDYKALKA 276
Query: 307 ----LNLASNGFTGVIPPELGQLINLQELILYENSLFGEIPKSILACKNLNKLDLSNNRF 362
L+ + + +N + + + + L L+
Sbjct: 277 IWEALDGKNWRYYSGTINNTIHSLNWNFNKEL-DMWGDQPGVDLDNNGRVTGLSLAGFGA 335
Query: 363 NGTIPNAICDMSRLQYLLLGQNSLKGEIPHEIGNCMKLLQLHIGSNYLTGSIPPEIGHIR 422
G +P+AI ++ L+ L G +S G+ +
Sbjct: 336 KGRVPDAIGQLTELKVLSFGTHSETV-SGRLFGDEELTPDM-----------------SE 377
Query: 423 NLQIALNLSFNHLHGSLPPELGKLDKLVSFDVSNNQLSGTIPSALKGMLSLIEVNFSNNL 482
+ + + + + L D L N ++ I + L ++ N
Sbjct: 378 ERKHRIRMHYKKMFLDYDQRLNLSDLLQDAINRNPEM-KPIKKDSRISLKDTQIGNLTNR 436
Query: 483 LTGPVPSF 490
+T +
Sbjct: 437 ITFISKAI 444
|
| >4ecn_A Leucine-rich repeat protein; leucine-rich repeats, DUF4458 domain, protein binding, extra protein, structural genomics; 2.80A {Bacteroides thetaiotaomicron} Length = 876 | Back alignment and structure |
|---|
Score = 44.5 bits (105), Expect = 2e-04
Identities = 11/73 (15%), Positives = 26/73 (35%)
Query: 428 LNLSFNHLHGSLPPELGKLDKLVSFDVSNNQLSGTIPSALKGMLSLIEVNFSNNLLTGPV 487
N + +L ++ ++ G +P A+ + L ++F + T
Sbjct: 304 FNKELDMWGDQPGVDLDNNGRVTGLSLAGFGAKGRVPDAIGQLTELKVLSFGTHSETVSG 363
Query: 488 PSFVPFQKSPNSS 500
F + +P+ S
Sbjct: 364 RLFGDEELTPDMS 376
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 232 bits (594), Expect = 2e-66
Identities = 88/447 (19%), Positives = 146/447 (32%), Gaps = 24/447 (5%)
Query: 70 LSRLQLRGN-ITLVSE-----LKALKRLDLSNNAFSGTIPSAFGNLSELEFLDLSLNKFG 123
L L L N + ++E KALK L S N LE L L N
Sbjct: 83 LDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHIS 142
Query: 124 GVIPRELGSLKDLRFFNISNNVLVGEIPDELKSLEKLE--DFQVSSNKLNGSIPFWVGNL 181
+ + + L+ + NN + +++ SL++ ++ N + I +
Sbjct: 143 SIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDI-AGIEPGAFDS 201
Query: 182 TNLRVFTAYENQLVGEIPDNLG--SVSELELLNLHSNQLEGPIPKSIFASGK---LEVLV 236
+ Q + I L ++ L L E I ++F +E +
Sbjct: 202 AVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDED-ISPAVFEGLCEMSVESIN 260
Query: 237 LTQNRLTGDIPELVGHCKSLSNIRIGNNDLVGVIPRAIGNVSGLTYFEADNNNLSGEIVP 296
L ++ L + + L +P + +S L N
Sbjct: 261 LQKHYFFNISSNTFHCFSGLQELDLTATHLSE-LPSGLVGLSTLKKLVLSANKFENLCQI 319
Query: 297 EFSQCSNLTLLNLASNGFTGVIPPE-LGQLINLQELILYENSL--FGEIPKSILACKNLN 353
S +LT L++ N + L L NL+EL L + + + +L
Sbjct: 320 SASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQ 379
Query: 354 KLDLSNNRFNGTIPNAICDMSRLQYLLLGQNSLKGEIPHEI-GNCMKLLQLHIGSNYLTG 412
L+LS N A + +L+ L L LK + N L L++ + L
Sbjct: 380 SLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDI 439
Query: 413 SIPPEIGHIRNLQIALNLSFNHLHG---SLPPELGKLDKLVSFDVSNNQLSGTIPSALKG 469
S + LQ LNL NH L L +L +S LS A
Sbjct: 440 SSEQLFDGLPALQH-LNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTS 498
Query: 470 MLSLIEVNFSNNLLTGPVPSFVPFQKS 496
+ + V+ S+N LT + K
Sbjct: 499 LKMMNHVDLSHNRLTSSSIEALSHLKG 525
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 221 bits (565), Expect = 2e-62
Identities = 78/431 (18%), Positives = 154/431 (35%), Gaps = 21/431 (4%)
Query: 68 LDLSRLQLR---GNITLVSELKALKRLDLSNNAFSGTIPSAFGNLSELEFLDLSLNKFGG 124
+ L L G + + + L+ S N + F L L FLDL+ +
Sbjct: 17 YNCENLGLNEIPGTL-----PNSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYW 71
Query: 125 VIPRELGSLKDLRFFNISNNVLVGEIPDELKSLEKLEDFQVSSNKLNGSIPFWVGNLTNL 184
+ S L ++ N L+ L + L+ ++ + N L
Sbjct: 72 IHEDTFQSQHRLDTLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTL 131
Query: 185 RVFTAYENQLVGEIPDNLGSVSELELLNLHSNQLEGPIPKSIFASGKLEVLVL--TQNRL 242
N + +L++L+ +N + + + + + L L N +
Sbjct: 132 ESLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDI 191
Query: 243 TGDIPELVGHCKSLSNIRIGNNDLVGVIPRAIGN--VSGLTYFEADNNNLSGEIVPEFSQ 300
G I ++ G + VI + + N + L ++ + F
Sbjct: 192 AG-IEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEG 250
Query: 301 CSNLTL--LNLASNGFTGVIPPELGQLINLQELILYENSLFGEIPKSILACKNLNKLDLS 358
+++ +NL + F + LQEL L L E+P ++ L KL LS
Sbjct: 251 LCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHL-SELPSGLVGLSTLKKLVLS 309
Query: 359 NNRFNGTIPNAICDMSRLQYLLLGQNSLKGEI-PHEIGNCMKLLQLHIGSNYLTGS--IP 415
N+F + + L +L + N+ + E+ + N L +L + + + S
Sbjct: 310 ANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCN 369
Query: 416 PEIGHIRNLQIALNLSFNHLHGSLPPELGKLDKLVSFDVSNNQLSGTIP-SALKGMLSLI 474
++ ++ +LQ LNLS+N + +L D++ +L S + + L
Sbjct: 370 LQLRNLSHLQS-LNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLK 428
Query: 475 EVNFSNNLLTG 485
+N S++LL
Sbjct: 429 VLNLSHSLLDI 439
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 215 bits (549), Expect = 3e-60
Identities = 78/432 (18%), Positives = 147/432 (34%), Gaps = 16/432 (3%)
Query: 67 KLDLSRLQLRG-NITLVSELKALKRLDLSNNAFSGTIPSAFGNLSELEFLDLSLNK-FGG 124
L L + + + LK LD NNA +L + L L+LN
Sbjct: 133 SLYLGSNHISSIKLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDIA 192
Query: 125 VIPRELGSLKDLRFFNISNNVLVGEIPDELK--SLEKLEDFQVSSNKLNGSIP--FWVGN 180
I + N + I LK +++ L P F
Sbjct: 193 GIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLC 252
Query: 181 LTNLRVFTAYENQLVGEIPDNLGSVSELELLNLHSNQLEGPIPKSIFASGKLEVLVLTQN 240
++ ++ + S L+ L+L + L +P + L+ LVL+ N
Sbjct: 253 EMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLSE-LPSGLVGLSTLKKLVLSAN 311
Query: 241 RLTGDIPELVGHCKSLSNIRIGNNDLVGVI-PRAIGNVSGLTYFEADNNNL--SGEIVPE 297
+ + SL+++ I N + + N+ L + ++++ S +
Sbjct: 312 KFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQ 371
Query: 298 FSQCSNLTLLNLASNGFTGVIPPELGQLINLQELILYENSLFGEIPKSILA-CKNLNKLD 356
S+L LNL+ N + + L+ L L L + +S L L+
Sbjct: 372 LRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLN 431
Query: 357 LSNNRFNGTIPNAICDMSRLQYLLLGQNSLKGEIPHEIG---NCMKLLQLHIGSNYLTGS 413
LS++ + + + LQ+L L N + +L L + L+
Sbjct: 432 LSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSI 491
Query: 414 IPPEIGHIRNLQIALNLSFNHLHGSLPPELGKLDKLVSFDVSNNQLSGTIPSALKGMLSL 473
++ + ++LS N L S L L + ++++N +S +PS L +
Sbjct: 492 DQHAFTSLKMMNH-VDLSHNRLTSSSIEALSHLKGIY-LNLASNHISIILPSLLPILSQQ 549
Query: 474 IEVNFSNNLLTG 485
+N N L
Sbjct: 550 RTINLRQNPLDC 561
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 191 bits (487), Expect = 6e-52
Identities = 66/438 (15%), Positives = 142/438 (32%), Gaps = 25/438 (5%)
Query: 59 DLNQAFVVKLDLSRLQLRGNITLVSELKALKRLDLSNNAFSGTIPSAFGN--LSELEFLD 116
L QA + L+L+ + G + + L+ I N + L
Sbjct: 175 SLQQATNLSLNLNGNDIAGIEPGAFDSAVFQSLNFGGTQNLLVIFKGLKNSTIQSLWLGT 234
Query: 117 LSLNKFGGVIPRELGSLKD--LRFFNISNNVLVGEIPDELKSLEKLEDFQVSSNKLNGSI 174
+ P L + + N+ + + L++ +++ L+ +
Sbjct: 235 FEDMDDEDISPAVFEGLCEMSVESINLQKHYFFNISSNTFHCFSGLQELDLTATHLS-EL 293
Query: 175 PFWVGNLTNLRVFTAYENQLVGEIPDNLGSVSELELLNLHSNQLEGPIPKSIFAS-GKLE 233
P + L+ L+ N+ + + L L++ N + + L
Sbjct: 294 PSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSIKGNTKRLELGTGCLENLENLR 353
Query: 234 VLVLTQNRLT--GDIPELVGHCKSLSNIRIGNNDLVGVIPRAIGNVSGLTYFEADNNNLS 291
L L+ + + + + L ++ + N+ + + A L + L
Sbjct: 354 ELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLKTEAFKECPQLELLDLAFTRLK 413
Query: 292 GEIVPE-FSQCSNLTLLNLASNGFTGVIPPELGQLINLQELILYENSLFGEIPKSILA-- 348
+ F L +LNL+ + L LQ L L N + +
Sbjct: 414 VKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQHLNLQGNHFPKGNIQKTNSLQ 473
Query: 349 -CKNLNKLDLSNNRFNGTIPNAICDMSRLQYLLLGQNSLKGEIPHEIGNCMKLLQLHIGS 407
L L LS + +A + + ++ L N L + + +K + L++ S
Sbjct: 474 TLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRLTSSSIEALSH-LKGIYLNLAS 532
Query: 408 NYLTGSIPPEIGHIRNLQIALNLSFNHLHGSLPPELGKLDKLVSFDVSNNQLSGTI---- 463
N+++ +P + + + +NL N L + + + +L T
Sbjct: 533 NHISIILPSLLPILSQQRT-INLRQNPLDCT--CSNIYFLEWY--KENMQKLEDTEDTLC 587
Query: 464 --PSALKGMLSLIEVNFS 479
P L+G + L +V S
Sbjct: 588 ENPPLLRG-VRLSDVTLS 604
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 191 bits (487), Expect = 6e-52
Identities = 78/412 (18%), Positives = 149/412 (36%), Gaps = 22/412 (5%)
Query: 67 KLDLSRLQLR----GNITLVSELKALKRLDLSNNAFSGTIPSAFGNLSELEFLDLSLNKF 122
LD + +++ + + L L+L+ N + I + + + L+ +
Sbjct: 157 VLDFQNNAIHYLSKEDMSSLQQATNLS-LNLNGNDIA-GIEPGAFDSAVFQSLNFGGTQN 214
Query: 123 GGVIPRELG-----SLKDLRFFNISNNVLVGEIPDELKSLEKLEDFQVSSNKLNGSIPFW 177
VI + L SL F ++ + + + + L + +E + +
Sbjct: 215 LLVIFKGLKNSTIQSLWLGTFEDMDDEDISPAVFEGLCEM-SVESINLQKHYFFNISSNT 273
Query: 178 VGNLTNLRVFTAYENQLVGEIPDNLGSVSELELLNLHSNQLEGPIPKSIFASGKLEVLVL 237
+ L+ L E+P L +S L+ L L +N+ E S L L +
Sbjct: 274 FHCFSGLQELDLTATHL-SELPSGLVGLSTLKKLVLSANKFENLCQISASNFPSLTHLSI 332
Query: 238 TQNRLTGDI-PELVGHCKSLSNIRIGNNDL--VGVIPRAIGNVSGLTYFEADNNNLSGEI 294
N ++ + + ++L + + ++D+ + N+S L N
Sbjct: 333 KGNTKRLELGTGCLENLENLRELDLSHDDIETSDCCNLQLRNLSHLQSLNLSYNEPLSLK 392
Query: 295 VPEFSQCSNLTLLNLASNGFTGVIPPE-LGQLINLQELILYENSLFGEIPKSILACKNLN 353
F +C L LL+LA L L+ L L + L + L
Sbjct: 393 TEAFKECPQLELLDLAFTRLKVKDAQSPFQNLHLLKVLNLSHSLLDISSEQLFDGLPALQ 452
Query: 354 KLDLSNNRFNGTI---PNAICDMSRLQYLLLGQNSLKGEIPHEIGNCMKLLQLHIGSNYL 410
L+L N F N++ + RL+ L+L L H + + + + N L
Sbjct: 453 HLNLQGNHFPKGNIQKTNSLQTLGRLEILVLSFCDLSSIDQHAFTSLKMMNHVDLSHNRL 512
Query: 411 TGSIPPEIGHIRNLQIALNLSFNHLHGSLPPELGKLDKLVSFDVSNNQLSGT 462
T S + H++ + LNL+ NH+ LP L L + + ++ N L T
Sbjct: 513 TSSSIEALSHLKGIY--LNLASNHISIILPSLLPILSQQRTINLRQNPLDCT 562
|
| >3t6q_A CD180 antigen; protein-protein complex, leucine rich repeat, MD-2 related L recognition, receptor, innate immunity, glycosylation, IMMU; HET: NAG BMA MAN; 1.90A {Mus musculus} PDB: 3b2d_A* 3rg1_A* Length = 606 | Back alignment and structure |
|---|
Score = 130 bits (330), Expect = 1e-31
Identities = 45/234 (19%), Positives = 75/234 (32%), Gaps = 8/234 (3%)
Query: 270 IPRAIGNVSGLTYFEADNNNLSGEIVPEFSQCSNLTLLNLASNGFTGVIPPELGQLINLQ 329
IP + + E N L FS+ NLT L+L + L
Sbjct: 27 IPGTLP--NSTECLEFSFNVLPTIQNTTFSRLINLTFLDLTRCQIYWIHEDTFQSQHRLD 84
Query: 330 ELILYENSLFGEIPKSILACKNLNKLDLSNNRFNGTIPNAICDMSRLQYLLLGQNSLKGE 389
L+L N L ++ K L L + + + L+ L LG N +
Sbjct: 85 TLVLTANPLIFMAETALSGPKALKHLFFIQTGISSIDFIPLHNQKTLESLYLGSNHISSI 144
Query: 390 IPHEIGNCMKLLQLHIGSNYLTGSIPPEIGHIRNLQ-IALNLSFNHLHGSLPPELGKLDK 448
+ KL L +N + ++ ++ ++LNL+ N + + P
Sbjct: 145 KLPKGFPTEKLKVLDFQNNAIHYLSKEDMSSLQQATNLSLNLNGNDI-AGIEPGAFDSAV 203
Query: 449 LVSFDVSNNQLSGTIPSALKG--MLSLIEVNFSNNLLTGPVPSFVPFQKSPNSS 500
S + Q I LK + SL F + P+ F+ S
Sbjct: 204 FQSLNFGGTQNLLVIFKGLKNSTIQSLWLGTFEDMDDEDISPA--VFEGLCEMS 255
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 219 bits (560), Expect = 9e-65
Identities = 96/317 (30%), Positives = 146/317 (46%), Gaps = 12/317 (3%)
Query: 575 SGASSQPSIIAGNVLVENLRQAIDLDAVVKATMK--DSNMIYCGTFSTVYKAVMPSGLIL 632
+S ++ + LV + L + +AT +I G F VYK V+ G +
Sbjct: 7 KATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDGAKV 66
Query: 633 SVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVALLLHNYLPNGTLA 692
++KR + E+E LS H +LV IGF + +L++ Y+ NG L
Sbjct: 67 ALKRRTPESS---QGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLK 123
Query: 693 QLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGE 752
+ L+ S P W RL I IG A GL +LH AIIH D+ S N+LLD +F P + +
Sbjct: 124 RHLYGSDL-PTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINILLDENFVPKITD 182
Query: 753 IEISKLLDPSKGTASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVE 812
ISK T + V G+ GYI PEY ++T +VYS+GVVL E+L R +
Sbjct: 183 FGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIV 242
Query: 813 EDFGEG-VDLVKWVHGAPARGETPEQILDARL-STVSFGWRKEMLTALKVALLCTDSTPA 870
+ V+L +W + G+ EQI+D L + + + A+ C +
Sbjct: 243 QSLPREMVNLAEWAVESHNNGQL-EQIVDPNLADKIRP---ESLRKFGDTAVKCLALSSE 298
Query: 871 KRPKMKKVVEMLQEIKQ 887
RP M V+ L+ +
Sbjct: 299 DRPSMGDVLWKLEYALR 315
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 218 bits (559), Expect = 1e-64
Identities = 83/284 (29%), Positives = 131/284 (46%), Gaps = 11/284 (3%)
Query: 604 KATMKDSNMIYCGTFSTVYKAVMPSGLILSVKRLKSMDRTIIHHQNK-MIRELEKLSKLC 662
+ N + G F VYK + ++VK+L +M + +E++ ++K
Sbjct: 30 RPISVGGNKMGEGGFGVVYKGYVN-NTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQ 88
Query: 663 HDNLVRPIGFVIYEDVALLLHNYLPNGTLAQLLHESTKQPDYRP-DWPTRLSIAIGVAEG 721
H+NLV +GF D L++ Y+PNG+L L P P W R IA G A G
Sbjct: 89 HENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTP---PLSWHMRCKIAQGAANG 145
Query: 722 LAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSKGTASISAVAGSFGYIPPE 781
+ FLH IH DI S N+LLD F + + +++ + T S + G+ Y+ PE
Sbjct: 146 INFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPE 205
Query: 782 YAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQILDA 841
++T ++YS+GVVLLEI+T V+E L+ +T E +D
Sbjct: 206 A-LRGEITPKSDIYSFGVVLLEIITGLPAVDEHREP-QLLLDIKEEIEDEEKTIEDYIDK 263
Query: 842 RLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEMLQEI 885
+++ + VA C KRP +KKV ++LQE+
Sbjct: 264 KMNDAD---STSVEAMYSVASQCLHEKKNKRPDIKKVQQLLQEM 304
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 207 bits (530), Expect = 7e-59
Identities = 90/431 (20%), Positives = 169/431 (39%), Gaps = 33/431 (7%)
Query: 56 IDCDLNQAFVVKLDLSRLQLRGNITLVSELKALKRLDLSNNAFSGTIPSAFGNLSELEFL 115
I D A +K L + + ++ ++L + L L+ L +
Sbjct: 17 IFTDTALAEKMKTVLGKTNVTDTVSQ-TDLDQVTTLQADRL--GIKSIDGVEYLNNLTQI 73
Query: 116 DLSLNKFGGVIPRELGSLKDLRFFNISNNVLVGEIPDELKSLEKLEDFQVSSNKLNGSIP 175
+ S N+ + P L +L L ++NN + P L +L L + +N++ P
Sbjct: 74 NFSNNQLTDITP--LKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFNNQITDIDP 129
Query: 176 FWVGNLTNLRVFTAYENQLVGEIPDNLGSVSELELLNLHSNQLEGPIPKSIFASGKLEVL 235
NLTNL N + L ++ L+ L+ NQ+ P + LE L
Sbjct: 130 L--KNLTNLNRLELSSNTISD--ISALSGLTSLQQLSF-GNQVTDLKP--LANLTTLERL 182
Query: 236 VLTQNRLTGDIPELVGHCKSLSNIRIGNNDLVGVIPRAIGNVSGLTYFEADNNNLSGEIV 295
++ N+++ DI L +L ++ NN + + P +G ++ L + N L +
Sbjct: 183 DISSNKVS-DISVL-AKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKD--I 236
Query: 296 PEFSQCSNLTLLNLASNGFTGVIPPELGQLINLQELILYENSLFGEIPKSILACKNLNKL 355
+ +NLT L+LA+N + + P L L L EL L N + P + L L
Sbjct: 237 GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALTNL 292
Query: 356 DLSNNRFNGTIPNAICDMSRLQYLLLGQNSLKGEIPHEIGNCMKLLQLHIGSNYLTGSIP 415
+L+ N+ P I ++ L YL L N++ P + + KL +L +N ++
Sbjct: 293 ELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFYNNKVSD--V 346
Query: 416 PEIGHIRNLQIALNLSFNHLHGSLPPELGKLDKLVSFDVSNNQLSGTIPSALKGMLSLIE 475
+ ++ N+ L+ N + L L ++ +++ + + +
Sbjct: 347 SSLANLTNINW-LSAGHNQISD--LTPLANLTRITQLGLNDQAWTNAPVNYKANVSIPNT 403
Query: 476 VNFSNNLLTGP 486
V L P
Sbjct: 404 VKNVTGALIAP 414
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 196 bits (500), Expect = 9e-55
Identities = 96/430 (22%), Positives = 165/430 (38%), Gaps = 34/430 (7%)
Query: 78 NITLVSELKALKRLDLSNNAFSGTIPSAFGNLSELEFLDLSLNKFGGVIPRELGSLKDLR 137
I + L + L + T+ +L ++ L + L +L
Sbjct: 16 QIFTDTALAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIK--SIDGVEYLNNLT 71
Query: 138 FFNISNNVLVGEIPDELKSLEKLEDFQVSSNKLNGSIPFWVGNLTNLRVFTAYENQLVGE 197
N SNN L P LK+L KL D +++N++ P NLTNL T + NQ+
Sbjct: 72 QINFSNNQLTDITP--LKNLTKLVDILMNNNQIADITPL--ANLTNLTGLTLFNNQITD- 126
Query: 198 IPDNLGSVSELELLNLHSNQLEGPIPKSIFASGKLEVLVLTQNRLTGDIPELVGHCKSLS 257
D L +++ L L L SN + + L+ L N++T P + + +L
Sbjct: 127 -IDPLKNLTNLNRLELSSNTISDISA--LSGLTSLQQLSF-GNQVTDLKP--LANLTTLE 180
Query: 258 NIRIGNNDLVGVIPRAIGNVSGLTYFEADNNNLSGEIVPEFSQCSNLTLLNLASNGFTGV 317
+ I +N + + + ++ L A NN +S + +NL L+L N +
Sbjct: 181 RLDISSNKVSDISV--LAKLTNLESLIATNNQISD--ITPLGILTNLDELSLNGNQLKDI 236
Query: 318 IPPELGQLINLQELILYENSLFGEIPKSILACKNLNKLDLSNNRFNGTIPNAICDMSRLQ 377
L L NL +L L N + P + L +L L N+ + P + ++ L
Sbjct: 237 --GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISP--LAGLTALT 290
Query: 378 YLLLGQNSLKGEIPHEIGNCMKLLQLHIGSNYLTGSIPPEIGHIRNLQIALNLSFNHLHG 437
L L +N L+ P I N L L + N ++ P + + LQ L N +
Sbjct: 291 NLELNENQLEDISP--ISNLKNLTYLTLYFNNISDISP--VSSLTKLQR-LFFYNNKV-- 343
Query: 438 SLPPELGKLDKLVSFDVSNNQLSGTIPSALKGMLSLIEVNFSNNLLTGPVPSFVPFQKSP 497
S L L + +NQ+S P L + + ++ ++ T ++ P
Sbjct: 344 SDVSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQAWTNAPVNYKANVSIP 401
Query: 498 NSSFFGNKGL 507
N+ L
Sbjct: 402 NTVKNVTGAL 411
|
| >1o6v_A Internalin A; bacterial infection, extracellular recognition, cell WALL attached, leucine rich repeat; 1.5A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 1o6s_A* 1o6t_A 2omz_A 2omy_A 2omw_A 2omv_A 2omt_A 2omx_A 2omu_A Length = 466 | Back alignment and structure |
|---|
Score = 183 bits (467), Expect = 2e-50
Identities = 93/403 (23%), Positives = 161/403 (39%), Gaps = 30/403 (7%)
Query: 67 KLDLSRLQLRGNITLVSELKALKRLDLSNNAFSGTIPSAFGNLSELEFLDLSLNKFGGVI 126
+ ++ Q+ +IT ++ L L L L NN + P NL+ L L+LS N +
Sbjct: 94 DILMNNNQIA-DITPLANLTNLTGLTLFNNQITDIDP--LKNLTNLNRLELSSNTISDIS 150
Query: 127 PRELGSLKDLRFFNISNNVLVGEIPDELKSLEKLEDFQVSSNKLNGSIPFWVGNLTNLRV 186
L L L+ + N V L +L LE +SSNK++ LTNL
Sbjct: 151 A--LSGLTSLQQLSFGNQVTD---LKPLANLTTLERLDISSNKVSDISVL--AKLTNLES 203
Query: 187 FTAYENQLVGEIPDNLGSVSELELLNLHSNQLEGPIPKSIFASGKLEVLVLTQNRLTGDI 246
A NQ+ P LG ++ L+ L+L+ NQL+ ++ + L L L N+++ ++
Sbjct: 204 LIATNNQISDITP--LGILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQIS-NL 258
Query: 247 PELVGHCKSLSNIRIGNNDLVGVIPRAIGNVSGLTYFEADNNNLSGEIVPEFSQCSNLTL 306
L L+ +++G N + + P + ++ LT E + N L + S NLT
Sbjct: 259 APL-SGLTKLTELKLGANQISNISP--LAGLTALTNLELNENQLED--ISPISNLKNLTY 313
Query: 307 LNLASNGFTGVIPPELGQLINLQELILYENSLFGEIPKSILACKNLNKLDLSNNRFNGTI 366
L L N + + P + L LQ L Y N + S+ N+N L +N+ +
Sbjct: 314 LTLYFNNISDISP--VSSLTKLQRLFFYNNKV--SDVSSLANLTNINWLSAGHNQISDLT 369
Query: 367 PNAICDMSRLQYLLLGQNSLKGEIPHEIGNCMKLLQLHIGSNYLTGSIPPEIGHIRNLQI 426
P + +++R+ L L + P + + P I +
Sbjct: 370 P--LANLTRITQLGLNDQAWTN-APVNYKANVSIPNTVKNVTGAL-IAPATISDGGSYT- 424
Query: 427 ALNLSFNHLHGSLPPELGKLDKLVSFDVSNNQLSGTIPSALKG 469
++++N + V+ SGT+ LK
Sbjct: 425 EPDITWNLPS-YTNEVSYTFSQPVTIGKGTTTFSGTVTQPLKA 466
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 204 bits (522), Expect = 1e-56
Identities = 86/467 (18%), Positives = 159/467 (34%), Gaps = 57/467 (12%)
Query: 66 VKLDLSRLQLRGNITLVSEL-KALKRLDLSNNAFSGTIPSAFGNLSELEFLDLSLNKFGG 124
+ +L + ++ + K +DLS N +F N SEL++LDLS +
Sbjct: 14 ITYQCMDQKLS---KVPDDIPSSTKNIDLSFNPLKILKSYSFSNFSELQWLDLSRCEIET 70
Query: 125 VIPRELGSLKDLRFFNISNNVLVGEIPDELKSLEKLEDFQVSSNKLNGSIPFWVGNLTNL 184
+ + L L ++ N + P L LE+ KL F +G L L
Sbjct: 71 IEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITL 130
Query: 185 RVFTAYENQLVG-EIPDNLGSVSELELLNLHSNQLEGP---------------------- 221
+ N + ++P +++ L ++L N ++
Sbjct: 131 KKLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSL 190
Query: 222 -----IPKSIFASGKLEVLVLTQNRLTGDIPELVGHCKSLSNIRI---------GNNDLV 267
I F KL L L N + +I + ++L+ + + +L
Sbjct: 191 NPIDFIQDQAFQGIKLHELTLRGNFNSSNIMKTC--LQNLAGLHVHRLILGEFKDERNLE 248
Query: 268 GVIPRAIGNVSGLTYFEAD--NNNLSGEIVPEFSQCSNLTLLNLASNGFTGVIPPELGQL 325
P + + +T E N + + +F +N++ ++LA + ++ +
Sbjct: 249 IFEPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKYL--EDVPKH 306
Query: 326 INLQELILYENSLFGEIPKSILACKNLNKLDLSNNRFNGTIPNAICDMSRLQYLLLGQNS 385
Q L + L + P L L L L+ N+ G+I + L YL L +N+
Sbjct: 307 FKWQSLSIIRCQL-KQFPTLDL--PFLKSLTLTMNK--GSISFKKVALPSLSYLDLSRNA 361
Query: 386 LK--GEIPHEIGNCMKLLQLHIGSNYLTGSIPPEIGHIRNLQIALNLSFNHLHGSLPPE- 442
L G + L L + N + + LQ L+ + L
Sbjct: 362 LSFSGCCSYSDLGTNSLRHLDLSFNGAI-IMSANFMGLEELQH-LDFQHSTLKRVTEFSA 419
Query: 443 LGKLDKLVSFDVSNNQLSGTIPSALKGMLSLIEVNFSNNLLTGPVPS 489
L+KL+ D+S G+ SL + + N S
Sbjct: 420 FLSLEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLS 466
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 200 bits (510), Expect = 6e-55
Identities = 86/445 (19%), Positives = 139/445 (31%), Gaps = 34/445 (7%)
Query: 70 LSRLQLRGN-ITLVSE-----LKALKRLDLSNNAFSGTIPSAFGNLSELEFLDLSLNKFG 123
LS L L GN I S L +L+ L + G L L+ L+++ N
Sbjct: 82 LSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLASLESFPIGQLITLKKLNVAHNFIH 141
Query: 124 GV-IPRELGSLKDLRFFNISNNVLVGEIPDELKSLEKLEDFQV----SSNKLNGSIPFWV 178
+P +L +L ++S N + ++L+ L + + S N ++ I
Sbjct: 142 SCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLNPID-FIQDQA 200
Query: 179 GNLTNLRVFTAYENQLVGEIPDN-LGSVSELELLNLHSNQLEGPIPKSIFASGKLEVLV- 236
L T N I L +++ L + L + + IF +E L
Sbjct: 201 FQGIKLHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIFEPSIMEGLCD 260
Query: 237 -------LTQNRLTGDIPELVGHCKSLSNIRIGNNDLVGVIPRAIGNVSGLTYFEADNNN 289
LT D ++S + + + +
Sbjct: 261 VTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKYLEDVP--KHFKWQSLSIIRCQ 318
Query: 290 LSGEIVPEFSQCSNLTLLNLASNGFTGVIPPELGQLINLQELILYENSL--FGEIPKSIL 347
L L L L N + I + L +L L L N+L G S L
Sbjct: 319 LKQ---FPTLDLPFLKSLTLTMNKGS--ISFKKVALPSLSYLDLSRNALSFSGCCSYSDL 373
Query: 348 ACKNLNKLDLSNNRFNGTIPNAICDMSRLQYLLLGQNSLKGEIPHE-IGNCMKLLQLHIG 406
+L LDLS N + + LQ+L ++LK + KLL L I
Sbjct: 374 GTNSLRHLDLSFNGAI-IMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYLDIS 432
Query: 407 SNYLTGSIPPEIGHIRNLQIALNLSFNHLHGSLPPE-LGKLDKLVSFDVSNNQLSGTIPS 465
+ +L L ++ N + L D+S QL
Sbjct: 433 YTNTKIDFDGIFLGLTSLNT-LKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQISWG 491
Query: 466 ALKGMLSLIEVNFSNNLLTGPVPSF 490
+ L +N S+N L S
Sbjct: 492 VFDTLHRLQLLNMSHNNLLFLDSSH 516
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 189 bits (482), Expect = 3e-51
Identities = 80/437 (18%), Positives = 142/437 (32%), Gaps = 29/437 (6%)
Query: 67 KLDLSRLQLRG--NITLVSELKALKRLDLSNNAFSGTIPSAFGNLSELEF----LDLSLN 120
KL+++ + S L L +DLS N + L E LD+SLN
Sbjct: 132 KLNVAHNFIHSCKLPAYFSNLTNLVHVDLSYNYIQTITVNDLQFLRENPQVNLSLDMSLN 191
Query: 121 KFGGVIPRELGSLKDLRFFNISNNVLVGEIPDE-------LKSLEKLEDFQVSSNKLNGS 173
+ + +K L + N I L + L
Sbjct: 192 PIDFIQDQAFQGIK-LHELTLRGNFNSSNIMKTCLQNLAGLHVHRLILGEFKDERNLEIF 250
Query: 174 IPFWVGNLTNLRVFTAY--ENQLVGEIPDNLGSVSELELLNLHSNQLEGPIPKSIFASGK 231
P + L ++ + + ++ + ++L ++ + + K
Sbjct: 251 EPSIMEGLCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKYL--EDVPKHFK 308
Query: 232 LEVLVLTQNRLTGDIPELVGHCKSLSNIRIGNNDLVGVIPRAIGNVSGLTYFEADNNNLS 291
+ L + + +L P L L ++ + N I + L+Y + N LS
Sbjct: 309 WQSLSIIRCQLK-QFPTL--DLPFLKSLTLTMNKGS--ISFKKVALPSLSYLDLSRNALS 363
Query: 292 --GEIVPEFSQCSNLTLLNLASNGFTGVIPPELGQLINLQELILYENSLFGEIPKSILA- 348
G ++L L+L+ NG ++ L LQ L ++L S
Sbjct: 364 FSGCCSYSDLGTNSLRHLDLSFNGAI-IMSANFMGLEELQHLDFQHSTLKRVTEFSAFLS 422
Query: 349 CKNLNKLDLSNNRFNGTIPNAICDMSRLQYLLLGQNSLKGEIPHEI-GNCMKLLQLHIGS 407
+ L LD+S ++ L L + NS K + N L L +
Sbjct: 423 LEKLLYLDISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSK 482
Query: 408 NYLTGSIPPEIGHIRNLQIALNLSFNHLHGSLPPELGKLDKLVSFDVSNNQLSGTIPSAL 467
L + LQ+ LN+S N+L +L L + D S N++ +
Sbjct: 483 CQLEQISWGVFDTLHRLQL-LNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQ 541
Query: 468 KGMLSLIEVNFSNNLLT 484
SL N +NN +
Sbjct: 542 HFPKSLAFFNLTNNSVA 558
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 4e-38
Identities = 59/330 (17%), Positives = 108/330 (32%), Gaps = 18/330 (5%)
Query: 60 LNQAFVVKLDLSRLQLRG-NITLVSELKALKRLDLSNNAFSGTIPSAFGNLSELEFLDLS 118
L + + L+ +I L + + L+ + + + L +
Sbjct: 258 LCDVTIDEFRLTYTNDFSDDIVKFHCLANVSAMSLAGVSIKYLEDVPK--HFKWQSLSII 315
Query: 119 LNKFGGVIPRELGSLKDLRFFNISNNVLVGEIPDELKSLEKLEDFQVSSNKLN--GSIPF 176
+ +L LK L ++ N I + +L L +S N L+ G +
Sbjct: 316 RCQLKQFPTLDLPFLKSL---TLTMNKG--SISFKKVALPSLSYLDLSRNALSFSGCCSY 370
Query: 177 WVGNLTNLRVFTAYENQLVGEIPDNLGSVSELELLNLHSNQLEGPIPKSIFAS-GKLEVL 235
+LR N + + N + EL+ L+ + L+ S F S KL L
Sbjct: 371 SDLGTNSLRHLDLSFNGAI-IMSANFMGLEELQHLDFQHSTLKRVTEFSAFLSLEKLLYL 429
Query: 236 VLTQNRLTGDIPELVGHCKSLSNIRIGNNDLVGVIPR-AIGNVSGLTYFEADNNNLSGEI 294
++ D + SL+ +++ N N + LT+ + L
Sbjct: 430 DISYTNTKIDFDGIFLGLTSLNTLKMAGNSFKDNTLSNVFANTTNLTFLDLSKCQLEQIS 489
Query: 295 VPEFSQCSNLTLLNLASNGFTGVIPPELGQLINLQELILYENSLFGEIPKSILACKNLNK 354
F L LLN++ N + QL +L L N + K+L
Sbjct: 490 WGVFDTLHRLQLLNMSHNNLLFLDSSHYNQLYSLSTLDCSFNRIETSKGILQHFPKSLAF 549
Query: 355 LDLSNNRFNGTIPNAICDMSRLQYLLLGQN 384
+L+NN IC+ + + Q
Sbjct: 550 FNLTNNSV-----ACICEHQKFLQWVKEQK 574
|
| >3vq2_A TLR4, TOLL-like receptor 4; leucine rich repeat MD-2 related lipid recognition, receptor immunity, lipid binding, glycosylation, secreted, immune SY; HET: NAG LP4 LP5 DAO MYR; 2.48A {Mus musculus} PDB: 3vq1_A* 2z64_A* Length = 606 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 2e-29
Identities = 45/227 (19%), Positives = 90/227 (39%), Gaps = 11/227 (4%)
Query: 268 GVIPRAIGNVSGLTYFEADNNNLSGEIVPEFSQCSNLTLLNLASNGFTGVIPPELGQLIN 327
G + I V +TY + LS ++ + S+ ++L+ N +
Sbjct: 2 GSLNPCIEVVPNITYQ-CMDQKLS-KVPDDIP--SSTKNIDLSFNPLKILKSYSFSNFSE 57
Query: 328 LQELILYENSLFGEIPKSILACKNLNKLDLSNNRFNGTIPNAICDMSRLQYLLLGQNSLK 387
LQ L L + K+ +L+ L L+ N P + ++ L+ L+ + L
Sbjct: 58 LQWLDLSRCEIETIEDKAWHGLHHLSNLILTGNPIQSFSPGSFSGLTSLENLVAVETKLA 117
Query: 388 GEIPHEIGNCMKLLQLHIGSNYLTG-SIPPEIGHIRNLQIALNLSFNHLHGSLPPELGKL 446
IG + L +L++ N++ +P ++ NL ++LS+N++ +L L
Sbjct: 118 SLESFPIGQLITLKKLNVAHNFIHSCKLPAYFSNLTNLVH-VDLSYNYIQTITVNDLQFL 176
Query: 447 ----DKLVSFDVSNNQLSGTIPSALKGMLSLIEVNFSNNLLTGPVPS 489
+S D+S N + A +G + L E+ N + +
Sbjct: 177 RENPQVNLSLDMSLNPIDFIQDQAFQG-IKLHELTLRGNFNSSNIMK 222
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 182 bits (464), Expect = 3e-51
Identities = 70/369 (18%), Positives = 148/369 (40%), Gaps = 27/369 (7%)
Query: 67 KLDLSRLQLRGNITLVSELKALKRLDLSNNAFSGTIPSAFGNLSELEFLDLSLNKFGGVI 126
L + I ++L R L + + + L + L ++ K +
Sbjct: 4 TLATLPAPI-NQIFPDADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKVASIQ 60
Query: 127 PRELGSLKDLRFFNISNNVLVGEIPDELKSLEKLEDFQVSSNKLNGSIPFWVGNLTNLRV 186
+ L +L + N++ N + P L +L KL + + +NK+ NLTNLR
Sbjct: 61 G--IEYLTNLEYLNLNGNQITDISP--LSNLVKLTNLYIGTNKITDISAL--QNLTNLRE 114
Query: 187 FTAYENQLVGEIPDNLGSVSELELLNLHSNQLEGPIPKSIFASGKLEVLVLTQNRLTGDI 246
E+ + L +++++ LNL +N + L L +T++++ D+
Sbjct: 115 LYLNEDNISD--ISPLANLTKMYSLNLGANHNLS-DLSPLSNMTGLNYLTVTESKVK-DV 170
Query: 247 PELVGHCKSLSNIRIGNNDLVGVIPRAIGNVSGLTYFEADNNNLSGEIVPEFSQCSNLTL 306
+ + L ++ + N + + P + +++ L YF A N ++ + + + L
Sbjct: 171 TPI-ANLTDLYSLSLNYNQIEDISP--LASLTSLHYFTAYVNQITD--ITPVANMTRLNS 225
Query: 307 LNLASNGFTGVIPPELGQLINLQELILYENSLFGEIPKSILACKNLNKLDLSNNRFNGTI 366
L + +N T + P L L L L + N + ++ L L++ +N+ +
Sbjct: 226 LKIGNNKITDLSP--LANLSQLTWLEIGTNQI--SDINAVKDLTKLKMLNVGSNQI--SD 279
Query: 367 PNAICDMSRLQYLLLGQNSLKGEIPHEIGNCMKLLQLHIGSNYLTGSIPPEIGHIRNLQI 426
+ + ++S+L L L N L E IG L L + N++T P + + +
Sbjct: 280 ISVLNNLSQLNSLFLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDS 337
Query: 427 ALNLSFNHL 435
+ + +
Sbjct: 338 -ADFANQVI 345
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 180 bits (460), Expect = 1e-50
Identities = 74/397 (18%), Positives = 143/397 (36%), Gaps = 52/397 (13%)
Query: 88 LKRLDLSNNAFSGTIPSAFGNLSELEFLDLSLNKFGGVIPRELGSLKDLRFFNISNNVLV 147
L + P +L+E L V+ L+ + ++ +
Sbjct: 2 AATLATLPAPINQIFP--DADLAEGIRAVLQKASVTDVVT--QEELESITKLVVAGEKV- 56
Query: 148 GEIPDELKSLEKLEDFQVSSNKLNGSIPFWVGNLTNLRVFTAYENQLVGEIPDNLGSVSE 207
++ L LE ++ N++ P NL L N++ L +++
Sbjct: 57 -ASIQGIEYLTNLEYLNLNGNQITDISPL--SNLVKLTNLYIGTNKI--TDISALQNLTN 111
Query: 208 LELLNLHSNQLEGPIPKSIFASGKLEVLVLTQNRLTGDIPELVGHCKSLSNIRIGNNDLV 267
L L L+ + + P + K+ L L N D+ L
Sbjct: 112 LRELYLNEDNISDISPLANLT--KMYSLNLGANHNLSDLSPL------------------ 151
Query: 268 GVIPRAIGNVSGLTYFEADNNNLSGEIVPEFSQCSNLTLLNLASNGFTGVIPPELGQLIN 327
N++GL Y + + V + ++L L+L N + P L L +
Sbjct: 152 -------SNMTGLNYLTVTESKVKD--VTPIANLTDLYSLSLNYNQIEDISP--LASLTS 200
Query: 328 LQELILYENSLFGEIPKSILACKNLNKLDLSNNRFNGTIPNAICDMSRLQYLLLGQNSLK 387
L Y N + P + LN L + NN+ P + ++S+L +L +G N +
Sbjct: 201 LHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITDLSP--LANLSQLTWLEIGTNQIS 256
Query: 388 GEIPHEIGNCMKLLQLHIGSNYLTGSIPPEIGHIRNLQIALNLSFNHLHGSLPPELGKLD 447
+ + + KL L++GSN ++ + ++ L L L+ N L +G L
Sbjct: 257 D--INAVKDLTKLKMLNVGSNQISD--ISVLNNLSQLNS-LFLNNNQLGNEDMEVIGGLT 311
Query: 448 KLVSFDVSNNQLSGTIPSALKGMLSLIEVNFSNNLLT 484
L + +S N ++ P L + + +F+N ++
Sbjct: 312 NLTTLFLSQNHITDIRP--LASLSKMDSADFANQVIK 346
|
| >4fmz_A Internalin; leucine rich repeat, structural genomic center for structural genomics, JCSG, protein structure INI PSI-biology; HET: MSE; 1.91A {Listeria monocytogenes serotype 4B} Length = 347 | Back alignment and structure |
|---|
Score = 179 bits (456), Expect = 5e-50
Identities = 71/356 (19%), Positives = 140/356 (39%), Gaps = 24/356 (6%)
Query: 56 IDCDLNQAFVVKLDLSRLQLRGNITLVSELKALKRLDLSNNAFSGTIPSAFGNLSELEFL 115
I D + A ++ L + + +T EL+++ +L ++ L+ LE+L
Sbjct: 15 IFPDADLAEGIRAVLQKASVTDVVTQ-EELESITKLVVAGEKV--ASIQGIEYLTNLEYL 71
Query: 116 DLSLNKFGGVIPRELGSLKDLRFFNISNNVLVGEIPDELKSLEKLEDFQVSSNKLNGSIP 175
+L+ N+ + P L +L L I N + L++L L + ++ + ++ P
Sbjct: 72 NLNGNQITDISP--LSNLVKLTNLYIGTNKI--TDISALQNLTNLRELYLNEDNISDISP 127
Query: 176 FWVGNLTNLRVFTAYENQLVGEIPDNLGSVSELELLNLHSNQLEGPIPKSIFASGKLEVL 235
NLT + N + L +++ L L + ++++ P I L L
Sbjct: 128 L--ANLTKMYSLNLGANHNLS-DLSPLSNMTGLNYLTVTESKVKDVTP--IANLTDLYSL 182
Query: 236 VLTQNRLTGDIPELVGHCKSLSNIRIGNNDLVGVIPRAIGNVSGLTYFEADNNNLSGEIV 295
L N++ DI L SL N + + P + N++ L + NN ++ +
Sbjct: 183 SLNYNQIE-DISPL-ASLTSLHYFTAYVNQITDITP--VANMTRLNSLKIGNNKITD--L 236
Query: 296 PEFSQCSNLTLLNLASNGFTGVIPPELGQLINLQELILYENSLFGEIPKSILACKNLNKL 355
+ S LT L + +N + + + L L+ L + N + + LN L
Sbjct: 237 SPLANLSQLTWLEIGTNQISDI--NAVKDLTKLKMLNVGSNQI--SDISVLNNLSQLNSL 292
Query: 356 DLSNNRFNGTIPNAICDMSRLQYLLLGQNSLKGEIPHEIGNCMKLLQLHIGSNYLT 411
L+NN+ I ++ L L L QN + P + + K+ + +
Sbjct: 293 FLNNNQLGNEDMEVIGGLTNLTTLFLSQNHITDIRP--LASLSKMDSADFANQVIK 346
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 177 bits (450), Expect = 3e-48
Identities = 93/433 (21%), Positives = 169/433 (39%), Gaps = 69/433 (15%)
Query: 67 KLDLSRLQLRGNITLVSELKALKRLDLSNNAFSGTIPSAFGNLSELEFLDLSLNKFGGVI 126
+L+L+ L L +L L+ L S N+ + +P +L L + +L +
Sbjct: 75 ELELNNLGLS---SLPELPPHLESLVASCNSLT-ELPELPQSLKSLLVDNNNLKALSDLP 130
Query: 127 PRELGSLKDLRFFNISNNVLVGEIPDELKSLEKLEDFQVSSNKLNGSIPFWVGNLTNLRV 186
P L+ L +SNN L ++P EL++ L+ V +N L +P +L +
Sbjct: 131 P----LLEYL---GVSNNQLE-KLP-ELQNSSFLKIIDVDNNSLK-KLPDLPPSLEFIAA 180
Query: 187 FTAYENQLVGEIPDNLGSVSELELLNLHSNQLEGPIPKSIFASGKLEVLVLTQNRLTGDI 246
NQL E+P+ L ++ L + +N L+ +P LE +V N L ++
Sbjct: 181 ---GNNQLE-ELPE-LQNLPFLTAIYADNNSLKK-LPDLP---LSLESIVAGNNILE-EL 230
Query: 247 PELVGHCKSLSNIRIGNNDLVGVIPRAIGNVSGLTYFEADNNNLSGEIVPEFSQCSNLTL 306
PEL + L+ I NN L +P + L +N L+ ++ + L +
Sbjct: 231 PEL-QNLPFLTTIYADNNLLK-TLPDLPPS---LEALNVRDNYLT-DLPELPQSLTFLDV 284
Query: 307 LNLASNGFTGVIPPELGQLINLQELILYENSLFGEIPKSILACKNLNKLDLSNNRFNGTI 366
+G + + P NL L N + + +L +L++SNN+ +
Sbjct: 285 SENIFSGLSELPP-------NLYYLNASSNEI-RSLCDLP---PSLEELNVSNNKLI-EL 332
Query: 367 PNAICDMSRLQYLLLGQNSLKGEIPHEIGNCMKLLQLHIGSNYLTGSIPPEIGHIRNLQI 426
P RL+ L+ N L E+P N L QLH+ N L P + +L++
Sbjct: 333 PALPP---RLERLIASFNHLA-EVPELPQN---LKQLHVEYNPLR-EFPDIPESVEDLRM 384
Query: 427 ---------------ALNLSFNHLHGSLPPELGKLDKLVSFDVSNNQLSGTIPSALKGML 471
L++ N L P ++ L +++ ++ A +
Sbjct: 385 NSHLAEVPELPQNLKQLHVETNPLR-EFPDIPESVEDL---RMNSERVVDPYEFAHETTD 440
Query: 472 SLIEVNFSNNLLT 484
L + F ++
Sbjct: 441 KLEDDVFEHHHHH 453
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 171 bits (436), Expect = 2e-46
Identities = 81/417 (19%), Positives = 154/417 (36%), Gaps = 71/417 (17%)
Query: 84 ELKALKRLDLSNNAFSGTIPSAFGNLSELEFLDLSLNKFGGVIPRELGSLKDLRFFNISN 143
L+ ++ + +P N+ + +++ P G +++ + +
Sbjct: 9 SNTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRD 67
Query: 144 NVLVGEIPDELKSLEKLEDFQVSSNKLNGSIPFWVGNLTNLRVFTAYENQLVGEIPDNLG 203
+ + +LE +++ L+ S+P +L +L N L E+P+
Sbjct: 68 CL--------DRQAHELE---LNNLGLS-SLPELPPHLESLVA---SCNSLT-ELPELPQ 111
Query: 204 SVSELELLNLHSNQLEGPIPKSIFASGKLEVLVLTQNRLTGDIPELVGHCKSLSNIRIGN 263
S+ L + N + L P LE L ++ N+L +PEL + L I + N
Sbjct: 112 SLKSLLVDNNNLKALSDLPP-------LLEYLGVSNNQLE-KLPEL-QNSSFLKIIDVDN 162
Query: 264 NDLVGVIPRAIGNVSGLTYFEADNNNLSGEIVPEFSQCSNLTLLNLASNGFTGVIPPELG 323
N L +P + L + A NN L E +PE LT + +N +P
Sbjct: 163 NSLK-KLPDLPPS---LEFIAAGNNQL--EELPELQNLPFLTAIYADNNSLK-KLPDLPL 215
Query: 324 QLINLQELILYENSLFGEIPKSILACKNLNKLDLSNNRFNGTIPNAICDMSRLQYLLLGQ 383
+L+ ++ N L E + L + NN T+P+ L+ L +
Sbjct: 216 ---SLESIVAGNNIL--EELPELQNLPFLTTIYADNNLLK-TLPDLPPS---LEALNVRD 266
Query: 384 NSLKGEIPHEIGNCMKLLQLHIGSNYLTGSIPPEIGHIRNLQIA---------------- 427
N L ++P + L L + N + + ++ L +
Sbjct: 267 NYLT-DLPELPQS---LTFLDVSENIFS-GLSELPPNLYYLNASSNEIRSLCDLPPSLEE 321
Query: 428 LNLSFNHLHGSLPPELGKLDKLVSFDVSNNQLSGTIPSALKGMLSLIEVNFSNNLLT 484
LN+S N L LP +L++L S N L+ +P + +L +++ N L
Sbjct: 322 LNVSNNKLI-ELPALPPRLERL---IASFNHLA-EVPELPQ---NLKQLHVEYNPLR 370
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 166 bits (422), Expect = 2e-44
Identities = 92/418 (22%), Positives = 159/418 (38%), Gaps = 65/418 (15%)
Query: 82 VSELKALKRLDLSNNAFSGTIPSAFGNLSE-------------LEFLDLSLNKFGGVIPR 128
+K+ + + + P G E L+L+ +P
Sbjct: 30 AENVKSKTEYYNAWSEWERNAPPGNGEQREMAVSRLRDCLDRQAHELELNNLGL-SSLPE 88
Query: 129 ELGSLKDLRFFNISNNVLVGEIPDELKSLEKLEDFQVSSNKLNGSIPFWVGNLTNLRVFT 188
L+ L S N L E+P+ +SL+ L + L+ P L L V
Sbjct: 89 LPPHLESL---VASCNSLT-ELPELPQSLKSLLVDNNNLKALSDLPP----LLEYLGV-- 138
Query: 189 AYENQLVGEIPDNLGSVSELELLNLHSNQLEGPIPKSIFASGKLEVLVLTQNRLTGDIPE 248
NQL ++P+ L + S L+++++ +N L+ +P LE + N+L ++PE
Sbjct: 139 -SNNQLE-KLPE-LQNSSFLKIIDVDNNSLKK-LPDLP---PSLEFIAAGNNQLE-ELPE 190
Query: 249 LVGHCKSLSNIRIGNNDLVGVIPRAIGNVSGLTYFEADNNNLSGEIVPEFSQCSNLTLLN 308
L + L+ I NN L +P + L A NN L +PE LT +
Sbjct: 191 L-QNLPFLTAIYADNNSLK-KLPDLPLS---LESIVAGNNILE--ELPELQNLPFLTTIY 243
Query: 309 LASNGFTGVIPPELGQLINLQELILYENSLFGEIPKSILACKNLNKLDLSNNRFNGTIPN 368
+N +P +L+ L + +N L ++P+ ++L LD+S N F+ +
Sbjct: 244 ADNNLLK-TLPDLPP---SLEALNVRDNYL-TDLPELP---QSLTFLDVSENIFS-GLSE 294
Query: 369 AICDMSRLQYLLLGQNSLKGEIPHEIGNCMKLLQLHIGSNYLTGSIPPEIGHIRNLQIAL 428
L YL N ++ + + L +L++ +N L +P L+ L
Sbjct: 295 LP---PNLYYLNASSNEIR-SLCDLPPS---LEELNVSNNKLI-ELPALPP---RLER-L 342
Query: 429 NLSFNHLHGSLPPELGKLDKLVSFDVSNNQLSGTIPSALKGMLSLIEVNFSNNLLTGP 486
SFNHL +P L +L V N L P + + L + + P
Sbjct: 343 IASFNHLA-EVPELPQNLKQL---HVEYNPLR-EFPDIPESVEDLRMNSHLAEVPELP 395
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 92.8 bits (231), Expect = 6e-20
Identities = 40/195 (20%), Positives = 61/195 (31%), Gaps = 39/195 (20%)
Query: 318 IPPELGQLINLQELILYENSLFGEIPKSILACKNLNKLDLSNNRFNGTIPNAI------- 370
I P LQE + + ++L E+P K+ + + + + P
Sbjct: 3 INPRNVSNTFLQEPLRHSSNL-TEMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMA 61
Query: 371 ------CDMSRLQYLLLGQNSLKGEIPHEIGNCMKLLQLHIGSNYLTGSIPPEIGHIRNL 424
C + L L L +P + L L N LT +P +++L
Sbjct: 62 VSRLRDCLDRQAHELELNNLGLS-SLPELPPH---LESLVASCNSLT-ELPELPQSLKSL 116
Query: 425 QIALNLSFNHLHGSLP---------------PELGKLDKLVSFDVSNNQLSGTIPSALKG 469
+ N + L P PEL L DV NN L +P
Sbjct: 117 LV-DNNNLKALSDLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLK-KLPDLPP- 173
Query: 470 MLSLIEVNFSNNLLT 484
SL + NN L
Sbjct: 174 --SLEFIAAGNNQLE 186
|
| >1jl5_A Outer protein YOPM; leucine-rich repeat, molecular pathogenesis, effector protein, virulence factor, toxin; 2.10A {Yersinia pestis} SCOP: c.10.2.6 PDB: 1g9u_A Length = 454 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 1e-12
Identities = 30/136 (22%), Positives = 50/136 (36%), Gaps = 18/136 (13%)
Query: 366 IPNAICDMSRLQYLLLGQNSLKGEIPHEIGNCMKLLQLHIGSNYLTGSIPPEIGHIRNLQ 425
I + LQ L ++L E+P E N + + + + PP G R +
Sbjct: 3 INPRNVSNTFLQEPLRHSSNLT-EMPVEAENVKSKTEYYNAWSEWERNAPPGNGEQREMA 61
Query: 426 IA------------LNLSFNHLHGSLPPELGKLDKLVSFDVSNNQLSGTIPSALKGMLSL 473
++ L L+ L SLP L+ L S N L+ +P + + SL
Sbjct: 62 VSRLRDCLDRQAHELELNNLGLS-SLPELPPHLESL---VASCNSLT-ELPELPQSLKSL 116
Query: 474 IEVNFSNNLLTGPVPS 489
+ N + L+ P
Sbjct: 117 LVDNNNLKALSDLPPL 132
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 179 bits (456), Expect = 4e-48
Identities = 86/457 (18%), Positives = 158/457 (34%), Gaps = 41/457 (8%)
Query: 69 DLSRLQLRGN-ITLVSE-----LKALKRLDLSNNAFSGTIPSAFGNLSELEFLDLSLNKF 122
L L N + + L+ LDLS A+ +LS L L L+ N
Sbjct: 29 STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPI 88
Query: 123 GGVIPRELGSLKDLRFFNISNNVLVGEIPDELKSLEKLEDFQVSSNKLN-GSIPFWVGNL 181
+ L L+ L + L+ L++ V+ N + +P + NL
Sbjct: 89 QSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNL 148
Query: 182 TNLRVFTAYENQLVGEIPDNLGSVSELEL----LNLHSNQLEGPIPKSIFASGKLEVLVL 237
TNL N++ +L + ++ L L+L N + I F +L L L
Sbjct: 149 TNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMNF-IQPGAFKEIRLHKLTL 207
Query: 238 TQNRLTGDIPELVGHCKSLSNIRI---------GNNDLVGVIPRAIGNVSGLTYFEADNN 288
N + ++ + + L+ + + +L A+ + LT E
Sbjct: 208 RNNFDSLNVMK--TCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLA 265
Query: 289 NLSG---EIVPEFSQCSNLTLLNLASNGFTGVIPPELGQLINLQELILYENSLFGEIPKS 345
L +I+ F+ +N++ +L S V + Q L L + P
Sbjct: 266 YLDYYLDDIIDLFNCLTNVSSFSLVSVTIERV--KDFSYNFGWQHLELVNCKFG-QFPTL 322
Query: 346 ILACKNLNKLDLSNNRFNGTIPNAICDMSRLQYLLLGQNSL--KGEIPHEIGNCMKLLQL 403
L K+L +L ++N+ D+ L++L L +N L KG L L
Sbjct: 323 KL--KSLKRLTFTSNKGGNAFSEV--DLPSLEFLDLSRNGLSFKGCCSQSDFGTTSLKYL 378
Query: 404 HIGSNYLTGSIPPEIGHIRNLQIALNLSFNHLHGSLPPE--LGKLDKLVSFDVSNNQLSG 461
+ N + ++ + L+ L+ ++L + L L+ D+S+
Sbjct: 379 DLSFNGVI-TMSSNFLGLEQLEH-LDFQHSNLK-QMSEFSVFLSLRNLIYLDISHTHTRV 435
Query: 462 TIPSALKGMLSLIEVNFSNNLLTGPVPSFVPFQKSPN 498
G+ SL + + N + F + N
Sbjct: 436 AFNGIFNGLSSLEVLKMAGNSFQENFLPDI-FTELRN 471
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 176 bits (448), Expect = 5e-47
Identities = 86/459 (18%), Positives = 155/459 (33%), Gaps = 55/459 (11%)
Query: 70 LSRLQLRGN-ITLVSE-----LKALKRLDLSNNAFSGTIPSAFGNLSELEFLDLSLNKFG 123
LS L L GN I ++ L +L++L + G+L L+ L+++ N
Sbjct: 78 LSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQ 137
Query: 124 GV-IPRELGSLKDLRFFNISNNVLVGEIPDELKSLEKLEDFQV----SSNKLNGSIPFWV 178
+P +L +L ++S+N + +L+ L ++ + S N +N I
Sbjct: 138 SFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGA 196
Query: 179 GNLTNLRVFTAYENQLVGEIPDN-LGSVSELELLNLHSNQLEG-----PIPKSIFASGKL 232
L T N + + ++ LE+ L + KS L
Sbjct: 197 FKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEG--L 254
Query: 233 EVLVLTQNRLTG------DIPELVGHCKSLSNIRIGNNDLVGVIPRAIGNVSGLTYFEAD 286
L + + RL DI +L ++S+ + + + V + G + E
Sbjct: 255 CNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFS--YNFGWQHLELV 312
Query: 287 NNNL-------------------SGEIVPEFSQCSNLTLLNLASNGFT--GVIPPELGQL 325
N G +L L+L+ NG + G
Sbjct: 313 NCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLSRNGLSFKGCCSQSDFGT 372
Query: 326 INLQELILYENSLFGEIPKSILACKNLNKLDLSNNRFNGTIP-NAICDMSRLQYLLLGQN 384
+L+ L L N + + + L + L LD ++ + + L YL +
Sbjct: 373 TSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHT 431
Query: 385 SLKGEIPHEIGNCMKLLQLHIGSNYLTGSIPPEI-GHIRNLQIALNLSFNHLHGSLPPE- 442
+ L L + N + P+I +RNL L+LS L L P
Sbjct: 432 HTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTF-LDLSQCQLE-QLSPTA 489
Query: 443 LGKLDKLVSFDVSNNQLSGTIPSALKGMLSLIEVNFSNN 481
L L ++++NQL + SL ++ N
Sbjct: 490 FNSLSSLQVLNMASNQLKSVPDGIFDRLTSLQKIWLHTN 528
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 173 bits (440), Expect = 5e-46
Identities = 95/455 (20%), Positives = 171/455 (37%), Gaps = 42/455 (9%)
Query: 68 LDLSRLQLRG-NITLVSELKALKRLDLSNNAFSGTIPSAFGNLSELEFLDLSLNKFGGVI 126
LDLSR +++ L L L L+ N AF LS L+ L +
Sbjct: 57 LDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLE 116
Query: 127 PRELGSLKDLRFFNISNNVL-VGEIPDELKSLEKLEDFQVSSNKLNGSIPFWVGNLTNLR 185
+G LK L+ N+++N++ ++P+ +L LE +SSNK+ + L +
Sbjct: 117 NFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMP 176
Query: 186 VFTAY----ENQLVGEIPDNLGSVSELELLNLHSNQLEGPIPKSIF---ASGKLEVLVLT 238
+ N + I L L L +N + K+ A ++ LVL
Sbjct: 177 LLNLSLDLSLNPM-NFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLG 235
Query: 239 QNRLTGDIPEL-VGHCKSLSNIRIGNNDLVGV------IPRAIGNVSGLTYFEADNNNLS 291
+ R G++ + + L N+ I L + I ++ ++ F + +
Sbjct: 236 EFRNEGNLEKFDKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIE 295
Query: 292 G-EIVPEFSQCSNLTLLNLASNGFTGVIPPEL----------------GQLINLQELILY 334
+ +L L+N F + L L +L+ L L
Sbjct: 296 RVKDFSYNFGWQHLELVNCKFGQFPTLKLKSLKRLTFTSNKGGNAFSEVDLPSLEFLDLS 355
Query: 335 ENSL--FGEIPKSILACKNLNKLDLSNNRFNGTIPNAICDMSRLQYLLLGQNSLKGEIPH 392
N L G +S +L LDLS N T+ + + +L++L ++LK
Sbjct: 356 RNGLSFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEF 414
Query: 393 EI-GNCMKLLQLHIGSNYLTGSIPPEI-GHIRNLQIALNLSFNHLHGSLPPE-LGKLDKL 449
+ + L+ L I + I + +L++ L ++ N + P+ +L L
Sbjct: 415 SVFLSLRNLIYLDISHTHTR-VAFNGIFNGLSSLEV-LKMAGNSFQENFLPDIFTELRNL 472
Query: 450 VSFDVSNNQLSGTIPSALKGMLSLIEVNFSNNLLT 484
D+S QL P+A + SL +N ++N L
Sbjct: 473 TFLDLSQCQLEQLSPTAFNSLSSLQVLNMASNQLK 507
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 1e-34
Identities = 85/423 (20%), Positives = 148/423 (34%), Gaps = 34/423 (8%)
Query: 67 KLDLS--RLQLRGNITLVSELKALKRLDLSNNAFSGTIPSAFGNLSELEF----LDLSLN 120
+L+++ +Q S L L+ LDLS+N + L ++ LDLSLN
Sbjct: 128 ELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLN 187
Query: 121 KFGGVIPRELGSLKDLRFFNISNNVLVGEIP----DELKSLEKLE---DFQVSSNKLNGS 173
I L + NN + L LE + L
Sbjct: 188 PMNF-IQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKF 246
Query: 174 IPFWVGNLTNLRVFTAYENQL---VGEIPDNLGSVSELELLNLHSNQLEGPIPKSIFASG 230
+ L NL + L + +I D ++ + +L S +E + + G
Sbjct: 247 DKSALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIER-VKDFSYNFG 305
Query: 231 KLEVLVLTQNRLTGDIPELVGHCKSLSNIRIGNNDLVGVIPRAIGNVSGLTYFEADNNNL 290
+ L L + P L KSL + +N + ++ L + + N L
Sbjct: 306 -WQHLELVNCKFG-QFPTL--KLKSLKRLTFTSNKGGNAF--SEVDLPSLEFLDLSRNGL 359
Query: 291 S--GEIVPEFSQCSNLTLLNLASNGFTGVIPPELGQLINLQELILYENSLFGEIPKSILA 348
S G ++L L+L+ NG + L L+ L ++L S+
Sbjct: 360 SFKGCCSQSDFGTTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFL 418
Query: 349 -CKNLNKLDLSNNRFNGTIPNAICDMSRLQYLLLGQNSLKGEIPHEIGNCMKLLQ-LHIG 406
+NL LD+S+ +S L+ L + NS + +I ++ L L +
Sbjct: 419 SLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLS 478
Query: 407 SNYLTGSIPPEI-GHIRNLQIALNLSFNHLHGSLPPE-LGKLDKLVSFDVSNNQLSGTIP 464
L + P + +LQ+ LN++ N L S+P +L L + N + P
Sbjct: 479 QCQLE-QLSPTAFNSLSSLQV-LNMASNQLK-SVPDGIFDRLTSLQKIWLHTNPWDCSCP 535
Query: 465 SAL 467
Sbjct: 536 RID 538
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 3e-28
Identities = 65/344 (18%), Positives = 113/344 (32%), Gaps = 24/344 (6%)
Query: 166 SSNKLNGSIPFWVGNL-TNLRVFTAYENQLVGEIPDNLGSVSELELLNLHSNQLEGPIPK 224
IP NL + + N L + S EL++L+L +++ I
Sbjct: 15 MELNFY-KIP---DNLPFSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQT-IED 69
Query: 225 SIFAS-GKLEVLVLTQNRLTGDIPELVGHCKSLSNIRIGNNDLVGVIPRAIGNVSGLTYF 283
+ S L L+LT N + SL + +L + IG++ L
Sbjct: 70 GAYQSLSHLSTLILTGNPIQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKEL 129
Query: 284 EADNNNL-SGEIVPEFSQCSNLTLLNLASNGFTGVIPPELGQLINLQ----ELILYENSL 338
+N + S ++ FS +NL L+L+SN + +L L + L L N +
Sbjct: 130 NVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPM 189
Query: 339 FGEIPKSILACKNLNKLDLSNNRFNGTIP-NAICDMSRLQYLLL------GQNSLKGEIP 391
I L+KL L NN + + I ++ L+ L + +L+
Sbjct: 190 -NFIQPGAFKEIRLHKLTLRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDK 248
Query: 392 HEIGNCMKLLQLHIGSNYLTGSIPPEIGHIRNLQIALNLSFNHLHGSLPPELGKLDKLVS 451
+ L YL + I L + S + +
Sbjct: 249 SALEGLCNLTIEEFRLAYLDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFGWQH 308
Query: 452 FDVSNNQLSGTIPSALKGMLSLIEVNFSNNLLTGPVPSFVPFQK 495
++ N + LK SL + F++N S V
Sbjct: 309 LELVNCKFGQFPTLKLK---SLKRLTFTSNKGGN-AFSEVDLPS 348
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 2e-24
Identities = 46/253 (18%), Positives = 86/253 (33%), Gaps = 8/253 (3%)
Query: 278 SGLTYFEADNNNLSGEIVPEFSQCSNLTLLNLASNGFTGVIPPELGQLINLQELILYENS 337
+ N L F L +L+L+ + L +L LIL N
Sbjct: 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNP 87
Query: 338 LFGEIPKSILACKNLNKLDLSNNRFNGTIPNAICDMSRLQYLLLGQNSLK-GEIPHEIGN 396
+ + +L KL I + L+ L + N ++ ++P N
Sbjct: 88 IQSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSN 147
Query: 397 CMKLLQLHIGSNYLTGSIPPEIGHIRNLQIA---LNLSFNHLHGSLPPELGKLDKLVSFD 453
L L + SN + ++ + + + L+LS N ++ + P K +L
Sbjct: 148 LTNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLHKLT 206
Query: 454 VSNNQLSGTIPSALKGMLSLIEVNFSNNLLTGPVPSFVPFQKSPNSSFFGNKGLCGEPLS 513
+ NN S + L+ +EV + L+ G + +K S+ G L E
Sbjct: 207 LRNNFDSLNVMKTCIQGLAGLEV---HRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFR 263
Query: 514 FSCGNANGPDSKN 526
+ + D +
Sbjct: 264 LAYLDYYLDDIID 276
|
| >2z63_A TOLL-like receptor 4, variable lymphocyte recepto; TLR4, MD-2, LPS, immune system; HET: NAG FUL; 2.00A {Homo sapiens} Length = 570 | Back alignment and structure |
|---|
Score = 100 bits (251), Expect = 4e-22
Identities = 48/279 (17%), Positives = 95/279 (34%), Gaps = 18/279 (6%)
Query: 255 SLSNIRIGNNDLVGVIPRAIGNVSGLTYFEADNNNLSGEIVPEFSQCSNLTLLNLASNGF 314
S N+ + N L + + + L + + + S+L+ L L N
Sbjct: 29 STKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPI 88
Query: 315 TGVIPPELGQLINLQELILYENSLFGEIPKSILACKNLNKLDLSNNRFN-GTIPNAICDM 373
+ L +LQ+L+ E +L I K L +L++++N +P ++
Sbjct: 89 QSLALGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNL 148
Query: 374 SRLQYLLLGQNSLKGEIPHEIGNCMKL----LQLHIGSNYLTGSIPPEIGHIRNLQIALN 429
+ L++L L N ++ ++ ++ L L + N + I P L L
Sbjct: 149 TNLEHLDLSSNKIQSIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLHK-LT 206
Query: 430 LSFNHLHGSLPPE-------LGKLDKLVSFDVSNNQLSGTIPSALKGMLSLIEVNFSNNL 482
L N ++ L ++ + L SAL+G+ +L F
Sbjct: 207 LRNNFDSLNVMKTCIQGLAGLEVHRLVLGEFRNEGNLEKFDKSALEGLCNLTIEEFRLAY 266
Query: 483 L----TGPVPSFVPFQKSPNSSFFGNKGLCGEPLSFSCG 517
L + F + S + S++ G
Sbjct: 267 LDYYLDDIIDLFNCLTNVSSFSLVSVTIERVKDFSYNFG 305
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 176 bits (448), Expect = 1e-47
Identities = 68/389 (17%), Positives = 127/389 (32%), Gaps = 23/389 (5%)
Query: 102 IPSAFGNLSELEFLDLSLNKFGGVIPRELGSLKDLRFFNISNNVLVGEIPDELKSLEKLE 161
I N + + ++ + + S +++ ++S N L +L KLE
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 162 DFQVSSNKLNGSIPFWVGNLTNLRVFTAYENQLVGEIPDNLGSVSELELLNLHSNQLEGP 221
+SSN L ++ +L+ LR N + L +E L+ +N +
Sbjct: 62 LLNLSSNVLYETLDL--ESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNISR- 113
Query: 222 IPKSIFASGKLEVLVLTQNRLTGDIPELVGHCKSLSNIRIGNNDLVGVIPRA-IGNVSGL 280
+ S + + L N++T G + + + N++ V + L
Sbjct: 114 VSCSRGQG--KKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTL 171
Query: 281 TYFEADNNNLSGEIVPEFSQCSNLTLLNLASNGFTGVIPPELGQLINLQELILYENSLFG 340
+ N + V + L L+L+SN + PE + + L N L
Sbjct: 172 EHLNLQYNFIY--DVKGQVVFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKL-V 227
Query: 341 EIPKSILACKNLNKLDLSNNRFN-GTIPNAICDMSRLQYLLLGQNSLKGEIPHEIGNCMK 399
I K++ +NL DL N F+ GT+ + R+Q + ++K C
Sbjct: 228 LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAK--QTVKKLTGQNEEECTV 285
Query: 400 LLQLHIGSNYLTGSIPPEIGHIRNLQIA----LNLSFNHLHGSLPPELGKLDKLVSFDVS 455
H G+ P + L+ L+ + L E + D
Sbjct: 286 PTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSGQGSET-ERLECERENQARQREIDAL 344
Query: 456 NNQLSGTIPSALKGMLSLIEVNFSNNLLT 484
Q I + I + L
Sbjct: 345 KEQYRTVIDQVTLRKQAKITLEQKKKALD 373
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 136 bits (343), Expect = 6e-34
Identities = 47/295 (15%), Positives = 100/295 (33%), Gaps = 18/295 (6%)
Query: 198 IPDNLGSVSELELLNLHSNQLEGPIPKSIFAS-GKLEVLVLTQNRLTGDIPELVGHCKSL 256
I + + + ++ + + L+ S+ S ++ L L+ N L+ + L
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQ-ALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKL 60
Query: 257 SNIRIGNNDLVGVIPRAIGNVSGLTYFEADNNNLSGEIVPEFSQCSNLTLLNLASNGFTG 316
+ + +N L + + ++S L + +NN + E ++ L+ A+N +
Sbjct: 61 ELLNLSSNVLYETLD--LESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNIS- 112
Query: 317 VIPPELGQLINLQELILYENSLFGEIPKSILACKNLNKLDLSNNRFNG-TIPNAICDMSR 375
+ GQ + + L N + + LDL N +
Sbjct: 113 RVSCSRGQ--GKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDT 170
Query: 376 LQYLLLGQNSLKGEIPHEIGNCMKLLQLHIGSNYLTGSIPPEIGHIRNLQIALNLSFNHL 435
L++L L N + ++ ++ KL L + SN L + PE + ++L N L
Sbjct: 171 LEHLNLQYNFIY-DVKGQV-VFAKLKTLDLSSNKLA-FMGPEFQSAAGVTW-ISLRNNKL 226
Query: 436 HGSLPPELGKLDKLVSFDVSNNQLSGTIPSALKGMLSLIEVNFSNNLLTGPVPSF 490
+ L L FD+ N ++ + +
Sbjct: 227 V-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVKKLTGQNE 280
|
| >3oja_A Leucine-rich immune molecule 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 487 | Back alignment and structure |
|---|
Score = 85.3 bits (211), Expect = 2e-17
Identities = 44/343 (12%), Positives = 98/343 (28%), Gaps = 37/343 (10%)
Query: 66 VKLDLSRLQLRG--NITLVSELKALKRLDLSNNAFSGTIPSAFGNLSELEFLDLSLNKFG 123
LDL ++ L + L+ L+L N ++L+ LDLS NK
Sbjct: 147 QYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNFIYDVKGQVV--FAKLKTLDLSSNKLA 204
Query: 124 GVIPRELGSLKDLRFFNISNNVLVGEIPDELKSLEKLEDFQVSSNKLN-GSIPFWVGNLT 182
+ E S + + ++ NN LV I L+ + LE F + N + G++ +
Sbjct: 205 -FMGPEFQSAAGVTWISLRNNKLV-LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQ 262
Query: 183 NLRVFTAYENQLVGEIPDNLGSVSELELLNLHSNQLE----------------------- 219
++ + + N + L + + E
Sbjct: 263 RVQTVA--KQTVKKLTGQNEEECTVPTLGHYGAYCCEDLPAPFADRLIALKRKEHALLSG 320
Query: 220 -----GPIPKSIFASGKLEVLVLTQNRLTGDIPELVGHCKSLSNIRIGNNDLVGVIPRAI 274
+ + + + + I ++ ++ + L +
Sbjct: 321 QGSETERLECERENQARQREIDALKEQYRTVIDQVTLRKQAKITLEQKKKALDEQVSNGR 380
Query: 275 GNVSGLTYFEADNNNLSGEIVPEFSQCSNLTLLNLASNGFTGVIPPELGQLINLQELILY 334
+ L Q L + + + Q +++ +Y
Sbjct: 381 RAHAELDGTLQQAVGQIELQHATEEQSPLQLLRAIVKRYEEMYVEQQSVQNNAIRDWDMY 440
Query: 335 ENSLFGEIPKSILACKNLNKLDLSNNRFNGTIPNAICDMSRLQ 377
++ ++ K + DL+ N T+ + L
Sbjct: 441 QHKETQLAEENARLKKLNGEADLALASANATLQELVVREQNLA 483
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 164 bits (418), Expect = 3e-45
Identities = 59/318 (18%), Positives = 114/318 (35%), Gaps = 40/318 (12%)
Query: 597 IDLDAVVKATM--KDSNMIYCGTFSTVYKAVMPSGLILSVKRLKSMDRTIIHHQNKMIRE 654
+ + + +M + + G F V+KA + ++VK + E
Sbjct: 14 LGTENLYFQSMPLQLLEVKARGRFGCVWKAQLL-NEYVAVKIFPI------QDKQSWQNE 66
Query: 655 LE--KLSKLCHDNLVRPIGFVIYEDVA----LLLHNYLPNGTLAQLLHESTKQPDYRPDW 708
E L + H+N+++ IG L+ + G+L+ L + W
Sbjct: 67 YEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKANV------VSW 120
Query: 709 PTRLSIAIGVAEGLAFLHH----------VAIIHLDISSGNVLLDADFKPLLGEIEISKL 758
IA +A GLA+LH AI H DI S NVLL + + + ++
Sbjct: 121 NELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALK 180
Query: 759 LDPSKGTASISAVAGSFGYIPPEYA-YTMQVTAPGN----VYSYGVVLLEILTTRLPVEE 813
+ K G+ Y+ PE + +Y+ G+VL E+ + +
Sbjct: 181 FEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADG 240
Query: 814 DFGEG-VDLVKWVHGAPARGETPEQILDARL-STVSFGWRK-EMLTAL-KVALLCTDSTP 869
E + + + P+ + E ++ + + W+K + L + C D
Sbjct: 241 PVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDA 300
Query: 870 AKRPKMKKVVEMLQEIKQ 887
R V E + ++++
Sbjct: 301 EARLSAGCVGERITQMQR 318
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 164 bits (418), Expect = 4e-45
Identities = 61/319 (19%), Positives = 103/319 (32%), Gaps = 21/319 (6%)
Query: 85 LKALKRLDLSNNAFSGTIPSAFGNLSELEFLDLSLNKFGGVIPRELGSLKDLRFFNISNN 144
+ L + D + + + + +
Sbjct: 11 SSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHS----AWRQANSNNPQIETRTGR 66
Query: 145 VLVGEIPDELKSL--EKLEDFQVSSNKLNGSIPFWVGNLTNLRVFTAYENQLVGEIPDNL 202
L D L+ ++ S L P L++L+ T L+ E+PD +
Sbjct: 67 ALK-ATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELPDTM 123
Query: 203 GSVSELELLNLHSNQLEGPIPKSIFASGKLEVLVLT-QNRLT--------GDIPELVGHC 253
+ LE L L N L +P SI + +L L + LT D
Sbjct: 124 QQFAGLETLTLARNPLRA-LPASIASLNRLRELSIRACPELTELPEPLASTDASGEHQGL 182
Query: 254 KSLSNIRIGNNDLVGVIPRAIGNVSGLTYFEADNNNLSGEIVPEFSQCSNLTLLNLASNG 313
+L ++R+ + +P +I N+ L + N+ LS + P L L+L
Sbjct: 183 VNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCT 240
Query: 314 FTGVIPPELGQLINLQELILYENSLFGEIPKSILACKNLNKLDLSNNRFNGTIPNAICDM 373
PP G L+ LIL + S +P I L KLDL +P+ I +
Sbjct: 241 ALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQL 300
Query: 374 SRLQYLLLGQNSLKGEIPH 392
+L+ + H
Sbjct: 301 PANCIILVPPHLQAQLDQH 319
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 163 bits (415), Expect = 9e-45
Identities = 54/319 (16%), Positives = 106/319 (33%), Gaps = 24/319 (7%)
Query: 178 VGNLTNLRVFTAYENQLVGEIPDNLGSVSELELLNLHSNQLEGPIPKSIFASGKLEVLVL 237
+ + + + D L + + S ++
Sbjct: 8 HHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQANS----NNPQIETR 63
Query: 238 TQNRLTGDIPELVGHCKS--LSNIRIGNNDLVGVIPRAIGNVSGLTYFEADNNNLSGEIV 295
T L +L+ + + + L P +S L + D L E+
Sbjct: 64 TGRALK-ATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQHMTIDAAGLM-ELP 120
Query: 296 PEFSQCSNLTLLNLASNGFTGVIPPELGQLINLQELILYENSLFGEIPKSI--------- 346
Q + L L LA N +P + L L+EL + E+P+ +
Sbjct: 121 DTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELTELPEPLASTDASGEH 179
Query: 347 LACKNLNKLDLSNNRFNGTIPNAICDMSRLQYLLLGQNSLKGEIPHEIGNCMKLLQLHIG 406
NL L L ++P +I ++ L+ L + + L + I + KL +L +
Sbjct: 180 QGLVNLQSLRLEWTGIR-SLPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDLR 237
Query: 407 SNYLTGSIPPEIGHIRNLQIALNLS-FNHLHGSLPPELGKLDKLVSFDVSNNQLSGTIPS 465
+ PP G L+ L L ++L +LP ++ +L +L D+ +PS
Sbjct: 238 GCTALRNYPPIFGGRAPLKR-LILKDCSNLL-TLPLDIHRLTQLEKLDLRGCVNLSRLPS 295
Query: 466 ALKGMLSLIEVNFSNNLLT 484
+ + + + +L
Sbjct: 296 LIAQLPANCIILVPPHLQA 314
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 89.6 bits (223), Expect = 2e-19
Identities = 24/172 (13%), Positives = 53/172 (30%), Gaps = 12/172 (6%)
Query: 316 GVIPPELGQLINLQELILYENSLFGEIPKSILACKNLNKLDLSNNRFNGTIPNAICDMSR 375
G + L ++ + + D + N +
Sbjct: 2 GSSHHHHHHSSGRENLYFQGSTALRPYHDVLSQWQRHYNADRNRWHSAWRQAN----SNN 57
Query: 376 LQYLLLGQNSLKGEIPHEIGNC--MKLLQLHIGSNYLTGSIPPEIGHIRNLQIALNLSFN 433
Q +LK + + + L + S L P + + +LQ + +
Sbjct: 58 PQIETRTGRALK-ATADLLEDATQPGRVALELRSVPLP-QFPDQAFRLSHLQH-MTIDAA 114
Query: 434 HLHGSLPPELGKLDKLVSFDVSNNQLSGTIPSALKGMLSLIEVNFS-NNLLT 484
L LP + + L + ++ N L +P+++ + L E++ LT
Sbjct: 115 GLM-ELPDTMQQFAGLETLTLARNPLR-ALPASIASLNRLRELSIRACPELT 164
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 83.1 bits (206), Expect = 3e-17
Identities = 26/138 (18%), Positives = 52/138 (37%), Gaps = 7/138 (5%)
Query: 70 LSRLQLRGN--ITL---VSELKALKRLDLSNNAFSGTIPSAFGNLSELEFLDLSLNKFGG 124
L L+L +L ++ L+ LK L + N+ S + A +L +LE LDL
Sbjct: 185 LQSLRLEWTGIRSLPASIANLQNLKSLKIRNSPLS-ALGPAIHHLPKLEELDLRGCTALR 243
Query: 125 VIPRELGSLKDLRFFNISNNVLVGEIPDELKSLEKLEDFQVSSNKLNGSIPFWVGNLTNL 184
P G L+ + + + +P ++ L +LE + +P + L
Sbjct: 244 NYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNLSRLPSLIAQLPAN 303
Query: 185 RVFTAYENQLVGEIPDNL 202
+ + ++ +
Sbjct: 304 CIILVPPHLQ-AQLDQHR 320
|
| >4fcg_A Uncharacterized protein; structural genomics, PSI-biology, midwest center for structu genomics, MCSG, LRR, N- and C-terminal helices; 2.00A {Xanthomonas campestris PV} Length = 328 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 6e-08
Identities = 21/94 (22%), Positives = 33/94 (35%), Gaps = 6/94 (6%)
Query: 70 LSRLQLRGNITLVS------ELKALKRLDLSNNAFSGTIPSAFGNLSELEFLDLSLNKFG 123
L L LRG L + LKRL L + + T+P L++LE LDL
Sbjct: 231 LEELDLRGCTALRNYPPIFGGRAPLKRLILKDCSNLLTLPLDIHRLTQLEKLDLRGCVNL 290
Query: 124 GVIPRELGSLKDLRFFNISNNVLVGEIPDELKSL 157
+P + L + ++ +
Sbjct: 291 SRLPSLIAQLPANCIILVPPHLQAQLDQHRPVAR 324
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 160 bits (406), Expect = 1e-41
Identities = 86/444 (19%), Positives = 156/444 (35%), Gaps = 42/444 (9%)
Query: 69 DLSRLQLRGN-ITLVSE-----LKALKRLDLSNNAFSG-TIPSAFGNLSELEFLDLSLNK 121
L L L N ++ +S L +LK L+L N + + S F NL+ L+ L + +
Sbjct: 75 SLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVE 134
Query: 122 FGGVIPRE-LGSLKDLRFFNISNNVLVGEIPDELKSLEKLEDFQVSSNKLNGSIPFWVGN 180
I R L L I L LKS+ + + ++ + +
Sbjct: 135 TFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADI 194
Query: 181 LTNLRVFTAYENQLVG---EIPDNLGSVSELELLNLHSNQLE----GPIPKSIFASGKLE 233
L+++R + L S ++ L + L + K + +L
Sbjct: 195 LSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELS 254
Query: 234 VLVLTQNRLTG----------DIPELVG-HCKSLSNIRIGNNDLVGVIPRAIGNVSGLTY 282
+ L G + EL ++ + I L + + +
Sbjct: 255 EVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKR 314
Query: 283 FEADNNNLSGEIVPEFSQCSNLTLLNLASNGFTGVIPPE---LGQLINLQELILYENSL- 338
+N+ + +L L+L+ N G +LQ L+L +N L
Sbjct: 315 ITVENSKVFLVPCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLR 374
Query: 339 -FGEIPKSILACKNLNKLDLSNNRFNGTIPNAICDMSRLQYLLLGQNSLKGEIPHEIGNC 397
+ + +L KNL LD+S N F+ +P++ ++++L L ++ + I
Sbjct: 375 SMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIR-VVKTCIPQ- 431
Query: 398 MKLLQLHIGSNYLTGSIPPEIGHIRNLQIALNLSFNHLHGSLPPELGKLDKLVSFDVSNN 457
L L + +N L S + LQ L +S N L +LP L+ +S N
Sbjct: 432 -TLEVLDVSNNNLD-SFSL---FLPRLQE-LYISRNKLK-TLPDA-SLFPVLLVMKISRN 483
Query: 458 QLSGTIPSALKGMLSLIEVNFSNN 481
QL + SL ++ N
Sbjct: 484 QLKSVPDGIFDRLTSLQKIWLHTN 507
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 6e-41
Identities = 69/425 (16%), Positives = 147/425 (34%), Gaps = 36/425 (8%)
Query: 88 LKRLDLSNNAFSGTIPSAFGNLSELEFLDLSLNKFGGVIPRELGSLKDLRFFNISNNVLV 147
+K LDLS N + + L+ L L ++ + SL L ++S+N L
Sbjct: 28 MKSLDLSFNKITYIGHGDLRACANLQVLILKSSRINTIEGDAFYSLGSLEHLDLSDNHLS 87
Query: 148 GEIPDELKSLEKLEDFQVSSNKLNG-SIPFWVGNLTNLRVFTAYENQLVGEIPDN-LGSV 205
L L+ + N + NLTNL+ + EI +
Sbjct: 88 SLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDFAGL 147
Query: 206 SELELLNLHSNQLEGPIPKSIFAS-GKLEVLVLTQNRLTGDIPELVGHCKSLSNIRIGNN 264
+ L L + + L S + L L + + S+ + + +
Sbjct: 148 TSLNELEIKALSLRN-YQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDT 206
Query: 265 DLVGVIPRAIGNVSGLTYFEADNNNLSG----------EIVPEFSQCSNLTLLNLASNGF 314
+L + + + S +++ + S + + NG
Sbjct: 207 NLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGL 266
Query: 315 TGVIPPELG--------QLINLQELILYENSLFGEIPKSILACKNLNKLDLSNNRFNGTI 366
P E + + ++ L + + LF ++ + + ++ + N++ +
Sbjct: 267 GDFNPSESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVF-LV 325
Query: 367 PNAICD-MSRLQYLLLGQNSLKGEIPHE---IGNCMKLLQLHIGSNYLTGSIPPEIG--- 419
P + + L++L L +N + E G L L + N+L S+
Sbjct: 326 PCSFSQHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLR-SMQKTGEILL 384
Query: 420 HIRNLQIALNLSFNHLHGSLPPELGKLDKLVSFDVSNNQLSGTIPSALKGMLSLIEVNFS 479
++NL L++S N H +P +K+ ++S+ + + + + +L ++ S
Sbjct: 385 TLKNLTS-LDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIR-VVKTCI--PQTLEVLDVS 439
Query: 480 NNLLT 484
NN L
Sbjct: 440 NNNLD 444
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 140 bits (354), Expect = 5e-35
Identities = 68/412 (16%), Positives = 152/412 (36%), Gaps = 19/412 (4%)
Query: 87 ALKRLDLSNNAFSGTIPSAFGNLSELEFLDLSLNKFGGVIPRELGSLKDLRFFNISNNVL 146
A D + +F+ +IPS G + ++ LDLS NK + +L + +L+ + ++ +
Sbjct: 6 ASGVCDGRSRSFT-SIPS--GLTAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRI 62
Query: 147 VGEIPDELKSLEKLEDFQVSSNKLNGSIPFWVGNLTNLRVFTAYENQLVG-EIPDNLGSV 205
D SL LE +S N L+ W G L++L+ N + ++
Sbjct: 63 NTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNL 122
Query: 206 SELELLNLHSNQLEGPIPKSIFAS-GKLEVLVLTQNRLTGDIPELVGHCKSLSNIRIGNN 264
+ L+ L + + + I + FA L L + L + + + + ++ + +
Sbjct: 123 TNLQTLRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTLHLS 182
Query: 265 DLVGVIPRAIGNVSGLTYFEADNNNLSGEIVPEFSQCSNLTLLNLASNGFTGVIPPELGQ 324
+ ++ +S + Y E + NL+ + + + + + +
Sbjct: 183 ESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNE 242
Query: 325 LINLQELILYENSLFGEIPKSILACKNLNKLDLSNNRFNGTIPNAICDMSRLQYLLLGQN 384
L+ L IL + + C D + + + + ++ L + Q
Sbjct: 243 LLKLLRYILELSEV------EFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQF 296
Query: 385 SLKGEIPHEIGNCMKLLQLHIGSNYLTGSIPPEIG-HIRNLQIALNLSFNHLHGSLPPE- 442
L ++ K+ ++ + ++ + +P H+++L+ L+LS N +
Sbjct: 297 YLFYDLSTVYSLLEKVKRITVENSKVF-LVPCSFSQHLKSLEF-LDLSENLMVEEYLKNS 354
Query: 443 --LGKLDKLVSFDVSNNQLS--GTIPSALKGMLSLIEVNFSNNLLTGPVPSF 490
G L + +S N L L + +L ++ S N S
Sbjct: 355 ACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFHPMPDSC 406
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 3e-25
Identities = 62/362 (17%), Positives = 121/362 (33%), Gaps = 46/362 (12%)
Query: 67 KLDLSRLQLRG-NITLVSELKALKRLDLSNNAFSGTIPSAFGNLSELEFLDLSLNKFGGV 125
+L++ L LR + ++ + L L + + + LS + +L+L
Sbjct: 152 ELEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLELRDTNLARF 211
Query: 126 IPRELG---SLKDLRFFNISNNVLV----GEIPDELKSLEKLEDFQVSSNKLNGSIPFWV 178
L ++ +VL E+ L+ + +L + + LNG F
Sbjct: 212 QFSPLPVDEVSSPMKKLAFRGSVLTDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNP 271
Query: 179 G-----------NLTNLRVFTAYENQLVGEIPDNLGSVSELELLNLHSNQLEGPIPKSIF 227
+R + L ++ + +++ + + ++++ +P S
Sbjct: 272 SESDVVSELGKVETVTIRRLHIPQFYLFYDLSTVYSLLEKVKRITVENSKVFL-VPCSFS 330
Query: 228 AS-GKLEVLVLTQNRLTGDI---PELVGHCKSLSNIRIGNNDL--VGVIPRAIGNVSGLT 281
LE L L++N + + G SL + + N L + + + LT
Sbjct: 331 QHLKSLEFLDLSENLMVEEYLKNSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLT 390
Query: 282 YFEADNNNLSGEIVPEFSQCSNLTLLNLASNGFTGV---IPPELGQLI------------ 326
+ N + + LNL+S G V IP L L
Sbjct: 391 SLDISRNTFH-PMPDSCQWPEKMRFLNLSSTGIRVVKTCIPQTLEVLDVSNNNLDSFSLF 449
Query: 327 --NLQELILYENSLFGEIPKSILACKNLNKLDLSNNRFNGTIPNAICDMSRLQYLLLGQN 384
LQEL + N L +P + L L + +S N+ ++ LQ + L N
Sbjct: 450 LPRLQELYISRNKL-KTLPDASL-FPVLLVMKISRNQLKSVPDGIFDRLTSLQKIWLHTN 507
Query: 385 SL 386
Sbjct: 508 PW 509
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 93.3 bits (232), Expect = 7e-20
Identities = 53/323 (16%), Positives = 100/323 (30%), Gaps = 52/323 (16%)
Query: 60 LNQAFVVKLDLSRLQLRGNITLVSELKALKRLDLSNNAFSGTIPSAFGNLSELEFLDLSL 119
+++F L L R L + + D + + + L +
Sbjct: 236 TDESFNELLKLLRYILELSEVEFDDCTLNGLGDFNPSESDVVSELGKVETVTIRRLHIPQ 295
Query: 120 NKFGGVIPRELGSLKDLRFFNISNN---VLVGEIPDELKSLEKLEDFQVSSNKLNGSIPF 176
+ L+ ++ + N+ ++ LKSLE L +S N +
Sbjct: 296 FYLFYDLSTVYSLLEKVKRITVENSKVFLVPCSFSQHLKSLEFL---DLSENLMVEEYLK 352
Query: 177 W---VGNLTNLRVFTAYENQL--VGEIPDNLGSVSELELLNLHSNQLEGPIPKSIFASGK 231
G +L+ +N L + + + L ++ L L++ N P+P S K
Sbjct: 353 NSACKGAWPSLQTLVLSQNHLRSMQKTGEILLTLKNLTSLDISRNTFH-PMPDSCQWPEK 411
Query: 232 LEVLVLTQNRLTGDIPELVGHCKSLSNIRIGNNDLVGVIPRAIGNVSGLTYFEADNNNLS 291
+ L L+ + V+ I L + NNNL
Sbjct: 412 MRFLNLSSTGIR-------------------------VVKTCI--PQTLEVLDVSNNNLD 444
Query: 292 GEIVPEFSQCSNLTLLNLASNGFTGVIPPELGQLINLQELILYENSLFGEIPKSILA-CK 350
F L L ++ N + P+ L + + N L +P I
Sbjct: 445 S--FSLFL--PRLQELYISRNKLKTL--PDASLFPVLLVMKISRNQL-KSVPDGIFDRLT 497
Query: 351 NLNKLDLSNNRFNGTIPNAICDM 373
+L K+ L N ++ + C
Sbjct: 498 SLQKIWLHTNPWDCS-----CPR 515
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 91.7 bits (228), Expect = 2e-19
Identities = 40/219 (18%), Positives = 74/219 (33%), Gaps = 6/219 (2%)
Query: 302 SNLTLLNLASNGFTGVIPPELGQLINLQELILYENSLFGEIPKSILAC-KNLNKLDLSNN 360
+ + L+L+ N T + +L NLQ LIL + + I +L LDLS+N
Sbjct: 26 AAMKSLDLSFNKITYIGHGDLRACANLQVLILKSSRI-NTIEGDAFYSLGSLEHLDLSDN 84
Query: 361 RFNGTIPNAICDMSRLQYLLLGQNSLKG-EIPHEIGNCMKLLQLHIGSNYLTGSIPPE-I 418
+ + +S L+YL L N + + N L L IG+ I
Sbjct: 85 HLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFPNLTNLQTLRIGNVETFSEIRRIDF 144
Query: 419 GHIRNLQIALNLSFNHLHGSLPPELGKLDKLVSFDVSNNQLSGTIPSALKGMLSLIEVNF 478
+ +L L + L L + + + ++ + + + S+ +
Sbjct: 145 AGLTSLNE-LEIKALSLRNYQSQSLKSIRDIHHLTLHLSESAFLLEIFADILSSVRYLEL 203
Query: 479 SNNLLTG-PVPSFVPFQKSPNSSFFGNKGLCGEPLSFSC 516
+ L + S +G SF+
Sbjct: 204 RDTNLARFQFSPLPVDEVSSPMKKLAFRGSVLTDESFNE 242
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 90.6 bits (225), Expect = 5e-19
Identities = 37/223 (16%), Positives = 66/223 (29%), Gaps = 7/223 (3%)
Query: 301 CSNLTLLNLASNGFTGVIPPELGQLINLQELILYENSLFGEIPKSILACKNLNKLDLSNN 360
C + + S FT IP L ++ L L N + + AC NL L L ++
Sbjct: 4 CDASGVCDGRSRSFT-SIPSGL--TAAMKSLDLSFNKITYIGHGDLRACANLQVLILKSS 60
Query: 361 RFNGTIPNAICDMSRLQYLLLGQNSLKGEIPHEIGNCMKLLQLHIGSNYLTG-SIPPEIG 419
R N +A + L++L L N L G L L++ N +
Sbjct: 61 RINTIEGDAFYSLGSLEHLDLSDNHLSSLSSSWFGPLSSLKYLNLMGNPYQTLGVTSLFP 120
Query: 420 HIRNLQIALNLSFNHLHGSLPPE-LGKLDKLVSFDVSNNQLSGTIPSALKGMLSLIEVNF 478
++ NLQ L + + L L ++ L +LK + + +
Sbjct: 121 NLTNLQT-LRIGNVETFSEIRRIDFAGLTSLNELEIKALSLRNYQSQSLKSIRDIHHLTL 179
Query: 479 SNNLLTGPVP-SFVPFQKSPNSSFFGNKGLCGEPLSFSCGNAN 520
+ + + +
Sbjct: 180 HLSESAFLLEIFADILSSVRYLELRDTNLARFQFSPLPVDEVS 222
|
| >2z81_A CD282 antigen, TOLL-like receptor 2, variable lymphocyte recepto; TLR2, PAM3CSK4, lipopeptide, innate immunity, cytoplasmic VE glycoprotein; HET: NAG BMA MAN PCJ; 1.80A {Mus musculus} PDB: 2z82_A* 3a7c_A* 3a79_A* 3a7b_A* 2z7x_A* Length = 549 | Back alignment and structure |
|---|
Score = 65.9 bits (161), Expect = 3e-11
Identities = 31/155 (20%), Positives = 59/155 (38%), Gaps = 10/155 (6%)
Query: 347 LACKNLNKLDLSNNRFNGTIPNAICDMSRLQYLLLGQNSLKGEIPHEIGNCMKLLQLHIG 406
L+C D + F +IP+ + + ++ L L N + ++ C L L +
Sbjct: 2 LSCDASGVCDGRSRSFT-SIPSGLT--AAMKSLDLSFNKITYIGHGDLRACANLQVLILK 58
Query: 407 SNYLTGSIPPEI-GHIRNLQIALNLSFNHLHGSLPPE-LGKLDKLVSFDVSNNQLSG-TI 463
S+ + +I + + +L+ L+LS NHL SL G L L ++ N +
Sbjct: 59 SSRIN-TIEGDAFYSLGSLEH-LDLSDNHLS-SLSSSWFGPLSSLKYLNLMGNPYQTLGV 115
Query: 464 PSALKGMLSLIEVNFSNNLLTGPVPSFVPFQKSPN 498
S + +L + N + F +
Sbjct: 116 TSLFPNLTNLQTLRIGNVETFSEIRRID-FAGLTS 149
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 150 bits (380), Expect = 4e-40
Identities = 60/337 (17%), Positives = 116/337 (34%), Gaps = 24/337 (7%)
Query: 102 IPSAFGNLSELEFLDLSLNKFGGVIPRELGSLKDLRFFNISNNVLVGEIPDELKSLEKLE 161
I N + + ++ + + S +++ ++S N L +L KLE
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 162 DFQVSSNKLNGSIPFWVGNLTNLRVFTAYENQLVGEIPDNLGSVSELELLNLHSNQLEGP 221
+SSN L ++ +L+ LR N + L +E L+ +N +
Sbjct: 62 LLNLSSNVLYETLDL--ESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNISR- 113
Query: 222 IPKSIFASGKLEVLVLTQNRLTGDIPELVGHCKSLSNIRIGNNDLVGV-IPRAIGNVSGL 280
+ S + + L N++T G + + + N++ V + L
Sbjct: 114 VSCSRGQG--KKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTL 171
Query: 281 TYFEADNNNLSGEIVPEFSQCSNLTLLNLASNGFTGVIPPELGQLINLQELILYENSLFG 340
+ N + V + L L+L+SN + PE + + L N L
Sbjct: 172 EHLNLQYNFIY--DVKGQVVFAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKL-V 227
Query: 341 EIPKSILACKNLNKLDLSNNRFN-GTIPNAICDMSRLQYLLLGQNSLKGEIPHEIGNCMK 399
I K++ +NL DL N F+ GT+ + R+Q + ++ +
Sbjct: 228 LIEKALRFSQNLEHFDLRGNGFHCGTLRDFFSKNQRVQTVAKQTVK---KLTGQNEEECT 284
Query: 400 LLQLHIGSNYLTGSIPPEIGHIRNLQIALNLSFNHLH 436
+ L Y +P + L +H H
Sbjct: 285 VPTLGHYGAYCCEDLPAPFA-----DRLIALGHHHHH 316
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 1e-38
Identities = 47/255 (18%), Positives = 93/255 (36%), Gaps = 16/255 (6%)
Query: 231 KLEVLVLTQNRLTGDIPELVGHCKSLSNIRIGNNDLVGVIPRAIGNVSGLTYFEADNNNL 290
+ ++ +T + L + L ++ + + N L + + + L +N L
Sbjct: 11 RYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLELLNLSSNVL 70
Query: 291 SGEIVPEFSQCSNLTLLNLASNGFTGVIPPELGQLINLQELILYENSLFGEIPKSILACK 350
+ S L L+L +N EL +++ L N++ + S +
Sbjct: 71 YE--TLDLESLSTLRTLDLNNNYVQ-----ELLVGPSIETLHAANNNI-SRVSCSRG--Q 120
Query: 351 NLNKLDLSNNRFNGTIPNAICDMSRLQYLLLGQNSLKG-EIPHEIGNCMKLLQLHIGSNY 409
+ L+NN+ SR+QYL L N + + L L++ N+
Sbjct: 121 GKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTLEHLNLQYNF 180
Query: 410 LTGSIPPEIGHIRNLQIALNLSFNHLHGSLPPELGKLDKLVSFDVSNNQLSGTIPSALKG 469
+ + ++ L+ L+LS N L + PE + + NN+L I AL+
Sbjct: 181 IY-DVKGQV-VFAKLKT-LDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV-LIEKALRF 235
Query: 470 MLSLIEVNFSNNLLT 484
+L + N
Sbjct: 236 SQNLEHFDLRGNGFH 250
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 2e-31
Identities = 42/240 (17%), Positives = 93/240 (38%), Gaps = 15/240 (6%)
Query: 246 IPELVGHCKSLSNIRIGNNDLVGVIPRAIGNVSGLTYFEADNNNLSGEIVPEFSQCSNLT 305
I E+ + ++ ++ L + + + + N LS + + + L
Sbjct: 2 IHEIKQNGNRYKIEKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTKLE 61
Query: 306 LLNLASNGFTGVIPPELGQLINLQELILYENSLFGEIPKSILACKNLNKLDLSNNRFNGT 365
LLNL+SN +L L L+ L L N + + +L ++ L +NN +
Sbjct: 62 LLNLSSNVLYET--LDLESLSTLRTLDLNNNYV-----QELLVGPSIETLHAANNNIS-R 113
Query: 366 IPNAICDMSRLQYLLLGQNSLKGEIPHEIGNCMKLLQLHIGSNYLTG-SIPPEIGHIRNL 424
+ + + + L N + + G ++ L + N + + L
Sbjct: 114 VSCSR--GQGKKNIYLANNKITMLRDLDEGCRSRVQYLDLKLNEIDTVNFAELAASSDTL 171
Query: 425 QIALNLSFNHLHGSLPPELGKLDKLVSFDVSNNQLSGTIPSALKGMLSLIEVNFSNNLLT 484
+ LNL +N ++ + ++ KL + D+S+N+L+ + + + ++ NN L
Sbjct: 172 EH-LNLQYNFIY-DVKGQVV-FAKLKTLDLSSNKLA-FMGPEFQSAAGVTWISLRNNKLV 227
|
| >3o53_A Protein LRIM1, AGAP006348-PA; leucine-rich repeat, protein binding; HET: NAG; 2.00A {Anopheles gambiae} Length = 317 | Back alignment and structure |
|---|
Score = 46.5 bits (111), Expect = 2e-05
Identities = 15/83 (18%), Positives = 28/83 (33%), Gaps = 2/83 (2%)
Query: 413 SIPPEIGHIRNLQIALNLSFNHLHGSLPPELGKLDKLVSFDVSNNQLSGTIPSALKGMLS 472
+I + +I ++ + L +L + D+S N LS + L
Sbjct: 1 AIHEIKQNGNRYKI-EKVTDSSLKQALASLRQSAWNVKELDLSGNPLSQISAADLAPFTK 59
Query: 473 LIEVNFSNNLLTGPVPSFVPFQK 495
L +N S+N+L
Sbjct: 60 LELLNLSSNVLYE-TLDLESLST 81
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 156 bits (395), Expect = 3e-39
Identities = 88/436 (20%), Positives = 159/436 (36%), Gaps = 39/436 (8%)
Query: 68 LDLSRLQLRGNI---TLVSELKALKRLDLSNNAFSG-TIPSAFGNLSELEFLDLSLNKFG 123
L L L + LKAL RLDLS N + +FG L+ L+ +D S N+
Sbjct: 102 LRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIF 161
Query: 124 GVIPRELGSL--KDLRFFNISNNVLVGEIP-DELKSLEKLEDFQVSSNKLNGSIPFWVGN 180
V EL L K L FF+++ N L + D K + + + ++G N
Sbjct: 162 LVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSG-------N 214
Query: 181 LTNLRVFTAYENQLVGEIPDNLGSVSELELLNLHSNQLEGPIPKSIFASGK---LEVLVL 237
+ + + N + +L + + ++ ++ FA + L L
Sbjct: 215 GWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKD-PDQNTFAGLARSSVRHLDL 273
Query: 238 TQNRLTGDIPELVGHCKSLSNIRIGNNDLVGVIPRAIGNVSGLTYFEADNNNLSGEIVPE 297
+ + + K L + + N + + A + L N L E+
Sbjct: 274 SHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLG-ELYSS 332
Query: 298 -FSQCSNLTLLNLASNGFTGVIPPELGQLINLQELILYENSLFGEIPKSILACKNLNKLD 356
F + ++L N + L LQ L L +N+L +I ++ +
Sbjct: 333 NFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNAL-----TTIHFIPSIPDIF 387
Query: 357 LSNNRFNGTIPNAICDMSRLQYLLLGQNSLKG-EIPHEIGNCMKLLQLHIGSNYLTGSIP 415
LS N+ T+P + L +N L+ +I + + L L + N + S
Sbjct: 388 LSGNKLV-TLPKINL---TANLIHLSENRLENLDILYFLLRVPHLQILILNQNRFS-SCS 442
Query: 416 PE--IGHIRNLQIALNLSFNHLHGSLPPEL-----GKLDKLVSFDVSNNQLSGTIPSALK 468
+ +L+ L L N L + EL L L +++N L+ P
Sbjct: 443 GDQTPSENPSLEQ-LFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFS 501
Query: 469 GMLSLIEVNFSNNLLT 484
+ +L ++ ++N LT
Sbjct: 502 HLTALRGLSLNSNRLT 517
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 155 bits (394), Expect = 4e-39
Identities = 93/459 (20%), Positives = 154/459 (33%), Gaps = 46/459 (10%)
Query: 69 DLSRLQLRGN-ITLVSE-----LKALKRLDLSNNAFSGTI-PSAFGNLSELEFLDLSLNK 121
RL L N I V+ L+ L+ L+L + TI AF NL L LDL +K
Sbjct: 25 TTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGSSK 84
Query: 122 FGGVIPRELGSLKDLRFFNISNNVLVGEI--PDELKSLEKLEDFQVSSNKLNGSIPFWV- 178
+ P L L + L + ++L+ L +S N++
Sbjct: 85 IYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHPSF 144
Query: 179 GNLTNLRVFTAYENQLVGEIPDNLGSVS--ELELLNLHSNQLEGPIPKSIFASGK----- 231
G L +L+ NQ+ L + L +L +N L +
Sbjct: 145 GKLNSLKSIDFSSNQIFLVCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPFRNM 204
Query: 232 -LEVLVLTQNRLTGDIPELVGHCKSLSNI------------RIGNNDLVGVIPRAIGNV- 277
LE+L ++ N T DI + S S G +++ +
Sbjct: 205 VLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFAGLA 264
Query: 278 -SGLTYFEADNNNLSGEIVPEFSQCSNLTLLNLASNGFTGVIPPELGQLINLQELILYEN 336
S + + + + + F +L +LNLA N + L NLQ L L N
Sbjct: 265 RSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYN 324
Query: 337 SLFGEIPKSILA-CKNLNKLDLSNNRFNGTIPNAICDMSRLQYLLLGQNSLKGEIPHEIG 395
L GE+ S + +DL N + +LQ L L N+L I
Sbjct: 325 LL-GELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNAL-----TTIH 378
Query: 396 NCMKLLQLHIGSNYLTGSIPPEIGHIRNLQIALNLSFNHLHG-SLPPELGKLDKLVSFDV 454
+ + + N L + I ++LS N L + L ++ L +
Sbjct: 379 FIPSIPDIFLSGNKLV-----TLPKINLTANLIHLSENRLENLDILYFLLRVPHLQILIL 433
Query: 455 SNNQLSGTIPSALKGML-SLIEVNFSNNLLTGPVPSFVP 492
+ N+ S SL ++ N+L + +
Sbjct: 434 NQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWETELC 472
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 2e-38
Identities = 82/428 (19%), Positives = 153/428 (35%), Gaps = 39/428 (9%)
Query: 85 LKALKRLDLSNNAFSGTIPSAFGNLSELEFLDLSLNKFGGVIPRE-LGSLKDLRFFNISN 143
L +RL LS N S+F L +L+ L+L I +E +L +LR ++ +
Sbjct: 23 LNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPLTIDKEAFRNLPNLRILDLGS 82
Query: 144 NVLVGEIPDELKSLEKLEDFQVSSNKLNGSI--PFWVGNLTNLRVFTAYENQLVG-EIPD 200
+ + PD + L L + ++ L+ ++ + NL L +NQ+ +
Sbjct: 83 SKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNLKALTRLDLSKNQIRSLYLHP 142
Query: 201 NLGSVSELELLNLHSNQLEGPIPKSIFAS---GKLEVLVLTQNRLTGDIPELVGHC---- 253
+ G ++ L+ ++ SNQ+ + + L L N L + G C
Sbjct: 143 SFGKLNSLKSIDFSSNQIFL-VCEHELEPLQGKTLSFFSLAANSLYSRVSVDWGKCMNPF 201
Query: 254 --KSLSNIRIGNNDLVGVIPRAIGN------------VSGLTYFEADNNNLSGEIVPEFS 299
L + + N I N + +N+ F+
Sbjct: 202 RNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAHHIMGAGFGFHNIKDPDQNTFA 261
Query: 300 --QCSNLTLLNLASNGFTGVIPPELGQLINLQELILYENSLFGEIPKSILACKNLNKLDL 357
S++ L+L+ + L +L+ L L N + ++ NL L+L
Sbjct: 262 GLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNL 321
Query: 358 SNNRFNGTIPNAICDMSRLQYLLLGQNSLKGEIPHEIGNCMKLLQLHIGSNYLTGSIPPE 417
S N + + ++ Y+ L +N + KL L + N LT
Sbjct: 322 SYNLLGELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALT-----T 376
Query: 418 IGHIRNLQIALNLSFNHLHGSLPPELGKLDKLVSFDVSNNQLSG-TIPSALKGMLSLIEV 476
I I ++ + LS N L +LP + + +S N+L I L + L +
Sbjct: 377 IHFIPSIPD-IFLSGNKLV-TLPKINLTANLI---HLSENRLENLDILYFLLRVPHLQIL 431
Query: 477 NFSNNLLT 484
+ N +
Sbjct: 432 ILNQNRFS 439
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 138 bits (348), Expect = 1e-33
Identities = 77/440 (17%), Positives = 143/440 (32%), Gaps = 49/440 (11%)
Query: 89 KRLDLSNNAFSGTIPSAFGNLSELEFLDLSLNKFGGVIPRELGSLKDLRFFNISNNVLVG 148
+ + +P L+ E L LS N V L+ L+ + +
Sbjct: 7 RIAFYRFCNLT-QVPQ---VLNTTERLLLSFNYIRTVTASSFPFLEQLQLLELGSQYTPL 62
Query: 149 EIPDE-LKSLEKLEDFQVSSNKLNGSIPFWVGNLTNLRVFTAYENQLVGEI--PDNLGSV 205
I E ++L L + S+K+ P L +L Y L + ++
Sbjct: 63 TIDKEAFRNLPNLRILDLGSSKIYFLHPDAFQGLFHLFELRLYFCGLSDAVLKDGYFRNL 122
Query: 206 SELELLNLHSNQLEGPIPKSIFAS-GKLEVLVLTQNRLT----GDIPELVGHCKSLSNIR 260
L L+L NQ+ F L+ + + N++ ++ L K+LS
Sbjct: 123 KALTRLDLSKNQIRSLYLHPSFGKLNSLKSIDFSSNQIFLVCEHELEPL--QGKTLSFFS 180
Query: 261 IGNNDLVGVIPRAIGNVSG------LTYFEADNNNLSGEIVPEFSQC------------S 302
+ N L + G L + N + +I FS
Sbjct: 181 LAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLILAH 240
Query: 303 NLTLLNLASNGFTGVIPPELGQL--INLQELILYENSLFGEIPKSILAC-KNLNKLDLSN 359
++ + L +++ L L +F + + K+L L+L+
Sbjct: 241 HIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVF-SLNSRVFETLKDLKVLNLAY 299
Query: 360 NRFNGTIPNAICDMSRLQYLLLGQNSLKGEIPHEIGNCMKLLQLHIGSNYLTGSIPPEI- 418
N+ N A + LQ L L N L K+ + + N++ I +
Sbjct: 300 NKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIA-IIQDQTF 358
Query: 419 GHIRNLQIALNLSFNHLHGSLPPELGKLDKLVSFDVSNNQLSGTIPSALKGMLSLIEVNF 478
+ LQ L+L N L + + + +S N+L T+P L+ ++
Sbjct: 359 KFLEKLQT-LDLRDNALT-----TIHFIPSIPDIFLSGNKLV-TLPK---INLTANLIHL 408
Query: 479 SNNLLTGPVPSFVPFQKSPN 498
S N L + + P+
Sbjct: 409 SENRLEN-LDILYFLLRVPH 427
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 2e-29
Identities = 65/306 (21%), Positives = 105/306 (34%), Gaps = 21/306 (6%)
Query: 88 LKRLDLSNNAFSGTIPSAFGNLSELEFLDLSLNKFGGVIPRELGSLKDLRFFNISNNVLV 147
++ LDLS+ F L +L+ L+L+ NK + L +L+ N+S N+L
Sbjct: 268 VRHLDLSHGFVFSLNSRVFETLKDLKVLNLAYNKINKIADEAFYGLDNLQVLNLSYNLLG 327
Query: 148 GEIPDELKSLEKLEDFQVSSNKLNGSIPFWVGNLTNLRVFTAYENQLVGEIPDNLGSVSE 207
L K+ + N + L L+ +N L + +
Sbjct: 328 ELYSSNFYGLPKVAYIDLQKNHIAIIQDQTFKFLEKLQTLDLRDNALT-----TIHFIPS 382
Query: 208 LELLNLHSNQLEGPIPKSIFASGKLEVLVLTQNRLTG-DIPELVGHCKSLSNIRIGNNDL 266
+ + L N+L +PK ++ L++NRL DI + L + + N
Sbjct: 383 IPDIFLSGNKLVT-LPKINLT---ANLIHLSENRLENLDILYFLLRVPHLQILILNQNRF 438
Query: 267 VGVIPRAI-GNVSGLTYFEADNNNLSGEIVPE-----FSQCSNLTLLNLASNGFTGVIPP 320
L N L E F S+L +L L N + P
Sbjct: 439 SSCSGDQTPSENPSLEQLFLGENMLQLAWETELCWDVFEGLSHLQVLYLNHNYLNSLPPG 498
Query: 321 ELGQLINLQELILYENSLFGEIPKSILACKNLNKLDLSNNRFNGTIPNAICDMSRLQYLL 380
L L+ L L N L + + L NL LD+S N+ P+ L L
Sbjct: 499 VFSHLTALRGLSLNSNRLT-VLSHNDLP-ANLEILDISRNQLLAPNPDV---FVSLSVLD 553
Query: 381 LGQNSL 386
+ N
Sbjct: 554 ITHNKF 559
|
| >3j0a_A TOLL-like receptor 5; membrane protein, leucine-rich repeat, asymmetric homodimer, glycoprotein, immune system; HET: NAG FUC; 26.00A {Homo sapiens} Length = 844 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 1e-28
Identities = 78/398 (19%), Positives = 141/398 (35%), Gaps = 45/398 (11%)
Query: 68 LDLSRLQLRGNITLVS-------ELKALKRLDLSNNAFSGTIPSAFGN------------ 108
L+ L +++ L+ LD+S N ++ I F N
Sbjct: 179 FSLAANSLYSRVSVDWGKCMNPFRNMVLEILDVSGNGWTVDITGNFSNAISKSQAFSLIL 238
Query: 109 LSELEFLDLSLNKFGGVIPRELGSLKD--LRFFNISNNVLVGEIPDELKSLEKLEDFQVS 166
+ + L +R ++S+ + ++L+ L+ ++
Sbjct: 239 AHHIMGAGFGFHNIKDPDQNTFAGLARSSVRHLDLSHGFVFSLNSRVFETLKDLKVLNLA 298
Query: 167 SNKLNGSIPFWVGNLTNLRVFTAYENQLVGEIPDNLGSVSELELLNLHSNQLEGPIPKSI 226
NK+N L NL+V N L N + ++ ++L N + I
Sbjct: 299 YNKINKIADEAFYGLDNLQVLNLSYNLLGELYSSNFYGLPKVAYIDLQKNHIAI-IQDQT 357
Query: 227 FAS-GKLEVLVLTQNRLTGDIPELVGHCKSLSNIRIGNNDLVGVIPRAIGNVSGLTYFEA 285
F KL+ L L N LT I + S+ +I + N LV + +
Sbjct: 358 FKFLEKLQTLDLRDNALT-TIHFI----PSIPDIFLSGNKLVTLPKINLT----ANLIHL 408
Query: 286 DNNNLSG-EIVPEFSQCSNLTLLNLASNGFTGVIPPEL-GQLINLQELILYENSL----F 339
N L +I+ + +L +L L N F+ + + +L++L L EN L
Sbjct: 409 SENRLENLDILYFLLRVPHLQILILNQNRFSSCSGDQTPSENPSLEQLFLGENMLQLAWE 468
Query: 340 GEIPKSILAC-KNLNKLDLSNNRFNGTIPNAICDMSRLQYLLLGQNSLKGEIPHEIGNCM 398
E+ + +L L L++N N P ++ L+ L L N L + H
Sbjct: 469 TELCWDVFEGLSHLQVLYLNHNYLNSLPPGVFSHLTALRGLSLNSNRLT-VLSHND-LPA 526
Query: 399 KLLQLHIGSNYLTGSIPPEIGHIRNLQIALNLSFNHLH 436
L L I N L + P+ +L + L+++ N
Sbjct: 527 NLEILDISRNQLL-APNPD--VFVSLSV-LDITHNKFI 560
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 7e-38
Identities = 68/354 (19%), Positives = 125/354 (35%), Gaps = 29/354 (8%)
Query: 88 LKRLDLSNNAFSGTIPSAFGNLSELEFLDLSLNKFGGVIPRELGSLKDLRFFNISNNVLV 147
+ + L+ + + + + L S + + N+++ +
Sbjct: 23 FYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIE 82
Query: 148 GEIPDE-LKSLEKLEDFQVSSNKLNGSIPFWV-GNLTNLRVFTAYENQLVGEIPDNL-GS 204
EI ++ + N + +P V N+ L V N L +P + +
Sbjct: 83 -EIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHN 139
Query: 205 VSELELLNLHSNQLEGPIPKSIFAS-GKLEVLVLTQNRLTGDIPELVGHCKSLSNIRIGN 263
+L L++ +N LE I F + L+ L L+ NRLT + SL + +
Sbjct: 140 TPKLTTLSMSNNNLER-IEDDTFQATTSLQNLQLSSNRLT-HVDL--SLIPSLFHANVSY 195
Query: 264 NDLVGVIPRAIGNVSGLTYFEADNNNLSGEIVPEFSQCSNLTLLNLASNGFTGVIPPELG 323
N L + + +A +N+++ +V LT+L L N T L
Sbjct: 196 NLL-----STLAIPIAVEELDASHNSIN--VVRG-PVNVELTILKLQHNNLTDT--AWLL 245
Query: 324 QLINLQELILYENSLFGEIPKSILA-CKNLNKLDLSNNRFNGTIPNAICDMSRLQYLLLG 382
L E+ L N L +I + L +L +SNNR + + L+ L L
Sbjct: 246 NYPGLVEVDLSYNEL-EKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLS 303
Query: 383 QNSLKGEIPHEIGNCMKLLQLHIGSNYLTGSIPPEIGHIRNLQIALNLSFNHLH 436
N L + +L L++ N + ++ L+ L LS N
Sbjct: 304 HNHLL-HVERNQPQFDRLENLYLDHNSIV-TLKL--STHHTLK-NLTLSHNDWD 352
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 144 bits (365), Expect = 1e-37
Identities = 78/353 (22%), Positives = 138/353 (39%), Gaps = 37/353 (10%)
Query: 150 IPDELKSLEKLEDFQVSSNKLNGSIPFWVGNLTNLRVFTAYENQLVGEIPDN-LGSVSEL 208
I L+ D + + F L N ++ T + + ++P L S ++
Sbjct: 13 IDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMR-KLPAALLDSFRQV 71
Query: 209 ELLNLHSNQLEGPIPKSIFAS-GKLEVLVLTQNRLTGDIPELVGHCKSLSNIRIGNNDLV 267
ELLNL+ Q+E I FA ++ L + N + P + + L+ + + NDL
Sbjct: 72 ELLNLNDLQIEE-IDTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS 130
Query: 268 GVIPRAIGNVSGLTYFEADNNNLSGEIVPE-FSQCSNLTLLNLASNGFTGVIPP------ 320
+ N LT NNNL I + F ++L L L+SN T +
Sbjct: 131 SLPRGIFHNTPKLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRLT-HVDLSLIPSL 188
Query: 321 -----------ELGQLINLQELILYENSLFGEIPKSILACKNLNKLDLSNNRFNGTIPNA 369
L I ++EL NS+ + L L L +N T
Sbjct: 189 FHANVSYNLLSTLAIPIAVEELDASHNSI-NVVRGP--VNVELTILKLQHNNL--TDTAW 243
Query: 370 ICDMSRLQYLLLGQNSLKGEIPHEI-GNCMKLLQLHIGSNYLTGSIPPEIGHIRNLQIAL 428
+ + L + L N L+ +I + +L +L+I +N L ++ I L++ L
Sbjct: 244 LLNYPGLVEVDLSYNELE-KIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKV-L 300
Query: 429 NLSFNHLHGSLPPELGKLDKLVSFDVSNNQLSGTIPSALKGMLSLIEVNFSNN 481
+LS NHL + + D+L + + +N + T+ + +L + S+N
Sbjct: 301 DLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLKLST--HHTLKNLTLSHN 349
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 2e-27
Identities = 48/290 (16%), Positives = 93/290 (32%), Gaps = 20/290 (6%)
Query: 198 IPDNLGSVSELELLNLHSNQLEGPIPKSIFASGKLEVLVLTQNRLTGDIPELVGHCKSLS 257
I NL +++ + +++ + + L+ + +
Sbjct: 13 IDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVE 72
Query: 258 NIRIGNNDLVGVIPRAIGNVSGLTYFEADNNNLSGEIVPE--FSQCSNLTLLNLASNGFT 315
+ + + + + A + N + +P F LT+L L N +
Sbjct: 73 LLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIR--YLPPHVFQNVPLLTVLVLERNDLS 130
Query: 316 GVIPPELGQLINLQELILYENSLFGEIPKSILA-CKNLNKLDLSNNRFNGTIPNAICDMS 374
+ L L + N+L I +L L LS+NR + ++ +
Sbjct: 131 SLPRGIFHNTPKLTTLSMSNNNL-ERIEDDTFQATTSLQNLQLSSNRLT-HVDLSL--IP 186
Query: 375 RLQYLLLGQNSLKGEIPHEIGNCMKLLQLHIGSNYLTGSIPPEIGHIRNLQIALNLSFNH 434
L + + N L + + + +L N + + + L I L L N+
Sbjct: 187 SLFHANVSYNLLS-----TLAIPIAVEELDASHNSIN-VVRGPV--NVELTI-LKLQHNN 237
Query: 435 LHGSLPPELGKLDKLVSFDVSNNQLSGTIPSALKGMLSLIEVNFSNNLLT 484
L L LV D+S N+L + M L + SNN L
Sbjct: 238 LTD--TAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRLV 285
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 84.7 bits (210), Expect = 1e-17
Identities = 38/178 (21%), Positives = 72/178 (40%), Gaps = 13/178 (7%)
Query: 70 LSRLQLRGN-ITLVSELKALKRLDLSNNAFSGTIPSAFGNLSELEFLDLSLNKFGGVIPR 128
L + N ++ ++ A++ LD S+N+ + + EL L L N
Sbjct: 188 LFHANVSYNLLSTLAIPIAVEELDASHNSIN-VVRG--PVNVELTILKLQHNNLTDT--A 242
Query: 129 ELGSLKDLRFFNISNNVLVGEIPDE-LKSLEKLEDFQVSSNKLNGSIPFWVGNLTNLRVF 187
L + L ++S N L +I +++LE +S+N+L ++ + + L+V
Sbjct: 243 WLLNYPGLVEVDLSYNELE-KIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVL 300
Query: 188 TAYENQLVGEIPDNLGSVSELELLNLHSNQLEGPIPKSIFASGKLEVLVLTQNRLTGD 245
N L+ + N LE L L N + + S + L+ L L+ N +
Sbjct: 301 DLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLKLSTHHT--LKNLTLSHNDWDCN 354
|
| >3o6n_A APL1; leucine-rich repeat, protein binding; HET: NAG; 1.85A {Anopheles gambiae} Length = 390 | Back alignment and structure |
|---|
Score = 84.3 bits (209), Expect = 2e-17
Identities = 40/229 (17%), Positives = 82/229 (35%), Gaps = 26/229 (11%)
Query: 70 LSRLQLRGN-ITLVSE-----LKALKRLDLSNNAFSGTIPSAFGNLSELEFLDLSLNKFG 123
L+ L + N + + + +L+ L LS+N + + + L ++S N
Sbjct: 143 LTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT-HVD--LSLIPSLFHANVSYNLL- 198
Query: 124 GVIPRELGSLKDLRFFNISNNVLVGEIPDELKSLEKLEDFQVSSNKLNGSIPFWVGNLTN 183
L + + S+N + + + +L ++ N L W+ N
Sbjct: 199 ----STLAIPIAVEELDASHNSIN-VVRGPV--NVELTILKLQHNNLT-DTA-WLLNYPG 249
Query: 184 LRVFTAYENQLVGEIPDN-LGSVSELELLNLHSNQLEGPIPKSIFASGKLEVLVLTQNRL 242
L N+L +I + + LE L + +N+L + L+VL L+ N L
Sbjct: 250 LVEVDLSYNELE-KIMYHPFVKMQRLERLYISNNRLVA-LNLYGQPIPTLKVLDLSHNHL 307
Query: 243 TGDIPELVGHCKSLSNIRIGNNDLVGVIPRAIGNVSGLTYFEADNNNLS 291
+ L N+ + +N +V + + L +N+
Sbjct: 308 L-HVERNQPQFDRLENLYLDHNSIVTL---KLSTHHTLKNLTLSHNDWD 352
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 9e-38
Identities = 76/395 (19%), Positives = 124/395 (31%), Gaps = 73/395 (18%)
Query: 57 DCDLNQAFVVKLDLSRLQLRGNITLVSEL-KALKRLDLSNNAFSGTIPSAFGNLSELEFL 115
C N L++ L TL L + L + +N + ++P+ L LE
Sbjct: 36 ACLNNG--NAVLNVGESGLT---TLPDCLPAHITTLVIPDNNLT-SLPALPPELRTLEVS 89
Query: 116 DLSLNKFGGVIPRELGSLKDLRFFNISNNVLVGEIPDELKSLEKLEDFQVSSNKLNGSIP 175
L +P L +L F+ +P L KL + N+L S+P
Sbjct: 90 GNQLTS----LPVLPPGLLELSIFSNPLT----HLPALPSGLCKLW---IFGNQLT-SLP 137
Query: 176 FWVGNLTNLRVFTAYENQLVGEIPDNLGSVSELELLNLHSNQLEGPIPKSIFASGKLEVL 235
L L V +NQL +P + +L N NQL +P L+ L
Sbjct: 138 VLPPGLQELSV---SDNQL-ASLPALPSELCKLWAYN---NQLTS-LPMLP---SGLQEL 186
Query: 236 VLTQNRLTGDIPELVGHCKSLSNIRIGNNDLVGVIPRAIGNVSGLTYFEADNNNLSGEIV 295
++ N+L +P L L + NN L +L
Sbjct: 187 SVSDNQLA-SLPTLPS---ELYKLWAYNNRL---------------------TSLPALP- 220
Query: 296 PEFSQCSNLTLLNLASNGFTGVIPPELGQLINLQELILYENSLFGEIPKSILACKNLNKL 355
S L L ++ N T +P L+EL++ N L +P L L
Sbjct: 221 ------SGLKELIVSGNRLTS-LPVLPS---ELKELMVSGNRL-TSLPMLP---SGLLSL 266
Query: 356 DLSNNRFNGTIPNAICDMSRLQYLLLGQNSLKGEIPHEIGNCMKLLQLHIGS-NYLTGSI 414
+ N+ +P ++ +S + L N L E + + + G +
Sbjct: 267 SVYRNQLT-RLPESLIHLSSETTVNLEGNPLS-ERTLQALREITSAPGYSGPIIRFDMAG 324
Query: 415 PPEIGHIRNLQIALNLSFNHLHGSLPPELGKLDKL 449
R L +A P +
Sbjct: 325 ASAPRETRALHLAAADWLVPAREGEPAPADRWHMF 359
|
| >3g06_A SSPH2 (leucine-rich repeat protein); E3 ubiquitin ligase, leucine rich repeat domain, type three effector, salmonella virulence factor; 1.90A {Salmonella typhimurium} Length = 622 | Back alignment and structure |
|---|
Score = 145 bits (368), Expect = 2e-36
Identities = 76/351 (21%), Positives = 120/351 (34%), Gaps = 71/351 (20%)
Query: 136 LRFFNISNNVLVGEIPDELKSLEKLEDFQVSSNKLNGSIPFWVGNLTNLRVFTAYENQLV 195
N+ + L +PD L + + N L S+P L L V NQL
Sbjct: 42 NAVLNVGESGL-TTLPDCL--PAHITTLVIPDNNLT-SLPALPPELRTLEV---SGNQLT 94
Query: 196 GEIPDNLGSVSELELLNLHSNQLEGPIPKSIFASGKLEVLVLTQNRLTGDIPELVGHCKS 255
+P + EL + + L +P L L + N+LT +P L +
Sbjct: 95 -SLPVLPPGLLELSIFSNPLTHLP-ALPSG------LCKLWIFGNQLT-SLPVLPPGLQE 145
Query: 256 LSNIRIGNNDLVGVIPRAIGNVSGLTYFEADNNNLSGEIVPEFSQCSNLTLLNLASNGFT 315
LS + +N L +L S L L +N T
Sbjct: 146 LS---VSDNQL---------------------ASLPALP-------SELCKLWAYNNQLT 174
Query: 316 GVIPPELGQLINLQELILYENSLFGEIPKSILACKNLNKLDLSNNRFNGTIPNAICDMSR 375
+P LQEL + +N L +P L KL NNR ++P S
Sbjct: 175 -SLPMLPS---GLQELSVSDNQL-ASLPTLP---SELYKLWAYNNRLT-SLPALP---SG 222
Query: 376 LQYLLLGQNSLKGEIPHEIGNCMKLLQLHIGSNYLTGSIPPEIGHIRNLQIALNLSFNHL 435
L+ L++ N L +P L +L + N LT S+P + +L ++ N L
Sbjct: 223 LKELIVSGNRLT-SLPVLPSE---LKELMVSGNRLT-SLPMLPSGLLSL----SVYRNQL 273
Query: 436 HGSLPPELGKLDKLVSFDVSNNQLSGTIPSALKGMLSLIEVNFSNNLLTGP 486
LP L L + ++ N LS ++ +S ++
Sbjct: 274 T-RLPESLIHLSSETTVNLEGNPLS-ERTLQALREITSAP-GYSGPIIRFD 321
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 3e-36
Identities = 73/402 (18%), Positives = 145/402 (36%), Gaps = 44/402 (10%)
Query: 82 VSELKALKRLDLSNNAFSGTIPSAFGNLSELEFLDLSLNKFGGVIPRELGSLKDLRFFNI 141
+L L LD N++ + + L+ L L + N + +L +L +
Sbjct: 38 EEQLATLTSLDCHNSSITDM--TGIEKLTGLTKLICTSNNITTL---DLSQNTNLTYLAC 92
Query: 142 SNNVLVGEIPDELKSLEKLEDFQVSSNKLNGSIPFWVGNLTNLRVFTAYENQLVGEIPDN 201
+N L + + L KL +NKL + L N L EI
Sbjct: 93 DSNKLT-NLD--VTPLTKLTYLNCDTNKLT-KLDV--SQNPLLTYLNCARNTLT-EID-- 143
Query: 202 LGSVSELELLNLHSNQLEGPIPKSIFASGKLEVLVLTQNRLTGDIPELVGHCKSLSNIRI 261
+ ++L L+ H N+ + + +L L + N++T ++ V K L+ +
Sbjct: 144 VSHNTQLTELDCHLNKKITKLD--VTPQTQLTTLDCSFNKIT-ELD--VSQNKLLNRLNC 198
Query: 262 GNNDLVGVIPRAIGNVSGLTYFEADNNNLSGEIVPEFSQCSNLTLLNLASNGFTGVIPPE 321
N++ + + LT+ + +N L+ EI + + + LT + + N T + +
Sbjct: 199 DTNNITKL---DLNQNIQLTFLDCSSNKLT-EI--DVTPLTQLTYFDCSVNPLTEL---D 249
Query: 322 LGQLINLQELILYENSLFGEIPKSILACKNLNKLDLSNNRFNGTIPNAICDMSRLQYLLL 381
+ L L L + L EI + L + ++L L
Sbjct: 250 VSTLSKLTTLHCIQTDL-LEID--LTHNTQLIYFQAEGC--RKIKELDVTHNTQLYLLDC 304
Query: 382 GQNSLKGEIPHEIGNCMKLLQLHIGSNYLTGSIPPEIGHIRNLQIALNLSFNHLHGSLPP 441
+ E+ + KL+ L++ + LT + + H L+ L+ H+
Sbjct: 305 QAAGIT-ELD--LSQNPKLVYLYLNNTELT-ELD--VSHNTKLKS-LSCVNAHI-QDFSS 356
Query: 442 ELGKLDKLVSFDVSNNQLSGTIPSALKGMLSLIEVNFSNNLL 483
+GK+ L + + Q L + + + S +LL
Sbjct: 357 -VGKIPALNNNFEAEGQTITMPKETLT--NNSLTIAVSPDLL 395
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 9e-35
Identities = 74/443 (16%), Positives = 131/443 (29%), Gaps = 46/443 (10%)
Query: 86 KALKRLDLSNNAFSGTIPSAFGNLSELEFLDLSLNKFGGVIPRELGSLKDLRFFNISNNV 145
+ T + L+ L LD + + + L L ++N
Sbjct: 18 DNFASEVAAAFEMQATDTISEEQLATLTSLDCHNSSITDMTG--IEKLTGLTKLICTSNN 75
Query: 146 LVGEIPDELKSLEKLEDFQVSSNKLNGSIPFWVGNLTNLRVFTAYENQLVGEIPDNLGSV 205
+ + L L SNKL ++ LT L N+L ++
Sbjct: 76 IT-TLD--LSQNTNLTYLACDSNKLT-NLDV--TPLTKLTYLNCDTNKL---TKLDVSQN 126
Query: 206 SELELLNLHSNQLEGPIPKSIFASG--KLEVLVLTQNRLTGDIPELVGHCKSLSNIRIGN 263
L LN N L I S +L L N+ + V L+ +
Sbjct: 127 PLLTYLNCARNTL-----TEIDVSHNTQLTELDCHLNKKITKLD--VTPQTQLTTLDCSF 179
Query: 264 NDLVGVIPRAIGNVSGLTYFEADNNNLSGEIVPEFSQCSNLTLLNLASNGFTGVIPPELG 323
N + + + L D NN++ + +Q LT L+ +SN T + ++
Sbjct: 180 NKITELD---VSQNKLLNRLNCDTNNITK---LDLNQNIQLTFLDCSSNKLTEI---DVT 230
Query: 324 QLINLQELILYENSLFGEIPKSILACKNLNKLDLSNNRFNGTIPNAICDMSRLQYLLLGQ 383
L L N L E+ S L L L I + ++L Y
Sbjct: 231 PLTQLTYFDCSVNPL-TELDVSTL--SKLTTLHCIQTDLL-EID--LTHNTQLIYFQAEG 284
Query: 384 NSLKGEIPHEIGNCMKLLQLHIGSNYLTGSIPPEIGHIRNLQIALNLSFNHLHGSLPPEL 443
E+ ++ + +L L + +T + + L L L+ L L +
Sbjct: 285 CRKIKEL--DVTHNTQLYLLDCQAAGIT-ELD--LSQNPKLVY-LYLNNTELT-ELD--V 335
Query: 444 GKLDKLVSFDVSNNQLSGTIPSALKGMLSLIEVNFSNNLLTGPVPSFVPFQKSPNSSFFG 503
KL S N + S + + +L + + +
Sbjct: 336 SHNTKLKSLSCVNAHIQ-DFSS-VGKIPALNNNFEAEGQTITMPKETLTNNSLTIAVSPD 393
Query: 504 NKGLCGEPLSFSCGNANGPDSKN 526
G P++ G+ D
Sbjct: 394 LLDQFGNPMNIEPGDGGVYDQAT 416
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 6e-29
Identities = 66/405 (16%), Positives = 135/405 (33%), Gaps = 44/405 (10%)
Query: 70 LSRLQLRGN-ITL--VSELKALKRLDLSNNAFSGTIPSAFGNLSELEFLDLSLNKFGGVI 126
L+ L N +T V+ L L L+ N + + L +L+ + N +
Sbjct: 87 LTYLACDSNKLTNLDVTPLTKLTYLNCDTNKLT-KLD--VSQNPLLTYLNCARNTLTEI- 142
Query: 127 PRELGSLKDLRFFNISNNVLVGEIPDELKSLEKLEDFQVSSNKLNGSIPFWVGNLTNLRV 186
++ L + N + ++ + +L S NK+ + L
Sbjct: 143 --DVSHNTQLTELDCHLNKKITKLD--VTPQTQLTTLDCSFNKIT-ELDV--SQNKLLNR 195
Query: 187 FTAYENQLVGEIPDNLGSVSELELLNLHSNQLEGPIPKSIFASG--KLEVLVLTQNRLTG 244
N + ++ L +L L+ SN+L I + +L + N LT
Sbjct: 196 LNCDTNNIT-KLD--LNQNIQLTFLDCSSNKL-----TEIDVTPLTQLTYFDCSVNPLT- 246
Query: 245 DIPELVGHCKSLSNIRIGNNDLVGVIPRAIGNVSGLTYFEADNNNLSGEIVPEFSQCSNL 304
++ V L+ + DL+ + + + + L YF+A+ E+ + + + L
Sbjct: 247 ELD--VSTLSKLTTLHCIQTDLLEI---DLTHNTQLIYFQAEGCRKIKEL--DVTHNTQL 299
Query: 305 TLLNLASNGFTGVIPPELGQLINLQELILYENSLFGEIPKSILACKNLNKLDLSNNRFNG 364
LL+ + G T + +L Q L L L L E+ + L L N
Sbjct: 300 YLLDCQAAGITEL---DLSQNPKLVYLYLNNTEL-TELD--VSHNTKLKSLSCVNAHIQ- 352
Query: 365 TIPNAICDMSRLQYLLLGQNSLKGEIPHEIGNCMKLLQLHIGSNYLTGSIPPEIGHIRNL 424
+ + + L + +P E L + + + L P +
Sbjct: 353 DFSS-VGKIPALNNNFEAEGQTI-TMPKETLTN-NSLTIAVSPDLLDQFGNPMNIEPGDG 409
Query: 425 QIALNLSFNHLHGSLPPELGKLDKLVSFDVSNNQLSGTIPSALKG 469
+ + +L + + +F N + GT+ + +
Sbjct: 410 GVYDQATNTITWENLSTDNPAVT--YTFTSENGAIVGTVTTPFEA 452
|
| >3bz5_A Internalin-J, INLJ; leucine rich repeat (LRR), cysteine ladder, asparagine ladder, virulence factor, solenoid, cell WALL; 2.70A {Listeria monocytogenes} Length = 457 | Back alignment and structure |
|---|
Score = 119 bits (299), Expect = 2e-28
Identities = 64/391 (16%), Positives = 129/391 (32%), Gaps = 66/391 (16%)
Query: 94 SNNAFSGTIPSAFGNLSELEFLDLSLNKFGGVIPRELGSLKDLRFFNISNNVLVGEIPDE 153
+F+ P N + + + +L +L L + N+ +
Sbjct: 7 QTQSFNDWFPDD--NFASEVAAAFEMQATDTISEEQLATLTSL---DCHNSSI--TDMTG 59
Query: 154 LKSLEKLEDFQVSSNKLNGSIPFWVGNLTNLRVFTAYENQLVGEIPDNLGSVSELELLNL 213
++ L L +SN + ++ TNL N+L + + +++L LN
Sbjct: 60 IEKLTGLTKLICTSNNIT-TLDL--SQNTNLTYLACDSNKLT-NLD--VTPLTKLTYLNC 113
Query: 214 HSNQLEGPIPKSIFASGKLEVLVLTQNRLTGDIPELVGHCKSLSNIRIGNNDLVGVIPRA 273
+N+L + S L L +N LT +I
Sbjct: 114 DTNKLT-KLDVSQNP--LLTYLNCARNTLT-EID-------------------------- 143
Query: 274 IGNVSGLTYFEADNNNLSGEIVPEFSQCSNLTLLNLASNGFTGVIPPELGQLINLQELIL 333
+ + + LT + N + + + + LT L+ + N T + ++ Q L L
Sbjct: 144 VSHNTQLTELDCHLNKKITK--LDVTPQTQLTTLDCSFNKITEL---DVSQNKLLNRLNC 198
Query: 334 YENSLFGEIPKSILACKNLNKLDLSNNRFNGTIPNAICDMSRLQYLLLGQNSLKGEIPHE 393
N++ ++ + L LD S+N+ I + +++L Y N L E+
Sbjct: 199 DTNNIT-KLD--LNQNIQLTFLDCSSNKLT-EID--VTPLTQLTYFDCSVNPLT-ELD-- 249
Query: 394 IGNCMKLLQLHIGSNYLTGSIPPEIGHIRNLQIALNLSFNHLHGSLPPELGKLDKLVSFD 453
+ KL LH L I + + + ++ +L D
Sbjct: 250 VSTLSKLTTLHCIQTDLL-EID-----LTHNTQLIYFQAEGCRKIKELDVTHNTQLYLLD 303
Query: 454 VSNNQLSGTIPSALKGMLSLIEVNFSNNLLT 484
++ + L L+ + +N LT
Sbjct: 304 CQAAGIT-ELD--LSQNPKLVYLYLNNTELT 331
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 1e-35
Identities = 62/350 (17%), Positives = 125/350 (35%), Gaps = 27/350 (7%)
Query: 66 VKLDLSRLQLRGNITLVSELKALKRLDLSNNAFSGTIPSAFGNLSELEFLDLSLNKFGGV 125
V +D+ + ++ L K + N+ + + ++E L+L+ + +
Sbjct: 32 VHIDMQTQDVYFGFEDIT-LNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIEEI 90
Query: 126 IPRELGSLKDLRFFNISNNVLVGEIPDELKSLEKLEDFQVSSNKLNGSIP---FWVGNLT 182
++ + N + P +++ L + N L+ S+P F N
Sbjct: 91 DTYAFAYAHTIQKLYMGFNAIRYLPPHVFQNVPLLTVLVLERNDLS-SLPRGIF--HNTP 147
Query: 183 NLRVFTAYENQLVGEIPDN-LGSVSELELLNLHSNQLEGPIPKSIFASGKLEVLVLTQNR 241
L + N L I D+ + + L+ L L SN+L + S+ S L ++ N
Sbjct: 148 KLTTLSMSNNNLE-RIEDDTFQATTSLQNLQLSSNRLTH-VDLSLIPS--LFHANVSYNL 203
Query: 242 LTGDIPELVGHCKSLSNIRIGNNDLVGVIPRAIGNVSGLTYFEADNNNLSGEIVPEFSQC 301
L+ + + ++ + +N + V LT + +NNL+
Sbjct: 204 LS-TLAIPI----AVEELDASHNSINVVRGPVNVE---LTILKLQHNNLTD--TAWLLNY 253
Query: 302 SNLTLLNLASNGFTGVIPPELGQLINLQELILYENSLFGEIPKSILACKNLNKLDLSNNR 361
L ++L+ N ++ ++ L+ L + N L + L LDLS+N
Sbjct: 254 PGLVEVDLSYNELEKIMYHPFVKMQRLERLYISNNRL-VALNLYGQPIPTLKVLDLSHNH 312
Query: 362 FNGTIPNAICDMSRLQYLLLGQNSLKGEIPHEIGNCMKLLQLHIGSNYLT 411
+ RL+ L L NS+ + + L L + N
Sbjct: 313 LL-HVERNQPQFDRLENLYLDHNSIV-TLK--LSTHHTLKNLTLSHNDWD 358
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 2e-35
Identities = 73/404 (18%), Positives = 149/404 (36%), Gaps = 31/404 (7%)
Query: 132 SLKDLRFFNISNNVLVGEIPDELKSLEKLEDFQVSSNKLNGSIPFWV-GNLTNLRVFTAY 190
D+ + +V G L + + + ++ + +P + + + +
Sbjct: 28 VFYDVHIDMQTQDVYFGFEDITLNNQKIVT---FKNSTMR-KLPAALLDSFRQVELLNLN 83
Query: 191 ENQLVGEIPDN-LGSVSELELLNLHSNQLEGPIPKSIFAS-GKLEVLVLTQNRLTGDIPE 248
+ Q+ EI ++ L + N + +P +F + L VLVL +N L+
Sbjct: 84 DLQIE-EIDTYAFAYAHTIQKLYMGFNAIRY-LPPHVFQNVPLLTVLVLERNDLSSLPRG 141
Query: 249 LVGHCKSLSNIRIGNNDLVGVIPRAIGNVSGLTYFEADNNNLSGEIVPEFSQCSNLTLLN 308
+ + L+ + + NN+L + + L + +N L+ + + S +L N
Sbjct: 142 IFHNTPKLTTLSMSNNNLERIEDDTFQATTSLQNLQLSSNRLT-HV--DLSLIPSLFHAN 198
Query: 309 LASNGFTGVIPPELGQLINLQELILYENSLFGEIPKSILACKNLNKLDLSNNRFNGTIPN 368
++ N + L I ++EL NS+ + L L L +N T
Sbjct: 199 VSYNLLS-----TLAIPIAVEELDASHNSI-NVVRGP--VNVELTILKLQHNNL--TDTA 248
Query: 369 AICDMSRLQYLLLGQNSLKGEIPHEI-GNCMKLLQLHIGSNYLTGSIPPEIGHIRNLQIA 427
+ + L + L N L+ +I + +L +L+I +N L ++ I L++
Sbjct: 249 WLLNYPGLVEVDLSYNELE-KIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKV- 305
Query: 428 LNLSFNHLHGSLPPELGKLDKLVSFDVSNNQLSGTIPSALKGMLSLIEVNFSNNLLTGPV 487
L+LS NHL + + D+L + + +N + T+ L +L + S+N
Sbjct: 306 LDLSHNHLL-HVERNQPQFDRLENLYLDHNSIV-TLK--LSTHHTLKNLTLSHNDWD-CN 360
Query: 488 PSFVPFQKSPNSSFFGNKGLCGEPLSFSCGNANGPDSKNYRHRV 531
F+ + C G K Y R+
Sbjct: 361 SLRALFRNVARPAVDDADQHCKIDYQLEHGLCCKESDKPYLDRL 404
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 1e-34
Identities = 73/389 (18%), Positives = 134/389 (34%), Gaps = 31/389 (7%)
Query: 88 LKRLDLSNNAFSGTIPSAFGNLSELEFLDLSLNKFGGVIPRELGSLKDLRFFNISNNVLV 147
+ + L+ + + + + L S + + N+++ +
Sbjct: 29 FYDVHIDMQTQDVYFGFEDITLNNQKIVTFKNSTMRKLPAALLDSFRQVELLNLNDLQIE 88
Query: 148 GEIPDE-LKSLEKLEDFQVSSNKLNGSIPFWV-GNLTNLRVFTAYENQLVGEIPDNL-GS 204
EI ++ + N + +P V N+ L V N L +P + +
Sbjct: 89 -EIDTYAFAYAHTIQKLYMGFNAIR-YLPPHVFQNVPLLTVLVLERNDLS-SLPRGIFHN 145
Query: 205 VSELELLNLHSNQLEGPIPKSIFAS-GKLEVLVLTQNRLTGDIPELVGHCKSLSNIRIGN 263
+L L++ +N LE I F + L+ L L+ NRLT + SL + +
Sbjct: 146 TPKLTTLSMSNNNLER-IEDDTFQATTSLQNLQLSSNRLT-HVDL--SLIPSLFHANVSY 201
Query: 264 NDLVGVIPRAIGNVSGLTYFEADNNNLSGEIVPEFSQCSNLTLLNLASNGFTGVIPPELG 323
N L + + +A +N+++ +V LT+L L N T L
Sbjct: 202 NLL-----STLAIPIAVEELDASHNSIN--VVRG-PVNVELTILKLQHNNLTDT--AWLL 251
Query: 324 QLINLQELILYENSLFGEIPKSILA-CKNLNKLDLSNNRFNGTIPNAICDMSRLQYLLLG 382
L E+ L N L +I + L +L +SNNR + + L+ L L
Sbjct: 252 NYPGLVEVDLSYNEL-EKIMYHPFVKMQRLERLYISNNRLV-ALNLYGQPIPTLKVLDLS 309
Query: 383 QNSLKGEIPHEIGNCMKLLQLHIGSNYLTGSIPPEIGHIRNLQIALNLSFNHLHGSLPPE 442
N L + +L L++ N + ++ L+ L LS N +
Sbjct: 310 HNHLL-HVERNQPQFDRLENLYLDHNSIV-TLKL--STHHTLKN-LTLSHNDWDCNSLRA 364
Query: 443 LGKLDKLVSFDVSNNQLSGTIPSALKGML 471
L + V + I L+ L
Sbjct: 365 L--FRNVARPAVDDADQHCKIDYQLEHGL 391
|
| >3oja_B Anopheles plasmodium-responsive leucine-rich REPE 1; coiled-coil, helix-loop-helix, leucine-rich repeat, protein; HET: NAG MAN; 2.70A {Anopheles gambiae} Length = 597 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 9e-27
Identities = 51/310 (16%), Positives = 97/310 (31%), Gaps = 22/310 (7%)
Query: 178 VGNLTNLRVFTAYENQLVGEIPDNLGSVSELELLNLHSNQLEGPIPKSIFASGKLEVLVL 237
VG V I NL +++ + +++
Sbjct: 1 VGGQQRYNVKP--RQPEYKCIDSNLQYDCVFYDVHIDMQTQDVYFGFEDITLNNQKIVTF 58
Query: 238 TQNRLTGDIPELVGHCKSLSNIRIGNNDLVGVIPRAIGNVSGLTYFEADNNNLSGEIVPE 297
+ + L+ + + + + + + + A + N + +P
Sbjct: 59 KNSTMRKLPAALLDSFRQVELLNLNDLQIEEIDTYAFAYAHTIQKLYMGFNAIR--YLPP 116
Query: 298 --FSQCSNLTLLNLASNGFTGVIPPELGQLINLQELILYENSLFGEIPKSILA-CKNLNK 354
F LT+L L N + + L L + N+L I +L
Sbjct: 117 HVFQNVPLLTVLVLERNDLSSLPRGIFHNTPKLTTLSMSNNNL-ERIEDDTFQATTSLQN 175
Query: 355 LDLSNNRFNGTIPNAICDMSRLQYLLLGQNSLKGEIPHEIGNCMKLLQLHIGSNYLTGSI 414
L LS+NR + ++ + L + + N L + + + +L N + +
Sbjct: 176 LQLSSNRLT-HVDLSL--IPSLFHANVSYNLLS-----TLAIPIAVEELDASHNSIN-VV 226
Query: 415 PPEIGHIRNLQIALNLSFNHLHGSLPPELGKLDKLVSFDVSNNQLSGTIPSALKGMLSLI 474
+ L I L L N+L + L LV D+S N+L + M L
Sbjct: 227 RGPV--NVELTI-LKLQHNNL--TDTAWLLNYPGLVEVDLSYNELEKIMYHPFVKMQRLE 281
Query: 475 EVNFSNNLLT 484
+ SNN L
Sbjct: 282 RLYISNNRLV 291
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 3e-35
Identities = 69/290 (23%), Positives = 120/290 (41%), Gaps = 63/290 (21%)
Query: 616 GTFSTVYKAVMPSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFV-- 673
G F V KA +++K+++S + I EL +LS++ H N+V+ G
Sbjct: 19 GAFGVVCKAKW-RAKDVAIKQIESES-----ERKAFIVELRQLSRVNHPNIVKLYGACLN 72
Query: 674 ----IYEDVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHH-- 727
+ E Y G+L +LH + P Y +S + ++G+A+LH
Sbjct: 73 PVCLVME--------YAEGGSLYNVLHGAEPLPYY--TAAHAMSWCLQCSQGVAYLHSMQ 122
Query: 728 -VAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSKGTA-----SISAVAGSFGYIPPE 781
A+IH D+ N+LL A L K+ D GTA ++ GS ++ PE
Sbjct: 123 PKALIHRDLKPPNLLLVAGGTVL-------KICD--FGTACDIQTHMTNNKGSAAWMAPE 173
Query: 782 ----YAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQ 837
Y+ + +V+S+G++L E++T R P F E + A G P
Sbjct: 174 VFEGSNYSEKC----DVFSWGIILWEVITRRKP----FDEIGGPAFRIMWAVHNGTRPPL 225
Query: 838 ILDARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEMLQEIKQ 887
I + M C P++RP M+++V+++ + +
Sbjct: 226 I-----KNLPKPIESLM-------TRCWSKDPSQRPSMEEIVKIMTHLMR 263
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 136 bits (344), Expect = 3e-34
Identities = 70/308 (22%), Positives = 116/308 (37%), Gaps = 20/308 (6%)
Query: 69 DLSRLQLRGN-ITLVSE-----LKALKRLDLSNNAFSGTIPSAFGNLSELEFLDLSLNKF 122
+ L L N I +++ L+ L+L+ N S P AF NL L L L N+
Sbjct: 33 ETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRL 92
Query: 123 GGVIPRELGSLKDLRFFNISNNVLVGEIPDELKSLEKLEDFQVSSNKLNGSIP---FWVG 179
+ L +L +IS N +V + + L L+ +V N L I F
Sbjct: 93 KLIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLV-YISHRAFS-- 149
Query: 180 NLTNLRVFTAYENQLVGEIPDN-LGSVSELELLNLHSNQLEGPIPKSIFAS-GKLEVLVL 237
L +L T + L IP L + L +L L + I F +L+VL +
Sbjct: 150 GLNSLEQLTLEKCNLT-SIPTEALSHLHGLIVLRLRHLNINA-IRDYSFKRLYRLKVLEI 207
Query: 238 TQNRLTGDIPELVGHCKSLSNIRIGNNDLVGVIPRAIGNVSGLTYFEADNNNLSGEIVPE 297
+ + + +L+++ I + +L V A+ ++ L + N +S I
Sbjct: 208 SHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPIS-TIEGS 266
Query: 298 -FSQCSNLTLLNLASNGFTGVIPPELGQLINLQELILYENSLFGEIPKSILAC-KNLNKL 355
+ L + L V P L L+ L + N L + +S+ NL L
Sbjct: 267 MLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQL-TTLEESVFHSVGNLETL 325
Query: 356 DLSNNRFN 363
L +N
Sbjct: 326 ILDSNPLA 333
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 4e-33
Identities = 72/328 (21%), Positives = 125/328 (38%), Gaps = 15/328 (4%)
Query: 89 KRLDLSNNAFSGTIPSAFGNLSELEFLDLSLNKFGGVIPRELGSLKDLRFFNISNNVLVG 148
+ + F +P +E LDL N+ + E S L ++ N++
Sbjct: 14 RAVLCHRKRFV-AVPEGI--PTETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSA 70
Query: 149 EIPDELKSLEKLEDFQVSSNKLNGSIP---FWVGNLTNLRVFTAYENQLVGEIPDNLGSV 205
P +L L + SN+L IP F L+NL EN++V + +
Sbjct: 71 VEPGAFNNLFNLRTLGLRSNRLK-LIPLGVFT--GLSNLTKLDISENKIVILLDYMFQDL 127
Query: 206 SELELLNLHSNQLEGPIPKSIFAS-GKLEVLVLTQNRLTGDIPELVGHCKSLSNIRIGNN 264
L+ L + N L I F+ LE L L + LT E + H L +R+ +
Sbjct: 128 YNLKSLEVGDNDLVY-ISHRAFSGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHL 186
Query: 265 DLVGVIPRAIGNVSGLTYFEADNNNLSGEIVPEFSQCSNLTLLNLASNGFTGVIPPELGQ 324
++ + + + L E + + P NLT L++ T V +
Sbjct: 187 NINAIRDYSFKRLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRH 246
Query: 325 LINLQELILYENSLFGEIPKSILA-CKNLNKLDLSNNRFNGTIPNAICDMSRLQYLLLGQ 383
L+ L+ L L N + I S+L L ++ L + P A ++ L+ L +
Sbjct: 247 LVYLRFLNLSYNPI-STIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSG 305
Query: 384 NSLKGEIPHEIGNCMKLLQ-LHIGSNYL 410
N L + + + + L+ L + SN L
Sbjct: 306 NQLT-TLEESVFHSVGNLETLILDSNPL 332
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 128 bits (324), Expect = 1e-31
Identities = 70/377 (18%), Positives = 121/377 (32%), Gaps = 81/377 (21%)
Query: 88 LKRLDLSNNAFSGTIPSAFGNLSELEFLDLSLNKFGGVIPRELGSLKDLRFFNISNNVLV 147
+ LDL N F + LE L+L+ N V P +L +LR + +N L
Sbjct: 34 TRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSAVEPGAFNNLFNLRTLGLRSNRLK 93
Query: 148 GEIPDELKSLEKLEDFQVSSNKLNGSIPFWVGNLTNLRVFTAYENQLVGEIPDNLGSVSE 207
IP + F L+NL EN++V + +
Sbjct: 94 -LIPLGV--------FT---------------GLSNLTKLDISENKIVILLDYMFQDLYN 129
Query: 208 LELLNLHSNQLEGPIPKSIFAS-GKLEVLVLTQNRLTGDIPELVGHCKSLSNIRIGNNDL 266
L+ L + N L I F+ LE L L + LT IP
Sbjct: 130 LKSLEVGDNDLVY-ISHRAFSGLNSLEQLTLEKCNLT-SIPTEA---------------- 171
Query: 267 VGVIPRAIGNVSGLTYFEADNNNLSGEIVPEFSQCSNLTLLNLASNGFTGVIPPELGQLI 326
S L +L L + +L
Sbjct: 172 -------------------------------LSHLHGLIVLRLRHLNINAIRDYSFKRLY 200
Query: 327 NLQELILYENSLFGEIPKSILACKNLNKLDLSNNRFNGTIPNAICDMSRLQYLLLGQNSL 386
L+ L + + + L NL L +++ A+ + L++L L N +
Sbjct: 201 RLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLTAVPYLAVRHLVYLRFLNLSYNPI 260
Query: 387 KGEIPHEI-GNCMKLLQLHIGSNYLTGSIPPEI-GHIRNLQIALNLSFNHLHGSLPPEL- 443
I + ++L ++ + L + P + L++ LN+S N L +L +
Sbjct: 261 S-TIEGSMLHELLRLQEIQLVGGQLA-VVEPYAFRGLNYLRV-LNVSGNQLT-TLEESVF 316
Query: 444 GKLDKLVSFDVSNNQLS 460
+ L + + +N L+
Sbjct: 317 HSVGNLETLILDSNPLA 333
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 125 bits (316), Expect = 2e-30
Identities = 69/309 (22%), Positives = 120/309 (38%), Gaps = 15/309 (4%)
Query: 182 TNLRVFTAYENQLVGEIPDNLGSVSELELLNLHSNQLEGPIPKSIFAS-GKLEVLVLTQN 240
T R+ +N++ D S LE L L+ N + + F + L L L N
Sbjct: 32 TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIVSA-VEPGAFNNLFNLRTLGLRSN 90
Query: 241 RLTGDIPELV-GHCKSLSNIRIGNNDLVGVIPRAIGNVSGLTYFEADNNNLSGEIVPE-F 298
RL IP V +L+ + I N +V ++ ++ L E +N+L I F
Sbjct: 91 RLK-LIPLGVFTGLSNLTKLDISENKIVILLDYMFQDLYNLKSLEVGDNDLV-YISHRAF 148
Query: 299 SQCSNLTLLNLASNGFTGVIPPELGQLINLQELILYENSLFGEIPKSILA-CKNLNKLDL 357
S ++L L L T + L L L L L ++ I L L++
Sbjct: 149 SGLNSLEQLTLEKCNLTSIPTEALSHLHGLIVLRLRHLNI-NAIRDYSFKRLYRLKVLEI 207
Query: 358 SNNRFNGTIPNAICDMSRLQYLLLGQNSLKGEIPHE-IGNCMKLLQLHIGSNYLTGSIPP 416
S+ + T+ L L + +L +P+ + + + L L++ N ++ +I
Sbjct: 208 SHWPYLDTMTPNCLYGLNLTSLSITHCNLT-AVPYLAVRHLVYLRFLNLSYNPIS-TIEG 265
Query: 417 EI-GHIRNLQIALNLSFNHLHGSLPPE-LGKLDKLVSFDVSNNQLSGTIPSALKGMLSLI 474
+ + LQ + L L + P L+ L +VS NQL+ S + +L
Sbjct: 266 SMLHELLRLQ-EIQLVGGQLA-VVEPYAFRGLNYLRVLNVSGNQLTTLEESVFHSVGNLE 323
Query: 475 EVNFSNNLL 483
+ +N L
Sbjct: 324 TLILDSNPL 332
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 2e-29
Identities = 69/295 (23%), Positives = 125/295 (42%), Gaps = 17/295 (5%)
Query: 197 EIPDNLGSVSELELLNLHSNQLEGPIPKSIFAS-GKLEVLVLTQNRLTGDIPELV-GHCK 254
+P+ + +E LL+L N+++ + + FAS LE L L +N ++ + +
Sbjct: 25 AVPEGI--PTETRLLDLGKNRIKT-LNQDEFASFPHLEELELNENIVS-AVEPGAFNNLF 80
Query: 255 SLSNIRIGNNDLVGVIPRAIGNVSGLTYFEADNNNLSGEIVPE--FSQCSNLTLLNLASN 312
+L + + +N L + +S LT + N + I+ + F NL L + N
Sbjct: 81 NLRTLGLRSNRLKLIPLGVFTGLSNLTKLDISENKIV--ILLDYMFQDLYNLKSLEVGDN 138
Query: 313 GFTGVIPPELGQLINLQELILYENSLFGEIPKSILA-CKNLNKLDLSNNRFNGTIPNAIC 371
+ L +L++L L + +L IP L+ L L L + N +
Sbjct: 139 DLVYISHRAFSGLNSLEQLTLEKCNL-TSIPTEALSHLHGLIVLRLRHLNINAIRDYSFK 197
Query: 372 DMSRLQYLLLGQNSLKGEIPHEIGNCMKLLQLHIGSNYLTGSIPPE-IGHIRNLQIALNL 430
+ RL+ L + + + L L I LT ++P + H+ L+ LNL
Sbjct: 198 RLYRLKVLEISHWPYLDTMTPNCLYGLNLTSLSITHCNLT-AVPYLAVRHLVYLRF-LNL 255
Query: 431 SFNHLHGSLPPE-LGKLDKLVSFDVSNNQLSGTIPSALKGMLSLIEVNFSNNLLT 484
S+N + ++ L +L +L + QL+ P A +G+ L +N S N LT
Sbjct: 256 SYNPIS-TIEGSMLHELLRLQEIQLVGGQLAVVEPYAFRGLNYLRVLNVSGNQLT 309
|
| >2id5_A Lingo-1, leucine rich repeat neuronal 6A; CNS-specific LRR-IG containing, ligand binding protein,membr protein; HET: NAG MAN; 2.70A {Homo sapiens} Length = 477 | Back alignment and structure |
|---|
Score = 84.0 bits (208), Expect = 5e-17
Identities = 42/194 (21%), Positives = 72/194 (37%), Gaps = 10/194 (5%)
Query: 302 SNLTLLNLASNGFTGVIPPELGQLINLQELILYENSLFGEIPKSILA-CKNLNKLDLSNN 360
+ LL+L N + E +L+EL L EN + + NL L L +N
Sbjct: 32 TETRLLDLGKNRIKTLNQDEFASFPHLEELELNENIV-SAVEPGAFNNLFNLRTLGLRSN 90
Query: 361 RFNGTIPNAICDMSRLQYLLLGQNSLKGEIPHEI-GNCMKLLQLHIGSNYLTGSIPPEI- 418
R +S L L + +N + + + + L L +G N L I
Sbjct: 91 RLKLIPLGVFTGLSNLTKLDISENKIV-ILLDYMFQDLYNLKSLEVGDNDLV-YISHRAF 148
Query: 419 GHIRNLQIALNLSFNHLHGSLPPE-LGKLDKLVSFDVSNNQLSGTIPSALKGMLSLIEVN 477
+ +L+ L L +L S+P E L L L+ + + ++ + K + L +
Sbjct: 149 SGLNSLEQ-LTLEKCNLT-SIPTEALSHLHGLIVLRLRHLNINAIRDYSFKRLYRLKVLE 206
Query: 478 FS-NNLLTGPVPSF 490
S L P+
Sbjct: 207 ISHWPYLDTMTPNC 220
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 1e-33
Identities = 65/278 (23%), Positives = 112/278 (40%), Gaps = 32/278 (11%)
Query: 616 GTFSTVYKAVMPSGLILSVKRLK-SMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVI 674
G F VY+A G ++VK + D I + +E + + L H N++ G +
Sbjct: 18 GGFGKVYRAFW-IGDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCL 76
Query: 675 YEDVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHH---VAII 731
E L+ + G L ++L R ++ A+ +A G+ +LH V II
Sbjct: 77 KEPNLCLVMEFARGGPLNRVLSGK------RIPPDILVNWAVQIARGMNYLHDEAIVPII 130
Query: 732 HLDISSGNVLLDADFKPLLGEIEISKLLD----PSKGTASISAVAGSFGYIPPEYAYTMQ 787
H D+ S N+L+ + +I K+ D + + AG++ ++ PE
Sbjct: 131 HRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTKMSAAGAYAWMAPEVIRASM 190
Query: 788 VTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQILDARLSTVS 847
+ +V+SYGV+L E+LT +P F G+D + +G ST
Sbjct: 191 FSKGSDVWSYGVLLWELLTGEVP----F-RGIDGLAVAYGVAMNKLALP-----IPSTCP 240
Query: 848 FGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEMLQEI 885
+ K M C + P RP +++ L I
Sbjct: 241 EPFAKLMED-------CWNPDPHSRPSFTNILDQLTTI 271
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 3e-33
Identities = 63/313 (20%), Positives = 106/313 (33%), Gaps = 49/313 (15%)
Query: 611 NMIYCGTFSTVYKAVMPSGLILSVKRLKSMDRTIIHHQNKMIRELE--KLSKLCHDNLVR 668
+I G + VYK + ++VK +R I E ++ + HDN+ R
Sbjct: 19 ELIGRGRYGAVYKGSL-DERPVAVKVFSFANR------QNFINEKNIYRVPLMEHDNIAR 71
Query: 669 PIGFVIYEDVALLLH-----NYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLA 723
I + Y PNG+L + L T DW + +A V GLA
Sbjct: 72 FIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLHT------SDWVSSCRLAHSVTRGLA 125
Query: 724 FLH---------HVAIIHLDISSGNVLLDADFKP------LLGEIEISKLLDPSKGTASI 768
+LH AI H D++S NVL+ D L + ++L+ P + +
Sbjct: 126 YLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAA 185
Query: 769 SAVAGSFGYIPPEYA-------YTMQVTAPGNVYSYGVVLLEIL---TTRLPVEEDFGEG 818
+ G+ Y+ PE ++Y+ G++ EI T P E
Sbjct: 186 ISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQ 245
Query: 819 VDLVKWVHGAPARGETPEQILDARLS-TVSFGWRKEMLTALKVALL---CTDSTPAKRPK 874
+ V P + + + W++ L + C D R
Sbjct: 246 MAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQDAEARLT 305
Query: 875 MKKVVEMLQEIKQ 887
+ E + E+
Sbjct: 306 AQXAEERMAELMM 318
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 1e-32
Identities = 59/288 (20%), Positives = 112/288 (38%), Gaps = 48/288 (16%)
Query: 616 GTFSTVYKAV-MPSGLILSVKRLKSMDRTIIHHQNKMI----RELEKLSKLCHDNLVRPI 670
G F V+K + ++++K L D + RE+ +S L H N+V+
Sbjct: 30 GGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLY 89
Query: 671 GFVIYEDVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLH--HV 728
G + + ++ ++P G L L + W +L + + +A G+ ++ +
Sbjct: 90 GLMH--NPPRMVMEFVPCGDLYHRLL----DKAHPIKWSVKLRLMLDIALGIEYMQNQNP 143
Query: 729 AIIHLDISSGNVLLDADFKPLLGEIEI-----SKLLDPSKGTASISAVAGSFGYIPPE-- 781
I+H D+ S N+ L + + ++ S+ S+S + G+F ++ PE
Sbjct: 144 PIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQS-----VHSVSGLLGNFQWMAPETI 198
Query: 782 ----YAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQ 837
+YT + + YS+ ++L ILT P +E + + + R PE
Sbjct: 199 GAEEESYTEKA----DTYSFAMILYTILTGEGPFDEYSYGKIKFINMIREEGLRPTIPED 254
Query: 838 ILDARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEMLQEI 885
R + LC P KRP +V+ L E+
Sbjct: 255 CPPR--------LRNVI-------ELCWSGDPKKRPHFSYIVKELSEL 287
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 2e-32
Identities = 68/285 (23%), Positives = 125/285 (43%), Gaps = 47/285 (16%)
Query: 616 GTFSTVYKAVMPSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIY 675
G+F TV++A G ++VK L D +RE+ + +L H N+V +G V
Sbjct: 48 GSFGTVHRAEW-HGSDVAVKILMEQDFHAERVNE-FLREVAIMKRLRHPNIVLFMGAVTQ 105
Query: 676 EDVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLH--HVAIIHL 733
++ YL G+L +LLH+ + D RLS+A VA+G+ +LH + I+H
Sbjct: 106 PPNLSIVTEYLSRGSLYRLLHK--SGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHR 163
Query: 734 DISSGNVLLD-------ADFKPLLGEIEISKLLDPSKGTASISAVAGSFGYIPPE----Y 782
++ S N+L+D DF G +S+L + S + AG+ ++ PE
Sbjct: 164 NLKSPNLLVDKKYTVKVCDF----G---LSRLK--ASTFLSSKSAAGTPEWMAPEVLRDE 214
Query: 783 AYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQILDAR 842
+ +VYS+GV+L E+ T + P + ++ + V + + E
Sbjct: 215 PSNEKS----DVYSFGVILWELATLQQP----W-GNLNPAQVVAAVGFKCKRLEIP---- 261
Query: 843 LSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEMLQEIKQ 887
++ + C + P KRP ++++L+ + +
Sbjct: 262 -RNLNPQVAAII-------EGCWTNEPWKRPSFATIMDLLRPLIK 298
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 131 bits (330), Expect = 3e-32
Identities = 84/438 (19%), Positives = 159/438 (36%), Gaps = 33/438 (7%)
Query: 68 LDLSRLQLRGNITLV-SELKALKRLDLSNNAFSGTIPSAFGNLSELEFLDLSLNKFGGV- 125
L +S +++ V + L+ LDLS+N I L+ LDLS N F +
Sbjct: 50 LIISHNRIQYLDISVFKFNQELEYLDLSHNKLV-KIS--CHPTVNLKHLDLSFNAFDALP 106
Query: 126 IPRELGSLKDLRFFNISNNVLVGEIPDELKSLEKLEDFQVSSNKLNGSIPFWVGNLTNLR 185
I +E G++ L+F +S L + L + V L +
Sbjct: 107 ICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHLNISKVLLVLGETYGEKEDP--EGLQDFN 164
Query: 186 VFTAYENQLVGEIPDNLGSVSELELLNLHSNQLEGPIPKSIFASGKLEVLVLTQNRLTGD 245
+ + + + VS + NL + ++ + + + + L N +
Sbjct: 165 TESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDNKCSYFLSILAKLQTNPKLSN 224
Query: 246 ---------------IPELVGHCK----SLSNIRIGNNDLVGVIPRAIGNVSGLTYFEAD 286
I +LV H S+SN+++ + ++ L+ +
Sbjct: 225 LTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLDFRDFDYSGTSLKALSIHQVV 284
Query: 287 NNNLSGEIVPEFSQCSNLTLLNLASNGFTGVIPPELGQLINLQELILYENSLFGEIPKSI 346
++ + SN+ + N +G V ++ L N L + ++
Sbjct: 285 SDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKISPFLHLDFSNNLLTDTVFENC 344
Query: 347 LACKNLNKLDLSNNRFN--GTIPNAICDMSRLQYLLLGQNSLKGEIPHEIGNCM-KLLQL 403
L L L N+ I M LQ L + QNS+ + + LL L
Sbjct: 345 GHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQNSVSYDEKKGDCSWTKSLLSL 404
Query: 404 HIGSNYLTGSIPPEIGHIRNLQIALNLSFNHLHGSLPPELGKLDKLVSFDVSNNQLSGTI 463
++ SN LT +I + +++ L+L N + S+P ++ KL+ L +V++NQL
Sbjct: 405 NMSSNILTDTIFRCLPP--RIKV-LDLHSNKIK-SIPKQVVKLEALQELNVASNQLKSVP 460
Query: 464 PSALKGMLSLIEVNFSNN 481
+ SL ++ N
Sbjct: 461 DGIFDRLTSLQKIWLHTN 478
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 126 bits (317), Expect = 2e-30
Identities = 78/456 (17%), Positives = 149/456 (32%), Gaps = 57/456 (12%)
Query: 88 LKRLDLSNNAFSGTIPSAFGNLSELEFLDLSLNKFGGVIPRELGSLKDLRFFNISNNVLV 147
L++S N S S +LS+L L +S N+ + ++L + ++S+N LV
Sbjct: 23 TTILNISQNYISELWTSDILSLSKLRILIISHNRIQYLDISVFKFNQELEYLDLSHNKLV 82
Query: 148 GEIPDELKSLEKLEDFQVSSNKLNGSIPFW--VGNLTNLRVFTAYENQLVGEIPDNL--- 202
+L+ L+ +S N + ++P GN++ L+ L +
Sbjct: 83 KISCHPTVNLKHLD---LSFNAFD-ALPICKEFGNMSQLKFLGLSTTHLEKSSVLPIAHL 138
Query: 203 -------------------GSVSELELLNLHSNQLEGPIPKSIFASGKLEVLVLTQNRLT 243
+ + +LH I V L + +
Sbjct: 139 NISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIK 198
Query: 244 GDIPELV--------------GHCKSLSNIRIGNNDLVGVIPRAIGNVSGLTYFEADNNN 289
+ + +L+ I + + + + YF N
Sbjct: 199 CVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVK 258
Query: 290 LSGEIVPEFSQCSN-----LTLLNLASNGFTGVIPPELGQLINLQELILYENSLFGEIPK 344
L G++ S L++ + S+ F N+ +
Sbjct: 259 LQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHML 318
Query: 345 SILACKNLNKLDLSNNRFNGTIPNAICDMSRLQYLLLGQNSLKGEIPHEIG---NCMKLL 401
LD SNN T+ ++ L+ L+L N LK E+ L
Sbjct: 319 CPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLK-ELSKIAEMTTQMKSLQ 377
Query: 402 QLHIGSNYLTGSIPPEI-GHIRNLQIALNLSFNHLHGSLPPELGKLDKLVSFDVSNNQLS 460
QL I N ++ ++L LN+S N L ++ L ++ D+ +N++
Sbjct: 378 QLDISQNSVSYDEKKGDCSWTKSLLS-LNMSSNILTDTIFRCL--PPRIKVLDLHSNKIK 434
Query: 461 GTIPSALKGMLSLIEVNFSNNLLTG-PVPSFVPFQK 495
+IP + + +L E+N ++N L P F
Sbjct: 435 -SIPKQVVKLEALQELNVASNQLKSVPDGIFDRLTS 469
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 90.3 bits (224), Expect = 5e-19
Identities = 62/340 (18%), Positives = 122/340 (35%), Gaps = 30/340 (8%)
Query: 73 LQLRGNITLVSELKALKRLD--------LSNNAFSGTIPSAFGNLSELEFLDLSLNKFGG 124
L L + + L+ + +N F + + ++ LE ++
Sbjct: 145 LVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLELSNIKCVLEDN 204
Query: 125 VIP---------RELGSLKDLRFFNISNNVLVGEIPDELKSLEKLEDFQVSSNKLNGSIP 175
+ L +L NI +L + F +S+ KL G +
Sbjct: 205 KCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSISNVKLQGQLD 264
Query: 176 FWVGNLTNLRVFTAYENQLVGEIPDNLGSV-----SELELLNLHSNQLEGPIPKSIFASG 230
F + + + +Q+V ++ S S + + N +
Sbjct: 265 FRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRMVHMLCPSKIS 324
Query: 231 KLEVLVLTQNRLTGDIPELVGHCKSLSNIRIGNNDL--VGVIPRAIGNVSGLTYFEADNN 288
L + N LT + E GH L + + N L + I + L + N
Sbjct: 325 PFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMKSLQQLDISQN 384
Query: 289 NLSGEIVPE-FSQCSNLTLLNLASNGFTGVIPPELGQLINLQELILYENSLFGEIPKSIL 347
++S + S +L LN++SN T I L ++ L L+ N + IPK ++
Sbjct: 385 SVSYDEKKGDCSWTKSLLSLNMSSNILTDTIFRCL--PPRIKVLDLHSNKIK-SIPKQVV 441
Query: 348 ACKNLNKLDLSNNRFNGTIPNAICD-MSRLQYLLLGQNSL 386
+ L +L++++N+ ++P+ I D ++ LQ + L N
Sbjct: 442 KLEALQELNVASNQLK-SVPDGIFDRLTSLQKIWLHTNPW 480
|
| >2z7x_B TOLL-like receptor 1, variable lymphocyte recepto; TLR2, TLR1, lipopeptide, innate immunity, glycoPro immune response, inflammatory response, leucine-rich repeat membrane, receptor; HET: NAG NDG MAN BMA PCJ; 2.10A {Homo sapiens} Length = 520 | Back alignment and structure |
|---|
Score = 88.4 bits (219), Expect = 2e-18
Identities = 61/374 (16%), Positives = 122/374 (32%), Gaps = 41/374 (10%)
Query: 4 LCFFSILLLGVLSKSQLVFAQLNDEPTLLAINKELIVPGWGVNGTNFCNWKGIDCDLNQA 63
+ +I + ++ + + IV + +
Sbjct: 135 IAHLNISKVLLVLGETYGEKEDPEGLQDFNTESLHIVFPTNKEFHFILDVSVKTVANLEL 194
Query: 64 FVVKLDLSRLQLRGNITLVSELKA---LKRLDLSNNAFSGTIPSAFGNL---SELEFLDL 117
+K L + ++++++L+ L L L+N + L + + + +
Sbjct: 195 SNIKCVLEDNKCSYFLSILAKLQTNPKLSNLTLNNIETTWNSFIRILQLVWHTTVWYFSI 254
Query: 118 SLNKFGGVIPRELG-----SLKDLRFFNISNNVLVGEIPDELKSLEKLEDFQVSSNKLNG 172
S K G + SLK L + ++V + + + +
Sbjct: 255 SNVKLQGQLDFRDFDYSGTSLKALSIHQVVSDVFGFPQSYIYEIFSNMNIKNFTVSGTRM 314
Query: 173 SIPFWVGNLTNLRVFTAYENQLVGEIPDNLGSVSELELLNLHSNQLEG-PIPKSIFAS-G 230
++ N L + +N G ++ELE L L NQL+ +
Sbjct: 315 VHMLCPSKISPFLHLDFSNNLLTDTVFENCGHLTELETLILQMNQLKELSKIAEMTTQMK 374
Query: 231 KLEVLVLTQNRLTGDIPELVGHCKSLSNIRIGNNDLVGVIPRAIGNVSGLTYFEADNNNL 290
L+ L ++QN ++ D + G C + L +N L
Sbjct: 375 SLQQLDISQNSVSYDEKK--GDCSWTKS---------------------LLSLNMSSNIL 411
Query: 291 SGEIVPEFSQCSNLTLLNLASNGFTGVIPPELGQLINLQELILYENSLFGEIPKSILA-C 349
+ I + +L+L SN IP ++ +L LQEL + N L +P I
Sbjct: 412 TDTIFRCLP--PRIKVLDLHSNKIK-SIPKQVVKLEALQELNVASNQL-KSVPDGIFDRL 467
Query: 350 KNLNKLDLSNNRFN 363
+L K+ L N ++
Sbjct: 468 TSLQKIWLHTNPWD 481
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 125 bits (315), Expect = 1e-31
Identities = 49/298 (16%), Positives = 103/298 (34%), Gaps = 65/298 (21%)
Query: 616 GTFSTVYKA-----VMPSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPI 670
G F VY V +++ + ++R RE+ + H+N+V +
Sbjct: 44 GRFGQVYHGRWHGEV-------AIRLID-IERDNEDQLKAFKREVMAYRQTRHENVVLFM 95
Query: 671 GFVIYEDVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAI 730
G + ++ + TL ++ + D IA + +G+ +LH I
Sbjct: 96 GACMSPPHLAIITSLCKGRTLYSVVRD----AKIVLDVNKTRQIAQEIVKGMGYLHAKGI 151
Query: 731 IHLDISSGNVLLD------ADFKPLLGEIEISKLLDPSKGTASISAVAGSFGYIPPEYAY 784
+H D+ S NV D DF G IS +L + + G ++ PE
Sbjct: 152 LHKDLKSKNVFYDNGKVVITDF----GLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIR 207
Query: 785 TMQVTAPGN---------VYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETP 835
+ + V++ G + E+ P + + +
Sbjct: 208 QLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWP-------------F------KTQPA 248
Query: 836 EQILDARLSTVSFGWRKEMLTA---LKVALL---CTDSTPAKRPKMKKVVEMLQEIKQ 887
E I+ + G + + +++ + C +RP K+++ML+++ +
Sbjct: 249 EAIIWQ----MGTGMKPNLSQIGMGKEISDILLFCWAFEQEERPTFTKLMDMLEKLPK 302
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 7e-31
Identities = 53/286 (18%), Positives = 105/286 (36%), Gaps = 50/286 (17%)
Query: 616 GTFSTVYKAVMPSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIY 675
++K G + VK LK D + ++ E +L H N++ +G
Sbjct: 21 NHSGELWKGRW-QGNDIVVKVLKVRDWSTRKSRD-FNEECPRLRIFSHPNVLPVLGACQS 78
Query: 676 EDVALLLH--NYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHH--VAII 731
+++P G+L +LH + ++ D + A+ +A G+AFLH I
Sbjct: 79 PPAPHPTLITHWMPYGSLYNVLH---EGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIP 135
Query: 732 HLDISSGNVLLDADFKPLLGEIEISKLLDPSKGTA---SISAVAGSFGYIPPE------- 781
++S +V++D D ++ + ++ PE
Sbjct: 136 RHALNSRSVMIDEDMTA--------RISM--ADVKFSFQSPGRMYAPAWVAPEALQKKPE 185
Query: 782 YAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQILDA 841
+++S+ V+L E++T +P F + ++ G P
Sbjct: 186 DTNRRSA----DMWSFAVLLWELVTREVP----F-ADLSNMEIGMKVALEGLRPTIP--- 233
Query: 842 RLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEMLQEIKQ 887
+S K M +C + PAKRPK +V +L++++
Sbjct: 234 --PGISPHVSKLM-------KICMNEDPAKRPKFDMIVPILEKMQD 270
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 8e-31
Identities = 66/298 (22%), Positives = 110/298 (36%), Gaps = 60/298 (20%)
Query: 616 GTFSTVYKAV-MPSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVI 674
G F K +G ++ +K L D Q ++E++ + L H N+++ IG +
Sbjct: 21 GCFGQAIKVTHRETGEVMVMKELIRFDEE---TQRTFLKEVKVMRCLEHPNVLKFIGVLY 77
Query: 675 YEDVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLD 734
+ + Y+ GTL ++ D + W R+S A +A G+A+LH + IIH D
Sbjct: 78 KDKRLNFITEYIKGGTLRGIIK----SMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRD 133
Query: 735 ISSGNVLLD-------ADF-----KPLLGEIEISKLLDPSKGTASISAVAGSFGYIPPE- 781
++S N L+ ADF V G+ ++ PE
Sbjct: 134 LNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEM 193
Query: 782 ---YAYTMQVTAPGNVYSYGVVLLEILTTR------LPVEEDFGEGVDLVKWVHGA--PA 830
+Y +V +V+S+G+VL EI+ LP DFG V
Sbjct: 194 INGRSYDEKV----DVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVR-----GFLDRYC 244
Query: 831 RGETPEQILDARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEMLQEIKQN 888
P + + C D P KRP K+ L+ ++ +
Sbjct: 245 PPNCPPSF-------------------FPITVRCCDLDPEKRPSFVKLEHWLETLRMH 283
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 9e-31
Identities = 60/289 (20%), Positives = 111/289 (38%), Gaps = 27/289 (9%)
Query: 88 LKRLDLSNNAFSGTIPSAFGNLSELEFLDLSLNKFGGVIPRELGSLKDLRFFNISNNVLV 147
LDL NN + F NL L L L NK + P L L +S N L
Sbjct: 54 TALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLK 113
Query: 148 GEIPDEL-KSLEKLEDFQVSSNKLNGSIP---FWVGNLTNLRVFTAYENQL-VGEIPDN- 201
E+P+++ K+L++L +V N++ + F L + V N L I +
Sbjct: 114 -ELPEKMPKTLQEL---RVHENEIT-KVRKSVF--NGLNQMIVVELGTNPLKSSGIENGA 166
Query: 202 LGSVSELELLNLHSNQLEGPIPKSIFASGKLEVLVLTQNRLTGDIPELV-GHCKSLSNIR 260
+ +L + + + IP+ + S L L L N++T + +L+ +
Sbjct: 167 FQGMKKLSYIRIADTNITT-IPQGLPPS--LTELHLDGNKIT-KVDAASLKGLNNLAKLG 222
Query: 261 IGNNDLVGVIPRAIGNVSGLTYFEADNNNLSGEIVPEFSQCSNLTLLNLASNGFTGV--- 317
+ N + V ++ N L +NN L ++ + + ++ L +N + +
Sbjct: 223 LSFNSISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSN 281
Query: 318 ---IPPELGQLINLQELILYENSL-FGEIPKSILAC-KNLNKLDLSNNR 361
P + + + L+ N + + EI S C + L N +
Sbjct: 282 DFCPPGYNTKKASYSGVSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNYK 330
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 1e-26
Identities = 59/275 (21%), Positives = 112/275 (40%), Gaps = 25/275 (9%)
Query: 197 EIPDN-LGSVSELELLNLHSNQLEGPIPKSIFAS-GKLEVLVLTQNRLTGDIPELVGHCK 254
EI D ++ L L L +N++ I FA KLE L L++N+L ++PE K
Sbjct: 66 EIKDGDFKNLKNLHTLILINNKISK-ISPGAFAPLVKLERLYLSKNQLK-ELPE--KMPK 121
Query: 255 SLSNIRIGNNDLVGVIPRAIGNVSGLTYFEADNNNLSGEIVPE--FSQCSNLTLLNLASN 312
+L +R+ N++ V ++ + E N L + F L+ + +A
Sbjct: 122 TLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADT 181
Query: 313 GFTGVIPPELGQLINLQELILYENSLFGEIPKSILA-CKNLNKLDLSNNRFNGTIPNAIC 371
T IP L +L EL L N + ++ + L NL KL LS N + ++
Sbjct: 182 NIT-TIPQGL--PPSLTELHLDGNKI-TKVDAASLKGLNNLAKLGLSFNSISAVDNGSLA 237
Query: 372 DMSRLQYLLLGQNSLKGEIPHEIGNCMKLLQLHIGSNYLTGSIPPE-------IGHIRNL 424
+ L+ L L N L ++P + + + +++ +N ++ +I +
Sbjct: 238 NTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNIS-AIGSNDFCPPGYNTKKASY 295
Query: 425 QIALNLSFNHL-HGSLPPEL-GKLDKLVSFDVSNN 457
++L N + + + P + + + N
Sbjct: 296 SG-VSLFSNPVQYWEIQPSTFRCVYVRAAVQLGNY 329
|
| >1xku_A Decorin; proteoglycan, leucine-rich repeat, structural protein; HET: NAG; 2.15A {Bos taurus} SCOP: c.10.2.7 PDB: 1xec_A* 1xcd_A* Length = 330 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 2e-23
Identities = 60/274 (21%), Positives = 109/274 (39%), Gaps = 22/274 (8%)
Query: 232 LEVLVLTQNRLTGDIPELVGHCKSLSNIRIGNNDLVGVIPRAIGNVSGLTYFEADNNNLS 291
L V+ + L +P+ + + + + NN + + N+ L NN +S
Sbjct: 33 LRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKIS 89
Query: 292 GEIVPE-FSQCSNLTLLNLASNGFTGVIPPELGQLINLQELILYENSLFGEIPKSILA-C 349
+I P F+ L L L+ N +P ++ LQEL ++EN + ++ KS+
Sbjct: 90 -KISPGAFAPLVKLERLYLSKNQLK-ELPEKM--PKTLQELRVHENEIT-KVRKSVFNGL 144
Query: 350 KNLNKLDLSNNRFNGTI--PNAICDMSRLQYLLLGQNSLKGEIPHEIGNCMKLLQLHIGS 407
+ ++L N + A M +L Y+ + ++ IP G L +LH+
Sbjct: 145 NQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQ--GLPPSLTELHLDG 201
Query: 408 NYLTGSIPPEI-GHIRNLQIALNLSFNHLHGSLPPE-LGKLDKLVSFDVSNNQLSGTIPS 465
N +T + + NL L LSFN + ++ L L ++NN+L +P
Sbjct: 202 NKIT-KVDAASLKGLNNLAK-LGLSFNSIS-AVDNGSLANTPHLRELHLNNNKLV-KVPG 257
Query: 466 ALKGMLSLIEVNFSNNLLTG-PVPSFVPFQKSPN 498
L + V NN ++ F P +
Sbjct: 258 GLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTK 291
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 3e-30
Identities = 62/281 (22%), Positives = 115/281 (40%), Gaps = 36/281 (12%)
Query: 616 GTFSTVYKA-----VMPSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPI 670
G+F TVYK V +VK L T Q E+ L K H N++ +
Sbjct: 35 GSFGTVYKGKWHGDV-------AVKMLNVTAPTPQQLQA-FKNEVGVLRKTRHVNILLFM 86
Query: 671 GFVIYEDVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAI 730
G+ +A++ + +L LH + + + + IA A G+ +LH +I
Sbjct: 87 GYSTAPQLAIVTQ-WCEGSSLYHHLH----ASETKFEMKKLIDIARQTARGMDYLHAKSI 141
Query: 731 IHLDISSGNVLLDADFKPLLGEIEISKLLDPSKGTASISAVAGSFGYIPPEYAYTMQVTA 790
IH D+ S N+ L D +G+ ++ G+ ++GS ++ PE MQ +
Sbjct: 142 IHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPE-VIRMQDSN 200
Query: 791 PGN----VYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQILDARLSTV 846
P + VY++G+VL E++T +LP ++ + RG + R +
Sbjct: 201 PYSFQSDVYAFGIVLYELMTGQLPY-----SNINNRDQIIEMVGRGSLSPDLSKVRSNCP 255
Query: 847 SFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEMLQEIKQ 887
++ M C +RP +++ ++E+ +
Sbjct: 256 K-RMKRLMAE-------CLKKKRDERPSFPRILAEIEELAR 288
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 4e-30
Identities = 85/397 (21%), Positives = 154/397 (38%), Gaps = 46/397 (11%)
Query: 110 SELEFLDLSLNKFGGVIPRELGSLKDLRFFNISNNVLVGEIPDEL-KSLEKLEDFQVSSN 168
+ + ++DLSLN + L+DL+F + I + + L L ++ N
Sbjct: 30 AHVNYVDLSLNSIAELNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDYN 89
Query: 169 KLNGSIPFWV-GNLTNLRVFTAYENQL-VGEIPDNL-GSVSELELLNLHSNQLEGPIPKS 225
+ + L NL V T + L + N ++ LE+L L N ++ P S
Sbjct: 90 QF-LQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPAS 148
Query: 226 IFAS-GKLEVLVLTQNRLTGDIPELVGHCKSLSNIRIGNNDLVGVIPRAIGNVSGLTYFE 284
F + + VL LT N++ I E + L S +T +
Sbjct: 149 FFLNMRRFHVLDLTFNKVK-SICEED--LLNFQGKHFTLLRL-----------SSITLQD 194
Query: 285 ADNNNLSGEIVPEFSQCSNLTLLNLASNGFTGVIPPELGQLIN---LQELILYENSL--- 338
+ L E + +++T L+L+ NGF + I +Q LIL +
Sbjct: 195 MNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGS 254
Query: 339 ------FGEIPKSI---LACKNLNKLDLSNNRFNGTIPNAICD-MSRLQYLLLGQNSLKG 388
F + L + DLS ++ + ++ + L+ L L QN +
Sbjct: 255 SFGHTNFKDPDNFTFKGLEASGVKTCDLSKSKIF-ALLKSVFSHFTDLEQLTLAQNEIN- 312
Query: 389 EIPHEI-GNCMKLLQLHIGSNYLTGSIPPEI-GHIRNLQIALNLSFNHLHGSLPPEL-GK 445
+I LL+L++ N+L SI + ++ L++ L+LS+NH+ +L +
Sbjct: 313 KIDDNAFWGLTHLLKLNLSQNFLG-SIDSRMFENLDKLEV-LDLSYNHIR-ALGDQSFLG 369
Query: 446 LDKLVSFDVSNNQLSGTIPS-ALKGMLSLIEVNFSNN 481
L L + NQL ++P + SL ++ N
Sbjct: 370 LPNLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTN 405
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 97.1 bits (242), Expect = 2e-21
Identities = 66/353 (18%), Positives = 123/353 (34%), Gaps = 42/353 (11%)
Query: 70 LSRLQLRGN-ITLVSE-----LKALKRLDLSNNAF-SGTIPS-AFGNLSELEFLDLSLNK 121
L L+L N + L L+ L L+ + F L+ LE L L N
Sbjct: 81 LIILKLDYNQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNN 140
Query: 122 FGGVIPREL-GSLKDLRFFNISNNVLVGEIPDELKSLEKLEDFQVSSNKLNGSIPFWVGN 180
+ P +++ +++ N + ++L + + F +
Sbjct: 141 IKKIQPASFFLNMRRFHVLDLTFNKVKSICEEDLLNFQGKH--------------FTLLR 186
Query: 181 LTNLRVFTAYENQLVGEIPDNLGSVSELELLNLHSNQLEGPIPKSIFASGKLEVLVLTQN 240
L+++ + E L E N + + L+L N + + K F Q+
Sbjct: 187 LSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKESMAKRFF---DAIAGTKIQS 243
Query: 241 RLTGDIPELVGHCKSLSNIRIGNNDLVGVIPRAIGNVSGLTYFEADNNNLSGEIVPE--F 298
+ + + + N G+ SG+ + + + + + F
Sbjct: 244 LILSNSYNMGSSFGHTNFKDPDNFTFKGLEA------SGVKTCDLSKSKIF--ALLKSVF 295
Query: 299 SQCSNLTLLNLASNGFTGVIPPELGQLINLQELILYENSLFGEIPKSILA-CKNLNKLDL 357
S ++L L LA N + L +L +L L +N L G I + L LDL
Sbjct: 296 SHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFL-GSIDSRMFENLDKLEVLDL 354
Query: 358 SNNRFNGTIPNAICD-MSRLQYLLLGQNSLKGEIPHEIGNCMKLLQ-LHIGSN 408
S N + + + L+ L L N LK +P I + + LQ + + +N
Sbjct: 355 SYNHI-RALGDQSFLGLPNLKELALDTNQLK-SVPDGIFDRLTSLQKIWLHTN 405
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 90.2 bits (224), Expect = 4e-19
Identities = 52/324 (16%), Positives = 106/324 (32%), Gaps = 36/324 (11%)
Query: 206 SELELLNLHSNQLEGPIPKSIFAS-GKLEVLVLTQNRLTGDIPELV-GHCKSLSNIRIGN 263
+ + ++L N + + ++ F+ L+ L + Q I SL +++
Sbjct: 30 AHVNYVDLSLNSIAE-LNETSFSRLQDLQFLKVEQQTPGLVIRNNTFRGLSSLIILKLDY 88
Query: 264 NDLVGVIPRAIGNVSGLTYFEADNNNLSGEIVPE--FSQCSNLTLLNLASNGFTGVIPPE 321
N + + A ++ L NL G ++ F ++L +L L N + P
Sbjct: 89 NQFLQLETGAFNGLANLEVLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPAS 148
Query: 322 L-GQLINLQELILYENSLFGEIPKSI---LACKNLNKLDLSNNRFNGTIPNAICD----- 372
+ L L N + I + K+ L LS+ +
Sbjct: 149 FFLNMRRFHVLDLTFNKV-KSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGN 207
Query: 373 ---MSRLQYLLLGQNSLKGEIPHEI-----GNCMKLLQLHIGSNYLTGSIPPEIGHIRNL 424
+ + L L N K + G ++ L L N + N
Sbjct: 208 PFKNTSITTLDLSGNGFKESMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNF 267
Query: 425 QIA---------LNLSFNHLHGSLPPEL-GKLDKLVSFDVSNNQLSGTIPSALKGMLSLI 474
+LS + + +L + L ++ N+++ +A G+ L+
Sbjct: 268 TFKGLEASGVKTCDLSKSKIF-ALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLL 326
Query: 475 EVNFSNNLLTGPVPSFVPFQKSPN 498
++N S N L + S + F+
Sbjct: 327 KLNLSQNFLGS-IDSRM-FENLDK 348
|
| >3v47_A TOLL-like receptor 5B and variable lymphocyte REC chimeric protein; innate immunity, leucine-rich repeat, innate immune receptor system; HET: NAG; 2.47A {Danio rerio} PDB: 3v44_A* Length = 455 | Back alignment and structure |
|---|
Score = 90.2 bits (224), Expect = 5e-19
Identities = 65/342 (19%), Positives = 119/342 (34%), Gaps = 42/342 (12%)
Query: 67 KLDLSRLQLRGNI---TLVSELKALKRLDLSNNAFSGTIP-SAFGNLSELEFLDLSLNKF 122
L L++ L G + L +L+ L L +N P S F N+ LDL+ NK
Sbjct: 107 VLTLTQCNLDGAVLSGNFFKPLTSLEMLVLRDNNIKKIQPASFFLNMRRFHVLDLTFNKV 166
Query: 123 GGVIPRELGSLKDLRF----------FNISNNVLVGEIPDELKSLEKLEDFQVSSNKLNG 172
+ +L + + F +++ L E + +S N
Sbjct: 167 KSICEEDLLNFQGKHFTLLRLSSITLQDMNEYWLGWEKCGNPFKNTSITTLDLSGNGFKE 226
Query: 173 SIPFWVGNLTNLRVFTAYENQLVGEIPDNLGSVSELELLNLHSNQLEGPIPKSIFASGKL 232
S+ + + + + G + + N LE +
Sbjct: 227 SMAKRFFDAIAGTKIQSLILSNSYNMGSSFGHTNFKDPDNFTFKGLEAS---------GV 277
Query: 233 EVLVLTQNRLTGDIPELV-GHCKSLSNIRIGNNDLVGVIPRAIGNVSGLTYFEADNNNLS 291
+ L+++++ + + V H L + + N++ + A ++ L N L
Sbjct: 278 KTCDLSKSKIF-ALLKSVFSHFTDLEQLTLAQNEINKIDDNAFWGLTHLLKLNLSQNFLG 336
Query: 292 GEIVPE--FSQCSNLTLLNLASNGFTGVIPPEL-GQLINLQELILYENSLFGEIPKSILA 348
+ F L +L+L+ N + + L NL+EL L N L +P I
Sbjct: 337 S--IDSRMFENLDKLEVLDLSYNHIR-ALGDQSFLGLPNLKELALDTNQL-KSVPDGIFD 392
Query: 349 C-KNLNKLDLSNNRFNGTIPNAICDMSRLQYLL--LGQNSLK 387
+L K+ L N ++ C R+ YL L +NS K
Sbjct: 393 RLTSLQKIWLHTNPWD-------CSCPRIDYLSRWLNKNSQK 427
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 6e-30
Identities = 67/319 (21%), Positives = 111/319 (34%), Gaps = 32/319 (10%)
Query: 129 ELGSLKDLRFFNISNNVLVGEIPDELKSLEKLEDFQVSSNKLNGSIPFWVGNLTNLRVFT 188
SL F+N + + EK + N+ + +
Sbjct: 9 NNFSLSQNSFYNTISGTY-ADYFSAWDKWEKQALPGENRNEAVSLLKE--CLINQFSELQ 65
Query: 189 AYENQLVGEIPDNLGSVSELELLNLHSNQLEGPIPKSIFASGKLEVLVLTQNRLTGDIPE 248
L +PDNL ++ +L + N L +P+ LE L NRL+ +PE
Sbjct: 66 LNRLNLS-SLPDNLPP--QITVLEITQNALI-SLPELP---ASLEYLDACDNRLS-TLPE 117
Query: 249 LVGHCKSLSNIRIGNNDLVGVIPRAIGNVSGLTYFEADNNNLSGEIVPEFSQCSNLTLLN 308
L K L + NN L ++P L Y ADNN L+ +PE ++L +L+
Sbjct: 118 LPASLKHL---DVDNNQLT-MLPELPAL---LEYINADNNQLTM--LPE--LPTSLEVLS 166
Query: 309 LASNGFTGVIPPELGQLINLQELILYENSLFGEIPKSILACKNLNK----LDLSNNRFNG 364
+ +N T +P +L+ L + N L +P + + + NR
Sbjct: 167 VRNNQLT-FLPELPE---SLEALDVSTNLL-ESLPAVPVRNHHSEETEIFFRCRENRIT- 220
Query: 365 TIPNAICDMSRLQYLLLGQNSLKGEIPHEIGNCMKLLQLHIGSNYLTGSIPPEIGHIRNL 424
IP I + ++L N L I + H Y + S + R L
Sbjct: 221 HIPENILSLDPTCTIILEDNPLSSRIRESLSQQTAQPDYHGPRIYFSMSDGQQNTLHRPL 280
Query: 425 QIALNLSFNHLHGSLPPEL 443
A+ F S ++
Sbjct: 281 ADAVTAWFPENKQSDVSQI 299
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 2e-29
Identities = 49/317 (15%), Positives = 100/317 (31%), Gaps = 56/317 (17%)
Query: 173 SIPFWVGNLTNLRVFTAYEN--QLVGEIPDNLGSVSELELLNLHSNQLEGPIPKSIFASG 230
SI + N +L + Y + + L + N+ + + +
Sbjct: 2 SIMLPINNNFSLSQNSFYNTISGTYADYFSAWDKWEKQALPGENRNEAVSLLKECLINQ- 60
Query: 231 KLEVLVLTQNRLTGDIPELVGHCKSLSNIRIGNNDLVGVIPRAIGNVSGLTYFEADNNNL 290
L L + L+ +P + +T E N L
Sbjct: 61 -FSELQLNRLNLS-------------------------SLPDNLP--PQITVLEITQNAL 92
Query: 291 SGEIVPEFSQCSNLTLLNLASNGFTGVIPPELGQLINLQELILYENSLFGEIPKSILACK 350
+ + +L L+ N + +P +L+ L + N L +P+
Sbjct: 93 I-SLPELPA---SLEYLDACDNRLS-TLPELPA---SLKHLDVDNNQL-TMLPELP---A 140
Query: 351 NLNKLDLSNNRFNGTIPNAICDMSRLQYLLLGQNSLKGEIPHEIGNCMKLLQLHIGSNYL 410
L ++ NN+ +P + L+ L + N L +P + L L + +N L
Sbjct: 141 LLEYINADNNQLT-MLPELP---TSLEVLSVRNNQLT-FLPELPES---LEALDVSTNLL 192
Query: 411 TGSIPPEIGHIRNLQ---IALNLSFNHLHGSLPPELGKLDKLVSFDVSNNQLSGTIPSAL 467
S+P + + I N + +P + LD + + +N LS I +L
Sbjct: 193 E-SLPAVPVRNHHSEETEIFFRCRENRIT-HIPENILSLDPTCTIILEDNPLSSRIRESL 250
Query: 468 KGMLSLIEVNFSNNLLT 484
+ + + +
Sbjct: 251 SQQTAQPDYHGPRIYFS 267
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 118 bits (296), Expect = 1e-27
Identities = 62/343 (18%), Positives = 121/343 (35%), Gaps = 50/343 (14%)
Query: 85 LKALKRLDLSNNAFSGTIPSAFGNLSELEFLDLSLNKFGGVIPRELGSLKDLRFFNISNN 144
L LS N+F TI + + + + N
Sbjct: 5 LPINNNFSLSQNSFYNTISGTYADY-----------------FSAWDKWEKQALPGENRN 47
Query: 145 VLVGEIPDELKSLEKLEDFQVSSNKLNGSIPFWVGNLTNLRVFTAYENQLVGEIPDNLGS 204
V + + L + + + Q++ L+ S+P + + V +N L+ +P+ S
Sbjct: 48 EAVSLLKECL--INQFSELQLNRLNLS-SLPDNLP--PQITVLEITQNALI-SLPELPAS 101
Query: 205 VSELELLNLHSNQLEGPIPKSIFASGKLEVLVLTQNRLTGDIPELVGHCKSLSNIRIGNN 264
LE L+ N+L +P+ L+ L + N+LT +PEL L I NN
Sbjct: 102 ---LEYLDACDNRLST-LPELP---ASLKHLDVDNNQLT-MLPELPA---LLEYINADNN 150
Query: 265 DLVGVIPRAIGNVSGLTYFEADNNNLSGEIVPEFSQCSNLTLLNLASNGFTGVIPPELGQ 324
L ++P + L NN L+ +PE +L L++++N +P +
Sbjct: 151 QLT-MLPELPTS---LEVLSVRNNQLTF--LPE--LPESLEALDVSTNLLES-LPAVPVR 201
Query: 325 LINLQE----LILYENSLFGEIPKSILACKNLNKLDLSNNRFNGTIPNAICDMSRLQYLL 380
+ +E EN + IP++IL+ + L +N + + Q
Sbjct: 202 NHHSEETEIFFRCRENRI-THIPENILSLDPTCTIILEDNPLS-SRIRESLSQQTAQPDY 259
Query: 381 LGQNSLKGEIPHEIGNCMKLLQLHIGSNYLTGSIPPEIGHIRN 423
G + + L + + + + ++ I +
Sbjct: 260 HGPRIYFSMSDGQQNTLHRPLADAV-TAWFPENKQSDVSQIWH 301
|
| >3cvr_A Invasion plasmid antigen; leucine rich repeat and alpha fold, ligase; 2.80A {Shigella flexneri 2A} Length = 571 | Back alignment and structure |
|---|
Score = 104 bits (261), Expect = 2e-23
Identities = 60/343 (17%), Positives = 116/343 (33%), Gaps = 37/343 (10%)
Query: 67 KLDLSRLQLRGNITLVSELKALKRLDLSNNAFSGTIPSAFGNLSELEFLDLSLNKFGGVI 126
L++++ L +L +L+ LD +N S T+P +L LD+ N+ ++
Sbjct: 84 VLEITQNALI---SLPELPASLEYLDACDNRLS-TLPELPASLKH---LDVDNNQL-TML 135
Query: 127 PRELGSLKDLRFFNISNNVLVGEIPDELKSLEKLEDFQVSSNKLNGSIPFWVGNLTNLRV 186
P L+ + N NN L +P+ SLE L V +N+L +P +L L V
Sbjct: 136 PELPALLEYI---NADNNQLT-MLPELPTSLEVLS---VRNNQLT-FLPELPESLEALDV 187
Query: 187 FTAYENQLVGEIPDNLGSVSELE----LLNLHSNQLEGPIPKSIFASGKLEVLVLTQNRL 242
N L +P E N++ IP++I + ++L N L
Sbjct: 188 ---STNLLE-SLPAVPVRNHHSEETEIFFRCRENRITH-IPENILSLDPTCTIILEDNPL 242
Query: 243 TGDIPELVGHCKSLSNIRIGNNDLVGVIPRAIGNVSGLTYFEADNNNLSGEIVPEFSQCS 302
+ I E + + + + N +A + SQ
Sbjct: 243 SSRIRESLSQQTAQPDYHGPRIYF--SMSDGQQNTLHRPLADAVTAWFPENKQSDVSQIW 300
Query: 303 NLTLLNLASNGFTGVIPPELGQLINLQELILYENSLFGEIPKSILACKNLNKLDLSNNRF 362
+ +N F+ L ++ + + + + +L +
Sbjct: 301 HAFEHEEHANTFSA-FLDRLSDTVSARNTSGFREQVAAWLE----KLSASAELRQQSFAV 355
Query: 363 NGTIPNAICD-----MSRLQYLLLGQNSLKGEIPHEIGNCMKL 400
+ D + L+ LL + +G ++ G + L
Sbjct: 356 AADATESCEDRVALTWNNLRKTLLVHQASEGLFDNDTGALLSL 398
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 4e-29
Identities = 64/289 (22%), Positives = 105/289 (36%), Gaps = 28/289 (9%)
Query: 88 LKRLDLSNNAFSGTIPSAFGNLSELEFLDLSLNKFGGVIPRELGSLKDLRFFNISNNVLV 147
LDL NN S F L L L L NK + + L+ L+ IS N LV
Sbjct: 56 TTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKISKIHEKAFSPLRKLQKLYISKNHLV 115
Query: 148 GEIPDEL-KSLEKLEDFQVSSNKLNGSIP---FWVGNLTNLRVFTAYENQL-VGEIPDNL 202
EIP L SL +L ++ N++ +P F L N+ N L
Sbjct: 116 -EIPPNLPSSLVEL---RIHDNRIR-KVPKGVF--SGLRNMNCIEMGGNPLENSGFEPGA 168
Query: 203 GSVSELELLNLHSNQLEGPIPKSIFASGKLEVLVLTQNRLTGDIPELV-GHCKSLSNIRI 261
+L L + +L G IPK + + L L L N++ I L + +
Sbjct: 169 FDGLKLNYLRISEAKLTG-IPKDLPET--LNELHLDHNKIQ-AIELEDLLRYSKLYRLGL 224
Query: 262 GNNDLVGVIPRAIGNVSGLTYFEADNNNLSGEIVPEFSQCSNLTLLNLASNGFTGVIPPE 321
G+N + + ++ + L DNN LS + L ++ L +N T +
Sbjct: 225 GHNQIRMIENGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNIT-KVGVN 282
Query: 322 -------LGQLINLQELILYENSL-FGEIPKSILAC-KNLNKLDLSNNR 361
+ + L+ N + + E+ + C + + N +
Sbjct: 283 DFCPVGFGVKRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNYK 331
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 2e-25
Identities = 58/297 (19%), Positives = 107/297 (36%), Gaps = 35/297 (11%)
Query: 191 ENQLVGEIPDN-LGSVSELELLNLHSNQLEGPIPKSIFAS-GKLEVLVLTQNRLTGDIPE 248
N + E+ + + L L L +N++ I + F+ KL+ L +++N L +IP
Sbjct: 63 NNDIS-ELRKDDFKGLQHLYALVLVNNKISK-IHEKAFSPLRKLQKLYISKNHLV-EIPP 119
Query: 249 LVGHCKSLSNIRIGNNDLVGVIPRAIGNVSGLTYFEADNNNLSGEIVPEFS-QCSNLTLL 307
SL +RI +N + V + + E N L + L L
Sbjct: 120 --NLPSSLVELRIHDNRIRKVPKGVFSGLRNMNCIEMGGNPLENSGFEPGAFDGLKLNYL 177
Query: 308 NLASNGFTGVIPPELGQLINLQELILYENSLFGEIPKSILA-CKNLNKLDLSNNRFNGTI 366
++ TG IP +L L EL L N + I L L +L L +N+
Sbjct: 178 RISEAKLTG-IPKDL--PETLNELHLDHNKI-QAIELEDLLRYSKLYRLGLGHNQIRMIE 233
Query: 367 PNAICDMSRLQYLLLGQNSLKGEIPHEIGNCMKLLQLHIGSNYLTGSIPPEIGHIRNLQI 426
++ + L+ L L N L +P + + L +++ +N +T +
Sbjct: 234 NGSLSFLPTLRELHLDNNKLS-RVPAGLPDLKLLQVVYLHTNNIT-KVGVN--------- 282
Query: 427 ALNLSFNHLHGSLPPELGKLDKLVSFDVSNNQLSGTI--PSALKGMLSLIEVNFSNN 481
F + + K + NN + P+ + + + + F N
Sbjct: 283 ----DFCPVGFGV-----KRAYYNGISLFNNPVPYWEVQPATFRCVTDRLAIQFGNY 330
|
| >2ft3_A Biglycan; proteoglycan, dimer interface, structural protein, signaling; HET: NAG FLC; 3.40A {Bos taurus} Length = 332 | Back alignment and structure |
|---|
Score = 100 bits (250), Expect = 6e-23
Identities = 61/258 (23%), Positives = 106/258 (41%), Gaps = 20/258 (7%)
Query: 232 LEVLVLTQNRLTGDIPELVGHCKSLSNIRIGNNDLVGVIPRAIGNVSGLTYFEADNNNLS 291
L V+ + L +P+ + + + + NND+ + + L NN +S
Sbjct: 35 LRVVQCSDLGLK-AVPKEIS--PDTTLLDLQNNDISELRKDDFKGLQHLYALVLVNNKIS 91
Query: 292 GEIVPE-FSQCSNLTLLNLASNGFTGVIPPELGQLINLQELILYENSLFGEIPKSILA-C 349
+I + FS L L ++ N IPP L +L EL +++N + ++PK + +
Sbjct: 92 -KIHEKAFSPLRKLQKLYISKNHLV-EIPPNL--PSSLVELRIHDNRIR-KVPKGVFSGL 146
Query: 350 KNLNKLDLSNNRF-NGTIPNAICDMSRLQYLLLGQNSLKGEIPHEIGNCMKLLQLHIGSN 408
+N+N +++ N N D +L YL + + L IP L +LH+ N
Sbjct: 147 RNMNCIEMGGNPLENSGFEPGAFDGLKLNYLRISEAKLT-GIPK--DLPETLNELHLDHN 203
Query: 409 YLTGSIPPEI-GHIRNLQIALNLSFNHLHGSLPPE-LGKLDKLVSFDVSNNQLSGTIPSA 466
+ +I E L L L N + + L L L + NN+LS +P+
Sbjct: 204 KIQ-AIELEDLLRYSKLYR-LGLGHNQIR-MIENGSLSFLPTLRELHLDNNKLS-RVPAG 259
Query: 467 LKGMLSLIEVNFSNNLLT 484
L + L V N +T
Sbjct: 260 LPDLKLLQVVYLHTNNIT 277
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 1e-28
Identities = 55/311 (17%), Positives = 103/311 (33%), Gaps = 64/311 (20%)
Query: 616 GTFSTVYKAVMPSGLILSVKRLKSMDRTIIHHQNKMIRELE--KLSKLCHDNLVRPIGFV 673
G + V+ G ++VK + + RE E + + H+N++ I
Sbjct: 48 GRYGEVWMGKW-RGEKVAVKVFFTTEE------ASWFRETEIYQTVLMRHENILGFIAAD 100
Query: 674 IYEDVA----LLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLH--- 726
I + L+ +Y NG+L L +T D + L +A GL LH
Sbjct: 101 IKGTGSWTQLYLITDYHENGSLYDYLKSTT------LDAKSMLKLAYSSVSGLCHLHTEI 154
Query: 727 -----HVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSKGTASIS--AVAGSFGYIP 779
AI H D+ S N+L+ + + ++ ++ I G+ Y+P
Sbjct: 155 FSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMP 214
Query: 780 PE----------YAYTMQVTAPGNVYSYGVVLLEILT----------TRLPVEEDFGEGV 819
PE + + ++YS+G++L E+ +LP +
Sbjct: 215 PEVLDESLNRNHFQSYIMA----DMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDP 270
Query: 820 DLVKWVHGAPARGETPEQILDARLSTVSFGWRKEMLTALKVALL--CTDSTPAKRPKMKK 877
+ P W + L+ C PA R +
Sbjct: 271 SYEDMREIVCIKKLRPS---------FPNRWSSDECLRQMGKLMTECWAHNPASRLTALR 321
Query: 878 VVEMLQEIKQN 888
V + L ++ ++
Sbjct: 322 VKKTLAKMSES 332
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 5e-28
Identities = 57/315 (18%), Positives = 104/315 (33%), Gaps = 78/315 (24%)
Query: 616 GTFSTVYKAVMPSGLILSVKRLKSMDRTIIHHQNKMIRELE--KLSKLCHDNLVRPIGFV 673
G + V++ G ++VK S + RE E L H+N++ I
Sbjct: 19 GRYGEVWRGSW-QGENVAVKIFSS------RDEKSWFRETELYNTVMLRHENILGFIASD 71
Query: 674 IYEDVA----LLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLH--- 726
+ + L+ +Y G+L L +T D + L I + +A GLA LH
Sbjct: 72 MTSRHSSTQLWLITHYHEMGSLYDYLQLTT------LDTVSCLRIVLSIASGLAHLHIEI 125
Query: 727 -----HVAIIHLDISSGNVLLD-------ADFKPLLGEIEISKLLDPSKGTASIS--AVA 772
AI H D+ S N+L+ AD G ++ + S +
Sbjct: 126 FGTQGKPAIAHRDLKSKNILVKKNGQCCIADL----G---LAVMHSQSTNQLDVGNNPRV 178
Query: 773 GSFGYIPPE----------YAYTMQVTAPGNVYSYGVVLLEILT----------TRLPVE 812
G+ Y+ PE + +V +++++G+VL E+ + P
Sbjct: 179 GTKRYMAPEVLDETIQVDCFDSYKRV----DIWAFGLVLWEVARRMVSNGIVEDYKPPFY 234
Query: 813 EDFGEGVDLVKWVHGAPARGETPEQILDARLSTVSFGWRKEMLTALKVALL--CTDSTPA 870
+ + P + W + L+ C P+
Sbjct: 235 DVVPNDPSFEDMRKVVCVDQQRPN---------IPNRWFSDPTLTSLAKLMKECWYQNPS 285
Query: 871 KRPKMKKVVEMLQEI 885
R ++ + L +I
Sbjct: 286 ARLTALRIKKTLTKI 300
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 6e-28
Identities = 55/310 (17%), Positives = 109/310 (35%), Gaps = 64/310 (20%)
Query: 616 GTFSTVYKAVMPSGLILSVKRLKSMDRTIIHHQNKMIRELE--KLSKLCHDNLVRPIGFV 673
G F V++ G ++VK S + RE E + L H+N++ I
Sbjct: 53 GRFGEVWRGKW-RGEEVAVKIFSS------REERSWFREAEIYQTVMLRHENILGFIAAD 105
Query: 674 IYEDVA----LLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLH--- 726
++ L+ +Y +G+L L+ T + +A+ A GLA LH
Sbjct: 106 NKDNGTWTQLWLVSDYHEHGSLFDYLNRYT------VTVEGMIKLALSTASGLAHLHMEI 159
Query: 727 -----HVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSKGTASIS--AVAGSFGYIP 779
AI H D+ S N+L+ + + ++ ++ D + T I+ G+ Y+
Sbjct: 160 VGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMA 219
Query: 780 PE----------YAYTMQVTAPGNVYSYGVVLLEILT----------TRLPVEEDFGEGV 819
PE + + ++Y+ G+V EI +LP +
Sbjct: 220 PEVLDDSINMKHFESFKRA----DIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDP 275
Query: 820 DLVKWVHGAPARGETPEQILDARLSTVSFGWRKEMLTALKVALL--CTDSTPAKRPKMKK 877
+ + + P + W+ + ++ C + A R +
Sbjct: 276 SVEEMRKVVCEQKLRPN---------IPNRWQSCEALRVMAKIMRECWYANGAARLTALR 326
Query: 878 VVEMLQEIKQ 887
+ + L ++ Q
Sbjct: 327 IKKTLSQLSQ 336
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 3e-27
Identities = 74/422 (17%), Positives = 145/422 (34%), Gaps = 38/422 (9%)
Query: 85 LKALKRLDLSNNAFSGTIPSAFGNLSELEFLDLSLNKFGGVIPR--ELGSLKDLRFFNIS 142
+ L+ LD+S+N I ++ L LDLS N F V+P E G+L L F +S
Sbjct: 99 NQDLEYLDVSHNRLQ-NIS--CCPMASLRHLDLSFNDFD-VLPVCKEFGNLTKLTFLGLS 154
Query: 143 NNVLVGEIPDELKSLEKLEDFQVSSNKLNGSIP------FWVGNLTNLRVFTAYENQLVG 196
+L + L + + ++ I + N T L + +
Sbjct: 155 AAKFRQL---DLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHLVFHPNSLFSV 211
Query: 197 EIPDNLGSVSELELLNLHSNQLEGPIPKS----IFASGKLEVLVLTQNRLTGDIPELVGH 252
++ ++ ++ L+L N+ N + + L + L T +
Sbjct: 212 QVNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHIETTWKCSVKLFQ 271
Query: 253 C---KSLSNIRIGNNDLVGVIPRAIGNVSGLTYFEADNNNLSGEIVPE-----FSQCSNL 304
+ + + I N + I R S ++ ++ +S + +
Sbjct: 272 FFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEM 331
Query: 305 TLLNLASNGFTGVIPPELGQLINLQELILYENSLFGEIPKSILACKNLNKLDLSNNRFNG 364
+ L+ + + + L +N + + K L L L N
Sbjct: 332 NIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLK- 390
Query: 365 TIPNAICDMSRLQYLLLGQNSLK----GEIPHEIGNCMKLLQLHIGSNYLTGSIPPEIGH 420
+ L SL +L L++ SN LTGS+ +
Sbjct: 391 NFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCLP- 449
Query: 421 IRNLQIALNLSFNHLHGSLPPELGKLDKLVSFDVSNNQLSGTIP-SALKGMLSLIEVNFS 479
+++ L+L N + S+P ++ L L +V++NQL ++P + SL +
Sbjct: 450 -PKVKV-LDLHNNRIM-SIPKDVTHLQALQELNVASNQLK-SVPDGVFDRLTSLQYIWLH 505
Query: 480 NN 481
+N
Sbjct: 506 DN 507
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 2e-22
Identities = 77/427 (18%), Positives = 143/427 (33%), Gaps = 48/427 (11%)
Query: 91 LDLSNNAFSGTIPSAFGNLSELEFLDLSLNKFGGVIPRELGSLKDLRFFNISNNVLVGEI 150
+D SN + +P + L LS N + ++ L +LR +S+N + +
Sbjct: 36 VDYSNRNLT-HVPK--DLPPRTKALSLSQNSISELRMPDISFLSELRVLRLSHNRI-RSL 91
Query: 151 P----DELKSLEKLEDFQVSSNKLNGSIPFWVGNLTNLRVFTAYENQL----VGEIPDNL 202
+ LE L+ VS N+L +I + +LR N V + NL
Sbjct: 92 DFHVFLFNQDLEYLD---VSHNRL-QNISC--CPMASLRHLDLSFNDFDVLPVCKEFGNL 145
Query: 203 GSVSELELLNLHSNQLEGPIPKSIFASGKLEVLVLTQNRLT---GDIPELVGHCKSLSNI 259
L L L + + + A L ++L G+ L ++ ++
Sbjct: 146 TK---LTFLGLSAAKFRQ-LDLLPVAHLHLSCILLDLVSYHIKGGETESLQIPNTTVLHL 201
Query: 260 RIGNNDLVGVIPRAIGNVSGLTYFEADNNNLSGEIVPEF----------SQCSNLTLLNL 309
N L V +V+ L + + N L+ E N+TL ++
Sbjct: 202 VFHPNSLFSVQ--VNMSVNALGHLQLSNIKLNDENCQRLMTFLSELTRGPTLLNVTLQHI 259
Query: 310 ASNGFTGVIPPELGQLINLQELILYENSLFGEIPKSI-----LACKNLNKLDLSNNRFNG 364
+ V + ++ L +Y ++ I + A K+L + N F
Sbjct: 260 ETTWKCSVKLFQFFWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLF 319
Query: 365 TIPNAICDMSRLQYLLLGQNSLKGEIPHEIGNCMKLLQLHIGSNYLTGSIPPEIGHIRNL 424
+ + + +L + + L+ N T S+ ++ L
Sbjct: 320 SKEALYSVFAEMNIKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRL 379
Query: 425 QIALNLSFNHLHGSLPPELGKLDKLVSFDVSNNQL----SGTIPSALKGMLSLIEVNFSN 480
Q L L N L + + S + + L S S++ +N S+
Sbjct: 380 QT-LILQRNGLK-NFFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSS 437
Query: 481 NLLTGPV 487
N+LTG V
Sbjct: 438 NMLTGSV 444
|
| >3a79_B TLR6, VLRB.59, TOLL-like receptor 6, variable lymphocyte recepto; diacyl lipopeptide, innate immunity, Leu repeat, cell membrane, cytoplasmic vesicle; HET: PXS NAG BMA NDG; 2.90A {Mus musculus} Length = 562 | Back alignment and structure |
|---|
Score = 90.3 bits (224), Expect = 7e-19
Identities = 47/240 (19%), Positives = 87/240 (36%), Gaps = 14/240 (5%)
Query: 60 LNQAFVVKLDLSRLQLRGNITLVS------ELKALKRLDLSNNAFSGTIPSAFGNLSELE 113
V L++ L + I LK+L + N F + + + +E+
Sbjct: 273 FWPRPVEYLNIYNLTITERIDREEFTYSETALKSLMIEHVKNQVFLFSKEALYSVFAEMN 332
Query: 114 FLDLSLNKFGGVIPRELGSLKDLRFFNISNNVLVGEIPDELKSLEKLEDFQVSSNKLNGS 173
LS++ + S F N + NV + +L++L+ + N L +
Sbjct: 333 IKMLSISDTPFIHMVCPPSPSSFTFLNFTQNVFTDSVFQGCSTLKRLQTLILQRNGLK-N 391
Query: 174 IPFWVGNLTNLRVFTAYENQLV----GEIPDNLGSVSELELLNLHSNQLEGPIPKSIFAS 229
N+ + L + +LNL SN L G + + +
Sbjct: 392 FFKVALMTKNMSSLETLDVSLNSLNSHAYDRTCAWAESILVLNLSSNMLTGSVFRCL--P 449
Query: 230 GKLEVLVLTQNRLTGDIPELVGHCKSLSNIRIGNNDLVGVIPRAIGNVSGLTYFEADNNN 289
K++VL L NR+ IP+ V H ++L + + +N L V ++ L Y +N
Sbjct: 450 PKVKVLDLHNNRIM-SIPKDVTHLQALQELNVASNQLKSVPDGVFDRLTSLQYIWLHDNP 508
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 103 bits (258), Expect = 3e-24
Identities = 55/246 (22%), Positives = 91/246 (36%), Gaps = 22/246 (8%)
Query: 255 SLSNIRIGNNDLVGVIPRAIGNVSGLTYFEADNNNLSGEIVPEFSQCSNLTL--LNLASN 312
++ RI + L G + + +SGL +N ++G P + + L LNL +
Sbjct: 74 TVRAARIPSRILFGAL--RVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNLRNV 131
Query: 313 GFTGV--IPPELGQLI--NLQELILYENSLFGEIPKSILACKNLNKLDLSNNRFNG--TI 366
+ EL Q + L+ L + + + + L+ LDLS+N G +
Sbjct: 132 SWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELGERGL 191
Query: 367 PNAICD--MSRLQYLLLGQN---SLKGEIPHEIGNCMKLLQLHIGSNYLTGSIPPEI-GH 420
+A+C LQ L L + G ++L L + N L +
Sbjct: 192 ISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAPSCDW 251
Query: 421 IRNLQIALNLSFNHLHGSLPPELGKLDKLVSFDVSNNQLSGTIPSALKGMLSLIEVNFSN 480
L LNLSF L +P L KL D+S N+L PS + + ++
Sbjct: 252 PSQLNS-LNLSFTGLK-QVPKGLPA--KLSVLDLSYNRLD-RNPSPD-ELPQVGNLSLKG 305
Query: 481 NLLTGP 486
N
Sbjct: 306 NPFLDS 311
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 91.1 bits (226), Expect = 4e-20
Identities = 49/250 (19%), Positives = 76/250 (30%), Gaps = 22/250 (8%)
Query: 204 SVSELELLNLHSNQLEGPIPKSIFASGKLEVLVLTQNRLTG--DIPELVGHCKSLSNIRI 261
S+ L + + L+ L L +TG P L L+ + +
Sbjct: 69 SLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILNL 128
Query: 262 GNNDLVGVIPRAIGNVS-----GLTYFEADNNNLSGEIVPEFSQCSNLTLLNLASNGFTG 316
N + + GL + + L+ L+L+ N G
Sbjct: 129 RNVSWAT-RDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELG 187
Query: 317 VIPPE----LGQLINLQELILYEN---SLFGEIPKSILACKNLNKLDLSNNRFNGTIPNA 369
+ LQ L L + G A L LDLS+N
Sbjct: 188 ERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRDAAGAP 247
Query: 370 ICD-MSRLQYLLLGQNSLKGEIPHEIGNCMKLLQLHIGSNYLTGSIPPEIGHIRNLQIAL 428
CD S+L L L LK ++P + KL L + N L + P + + L
Sbjct: 248 SCDWPSQLNSLNLSFTGLK-QVPKGLPA--KLSVLDLSYNRLDRN--PSPDELPQVGN-L 301
Query: 429 NLSFNHLHGS 438
+L N S
Sbjct: 302 SLKGNPFLDS 311
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 81.5 bits (201), Expect = 7e-17
Identities = 36/193 (18%), Positives = 63/193 (32%), Gaps = 18/193 (9%)
Query: 65 VVKLDLSRLQLRGNITLVSEL-----KALKRLDLSNNAFSGTIPSAFGNLSELEFLDLSL 119
+ L+L + ++EL LK L ++ L LDLS
Sbjct: 123 LNILNLRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSD 182
Query: 120 NKFGG-------VIPRELGSLKDLRFFNISNNVLVGEIPDELKSLEKLEDFQVSSNKLNG 172
N G + P + +L+ L N G + +L+ +S N L
Sbjct: 183 NPELGERGLISALCPLKFPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRD 242
Query: 173 SIPFWV-GNLTNLRVFTAYENQLVGEIPDNLGSVSELELLNLHSNQLEGPIPKSIFASGK 231
+ + L L ++P L ++L +L+L N+L+ P +
Sbjct: 243 AAGAPSCDWPSQLNSLNLSFTGLK-QVPKGLP--AKLSVLDLSYNRLDR-NPSPDELP-Q 297
Query: 232 LEVLVLTQNRLTG 244
+ L L N
Sbjct: 298 VGNLSLKGNPFLD 310
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 78.8 bits (194), Expect = 6e-16
Identities = 45/265 (16%), Positives = 80/265 (30%), Gaps = 38/265 (14%)
Query: 68 LDLSRLQLRGNITLVSELKA---------LKRLDLSNNAFSGTIPSAFG-----NLSELE 113
L L RL +R L L+ L L N +GT P +L+ L
Sbjct: 68 LSLKRLTVRAARIPSRILFGALRVLGISGLQELTLENLEVTGTAPPPLLEATGPDLNILN 127
Query: 114 FLDLSLNKFGGVIPR-ELGSLKDLRFFNISNNVLVGEIPDELKSLEKLEDFQVSSNKLNG 172
++S + + L+ +I+ + ++++ L +S N G
Sbjct: 128 LRNVSWATRDAWLAELQQWLKPGLKVLSIAQAHSLNFSCEQVRVFPALSTLDLSDNPELG 187
Query: 173 SIPFWVGNLTNLRVFTAYENQLVGEIPDNLGSVSELELLNLHSNQLEGPIPKSIFASGKL 232
P ++ L L N G A +L
Sbjct: 188 ERGLISAL-----------------CPLKFPTLQVLALRNAGMETPSGVCSALAAARVQL 230
Query: 233 EVLVLTQNRLTGDIPELV-GHCKSLSNIRIGNNDLVGVIPRAIGNVSGLTYFEADNNNLS 291
+ L L+ N L L+++ + L V P+ + + L+ + N L
Sbjct: 231 QGLDLSHNSLRDAAGAPSCDWPSQLNSLNLSFTGLKQV-PKGLP--AKLSVLDLSYNRLD 287
Query: 292 GEIVPEFSQCSNLTLLNLASNGFTG 316
P + + L+L N F
Sbjct: 288 R--NPSPDELPQVGNLSLKGNPFLD 310
|
| >1wwl_A Monocyte differentiation antigen CD14; LPS, immune system; HET: NAG; 2.50A {Mus musculus} Length = 312 | Back alignment and structure |
|---|
Score = 74.5 bits (183), Expect = 1e-14
Identities = 39/236 (16%), Positives = 66/236 (27%), Gaps = 34/236 (14%)
Query: 275 GNVSGLTYFEADNNNLSGEIVPEFSQCSNLTLLNLASNGFTGVIPPELGQLIN---LQEL 331
G S + + + + +L L + + I +++ LQEL
Sbjct: 41 GGRSLEYLLKRVDTEADLGQFTDIIKSLSLKRLTVRAARIPSRILFGALRVLGISGLQEL 100
Query: 332 ILYENSLFGEIPKSILAC--KNLNKLDLSNNRFNGTIPNAICDMSRLQYLLLGQNSLKGE 389
L + G P +L +LN L+L N + ++ LQ L
Sbjct: 101 TLENLEVTGTAPPPLLEATGPDLNILNLRNVSWATRDA----WLAELQQWLK-------- 148
Query: 390 IPHEIGNCMKLLQLHIGSNYLTGSIPPEIGHIRNLQIALNLSFNHLHGSLPPE----LGK 445
L L I + ++ L L+LS N G K
Sbjct: 149 --------PGLKVLSIAQAHSLNFSCEQVRVFPALST-LDLSDNPELGERGLISALCPLK 199
Query: 446 LDKLVSFDVSNNQ---LSGTIPSALKGMLSLIEVNFSNNLLTGPVPSFVPFQKSPN 498
L + N SG + + L ++ S+N L
Sbjct: 200 FPTLQVLALRNAGMETPSGVCSALAAARVQLQGLDLSHNSLRD-AAGAPSCDWPSQ 254
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 5e-24
Identities = 58/295 (19%), Positives = 109/295 (36%), Gaps = 22/295 (7%)
Query: 197 EIPDNLGSVSELELLNLHSNQLEGPIPKSIFAS-GKLEVLVLTQNRLTGDIPELVGHCKS 255
+P + S L L SN+L+ +P +F +L L L+ N L+
Sbjct: 21 SVPTGIPS--SATRLELESNKLQS-LPHGVFDKLTQLTKLSLSSNGLS-FKGCCSQSDFG 76
Query: 256 LSNIR---IGNNDLVGVIPRAIGNVSGLTYFEADNNNLSGEIVPE--FSQCSNLTLLNLA 310
++++ + N ++ + + L + + ++NL ++ F NL L+++
Sbjct: 77 TTSLKYLDLSFNGVI-TMSSNFLGLEQLEHLDFQHSNLK-QMSEFSVFLSLRNLIYLDIS 134
Query: 311 SNGFTGVIPPELGQLINLQELILYENSLFGEIPKSILA-CKNLNKLDLSNNRFNGTIPNA 369
L +L+ L + NS I +NL LDLS + P A
Sbjct: 135 HTHTRVAFNGIFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTA 194
Query: 370 ICDMSRLQYLLLGQNSLKGEIPHEIGNCMKLLQ-LHIGSNYLTGSIPPEI--GHIRNLQI 426
+S LQ L + N+ + C+ LQ L N++ + + +L
Sbjct: 195 FNSLSSLQVLNMSHNNFF-SLDTFPYKCLNSLQVLDYSLNHIM-TSKKQELQHFPSSLAF 252
Query: 427 ALNLSFNHLH--GSLPPELGKLDKLVSFDVSNNQLSGTIPSALKGMLSLIEVNFS 479
LNL+ N L + V ++ PS +GM ++ +N +
Sbjct: 253 -LNLTQNDFACTCEHQSFLQWIKDQRQLLVEVERMECATPSDKQGM-PVLSLNIT 305
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 2e-23
Identities = 49/234 (20%), Positives = 85/234 (36%), Gaps = 14/234 (5%)
Query: 88 LKRLDLSNNAFSGTIPSAFGNLSELEFLDLSLNK--FGGVIPRELGSLKDLRFFNISNNV 145
RL+L +N F L++L L LS N F G + L++ ++S N
Sbjct: 30 ATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSFNG 89
Query: 146 LVGEIPDELKSLEKLEDFQVSSNKLNGSIPFWV-GNLTNLRVFTAYENQLVGEIPDN-LG 203
++ + LE+LE + L F V +L NL +
Sbjct: 90 VI-TMSSNFLGLEQLEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTR-VAFNGIFN 147
Query: 204 SVSELELLNLHSNQLEGPIPKSIFAS-GKLEVLVLTQNRLTGDIPELVGHC-KSLSNIRI 261
+S LE+L + N + IF L L L+Q +L + + SL + +
Sbjct: 148 GLSSLEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLE-QLSPTAFNSLSSLQVLNM 206
Query: 262 GNNDLVGVIPRAIGNVSGLTYFEADNNNLSGEIVPE---FSQCSNLTLLNLASN 312
+N+ + ++ L + N++ + S+L LNL N
Sbjct: 207 SHNNFFSLDTFPYKCLNSLQVLDYSLNHIM--TSKKQELQHFPSSLAFLNLTQN 258
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 96.6 bits (241), Expect = 6e-22
Identities = 49/214 (22%), Positives = 83/214 (38%), Gaps = 12/214 (5%)
Query: 278 SGLTYFEADNNNLSGEIVPEFSQCSNLTLLNLASNGFT--GVIPPELGQLINLQELILYE 335
S T E ++N L F + + LT L+L+SNG + G +L+ L L
Sbjct: 28 SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSSNGLSFKGCCSQSDFGTTSLKYLDLSF 87
Query: 336 NSLFGEIPKSILACKNLNKLDLSNNRFNGTIP--NAICDMSRLQYLLLGQNSLKGEIPHE 393
N + + + L + L LD ++ + + + L YL + + +
Sbjct: 88 NGV-ITMSSNFLGLEQLEHLDFQHSNLK-QMSEFSVFLSLRNLIYLDISHTHTR-VAFNG 144
Query: 394 I-GNCMKLLQLHIGSNYLTGSIPPEI-GHIRNLQIALNLSFNHLHGSLPPE-LGKLDKLV 450
I L L + N + P+I +RNL L+LS L L P L L
Sbjct: 145 IFNGLSSLEVLKMAGNSFQENFLPDIFTELRNLTF-LDLSQCQLE-QLSPTAFNSLSSLQ 202
Query: 451 SFDVSNNQLSGTIPSALKGMLSLIEVNFSNNLLT 484
++S+N K + SL +++S N +
Sbjct: 203 VLNMSHNNFFSLDTFPYKCLNSLQVLDYSLNHIM 236
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 68.5 bits (168), Expect = 2e-12
Identities = 38/161 (23%), Positives = 62/161 (38%), Gaps = 15/161 (9%)
Query: 70 LSRLQLRGN-ITLVSE------LKALKRLDLSNNAFSGTIPSAFGNLSELEFLDLSLNKF 122
L L + + + +SE L+ L LD+S+ F LS LE L ++ N F
Sbjct: 103 LEHLDFQHSNLKQMSEFSVFLSLRNLIYLDISHTHTRVAFNGIFNGLSSLEVLKMAGNSF 162
Query: 123 GGVIPRE-LGSLKDLRFFNISNNVLVGEIPDE-LKSLEKLEDFQVSSNKLNGSIPFWV-G 179
+ L++L F ++S L ++ SL L+ +S N S+ +
Sbjct: 163 QENFLPDIFTELRNLTFLDLSQCQLE-QLSPTAFNSLSSLQVLNMSHNNFF-SLDTFPYK 220
Query: 180 NLTNLRVFTAYENQLVGEIPDNL--GSVSELELLNLHSNQL 218
L +L+V N ++ S L LNL N
Sbjct: 221 CLNSLQVLDYSLNHIM-TSKKQELQHFPSSLAFLNLTQNDF 260
|
| >2z66_A Variable lymphocyte receptor B, TOLL-like recepto; TLR4, TOLL-like receptor, MD-2, LPS, leucine-rich repeat, glycoprotein, immune response; HET: NAG BMA FUL; 1.90A {Eptatretus burgeri} Length = 306 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 5e-07
Identities = 28/110 (25%), Positives = 44/110 (40%), Gaps = 8/110 (7%)
Query: 70 LSRLQLRGN--ITLVSE-----LKALKRLDLSNNAFSGTIPSAFGNLSELEFLDLSLNKF 122
L L++ GN L+ L LDLS P+AF +LS L+ L++S N F
Sbjct: 152 LEVLKMAGNSFQENFLPDIFTELRNLTFLDLSQCQLEQLSPTAFNSLSSLQVLNMSHNNF 211
Query: 123 GGVIPRELGSLKDLRFFNISNNVLVGEIPDELKSLEK-LEDFQVSSNKLN 171
+ L L+ + S N ++ EL+ L ++ N
Sbjct: 212 FSLDTFPYKCLNSLQVLDYSLNHIMTSKKQELQHFPSSLAFLNLTQNDFA 261
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 1e-22
Identities = 54/261 (20%), Positives = 104/261 (39%), Gaps = 21/261 (8%)
Query: 229 SGKLEVLVLTQNRLT---GDIPELVGHCKSLSNIRIGNNDLVGVIPRAIGNVSGLTYFEA 285
S + ++ + L I + + + N + + + ++ L +
Sbjct: 42 SNQFSKVICVRKNLREVPDGIST------NTRLLNLHENQIQIIKVNSFKHLRHLEILQL 95
Query: 286 DNNNLSGEIVPE-FSQCSNLTLLNLASNGFTGVIPPELGQLINLQELILYENSLFGEIPK 344
N++ I F+ +NL L L N T + L L+EL L N + IP
Sbjct: 96 SRNHIR-TIEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPI-ESIPS 153
Query: 345 SILA-CKNLNKLDLSNNRFNGTIP-NAICDMSRLQYLLLGQNSLKGEIPHEIGNCMKLLQ 402
+L +LDL + I A +S L+YL L +L+ EIP+ + +KL +
Sbjct: 154 YAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIPN-LTPLIKLDE 211
Query: 403 LHIGSNYLTGSIPPEI-GHIRNLQIALNLSFNHLHGSLPPE-LGKLDKLVSFDVSNNQLS 460
L + N+L+ +I P + +LQ L + + + + L LV ++++N L+
Sbjct: 212 LDLSGNHLS-AIRPGSFQGLMHLQK-LWMIQSQIQ-VIERNAFDNLQSLVEINLAHNNLT 268
Query: 461 GTIPSALKGMLSLIEVNFSNN 481
+ L ++ +N
Sbjct: 269 LLPHDLFTPLHHLERIHLHHN 289
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 94.8 bits (236), Expect = 1e-20
Identities = 49/242 (20%), Positives = 92/242 (38%), Gaps = 17/242 (7%)
Query: 150 IPDELKSLEKLEDFQVSSNKLNGSIPFWVGNLTNLRVFTAYENQLVGEIPDN-LGSVSEL 208
I + L + N++ +L +L + N + I ++ L
Sbjct: 62 ISTNTRLLN------LHENQIQIIKVNSFKHLRHLEILQLSRNHI-RTIEIGAFNGLANL 114
Query: 209 ELLNLHSNQLEGPIPKSIFAS-GKLEVLVLTQNRLTGDIPELV-GHCKSLSNIRIG-NND 265
L L N+L IP F KL+ L L N + IP SL + +G
Sbjct: 115 NTLELFDNRLTT-IPNGAFVYLSKLKELWLRNNPIE-SIPSYAFNRIPSLRRLDLGELKR 172
Query: 266 LVGVIPRAIGNVSGLTYFEADNNNLSGEIVPEFSQCSNLTLLNLASNGFTGVIPPELGQL 325
L + A +S L Y NL +P + L L+L+ N + + P L
Sbjct: 173 LSYISEGAFEGLSNLRYLNLAMCNLRE--IPNLTPLIKLDELDLSGNHLSAIRPGSFQGL 230
Query: 326 INLQELILYENSLFGEIPKSILAC-KNLNKLDLSNNRFNGTIPNAICDMSRLQYLLLGQN 384
++LQ+L + ++ + I ++ ++L +++L++N + + L+ + L N
Sbjct: 231 MHLQKLWMIQSQI-QVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHN 289
Query: 385 SL 386
Sbjct: 290 PW 291
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 94.0 bits (234), Expect = 2e-20
Identities = 54/255 (21%), Positives = 88/255 (34%), Gaps = 33/255 (12%)
Query: 88 LKRLDLSNNAFSGTIPSAFGNLSELEFLDLSLNKFGGVIPRELGSLKDLRFFNISNNVLV 147
+ L+L N ++F +L LE L LS N + L +L + +N L
Sbjct: 66 TRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRLT 125
Query: 148 GEIPDE-LKSLEKLEDFQVSSNKLNGSIPFWVGNLTNLRVFTAYENQLVGEIPDNLGSVS 206
IP+ L KL++ + +N + SIP +
Sbjct: 126 -TIPNGAFVYLSKLKELWLRNNPIE-SIP-----------------------SYAFNRIP 160
Query: 207 ELELLNL-HSNQLEGPIPKSIFAS-GKLEVLVLTQNRLTGDIPELVGHCKSLSNIRIGNN 264
L L+L +L I + F L L L L +IP L L + + N
Sbjct: 161 SLRRLDLGELKRLSY-ISEGAFEGLSNLRYLNLAMCNLR-EIPNL-TPLIKLDELDLSGN 217
Query: 265 DLVGVIPRAIGNVSGLTYFEADNNNLSGEIVPE-FSQCSNLTLLNLASNGFTGVIPPELG 323
L + P + + L + + I F +L +NLA N T +
Sbjct: 218 HLSAIRPGSFQGLMHLQKLWMIQSQIQ-VIERNAFDNLQSLVEINLAHNNLTLLPHDLFT 276
Query: 324 QLINLQELILYENSL 338
L +L+ + L+ N
Sbjct: 277 PLHHLERIHLHHNPW 291
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 91.3 bits (227), Expect = 2e-19
Identities = 46/203 (22%), Positives = 75/203 (36%), Gaps = 11/203 (5%)
Query: 70 LSRLQLRGN-ITLVSE-----LKALKRLDLSNNAFSGTIPSAFGNLSELEFLDLSLNKFG 123
L LQL N I + L L L+L +N + AF LS+L+ L L N
Sbjct: 90 LEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRLTTIPNGAFVYLSKLKELWLRNNPIE 149
Query: 124 GVIPRELGSLKDLRFFNISNNVLVGEIPDE-LKSLEKLEDFQVSSNKLNGSIPFWVGNLT 182
+ + LR ++ + I + + L L ++ L IP L
Sbjct: 150 SIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNLAMCNLR-EIPNL-TPLI 207
Query: 183 NLRVFTAYENQLVGEIPDNLGSVSELELLNLHSNQLEGPIPKSIFAS-GKLEVLVLTQNR 241
L N L P + + L+ L + +Q++ I ++ F + L + L N
Sbjct: 208 KLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQV-IERNAFDNLQSLVEINLAHNN 266
Query: 242 LTGDIPELVGHCKSLSNIRIGNN 264
LT +L L I + +N
Sbjct: 267 LTLLPHDLFTPLHHLERIHLHHN 289
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 89.8 bits (223), Expect = 5e-19
Identities = 55/221 (24%), Positives = 84/221 (38%), Gaps = 9/221 (4%)
Query: 192 NQLVGEIPDNLGSVSELELLNLHSNQLEGPIPKSIFAS-GKLEVLVLTQNRLTGDIPELV 250
NQ+ ++ + LE+L L N + I F L L L NRLT
Sbjct: 74 NQIQIIKVNSFKHLRHLEILQLSRNHIRT-IEIGAFNGLANLNTLELFDNRLTTIPNGAF 132
Query: 251 GHCKSLSNIRIGNNDLVGVIPRAIGNVSGLTYFEADNNNLSGEIVPE-FSQCSNLTLLNL 309
+ L + + NN + + A + L + I F SNL LNL
Sbjct: 133 VYLSKLKELWLRNNPIESIPSYAFNRIPSLRRLDLGELKRLSYISEGAFEGLSNLRYLNL 192
Query: 310 ASNGFTGVIPPELGQLINLQELILYENSLFGEIPKSILA-CKNLNKLDLSNNRFNGTIPN 368
A + P L LI L EL L N L I +L KL + ++ N
Sbjct: 193 AMCNLREI--PNLTPLIKLDELDLSGNHL-SAIRPGSFQGLMHLQKLWMIQSQIQVIERN 249
Query: 369 AICDMSRLQYLLLGQNSLKGEIPHEIGNCMKLLQ-LHIGSN 408
A ++ L + L N+L +PH++ + L+ +H+ N
Sbjct: 250 AFDNLQSLVEINLAHNNLT-LLPHDLFTPLHHLERIHLHHN 289
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 87.9 bits (218), Expect = 2e-18
Identities = 53/233 (22%), Positives = 86/233 (36%), Gaps = 17/233 (7%)
Query: 69 DLSRLQLRGN-ITLVSE-----LKALKRLDLSNNAFSGTIPSAFGNLSELEFLDLSLNKF 122
+ L L N I ++ L+ L+ L LS N AF L+ L L+L N+
Sbjct: 65 NTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHIRTIEIGAFNGLANLNTLELFDNRL 124
Query: 123 GGVIPRELGSLKDLRFFNISNNVLVGEIPDEL-KSLEKLEDFQVSSNKLNGSIP---FWV 178
+ L L+ + NN + IP + L + K I F
Sbjct: 125 TTIPNGAFVYLSKLKELWLRNNPIE-SIPSYAFNRIPSLRRLDLGELKRLSYISEGAF-- 181
Query: 179 GNLTNLRVFTAYENQLVGEIPDNLGSVSELELLNLHSNQLEGPIPKSIFAS-GKLEVLVL 237
L+NLR L EIP+ L + +L+ L+L N L I F L+ L +
Sbjct: 182 EGLSNLRYLNLAMCNLR-EIPN-LTPLIKLDELDLSGNHLSA-IRPGSFQGLMHLQKLWM 238
Query: 238 TQNRLTGDIPELVGHCKSLSNIRIGNNDLVGVIPRAIGNVSGLTYFEADNNNL 290
Q+++ + +SL I + +N+L + + L +N
Sbjct: 239 IQSQIQVIERNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHNPW 291
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 87.5 bits (217), Expect = 3e-18
Identities = 51/187 (27%), Positives = 79/187 (42%), Gaps = 10/187 (5%)
Query: 302 SNLTLLNLASNGFTGVIPPELGQLINLQELILYENSLFGEIPKSILA-CKNLNKLDLSNN 360
+N LLNL N + L +L+ L L N + I NLN L+L +N
Sbjct: 64 TNTRLLNLHENQIQIIKVNSFKHLRHLEILQLSRNHI-RTIEIGAFNGLANLNTLELFDN 122
Query: 361 RFNGTIPNAICDMSRLQYLLLGQNSLKGEIPHEI-GNCMKLLQLHIGS-NYLTGSIPPEI 418
R A +S+L+ L L N ++ IP L +L +G L+ I
Sbjct: 123 RLTTIPNGAFVYLSKLKELWLRNNPIE-SIPSYAFNRIPSLRRLDLGELKRLS-YISEGA 180
Query: 419 -GHIRNLQIALNLSFNHLHGSLPPELGKLDKLVSFDVSNNQLSGTIPSALKGMLSLIEVN 477
+ NL+ LNL+ +L P L L KL D+S N LS P + +G++ L ++
Sbjct: 181 FEGLSNLR-YLNLAMCNL--REIPNLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLW 237
Query: 478 FSNNLLT 484
+ +
Sbjct: 238 MIQSQIQ 244
|
| >3zyj_A Leucine-rich repeat-containing protein 4C; cell adhesion, synapse; HET: NAG BMA MAN; 3.25A {Homo sapiens} Length = 440 | Back alignment and structure |
|---|
Score = 54.0 bits (130), Expect = 1e-07
Identities = 28/102 (27%), Positives = 44/102 (43%), Gaps = 1/102 (0%)
Query: 67 KLDLSRLQLRGNITLVSELKALKRLDLSNNAFSGTIPSAFGNLSELEFLDLSLNKFGGVI 126
L+L+ LR I ++ L L LDLS N S P +F L L+ L + ++ +
Sbjct: 189 YLNLAMCNLR-EIPNLTPLIKLDELDLSGNHLSAIRPGSFQGLMHLQKLWMIQSQIQVIE 247
Query: 127 PRELGSLKDLRFFNISNNVLVGEIPDELKSLEKLEDFQVSSN 168
+L+ L N+++N L D L LE + N
Sbjct: 248 RNAFDNLQSLVEINLAHNNLTLLPHDLFTPLHHLERIHLHHN 289
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 97.8 bits (244), Expect = 1e-22
Identities = 48/217 (22%), Positives = 85/217 (39%), Gaps = 12/217 (5%)
Query: 270 IPRAIGNVSGLTYFEADNNNLSGEIVPEFSQCSNLTLLNLASNGFTGVIPPELGQLINLQ 329
+P I + N +S F C NLT+L L SN + L L+
Sbjct: 26 VPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLE 83
Query: 330 ELILYENSLFGEIPKSILA-CKNLNKLDLSNNRFNGTIP-NAICDMSRLQYLLLGQNSLK 387
+L L +N+ + + L+ L L + ++ LQYL L N+L+
Sbjct: 84 QLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNALQ 142
Query: 388 GEIPHEI-GNCMKLLQLHIGSNYLTGSIPPEI-GHIRNLQIALNLSFNHLHGSLPPE-LG 444
+P + + L L + N ++ S+P + +L L L N + + P
Sbjct: 143 -ALPDDTFRDLGNLTHLFLHGNRIS-SVPERAFRGLHSLDR-LLLHQNRVA-HVHPHAFR 198
Query: 445 KLDKLVSFDVSNNQLSGTIPSALKGMLSLIEVNFSNN 481
L +L++ + N LS AL + +L + ++N
Sbjct: 199 DLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDN 235
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 92.4 bits (230), Expect = 1e-20
Identities = 43/210 (20%), Positives = 77/210 (36%), Gaps = 13/210 (6%)
Query: 88 LKRLDLSNNAFSGTIPSAFGNLSELEFLDLSLNKFGGVIPRELGSLKDLRFFNISNNVLV 147
+R+ L N S ++F L L L N + L L ++S+N +
Sbjct: 34 SQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQL 93
Query: 148 GEIPDE-LKSLEKLEDFQVSSNKLNGSIP---FWVGNLTNLRVFTAYENQLVGEIPDN-L 202
+ L +L + L + F L L+ +N L +PD+
Sbjct: 94 RSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLF--RGLAALQYLYLQDNALQ-ALPDDTF 149
Query: 203 GSVSELELLNLHSNQLEGPIPKSIFAS-GKLEVLVLTQNRLTGDIPELV-GHCKSLSNIR 260
+ L L LH N++ +P+ F L+ L+L QNR+ + L +
Sbjct: 150 RDLGNLTHLFLHGNRISS-VPERAFRGLHSLDRLLLHQNRVA-HVHPHAFRDLGRLMTLY 207
Query: 261 IGNNDLVGVIPRAIGNVSGLTYFEADNNNL 290
+ N+L + A+ + L Y ++N
Sbjct: 208 LFANNLSALPTEALAPLRALQYLRLNDNPW 237
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 3e-19
Identities = 42/188 (22%), Positives = 73/188 (38%), Gaps = 10/188 (5%)
Query: 302 SNLTLLNLASNGFTGVIPPELGQLINLQELILYENSLFGEIPKSILAC-KNLNKLDLSNN 360
+ + L N + V NL L L+ N L I + L +LDLS+N
Sbjct: 32 AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVL-ARIDAAAFTGLALLEQLDLSDN 90
Query: 361 RFNGTIP-NAICDMSRLQYLLLGQNSLKGEIPHEI-GNCMKLLQLHIGSNYLTGSIPPEI 418
++ + RL L L + L+ E+ + L L++ N L ++P +
Sbjct: 91 AQLRSVDPATFHGLGRLHTLHLDRCGLQ-ELGPGLFRGLAALQYLYLQDNALQ-ALPDDT 148
Query: 419 -GHIRNLQIALNLSFNHLHGSLPPE-LGKLDKLVSFDVSNNQLSGTIPSALKGMLSLIEV 476
+ NL L L N + S+P L L + N+++ P A + + L+ +
Sbjct: 149 FRDLGNLTH-LFLHGNRIS-SVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTL 206
Query: 477 NFSNNLLT 484
N L+
Sbjct: 207 YLFANNLS 214
|
| >1ozn_A Reticulon 4 receptor; NOGO receptor, MAD, myelination inhibition, OMGP, MAG, NOGO- signal transduction, neuronal regeneration, ligand binding; HET: NDG MAN NAG BMA; 1.52A {Homo sapiens} SCOP: c.10.2.7 PDB: 1p8t_A* 3kj4_A* Length = 285 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 1e-07
Identities = 29/106 (27%), Positives = 41/106 (38%), Gaps = 8/106 (7%)
Query: 70 LSRLQLRGN-ITLVSE-----LKALKRLDLSNNAFSGTIPSAFGNLSELEFLDLSLNKFG 123
L L L+ N + + + L L L L N S AF L L+ L L N+
Sbjct: 131 LQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVA 190
Query: 124 GVIPRELGSLKDLRFFNISNNVLVGEIPDE-LKSLEKLEDFQVSSN 168
V P L L + N L +P E L L L+ +++ N
Sbjct: 191 HVHPHAFRDLGRLMTLYLFANNLS-ALPTEALAPLRALQYLRLNDN 235
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 98.7 bits (246), Expect = 3e-22
Identities = 58/310 (18%), Positives = 102/310 (32%), Gaps = 36/310 (11%)
Query: 88 LKRLDLSNNAFSGTIPSAFGNLSELEFLDLSLNKFGGVIPRELGSLKDLRFFNISNNVLV 147
+K LDLSNN + S L+ L L+ N + SL L ++S N L
Sbjct: 54 VKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEEDSFSSLGSLEHLDLSYNYLS 113
Query: 148 GEIPDEL-KSLEKLEDFQVSSNKLNGSIP--FWVGNLTNLRVFTAYENQLVGEIPDN-LG 203
+ K L L + N ++ +LT L++ +I
Sbjct: 114 -NLSSSWFKPLSSLTFLNLLGNPYK-TLGETSLFSHLTKLQILRVGNMDTFTKIQRKDFA 171
Query: 204 SVSELELLNLHSNQLEGPIPKSIFAS-GKLEVLVLTQNRLTGDIPELVGHCKSLSNIRIG 262
++ LE L + ++ L+ S + L+L + + V S+ + +
Sbjct: 172 GLTFLEELEIDASDLQS-YEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVECLELR 230
Query: 263 NNDLVGVIPRAIGNVSGLTYFEADNNNLSGEIVPEFSQCSNLTLLNLASNGFTGVIPPEL 322
+ DL + + + + + + L
Sbjct: 231 DTDLDTFHFSELSTGETNS----------------LIKKFTFRNVKITDESLF-QVMKLL 273
Query: 323 GQLINLQELILYENSLFGEIPKSILA-CKNLNKLDLSNNRFNGTIPNAICDMSRLQYL-- 379
Q+ L EL N L +P I +L K+ L N ++ C R+ YL
Sbjct: 274 NQISGLLELEFSRNQLKS-VPDGIFDRLTSLQKIWLHTNPWD-------CSCPRIDYLSR 325
Query: 380 LLGQNSLKGE 389
L +NS K +
Sbjct: 326 WLNKNSQKEQ 335
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 93.6 bits (233), Expect = 1e-20
Identities = 51/281 (18%), Positives = 102/281 (36%), Gaps = 17/281 (6%)
Query: 212 NLHSNQLEGPIPKSIFASGKLEVLVLTQNRLTGDIPELVGHCKSLSNIRIGNNDLVGVIP 271
S L IP + + ++ L L+ NR+T + C +L + + +N + +
Sbjct: 37 KGSSGSLNS-IPSGLTEA--VKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGINTIEE 93
Query: 272 RAIGNVSGLTYFEADNNNLSGEIVPE--FSQCSNLTLLNLASNGFTGVIPPEL-GQLINL 328
+ ++ L + + N LS + F S+LT LNL N + + L L L
Sbjct: 94 DSFSSLGSLEHLDLSYNYLS--NLSSSWFKPLSSLTFLNLLGNPYKTLGETSLFSHLTKL 151
Query: 329 QELILYENSLFGEIPKSILA-CKNLNKLDLSNNRFNGTIPNAICDMSRLQYLLLGQNSLK 387
Q L + F +I + A L +L++ + P ++ + + +L+L
Sbjct: 152 QILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHLILHMKQHI 211
Query: 388 GEIPHEIGNCMKLLQ-LHIGSNYLTGSIPPEI--GHIRNLQIALNLSFNHLHG----SLP 440
+ + ++ L + L E+ G +L + +
Sbjct: 212 -LLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVM 270
Query: 441 PELGKLDKLVSFDVSNNQLSGTIPSALKGMLSLIEVNFSNN 481
L ++ L+ + S NQL + SL ++ N
Sbjct: 271 KLLNQISGLLELEFSRNQLKSVPDGIFDRLTSLQKIWLHTN 311
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 78.6 bits (194), Expect = 1e-15
Identities = 43/221 (19%), Positives = 81/221 (36%), Gaps = 14/221 (6%)
Query: 302 SNLTLLNLASNGFTGVIPPELGQLINLQELILYENSLFGEIPKSILAC-KNLNKLDLSNN 360
+ L+L++N T + +L + +NLQ L+L N + I + + +L LDLS N
Sbjct: 52 EAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGI-NTIEEDSFSSLGSLEHLDLSYN 110
Query: 361 RFNGTIPNAICD-MSRLQYLLLGQNSLKGEIPHEI--GNCMKLLQLHIGSNYLTGSIPPE 417
+ ++ +S L +L L N K + + KL L +G+ I +
Sbjct: 111 YL-SNLSSSWFKPLSSLTFLNLLGNPYK-TLGETSLFSHLTKLQILRVGNMDTFTKIQRK 168
Query: 418 I-GHIRNLQIALNLSFNHLHGSLPPE-LGKLDKLVSFDVSNNQLSGTIPSALKGMLSLIE 475
+ L+ L + + L S P+ L + + + Q + + S+
Sbjct: 169 DFAGLTFLE-ELEIDASDLQ-SYEPKSLKSIQNVSHLILHMKQHILLLEIFVDVTSSVEC 226
Query: 476 VNFSNNLLTGPVPSFVP---FQKSPNSSFFGNKGLCGEPLS 513
+ + L S + F N + E L
Sbjct: 227 LELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLF 267
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 75.9 bits (187), Expect = 8e-15
Identities = 45/236 (19%), Positives = 83/236 (35%), Gaps = 23/236 (9%)
Query: 270 IPRAIGNVSGLTYFEADNNNLSGEIVPEFSQCSNLTLLNLASNGFTGVIPPEL-GQLINL 328
IP + + + NN ++ + +C NL L L SNG I + L +L
Sbjct: 46 IPSGL--TEAVKSLDLSNNRITYISNSDLQRCVNLQALVLTSNGIN-TIEEDSFSSLGSL 102
Query: 329 QELILYENSLFGEIPKSILA-CKNLNKLDLSNNRFNGTIPNAIC--DMSRLQYLLLGQNS 385
+ L L N L + S +L L+L N + T+ +++LQ L +G
Sbjct: 103 EHLDLSYNYL-SNLSSSWFKPLSSLTFLNLLGNPYK-TLGETSLFSHLTKLQILRVGNMD 160
Query: 386 LKGEIPHEI-GNCMKLLQLHIGSNYLTGSIPPEI-GHIRNLQIALNLSFNHLHGSLPPEL 443
+I + L +L I ++ L S P+ I+N+ L L L
Sbjct: 161 TFTKIQRKDFAGLTFLEELEIDASDLQ-SYEPKSLKSIQNVSH-LILHMKQHI-LLLEIF 217
Query: 444 -GKLDKLVSFDVSNNQLSGT----IPS----ALKGMLSLIEVNFSNNLLTGPVPSF 490
+ ++ + L + + +L + V ++ L +
Sbjct: 218 VDVTSSVECLELRDTDLDTFHFSELSTGETNSLIKKFTFRNVKITDESLFQVMKLL 273
|
| >2z80_A TOLL-like receptor 2, variable lymphocyte recepto; TLR2, lipopeptide, innate immunity, glycoprotein, immune RES inflammatory response; HET: NAG; 1.80A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 64.4 bits (157), Expect = 5e-11
Identities = 31/189 (16%), Positives = 59/189 (31%), Gaps = 26/189 (13%)
Query: 63 AFVVKLDLSRLQLRGNITLVS-------ELKALKRLDLSNNAFSGTIPSAFGNLSELEFL 115
F L L++ T L L+ L++ + P + ++ + L
Sbjct: 144 LFSHLTKLQILRVGNMDTFTKIQRKDFAGLTFLEELEIDASDLQSYEPKSLKSIQNVSHL 203
Query: 116 DLSLNKFGGVIPRELGSLKDLRFFNISNNVLVGEIPDELKSLEKLEDFQVSSNKLNGSIP 175
L + + ++ + + + + L EL + E +N L
Sbjct: 204 ILHMKQHILLLEIFVDVTSSVECLELRDTDLDTFHFSELSTGE--------TNSL----- 250
Query: 176 FWVGNLTNLRVFTAYENQLVGEIPDNLGSVSELELLNLHSNQLEGPIPKSIFAS-GKLEV 234
R + L ++ L +S L L NQL+ +P IF L+
Sbjct: 251 ---IKKFTFRNVKITDESLF-QVMKLLNQISGLLELEFSRNQLKS-VPDGIFDRLTSLQK 305
Query: 235 LVLTQNRLT 243
+ L N
Sbjct: 306 IWLHTNPWD 314
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 97.1 bits (242), Expect = 4e-22
Identities = 57/266 (21%), Positives = 107/266 (40%), Gaps = 20/266 (7%)
Query: 56 IDCDLNQAFVVKLDLSRLQLRGNITLVSELKALKRLDLSNNAFSGTIPSAFGNLSELEFL 115
I D A +K+ + + +T ++L + L + TI L+ L L
Sbjct: 12 IFPDPALANAIKIAAGKSNVTDTVTQ-ADLDGITTLSAFGTGVT-TI-EGVQYLNNLIGL 68
Query: 116 DLSLNKFGGVIPRELGSLKDLRFFNISNNVLVGEIPDELKSLEKLEDFQVSSNKLNGSIP 175
+L N+ + P L +L + +S N L + + L+ ++ ++S ++ P
Sbjct: 69 ELKDNQITDLAP--LKNLTKITELELSGNPL--KNVSAIAGLQSIKTLDLTSTQITDVTP 124
Query: 176 FWVGNLTNLRVFTAYENQLVGEIPDNLGSVSELELLNLHSNQLEGPIPKSIFASGKLEVL 235
L+NL+V NQ+ I L ++ L+ L++ + Q+ P + KL L
Sbjct: 125 L--AGLSNLQVLYLDLNQIT-NIS-PLAGLTNLQYLSIGNAQVSDLTP--LANLSKLTTL 178
Query: 236 VLTQNRLTGDIPELVGHCKSLSNIRIGNNDLVGVIPRAIGNVSGLTYFEADNNNLSGEIV 295
N+++ DI L +L + + NN + V P + N S L N ++ + V
Sbjct: 179 KADDNKIS-DISPL-ASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTNQTITNQPV 234
Query: 296 PEFSQCSNLTLLNLASNGFTGVIPPE 321
+NL + N+ I P
Sbjct: 235 FYN---NNLVVPNVVKGPSGAPIAPA 257
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 94.0 bits (234), Expect = 4e-21
Identities = 59/262 (22%), Positives = 102/262 (38%), Gaps = 20/262 (7%)
Query: 254 KSLSNIRIGNNDLVGVIPRAIGNVSGLTYFEADNNNLSGEIVPEFSQCSNLTLLNLASNG 313
+ I G +++ + ++ G+T A ++ + +NL L L N
Sbjct: 19 ANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVTT--IEGVQYLNNLIGLELKDNQ 74
Query: 314 FTGVIPPELGQLINLQELILYENSLFGEIPKSILACKNLNKLDLSNNRFNGTIPNAICDM 373
T + P L L + EL L N L + +I +++ LDL++ + P + +
Sbjct: 75 ITDLAP--LKNLTKITELELSGNPL--KNVSAIAGLQSIKTLDLTSTQITDVTP--LAGL 128
Query: 374 SRLQYLLLGQNSLKGEIPHEIGNCMKLLQLHIGSNYLTGSIPPEIGHIRNLQIALNLSFN 433
S LQ L L N + I + L L IG+ ++ + P + ++ L L N
Sbjct: 129 SNLQVLYLDLNQIT-NIS-PLAGLTNLQYLSIGNAQVS-DLTP-LANLSKLTT-LKADDN 183
Query: 434 HLHGSLPPELGKLDKLVSFDVSNNQLSGTIPSALKGMLSLIEVNFSNNLLTGPVPSFVPF 493
+ + P L L L+ + NNQ+S S L +L V +N +T +
Sbjct: 184 KIS-DISP-LASLPNLIEVHLKNNQISDV--SPLANTSNLFIVTLTNQTITNQPVFYNNN 239
Query: 494 QKSPNSSFFGNKGLCGEPLSFS 515
PN G G P + S
Sbjct: 240 LVVPNVV-KGPSGAPIAPATIS 260
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 90.9 bits (226), Expect = 4e-20
Identities = 49/290 (16%), Positives = 104/290 (35%), Gaps = 24/290 (8%)
Query: 78 NITLVSELKALKRLDLSNNAFSGTIPSAFGNLSELEFLDLSLNKFGGVIPRELGSLKDLR 137
I L ++ + + T+ +L + L + + L +L
Sbjct: 11 VIFPDPALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVTTIEG--VQYLNNLI 66
Query: 138 FFNISNNVLVGEIPD--ELKSLEKLEDFQVSSNKLNGSIPFWVGNLTNLRVFTAYENQLV 195
+ +N +I D LK+L K+ + ++S N L L +++ Q+
Sbjct: 67 GLELKDN----QITDLAPLKNLTKITELELSGNPLKNVSAI--AGLQSIKTLDLTSTQIT 120
Query: 196 GEIPDNLGSVSELELLNLHSNQLEGPIPKSIFASGKLEVLVLTQNRLTGDIPELVGHCKS 255
L +S L++L L NQ+ P + L+ L + +++ D+ L +
Sbjct: 121 D--VTPLAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVS-DLTPL-ANLSK 174
Query: 256 LSNIRIGNNDLVGVIPRAIGNVSGLTYFEADNNNLSGEIVPEFSQCSNLTLLNLASNGFT 315
L+ ++ +N + + P + ++ L NN +S V + SNL ++ L + T
Sbjct: 175 LTTLKADDNKISDISP--LASLPNLIEVHLKNNQISD--VSPLANTSNLFIVTLTNQTIT 230
Query: 316 GVIPPELGQLINLQELILYENSLFGEIPKSILACKNLNKLDLSNNRFNGT 365
L+ + + P +I +L+ N +
Sbjct: 231 NQPVFYNNNLVVPNVVKGPSGAPI--APATISDNGTYASPNLTWNLTSFI 278
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 74.0 bits (182), Expect = 2e-14
Identities = 35/186 (18%), Positives = 73/186 (39%), Gaps = 15/186 (8%)
Query: 299 SQCSNLTLLNLASNGFTGVIPPELGQLINLQELILYENSLFGEIPKSILACKNLNKLDLS 358
+N + + T + L + L + + + + NL L+L
Sbjct: 16 PALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGV--TTIEGVQYLNNLIGLELK 71
Query: 359 NNRFNGTIPNAICDMSRLQYLLLGQNSLKGEIPHEIGNCMKLLQLHIGSNYLTGSIPPEI 418
+N+ + + +++++ L L N LK + I + L + S +T + P +
Sbjct: 72 DNQIT-DLAP-LKNLTKITELELSGNPLK-NVS-AIAGLQSIKTLDLTSTQIT-DVTP-L 125
Query: 419 GHIRNLQIALNLSFNHLHGSLPPELGKLDKLVSFDVSNNQLSGTIPSALKGMLSLIEVNF 478
+ NLQ+ L L N + ++ P L L L + N Q+S + L + L +
Sbjct: 126 AGLSNLQV-LYLDLNQIT-NISP-LAGLTNLQYLSIGNAQVSDL--TPLANLSKLTTLKA 180
Query: 479 SNNLLT 484
+N ++
Sbjct: 181 DDNKIS 186
|
| >1h6u_A Internalin H; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.8A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 Length = 308 | Back alignment and structure |
|---|
Score = 70.9 bits (174), Expect = 2e-13
Identities = 54/233 (23%), Positives = 97/233 (41%), Gaps = 22/233 (9%)
Query: 67 KLDLSRLQLRGNITLVSELKALKRLDLSNNAFSGTIPSAFGNLSELEFLDLSLNKFGGVI 126
+L+LS L+ N++ ++ L+++K LDL++ + P LS L+ L L LN+ +
Sbjct: 89 ELELSGNPLK-NVSAIAGLQSIKTLDLTSTQITDVTP--LAGLSNLQVLYLDLNQITNIS 145
Query: 127 PRELGSLKDLRFFNISNNVLVGEIPDELKSLEKLEDFQVSSNKLNGSIPFWVGNLTNLRV 186
P L L +L++ +I N + P L +L KL + NK++ I + +L NL
Sbjct: 146 P--LAGLTNLQYLSIGNAQVSDLTP--LANLSKLTTLKADDNKIS-DISP-LASLPNLIE 199
Query: 187 FTAYENQLVGEIPDNLGSVSELELLNLHSNQLEGPIPKSIFASGKLEVLVLTQNRLTGDI 246
NQ+ P L + S L ++ L + + +F + L V + + I
Sbjct: 200 VHLKNNQISDVSP--LANTSNLFIVTLTNQTITNQ---PVFYNNNLVVPNVVKGPSGAPI 254
Query: 247 PELVGHCKSLSNIRIGNNDLVGVIPRAIGNVSGLTYFEADNNNLSGEIVPEFS 299
N + +L + I NVS + + + FS
Sbjct: 255 APA----TISDNGTYASPNLTWNLTSFINNVS----YTFNQSVTFKNTTVPFS 299
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 94.8 bits (236), Expect = 1e-20
Identities = 58/259 (22%), Positives = 90/259 (34%), Gaps = 20/259 (7%)
Query: 88 LKRLDLSNNAFSGTIPSAFGNLSELEFLDLSLNKFGGVIPRELGSLKDLRFFNISNNVLV 147
++ + S +P S +L+L N + L L + N +
Sbjct: 56 FSKVVCTRRGLS-EVPQGI--PSNTRYLNLMENNIQMIQADTFRHLHHLEVLQLGRNSI- 111
Query: 148 GEIPDE-LKSLEKLEDFQVSSNKLNGSIP---FWVGNLTNLRVFTAYENQLVGEIPDN-L 202
+I L L ++ N L IP F L+ LR N + IP
Sbjct: 112 RQIEVGAFNGLASLNTLELFDNWLT-VIPSGAFE--YLSKLRELWLRNNPIE-SIPSYAF 167
Query: 203 GSVSELELLNL-HSNQLEGPIPKSIFAS-GKLEVLVLTQNRLTGDIPELVGHCKSLSNIR 260
V L L+L +LE I + F L+ L L + D+P L L +
Sbjct: 168 NRVPSLMRLDLGELKKLEY-ISEGAFEGLFNLKYLNLGMCNIK-DMPNLT-PLVGLEELE 224
Query: 261 IGNNDLVGVIPRAIGNVSGLTYFEADNNNLSGEIVPE-FSQCSNLTLLNLASNGFTGVIP 319
+ N + P + +S L N+ +S I F ++L LNLA N + +
Sbjct: 225 MSGNHFPEIRPGSFHGLSSLKKLWVMNSQVS-LIERNAFDGLASLVELNLAHNNLSSLPH 283
Query: 320 PELGQLINLQELILYENSL 338
L L EL L+ N
Sbjct: 284 DLFTPLRYLVELHLHHNPW 302
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 93.7 bits (233), Expect = 3e-20
Identities = 58/247 (23%), Positives = 103/247 (41%), Gaps = 18/247 (7%)
Query: 197 EIPDNLGSVSELELLNLHSNQLEGPIPKSIFAS-GKLEVLVLTQNRLTGDIPELV-GHCK 254
E+P + S LNL N ++ I F LEVL L +N + I
Sbjct: 68 EVPQGI--PSNTRYLNLMENNIQM-IQADTFRHLHHLEVLQLGRNSIR-QIEVGAFNGLA 123
Query: 255 SLSNIRIGNNDLVGVIPRAIGNVSGLTYFEADNNNLSGEIVPE--FSQCSNLTLLNLASN 312
SL+ + + +N L + A +S L NN + +P F++ +L L+L
Sbjct: 124 SLNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPIE--SIPSYAFNRVPSLMRLDLGEL 181
Query: 313 GFTGVIPPE-LGQLINLQELILYENSLFGEIPKSILACKNLNKLDLSNNRFNGTIPNAIC 371
I L NL+ L L ++ ++P ++ L +L++S N F P +
Sbjct: 182 KKLEYISEGAFEGLFNLKYLNLGMCNIK-DMP-NLTPLVGLEELEMSGNHFPEIRPGSFH 239
Query: 372 DMSRLQYLLLGQNSLKGEIPHE-IGNCMKLLQLHIGSNYLTGSIPPEI-GHIRNLQIALN 429
+S L+ L + + + I L++L++ N L+ S+P ++ +R L L+
Sbjct: 240 GLSSLKKLWVMNSQVS-LIERNAFDGLASLVELNLAHNNLS-SLPHDLFTPLRYLV-ELH 296
Query: 430 LSFNHLH 436
L N +
Sbjct: 297 LHHNPWN 303
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 91.0 bits (226), Expect = 2e-19
Identities = 42/203 (20%), Positives = 74/203 (36%), Gaps = 11/203 (5%)
Query: 70 LSRLQLRGN-ITLVSE-----LKALKRLDLSNNAFSGTIPSAFGNLSELEFLDLSLNKFG 123
L LQL N I + L +L L+L +N + AF LS+L L L N
Sbjct: 101 LEVLQLGRNSIRQIEVGAFNGLASLNTLELFDNWLTVIPSGAFEYLSKLRELWLRNNPIE 160
Query: 124 GVIPRELGSLKDLRFFNISNNVLVGEIPDE-LKSLEKLEDFQVSSNKLNGSIPFWVGNLT 182
+ + L ++ + I + + L L+ + + +P L
Sbjct: 161 SIPSYAFNRVPSLMRLDLGELKKLEYISEGAFEGLFNLKYLNLGMCNIK-DMPNLT-PLV 218
Query: 183 NLRVFTAYENQLVGEIPDNLGSVSELELLNLHSNQLEGPIPKSIFAS-GKLEVLVLTQNR 241
L N P + +S L+ L + ++Q+ I ++ F L L L N
Sbjct: 219 GLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSL-IERNAFDGLASLVELNLAHNN 277
Query: 242 LTGDIPELVGHCKSLSNIRIGNN 264
L+ +L + L + + +N
Sbjct: 278 LSSLPHDLFTPLRYLVELHLHHN 300
|
| >3zyi_A Leucine-rich repeat-containing protein 4; cell adhesion, LRRC4 complex, synapse; HET: NAG; 2.60A {Homo sapiens} PDB: 3zyo_A* 3zyn_A* 2dl9_A Length = 452 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 6e-08
Identities = 23/101 (22%), Positives = 44/101 (43%), Gaps = 1/101 (0%)
Query: 68 LDLSRLQLRGNITLVSELKALKRLDLSNNAFSGTIPSAFGNLSELEFLDLSLNKFGGVIP 127
L+L ++ ++ ++ L L+ L++S N F P +F LS L+ L + ++ +
Sbjct: 201 LNLGMCNIK-DMPNLTPLVGLEELEMSGNHFPEIRPGSFHGLSSLKKLWVMNSQVSLIER 259
Query: 128 RELGSLKDLRFFNISNNVLVGEIPDELKSLEKLEDFQVSSN 168
L L N+++N L D L L + + N
Sbjct: 260 NAFDGLASLVELNLAHNNLSSLPHDLFTPLRYLVELHLHHN 300
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 88.7 bits (220), Expect = 4e-19
Identities = 42/232 (18%), Positives = 76/232 (32%), Gaps = 14/232 (6%)
Query: 88 LKRLDLSNNAFSGTIPSAFGNLSELEFLDLSLNKFGGVIPRE-LGSLKDLRFFNISNNVL 146
L AF +LE +++S N VI + +L L I
Sbjct: 32 AIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANN 91
Query: 147 VGEIPDE-LKSLEKLEDFQVSSNKLNGSIP-FWVGNLTNLRVFTAYENQLVGEIPDNL-- 202
+ I E ++L L+ +S+ + +P + + +N + I N
Sbjct: 92 LLYINPEAFQNLPNLQYLLISNTGIK-HLPDVHKIHSLQKVLLDIQDNINIHTIERNSFV 150
Query: 203 GSVSELELLNLHSNQLEGPIPKSIFAS-GKLEVLVLTQNRLTGDIPELV-GHCKSLSNIR 260
G E +L L+ N ++ I S F E+ + N L ++P V +
Sbjct: 151 GLSFESVILWLNKNGIQE-IHNSAFNGTQLDELNLSDNNNLE-ELPNDVFHGASGPVILD 208
Query: 261 IGNNDLVGVIPRAIGNVSGLTYFEADNNNLSGEIVPEFSQCSNLTLLNLASN 312
I + + + N+ L NL +P + L +L
Sbjct: 209 ISRTRIHSLPSYGLENLKKLRAR--STYNLK--KLPTLEKLVALMEASLTYP 256
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 80.6 bits (199), Expect = 2e-16
Identities = 55/281 (19%), Positives = 98/281 (34%), Gaps = 44/281 (15%)
Query: 209 ELLNLHSNQLEGPIPKSIFASGKLEVLVLTQNRLTGDIPELV-GHCKSLSNIRIGNNDLV 267
+ +++ IP + + L +L I + L I I ND++
Sbjct: 12 RVFLCQESKVTE-IPSDLPRN--AIELRFVLTKLR-VIQKGAFSGFGDLEKIEISQNDVL 67
Query: 268 GVIPR-AIGNVSGLTYFEADNNNLSGEIVPE-FSQCSNLTLLNLASNGFTGVIPPELGQ- 324
VI N+ L + N I PE F NL L +++ G +P
Sbjct: 68 EVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIK-HLPDVHKIH 126
Query: 325 LINLQELILYENSLFGEIPKSILA--CKNLNKLDLSNNRFNGTIPNAICDMSRLQYLLLG 382
+ L + +N I ++ L L+ N I N+ + ++L L L
Sbjct: 127 SLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQ-EIHNSAFNGTQLDELNLS 185
Query: 383 QNSLKGEIPHEIGNCMKLLQLHIGSNYLTGSIPPEI-GHIRNLQIALNLSFNHLHGSLPP 441
N N L +P ++ I L++S +H SLP
Sbjct: 186 DN-----------------------NNLE-ELPNDVFHGASGPVI-LDISRTRIH-SLPS 219
Query: 442 E-LGKLDKLVSFDVSNNQLSGTIPSALKGMLSLIEVNFSNN 481
L L KL + N + +P+ L+ +++L+E + +
Sbjct: 220 YGLENLKKLRARSTYNLK---KLPT-LEKLVALMEASLTYP 256
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 76.4 bits (188), Expect = 6e-15
Identities = 45/279 (16%), Positives = 85/279 (30%), Gaps = 43/279 (15%)
Query: 91 LDLSNNAFSGTIPSAFGNLSELEFLDLSLNKFGGVIPRELGSLKDLRFFNISNNVLVGEI 150
+ + IPS L L K + DL IS N ++ I
Sbjct: 14 FLCQESKVT-EIPSDL--PRNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVI 70
Query: 151 P----DELKSLEKLEDFQVSSNKLNGSIPFWVGNLTNLRVFTAYENQLVGEIPDNLGSVS 206
L L ++ + +N L I P+ ++
Sbjct: 71 EADVFSNLPKLHEIRIEK--ANNLL-YIN-----------------------PEAFQNLP 104
Query: 207 ELELLNLHSNQLEGPIPKSIFA-SGKLEVLVLTQNRLTGDIPE--LVGHCKSLSNIRIGN 263
L+ L + + ++ +P S + +L + N I VG + +
Sbjct: 105 NLQYLLISNTGIKH-LPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNK 163
Query: 264 NDLVGVIPRAIGNVSGLTYFEADNNNLSGEIVPE-FSQCSNLTLLNLASNGFTGVIPPEL 322
N + + A +DNNNL E+ + F S +L+++ + L
Sbjct: 164 NGIQEIHNSAFNGTQLDELNLSDNNNLE-ELPNDVFHGASGPVILDISRTRIHSLPSYGL 222
Query: 323 GQLINLQELILYENSLFGEIPKSILACKNLNKLDLSNNR 361
L L+ Y ++P ++ L + L+
Sbjct: 223 ENLKKLRARSTYNLK---KLP-TLEKLVALMEASLTYPS 257
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 74.1 bits (182), Expect = 3e-14
Identities = 28/189 (14%), Positives = 58/189 (30%), Gaps = 9/189 (4%)
Query: 302 SNLTLLNLASNGFTGVIPPELGQLINLQELILYENSLFGEIPKSILA-CKNLNKLDLSNN 360
N L + +L+++ + +N + I + + L+++ +
Sbjct: 30 RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKA 89
Query: 361 RFNGTIPNAICD-MSRLQYLLLGQNSLKGEIPHEI-GNCMKLLQLHIGSNYLTGSIPPEI 418
I + LQYLL+ +K +P + ++ + L I N +I
Sbjct: 90 NNLLYINPEAFQNLPNLQYLLISNTGIK-HLPDVHKIHSLQKVLLDIQDNINIHTIERNS 148
Query: 419 --GHIRNLQIALNLSFNHLHGSLPPE-LGKLDKLVSFDVSNNQLSGTIPSALKGMLSLIE 475
G I L L+ N + + NN L G +
Sbjct: 149 FVGLSFESVI-LWLNKNGIQ-EIHNSAFNGTQLDELNLSDNNNLEELPNDVFHGASGPVI 206
Query: 476 VNFSNNLLT 484
++ S +
Sbjct: 207 LDISRTRIH 215
|
| >4ay9_X Follicle-stimulating hormone receptor; hormone-receptor complex, leucine-rich repeats, LRR, GPCR; HET: TYS NAG; 2.50A {Homo sapiens} PDB: 1xwd_C* Length = 350 | Back alignment and structure |
|---|
Score = 48.3 bits (115), Expect = 7e-06
Identities = 25/163 (15%), Positives = 55/163 (33%), Gaps = 21/163 (12%)
Query: 70 LSRLQLRGNITLVS-------ELKALKRLDLSNNAFSGTIPS-AFGNLSELEFLDLSLNK 121
L +++ L+ L L+ L +SN +P + + LD+ N
Sbjct: 81 LHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIK-HLPDVHKIHSLQKVLLDIQDNI 139
Query: 122 FGGVIPREL--GSLKDLRFFNISNNVLVGEIPDE-LKSLEKLEDFQVSSNKLNGSIP--- 175
I R G + ++ N + EI + + E +N L +P
Sbjct: 140 NIHTIERNSFVGLSFESVILWLNKNGIQ-EIHNSAFNGTQLDELNLSDNNNLE-ELPNDV 197
Query: 176 FWVGNLTNLRVFTAYENQLVGEIPDN-LGSVSELELLNLHSNQ 217
F + + ++ +P L ++ +L + ++ +
Sbjct: 198 FH--GASGPVILDISRTRIH-SLPSYGLENLKKLRARSTYNLK 237
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 87.4 bits (217), Expect = 9e-19
Identities = 51/287 (17%), Positives = 109/287 (37%), Gaps = 37/287 (12%)
Query: 616 GTFSTVYKAV-MPSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVI 674
G FS V + G ++KR+ ++ + + RE + H N++R + + +
Sbjct: 40 GGFSYVDLVEGLHDGHFYALKRILCHEQ---QDREEAQREADMHRLFNHPNILRLVAYCL 96
Query: 675 YEDVA----LLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAI 730
E A LL + GTL + + ++ + L + +G+ GL +H
Sbjct: 97 RERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTE-DQILWLLLGICRGLEAIHAKGY 155
Query: 731 IHLDISSGNVLLDADFKPLLGEIEISKLLDPSKGTASISAVA-------GSFGYIPPE-- 781
H D+ N+LL + +P+L ++ + + + Y PE
Sbjct: 156 AHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELF 215
Query: 782 --YAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQIL 839
++ + + +V+S G VL ++ P + F +G++ +
Sbjct: 216 SVQSHCV-IDERTDVWSLGCVLYAMMFGEGPYDMVF--------------QKGDSVALAV 260
Query: 840 DARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEMLQEIK 886
+LS L L +++ D P +RP + ++ L+ ++
Sbjct: 261 QNQLSIPQSPRHSSALWQLLNSMMTVD--PHQRPHIPLLLSQLEALQ 305
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 90.2 bits (223), Expect = 1e-18
Identities = 41/261 (15%), Positives = 94/261 (36%), Gaps = 24/261 (9%)
Query: 154 LKSLEKLEDFQVSSNKLNGSIPFWVGNLTNLRVFTAYENQLVGEIPDNLGSVSELELLNL 213
+ + + + ++ L ++ A + + + + + + L L
Sbjct: 17 DDAFAETIKDNLKKKSVTDAVTQ--NELNSIDQIIANNSDIK-SV-QGIQYLPNVTKLFL 72
Query: 214 HSNQLEGPIPKSIFASG---KLEVLVLTQNRLTGDIPELVGHCKSLSNIRIGNNDLVGVI 270
+ N+L I L L L +N++ D+ L K L ++ + +N + +
Sbjct: 73 NGNKL-----TDIKPLTNLKNLGWLFLDENKIK-DLSSL-KDLKKLKSLSLEHNGISDIN 125
Query: 271 PRAIGNVSGLTYFEADNNNLSGEIVPEFSQCSNLTLLNLASNGFTGVIPPELGQLINLQE 330
+ ++ L NN ++ + S+ + L L+L N + + L L LQ
Sbjct: 126 G--LVHLPQLESLYLGNNKIT--DITVLSRLTKLDTLSLEDNQISDI--VPLAGLTKLQN 179
Query: 331 LILYENSLFGEIPKSILACKNLNKLDLSNNRFNGTIPNAICDMSRLQYLLLGQNSLKGEI 390
L L +N + +++ KNL+ L+L + N ++ + SL
Sbjct: 180 LYLSKNHI--SDLRALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSL--VT 235
Query: 391 PHEIGNCMKLLQLHIGSNYLT 411
P I + + ++ +
Sbjct: 236 PEIISDDGDYEKPNVKWHLPE 256
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 89.8 bits (222), Expect = 1e-18
Identities = 47/281 (16%), Positives = 94/281 (33%), Gaps = 22/281 (7%)
Query: 88 LKRLDLSNNAFSGTIPSAFGNLSELEFLDLSLNKFGGVIPRELGSLKDLRFFNISNNVLV 147
+ + P +E +L + L + +N+
Sbjct: 1 MGETITVSTPIKQIFP--DDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNS--- 53
Query: 148 GEIPD--ELKSLEKLEDFQVSSNKLNGSIPFWVGNLTNLRVFTAYENQLVGEIPDNLGSV 205
+I ++ L + ++ NKL P NL NL EN++ ++ +L +
Sbjct: 54 -DIKSVQGIQYLPNVTKLFLNGNKLTDIKPL--TNLKNLGWLFLDENKIK-DL-SSLKDL 108
Query: 206 SELELLNLHSNQLEGPIPKSIFASGKLEVLVLTQNRLTGDIPELVGHCKSLSNIRIGNND 265
+L+ L+L N + + +LE L L N++T DI L L + + +N
Sbjct: 109 KKLKSLSLEHNGIS--DINGLVHLPQLESLYLGNNKIT-DITVL-SRLTKLDTLSLEDNQ 164
Query: 266 LVGVIPRAIGNVSGLTYFEADNNNLSGEIVPEFSQCSNLTLLNLASNGFTGVIPPELGQL 325
+ ++P + ++ L N++S + + NL +L L S L
Sbjct: 165 ISDIVP--LAGLTKLQNLYLSKNHIS--DLRALAGLKNLDVLELFSQECLNKPINHQSNL 220
Query: 326 INLQELILYENSLFGEIPKSILACKNLNKLDLSNNRFNGTI 366
+ + + SL S + F +
Sbjct: 221 VVPNTVKNTDGSLVTPEIISDDGDYEKPNVKWHLPEFTNEV 261
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 86.7 bits (214), Expect = 1e-17
Identities = 58/324 (17%), Positives = 109/324 (33%), Gaps = 19/324 (5%)
Query: 208 LELLNLHSNQLEGPIPKSIFASGKLEVLVLTQNRLTGDIPELVGHCKSLSNIRIGNNDLV 267
+ S ++ P FA + L + +T D S+ I N+D+
Sbjct: 1 MGETITVSTPIKQIFPDDAFA--ETIKDNLKKKSVT-DAVTQ-NELNSIDQIIANNSDIK 56
Query: 268 GVIPRAIGNVSGLTYFEADNNNLSGEIVPEFSQCSNLTLLNLASNGFTGVIPPELGQLIN 327
V + I + +T + N L+ + + NL L L N + L L
Sbjct: 57 SV--QGIQYLPNVTKLFLNGNKLTD--IKPLTNLKNLGWLFLDENKIKDLSS--LKDLKK 110
Query: 328 LQELILYENSLFGEIPKSILACKNLNKLDLSNNRFNGTIPNAICDMSRLQYLLLGQNSLK 387
L+ L L N + +I ++ L L L NN+ T + +++L L L N +
Sbjct: 111 LKSLSLEHNGI-SDIN-GLVHLPQLESLYLGNNKI--TDITVLSRLTKLDTLSLEDNQIS 166
Query: 388 GEIPHEIGNCMKLLQLHIGSNYLTGSIPPEIGHIRNLQIALNLSFNHLHGSLPPELGKLD 447
+I + KL L++ N+++ + + ++NL + L L L
Sbjct: 167 -DIV-PLAGLTKLQNLYLSKNHIS-DLRA-LAGLKNLDV-LELFSQECLNKPINHQSNLV 221
Query: 448 KLVSFDVSNNQLSGTIPSALKGMLSLIEVNFSNNLLTGPVPSFVPFQKSPNSSFFGNKGL 507
+ ++ L + G V + T V + + G
Sbjct: 222 VPNTVKNTDGSLVTPEIISDDGDYEKPNVKWHLPEFTNEVSFIFYQPVTIGKAKARFHGR 281
Query: 508 CGEPLSFSCGNANGPDSKNYRHRV 531
+PL + D + +V
Sbjct: 282 VTQPLKEVYTVSYDVDGTVIKTKV 305
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 85.9 bits (212), Expect = 2e-17
Identities = 52/259 (20%), Positives = 110/259 (42%), Gaps = 21/259 (8%)
Query: 56 IDCDLNQAFVVKLDLSRLQLRGNITLVSELKALKRLDLSNNAFSGTIPSAFGNLSELEFL 115
I D A +K +L + + +T +EL ++ ++ +N+ ++ L + L
Sbjct: 14 IFPDDAFAETIKDNLKKKSVTDAVTQ-NELNSIDQIIANNSDIK-SV-QGIQYLPNVTKL 70
Query: 116 DLSLNKFGGVIPRELGSLKDLRFFNISNNVLVGEIPD--ELKSLEKLEDFQVSSNKLNGS 173
L+ NK + P L +LK+L + + N +I D LK L+KL+ + N ++
Sbjct: 71 FLNGNKLTDIKP--LTNLKNLGWLFLDEN----KIKDLSSLKDLKKLKSLSLEHNGIS-D 123
Query: 174 IPFWVGNLTNLRVFTAYENQLVGEIPDNLGSVSELELLNLHSNQLEGPIPKSIFASGKLE 233
I + +L L N++ L +++L+ L+L NQ+ +P + KL+
Sbjct: 124 ING-LVHLPQLESLYLGNNKI--TDITVLSRLTKLDTLSLEDNQISDIVPLAGL--TKLQ 178
Query: 234 VLVLTQNRLTGDIPELVGHCKSLSNIRIGNNDLVGVIPRAIGNVSGLTYFEADNNNLSGE 293
L L++N ++ D+ L K+L + + + + + N+ + + +L
Sbjct: 179 NLYLSKNHIS-DLRAL-AGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSL--V 234
Query: 294 IVPEFSQCSNLTLLNLASN 312
S + N+ +
Sbjct: 235 TPEIISDDGDYEKPNVKWH 253
|
| >1m9s_A Internalin B; cell invasion, GW domains, SH3 domains, signaling protein; 2.65A {Listeria monocytogenes} SCOP: b.1.18.15 b.34.11.1 b.34.11.1 b.34.11.1 c.10.2.1 PDB: 2y5q_A Length = 605 | Back alignment and structure |
|---|
Score = 49.7 bits (118), Expect = 3e-06
Identities = 30/166 (18%), Positives = 53/166 (31%), Gaps = 12/166 (7%)
Query: 70 LSRLQLRGN----ITLVSELKALKRLDLSNNAFSGTIPSAFGNLSELEFLDLSLNKFGGV 125
L L L N IT++S L L L L +N S I L++L+ L LS N +
Sbjct: 133 LESLYLGNNKITDITVLSRLTKLDTLSLEDNQIS-DI-VPLAGLTKLQNLYLSKNHISDL 190
Query: 126 IPRELGSLKDLRFFNISNNVLVGEIPDELKSLEKLEDFQVSSNKLNG----SIPFWVGNL 181
R L LK+L + + + + + +L + + L S
Sbjct: 191 --RALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSLVTPEIISDDGDYEKP 248
Query: 182 TNLRVFTAYENQLVGEIPDNLGSVSELELLNLHSNQLEGPIPKSIF 227
+ N++ + + Q + +
Sbjct: 249 NVKWHLPEFTNEVSFIFYQPVTIGKAKARFHGRVTQPLKEVYTVSY 294
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 1e-18
Identities = 29/175 (16%), Positives = 63/175 (36%), Gaps = 10/175 (5%)
Query: 287 NNNLSGEIVPEFSQCSNLTLLNLASNGFTGVIPPELGQLINLQELILYENSLFGEIPKSI 346
+ + I +Q ++LT + LA+ T + + N+++L + I
Sbjct: 31 GQSSTANI--TEAQMNSLTYITLANINVTDLTG--IEYAHNIKDLTINNIHA--TNYNPI 84
Query: 347 LACKNLNKLDLSNNRFNGTIPNAICDMSRLQYLLLGQNSLKGEIPHEIGNCMKLLQLHIG 406
NL +L + + ++ L L + ++ I +I K+ + +
Sbjct: 85 SGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINTLPKVNSIDLS 144
Query: 407 SNYLTGSIPPEIGHIRNLQIALNLSFNHLHGSLPPELGKLDKLVSFDVSNNQLSG 461
N I P + + L+ LN+ F+ +H + KL + + G
Sbjct: 145 YNGAITDIMP-LKTLPELKS-LNIQFDGVH-DYRG-IEDFPKLNQLYAFSQTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 78.5 bits (194), Expect = 1e-16
Identities = 23/128 (17%), Positives = 51/128 (39%), Gaps = 4/128 (3%)
Query: 67 KLDLSRLQLRGNITLVSELKALKRLDLSNNAFSGTIPSAFGNLSELEFLDLSLNKFGGVI 126
L ++ + N +S L L+RL + + L+ L LD+S + I
Sbjct: 70 DLTINNIHAT-NYNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSI 128
Query: 127 PRELGSLKDLRFFNISNNVLVGEIPDELKSLEKLEDFQVSSNKLNGSIPFWVGNLTNLRV 186
++ +L + ++S N + +I LK+L +L+ + + ++ + L
Sbjct: 129 LTKINTLPKVNSIDLSYNGAITDI-MPLKTLPELKSLNIQFDGVHDYRGI--EDFPKLNQ 185
Query: 187 FTAYENQL 194
A+ +
Sbjct: 186 LYAFSQTI 193
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 4e-16
Identities = 32/186 (17%), Positives = 64/186 (34%), Gaps = 9/186 (4%)
Query: 59 DLNQAFVVKLDLSRLQLRGNITLVSELKALKRLDLSNNAFSGTIPSAFGNLSELEFLDLS 118
D + L + NIT +++ +L + L+N + + ++ L ++
Sbjct: 19 DSTFKAYLNGLLGQSST-ANIT-EAQMNSLTYITLANINVTDL--TGIEYAHNIKDLTIN 74
Query: 119 LNKFGGVIPRELGSLKDLRFFNISNNVLVGEIPDELKSLEKLEDFQVSSNKLNGSIPFWV 178
P + L +L I + + L L L +S + + SI +
Sbjct: 75 NIHATNYNP--ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKI 132
Query: 179 GNLTNLRVFTAYENQLVGEIPDNLGSVSELELLNLHSNQLEGPIPKSIFASGKLEVLVLT 238
L + N + +I L ++ EL+ LN+ + + F KL L
Sbjct: 133 NTLPKVNSIDLSYNGAITDI-MPLKTLPELKSLNIQFDGVHDYRGIEDFP--KLNQLYAF 189
Query: 239 QNRLTG 244
+ G
Sbjct: 190 SQTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 7e-16
Identities = 33/209 (15%), Positives = 73/209 (34%), Gaps = 16/209 (7%)
Query: 87 ALKRLDLSNNAFSGTIPSAFGNLSELEFLDLSLNKFGGVIPRELGSLKDLRFFNISNNVL 146
A ++ L + + IP + L + + ++ SL + ++N
Sbjct: 2 AAEQTGLKASQDNVNIPDS--TFKAYLNGLLGQSSTANITEAQMNSLTYI---TLANI-- 54
Query: 147 VGEIPD--ELKSLEKLEDFQVSSNKLNGSIPFWVGNLTNLRVFTAYENQLVGEIPDNLGS 204
+ D ++ ++D +++ P L+NL + + NL
Sbjct: 55 --NVTDLTGIEYAHNIKDLTINNIHATNYNPI--SGLSNLERLRIMGKDVTSDKIPNLSG 110
Query: 205 VSELELLNLHSNQLEGPIPKSIFASGKLEVLVLTQNRLTGDIPELVGHCKSLSNIRIGNN 264
++ L LL++ + + I I K+ + L+ N DI L L ++ I +
Sbjct: 111 LTSLTLLDISHSAHDDSILTKINTLPKVNSIDLSYNGAITDIMPL-KTLPELKSLNIQFD 169
Query: 265 DLVGVIPRAIGNVSGLTYFEADNNNLSGE 293
+ I + L A + + G+
Sbjct: 170 GVHDYRG--IEDFPKLNQLYAFSQTIGGK 196
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 5e-14
Identities = 34/187 (18%), Positives = 62/187 (33%), Gaps = 7/187 (3%)
Query: 226 IFASGKLEVLVLTQNRLTGDIPELVGHCKSLSNIRIGNNDLVGVIPRAIGNVSGLTYFEA 285
+ + + SL+ I + N ++ + I +
Sbjct: 16 NIPDSTFKAYLNGLLGQSSTANITEAQMNSLTYITLANINVTDLTG--IEYAHNIKDLTI 73
Query: 286 DNNNLSGEIVPEFSQCSNLTLLNLASNGFTGVIPPELGQLINLQELILYENSLFGEIPKS 345
+N + + S SNL L + T P L L +L L + ++ I
Sbjct: 74 NNIHATN--YNPISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTK 131
Query: 346 ILACKNLNKLDLSNNRFNGTIPNAICDMSRLQYLLLGQNSLKGEIPHEIGNCMKLLQLHI 405
I +N +DLS N I + + L+ L + + + I + KL QL+
Sbjct: 132 INTLPKVNSIDLSYNGAITDI-MPLKTLPELKSLNIQFDGVHDYRG--IEDFPKLNQLYA 188
Query: 406 GSNYLTG 412
S + G
Sbjct: 189 FSQTIGG 195
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 8e-13
Identities = 27/158 (17%), Positives = 54/158 (34%), Gaps = 6/158 (3%)
Query: 327 NLQELILYENSLFGEIPKSILACKNLNKLDLSNNRFNGTIPNAICDMSRLQYLLLGQNSL 386
+ + + +L + L+N I ++ L +
Sbjct: 21 TFKAYLNGLLGQSSTANITEAQMNSLTYITLANINVTDLTG--IEYAHNIKDLTINNIHA 78
Query: 387 KGEIPHEIGNCMKLLQLHIGSNYLTGSIPPEIGHIRNLQIALNLSFNHLHGSLPPELGKL 446
P I L +L I +T P + + +L + L++S + S+ ++ L
Sbjct: 79 TNYNP--ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTL-LDISHSAHDDSILTKINTL 135
Query: 447 DKLVSFDVSNNQLSGTIPSALKGMLSLIEVNFSNNLLT 484
K+ S D+S N I LK + L +N + +
Sbjct: 136 PKVNSIDLSYNGAITDI-MPLKTLPELKSLNIQFDGVH 172
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 8e-09
Identities = 23/132 (17%), Positives = 47/132 (35%), Gaps = 5/132 (3%)
Query: 350 KNLNKLDLSNNRFNGTIPNAICDMSRLQYLLLGQNSLKGEIPHEIGNCMKLLQLHIGSNY 409
+ T M+ L Y+ L ++ ++ I + L I + +
Sbjct: 20 STFKAYLNGLLGQSSTANITEAQMNSLTYITLANINVT-DLTG-IEYAHNIKDLTINNIH 77
Query: 410 LTGSIPPEIGHIRNLQIALNLSFNHLHGSLPPELGKLDKLVSFDVSNNQLSGTIPSALKG 469
T P I + NL+ L + + P L L L D+S++ +I + +
Sbjct: 78 ATNYNP--ISGLSNLER-LRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILTKINT 134
Query: 470 MLSLIEVNFSNN 481
+ + ++ S N
Sbjct: 135 LPKVNSIDLSYN 146
|
| >4ezg_A Putative uncharacterized protein; internalin-A, leucine-rich repeat protein, structural genomi center for structural genomics, JCSG; HET: MSE; 1.50A {Listeria monocytogenes} Length = 197 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 6e-05
Identities = 20/111 (18%), Positives = 42/111 (37%), Gaps = 8/111 (7%)
Query: 379 LLLGQNSLKGEIPHEIGNCMKLLQLHIGSNYLTGSIPPEIGHIRNLQIALNLSFNHLHGS 438
LLGQ+S I L + + + +T + I + N++ L ++ H
Sbjct: 28 GLLGQSST-ANI--TEAQMNSLTYITLANINVT-DLTG-IEYAHNIKD-LTINNIHATNY 81
Query: 439 LPPELGKLDKLVSFDVSNNQLSGTIPSALKGMLSLIEVNFSNNLLTGPVPS 489
P + L L + ++ L G+ SL ++ S++ + +
Sbjct: 82 NP--ISGLSNLERLRIMGKDVTSDKIPNLSGLTSLTLLDISHSAHDDSILT 130
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 83.5 bits (207), Expect = 1e-17
Identities = 42/204 (20%), Positives = 70/204 (34%), Gaps = 13/204 (6%)
Query: 286 DNNNLSGEIVPE-FSQCSNLTLLNLASNGFTGVIPPEL-GQLINLQELILYENSLFGEIP 343
N L + F L +L+L+ I L +L LIL N + +
Sbjct: 36 SFNPLR-HLGSYSFFSFPELQVLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGNPI-QSLA 92
Query: 344 KSILA-CKNLNKLDLSNNRFNGTIPNAICDMSRLQYLLLGQNSLKGEIPHEI-GNCMKLL 401
+ +L KL I + L+ L + N ++ E N L
Sbjct: 93 LGAFSGLSSLQKLVAVETNLASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLE 152
Query: 402 QLHIGSNYLTGSIPPEI----GHIRNLQIALNLSFNHLHGSLPPELGKLDKLVSFDVSNN 457
L + SN + SI + L ++L+LS N ++ + P K +L + N
Sbjct: 153 HLDLSSNKIQ-SIYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLKELALDTN 210
Query: 458 QLSGTIPSALKGMLSLIEVNFSNN 481
QL + SL ++ N
Sbjct: 211 QLKSVPDGIFDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 2e-15
Identities = 48/214 (22%), Positives = 80/214 (37%), Gaps = 22/214 (10%)
Query: 88 LKRLDLSNNAFSGTIPSAFGNLSELEFLDLSLNKFGGVIP----RELGSLKDLRFFNISN 143
K LDLS N +F + EL+ LDLS + I + L L L N
Sbjct: 30 TKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEI-QTIEDGAYQSLSHLSTLILTG--N 86
Query: 144 NV--LVGEIPDELKSLEKLEDFQVSSNKLNGSIPFWV-GNLTNLRVFTAYENQL-VGEIP 199
+ L L SL+KL L S+ + G+L L+ N + ++P
Sbjct: 87 PIQSLALGAFSGLSSLQKL---VAVETNLA-SLENFPIGHLKTLKELNVAHNLIQSFKLP 142
Query: 200 DNLGSVSELELLNLHSNQLEGPIPKSIFAS-GKLEV----LVLTQNRLTGDIPELVGHCK 254
+ +++ LE L+L SN+++ I + ++ + L L+ N + I
Sbjct: 143 EYFSNLTNLEHLDLSSNKIQS-IYCTDLRVLHQMPLLNLSLDLSLNPMN-FIQPGAFKEI 200
Query: 255 SLSNIRIGNNDLVGVIPRAIGNVSGLTYFEADNN 288
L + + N L V ++ L N
Sbjct: 201 RLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 71.2 bits (175), Expect = 1e-13
Identities = 48/207 (23%), Positives = 73/207 (35%), Gaps = 38/207 (18%)
Query: 70 LSRLQLRGN-ITLVSE-----LKALKRLDLSNNAFSGTIPS-AFGNLSELEFLDLSLNKF 122
L L L I + + L L L L+ N ++ AF LS L+ L
Sbjct: 54 LQVLDLSRCEIQTIEDGAYQSLSHLSTLILTGNPIQ-SLALGAFSGLSSLQKLVAVETNL 112
Query: 123 GGVIPRELGSLKDLRFFNISNNVLVGEIPDELKSLEKLEDFQVSSNKLNGSIPFWVGNLT 182
+ +G LK L+ N+++N ++S + E F NLT
Sbjct: 113 ASLENFPIGHLKTLKELNVAHN--------LIQSFKLPEYFS---------------NLT 149
Query: 183 NLRVFTAYENQLVGEIP----DNLGSVSELEL-LNLHSNQLEGPIPKSIFASGKLEVLVL 237
NL N++ I L + L L L+L N + I F +L+ L L
Sbjct: 150 NLEHLDLSSNKIQ-SIYCTDLRVLHQMPLLNLSLDLSLNPMNF-IQPGAFKEIRLKELAL 207
Query: 238 TQNRLTGDIPELVGHCKSLSNIRIGNN 264
N+L + SL I + N
Sbjct: 208 DTNQLKSVPDGIFDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 70.8 bits (174), Expect = 2e-13
Identities = 53/230 (23%), Positives = 90/230 (39%), Gaps = 39/230 (16%)
Query: 197 EIPDNLGSVSELELLNLHSNQLEGPIPKSIFAS-GKLEVLVLTQNRLTGDIPELVGHCKS 255
+IPDNL + L+L N L + F S +L+VL L++ + I + G +S
Sbjct: 21 KIPDNLPF--STKNLDLSFNPLRH-LGSYSFFSFPELQVLDLSRCEIQ-TIED--GAYQS 74
Query: 256 LSNIRIGNNDLVGVIPRAIGNVSGLTYFEADNNNLSGEIVPE-FSQCSNLTLLNLASNGF 314
LS+ L+ N + + FS S+L L
Sbjct: 75 LSH---------------------LSTLILTGNPIQ-SLALGAFSGLSSLQKLVAVETNL 112
Query: 315 TGVIPPELGQLINLQELILYENSL-FGEIPKSILACKNLNKLDLSNNRFNGTIPNAICD- 372
+ +G L L+EL + N + ++P+ NL LDLS+N+ +I
Sbjct: 113 ASLENFPIGHLKTLKELNVAHNLIQSFKLPEYFSNLTNLEHLDLSSNKIQ-SIYCTDLRV 171
Query: 373 MSRLQY----LLLGQNSLKGEIPHEIGNCMKLLQLHIGSNYLTGSIPPEI 418
+ ++ L L N + I ++L +L + +N L S+P I
Sbjct: 172 LHQMPLLNLSLDLSLNPMN-FIQPGAFKEIRLKELALDTNQLK-SVPDGI 219
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 1e-11
Identities = 47/234 (20%), Positives = 86/234 (36%), Gaps = 34/234 (14%)
Query: 110 SELEFLDLSLNKFGGVIPRELGSLKDLRFFNISNNVLVGEIP----DELKSLEKLEDFQV 165
+ LDLS N + S +L+ ++S + I L L L +
Sbjct: 28 FSTKNLDLSFNPLRHLGSYSFFSFPELQVLDLSRCEI-QTIEDGAYQSLSHLSTLI---L 83
Query: 166 SSNKLNGSIPFWV-GNLTNLRVFTAYENQLVGEIPDNL-GSVSELELLNLHSNQLEGPIP 223
+ N + S+ L++L+ A E L + + G + L+ LN+ N ++
Sbjct: 84 TGNPIQ-SLALGAFSGLSSLQKLVAVETNLA-SLENFPIGHLKTLKELNVAHNLIQSFKL 141
Query: 224 KSIFAS-GKLEVLVLTQNRLTGDIPELVGHCKSLSNIRIGNNDLVGVIPRAIGNVSGLTY 282
F++ LE L L+ N++ I + L + + N L
Sbjct: 142 PEYFSNLTNLEHLDLSSNKIQ-SIYC--TDLRVLHQMPLLNLSL---------------- 182
Query: 283 FEADNNNLSGEIVPEFSQCSNLTLLNLASNGFTGVIPPELGQLINLQELILYEN 336
+ N ++ I P + L L L +N V +L +LQ++ L+ N
Sbjct: 183 -DLSLNPMN-FIQPGAFKEIRLKELALDTNQLKSVPDGIFDRLTSLQKIWLHTN 234
|
| >2z62_A TOLL-like receptor 4, variable lymphocyte recepto; TLR, VLR hybrid, MD-2, LPS, glycoprotein response, inflammatory response, innate immunity; HET: NAG FUL BMA; 1.70A {Homo sapiens} PDB: 2z65_A* 3ul8_A* 3ula_A* 3ul7_A* Length = 276 | Back alignment and structure |
|---|
Score = 58.8 bits (143), Expect = 1e-09
Identities = 39/195 (20%), Positives = 68/195 (34%), Gaps = 24/195 (12%)
Query: 299 SQCSN-LTLLNLASNGFTGV---IPPELGQLINLQELILYENSLFGEIPKSILA-CKNLN 353
F + +P + + L L N L + L
Sbjct: 3 CVEVVPNITYQCMELNFYKIPDNLPF------STKNLDLSFNPL-RHLGSYSFFSFPELQ 55
Query: 354 KLDLSNNRFNGTIPNAICD-MSRLQYLLLGQNSLKGEIPHEI-GNCMKLLQLHIGSNYLT 411
LDLS TI + +S L L+L N ++ + L +L L
Sbjct: 56 VLDLSRCEIQ-TIEDGAYQSLSHLSTLILTGNPIQ-SLALGAFSGLSSLQKLVAVETNLA 113
Query: 412 GSIPPEI-GHIRNLQIALNLSFNHLHGSLPPE--LGKLDKLVSFDVSNNQLSGTIPS-AL 467
S+ GH++ L+ LN++ N + S L L D+S+N++ +I L
Sbjct: 114 -SLENFPIGHLKTLKE-LNVAHNLIQ-SFKLPEYFSNLTNLEHLDLSSNKIQ-SIYCTDL 169
Query: 468 KGMLSLIEVNFSNNL 482
+ + + +N S +L
Sbjct: 170 RVLHQMPLLNLSLDL 184
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 83.4 bits (207), Expect = 1e-17
Identities = 68/293 (23%), Positives = 111/293 (37%), Gaps = 69/293 (23%)
Query: 619 STVYKAVMPSGLILS----VKRLK---SMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIG 671
STVY A IL+ +K + + + RE+ S+L H N+V
Sbjct: 25 STVYLAED---TILNIKVAIKAIFIPPREKEETL---KRFEREVHNSSQLSHQNIVS--- 75
Query: 672 FVIY-----EDVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLH 726
+ +D L+ Y+ TL++ + T ++ + +G+ H
Sbjct: 76 --MIDVDEEDDCYYLVMEYIEGPTLSEYIES-----HGPLSVDTAINFTNQILDGIKHAH 128
Query: 727 HVAIIHLDISSGNVLLD-------ADFKPLLGEIEISKLLDPSKGTASISAVAGSFGYIP 779
+ I+H DI N+L+D DF G I+K L + T + + V G+ Y
Sbjct: 129 DMRIVHRDIKPQNILIDSNKTLKIFDF----G---IAKALSETSLTQT-NHVLGTVQYFS 180
Query: 780 PEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQI- 838
PE A ++YS G+VL E+L P F GET I
Sbjct: 181 PEQAKGEATDECTDIYSIGIVLYEMLVGEPP----F---------------NGETAVSIA 221
Query: 839 ---LDARLSTVSFGWRKEMLTAL-KVALLCTDSTPAKRPKMKKVVEMLQEIKQ 887
+ + V+ RK++ +L V L T+ A R K + EM ++
Sbjct: 222 IKHIQDSVPNVTTDVRKDIPQSLSNVILRATEKDKANRY--KTIQEMKDDLSS 272
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 82.5 bits (204), Expect = 2e-17
Identities = 23/183 (12%), Positives = 46/183 (25%), Gaps = 38/183 (20%)
Query: 651 MIRELEKLSKLCHDNLVRPIGFVIYEDVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPT 710
+ +LS++ + R + V L++ ++ G+L ++ P
Sbjct: 78 TLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVADT-------SPSPVG 130
Query: 711 RLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSKGTASISA 770
+ +A H + V + D G
Sbjct: 131 AIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSID------------------GD----V 168
Query: 771 VAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGV--DLVKWVHGA 828
V +P ++ G L +L R P+ E + G
Sbjct: 169 VLAYPATMPD-------ANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQ 221
Query: 829 PAR 831
P
Sbjct: 222 PIE 224
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 82.7 bits (205), Expect = 6e-17
Identities = 57/293 (19%), Positives = 104/293 (35%), Gaps = 62/293 (21%)
Query: 616 GTFSTVYKAVMPSGLIL-SVKRLK--SMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGF 672
G F V+ + + L +VK + K ++E L + H N+VR IG
Sbjct: 125 GNFGEVFSGRLRADNTLVAVKSCRETLPPDLKA----KFLQEARILKQYSHPNIVRLIGV 180
Query: 673 VIYEDVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIH 732
+ ++ + G L + R T L + A G+ +L IH
Sbjct: 181 CTQKQPIYIVMELVQGGDFLTFL----RTEGARLRVKTLLQMVGDAAAGMEYLESKCCIH 236
Query: 733 LDISSGNVLLD-------ADFKPLLGEIEISKLLDPSKGTASISAVAGSFGYIP-----P 780
D+++ N L+ +DF G +S+ AS G +P P
Sbjct: 237 RDLAARNCLVTEKNVLKISDF----G---MSREEADGVYAAS-----GGLRQVPVKWTAP 284
Query: 781 EYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQILD 840
E + ++ +V+S+G++L E + G +P + +Q +
Sbjct: 285 EALNYGRYSSESDVWSFGILLWETFS--------LGA----------SPYPNLSNQQTRE 326
Query: 841 ARLSTVSFGWR----KEMLTAL-KVALLCTDSTPAKRPKMKKVVEMLQEIKQN 888
V G R + A+ ++ C P +RP + + LQ I++
Sbjct: 327 F----VEKGGRLPCPELCPDAVFRLMEQCWAYEPGQRPSFSTIYQELQSIRKR 375
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 81.6 bits (202), Expect = 6e-17
Identities = 56/272 (20%), Positives = 113/272 (41%), Gaps = 19/272 (6%)
Query: 616 GTFSTVYKAV-MPSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVI 674
G FS VY+A + G+ +++K+++ D + I+E++ L +L H N+++ I
Sbjct: 43 GQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFI 102
Query: 675 YEDVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLD 734
++ ++ G L++++ KQ P+ T + + L +H ++H D
Sbjct: 103 EDNELNIVLELADAGDLSRMIKHFKKQKRLIPE-RTVWKYFVQLCSALEHMHSRRVMHRD 161
Query: 735 ISSGNVLLDADFKPLLGEIEISKLLDPSKGTASISAVAGSFGYIPPEYAYTMQVTAPGNV 794
I NV + A LG++ + + A ++ G+ Y+ PE + ++
Sbjct: 162 IKPANVFITATGVVKLGDLGLGRFFSSKTTAA--HSLVGTPYYMSPERIHENGYNFKSDI 219
Query: 795 YSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQILDARLSTVSFGWRKEM 854
+S G +L E+ + P D L K + + + P + S E
Sbjct: 220 WSLGCLLYEMAALQSPFYGDKMNLYSLCKKIE----QCDYPP-LPSDHYS--------EE 266
Query: 855 LTALKVALLCTDSTPAKRPKMKKVVEMLQEIK 886
L L + D P KRP + V ++ + +
Sbjct: 267 LRQLVNMCINPD--PEKRPDVTYVYDVAKRMH 296
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 81.1 bits (201), Expect = 9e-17
Identities = 50/216 (23%), Positives = 80/216 (37%), Gaps = 47/216 (21%)
Query: 619 STVYKAVMPSGLILS----VKRLK---SMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIG 671
S V+ A L VK L+ + D + + RE + + L H +V
Sbjct: 26 SEVHLAR---DLRDHRDVAVKVLRADLARDPSFYL---RFRREAQNAAALNHPAIVA--- 76
Query: 672 FVIY----EDVALLLHNYL-----PNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGL 722
+Y + Y+ TL ++H + + + + L
Sbjct: 77 --VYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHT-----EGPMTPKRAIEVIADACQAL 129
Query: 723 AFLHHVAIIHLDISSGNVLLD-------ADFKPLLGEIEISKLLDPSKGT-ASISAVAGS 774
F H IIH D+ N+++ DF G I++ + S + +AV G+
Sbjct: 130 NFSHQNGIIHRDVKPANIMISATNAVKVMDF----G---IARAIADSGNSVTQTAAVIGT 182
Query: 775 FGYIPPEYAYTMQVTAPGNVYSYGVVLLEILTTRLP 810
Y+ PE A V A +VYS G VL E+LT P
Sbjct: 183 AQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPP 218
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 81.6 bits (201), Expect = 1e-16
Identities = 38/295 (12%), Positives = 75/295 (25%), Gaps = 45/295 (15%)
Query: 616 GTFSTVYKAV-MPSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVR------ 668
G S V+ + ++K ++ ++L ++
Sbjct: 73 GDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLGESPEEARDRRR 132
Query: 669 -------------------PIGFVIYEDVALLLHNYLPNGTLAQLLHESTKQPDYRPDWP 709
G Y LL + L L +R D
Sbjct: 133 LLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEG 192
Query: 710 T--RLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSKGTAS 767
+ + A L ++H + N+ + D + +LG++ +
Sbjct: 193 ILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVG-----TR 247
Query: 768 ISAVAGSFGYIPPEY--AYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWV 825
A + Y P E+ A T T N + G+ + + LP K
Sbjct: 248 GPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRP 307
Query: 826 HGAPARGETPEQILDARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVE 880
++ L + + L L D +R + +E
Sbjct: 308 SLRVPGTDSLAFGSCTPLP--------DFVKTLIGRFLNFD--RRRRLLPLEAME 352
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 80.2 bits (198), Expect = 1e-16
Identities = 46/183 (25%), Positives = 72/183 (39%), Gaps = 11/183 (6%)
Query: 302 SNLTLLNLASNGFTGVIPPELGQLINLQELILYENSLFGEIPKSILACKNLNKLDLSNNR 361
+ T+L+L+ N L L +L L L L L LDLS+N+
Sbjct: 31 KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVDGTL--PVLGTLDLSHNQ 88
Query: 362 FNGTIPNAICDMSRLQYLLLGQNSLKGEIPHEI-GNCMKLLQLHIGSNYLTGSIPPEI-G 419
++P + L L + N L +P +L +L++ N L ++PP +
Sbjct: 89 LQ-SLPLLGQTLPALTVLDVSFNRLT-SLPLGALRGLGELQELYLKGNELK-TLPPGLLT 145
Query: 420 HIRNLQIALNLSFNHLHGSLPPEL-GKLDKLVSFDVSNNQLSGTIPSALKGMLSLIEVNF 478
L+ L+L+ N+L LP L L+ L + + N L TIP G L
Sbjct: 146 PTPKLEK-LSLANNNLT-ELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAFL 202
Query: 479 SNN 481
N
Sbjct: 203 HGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 78.2 bits (193), Expect = 6e-16
Identities = 44/180 (24%), Positives = 72/180 (40%), Gaps = 10/180 (5%)
Query: 88 LKRLDLSNNAFSGTIPSAFGNLSELEFLDLSLNKFGGVIPRELGSLKDLRFFNISNNVLV 147
L LS N + + L L+L + + + G+L L ++S+N L
Sbjct: 33 TTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKL--QVDGTLPVLGTLDLSHNQLQ 90
Query: 148 GEIPDELKSLEKLEDFQVSSNKLNGSIPFWV-GNLTNLRVFTAYENQLVGEIPDNL-GSV 205
+P ++L L VS N+L S+P L L+ N+L +P L
Sbjct: 91 -SLPLLGQTLPALTVLDVSFNRLT-SLPLGALRGLGELQELYLKGNELK-TLPPGLLTPT 147
Query: 206 SELELLNLHSNQLEGPIPKSIFAS-GKLEVLVLTQNRLTGDIPELVGHCKSLSNIRIGNN 264
+LE L+L +N L +P + L+ L+L +N L IP+ L + N
Sbjct: 148 PKLEKLSLANNNLTE-LPAGLLNGLENLDTLLLQENSLYT-IPKGFFGSHLLPFAFLHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 8e-15
Identities = 46/184 (25%), Positives = 67/184 (36%), Gaps = 34/184 (18%)
Query: 63 AFVVKLDLSRLQLRGN----ITLVSELKALKRLDLSNNAFSGTIPSAFGNLSELEFLDLS 118
+ L++L L + + L L LDLS+N ++P L L LD+S
Sbjct: 50 TLMPYTRLTQLNLDRAELTKLQVDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVS 108
Query: 119 LNKFGGVIPRELGSLKDLRFFNISNNVLVGEIPDELKSLEKLEDFQVSSNKLNGSIPFWV 178
N+ L SL L L L++L + N+L ++P +
Sbjct: 109 FNR--------LTSL--------PLGAL-----RGLGELQEL---YLKGNELK-TLPPGL 143
Query: 179 -GNLTNLRVFTAYENQLVGEIPDNL-GSVSELELLNLHSNQLEGPIPKSIFASGKLEVLV 236
L + N L E+P L + L+ L L N L IPK F S L
Sbjct: 144 LTPTPKLEKLSLANNNLT-ELPAGLLNGLENLDTLLLQENSLYT-IPKGFFGSHLLPFAF 201
Query: 237 LTQN 240
L N
Sbjct: 202 LHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 73.6 bits (181), Expect = 2e-14
Identities = 45/184 (24%), Positives = 69/184 (37%), Gaps = 14/184 (7%)
Query: 206 SELELLNLHSNQLEGPIPKSIFAS-GKLEVLVLTQNRLTGDIPELVGHCKSLSNIRIGNN 264
+ +L+L N L + +L L L + LT + G L + + +N
Sbjct: 31 KDTTILHLSENLLYT-FSLATLMPYTRLTQLNLDRAELT-KLQVD-GTLPVLGTLDLSHN 87
Query: 265 DLVGVIPRAIGNVSGLTYFEADNNNLSGEIVPE--FSQCSNLTLLNLASNGFTGVIPPEL 322
L +P + LT + N L+ +P L L L N +PP L
Sbjct: 88 QLQ-SLPLLGQTLPALTVLDVSFNRLTS--LPLGALRGLGELQELYLKGNELK-TLPPGL 143
Query: 323 -GQLINLQELILYENSLFGEIPKSILAC-KNLNKLDLSNNRFNGTIPNAICDMSRLQYLL 380
L++L L N+L E+P +L +NL+ L L N TIP L +
Sbjct: 144 LTPTPKLEKLSLANNNL-TELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFAF 201
Query: 381 LGQN 384
L N
Sbjct: 202 LHGN 205
|
| >1p9a_G Platelet glycoprotein IB alpha chain precursor; platelet receptors, glycocalicin, leucine rich repeats, BLOO clotting; HET: NAG BMA; 1.70A {Homo sapiens} SCOP: c.10.2.7 PDB: 1ook_G* 1qyy_A* 3pmh_G* 1m0z_A 1m10_B 1sq0_B 1gwb_A* 1p8v_A* 1u0n_D 3p72_A Length = 290 | Back alignment and structure |
|---|
Score = 72.1 bits (177), Expect = 7e-14
Identities = 45/192 (23%), Positives = 69/192 (35%), Gaps = 18/192 (9%)
Query: 299 SQCS-NLTLLNLASNGFTGV---IPPELGQLINLQELILYENSLFGEIPKSILACKNLNK 354
+ +N T + +P + L L EN L+ +++ L +
Sbjct: 6 VSKVASHLEVNCDKRNLTALPPDLPK------DTTILHLSENLLYTFSLATLMPYTRLTQ 59
Query: 355 LDLSNNRFNGTIPNAICDMSRLQYLLLGQNSLKGEIPHEIGNCMKLLQLHIGSNYLTGSI 414
L+L T + L L L N L+ +P L L + N LT S+
Sbjct: 60 LNLDRAEL--TKLQVDGTLPVLGTLDLSHNQLQ-SLPLLGQTLPALTVLDVSFNRLT-SL 115
Query: 415 PPEI-GHIRNLQIALNLSFNHLHGSLPPEL-GKLDKLVSFDVSNNQLSGTIPSALKGMLS 472
P + LQ L L N L +LPP L KL ++NN L+ L G+ +
Sbjct: 116 PLGALRGLGELQE-LYLKGNELK-TLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLEN 173
Query: 473 LIEVNFSNNLLT 484
L + N L
Sbjct: 174 LDTLLLQENSLY 185
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 3e-16
Identities = 40/218 (18%), Positives = 82/218 (37%), Gaps = 36/218 (16%)
Query: 616 GTFSTVYKAV-MPSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLC-HDNLVRPIGFV 673
G F +V+K V G I ++KR K + QN +RE+ + L H ++VR
Sbjct: 22 GEFGSVFKCVKRLDGCIYAIKRSKKPLAGSVDEQNA-LREVYAHAVLGQHSHVVRYFSAW 80
Query: 674 IYEDVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHL 733
+D L+ + Y G+LA + E+ + Y + + + V GL ++H ++++H+
Sbjct: 81 AEDDHMLIQNEYCNGGSLADAISENYRIMSYFKE-AELKDLLLQVGRGLRYIHSMSLVHM 139
Query: 734 DISSGNVLLDADFKPLLGEIEISKLLDPSKGTASISAVA--GSFG--------------- 776
DI N+ + + AS + G G
Sbjct: 140 DIKPSNIFISRT-----SIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQVEEGDS 194
Query: 777 -YIPPE-----YAYTMQVTAPGNVYSYGVVLLEILTTR 808
++ E Y + + ++++ + ++
Sbjct: 195 RFLANEVLQENYTHLPKA----DIFALALTVVCAAGAE 228
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 79.3 bits (196), Expect = 3e-16
Identities = 45/220 (20%), Positives = 87/220 (39%), Gaps = 39/220 (17%)
Query: 616 GTFSTVYKAV-MPSGLILSVK--RLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGF 672
G F V++A ++K RL + + + K++RE++ L+KL H +VR
Sbjct: 16 GGFGVVFEAKNKVDDCNYAIKRIRLPNRELA----REKVMREVKALAKLEHPGIVRYFNA 71
Query: 673 VIYEDVALLLHN------------YLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAE 720
+ ++ L L ++ + + L I + +AE
Sbjct: 72 WLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNG--RCTIEERERSVCLHIFLQIAE 129
Query: 721 GLAFLHHVAIIHLDISSGNVLLDA-------DF---KPLLGEIEISKLLDPSKGTASISA 770
+ FLH ++H D+ N+ DF + + E +L P A +
Sbjct: 130 AVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTG 189
Query: 771 VAGSFGYIPPE----YAYTMQVTAPGNVYSYGVVLLEILT 806
G+ Y+ PE +Y+ +V +++S G++L E+L
Sbjct: 190 QVGTKLYMSPEQIHGNSYSHKV----DIFSLGLILFELLY 225
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 5e-16
Identities = 35/214 (16%), Positives = 70/214 (32%), Gaps = 13/214 (6%)
Query: 278 SGLTYFEADNNNLSGEIVPEFSQCSNLTLLNLASNGFTGVIPPELGQLINLQELILYENS 337
F ++ +P + L L + L N+ + + +
Sbjct: 11 HQEEDFRVTCKDIQR--IPSLP--PSTQTLKLIETHLRTIPSHAFSNLPNISRIYVSIDV 66
Query: 338 LFGEIPKSILA-CKNLNKLDLSNNRFNGTIP-NAICDMSRLQYLLLGQNSLKGEIPHE-- 393
++ + +++ N R I +A+ ++ L++L + LK P
Sbjct: 67 TLQQLESHSFYNLSKVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLK-MFPDLTK 125
Query: 394 IGNCMKLLQLHIGSNYLTGSIPPEI-GHIRNLQIALNLSFNHLHGSLPPELGKLDKLVSF 452
+ + L I N SIP + N + L L N S+ KL +
Sbjct: 126 VYSTDIFFILEITDNPYMTSIPVNAFQGLCNETLTLKLYNNGFT-SVQGYAFNGTKLDAV 184
Query: 453 DVSNNQLSGTIPS-ALKGMLSLIEV-NFSNNLLT 484
++ N+ I A G+ S + + S +T
Sbjct: 185 YLNKNKYLTVIDKDAFGGVYSGPSLLDVSQTSVT 218
|
| >2xwt_C Thyrotropin receptor; signaling protein-immune system complex, GPCR, graves' disea autoimmunity, receptor-autoantibody complex; HET: NAG BMA MAN; 1.90A {Homo sapiens} PDB: 3g04_C* Length = 239 | Back alignment and structure |
|---|
Score = 75.8 bits (187), Expect = 2e-15
Identities = 42/214 (19%), Positives = 80/214 (37%), Gaps = 13/214 (6%)
Query: 78 NITLVSEL-KALKRLDLSNNAFSGTIPS-AFGNLSELEFLDLSLNKFGGVIPREL-GSLK 134
+I + L + + L L TIPS AF NL + + +S++ + +L
Sbjct: 22 DIQRIPSLPPSTQTLKLIETHLR-TIPSHAFSNLPNISRIYVSIDVTLQQLESHSFYNLS 80
Query: 135 DLRFFNISNNVLVGEIPDE-LKSLEKLEDFQVSSNKLNGSIP--FWVGNLTNLRVFTAYE 191
+ I N + I + LK L L+ + + L P V + + +
Sbjct: 81 KVTHIEIRNTRNLTYIDPDALKELPLLKFLGIFNTGLK-MFPDLTKVYSTDIFFILEITD 139
Query: 192 NQLVGEIPDNL--GSVSELELLNLHSNQLEGPIPKSIFASGKLEVLVLTQNRLTGDIPE- 248
N + IP N G +E L L++N + F KL+ + L +N+ I +
Sbjct: 140 NPYMTSIPVNAFQGLCNETLTLKLYNNGFTS-VQGYAFNGTKLDAVYLNKNKYLTVIDKD 198
Query: 249 -LVGHCKSLSNIRIGNNDLVGVIPRAIGNVSGLT 281
G S + + + + + + ++ L
Sbjct: 199 AFGGVYSGPSLLDVSQTSVTALPSKGLEHLKELI 232
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 78.4 bits (194), Expect = 7e-16
Identities = 42/201 (20%), Positives = 69/201 (34%), Gaps = 23/201 (11%)
Query: 619 STVYKAVMPS-GLILSVKRLK---SMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVI 674
VY+A I+++K + S D +M RE +L ++V I
Sbjct: 48 GDVYEAEDTVRERIVALKLMSETLSSDPVFRT---RMQREARTAGRLQEPHVVP-----I 99
Query: 675 Y-----EDVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVA 729
+ + + + LA +L P ++I + L H
Sbjct: 100 HDFGEIDGQLYVDMRLINGVDLAAMLRR-----QGPLAPPRAVAIVRQIGSALDAAHAAG 154
Query: 730 IIHLDISSGNVLLDADFKPLLGEIEISKLLDPSKGTASISAVAGSFGYIPPEYAYTMQVT 789
H D+ N+L+ AD L + I+ K T G+ Y+ PE T
Sbjct: 155 ATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQL-GNTVGTLYYMAPERFSESHAT 213
Query: 790 APGNVYSYGVVLLEILTTRLP 810
++Y+ VL E LT P
Sbjct: 214 YRADIYALTCVLYECLTGSPP 234
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 78.9 bits (194), Expect = 9e-16
Identities = 37/240 (15%), Positives = 78/240 (32%), Gaps = 29/240 (12%)
Query: 603 VKATMKDSNMIYC-------GTFSTVYKAVMPSGLILSVKR---LKSMDRTIIHHQNKMI 652
K + + + G F+ VY+A K+ LK
Sbjct: 56 PKTEFQLGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPANPWEFYIGT 115
Query: 653 RELEKLSKLCHDNLVRPIGFVIYEDVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRL 712
+ +E+L ++ ++++ ++L+ GTL ++ P+ +
Sbjct: 116 QLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVI 175
Query: 713 SIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEIS---KLLD--------P 761
S A+ + + +H IIH DI N +L F E ++S L+D
Sbjct: 176 SFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKL 235
Query: 762 SKGTASISAVAGSFGYIPPE----YAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGE 817
+A + G+ E + Q+ + + + +L ++ G
Sbjct: 236 FPKGTIFTAKCETSGFQCVEMLSNKPWNYQI----DYFGVAATVYCMLFGTYMKVKNEGG 291
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 77.4 bits (191), Expect = 1e-15
Identities = 40/236 (16%), Positives = 89/236 (37%), Gaps = 22/236 (9%)
Query: 154 LKSLEKLEDFQVSSNKLNGSIPFWVGNLTNLRVFTAYENQLVGEIPDNLGSVSELELLNL 213
+ + + + ++ L ++ A + + + + + + L L
Sbjct: 20 DDAFAETIKDNLKKKSVTDAVTQ--NELNSIDQIIANNSDIK-SV-QGIQYLPNVTKLFL 75
Query: 214 HSNQLEGPIPKSIFASG---KLEVLVLTQNRLTGDIPELVGHCKSLSNIRIGNNDLVGVI 270
+ N+L I L L L +N++ D+ L K L ++ + +N + +
Sbjct: 76 NGNKL-----TDIKPLANLKNLGWLFLDENKVK-DLSSL-KDLKKLKSLSLEHNGISDIN 128
Query: 271 PRAIGNVSGLTYFEADNNNLSGEIVPEFSQCSNLTLLNLASNGFTGVIPPELGQLINLQE 330
+ ++ L NN ++ + S+ + L L+L N + ++P L L LQ
Sbjct: 129 G--LVHLPQLESLYLGNNKIT--DITVLSRLTKLDTLSLEDNQISDIVP--LAGLTKLQN 182
Query: 331 LILYENSLFGEIPKSILACKNLNKLDLSNNRFNGTIPNAICDMSRLQYLLLGQNSL 386
L L +N + +++ KNL+ L+L + N ++ + SL
Sbjct: 183 LYLSKNHI--SDLRALAGLKNLDVLELFSQECLNKPINHQSNLVVPNTVKNTDGSL 236
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 74.7 bits (184), Expect = 1e-14
Identities = 41/289 (14%), Positives = 93/289 (32%), Gaps = 40/289 (13%)
Query: 78 NITLVSELKALKRLDLSNNAFSGTIPSAFGNLSELEFLDLSLNKFGGVIPRELGSLKDLR 137
I + +L + + + L+ ++ + + + V + L ++
Sbjct: 16 QIFSDDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSVQG--IQYLPNVT 71
Query: 138 FFNISNNVLVGEIPDELKSLEKLEDFQVSSNKLNGSIPFWVGNLTNLRVFTAYENQLVGE 197
++ N L +I L +L+ L + NK+ + + +L L+ + N +
Sbjct: 72 KLFLNGNKLT-DIKP-LANLKNLGWLFLDENKVK-DLSS-LKDLKKLKSLSLEHNGI--S 125
Query: 198 IPDNLGSVSELELLNLHSNQLEGPIPKSIFASGKLEVLVLTQNRLTGDIPELVGHCKSLS 257
+ L + +LE L L +N++ DI L L
Sbjct: 126 DINGLVHLPQLESLYLGNNKIT-------------------------DITVL-SRLTKLD 159
Query: 258 NIRIGNNDLVGVIPRAIGNVSGLTYFEADNNNLSGEIVPEFSQCSNLTLLNLASNGFTGV 317
+ + +N + ++P + ++ L N++S + + NL +L L S
Sbjct: 160 TLSLEDNQISDIVP--LAGLTKLQNLYLSKNHISD--LRALAGLKNLDVLELFSQECLNK 215
Query: 318 IPPELGQLINLQELILYENSLFGEIPKSILACKNLNKLDLSNNRFNGTI 366
L+ + + SL S + F +
Sbjct: 216 PINHQSNLVVPNTVKNTDGSLVTPEIISDDGDYEKPNVKWHLPEFTNEV 264
|
| >1h6t_A Internalin B; cell adhesion, leucine rich repeat, IG-like domain, EF-hand domain; 1.6A {Listeria monocytogenes} SCOP: b.1.18.15 c.10.2.1 PDB: 2wqu_A 2uzy_A 2uzx_A 2wqv_A* 2wqw_A 2wqx_A 1d0b_A 1otn_A 1oto_A 1otm_A Length = 291 | Back alignment and structure |
|---|
Score = 73.9 bits (182), Expect = 2e-14
Identities = 41/200 (20%), Positives = 84/200 (42%), Gaps = 17/200 (8%)
Query: 285 ADNNNLSGEIVPEFSQCSNLTLLNLASNGFTGVIPPELGQLINLQELILYENSLFGEIPK 344
+ +I + NL T + +L ++ ++I + + + +
Sbjct: 9 TVPTPIK-QIFS-DDAFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDI-KSV-Q 62
Query: 345 SILACKNLNKLDLSNNRFNGTIPNAICDMSRLQYLLLGQNSLKGEIPHEIGNCMKLLQLH 404
I N+ KL L+ N+ I + ++ L +L L +N +K ++ + + KL L
Sbjct: 63 GIQYLPNVTKLFLNGNKLT-DIKP-LANLKNLGWLFLDENKVK-DLS-SLKDLKKLKSLS 118
Query: 405 IGSNYLTGSIPPEIGHIRNLQIALNLSFNHLHGSLPPELGKLDKLVSFDVSNNQLSGTIP 464
+ N ++ I + H+ L+ L L N + + L +L KL + + +NQ+S I
Sbjct: 119 LEHNGIS-DING-LVHLPQLES-LYLGNNKIT-DITV-LSRLTKLDTLSLEDNQIS-DI- 171
Query: 465 SALKGMLSLIEVNFSNNLLT 484
L G+ L + S N ++
Sbjct: 172 VPLAGLTKLQNLYLSKNHIS 191
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 1e-15
Identities = 49/183 (26%), Positives = 87/183 (47%), Gaps = 12/183 (6%)
Query: 88 LKRLDLSNNAFSGTIPSAFGNLSELEFLDLSLNKFGGVIPRELGSLKDLRFFNISNNVLV 147
K+LDL +N S AF L++L L L+ NK + LK+L +++N L
Sbjct: 39 TKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQTLPAGIFKELKNLETLWVTDNKLQ 98
Query: 148 ---GEIPDELKSLEKLEDFQVSSNKLNGSIPFWV-GNLTNLRVFTAYENQLVGEIPDNL- 202
+ D+L +L +L ++ N+L S+P V +LT L + N+L +P +
Sbjct: 99 ALPIGVFDQLVNLAEL---RLDRNQLK-SLPPRVFDSLTKLTYLSLGYNELQ-SLPKGVF 153
Query: 203 GSVSELELLNLHSNQLEGPIPKSIFAS-GKLEVLVLTQNRLTGDIPELVGHCKSLSNIRI 261
++ L+ L L++NQL+ +P+ F +L+ L L N+L + L +++
Sbjct: 154 DKLTSLKELRLYNNQLKR-VPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQL 212
Query: 262 GNN 264
N
Sbjct: 213 QEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 1e-12
Identities = 50/185 (27%), Positives = 82/185 (44%), Gaps = 11/185 (5%)
Query: 302 SNLTLLNLASNGFTGVIPPELGQLINLQELILYENSLFGEIPKSILAC-KNLNKLDLSNN 360
++ L+L SN + + +L L+ L L +N L +P I KNL L +++N
Sbjct: 37 ADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKL-QTLPAGIFKELKNLETLWVTDN 95
Query: 361 RFNGTIPNAICD-MSRLQYLLLGQNSLKGEIPHEI-GNCMKLLQLHIGSNYLTGSIPPEI 418
+ +P + D + L L L +N LK +P + + KL L +G N L S+P +
Sbjct: 96 KLQ-ALPIGVFDQLVNLAELRLDRNQLK-SLPPRVFDSLTKLTYLSLGYNELQ-SLPKGV 152
Query: 419 -GHIRNLQIALNLSFNHLHGSLPPEL-GKLDKLVSFDVSNNQLSGTIPSALKGMLSLIEV 476
+ +L+ L L N L +P KL +L + + NNQL A + L +
Sbjct: 153 FDKLTSLKE-LRLYNNQLK-RVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKML 210
Query: 477 NFSNN 481
N
Sbjct: 211 QLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 1e-11
Identities = 50/195 (25%), Positives = 82/195 (42%), Gaps = 25/195 (12%)
Query: 301 CSN-LTLLNLASNGFTGV---IPPELGQLINLQELILYENSLFGEIPKSILACKNLNKLD 356
C+N ++ +S T + IP + ++L L N L K+ L L
Sbjct: 14 CNNNKNSVDCSSKKLTAIPSNIPA------DTKKLDLQSNKLSSLPSKAFHRLTKLRLLY 67
Query: 357 LSNNRFNGTIPNAICD-MSRLQYLLLGQNSLKGEIPHEIGNCMKLLQ-LHIGSNYLTGSI 414
L++N+ T+P I + L+ L + N L+ +P + + + L L + N L S+
Sbjct: 68 LNDNKLQ-TLPAGIFKELKNLETLWVTDNKLQ-ALPIGVFDQLVNLAELRLDRNQLK-SL 124
Query: 415 PPEI-GHIRNLQIALNLSFNHLHGSLPP----ELGKLDKLVSFDVSNNQLSGTIPSALKG 469
PP + + L L+L +N L SLP +L L +L + NNQL A
Sbjct: 125 PPRVFDSLTKLTY-LSLGYNELQ-SLPKGVFDKLTSLKEL---RLYNNQLKRVPEGAFDK 179
Query: 470 MLSLIEVNFSNNLLT 484
+ L + NN L
Sbjct: 180 LTELKTLKLDNNQLK 194
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 5e-11
Identities = 55/210 (26%), Positives = 80/210 (38%), Gaps = 41/210 (19%)
Query: 198 IPDNLGSVSELELLNLHSNQLEGPIPKSIFAS-GKLEVLVLTQNRLTGDIPELVGHCKSL 256
IP + + L+L SN+L +P F KL +L L N+L +P G K L
Sbjct: 35 IPADT------KKLDLQSNKLSS-LPSKAFHRLTKLRLLYLNDNKLQ-TLP--AGIFKEL 84
Query: 257 SNIRIGNNDLVGVIPRAIGNVSGLTYFEADNNNLSGEIVPE--FSQCSNLTLLNLASNGF 314
N L +N L +P F Q NL L L N
Sbjct: 85 KN---------------------LETLWVTDNKLQA--LPIGVFDQLVNLAELRLDRNQL 121
Query: 315 TGVIPPEL-GQLINLQELILYENSLFGEIPKSILAC-KNLNKLDLSNNRFNGTIPNAICD 372
+PP + L L L L N L +PK + +L +L L NN+ A
Sbjct: 122 KS-LPPRVFDSLTKLTYLSLGYNEL-QSLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDK 179
Query: 373 MSRLQYLLLGQNSLKGEIPHEIGNCMKLLQ 402
++ L+ L L N LK +P + ++ L+
Sbjct: 180 LTELKTLKLDNNQLK-RVPEGAFDSLEKLK 208
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 7e-10
Identities = 58/229 (25%), Positives = 88/229 (38%), Gaps = 35/229 (15%)
Query: 88 LKRLDLSNNAFSGTIPSAFGNLSELEFLDLSLNKFGGVIPRELGSLKDLRFFNISNNVLV 147
+D S+ + IPS ++ + LDL NK ++ +
Sbjct: 18 KNSVDCSSKKLT-AIPS--NIPADTKKLDLQSNKLS----------------SLPSKA-- 56
Query: 148 GEIPDELKSLEKLEDFQVSSNKLNGSIPFWV-GNLTNLRVFTAYENQLVGEIPDNL-GSV 205
L KL ++ NKL ++P + L NL +N+L +P + +
Sbjct: 57 ------FHRLTKLRLLYLNDNKLQ-TLPAGIFKELKNLETLWVTDNKLQ-ALPIGVFDQL 108
Query: 206 SELELLNLHSNQLEGPIPKSIFAS-GKLEVLVLTQNRLTGDIPELV-GHCKSLSNIRIGN 263
L L L NQL+ +P +F S KL L L N L +P+ V SL +R+ N
Sbjct: 109 VNLAELRLDRNQLKS-LPPRVFDSLTKLTYLSLGYNELQ-SLPKGVFDKLTSLKELRLYN 166
Query: 264 NDLVGVIPRAIGNVSGLTYFEADNNNLSGEIVPEFSQCSNLTLLNLASN 312
N L V A ++ L + DNN L F L +L L N
Sbjct: 167 NQLKRVPEGAFDKLTELKTLKLDNNQLKRVPEGAFDSLEKLKMLQLQEN 215
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 9e-10
Identities = 58/230 (25%), Positives = 99/230 (43%), Gaps = 22/230 (9%)
Query: 166 SSNKLNGSIPFWVGNLTNLRVFTAYENQLVGEIPDNLGSVSELELLNLHSNQLEGPIPKS 225
SS KL +IP + + N+L +++L LL L+ N+L+ +P
Sbjct: 24 SSKKLT-AIP--SNIPADTKKLDLQSNKLSSLPSKAFHRLTKLRLLYLNDNKLQT-LPAG 79
Query: 226 IFAS-GKLEVLVLTQNRLTGDIPELV-GHCKSLSNIRIGNNDLVGVIPRAIGNVSGLTYF 283
IF LE L +T N+L +P V +L+ +R+ N L + PR +++ LTY
Sbjct: 80 IFKELKNLETLWVTDNKLQ-ALPIGVFDQLVNLAELRLDRNQLKSLPPRVFDSLTKLTYL 138
Query: 284 EADNNNLSGEIVPE--FSQCSNLTLLNLASNGFTGVIPPELGQLINLQELILYENSLFGE 341
N L +P+ F + ++L L L +N V +L L+ L L N L
Sbjct: 139 SLGYNELQ--SLPKGVFDKLTSLKELRLYNNQLKRVPEGAFDKLTELKTLKLDNNQL-KR 195
Query: 342 IPKSILAC-KNLNKLDLSNNRFNGTIPNAICDMSRLQYL--LLGQNSLKG 388
+P+ + L L L N ++ C + + Y+ L + + +G
Sbjct: 196 VPEGAFDSLEKLKMLQLQENPWD-------CTCNGIIYMAKWLKKKADEG 238
|
| >2o6q_A Variable lymphocyte receptor A; leucine-rich repeat protein, LRR, immune system; 2.50A {Eptatretus burgeri} Length = 270 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 7e-09
Identities = 52/181 (28%), Positives = 77/181 (42%), Gaps = 38/181 (20%)
Query: 70 LSRLQLRGN-ITLVSE-----LKALKRLDLSNNAFSGTIPS-AFGNLSELEFLDLSLNKF 122
L L L N + + LK L+ L +++N +P F L L L L N+
Sbjct: 63 LRLLYLNDNKLQTLPAGIFKELKNLETLWVTDNKLQ-ALPIGVFDQLVNLAELRLDRNQ- 120
Query: 123 GGVIPRELGSLKDLRFFNISNNVLVGEIPDELKSLEKLEDFQVSSNKLNGSIPFWV-GNL 181
L SL F SL KL + N+L S+P V L
Sbjct: 121 -------LKSLPPRVF----------------DSLTKLTYLSLGYNELQ-SLPKGVFDKL 156
Query: 182 TNLRVFTAYENQLVGEIPDNL-GSVSELELLNLHSNQLEGPIPKSIFAS-GKLEVLVLTQ 239
T+L+ Y NQL +P+ ++EL+ L L +NQL+ +P+ F S KL++L L +
Sbjct: 157 TSLKELRLYNNQL-KRVPEGAFDKLTELKTLKLDNNQLKR-VPEGAFDSLEKLKMLQLQE 214
Query: 240 N 240
N
Sbjct: 215 N 215
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 79.9 bits (197), Expect = 2e-15
Identities = 44/283 (15%), Positives = 92/283 (32%), Gaps = 60/283 (21%)
Query: 616 GTFSTVYKAV--MPSGLILSVKRLK-SMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGF 672
G +Y A+ +G + +K L S D + E + L+++ H ++V+ F
Sbjct: 91 GGLGWIYLALDRNVNGRPVVLKGLVHSGDAEAQA---MAMAERQFLAEVVHPSIVQIFNF 147
Query: 673 VIYEDVALLLHNYL-----PNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHH 727
V + D Y+ +L + + + ++ + + L++LH
Sbjct: 148 VEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ-------KLPVAEAIAYLLEILPALSYLHS 200
Query: 728 VAIIHLDISSGNVLLD------ADFKPLLGEIEISKLLDPSKGTASISAVAGSFGYIPPE 781
+ +++ D+ N++L D G ++ + G+ G+ PE
Sbjct: 201 IGLVYNDLKPENIMLTEEQLKLIDL----G---AVSRINSF------GYLYGTPGFQAPE 247
Query: 782 YAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQ---- 837
T T ++Y+ G L + + V + +T +
Sbjct: 248 IVRT-GPTVATDIYTVGRTLAALTLDLPTRNGRY------VDGLPEDDPVLKTYDSYGRL 300
Query: 838 ILDA-------RLSTVSFGWRKEMLTALKVALLCTDSTPAKRP 873
+ A R +T EM L L + P
Sbjct: 301 LRRAIDPDPRQRFTTAE-----EMSAQLTGVLREVVAQDTGVP 338
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 77.0 bits (190), Expect = 2e-15
Identities = 50/205 (24%), Positives = 82/205 (40%), Gaps = 23/205 (11%)
Query: 616 GTFSTVYKAV-MPSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVI 674
G+F TVYK + + + ++ L+ T + + E E L L H N+VR
Sbjct: 37 GSFKTVYKGLDTETTVEVAWCELQDRKLTK-SERQRFKEEAEMLKGLQHPNIVRFYDS-- 93
Query: 675 YEDVALLLHN------YLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLH-- 726
+E + +GTL L S + +GL FLH
Sbjct: 94 WESTVKGKKCIVLVTELMTSGTLKTYLKRFKV-----MKIKVLRSWCRQILKGLQFLHTR 148
Query: 727 HVAIIHLDISSGNVLLDADFKPLLGEIEISKL-LDPSKGTASISAVAGSFGYIPPEYAYT 785
IIH D+ N+ + G ++I L L K + AV G+ ++ PE Y
Sbjct: 149 TPPIIHRDLKCDNIFITGP----TGSVKIGDLGLATLKRASFAKAVIGTPEFMAPEM-YE 203
Query: 786 MQVTAPGNVYSYGVVLLEILTTRLP 810
+ +VY++G+ +LE+ T+ P
Sbjct: 204 EKYDESVDVYAFGMCMLEMATSEYP 228
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 76.9 bits (190), Expect = 8e-15
Identities = 70/404 (17%), Positives = 134/404 (33%), Gaps = 60/404 (14%)
Query: 68 LDLS--RLQLRGNITLVSELKALKRLDLSNNAFSGT----IPSAFGNLSELEFLDLSLNK 121
LD+ L L+ L+ + + L + + I SA L L+L N+
Sbjct: 8 LDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNE 67
Query: 122 FGGVIPRELGS-LKD----LRFFNISNNVL----VGEIPDELKSLEKLEDFQVSSNKLNG 172
G V + L+ ++ ++ N L G + L++L L++ +S N L
Sbjct: 68 LGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGD 127
Query: 173 S-----IPFWVGNLTNLRVFTAYENQLVGEIPDNLGSV----SELELLNLHSNQLEGPIP 223
+ + L L + L SV + + L + +N +
Sbjct: 128 AGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGV 187
Query: 224 KSIFAS-----GKLEVLVLTQNRLTGD----IPELVGHCKSLSNIRIGNNDL----VGVI 270
+ + +LE L L +T D + +V SL + +G+N L + +
Sbjct: 188 RVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVASKASLRELALGSNKLGDVGMAEL 247
Query: 271 PRAIGNVS-GLTYFEADNNNLSGE----IVPEFSQCSNLTLLNLASNGFTGVIPPELGQL 325
+ + S L ++ + + +L L+LA N L +
Sbjct: 248 CPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLLCET 307
Query: 326 I-----NLQELILYENSL----FGEIPKSILACKNLNKLDLSNNRFNGTIPNAICDM--- 373
+ L+ L + S + + L +L +SNNR +C
Sbjct: 308 LLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQ 367
Query: 374 --SRLQYLLLGQNSLKGE----IPHEIGNCMKLLQLHIGSNYLT 411
S L+ L L + + + L +L + +N L
Sbjct: 368 PGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLG 411
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 76.5 bits (189), Expect = 1e-14
Identities = 71/449 (15%), Positives = 147/449 (32%), Gaps = 94/449 (20%)
Query: 88 LKRLDLSNNAFSGT-IPSAFGNLSELEFLDLSLNKFG----GVIPRELGSLKDLRFFNIS 142
++ LD+ S L + + + L I L L N+
Sbjct: 5 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 64
Query: 143 NNVL----VGEIPDELKSLE-KLEDFQVSSNKLNGSIPFWVGNLTNLRVFTAYENQLVGE 197
+N L V + L++ K++ + + L G
Sbjct: 65 SNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLT--------------------GAGCGV 104
Query: 198 IPDNLGSVSELELLNLHSNQLEGPIPKSIFASG-----KLEVLVLTQNRLT----GDIPE 248
+ L ++ L+ L+L N L + + +LE L L L+ +
Sbjct: 105 LSSTLRTLPTLQELHLSDNLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLAS 164
Query: 249 LVGHCKSLSNIRIGNNDL--VGVIPRAIG-----NVSGLTYFEADNNNLSGE----IVPE 297
++ + + NND+ GV R + + L + ++ ++ + +
Sbjct: 165 VLRAKPDFKELTVSNNDINEAGV--RVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGI 222
Query: 298 FSQCSNLTLLNLASN-----GFTGVIPPELGQLINLQELILYENSL----FGEIPKSILA 348
+ ++L L L SN G + P L L+ L ++E + G++ + + A
Sbjct: 223 VASKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRA 282
Query: 349 CKNLNKLDLSNNRFNGTIPNAICDM-----SRLQYLLLGQNSLKGEIPHEIGNCMK---- 399
++L +L L+ N +C+ +L+ L + S + +
Sbjct: 283 KESLKELSLAGNELGDEGARLLCETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRF 342
Query: 400 LLQLHIGSNYLTGSIPPEIGHIRNLQIALNLSFNHLHGSLPPELGKLDKLVSFDVSNNQL 459
LL+L I +N + ++ L L +++ +
Sbjct: 343 LLELQISNN--------RLEDAGVRELCQGLGQPG------------SVLRVLWLADCDV 382
Query: 460 S----GTIPSALKGMLSLIEVNFSNNLLT 484
S ++ + L SL E++ SNN L
Sbjct: 383 SDSSCSSLAATLLANHSLRELDLSNNCLG 411
|
| >1z7x_W Ribonuclease inhibitor; leucine-rich repeat, enzyme- inhibitor complex, structural genomics, protein structure initiative, PSI, CESG; HET: CIT; 1.95A {Homo sapiens} SCOP: c.10.1.1 PDB: 2q4g_W* 2bex_A 1a4y_A 2bnh_A 1dfj_I Length = 461 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 4e-11
Identities = 53/316 (16%), Positives = 108/316 (34%), Gaps = 58/316 (18%)
Query: 206 SELELLNLHSNQL-EGPIPKSIFASGKLEVLVLTQNRLT----GDIPELVGHCKSLSNIR 260
+++ L++ +L + + + + +V+ L LT DI + +L+ +
Sbjct: 3 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 62
Query: 261 IGNNDL----VGVIPRAIGNVS-GLTYFEADNNNLSGE----IVPEFSQCSNLTLLNLAS 311
+ +N+L V + + + S + N L+G + L L+L+
Sbjct: 63 LRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSD 122
Query: 312 NGFTGVIPPELGQLI-----NLQELILYENSLFGE----IPKSILACKNLNKLDLSNNRF 362
N L + + L++L L SL + + A + +L +SNN
Sbjct: 123 NLLGDAGLQLLCEGLLDPQCRLEKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDI 182
Query: 363 NGTIPNAICDM-----SRLQYLLLGQNSLKGEIPHEIGNCMKLLQLHIGSNYLTGSIPPE 417
N +C +L+ L L + + + L + S
Sbjct: 183 NEAGVRVLCQGLKDSPCQLEALKLESCGVTSD-------NCRDLCGIVASK--------- 226
Query: 418 IGHIRNLQIALNLSFNHLHGS-----LPPELGKLDKLVSFDVSNNQLS----GTIPSALK 468
+L+ L L N L P L +L + + ++ G + L+
Sbjct: 227 ----ASLRE-LALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLR 281
Query: 469 GMLSLIEVNFSNNLLT 484
SL E++ + N L
Sbjct: 282 AKESLKELSLAGNELG 297
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 76.2 bits (187), Expect = 1e-14
Identities = 39/299 (13%), Positives = 73/299 (24%), Gaps = 58/299 (19%)
Query: 616 GTFSTVYKAVMP-SGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKL----------CHD 664
+A +G V +R + +M E+ +L L H
Sbjct: 89 EDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHL 148
Query: 665 NLVRPI----------------GFVIYEDVALLLHNYLPNGTLAQLLHE--STKQPDYRP 706
+ P ++ L S
Sbjct: 149 RFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSL 208
Query: 707 DWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSKGTA 766
RL + + V LA LHH ++H + +++LD L E S +
Sbjct: 209 VHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGASAVSP 268
Query: 767 SISAVAGSFGYIPPEYAYTMQ-----VTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDL 821
Q +T + ++ G+ + I LP +D +
Sbjct: 269 IGRGF-APPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDD--AALGG 325
Query: 822 VKWVHGAPARGETPEQILDARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVE 880
+W+ + P+ + L L R + +E
Sbjct: 326 SEWIFRSCKN--IPQPVRA-----------------LLEGFLRYP--KEDRLLPLQAME 363
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 75.2 bits (185), Expect = 1e-14
Identities = 52/258 (20%), Positives = 87/258 (33%), Gaps = 32/258 (12%)
Query: 565 KASKSADVADSGASSQPSIIAGNVLVENLRQAIDLDAVVKATMKDSNMIYCGTFSTVYKA 624
K S + G +L E L+ M + G+F V++
Sbjct: 18 KTWSSGSAKLQRLGPETEDNEGVLLTEKLKPVDYEYREEVHWMTHQPRVGRGSFGEVHRM 77
Query: 625 V-MPSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVALLLH 683
+G +VK + + + EL + L +V G V +
Sbjct: 78 KDKQTGFQCAVK--------KVRLEVFRVEELVACAGLSSPRIVPLYGAVREGPWVNIFM 129
Query: 684 NYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLD 743
L G+L QL+ + P+ L EGL +LH I+H D+ + NVLL
Sbjct: 130 ELLEGGSLGQLIKQMGCLPE-----DRALYYLGQALEGLEYLHTRRILHGDVKADNVLLS 184
Query: 744 --------ADFKPLLGEIEISKLLDPSKGTASISA---VAGSFGYIPPEYAYTMQVTAPG 792
DF G + L P S+ + G+ ++ PE A
Sbjct: 185 SDGSRAALCDF----G---HALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKV 237
Query: 793 NVYSYGVVLLEILTTRLP 810
+++S ++L +L P
Sbjct: 238 DIWSSCCMMLHMLNGCHP 255
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 75.0 bits (184), Expect = 2e-14
Identities = 41/307 (13%), Positives = 80/307 (26%), Gaps = 73/307 (23%)
Query: 616 GTFSTVYKAV-MPSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLC------------ 662
+A +G V +R + +M E+ +L L
Sbjct: 84 EDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHL 143
Query: 663 -------------HDNLVRPIG-FVIYEDVALLLHNYLPNGTLAQLLHE--STKQPDYRP 706
++R ++ L S
Sbjct: 144 RFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSL 203
Query: 707 DWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLD--PSKG 764
RL + + V LA LHH ++H + +++LD G + L
Sbjct: 204 VHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQR-----GGV---FLTGFEHLVR 255
Query: 765 TASISAVAGSFGYIPPEYAYTMQVTAPG-----------NVYSYGVVLLEILTTRLPVEE 813
+ + S G+ PPE + + ++ G+V+ I LP+ +
Sbjct: 256 DGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITK 315
Query: 814 DFGEGVDLVKWVHGAPARGETPEQILDARLSTVSFGWRKEMLTALKVALLCTDSTPAKRP 873
D + +W+ + P+ + L L R
Sbjct: 316 D--AALGGSEWIFRSCKN--IPQPVRA-----------------LLEGFLRYP--KEDRL 352
Query: 874 KMKKVVE 880
+ +E
Sbjct: 353 LPLQAME 359
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 73.5 bits (181), Expect = 3e-14
Identities = 47/217 (21%), Positives = 84/217 (38%), Gaps = 39/217 (17%)
Query: 612 MIYCGTFSTVYKAV-MPSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPI 670
++ GT+ VY + + + +++K + D + E+ L H N+V+ +
Sbjct: 29 VLGKGTYGIVYAGRDLSNQVRIAIKEIPERDSRYS---QPLHEEIALHKHLKHKNIVQYL 85
Query: 671 GFVIYEDVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVA---EGLAFLHH 727
G + +P G+L+ LL + + P +I EGL +LH
Sbjct: 86 GSFSENGFIKIFMEQVPGGSLSALL-----RSKWGPLKDNEQTIGFYTKQILEGLKYLHD 140
Query: 728 VAIIHLDISSGNVLLD--------ADFKPLLGEIEISKLLDPSKGTASISAVAGSFGYIP 779
I+H DI NVL++ +DF G SK L + G+ Y+
Sbjct: 141 NQIVHRDIKGDNVLINTYSGVLKISDF----G---TSKRL--AGINPCTETFTGTLQYMA 191
Query: 780 PE------YAYTMQVTAPGNVYSYGVVLLEILTTRLP 810
PE Y +++S G ++E+ T + P
Sbjct: 192 PEIIDKGPRGY----GKAADIWSLGCTIIEMATGKPP 224
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 73.1 bits (180), Expect = 3e-14
Identities = 56/284 (19%), Positives = 99/284 (34%), Gaps = 43/284 (15%)
Query: 616 GTFSTVYKAVMPSGLILSVKR-----LKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPI 670
GTF+ ++K V LK +D+ ++ +SKL H +LV
Sbjct: 19 GTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESFFEAASMMSKLSHKHLVLNY 78
Query: 671 GFVIYEDVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAI 730
G + D +L+ ++ G+L L K+ + +L +A +A + FL +
Sbjct: 79 GVCVCGDENILVQEFVKFGSLDTYL----KKNKNCINILWKLEVAKQLAAAMHFLEENTL 134
Query: 731 IHLDISSGNVLLDADFKPLLGEIEISKLLDPSKGTASISAVAGSFGYIP-----PE-YAY 784
IH ++ + N+LL + G KL DP G SI+ + PE
Sbjct: 135 IHGNVCAKNILLIREEDRKTGNPPFIKLSDP--GI-SITVLPKDILQERIPWVPPECIEN 191
Query: 785 TMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQILDARLS 844
+ + +S+G L EI + G+ P ++ L
Sbjct: 192 PKNLNLATDKWSFGTTLWEICS--------GGD----------KPLSALDSQRKLQF--- 230
Query: 845 TVSFGWR--KEMLTAL-KVALLCTDSTPAKRPKMKKVVEMLQEI 885
+ L + C D P RP + ++ L +
Sbjct: 231 -YEDRHQLPAPKAAELANLINNCMDYEPDHRPSFRAIIRDLNSL 273
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 74.8 bits (184), Expect = 4e-14
Identities = 59/292 (20%), Positives = 111/292 (38%), Gaps = 64/292 (21%)
Query: 616 GTFSTVYKAVMPSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIY 675
G F V+ +++K LK + ++E + + KL H+ LV+ V+
Sbjct: 195 GCFGEVWMGTWNGTTRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYA-VVS 249
Query: 676 EDVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDI 735
E+ ++ Y+ G+L L T + P + +A +A G+A++ + +H D+
Sbjct: 250 EEPIYIVTEYMSKGSLLDFLKGETGKY---LRLPQLVDMAAQIASGMAYVERMNYVHRDL 306
Query: 736 SSGNVLLD-------ADF---KPLLGEI----EISKLLDPSKGTASISAVAGSFGYIPPE 781
+ N+L+ ADF + + + +K P K TA PE
Sbjct: 307 RAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF--PIKWTA-------------PE 351
Query: 782 YAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQILDA 841
A + T +V+S+G++L E+ T G P G ++LD
Sbjct: 352 AALYGRFTIKSDVWSFGILLTELTT--------KGR----------VPYPGMVNREVLDQ 393
Query: 842 RLSTVSFGWRKEM-----LTALKVALLCTDSTPAKRPKMKKVVEMLQEIKQN 888
V G+R + + C P +RP + + L++ +
Sbjct: 394 ----VERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 441
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 74.9 bits (184), Expect = 4e-14
Identities = 59/292 (20%), Positives = 111/292 (38%), Gaps = 64/292 (21%)
Query: 616 GTFSTVYKAVMPSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIY 675
G F V+ +++K LK + ++E + + KL H+ LV+ V+
Sbjct: 278 GCFGEVWMGTWNGTTRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYA-VVS 332
Query: 676 EDVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDI 735
E+ ++ Y+ G+L L T + P + +A +A G+A++ + +H D+
Sbjct: 333 EEPIYIVTEYMSKGSLLDFLKGETGK---YLRLPQLVDMAAQIASGMAYVERMNYVHRDL 389
Query: 736 SSGNVLLD-------ADF---KPLLGEI----EISKLLDPSKGTASISAVAGSFGYIPPE 781
+ N+L+ ADF + + + +K P K TA PE
Sbjct: 390 RAANILVGENLVCKVADFGLARLIEDNEYTARQGAKF--PIKWTA-------------PE 434
Query: 782 YAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQILDA 841
A + T +V+S+G++L E+ T G P G ++LD
Sbjct: 435 AALYGRFTIKSDVWSFGILLTELTT--------KGR----------VPYPGMVNREVLDQ 476
Query: 842 RLSTVSFGWRKEM-----LTALKVALLCTDSTPAKRPKMKKVVEMLQEIKQN 888
V G+R + + C P +RP + + L++ +
Sbjct: 477 ----VERGYRMPCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 524
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 74.8 bits (184), Expect = 5e-14
Identities = 59/295 (20%), Positives = 111/295 (37%), Gaps = 68/295 (23%)
Query: 616 GTFSTVYKAVM-PSGLILSVKRLK--SMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGF 672
G + VY+ V L ++VK LK +M+ + ++E + ++ H NLV+ +G
Sbjct: 231 GQYGEVYEGVWKKYSLTVAVKTLKEDTME------VEEFLKEAAVMKEIKHPNLVQLLGV 284
Query: 673 VIYEDVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIH 732
E ++ ++ G L L E +Q L +A ++ + +L IH
Sbjct: 285 CTREPPFYIITEFMTYGNLLDYLRECNRQE---VSAVVLLYMATQISSAMEYLEKKNFIH 341
Query: 733 LDISSGNVLLD-------ADFKPLLGEIEISKLLDPSKGTASISAVAGSFGYIPPEYAYT 785
++++ N L+ ADF G +S+L+ TA A + PE
Sbjct: 342 RNLAARNCLVGENHLVKVADF----G---LSRLMTGDTYTAHAGAKF-PIKWTAPESLAY 393
Query: 786 MQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQILDARLST 845
+ + +V+++GV+L EI T +G +P G Q+ +
Sbjct: 394 NKFSIKSDVWAFGVLLWEIAT--------YGM----------SPYPGIDLSQVYEL---- 431
Query: 846 VSFGWRKE------------MLTALKVALLCTDSTPAKRPKMKKVVEMLQEIKQN 888
+ +R E M C P+ RP ++ + + + Q
Sbjct: 432 LEKDYRMERPEGCPEKVYELM-------RACWQWNPSDRPSFAEIHQAFETMFQE 479
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 74.4 bits (182), Expect = 7e-14
Identities = 50/281 (17%), Positives = 93/281 (33%), Gaps = 33/281 (11%)
Query: 166 SSNKLNGSIPFWVGNLTNLRVFTAYENQLVGEIPDNLGSVSELELLNLHSNQLEGPIPKS 225
+ + N W+ +L + I S E LL +
Sbjct: 289 TPDGRNRPSHVWLCDLPAASLNDQLPQHTFRVIWTGSDSQKECVLLKDRPECW----CRD 344
Query: 226 IFASGKLEVLVLTQNRLTGDIPELVGHCKSLSNIRIGNNDLVGVIPRAIGNVSGLTYFEA 285
+L L+ + T + + CK L + N + I + + L Y +
Sbjct: 345 SATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTIILLMRALDPLLYEKE 403
Query: 286 DNNNLSG---------------------EIVPEFSQCSNLTLLNLASNGFTGVIPPELGQ 324
S E + +++ +L+LA T + L Q
Sbjct: 404 TLQYFSTLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDLTVL--CHLEQ 461
Query: 325 LINLQELILYENSLFGEIPKSILACKNLNKLDLSNNRFNGTIPNAICDMSRLQYLLLGQN 384
L+ + L L N L +P ++ A + L L S+N + + ++ RLQ LLL N
Sbjct: 462 LLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVDG-VANLPRLQELLLCNN 518
Query: 385 SLKG-EIPHEIGNCMKLLQLHIGSNYLTGSIPPEIGHIRNL 424
L+ + +C +L+ L++ N L + +
Sbjct: 519 RLQQSAAIQPLVSCPRLVLLNLQGNSLC-QEEGIQERLAEM 558
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 67.9 bits (165), Expect = 7e-12
Identities = 46/275 (16%), Positives = 77/275 (28%), Gaps = 40/275 (14%)
Query: 253 CKSLSNIRIGNNDLVGVIPRAIGNVSGLTYFEADNNNLSGEIVPEFSQCSNLTLLNLA-- 310
+L + V N + + +P+ + T +
Sbjct: 271 MGTLLLMVDEAPLSVEWRTPDGRNRPSHVWLCDLPAASLNDQLPQHTFRVIWTGSDSQKE 330
Query: 311 ---SNGFTGVIPPELGQLINLQELILYENSLFGEIPKSILACKNLNKLDLSNNRFNGTIP 367
+ L L + + +CK L +L+ N TI
Sbjct: 331 CVLLKDRPECWCRDSATDEQLFRCELSVEKST-VLQSELESCKELQELEPENKWCLLTI- 388
Query: 368 NAICDMSRLQYLLLGQNSLK------------------------GEIPHEIGNCMKLLQL 403
I M L LL + +L+ E + L
Sbjct: 389 --ILLMRALDPLLYEKETLQYFSTLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVL 446
Query: 404 HIGSNYLTGSIPPEIGHIRNLQIALNLSFNHLHGSLPPELGKLDKLVSFDVSNNQLSGTI 463
H+ LT + + + + L+LS N L +LPP L L L S+N L +
Sbjct: 447 HLAHKDLT--VLCHLEQLLLVTH-LDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NV 501
Query: 464 PSALKGMLSLIEVNFSNNLLTGPVPSFVPFQKSPN 498
+ + L E+ NN L + P P
Sbjct: 502 DG-VANLPRLQELLLCNNRLQQ-SAAIQPLVSCPR 534
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 56.3 bits (135), Expect = 3e-08
Identities = 38/154 (24%), Positives = 56/154 (36%), Gaps = 14/154 (9%)
Query: 74 QLRGNITLVSELKALKRLDLSNNAFSGTIPSAFGNLSEL--------EFLDLSLNKFGGV 125
L + LK +D A+ + S F + + L L+
Sbjct: 397 PLLYEKETLQYFSTLKAVDPMRAAYLDDLRSKFLLENSVLKMEYADVRVLHLAHKDL--T 454
Query: 126 IPRELGSLKDLRFFNISNNVLVGEIPDELKSLEKLEDFQVSSNKLNGSIPFWVGNLTNLR 185
+ L L + ++S+N L +P L +L LE Q S N L ++ V NL L+
Sbjct: 455 VLCHLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE-NVDG-VANLPRLQ 511
Query: 186 VFTAYENQLVG-EIPDNLGSVSELELLNLHSNQL 218
N+L L S L LLNL N L
Sbjct: 512 ELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSL 545
|
| >1dce_A Protein (RAB geranylgeranyltransferase alpha subunit); 2.0 A resolution, N-formylmethionine, alpha subunit; HET: FME; 2.00A {Rattus norvegicus} SCOP: a.118.6.1 b.7.4.1 c.10.2.2 PDB: 1ltx_A* Length = 567 | Back alignment and structure |
|---|
Score = 54.4 bits (130), Expect = 1e-07
Identities = 26/99 (26%), Positives = 41/99 (41%), Gaps = 4/99 (4%)
Query: 63 AFVVKLDLSRLQLRGNITLVSELKALKRLDLSNNAFSGTIPSAFGNLSELEFLDLSLNKF 122
V LDLS +LR ++ L+ L+ L S+NA + NL L+ L L N+
Sbjct: 463 LLVTHLDLSHNRLRALPPALAALRCLEVLQASDNALE-NVDG-VANLPRLQELLLCNNRL 520
Query: 123 GGV-IPRELGSLKDLRFFNISNNVLVGEIPDELKSLEKL 160
+ L S L N+ N L + + L ++
Sbjct: 521 QQSAAIQPLVSCPRLVLLNLQGNSLC-QEEGIQERLAEM 558
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 71.6 bits (176), Expect = 1e-13
Identities = 45/219 (20%), Positives = 83/219 (37%), Gaps = 38/219 (17%)
Query: 616 GTFSTVYKAV-MPSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVI 674
G F V+KA G +KR + ++ K RE++ L+KL H N+V G
Sbjct: 22 GGFGQVFKAKHRIDGKTYVIKR-------VKYNNEKAEREVKALAKLDHVNIVHYNGCWD 74
Query: 675 YEDVALLLHN----------------YLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGV 718
D + + GTL Q + + + D L + +
Sbjct: 75 GFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEK---LDKVLALELFEQI 131
Query: 719 AEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSKGTASISAVAGSFGYI 778
+G+ ++H +I+ D+ N+ L + +G+ + L + G+ Y+
Sbjct: 132 TKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKN---DGKRTRSKGTLRYM 188
Query: 779 PPE----YAYTMQVTAPGNVYSYGVVLLEILTTRLPVEE 813
PE Y +V ++Y+ G++L E+L E
Sbjct: 189 SPEQISSQDYGKEV----DLYALGLILAELLHVCDTAFE 223
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 1e-13
Identities = 62/309 (20%), Positives = 112/309 (36%), Gaps = 75/309 (24%)
Query: 616 GTFSTVYKAVM-----PSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPI 670
G F V +G +++VK LK+ H++ +E++ L L H+++++
Sbjct: 42 GHFGKVSLYCYDPTNDGTGEMVAVKALKADAGP--QHRSGWKQEIDILRTLYHEHIIKYK 99
Query: 671 GFVIYEDVA---LLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHH 727
G + A L+ Y+P G+L L P + L A + EG+A+LH
Sbjct: 100 G-CCEDAGAASLQLVMEYVPLGSLRDYL------PRHSIGLAQLLLFAQQICEGMAYLHA 152
Query: 728 VAIIHLDISSGNVLLD-------ADFKPLLGEIEISKLLDPSKGTASISAVAGSFGYIP- 779
IH D+++ NVLLD DF G ++K + G P
Sbjct: 153 QHYIHRDLAARNVLLDNDRLVKIGDF----G---LAKAVPEGHEY----YRVREDGDSPV 201
Query: 780 ----PEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGE----GVDLVKWVHGAPAR 831
PE + +V+S+GV L E+LT + + G
Sbjct: 202 FWYAPECLKEYKFYYASDVWSFGVTLYELLT--------HCDSSQSPPTKFLELIGIAQG 253
Query: 832 GETPEQILDARLSTVSFGWRKE------------MLTALKVALLCTDSTPAKRPKMKKVV 879
T ++ + + G R M C ++ + RP + ++
Sbjct: 254 QMTVLRLTEL----LERGERLPRPDKCPAEVYHLM-------KNCWETEASFRPTFENLI 302
Query: 880 EMLQEIKQN 888
+L+ + +
Sbjct: 303 PILKTVHEK 311
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 71.1 bits (175), Expect = 1e-13
Identities = 46/205 (22%), Positives = 80/205 (39%), Gaps = 16/205 (7%)
Query: 616 GTFSTVYKAV-MPSGLILSVK--RLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIG- 671
G++ K G IL K SM + ++ E+ L +L H N+VR
Sbjct: 17 GSYGRCQKIRRKSDGKILVWKELDYGSMTE---AEKQMLVSEVNLLRELKHPNIVRYYDR 73
Query: 672 FVIYEDVALLLH-NYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLH---- 726
+ + L + Y G LA ++ + TK+ Y + L + + L H
Sbjct: 74 IIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDE-EFVLRVMTQLTLALKECHRRSD 132
Query: 727 -HVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSKGTASISAVAGSFGYIPPEYAYT 785
++H D+ NV LD LG+ ++++L+ A G+ Y+ PE
Sbjct: 133 GGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFA--KTFVGTPYYMSPEQMNR 190
Query: 786 MQVTAPGNVYSYGVVLLEILTTRLP 810
M +++S G +L E+ P
Sbjct: 191 MSYNEKSDIWSLGCLLYELCALMPP 215
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 72.9 bits (179), Expect = 1e-13
Identities = 56/287 (19%), Positives = 100/287 (34%), Gaps = 64/287 (22%)
Query: 616 GTFSTVYKAVMPSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLC-HDNLVRPIGFVI 674
G T+ M ++VKR+ + RE++ L + H N++R
Sbjct: 35 GAEGTIVYRGMFDNRDVAVKRILPECFSFAD------REVQLLRESDEHPNVIRYFCT-- 86
Query: 675 YEDVALLLHNYLP----NGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAI 730
+D Y+ TL + + +Q D+ +++ GLA LH + I
Sbjct: 87 EKDRQFQ---YIAIELCAATLQEYV----EQKDFAHLGLEPITLLQQTTSGLAHLHSLNI 139
Query: 731 IHLDISSGNVLLDADFKPLLGEIEI-----SKLLDPSKGTASI-SAVAGSFGYIPPEY-- 782
+H D+ N+L+ + I K L + + S S V G+ G+I PE
Sbjct: 140 VHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLS 199
Query: 783 -----AYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQ 837
T V +++S G V +++ G+ G++ ++
Sbjct: 200 EDCKENPTYTV----DIFSAGCVFYYVIS-------------------EGSHPFGKSLQR 236
Query: 838 ILDARLSTVSFGWRKEMLTALKVA------LLCTDSTPAKRPKMKKV 878
+ L S +A ++ D P KRP K V
Sbjct: 237 QANILLGACSLDCLHPEKHEDVIARELIEKMIAMD--PQKRPSAKHV 281
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 72.0 bits (177), Expect = 2e-13
Identities = 40/198 (20%), Positives = 75/198 (37%), Gaps = 11/198 (5%)
Query: 616 GTFSTVYKAV-MPSGLILSVK--RLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGF 672
G+F G +K + M + + RE+ L+ + H N+V+
Sbjct: 35 GSFGKAILVKSTEDGRQYVIKEINISRMSS---KEREESRREVAVLANMKHPNIVQYRES 91
Query: 673 VIYEDVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIH 732
++ +Y G L + ++ L + + L +H I+H
Sbjct: 92 FEENGSLYIVMDYCEGGDLFKRINAQKGVL---FQEDQILDWFVQICLALKHVHDRKILH 148
Query: 733 LDISSGNVLLDADFKPLLGEIEISKLLDPSKGTASISAVAGSFGYIPPEYAYTMQVTAPG 792
DI S N+ L D LG+ I+++L+ + A A G+ Y+ PE
Sbjct: 149 RDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELA--RACIGTPYYLSPEICENKPYNNKS 206
Query: 793 NVYSYGVVLLEILTTRLP 810
++++ G VL E+ T +
Sbjct: 207 DIWALGCVLYELCTLKHA 224
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 70.7 bits (174), Expect = 3e-13
Identities = 55/295 (18%), Positives = 110/295 (37%), Gaps = 63/295 (21%)
Query: 616 GTFSTVYKAV-MPSGLILS----VKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPI 670
G F TVYK + +P G + +K L+ + T +++ E ++ + + ++ R +
Sbjct: 26 GAFGTVYKGLWIPEGEKVKIPVAIKELR--EATSPKANKEILDEAYVMASVDNPHVCRLL 83
Query: 671 GFVIYEDVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAI 730
G + L+ +P G L + ++ L+ + +A+G+ +L +
Sbjct: 84 G-ICLTSTVQLITQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQIAKGMNYLEDRRL 138
Query: 731 IHLDISSGNVLLD-------ADFKPLLGEIEISKLLDPSKGTASISAVAGSFGYIP---- 779
+H D+++ NVL+ DF G ++KLL + G +P
Sbjct: 139 VHRDLAARNVLVKTPQHVKITDF----G---LAKLLGAEEKEYHAEG-----GKVPIKWM 186
Query: 780 -PEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQI 838
E T +V+SYGV + E++T FG P G +I
Sbjct: 187 ALESILHRIYTHQSDVWSYGVTVWELMT--------FGS----------KPYDGIPASEI 228
Query: 839 LDARLSTVSFGWRKEM----LTAL-KVALLCTDSTPAKRPKMKKVVEMLQEIKQN 888
+ G R + + C RPK ++++ ++ ++
Sbjct: 229 SSI----LEKGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRELIIEFSKMARD 279
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 3e-13
Identities = 67/292 (22%), Positives = 105/292 (35%), Gaps = 58/292 (19%)
Query: 616 GTFSTVYKAV--MPSGLILSV--KRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIG 671
G+F V + PSG +SV K LK + + IRE+ + L H NL+R G
Sbjct: 29 GSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYG 88
Query: 672 FVIYEDVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAII 731
V+ + ++ P G+L L ++ T A+ VAEG+ +L I
Sbjct: 89 VVLTPPMKMVTE-LAPLGSLLDRL----RKHQGHFLLGTLSRYAVQVAEGMGYLESKRFI 143
Query: 732 HLDISSGNVLLD-------ADFKPLLGEIEISKLLDPSKGTASISAVAGSFGYIP----- 779
H D+++ N+LL DF G + + L + V +P
Sbjct: 144 HRDLAARNLLLATRDLVKIGDF----G---LMRALPQNDDH----YVMQEHRKVPFAWCA 192
Query: 780 PEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQIL 839
PE T + + + +GV L E+ T +G+ P G QIL
Sbjct: 193 PESLKTRTFSHASDTWMFGVTLWEMFT--------YGQ----------EPWIGLNGSQIL 234
Query: 840 DARLSTVSFGWRKEM----LTAL-KVALLCTDSTPAKRPKMKKVVEMLQEIK 886
G R + V + C P RP + + L E +
Sbjct: 235 HK---IDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 283
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 71.7 bits (176), Expect = 3e-13
Identities = 56/295 (18%), Positives = 112/295 (37%), Gaps = 64/295 (21%)
Query: 613 IYCGTFSTVYKAVMPSGLILSVKRLK--SMDRTIIHHQNKMIRELEKLSKLCHDNLVRPI 670
+ G F V+ A ++VK +K SM + E + L HD LV+
Sbjct: 196 LGAGQFGEVWMATYNKHTKVAVKTMKPGSMSV------EAFLAEANVMKTLQHDKLVKLH 249
Query: 671 GFVIYEDVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAI 730
V+ ++ ++ ++ G+L L P + + +AEG+AF+
Sbjct: 250 A-VVTKEPIYIITEFMAKGSLLDFLKSDEGSK---QPLPKLIDFSAQIAEGMAFIEQRNY 305
Query: 731 IHLDISSGNVLLDADFKPLLGEIEISKLLDPSKGTASISAVAGSFGYIP-----PEYAYT 785
IH D+ + N+L+ A + + ++++++ ++ TA P PE
Sbjct: 306 IHRDLRAANILVSASLVCKIADFGLARVIEDNEYTAREG------AKFPIKWTAPEAINF 359
Query: 786 MQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQILDARLST 845
T +V+S+G++L+EI+T +G P G + +++ A
Sbjct: 360 GSFTIKSDVWSFGILLMEIVT--------YGR----------IPYPGMSNPEVIRA---- 397
Query: 846 VSFGWRKE------------MLTALKVALLCTDSTPAKRPKMKKVVEMLQEIKQN 888
+ G+R M+ C + P +RP + + +L +
Sbjct: 398 LERGYRMPRPENCPEELYNIMMR-------CWKNRPEERPTFEYIQSVLDDFYTA 445
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 4e-13
Identities = 63/307 (20%), Positives = 115/307 (37%), Gaps = 69/307 (22%)
Query: 616 GTFSTVYKAVMP-----SGLILSVKRLK--SMDRTIIHHQNKMIRELEKLSKLCHDNLVR 668
G F +V +G +++VK+L+ + + H RE+E L L HDN+V+
Sbjct: 21 GNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEE-----HLRDFEREIEILKSLQHDNIVK 75
Query: 669 PIGFVIYEDVA---LLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFL 725
G V Y L+ YLP G+L L ++ R D L + +G+ +L
Sbjct: 76 YKG-VCYSAGRRNLKLIMEYLPYGSLRDYL----QKHKERIDHIKLLQYTSQICKGMEYL 130
Query: 726 HHVAIIHLDISSGNVLLD-------ADFKPLLGEIEISKLLDPSKGTASISAVAGSFGYI 778
IH D+++ N+L++ DF G ++K+L K G
Sbjct: 131 GTKRYIHRDLATRNILVENENRVKIGDF----G---LTKVLPQDKEF----FKVKEPGES 179
Query: 779 P-----PEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGE 833
P PE + + +V+S+GVVL E+ T E+ + ++ +
Sbjct: 180 PIFWYAPESLTESKFSVASDVWSFGVVLYELFTYI---EKSKSPPAEFMRMIGNDKQGQM 236
Query: 834 TPEQILDARLSTVSFGWRKE------------MLTALKVALLCTDSTPAKRPKMKKVVEM 881
+++ + R M C ++ +RP + +
Sbjct: 237 IVFHLIEL----LKNNGRLPRPDGCPDEIYMIM-------TECWNNNVNQRPSFRDLALR 285
Query: 882 LQEIKQN 888
+ +I+ N
Sbjct: 286 VDQIRDN 292
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 69.3 bits (170), Expect = 5e-13
Identities = 36/213 (16%), Positives = 77/213 (36%), Gaps = 16/213 (7%)
Query: 274 IGNVSGLTYFEADNNNLSGEIVPEFSQCSNLTLLNLASNGFTGVIPPELGQLINLQELIL 333
++ +++ ++V + S + N ++ + + NL+EL L
Sbjct: 15 DPGLANAVKQNLGKQSVT-DLVS-QKELSGVQNFNGDNSNIQSLAG--MQFFTNLKELHL 70
Query: 334 YENSLFGEIPKSILACKNLNKLDLSNNRFNGTIPNAICDMSRLQYLLLGQNSLKGEIPHE 393
N + ++ + L +L ++ NR + + L L L N L+
Sbjct: 71 SHNQI-SDL-SPLKDLTKLEELSVNRNRLK-NLNG--IPSACLSRLFLDNNELRD--TDS 123
Query: 394 IGNCMKLLQLHIGSNYLTGSIPPEIGHIRNLQIALNLSFNHLHGSLPPELGKLDKLVSFD 453
+ + L L I +N L SI +G + L++ L+L N + + L +L K+ D
Sbjct: 124 LIHLKNLEILSIRNNKLK-SIVM-LGFLSKLEV-LDLHGNEIT-NTGG-LTRLKKVNWID 178
Query: 454 VSNNQLSGTIPSALKGMLSLIEVNFSNNLLTGP 486
++ + + V + P
Sbjct: 179 LTGQKCVNEPVKYQPELYITNTVKDPDGRWISP 211
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 3e-11
Identities = 50/265 (18%), Positives = 101/265 (38%), Gaps = 21/265 (7%)
Query: 56 IDCDLNQAFVVKLDLSRLQLRGNITLVSELKALKRLDLSNNAFSGTIPSAFGNLSELEFL 115
+ D A VK +L + + ++ EL ++ + N+ ++ + + L+ L
Sbjct: 12 VFPDPGLANAVKQNLGKQSVT-DLVSQKELSGVQNFNGDNSNIQ-SL-AGMQFFTNLKEL 68
Query: 116 DLSLNKFGGVIPRELGSLKDLRFFNISNNVLVGEIPDELKSLEKLEDFQVSSNKLNGSIP 175
LS N+ + P L L L +++ N L L +L + +N+L +
Sbjct: 69 HLSHNQISDLSP--LKDLTKLEELSVNRNRLKNLNGIPSACLSRLF---LDNNELRDTDS 123
Query: 176 FWVGNLTNLRVFTAYENQLVGEIPDNLGSVSELELLNLHSNQLEGPIPKSIFASGKLEVL 235
+L NL + + N+L I LG +S+LE+L+LH N++ + K+ +
Sbjct: 124 L--IHLKNLEILSIRNNKLK-SI-VMLGFLSKLEVLDLHGNEITNTGG--LTRLKKVNWI 177
Query: 236 VLTQNRLTGDIPELVGHCKSLSNIRIGNNDLVGVIPRAIGNVSGLTYFEADNNNLS--GE 293
LT + + + + ++ + D + P I N E
Sbjct: 178 DLTGQKCVNEPVKYQPELYITNTVK--DPDGRWISPYYISNGGSYVDGCVLWELPVYTDE 235
Query: 294 IVPEFSQCSNLTLLNLASNGFTGVI 318
+ +FS+ + F G +
Sbjct: 236 VSYKFSE---YINVGETEAIFDGTV 257
|
| >1xeu_A Internalin C; cellular invasion, leucine-rich repeat, cell invasion; 2.05A {Listeria monocytogenes} Length = 263 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 3e-11
Identities = 40/190 (21%), Positives = 79/190 (41%), Gaps = 15/190 (7%)
Query: 78 NITLVSELKALKRLDLSNNAFSGTIPSAFGNLSELEFLDLSLNKFGGVIPRELGSLKDLR 137
+ L + +L S T + LS ++ + + + + +L+
Sbjct: 11 QVFPDPGLANAVKQNLGKQ--SVTDLVSQKELSGVQNFNGDNSNIQSLAG--MQFFTNLK 66
Query: 138 FFNISNNVLVGEIPDELKSLEKLEDFQVSSNKLNGSIPFWVGNLTNLRVFTAYENQLVGE 197
++S+N + ++ LK L KLE+ V+ N+L ++ L N+L
Sbjct: 67 ELHLSHNQIS-DLSP-LKDLTKLEELSVNRNRLK-NLNG--IPSACLSRLFLDNNEL--R 119
Query: 198 IPDNLGSVSELELLNLHSNQLEGPIPKSIFASGKLEVLVLTQNRLTGDIPELVGHCKSLS 257
D+L + LE+L++ +N+L+ + + KLEVL L N +T + L K ++
Sbjct: 120 DTDSLIHLKNLEILSIRNNKLKSIVMLGFLS--KLEVLDLHGNEIT-NTGGL-TRLKKVN 175
Query: 258 NIRIGNNDLV 267
I + V
Sbjct: 176 WIDLTGQKCV 185
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 69.6 bits (171), Expect = 5e-13
Identities = 60/308 (19%), Positives = 118/308 (38%), Gaps = 73/308 (23%)
Query: 616 GTFSTVYKAVMP-----SGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPI 670
G F V +G ++VK LK + +H + +E+E L L H+N+V+
Sbjct: 32 GHFGKVELCRYDPEGDNTGEQVAVKSLK--PESGGNHIADLKKEIEILRNLYHENIVKYK 89
Query: 671 GFVIYEDVA---LLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHH 727
G + ED L+ +LP+G+L + L + + + +L A+ + +G+ +L
Sbjct: 90 G-ICTEDGGNGIKLIMEFLPSGSLKEYL----PKNKNKINLKQQLKYAVQICKGMDYLGS 144
Query: 728 VAIIHLDISSGNVLLD-------ADFKPLLGEIEISKLLDPSKGTASISAVAGSFGYIP- 779
+H D+++ NVL++ DF G ++K ++ K P
Sbjct: 145 RQYVHRDLAARNVLVESEHQVKIGDF----G---LTKAIETDKEY----YTVKDDRDSPV 193
Query: 780 ----PEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGE----GVDLVKWVHGAPAR 831
PE + +V+S+GV L E+LT + + + L + G
Sbjct: 194 FWYAPECLMQSKFYIASDVWSFGVTLHELLT--------YCDSDSSPMALFLKMIGPTHG 245
Query: 832 GETPEQILDARLSTVSFGWRKE------------MLTALKVALLCTDSTPAKRPKMKKVV 879
T ++++ + G R M C + P+ R + ++
Sbjct: 246 QMTVTRLVNT----LKEGKRLPCPPNCPDEVYQLM-------RKCWEFQPSNRTSFQNLI 294
Query: 880 EMLQEIKQ 887
E + + +
Sbjct: 295 EGFEALLK 302
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 69.8 bits (171), Expect = 1e-12
Identities = 41/217 (18%), Positives = 78/217 (35%), Gaps = 37/217 (17%)
Query: 615 CGTFSTVYKAVMPSGLILSVKR--LKSMDRTIIHHQNKMIRELEKLSKLCH--DNLVRPI 670
G S V++ + I ++K L+ D + + E+ L+KL D ++R
Sbjct: 66 SGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTL---DSYRNEIAYLNKLQQHSDKIIRLY 122
Query: 671 GFVIYEDVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAI 730
+ I + ++ N L L + R S + E + +H I
Sbjct: 123 DYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDP-----WERKSYWKNMLEAVHTIHQHGI 176
Query: 731 IHLDISSGNVLLD------ADFKPLLGEIEISKLLDPSKGTASISAVAGSFGYIPPE--- 781
+H D+ N L+ DF G I+ + P + + G+ Y+PPE
Sbjct: 177 VHSDLKPANFLIVDGMLKLIDF----G---IANQMQPDTTSVVKDSQVGAVNYMPPEAIK 229
Query: 782 --------YAYTMQVTAPGNVYSYGVVLLEILTTRLP 810
+++ +V+S G +L + + P
Sbjct: 230 DMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 266
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 68.9 bits (169), Expect = 1e-12
Identities = 62/307 (20%), Positives = 114/307 (37%), Gaps = 69/307 (22%)
Query: 616 GTFSTVYKAVMP-----SGLILSVKRLK--SMDRTIIHHQNKMIRELEKLSKLCHDNLVR 668
G F +V +G +++VK+L+ + + H RE+E L L HDN+V+
Sbjct: 52 GNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEE-----HLRDFEREIEILKSLQHDNIVK 106
Query: 669 PIGFVIYEDVA---LLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFL 725
G V Y L+ YLP G+L L ++ R D L + +G+ +L
Sbjct: 107 YKG-VCYSAGRRNLKLIMEYLPYGSLRDYL----QKHKERIDHIKLLQYTSQICKGMEYL 161
Query: 726 HHVAIIHLDISSGNVLLD-------ADFKPLLGEIEISKLLDPSKGTASISAVAGSFGYI 778
IH D+++ N+L++ DF G ++K+L K G
Sbjct: 162 GTKRYIHRDLATRNILVENENRVKIGDF----G---LTKVLPQDKEY----YKVKEPGES 210
Query: 779 P-----PEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGE 833
P PE + + +V+S+GVVL E+ T E+ + ++ +
Sbjct: 211 PIFWYAPESLTESKFSVASDVWSFGVVLYELFTYI---EKSKSPPAEFMRMIGNDKQGQM 267
Query: 834 TPEQILDARLSTVSFGWRKE------------MLTALKVALLCTDSTPAKRPKMKKVVEM 881
+++ + R M C ++ +RP + +
Sbjct: 268 IVFHLIEL----LKNNGRLPRPDGCPDEIYMIM-------TECWNNNVNQRPSFRDLALR 316
Query: 882 LQEIKQN 888
+ +I+
Sbjct: 317 VDQIRDQ 323
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 70.7 bits (173), Expect = 1e-12
Identities = 60/296 (20%), Positives = 111/296 (37%), Gaps = 67/296 (22%)
Query: 616 GTFSTVYKAV--MPSGLILSV--KRLK--SMDRTIIHHQNKMIRELEKLSKLCHDNLVRP 669
G F V++ + P ++V K K + D + K ++E + + H ++V+
Sbjct: 401 GQFGDVHQGIYMSPENPAMAVAIKTCKNCTSDSV----REKFLQEALTMRQFDHPHIVKL 456
Query: 670 IGFVIYEDVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVA 729
IG VI E+ ++ G L L + + D + + A ++ LA+L
Sbjct: 457 IG-VITENPVWIIMELCTLGELRSFL----QVRKFSLDLASLILYAYQLSTALAYLESKR 511
Query: 730 IIHLDISSGNVLLD-------ADFKPLLGEIEISKLLDPSKGTASISAVAGSFGYIP--- 779
+H DI++ NVL+ DF G +S+ ++ + S G +P
Sbjct: 512 FVHRDIAARNVLVSSNDCVKLGDF----G---LSRYME------DSTYYKASKGKLPIKW 558
Query: 780 --PEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQ 837
PE + T+ +V+ +GV + EIL G P +G
Sbjct: 559 MAPESINFRRFTSASDVWMFGVCMWEILM--------HGV----------KPFQGVKNND 600
Query: 838 ILDARLSTVSFGWRKEM----LTAL-KVALLCTDSTPAKRPKMKKVVEMLQEIKQN 888
++ + G R M L + C P++RP+ ++ L I +
Sbjct: 601 VIGR----IENGERLPMPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILEE 652
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 69.0 bits (169), Expect = 1e-12
Identities = 42/221 (19%), Positives = 79/221 (35%), Gaps = 45/221 (20%)
Query: 615 CGTFSTVYKAVMPSGLILSVKR--LKSMDRTIIHHQNKMIRELEKLSKLCH--DNLVRPI 670
G S V++ + I ++K L+ D + + E+ L+KL D ++R
Sbjct: 19 SGGSSKVFQVLNEKKQIYAIKYVNLEEADNQTL---DSYRNEIAYLNKLQQHSDKIIRLY 75
Query: 671 GFVIYEDVALLLHNYL----PNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLH 726
+ I + + Y+ N L L + R S + E + +H
Sbjct: 76 DYEITDQ-----YIYMVMECGNIDLNSWLKKKKSIDP-----WERKSYWKNMLEAVHTIH 125
Query: 727 HVAIIHLDISSGNVLLD------ADFKPLLGEIEISKLLDPSKGTASISAVAGSFGYIPP 780
I+H D+ N L+ DF G I+ + P + + G+ Y+PP
Sbjct: 126 QHGIVHSDLKPANFLIVDGMLKLIDF----G---IANQMQPDTTSVVKDSQVGTVNYMPP 178
Query: 781 E-----------YAYTMQVTAPGNVYSYGVVLLEILTTRLP 810
E +++ +V+S G +L + + P
Sbjct: 179 EAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 219
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 69.1 bits (169), Expect = 1e-12
Identities = 49/235 (20%), Positives = 83/235 (35%), Gaps = 30/235 (12%)
Query: 299 SQCS-NLTLLNLASNGFTGV---IPPELGQLINLQELILYENSLFGEIPKSILAC-KNLN 353
+ C +L+ + V +P L L N+L + NL+
Sbjct: 14 ANCLCASNILSCSKQQLPNVPQSLPS------YTALLDLSHNNLSRLRAEWTPTRLTNLH 67
Query: 354 KLDLSNNRFNGTIP-NAICDMSRLQYLLLGQNSLKGEIPHEI-GNCMKLLQLHIGSNYLT 411
L LS+N N I A + L+YL L N L + + + L L + +N++
Sbjct: 68 SLLLSHNHLN-FISSEAFVPVPNLRYLDLSSNHLH-TLDEFLFSDLQALEVLLLYNNHIV 125
Query: 412 GSIPPEI-GHIRNLQIALNLSFNHLHGSLPPE----LGKLDKLVSFDVSNNQLSGTIPSA 466
+ + LQ L LS N + P E KL KL+ D+S+N+L +
Sbjct: 126 -VVDRNAFEDMAQLQK-LYLSQNQIS-RFPVELIKDGNKLPKLMLLDLSSNKLKKLPLTD 182
Query: 467 LKGM--LSLIEVNFSNNLLT-----GPVPSFVPFQKSPNSSFFGNKGLCGEPLSF 514
L+ + + NN L + S +++ + F C
Sbjct: 183 LQKLPAWVKNGLYLHNNPLECDCKLYQLFSHWQYRQLSSVMDFQEDLYCMHSKKL 237
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 65.2 bits (159), Expect = 3e-11
Identities = 38/165 (23%), Positives = 66/165 (40%), Gaps = 18/165 (10%)
Query: 69 DLSRLQLRGN-ITLV------SELKALKRLDLSNNAFSGTIPS-AFGNLSELEFLDLSLN 120
+ L L N ++ + + L L L LS+N + I S AF + L +LDLS N
Sbjct: 40 YTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPVPNLRYLDLSSN 98
Query: 121 KFGGVIPRELGSLKDLRFFNISNNVLVGEIPDE-LKSLEKLEDFQVSSNKLNGSIPFWV- 178
+ L+ L + NN +V + + + +L+ +S N+++ P +
Sbjct: 99 HLHTLDEFLFSDLQALEVLLLYNNHIV-VVDRNAFEDMAQLQKLYLSQNQIS-RFPVELI 156
Query: 179 ---GNLTNLRVFTAYENQLVGEIPDNLGSVSELEL--LNLHSNQL 218
L L + N+L +L + L LH+N L
Sbjct: 157 KDGNKLPKLMLLDLSSNKLKKLPLTDLQKLPAWVKNGLYLHNNPL 201
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 59.5 bits (144), Expect = 2e-09
Identities = 41/178 (23%), Positives = 64/178 (35%), Gaps = 18/178 (10%)
Query: 197 EIPDNLGSVSELELLNLHSNQLEGPIPKSIFAS-GKLEVLVLTQNRLTGDIPELV-GHCK 254
+P +L S LL+L N L + L L+L+ N L I
Sbjct: 32 NVPQSLPS--YTALLDLSHNNLSRLRAEWTPTRLTNLHSLLLSHNHLN-FISSEAFVPVP 88
Query: 255 SLSNIRIGNNDLVGVIPRAIGNVSGLTYFEADNNNLSGEIVPE--FSQCSNLTLLNLASN 312
+L + + +N L + ++ L NN++ +V F + L L L+ N
Sbjct: 89 NLRYLDLSSNHLHTLDEFLFSDLQALEVLLLYNNHIV--VVDRNAFEDMAQLQKLYLSQN 146
Query: 313 GFTGVIPPE----LGQLINLQELILYENSLFGEIPKSI---LACKNLNKLDLSNNRFN 363
+ P E +L L L L N L ++P + L N L L NN
Sbjct: 147 QIS-RFPVELIKDGNKLPKLMLLDLSSNKL-KKLPLTDLQKLPAWVKNGLYLHNNPLE 202
|
| >2xot_A Amphoterin-induced protein 1; cell adhesion, neuronal protein, neurite growth regulation; HET: NAG BMA; 2.00A {Mus musculus} Length = 361 | Back alignment and structure |
|---|
Score = 58.3 bits (141), Expect = 4e-09
Identities = 42/196 (21%), Positives = 73/196 (37%), Gaps = 38/196 (19%)
Query: 222 IPKSIFASGKLEVLVLTQNRLTGDIPELVGHCKSLSNIRIGNNDLVGVIPRAIGNVSGLT 281
+P+S+ + +L L+ N L+ E ++ L
Sbjct: 33 VPQSLPSY--TALLDLSHNNLSRLRAEWTPT-----------------------RLTNLH 67
Query: 282 YFEADNNNLSGEIVPE-FSQCSNLTLLNLASNGFTGVIPPE-LGQLINLQELILYENSLF 339
+N+L+ I E F NL L+L+SN + L L+ L+LY N +
Sbjct: 68 SLLLSHNHLN-FISSEAFVPVPNLRYLDLSSNHLH-TLDEFLFSDLQALEVLLLYNNHI- 124
Query: 340 GEIPKSILA-CKNLNKLDLSNNRFNGTIPNAICDMSR---LQYLLLGQNSLKGEIPHEIG 395
+ ++ L KL LS N+ + I D ++ L L L N LK ++P
Sbjct: 125 VVVDRNAFEDMAQLQKLYLSQNQISRFPVELIKDGNKLPKLMLLDLSSNKLK-KLPLTDL 183
Query: 396 NCMKLLQ---LHIGSN 408
+ L++ +N
Sbjct: 184 QKLPAWVKNGLYLHNN 199
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 70.0 bits (171), Expect = 2e-12
Identities = 51/207 (24%), Positives = 84/207 (40%), Gaps = 33/207 (15%)
Query: 615 CGTFSTVYKAV--MPSGLIL-SVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIG 671
CG F +V + V M I ++K LK T +M+RE + + +L + +VR IG
Sbjct: 346 CGNFGSVRQGVYRMRKKQIDVAIKVLKQG--TEKADTEEMMREAQIMHQLDNPYIVRLIG 403
Query: 672 FVIYEDVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAII 731
E + +L+ G L + L + V+ G+ +L +
Sbjct: 404 VCQAEAL-MLVMEMAGGGPLHKFL----VGKREEIPVSNVAELLHQVSMGMKYLEEKNFV 458
Query: 732 HLDISSGNVLLD-------ADFKPLLGEIEISKLLDPSKGTASISAVAGSFGYIP----- 779
H ++++ NVLL +DF G +SK L A S G P
Sbjct: 459 HRNLAARNVLLVNRHYAKISDF----G---LSKALGADDSY----YTARSAGKWPLKWYA 507
Query: 780 PEYAYTMQVTAPGNVYSYGVVLLEILT 806
PE + ++ +V+SYGV + E L+
Sbjct: 508 PECINFRKFSSRSDVWSYGVTMWEALS 534
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 68.1 bits (167), Expect = 2e-12
Identities = 59/307 (19%), Positives = 107/307 (34%), Gaps = 76/307 (24%)
Query: 616 GTFSTVYKAVM--PSGLILSV--KRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIG 671
G F +V + + G L V K +K D + + + E + H N++R +G
Sbjct: 45 GEFGSVMEGNLKQEDGTSLKVAVKTMKL-DNSSQREIEEFLSEAACMKDFSHPNVIRLLG 103
Query: 672 FVIYEDVALLLHNYL-----PNGTLAQ-LLHESTKQPDYRPDWPTRLSIAIGVAEGLAFL 725
I + + G L LL+ + T L + +A G+ +L
Sbjct: 104 VCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYL 163
Query: 726 HHVAIIHLDISSGNVLLD-------ADFKPLLG---EIE---------ISKLLDPSKGTA 766
+ +H D+++ N +L ADF G +I I+K+ P K A
Sbjct: 164 SNRNFLHRDLAARNCMLRDDMTVCVADF----GLSKKIYSGDYYRQGRIAKM--PVKWIA 217
Query: 767 SISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVH 826
S + T+ +V+++GV + EI T G
Sbjct: 218 IESLADRVY-------------TSKSDVWAFGVTMWEIAT--------RGM--------- 247
Query: 827 GAPARGETPEQILDARLSTVSFGWRKEM----LTAL-KVALLCTDSTPAKRPKMKKVVEM 881
P G ++ D + G R + L L ++ C + P RP +
Sbjct: 248 -TPYPGVQNHEMYDY----LLHGHRLKQPEDCLDELYEIMYSCWRTDPLDRPTFSVLRLQ 302
Query: 882 LQEIKQN 888
L+++ ++
Sbjct: 303 LEKLLES 309
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 69.0 bits (169), Expect = 2e-12
Identities = 57/300 (19%), Positives = 97/300 (32%), Gaps = 69/300 (23%)
Query: 616 GTFSTVYKAVMPSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLC-HDNLVRPIGFVI 674
G+ TV G ++VKR+ I + + E++ L++ H N++R
Sbjct: 26 GSSGTVVFQGSFQGRPVAVKRML------IDFCDIALMEIKLLTESDDHPNVIRYYCS-- 77
Query: 675 YEDVALLLHNY------LPNGTLAQLLHESTKQPDYRPDWPTRLSIAI--GVAEGLAFLH 726
+ L N L L+ + I++ +A G+A LH
Sbjct: 78 ETT-----DRFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLH 132
Query: 727 HVAIIHLDISSGNVLLDADFKPLLGEIE-------------ISKLLDP--SKGTASISAV 771
+ IIH D+ N+L+ + + + K LD S +++
Sbjct: 133 SLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNP 192
Query: 772 AGSFGYIPPEYAYTMQVTAPGNVY-------SYGVVLLEILTT-RLPVEEDFGEGVDLVK 823
+G+ G+ PE S G V IL+ + P FG+
Sbjct: 193 SGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHP----FGD------ 242
Query: 824 WVHGAPARGETPEQILDARLSTVSF---GWRKEMLTA--LKVALLCTDSTPAKRPKMKKV 878
+ I+ S R + A L ++ D P KRP KV
Sbjct: 243 -------KYSRESNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHD--PLKRPTAMKV 293
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 67.2 bits (165), Expect = 2e-12
Identities = 56/299 (18%), Positives = 114/299 (38%), Gaps = 78/299 (26%)
Query: 616 GTFSTVYKAVMPSGLILSVKRLK--SMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFV 673
G F V+ + +++K ++ +M + I E E + KL H LV+ G
Sbjct: 19 GQFGLVHLGYWLNKDKVAIKTIREGAMS------EEDFIEEAEVMMKLSHPKLVQLYGVC 72
Query: 674 IYEDVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHL 733
+ + L+ ++ +G L+ L + T L + + V EG+A+L +IH
Sbjct: 73 LEQAPICLVTEFMEHGCLSDYL----RTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHR 128
Query: 734 DISSGNVLLD-------ADFKPLLGEIEISKLLDPSKGTASISAVAGSFGYIP-----PE 781
D+++ N L+ +DF G +++ + + T+S P PE
Sbjct: 129 DLAARNCLVGENQVIKVSDF----G---MTRFVLDDQYTSSTG------TKFPVKWASPE 175
Query: 782 YAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQILDA 841
+ ++ +V+S+GV++ E+ + G+ P + ++++
Sbjct: 176 VFSFSRYSSKSDVWSFGVLMWEVFS--------EGK----------IPYENRSNSEVVED 217
Query: 842 RLSTVSFGWRKE------------MLTALKVALLCTDSTPAKRPKMKKVVEMLQEIKQN 888
+S G+R M C P RP +++ L EI ++
Sbjct: 218 ----ISTGFRLYKPRLASTHVYQIMNH-------CWRERPEDRPAFSRLLRQLAEIAES 265
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 3e-12
Identities = 42/220 (19%), Positives = 79/220 (35%), Gaps = 45/220 (20%)
Query: 616 GTFSTVYKAVMPSGLILSVKR--LKSMDRTIIHHQNKMIRELEKLSKLCH--DNLVRPIG 671
G S V++ + I ++K L+ D + + E+ L+KL D ++R
Sbjct: 39 GGSSKVFQVLNEKKQIYAIKYVNLEEADNQTL---DSYRNEIAYLNKLQQHSDKIIRLYD 95
Query: 672 FVIYEDVALLLHNYL----PNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHH 727
+ I + + Y+ N L L + R S + E + +H
Sbjct: 96 YEITDQ-----YIYMVMECGNIDLNSWLKKKKSIDP-----WERKSYWKNMLEAVHTIHQ 145
Query: 728 VAIIHLDISSGNVLLD------ADFKPLLGEIEISKLLDPSKGTASISAVAGSFGYIPPE 781
I+H D+ N L+ DF G I+ + P + + G+ Y+PPE
Sbjct: 146 HGIVHSDLKPANFLIVDGMLKLIDF----G---IANQMQPDTTSVVKDSQVGTVNYMPPE 198
Query: 782 -----------YAYTMQVTAPGNVYSYGVVLLEILTTRLP 810
+++ +V+S G +L + + P
Sbjct: 199 AIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTP 238
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 66.8 bits (164), Expect = 4e-12
Identities = 58/303 (19%), Positives = 107/303 (35%), Gaps = 81/303 (26%)
Query: 616 GTFSTVYKAV--MPSGLILSV--KRLK--SMDRTIIHHQNKMIRELEKLSKLCHDNLVRP 669
G F VY+ V G ++V K K + K + E + L H ++V+
Sbjct: 23 GFFGEVYEGVYTNHKGEKINVAVKTCKKDCTLDN----KEKFMSEAVIMKNLDHPHIVKL 78
Query: 670 IGFVIYEDVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVA 729
IG +I E+ ++ P G L L ++ T + ++ + + +A+L +
Sbjct: 79 IG-IIEEEPTWIIMELYPYGELGHYL----ERNKNSLKVLTLVLYSLQICKAMAYLESIN 133
Query: 730 IIHLDISSGNVLLD-------ADFKPLLGEIEISKLLDPSKGTASISAVAGSFGYIP--- 779
+H DI+ N+L+ DF G +S+ ++ S +P
Sbjct: 134 CVHRDIAVRNILVASPECVKLGDF----G---LSRYIEDE------DYYKASVTRLPIKW 180
Query: 780 --PEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQ 837
PE + T +V+ + V + EIL+ FG+ P +
Sbjct: 181 MSPESINFRRFTTASDVWMFAVCMWEILS--------FGK----------QPFFWLENKD 222
Query: 838 ILDARLSTVSFGWRKE------------MLTALKVALLCTDSTPAKRPKMKKVVEMLQEI 885
++ + G R M C D P+ RP+ ++V L ++
Sbjct: 223 VIGV----LEKGDRLPKPDLCPPVLYTLM-------TRCWDYDPSDRPRFTELVCSLSDV 271
Query: 886 KQN 888
Q
Sbjct: 272 YQM 274
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 6e-12
Identities = 60/315 (19%), Positives = 107/315 (33%), Gaps = 91/315 (28%)
Query: 616 GTFSTVYKAVM----PSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIG 671
G F +V +A + S + ++VK LK+ D + +RE + + H ++ + +G
Sbjct: 34 GEFGSVREAQLKQEDGSFVKVAVKMLKA-DIIASSDIEEFLREAACMKEFDHPHVAKLVG 92
Query: 672 FVIYEDVALLLHN------YLPNGTLAQ-LLHESTKQPDYRPDWPTRLSIAIGVAEGLAF 724
+ L ++ +G L LL + + T + + +A G+ +
Sbjct: 93 VSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEY 152
Query: 725 LHHVAIIHLDISSGNVLLD-------ADFKPLLG---EIE---------ISKLLDPSKGT 765
L IH D+++ N +L ADF G +I SKL P K
Sbjct: 153 LSSRNFIHRDLAARNCMLAEDMTVCVADF----GLSRKIYSGDYYRQGCASKL--PVKWL 206
Query: 766 ASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWV 825
A S + T +V+++GV + EI+T G
Sbjct: 207 ALESLADNLY-------------TVHSDVWAFGVTMWEIMT--------RG--------- 236
Query: 826 HGAPARGETPEQILDARLSTVSFGWRKE------------MLTALKVALLCTDSTPAKRP 873
P G +I + + G R + M C + P +RP
Sbjct: 237 -QTPYAGIENAEIYNY----LIGGNRLKQPPECMEEVYDLM-------YQCWSADPKQRP 284
Query: 874 KMKKVVEMLQEIKQN 888
+ L+ I +
Sbjct: 285 SFTCLRMELENILGH 299
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 66.1 bits (162), Expect = 6e-12
Identities = 51/299 (17%), Positives = 108/299 (36%), Gaps = 78/299 (26%)
Query: 616 GTFSTVYKAVMPSGLILSVKRLK--SMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFV 673
G F V +++K +K SM ++ I E + + L H+ LV+ G
Sbjct: 35 GQFGVVKYGKWRGQYDVAIKMIKEGSMSE------DEFIEEAKVMMNLSHEKLVQLYGVC 88
Query: 674 IYEDVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHL 733
+ ++ Y+ NG L L ++ +R L + V E + +L +H
Sbjct: 89 TKQRPIFIITEYMANGCLLNYL----REMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHR 144
Query: 734 DISSGNVLLD-------ADFKPLLGEIEISKLLDPSKGTASISAVAGSFGYIP-----PE 781
D+++ N L++ +DF G +S+ + + T+S+ + P PE
Sbjct: 145 DLAARNCLVNDQGVVKVSDF----G---LSRYVLDDEYTSSVGSK------FPVRWSPPE 191
Query: 782 YAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQILDA 841
+ ++ +++++GV++ EI + G+ P T + +
Sbjct: 192 VLMYSKFSSKSDIWAFGVLMWEIYS--------LGK----------MPYERFTNSETAEH 233
Query: 842 RLSTVSFGWRKE------------MLTALKVALLCTDSTPAKRPKMKKVVEMLQEIKQN 888
++ G R M + C +RP K ++ + ++
Sbjct: 234 ----IAQGLRLYRPHLASEKVYTIMYS-------CWHEKADERPTFKILLSNILDVMDE 281
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 7e-12
Identities = 65/309 (21%), Positives = 109/309 (35%), Gaps = 74/309 (23%)
Query: 616 GTFSTVYKAVMP-----SGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPI 670
G F +V +G +++VK+L+ Q RE++ L L D +V+
Sbjct: 34 GNFGSVELCRYDPLGDNTGALVAVKQLQHSG---PDQQRDFQREIQILKALHSDFIVKYR 90
Query: 671 GFVIYEDVA---LLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHH 727
G V Y L+ YLP+G L L ++ R D L + + +G+ +L
Sbjct: 91 G-VSYGPGRQSLRLVMEYLPSGCLRDFL----QRHRARLDASRLLLYSSQICKGMEYLGS 145
Query: 728 VAIIHLDISSGNVLLD-------ADFKPLLGEIEISKLLDPSKGTASISAVAGSFGYIP- 779
+H D+++ N+L++ ADF G ++KLL K V G P
Sbjct: 146 RRCVHRDLAARNILVESEAHVKIADF----G---LAKLLPLDKDY----YVVREPGQSPI 194
Query: 780 ----PEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGE----GVDLVKWVHGAPAR 831
PE + +V+S+GVVL E+ T + + + G
Sbjct: 195 FWYAPESLSDNIFSRQSDVWSFGVVLYELFT--------YCDKSCSPSAEFLRMMGCERD 246
Query: 832 GETPEQILDARLSTVSFGWRKE------------MLTALKVALLCTDSTPAKRPKMKKVV 879
++L+ + G R M LC +P RP +
Sbjct: 247 VPALSRLLEL----LEEGQRLPAPPACPAEVHELM-------KLCWAPSPQDRPSFSALG 295
Query: 880 EMLQEIKQN 888
L +
Sbjct: 296 PQLDMLWSG 304
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 66.3 bits (162), Expect = 1e-11
Identities = 64/301 (21%), Positives = 107/301 (35%), Gaps = 64/301 (21%)
Query: 616 GTFSTVYKAV------MPSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRP 669
G F VY+ PS L ++VK L + + + E +SK H N+VR
Sbjct: 82 GAFGEVYEGQVSGMPNDPSPLQVAVKTLP--EVCSEQDELDFLMEALIISKFNHQNIVRC 139
Query: 670 IGFVIYEDVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTR--LSIAIGVAEGLAFLHH 727
IG + +L + G L L E+ +P L +A +A G +L
Sbjct: 140 IGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE 199
Query: 728 VAIIHLDISSGNVLLDADFKPLLGEIEISKLLD--PSKGTASISA-VAGSFGYIP----- 779
IH DI++ N LL G ++K+ D ++ G +P
Sbjct: 200 NHFIHRDIAARNCLLTCP-----GPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMP 254
Query: 780 PEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQIL 839
PE T+ + +S+GV+L EI + G P ++ +++L
Sbjct: 255 PEAFMEGIFTSKTDTWSFGVLLWEIFS--------LGY----------MPYPSKSNQEVL 296
Query: 840 DARLSTVSFGWRKE------------MLTALKVALLCTDSTPAKRPKMKKVVEMLQEIKQ 887
+ V+ G R + M C P RP ++E ++ Q
Sbjct: 297 EF----VTSGGRMDPPKNCPGPVYRIM-------TQCWQHQPEDRPNFAIILERIEYCTQ 345
Query: 888 N 888
+
Sbjct: 346 D 346
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 1e-11
Identities = 55/295 (18%), Positives = 111/295 (37%), Gaps = 63/295 (21%)
Query: 616 GTFSTVYKAV-MPSGLILS----VKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPI 670
G F TVYK + +P G + +K L+ + T +++ E ++ + + ++ R +
Sbjct: 26 GAFGTVYKGLWIPEGEKVKIPVAIKELR--EATSPKANKEILDEAYVMASVDNPHVCRLL 83
Query: 671 GFVIYEDVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAI 730
G + L+ +P G L + ++ L+ + +A+G+ +L +
Sbjct: 84 G-ICLTSTVQLITQLMPFGCLLDYV----REHKDNIGSQYLLNWCVQIAKGMNYLEDRRL 138
Query: 731 IHLDISSGNVLLD-------ADFKPLLGEIEISKLLDPSKGTASISAVAGSFGYIP---- 779
+H D+++ NVL+ DF G ++KLL + G +P
Sbjct: 139 VHRDLAARNVLVKTPQHVKITDF----G---LAKLLGAEEKEYHAEG-----GKVPIKWM 186
Query: 780 -PEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQI 838
E T +V+SYGV + E++T FG P G +I
Sbjct: 187 ALESILHRIYTHQSDVWSYGVTVWELMT--------FGS----------KPYDGIPASEI 228
Query: 839 LDARLSTVSFGWRKEM----LTAL-KVALLCTDSTPAKRPKMKKVVEMLQEIKQN 888
+ G R + + + C RPK ++++ ++ ++
Sbjct: 229 SSI----LEKGERLPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 279
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 1e-11
Identities = 57/292 (19%), Positives = 101/292 (34%), Gaps = 60/292 (20%)
Query: 616 GTFSTVYKAVM--PSGLILSV--KRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIG 671
G F VY + G + K L T I ++ + E + H N++ +G
Sbjct: 36 GHFGCVYHGTLLDNDGKKIHCAVKSLN--RITDIGEVSQFLTEGIIMKDFSHPNVLSLLG 93
Query: 672 FVIYEDVALL-LHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAI 730
+ + + L + Y+ +G L + T P + + VA+G+ +L
Sbjct: 94 ICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTV----KDLIGFGLQVAKGMKYLASKKF 149
Query: 731 IHLDISSGNVLLD-------ADFKPLLGEIEISKLLDPSKGTASISAVAGSFGYIP---- 779
+H D+++ N +LD ADF G +++ + S + +P
Sbjct: 150 VHRDLAARNCMLDEKFTVKVADF----G---LARDMY---DKEYYSVHNKTGAKLPVKWM 199
Query: 780 -PEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQI 838
E T + T +V+S+GV+L E++T G P I
Sbjct: 200 ALESLQTQKFTTKSDVWSFGVLLWELMT--------RGA----------PPYPDVNTFDI 241
Query: 839 LDARLSTVSFGWRKEM----LTAL-KVALLCTDSTPAKRPKMKKVVEMLQEI 885
+ G R L +V L C RP ++V + I
Sbjct: 242 TVY----LLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAI 289
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 65.4 bits (160), Expect = 1e-11
Identities = 46/207 (22%), Positives = 86/207 (41%), Gaps = 33/207 (15%)
Query: 615 CGTFSTVYKAV--MPSGLIL-SVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIG 671
G F TV K M + +VK LK+ + +++++ E + +L + +VR IG
Sbjct: 27 SGNFGTVKKGYYQMKKVVKTVAVKILKN-EANDPALKDELLAEANVMQQLDNPYIVRMIG 85
Query: 672 FVIYEDVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAII 731
E L++ G L + L ++ + + V+ G+ +L +
Sbjct: 86 ICEAESWMLVME-MAELGPLNKYLQQNRHVK-----DKNIIELVHQVSMGMKYLEESNFV 139
Query: 732 HLDISSGNVLLD-------ADFKPLLGEIEISKLLDPSKGTASISAVAGSFGYIP----- 779
H D+++ NVLL +DF G +SK L + A + G P
Sbjct: 140 HRDLAARNVLLVTQHYAKISDF----G---LSKALRADENY----YKAQTHGKWPVKWYA 188
Query: 780 PEYAYTMQVTAPGNVYSYGVVLLEILT 806
PE + ++ +V+S+GV++ E +
Sbjct: 189 PECINYYKFSSKSDVWSFGVLMWEAFS 215
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 2e-11
Identities = 49/209 (23%), Positives = 89/209 (42%), Gaps = 37/209 (17%)
Query: 616 GTFSTVYKAV--MPSGLILSV--KRLK--SMDRTIIHHQNKMIRELEKLSKLCHDNLVRP 669
G V +P + V K LK +R + + E + + H N++R
Sbjct: 60 GDSGEVCYGRLRVPGQRDVPVAIKALKAGYTERQ----RRDFLSEASIMGQFDHPNIIRL 115
Query: 670 IGFVIYEDVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVA 729
G V +A+++ Y+ NG+L L + D + + + GV G+ +L +
Sbjct: 116 EGVVTRGRLAMIVTEYMENGSLDTFL----RTHDGQFTIMQLVGMLRGVGAGMRYLSDLG 171
Query: 730 IIHLDISSGNVLLD-------ADFKPLLGEIEISKLLDPSKGTASISAVAGSFGYIP--- 779
+H D+++ NVL+D +DF G +S++L+ A + G IP
Sbjct: 172 YVHRDLAARNVLVDSNLVCKVSDF----G---LSRVLEDDPDAAYTTTG----GKIPIRW 220
Query: 780 --PEYAYTMQVTAPGNVYSYGVVLLEILT 806
PE ++ +V+S+GVV+ E+L
Sbjct: 221 TAPEAIAFRTFSSASDVWSFGVVMWEVLA 249
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 65.3 bits (159), Expect = 2e-11
Identities = 38/273 (13%), Positives = 81/273 (29%), Gaps = 32/273 (11%)
Query: 611 NMIYCGTFSTVYKAVMPSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPI 670
+ K I + + ++ ++ N V +
Sbjct: 68 RYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQL 127
Query: 671 GFVIYEDVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAI 730
+ + L ++ + + L I I +AE + FLH +
Sbjct: 128 QPSSPKVYLYIQMQLCRKENLKDWMNR--RCSLEDREHGVCLHIFIQIAEAVEFLHSKGL 185
Query: 731 IHLDISSGNVLLDA-------DF---KPLLGEIEISKLLDPSKGTASISAVAGSFGYIPP 780
+H D+ N+ DF + + E +L P A+ + G+ Y+ P
Sbjct: 186 MHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSP 245
Query: 781 EYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQILD 840
E + + +++S G++L E+L + + E I D
Sbjct: 246 EQIHGNNYSHKVDIFSLGLILFELL--------------------YSFSTQMERVRIITD 285
Query: 841 ARLSTVSFGWRKEMLTALKVALLCTDSTPAKRP 873
R + ++ + +P +RP
Sbjct: 286 VRNLKFPLLFTQKYPQEHMMVQDMLSPSPTERP 318
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 2e-11
Identities = 59/295 (20%), Positives = 113/295 (38%), Gaps = 68/295 (23%)
Query: 616 GTFSTVYKAVM-PSGLILSVKRLK--SMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGF 672
G + VY+ V L ++VK LK +M+ + ++E + ++ H NLV+ +G
Sbjct: 24 GQYGEVYEGVWKKYSLTVAVKTLKEDTMEV------EEFLKEAAVMKEIKHPNLVQLLGV 77
Query: 673 VIYEDVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIH 732
E ++ ++ G L L E +Q L +A ++ + +L IH
Sbjct: 78 CTREPPFYIITEFMTYGNLLDYLRECNRQ---EVSAVVLLYMATQISSAMEYLEKKNFIH 134
Query: 733 LDISSGNVLLD-------ADF---KPLLGEI----EISKLLDPSKGTASISAVAGSFGYI 778
D+++ N L+ ADF + + G+ +K P K TA
Sbjct: 135 RDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAHAGAKF--PIKWTA------------ 180
Query: 779 PPEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQI 838
PE + + +V+++GV+L EI T +G +P G Q+
Sbjct: 181 -PESLAYNKFSIKSDVWAFGVLLWEIAT--------YGM----------SPYPGIDLSQV 221
Query: 839 LDARLSTVSFGWRKEM----LTAL-KVALLCTDSTPAKRPKMKKVVEMLQEIKQN 888
+ + +R E + ++ C P+ RP ++ + + + Q
Sbjct: 222 YEL----LEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQE 272
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 66.2 bits (162), Expect = 2e-11
Identities = 59/296 (19%), Positives = 105/296 (35%), Gaps = 76/296 (25%)
Query: 616 GTFSTVYKAVMPSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIY 675
G F V G ++VK +K+ + E +++L H NLV+ +G ++
Sbjct: 204 GEFGDVMLGDY-RGNKVAVKCIKND-----ATAQAFLAEASVMTQLRHSNLVQLLGVIVE 257
Query: 676 EDVALLL-HNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLD 734
E L + Y+ G+L L + L ++ V E + +L +H D
Sbjct: 258 EKGGLYIVTEYMAKGSLVDYLRSRGRSV---LGGDCLLKFSLDVCEAMEYLEGNNFVHRD 314
Query: 735 ISSGNVLLD-------ADF---KPLLGEIEISKLLDPSKGTASISAVAGSFGYIPPEYAY 784
+++ NVL+ +DF K + KL P K TA PE
Sbjct: 315 LAARNVLVSEDNVAKVSDFGLTKEASSTQDTGKL--PVKWTA-------------PEALR 359
Query: 785 TMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQILDARLS 844
+ + +V+S+G++L EI + FG P + ++
Sbjct: 360 EKKFSTKSDVWSFGILLWEIYS--------FGR----------VPYPRIPLKDVVPR--- 398
Query: 845 TVSFGWRKE------------MLTALKVALLCTDSTPAKRPKMKKVVEMLQEIKQN 888
V G++ + M C A RP ++ E L+ I+ +
Sbjct: 399 -VEKGYKMDAPDGCPPAVYDVMKN-------CWHLDAATRPTFLQLREQLEHIRTH 446
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 2e-11
Identities = 62/294 (21%), Positives = 106/294 (36%), Gaps = 60/294 (20%)
Query: 615 CGTFSTVYKAV--MPSGLIL-SVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIG 671
CG F +V + V M I ++K LK T +M+RE + + +L + +VR IG
Sbjct: 20 CGNFGSVRQGVYRMRKKQIDVAIKVLKQG--TEKADTEEMMREAQIMHQLDNPYIVRLIG 77
Query: 672 FVIYEDVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAII 731
V + +L+ G L + L + V+ G+ +L +
Sbjct: 78 -VCQAEALMLVMEMAGGGPLHKFL----VGKREEIPVSNVAELLHQVSMGMKYLEEKNFV 132
Query: 732 HLDISSGNVLLD-------ADFKPLLGEIEISKLLDPSKGTASISAVAGSFGYIP----- 779
H D+++ NVLL +DF G +SK L A S G P
Sbjct: 133 HRDLAARNVLLVNRHYAKISDF----G---LSKALGADDSY----YTARSAGKWPLKWYA 181
Query: 780 PEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQIL 839
PE + ++ +V+SYGV + E L+ +G+ P + +++
Sbjct: 182 PECINFRKFSSRSDVWSYGVTMWEALS--------YGQ----------KPYKKMKGPEVM 223
Query: 840 DARLSTVSFGWRKEM----LTAL-KVALLCTDSTPAKRPKMKKVVEMLQEIKQN 888
+ G R E L + C RP V + ++ +
Sbjct: 224 AF----IEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 273
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 2e-11
Identities = 64/303 (21%), Positives = 122/303 (40%), Gaps = 78/303 (25%)
Query: 616 GTFSTVYKAV--MPSGLILSV--KRLK--SMDRTIIHHQNKMIRELEKLSKLCHDNLVRP 669
G F V +PS +SV K LK ++ + + E + + H N++R
Sbjct: 56 GEFGEVCSGRLKLPSKKEISVAIKTLKVGYTEKQ----RRDFLGEASIMGQFDHPNIIRL 111
Query: 670 IGFVIYEDVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVA 729
G V +++ Y+ NG+L L ++ D + + + G+A G+ +L +
Sbjct: 112 EGVVTKSKPVMIVTEYMENGSLDSFL----RKHDAQFTVIQLVGMLRGIASGMKYLSDMG 167
Query: 730 IIHLDISSGNVLLD-------ADFKPLLGEIEISKLLDPSKGTASISAVAGSFGYIP--- 779
+H D+++ N+L++ +DF G + ++L+ A + G IP
Sbjct: 168 YVHRDLAARNILINSNLVCKVSDF----G---LGRVLEDDPEAAYTT----RGGKIPIRW 216
Query: 780 --PEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQ 837
PE + T+ +V+SYG+VL E+++ +GE P + +
Sbjct: 217 TSPEAIAYRKFTSASDVWSYGIVLWEVMS--------YGE----------RPYWEMSNQD 258
Query: 838 ILDARLSTVSFGWRKE------------MLTALKVALLCTDSTPAKRPKMKKVVEMLQEI 885
++ A V G+R ML C RPK +++V +L ++
Sbjct: 259 VIKA----VDEGYRLPPPMDCPAALYQLMLD-------CWQKDRNNRPKFEQIVSILDKL 307
Query: 886 KQN 888
+N
Sbjct: 308 IRN 310
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 64.5 bits (158), Expect = 2e-11
Identities = 64/299 (21%), Positives = 109/299 (36%), Gaps = 78/299 (26%)
Query: 616 GTFSTVYKAVMPSGLILSVKRLK--SMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFV 673
G F V+ ++VK LK SM + + E + +L H LVR V
Sbjct: 24 GQFGEVWMGYYNGHTKVAVKSLKQGSMSP------DAFLAEANLMKQLQHQRLVRLYA-V 76
Query: 674 IYEDVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHL 733
+ ++ ++ Y+ NG+L L + L +A +AEG+AF+ IH
Sbjct: 77 VTQEPIYIITEYMENGSLVDFLKTPSGIK---LTINKLLDMAAQIAEGMAFIEERNYIHR 133
Query: 734 DISSGNVLLD-------ADFKPLLGEIEISKLLDPSKGTASISAVAGSFGYIP-----PE 781
D+ + N+L+ ADF G +++L++ ++ TA P PE
Sbjct: 134 DLRAANILVSDTLSCKIADF----G---LARLIEDNEYTAREG------AKFPIKWTAPE 180
Query: 782 YAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQILDA 841
T +V+S+G++L EI+T G P G T +++
Sbjct: 181 AINYGTFTIKSDVWSFGILLTEIVT--------HGR----------IPYPGMTNPEVIQN 222
Query: 842 RLSTVSFGWRKE------------MLTALKVALLCTDSTPAKRPKMKKVVEMLQEIKQN 888
+ G+R M LC P RP + +L++
Sbjct: 223 ----LERGYRMVRPDNCPEELYQLM-------RLCWKERPEDRPTFDYLRSVLEDFFTA 270
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 2e-11
Identities = 58/295 (19%), Positives = 102/295 (34%), Gaps = 60/295 (20%)
Query: 616 GTFSTVYKAVM--PSGLILSV--KRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIG 671
G F VY + G + K L T I ++ + E + H N++ +G
Sbjct: 100 GHFGCVYHGTLLDNDGKKIHCAVKSLN--RITDIGEVSQFLTEGIIMKDFSHPNVLSLLG 157
Query: 672 FVIYEDVALLL-HNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAI 730
+ + + L+ Y+ +G L + T P + + + VA+G+ FL
Sbjct: 158 ICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVK----DLIGFGLQVAKGMKFLASKKF 213
Query: 731 IHLDISSGNVLLD-------ADFKPLLGEIEISKLLDPSKGTASISAVAGSFGYIP---- 779
+H D+++ N +LD ADF G +++ + S + +P
Sbjct: 214 VHRDLAARNCMLDEKFTVKVADF----G---LARDM---YDKEFDSVHNKTGAKLPVKWM 263
Query: 780 -PEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQI 838
E T + T +V+S+GV+L E++T G P I
Sbjct: 264 ALESLQTQKFTTKSDVWSFGVLLWELMT--------RGA----------PPYPDVNTFDI 305
Query: 839 LDARLSTVSFGWRKEM----LTAL-KVALLCTDSTPAKRPKMKKVVEMLQEIKQN 888
+ G R L +V L C RP ++V + I
Sbjct: 306 TVY----LLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFST 356
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 3e-11
Identities = 45/198 (22%), Positives = 69/198 (34%), Gaps = 22/198 (11%)
Query: 616 GTFSTVYKAV-MPSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLC-HDNLVRPIGFV 673
G++ V+K G + +VKR S R K+ E+ K+ H VR
Sbjct: 68 GSYGEVFKVRSKEDGRLYAVKRSMSPFRGPKDRARKL-AEVGSHEKVGQHPCCVRLEQAW 126
Query: 674 IYEDVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHL 733
E L L L +L Q P+ LA LH ++HL
Sbjct: 127 E-EGGILYLQTELCGPSLQQHCE---AWGASLPE-AQVWGYLRDTLLALAHLHSQGLVHL 181
Query: 734 DISSGNVLLDAD--FKPLLGEIEISKLLDPSKGTASISAVAGSFGYIPPEY---AYTMQV 788
D+ N+ L K LG+ + L + G Y+ PE +Y
Sbjct: 182 DVKPANIFLGPRGRCK--LGDFGLLVELGTAGAGEV---QEGDPRYMAPELLQGSYGTAA 236
Query: 789 TAPGNVYSYGVVLLEILT 806
+V+S G+ +LE+
Sbjct: 237 ----DVFSLGLTILEVAC 250
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 63.6 bits (155), Expect = 3e-11
Identities = 45/158 (28%), Positives = 74/158 (46%), Gaps = 12/158 (7%)
Query: 89 KRLDLSNNAFSGTIPSAFGNLSELEFLDLSLNKFGGVIPRELGSLKDLRFFNISNN---V 145
++LDL + + + F L++L +L+L N+ + L +L ++NN
Sbjct: 38 EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQTLSAGVFDDLTELGTLGLANNQLAS 97
Query: 146 LVGEIPDELKSLEKLEDFQVSSNKLNGSIPFWV-GNLTNLRVFTAYENQLVGEIPDNL-G 203
L + D L L+KL + N+L S+P V LT L+ NQL IP
Sbjct: 98 LPLGVFDHLTQLDKL---YLGGNQLK-SLPSGVFDRLTKLKELRLNTNQL-QSIPAGAFD 152
Query: 204 SVSELELLNLHSNQLEGPIPKSIFAS-GKLEVLVLTQN 240
++ L+ L+L +NQL+ +P F GKL+ + L N
Sbjct: 153 KLTNLQTLSLSTNQLQS-VPHGAFDRLGKLQTITLFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 2e-07
Identities = 43/189 (22%), Positives = 74/189 (39%), Gaps = 19/189 (10%)
Query: 301 CSN-LTLLNLASNGFTGV---IPPELGQLINLQELILYENSLFGEIPKSILACKNLNKLD 356
C+ ++ V IP + ++L L L + L L+
Sbjct: 12 CNEGKKEVDCQGKSLDSVPSGIP------ADTEKLDLQSTGLATLSDATFRGLTKLTWLN 65
Query: 357 LSNNRFNGTIPNAICD-MSRLQYLLLGQNSLKGEIPHEIGNCM-KLLQLHIGSNYLTGSI 414
L N+ T+ + D ++ L L L N L +P + + + +L +L++G N L S+
Sbjct: 66 LDYNQL-QTLSAGVFDDLTELGTLGLANNQLA-SLPLGVFDHLTQLDKLYLGGNQLK-SL 122
Query: 415 PPEI-GHIRNLQIALNLSFNHLHGSLPPEL-GKLDKLVSFDVSNNQLSGTIPSALKGMLS 472
P + + L+ L L+ N L S+P KL L + +S NQL A +
Sbjct: 123 PSGVFDRLTKLKE-LRLNTNQLQ-SIPAGAFDKLTNLQTLSLSTNQLQSVPHGAFDRLGK 180
Query: 473 LIEVNFSNN 481
L + N
Sbjct: 181 LQTITLFGN 189
|
| >3m19_A Variable lymphocyte receptor A diversity region; adaptive immunity, antibody, T cell, leucine-rich repeat, immune system; 1.70A {Petromyzon marinus} PDB: 3m18_A Length = 251 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 8e-05
Identities = 44/202 (21%), Positives = 66/202 (32%), Gaps = 60/202 (29%)
Query: 209 ELLNLHSNQLEGPIPKSIFASGKLEVLVLTQNRLTGDIPELVGHCKSLSNIRIGNNDLVG 268
E L+L S L + KL L L N+L
Sbjct: 38 EKLDLQSTGLATLSDATFRGLTKLTWLNLDYNQLQ------------------------- 72
Query: 269 VIPRAIGNVSGLTYFEADNNNLSGEIVPEFSQCSNLTLLNLASNGFTGVIPPEL-GQLIN 327
+ + F + L L LA+N +P + L
Sbjct: 73 TLSAGV-----------------------FDDLTELGTLGLANNQLA-SLPLGVFDHLTQ 108
Query: 328 LQELILYENSLFGEIPKSI---LACKNLNKLDLSNNRFNGTIPNAICD-MSRLQYLLLGQ 383
L +L L N L +P + L L +L L+ N+ +IP D ++ LQ L L
Sbjct: 109 LDKLYLGGNQL-KSLPSGVFDRLT--KLKELRLNTNQLQ-SIPAGAFDKLTNLQTLSLST 164
Query: 384 NSLKGEIPHEIGNCMKLLQLHI 405
N L+ +PH + + LQ I
Sbjct: 165 NQLQS-VPHGAFDRLGKLQ-TI 184
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 63.7 bits (156), Expect = 4e-11
Identities = 57/298 (19%), Positives = 112/298 (37%), Gaps = 78/298 (26%)
Query: 616 GTFSTVYKAVMPSGLILSVKRLK--SMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFV 673
G F V ++VK +K SM ++ +E + + KL H LV+ G
Sbjct: 19 GQFGVVKLGKWKGQYDVAVKMIKEGSMSE------DEFFQEAQTMMKLSHPKLVKFYGVC 72
Query: 674 IYEDVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHL 733
E ++ Y+ NG L L + + L + V EG+AFL IH
Sbjct: 73 SKEYPIYIVTEYISNGCLLNYL----RSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHR 128
Query: 734 DISSGNVLLD-------ADFKPLLGEIEISKLLDPSKGTASISAVAGSFGYIP-----PE 781
D+++ N L+D +DF G +++ + + +S+ P PE
Sbjct: 129 DLAARNCLVDRDLCVKVSDF----G---MTRYVLDDQYVSSVG------TKFPVKWSAPE 175
Query: 782 YAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQILDA 841
+ + ++ +V+++G+++ E+ + G+ P T +++
Sbjct: 176 VFHYFKYSSKSDVWAFGILMWEVFS--------LGK----------MPYDLYTNSEVVLK 217
Query: 842 RLSTVSFGWRKE------------MLTALKVALLCTDSTPAKRPKMKKVVEMLQEIKQ 887
VS G R M + C P KRP ++++ ++ +++
Sbjct: 218 ----VSQGHRLYRPHLASDTIYQIMYS-------CWHELPEKRPTFQQLLSSIEPLRE 264
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 63.8 bits (156), Expect = 4e-11
Identities = 62/295 (21%), Positives = 108/295 (36%), Gaps = 66/295 (22%)
Query: 616 GTFSTVYKAVMPSGLILS----VKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIG 671
G F VY +K L T + +RE + L H N++ IG
Sbjct: 32 GHFGVVYHGEYIDQAQNRIQCAIKSLS--RITEMQQVEAFLREGLLMRGLNHPNVLALIG 89
Query: 672 FVIYED-VALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAI 730
++ + + +L Y+ +G L Q + + P +S + VA G+ +L
Sbjct: 90 IMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTV----KDLISFGLQVARGMEYLAEQKF 145
Query: 731 IHLDISSGNVLLD-------ADFKPLLG---EIEISKLLDPSKGTASISAVAGSFGYIP- 779
+H D+++ N +LD ADF G +I + + +P
Sbjct: 146 VHRDLAARNCMLDESFTVKVADF----GLARDILDREYYSVQQHRH---------ARLPV 192
Query: 780 ----PEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETP 835
E T + T +V+S+GV+L E+LT G P R P
Sbjct: 193 KWTALESLQTYRFTTKSDVWSFGVLLWELLT--------RGA----------PPYRHIDP 234
Query: 836 EQILDARLSTVSFGWRKEM----LTAL-KVALLCTDSTPAKRPKMKKVVEMLQEI 885
+ ++ G R +L +V C ++ PA RP + +V +++I
Sbjct: 235 FDLTHF----LAQGRRLPQPEYCPDSLYQVMQQCWEADPAVRPTFRVLVGEVEQI 285
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 63.4 bits (155), Expect = 5e-11
Identities = 61/298 (20%), Positives = 108/298 (36%), Gaps = 71/298 (23%)
Query: 616 GTFSTVYKAV--MPSGLILSV--KRLK--SMDRTIIHHQNKMIRELEKLSKLCHDNLVRP 669
G F V++ + P L+V K K + D + K ++E + + H ++V+
Sbjct: 26 GQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSV----REKFLQEALTMRQFDHPHIVKL 81
Query: 670 IGFVIYEDVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVA 729
IG VI E+ ++ G L L + Y D + + A ++ LA+L
Sbjct: 82 IG-VITENPVWIIMELCTLGELRSFL----QVRKYSLDLASLILYAYQLSTALAYLESKR 136
Query: 730 IIHLDISSGNVLLDADFKPLLGEIEISKLLD--PSKGTASISAVAGSFGYIP-----PEY 782
+H DI++ NVL+ ++ KL D S+ + S G +P PE
Sbjct: 137 FVHRDIAARNVLVSSND--------CVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPES 188
Query: 783 AYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQILDAR 842
+ T+ +V+ +GV + EIL G P +G ++
Sbjct: 189 INFRRFTSASDVWMFGVCMWEILM--------HGV----------KPFQGVKNNDVIGR- 229
Query: 843 LSTVSFGWRKE------------MLTALKVALLCTDSTPAKRPKMKKVVEMLQEIKQN 888
+ G R M C P++RP+ ++ L I +
Sbjct: 230 ---IENGERLPMPPNCPPTLYSLM-------TKCWAYDPSRRPRFTELKAQLSTILEE 277
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 6e-11
Identities = 61/295 (20%), Positives = 112/295 (37%), Gaps = 63/295 (21%)
Query: 616 GTFSTVYKAV-MPSGLILS----VKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPI 670
G F TV+K V +P G + +K ++ D++ + + + L H ++VR +
Sbjct: 24 GVFGTVHKGVWIPEGESIKIPVCIKVIE--DKSGRQSFQAVTDHMLAIGSLDHAHIVRLL 81
Query: 671 GFVIYEDVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAI 730
G + L+ YLP G+L + +Q L+ + +A+G+ +L +
Sbjct: 82 GLCPGSSLQLVTQ-YLPLGSLLDHV----RQHRGALGPQLLLNWGVQIAKGMYYLEEHGM 136
Query: 731 IHLDISSGNVLLD-------ADFKPLLGEIEISKLLDPSKGTASISAVAGSFGYIP---- 779
+H ++++ NVLL ADF G ++ LL P + S P
Sbjct: 137 VHRNLAARNVLLKSPSQVQVADF----G---VADLLPPDD-----KQLLYSEAKTPIKWM 184
Query: 780 -PEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQI 838
E + + T +V+SYGV + E++T FG P G ++
Sbjct: 185 ALESIHFGKYTHQSDVWSYGVTVWELMT--------FGA----------EPYAGLRLAEV 226
Query: 839 LDARLSTVSFGWRKEM----LTAL-KVALLCTDSTPAKRPKMKKVVEMLQEIKQN 888
D + G R + V + C RP K++ + ++
Sbjct: 227 PDL----LEKGERLAQPQICTIDVYMVMVKCWMIDENIRPTFKELANEFTRMARD 277
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 65.1 bits (158), Expect = 7e-11
Identities = 43/217 (19%), Positives = 87/217 (40%), Gaps = 33/217 (15%)
Query: 616 GTFSTVYKAV-MPSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVI 674
G F V + + +G +++K+ + ++ + E++ + KL H N+V +
Sbjct: 25 GGFGYVLRWIHQDTGEQVAIKQCRQ--ELSPKNRERWCLEIQIMKKLNHPNVVS--AREV 80
Query: 675 YEDVALLLHN--------YLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLH 726
+ + L N Y G L + L++ + ++ ++ L +LH
Sbjct: 81 PDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEG--PIRTLLSDISSALRYLH 138
Query: 727 HVAIIHLDISSGNVLLDADFKPLLGEIEI-----SKLLDPSKGTASISAVAGSFGYIPPE 781
IIH D+ N++L + L+ +I +K LD + G+ Y+ PE
Sbjct: 139 ENRIIHRDLKPENIVLQPGPQRLI--HKIIDLGYAKELDQGELCTE---FVGTLQYLAPE 193
Query: 782 Y----AYTMQVTAPGNVYSYGVVLLEILTTRLPVEED 814
YT+ V + +S+G + E +T P +
Sbjct: 194 LLEQKKYTVTV----DYWSFGTLAFECITGFRPFLPN 226
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 7e-11
Identities = 30/130 (23%), Positives = 56/130 (43%), Gaps = 4/130 (3%)
Query: 89 KRLDLSNNAFSGTIPSAFGNLSELEFLDLSLNKFGGVIPRELGSLKDLRFFNISNNVLVG 148
+ L N P AF +L +DLS N+ + P L+ L + N +
Sbjct: 35 TEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKIT- 93
Query: 149 EIPDEL-KSLEKLEDFQVSSNKLNGSIPFWV-GNLTNLRVFTAYENQLVGEIPDNLGSVS 206
E+P L + L L+ +++NK+N + +L NL + + Y+N+L +
Sbjct: 94 ELPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLR 152
Query: 207 ELELLNLHSN 216
++ ++L N
Sbjct: 153 AIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 5e-08
Identities = 27/144 (18%), Positives = 58/144 (40%), Gaps = 9/144 (6%)
Query: 341 EIPKSILACKNLNKLDLSNNRFNGTIPNAICDMSRLQYLLLGQNSLKGEIPHEI-GNCMK 399
EIP ++ + ++ L N P A +L+ + L N + E+ +
Sbjct: 25 EIPTNLPE--TITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRS 81
Query: 400 LLQLHIGSNYLTGSIPPEI-GHIRNLQIALNLSFNHLHGSLPPEL-GKLDKLVSFDVSNN 457
L L + N +T +P + + +LQ+ L L+ N ++ L + L L + +N
Sbjct: 82 LNSLVLYGNKIT-ELPKSLFEGLFSLQL-LLLNANKIN-CLRVDAFQDLHNLNLLSLYDN 138
Query: 458 QLSGTIPSALKGMLSLIEVNFSNN 481
+L + ++ ++ + N
Sbjct: 139 KLQTIAKGTFSPLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 4e-07
Identities = 25/130 (19%), Positives = 53/130 (40%), Gaps = 8/130 (6%)
Query: 211 LNLHSNQLEGPIPKSIFAS-GKLEVLVLTQNRLTGDIPELV-GHCKSLSNIRIGNNDLVG 268
+ L N ++ IP F+ KL + L+ N+++ ++ +SL+++ + N +
Sbjct: 37 IRLEQNTIKV-IPPGAFSPYKKLRRIDLSNNQIS-ELAPDAFQGLRSLNSLVLYGNKITE 94
Query: 269 VIPRAIGNVSGLTYFEADNNNLSGEIVPE--FSQCSNLTLLNLASNGFTGVIPPELGQLI 326
+ + L + N ++ + F NL LL+L N + L
Sbjct: 95 LPKSLFEGLFSLQLLLLNANKINC--LRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLR 152
Query: 327 NLQELILYEN 336
+Q + L +N
Sbjct: 153 AIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 2e-06
Identities = 28/135 (20%), Positives = 52/135 (38%), Gaps = 11/135 (8%)
Query: 302 SNLTLLNLASNGFTGVIPPELGQLINLQELILYENSLFGEIPKSILAC-KNLNKLDLSNN 360
+T + L N + P L+ + L N + E+ ++LN L L N
Sbjct: 32 ETITEIRLEQNTIKVIPPGAFSPYKKLRRIDLSNNQI-SELAPDAFQGLRSLNSLVLYGN 90
Query: 361 RFNGTIPNAICD-MSRLQYLLLGQNSLKGEIPHEIGNCMKLLQ-LHIGSNYLTGSIPPEI 418
+ +P ++ + + LQ LLL N + + + + L L + N L +I
Sbjct: 91 KIT-ELPKSLFEGLFSLQLLLLNANKIN-CLRVDAFQDLHNLNLLSLYDNKLQ-TIAKGT 147
Query: 419 ----GHIRNLQIALN 429
I+ + +A N
Sbjct: 148 FSPLRAIQTMHLAQN 162
|
| >2v9t_B SLIT homolog 2 protein N-product; structural protein-receptor complex, developmental protein, domain, roundabout, chemotaxis, LRR domain; 1.70A {Homo sapiens} PDB: 2v9s_A Length = 220 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 3e-06
Identities = 24/105 (22%), Positives = 42/105 (40%), Gaps = 6/105 (5%)
Query: 70 LSRLQLRGN-ITLVSE-----LKALKRLDLSNNAFSGTIPSAFGNLSELEFLDLSLNKFG 123
L R+ L N I+ ++ L++L L L N + S F L L+ L L+ NK
Sbjct: 58 LRRIDLSNNQISELAPDAFQGLRSLNSLVLYGNKITELPKSLFEGLFSLQLLLLNANKIN 117
Query: 124 GVIPRELGSLKDLRFFNISNNVLVGEIPDELKSLEKLEDFQVSSN 168
+ L +L ++ +N L L ++ ++ N
Sbjct: 118 CLRVDAFQDLHNLNLLSLYDNKLQTIAKGTFSPLRAIQTMHLAQN 162
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 63.7 bits (155), Expect = 1e-10
Identities = 59/308 (19%), Positives = 107/308 (34%), Gaps = 54/308 (17%)
Query: 616 GTFSTVYKAV-MPSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVI 674
G + V++ +G + ++K + + + + +RE E L KL H N+V+ F I
Sbjct: 20 GATANVFRGRHKKTGDLFAIKVFNN--ISFLRPVDVQMREFEVLKKLNHKNIVK--LFAI 75
Query: 675 YEDVA----LLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAI 730
E+ +L+ + P G+L +L E + L + V G+ L I
Sbjct: 76 EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPES--EFLIVLRDVVGGMNHLRENGI 133
Query: 731 IHLDISSGNVLLD-----------ADFKPLLGEIEISKLLDPSKGTASISAVAGSFGYIP 779
+H +I GN++ DF G ++ L+ + S + G+ Y+
Sbjct: 134 VHRNIKPGNIMRVIGEDGQSVYKLTDF----G---AARELEDDEQFVS---LYGTEEYLH 183
Query: 780 PE-YAYTMQVTAPGNVY-------SYGVVLLEILTTRLPVEEDFGEGVD---LVKWVHGA 828
P+ Y + Y S GV T LP G + + K + G
Sbjct: 184 PDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGK 243
Query: 829 PARGETPEQILDARLSTVSFG---------WRKEMLTALKVALLCTDSTPAKRPKMKKVV 879
P+ + Q + S + +LT + +L D K +
Sbjct: 244 PSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEAD--QEKCWGFDQFF 301
Query: 880 EMLQEIKQ 887
+I
Sbjct: 302 AETSDILH 309
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 62.9 bits (153), Expect = 1e-10
Identities = 59/308 (19%), Positives = 107/308 (34%), Gaps = 54/308 (17%)
Query: 616 GTFSTVYKAV-MPSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVI 674
G + V++ +G + ++K + + + + +RE E L KL H N+V+ F I
Sbjct: 20 GATANVFRGRHKKTGDLFAIKVFNN--ISFLRPVDVQMREFEVLKKLNHKNIVK--LFAI 75
Query: 675 YEDVA----LLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAI 730
E+ +L+ + P G+L +L E + L + V G+ L I
Sbjct: 76 EEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPES--EFLIVLRDVVGGMNHLRENGI 133
Query: 731 IHLDISSGNVLLD-----------ADFKPLLGEIEISKLLDPSKGTASISAVAGSFGYIP 779
+H +I GN++ DF G ++ L+ + S+ G+ Y+
Sbjct: 134 VHRNIKPGNIMRVIGEDGQSVYKLTDF----G---AARELEDDEQFVSL---YGTEEYLH 183
Query: 780 PE-YAYTMQVTAPGNVY-------SYGVVLLEILTTRLPVEEDFGEGVD---LVKWVHGA 828
P+ Y + Y S GV T LP G + + K + G
Sbjct: 184 PDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGK 243
Query: 829 PARGETPEQILDARLSTVSFGWR---------KEMLTALKVALLCTDSTPAKRPKMKKVV 879
P+ + Q + S + +LT + +L D K +
Sbjct: 244 PSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEAD--QEKCWGFDQFF 301
Query: 880 EMLQEIKQ 887
+I
Sbjct: 302 AETSDILH 309
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 63.3 bits (154), Expect = 1e-10
Identities = 58/269 (21%), Positives = 110/269 (40%), Gaps = 24/269 (8%)
Query: 616 GTFSTVYKAV-MPSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIG-FV 673
G V+K PSGL+++ K + + I +Q +IREL+ L + +V G F
Sbjct: 44 GNGGVVFKVSHKPSGLVMARKLIHLEIKPAIRNQ--IIRELQVLHECNSPYIVGFYGAFY 101
Query: 674 IYEDVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVA-IIH 732
++++ + ++ G+L Q+L ++ + P+ ++I V +GL +L I+H
Sbjct: 102 SDGEISICM-EHMDGGSLDQVLKKAGRIPE-----QILGKVSIAVIKGLTYLREKHKIMH 155
Query: 733 LDISSGNVLLDADFKPLLGEIEISKLLD---PSKGTASISA-VAGSFGYIPPEYAYTMQV 788
D+ N+L+++ GEI KL D + S++ G+ Y+ PE
Sbjct: 156 RDVKPSNILVNSR-----GEI---KLCDFGVSGQLIDSMANSFVGTRSYMSPERLQGTHY 207
Query: 789 TAPGNVYSYGVVLLEILTTRLP-VEEDFGEGVDLVKWVHGAPARGETPEQILDARLSTVS 847
+ +++S G+ L+E+ R P D E + A P R
Sbjct: 208 SVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKF 267
Query: 848 FGWRKEMLTALKVALLCTDSTPAKRPKMK 876
+ + ++ + P K P
Sbjct: 268 GMDSRPPMAIFELLDYIVNEPPPKLPSGV 296
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 1e-10
Identities = 65/301 (21%), Positives = 108/301 (35%), Gaps = 64/301 (21%)
Query: 616 GTFSTVYKAV------MPSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRP 669
G F VY+ PS L ++VK L + + + E +SK H N+VR
Sbjct: 41 GAFGEVYEGQVSGMPNDPSPLQVAVKTLP--EVCSEQDELDFLMEALIISKFNHQNIVRC 98
Query: 670 IGFVIYEDVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTR--LSIAIGVAEGLAFLHH 727
IG + +L + G L L E+ +P L +A +A G +L
Sbjct: 99 IGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE 158
Query: 728 VAIIHLDISSGNVLLDADFKPLLGEIEISKLLD--PSKGTASISA-VAGSFGYIP----- 779
IH DI++ N LL G ++K+ D ++ S G +P
Sbjct: 159 NHFIHRDIAARNCLLTCP-----GPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMP 213
Query: 780 PEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQIL 839
PE T+ + +S+GV+L EI + G P ++ +++L
Sbjct: 214 PEAFMEGIFTSKTDTWSFGVLLWEIFS--------LGY----------MPYPSKSNQEVL 255
Query: 840 DARLSTVSFGWRKE------------MLTALKVALLCTDSTPAKRPKMKKVVEMLQEIKQ 887
+ V+ G R + M C P RP ++E ++ Q
Sbjct: 256 EF----VTSGGRMDPPKNCPGPVYRIM-------TQCWQHQPEDRPNFAIILERIEYCTQ 304
Query: 888 N 888
+
Sbjct: 305 D 305
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 62.9 bits (153), Expect = 1e-10
Identities = 58/296 (19%), Positives = 101/296 (34%), Gaps = 52/296 (17%)
Query: 616 GTFSTVYKAV-MPSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLC-HDNLVRPIGFV 673
G F+ VY+A + SG ++KRL S + +I+E+ + KL H N+V+
Sbjct: 39 GGFAFVYEAQDVGSGREYALKRLLSNEE---EKNRAIIQEVCFMKKLSGHPNIVQFCSAA 95
Query: 674 IY-------EDVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLH 726
LL L G L + L + + D T L I + +H
Sbjct: 96 SIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCD--TVLKIFYQTCRAVQHMH 153
Query: 727 H--VAIIHLDISSGNVLLDADFKPLLG--------EIEISKLLDPSKGTASISAVA--GS 774
IIH D+ N+LL L + + +
Sbjct: 154 RQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTT 213
Query: 775 FGYIPPE----YAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPA 830
Y PE Y+ + ++++ G +L + + P E
Sbjct: 214 PMYRTPEIIDLYSNFP-IGEKQDIWALGCILYLLCFRQHPFE------------------ 254
Query: 831 RGETPEQILDARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEMLQEIK 886
+I++ + S + + +L A+L + P +R + +VV LQEI
Sbjct: 255 -DGAKLRIVNGKYSIPPHDTQYTVFHSLIRAMLQVN--PEERLSIAEVVHQLQEIA 307
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 62.2 bits (152), Expect = 1e-10
Identities = 56/300 (18%), Positives = 104/300 (34%), Gaps = 84/300 (28%)
Query: 616 GTFSTVYKAVMPSGLILSVKRLK--SMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFV 673
G F V G ++VK +K + + + E +++L H NLV+ +G +
Sbjct: 32 GEFGDVMLGDY-RGNKVAVKCIKNDATAQ-------AFLAEASVMTQLRHSNLVQLLGVI 83
Query: 674 IYEDVALLL-HNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIH 732
+ E L + Y+ G+L L + L ++ V E + +L +H
Sbjct: 84 VEEKGGLYIVTEYMAKGSLVDYLRSRGRSV---LGGDCLLKFSLDVCEAMEYLEGNNFVH 140
Query: 733 LDISSGNVLLD-------ADFKPLLGEIEISKLLDPSKGTASISAVAGSFGYIP-----P 780
D+++ NVL+ +DF G ++ G +P P
Sbjct: 141 RDLAARNVLVSEDNVAKVSDF-----------------GLTKEASSTQDTGKLPVKWTAP 183
Query: 781 EYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQILD 840
E + + +V+S+G++L EI + FG P + ++
Sbjct: 184 EALREKKFSTKSDVWSFGILLWEIYS--------FGR----------VPYPRIPLKDVVP 225
Query: 841 ARLSTVSFGWRKE------------MLTALKVALLCTDSTPAKRPKMKKVVEMLQEIKQN 888
V G++ + M C A RP ++ E L+ IK +
Sbjct: 226 R----VEKGYKMDAPDGCPPAVYEVMKN-------CWHLDAAMRPSFLQLREQLEHIKTH 274
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 1e-10
Identities = 45/214 (21%), Positives = 91/214 (42%), Gaps = 46/214 (21%)
Query: 616 GTFSTVYKAV--MPSGLILS---VKRLK--SMDRTIIHHQNKMIRELEKLSKLCHDNLVR 668
G F VYK + SG +K LK ++ + + E + + H N++R
Sbjct: 55 GEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTEKQ----RVDFLGEAGIMGQFSHHNIIR 110
Query: 669 PIGFVIYEDVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHV 728
G + +++ Y+ NG L + L ++ D + + G+A G+ +L ++
Sbjct: 111 LEGVISKYKPMMIITEYMENGALDKFL----REKDGEFSVLQLVGMLRGIAAGMKYLANM 166
Query: 729 AIIHLDISSGNVLLD-------ADF---KPLLGEIEI------SKLLDPSKGTASISAVA 772
+H D+++ N+L++ +DF + L + E K+ P + TA +
Sbjct: 167 NYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKI--PIRWTAPEAISY 224
Query: 773 GSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILT 806
F T+ +V+S+G+V+ E++T
Sbjct: 225 RKF-------------TSASDVWSFGIVMWEVMT 245
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 61.5 bits (150), Expect = 2e-10
Identities = 59/217 (27%), Positives = 95/217 (43%), Gaps = 44/217 (20%)
Query: 616 GTFSTVYKAV-MPSGLILSVKRLKSMDRTIIHHQN---KMIRELEKLSKLCHDNLVRPIG 671
G F VY A S IL+ LK + + + ++ RE+E S L H N++R G
Sbjct: 20 GKFGNVYLAREKQSKFILA---LKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYG 76
Query: 672 FV-----IYEDVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLH 726
+ +Y L+ Y P GT+ + L + +K + R T I +A L++ H
Sbjct: 77 YFHDATRVY-----LILEYAPLGTVYRELQKLSKFDEQR----TATYIT-ELANALSYCH 126
Query: 727 HVAIIHLDISSGNVLLDADFKPLLGEIEI-----SKLLDPSKGTASISAVAGSFGYIPPE 781
+IH DI N+LL + GE++I S S+ T G+ Y+PPE
Sbjct: 127 SKRVIHRDIKPENLLLGSA-----GELKIADFGWSVHAPSSRRTDL----CGTLDYLPPE 177
Query: 782 ----YAYTMQVTAPGNVYSYGVVLLEILTTRLPVEED 814
+ +V +++S GV+ E L + P E +
Sbjct: 178 MIEGRMHDEKV----DLWSLGVLCYEFLVGKPPFEAN 210
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 62.2 bits (151), Expect = 3e-10
Identities = 27/135 (20%), Positives = 58/135 (42%), Gaps = 11/135 (8%)
Query: 615 CGTFSTVYKAV-MPSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFV 673
TV A P+G ++V+R+ +++ + EL H N+V
Sbjct: 37 FEDLMTVNLARYKPTGEYVTVRRI-NLEACSNEMVTFLQGELHVSKLFNHPNIVPYRATF 95
Query: 674 IYEDVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAI---GVAEGLAFLHHVAI 730
I ++ ++ +++ G+ L+ + D L+IA GV + L ++HH+
Sbjct: 96 IADNELWVVTSFMAYGSAKDLICT------HFMDGMNELAIAYILQGVLKALDYIHHMGY 149
Query: 731 IHLDISSGNVLLDAD 745
+H + + ++L+ D
Sbjct: 150 VHRSVKASHILISVD 164
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 61.5 bits (150), Expect = 3e-10
Identities = 57/311 (18%), Positives = 102/311 (32%), Gaps = 90/311 (28%)
Query: 616 GTFSTVYKAVMPSGLILS------VKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRP 669
G+F VY+ V + +K + + + + + + E + + ++VR
Sbjct: 36 GSFGMVYEGVAKGVVKDEPETRVAIKTVN--EAASMRERIEFLNEASVMKEFNCHHVVRL 93
Query: 670 IGFVIYEDVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTR-----LSIAIGVAEGLAF 724
+G V L++ + G L L P + +A +A+G+A+
Sbjct: 94 LGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAY 153
Query: 725 LHHVAIIHLDISSGNVLLD-------ADFKPLLG-----------EIEISKLLDPSKGTA 766
L+ +H D+++ N ++ DF G LL P + +
Sbjct: 154 LNANKFVHRDLAARNCMVAEDFTVKIGDF----GMTRDIYETDYYRKGGKGLL-PVRWMS 208
Query: 767 SISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVH 826
S G F T +V+S+GVVL EI T E
Sbjct: 209 PESLKDGVF-------------TTYSDVWSFGVVLWEIAT--------LAE--------- 238
Query: 827 GAPARGETPEQILDARLSTVSFGWRKE------------MLTALKVALLCTDSTPAKRPK 874
P +G + EQ+L V G + M C P RP
Sbjct: 239 -QPYQGLSNEQVLRF----VMEGGLLDKPDNCPDMLFELMRM-------CWQYNPKMRPS 286
Query: 875 MKKVVEMLQEI 885
+++ ++E
Sbjct: 287 FLEIISSIKEE 297
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 4e-10
Identities = 34/145 (23%), Positives = 66/145 (45%), Gaps = 19/145 (13%)
Query: 616 GTFSTVYKAV-MPSGLILSVKRLKSMDRTIIHHQNKM---IRELEKLSKLCHDNLVRPIG 671
G + V A P +++KR+ +++ Q M ++E++ +S+ H N+V
Sbjct: 26 GATAVVQAAYCAPKKEKVAIKRIN-LEKC----QTSMDELLKEIQAMSQCHHPNIVSYYT 80
Query: 672 FVIYEDVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAE---GLAFLHHV 728
+ +D L+ L G++ ++ + +++ +IA + E GL +LH
Sbjct: 81 SFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKN 140
Query: 729 AIIHLDISSGNVLLD-------ADF 746
IH D+ +GN+LL ADF
Sbjct: 141 GQIHRDVKAGNILLGEDGSVQIADF 165
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 59.9 bits (146), Expect = 7e-10
Identities = 47/217 (21%), Positives = 93/217 (42%), Gaps = 41/217 (18%)
Query: 616 GTFSTVYKAV-MPSGLILSVKRLKSMDRTIIHHQN---KMIRELEKLSKLCHDNLVRPIG 671
G+F+ VY+A + +GL ++ +K +D+ ++ ++ E++ +L H +++
Sbjct: 22 GSFAGVYRAESIHTGLEVA---IKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYN 78
Query: 672 FVIY--EDVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVA 729
V L+L NG + + L K + R + + G+ +LH
Sbjct: 79 -YFEDSNYVYLVLE-MCHNGEMNRYLKNRVKP---FSENEARHFMH-QIITGMLYLHSHG 132
Query: 730 IIHLDISSGNVLLDADFKPLLGEIEIS------KLLDPS--KGTASISAVAGSFGYIPPE 781
I+H D++ N+LL + I+I+ +L P T + G+ YI PE
Sbjct: 133 ILHRDLTLSNLLLTRN-----MNIKIADFGLATQLKMPHEKHYT-----LCGTPNYISPE 182
Query: 782 ----YAYTMQVTAPGNVYSYGVVLLEILTTRLPVEED 814
A+ ++ +V+S G + +L R P + D
Sbjct: 183 IATRSAHGLES----DVWSLGCMFYTLLIGRPPFDTD 215
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 1e-09
Identities = 45/172 (26%), Positives = 81/172 (47%), Gaps = 19/172 (11%)
Query: 295 VPEFSQCSNLTLLNLASNGFTGVIPPELGQLINLQELILYENSLFGEIPKSILAC---KN 351
++ +++ + ++ V + L N++ L L N L I A N
Sbjct: 34 AVTQNELNSIDQIIANNSDIKSV--QGIQYLPNVRYLALGGNKL-----HDISALKELTN 86
Query: 352 LNKLDLSNNRFNGTIPNAICD-MSRLQYLLLGQNSLKGEIPHEIGNCMKLLQ-LHIGSNY 409
L L L+ N+ ++PN + D ++ L+ L+L +N L+ +P + + + L L++ N
Sbjct: 87 LTYLILTGNQLQ-SLPNGVFDKLTNLKELVLVENQLQ-SLPDGVFDKLTNLTYLNLAHNQ 144
Query: 410 LTGSIPPEI-GHIRNLQIALNLSFNHLHGSLPPEL-GKLDKLVSFDVSNNQL 459
L S+P + + NL L+LS+N L SLP + KL +L + NQL
Sbjct: 145 LQ-SLPKGVFDKLTNLTE-LDLSYNQLQ-SLPEGVFDKLTQLKDLRLYQNQL 193
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 3e-08
Identities = 47/182 (25%), Positives = 72/182 (39%), Gaps = 40/182 (21%)
Query: 69 DLSRLQLRGN-ITLVS---ELKALKRLDLSNNAFSGTIPSAFGNLSELEFLDLSLNKFGG 124
++ L L GN + +S EL L L L+ N F L+ L+ L L N+
Sbjct: 64 NVRYLALGGNKLHDISALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQLQS 123
Query: 125 VIPRELGSLKDLRFFNISNNVLVGEIPDELKSLEKLEDFQVSSNKLNGSIPFWV-GNLTN 183
+ + D+L +L L ++ N+L S+P V LTN
Sbjct: 124 LPDG---------------------VFDKLTNLTYL---NLAHNQLQ-SLPKGVFDKLTN 158
Query: 184 LRVFTAYENQLVGEIP----DNLGSVSELELLNLHSNQLEGPIPKSIFAS-GKLEVLVLT 238
L NQL +P D L +L+ L L+ NQL+ +P +F L+ + L
Sbjct: 159 LTELDLSYNQL-QSLPEGVFDKLT---QLKDLRLYQNQLKS-VPDGVFDRLTSLQYIWLH 213
Query: 239 QN 240
N
Sbjct: 214 DN 215
|
| >3rfs_A Internalin B, repeat modules, variable lymphocyte B; LRR, protein binding, plasma; 1.70A {Listeria monocytogenes} PDB: 3rfj_A Length = 272 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 3e-07
Identities = 50/197 (25%), Positives = 84/197 (42%), Gaps = 15/197 (7%)
Query: 222 IPKSIFASGKLEVLVLTQNRLTGDIPELVGHCKSLSNIRIGNNDLVGVIPRAIGNVSGLT 281
P FA L + +T D S+ I N+D+ V + I + +
Sbjct: 13 FPDDAFAETI--KANLKKKSVT-DAVTQNE-LNSIDQIIANNSDIKSV--QGIQYLPNVR 66
Query: 282 YFEADNNNLSGEIVPEFSQCSNLTLLNLASNGFTGVIPPELGQLINLQELILYENSLFGE 341
Y N L + + +NLT L L N + +L NL+EL+L EN L
Sbjct: 67 YLALGGNKLHD--ISALKELTNLTYLILTGNQLQSLPNGVFDKLTNLKELVLVENQL-QS 123
Query: 342 IPKSILAC-KNLNKLDLSNNRFNGTIPNAICD-MSRLQYLLLGQNSLKGEIPHEIGNCM- 398
+P + NL L+L++N+ ++P + D ++ L L L N L+ +P + + +
Sbjct: 124 LPDGVFDKLTNLTYLNLAHNQLQ-SLPKGVFDKLTNLTELDLSYNQLQ-SLPEGVFDKLT 181
Query: 399 KLLQLHIGSNYLTGSIP 415
+L L + N L S+P
Sbjct: 182 QLKDLRLYQNQLK-SVP 197
|
| >2p1m_B Transport inhibitor response 1 protein; F-BOX, leucine rich repeat, signaling protein; HET: IHP; 1.80A {Arabidopsis thaliana} PDB: 2p1n_B* 2p1o_B* 2p1p_B* 2p1q_B* 3c6n_B* 3c6o_B* 3c6p_B* Length = 594 | Back alignment and structure |
|---|
Score = 60.7 bits (147), Expect = 1e-09
Identities = 57/399 (14%), Positives = 119/399 (29%), Gaps = 53/399 (13%)
Query: 70 LSRLQLRG--NIT------LVSELKALKRLDLSNNAFSGTIPSAFGNLSE----LEFLDL 117
L L + + + + LK LDL + + + L L++
Sbjct: 132 FKVLVLSSCEGFSTDGLAAIAATCRNLKELDLRESDVDDVSGHWLSHFPDTYTSLVSLNI 191
Query: 118 SLNKFG---GVIPRELGSLKDLRFFNISNNVLVGEIPDELKSLEKLEDFQVSSNKLNGSI 174
S + R + +L+ ++ V + ++ L+ +LE+
Sbjct: 192 SCLASEVSFSALERLVTRCPNLKSLKLNRAVPLEKLATLLQRAPQLEELGTGGYTAEVRP 251
Query: 175 PFWVG------NLTNLRVFTAYENQLVGEIPDNLGSVSELELLNLHSNQLEGPIPKSIFA 228
+ G LR + + + + +P S L LNL ++ +
Sbjct: 252 DVYSGLSVALSGCKELRCLSGFWDAVPAYLPAVYSVCSRLTTLNLSYATVQSYDLVKLLC 311
Query: 229 SG-KLEVLVLTQNRLTGDIPELVGHCKSLSNIRIGNNDLVGVIPRAIGNVSGLTYFEADN 287
KL+ L + + L CK L +R+ ++ + P GL
Sbjct: 312 QCPKLQRLWVLDYIEDAGLEVLASTCKDLRELRVFPSEPFVMEPNVALTEQGLVSV---- 367
Query: 288 NNLSGEIVPEFSQCSNLTLLNLASNGFTGVIPPELGQ-LINLQELILYENSLFGEIPKSI 346
C L + T + + N+ L ++
Sbjct: 368 ----------SMGCPKLESVLYFCRQMTNAALITIARNRPNMTRFRLCIIEPKAPDYLTL 417
Query: 347 L-----------ACKNLNKLDLSNNRFNGTIPNAICDMSRLQYLLLG--QNSLKGEIPHE 393
CK+L +L LS + +++ L + +S G + H
Sbjct: 418 EPLDIGFGAIVEHCKDLRRLSLSGLLTDKVFEYIGTYAKKMEMLSVAFAGDSDLG-MHHV 476
Query: 394 IGNCMKLLQLHI-GSNYLTGSIPPEIGHIRNLQIALNLS 431
+ C L +L I + ++ + ++ L +S
Sbjct: 477 LSGCDSLRKLEIRDCPFGDKALLANASKLETMRS-LWMS 514
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 2e-09
Identities = 44/223 (19%), Positives = 83/223 (37%), Gaps = 45/223 (20%)
Query: 616 GTFSTVYKAV-MPSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVI 674
G F V KA ++K+++ + + + ++ E+ L+ L H +VR +
Sbjct: 17 GAFGQVVKARNALDSRYYAIKKIRHTEEKL----STILSEVMLLASLNHQYVVRYYAAWL 72
Query: 675 YEDVALLLHN-------------YLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEG 721
+ Y NGTL L+H W + + E
Sbjct: 73 ERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYW----RLFRQILEA 128
Query: 722 LAFLHHVAIIHLDISSGNVLLD-------ADF---KPLLGEIEISKLLDPSKGTASISA- 770
L+++H IIH D+ N+ +D DF K + ++I KL + +S +
Sbjct: 129 LSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLT 188
Query: 771 -VAGSFGYIPPEYAYTMQVTAPGN------VYSYGVVLLEILT 806
G+ Y+ E + G+ +YS G++ E++
Sbjct: 189 SAIGTAMYVATE-----VLDGTGHYNEKIDMYSLGIIFFEMIY 226
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 58.2 bits (141), Expect = 2e-09
Identities = 36/141 (25%), Positives = 53/141 (37%), Gaps = 25/141 (17%)
Query: 89 KRLDLSNNAFSGTIPSAFGNLSELEFLDLSLNKFGGVIPRELGSLKDLRFFNISNNVLVG 148
+ L L +N + P F +L L+ L L N+ G + SL L ++ N
Sbjct: 43 QILYLHDNQITKLEPGVFDSLINLKELYLGSNQLGALPVGVFDSLTQLTVLDLGTN---- 98
Query: 149 EIPDELKSLE--------KLEDFQVSSNKLNGSIPFWVGNLTNLRVFTAYENQLVGEIP- 199
+L L L++ + NKL +P + LT+L +NQL IP
Sbjct: 99 ----QLTVLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQL-KSIPH 152
Query: 200 ---DNLGSVSELELLNLHSNQ 217
D L S L L N
Sbjct: 153 GAFDRLSS---LTHAYLFGNP 170
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 2e-06
Identities = 36/142 (25%), Positives = 57/142 (40%), Gaps = 8/142 (5%)
Query: 342 IPKSILACKNLNKLDLSNNRFNGTIPNAICDMSRLQYLLLGQNSLKGEIPHEIGNCMKLL 401
+P I N L L +N+ P + L+ L LG N L +P + + + L
Sbjct: 34 VPAGIPT--NAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQLG-ALPVGVFDSLTQL 90
Query: 402 Q-LHIGSNYLTGSIPPEI-GHIRNLQIALNLSFNHLHGSLPPELGKLDKLVSFDVSNNQL 459
L +G+N LT +P + + +L+ L + N L LP + +L L + NQL
Sbjct: 91 TVLDLGTNQLT-VLPSAVFDRLVHLKE-LFMCCNKLT-ELPRGIERLTHLTHLALDQNQL 147
Query: 460 SGTIPSALKGMLSLIEVNFSNN 481
A + SL N
Sbjct: 148 KSIPHGAFDRLSSLTHAYLFGN 169
|
| >3e6j_A Variable lymphocyte receptor diversity region; variable lymphocyte receptors, VLR, leucine-rich repeat, LRR adaptive immunity, immune system; HET: DR2; 1.67A {Petromyzon marinus} Length = 229 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 3e-05
Identities = 39/116 (33%), Positives = 55/116 (47%), Gaps = 6/116 (5%)
Query: 302 SNLTLLNLASNGFTGVIPPELGQLINLQELILYENSLFGEIPKSIL-ACKNLNKLDLSNN 360
+N +L L N T + P LINL+EL L N L G +P + + L LDL N
Sbjct: 40 TNAQILYLHDNQITKLEPGVFDSLINLKELYLGSNQL-GALPVGVFDSLTQLTVLDLGTN 98
Query: 361 RFNGTIPNAICD-MSRLQYLLLGQNSLKGEIPHEIGNCMKLLQLHIGSNYLTGSIP 415
+ +P+A+ D + L+ L + N L E+P I L L + N L SIP
Sbjct: 99 QLT-VLPSAVFDRLVHLKELFMCCNKLT-ELPRGIERLTHLTHLALDQNQLK-SIP 151
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 58.4 bits (142), Expect = 2e-09
Identities = 60/320 (18%), Positives = 107/320 (33%), Gaps = 97/320 (30%)
Query: 616 GTFSTVYKAVMPSGLILS------VKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRP 669
G F V+ A + VK LK + RE E L+ L H+++V+
Sbjct: 26 GAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLA---ARKDFQREAELLTNLQHEHIVKF 82
Query: 670 IGFVIYEDVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTR-----------LSIAIGV 718
G D +++ Y+ +G L + L D R L IA +
Sbjct: 83 YGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 142
Query: 719 AEGLAFLHHVAIIHLDISSGNVLLD-------ADFKPLLG-----------EIEISKLLD 760
A G+ +L +H D+++ N L+ DF G + +L
Sbjct: 143 ASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDF----GMSRDVYSTDYYRVGGHTML- 197
Query: 761 PSKGTASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVD 820
P + S + F T +V+S+GV+L EI T +G+
Sbjct: 198 PIRWMPPESIMYRKF-------------TTESDVWSFGVILWEIFT--------YGK--- 233
Query: 821 LVKWVHGAPARGETPEQILDARLSTVSFGWRKE------------MLTALKVALLCTDST 868
P + ++++ ++ G E M L C
Sbjct: 234 -------QPWFQLSNTEVIEC----ITQGRVLERPRVCPKEVYDVM-------LGCWQRE 275
Query: 869 PAKRPKMKKVVEMLQEIKQN 888
P +R +K++ ++L + +
Sbjct: 276 PQQRLNIKEIYKILHALGKA 295
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 58.4 bits (142), Expect = 3e-09
Identities = 53/319 (16%), Positives = 106/319 (33%), Gaps = 102/319 (31%)
Query: 616 GTFSTVYKAVMPSGLILS------VKRLK--SMDRTIIHHQNKMIRELEKLSKLCHDNLV 667
F VYK + +K LK + + + E ++L H N+V
Sbjct: 20 DRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKAEGPL----REEFRHEAMLRARLQHPNVV 75
Query: 668 RPIGFVIYEDVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTR-----------LSIAI 716
+G V + ++ +Y +G L + L + D R + +
Sbjct: 76 CLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVA 135
Query: 717 GVAEGLAFLHHVAIIHLDISSGNVLLD-------ADFKPLLG---EIEIS---------K 757
+A G+ +L ++H D+++ NVL+ +D G E+ +
Sbjct: 136 QIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDL----GLFREVYAADYYKLLGNSL 191
Query: 758 LLDPSKGTASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGE 817
L P + A + + G F + +++SYGVVL E+ + +G
Sbjct: 192 L--PIRWMAPEAIMYGKF-------------SIDSDIWSYGVVLWEVFS--------YGL 228
Query: 818 GVDLVKWVHGAPARGETPEQILDARLSTVSFGWRKE------------MLTALKVALLCT 865
P G + + +++ + M + C
Sbjct: 229 ----------QPYCGYSNQDVVEM----IRNRQVLPCPDDCPAWVYALM-------IECW 267
Query: 866 DSTPAKRPKMKKVVEMLQE 884
+ P++RP+ K + L+
Sbjct: 268 NEFPSRRPRFKDIHSRLRA 286
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 3e-09
Identities = 64/325 (19%), Positives = 101/325 (31%), Gaps = 108/325 (33%)
Query: 616 GTFSTVYKAVMPSGLILS------VKRLK--SMDRTIIHHQNKMIRELEKLSKLCHDNLV 667
G F V+ A + L VK LK S + RE E L+ L H ++V
Sbjct: 52 GAFGKVFLAECHNLLPEQDKMLVAVKALKEASES-----ARQDFQREAELLTMLQHQHIV 106
Query: 668 RPIGFVIYEDVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTR----------LSIAIG 717
R G L++ Y+ +G L + L L++A
Sbjct: 107 RFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQ 166
Query: 718 VAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSKGTASISAVAGSFG- 776
VA G+ +L + +H D+++ N L+ + K+ D FG
Sbjct: 167 VAAGMVYLAGLHFVHRDLATRNCLVGQGL--------VVKIGD--------------FGM 204
Query: 777 --YIPPEYAYTMQV--------TAP-----------GNVYSYGVVLLEILTTRLPVEEDF 815
I Y + P +V+S+GVVL EI T +
Sbjct: 205 SRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFT--------Y 256
Query: 816 GEGVDLVKWVHGAPARGETPEQILDARLSTVSFGWRKE------------MLTALKVALL 863
G+ P + + +D ++ G E M
Sbjct: 257 GK----------QPWYQLSNTEAIDC----ITQGRELERPRACPPEVYAIMRG------- 295
Query: 864 CTDSTPAKRPKMKKVVEMLQEIKQN 888
C P +R +K V LQ + Q
Sbjct: 296 CWQREPQQRHSIKDVHARLQALAQA 320
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 4e-09
Identities = 42/217 (19%), Positives = 81/217 (37%), Gaps = 42/217 (19%)
Query: 616 GTFSTVYKAV-MPSGLILSVKRLKSMDRTIIHHQN---KMIRELEKLSKLCHDNLVRPIG 671
G F+ ++ + + + K + ++++ + KM E+ L H ++V G
Sbjct: 52 GGFAKCFEISDADTKEVFA---GKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 108
Query: 672 FVIY--EDVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVA 729
+ V ++L +L +L + R + G +LH
Sbjct: 109 -FFEDNDFVFVVLE-LCRRRSLLELHKRRKALTEPE----AR-YYLRQIVLGCQYLHRNR 161
Query: 730 IIHLDISSGNVLLDADFKPLLGEIEISKLLDPSKGTASISAVAGSF-----G---YIPPE 781
+IH D+ GN+ L+ D E++I G A+ G G YI PE
Sbjct: 162 VIHRDLKLGNLFLNED-----LEVKIGDF-----GLATKVEYDGERKKVLCGTPNYIAPE 211
Query: 782 Y----AYTMQVTAPGNVYSYGVVLLEILTTRLPVEED 814
++ +V +V+S G ++ +L + P E
Sbjct: 212 VLSKKGHSFEV----DVWSIGCIMYTLLVGKPPFETS 244
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 4e-09
Identities = 33/144 (22%), Positives = 61/144 (42%), Gaps = 27/144 (18%)
Query: 616 GTFSTVYKAV-MPSGLILSVKR--LKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGF 672
G TVY A+ + +G +++++ L+ + + +I E+ + + + N+V +
Sbjct: 31 GASGTVYTAMDVATGQEVAIRQMNLQQQPK-----KELIINEILVMRENKNPNIVNYLDS 85
Query: 673 VIYEDVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAI---GVAEGLAFLHHVA 729
+ D ++ YL G+L ++ E+ IA + L FLH
Sbjct: 86 YLVGDELWVVMEYLAGGSLTDVVTETCMDEGQ---------IAAVCRECLQALEFLHSNQ 136
Query: 730 IIHLDISSGNVLLD-------ADF 746
+IH DI S N+LL DF
Sbjct: 137 VIHRDIKSDNILLGMDGSVKLTDF 160
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 58.0 bits (141), Expect = 4e-09
Identities = 42/217 (19%), Positives = 81/217 (37%), Gaps = 42/217 (19%)
Query: 616 GTFSTVYKAV-MPSGLILSVKRLKSMDRTIIHHQN---KMIRELEKLSKLCHDNLVRPIG 671
G F+ ++ + + + K + ++++ + KM E+ L H ++V G
Sbjct: 26 GGFAKCFEISDADTKEVFA---GKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHG 82
Query: 672 FVIY--EDVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVA 729
+ V ++L +L +L + R + G +LH
Sbjct: 83 -FFEDNDFVFVVLE-LCRRRSLLELHKRRKALTEPE----AR-YYLRQIVLGCQYLHRNR 135
Query: 730 IIHLDISSGNVLLDADFKPLLGEIEISKLLDPSKGTASISAVAGSF-----G---YIPPE 781
+IH D+ GN+ L+ D E++I G A+ G G YI PE
Sbjct: 136 VIHRDLKLGNLFLNED-----LEVKIGDF-----GLATKVEYDGERKKVLCGTPNYIAPE 185
Query: 782 ----YAYTMQVTAPGNVYSYGVVLLEILTTRLPVEED 814
++ +V +V+S G ++ +L + P E
Sbjct: 186 VLSKKGHSFEV----DVWSIGCIMYTLLVGKPPFETS 218
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 4e-09
Identities = 42/212 (19%), Positives = 70/212 (33%), Gaps = 45/212 (21%)
Query: 563 QEKASKSADVADSGASSQPSIIAGNVLVENLRQAIDLDAVVKATMKDSNMIYC------- 615
S D+ Q ++ LR +D D ++
Sbjct: 4 HHHHSSGVDLGTENLYFQSGVVTHEQFKAALRMVVDQG--------DPRLLLDSYVKIGE 55
Query: 616 GTFSTVYKAV-MPSGLILSVKRL---KSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIG 671
G+ V A SG ++VK + K R ++ E+ + H N+V
Sbjct: 56 GSTGIVCLAREKHSGRQVAVKMMDLRKQQRRELL------FNEVVIMRDYQHFNVVEMYK 109
Query: 672 FVIYEDVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAE---GLAFLHHV 728
+ + +L +L G L ++ + + IA LA+LH
Sbjct: 110 SYLVGEELWVLMEFLQGGALTDIVSQVRLNEEQ---------IATVCEAVLQALAYLHAQ 160
Query: 729 AIIHLDISSGNVLLDADFKPLLGEIEISKLLD 760
+IH DI S ++LL D G + KL D
Sbjct: 161 GVIHRDIKSDSILLTLD-----GRV---KLSD 184
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 5e-09
Identities = 36/158 (22%), Positives = 63/158 (39%), Gaps = 33/158 (20%)
Query: 616 GTFSTVYKAV-MPSGLILSVK--RLKSMDRTIIHHQNKMIRELEKLSKLC-HDNLVRPIG 671
GT+ VYK + +G + ++K + + I +E+ L K H N+ G
Sbjct: 35 GTYGQVYKGRHVKTGQLAAIKVMDVTGDEEEEI------KQEINMLKKYSHHRNIATYYG 88
Query: 672 FVIYEDVALLLHN------YLPNGTLAQLLHESTKQPDYRPDWPTRLSIAI---GVAEGL 722
I ++ + + G++ L+ + + +W IA + GL
Sbjct: 89 AFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNT-LKEEW-----IAYICREILRGL 142
Query: 723 AFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLD 760
+ LH +IH DI NVLL + E+ KL+D
Sbjct: 143 SHLHQHKVIHRDIKGQNVLLTEN-----AEV---KLVD 172
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 5e-09
Identities = 65/324 (20%), Positives = 115/324 (35%), Gaps = 101/324 (31%)
Query: 616 GTFSTVYKAVMPSGLILS--------VKRLK--SMDRTIIHHQNKMIRELEKLSKL-CHD 664
G F V A VK LK + ++ + ++ E+E + + H
Sbjct: 92 GCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDATEKD----LSDLVSEMEMMKMIGKHK 147
Query: 665 NLVRPIGFVIYEDVALLLHNYLPNGTLAQLL-----------HESTKQPDYRPDWPTRLS 713
N++ +G + ++ Y G L + L ++ + P+ + + +S
Sbjct: 148 NIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVS 207
Query: 714 IAIGVAEGLAFLHHVAIIHLDISSGNVLLD-------ADFKPLLGEIEISKLLDPSKGTA 766
+A G+ +L IH D+++ NVL+ ADF G L ++
Sbjct: 208 CTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADF----G------L---ARDIN 254
Query: 767 SISA-VAGSFGYIP-----PE----YAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFG 816
+I + G +P PE YT Q +V+S+GV++ EI T G
Sbjct: 255 NIDYYKKTTNGRLPVKWMAPEALFDRVYTHQ----SDVWSFGVLMWEIFT--------LG 302
Query: 817 EGVDLVKWVHGAPARGETPEQILDARLSTVSFGWRKE------------MLTALKVALLC 864
G+P G E++ + G R + M C
Sbjct: 303 ----------GSPYPGIPVEELFKL----LKEGHRMDKPANCTNELYMMMRD-------C 341
Query: 865 TDSTPAKRPKMKKVVEMLQEIKQN 888
+ P++RP K++VE L I
Sbjct: 342 WHAVPSQRPTFKQLVEDLDRILTL 365
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 58.2 bits (141), Expect = 6e-09
Identities = 55/327 (16%), Positives = 107/327 (32%), Gaps = 69/327 (21%)
Query: 88 LKRLDLSNNAFSG----TIPSAFGNLSELEFLDLSLNKFGGVIPRELG-------SLKDL 136
++ L +A + ++ + ++ + LS N G R L L+
Sbjct: 6 IEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIA 65
Query: 137 RFFNISNNVLVGEIPDELKSLEKLEDFQVSSNKLNGSIPFWVGNLTNLRVFTAYENQL-- 194
F +I + EIP+ L+ L + + L +R+ +N
Sbjct: 66 EFSDIFTGRVKDEIPEALRLLLQA----LLKCP----------KLHTVRL---SDNAFGP 108
Query: 195 --VGEIPDNLGSVSELELLNLHSNQL-------------EGPIPKSIFASGKLEVLVLTQ 239
+ D L + LE L LH+N L E + K + L ++ +
Sbjct: 109 TAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGR 168
Query: 240 NRLTGD----IPELVGHCKSLSNIRIGNNDL-----VGVIPRAIGNVSGLTYFEADNNNL 290
NRL + + L +++ N + ++ + L + +N
Sbjct: 169 NRLENGSMKEWAKTFQSHRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTF 228
Query: 291 SGE----IVPEFSQCSNLTLLNLASNGFTGV----IPPELGQLIN--LQELILYENSLFG 340
+ + NL L L + + +L N LQ L L N +
Sbjct: 229 THLGSSALAIALKSWPNLRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIEL 288
Query: 341 EIPKSILA-----CKNLNKLDLSNNRF 362
+ +++ +L L+L+ NRF
Sbjct: 289 DAVRTLKTVIDEKMPDLLFLELNGNRF 315
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 1e-08
Identities = 65/380 (17%), Positives = 109/380 (28%), Gaps = 101/380 (26%)
Query: 68 LDLSRLQLRGN-IT------LVSELKA---LKRLDLSNNAFSGT----IPSAFGNLSELE 113
+ L+ + IT + + L +K + LS N + + +LE
Sbjct: 4 FSIEGKSLKLDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLE 63
Query: 114 FLDLSLNKFGGVIPRELGSLKDLRFFNISNNVLVGEIPDELKSLEKLEDFQVSSNKLNGS 173
+ S G V +L+ + L KL ++S N
Sbjct: 64 IAEFSDIFTGRVKDEIPEALR--------------LLLQALLKCPKLHTVRLSDNAF--- 106
Query: 174 IPFWVGNLTNLRVFTAYENQLVGEIPDNLGSVSELELLNLHSNQL-------------EG 220
+ D L + LE L LH+N L E
Sbjct: 107 -----------------GPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQAGAKIARALQEL 149
Query: 221 PIPKSIFASGKLEVLVLTQNRLTGD----IPELVGHCKSLSNIRIGNNDLVGVIPRAIGN 276
+ K + L ++ +NRL + + L +++ N + R G
Sbjct: 150 AVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQNGI-----RPEGI 204
Query: 277 VSGLTYFEADNNNLSGEIVPEFSQCSNLTLLNLASNGFTG----VIPPELGQLINLQELI 332
L + C L +L+L N FT + L NL+EL
Sbjct: 205 EHLLLEG--------------LAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELG 250
Query: 333 LYENSLFGE----IPKSILACKN--LNKLDLSNNRFNGTIPNAICD-----MSRLQYLLL 381
L + L + + +N L L L N + M L +L L
Sbjct: 251 LNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLEL 310
Query: 382 GQNSL--KGEIPHEIGNCMK 399
N + ++ EI
Sbjct: 311 NGNRFSEEDDVVDEIREVFS 330
|
| >2ca6_A RAN GTPase-activating protein 1; GAP, GTPase activation, hemihedral twinning, leucine-rich repeat protein, LRR, merohedral twinning; 2.2A {Schizosaccharomyces pombe} SCOP: c.10.1.2 PDB: 1k5g_C* 1k5d_C 1yrg_A Length = 386 | Back alignment and structure |
|---|
Score = 54.3 bits (131), Expect = 9e-08
Identities = 41/246 (16%), Positives = 83/246 (33%), Gaps = 49/246 (19%)
Query: 287 NNNLSGE----IVPEFSQCSNLTLLNLASNGFTG----VIPPELGQLINLQELILYENS- 337
+ ++ E + + ++ + L+ N + + +L+ +
Sbjct: 13 LDAITTEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFT 72
Query: 338 --LFGEIP-------KSILACKNLNKLDLSNNRFNGTIPNAICDM----SRLQYLLLGQN 384
+ EIP +++L C L+ + LS+N F T + D + L++L L N
Sbjct: 73 GRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNN 132
Query: 385 SL-------------KGEIPHEIGNCMKLLQLHIGSNYLTG----SIPPEIGHIRNLQIA 427
L + + + N L + G N L R L
Sbjct: 133 GLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLH-T 191
Query: 428 LNLSFNHLH-----GSLPPELGKLDKLVSFDVSNNQLSGT----IPSALKGMLSLIEVNF 478
+ + N + L L +L D+ +N + + ALK +L E+
Sbjct: 192 VKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGL 251
Query: 479 SNNLLT 484
++ LL+
Sbjct: 252 NDCLLS 257
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 6e-09
Identities = 38/147 (25%), Positives = 62/147 (42%), Gaps = 31/147 (21%)
Query: 616 GTFSTVYKAV-MPSGLILSVKR--LKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGF 672
G F VYKA +G + + K KS + I E+E L+ H +V+ +G
Sbjct: 30 GAFGKVYKAKNKETGALAAAKVIETKSEEE-----LEDYIVEIEILATCDHPYIVKLLGA 84
Query: 673 VIYEDVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLS---IAI---GVAEGLAFLH 726
++ ++ + P G + ++ E + L+ I + + E L FLH
Sbjct: 85 YYHDGKLWIMIEFCPGGAVDAIMLELDR----------GLTEPQIQVVCRQMLEALNFLH 134
Query: 727 HVAIIHLDISSGNVLLD-------ADF 746
IIH D+ +GNVL+ ADF
Sbjct: 135 SKRIIHRDLKAGNVLMTLEGDIRLADF 161
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 7e-09
Identities = 56/236 (23%), Positives = 88/236 (37%), Gaps = 76/236 (32%)
Query: 616 GTFSTVYKAVMPSGLILS-------VKRLK--SMDRTIIHHQNKMIRELEKLSKL-CHDN 665
G F V +A GL VK LK + + ++ EL+ +S L H+N
Sbjct: 57 GAFGKVVEATAF-GLGKEDAVLKVAVKMLKSTAHADE----KEALMSELKIMSHLGQHEN 111
Query: 666 LVRPIGFVIYEDVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTR---------LSIAI 716
+V +G + L++ Y G L L ++ + P + L +
Sbjct: 112 IVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHFSS 171
Query: 717 GVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSKGTASISAVAGSFG 776
VA+G+AFL IH D+++ NVLL ++K+ D FG
Sbjct: 172 QVAQGMAFLASKNCIHRDVAARNVLLTNGH--------VAKIGD--------------FG 209
Query: 777 ----------YI------------PPE----YAYTMQVTAPGNVYSYGVVLLEILT 806
YI PE YT+Q +V+SYG++L EI +
Sbjct: 210 LARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQ----SDVWSYGILLWEIFS 261
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 8e-09
Identities = 33/144 (22%), Positives = 58/144 (40%), Gaps = 26/144 (18%)
Query: 616 GTFSTVYKAV-MPSGLILSVKR--LKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGF 672
G+F V+K + + ++++K L+ + I + +E+ LS+ + + G
Sbjct: 33 GSFGEVFKGIDNRTQKVVAIKIIDLEEAEDEI----EDIQQEITVLSQCDSPYVTKYYGS 88
Query: 673 VIYEDVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAI---GVAEGLAFLHHVA 729
+ + ++ YL G+ LL IA + +GL +LH
Sbjct: 89 YLKDTKLWIIMEYLGGGSALDLLEPGPLDETQ---------IATILREILKGLDYLHSEK 139
Query: 730 IIHLDISSGNVLLD-------ADF 746
IH DI + NVLL ADF
Sbjct: 140 KIHRDIKAANVLLSEHGEVKLADF 163
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 9e-09
Identities = 68/318 (21%), Positives = 107/318 (33%), Gaps = 97/318 (30%)
Query: 616 GTFSTVYKAVMPSGLILS---VKRLK--SMDRTIIHHQNKMIRELEKLSKL-CHDNLVRP 669
G F V KA + + +KR+K + ELE L KL H N++
Sbjct: 36 GNFGQVLKARIKKDGLRMDAAIKRMKEYASKDD----HRDFAGELEVLCKLGHHPNIINL 91
Query: 670 IGFVIYEDVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTR-----------LSIAIGV 718
+G + L Y P+G L L +S L A V
Sbjct: 92 LGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADV 151
Query: 719 AEGLAFLHHVAIIHLDISSGNVLLD-------ADFKPLLGEIEISKLLDPSKGTASISAV 771
A G+ +L IH D+++ N+L+ ADF G +S+ + V
Sbjct: 152 ARGMDYLSQKQFIHRDLAARNILVGENYVAKIADF----G---LSRGQE--------VYV 196
Query: 772 AGSFGYIP-----PE----YAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLV 822
+ G +P E YT +V+SYGV+L EI++ G
Sbjct: 197 KKTMGRLPVRWMAIESLNYSVYTTN----SDVWSYGVLLWEIVS--------LG------ 238
Query: 823 KWVHGAPARGETPEQILDARLSTVSFGWRKE------------MLTALKVALLCTDSTPA 870
G P G T ++ + + G+R E M C P
Sbjct: 239 ----GTPYCGMTCAELYEK----LPQGYRLEKPLNCDDEVYDLMRQ-------CWREKPY 283
Query: 871 KRPKMKKVVEMLQEIKQN 888
+RP +++ L + +
Sbjct: 284 ERPSFAQILVSLNRMLEE 301
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 9e-09
Identities = 57/224 (25%), Positives = 86/224 (38%), Gaps = 48/224 (21%)
Query: 616 GTFSTVYKAVMPSGLILS-------VKRLKSMDRTIIHHQNKMIRELEKLSKL-CHDNLV 667
G F V +A GLI S VK LK + + ++ EL+ LS L H N+V
Sbjct: 34 GAFGKVVEATAY-GLIKSDAAMTVAVKMLK--PSAHLTEREALMSELKVLSYLGNHMNIV 90
Query: 668 RPIGFVIYEDVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTR-------------LSI 714
+G L++ Y G L L P LS
Sbjct: 91 NLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSF 150
Query: 715 AIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLD--PSKGTASISA-V 771
+ VA+G+AFL IH D+++ N+LL I+K+ D ++ + S V
Sbjct: 151 SYQVAKGMAFLASKNCIHRDLAARNILLTHGR--------ITKICDFGLARDIKNDSNYV 202
Query: 772 AGSFGYIP-----PE----YAYTMQVTAPGNVYSYGVVLLEILT 806
+P PE YT + +V+SYG+ L E+ +
Sbjct: 203 VKGNARLPVKWMAPESIFNCVYTFE----SDVWSYGIFLWELFS 242
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 57.0 bits (138), Expect = 1e-08
Identities = 32/145 (22%), Positives = 65/145 (44%), Gaps = 29/145 (20%)
Query: 616 GTFSTVYKAV-MPSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVI 674
G++ +VYKA+ +G I+++K++ ++I+E+ + + ++V+ G
Sbjct: 40 GSYGSVYKAIHKETGQIVAIKQVPVESDL-----QEIIKEISIMQQCDSPHVVKYYGSYF 94
Query: 675 YEDVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLS---IAI---GVAEGLAFLHHV 728
++ Y G+++ ++ L+ IA +GL +LH +
Sbjct: 95 KNTDLWIVMEYCGAGSVSDIIRLR----------NKTLTEDEIATILQSTLKGLEYLHFM 144
Query: 729 AIIHLDISSGNVLLD-------ADF 746
IH DI +GN+LL+ ADF
Sbjct: 145 RKIHRDIKAGNILLNTEGHAKLADF 169
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 1e-08
Identities = 62/314 (19%), Positives = 112/314 (35%), Gaps = 87/314 (27%)
Query: 616 GTFSTVYKAVMPSGLILS--------VKRLKSMDRTIIHHQNKMIRELEKLSKL-CHDNL 666
G F V A VK LK D + ++ E+E + + H N+
Sbjct: 46 GAFGQVVMAEAVGIDKDKPKEAVTVAVKMLK--DDATEKDLSDLVSEMEMMKMIGKHKNI 103
Query: 667 VRPIGFVIYEDVALLLHNYLPNGTL-----------AQLLHESTKQPDYRPDWPTRLSIA 715
+ +G + ++ Y G L + ++ + P+ + + +S
Sbjct: 104 INLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCT 163
Query: 716 IGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLD--PSKGTASISA-VA 772
+A G+ +L IH D+++ NVL+ + + K+ D ++ +I
Sbjct: 164 YQLARGMEYLASQKCIHRDLAARNVLVTENN--------VMKIADFGLARDINNIDYYKK 215
Query: 773 GSFGYIP-----PE----YAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVK 823
+ G +P PE YT Q +V+S+GV++ EI T G
Sbjct: 216 TTNGRLPVKWMAPEALFDRVYTHQ----SDVWSFGVLMWEIFT--------LG------- 256
Query: 824 WVHGAPARGETPEQILDARLSTVSFGWRKE------------MLTALKVALLCTDSTPAK 871
G+P G E++ + G R + M C + P++
Sbjct: 257 ---GSPYPGIPVEELFKL----LKEGHRMDKPANCTNELYMMMRD-------CWHAVPSQ 302
Query: 872 RPKMKKVVEMLQEI 885
RP K++VE L I
Sbjct: 303 RPTFKQLVEDLDRI 316
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 56.3 bits (135), Expect = 2e-08
Identities = 22/112 (19%), Positives = 36/112 (32%), Gaps = 3/112 (2%)
Query: 301 CSNLTLLNLASNGFTGVIPPELGQLINLQELILYENSLFGEIPKSILA-CKNLNKLDLSN 359
+ L +G L NL EL + + L L L +
Sbjct: 7 PHGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVK 65
Query: 360 NRFNGTIPNAICDMSRLQYLLLGQNSLKGEIPHEIGNCMKLLQLHIGSNYLT 411
+ P+A RL L L N+L+ + + + L +L + N L
Sbjct: 66 SGLRFVAPDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPLH 116
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 54.0 bits (129), Expect = 9e-08
Identities = 26/155 (16%), Positives = 47/155 (30%), Gaps = 13/155 (8%)
Query: 252 HCKSLSNIRIGNNDLVGVIPRAIGNVSGLTYFEADNNNLSGEIVPE-FSQCSNLTLLNLA 310
S +R + + + LT +N + L L +
Sbjct: 6 CPHGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIV 64
Query: 311 SNGFTGVIPPE-LGQLINLQELILYENSLFGEIPKSILACKNLNKLDLSNNRFNGTIPNA 369
+G + P+ L L L N+L + + +L +L LS N +
Sbjct: 65 KSGLR-FVAPDAFHFTPRLSRLNLSFNAL-ESLSWKTVQGLSLQELVLSGNPLH------ 116
Query: 370 ICDMSRLQYLLLGQNSLKGEIPHEIGNCMKLLQLH 404
C L++L + G +P + C L
Sbjct: 117 -CS-CALRWLQRWEEEGLGGVPEQKLQCHGQGPLA 149
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 52.8 bits (126), Expect = 3e-07
Identities = 22/105 (20%), Positives = 41/105 (39%), Gaps = 4/105 (3%)
Query: 236 VLTQNRLTGDIPELVGHCKSLSNIRI-GNNDLVGVIPRAIGNVSGLTYFEADNNNLSGEI 294
+ D + ++L+ + I L + R + + L + L +
Sbjct: 13 LRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FV 71
Query: 295 VPE-FSQCSNLTLLNLASNGFTGVIPPELGQLINLQELILYENSL 338
P+ F L+ LNL+ N + + Q ++LQEL+L N L
Sbjct: 72 APDAFHFTPRLSRLNLSFNALE-SLSWKTVQGLSLQELVLSGNPL 115
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 50.9 bits (121), Expect = 1e-06
Identities = 21/97 (21%), Positives = 34/97 (35%), Gaps = 4/97 (4%)
Query: 149 EIPDELKSLEKLEDFQVSSNKLNGSIPFWV-GNLTNLRVFTAYENQLVGEIPDN-LGSVS 206
+ L E L + + + + + L LR T ++ L + +
Sbjct: 22 DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLR-FVAPDAFHFTP 80
Query: 207 ELELLNLHSNQLEGPIPKSIFASGKLEVLVLTQNRLT 243
L LNL N LE + L+ LVL+ N L
Sbjct: 81 RLSRLNLSFNALES-LSWKTVQGLSLQELVLSGNPLH 116
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 47.0 bits (111), Expect = 2e-05
Identities = 22/111 (19%), Positives = 36/111 (32%), Gaps = 15/111 (13%)
Query: 51 CNWK-GIDC------DLNQAFVVKLDLSRLQLRGNITLVS-------ELKALKRLDLSNN 96
+ G+ C D +L+ L + L L L+ L + +
Sbjct: 7 PHGSSGLRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKS 66
Query: 97 AFSGTIPSAFGNLSELEFLDLSLNKFGGVIPRELGSLKDLRFFNISNNVLV 147
P AF L L+LS N + + + L L+ +S N L
Sbjct: 67 GLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLS-LQELVLSGNPLH 116
|
| >2ifg_A High affinity nerve growth factor receptor; TRK, TRKA, receptor-ligand complex transferase; HET: NAG NDG MAN BMA; 3.40A {Homo sapiens} SCOP: b.1.1.4 b.1.1.4 c.10.2.7 Length = 347 | Back alignment and structure |
|---|
Score = 44.3 bits (104), Expect = 1e-04
Identities = 20/113 (17%), Positives = 28/113 (24%), Gaps = 3/113 (2%)
Query: 397 CMKLLQLHIGSNYLTGSIPPEIGHIRNLQIALNLSFNHLHGSLPPE-LGKLDKLVSFDVS 455
L + + NL L + L L L +L + +
Sbjct: 7 PHGSSGLRCTRDGAL-DSLHHLPGAENLTE-LYIENQQHLQHLELRDLRGLGELRNLTIV 64
Query: 456 NNQLSGTIPSALKGMLSLIEVNFSNNLLTGPVPSFVPFQKSPNSSFFGNKGLC 508
+ L P A L +N S N L V GN C
Sbjct: 65 KSGLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHC 117
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 3e-08
Identities = 50/237 (21%), Positives = 93/237 (39%), Gaps = 46/237 (19%)
Query: 616 GTFSTVYKAV-MPSGLILSVKRLKSMDRTI-IHHQNKMIRELEKLSKLC-HDNLVRPIG- 671
G + V K +PSG I++VKR + T+ Q +++ +L+ + V G
Sbjct: 18 GAYGVVEKMRHVPSGQIMAVKR---IRATVNSQEQKRLLMDLDISMRTVDCPFTVTFYGA 74
Query: 672 FVIYEDVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLS-IAIGVAEGLAFLHHVA- 729
DV + + + + +L + + + P+ L IA+ + + L LH
Sbjct: 75 LFREGDVWICM-ELM-DTSLDKFYKQVIDKGQTIPE--DILGKIAVSIVKALEHLHSKLS 130
Query: 730 IIHLDISSGNVLLD-------ADFKPLLGEIEISKLLDPSKGTASISA--VAGSFGYIPP 780
+IH D+ NVL++ DF G IS L ++ AG Y+ P
Sbjct: 131 VIHRDVKPSNVLINALGQVKMCDF----G---ISGYL-----VDDVAKDIDAGCKPYMAP 178
Query: 781 E--------YAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAP 829
E Y+++ +++S G+ ++E+ R P + L + V
Sbjct: 179 ERINPELNQKGYSVK----SDIWSLGITMIELAILRFPYDSWGTPFQQLKQVVEEPS 231
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 54.9 bits (133), Expect = 3e-08
Identities = 51/215 (23%), Positives = 93/215 (43%), Gaps = 40/215 (18%)
Query: 616 GTFSTVYKAV-MPSGLILSVKRL--KSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGF 672
G F VY A + I+++K L +++ + HQ + RE+E S L H N++R +
Sbjct: 25 GKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLR--REIEIQSHLRHPNILRMYNY 82
Query: 673 V-----IYEDVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHH 727
IY L+ + P G L + L + + + R + + +A+ L + H
Sbjct: 83 FHDRKRIY-----LMLEFAPRGELYKELQKHGRFDEQR----SATFME-ELADALHYCHE 132
Query: 728 VAIIHLDISSGNVLLDADFKPLLGEIEIS----KLLDPSKGTASISAVAGSFGYIPPE-- 781
+IH DI N+L+ GE++I+ + PS ++ G+ Y+PPE
Sbjct: 133 RKVIHRDIKPENLLMGYK-----GELKIADFGWSVHAPSLRRRTM---CGTLDYLPPEMI 184
Query: 782 --YAYTMQVTAPGNVYSYGVVLLEILTTRLPVEED 814
+ +V +++ GV+ E L P +
Sbjct: 185 EGKTHDEKV----DLWCAGVLCYEFLVGMPPFDSP 215
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 4e-08
Identities = 46/216 (21%), Positives = 77/216 (35%), Gaps = 33/216 (15%)
Query: 559 MRERQEKASKSADVADSGASSQPSIIAGNVLVENLRQAIDLDAVVKATMKDSNMIYC--- 615
M D+ + + D D D ++
Sbjct: 1 MSYYHHHHHHDYDIPTTENLYFQGAMDPMPAGGRAGSLKDPDVAELFFKDDPEKLFSDLR 60
Query: 616 ----GTFSTVYKAV-MPSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPI 670
G+F VY A + + ++++K++ + +I+E+ L KL H N ++
Sbjct: 61 EIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYR 120
Query: 671 GFVIYEDVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLS---IAI---GVAEGLAF 724
G + E A L+ Y G+ + LL L IA G +GLA+
Sbjct: 121 GCYLREHTAWLVMEYCL-GSASDLLEVH----------KKPLQEVEIAAVTHGALQGLAY 169
Query: 725 LHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLD 760
LH +IH D+ +GN+LL G + KL D
Sbjct: 170 LHSHNMIHRDVKAGNILLSEP-----GLV---KLGD 197
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 4e-08
Identities = 37/184 (20%), Positives = 72/184 (39%), Gaps = 45/184 (24%)
Query: 51 CNWKGIDCDLNQAFVVK----LDLSRLQLRGN-ITLVS------ELKALKRLDLSNNAFS 99
C +DC + + + L+L N T++ +L L++++ SNN +
Sbjct: 11 CEGTTVDCSNQKLNKIPEHIPQYTAELRLNNNEFTVLEATGIFKKLPQLRKINFSNNKIT 70
Query: 100 GTIPSAFGNLSELEFLDLSLNKFGGVIPRELGSLKDLRFFNISNNVLVGEIPDELKSLEK 159
AF S + + L+ N+ L++++ K LE
Sbjct: 71 DIEEGAFEGASGVNEILLTSNR-----------LENVQ-------------HKMFKGLES 106
Query: 160 LEDFQVSSNKLNGSIPFWV-GNLTNLRVFTAYENQLVGEIP----DNLGSVSELELLNLH 214
L+ + SN++ + L+++R+ + Y+NQ+ + D L S L LNL
Sbjct: 107 LKTLMLRSNRIT-CVGNDSFIGLSSVRLLSLYDNQIT-TVAPGAFDTLHS---LSTLNLL 161
Query: 215 SNQL 218
+N
Sbjct: 162 ANPF 165
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 8e-08
Identities = 33/190 (17%), Positives = 62/190 (32%), Gaps = 40/190 (21%)
Query: 299 SQCS-NLTLLNLASNGFTGV---IPPELGQLINLQELILYENSLFGEIPKSILA-CKNLN 353
+C T ++ ++ + IP EL L N I L
Sbjct: 7 EKCRCEGTTVDCSNQKLNKIPEHIPQ------YTAELRLNNNEFTVLEATGIFKKLPQLR 60
Query: 354 KLDLSNNRFNGTIPNAICDMSRLQYLLLGQNSLKGEIPHEIGNCMKLLQLHIGSNYLTGS 413
K++ SNN+ A S + +LL N L+ +
Sbjct: 61 KINFSNNKITDIEEGAFEGASGVNEILLTSNRLE-------------------------N 95
Query: 414 IPPEI-GHIRNLQIALNLSFNHLHGSLPPEL-GKLDKLVSFDVSNNQLSGTIPSALKGML 471
+ ++ + +L+ L L N + + + L + + +NQ++ P A +
Sbjct: 96 VQHKMFKGLESLKT-LMLRSNRIT-CVGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLH 153
Query: 472 SLIEVNFSNN 481
SL +N N
Sbjct: 154 SLSTLNLLAN 163
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 2e-07
Identities = 25/127 (19%), Positives = 51/127 (40%), Gaps = 7/127 (5%)
Query: 286 DNNNLSG-EIVPEFSQCSNLTLLNLASNGFTGVIPPELGQLINLQELILYENSLFGEIPK 344
+NN + E F + L +N ++N T + + E++L N L +
Sbjct: 40 NNNEFTVLEATGIFKKLPQLRKINFSNNKITDIEEGAFEGASGVNEILLTSNRL-ENVQH 98
Query: 345 SILA-CKNLNKLDLSNNRFNGTIPNAICD-MSRLQYLLLGQNSLKGEIPHEIGNCMKLLQ 402
+ ++L L L +NR + N +S ++ L L N + + + + L
Sbjct: 99 KMFKGLESLKTLMLRSNRIT-CVGNDSFIGLSSVRLLSLYDNQIT-TVAPGAFDTLHSLS 156
Query: 403 -LHIGSN 408
L++ +N
Sbjct: 157 TLNLLAN 163
|
| >2v70_A SLIT-2, SLIT homolog 2 protein N-product; neurogenesis, glycoprotein, secreted, chemotaxis, LRR structural protein, differentiation; HET: NAG; 3.01A {Homo sapiens} Length = 220 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 4e-07
Identities = 32/178 (17%), Positives = 63/178 (35%), Gaps = 51/178 (28%)
Query: 89 KRLDLSNNAFSGTIPSA-FGNLSELEFLDLSLNKFGGVIPRELGSLKDLRFFNISNNVLV 147
L L+NN F+ + F L +L ++ S NK + +++ F
Sbjct: 35 AELRLNNNEFTVLEATGIFKKLPQLRKINFSNNK--------ITDIEEGAF--------- 77
Query: 148 GEIPDELKSLEKLEDFQVSSNKLNGSIPFWVGNLTNLRVFTAYENQLVGEIPDNLGSVSE 207
+ + ++ ++SN+L ++ ++F L
Sbjct: 78 ----EGASGVNEI---LLTSNRLE-NVQ--------HKMF------------KGL---ES 106
Query: 208 LELLNLHSNQLEGPIPKSIFAS-GKLEVLVLTQNRLTGDIPELVGHCKSLSNIRIGNN 264
L+ L L SN++ + F + +L L N++T P SLS + + N
Sbjct: 107 LKTLMLRSNRITC-VGNDSFIGLSSVRLLSLYDNQITTVAPGAFDTLHSLSTLNLLAN 163
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 55.1 bits (133), Expect = 5e-08
Identities = 66/319 (20%), Positives = 112/319 (35%), Gaps = 91/319 (28%)
Query: 616 GTFSTVYKAVMPSGLILS--------VKRLK--SMDRTIIHHQNKMIRELEKLSKL-CHD 664
G F V A VK LK + ++ + +I E+E + + H
Sbjct: 80 GAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATEKD----LSDLISEMEMMKMIGKHK 135
Query: 665 NLVRPIGFVIYEDVALLLHNYLPNGTL-----------AQLLHESTKQPDYRPDWPTRLS 713
N++ +G + ++ Y G L + + + P+ + +S
Sbjct: 136 NIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVS 195
Query: 714 IAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLD--PSKGTASISA- 770
A VA G+ +L IH D+++ NVL+ D + K+ D ++ I
Sbjct: 196 CAYQVARGMEYLASKKCIHRDLAARNVLVTEDN--------VMKIADFGLARDIHHIDYY 247
Query: 771 VAGSFGYIP-----PE----YAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDL 821
+ G +P PE YT Q +V+S+GV+L EI T G
Sbjct: 248 KKTTNGRLPVKWMAPEALFDRIYTHQ----SDVWSFGVLLWEIFT--------LG----- 290
Query: 822 VKWVHGAPARGETPEQILDARLSTVSFGWRKE------------MLTALKVALLCTDSTP 869
G+P G E++ + G R + M C + P
Sbjct: 291 -----GSPYPGVPVEELFKL----LKEGHRMDKPSNCTNELYMMMRD-------CWHAVP 334
Query: 870 AKRPKMKKVVEMLQEIKQN 888
++RP K++VE L I
Sbjct: 335 SQRPTFKQLVEDLDRIVAL 353
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 6e-08
Identities = 50/214 (23%), Positives = 81/214 (37%), Gaps = 37/214 (17%)
Query: 616 GTFSTVYKAV-MPSGLILSVKRLK-SMDRTIIHHQNKMIRELEKLSKLC-HDNLVRPIG- 671
G + +V K V PSG I++VKR++ ++D Q +++ +L+ + + +V+ G
Sbjct: 33 GAYGSVNKMVHKPSGQIMAVKRIRSTVDEKE---QKQLLMDLDVVMRSSDCPYIVQFYGA 89
Query: 672 FVIYEDVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVA-I 730
D + + + + + + D I + + L L I
Sbjct: 90 LFREGDCWICM-ELM-STSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKI 147
Query: 731 IHLDISSGNVLLD-------ADFKPLLGEIEISKLLDPSKGTASISAVAGSFGYIPPEYA 783
IH DI N+LLD DF G IS L S AG Y+ PE
Sbjct: 148 IHRDIKPSNILLDRSGNIKLCDF----G---ISGQLVDSIAKTRD---AGCRPYMAPE-- 195
Query: 784 YTMQVTAPGNVYSY-------GVVLLEILTTRLP 810
+ +A Y G+ L E+ T R P
Sbjct: 196 -RIDPSASRQGYDVRSDVWSLGITLYELATGRFP 228
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 1e-07
Identities = 64/334 (19%), Positives = 109/334 (32%), Gaps = 116/334 (34%)
Query: 616 GTFSTVYKAVMPSGLILS------VKRLK--SMDRTIIHHQNKMIRELEKLSKLCHDNLV 667
G F V++A P L VK LK + Q RE +++ + N+V
Sbjct: 58 GAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASADM----QADFQREAALMAEFDNPNIV 113
Query: 668 RPIG--------FVIYE-----DVALLLHNYL----PNGTLAQLLHESTKQPDYRPDWPT 710
+ +G +++E D L+ +L P+ + + + + P
Sbjct: 114 KLLGVCAVGKPMCLLFEYMAYGD----LNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPP 169
Query: 711 RLS------IAIGVAEGLAFLHHVAIIHLDISSGNVLLD-------ADFKPLLG------ 751
LS IA VA G+A+L +H D+++ N L+ ADF G
Sbjct: 170 PLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADF----GLSRNIY 225
Query: 752 -----EIEISKLLDPSKGTASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILT 806
+ + + + P + S + T +V++YGVVL EI +
Sbjct: 226 SADYYKADGNDAI-PIRWMPPESIFYNRY-------------TTESDVWAYGVVLWEIFS 271
Query: 807 TRLPVEEDFGEGVDLVKWVHGAPARGETPEQILDARLSTVSFGWRKE------------M 854
+G P G E+++ V G M
Sbjct: 272 --------YGL----------QPYYGMAHEEVIYY----VRDGNILACPENCPLELYNLM 309
Query: 855 LTALKVALLCTDSTPAKRPKMKKVVEMLQEIKQN 888
C PA RP + +LQ + +
Sbjct: 310 RL-------CWSKLPADRPSFCSIHRILQRMCER 336
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 53.4 bits (129), Expect = 1e-07
Identities = 62/328 (18%), Positives = 109/328 (33%), Gaps = 104/328 (31%)
Query: 616 GTFSTVYKAVMPSGLILS------VKRLK--SMDRTIIHHQNKMIRELEKLSKLCHDNLV 667
G F V KA + VK LK + ++ E L ++ H +++
Sbjct: 34 GEFGKVVKATAFHLKGRAGYTTVAVKMLKENASPSE----LRDLLSEFNVLKQVNHPHVI 89
Query: 668 RPIG--------FVIYE-----DVALLLHNYL----------PNGTLAQLLHESTKQPDY 704
+ G +I E L +L ++ +
Sbjct: 90 KLYGACSQDGPLLLIVEYAKYGS----LRGFLRESRKVGPGYLGSGGSRNSSSLDHPDER 145
Query: 705 RPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLD--PS 762
+S A +++G+ +L + ++H D+++ N+L+ K+ D S
Sbjct: 146 ALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGR--------KMKISDFGLS 197
Query: 763 KGTASISA-VAGSFGYIP-----PE----YAYTMQVTAPGNVYSYGVVLLEILTTRLPVE 812
+ + V S G IP E + YT Q +V+S+GV+L EI+T
Sbjct: 198 RDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQ----SDVWSFGVLLWEIVT------ 247
Query: 813 EDFGEGVDLVKWVHGAPARGETPEQILDARLSTVSFGWRKE------------MLTALKV 860
G G P G PE++ + + G R E M
Sbjct: 248 --LG----------GNPYPGIPPERLFNL----LKTGHRMERPDNCSEEMYRLM------ 285
Query: 861 ALLCTDSTPAKRPKMKKVVEMLQEIKQN 888
L C P KRP + + L+++
Sbjct: 286 -LQCWKQEPDKRPVFADISKDLEKMMVK 312
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 2e-07
Identities = 45/158 (28%), Positives = 64/158 (40%), Gaps = 36/158 (22%)
Query: 89 KRLDLSNNAFSGTIPSAFGNLSELEFLDLSLNKFGGVIPRELGSLKDLRFFNISNNVLVG 148
LDL N+ F L+ L L L NK L SL G
Sbjct: 31 TYLDLETNSLKSLPNGVFDELTSLTQLYLGGNK--------LQSLP------------NG 70
Query: 149 EIPDELKSLEKLEDFQVSSNKLNGSIPFWV-GNLTNLRVFTAYENQLVGEIP----DNLG 203
+ ++L SL L +S+N+L S+P V LT L+ NQL +P D L
Sbjct: 71 -VFNKLTSLTYL---NLSTNQLQ-SLPNGVFDKLTQLKELALNTNQL-QSLPDGVFDKLT 124
Query: 204 SVSELELLNLHSNQLEGPIPKSIFAS-GKLEVLVLTQN 240
+L+ L L+ NQL+ +P +F L+ + L N
Sbjct: 125 ---QLKDLRLYQNQLKS-VPDGVFDRLTSLQYIWLHDN 158
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 47.7 bits (114), Expect = 3e-06
Identities = 35/129 (27%), Positives = 62/129 (48%), Gaps = 10/129 (7%)
Query: 281 TYFEADNNNLSGEIVPEFSQCSNLTLLNLASNGFTGVIPPELGQLINLQELILYENSLFG 340
TY + + N+L F + ++LT L L N + +L +L L L N L
Sbjct: 31 TYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQSLPNGVFNKLTSLTYLNLSTNQL-Q 89
Query: 341 EIPKSI---LACKNLNKLDLSNNRFNGTIPNAICD-MSRLQYLLLGQNSLKGEIPHEIGN 396
+P + L L +L L+ N+ ++P+ + D +++L+ L L QN LK +P + +
Sbjct: 90 SLPNGVFDKLT--QLKELALNTNQLQ-SLPDGVFDKLTQLKDLRLYQNQLKS-VPDGVFD 145
Query: 397 CMKLLQLHI 405
+ LQ +I
Sbjct: 146 RLTSLQ-YI 153
|
| >2o6s_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 1.50A {Eptatretus burgeri} Length = 208 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 3e-05
Identities = 35/121 (28%), Positives = 55/121 (45%), Gaps = 9/121 (7%)
Query: 342 IPKSILACKNLNKLDLSNNRFNGTIPNAICDMSRLQYLLLGQNSLKGEIPHEIGNCMKLL 401
+P I A LDL N +++ L L LG N L+ +P+ + N + L
Sbjct: 22 VPTGIPA--QTTYLDLETNSLKSLPNGVFDELTSLTQLYLGGNKLQ-SLPNGVFNKLTSL 78
Query: 402 Q-LHIGSNYLTGSIPPEI-GHIRNLQIALNLSFNHLHGSLPPEL-GKLDKLVSFDVSNNQ 458
L++ +N L S+P + + L+ L L+ N L SLP + KL +L + NQ
Sbjct: 79 TYLNLSTNQLQ-SLPNGVFDKLTQLKE-LALNTNQLQ-SLPDGVFDKLTQLKDLRLYQNQ 135
Query: 459 L 459
L
Sbjct: 136 L 136
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 3e-07
Identities = 40/170 (23%), Positives = 65/170 (38%), Gaps = 43/170 (25%)
Query: 718 VAE---GLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEI-----SKLLDPSKGTASIS 769
+ E L +L + IIH D+ N+LLD G + I + +L +
Sbjct: 121 ICELVMALDYLQNQRIIHRDMKPDNILLDEH-----GHVHITDFNIAAMLPRETQITT-- 173
Query: 770 AVAGSFGYIPPEYAYTMQVTAPGNVY-------SYGVVLLEILTTRLPVEEDFGEGVDLV 822
+AG+ Y+ PE M + G Y S GV E+L R P +
Sbjct: 174 -MAGTKPYMAPE----MFSSRKGAGYSFAVDWWSLGVTAYELLRGRRP----Y------- 217
Query: 823 KWVHGAPARGETPEQILDARLSTVSFGWRKEMLTALKVALLCTDSTPAKR 872
+ + + E ++ S W +EM++ LK LL + P +R
Sbjct: 218 -HIRSSTSSKEIVHTFETTVVTYPSA-WSQEMVSLLK-KLLEPN--PDQR 262
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 4e-07
Identities = 46/222 (20%), Positives = 77/222 (34%), Gaps = 45/222 (20%)
Query: 616 GTFSTVYKAV------MPSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKL-CHDNLVR 668
G F V +A + ++VK LK + ++ EL+ L + H N+V
Sbjct: 38 GAFGQVIEADAFGIDKTATCRTVAVKMLK--EGATHSEHRALMSELKILIHIGHHLNVVN 95
Query: 669 PIGFVIYEDVALL----------LHNYL--PNGTLAQLLHESTKQPDYRPDWPTRLSIAI 716
+G L+ L YL + +
Sbjct: 96 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSF 155
Query: 717 GVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLD--PSKGTASISA-VAG 773
VA+G+ FL IH D+++ N+LL + K+ D ++ V
Sbjct: 156 QVAKGMEFLASRKCIHRDLAARNILLSEKN--------VVKICDFGLARDIYKDPDYVRK 207
Query: 774 SFGYIP-----PE----YAYTMQVTAPGNVYSYGVVLLEILT 806
+P PE YT+Q +V+S+GV+L EI +
Sbjct: 208 GDARLPLKWMAPETIFDRVYTIQ----SDVWSFGVLLWEIFS 245
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 8e-07
Identities = 31/135 (22%), Positives = 51/135 (37%), Gaps = 35/135 (25%)
Query: 89 KRLDLSNNAFSGTIPSAFGNLSELEFLDLSLNKFGGVIPRELGSLKDLRFFNISNNVLVG 148
L L N F+ +P N L +DLS N+ + +L SN
Sbjct: 34 TELYLDGNQFT-LVPKELSNYKHLTLIDLSNNR--------ISTL--------SNQSF-- 74
Query: 149 EIPDELKSLEKLEDFQVSSNKLNGSIPFWV-GNLTNLRVFTAYENQLVGEIP----DNLG 203
+ L L +S N+L IP L +LR+ + + N + +P ++L
Sbjct: 75 ---SNMTQLLTLI---LSYNRLR-CIPPRTFDGLKSLRLLSLHGNDI-SVVPEGAFNDLS 126
Query: 204 SVSELELLNLHSNQL 218
+ L L + +N L
Sbjct: 127 A---LSHLAIGANPL 138
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 45.8 bits (109), Expect = 1e-05
Identities = 35/101 (34%), Positives = 51/101 (50%), Gaps = 10/101 (9%)
Query: 69 DLSRLQLRGN-ITLV----SELKALKRLDLSNNAFSGTIPSAFGNLSELEFLDLSLNKFG 123
D++ L L GN TLV S K L +DLSNN S +F N+++L L LS N+
Sbjct: 32 DVTELYLDGNQFTLVPKELSNYKHLTLIDLSNNRISTLSNQSFSNMTQLLTLILSYNRLR 91
Query: 124 GVIPRELGSLKDLRFFNISNNVLVGEIP----DELKSLEKL 160
+ PR LK LR ++ N + +P ++L +L L
Sbjct: 92 CIPPRTFDGLKSLRLLSLHGNDI-SVVPEGAFNDLSALSHL 131
|
| >2wfh_A SLIT homolog 2 protein C-product; developmental protein, neurogenesis, splicing, glycoprotein, leucine-rich repeat, disulfide bond, differentiation; 1.80A {Homo sapiens} Length = 193 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 2e-04
Identities = 28/102 (27%), Positives = 46/102 (45%), Gaps = 7/102 (6%)
Query: 286 DNNNLSGEIVPEFSQCSNLTLLNLASNGFTGVIPPEL-GQLINLQELILYENSLFGEIPK 344
D N + + E S +LTL++L++N + + + + L LIL N L IP
Sbjct: 39 DGNQFT-LVPKELSNYKHLTLIDLSNNRIS-TLSNQSFSNMTQLLTLILSYNRL-RCIPP 95
Query: 345 SILA-CKNLNKLDLSNNRFNGTIPNAICD-MSRLQYLLLGQN 384
K+L L L N + +P + +S L +L +G N
Sbjct: 96 RTFDGLKSLRLLSLHGNDIS-VVPEGAFNDLSALSHLAIGAN 136
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 51.1 bits (123), Expect = 8e-07
Identities = 52/234 (22%), Positives = 87/234 (37%), Gaps = 63/234 (26%)
Query: 616 GTFSTVYKAVMPSGLILS-------VKRLKSMDRTIIHHQNKMIRELEKLSKL-CHDNLV 667
G F V A G+ + VK LK ++ + ++ EL+ +++L H+N+V
Sbjct: 56 GAFGKVMNATAY-GISKTGVSIQVAVKMLK--EKADSSEREALMSELKMMTQLGSHENIV 112
Query: 668 RPIGFVIYEDVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTR---------------- 711
+G L+ Y G L L ++
Sbjct: 113 NLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFE 172
Query: 712 --LSIAIGVAEGLAFLHHVAIIHLDISSGNVLLD-------ADFKPLLGEIEISKLLDPS 762
L A VA+G+ FL + +H D+++ NVL+ DF G L +
Sbjct: 173 DLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDF----G------L---A 219
Query: 763 KGTASISA-VAGSFGYIP-----PE----YAYTMQVTAPGNVYSYGVVLLEILT 806
+ S S V +P PE YT++ +V+SYG++L EI +
Sbjct: 220 RDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIK----SDVWSYGILLWEIFS 269
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 9e-07
Identities = 50/212 (23%), Positives = 83/212 (39%), Gaps = 36/212 (16%)
Query: 616 GTFSTVYKAV-MPSGLILSVKRLKSMDRTIIHHQNKMI-RELEKLSKLC-HDNLVRPIG- 671
GT V+K +G +++VK+ M R+ +NK I +L+ + K +V+ G
Sbjct: 36 GTCGQVWKMRFRKTGHVIAVKQ---MRRSGNKEENKRILMDLDVVLKSHDCPYIVQCFGT 92
Query: 672 FVIYEDVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHV-AI 730
F+ DV + + + P+ + + + + L +L +
Sbjct: 93 FITNTDVFIAM-ELMGTCAEKLKKRMQGPIPE-----RILGKMTVAIVKALYYLKEKHGV 146
Query: 731 IHLDISSGNVLLD-------ADFKPLLGEIEISKLLDPSKGTASISAVAGSFGYIPPEYA 783
IH D+ N+LLD DF G IS L K AG Y+ PE
Sbjct: 147 IHRDVKPSNILLDERGQIKLCDF----G---ISGRLVDDKAKDRS---AGCAAYMAPERI 196
Query: 784 YTMQVTAPG-----NVYSYGVVLLEILTTRLP 810
T P +V+S G+ L+E+ T + P
Sbjct: 197 DPPDPTKPDYDIRADVWSLGISLVELATGQFP 228
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 49.3 bits (118), Expect = 1e-06
Identities = 30/166 (18%), Positives = 59/166 (35%), Gaps = 32/166 (19%)
Query: 321 ELGQLINLQELILY-ENSLFGEIPKSILACKNLNKLDLSNNRFNGTIPNAICDMSRLQYL 379
+ +++ L+ ++ ++ K L LS N I + + M L+ L
Sbjct: 18 KSVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNI-EKISS-LSGMENLRIL 75
Query: 380 LLGQNSLKGEIPHEIGNCMKLLQLHIGSNYLTGSIPPEIGHIRNLQIALNLSFNHLHGSL 439
LG+N +K +I + L +L I N +I + ++
Sbjct: 76 SLGRNLIK-KIENLDAVADTLEELWISYN--------QIASLSGIE-------------- 112
Query: 440 PPELGKLDKLVSFDVSNNQLSG-TIPSALKGMLSLIEVNFSNNLLT 484
KL L +SNN+++ L + L ++ + N L
Sbjct: 113 -----KLVNLRVLYMSNNKITNWGEIDKLAALDKLEDLLLAGNPLY 153
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 47.8 bits (114), Expect = 4e-06
Identities = 35/147 (23%), Positives = 50/147 (34%), Gaps = 8/147 (5%)
Query: 57 DCDLNQAFVVKLDLSRLQLRGNITLVSELKALKRLDLSNNAFSGTIPSAFGNLSELEFLD 116
+A V+L + +S LKA K L LS N I S+ + L L
Sbjct: 19 SVVATEAEKVELHGMIPPIEKMDATLSTLKACKHLALSTNNIE-KI-SSLSGMENLRILS 76
Query: 117 LSLNKFGGVIPRELGSLKDLRFFNISNNVLVGEIPDELKSLEKLEDFQVSSNKLN--GSI 174
L N I L IS N + ++ L L +S+NK+ G I
Sbjct: 77 LGRNLI-KKIENLDAVADTLEELWISYNQI--ASLSGIEKLVNLRVLYMSNNKITNWGEI 133
Query: 175 PFWVGNLTNLRVFTAYENQLVGEIPDN 201
+ L L N L + +N
Sbjct: 134 DK-LAALDKLEDLLLAGNPLYNDYKEN 159
|
| >1ds9_A Outer arm dynein; leucine-rich repeat, beta-BETA-alpha cylinder, flagella, contractIle protein; NMR {Chlamydomonas reinhardtii} SCOP: c.10.3.1 PDB: 1m9l_A Length = 198 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 8e-05
Identities = 35/178 (19%), Positives = 65/178 (36%), Gaps = 54/178 (30%)
Query: 197 EIPDNLGSVSELELLNLHSNQLEGPIPKSIFASG-----KLEVLVLTQNRLTGDIPELVG 251
++ L ++ + L L +N +E I S L +L L +N + I L
Sbjct: 39 KMDATLSTLKACKHLALSTNNIE-----KI--SSLSGMENLRILSLGRNLIK-KIENLDA 90
Query: 252 HCKSLSNIRIGNNDLVGVIPRAIGNVSGLTYFEADNNNLSGEIVPEFSQCSNLTLLNLAS 311
+L + I N I ++SG+ + NL +L +++
Sbjct: 91 VADTLEELWISYN--------QIASLSGI------------------EKLVNLRVLYMSN 124
Query: 312 N---GFTGVIPPELGQLINLQELILYENSLFGEIPKS----------ILACKNLNKLD 356
N + + L L L++L+L N L+ + ++ + NL KLD
Sbjct: 125 NKITNWGEIDK--LAALDKLEDLLLAGNPLYNDYKENNATSEYRIEVVKRLPNLKKLD 180
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 49.8 bits (119), Expect = 2e-06
Identities = 41/252 (16%), Positives = 75/252 (29%), Gaps = 70/252 (27%)
Query: 616 GTFSTVYKAV-MPSGLILSVK--RLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGF 672
G++ V A+ + I ++K + + ++ E+ + KL H N+ R
Sbjct: 37 GSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEV 96
Query: 673 VIYED-------------------------------VALLLHNYLPNGTLAQLLHESTKQ 701
YED ++ + +
Sbjct: 97 --YEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSI 154
Query: 702 PDYRPDWPTRLS------IAIGVAEGLAFLHHVAIIHLDISSGNVLLD---------ADF 746
+R I + L +LH+ I H DI N L DF
Sbjct: 155 HGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDF 214
Query: 747 KPLLGEIEISKLLDPSK--GTASISAVAGSFGYIPPE------YAYTMQVTAPGNVYSYG 798
G +SK ++ AG+ ++ PE +Y + + +S G
Sbjct: 215 ----G---LSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKC----DAWSAG 263
Query: 799 VVLLEILTTRLP 810
V+L +L +P
Sbjct: 264 VLLHLLLMGAVP 275
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 2e-06
Identities = 52/326 (15%), Positives = 111/326 (34%), Gaps = 53/326 (16%)
Query: 208 LELLNLHSNQLEGPIPKSIFA-----SGKLEVLVLTQNRLTGD----IPELVGHCK-SLS 257
+ L+L N L + + L L+ N L + +++ +++
Sbjct: 24 VTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILAAIPANVT 83
Query: 258 NIRIGNNDL----VGVIPRAIGNV-SGLTYFEADNNNLSGEIVPEFSQ-----CSNLTLL 307
++ + N L + + + + +T + N+ S + EF Q +++T L
Sbjct: 84 SLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFSSKSSSEFKQAFSNLPASITSL 143
Query: 308 NLASNGFTGVIPPELGQLI-----NLQELILYENSL-------FGEIPKSILACKNLNKL 355
NL N EL Q++ N+ L L N+L + SI ++ L
Sbjct: 144 NLRGNDLGIKSSDELIQILAAIPANVNSLNLRGNNLASKNCAELAKFLASI--PASVTSL 201
Query: 356 DLSNNRFNGTIPNAICDM-----SRLQYLLLGQNSLKGEIPHEIGNCMK----LLQLHIG 406
DLS N + + + + L L N L G + L +++
Sbjct: 202 DLSANLLGLKSYAELAYIFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLD 261
Query: 407 SNYLTGSIPPE--------IGHIRNLQIALNLSFNHLHGSLPPELGKLDKLVSFDVSNNQ 458
+ + ++ E +I+ + + ++ + +H S + L + +S
Sbjct: 262 YDIV-KNMSKEQCKALGAAFPNIQKIIL-VDKNGKEIHPSHSIPISNLIRELSGKADVPS 319
Query: 459 LSGTIPSALKGMLSLIEVNFSNNLLT 484
L + + IE + L
Sbjct: 320 LLNQCLIFAQKHQTNIEDLNIPDELR 345
|
| >3goz_A Leucine-rich repeat-containing protein; LEGL7, NESG, LGR148, structural genomics, PSI-2, protein structure initiative; 2.10A {Legionella pneumophila subsp} Length = 362 | Back alignment and structure |
|---|
Score = 45.1 bits (107), Expect = 7e-05
Identities = 61/393 (15%), Positives = 115/393 (29%), Gaps = 93/393 (23%)
Query: 81 LVSELKALKRLDLSNNAFSGTIPSAFG-----NLSELEFLDLSLNKFGGVIPRELGSL-- 133
S + LDLS N + + L+LS N G EL +
Sbjct: 17 FTSIPHGVTSLDLSLNNLYSISTVELIQAFANTPASVTSLNLSGNSLGFKNSDELVQILA 76
Query: 134 ---KDLRFFNISNNVL----VGEIPDELKSL-EKLEDFQVSSNKLNGSIPFWVGNLTNLR 185
++ N+S N L E+ L ++ + + N +
Sbjct: 77 AIPANVTSLNLSGNFLSYKSSDELVKTLAAIPFTITVLDLGWNDFS-------------- 122
Query: 186 VFTAYENQLVGEIPDNLGSV-SELELLNLHSNQLEGPIPKSIFASG------KLEVLVLT 238
++ E ++ + + LNL N L G + L L
Sbjct: 123 ------SKSSSEFKQAFSNLPASITSLNLRGNDL-GIKSSDELIQILAAIPANVNSLNLR 175
Query: 239 QNRLTGDIPELVGHCKSLSNIRIGNNDLVGVIPRAIGNVSGLTYFEADNNNLSGEIVPEF 298
N L +C L+ + +T + N L + E
Sbjct: 176 GNNLASK------NCAELAKFLASIP-------------ASVTSLDLSANLLGLKSYAEL 216
Query: 299 SQC-----SNLTLLNLASNGFTGVIPPELGQLI----NLQELILYENSLFGEIPKSILA- 348
+ +++ LNL N G L L +LQ + L + + + A
Sbjct: 217 AYIFSSIPNHVVSLNLCLNCLHGPSLENLKLLKDSLKHLQTVYLDYDIVKNMSKEQCKAL 276
Query: 349 ------CKNLNKLDLSNNRFNGTIPNAICDMSRLQYLLLGQNSLKGEIPHEIGNCMKLLQ 402
+ + +D + + + I ++ + + S K ++P + C+ Q
Sbjct: 277 GAAFPNIQKIILVDKNGKEIHPSHSIPISNL-------IRELSGKADVPSLLNQCLIFAQ 329
Query: 403 LHIGSNYLTGSIPPEIGHIRNLQIALNLSFNHL 435
H +N +IP E+ + L
Sbjct: 330 KHQ-TNIEDLNIPDELRE-------SIQTCKPL 354
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 47.4 bits (113), Expect = 3e-06
Identities = 25/97 (25%), Positives = 42/97 (43%), Gaps = 7/97 (7%)
Query: 68 LDLSRLQLRGNITLVSELKALKRLDLSNNAFSGTIPSAFGNLSELEFLDLSLNKFGGVIP 127
LD + L +E L+ L L N ++ S L +L+ L+LS N+ G +
Sbjct: 31 LDNCKSNDGKIEGLTAEFVNLEFLSLINVGLI-SV-SNLPKLPKLKKLELSENRIFGGLD 88
Query: 128 RELGSLKDLRFFNISNNVLVGEIPDELKSLEKLEDFQ 164
L +L N+S N L ++ +LE L+ +
Sbjct: 89 MLAEKLPNLTHLNLSGNKL-----KDISTLEPLKKLE 120
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 45.9 bits (109), Expect = 9e-06
Identities = 27/100 (27%), Positives = 44/100 (44%), Gaps = 5/100 (5%)
Query: 287 NNNLSGEIVPEFSQCSNLTLLNLASNGFTGVIPPELGQLINLQELILYENSLFGEIPKSI 346
+ G+I ++ NL L+L + G V L +L L++L L EN +FG +
Sbjct: 34 CKSNDGKIEGLTAEFVNLEFLSLINVGLISVSN--LPKLPKLKKLELSENRIFGGLDMLA 91
Query: 347 LACKNLNKLDLSNNRFN--GTIPNAICDMSRLQYLLLGQN 384
NL L+LS N+ T+ + + L+ L L
Sbjct: 92 EKLPNLTHLNLSGNKLKDISTL-EPLKKLECLKSLDLFNC 130
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 43.6 bits (103), Expect = 5e-05
Identities = 26/111 (23%), Positives = 45/111 (40%), Gaps = 12/111 (10%)
Query: 67 KLDLSRLQLRGNITLVSELKALKRLDLSNNAFSGTIPSAFGNLSELEFLDLSLNK---FG 123
L L + L +++ + +L LK+L+LS N G + L L L+LS NK
Sbjct: 53 FLSLINVGLI-SVSNLPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLKDIS 111
Query: 124 GVIPRELGSLKDLRFFNISNNVLVGE------IPDELKSLEKLEDFQVSSN 168
+ P L L+ L+ ++ N + + L L L+ +
Sbjct: 112 TLEP--LKKLECLKSLDLFNCEVTNLNDYRESVFKLLPQLTYLDGYDREDQ 160
|
| >2ell_A Acidic leucine-rich nuclear phosphoprotein 32 FAM B; phapi2 protein, silver-stainable protein SSP29, acidic prote in leucines, structural genomics; NMR {Homo sapiens} PDB: 2rr6_A 2jqd_A Length = 168 | Back alignment and structure |
|---|
Score = 40.1 bits (94), Expect = 8e-04
Identities = 27/105 (25%), Positives = 39/105 (37%), Gaps = 6/105 (5%)
Query: 71 SRLQLRGNITLV---SELKALKRLDLSNNAFS-GTIPSAFGNLSELEFLDLSLNKFGGVI 126
S + ++ I L A++ L L N + G I LEFL L V
Sbjct: 6 SGMDMKRRIHLELRNRTPAAVRELVLDNCKSNDGKIEGLTAEFVNLEFLSLINVGLISVS 65
Query: 127 PRELGSLKDLRFFNISNNVLVGEIPDELKSLEKLEDFQVSSNKLN 171
L L L+ +S N + G + + L L +S NKL
Sbjct: 66 N--LPKLPKLKKLELSENRIFGGLDMLAEKLPNLTHLNLSGNKLK 108
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 3e-06
Identities = 57/288 (19%), Positives = 101/288 (35%), Gaps = 70/288 (24%)
Query: 616 GTFSTVYKAVM-PSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVI 674
G+F V +G +VK + + ++RE++ L +L H N+++ F
Sbjct: 37 GSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEF-- 94
Query: 675 YED---VALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLS------IAIGVAEGLAFL 725
+ED L+ G L + R S I V G+ ++
Sbjct: 95 FEDKGYFYLVG-EVYTGGELFDEIISRK-----------RFSEVDAARIIRQVLSGITYM 142
Query: 726 HHVAIIHLDISSGNVLLD----------ADFKPLLGEIEISKLLDPSKGTASISAVAGSF 775
H I+H D+ N+LL+ DF G +S + SK + G+
Sbjct: 143 HKNKIVHRDLKPENLLLESKSKDANIRIIDF----G---LSTHFEASK---KMKDKIGTA 192
Query: 776 GYIPPE---YAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARG 832
YI PE Y + +V+S GV+L +L+ P F
Sbjct: 193 YYIAPEVLHGTYDEKC----DVWSTGVILYILLSGCPP----F-----------NGANEY 233
Query: 833 ETPEQILDARLSTVSFGWRKEMLTA--LKVALLCTDSTPAKRPKMKKV 878
+ +++ + + W+K +A L +L P+ R +
Sbjct: 234 DILKKVEKGKYTFELPQWKKVSESAKDLIRKMLTYV--PSMRISARDA 279
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 4e-06
Identities = 47/219 (21%), Positives = 80/219 (36%), Gaps = 45/219 (20%)
Query: 616 GTFSTVYKAV-MPSGLILSVK-----RLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRP 669
G V A + ++++ + + E+E L KL H +++
Sbjct: 146 GACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKI 205
Query: 670 IGFVIYEDVALLLHNYLPNGTL------AQLLHESTKQPDYRPDWPTRLSIAIGVAEGLA 723
F ED ++L + G L + L E+T +L + +
Sbjct: 206 KNFFDAEDYYIVL-ELMEGGELFDKVVGNKRLKEAT----------CKL-YFYQMLLAVQ 253
Query: 724 FLHHVAIIHLDISSGNVLLDADFKPLLGEIEI-----SKLLDPSKGTASISAVAGSFGYI 778
+LH IIH D+ NVLL + + L I+I SK+L + + G+ Y+
Sbjct: 254 YLHENGIIHRDLKPENVLLSSQEEDCL--IKITDFGHSKILGETSLM---RTLCGTPTYL 308
Query: 779 PPE-------YAYTMQVTAPGNVYSYGVVLLEILTTRLP 810
PE Y V + +S GV+L L+ P
Sbjct: 309 APEVLVSVGTAGYNRAV----DCWSLGVILFICLSGYPP 343
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 5e-06
Identities = 53/286 (18%), Positives = 100/286 (34%), Gaps = 67/286 (23%)
Query: 616 GTFSTVYKAVM-PSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVI 674
G + V + + ++K ++ +K++ E+ L L H N+++ F
Sbjct: 48 GAYGEVLLCRDKVTHVERAIKIIRK-TSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDF-- 104
Query: 675 YED---VALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAII 731
+ED L++ G L + K + I V G+ +LH I+
Sbjct: 105 FEDKRNYYLVM-ECYKGGELFDEIIHRMKFNEVDA-----AVIIKQVLSGVTYLHKHNIV 158
Query: 732 HLDISSGNVLLD----------ADFKPLLGEIEISKLLDPSKGTASISAVAGSFGYIPPE 781
H D+ N+LL+ DF G +S + + K + G+ YI PE
Sbjct: 159 HRDLKPENLLLESKEKDALIKIVDF----G---LSAVFENQK---KMKERLGTAYYIAPE 208
Query: 782 ---YAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQI 838
Y + +V+S GV+L +L P G E ++
Sbjct: 209 VLRKKYDEKC----DVWSIGVILFILLAGYPPF---------------GGQTDQEILRKV 249
Query: 839 LDARLSTVSFGWR------KEMLTALKVALLCTDSTPAKRPKMKKV 878
+ + S W+ K+++ +L D +R ++
Sbjct: 250 EKGKYTFDSPEWKNVSEGAKDLIK----QMLQFD--SQRRISAQQA 289
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 46.2 bits (110), Expect = 6e-06
Identities = 23/93 (24%), Positives = 42/93 (45%), Gaps = 10/93 (10%)
Query: 287 NNNLSGEIVPEFSQCSNLTLLNLASNGFTGVIPPELGQLINLQELILYENSLFGEIPKSI 346
+ + G++ + L L+ + G T + L +L L++L L +N + G +
Sbjct: 27 SRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELSDNRVSGGLEVLA 84
Query: 347 LACKNLNKLDLSNNRFNGTIPNAICDMSRLQYL 379
C NL L+LS N+ I D+S ++ L
Sbjct: 85 EKCPNLTHLNLSGNK--------IKDLSTIEPL 109
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 2e-05
Identities = 22/79 (27%), Positives = 37/79 (46%), Gaps = 2/79 (2%)
Query: 67 KLDLSRLQLRGNITLVSELKALKRLDLSNNAFSGTIPSAFGNLSELEFLDLSLNKFGGV- 125
L + L +I + +L LK+L+LS+N SG + L L+LS NK +
Sbjct: 46 FLSTINVGLT-SIANLPKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLS 104
Query: 126 IPRELGSLKDLRFFNISNN 144
L L++L+ ++ N
Sbjct: 105 TIEPLKKLENLKSLDLFNC 123
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 42.7 bits (101), Expect = 7e-05
Identities = 26/133 (19%), Positives = 46/133 (34%), Gaps = 30/133 (22%)
Query: 231 KLEVLVLTQNRLT-GDIPELVGHCKSLSNIRIGNNDLVGVIPRAIGNVSGLTYFEADNNN 289
++ LVL +R G + L + L + N + +++ L
Sbjct: 18 DVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVG--------LTSIANL--------- 60
Query: 290 LSGEIVPEFSQCSNLTLLNLASNGFTGVIPPELGQLINLQELILYENSL--FGEIPKSIL 347
+ + L L L+ N +G + + NL L L N + I + +
Sbjct: 61 ---------PKLNKLKKLELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTI-EPLK 110
Query: 348 ACKNLNKLDLSNN 360
+NL LDL N
Sbjct: 111 KLENLKSLDLFNC 123
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 2e-04
Identities = 23/112 (20%), Positives = 45/112 (40%), Gaps = 8/112 (7%)
Query: 327 NLQELILYENSL-FGEIPKSILACKNLNKLDLSNNRFNGTIPNAICDMSRLQYLLLGQNS 385
+++EL+L + G++ + L L N +I N + +++L+ L L N
Sbjct: 18 DVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-SIAN-LPKLNKLKKLELSDNR 75
Query: 386 LKGEIPHEIGNCMKLLQLHIGSNYLTGSIPPEIGHIRNLQIALNLSFNHLHG 437
+ G + C L L++ N + ++ I L+ NL L
Sbjct: 76 VSGGLEVLAEKCPNLTHLNLSGNKIK-----DLSTIEPLKKLENLKSLDLFN 122
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 2e-04
Identities = 28/136 (20%), Positives = 47/136 (34%), Gaps = 29/136 (21%)
Query: 348 ACKNLNKLDLSNNRFN-GTIPNAICDMSRLQYLLLGQNSLKGEIPHEIGNCMKLLQLHIG 406
++ +L L N+R N G + + L++L L I N KL +L
Sbjct: 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLT-----SIANLPKLNKLKK- 68
Query: 407 SNYLTGSIPPEIGHIRNLQIALNLSFNHLHGSLPPELGKLDKLVSFDVSNNQLSG-TIPS 465
L LS N + G L K L ++S N++ +
Sbjct: 69 ---------------------LELSDNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIE 107
Query: 466 ALKGMLSLIEVNFSNN 481
LK + +L ++ N
Sbjct: 108 PLKKLENLKSLDLFNC 123
|
| >2je0_A Acidic leucine-rich nuclear phosphoprotein 32 FAM member A; nuclear protein; 2.40A {Homo sapiens} PDB: 2je1_A Length = 149 | Back alignment and structure |
|---|
Score = 40.0 bits (94), Expect = 8e-04
Identities = 24/111 (21%), Positives = 40/111 (36%), Gaps = 4/111 (3%)
Query: 84 ELKALKRLDLSNNAFS-GTIPSAFGNLSELEFLDLSLNKFGGVIPRELGSLKDLRFFNIS 142
+K L L N+ + G + ELEFL + L L L+ +S
Sbjct: 15 TPSDVKELVLDNSRSNEGKLEGLTDEFEELEFLSTINVGLTSI--ANLPKLNKLKKLELS 72
Query: 143 NNVLVGEIPDELKSLEKLEDFQVSSNKLNG-SIPFWVGNLTNLRVFTAYEN 192
+N + G + + L +S NK+ S + L NL+ +
Sbjct: 73 DNRVSGGLEVLAEKCPNLTHLNLSGNKIKDLSTIEPLKKLENLKSLDLFNC 123
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 47.8 bits (114), Expect = 1e-05
Identities = 38/138 (27%), Positives = 68/138 (49%), Gaps = 18/138 (13%)
Query: 616 GTFSTVYKAV-MPSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVI 674
G+F VY+A SG ++++K+ ++ + REL+ + KL H N+VR + +
Sbjct: 65 GSFGVVYQAKLCDSGELVAIKK-------VLQDKRFKNRELQIMRKLDHCNIVR-LRYFF 116
Query: 675 Y------EDVAL-LLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHH 727
Y ++V L L+ +Y+P T+ ++ ++ P +L + LA++H
Sbjct: 117 YSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKL-YMYQLFRSLAYIHS 174
Query: 728 VAIIHLDISSGNVLLDAD 745
I H DI N+LLD D
Sbjct: 175 FGICHRDIKPQNLLLDPD 192
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 47.3 bits (111), Expect = 2e-05
Identities = 22/185 (11%), Positives = 64/185 (34%), Gaps = 19/185 (10%)
Query: 100 GTIPSAFGNLSELEFLDLSLNKFGGVIPRELGSLKDLRFFN--ISNNVLVGEIPDELKSL 157
+ + L L + + + +LK L + + ++V+ + +L +L
Sbjct: 162 VDLSPVLDAMPLLNNLKIKGTNNLSIGKKPRPNLKSLEIISGGLPDSVVEDILGSDLPNL 221
Query: 158 EKLEDFQVSSNKLNGSIP------FWVGNLTNLRVFTAYENQLVGEIPDNLGS---VSEL 208
EKL + + F NL+ + + + + + +L
Sbjct: 222 EKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQL 281
Query: 209 ELLNLHSNQLEGPIPKSIFASGK----LEVLVLTQNRLTGD----IPELVGHCKSLSNIR 260
E +++ + L + + L+ + + N L+ + + + + +S+ +
Sbjct: 282 ETMDISAGVLTDEGARLLLDHVDKIKHLKFINMKYNYLSDEMKKELQKSLPMKIDVSDSQ 341
Query: 261 IGNND 265
++D
Sbjct: 342 EYDDD 346
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 46.9 bits (110), Expect = 2e-05
Identities = 28/194 (14%), Positives = 64/194 (32%), Gaps = 37/194 (19%)
Query: 58 CDLNQAFVVKLDLSRLQLRGNITL---VSELKALKRLDLSNNAFSGTIPSAFG--NLSEL 112
DL+ L+ L+++G L LK L++ + ++ +L L
Sbjct: 162 VDLSPVLDAMPLLNNLKIKGTNNLSIGKKPRPNLKSLEIISGGLPDSVVEDILGSDLPNL 221
Query: 113 EFLDLSL---NKFGGVIPREL------GSLKDLRFFNISNNVLVGEIPDEL---KSLEKL 160
E L L + + +L++ I + + + L +L
Sbjct: 222 EKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDILPQL 281
Query: 161 EDFQVSSNKLNGSIPFWVGNLTNLRVFTAYENQLVGEIPDNLGSVSELELLNLHSNQLEG 220
E +S+ L ++ + D++ + L+ +N+ N L
Sbjct: 282 ETMDISAGVLT--------------------DEGARLLLDHVDKIKHLKFINMKYNYLSD 321
Query: 221 PIPKSIFASGKLEV 234
+ K + S +++
Sbjct: 322 EMKKELQKSLPMKI 335
|
| >2ra8_A Uncharacterized protein Q64V53_bacfr; WGR domain, LRR domain, leucine rich repeats, BFR43, structural genomics, PSI-2; 1.95A {Bacteroides fragilis} Length = 362 | Back alignment and structure |
|---|
Score = 43.4 bits (101), Expect = 2e-04
Identities = 29/195 (14%), Positives = 53/195 (27%), Gaps = 40/195 (20%)
Query: 292 GEIVPEFSQCSNLTLLNLASNGFTGVIPPELGQLINLQELILYENSLFGEIPKSILACK- 350
++ P L L + + NL+ L + L + + IL
Sbjct: 162 VDLSPVLDAMPLLNNLKIKGTNNLSIGKK---PRPNLKSLEIISGGLPDSVVEDILGSDL 218
Query: 351 -NLNKLDLSNNRFNGTIPNAICDMS---------RLQYLLLGQNSLKGEIPHEIGNCMKL 400
NL KL L + + L++L + + + L
Sbjct: 219 PNLEKLVLYVGVEDYGFDGDMNVFRPLFSKDRFPNLKWLGIVDAEEQNVVVEMFLESDIL 278
Query: 401 LQLHIGSNYLTGSIPPEIGHIRNLQIALNLSFNHLHGS----LPPELGKLDKLVSFDVSN 456
QL +++S L L + K+ L ++
Sbjct: 279 PQLET----------------------MDISAGVLTDEGARLLLDHVDKIKHLKFINMKY 316
Query: 457 NQLSGTIPSALKGML 471
N LS + L+ L
Sbjct: 317 NYLSDEMKKELQKSL 331
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 47.5 bits (112), Expect = 2e-05
Identities = 65/508 (12%), Positives = 143/508 (28%), Gaps = 135/508 (26%)
Query: 341 EIPKSILACKNLNKLDLSNNRFNGTIPNAICDMSRLQYLLLGQNSLKGEIPHEIGNCMKL 400
++PKSIL+ + ++ + +S + +GT L K E ++
Sbjct: 40 DMPKSILSKEEIDHIIMSKDAVSGT------------LRLFWTLLSKQE---------EM 78
Query: 401 LQLHIGS----NY--LTGSIPPEIGHIRNLQIALNLSF-----NHLHGSLPPELGKLDKL 449
+Q + NY L I Q ++ + L+
Sbjct: 79 VQKFVEEVLRINYKFLMSPI-----KTEQRQPSMMTRMYIEQRDRLYNDNQV-------F 126
Query: 450 VSFDVSNNQLSGTIPSALK-----------GMLSLIEVNFSNNLLTGPVPSFVPFQ-KSP 497
++VS Q + AL G+L + V Q K
Sbjct: 127 AKYNVSRLQPYLKLRQALLELRPAKNVLIDGVLG-----SGKTWVALDVCLSYKVQCKMD 181
Query: 498 NSSFFGNKGLCGEP-----------LSFSCGNANGPD-SKNYRHRV-------------- 531
F+ N C P + D S N + R+
Sbjct: 182 FKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAELRRLLKSK 241
Query: 532 SYR---IILAVVGSG--LAVF-ISVTVVVLLFMMRERQEKASKSADVADSGASSQPSIIA 585
Y ++L V + F +S +++ ++ V D +++ + I+
Sbjct: 242 PYENCLLVLLNVQNAKAWNAFNLSCKILLT-----------TRFKQVTDFLSAATTTHIS 290
Query: 586 GNVLVENLRQAIDLDAVVKATMKDSNMIYCGTFSTVYKAVMPSGLILSV--KRLKSMDRT 643
+ L ++K + P LS+ + ++ T
Sbjct: 291 LDHHSMTLTPDEVKSLLLKYL----DCR-PQDLPREVLTTNP--RRLSIIAESIRDGLAT 343
Query: 644 IIHHQNKMIRELEKLSKLCHDNL----VRPIGFVIYEDVALLLHN-YLPNGTLAQLLHES 698
+ ++ +L + + + L R +++ +++ + ++P L+ + +
Sbjct: 344 WDNWKHVNCDKLTTIIESSLNVLEPAEYRK----MFDRLSVFPPSAHIPTILLSLIWFDV 399
Query: 699 TKQ--PDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEIS 756
K + E + I+L++ A + ++ I
Sbjct: 400 IKSDVMVVVNKLHKYSLVEKQPKESTISIPS---IYLELKVKLENEYALHRSIVDHYNIP 456
Query: 757 KLLDPSKGTASISAVAGSFGYIPPEYAY 784
K D Y Y++
Sbjct: 457 KTFDSDDLIPPY-----LDQYF---YSH 476
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 44.8 bits (105), Expect = 1e-04
Identities = 73/448 (16%), Positives = 146/448 (32%), Gaps = 99/448 (22%)
Query: 53 WKGIDCDLNQAFVVKLDLSRLQ--LRGNITLVSELKALKRLDLSNNAFSGTIPSAFGNLS 110
+K I AFV D +Q + ++ + + + +S +A SGT
Sbjct: 18 YKDILSVFEDAFVDNFDCKDVQDMPKSILSK----EEIDHIIMSKDAVSGT--------- 64
Query: 111 ELEFLDLSLNKFGGVIPRELGSL--KDLRFFNISNNVLVGEIPDELKSLEKLEDFQVSS- 167
L L+K ++ + + + + +F L+ I E + + +
Sbjct: 65 -LRLFWTLLSKQEEMVQKFVEEVLRINYKF-------LMSPIKTEQRQPSMMTRMYIEQR 116
Query: 168 NKL-NGSIPFWVGNLTNLRVFTAYENQLVGEIPDN-------LG---SVSELELLNLHSN 216
++L N + F N++ L+ + L+ P LG + + L S
Sbjct: 117 DRLYNDNQVFAKYNVSRLQPYLKLRQALLELRPAKNVLIDGVLGSGKTW--VALDVCLSY 174
Query: 217 QLEGPIPKSIF--ASGKL---EVLVLTQNRLTGDI-PELVGHCKSLSNIRIGNNDLVGVI 270
+++ + IF E ++ +L I P SNI++ + + +
Sbjct: 175 KVQCKMDFKIFWLNLKNCNSPETVLEMLQKLLYQIDPNWTSRSDHSSNIKLRIHSIQAEL 234
Query: 271 PRAIGNVSGLTYFEA----DNNNLSGEIVPEFS-QCSNLTLLNLASNGFTGVIPPELGQL 325
R + + Y N + + F+ C LL T +
Sbjct: 235 RRLLKSKP---YENCLLVLLNVQ-NAKAWNAFNLSCK--ILLTTRFKQVTDFLSAATTTH 288
Query: 326 INLQELILYENSLFGEIPKSILA-CKNLNKLDLSNNRFNGTIPNAICDMSRLQYLLLGQN 384
I+L +L + KS+L + DL P + + + ++ +
Sbjct: 289 ISLDHH---SMTLTPDEVKSLLLKYLDCRPQDL---------PREVLTTNPRRLSIIAE- 335
Query: 385 SLKGEIPHEIGNCMKLLQLHIGSNYLTGSIPPEIGHIRNLQIALNLSFNHLHGSLPPELG 444
S++ + N H+ + L + S N L P E
Sbjct: 336 SIR-DGLATWDN-----WKHVNCD--------------KLTTIIESSLNVLE---PAEYR 372
Query: 445 KL-DKLVSFDVSNNQLSGTIPSALKGML 471
K+ D+L F S + IP+ L ++
Sbjct: 373 KMFDRLSVFPPSAH-----IPTILLSLI 395
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 46.1 bits (110), Expect = 3e-05
Identities = 39/187 (20%), Positives = 70/187 (37%), Gaps = 47/187 (25%)
Query: 616 GTFSTVYKAV-MPSGLILSVKRLKSMDR-------TIIHHQNKMIRELEKLSKLCHDNLV 667
GT+ VYKA+ + +++KR++ ++ T IRE+ L +L H N++
Sbjct: 45 GTYGEVYKAIDTVTNETVAIKRIR-LEHEEEGVPGT-------AIREVSLLKELQHRNII 96
Query: 668 RPIGFVIYEDVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRL--SIAIGVAEGLAFL 725
+ + L+ Y N L + + D PD R+ S + G+ F
Sbjct: 97 ELKSVIHHNHRLHLIFEYAEN-DLKKYM-------DKNPDVSMRVIKSFLYQLINGVNFC 148
Query: 726 HHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSKGTASISAVAGSFG----YIPPE 781
H +H D+ N+LL + K+ D FG + P
Sbjct: 149 HSRRCLHRDLKPQNLLLSVSDASETPVL---KIGD--------------FGLARAFGIPI 191
Query: 782 YAYTMQV 788
+T ++
Sbjct: 192 RQFTHEI 198
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 43.8 bits (104), Expect = 5e-05
Identities = 39/134 (29%), Positives = 53/134 (39%), Gaps = 34/134 (25%)
Query: 89 KRLDLSNNAFSGTIPSAFGNLSELEFLDLSLNKFGGVIPRELGSLKDLRFFNISNNVLVG 148
RL+L +N F L++L L LS N+ + SL D F
Sbjct: 31 TRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQ--------IQSLPDGVF---------- 72
Query: 149 EIPDELKSLEKLEDFQVSSNKLNGSIPFWV-GNLTNLRVFTAYENQLVGEIP----DNLG 203
D+L L L + NKL S+P V LT L+ NQL +P D L
Sbjct: 73 ---DKLTKLTIL---YLHENKLQ-SLPNGVFDKLTQLKELALDTNQLKS-VPDGIFDRLT 124
Query: 204 SVSELELLNLHSNQ 217
S L+ + LH+N
Sbjct: 125 S---LQKIWLHTNP 135
|
| >2o6r_A Variable lymphocyte receptor B; leucine-rich repeat protein, LRR, immune system; 2.30A {Eptatretus burgeri} Length = 177 | Back alignment and structure |
|---|
Score = 41.5 bits (98), Expect = 4e-04
Identities = 30/106 (28%), Positives = 49/106 (46%), Gaps = 6/106 (5%)
Query: 302 SNLTLLNLASNGFTGVIPPELGQLINLQELILYENSLFGEIPKSIL-ACKNLNKLDLSNN 360
S+ T L L SN + +L L +L L +N + +P + L L L N
Sbjct: 28 SSATRLELESNKLQSLPHGVFDKLTQLTKLSLSQNQI-QSLPDGVFDKLTKLTILYLHEN 86
Query: 361 RFNGTIPNAICD-MSRLQYLLLGQNSLKGEIPHEIGNCMKLLQLHI 405
+ ++PN + D +++L+ L L N LK +P I + + LQ I
Sbjct: 87 KLQ-SLPNGVFDKLTQLKELALDTNQLKS-VPDGIFDRLTSLQ-KI 129
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 43.5 bits (103), Expect = 7e-05
Identities = 25/109 (22%), Positives = 42/109 (38%), Gaps = 14/109 (12%)
Query: 68 LDLSRLQLRGNITLVSELKALKRLDLSNNAFSGTIPSAFGNLSELEFLDLSLNK---FGG 124
+D S ++R + L+ LK L ++NN L +L L L+ N G
Sbjct: 47 IDFSDNEIR-KLDGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGD 105
Query: 125 VIPRELGSLKDLRFFNISNNVLVGEIPD-------ELKSLEKLEDFQVS 166
+ P L SLK L + I N + ++ + L+ +V
Sbjct: 106 LDP--LASLKSLTYLCILRNPVT-NKKHYRLYVIYKVPQVRVLDFQKVK 151
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 2e-04
Identities = 20/118 (16%), Positives = 41/118 (34%), Gaps = 8/118 (6%)
Query: 320 PELGQLINLQELILYENSLFGEIPKSILACKNLNKLDLSNNRFNGTIPNAICDMSRLQYL 379
+ + +EL L + I + +D S+N + + RL+ L
Sbjct: 13 AQYTNAVRDRELDLRGYKI-PVIENLGATLDQFDAIDFSDNEIR-KLDG-FPLLRRLKTL 69
Query: 380 LLGQNSLKGEIPHEIGNCMKLLQLHIGSNYLTGSIPPEIGHIRNLQIALNLSFNHLHG 437
L+ N + L +L + +N L E+G + L +L++ +
Sbjct: 70 LVNNNRICRIGEGLDQALPDLTELILTNNSLV-----ELGDLDPLASLKSLTYLCILR 122
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 40.8 bits (96), Expect = 5e-04
Identities = 17/100 (17%), Positives = 35/100 (35%), Gaps = 5/100 (5%)
Query: 287 NNNLSGEIVPEFSQCSNLTLLNLASNGFTGVIPPELGQLINLQELILYENSLFGEIPKSI 346
I + ++ + N + L L+ L++ N +
Sbjct: 27 RGYKIPVIENLGATLDQFDAIDFSDNEIRKLDG--FPLLRRLKTLLVNNNRICRIGEGLD 84
Query: 347 LACKNLNKLDLSNNRFN--GTIPNAICDMSRLQYLLLGQN 384
A +L +L L+NN G + + + + L YL + +N
Sbjct: 85 QALPDLTELILTNNSLVELGDL-DPLASLKSLTYLCILRN 123
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 40.4 bits (95), Expect = 8e-04
Identities = 20/104 (19%), Positives = 35/104 (33%), Gaps = 10/104 (9%)
Query: 289 NLSGEIV---PEFSQCSNLTLLNLASNGFTGVIPPELGQLINLQELILYENSL--FGEIP 343
L+ E++ +++ L+L VI L + +N + P
Sbjct: 3 KLTAELIEQAAQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKLDGFP 61
Query: 344 KSILACKNLNKLDLSNNRFNGTIPNAICDMSRLQYLLLGQNSLK 387
+ L L ++NNR + L L+L NSL
Sbjct: 62 L----LRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLV 101
|
| >1a9n_A U2A', U2A'; complex (nuclear protein/RNA), RNA, snRNP, ribonucleoprotein, RNA binding protein/RNA complex; 2.38A {Homo sapiens} SCOP: c.10.2.4 Length = 176 | Back alignment and structure |
|---|
Score = 40.0 bits (94), Expect = 9e-04
Identities = 18/126 (14%), Positives = 43/126 (34%), Gaps = 5/126 (3%)
Query: 191 ENQLVGEIPDNLGSVSELELLNLHSNQLEGPIPKSIFASGKLEVLVLTQNRLTGDIPELV 250
+L+ + + L+L ++ I + + + + N + + +
Sbjct: 5 TAELIEQAA-QYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIR-KL-DGF 60
Query: 251 GHCKSLSNIRIGNNDLVGVIPRAIGNVSGLTYFEADNNNLSG-EIVPEFSQCSNLTLLNL 309
+ L + + NN + + + LT NN+L + + +LT L +
Sbjct: 61 PLLRRLKTLLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCI 120
Query: 310 ASNGFT 315
N T
Sbjct: 121 LRNPVT 126
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 1e-04
Identities = 36/191 (18%), Positives = 69/191 (36%), Gaps = 57/191 (29%)
Query: 616 GTFSTVYKAV-MPSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVI 674
G F V++ V +G + K ++ + + E+ +++L H L+
Sbjct: 62 GAFGVVHRCVEKATGRVFVAK---FINTPYPLDKYTVKNEISIMNQLHHPKLINLHD--A 116
Query: 675 YED---VALLLHNYLPNGTL-------AQLLHES-----TKQPDYRPDWPTRLSIAIGVA 719
+ED + L+L +L G L + E+ +Q
Sbjct: 117 FEDKYEMVLIL-EFLSGGELFDRIAAEDYKMSEAEVINYMRQ----------------AC 159
Query: 720 EGLAFLHHVAIIHLDISSGNVLLD---------ADFKPLLGEIEISKLLDPSKGTASISA 770
EGL +H +I+HLDI N++ + DF G ++ L+P + +
Sbjct: 160 EGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDF----G---LATKLNPDE---IVKV 209
Query: 771 VAGSFGYIPPE 781
+ + PE
Sbjct: 210 TTATAEFAAPE 220
|
| >3ogk_B Coronatine-insensitive protein 1; leucine rich repeat, ubiquitin ligase, SCF, protein binding; HET: OGK; 2.80A {Arabidopsis thaliana} PDB: 3ogl_B* 3ogm_B* Length = 592 | Back alignment and structure |
|---|
Score = 44.9 bits (106), Expect = 1e-04
Identities = 48/347 (13%), Positives = 102/347 (29%), Gaps = 36/347 (10%)
Query: 68 LDLSRLQLRGNITLVSELKALKRLDLSNNAFSGTIPSAFGNLSELEFLDLSLNKF--GGV 125
+ + ++ + L+ + +P + NL L +
Sbjct: 225 VKVGDFEILELVGFFKAAANLEEFCGGSLNEDIGMPEKYMNLVFPRKLCRLGLSYMGPNE 284
Query: 126 IPRELGSLKDLRFFNISNNVLVGEIPDEL-KSLEKLEDFQVSSNKLNGSIPFWVGNLTNL 184
+P +R ++ +L E L + LE + + + + L
Sbjct: 285 MPILFPFAAQIRKLDLLYALLETEDHCTLIQKCPNLEVLETRNVIGDRGLEVLAQYCKQL 344
Query: 185 RVFTAYENQLVGEIPDNLGSVSELELLNLHSNQLEGPIPKSIFASGKLEVLVLTQNRLTG 244
+ + D G VS+ L+ L +LE + + + +T
Sbjct: 345 KRLRIERGADEQGMEDEEGLVSQRGLIALAQG------------CQELEYMAVYVSDITN 392
Query: 245 D-IPELVGHCKSLSNIRIGNNDLVGVIPRAIGNVSGLTYFEADNNNLSGEIVPEFSQCSN 303
+ + + + K+L + R+ + +T DN + C
Sbjct: 393 ESLESIGTYLKNLCDFRLVL----------LDREERITDLPLDN-----GVRSLLIGCKK 437
Query: 304 LTLLNLASN--GFTGVIPPELGQL-INLQELILYENSLFGEIPKSILA-CKNLNKLDLSN 359
L G T + +GQ N++ ++L E C NL KL++
Sbjct: 438 LRRFAFYLRQGGLTDLGLSYIGQYSPNVRWMLLGYVGESDEGLMEFSRGCPNLQKLEMRG 497
Query: 360 NRF-NGTIPNAICDMSRLQYLLLGQNSLKGEIPHEIGNCMKLLQLHI 405
F I A+ + L+YL + + + +
Sbjct: 498 CCFSERAIAAAVTKLPSLRYLWVQGYRASMTGQDLMQMARPYWNIEL 544
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 1e-04
Identities = 42/297 (14%), Positives = 95/297 (31%), Gaps = 48/297 (16%)
Query: 616 GTFSTVYKA----------VMPSGLILSVKRLKSMDRTIIHHQN---KMIRELEKLSKLC 662
G F+ + L+ + + I ++ EL+ ++ +
Sbjct: 42 GKFNKIILCEKDNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIK 101
Query: 663 HDNLVRPIGFVIYEDVAL-LLHNYLPNGTLAQLLHES---TKQPDYRPDWPTRLSIAIGV 718
++ + G +I + +++ Y+ N ++ + K I V
Sbjct: 102 NEYCLTCEG-IITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSV 160
Query: 719 AEGLAFLH-HVAIIHLDISSGNVLLDADFKPLLGEIEI-----SKLLDPSKGTASISAVA 772
+++H I H D+ N+L+D + G +++ S+ + K I
Sbjct: 161 LNSFSYIHNEKNICHRDVKPSNILMDKN-----GRVKLSDFGESEYMVDKK----IKGSR 211
Query: 773 GSFGYIPPE------YAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVH 826
G++ ++PPE +V +++S G+ L + +P
Sbjct: 212 GTYEFMPPEFFSNESSYNGAKV----DIWSLGICLYVMFYNVVPFSLKISLVELFNNIRT 267
Query: 827 GA---PARGETPEQILDARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVE 880
P L + ST S + L + PA+R + ++
Sbjct: 268 KNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKN--PAERITSEDALK 322
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 44.4 bits (105), Expect = 1e-04
Identities = 30/149 (20%), Positives = 63/149 (42%), Gaps = 16/149 (10%)
Query: 616 GTFSTVYKAV---MPSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIG- 671
GT+ VYKA ++K+++ ++ RE+ L +L H N++
Sbjct: 32 GTYGHVYKAKRKDGKDDKDYALKQIEGTGISM-----SACREIALLRELKHPNVISLQKV 86
Query: 672 FVIYEDVAL-LLHNYLPNGTLAQLLHESTKQPDYRPDWP----TRLSIAIGVAEGLAFLH 726
F+ + D + LL +Y + L ++ + S+ + +G+ +LH
Sbjct: 87 FLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLH 145
Query: 727 HVAIIHLDISSGNVLLDADFKPLLGEIEI 755
++H D+ N+L+ + P G ++I
Sbjct: 146 ANWVLHRDLKPANILVMGE-GPERGRVKI 173
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 1e-04
Identities = 56/297 (18%), Positives = 100/297 (33%), Gaps = 89/297 (29%)
Query: 616 GTFSTVYKAVM-PSGLILSVK-----RLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRP 669
G+F V K + +VK K+ D + ++RE+E L KL H N+++
Sbjct: 33 GSFGEVLKCKDRITQQEYAVKVINKASAKNKDT------STILREVELLKKLDHPNIMKL 86
Query: 670 IGFVIYEDVALLLH---NYLPNGTLAQLLHESTKQPDYRPDWPTRLS------IAIGVAE 720
ED + + G L + + R S I V
Sbjct: 87 FEI--LED-SSSFYIVGELYTGGELFDEIIKRK-----------RFSEHDAARIIKQVFS 132
Query: 721 GLAFLHHVAIIHLDISSGNVLLD----------ADFKPLLGEIEISKLLDPSKGTASISA 770
G+ ++H I+H D+ N+LL+ DF G +S + +
Sbjct: 133 GITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDF----G---LSTCFQQNT---KMKD 182
Query: 771 VAGSFGYIPPE---YAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHG 827
G+ YI PE Y + +V+S GV+L +L+ P F
Sbjct: 183 RIGTAYYIAPEVLRGTYDEKC----DVWSAGVILYILLSGTPP----F-----------Y 223
Query: 828 APARGETPEQILDARLSTVSFGWR------KEMLTALKVALLCTDSTPAKRPKMKKV 878
+ +++ + + WR K+++ +L P+ R +
Sbjct: 224 GKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIR----KMLTFH--PSLRITATQC 274
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 44.3 bits (105), Expect = 1e-04
Identities = 52/305 (17%), Positives = 96/305 (31%), Gaps = 94/305 (30%)
Query: 616 GTFSTVYKAVM-PSGLILSVKRLK----------SMDRTIIHHQNKMIRELEKLSKLCHD 664
G + V ++K +K ++ I ++ E+ L L H
Sbjct: 47 GAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHP 106
Query: 665 NLVRPIGFVIYEDVALLLHNYL-----PNGTLAQLLHESTKQPDYRPDWPTRLS------ 713
N+++ +ED + YL G L + + +
Sbjct: 107 NIIKLFDV--FEDK---KYFYLVTEFYEGGELFEQIINRH-----------KFDECDAAN 150
Query: 714 IAIGVAEGLAFLHHVAIIHLDISSGNVLLD----------ADFKPLLGEIEISKLLDPSK 763
I + G+ +LH I+H DI N+LL+ DF G +S
Sbjct: 151 IMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDF----G---LSSFFSKDY 203
Query: 764 GTASISAVAGSFGYIPPE---YAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDF-GEGV 819
+ G+ YI PE Y + +V+S GV++ +L P F G+
Sbjct: 204 ---KLRDRLGTAYYIAPEVLKKKYNEKC----DVWSCGVIMYILLCGYPP----FGGQND 252
Query: 820 DLVKWVHGAPARGETPEQILDARLSTVSFGWR------KEMLTALKVALLCTDSTPAKRP 873
+ +++ + W+ KE++ +L D KR
Sbjct: 253 Q------------DIIKKVEKGKYYFDFNDWKNISDEAKELIK----LMLTYD--YNKRC 294
Query: 874 KMKKV 878
++
Sbjct: 295 TAEEA 299
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 43.6 bits (103), Expect = 2e-04
Identities = 34/134 (25%), Positives = 57/134 (42%), Gaps = 15/134 (11%)
Query: 616 GTFSTVYKAV-MPSGLILSVKRLKSMDRTIIHHQNKM-IRELEKLSKLCHD---NLVRPI 670
G+F V KA +++K +++ R H Q IR LE L K D N++ +
Sbjct: 108 GSFGQVVKAYDHKVHQHVALKMVRNEKR--FHRQAAEEIRILEHLRKQDKDNTMNVIHML 165
Query: 671 GFVIYEDVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRL--SIAIGVAEGLAFLHHV 728
+ + H + L+ L+E K+ ++ + L A + + L LH
Sbjct: 166 ENFTFRN-----HICMTFELLSMNLYELIKKNKFQG-FSLPLVRKFAHSILQCLDALHKN 219
Query: 729 AIIHLDISSGNVLL 742
IIH D+ N+LL
Sbjct: 220 RIIHCDLKPENILL 233
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 43.0 bits (102), Expect = 3e-04
Identities = 38/203 (18%), Positives = 77/203 (37%), Gaps = 37/203 (18%)
Query: 616 GTFSTVYKAVM-PSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVI 674
G F V+ SGL +K + ++ E+E L L H N+++ +
Sbjct: 33 GAFGDVHLVEERSSGLERVIKTINK--DRSQVPMEQIEAEIEVLKSLDHPNIIKIFE--V 88
Query: 675 YED---VALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAII 731
+ED + +++ G L + + + + + + + LA+ H ++
Sbjct: 89 FEDYHNMYIVM-ETCEGGELLERIVSAQARGKALSEGYVA-ELMKQMMNALAYFHSQHVV 146
Query: 732 HLDISSGNVLLD----------ADFKPLLGEIEISKLLDPSKGTASISAVAGSFGYIPPE 781
H D+ N+L DF G +++L + + AG+ Y+ PE
Sbjct: 147 HKDLKPENILFQDTSPHSPIKIIDF----G---LAELFKSDE---HSTNAAGTALYMAPE 196
Query: 782 ---YAYTMQVTAPGNVYSYGVVL 801
T + +++S GVV+
Sbjct: 197 VFKRDVTFKC----DIWSAGVVM 215
|
| >3g39_A Variable lymphocyte receptor VLRB.2D; antibody, X-RAY, crystallography, immune system; 1.55A {Petromyzon marinus} PDB: 3g3a_A 3g3b_A 3twi_D Length = 170 | Back alignment and structure |
|---|
Score = 41.4 bits (98), Expect = 3e-04
Identities = 34/109 (31%), Positives = 49/109 (44%), Gaps = 8/109 (7%)
Query: 299 SQCS-NLTLLNLASNGFTGVIPPELGQLINLQELILYENSLFGEIPKSILACKNLNKLDL 357
SQCS + T ++ + V P G Q L LY+N + P L +LDL
Sbjct: 5 SQCSCSGTTVDCSGKSLASV-PT--GIPTTTQVLYLYDNQITKLEPGVFDRLTQLTRLDL 61
Query: 358 SNNRFNGTIPNAICD-MSRLQYLLLGQNSLKGEIPHEIGNCMKLLQLHI 405
NN+ +P + D +++L L L N LK IP + +K L HI
Sbjct: 62 DNNQLT-VLPAGVFDKLTQLTQLSLNDNQLKS-IPRGAFDNLKSLT-HI 107
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 43.3 bits (102), Expect = 3e-04
Identities = 35/191 (18%), Positives = 66/191 (34%), Gaps = 57/191 (29%)
Query: 616 GTFSTVYKAV-MPSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVI 674
G F V++ +G + K + + + +E++ +S L H LV
Sbjct: 168 GAFGVVHRVTERATGNNFAAK---FVMTPHESDKETVRKEIQTMSVLRHPTLVNLHD--A 222
Query: 675 YED---VALLLHNYLPNGTL-------AQLLHES-----TKQPDYRPDWPTRLSIAIGVA 719
+ED + ++ ++ G L + E +Q V
Sbjct: 223 FEDDNEMVMIY-EFMSGGELFEKVADEHNKMSEDEAVEYMRQ----------------VC 265
Query: 720 EGLAFLHHVAIIHLDISSGNVLLD---------ADFKPLLGEIEISKLLDPSKGTASISA 770
+GL +H +HLD+ N++ DF G ++ LDP + S+
Sbjct: 266 KGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDF----G---LTAHLDPKQ---SVKV 315
Query: 771 VAGSFGYIPPE 781
G+ + PE
Sbjct: 316 TTGTAEFAAPE 326
|
| >2r9u_A Variable lymphocyte receptor; adaptive immunity, VLR, leucine-rich repeat, LRR, system; 2.10A {Petromyzon marinus} Length = 174 | Back alignment and structure |
|---|
Score = 41.1 bits (97), Expect = 4e-04
Identities = 34/112 (30%), Positives = 49/112 (43%), Gaps = 14/112 (12%)
Query: 299 SQCS-NLTLLNLASNGFTGV---IPPELGQLINLQELILYENSLFGEIPKSILACKNLNK 354
SQCS + TL+N + V IP + Q L L N + P NL +
Sbjct: 8 SQCSCDQTLVNCQNIRLASVPAGIP------TDKQRLWLNNNQITKLEPGVFDHLVNLQQ 61
Query: 355 LDLSNNRFNGTIPNAICD-MSRLQYLLLGQNSLKGEIPHEIGNCMKLLQLHI 405
L ++N+ IP + D +++L L L N LK IP + +K L HI
Sbjct: 62 LYFNSNKLT-AIPTGVFDKLTQLTQLDLNDNHLKS-IPRGAFDNLKSLT-HI 110
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 5e-04
Identities = 35/193 (18%), Positives = 70/193 (36%), Gaps = 54/193 (27%)
Query: 616 GTFSTVYKAV-MPSGLILSVKRL---KSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIG 671
G F+ V K +GL + K + +S + ++ RE+ L ++ H N++
Sbjct: 23 GQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHD 82
Query: 672 FVIYED---VALLLHNYLPNGTL---------------AQLLHESTKQPDYRPDWPTRLS 713
+YE+ V L+L + G L + KQ
Sbjct: 83 --VYENRTDVVLIL-ELVSGGELFDFLAQKESLSEEEATSFI----KQ------------ 123
Query: 714 IAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEI-----SKLLDPSKGTASI 768
+ +G+ +LH I H D+ N++L D + I++ + ++
Sbjct: 124 ----ILDGVNYLHTKKIAHFDLKPENIML-LDKNIPIPHIKLIDFGLAHEIEDGV---EF 175
Query: 769 SAVAGSFGYIPPE 781
+ G+ ++ PE
Sbjct: 176 KNIFGTPEFVAPE 188
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 42.2 bits (100), Expect = 5e-04
Identities = 35/193 (18%), Positives = 62/193 (32%), Gaps = 62/193 (32%)
Query: 616 GTFSTVYKAV-MPSGLILSVK--RLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGF 672
G F V++ V S K ++K D+ + +E+ L+ H N++
Sbjct: 16 GEFGIVHRCVETSSKKTYMAKFVKVKGTDQ------VLVKKEISILNIARHRNILHLHE- 68
Query: 673 VIYED---VALLLHNYLPNGTL-------AQLLHES-----TKQPDYRPDWPTRLSIAIG 717
+E + ++ ++ + A L+E Q
Sbjct: 69 -SFESMEELVMIF-EFISGLDIFERINTSAFELNEREIVSYVHQ---------------- 110
Query: 718 VAEGLAFLHHVAIIHLDISSGNVLLD---------ADFKPLLGEIEISKLLDPSKGTASI 768
V E L FLH I H DI N++ +F G ++ L P +
Sbjct: 111 VCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEF----G---QARQLKPGD---NF 160
Query: 769 SAVAGSFGYIPPE 781
+ + Y PE
Sbjct: 161 RLLFTAPEYYAPE 173
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 41.8 bits (99), Expect = 5e-04
Identities = 44/221 (19%), Positives = 76/221 (34%), Gaps = 78/221 (35%)
Query: 616 GTFSTVYKAV-MPSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVI 674
G FS V+ +G + ++K + ++ + + E+ L K+ H+N+V
Sbjct: 20 GAFSEVFLVKQRLTGKLFALK---CIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDI-- 74
Query: 675 YEDVALLLHNYL-----PNGTL---------------AQLLHESTKQPDYRPDWPTRLSI 714
YE H YL G L + ++ +Q
Sbjct: 75 YESTT---HYYLVMQLVSGGELFDRILERGVYTEKDASLVI----QQ------------- 114
Query: 715 AIGVAEGLAFLHHVAIIHLDISSGNVLLD----------ADFKPLLGEIEISKLLDPSKG 764
V + +LH I+H D+ N+L DF G +SK+
Sbjct: 115 ---VLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDF----G---LSKMEQNGI- 163
Query: 765 TASISAVAGSFGYIPPE----YAYTMQVTAPGNVYSYGVVL 801
+S G+ GY+ PE Y+ V + +S GV+
Sbjct: 164 ---MSTACGTPGYVAPEVLAQKPYSKAV----DCWSIGVIT 197
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 42.3 bits (100), Expect = 5e-04
Identities = 29/137 (21%), Positives = 55/137 (40%), Gaps = 17/137 (12%)
Query: 616 GTFSTVYKAVMPSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIY 675
G+F V++A + +++K+ ++ + REL+ + + H N+V + Y
Sbjct: 51 GSFGVVFQAKLVESDEVAIKK-------VLQDKRFKNRELQIMRIVKHPNVVD-LKAFFY 102
Query: 676 EDVALLLHNYL-------PNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHV 728
+ +L P T+ + K P +L + LA++H +
Sbjct: 103 SNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKL-YMYQLLRSLAYIHSI 160
Query: 729 AIIHLDISSGNVLLDAD 745
I H DI N+LLD
Sbjct: 161 GICHRDIKPQNLLLDPP 177
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 41.8 bits (99), Expect = 6e-04
Identities = 36/203 (17%), Positives = 76/203 (37%), Gaps = 42/203 (20%)
Query: 616 GTFSTVYKAVM-PSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVI 674
G++ V AV + + + K + + + ++ +E+E + L H N++R
Sbjct: 20 GSWGEVKIAVQKGTRIRRAAK---KIPKYFVEDVDRFKQEIEIMKSLDHPNIIRLYE--T 74
Query: 675 YED---VALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAII 731
+ED + L++ G +L + +R R+ + +A+ H + +
Sbjct: 75 FEDNTDIYLVM-ELCTGG---ELFERVVHKRVFRESDAARIMKDV--LSAVAYCHKLNVA 128
Query: 732 HLDISSGNVLLD----------ADFKPLLGEIEISKLLDPSKGTASISAVAGSFGYIPPE 781
H D+ N L DF G ++ P K + G+ Y+ P+
Sbjct: 129 HRDLKPENFLFLTDSPDSPLKLIDF----G---LAARFKPGK---MMRTKVGTPYYVSPQ 178
Query: 782 ---YAYTMQVTAPGNVYSYGVVL 801
Y + + +S GV++
Sbjct: 179 VLEGLYGPEC----DEWSAGVMM 197
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 40.8 bits (96), Expect = 6e-04
Identities = 21/92 (22%), Positives = 35/92 (38%), Gaps = 12/92 (13%)
Query: 155 KSLEKLEDFQVSSNKLNGSIPFWV-GNLTNLRVFTAYENQLVGEIP----DNLGSVSELE 209
L L ++ N+L I ++++ EN++ EI L +L+
Sbjct: 51 GRLPHLVKLELKRNQLT-GIEPNAFEGASHIQELQLGENKI-KEISNKMFLGL---HQLK 105
Query: 210 LLNLHSNQLEGPIPKSIFAS-GKLEVLVLTQN 240
LNL+ NQ+ + F L L L N
Sbjct: 106 TLNLYDNQISC-VMPGSFEHLNSLTSLNLASN 136
|
| >1w8a_A SLIT protein; signaling protein, secreted protein, AXON guidance, leucine-rich repeat glycoprotein, EGF-like domain, signal protein; 2.8A {Drosophila melanogaster} SCOP: c.10.2.7 Length = 192 | Back alignment and structure |
|---|
Score = 40.4 bits (95), Expect = 8e-04
Identities = 30/105 (28%), Positives = 46/105 (43%), Gaps = 12/105 (11%)
Query: 287 NNNLSGEIVPE--FSQCSNLTLLNLASNGFTGVIPPEL-GQLINLQELILYENSLFGEIP 343
N+N G I + F + +L L L N TG I P ++QEL L EN + EI
Sbjct: 37 NDNELGRISSDGLFGRLPHLVKLELKRNQLTG-IEPNAFEGASHIQELQLGENKI-KEIS 94
Query: 344 KSI---LACKNLNKLDLSNNRFNGTIPNAICD-MSRLQYLLLGQN 384
+ L L L+L +N+ + + + ++ L L L N
Sbjct: 95 NKMFLGLH--QLKTLNLYDNQIS-CVMPGSFEHLNSLTSLNLASN 136
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 41.8 bits (99), Expect = 6e-04
Identities = 35/142 (24%), Positives = 60/142 (42%), Gaps = 20/142 (14%)
Query: 616 GTFSTVYKAV-MPSGLILSVKRLK-SMDRTIIHHQNKM-IRELEKLSKLCHDNLVRPIGF 672
G++ V+K +G I+++K+ S D +I K+ +RE+ L +L H NLV +
Sbjct: 14 GSYGVVFKCRNRDTGQIVAIKKFLESEDDPVI---KKIALREIRMLKQLKHPNLVNLLE- 69
Query: 673 VIYEDVAL-LLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAII 731
V L L+ Y + T+ L + ++ SI + + F H I
Sbjct: 70 VFRRKRRLHLVFEYCDH-TVLHEL-DRYQRG---VPEHLVKSITWQTLQAVNFCHKHNCI 124
Query: 732 HLDISSGNVLLD-------ADF 746
H D+ N+L+ DF
Sbjct: 125 HRDVKPENILITKHSVIKLCDF 146
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 42.0 bits (99), Expect = 6e-04
Identities = 23/105 (21%), Positives = 37/105 (35%), Gaps = 18/105 (17%)
Query: 718 VAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEI-----SKLLDPSKGTASISAVA 772
+ + +H + +H DI N+LLD G I + L S+ AV
Sbjct: 171 IVMAIDSVHRLGYVHRDIKPDNILLDRC-----GHIRLADFGSCLKLRADGTVRSLVAV- 224
Query: 773 GSFGYIPPEYAYTMQVTAPGNVY-------SYGVVLLEILTTRLP 810
G+ Y+ PE + Y + GV E+ + P
Sbjct: 225 GTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTP 269
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 41.8 bits (99), Expect = 7e-04
Identities = 34/154 (22%), Positives = 59/154 (38%), Gaps = 36/154 (23%)
Query: 616 GTFSTVYKAV-MPSGLILSVKRLKSMDR-------TIIHHQNKMIRELEKLSKLCHDNLV 667
GTF V+KA +G +++K++ M+ T +RE++ L L H+N+V
Sbjct: 28 GTFGEVFKARHRKTGQKVALKKVL-MENEKEGFPIT-------ALREIKILQLLKHENVV 79
Query: 668 RPIGFVIYEDVALLLHN--------YLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVA 719
I + + + LA LL + + +
Sbjct: 80 NLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLS----NVLVKFTLSEIKRVMQMLL 134
Query: 720 EGLAFLHHVAIIHLDISSGNVLLD-------ADF 746
GL ++H I+H D+ + NVL+ ADF
Sbjct: 135 NGLYYIHRNKILHRDMKAANVLITRDGVLKLADF 168
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 41.8 bits (99), Expect = 7e-04
Identities = 34/147 (23%), Positives = 67/147 (45%), Gaps = 27/147 (18%)
Query: 616 GTFSTVYKAV-MPSGLILSVKRLKSMDRTIIHHQNKM--------IRELEKLSKLCHDNL 666
G F+TVYKA + I+++K++K + H+++ +RE++ L +L H N+
Sbjct: 21 GQFATVYKARDKNTNQIVAIKKIK------LGHRSEAKDGINRTALREIKLLQELSHPNI 74
Query: 667 VRPIGFVIYEDVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLH 726
+ + ++ L+ +++ L ++ K + + +GL +LH
Sbjct: 75 IGLLDAFGHKSNISLVFDFMETD-LEVII----KDNSLVLTPSHIKAYMLMTLQGLEYLH 129
Query: 727 HVAIIHLDISSGNVLLD-------ADF 746
I+H D+ N+LLD ADF
Sbjct: 130 QHWILHRDLKPNNLLLDENGVLKLADF 156
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 8e-04
Identities = 38/191 (19%), Positives = 73/191 (38%), Gaps = 57/191 (29%)
Query: 616 GTFSTVYKAVM-PSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVI 674
G F V+K +GL L+ K + + + ++ E+ +++L H NL++
Sbjct: 100 GRFGQVHKCEETATGLKLAAK---IIKTRGMKDKEEVKNEISVMNQLDHANLIQLYD--A 154
Query: 675 YED---VALLLHNYLPNGTL-------AQLLHES-----TKQPDYRPDWPTRLSIAIGVA 719
+E + L++ Y+ G L + L E KQ +
Sbjct: 155 FESKNDIVLVM-EYVDGGELFDRIIDESYNLTELDTILFMKQ----------------IC 197
Query: 720 EGLAFLHHVAIIHLDISSGNVLLD---------ADFKPLLGEIEISKLLDPSKGTASISA 770
EG+ +H + I+HLD+ N+L DF G +++ P + +
Sbjct: 198 EGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDF----G---LARRYKPRE---KLKV 247
Query: 771 VAGSFGYIPPE 781
G+ ++ PE
Sbjct: 248 NFGTPEFLAPE 258
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 41.5 bits (98), Expect = 8e-04
Identities = 46/220 (20%), Positives = 74/220 (33%), Gaps = 65/220 (29%)
Query: 616 GTFSTVYKAV-MPSGLILSVK-----RLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRP 669
G V A + +++K + + E+E L KL H +++
Sbjct: 21 GACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKI 80
Query: 670 IGFVIYEDVALLLHNYLPNGTL------AQLLHEST-----KQPDYRPDWPTRLSIAIGV 718
F ED ++L + G L + L E+T Q +
Sbjct: 81 KNFFDAEDYYIVL-ELMEGGELFDKVVGNKRLKEATCKLYFYQ----------------M 123
Query: 719 AEGLAFLHHVAIIHLDISSGNVLLD----------ADFKPLLGEIEISKLLDPSKGTASI 768
+ +LH IIH D+ NVLL DF G SK+L + +
Sbjct: 124 LLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDF----G---HSKILGETS---LM 173
Query: 769 SAVAGSFGYIPPE-------YAYTMQVTAPGNVYSYGVVL 801
+ G+ Y+ PE Y V + +S GV+L
Sbjct: 174 RTLCGTPTYLAPEVLVSVGTAGYNRAV----DCWSLGVIL 209
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 41.5 bits (98), Expect = 9e-04
Identities = 37/189 (19%), Positives = 72/189 (38%), Gaps = 46/189 (24%)
Query: 616 GTFSTVYKAV-MPSGLILSVKRL---KSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIG 671
G F+ V K +GL + K + +S + ++ RE+ L ++ H N++
Sbjct: 23 GQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHD 82
Query: 672 FVIYED---VALLLHNYLPNGTL------AQLLHES-----TKQPDYRPDWPTRLSIAIG 717
+YE+ V L+L + G L + L E KQ
Sbjct: 83 --VYENRTDVVLIL-ELVSGGELFDFLAQKESLSEEEATSFIKQ---------------- 123
Query: 718 VAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEI-----SKLLDPSKGTASISAVA 772
+ +G+ +LH I H D+ N++L D + I++ + ++ +
Sbjct: 124 ILDGVNYLHTKKIAHFDLKPENIML-LDKNIPIPHIKLIDFGLAHEIEDGV---EFKNIF 179
Query: 773 GSFGYIPPE 781
G+ ++ PE
Sbjct: 180 GTPEFVAPE 188
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
No hit with probability above 80.00
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 888 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 2e-48 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 6e-44 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 8e-44 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 5e-43 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 1e-42 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 1e-42 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 3e-42 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 1e-41 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 2e-41 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 2e-40 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 3e-40 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 3e-40 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 8e-40 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 2e-39 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 2e-39 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 2e-39 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 6e-39 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 3e-38 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 8e-38 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 2e-37 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 6e-37 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 2e-36 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 3e-36 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 3e-36 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 2e-35 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 6e-35 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 2e-33 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 2e-33 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 3e-33 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 5e-33 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 2e-31 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 2e-30 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 4e-29 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 6e-29 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 8e-29 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 1e-28 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 1e-28 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 2e-27 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 2e-27 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 5e-27 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 9e-21 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 2e-20 | |
| d1xkua_ | 305 | c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 99 | 8e-17 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 6e-27 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 8e-27 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 2e-24 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 1e-17 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 7e-15 | |
| d2omza2 | 384 | c.10.2.1 (A:33-416) Internalin A {Listeria monocyt | 6e-12 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 2e-26 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 9e-26 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 2e-25 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 3e-25 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 7e-25 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 2e-21 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 8e-20 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 2e-18 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 2e-16 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 6e-14 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 5e-11 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 3e-05 | |
| d1ozna_ | 284 | c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 recept | 0.003 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 2e-24 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 2e-24 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 4e-24 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 5e-24 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 3e-23 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 9e-09 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 6e-05 | |
| d1ogqa_ | 313 | c.10.2.8 (A:) Polygalacturonase inhibiting protein | 6e-05 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 6e-24 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 7e-24 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 3e-23 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 4e-23 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 1e-22 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 2e-22 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 5e-22 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 7e-22 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 3e-21 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 2e-19 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 7e-19 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 2e-18 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 2e-17 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 1e-16 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 2e-16 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 1e-12 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 5e-10 | |
| d1p9ag_ | 266 | c.10.2.7 (G:) von Willebrand factor binding domain | 2e-09 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 2e-12 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 5e-12 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 2e-10 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 1e-09 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 3e-09 | |
| d2astb2 | 284 | c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p1 | 2e-05 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 4e-09 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 8e-09 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 3e-08 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 2e-07 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 2e-07 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 6e-07 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 5e-05 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 6e-04 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 7e-04 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 0.001 | |
| d1jl5a_ | 353 | c.10.2.6 (A:) Leucine rich effector protein YopM { | 0.002 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 6e-09 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 3e-08 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 9e-08 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 2e-07 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 7e-07 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 8e-06 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 4e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 8e-05 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 1e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 4e-04 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.001 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.001 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.002 | |
| d1z7xw1 | 460 | c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human ( | 0.003 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 2e-08 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 5e-05 | |
| d2ca6a1 | 344 | c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal dom | 5e-05 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 4e-08 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 1e-07 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 2e-07 | |
| d1h6ua2 | 227 | c.10.2.1 (A:36-262) Internalin H {Listeria monocyt | 3e-04 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 2e-07 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 1e-06 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 2e-05 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 3e-05 | |
| d1dcea3 | 124 | c.10.2.2 (A:444-567) Rab geranylgeranyltransferase | 4e-04 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 4e-07 | |
| d1w8aa_ | 192 | c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanoga | 2e-04 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 2e-06 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 8e-05 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 4e-04 | |
| d1h6ta2 | 210 | c.10.2.1 (A:31-240) Internalin B {Listeria monocyt | 0.002 | |
| d2ifga3 | 156 | c.10.2.7 (A:36-191) High affinity nerve growth fac | 4e-06 | |
| d2ifga3 | 156 | c.10.2.7 (A:36-191) High affinity nerve growth fac | 1e-05 | |
| d2ifga3 | 156 | c.10.2.7 (A:36-191) High affinity nerve growth fac | 0.001 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 1e-05 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 3e-05 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 7e-05 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 0.001 | |
| d1xwdc1 | 242 | c.10.2.7 (C:18-259) Follicle-stimulating hormone r | 0.004 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 9e-05 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 5e-04 | |
| d1a9na_ | 162 | c.10.2.4 (A:) Splicesomal U2A' protein {Human (Hom | 0.004 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 1e-04 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 0.002 | |
| d2omxa2 | 199 | c.10.2.1 (A:37-235) Internalin B {Listeria monocyt | 0.004 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 2e-04 | |
| d1koha1 | 162 | c.10.2.3 (A:201-362) mRNA export factor tap {Human | 5e-04 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (434), Expect = 2e-48
Identities = 55/276 (19%), Positives = 111/276 (40%), Gaps = 24/276 (8%)
Query: 616 GTFSTVYKAVMPSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIY 675
G+F TVYK + + + + + E+ L K H N++ +G+
Sbjct: 19 GSFGTVYKGKWHGDVAVKMLNVTAPTP---QQLQAFKNEVGVLRKTRHVNILLFMGYSTA 75
Query: 676 EDVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDI 735
+A++ + +L LH + + + + IA A+G+ +LH +IIH D+
Sbjct: 76 PQLAIVT-QWCEGSSLYHHLH----IIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDL 130
Query: 736 SSGNVLLDADFKPLLGEIEISKLLDPSKGTASISAVAGSFGYIPPEYAYTMQ---VTAPG 792
S N+ L D +G+ ++ + G+ ++GS ++ PE +
Sbjct: 131 KSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQS 190
Query: 793 NVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQILDARLSTVSFGWRK 852
+VY++G+VL E++T +LP + G L LS V K
Sbjct: 191 DVYAFGIVLYELMTGQLPYSNINNRDQIIFMVGRG----------YLSPDLSKVRSNCPK 240
Query: 853 EMLTALKVALLCTDSTPAKRPKMKKVVEMLQEIKQN 888
M ++ C +RP +++ ++ + ++
Sbjct: 241 AM---KRLMAECLKKKRDERPLFPQILASIELLARS 273
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (399), Expect = 6e-44
Identities = 47/274 (17%), Positives = 108/274 (39%), Gaps = 28/274 (10%)
Query: 616 GTFSTVYKAVMPSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIY 675
G F V+ + +++K ++ + + I E E + KL H LV+ G +
Sbjct: 16 GQFGLVHLGYWLNKDKVAIKTIREGAMS----EEDFIEEAEVMMKLSHPKLVQLYGVCLE 71
Query: 676 EDVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDI 735
+ L+ ++ +G L+ L T L + + V EG+A+L +IH D+
Sbjct: 72 QAPICLVFEFMEHGCLSDYLRT----QRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDL 127
Query: 736 SSGNVLLDADFKPLLGEIEISKLLDPSKGTASISAVAGSFGYIPPEYAYTMQVTAPGNVY 795
++ N L+ + + + +++ + + T+S + PE + ++ +V+
Sbjct: 128 AARNCLVGENQVIKVSDFGMTRFVLDDQYTSSTG-TKFPVKWASPEVFSFSRYSSKSDVW 186
Query: 796 SYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQILDARLSTVS-FGWRKEM 854
S+GV++ E+ + P + ++++ + + R
Sbjct: 187 SFGVLMWEVFSEGKI------------------PYENRSNSEVVEDISTGFRLYKPRLAS 228
Query: 855 LTALKVALLCTDSTPAKRPKMKKVVEMLQEIKQN 888
++ C P RP +++ L EI ++
Sbjct: 229 THVYQIMNHCWKERPEDRPAFSRLLRQLAEIAES 262
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 158 bits (401), Expect = 8e-44
Identities = 60/298 (20%), Positives = 109/298 (36%), Gaps = 46/298 (15%)
Query: 616 GTFSTVYKAVMP------SGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRP 669
G F V++A P +++VK LK + Q RE +++ + N+V+
Sbjct: 24 GAFGRVFQARAPGLLPYEPFTMVAVKMLK--EEASADMQADFQREAALMAEFDNPNIVKL 81
Query: 670 IGFVIYEDVALLLHNYLPNGTLAQLLHESTKQPDYRP-------------------DWPT 710
+G LL Y+ G L + L +
Sbjct: 82 LGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAE 141
Query: 711 RLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSKGTASISA 770
+L IA VA G+A+L +H D+++ N L+ + + + +S+ + + +
Sbjct: 142 QLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGN 201
Query: 771 VAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPA 830
A ++PPE + + T +V++YGVVL EI + L P
Sbjct: 202 DAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQ------------------PY 243
Query: 831 RGETPEQILDARLSTVSFGWRKEMLTALK-VALLCTDSTPAKRPKMKKVVEMLQEIKQ 887
G E+++ + L + LC PA RP + +LQ + +
Sbjct: 244 YGMAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE 301
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (393), Expect = 5e-43
Identities = 52/270 (19%), Positives = 99/270 (36%), Gaps = 26/270 (9%)
Query: 616 GTFSTVYKAVMPSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIY 675
G F V+ ++VK LK + + E + +L H LVR V
Sbjct: 24 GQFGEVWMGYYNGHTKVAVKSLKQGSM----SPDAFLAEANLMKQLQHQRLVRLYAVVTQ 79
Query: 676 EDVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDI 735
E + ++ Y+ NG+L L + L +A +AEG+AF+ IH D+
Sbjct: 80 EPIYIIT-EYMENGSLVDFLK---TPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDL 135
Query: 736 SSGNVLLDADFKPLLGEIEISKLLDPSKGTASISAVAGSFGYIPPEYAYTMQVTAPGNVY 795
+ N+L+ + + +++L++ ++ + + PE T +V+
Sbjct: 136 RAANILVSDTLSCKIADFGLARLIEDNE-YTAREGAKFPIKWTAPEAINYGTFTIKSDVW 194
Query: 796 SYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQILDARLSTVSFGWRKEML 855
S+G++L EI+T + G R P+ +
Sbjct: 195 SFGILLTEIVTHGRIPYPGMTNPEVIQNLERG--YRMVRPDNCPEE-------------- 238
Query: 856 TALKVALLCTDSTPAKRPKMKKVVEMLQEI 885
++ LC P RP + +L++
Sbjct: 239 -LYQLMRLCWKERPEDRPTFDYLRSVLEDF 267
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (389), Expect = 1e-42
Identities = 45/270 (16%), Positives = 101/270 (37%), Gaps = 26/270 (9%)
Query: 616 GTFSTVYKAVMPSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIY 675
G F V +++K +K + +++ I E + + L H+ LV+ G
Sbjct: 15 GQFGVVKYGKWRGQYDVAIKMIKEGSMS----EDEFIEEAKVMMNLSHEKLVQLYGVCTK 70
Query: 676 EDVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDI 735
+ ++ Y+ NG L L + +R L + V E + +L +H D+
Sbjct: 71 QRPIFIITEYMANGCLLNYLR----EMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDL 126
Query: 736 SSGNVLLDADFKPLLGEIEISKLLDPSKGTASISAVAGSFGYIPPEYAYTMQVTAPGNVY 795
++ N L++ + + +S+ + + T+S+ + + PPE + ++ +++
Sbjct: 127 AARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSVGSK-FPVRWSPPEVLMYSKFSSKSDIW 185
Query: 796 SYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQILDARLSTVSFGWRKEML 855
++GV++ EI + E F G R P +
Sbjct: 186 AFGVLMWEIYSLGKMPYERFTNSETAEHIAQG--LRLYRPHLASEK-------------- 229
Query: 856 TALKVALLCTDSTPAKRPKMKKVVEMLQEI 885
+ C +RP K ++ + ++
Sbjct: 230 -VYTIMYSCWHEKADERPTFKILLSNILDV 258
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (391), Expect = 1e-42
Identities = 52/274 (18%), Positives = 109/274 (39%), Gaps = 28/274 (10%)
Query: 616 GTFSTVYKAVMPSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIY 675
G F V+ +++K LK + ++E + + KL H+ LV+ V
Sbjct: 28 GCFGEVWMGTWNGTTRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYAVVSE 83
Query: 676 EDVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDI 735
E + ++ Y+ G+L L T + P + +A +A G+A++ + +H D+
Sbjct: 84 EPIYIVTE-YMSKGSLLDFLKGETGKYLR---LPQLVDMAAQIASGMAYVERMNYVHRDL 139
Query: 736 SSGNVLLDADFKPLLGEIEISKLLDPSKGTASISAVAGSFGYIPPEYAYTMQVTAPGNVY 795
+ N+L+ + + + +++L++ ++ TA + PE A + T +V+
Sbjct: 140 RAANILVGENLVCKVADFGLARLIEDNEYTAR-QGAKFPIKWTAPEAALYGRFTIKSDVW 198
Query: 796 SYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQILDARLSTVSFGWRKEML 855
S+G++L E+ T P G ++LD E
Sbjct: 199 SFGILLTELTTKGRV------------------PYPGMVNREVLDQVERGYRMPCPPECP 240
Query: 856 TALK-VALLCTDSTPAKRPKMKKVVEMLQEIKQN 888
+L + C P +RP + + L++ +
Sbjct: 241 ESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 274
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (390), Expect = 3e-42
Identities = 58/290 (20%), Positives = 104/290 (35%), Gaps = 38/290 (13%)
Query: 616 GTFSTVYKAVM------PSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLC-HDNLVR 668
G F V +A + + ++VK LK + + ++ EL+ LS L H N+V
Sbjct: 34 GAFGKVVEATAYGLIKSDAAMTVAVKMLK--PSAHLTEREALMSELKVLSYLGNHMNIVN 91
Query: 669 PIGFVIYEDVALLLHNYLPNGTLAQLLHESTKQPDYRP-------------DWPTRLSIA 715
+G L++ Y G L L D LS +
Sbjct: 92 LLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFS 151
Query: 716 IGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSKGTASISAVAGSF 775
VA+G+AFL IH D+++ N+LL + + +++ +
Sbjct: 152 YQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPV 211
Query: 776 GYIPPEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETP 835
++ PE + T +V+SYG+ L E+ + K + R +P
Sbjct: 212 KWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGF-RMLSP 270
Query: 836 EQILDARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEMLQEI 885
E + C D+ P KRP K++V+++++
Sbjct: 271 EHAPAE---------------MYDIMKTCWDADPLKRPTFKQIVQLIEKQ 305
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 152 bits (384), Expect = 1e-41
Identities = 53/279 (18%), Positives = 108/279 (38%), Gaps = 26/279 (9%)
Query: 611 NMIYCGTFSTVYKAVMP-SGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRP 669
+ + G + VY+ V L ++VK LK + ++E + ++ H NLV+
Sbjct: 23 HKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQL 78
Query: 670 IGFVIYEDVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVA 729
+G E ++ ++ G L L E +Q L +A ++ + +L
Sbjct: 79 LGVCTREPPFYIITEFMTYGNLLDYLRECNRQE---VSAVVLLYMATQISSAMEYLEKKN 135
Query: 730 IIHLDISSGNVLLDADFKPLLGEIEISKLLDPSKGTASISAVAGSFGYIPPEYAYTMQVT 789
IH D+++ N L+ + + + +S+L+ TA + + PE + +
Sbjct: 136 FIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTAH-AGAKFPIKWTAPESLAYNKFS 194
Query: 790 APGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQILDARLSTVSFG 849
+V+++GV+L EI T + G + V + R E PE +
Sbjct: 195 IKSDVWAFGVLLWEIATYGMSPYP--GIDLSQVYELLEKDYRMERPEGCPEK-------- 244
Query: 850 WRKEMLTALKVALLCTDSTPAKRPKMKKVVEMLQEIKQN 888
++ C P+ RP ++ + + + Q
Sbjct: 245 -------VYELMRACWQWNPSDRPSFAEIHQAFETMFQE 276
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (383), Expect = 2e-41
Identities = 53/295 (17%), Positives = 108/295 (36%), Gaps = 34/295 (11%)
Query: 616 GTFSTVYKAVMPSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIY 675
G F V++ G ++VK S + + E+ + L H+N++ I
Sbjct: 14 GRFGEVWRGKW-RGEEVAVKIFSSREERSWFRE----AEIYQTVMLRHENILGFIAADNK 68
Query: 676 EDVAL----LLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVA-- 729
++ L+ +Y +G+L L+ Y + +A+ A GLA LH
Sbjct: 69 DNGTWTQLWLVSDYHEHGSLFDYLNR------YTVTVEGMIKLALSTASGLAHLHMEIVG 122
Query: 730 ------IIHLDISSGNVLLDADFKPLLGEIEISKLLDPSKGTASISA--VAGSFGYIPPE 781
I H D+ S N+L+ + + ++ ++ D + T I+ G+ Y+ PE
Sbjct: 123 TQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPE 182
Query: 782 YAYTM------QVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETP 835
+ ++Y+ G+V EI + V P+ E
Sbjct: 183 VLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMR 242
Query: 836 EQILDARLSTV---SFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEMLQEIKQ 887
+ + + +L + + + K+ C + A R ++ + L ++ Q
Sbjct: 243 KVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 297
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 149 bits (376), Expect = 2e-40
Identities = 50/286 (17%), Positives = 116/286 (40%), Gaps = 32/286 (11%)
Query: 611 NMIYCGTFSTVYKAVMPS----GLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNL 666
+I G F V + + +++K LKS + + E + + H N+
Sbjct: 32 QVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKS--GYTEKQRRDFLSEASIMGQFDHPNV 89
Query: 667 VRPIGFVIYEDVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLH 726
+ G V +++ ++ NG+L L ++ + + + G+A G+ +L
Sbjct: 90 IHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDG----QFTVIQLVGMLRGIAAGMKYLA 145
Query: 727 HVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSKGTASISAVAGSFG---YIPPEYA 783
+ +H D+++ N+L++++ + + +S+ L+ + ++ G + PE
Sbjct: 146 DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAI 205
Query: 784 YTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQILDARL 843
+ T+ +V+SYG+V+ E+++ P T + +++A
Sbjct: 206 QYRKFTSASDVWSYGIVMWEVMSYGER------------------PYWDMTNQDVINAIE 247
Query: 844 STVSFGWRKEMLTALK-VALLCTDSTPAKRPKMKKVVEMLQEIKQN 888
+ +AL + L C RPK ++V L ++ +N
Sbjct: 248 QDYRLPPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRN 293
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (371), Expect = 3e-40
Identities = 51/275 (18%), Positives = 100/275 (36%), Gaps = 34/275 (12%)
Query: 616 GTFSTVYKAVMPSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIY 675
G F V G ++VK +K+ + E +++L H NLV+ +G ++
Sbjct: 18 GEFGDVMLGDY-RGNKVAVKCIKNDAT-----AQAFLAEASVMTQLRHSNLVQLLGVIVE 71
Query: 676 EDVAL-LLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLD 734
E L ++ Y+ G+L L + L ++ V E + +L +H D
Sbjct: 72 EKGGLYIVTEYMAKGSLVDYLRSRGRSV---LGGDCLLKFSLDVCEAMEYLEGNNFVHRD 128
Query: 735 ISSGNVLLDADFKPLLGEIEISKLLDPSKGTASISAVAGSFGYIPPEYAYTMQVTAPGNV 794
+++ NVL+ D + + ++K ++ T + PE + + +V
Sbjct: 129 LAARNVLVSEDNVAKVSDFGLTKEASSTQDT-----GKLPVKWTAPEALREKKFSTKSDV 183
Query: 795 YSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQILDARLSTVSFGWRKEM 854
+S+G++L EI + P + ++
Sbjct: 184 WSFGILLWEIYSFGRV------------------PYPRIPLKDVVPRVEKGYKMDAPDGC 225
Query: 855 LTALK-VALLCTDSTPAKRPKMKKVVEMLQEIKQN 888
A+ V C A RP ++ E L+ IK +
Sbjct: 226 PPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKTH 260
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (372), Expect = 3e-40
Identities = 49/282 (17%), Positives = 97/282 (34%), Gaps = 30/282 (10%)
Query: 609 DSNMIYCGTFSTVYKAVMP---SGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDN 665
+ + G F TV K ++VK LK+ + +++++ E + +L +
Sbjct: 11 EDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKN-EANDPALKDELLAEANVMQQLDNPY 69
Query: 666 LVRPIGFVIYEDVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFL 725
+VR IG E L++ G L + L + + + + V+ G+ +L
Sbjct: 70 IVRMIGICEAESWMLVME-MAELGPLNKYLQQ-----NRHVKDKNIIELVHQVSMGMKYL 123
Query: 726 HHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSKGTASIS-AVAGSFGYIPPEYAY 784
+H D+++ NVLL + + +SK L + + PE
Sbjct: 124 EESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECIN 183
Query: 785 TMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQILDARLS 844
+ ++ +V+S+GV++ E + P RG ++
Sbjct: 184 YYKFSSKSDVWSFGVLMWEAFSYGQK------------------PYRGMKGSEVTAMLEK 225
Query: 845 TVSFGWRKEMLTALK-VALLCTDSTPAKRPKMKKVVEMLQEI 885
G + + LC RP V L+
Sbjct: 226 GERMGCPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNY 267
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (372), Expect = 8e-40
Identities = 50/284 (17%), Positives = 106/284 (37%), Gaps = 32/284 (11%)
Query: 616 GTFSTVYKAV------MPSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRP 669
G+F VY+ V +++K + + + + + + E + + ++VR
Sbjct: 31 GSFGMVYEGVAKGVVKDEPETRVAIKTVN--EAASMRERIEFLNEASVMKEFNCHHVVRL 88
Query: 670 IGFVIYEDVALLLHNYLPNGTLAQLLHESTKQPDYRP-----DWPTRLSIAIGVAEGLAF 724
+G V L++ + G L L P + +A +A+G+A+
Sbjct: 89 LGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAY 148
Query: 725 LHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSKGTASISAVAGSFGYIPPEYAY 784
L+ +H D+++ N ++ DF +G+ +++ + + ++ PE
Sbjct: 149 LNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLK 208
Query: 785 TMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQILDARLS 844
T +V+S+GVVL EI T P +G + EQ+L +
Sbjct: 209 DGVFTTYSDVWSFGVVLWEIATLAEQ------------------PYQGLSNEQVLRFVME 250
Query: 845 TVSFGWRKEMLTALK-VALLCTDSTPAKRPKMKKVVEMLQEIKQ 887
L + +C P RP +++ ++E +
Sbjct: 251 GGLLDKPDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (369), Expect = 2e-39
Identities = 55/285 (19%), Positives = 109/285 (38%), Gaps = 30/285 (10%)
Query: 610 SNMIYCGTFSTVYKAVMP----SGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDN 665
+ +I G F VY + + +VK L + I ++ + E + H N
Sbjct: 32 NEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITD--IGEVSQFLTEGIIMKDFSHPN 89
Query: 666 LVRPIGFVI-YEDVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAF 724
++ +G + E L++ Y+ +G L + T P + + VA+G+ F
Sbjct: 90 VLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETH----NPTVKDLIGFGLQVAKGMKF 145
Query: 725 LHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSKGTA--SISAVAGSFGYIPPEY 782
L +H D+++ N +LD F + + +++ + + + + + ++ E
Sbjct: 146 LASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALES 205
Query: 783 AYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQILDAR 842
T + T +V+S+GV+L E++T P D D+ ++ R PE D
Sbjct: 206 LQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDV-NTFDITVYLLQGR-RLLQPEYCPDP- 262
Query: 843 LSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEMLQEIKQ 887
+V L C RP ++V + I
Sbjct: 263 --------------LYEVMLKCWHPKAEMRPSFSELVSRISAIFS 293
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 146 bits (370), Expect = 2e-39
Identities = 49/293 (16%), Positives = 98/293 (33%), Gaps = 43/293 (14%)
Query: 616 GTFSTVYKAVMPS------GLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLC-HDNLVR 668
G F V A + ++VK LK ++ + ++ EL+ +++L H+N+V
Sbjct: 48 GAFGKVMNATAYGISKTGVSIQVAVKMLK--EKADSSEREALMSELKMMTQLGSHENIVN 105
Query: 669 PIGFVIYEDVALLLHNYLPNGTLAQLLHESTKQPDYRP------------------DWPT 710
+G L+ Y G L L ++ +
Sbjct: 106 LLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFED 165
Query: 711 RLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSKGTASISA 770
L A VA+G+ FL + +H D+++ NVL+ + + +++ +
Sbjct: 166 LLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGN 225
Query: 771 VAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPA 830
++ PE + T +V+SYG++L EI + + + K +
Sbjct: 226 ARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGF- 284
Query: 831 RGETPEQILDARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEMLQ 883
+ + P + + C KRP + L
Sbjct: 285 KMDQPFYATEE---------------IYIIMQSCWAFDSRKRPSFPNLTSFLG 322
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (366), Expect = 2e-39
Identities = 55/287 (19%), Positives = 123/287 (42%), Gaps = 29/287 (10%)
Query: 608 KDSNMIYCGTFSTVYKAVMPSG-----LILSVKRLKSMDRTIIHHQNKMIRELEKLSKLC 662
+I G F VYK ++ + + +++K LK + + E + +
Sbjct: 10 TRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLK--AGYTEKQRVDFLGEAGIMGQFS 67
Query: 663 HDNLVRPIGFVIYEDVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGL 722
H N++R G + +++ Y+ NG L + L E D + + G+A G+
Sbjct: 68 HHNIIRLEGVISKYKPMMIITEYMENGALDKFLRE----KDGEFSVLQLVGMLRGIAAGM 123
Query: 723 AFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLL-DPSKGTASISAVAGSFGYIPPE 781
+L ++ +H D+++ N+L++++ + + +S++L D + T + S + PE
Sbjct: 124 KYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPE 183
Query: 782 YAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQILDA 841
+ T+ +V+S+G+V+ E++T + +++K ++ R TP A
Sbjct: 184 AISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNH-EVMKAIN-DGFRLPTPMDCPSA 241
Query: 842 RLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEMLQEIKQN 888
++ + C A+RPK +V +L ++ +
Sbjct: 242 ---------------IYQLMMQCWQQERARRPKFADIVSILDKLIRA 273
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 144 bits (364), Expect = 6e-39
Identities = 50/278 (17%), Positives = 96/278 (34%), Gaps = 30/278 (10%)
Query: 616 GTFSTVYKAVM---PSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGF 672
G F +V + V + +++K LK +M+RE + + +L + +VR IG
Sbjct: 20 GNFGSVRQGVYRMRKKQIDVAIKVLKQGTEK--ADTEEMMREAQIMHQLDNPYIVRLIGV 77
Query: 673 VIYEDVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIH 732
E + L++ G L + L + V+ G+ +L +H
Sbjct: 78 CQAEALMLVM-EMAGGGPLHKFLV----GKREEIPVSNVAELLHQVSMGMKYLEEKNFVH 132
Query: 733 LDISSGNVLLDADFKPLLGEIEISKLLDPSKGTASI-SAVAGSFGYIPPEYAYTMQVTAP 791
D+++ NVLL + + +SK L + SA + PE + ++
Sbjct: 133 RDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSR 192
Query: 792 GNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQILDARLSTVSFGWR 851
+V+SYGV + E L+ P + +++
Sbjct: 193 SDVWSYGVTMWEALSYGQK------------------PYKKMKGPEVMAFIEQGKRMECP 234
Query: 852 KEMLTALK-VALLCTDSTPAKRPKMKKVVEMLQEIKQN 888
E L + C RP V + ++ +
Sbjct: 235 PECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYS 272
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (358), Expect = 3e-38
Identities = 56/276 (20%), Positives = 99/276 (35%), Gaps = 26/276 (9%)
Query: 616 GTFSTVYKAVMPS----GLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIG 671
G+F V + + + ++VK LK + + IRE+ + L H NL+R G
Sbjct: 19 GSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYG 78
Query: 672 FVIYEDVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAII 731
V+ + ++ P G+L L + T A+ VAEG+ +L I
Sbjct: 79 VVLTPPMKMVTE-LAPLGSLLDRLRKHQG----HFLLGTLSRYAVQVAEGMGYLESKRFI 133
Query: 732 HLDISSGNVLLDADFKPLLGEIEISKLLDPSKGTASIS-AVAGSFGYIPPEYAYTMQVTA 790
H D+++ N+LL +G+ + + L + + F + PE T +
Sbjct: 134 HRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSH 193
Query: 791 PGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQILDARLSTVSFGW 850
+ + +GV L E+ T G ++ + R PE
Sbjct: 194 ASDTWMFGVTLWEMFTYGQEPWIGL-NGSQILHKIDKEGERLPRPEDCPQD--------- 243
Query: 851 RKEMLTALKVALLCTDSTPAKRPKMKKVVEMLQEIK 886
V + C P RP + + L E +
Sbjct: 244 ------IYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 273
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 141 bits (357), Expect = 8e-38
Identities = 48/282 (17%), Positives = 105/282 (37%), Gaps = 27/282 (9%)
Query: 611 NMIYCGTFSTVYKAV-MPSGLILSVKR-LKSMDRTIIHHQNKMI-RELEKLSKLCHDNLV 667
++ G F TVYK + +P G + + +K + NK I E ++ + + ++
Sbjct: 15 KVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVC 74
Query: 668 RPIGFVIYEDVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHH 727
R +G + V L+ +P G L + ++ L+ + +A+G+ +L
Sbjct: 75 RLLGICLTSTVQLITQ-LMPFGCL----LDYVREHKDNIGSQYLLNWCVQIAKGMNYLED 129
Query: 728 VAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSKGTASISAVAGSFGYIPPEYAYTMQ 787
++H D+++ NVL+ + + ++KLL + ++ E
Sbjct: 130 RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRI 189
Query: 788 VTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQILDARLSTVS 847
T +V+SYGV + E++T P G +I
Sbjct: 190 YTHQSDVWSYGVTVWELMTFGSK------------------PYDGIPASEISSILEKGER 231
Query: 848 FGWRKEMLTALK-VALLCTDSTPAKRPKMKKVVEMLQEIKQN 888
+ + + C RPK ++++ ++ ++
Sbjct: 232 LPQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD 273
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (353), Expect = 2e-37
Identities = 57/290 (19%), Positives = 99/290 (34%), Gaps = 33/290 (11%)
Query: 611 NMIYCGTFSTVYKAVMPSGLILSVKRLKSMDRTIIHHQNKMI-RELEKLSKLC-HDNLVR 668
++I G F V KA + + +K M ++ ELE L KL H N++
Sbjct: 16 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIIN 75
Query: 669 PIGFVIYEDVALLLHNYLPNGTLAQLLHEST-----------KQPDYRPDWPTRLSIAIG 717
+G + L Y P+G L L +S L A
Sbjct: 76 LLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAAD 135
Query: 718 VAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSKGTASISAVAGSFGY 777
VA G+ +L IH D+++ N+L+ ++ + + +S+ + + +
Sbjct: 136 VARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKK---TMGRLPVRW 192
Query: 778 IPPEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQ 837
+ E T +V+SYGV+L EI++ K G R E P
Sbjct: 193 MAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQG--YRLEKPLN 250
Query: 838 ILDARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEMLQEIKQ 887
D + C P +RP +++ L + +
Sbjct: 251 CDDE---------------VYDLMRQCWREKPYERPSFAQILVSLNRMLE 285
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (352), Expect = 6e-37
Identities = 56/272 (20%), Positives = 111/272 (40%), Gaps = 13/272 (4%)
Query: 616 GTFSTVYKAV-MPSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVI 674
G V+K PSGL+++ K + + I +N++IREL+ L + +V G
Sbjct: 17 GNGGVVFKVSHKPSGLVMARKLIHLEIKPAI--RNQIIRELQVLHECNSPYIVGFYGAFY 74
Query: 675 YEDVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVA-IIHL 733
+ + ++ G+L Q+L ++ R ++I V +GL +L I+H
Sbjct: 75 SDGEISICMEHMDGGSLDQVLKKAG-----RIPEQILGKVSIAVIKGLTYLREKHKIMHR 129
Query: 734 DISSGNVLLDADFKPLLGEIEISKLLDPSKGTASISAVAGSFGYIPPEYAYTMQVTAPGN 793
D+ N+L+++ + L + +S L S + + G+ Y+ PE + +
Sbjct: 130 DVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSFV----GTRSYMSPERLQGTHYSVQSD 185
Query: 794 VYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQILDARLSTVSFGWRKE 853
++S G+ L+E+ R P+ + ++L+ ETP + S+G
Sbjct: 186 IWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSR 245
Query: 854 MLTALKVALLCTDSTPAKRPKMKKVVEMLQEI 885
A+ L + P + Q+
Sbjct: 246 PPMAIFELLDYIVNEPPPKLPSGVFSLEFQDF 277
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (344), Expect = 2e-36
Identities = 54/277 (19%), Positives = 109/277 (39%), Gaps = 31/277 (11%)
Query: 616 GTFSTVYKAVMPS----GLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIG 671
G F V++ + S L +++K K+ + K ++E + + H ++V+ IG
Sbjct: 18 GQFGDVHQGIYMSPENPALAVAIKTCKNCTSD--SVREKFLQEALTMRQFDHPHIVKLIG 75
Query: 672 FVIYEDVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAII 731
VI E+ ++ G L L Y D + + A ++ LA+L +
Sbjct: 76 -VITENPVWIIMELCTLGELRSFLQ----VRKYSLDLASLILYAYQLSTALAYLESKRFV 130
Query: 732 HLDISSGNVLLDADFKPLLGEIEISKLLDPSKGTASISAVAGSFGYIPPEYAYTMQVTAP 791
H DI++ NVL+ ++ LG+ +S+ ++ S + S ++ PE + T+
Sbjct: 131 HRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKA-SKGKLPIKWMAPESINFRRFTSA 189
Query: 792 GNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQILDARLSTVSFGWR 851
+V+ +GV + EIL + P +G ++ +
Sbjct: 190 SDVWMFGVCMWEILMHGVK------------------PFQGVKNNDVIGRIENGERLPMP 231
Query: 852 KEMLTALK-VALLCTDSTPAKRPKMKKVVEMLQEIKQ 887
L + C P++RP+ ++ L I +
Sbjct: 232 PNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 268
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 135 bits (342), Expect = 3e-36
Identities = 60/267 (22%), Positives = 109/267 (40%), Gaps = 31/267 (11%)
Query: 616 GTFSTVYKAVMP-SGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVI 674
G F VY A S IL++K L ++++ RE+E S L H N++R G+
Sbjct: 17 GKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFH 76
Query: 675 YEDVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLD 734
L+ Y P GT+ + L + + + D + +A L++ H +IH D
Sbjct: 77 DATRVYLILEYAPLGTVYRELQKLS-----KFDEQRTATYITELANALSYCHSKRVIHRD 131
Query: 735 ISSGNVLLDADFKPLLGEIEISKLLDPSKGTASISAVAGSFGYIPPEYAYTMQVTAPGNV 794
I N+LL + + + + S S+ + + G+ Y+PPE ++
Sbjct: 132 IKPENLLLGSAGELKIADFGWSVHAPSSR----RTTLCGTLDYLPPEMIEGRMHDEKVDL 187
Query: 795 YSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQILDARLSTVSFGWRKEM 854
+S GV+ E L + P E T ++ R+S V F + +
Sbjct: 188 WSLGVLCYEFLVGKPPFE-------------------ANTYQETYK-RISRVEFTFPDFV 227
Query: 855 LTALK-VALLCTDSTPAKRPKMKKVVE 880
+ + P++RP +++V+E
Sbjct: 228 TEGARDLISRLLKHNPSQRPMLREVLE 254
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 136 bits (344), Expect = 3e-36
Identities = 57/291 (19%), Positives = 103/291 (35%), Gaps = 41/291 (14%)
Query: 616 GTFSTVYKAVMPS--------GLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLC-HDNL 666
G F V A ++VK LKS + +I E+E + + H N+
Sbjct: 24 GAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKS--DATEKDLSDLISEMEMMKMIGKHKNI 81
Query: 667 VRPIGFVIYEDVALLLHNYLPNGTLAQLLH-----------ESTKQPDYRPDWPTRLSIA 715
+ +G + ++ Y G L + L + P+ + +S A
Sbjct: 82 INLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCA 141
Query: 716 IGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSKGTASISAVAGSF 775
VA G+ +L IH D+++ NVL+ D + + +++ + +
Sbjct: 142 YQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPV 201
Query: 776 GYIPPEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETP 835
++ PE + T +V+S+GV+L EI T P G
Sbjct: 202 KWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGS------------------PYPGVPV 243
Query: 836 EQILDARLSTVSFGWRKEMLTALK-VALLCTDSTPAKRPKMKKVVEMLQEI 885
E++ L + C + P++RP K++VE L I
Sbjct: 244 EELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRI 294
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (338), Expect = 2e-35
Identities = 48/291 (16%), Positives = 97/291 (33%), Gaps = 37/291 (12%)
Query: 616 GTFSTVYKAVM------PSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRP 669
G F V +A + ++VK LK + ++ EL+ L + H V
Sbjct: 24 GAFGQVIEADAFGIDKTATCRTVAVKMLK--EGATHSEHRALMSELKILIHIGHHLNVVN 81
Query: 670 IGFVIYED--VALLLHNYLPNGTLAQLLHESTKQPDYRP-----------DWPTRLSIAI 716
+ + +++ + G L+ L + + +
Sbjct: 82 LLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSF 141
Query: 717 GVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSKGTASISAVAGSFG 776
VA+G+ FL IH D+++ N+LL + + +++ +
Sbjct: 142 QVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLK 201
Query: 777 YIPPEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPE 836
++ PE + T +V+S+GV+L EI + + + + R P+
Sbjct: 202 WMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGT-RMRAPD 260
Query: 837 QILDARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEMLQEIKQ 887
+ L C P++RP ++VE L + Q
Sbjct: 261 YTTPE---------------MYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 296
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 132 bits (332), Expect = 6e-35
Identities = 49/267 (18%), Positives = 96/267 (35%), Gaps = 25/267 (9%)
Query: 616 GTFSTVYKAV-MPSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVI 674
G + V AV + ++VK + + + + +E+ L H+N+V+ G
Sbjct: 16 GAYGEVQLAVNRVTEEAVAVKIVDM--KRAVDCPENIKKEICINKMLNHENVVKFYGHRR 73
Query: 675 YEDVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLD 734
++ L Y G L + PD P + G+ +LH + I H D
Sbjct: 74 EGNIQYLFLEYCSGGELFDRIE-----PDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRD 128
Query: 735 ISSGNVLLDADFKPLLGEIEISKLLDPSKGTASISAVAGSFGYIPPEYAYTMQV-TAPGN 793
I N+LLD + + ++ + + ++ + G+ Y+ PE + P +
Sbjct: 129 IKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVD 188
Query: 794 VYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQILDARLSTVSFGWRKE 853
V+S G+VL +L LP ++ + W +
Sbjct: 189 VWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPWKKIDSAPL----------- 237
Query: 854 MLTALKVALLCTDSTPAKRPKMKKVVE 880
AL +L + P+ R + + +
Sbjct: 238 ---ALLHKILVEN--PSARITIPDIKK 259
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 128 bits (322), Expect = 2e-33
Identities = 48/266 (18%), Positives = 101/266 (37%), Gaps = 28/266 (10%)
Query: 616 GTFSTVYKAV-MPSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVI 674
G TVY A+ + +G ++++++ + + +I E+ + + + N+V + +
Sbjct: 31 GASGTVYTAMDVATGQEVAIRQMNLQQQP---KKELIINEILVMRENKNPNIVNYLDSYL 87
Query: 675 YEDVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLD 734
D ++ YL G+L ++ E D ++ + L FLH +IH D
Sbjct: 88 VGDELWVVMEYLAGGSLTDVVTE------TCMDEGQIAAVCRECLQALEFLHSNQVIHRD 141
Query: 735 ISSGNVLLDADFKPLLGEIEISKLLDPSKGTASISAVAGSFGYIPPEYAYTMQVTAPGNV 794
I S N+LL D L + + P + S + G+ ++ PE ++
Sbjct: 142 IKSDNILLGMDGSVKLTDFGFCAQITPEQSKR--STMVGTPYWMAPEVVTRKAYGPKVDI 199
Query: 795 YSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQILDARLSTVSFGWRKEM 854
+S G++ +E++ P + L + PE++ +
Sbjct: 200 WSLGIMAIEMIEGEPPYLNENPLRA-LYLIATNGTPELQNPEKL-------------SAI 245
Query: 855 LTALKVALLCTDSTPAKRPKMKKVVE 880
L D KR K++++
Sbjct: 246 FRDFLNRCLDMD--VEKRGSAKELLQ 269
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 128 bits (323), Expect = 2e-33
Identities = 52/271 (19%), Positives = 100/271 (36%), Gaps = 36/271 (13%)
Query: 616 GTFSTVYKAV-MPSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVI 674
G+F VY A + + ++++K++ + +I+E+ L KL H N ++ G +
Sbjct: 26 GSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYL 85
Query: 675 YEDVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLD 734
E A L+ Y L ++ G +GLA+LH +IH D
Sbjct: 86 REHTAWLVMEYCLGSASDLLEVHKKPLQ-----EVEIAAVTHGALQGLAYLHSHNMIHRD 140
Query: 735 ISSGNVLLDADFKPLLGEIEISKLLDPSKGTASISAVAGSFGYIPPEYAYTM---QVTAP 791
+ +GN+LL LG+ + ++ P+ + G+ ++ PE M Q
Sbjct: 141 VKAGNILLSEPGLVKLGDFGSASIMAPAN------SFVGTPYWMAPEVILAMDEGQYDGK 194
Query: 792 GNVYSYGVVLLEILTTRLPVEEDFGEGV--DLVKWVHGAPARGETPEQILDARLSTVSFG 849
+V+S G+ +E+ + P+ + + A G E +
Sbjct: 195 VDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQSGHWSEYFRN--------- 245
Query: 850 WRKEMLTALKVALLCTDSTPAKRPKMKKVVE 880
C P RP + +++
Sbjct: 246 ----------FVDSCLQKIPQDRPTSEVLLK 266
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (321), Expect = 3e-33
Identities = 47/271 (17%), Positives = 92/271 (33%), Gaps = 31/271 (11%)
Query: 616 GTFSTVYKAV-MPSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVI 674
G F VYKA + ++ + K + + + E++ L+ H N+V+ +
Sbjct: 23 GAFGKVYKAQNKETSVLAAAKVIDTKSE---EELEDYMVEIDILASCDHPNIVKLLDAFY 79
Query: 675 YEDVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLD 734
YE+ +L + G + ++ E + + + L +LH IIH D
Sbjct: 80 YENNLWILIEFCAGGAVDAVMLELER----PLTESQIQVVCKQTLDALNYLHDNKIIHRD 135
Query: 735 ISSGNVLLDADFKPLLGEIEISKLLDPSKGTASISAVAGSFGYIPPEYAYTMQ-----VT 789
+ +GN+L D L + +S + + G+ ++ PE
Sbjct: 136 LKAGNILFTLDGDIKLADFGVSAKNTRTIQRR--DSFIGTPYWMAPEVVMCETSKDRPYD 193
Query: 790 APGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQILDARLSTVSFG 849
+V+S G+ L+E+ P E V L+K P P + +
Sbjct: 194 YKADVWSLGITLIEMAEIEPPHHELNPMRV-LLKIAKSEPPTLAQPSRWSSNFKDFLKKC 252
Query: 850 WRKEMLTALKVALLCTDSTPAKRPKMKKVVE 880
K R ++++
Sbjct: 253 LEKN---------------VDARWTTSQLLQ 268
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 126 bits (318), Expect = 5e-33
Identities = 53/273 (19%), Positives = 103/273 (37%), Gaps = 30/273 (10%)
Query: 616 GTFSTVYKAVM-PSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVI 674
G++ K G IL K L + ++ E+ L +L H N+VR +I
Sbjct: 15 GSYGRCQKIRRKSDGKILVWKELD-YGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRII 73
Query: 675 YE--DVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVA--- 729
++ Y G LA ++ + TK+ Y D L + + L H +
Sbjct: 74 DRTNTTLYIVMEYCEGGDLASVITKGTKERQY-LDEEFVLRVMTQLTLALKECHRRSDGG 132
Query: 730 --IIHLDISSGNVLLDADFKPLLGEIEISKLLDPSKGTASISAVAGSFGYIPPEYAYTMQ 787
++H D+ NV LD LG+ ++++L+ A A G+ Y+ PE M
Sbjct: 133 HTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAK--AFVGTPYYMSPEQMNRMS 190
Query: 788 VTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQILDARLSTVS 847
+++S G +L E+ P ++ E +I + + +
Sbjct: 191 YNEKSDIWSLGCLLYELCALMPPFTAF---------------SQKELAGKIREGKFRRIP 235
Query: 848 FGWRKEMLTALKVALLCTDSTPAKRPKMKKVVE 880
+ + E ++ + RP +++++E
Sbjct: 236 YRYSDE---LNEIITRMLNLKDYHRPSVEEILE 265
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (306), Expect = 2e-31
Identities = 53/273 (19%), Positives = 100/273 (36%), Gaps = 35/273 (12%)
Query: 616 GTFSTVYKAV-MPSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGF-- 672
G+F TVYK + + + ++ L+ + + + E E L L H N+VR
Sbjct: 20 GSFKTVYKGLDTETTVEVAWCELQD-RKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWE 78
Query: 673 --VIYEDVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLH--HV 728
V + +L+ + +GTL L S + +GL FLH
Sbjct: 79 STVKGKKCIVLVTELMTSGTLKTYLKRFK-----VMKIKVLRSWCRQILKGLQFLHTRTP 133
Query: 729 AIIHLDISSGNVLLDA-DFKPLLGEIEISKLLDPSKGTASISAVAGSFGYIPPEYAYTMQ 787
IIH D+ N+ + +G++ ++ L S A V G+ ++ PE Y +
Sbjct: 134 PIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAKA----VIGTPEFMAPEM-YEEK 188
Query: 788 VTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQILDARLSTVS 847
+VY++G+ +LE+ T+ P E + + V + +
Sbjct: 189 YDESVDVYAFGMCMLEMATSEYPYSECQNA-AQIYRRVTSGVKPASFDKVAIPE------ 241
Query: 848 FGWRKEMLTALKVALLCTDSTPAKRPKMKKVVE 880
++ C +R +K ++
Sbjct: 242 ---------VKEIIEGCIRQNKDERYSIKDLLN 265
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 119 bits (300), Expect = 2e-30
Identities = 40/200 (20%), Positives = 80/200 (40%), Gaps = 6/200 (3%)
Query: 616 GTFSTVYKAV-MPSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVI 674
G+FSTV A + + ++K L+ + + RE + +S+L H V+
Sbjct: 19 GSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQ 78
Query: 675 YEDVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLD 734
++ +Y NG L + + + D + L +LH IIH D
Sbjct: 79 DDEKLYFGLSYAKNGELLKYIRKIG-----SFDETCTRFYTAEIVSALEYLHGKGIIHRD 133
Query: 735 ISSGNVLLDADFKPLLGEIEISKLLDPSKGTASISAVAGSFGYIPPEYAYTMQVTAPGNV 794
+ N+LL+ D + + +K+L P A ++ G+ Y+ PE ++
Sbjct: 134 LKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDL 193
Query: 795 YSYGVVLLEILTTRLPVEED 814
++ G ++ +++ P
Sbjct: 194 WALGCIIYQLVAGLPPFRAG 213
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 117 bits (294), Expect = 4e-29
Identities = 41/268 (15%), Positives = 93/268 (34%), Gaps = 28/268 (10%)
Query: 616 GTFSTVYKAV-MPSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVI 674
G F V++ +G + K + + + + + +E++ +S L H LV
Sbjct: 37 GAFGVVHRVTERATGNNFAAKFVMTPHES---DKETVRKEIQTMSVLRHPTLVNLHDAFE 93
Query: 675 YEDVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLD 734
++ ++++ ++ G L + + + + + V +GL +H +HLD
Sbjct: 94 DDNEMVMIYEFMSGGELFEKVADEHN----KMSEDEAVEYMRQVCKGLCHMHENNYVHLD 149
Query: 735 ISSGNVLLDADF--KPLLGEIEISKLLDPSKGTASISAVAGSFGYIPPEYAYTMQVTAPG 792
+ N++ + L + ++ LDP + G+ + PE A V
Sbjct: 150 LKPENIMFTTKRSNELKLIDFGLTAHLDPKQSVKV---TTGTAEFAAPEVAEGKPVGYYT 206
Query: 793 NVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQILDARLSTVSFGWRK 852
+++S GV+ +L+ P G ET + + +
Sbjct: 207 DMWSVGVLSYILLSGLSP---------------FGGENDDETLRNVKSCDWNMDDSAFSG 251
Query: 853 EMLTALKVALLCTDSTPAKRPKMKKVVE 880
+ P R + + +E
Sbjct: 252 ISEDGKDFIRKLLLADPNTRMTIHQALE 279
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 117 bits (293), Expect = 6e-29
Identities = 43/268 (16%), Positives = 91/268 (33%), Gaps = 28/268 (10%)
Query: 616 GTFSTVYKAV-MPSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVI 674
G F V++ V +G + K + + + + E+ +++L H L+
Sbjct: 40 GAFGVVHRCVEKATGRVFVAKFINTPY---PLDKYTVKNEISIMNQLHHPKLINLHDAFE 96
Query: 675 YEDVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLD 734
+ +L+ +L G L + DY+ ++ EGL +H +I+HLD
Sbjct: 97 DKYEMVLILEFLSGGELFDRI----AAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLD 152
Query: 735 ISSGNVLLDADFKPLLGEIE--ISKLLDPSKGTASISAVAGSFGYIPPEYAYTMQVTAPG 792
I N++ + + I+ ++ L+P + + + PE V
Sbjct: 153 IKPENIMCETKKASSVKIIDFGLATKLNPDEIVKV---TTATAEFAAPEIVDREPVGFYT 209
Query: 793 NVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQILDARLSTVSFGWRK 852
++++ GV+ +L+ P + ET + + +
Sbjct: 210 DMWAIGVLGYVLLSGLSPFAGEDDL---------------ETLQNVKRCDWEFDEDAFSS 254
Query: 853 EMLTALKVALLCTDSTPAKRPKMKKVVE 880
A P KR + +E
Sbjct: 255 VSPEAKDFIKNLLQKEPRKRLTVHDALE 282
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 115 bits (288), Expect = 8e-29
Identities = 51/289 (17%), Positives = 107/289 (37%), Gaps = 22/289 (7%)
Query: 616 GTFSTVYKA--VMPSGLILSVKRLK--SMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIG 671
G + V+KA + G +++KR++ + + + + + L L H N+VR
Sbjct: 18 GAYGKVFKARDLKNGGRFVALKRVRVQTGEEGMPLSTIREVAVLRHLETFEHPNVVRLFD 77
Query: 672 FVIYEDVALLLHNYLPNGTLAQ-LLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAI 730
L + Q L K P+ T + + GL FLH +
Sbjct: 78 VCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRV 137
Query: 731 IHLDISSGNVLLDADFKPLLGEIEISKLLDPSKGTASISAVAGSFGYIPPEYAYTMQVTA 790
+H D+ N+L+ + + L + ++++ ++++V + Y PE
Sbjct: 138 VHRDLKPQNILVTSSGQIKLADFGLARIYSFQM---ALTSVVVTLWYRAPEVLLQSSYAT 194
Query: 791 PGNVYSYGVVLLEILTTRLPVE-EDFGEGVDLVKWVHGAPARGETPEQILDARLSTVSFG 849
P +++S G + E+ + + + + V G P + P + R + S
Sbjct: 195 PVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKS 254
Query: 850 WRK---------EMLTALKVALLCTDSTPAKRPKMKKVVEM--LQEIKQ 887
+ E+ L + L + PAKR + Q++++
Sbjct: 255 AQPIEKFVTDIDELGKDLLLKCLTFN--PAKRISAYSALSHPYFQDLER 301
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 114 bits (286), Expect = 1e-28
Identities = 59/278 (21%), Positives = 96/278 (34%), Gaps = 28/278 (10%)
Query: 616 GTFSTVYKAV-MPSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVI 674
G S V+ A + ++VK L++ + RE + + L H +V
Sbjct: 18 GGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGE 77
Query: 675 YEDVAL----LLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAI 730
E A ++ Y+ TL ++H + + + L F H I
Sbjct: 78 AETPAGPLPYIVMEYVDGVTLRDIVHTEG-----PMTPKRAIEVIADACQALNFSHQNGI 132
Query: 731 IHLDISSGNVLLDADFKPLLGEIEISKLL-DPSKGTASISAVAGSFGYIPPEYAYTMQVT 789
IH D+ N+++ A + + I++ + D +AV G+ Y+ PE A V
Sbjct: 133 IHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVD 192
Query: 790 APGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQILDARLSTVSFG 849
A +VYS G VL E+LT P D V + P LS
Sbjct: 193 ARSDVYSLGCVLYEVLTGEPPFTGD-----SPVSVAYQHVREDPIPPSARHEGLSA---- 243
Query: 850 WRKEMLTALKVALLCTDSTPAKRPKMKKVVEMLQEIKQ 887
V L P R + EM ++ +
Sbjct: 244 ------DLDAVVLKALAKNPENRYQT--AAEMRADLVR 273
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 114 bits (287), Expect = 1e-28
Identities = 36/282 (12%), Positives = 90/282 (31%), Gaps = 29/282 (10%)
Query: 616 GTFSTVYKAV-MPSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVI 674
G+F +Y + +G +++K + ++ E + + + I +
Sbjct: 18 GSFGDIYLGTDIAAGEEVAIKLECVKTK-----HPQLHIESKIYKMMQGGVGIPTIRWCG 72
Query: 675 YEDVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLD 734
E ++ L +L L + ++ + T L +A + + ++H IH D
Sbjct: 73 AEGDYNVMVMELLGPSLEDLFNFCSR----KFSLKTVLLLADQMISRIEYIHSKNFIHRD 128
Query: 735 ISSGNVL---LDADFKPLLGEIEISKLLDPSKGTASI-----SAVAGSFGYIPPEYAYTM 786
+ N L + + ++K ++ I + G+ Y +
Sbjct: 129 VKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGI 188
Query: 787 QVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQILDARLSTV 846
+ + ++ S G VL+ LP + K+ + + TP ++L +
Sbjct: 189 EQSRRDDLESLGYVLMYFNLGSLPWQGLKAATK-RQKYERISEKKMSTPIEVLCKGYPS- 246
Query: 847 SFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEMLQEIKQN 888
C +P + ++ + +
Sbjct: 247 ---------EFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHR 279
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 111 bits (279), Expect = 2e-27
Identities = 53/274 (19%), Positives = 102/274 (37%), Gaps = 29/274 (10%)
Query: 611 NMIYCGTFSTVYKAV-MPSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRP 669
+++ G FS V A + ++++K + + + + M E+ L K+ H N+V
Sbjct: 15 DVLGTGAFSEVILAEDKRTQKLVAIKCIAK--KALEGKEGSMENEIAVLHKIKHPNIVAL 72
Query: 670 IGFVIYEDVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVA 729
L+ + G L + E + V + + +LH +
Sbjct: 73 DDIYESGGHLYLIMQLVSGGELFDRIVEKG-----FYTERDASRLIFQVLDAVKYLHDLG 127
Query: 730 IIHLDISSGNVLL---DADFKPLLGEIEISKLLDPSKGTASISAVAGSFGYIPPEYAYTM 786
I+H D+ N+L D D K ++ + +SK+ DP ++ G+ GY+ PE
Sbjct: 128 IVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLST---ACGTPGYVAPEVLAQK 184
Query: 787 QVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQILDARLSTV 846
+ + +S GV+ +L P ++ + EQIL A
Sbjct: 185 PYSKAVDCWSIGVIAYILLCGYPPFYDENDA---------------KLFEQILKAEYEFD 229
Query: 847 SFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVE 880
S W +A + P KR ++ ++
Sbjct: 230 SPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQ 263
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 111 bits (278), Expect = 2e-27
Identities = 46/200 (23%), Positives = 79/200 (39%), Gaps = 11/200 (5%)
Query: 616 GTFSTVYKAV-MPSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVI 674
G+F V+ +G ++K LK + E LS + H ++R G
Sbjct: 15 GSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQ 74
Query: 675 YEDVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLD 734
++ +Y+ G L LL +S R P A V L +LH II+ D
Sbjct: 75 DAQQIFMIMDYIEGGELFSLLRKS-----QRFPNPVAKFYAAEVCLALEYLHSKDIIYRD 129
Query: 735 ISSGNVLLDADFKPLLGEIEISKLLDPSKGTASISAVAGSFGYIPPEYAYTMQVTAPGNV 794
+ N+LLD + + + +K + T + G+ YI PE T +
Sbjct: 130 LKPENILLDKNGHIKITDFGFAKYVPDVTYT-----LCGTPDYIAPEVVSTKPYNKSIDW 184
Query: 795 YSYGVVLLEILTTRLPVEED 814
+S+G+++ E+L P +
Sbjct: 185 WSFGILIYEMLAGYTPFYDS 204
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 110 bits (274), Expect = 5e-27
Identities = 59/315 (18%), Positives = 105/315 (33%), Gaps = 27/315 (8%)
Query: 51 CNWKGIDCDLNQAFVVKLDLSRLQLRGNITLVSELKALKRLDLSNNAFSGTIPSAFGNLS 110
C+ + + C V DL LDL NN + F NL
Sbjct: 10 CHLRVVQCSDLGLEKVPKDLP--------------PDTALLDLQNNKITEIKDGDFKNLK 55
Query: 111 ELEFLDLSLNKFGGVIPRELGSLKDLRFFNISNNVLVGEIPDELKSLEKLEDFQVSSNKL 170
L L L NK + P L L +S N L K+L++L + K+
Sbjct: 56 NLHTLILINNKISKISPGAFAPLVKLERLYLSKNQLKELPEKMPKTLQELRVHENEITKV 115
Query: 171 NGSIPFWVGNLTNLRVFTAYENQLVGEIPDNLGSVSELELLNLHSNQLEGPIPKSIFASG 230
S+ F N + + G + +L + + + IP+ + S
Sbjct: 116 RKSV-FNGLNQMIVVELGTNPLKSSGIENGAFQGMKKLSYIRIADTNIT-TIPQGLPPS- 172
Query: 231 KLEVLVLTQNRLTGDIPELVGHCKSLSNIRIGNNDLVGVIPRAIGNVSGLTYFEADNNNL 290
L L L N++T + +L+ + + N + V ++ N L +NN L
Sbjct: 173 -LTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKL 231
Query: 291 SGEIVPEFSQCSNLTLLNLASNGFTGV------IPPELGQLINLQELILYENSL-FGEIP 343
+ + ++ L +N + + P + + + L+ N + + EI
Sbjct: 232 VKVP-GGLADHKYIQVVYLHNNNISAIGSNDFCPPGYNTKKASYSGVSLFSNPVQYWEIQ 290
Query: 344 KSILAC-KNLNKLDL 357
S C + L
Sbjct: 291 PSTFRCVYVRAAVQL 305
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 91.6 bits (226), Expect = 9e-21
Identities = 43/256 (16%), Positives = 91/256 (35%), Gaps = 5/256 (1%)
Query: 182 TNLRVFTAYENQLVGEIPDNLGSVSELELLNLHSNQLEGPIPKSIFASGKLEVLVLTQNR 241
+ + N++ + ++ L L L +N++ P + KLE L L++N+
Sbjct: 31 PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQ 90
Query: 242 LTGDIPELVGHCKSLSNIRIGNNDLVGVIPRAIGNVSGLTYFEADNNNLSGEIVPEFSQC 301
L ++ + L + + + + + + SG F
Sbjct: 91 LKELPEKMPKTLQELRVHENEITKVRKSVFNGLNQMIVV-ELGTNPLKSSGIENGAFQGM 149
Query: 302 SNLTLLNLASNGFTGVIPPELGQLINLQELILYENSLFGEIPKSILACKNLNKLDLSNNR 361
L+ + +A T + G +L EL L N + S+ NL KL LS N
Sbjct: 150 KKLSYIRIADTNITTIPQ---GLPPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNS 206
Query: 362 FNGTIPNAICDMSRLQYLLLGQNSLKGEIPHEIGNCMKLLQLHIGSNYLTGSIPPEIGHI 421
+ ++ + L+ L L N L ++P + + + +++ +N ++ +
Sbjct: 207 ISAVDNGSLANTPHLRELHLNNNKLV-KVPGGLADHKYIQVVYLHNNNISAIGSNDFCPP 265
Query: 422 RNLQIALNLSFNHLHG 437
+ S L
Sbjct: 266 GYNTKKASYSGVSLFS 281
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 90.9 bits (224), Expect = 2e-20
Identities = 37/215 (17%), Positives = 79/215 (36%), Gaps = 5/215 (2%)
Query: 302 SNLTLLNLASNGFTGVIPPELGQLINLQELILYENSLFGEIPKSILACKNLNKLDLSNNR 361
+ LL+L +N T + + L NL LIL N + P + L +L LS N+
Sbjct: 31 PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSKNQ 90
Query: 362 FNGTIPNAICDMSRLQYLLLGQNSLKGEIPHEIGNCMKLLQLHIGSNYLTGSIPPEIGHI 421
+ L+ ++ + + + N M +++L +G +
Sbjct: 91 LKELPEKMPKTLQELRVHENEITKVRKSVFNGL-NQMIVVELGTNPLKSSGIENGAFQGM 149
Query: 422 RNLQIALNLSFNHLHGSLPPELGKLDKLVSFDVSNNQLSGTIPSALKGMLSLIEVNFSNN 481
+ L ++ ++ ++P L L + N+++ ++LKG+ +L ++ S N
Sbjct: 150 KKLSYI-RIADTNIT-TIPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFN 205
Query: 482 LLTGPVPSFVPFQKSPNSSFFGNKGLCGEPLSFSC 516
++ + N L P +
Sbjct: 206 SISAVDNGSLANTPHLRELHLNNNKLVKVPGGLAD 240
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Score = 80.1 bits (196), Expect = 8e-17
Identities = 52/238 (21%), Positives = 90/238 (37%), Gaps = 11/238 (4%)
Query: 270 IPRAIGNVSGLTYFEADNNNLSGEIVPEFSQCSNLTLLNLASNGFTGVIPPELGQLINLQ 329
+P+ + + NN ++ +F NL L L +N + + P L+ L+
Sbjct: 25 VPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLE 82
Query: 330 ELILYENSLFGEIPKSILACKNLNKLDLSNNRFNGTIPNAICDMSRLQYLLLGQNSLK-- 387
L L +N L E+P+ + K L +L + N + ++++ + LG N LK
Sbjct: 83 RLYLSKNQL-KELPEKM--PKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSS 139
Query: 388 GEIPHEIGNCMKLLQLHIGSNYLTGSIPPEIGHIRNLQIALNLSFNHLHGSLPPELGKLD 447
G KL + I +T +IP G +L L+L N + L L+
Sbjct: 140 GIENGAFQGMKKLSYIRIADTNIT-TIPQ--GLPPSLTE-LHLDGNKITKVDAASLKGLN 195
Query: 448 KLVSFDVSNNQLSGTIPSALKGMLSLIEVNFSNNLLTGPVPSFVPFQKSPNSSFFGNK 505
L +S N +S +L L E++ +NN L + N
Sbjct: 196 NLAKLGLSFNSISAVDNGSLANTPHLRELHLNNNKLVKVPGGLADHKYIQVVYLHNNN 253
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 110 bits (275), Expect = 6e-27
Identities = 41/268 (15%), Positives = 92/268 (34%), Gaps = 29/268 (10%)
Query: 616 GTFSTVYKAV-MPSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVI 674
G F V++ V S K +K Q + +E+ L+ H N++
Sbjct: 16 GEFGIVHRCVETSSKKTYMAKFVKVKGT----DQVLVKKEISILNIARHRNILHLHESFE 71
Query: 675 YEDVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLD 734
+ +++ ++ + + ++ S + + +S V E L FLH I H D
Sbjct: 72 SMEELVMIFEFISGLDIFERINTS----AFELNEREIVSYVHQVCEALQFLHSHNIGHFD 127
Query: 735 ISSGNVLLDAD--FKPLLGEIEISKLLDPSKGTASISAVAGSFGYIPPEYAYTMQVTAPG 792
I N++ + E ++ L P + + Y PE V+
Sbjct: 128 IRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLF---TAPEYYAPEVHQHDVVSTAT 184
Query: 793 NVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQILDARLSTVSFGWRK 852
+++S G ++ +L+ P + + + E I++A + +++
Sbjct: 185 DMWSLGTLVYVLLSGINPFLAETNQ---------------QIIENIMNAEYTFDEEAFKE 229
Query: 853 EMLTALKVALLCTDSTPAKRPKMKKVVE 880
+ A+ R + ++
Sbjct: 230 ISIEAMDFVDRLLVKERKSRMTASEALQ 257
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 111 bits (277), Expect = 8e-27
Identities = 68/402 (16%), Positives = 136/402 (33%), Gaps = 33/402 (8%)
Query: 56 IDCDLNQAFVVKLDLSRLQLRGNITLVSELKALKRLDLSNNAFSGTIPSAFGNLSELEFL 115
I D A +K L + + ++ ++L + L L+ L +
Sbjct: 15 IFTDTALAEKMKTVLGKTNVTDTVSQ-TDLDQVTTLQADRLGIKSI--DGVEYLNNLTQI 71
Query: 116 DLSLNKFGGVIPRELGSLKDLRFFNISNNVLVGEIPDELKSLEKLEDFQVSSNKLNGSIP 175
+ S N+ + P L +L L ++NN + P + +
Sbjct: 72 NFSNNQLTDITP--LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQIT----DI 125
Query: 176 FWVGNLTNLRVFTAYENQLVGEIPDNLGSVSELELLNLHSNQLEGPIPKSIFASGKLEVL 235
+ NLTNL N + + + + + +
Sbjct: 126 DPLKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTD-------LKPLANLTTLE 178
Query: 236 VLTQNRLTGDIPELVGHCKSLSNIRIGNNDLVGVIPRAIGNVSGLTYFEADNNNLSGEIV 295
L + ++ +L ++ NN + + P I ++ L + N L +
Sbjct: 179 RLDISSNKVSDISVLAKLTNLESLIATNNQISDITPLGI--LTNLDELSLNGNQLKD--I 234
Query: 296 PEFSQCSNLTLLNLASNGFTGVIPPELGQLINLQELILYENSLFGEIPKSILACKNLNKL 355
+ +NLT L+LA+N + + P L L L EL L N + P + L
Sbjct: 235 GTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISPLAGLTALTNL-- 290
Query: 356 DLSNNRFNGTIPNAICDMSRLQYLLLGQNSLKGEIPHEIGNCMKLLQLHIGSNYLTGSIP 415
N + I ++ L YL L N++ P + + KL +L +N ++
Sbjct: 291 --ELNENQLEDISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--V 344
Query: 416 PEIGHIRNLQIALNLSFNHLHGSLPPELGKLDKLVSFDVSNN 457
+ ++ N+ L+ N + P L L ++ +++
Sbjct: 345 SSLANLTNINW-LSAGHNQISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 104 bits (259), Expect = 2e-24
Identities = 64/388 (16%), Positives = 119/388 (30%), Gaps = 38/388 (9%)
Query: 108 NLSELEFLDLSLNKFGGVIP-RELGSLKDLRFFNISNNVLVGEIPDELKSLEKLEDFQVS 166
L+E L + +L + L+ + + D ++ L L S
Sbjct: 20 ALAEKMKTVLGKTNVTDTVSQTDLDQVTTLQADRLGIKSI-----DGVEYLNNLTQINFS 74
Query: 167 SNKLNGSIPFWVGNLTNLRV----FTAYENQLVGEIPDNLGSVSELELLNLHSNQLEGPI 222
+N+L P NLT L + NL ++ + L+
Sbjct: 75 NNQLTDITPL--KNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLT 132
Query: 223 PKSIFASGKLEVLVLTQNRLTGDIPELVGHCKSLSNIRIGN---------NDLVGVIPRA 273
+ + ++ + +L + + N +
Sbjct: 133 NLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANLTTLERLDISSNKVSDISV 192
Query: 274 IGNVSGLTYFEADNNNLSGEIVPEFSQCSNLTLLNLASNGFTGVIPPELGQLINLQELIL 333
+ ++ L A NN +S + +NL L+L N L L NL +L L
Sbjct: 193 LAKLTNLESLIATNNQISD--ITPLGILTNLDELSLNGNQLKD--IGTLASLTNLTDLDL 248
Query: 334 YENSLFGEIPKSILACKNLNKLDLSNNRFNGTIPNAICDMSRLQYLLLGQNSLKGEIPHE 393
N + P + L +L L N+ + P A N + E
Sbjct: 249 ANNQISNLAP--LSGLTKLTELKLGANQISNISPLAGLTALTNLE----LNENQLEDISP 302
Query: 394 IGNCMKLLQLHIGSNYLTGSIPPEIGHIRNLQIALNLSFNHLHGSLPPELGKLDKLVSFD 453
I N L L + N ++ P + + LQ L + N + L L +
Sbjct: 303 ISNLKNLTYLTLYFNNISDISP--VSSLTKLQR-LFFANNKVSD--VSSLANLTNINWLS 357
Query: 454 VSNNQLSGTIPSALKGMLSLIEVNFSNN 481
+NQ+S P L + + ++ ++
Sbjct: 358 AGHNQISDLTP--LANLTRITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 83.9 bits (206), Expect = 1e-17
Identities = 61/384 (15%), Positives = 127/384 (33%), Gaps = 47/384 (12%)
Query: 136 LRFFNISNNVLVGEI-PDELKSLEKLEDFQVSSNKLNGSIPFWVGNLTNLRVFTAYENQL 194
L I+ + + +I D +L + + + ++ +L + A +
Sbjct: 1 LGSATITQDTPINQIFTDT--ALAEKMKTVLGKTNVTDTVSQT--DLDQVTTLQADRLGI 56
Query: 195 VGEIPDNLGSVSELELLNLHSNQLEGPIP-------KSIFASGKLEVLVLTQNRLTGDIP 247
+ D + ++ L +N +NQL P I + + LT
Sbjct: 57 --KSIDGVEYLNNLTQINFSNNQLTDITPLKNLTKLVDILMNNNQIADITPLANLTNLTG 114
Query: 248 ELVGHCKSLSNIRIGNNDLVGVIPRAIGNVSGLTYFEADNNNLSGEIVPEFSQCSNLTLL 307
+ + + + N + + + +S ++ + + + L L
Sbjct: 115 LTLFNNQITDIDPLKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTDLKPLANL 174
Query: 308 NLASNGF----TGVIPPELGQLINLQELILYENSLFGEIPKSILACKNLNKLDLSNNRFN 363
L +L NL+ LI N + P I NL++L L+ N+
Sbjct: 175 TTLERLDISSNKVSDISVLAKLTNLESLIATNNQISDITPLGI--LTNLDELSLNGNQLK 232
Query: 364 GTIPNAICDMSRLQYLLLGQNSLKGEIPHEIGNCMKLLQLHIGSNYLTGSIPPEIGHIRN 423
+ ++ L L L N + P + KL +L +G+N ++ P
Sbjct: 233 D--IGTLASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNISPLAGLTALT 288
Query: 424 LQIA-------------------LNLSFNHLHGSLPPELGKLDKLVSFDVSNNQLSGTIP 464
L L FN++ P + L KL +NN++S
Sbjct: 289 NLELNENQLEDISPISNLKNLTYLTLYFNNISDISP--VSSLTKLQRLFFANNKVSD--V 344
Query: 465 SALKGMLSLIEVNFSNNLLTGPVP 488
S+L + ++ ++ +N ++ P
Sbjct: 345 SSLANLTNINWLSAGHNQISDLTP 368
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 75.0 bits (183), Expect = 7e-15
Identities = 41/190 (21%), Positives = 74/190 (38%), Gaps = 13/190 (6%)
Query: 51 CNWKGIDCDLNQAFVVKLDLSRLQLRGNITLVSELKALKRLDLSNNAFSGTIPSAFGNLS 110
I + +L L+ QL+ I ++ L L LDL+NN S P L+
Sbjct: 207 NQISDITPLGILTNLDELSLNGNQLKD-IGTLASLTNLTDLDLANNQISNLAP--LSGLT 263
Query: 111 ELEFLDLSLNKFGGVIPRELGSLKDLRFFNISNNVLVGEIPDELKSLEKLEDFQVSSNKL 170
+L L L N+ + P L L L ++ N E + +L+ L + N +
Sbjct: 264 KLTELKLGANQISNISP--LAGLTALTNLELNENQ--LEDISPISNLKNLTYLTLYFNNI 319
Query: 171 NGSIPFWVGNLTNLRVFTAYENQLVGEIPDNLGSVSELELLNLHSNQLEGPIPKSIFASG 230
+ P +LT L+ N++ +L +++ + L+ NQ+ P +
Sbjct: 320 SDISPV--SSLTKLQRLFFANNKVSD--VSSLANLTNINWLSAGHNQISDLTP--LANLT 373
Query: 231 KLEVLVLTQN 240
++ L L
Sbjct: 374 RITQLGLNDQ 383
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} Length = 384 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Score = 65.8 bits (159), Expect = 6e-12
Identities = 21/104 (20%), Positives = 38/104 (36%), Gaps = 5/104 (4%)
Query: 41 PGWGVNGTNFCNWKGIDCDLNQAFVVKLDLSRLQLRGNITLVSELKALKRLDLSNNAFSG 100
N + I N + L L + + S L L+RL +NN S
Sbjct: 285 TALTNLELNENQLEDISPISNLKNLTYLTLYFNNISDISPV-SSLTKLQRLFFANNKVSD 343
Query: 101 TIPSAFGNLSELEFLDLSLNKFGGVIPRELGSLKDLRFFNISNN 144
S+ NL+ + +L N+ + P L +L + +++
Sbjct: 344 --VSSLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQ 383
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 107 bits (268), Expect = 2e-26
Identities = 50/279 (17%), Positives = 89/279 (31%), Gaps = 37/279 (13%)
Query: 616 GTFSTVYKAV-MPSGLILSVKRLKSMDRTIIHHQNK------MIRELEKLSKL-CHDNLV 667
G S V + + P+ +VK + + ++E++ L K+ H N++
Sbjct: 14 GVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNII 73
Query: 668 RPIGFVIYEDVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHH 727
+ L+ + + G L L E I + E + LH
Sbjct: 74 QLKDTYETNTFFFLVFDLMKKGELFDYLTEKV-----TLSEKETRKIMRALLEVICALHK 128
Query: 728 VAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSKGTASISAVAGSFGYIPPEYAYTMQ 787
+ I+H D+ N+LLD D L + S LDP + + V G+ Y+ PE
Sbjct: 129 LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE---KLREVCGTPSYLAPEIIECSM 185
Query: 788 VTAPGN------VYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQILDA 841
++S GV++ +L P + I+
Sbjct: 186 NDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHR---------------KQMLMLRMIMSG 230
Query: 842 RLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVE 880
S W T + P KR ++ +
Sbjct: 231 NYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALA 269
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 106 bits (264), Expect = 9e-26
Identities = 32/284 (11%), Positives = 83/284 (29%), Gaps = 31/284 (10%)
Query: 616 GTFSTVYKAV-MPSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVI 674
G+F +++ + + +++K ++ E L + + +
Sbjct: 16 GSFGVIFEGTNLLNNQQVAIKFEPRR-----SDAPQLRDEYRTYKLLAGCTGIPNVYYFG 70
Query: 675 YEDVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLD 734
E + +L L +L LL + + T A + + +H ++++ D
Sbjct: 71 QEGLHNVLVIDLLGPSLEDLLDLCGR----KFSVKTVAMAAKQMLARVQSIHEKSLVYRD 126
Query: 735 ISSGNVLLDADFKPLLGEIEI-----SKLLDPSKGTASI-----SAVAGSFGYIPPEYAY 784
I N L+ I + K I ++G+ Y+
Sbjct: 127 IKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHL 186
Query: 785 TMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQILDARLS 844
+ + ++ + G V + L LP + G + ++
Sbjct: 187 GREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCA---- 242
Query: 845 TVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEMLQEIKQN 888
G+ +E + + P + + ++ +
Sbjct: 243 ----GFPEEFYKYMH---YARNLAFDATPDYDYLQGLFSKVLER 279
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 106 bits (265), Expect = 2e-25
Identities = 42/286 (14%), Positives = 111/286 (38%), Gaps = 31/286 (10%)
Query: 616 GTFSTVYKAV-MPSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVI 674
G + V A + + +++K++ + + + +RE++ L + H+N++ +
Sbjct: 19 GAYGMVCSAYDNVNKVRVAIKKISPFEHQ--TYCQRTLREIKILLRFRHENIIGINDIIR 76
Query: 675 YEDVA----LLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAI 730
+ + L +L L +LL + GL ++H +
Sbjct: 77 APTIEQMKDVYLVTHLMGADLYKLLKT------QHLSNDHICYFLYQILRGLKYIHSANV 130
Query: 731 IHLDISSGNVLLDADFKPLLGEIEISKLLDPSKGT-ASISAVAGSFGYIPPEYAYT-MQV 788
+H D+ N+LL+ + + ++++ DP ++ + Y PE
Sbjct: 131 LHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGY 190
Query: 789 TAPGNVYSYGVVLLEILTTRLP-VEEDFGEGVDLVKWVHGAPARGETPEQILDARLSTVS 847
T +++S G +L E+L+ R + + + ++ + + G+P++ + I + +
Sbjct: 191 TKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLL 250
Query: 848 FGWRKEMLTALKV-------------ALLCTDSTPAKRPKMKKVVE 880
K + ++ +L + P KR ++++ +
Sbjct: 251 SLPHKNKVPWNRLFPNADSKALDLLDKMLTFN--PHKRIEVEQALA 294
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 105 bits (262), Expect = 3e-25
Identities = 45/197 (22%), Positives = 75/197 (38%), Gaps = 9/197 (4%)
Query: 616 GTFSTVYKAV-MPSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLC-HDNLVRPIGFV 673
G+F V+ A + ++K LK + + E LS H L
Sbjct: 13 GSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTF 72
Query: 674 IYEDVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHL 733
++ + YL G L + ++ D A + GL FLH I++
Sbjct: 73 QTKENLFFVMEYLNGGDLMYHIQSC-----HKFDLSRATFYAAEIILGLQFLHSKGIVYR 127
Query: 734 DISSGNVLLDADFKPLLGEIEISKLLDPSKGTASISAVAGSFGYIPPEYAYTMQVTAPGN 793
D+ N+LLD D + + + K G A + G+ YI PE + +
Sbjct: 128 DLKLDNILLDKDGHIKIADFGMCKENML--GDAKTNTFCGTPDYIAPEILLGQKYNHSVD 185
Query: 794 VYSYGVVLLEILTTRLP 810
+S+GV+L E+L + P
Sbjct: 186 WWSFGVLLYEMLIGQSP 202
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 103 bits (256), Expect = 7e-25
Identities = 62/276 (22%), Positives = 109/276 (39%), Gaps = 9/276 (3%)
Query: 211 LNLHSNQLEGPIPKSIFASGKLEVLVLTQNRLTGDIPELVGHCKSLSNIRIGNNDLVGVI 270
+ L+ +P I A+ + + L NR++ C++L+ + + +N L +
Sbjct: 16 TSCPQQGLQA-VPVGIPAA--SQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARID 72
Query: 271 PRAIGNVSGLTYFEADNNNLSGEIVP-EFSQCSNLTLLNLASNGFTGVIPPELGQLINLQ 329
A ++ L + +N + P F L L+L G + P L LQ
Sbjct: 73 AAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQ 132
Query: 330 ELILYENSLFGEIPKSILACKNLNKLDLSNNRFNGTIPNAICDMSRLQYLLLGQNSLKGE 389
L L +N+L + NL L L NR + A + L LLL QN +
Sbjct: 133 YLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHV 192
Query: 390 IPHEIGNCMKLLQLHIGSNYLTGSIPPEIGHIRNLQIALNLSFNHLHGSLPPELGKLDKL 449
PH + +L+ L++ +N L+ + +R LQ L L+ N L
Sbjct: 193 HPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQY-LRLNDNPWVCD-CRARPLWAWL 250
Query: 450 VSFDVSNNQLSGTIPSALKGMLSLIEVNFSNNLLTG 485
F S++++ ++P L G L + ++ L G
Sbjct: 251 QKFRGSSSEVPCSLPQRLAG-RDLKRLAAND--LQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 93.0 bits (229), Expect = 2e-21
Identities = 56/266 (21%), Positives = 88/266 (33%), Gaps = 8/266 (3%)
Query: 197 EIPDNLGSVSELELLNLHSNQLEGPIPKSIFASGKLEVLVLTQNRLTGDIPELVGHCKSL 256
+P + + + + LH N++ S A L +L L N L L
Sbjct: 25 AVPVGIPA--ASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALL 82
Query: 257 SNIRIGNNDLVGVI-PRAIGNVSGLTYFEADNNNLSGEIVPEFSQCSNLTLLNLASNGFT 315
+ + +N + + P + L D L F + L L L N
Sbjct: 83 EQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQ 142
Query: 316 GVIPPELGQLINLQELILYENSLFGEIPKSILACKNLNKLDLSNNRFNGTIPNAICDMSR 375
+ L NL L L+ N + ++ +L++L L NR P+A D+ R
Sbjct: 143 ALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGR 202
Query: 376 LQYLLLGQNSLKGEIPHEIGNCMKLLQLHIGSNYLTGSIPPEIGHIRNLQIALNLSFNHL 435
L L L N+L + L L + N LQ S + +
Sbjct: 203 LMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRA-RPLWAWLQ-KFRGSSSEV 260
Query: 436 HGSLPPELGKLDKLVSFDVSNNQLSG 461
SLP L D ++ N L G
Sbjct: 261 PCSLPQRLAGRDLK---RLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 88.3 bits (217), Expect = 8e-20
Identities = 51/277 (18%), Positives = 85/277 (30%), Gaps = 8/277 (2%)
Query: 89 KRLDLSNNAFSGTIPSAFGNLSELEFLDLSLNKFGGVIPRELGSLKDLRFFNISNNVLVG 148
+P + + + L N+ V + ++L + +NVL
Sbjct: 14 VTTSCPQQGLQ-AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLAR 70
Query: 149 EIPDELKSLEKLEDFQVSSNKLNGSI-PFWVGNLTNLRVFTAYENQLVGEIPDNLGSVSE 207
L LE +S N S+ P L L L P ++
Sbjct: 71 IDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAA 130
Query: 208 LELLNLHSNQLEGPIPKSIFASGKLEVLVLTQNRLTGDIPELVGHCKSLSNIRIGNNDLV 267
L+ L L N L+ + G L L L NR++ SL + + N +
Sbjct: 131 LQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVA 190
Query: 268 GVIPRAIGNVSGLTYFEADNNNLSGEIVPEFSQCSNLTLLNLASNGFTGVIPPELGQLIN 327
V P A ++ L NNLS + L L L N +
Sbjct: 191 HVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVC-DCRARPLWAW 249
Query: 328 LQELILYENSLFGEIPKSILACKNLNKLDLSNNRFNG 364
LQ+ + + +P+ + + L+ N G
Sbjct: 250 LQKFRGSSSEVPCSLPQRL---AGRDLKRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 84.5 bits (207), Expect = 2e-18
Identities = 51/266 (19%), Positives = 96/266 (36%), Gaps = 9/266 (3%)
Query: 149 EIPDEL-KSLEKLEDFQVSSNKLNGSIPFWVGNLTNLRVFTAYENQLVGEIPDNLGSVSE 207
+P + + +++ + N+++ NL + + N L ++
Sbjct: 25 AVPVGIPAASQRIF---LHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLAL 81
Query: 208 LELLNLHSNQLEGPIPKSIFAS-GKLEVLVLTQNRLTGDIPELVGHCKSLSNIRIGNNDL 266
LE L+L N + + F G+L L L + L P L +L + + +N L
Sbjct: 82 LEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNAL 141
Query: 267 VGVIPRAIGNVSGLTYFEADNNNLSGEIVPEFSQCSNLTLLNLASNGFTGVIPPELGQLI 326
+ ++ LT+ N +S F +L L L N V P L
Sbjct: 142 QALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLG 201
Query: 327 NLQELILYENSLFGEIPKSILACKNLNKLDLSNNRFNGTIPNAICDMSRLQYLLLGQNSL 386
L L L+ N+L +++ + L L L++N + + LQ + +
Sbjct: 202 RLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRA-RPLWAWLQKFRGSSSEV 260
Query: 387 KGEIPHEIGNCMKLLQLHIGSNYLTG 412
+P + L +L +N L G
Sbjct: 261 PCSLPQRLAG-RDLKRLA--ANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 78.7 bits (192), Expect = 2e-16
Identities = 49/254 (19%), Positives = 82/254 (32%), Gaps = 29/254 (11%)
Query: 88 LKRLDLSNNAFSGTIPSAFGNLSELEFLDLSLNKF------------------------- 122
+R+ L N S ++F L L L N
Sbjct: 34 SQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQL 93
Query: 123 GGVIPRELGSLKDLRFFNISNNVLVGEIPDELKSLEKLEDFQVSSNKLNGSIPFWVGNLT 182
V P L L ++ L P + L L+ + N L +L
Sbjct: 94 RSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLG 153
Query: 183 NLRVFTAYENQLVGEIPDNLGSVSELELLNLHSNQLEGPIPKSIFASGKLEVLVLTQNRL 242
NL + N++ + L+ L LH N++ P + G+L L L N L
Sbjct: 154 NLTHLFLHGNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNL 213
Query: 243 TGDIPELVGHCKSLSNIRIGNNDLVGVIPRAIGNVSGLTYFEADNNNLSGEIVPEFSQCS 302
+ E + ++L +R+ +N V RA + L F ++ + + +
Sbjct: 214 SALPTEALAPLRALQYLRLNDNPWVC-DCRARPLWAWLQKFRGSSSEVPCSLPQRL---A 269
Query: 303 NLTLLNLASNGFTG 316
L LA+N G
Sbjct: 270 GRDLKRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 71.0 bits (172), Expect = 6e-14
Identities = 39/239 (16%), Positives = 70/239 (29%), Gaps = 26/239 (10%)
Query: 302 SNLTLLNLASNGFTGVIPPELGQLINLQELILYENSLFGEI------------------- 342
+ + L N + V NL L L+ N L
Sbjct: 32 AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNA 91
Query: 343 ------PKSILACKNLNKLDLSNNRFNGTIPNAICDMSRLQYLLLGQNSLKGEIPHEIGN 396
P + L+ L L P ++ LQYL L N+L+ +
Sbjct: 92 QLRSVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRD 151
Query: 397 CMKLLQLHIGSNYLTGSIPPEIGHIRNLQIALNLSFNHLHGSLPPELGKLDKLVSFDVSN 456
L L + N ++ + +L L N + P L +L++ +
Sbjct: 152 LGNLTHLFLHGNRISSVPERAFRGLHSLDRL-LLHQNRVAHVHPHAFRDLGRLMTLYLFA 210
Query: 457 NQLSGTIPSALKGMLSLIEVNFSNNLLTGPVPSFVPFQKSPNSSFFGNKGLCGEPLSFS 515
N LS AL + +L + ++N + + ++ C P +
Sbjct: 211 NNLSALPTEALAPLRALQYLRLNDNPWVCDCRARPLWAWLQKFRGSSSEVPCSLPQRLA 269
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 62.1 bits (149), Expect = 5e-11
Identities = 36/187 (19%), Positives = 63/187 (33%), Gaps = 6/187 (3%)
Query: 83 SELKALKRLDLSNNAFSGTIPSAFGNLSELEFLDLSLNKFGGVIPRELGSLKDLRFFNIS 142
L L L L P F L+ L++L L N + L +L +
Sbjct: 102 HGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLH 161
Query: 143 NNVLVGEIPDELKSLEKLEDFQVSSNKLNGSIPFWVGNLTNLRVFTAYENQLVGEIPDNL 202
N + + L L+ + N++ P +L L + N L + L
Sbjct: 162 GNRISSVPERAFRGLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEAL 221
Query: 203 GSVSELELLNLHSNQLEGPIPKSIFASGKLEVLVLTQNRLTGDIPE-LVGHCKSLSNIRI 261
+ L+ L L+ N + L+ + + + +P+ L G + L +
Sbjct: 222 APLRALQYLRLNDNPWVCDCRARPLWA-WLQKFRGSSSEVPCSLPQRLAG--RDLKRLA- 277
Query: 262 GNNDLVG 268
NDL G
Sbjct: 278 -ANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.4 bits (103), Expect = 3e-05
Identities = 11/87 (12%), Positives = 25/87 (28%), Gaps = 3/87 (3%)
Query: 38 LIVPGWGVNGTNFCNWKGIDCDLNQAFVVKLDLSRLQLRGNITLVSELKALKRLDLSNNA 97
L N + + + L L+ + L++ S++
Sbjct: 200 LGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVCDCRARPLWAWLQKFRGSSSE 259
Query: 98 FSGTIPSAFGNLSELEFLDLSLNKFGG 124
++P L+ + L+ N G
Sbjct: 260 VPCSLPQ---RLAGRDLKRLAANDLQG 283
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.3 bits (87), Expect = 0.003
Identities = 28/174 (16%), Positives = 47/174 (27%), Gaps = 5/174 (2%)
Query: 349 CKNLNKL--DLSNNRFNGTIPNAICDMSRLQYLLLGQNSLKGEIPHEIGNCMKLLQLHIG 406
C N K+ +P I + Q + L N + C L L +
Sbjct: 8 CYNEPKVTTSCPQQGLQ-AVPVGI--PAASQRIFLHGNRISHVPAASFRACRNLTILWLH 64
Query: 407 SNYLTGSIPPEIGHIRNLQIALNLSFNHLHGSLPPELGKLDKLVSFDVSNNQLSGTIPSA 466
SN L + L+ L P L +L + + L P
Sbjct: 65 SNVLARIDAAAFTGLALLEQLDLSDNAQLRSVDPATFHGLGRLHTLHLDRCGLQELGPGL 124
Query: 467 LKGMLSLIEVNFSNNLLTGPVPSFVPFQKSPNSSFFGNKGLCGEPLSFSCGNAN 520
+G+ +L + +N L + F + P G +
Sbjct: 125 FRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFRGLHS 178
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 102 bits (254), Expect = 2e-24
Identities = 41/277 (14%), Positives = 101/277 (36%), Gaps = 21/277 (7%)
Query: 616 GTFSTVYKAVMPSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIY 675
GT+ VYKA G ++K+++ +++ + IRE+ L +L H N+V+ +
Sbjct: 13 GTYGVVYKAQNNYGETFALKKIR-LEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHT 71
Query: 676 EDVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDI 735
+ +L+ +L L + + T S + + G+A+ H ++H D+
Sbjct: 72 KKRLVLVFEHLDQDLKKLLDVC-----EGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDL 126
Query: 736 SSGNVLLDADFKPLLGEIEISKLLDPSKGTASISAVAGSFGYIPPEYAYTMQVTAPGNVY 795
N+L++ + + + + +++ + + P + + + +++
Sbjct: 127 KPQNLLINREGELKIADFGLARAFG-IPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIW 185
Query: 796 SYGVVLLEILTTRLPVE-EDFGEGVDLVKWVHGAPARGETPEQILDARLSTVSFGWRKEM 854
S G + E++ + + + + G P P + +
Sbjct: 186 SVGCIFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLP 245
Query: 855 LTALKVA-----------LLCTDSTPAKRPKMKKVVE 880
+ +L D P +R K+ +E
Sbjct: 246 WESFLKGLDESGIDLLSKMLKLD--PNQRITAKQALE 280
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 102 bits (255), Expect = 2e-24
Identities = 48/286 (16%), Positives = 106/286 (37%), Gaps = 24/286 (8%)
Query: 611 NMIYCGTFSTVYKAV-MPSGLILSVKRLKSMDRTIIHHQ--NKMIRELEKLSKLCHDNLV 667
+ + G F+TVYKA + I+++K++K R+ +RE++ L +L H N++
Sbjct: 4 DFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNII 63
Query: 668 RPIGFVIYEDVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHH 727
+ ++ L+ +++ + S + + +GL +LH
Sbjct: 64 GLLDAFGHKSNISLVFDFMETDLEVIIKDNS-----LVLTPSHIKAYMLMTLQGLEYLHQ 118
Query: 728 VAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSKGTASISAVAGSFGYIPPEYAYTMQ 787
I+H D+ N+LLD + L + ++K + + Y PE + +
Sbjct: 119 HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRA--YTHQVVTRWYRAPELLFGAR 176
Query: 788 V-TAPGNVYSYGVVLLEILTTRLPVE-EDFGEGVDLVKWVHGAPARGETPEQILDARLST 845
+ ++++ G +L E+L + + + + + G P + P+ T
Sbjct: 177 MYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVT 236
Query: 846 VSFGWRKEMLTALKVA----------LLCTDSTPAKRPKMKKVVEM 881
+ A L + P R + ++M
Sbjct: 237 FKSFPGIPLHHIFSAAGDDLLDLIQGLFLFN--PCARITATQALKM 280
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 101 bits (252), Expect = 4e-24
Identities = 50/287 (17%), Positives = 105/287 (36%), Gaps = 23/287 (8%)
Query: 616 GTFSTVYKAV-MPSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVI 674
GT+ VYKA +G ++++K+++ +D + IRE+ L +L H N+V+ + +
Sbjct: 13 GTYGVVYKARNKLTGEVVALKKIR-LDTETEGVPSTAIREISLLKELNHPNIVKLLDVIH 71
Query: 675 YEDVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLD 734
E+ L+ +L + P S + +GLAF H ++H D
Sbjct: 72 TENKLYLVFEFLHQDLKKFMD----ASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRD 127
Query: 735 ISSGNVLLDADFKPLLGEIEISKLLDPSKGTASISAVAGSFGYIPPEYAYTMQVTAPGNV 794
+ N+L++ + L + +++ V + P + ++
Sbjct: 128 LKPQNLLINTEGAIKLADFGLARAFG-VPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDI 186
Query: 795 YSYGVVLLEILTTRLPVE-EDFGEGVDLVKWVHGAPARGETPEQILDARLSTVSFGWRKE 853
+S G + E++T R + + + + G P P W ++
Sbjct: 187 WSLGCIFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQ 246
Query: 854 MLTALKVA-----------LLCTDSTPAKRPKMKKVVEM--LQEIKQ 887
+ + +L D P KR K + Q++ +
Sbjct: 247 DFSKVVPPLDEDGRSLLSQMLHYD--PNKRISAKAALAHPFFQDVTK 291
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 101 bits (251), Expect = 5e-24
Identities = 68/265 (25%), Positives = 112/265 (42%), Gaps = 8/265 (3%)
Query: 256 LSNIRIGNNDLVGV--IPRAIGNVSGLTYFE-ADNNNLSGEIVPEFSQCSNLTLLNLASN 312
++N+ + +L IP ++ N+ L + NNL G I P ++ + L L +
Sbjct: 52 VNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHT 111
Query: 313 GFTGVIPPELGQLINLQELILYENSLFGEIPKSILACKNLNKLDLSNNRFNGTIPNAICD 372
+G IP L Q+ L L N+L G +P SI + NL + NR +G IP++
Sbjct: 112 NVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGS 171
Query: 373 MSRLQY-LLLGQNSLKGEIPHEIGNCMKLLQLHIGSNYLTGSIPPEIGHIRNLQIALNLS 431
S+L + + +N L G+IP N + + +
Sbjct: 172 FSKLFTSMTISRNRLTGKIPPTFANLNLAFVDL---SRNMLEGDASVLFGSDKNTQKIHL 228
Query: 432 FNHLHGSLPPELGKLDKLVSFDVSNNQLSGTIPSALKGMLSLIEVNFSNNLLTGPVPSFV 491
+ ++G L D+ NN++ GT+P L + L +N S N L G +P
Sbjct: 229 AKNSLAFDLGKVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGG 288
Query: 492 PFQKSPNSSFFGNKGLCGEPLSFSC 516
Q+ S++ NK LCG PL +C
Sbjct: 289 NLQRFDVSAYANNKCLCGSPLP-AC 312
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 99.4 bits (246), Expect = 3e-23
Identities = 83/309 (26%), Positives = 126/309 (40%), Gaps = 18/309 (5%)
Query: 26 NDEPTLLAINKELIVPG----WGVNGTNFCN--WKGIDCDLNQAF--VVKLDLSRLQLRG 77
D+ LL I K+L P W + T+ CN W G+ CD + V LDLS L L
Sbjct: 6 QDKQALLQIKKDLGNPTTLSSW-LPTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPK 64
Query: 78 NITLVSELKALKRL---DLSNNA-FSGTIPSAFGNLSELEFLDLSLNKFGGVIPRELGSL 133
+ S L L L + G IP A L++L +L ++ G IP L +
Sbjct: 65 PYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQI 124
Query: 134 KDLRFFNISNNVLVGEIPDELKSLEKLEDFQVSSNKLNGSIPFWVGNLTNLRV-FTAYEN 192
K L + S N L G +P + SL L N+++G+IP G+ + L T N
Sbjct: 125 KTLVTLDFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRN 184
Query: 193 QLVGEIPDNLGSVSELELLNLHSNQLEGPIPKSIFASGKLEVLVLTQNRLTGDIPELVGH 252
+L G+IP +++ S + +F S K + VG
Sbjct: 185 RLTGKIPPTFANLNLAF--VDLSRNMLEGDASVLFGSDKNTQKIHLAKNSLAFDLGKVGL 242
Query: 253 CKSLSNIRIGNNDLVGVIPRAIGNVSGLTYFEADNNNLSGEIVPEFSQCSNLTLLNLASN 312
K+L+ + + NN + G +P+ + + L NNL GEI P+ + A+N
Sbjct: 243 SKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEI-PQGGNLQRFDVSAYANN 301
Query: 313 -GFTGVIPP 320
G P
Sbjct: 302 KCLCGSPLP 310
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 55.5 bits (132), Expect = 9e-09
Identities = 15/64 (23%), Positives = 29/64 (45%), Gaps = 3/64 (4%)
Query: 163 FQVSSNKLNGSIPFWVGNLTNLRVFTAYENQLVGEIPDNLGSVSELELLNLHSNQL--EG 220
+ +N++ G++P + L L N L GEIP G++ ++ +N+
Sbjct: 249 LDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIP-QGGNLQRFDVSAYANNKCLCGS 307
Query: 221 PIPK 224
P+P
Sbjct: 308 PLPA 311
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 43.6 bits (101), Expect = 6e-05
Identities = 42/150 (28%), Positives = 66/150 (44%), Gaps = 5/150 (3%)
Query: 314 FTGVIPPELGQLINLQELILYENSLFG--EIPKSILACKNLNKLDLSNN-RFNGTIPNAI 370
+ GV+ Q + L L +L IP S+ LN L + G IP AI
Sbjct: 38 WLGVLCDTDTQTYRVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAI 97
Query: 371 CDMSRLQYLLLGQNSLKGEIPHEIGNCMKLLQLHIGSNYLTGSIPPEIGHIRNLQIALNL 430
+++L YL + ++ G IP + L+ L N L+G++PP I + NL
Sbjct: 98 AKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSGTLPPSISSLPNLVGI-TF 156
Query: 431 SFNHLHGSLPPELGKLDKLVS-FDVSNNQL 459
N + G++P G KL + +S N+L
Sbjct: 157 DGNRISGAIPDSYGSFSKLFTSMTISRNRL 186
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} Length = 313 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Score = 43.6 bits (101), Expect = 6e-05
Identities = 39/134 (29%), Positives = 63/134 (47%), Gaps = 4/134 (2%)
Query: 351 NLNKLDLSNNRFNG--TIPNAICDMSRLQYLLLGQN-SLKGEIPHEIGNCMKLLQLHIGS 407
+N LDLS IP+++ ++ L +L +G +L G IP I +L L+I
Sbjct: 51 RVNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITH 110
Query: 408 NYLTGSIPPEIGHIRNLQIALNLSFNHLHGSLPPELGKLDKLVSFDVSNNQLSGTIPSAL 467
++G+IP + I+ L + S+N L G+LPP + L LV N++SG IP +
Sbjct: 111 TNVSGAIPDFLSQIKTLVTL-DFSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSY 169
Query: 468 KGMLSLIEVNFSNN 481
L +
Sbjct: 170 GSFSKLFTSMTISR 183
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 102 bits (255), Expect = 6e-24
Identities = 51/290 (17%), Positives = 95/290 (32%), Gaps = 35/290 (12%)
Query: 606 TMKD---SNMIYCGTFSTVYKAVMP-SGLILSVKRLK---SMDRTIIHHQNKMIRELEKL 658
TM D +I G F VY +G + ++K L + L +
Sbjct: 2 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLV 61
Query: 659 SKLCHDNLVRPIGFVIYEDVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGV 718
S +V D + + + G L L + A +
Sbjct: 62 STGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQ-----HGVFSEADMRFYAAEI 116
Query: 719 AEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSKGTASISAVAGSFGYI 778
GL +H+ +++ D+ N+LLD + ++ ++ K AS+ G+ GY+
Sbjct: 117 ILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPHASV----GTHGYM 172
Query: 779 PPEYAYT-MQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQ 837
PE + + + +S G +L ++L P + + + + E P+
Sbjct: 173 APEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTM-AVELPDS 231
Query: 838 ILDARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEMLQEIKQ 887
L +L LL D +R QE+K+
Sbjct: 232 F-------------SPELRSLLEGLLQRD--VNRRLGCLG--RGAQEVKE 264
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 101 bits (253), Expect = 7e-24
Identities = 38/271 (14%), Positives = 86/271 (31%), Gaps = 28/271 (10%)
Query: 616 GTFSTVYKAV-MPSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLC-HDNLVRPIG-- 671
G V + + ++K ++ K RE+E + ++VR +
Sbjct: 23 GINGKVLQIFNKRTQEKFALK--------MLQDCPKARREVELHWRASQCPHIVRIVDVY 74
Query: 672 --FVIYEDVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVA 729
L++ L G L + + D I + E + +LH +
Sbjct: 75 ENLYAGRKCLLIVMECLDGGELFSRIQ---DRGDQAFTEREASEIMKSIGEAIQYLHSIN 131
Query: 730 IIHLDISSGNVLLDADFKPLLGEIEISKLLDPSKGTASISAVAGSFGYIPPEYAYTMQVT 789
I H D+ N+L + + ++ + S++ + Y+ PE +
Sbjct: 132 IAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYD 191
Query: 790 APGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQILDARLSTVSFG 849
+++S GV++ +L P + HG +I + +
Sbjct: 192 KSCDMWSLGVIMYILLCGYPPFYSN-----------HGLAISPGMKTRIRMGQYEFPNPE 240
Query: 850 WRKEMLTALKVALLCTDSTPAKRPKMKKVVE 880
W + + + P +R + + +
Sbjct: 241 WSEVSEEVKMLIRNLLKTEPTQRMTITEFMN 271
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 98.6 bits (245), Expect = 3e-23
Identities = 46/274 (16%), Positives = 100/274 (36%), Gaps = 43/274 (15%)
Query: 616 GTFSTVYKAV-MPSGLILSVKRLKS---MDRTIIHHQNKMIRELEKLSKL--CHDNLVRP 669
G F +VY + + L +++K ++ D + + ++ E+ L K+ ++R
Sbjct: 15 GGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRL 74
Query: 670 IGFVIYEDVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVA 729
+ + D +L+ S V E + H+
Sbjct: 75 LDWFERPDSFVLILERPEPVQDLFDFITERG----ALQEELARSFFWQVLEAVRHCHNCG 130
Query: 730 IIHLDISSGNVLLDAD-FKPLLGEIEISKLLDPSKGTASISAVAGSFGYIPPEYAYTMQV 788
++H DI N+L+D + + L + LL + T G+ Y PPE+ +
Sbjct: 131 VLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYT----DFDGTRVYSPPEWIRYHRY 186
Query: 789 -TAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQILDARLSTVS 847
V+S G++L +++ +P E D E+I+ ++
Sbjct: 187 HGRSAAVWSLGILLYDMVCGDIPFEHD---------------------EEIIRGQVF--- 222
Query: 848 FGWRKEMLTALK-VALLCTDSTPAKRPKMKKVVE 880
+R+ + + + + C P+ RP +++
Sbjct: 223 --FRQRVSSECQHLIRWCLALRPSDRPTFEEIQN 254
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 98.5 bits (244), Expect = 4e-23
Identities = 46/279 (16%), Positives = 98/279 (35%), Gaps = 23/279 (8%)
Query: 616 GTFSTVYKAV-MPSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVI 674
GT+ TV+KA + I+++KR++ +D + +RE+ L +L H N+VR +
Sbjct: 13 GTYGTVFKAKNRETHEIVALKRVR-LDDDDEGVPSSALREICLLKELKHKNIVRLHDVLH 71
Query: 675 YEDVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLD 734
+ L+ + + D S + +GL F H ++H D
Sbjct: 72 SDKKLTLVFEFCDQDLKKY-----FDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRD 126
Query: 735 ISSGNVLLDADFKPLLGEIEISKLLDPSKGTASISAVAGSFGYIPPEYAYTMQVTAPGNV 794
+ N+L++ + + L +++ S V + P + ++
Sbjct: 127 LKPQNLLINRNGELKLANFGLARAFGIPVRCYSAE-VVTLWYRPPDVLFGAKLYSTSIDM 185
Query: 795 YSYGVVLLEILTTRLPV--EEDFGEGVDLVKWVHGAPARGETPEQILDARLSTVSFGWRK 852
+S G + E+ P+ D + + + + G P + P
Sbjct: 186 WSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPAT 245
Query: 853 EMLTALKV-----------ALLCTDSTPAKRPKMKKVVE 880
L + LL + P +R ++ ++
Sbjct: 246 TSLVNVVPKLNATGRDLLQNLLKCN--PVQRISAEEALQ 282
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 98.3 bits (244), Expect = 1e-22
Identities = 52/290 (17%), Positives = 87/290 (30%), Gaps = 36/290 (12%)
Query: 604 KATMKD---SNMIYCGTFSTVYKAV-MPSGLILSVKRLKSMDRTIIHHQNKMIRELEKLS 659
K TM D ++ GTF V +G ++K L+ + E L
Sbjct: 1 KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 60
Query: 660 KLCHDNLVRPIGFVIYEDVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVA 719
H L D + Y G L L + +
Sbjct: 61 NTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSR-----ERVFTEERARFYGAEIV 115
Query: 720 EGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSKGTASISAVAGSFGYIP 779
L +LH +++ DI N++LD D + + + K T G+ Y+
Sbjct: 116 SALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKT--FCGTPEYLA 173
Query: 780 PEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQIL 839
PE + + GVV+ E++ RLP + E++
Sbjct: 174 PEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFY-------------------NQDHERLF 214
Query: 840 DARLSTVSFGWRK--EMLTALKVALLCTDSTPAKRPKMKKVVEMLQEIKQ 887
+ L R +L LL D P +R +E+ +
Sbjct: 215 ELILMEEIRFPRTLSPEAKSLLAGLLKKD--PKQRLGGGP--SDAKEVME 260
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 96.4 bits (239), Expect = 2e-22
Identities = 43/273 (15%), Positives = 89/273 (32%), Gaps = 31/273 (11%)
Query: 616 GTFSTVYKAV-MPSGLILSVKRLK---SMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIG 671
G F+ V K +GL + K +K + + + RE+ L ++ H N++
Sbjct: 21 GQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHE 80
Query: 672 FVIYEDVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAII 731
+ +L+ + G L L E + G+ +LH + I
Sbjct: 81 VYENKTDVILILELVAGGELFDFLAE-----KESLTEEEATEFLKQILNGVYYLHSLQIA 135
Query: 732 HLDISSGNVLLDADFKPL----LGEIEISKLLDPSKGTASISAVAGSFGYIPPEYAYTMQ 787
H D+ N++L P + + ++ +D + G+ ++ PE
Sbjct: 136 HFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN---EFKNIFGTPEFVAPEIVNYEP 192
Query: 788 VTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQILDARLSTVS 847
+ +++S GV+ +L+ P D + ET +
Sbjct: 193 LGLEADMWSIGVITYILLSGASPFLGDTKQ---------------ETLANVSAVNYEFED 237
Query: 848 FGWRKEMLTALKVALLCTDSTPAKRPKMKKVVE 880
+ A P KR ++ ++
Sbjct: 238 EYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 96.4 bits (239), Expect = 5e-22
Identities = 66/301 (21%), Positives = 108/301 (35%), Gaps = 35/301 (11%)
Query: 608 KDSNMIYCGTFSTVYKAV-MPSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNL 666
D+ +I G+F VY+A SG ++++K++ + REL+ + KL H N+
Sbjct: 23 TDTKVIGNGSFGVVYQAKLCDSGELVAIKKVL-------QDKRFKNRELQIMRKLDHCNI 75
Query: 667 VRPIGFVIYEDVA------LLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAE 720
VR F L+ +Y+P H S + +
Sbjct: 76 VRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQ--TLPVIYVKLYMYQLFR 133
Query: 721 GLAFLHHVAIIHLDISSGNVLLDAD-FKPLLGEIEISKLLDPSKGTASISAVAGSFGYIP 779
LA++H I H DI N+LLD D L + +K L G ++S + + P
Sbjct: 134 SLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVR--GEPNVSYICSRYYRAP 191
Query: 780 PEYAYTMQVTAPGNVYSYGVVLLEILTTRLP-VEEDFGEGVDLVKWVHGAPARGETPE-- 836
T+ +V+S G VL E+L + + + + + V G P R + E
Sbjct: 192 ELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMN 251
Query: 837 ---------QILDARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEM--LQEI 885
QI + V AL LL P R + E+
Sbjct: 252 PNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYT--PTARLTPLEACAHSFFDEL 309
Query: 886 K 886
+
Sbjct: 310 R 310
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 95.3 bits (236), Expect = 7e-22
Identities = 48/285 (16%), Positives = 102/285 (35%), Gaps = 21/285 (7%)
Query: 616 GTFSTVYKAV-MPSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVI 674
GTF V+KA +G +++K++ M+ +RE++ L L H+N+V I
Sbjct: 21 GTFGEVFKARHRKTGQKVALKKVL-MENEKEGFPITALREIKILQLLKHENVVNLIEICR 79
Query: 675 YEDVALLLHN---YLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAII 731
+ YL L + + + GL ++H I+
Sbjct: 80 TKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKIL 139
Query: 732 HLDISSGNVLLDADFKPLLGEIEISKLLDPSKGTA--SISAVAGSFGYIPPEYAYTMQ-V 788
H D+ + NVL+ D L + +++ +K + + + Y PPE +
Sbjct: 140 HRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDY 199
Query: 789 TAPGNVYSYGVVLLEILTTRLPVE-EDFGEGVDLVKWVHGAPARGETPE----------Q 837
P +++ G ++ E+ T ++ + L+ + G+ P +
Sbjct: 200 GPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLE 259
Query: 838 ILDARLSTVSFGWRKEMLTALKVALL--CTDSTPAKRPKMKKVVE 880
++ + V + + + L+ PA+R +
Sbjct: 260 LVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALN 304
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 94.1 bits (233), Expect = 3e-21
Identities = 45/273 (16%), Positives = 86/273 (31%), Gaps = 32/273 (11%)
Query: 616 GTFSTVYKAV-MPSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVI 674
G+F V SG ++K L + + E L + LV+
Sbjct: 52 GSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFK 111
Query: 675 YEDVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLD 734
++ Y+ G + L R P A + +LH + +I+ D
Sbjct: 112 DNSNLYMVMEYVAGGEMFSHLRRIG-----RFSEPHARFYAAQIVLTFEYLHSLDLIYRD 166
Query: 735 ISSGNVLLDADFKPLLGEIEISKLLDPSKGTASISAVAGSFGYIPPEYAYTMQVTAPGNV 794
+ N+L+D + + +K + T + G+ + PE + +
Sbjct: 167 LKPENLLIDQQGYIQVTDFGFAKRVKGRTWT-----LCGTPEALAPEIILSKGYNKAVDW 221
Query: 795 YSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQILDARLSTVSFGWRKEM 854
++ GV++ E+ P D + + + + + + P
Sbjct: 222 WALGVLIYEMAAGYPPFFAD--QPIQIYEKIV--SGKVRFPSHF-------------SSD 264
Query: 855 LTALKVALLCTDSTPAKRPKMKKVVEMLQEIKQ 887
L L LL D KR K + +IK
Sbjct: 265 LKDLLRNLLQVD--LTKRFGNLK--NGVNDIKN 293
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 88.3 bits (218), Expect = 2e-19
Identities = 32/196 (16%), Positives = 79/196 (40%), Gaps = 7/196 (3%)
Query: 616 GTFSTVYKAV-MPSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVI 674
G + V AV +G +++K+L ++ + + + REL L + H+N++ +
Sbjct: 29 GAYGAVCSAVDGRTGAKVAIKKLYRPFQSELFAK-RAYRELRLLKHMRHENVIGLLDVFT 87
Query: 675 YEDVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLD 734
++ ++ + + + + +GL ++H IIH D
Sbjct: 88 PDETLDDFTDFYLVMPFMGTDLGKLMK-HEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRD 146
Query: 735 ISSGNVLLDADFKPLLGEIEISKLLDPSKGTASISAVAGSFGYIPPEYAYTMQVTAPGNV 794
+ GN+ ++ D + + + +++ D V + P M+ T ++
Sbjct: 147 LKPGNLAVNEDCELKILDFGLARQADSEMTG----YVVTRWYRAPEVILNWMRYTQTVDI 202
Query: 795 YSYGVVLLEILTTRLP 810
+S G ++ E++T +
Sbjct: 203 WSVGCIMAEMITGKTL 218
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 87.0 bits (214), Expect = 7e-19
Identities = 52/256 (20%), Positives = 93/256 (36%), Gaps = 20/256 (7%)
Query: 616 GTFSTVYKAV-MPSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVI 674
G FSTV+ A M + +++K ++ + E++ L ++ + +
Sbjct: 24 GHFSTVWLAKDMVNNTHVAMKIVRGDK----VYTEAAEDEIKLLQRVNDADNTKEDSMGA 79
Query: 675 YEDVALLLH--NYLPNGTLAQLLHEST---------KQPDYRPDWPTRLSIAIGVAEGLA 723
+ LL H + PNG ++ E K I+ + GL
Sbjct: 80 NHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLD 139
Query: 724 FLHHVA-IIHLDISSGNVLLDA-DFKPLLGEIEISKLLDPSKGTASISAVAGSFGYIPPE 781
++H IIH DI NVL++ D L +I+I+ L + + + Y PE
Sbjct: 140 YMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEHYTNSIQTREYRSPE 199
Query: 782 YAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGV--DLVKWVHGAPARGETPEQIL 839
+++S ++ E++T E D G D GE P +L
Sbjct: 200 VLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLL 259
Query: 840 DARLSTVSFGWRKEML 855
T +F + +L
Sbjct: 260 RNGKYTRTFFNSRGLL 275
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 85.3 bits (210), Expect = 2e-18
Identities = 52/284 (18%), Positives = 107/284 (37%), Gaps = 35/284 (12%)
Query: 616 GTFSTVYKAV-MPSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFV- 673
G + +V A +GL ++VK+L ++IIH + + REL L + H+N++ +
Sbjct: 29 GAYGSVCAAFDTKTGLRVAVKKLSRPFQSIIHAK-RTYRELRLLKHMKHENVIGLLDVFT 87
Query: 674 ----IYEDVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVA 729
+ E + L +L L ++ + + + GL ++H
Sbjct: 88 PARSLEEFNDVYLVTHLMGADLNNIVKC------QKLTDDHVQFLIYQILRGLKYIHSAD 141
Query: 730 IIHLDISSGNVLLDADFKPLLGEIEISKLLDPSKGTASISAVAGSFGYIPPEYAYTMQVT 789
IIH D+ N+ ++ D + + + +++ D + + P M
Sbjct: 142 IIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMTGYVATR----WYRAPEIMLNWMHYN 197
Query: 790 APGNVYSYGVVLLEILTTRLP-------------VEEDFGEGVDLVKWVHGAPARG--ET 834
+++S G ++ E+LT R + G +L+K + AR ++
Sbjct: 198 QTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQS 257
Query: 835 PEQILDARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKV 878
Q+ + V G + L+ +L D KR +
Sbjct: 258 LTQMPKMNFANVFIGANPLAVDLLE-KMLVLD--SDKRITAAQA 298
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 81.8 bits (201), Expect = 2e-17
Identities = 38/201 (18%), Positives = 79/201 (39%), Gaps = 23/201 (11%)
Query: 616 GTFSTVYKAV-MPSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKL-CHDNLVRPIGFV 673
G +S V++A+ + + + VK LK + + K+ RE++ L L N++ V
Sbjct: 46 GKYSEVFEAINITNNEKVVVKILKPVKK------KKIKREIKILENLRGGPNIITLADIV 99
Query: 674 IYED--VALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAII 731
L+ ++ N QL + + L + H + I+
Sbjct: 100 KDPVSRTPALVFEHVNNTDFKQLYQ--------TLTDYDIRFYMYEILKALDYCHSMGIM 151
Query: 732 HLDISSGNVLLDADFKPL-LGEIEISKLLDPSKGTASISAVAGSFGYIPPEYAYTMQ-VT 789
H D+ NV++D + + L L + +++ P + + S + PE Q
Sbjct: 152 HRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ---EYNVRVASRYFKGPELLVDYQMYD 208
Query: 790 APGNVYSYGVVLLEILTTRLP 810
+++S G +L ++ + P
Sbjct: 209 YSLDMWSLGCMLASMIFRKEP 229
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 80.4 bits (197), Expect = 1e-16
Identities = 30/202 (14%), Positives = 70/202 (34%), Gaps = 19/202 (9%)
Query: 616 GTFSTVYKAV-MPSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVI 674
G V A +++K+L + H + + REL + + H N++ +
Sbjct: 28 GAQGIVCAAYDAVLDRNVAIKKLSRPFQNQTHAK-RAYRELVLMKCVNHKNIISLLNVFT 86
Query: 675 YEDVA------LLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHV 728
+ L+ + + D + + G+ LH
Sbjct: 87 PQKTLEEFQDVYLVMELMDANLCQVIQM--------ELDHERMSYLLYQMLCGIKHLHSA 138
Query: 729 AIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSKGTASISAVAGSFGYIPPEYAYTMQV 788
IIH D+ N+++ +D + + +++ S + + Y PE M
Sbjct: 139 GIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM---TPYVVTRYYRAPEVILGMGY 195
Query: 789 TAPGNVYSYGVVLLEILTTRLP 810
+++S G ++ E++ ++
Sbjct: 196 KENVDIWSVGCIMGEMVRHKIL 217
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 79.5 bits (195), Expect = 2e-16
Identities = 48/280 (17%), Positives = 93/280 (33%), Gaps = 31/280 (11%)
Query: 616 GTFSTVYKAV----MPSGLILSVKRL-KSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPI 670
G + V+ +G + ++K L K+ E + L + + +
Sbjct: 35 GAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTL 94
Query: 671 GFVIYEDVALLLH-NYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVA 729
+ + L L +Y+ G L L + + ++ + L LH +
Sbjct: 95 HYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVG-----EIVLALEHLHKLG 149
Query: 730 IIHLDISSGNVLLDADFKPLLGEIEISKLLDPSKGTASISAVAGSFGYIPPEYAYTMQ-- 787
II+ DI N+LLD++ +L + +SK + + G+ Y+ P+
Sbjct: 150 IIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFC-GTIEYMAPDIVRGGDSG 208
Query: 788 VTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQILDARLSTVS 847
+ +S GV++ E+LT P D + +I L +
Sbjct: 209 HDKAVDWWSLGVLMYELLTGASPFTVD---------------GEKNSQAEISRRILKSEP 253
Query: 848 FGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEMLQEIKQ 887
++ A + P KR EIK+
Sbjct: 254 PYPQEMSALAKDLIQRLLMKDPKKRLGCGP--RDADEIKE 291
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 67.0 bits (162), Expect = 1e-12
Identities = 37/208 (17%), Positives = 65/208 (31%), Gaps = 8/208 (3%)
Query: 274 IGNVSGLTYFEADNNNLSGEIVPEFSQCSNLTLLNLASNGFTGVIPPELGQLINLQELIL 333
+ V+ D NL+ + P+ + T+L+L+ N L L +L L
Sbjct: 6 VSKVASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNL 62
Query: 334 YENSLFGEIPKSILACKNLNKLDLSNNRFNGTIPNAICDMSRLQYLLLGQNSLKGEIPHE 393
L L L + + + + ++ L + +P
Sbjct: 63 DRAELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDV----SFNRLTSLPLG 118
Query: 394 IGNCMKLLQLHIGSNYLTGSIPPEIGHIRNLQIALNLSFNHLHGSLPPELGKLDKLVSFD 453
+ LQ ++PP + L+L+ N+L L L+ L +
Sbjct: 119 ALRGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLL 178
Query: 454 VSNNQLSGTIPSALKGMLSLIEVNFSNN 481
+ N L TIP G L N
Sbjct: 179 LQENSLY-TIPKGFFGSHLLPFAFLHGN 205
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 59.0 bits (141), Expect = 5e-10
Identities = 41/211 (19%), Positives = 67/211 (31%), Gaps = 27/211 (12%)
Query: 58 CDLNQ-AFVVKLDLSRLQLRGNITLVSEL-KALKRLDLSNNAFSGTIPSAFGNLSELEFL 115
C++++ A ++++ + L L +L K L LS N + + L L
Sbjct: 4 CEVSKVASHLEVNCDKRNLT---ALPPDLPKDTTILHLSENLLYTFSLATLMPYTRLTQL 60
Query: 116 DLS-LNKFGGVIPRELGSLKDLRFFNISN--------------------NVLVGEIPDEL 154
+L + L L L + N L L
Sbjct: 61 NLDRAELTKLQVDGTLPVLGTLDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGAL 120
Query: 155 KSLEKLEDFQVSSNKLNGSIPFWVGNLTNLRVFTAYENQLVGEIPDNLGSVSELELLNLH 214
+ L +L++ + N+L P + L + N L L + L+ L L
Sbjct: 121 RGLGELQELYLKGNELKTLPPGLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQ 180
Query: 215 SNQLEGPIPKSIFASGKLEVLVLTQNRLTGD 245
N L IPK F S L L N +
Sbjct: 181 ENSLY-TIPKGFFGSHLLPFAFLHGNPWLCN 210
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} Length = 266 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Score = 57.4 bits (137), Expect = 2e-09
Identities = 42/205 (20%), Positives = 69/205 (33%), Gaps = 29/205 (14%)
Query: 197 EIPDNLGSVSELELLNLHSNQLEGPIPKSIFASGKLEVLVL------------------- 237
+P +L + +L+L N L ++ +L L L
Sbjct: 24 ALPPDLPK--DTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELTKLQVDGTLPVLGT 81
Query: 238 --TQNRLTGDIPELVGHCKSLSNIRIGNNDLVGVIPRAIGNVSGLTYFEADNNNLSGEIV 295
+ +P L +L+ + + N L + A+ + L N L
Sbjct: 82 LDLSHNQLQSLPLLGQTLPALTVLDVSFNRLTSLPLGALRGLGELQELYLKGNELKTLPP 141
Query: 296 PEFSQCSNLTLLNLASNGFTGVIPPELGQLINLQELILYENSLFGEIPKSILACKNLNKL 355
+ L L+LA+N T + L L NL L+L ENSL+ IPK L
Sbjct: 142 GLLTPTPKLEKLSLANNNLTELPAGLLNGLENLDTLLLQENSLY-TIPKGFFGSHLLPFA 200
Query: 356 DLSNNRFNGTIPNAICDMSRLQYLL 380
L N + C++ + L
Sbjct: 201 FLHGNPWLCN-----CEILYFRRWL 220
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 64.4 bits (156), Expect = 2e-12
Identities = 21/141 (14%), Positives = 42/141 (29%), Gaps = 17/141 (12%)
Query: 611 NMIYCGTFSTVYKAVMPSGLILSVKRLK-------SMDRTIIHHQNKMIRELEKLSKLCH 663
++ G S V+ VK K + + + ++
Sbjct: 6 KLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEF 65
Query: 664 DNLVRPIGFVIYEDVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTR-LSIAIGVAEGL 722
L + G + + A + +L E + + + E +
Sbjct: 66 RALQKLQGLAVPKVYAWEGN---------AVLMELIDAKELYRVRVENPDEVLDMILEEV 116
Query: 723 AFLHHVAIIHLDISSGNVLLD 743
A +H I+H D+S NVL+
Sbjct: 117 AKFYHRGIVHGDLSQYNVLVS 137
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 65.1 bits (157), Expect = 5e-12
Identities = 50/285 (17%), Positives = 90/285 (31%), Gaps = 24/285 (8%)
Query: 89 KRLDLSNNAFSGTIPSAFGNLSELEFLDLSLNK-FGGVIPRELGSLKDLRFFNISNNVLV 147
+ LDL+ P G L + + F E S ++ ++SN+V+
Sbjct: 3 QTLDLTGKNLH---PDVTGRLLSQGVIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIE 59
Query: 148 GE-IPDELKSLEKLEDFQVSSNKLNGSIPFWVGNLTNLRVFTAYENQLVGEIPDNLGSVS 206
+ L KL++ + +L+ I + +NL E S
Sbjct: 60 VSTLHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSS 119
Query: 207 ELELLNLHSNQLEGPIPKSIFASGKLEVLVLTQNRLTGDIPELVGHCKSLSNIRIGNNDL 266
L L+ + K + + +TQ L+G L S R N
Sbjct: 120 CSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLV- 178
Query: 267 VGVIPRAIGNVSGLTYFEADNNNLSGEIVPEFSQCSNLTLLNLAS-NGFTGVIPPELGQL 325
+D+ L + EF Q + L L+L+ ELG++
Sbjct: 179 --------------HLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEI 224
Query: 326 INLQELILYENSLFGEIPKSILACKNLNKLDLSNNRFNGTIPNAI 370
L+ L ++ G + A + L ++ + F I
Sbjct: 225 PTLKTLQVFGIVPDGTLQLLKEALPH---LQINCSHFTTIARPTI 266
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 60.5 bits (145), Expect = 2e-10
Identities = 34/269 (12%), Positives = 82/269 (30%), Gaps = 15/269 (5%)
Query: 67 KLDLSRLQLRGNITLVSELKALKRLDLSNNAFSGTIPSAFGNLSELEFLDLSLNKF-GGV 125
LDL+ L ++T + + + + F ++ +DLS +
Sbjct: 4 TLDLTGKNLHPDVTGRLLSQGVIAFRCPRSFMDQPLAEHFSPFR-VQHMDLSNSVIEVST 62
Query: 126 IPRELGSLKDLRFFNISNNVLVGEIPDELKSLEKLE--DFQVSSNKLNGSIPFWVGNLTN 183
+ L L+ ++ L I + L L + S ++ + + +
Sbjct: 63 LHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSR 122
Query: 184 LRVFTAYENQLVG------EIPDNLGSVSELELLNLHSNQLEGPIPKSIFASGKLEVLVL 237
L + ++++L L N + + + L L L
Sbjct: 123 LDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDL 182
Query: 238 TQNRL-TGDIPELVGHCKSLSNIRI-GNNDLVGVIPRAIGNVSGLTYFEADNNNLSGEIV 295
+ + + D + L ++ + D++ +G + L + G +
Sbjct: 183 SDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQ 242
Query: 296 PEFSQCSNLTLLNLASNGFTGVIPPELGQ 324
+ L + + FT + P +G
Sbjct: 243 LLKEALPH---LQINCSHFTTIARPTIGN 268
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 58.2 bits (139), Expect = 1e-09
Identities = 47/281 (16%), Positives = 98/281 (34%), Gaps = 17/281 (6%)
Query: 235 LVLTQNRLTGDIPELVGHCKSLSNIRIGNNDLVGVIPRAIGNVSGLTYFEADNNNLSGEI 294
L LT L D+ + + + R + + + + + + N+ +
Sbjct: 5 LDLTGKNLHPDVTGRLLS-QGVIAFRCPRSFMDQPLAEHFSPFR-VQHMDLSNSVIEVST 62
Query: 295 VPEF-SQCSNLTLLNLASNGFTGVIPPELGQLINLQELILY--ENSLFGEIPKSILACKN 351
+ SQCS L L+L + I L + NL L L + + +C
Sbjct: 63 LHGILSQCSKLQNLSLEGLRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSR 122
Query: 352 LNKLDL------SNNRFNGTIPNAICDMSRLQYLLLGQNSLKGEIPHEIGNCMKLLQLHI 405
L++L+L + + + +++L +N K ++ + C L+ L +
Sbjct: 123 LDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDL 182
Query: 406 GSNYLTGSIPPEIGHIRNLQIALNLSF-NHLHGSLPPELGKLDKLVSFDVSNNQLSGTIP 464
+ + + + N L+LS + ELG++ L + V GT+
Sbjct: 183 SDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQ 242
Query: 465 SALKGMLSLIEVNFSNNLLTGPVPSFVPFQKSPNSSFFGNK 505
+ + L + + T + +K N +G K
Sbjct: 243 LLKEALPHL---QINCSHFTTIARPTIGNKK--NQEIWGIK 278
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 57.0 bits (136), Expect = 3e-09
Identities = 36/256 (14%), Positives = 82/256 (32%), Gaps = 14/256 (5%)
Query: 65 VVKLDLSRLQLRGNITLVSELKALKRLDLSNNAFSG-TIPSAFGNLSELEFLDLSLNKFG 123
V+ R + + ++ +DLSN+ T+ S+L+ L L +
Sbjct: 25 VIAFRCPRSFMDQPLAEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEGLRLS 84
Query: 124 GVIPRELGSLKDLRFFNISNNVLVGEIPDE--------LKSLEKLEDFQVSSNKLNGSIP 175
I L +L N+S E + L L F + + ++
Sbjct: 85 DPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVA 144
Query: 176 FWVGNLTNLRVFTAYENQLVGEIPDNLGSVSELELLNLHSNQLEGPIPKSIFASGK-LEV 234
+T L + +N ++ + L L+L + + F L+
Sbjct: 145 HVSETITQLNLSGYRKNLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQH 204
Query: 235 LVLTQ-NRLTGDIPELVGHCKSLSNIRIGNNDLVGVIPRAIGNVSGLTYFEADNNNLSGE 293
L L++ + + +G +L +++ G + L + + + ++ +
Sbjct: 205 LSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGTLQLLK---EALPHLQINCSHFTTI 261
Query: 294 IVPEFSQCSNLTLLNL 309
P N + +
Sbjct: 262 ARPTIGNKKNQEIWGI 277
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} Length = 284 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.1 bits (105), Expect = 2e-05
Identities = 15/101 (14%), Positives = 35/101 (34%), Gaps = 4/101 (3%)
Query: 354 KLDLSNNRFNGTIPNAICDMSRLQYLLLGQNSLKGEIPHEIGNCMKLLQLHIGSNYLTGS 413
LDL+ + + + + ++ + + E + ++ + + ++ + S
Sbjct: 4 TLDLTGKNLHPDVTGRLLSQG-VIAFRCPRSFMDQPLA-EHFSPFRVQHMDLSNSVIEVS 61
Query: 414 IPPEI-GHIRNLQIALNLSFNHLHGSLPPELGKLDKLVSFD 453
I LQ L+L L + L K LV +
Sbjct: 62 TLHGILSQCSKLQ-NLSLEGLRLSDPIVNTLAKNSNLVRLN 101
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 56.8 bits (135), Expect = 4e-09
Identities = 26/94 (27%), Positives = 41/94 (43%), Gaps = 9/94 (9%)
Query: 333 LYENSLFGEIPKSILACKNLNKLDLSNNRFNGTIPNAICDMSRLQYLLLGQNSLKGEIPH 392
Y N+ EI +L +L++SNN+ +P RL+ L+ N L E+P
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALP---PRLERLIASFNHLA-EVPE 321
Query: 393 EIGNCMKLLQLHIGSNYLTGSIPPEIGHIRNLQI 426
N L QLH+ N L P + +L++
Sbjct: 322 LPQN---LKQLHVEYNPLR-EFPDIPESVEDLRM 351
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 56.0 bits (133), Expect = 8e-09
Identities = 27/94 (28%), Positives = 41/94 (43%), Gaps = 9/94 (9%)
Query: 93 LSNNAFSGTIPSAFGNLSELEFLDLSLNKFGGVIPRELGSLKDLRFFNISNNVLVGEIPD 152
NA S I S LE L++S NK +P L+ L S N L E+P+
Sbjct: 267 YYLNASSNEIRSLCDLPPSLEELNVSNNKLIE-LPALPPRLERL---IASFNHL-AEVPE 321
Query: 153 ELKSLEKLEDFQVSSNKLNGSIPFWVGNLTNLRV 186
++L++L V N L P ++ +LR+
Sbjct: 322 LPQNLKQLH---VEYNPLR-EFPDIPESVEDLRM 351
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 54.4 bits (129), Expect = 3e-08
Identities = 22/91 (24%), Positives = 36/91 (39%), Gaps = 9/91 (9%)
Query: 287 NNNLSGEIVPEFSQCSNLTLLNLASNGFTGVIPPELGQLINLQELILYENSLFGEIPKSI 346
N S EI +L LN+++N +P L+ LI N L E+P+
Sbjct: 269 LNASSNEIRSLCDLPPSLEELNVSNNKLIE-LPALPP---RLERLIASFNHL-AEVPELP 323
Query: 347 LACKNLNKLDLSNNRFNGTIPNAICDMSRLQ 377
+NL +L + N P+ + L+
Sbjct: 324 ---QNLKQLHVEYNPLR-EFPDIPESVEDLR 350
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 51.7 bits (122), Expect = 2e-07
Identities = 25/103 (24%), Positives = 37/103 (35%), Gaps = 10/103 (9%)
Query: 371 CDMSRLQYLLLGQNSLKGEIPHEIGNCMKLLQLHIGSNYLTGSIPPEIGHIRNLQIALNL 430
+S L L N+ EI L +L++ +N L +P + L
Sbjct: 257 SGLSELPPNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPRLERL----IA 311
Query: 431 SFNHLHGSLPPELGKLDKLVSFDVSNNQLSGTIPSALKGMLSL 473
SFNHL +P L +L V N L P + + L
Sbjct: 312 SFNHL-AEVPELPQNLKQL---HVEYNPLR-EFPDIPESVEDL 349
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 51.4 bits (121), Expect = 2e-07
Identities = 20/96 (20%), Positives = 36/96 (37%), Gaps = 12/96 (12%)
Query: 168 NKLNGSIPFWVGNLTNLRVFTAYENQLVGEIPDNLGSVSELELLNLHSNQLEGPIPKSIF 227
N + I +L N+L+ E+P LE L N L +P+
Sbjct: 270 NASSNEIRSLCDLPPSLEELNVSNNKLI-ELPALPPR---LERLIASFNHLAE-VPELP- 323
Query: 228 ASGKLEVLVLTQNRLTGDIPELVGHCKSLSNIRIGN 263
L+ L + N L P++ S+ ++R+ +
Sbjct: 324 --QNLKQLHVEYNPLRE-FPDIPE---SVEDLRMNS 353
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 50.2 bits (118), Expect = 6e-07
Identities = 20/98 (20%), Positives = 37/98 (37%), Gaps = 8/98 (8%)
Query: 43 WGVNGTNFCNWKGIDCDLNQAFVVKLDLSRLQLRGNITLVSELKALKRLDLSNNAFSGTI 102
+ N + + + +L++S +L L + L+RL S N + +
Sbjct: 264 PNLYYLNASSNEIRSLCDLPPSLEELNVSNNKLI---ELPALPPRLERLIASFNHLA-EV 319
Query: 103 PSAFGNLSELEFLDLSLNKFGGVIPRELGSLKDLRFFN 140
P NL + L + N P S++DLR +
Sbjct: 320 PELPQNLKQ---LHVEYNPLRE-FPDIPESVEDLRMNS 353
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 44.0 bits (102), Expect = 5e-05
Identities = 26/91 (28%), Positives = 38/91 (41%), Gaps = 9/91 (9%)
Query: 190 YENQLVGEIPDNLGSVSELELLNLHSNQLEGPIPKSIFASGKLEVLVLTQNRLTGDIPEL 249
Y N EI LE LN+ +N+L +P +LE L+ + N L ++PEL
Sbjct: 268 YLNASSNEIRSLCDLPPSLEELNVSNNKLIE-LPALP---PRLERLIASFNHLA-EVPEL 322
Query: 250 VGHCKSLSNIRIGNNDLVGVIPRAIGNVSGL 280
+ K L + N L P +V L
Sbjct: 323 PQNLKQLH---VEYNPLRE-FPDIPESVEDL 349
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 40.6 bits (93), Expect = 6e-04
Identities = 17/71 (23%), Positives = 29/71 (40%), Gaps = 6/71 (8%)
Query: 57 DCDLNQAFVVKLDLSRLQLRGNITLVSELKALKRLDLSNNAFSGTIPSAFGNLSELEFLD 116
DC Q +L+L+ L L +L L+ L S N+ + +P +L L +
Sbjct: 34 DCLDRQ--AHELELNNLGLS---SLPELPPHLESLVASCNSLT-ELPELPQSLKSLLVDN 87
Query: 117 LSLNKFGGVIP 127
+L + P
Sbjct: 88 NNLKALSDLPP 98
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 40.6 bits (93), Expect = 7e-04
Identities = 48/287 (16%), Positives = 86/287 (29%), Gaps = 19/287 (6%)
Query: 208 LELLNLHSNQLEGPIPKSIFASGKLEVLVLTQNRLTGDIPELVGHCKS---LSNIRIGNN 264
L L++ L +P+ LE LV + N LT ++PEL KS +N +
Sbjct: 40 AHELELNNLGLSS-LPELP---PHLESLVASCNSLT-ELPELPQSLKSLLVDNNNLKALS 94
Query: 265 DLVGVIPRAIGNVSGLTYFEADNNNLSGEIVPEFSQCSNLTLLNLASNGFTGVIPPELGQ 324
DL ++ + + L N+ +I+ + S F +L +
Sbjct: 95 DLPPLLEYLGVSNNQLEKLPELQNSSFLKIIDVDNNSLKKLPDLPPSLEFIAAGNNQLEE 154
Query: 325 LINLQELILYENSLFGEIPKSILACKNLNKLDLSNNRFNGTIPNAICDMSRLQYLLLGQN 384
L LQ L L L+ + + ++ L + N
Sbjct: 155 LPELQNLPFLTAIYADNNSLKKLPDLPLSLESIVAGNNILEELPELQNLPFLTTIYADNN 214
Query: 385 SLKGEIPHEIGNCMKLLQLH-------IGSNYLTGSIPPEIGHIRNLQIALNLSFNHLHG 437
LK ++ + + + + I + N
Sbjct: 215 LLKTLPDLPPSLEALNVRDNYLTDLPELPQSLTFLDVSENIFSGLSELPPNLYYLNASSN 274
Query: 438 SLPPELGKLDKLVSFDVSNNQLSGTIPSALKGMLSLIEVNFSNNLLT 484
+ L +VSNN+L +P+ L + S N L
Sbjct: 275 EIRSLCDLPPSLEELNVSNNKLI-ELPALPP---RLERLIASFNHLA 317
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 39.4 bits (90), Expect = 0.001
Identities = 15/64 (23%), Positives = 26/64 (40%), Gaps = 8/64 (12%)
Query: 301 CSNLTLLNLASNGFTGVIPPELGQLINLQELILYENSLFGEIPKSILACKNLNKLDLSNN 360
L L + G + +P +L+ L+ NSL E+P+ ++L L + NN
Sbjct: 37 DRQAHELELNNLGLS-SLPELPP---HLESLVASCNSL-TELPELP---QSLKSLLVDNN 88
Query: 361 RFNG 364
Sbjct: 89 NLKA 92
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} Length = 353 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Score = 38.7 bits (88), Expect = 0.002
Identities = 11/61 (18%), Positives = 28/61 (45%), Gaps = 7/61 (11%)
Query: 349 CKNLNKLDLSNNRFNGTIPNAICDMSRLQYLLLGQNSLKGEIPHEIGNC--MKLLQLHIG 406
+ ++L+L+N + ++P L+ L+ NSL E+P + + + ++
Sbjct: 37 DRQAHELELNNLGLS-SLPELP---PHLESLVASCNSLT-ELPELPQSLKSLLVDNNNLK 91
Query: 407 S 407
+
Sbjct: 92 A 92
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 56.9 bits (135), Expect = 6e-09
Identities = 18/117 (15%), Positives = 40/117 (34%), Gaps = 10/117 (8%)
Query: 303 NLTLLNLASNGFTGVIPPEL-GQLINLQELILYENSL----FGEIPKSILACKNLNKLDL 357
++ L++ + EL L Q + L + L +I ++ L +L+L
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 358 SNNRFNGTIPNAICDM-----SRLQYLLLGQNSLKGEIPHEIGNCMKLLQLHIGSNY 409
+N + + ++Q L L L G + + ++ L +
Sbjct: 63 RSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHL 119
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 54.6 bits (129), Expect = 3e-08
Identities = 20/81 (24%), Positives = 34/81 (41%), Gaps = 9/81 (11%)
Query: 88 LKRLDLSNNAFSGT----IPSAFGNLSELEFLDLSLNKFGGVIPRELG-SLKD----LRF 138
L+ L L++ S + + + L LDLS N G +L S++ L
Sbjct: 371 LRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQ 430
Query: 139 FNISNNVLVGEIPDELKSLEK 159
+ + E+ D L++LEK
Sbjct: 431 LVLYDIYWSEEMEDRLQALEK 451
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 53.1 bits (125), Expect = 9e-08
Identities = 15/73 (20%), Positives = 26/73 (35%), Gaps = 6/73 (8%)
Query: 67 KLDLSRLQL--RGNITLVSELKALKRLDLSNNAFSG----TIPSAFGNLSELEFLDLSLN 120
LD+ +L L+ L+ + + L + + I SA L L+L N
Sbjct: 6 SLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSN 65
Query: 121 KFGGVIPRELGSL 133
+ G V +
Sbjct: 66 ELGDVGVHCVLQG 78
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 51.9 bits (122), Expect = 2e-07
Identities = 17/116 (14%), Positives = 30/116 (25%), Gaps = 5/116 (4%)
Query: 326 INLQELILYENSLFGEIPKSIL-ACKNLNKLDLSNNRFNG----TIPNAICDMSRLQYLL 380
+++Q L + L +L + + L + I +A+ L L
Sbjct: 2 LDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 61
Query: 381 LGQNSLKGEIPHEIGNCMKLLQLHIGSNYLTGSIPPEIGHIRNLQIALNLSFNHLH 436
L N L H + ++ I L G L
Sbjct: 62 LRSNELGDVGVHCVLQGLQTPSCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQEL 117
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 50.4 bits (118), Expect = 7e-07
Identities = 19/91 (20%), Positives = 34/91 (37%), Gaps = 10/91 (10%)
Query: 327 NLQELILYENSLFGE----IPKSILACKNLNKLDLSNNRFNGTIPNAICD-----MSRLQ 377
L+ L L + + + ++LA +L +LDLSNN + + L+
Sbjct: 370 VLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLE 429
Query: 378 YLLLGQNSLKGEIPHEIGNCMKLL-QLHIGS 407
L+L E+ + K L + S
Sbjct: 430 QLVLYDIYWSEEMEDRLQALEKDKPSLRVIS 460
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.9 bits (109), Expect = 8e-06
Identities = 18/107 (16%), Positives = 26/107 (24%), Gaps = 15/107 (14%)
Query: 43 WGVNGTNFCNWKGIDCDLNQAFVVKLDLSRLQLRGN----------ITLVSELKALKRLD 92
N G+ L L L + +L+ LD
Sbjct: 344 ELQISNNRLEDAGVRELCQGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELD 403
Query: 93 LSNNAFSGTIPSAFG-----NLSELEFLDLSLNKFGGVIPRELGSLK 134
LSNN LE L L + + L +L+
Sbjct: 404 LSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSEEMEDRLQALE 450
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.5 bits (108), Expect = 1e-05
Identities = 15/95 (15%), Positives = 27/95 (28%), Gaps = 7/95 (7%)
Query: 88 LKRLDLSNNAFSGT-IPSAFGNLSELEFLDLSLNKFGGV----IPRELGSLKDLRFFNIS 142
++ LD+ S L + + + L I L L N+
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLR 63
Query: 143 NNVLVGEIPDELKSLEKLEDFQVSSNKLNGSIPFW 177
+N L + L+ L+ KL+
Sbjct: 64 SNELGDVGVHCV--LQGLQTPSCKIQKLSLQNCCL 96
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 46.1 bits (107), Expect = 1e-05
Identities = 14/87 (16%), Positives = 32/87 (36%), Gaps = 9/87 (10%)
Query: 276 NVSGLTYFEADNNNLSGE----IVPEFSQCSNLTLLNLASNGFTGVIPPELGQLI----- 326
S L + ++S + +L L+L++N +L + +
Sbjct: 367 PGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGC 426
Query: 327 NLQELILYENSLFGEIPKSILACKNLN 353
L++L+LY+ E+ + A +
Sbjct: 427 LLEQLVLYDIYWSEEMEDRLQALEKDK 453
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.6 bits (103), Expect = 4e-05
Identities = 13/91 (14%), Positives = 32/91 (35%), Gaps = 13/91 (14%)
Query: 349 CKNLNKLDLSNNRFNGT----IPNAICDMSRLQYLLLGQNSLKGEIPHEIGNCMK----- 399
L L L++ + + + + L+ L L N L ++ ++
Sbjct: 368 GSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCL 427
Query: 400 LLQLHIGSNYLTGSIPPEIGHIR----NLQI 426
L QL + Y + + + + +L++
Sbjct: 428 LEQLVLYDIYWSEEMEDRLQALEKDKPSLRV 458
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.8 bits (101), Expect = 8e-05
Identities = 19/112 (16%), Positives = 34/112 (30%), Gaps = 26/112 (23%)
Query: 229 SGKLEVLVLTQNRLT-GDIPELVGHCKSLSNIRIGNNDLVGVIPRAIGNVSGLTYFEADN 287
S ++ L + L+ EL+ + +R+ + L + I +
Sbjct: 1 SLDIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSA---------- 50
Query: 288 NNLSGEIVPEFSQCSNLTLLNLASNGFTGVIPPELGQLI-----NLQELILY 334
L LNL SN V + Q + +Q+L L
Sbjct: 51 ----------LRVNPALAELNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQ 92
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.0 bits (99), Expect = 1e-04
Identities = 13/76 (17%), Positives = 27/76 (35%), Gaps = 5/76 (6%)
Query: 111 ELEFLDLSLNKFGGVIPREL-GSLKDLRFFNISNNVL----VGEIPDELKSLEKLEDFQV 165
+++ LD+ + EL L+ + + + L +I L+ L + +
Sbjct: 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 166 SSNKLNGSIPFWVGNL 181
SN+L V
Sbjct: 63 RSNELGDVGVHCVLQG 78
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 42.7 bits (98), Expect = 1e-04
Identities = 18/84 (21%), Positives = 36/84 (42%), Gaps = 7/84 (8%)
Query: 423 NLQIALNLSFNHLHGSLPPEL-GKLDKLVSFDVSNNQLSG----TIPSALKGMLSLIEVN 477
++Q +L++ L + EL L + + + L+ I SAL+ +L E+N
Sbjct: 3 DIQ-SLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELN 61
Query: 478 FSNNLLTGP-VPSFVPFQKSPNSS 500
+N L V + ++P+
Sbjct: 62 LRSNELGDVGVHCVLQGLQTPSCK 85
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.5 bits (95), Expect = 4e-04
Identities = 12/78 (15%), Positives = 26/78 (33%), Gaps = 6/78 (7%)
Query: 400 LLQLHIGSNYLTGSIPPEI-GHIRNLQIALNLSFNHLHG----SLPPELGKLDKLVSFDV 454
+ L I L+ + E+ ++ Q+ + L L + L L ++
Sbjct: 4 IQSLDIQCEELSDARWAELLPLLQQCQV-VRLDDCGLTEARCKDISSALRVNPALAELNL 62
Query: 455 SNNQLSGTIPSALKGMLS 472
+N+L + L
Sbjct: 63 RSNELGDVGVHCVLQGLQ 80
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.3 bits (92), Expect = 0.001
Identities = 17/97 (17%), Positives = 33/97 (34%), Gaps = 10/97 (10%)
Query: 175 PFWVGNLTNLRVFTAYENQLVGE----IPDNLGSVSELELLNLHSNQLEGPIPKSIFAS- 229
+ LRV + + + L + L L+L +N L + S
Sbjct: 362 QGLGQPGSVLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESV 421
Query: 230 ----GKLEVLVLTQNRLTGDIPELVGH-CKSLSNIRI 261
LE LVL + ++ + + K ++R+
Sbjct: 422 RQPGCLLEQLVLYDIYWSEEMEDRLQALEKDKPSLRV 458
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.6 bits (90), Expect = 0.001
Identities = 13/73 (17%), Positives = 23/73 (31%), Gaps = 9/73 (12%)
Query: 428 LNLSFNHLHG----SLPPELGKLDKLVSFDVSNNQLSGTIPSALKGML-----SLIEVNF 478
L L+ + SL L L D+SNN L L + L ++
Sbjct: 374 LWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVL 433
Query: 479 SNNLLTGPVPSFV 491
+ + + +
Sbjct: 434 YDIYWSEEMEDRL 446
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.8 bits (88), Expect = 0.002
Identities = 15/99 (15%), Positives = 26/99 (26%), Gaps = 23/99 (23%)
Query: 231 KLEVLVLTQNRLTGD----IPELVGHCKSLSNIRIGNNDLVGVIPRAIGNVSGLTYFEAD 286
L VL L ++ + + SL + + NN L + E+
Sbjct: 370 VLRVLWLADCDVSDSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLV--------ESV 421
Query: 287 NNNLSGEIVPEFSQCSNLTLLNLASNGFTGVIPPELGQL 325
L L L ++ + L L
Sbjct: 422 RQP-----------GCLLEQLVLYDIYWSEEMEDRLQAL 449
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} Length = 460 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.4 bits (87), Expect = 0.003
Identities = 16/94 (17%), Positives = 32/94 (34%), Gaps = 6/94 (6%)
Query: 156 SLEKLEDFQVSSNKLNGS-IPFWVGNLTNLRVFTAYENQL----VGEIPDNLGSVSELEL 210
SL+ ++ + +L+ + + L +V + L +I L L
Sbjct: 1 SLD-IQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAE 59
Query: 211 LNLHSNQLEGPIPKSIFASGKLEVLVLTQNRLTG 244
LNL SN+L + + + + L
Sbjct: 60 LNLRSNELGDVGVHCVLQGLQTPSCKIQKLSLQN 93
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 54.9 bits (130), Expect = 2e-08
Identities = 44/310 (14%), Positives = 94/310 (30%), Gaps = 32/310 (10%)
Query: 84 ELKALKRLDLSNNAFSGTIPSAFGNLSELEFLDLSLNKFGG----VIPRELGSLKDLRFF 139
E K+LK ++ ++ + ++ + LS N G + + S KDL
Sbjct: 6 EGKSLKLDAITTEDEK-SVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIA 64
Query: 140 NISNN---VLVGEIPDELKSLEKLEDFQVSSNKLNGSIPFWVGNLTNLRVFTAYENQLVG 196
S+ + EIP+ L+ L + + + S + + ++ +
Sbjct: 65 EFSDIFTGRVKDEIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLE 124
Query: 197 EIPDNLGSVSELELLNLHSNQLEGPIPKSIFASGKLEVLVLTQNRLTGDIPELVGHC--- 253
+ + + + E + K + L ++ +NRL +
Sbjct: 125 HLYLHNNGLGPQAGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQS 184
Query: 254 ------KSLSNIRIGNNDLVGVIPRAIGNVSGL----TYFEADNNNLSGEIVPEFSQCSN 303
+ I + ++ + L + S + N
Sbjct: 185 HRLLHTVKMVQNGIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPN 244
Query: 304 LTLLNLASNGFTGVIPPELGQ------LINLQELILYENSLFGEIPKSILA-----CKNL 352
L L L + + I LQ L L N + + +++ +L
Sbjct: 245 LRELGLNDCLLSARGAAAVVDAFSKLENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDL 304
Query: 353 NKLDLSNNRF 362
L+L+ NRF
Sbjct: 305 LFLELNGNRF 314
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 44.1 bits (102), Expect = 5e-05
Identities = 33/322 (10%), Positives = 80/322 (24%), Gaps = 33/322 (10%)
Query: 192 NQLVGEIPDNLGSVSELELLNLHSNQL--EGP--IPKSIFASGKLEVLVLTQNRLTGDIP 247
+ + L ++ + L N + E + ++I + LE+ +
Sbjct: 17 TEDEKSVFAVLLEDDSVKEIVLSGNTIGTEAARWLSENIASKKDLEIAEFSDIFTGRVKD 76
Query: 248 ELVGHCKSLSNIRIGNNDLV---GVIPRAIGNVSGLTYFEADNNNLSGEIVPEFSQCSNL 304
E+ + L + L + + +
Sbjct: 77 EIPEALRLLLQALLKCPKLHTVRLSDNAFGPTAQEPLIDFLSKHTPLEHLYLHNNGLGPQ 136
Query: 305 TLLNLASNGFTGVIPPELGQLINLQELILYENSLFGEIPKSILA----CKNLNKLDLSNN 360
+A + + L+ +I N L K + L+ + + N
Sbjct: 137 AGAKIARALQELAVNKKAKNAPPLRSIICGRNRLENGSMKEWAKTFQSHRLLHTVKMVQN 196
Query: 361 RFNGTIPNAICDMSRLQYLLL---------GQNSLKGEIPHEIGNCMKLLQLHIGSNYLT 411
+ L + + + + L +L + L+
Sbjct: 197 GIRPEGIEHLLLEGLAYCQELKVLDLQDNTFTHLGSSALAIALKSWPNLRELGLNDCLLS 256
Query: 412 GSIPPEIGHI------RNLQIALNLSFNHLHGSLPPEL-----GKLDKLVSFDVSNNQLS 460
+ LQ L L +N + L K+ L+ +++ N+ S
Sbjct: 257 ARGAAAVVDAFSKLENIGLQT-LRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFS 315
Query: 461 GTIPSALKGMLSLIEVNFSNNL 482
+ + + L
Sbjct: 316 E-EDDVVDEIREVFSTRGRGEL 336
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 344 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 44.1 bits (102), Expect = 5e-05
Identities = 17/86 (19%), Positives = 29/86 (33%), Gaps = 19/86 (22%)
Query: 84 ELKALKRLDLSNNAFSGTIPSA-----FGNLSELEFLDLSLNKFG--GVIPRELGSLKDL 136
E L+ L L N + +L FL+L+ N+F + E+ +
Sbjct: 271 ENIGLQTLRLQYNEIELDAVRTLKTVIDEKMPDLLFLELNGNRFSEEDDVVDEIREVFST 330
Query: 137 RFFNISNNVLVGEIPDELKSLEKLED 162
R EL L+ +E+
Sbjct: 331 RGRG------------ELDELDDMEE 344
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 52.7 bits (125), Expect = 4e-08
Identities = 32/219 (14%), Positives = 62/219 (28%), Gaps = 23/219 (10%)
Query: 276 NVSGLTYFEADNNNLSGEIVPEFSQCSNLTLLNLASNGFTGVIPPELGQLINLQELILYE 335
++ A +N++ + + +T L+ G T + + L NL L L +
Sbjct: 17 ALANAIKIAAGKSNVTDTVT--QADLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKD 72
Query: 336 NSLFGEIPKSILACKNLNKLDLSNNRFNGTIPNAICDMSRLQYLLLGQ------------ 383
N + P L +L + + I +
Sbjct: 73 NQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQ 132
Query: 384 --NSLKGEIPHEIGNCMKLLQLHIGSNYLTGSIPPEIGHIRNLQIALNLSFNHLHGSLPP 441
+I + ++ S + ++ L N +
Sbjct: 133 VLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKA-DDNKISD--IS 189
Query: 442 ELGKLDKLVSFDVSNNQLSGTIPSALKGMLSLIEVNFSN 480
L L L+ + NNQ+S P L +L V +N
Sbjct: 190 PLASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTN 226
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 51.6 bits (122), Expect = 1e-07
Identities = 28/226 (12%), Positives = 66/226 (29%), Gaps = 18/226 (7%)
Query: 108 NLSELEFLDLSLNKFGGVIPRELGSLKDLRFFNISNNVLVGEIPDELKSLEKLEDFQVSS 167
L+ + + + + L + + + + ++ L L ++
Sbjct: 17 ALANAIKIAAGKSNVTDTVTQA--DLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKD 72
Query: 168 NKLNGSIPFWVGNLTNLRVFTAYENQLVGEIPDNLGSVSELELLNLHSNQLEGPIPKSIF 227
N++ P + + V I + ++ ++
Sbjct: 73 NQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNLQ 132
Query: 228 ASGKLEVLVLTQNRLTGDIPELVGHCKSLSNIRIGNNDLVGVIPRAIGNVSGLTYFEADN 287
+ + L G + + + N+S LT +AD+
Sbjct: 133 VLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTP----------LANLSKLTTLKADD 182
Query: 288 NNLSGEIVPEFSQCSNLTLLNLASNGFTGVIPPELGQLINLQELIL 333
N +S + + NL ++L +N + V P L NL + L
Sbjct: 183 NKISD--ISPLASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTL 224
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 50.8 bits (120), Expect = 2e-07
Identities = 29/219 (13%), Positives = 67/219 (30%), Gaps = 21/219 (9%)
Query: 59 DLNQAFVVKLDLSRLQLRGNITLVSELKALKRLDLSNNAFSGTIPSAFGNLSELEFLDLS 118
D A +K+ + + +T ++L + L + L+ L L+L
Sbjct: 15 DPALANAIKIAAGKSNVTDTVTQ-ADLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELK 71
Query: 119 LNKFGGVIPRELGSLKDLRFFNISNNVLVGEIPDELKSLEKLEDFQVSSNKLNGSIPFWV 178
N+ + P + + + + V I ++ + +
Sbjct: 72 DNQITDLAPLKNLTKITELELSGNPLKNVSAIAGLQSIKTLDLTSTQITDVTPLAGLSNL 131
Query: 179 GNLTNLRVFTAYENQLVG--------------EIPDNLGSVSELELLNLHSNQLEGPIPK 224
L + L G L ++S+L L N++ P
Sbjct: 132 QVLYLDLNQITNISPLAGLTNLQYLSIGNAQVSDLTPLANLSKLTTLKADDNKISDISP- 190
Query: 225 SIFASGKLEVLVLTQNRLTGDIPELVGHCKSLSNIRIGN 263
+ + L + L N+++ P + + +L + + N
Sbjct: 191 -LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTN 226
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} Length = 227 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Score = 40.8 bits (94), Expect = 3e-04
Identities = 19/67 (28%), Positives = 29/67 (43%), Gaps = 5/67 (7%)
Query: 151 PDELKSLEKLEDFQVSSNKLNGSIPFWVGNLTNLRVFTAYENQLVGEIPDNLGSVSELEL 210
L +L KL + NK++ P +L NL NQ+ P L + S L +
Sbjct: 166 LTPLANLSKLTTLKADDNKISDISPL--ASLPNLIEVHLKNNQISDVSP--LANTSNLFI 221
Query: 211 LNLHSNQ 217
+ L +NQ
Sbjct: 222 VTL-TNQ 227
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 48.6 bits (115), Expect = 2e-07
Identities = 28/119 (23%), Positives = 49/119 (41%), Gaps = 7/119 (5%)
Query: 307 LNLASNGFTGVIPPELGQLINLQELILYENSLFGEIPKSILACKNLNKLDLSNNRFNGTI 366
L+LA T + L QL+ + L L N L P ++ A + L L +
Sbjct: 3 LHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQ--ASDNALEN 57
Query: 367 PNAICDMSRLQYLLLGQNSLKG-EIPHEIGNCMKLLQLHIGSNYLTGSIPPEIGHIRNL 424
+ + ++ RLQ LLL N L+ + +C +L+ L++ N L + +
Sbjct: 58 VDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ-EEGIQERLAEM 115
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 46.2 bits (109), Expect = 1e-06
Identities = 25/121 (20%), Positives = 51/121 (42%), Gaps = 7/121 (5%)
Query: 89 KRLDLSNNAFSGTIPSAFGNLSELEFLDLSLNKFGGVIPRELGSLKDLRFFNISNNVLVG 148
+ L L++ T+ L + LDLS N+ + P L +L+ L S+N
Sbjct: 1 RVLHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRALPP-ALAALRCLEVLQASDN--AL 55
Query: 149 EIPDELKSLEKLEDFQVSSNKLNG-SIPFWVGNLTNLRVFTAYENQLVGEIPDNLGSVSE 207
E D + +L +L++ + +N+L + + + L + N L + ++E
Sbjct: 56 ENVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLC-QEEGIQERLAE 114
Query: 208 L 208
+
Sbjct: 115 M 115
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 42.4 bits (99), Expect = 2e-05
Identities = 25/125 (20%), Positives = 43/125 (34%), Gaps = 7/125 (5%)
Query: 211 LNLHSNQLEGPIPKSIFASGKLEVLVLTQNRLTGDIPELVGHCKSLSNIRIGNNDLVGVI 270
L+L L + + + L L+ NRL P L + L ++ +N L V
Sbjct: 3 LHLAHKDLT--VLCHLEQLLLVTHLDLSHNRLRALPPAL-AALRCLEVLQASDNALENVD 59
Query: 271 PRAIGNVSGLTYFEADNNNLSGEIVPEFSQCSNLTLLNLASNGFTGV--IPPELGQLI-N 327
A +N + C L LLNL N I L +++ +
Sbjct: 60 GVANLPRLQELLL-CNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQEEGIQERLAEMLPS 118
Query: 328 LQELI 332
+ ++
Sbjct: 119 VSSIL 123
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 42.4 bits (99), Expect = 3e-05
Identities = 28/118 (23%), Positives = 41/118 (34%), Gaps = 6/118 (5%)
Query: 68 LDLSRLQLRGNITLVSELKALKRLDLSNNAFSGTIPSAFGNLSELEFLDLSLNKFGGVIP 127
L L+ L + + +L + LDLS+N P+ L LE L S N V
Sbjct: 3 LHLAHKDLT-VLCHLEQLLLVTHLDLSHNRLRALPPA-LAALRCLEVLQASDNALENVDG 60
Query: 128 RELGSLKDLRFFNISNNVLVG-EIPDELKSLEKLEDFQVSSNKLNGSIPFWVGNLTNL 184
+L L+ + NN L L S +L + N L L +
Sbjct: 61 VA--NLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ-EEGIQERLAEM 115
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 124 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 38.9 bits (90), Expect = 4e-04
Identities = 20/110 (18%), Positives = 39/110 (35%), Gaps = 7/110 (6%)
Query: 377 QYLLLGQNSLKGEIPHEIGNCMKLLQLHIGSNYLTGSIPPEIGHIRNLQIALNLSFNHLH 436
+ L L L + + + + L + N L +PP + +R L++ +
Sbjct: 1 RVLHLAHKDL--TVLCHLEQLLLVTHLDLSHNRLRA-LPPALAALRCLEVL---QASDNA 54
Query: 437 GSLPPELGKLDKLVSFDVSNNQLSGT-IPSALKGMLSLIEVNFSNNLLTG 485
+ L +L + NN+L + L L+ +N N L
Sbjct: 55 LENVDGVANLPRLQELLLCNNRLQQSAAIQPLVSCPRLVLLNLQGNSLCQ 104
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 49.4 bits (116), Expect = 4e-07
Identities = 38/174 (21%), Positives = 69/174 (39%), Gaps = 7/174 (4%)
Query: 197 EIPDNLGSVSELELLNLHSNQLEGPIPKSIFASGK-LEVLVLTQNRLTGDIPELVGHCKS 255
EIP ++ L L+ N+L +F L L L +N+LTG P
Sbjct: 22 EIPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASH 79
Query: 256 LSNIRIGNNDLVGVIPRAIGNVSGLTYFEADNNNLSGEIVPEFSQCSNLTLLNLASNGFT 315
+ +++G N + + + + L +N +S + F ++LT LNLASN F
Sbjct: 80 IQELQLGENKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFN 139
Query: 316 GVIPPELGQLINLQELILYENSLFGEIPKSILACKNLNKLDLSNNRFNGTIPNA 369
L++ L + P + +++ DL ++ F + N+
Sbjct: 140 CNCHLA-WFAEWLRKKSLNGGAARCGAPSKV---RDVQIKDLPHSEFKCSSENS 189
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} Length = 192 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Score = 40.9 bits (94), Expect = 2e-04
Identities = 26/175 (14%), Positives = 52/175 (29%), Gaps = 26/175 (14%)
Query: 341 EIPKSILACKNLNKLDLSNNRFNGTIPNAICDMSRLQYLLLGQNSLKGEIPHEIGNCMKL 400
EIP+ I + +L L++N + + L + + I
Sbjct: 22 EIPRDIPL--HTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASH 79
Query: 401 LQLHIGSNYLTGSIPPEIGHIRNLQIALNLSFNHLHGSLPPELGKLDKLVSFDVSNNQLS 460
+Q I ++ L +L + ++ +NQ+S
Sbjct: 80 IQELQLGENKIKEISNKM------------------------FLGLHQLKTLNLYDNQIS 115
Query: 461 GTIPSALKGMLSLIEVNFSNNLLTGPVPSFVPFQKSPNSSFFGNKGLCGEPLSFS 515
+P + + + SL +N ++N + S G CG P
Sbjct: 116 CVMPGSFEHLNSLTSLNLASNPFNCNCHLAWFAEWLRKKSLNGGAARCGAPSKVR 170
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 47.3 bits (111), Expect = 2e-06
Identities = 34/207 (16%), Positives = 63/207 (30%), Gaps = 30/207 (14%)
Query: 292 GEIVPEFSQCSNLTLLNLASNGFTGVIPPELGQLINLQELILYENSLFGEIPKSILACKN 351
+I + + NL T + +L ++ ++I + + I N
Sbjct: 15 KQIFSD-DAFAETIKDNLKKKSVTDAVTQN--ELNSIDQIIANNSDIKSVQG--IQYLPN 69
Query: 352 LNKLDLSNNRFNGTIPNAICDMSRLQYLLLGQNSLKGEIPHEIGNCMKLLQLHIGSNYLT 411
+ KL L+ N+ I ++ L+ L +K L+ +
Sbjct: 70 VTKLFLNGNKLTD-----IKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGI 124
Query: 412 GSIPP------------------EIGHIRNLQIALNLSFNHLHGSLPPELGKLDKLVSFD 453
I +I + L LS S L L KL +
Sbjct: 125 SDINGLVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVPLAGLTKLQNLY 184
Query: 454 VSNNQLSGTIPSALKGMLSLIEVNFSN 480
+S N +S AL G+ +L + +
Sbjct: 185 LSKNHISD--LRALAGLKNLDVLELFS 209
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 42.3 bits (98), Expect = 8e-05
Identities = 33/196 (16%), Positives = 70/196 (35%), Gaps = 25/196 (12%)
Query: 59 DLNQAFVVKLDLSRLQLRGNITLVSELKALKRLDLSNNAFSGTIPSAFGNLSELEFLDLS 118
D A +K +L + + +T +EL ++ ++ +N+ L + L L+
Sbjct: 20 DDAFAETIKDNLKKKSVTDAVTQ-NELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLN 76
Query: 119 LNKFGGVIPRELGSLKDLRFFNISNNVL-----------------VGEIPDELKSLEKLE 161
NK + L +LK+L + + N + ++ L L
Sbjct: 77 GNKLTD--IKPLANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDINGLVHLP 134
Query: 162 DFQVSSNKLNGSIPFWVGNLTNLRVFTAYENQLVGEIPDNLGSVSELELLNLHSNQLEGP 221
+ N V + + E+ + +I L +++L+ L L N +
Sbjct: 135 QLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVP-LAGLTKLQNLYLSKNHISD- 192
Query: 222 IPKSIFASGKLEVLVL 237
+++ L+VL L
Sbjct: 193 -LRALAGLKNLDVLEL 207
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 40.4 bits (93), Expect = 4e-04
Identities = 28/203 (13%), Positives = 62/203 (30%), Gaps = 16/203 (7%)
Query: 132 SLKDLRFFNISNNVLVGEIPDELKSLEKLEDFQVSSNKLNGSIPFWVGNLTNLRVFTAYE 191
+ + N+ + + L ++ +++ + L N+
Sbjct: 22 AFAETIKDNLKKKSVTDAVT--QNELNSIDQIIANNSDIKSVQGI--QYLPNVTKLFLNG 77
Query: 192 NQLVGEIPDNLGSVSELELLNLHSNQLEGPIPKSIFASGKLEVLVLTQNRLTGDIPELVG 251
N+L P ++ L+ L S K + ++ DI LV
Sbjct: 78 NKLTDIKP-----LANLKNLGWLFLDENKVKDLSSLKDLKKLKSLSLEHNGISDINGLVH 132
Query: 252 HCKSLSNIRIGNNDLVGVIPRAIGNVSGLTYFEADNNNLSGEIVPEFSQCSNLTLLNLAS 311
+ S N + + + L+ + +++ + + L L L+
Sbjct: 133 LPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDI-----VPLAGLTKLQNLYLSK 187
Query: 312 NGFTGVIPPELGQLINLQELILY 334
N + + L L NL L L+
Sbjct: 188 NHISDL--RALAGLKNLDVLELF 208
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 210 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 38.1 bits (87), Expect = 0.002
Identities = 16/81 (19%), Positives = 27/81 (33%), Gaps = 2/81 (2%)
Query: 38 LIVPGWGVNGTNFCNWKGIDCDLNQAFVVKLDLSRLQLRGNITLVSELKALKRLDLSNNA 97
L+ + N L++ + +I ++ L L+ L LS N
Sbjct: 130 LVHLPQLESLYLGNNKITDITVLSRLTKLDTLSLEDNQISDIVPLAGLTKLQNLYLSKNH 189
Query: 98 FSGTIPSAFGNLSELEFLDLS 118
S A L L+ L+L
Sbjct: 190 ISD--LRALAGLKNLDVLELF 208
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.5 bits (106), Expect = 4e-06
Identities = 24/137 (17%), Positives = 44/137 (32%), Gaps = 3/137 (2%)
Query: 68 LDLSRLQLRGNITLVSELKALKRLDLSNNAFSGTIPS-AFGNLSELEFLDLSLNKFGGVI 126
L +R ++ + + L L + N + L EL L + + V
Sbjct: 13 LRCTRDGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVA 72
Query: 127 PRELGSLKDLRFFNISNNVLVGEIPDELKSLEKLEDFQVSSNKLNGSI-PFWVGNLTNLR 185
P L N+S N + + + L++ +S N L+ S W+
Sbjct: 73 PDAFHFTPRLSRLNLSFN-ALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQRWEEEG 131
Query: 186 VFTAYENQLVGEIPDNL 202
+ E +L L
Sbjct: 132 LGGVPEQKLQCHGQGPL 148
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.0 bits (102), Expect = 1e-05
Identities = 21/149 (14%), Positives = 45/149 (30%), Gaps = 2/149 (1%)
Query: 278 SGLTYFEADNNNLSGEIVPEFSQCSNLTLLNLASNGFTGVIPPEL-GQLINLQELILYEN 336
G + + + + NLT L + + + L L+ L + ++
Sbjct: 8 HGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKS 66
Query: 337 SLFGEIPKSILACKNLNKLDLSNNRFNGTIPNAICDMSRLQYLLLGQNSLKGEIPHEIGN 396
L P + L++L+LS N + +S + +L G +
Sbjct: 67 GLRFVAPDAFHFTPRLSRLNLSFNALESLSWKTVQGLSLQELVLSGNPLHCSCALRWLQR 126
Query: 397 CMKLLQLHIGSNYLTGSIPPEIGHIRNLQ 425
+ + L + H+ N
Sbjct: 127 WEEEGLGGVPEQKLQCHGQGPLAHMPNAS 155
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} Length = 156 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 38.2 bits (87), Expect = 0.001
Identities = 24/153 (15%), Positives = 40/153 (26%), Gaps = 5/153 (3%)
Query: 349 CKNLNKLDLSNNRFNGTIPNAICDMSRLQYLLLGQNSLKGEIPHEIGNCMKLLQLHIGSN 408
+ L + + + + L L + + + L+
Sbjct: 7 PHGSSGLRCTRDGAL-DSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVK 65
Query: 409 YLTGSIPPEIGHIRNLQIALNLSFNHLHGSLPPELGKLDKLVSFDVSNNQLS-GTIPSAL 467
+ P+ H LNLSFN SL + + L +S N L L
Sbjct: 66 SGLRFVAPDAFHFTPRLSRLNLSFNA-LESLSWKTVQGLSLQELVLSGNPLHCSCALRWL 124
Query: 468 KGMLSLIEVNFSNNLLTGPVPSFVPFQKSPNSS 500
+ L P PN+S
Sbjct: 125 QRWEEEGLGGVPEQKLQCHGQG--PLAHMPNAS 155
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 45.7 bits (106), Expect = 1e-05
Identities = 33/245 (13%), Positives = 67/245 (27%), Gaps = 20/245 (8%)
Query: 51 CNWKGIDCDLNQAFVVKLDLSRLQLRGNITLVSELKALKRLDLSNNAFSGTIPSAFGNLS 110
C+ + C ++ + DL R L AF
Sbjct: 8 CSNRVFLCQESKVTEIPSDLPR--------------NAIELRFVLTKLRVIQKGAFSGFG 53
Query: 111 ELEFLDLSLNKFGGVIPRELGSLKDLRFFNI----SNNVLVGEIPDELKSLEKLEDFQVS 166
+LE +++S N VI ++ S +N + + + + +
Sbjct: 54 DLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNT 113
Query: 167 SNKLNGSIPFWVGNLTNLRVFTAYENQLVGEIPDNLGSVSELELLNLHSNQLEGPIPKSI 226
K + L N E +G E +L L+ N ++ +
Sbjct: 114 GIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAF 173
Query: 227 FASGKLEVLVLTQNRLTGDIPELVGHCKSLSNIRIGNNDLVGVIPRAIGNVSGLTYFEAD 286
+ E+ + N L ++ + I + + + N+ L
Sbjct: 174 NGTQLDELNLSDNNNLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRAR--S 231
Query: 287 NNNLS 291
NL
Sbjct: 232 TYNLK 236
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 44.1 bits (102), Expect = 3e-05
Identities = 16/60 (26%), Positives = 21/60 (35%), Gaps = 10/60 (16%)
Query: 102 IPSAFGNLSELEFLDLSLNKFGGVIPRELGSLKDLRFFNISNNVLVGEIPDELKSLEKLE 161
F S LD+S + + L +LK LR + N LK L LE
Sbjct: 193 PNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYN----------LKKLPTLE 242
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.0 bits (99), Expect = 7e-05
Identities = 30/223 (13%), Positives = 58/223 (26%), Gaps = 30/223 (13%)
Query: 286 DNNNLSGEIVPEFSQCSNLTLLNLASNGFTGVIPPELGQLINLQELILYENSLFGEI--- 342
+ ++ EI + N L + +L+++ + +N + I
Sbjct: 16 QESKVT-EIPSDLP--RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEAD 72
Query: 343 -----------------------PKSILACKNLNKLDLSNNRFNGTIPNAICDMSRLQYL 379
P++ NL L +SN + L
Sbjct: 73 VFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQKVLL 132
Query: 380 LLGQNSLKGEIPHEIGNCMKLLQLHIGSNYLTGSIPPEIGHIRNLQIALNLSFNHLHGSL 439
+ N I + + + N LNLS N+ L
Sbjct: 133 DIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNLEEL 192
Query: 440 PPE-LGKLDKLVSFDVSNNQLSGTIPSALKGMLSLIEVNFSNN 481
P + V D+S ++ L+ + L + N
Sbjct: 193 PNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARSTYNL 235
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.1 bits (89), Expect = 0.001
Identities = 10/54 (18%), Positives = 22/54 (40%), Gaps = 4/54 (7%)
Query: 339 FGEIPKSILA-CKNLNKLDLSNNRFNGTIPNAICDMSRLQYLLLGQNSLKGEIP 391
E+P + LD+S R + + ++ +L+ +LK ++P
Sbjct: 189 LEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARST--YNLK-KLP 239
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 242 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 37.6 bits (85), Expect = 0.004
Identities = 32/236 (13%), Positives = 63/236 (26%), Gaps = 13/236 (5%)
Query: 211 LNLHSNQLEGPIPKSIFASGKLEVLVLTQNRLTGDIPELVGHCKSLSNIRIGNNDLVGVI 270
+++ IP + + L +L L I I ND++ VI
Sbjct: 13 FLCQESKVTE-IPSDLPRN--AIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVI 69
Query: 271 PRAIGNVSGLTYFEA----DNNNLSGEIVPEFSQCSNLTLLNLASNGFTGVIPPELGQLI 326
+ + + +N + L++ +
Sbjct: 70 EADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYLLISNTGIKHLPDVHKIHSLQK 129
Query: 327 NLQELILYENSLFGEIPKSILACKNLNKLDLSNNRFNGTIPNAICDMSRLQYLLLGQNSL 386
L ++ N E + L L+ N A + L N+L
Sbjct: 130 VLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQEIHNCAFNGTQLDELNLSDNNNL 189
Query: 387 KGEIPHEIGNCMKLLQLHIGSNYLTGSIPPEI-GHIRNLQIALNLSFNHLHGSLPP 441
+ + L I + S+P +++ L+ S +L LP
Sbjct: 190 EELPNDVFHGASGPVILDISRTRIH-SLPSYGLENLKKLRA---RSTYNL-KKLPT 240
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 41.5 bits (96), Expect = 9e-05
Identities = 21/136 (15%), Positives = 40/136 (29%), Gaps = 7/136 (5%)
Query: 295 VPEFSQCSNLTLLNLASNGFTGVIPPELGQLINLQELILYENSLFGEIPKSILACKNLNK 354
+++ L+L VI L + +N + +L + L
Sbjct: 11 AAQYTNAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKLDGFPLL--RRLKT 67
Query: 355 LDLSNNRFNGTIPNAICDMSRLQYLLLGQNSLKGEIPHEIGNCMKLLQLHIGSN----YL 410
L ++NNR + L L+L NSL + +K L
Sbjct: 68 LLVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNK 127
Query: 411 TGSIPPEIGHIRNLQI 426
I + +++
Sbjct: 128 KHYRLYVIYKVPQVRV 143
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.5 bits (91), Expect = 5e-04
Identities = 19/137 (13%), Positives = 40/137 (29%), Gaps = 6/137 (4%)
Query: 320 PELGQLINLQELILYENSLFGEIPKSILACKNLNKLDLSNNRFNGTIPNAICDMSRLQYL 379
+ + +EL L + I + +D S+N + RL+ L
Sbjct: 12 AQYTNAVRDRELDLRGYKI-PVIENLGATLDQFDAIDFSDNEIRKLDGF--PLLRRLKTL 68
Query: 380 LLGQNSLKGEIPHEIGNCMKLLQLHIGSNYLTGSIPPEIGHIRNLQIALNLS---FNHLH 436
L+ N + L +L + +N L + L + +
Sbjct: 69 LVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKK 128
Query: 437 GSLPPELGKLDKLVSFD 453
+ K+ ++ D
Sbjct: 129 HYRLYVIYKVPQVRVLD 145
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Score = 36.8 bits (84), Expect = 0.004
Identities = 27/136 (19%), Positives = 49/136 (36%), Gaps = 7/136 (5%)
Query: 104 SAFGNLSELEFLDLSLNKFGGVIPRELGSLKDLRFFNISNNVLVGEIPDELKSLEKLEDF 163
+ + N LDL K VI +L + S+N + D L +L+
Sbjct: 12 AQYTNAVRDRELDLRGYKI-PVIENLGATLDQFDAIDFSDNEI--RKLDGFPLLRRLKTL 68
Query: 164 QVSSNKLNGSIPFWVGNLTNLRVFTAYENQLVG----EIPDNLGSVSELELLNLHSNQLE 219
V++N++ L +L N LV + +L S++ L +L +
Sbjct: 69 LVNNNRICRIGEGLDQALPDLTELILTNNSLVELGDLDPLASLKSLTYLCILRNPVTNKK 128
Query: 220 GPIPKSIFASGKLEVL 235
I+ ++ VL
Sbjct: 129 HYRLYVIYKVPQVRVL 144
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 42.0 bits (97), Expect = 1e-04
Identities = 30/187 (16%), Positives = 55/187 (29%), Gaps = 17/187 (9%)
Query: 287 NNNLSGEIVPEFSQCSNLTLLNLASNGFTGVIPPELGQLINLQELILYENSLFGEIPKSI 346
N++ + + +T L G + + L NL ++ N L P
Sbjct: 27 KTNVTDTV--SQTDLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFSNNQLTDITPLKN 82
Query: 347 LACKNLNKLDLSNNRFNGTIPNAICDMSRLQYLLLGQNSLKGEIPHEIGNCMKLLQLHIG 406
L N I + + L + + + N L +L +
Sbjct: 83 LTKLV------DILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPLKNLTNLNRLELS 136
Query: 407 SNYLTGSIPPEIGHIRNLQIALNLSFNHLHGSLPPELGKLDKLVSFDVSNNQLSGTIPSA 466
SN ++ + L L L L D+S+N++S S
Sbjct: 137 SNTISDISALSGLTSLQQLNFSSNQVTDL-----KPLANLTTLERLDISSNKVSD--ISV 189
Query: 467 LKGMLSL 473
L + +L
Sbjct: 190 LAKLTNL 196
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 38.5 bits (88), Expect = 0.002
Identities = 10/66 (15%), Positives = 22/66 (33%), Gaps = 3/66 (4%)
Query: 59 DLNQAFVVKLDLSRLQLRGNITLVSELKALKRLDLSNNAFSGTIPSAFGNLSELEFLDLS 118
D A +K L + + ++ ++L + L L+ L ++ S
Sbjct: 14 DTALAEKMKTVLGKTNVTDTVSQ-TDLDQVTTLQADRLGIKSI--DGVEYLNNLTQINFS 70
Query: 119 LNKFGG 124
N+
Sbjct: 71 NNQLTD 76
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} Length = 199 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Score = 37.3 bits (85), Expect = 0.004
Identities = 30/199 (15%), Positives = 63/199 (31%), Gaps = 16/199 (8%)
Query: 133 LKDLRFFNISNNVLVGEIPDELKSLEKLEDFQVSSNKLNGSIPFWVGNLTNLRVFTAYEN 192
L + + + + L+++ Q + SI V L NL N
Sbjct: 17 LAEKMKTVLGKTNVTDTVS--QTDLDQVTTLQADRLGIK-SID-GVEYLNNLTQINFSNN 72
Query: 193 QLVGEIPDNLGSVSELELLNLHSNQLEGPIPKSIFASGKLEVLVLTQNRLTGDIPELVGH 252
QL P L+ L + L + + I ++
Sbjct: 73 QLTDITP--------LKNLTKLVDILMNNNQIADITPLANLTNLTGLTLFNNQITDIDPL 124
Query: 253 CKSLSNIRIGNNDLVGVIPRAIGNVSGLTYFEADNNNLSGEIVPEFSQCSNLTLLNLASN 312
+ R+ + A+ ++ L +N ++ + + + L L+++SN
Sbjct: 125 KNLTNLNRLELSSNTISDISALSGLTSLQQLNFSSNQVTD--LKPLANLTTLERLDISSN 182
Query: 313 GFTGVIPPELGQLINLQEL 331
+ + L +L NL+ L
Sbjct: 183 KVSDI--SVLAKLTNLESL 199
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 40.2 bits (93), Expect = 2e-04
Identities = 21/134 (15%), Positives = 43/134 (32%), Gaps = 6/134 (4%)
Query: 92 DLSNNAFSGTIPSAFGNLSELEFLDLSLNKFGGVIPRELGSLKDLRFFNISNNVLVGEIP 151
+L + + L L +L + N +++ +
Sbjct: 3 ELKPEQVE-QLKLIMSKRYDGSQQALDLKGLR--SDPDLVAQNIDVVLNRRSSMAA-TLR 58
Query: 152 DELKSLEKLEDFQVSSNKLNG--SIPFWVGNLTNLRVFTAYENQLVGEIPDNLGSVSELE 209
+++ +L +S+N+L + V NL++ N+L E + +LE
Sbjct: 59 IIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLE 118
Query: 210 LLNLHSNQLEGPIP 223
L L N L
Sbjct: 119 ELWLDGNSLSDTFR 132
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} Length = 162 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Score = 39.4 bits (91), Expect = 5e-04
Identities = 24/110 (21%), Positives = 46/110 (41%), Gaps = 6/110 (5%)
Query: 68 LDLSRLQLRGNITLVSELKALKRLDLSNNAFSGTIPSAFGNLSELEFLDLSLNKFGGV-- 125
LDL L+ + + L+ ++ + T+ N+ EL L+LS N+ +
Sbjct: 27 LDLKGLR---SDPDLVAQNIDVVLNRRSS-MAATLRIIEENIPELLSLNLSNNRLYRLDD 82
Query: 126 IPRELGSLKDLRFFNISNNVLVGEIPDELKSLEKLEDFQVSSNKLNGSIP 175
+ + +L+ N+S N L E + KLE+ + N L+ +
Sbjct: 83 MSSIVQKAPNLKILNLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFR 132
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 888 | |||
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1ogqa_ | 313 | Polygalacturonase inhibiting protein PGIP {Kidney | 100.0 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 100.0 | |
| d2omza2 | 384 | Internalin A {Listeria monocytogenes [TaxId: 1639] | 100.0 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 100.0 | |
| d1xkua_ | 305 | Decorin {Cow (Bos taurus) [TaxId: 9913]} | 100.0 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 100.0 | |
| d1ozna_ | 284 | Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Huma | 100.0 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 100.0 | |
| d1p9ag_ | 266 | von Willebrand factor binding domain of glycoprote | 100.0 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.96 | |
| d1jl5a_ | 353 | Leucine rich effector protein YopM {Yersinia pesti | 99.96 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.95 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.94 | |
| d1xwdc1 | 242 | Follicle-stimulating hormone receptor {Human (Homo | 99.94 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.93 | |
| d1h6ua2 | 227 | Internalin H {Listeria monocytogenes [TaxId: 1639] | 99.92 | |
| d1z7xw1 | 460 | Ribonuclease inhibitor {Human (Homo sapiens) [TaxI | 99.92 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.91 | |
| d1w8aa_ | 192 | Slit {Fruit fly (Drosophila melanogaster) [TaxId: | 99.91 | |
| d1h6ta2 | 210 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.89 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.89 | |
| d2omxa2 | 199 | Internalin B {Listeria monocytogenes [TaxId: 1639] | 99.89 | |
| d2ca6a1 | 344 | Rna1p (RanGAP1), N-terminal domain {Fission yeast | 99.79 | |
| d2astb2 | 284 | Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sa | 99.79 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.75 | |
| d1a9na_ | 162 | Splicesomal U2A' protein {Human (Homo sapiens) [Ta | 99.74 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.7 | |
| d1dcea3 | 124 | Rab geranylgeranyltransferase alpha-subunit, C-ter | 99.69 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.66 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.65 | |
| d2ifga3 | 156 | High affinity nerve growth factor receptor, N-term | 99.65 | |
| d1m9la_ | 198 | Outer arm dynein light chain 1 {Green algae (Chlam | 99.65 | |
| d1koha1 | 162 | mRNA export factor tap {Human (Homo sapiens) [TaxI | 98.81 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.8 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 98.54 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 98.32 | |
| d1pgva_ | 167 | Tropomodulin C-terminal domain {nematode (Caenorha | 97.95 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 97.84 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 97.61 | |
| d1io0a_ | 166 | Tropomodulin C-terminal domain {Chicken (Gallus ga | 97.04 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.49 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=383.13 Aligned_cols=264 Identities=21% Similarity=0.332 Sum_probs=209.5
Q ss_pred HHHCCCCCEEEECCCCEEEEEEECCCCEEEEEEEECCCHHHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEECCEEEEEE
Q ss_conf 87147866254266442999981799689999931267145687999999999985037993254435787289529998
Q 002721 604 KATMKDSNMIYCGTFSTVYKAVMPSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVALLLH 683 (888)
Q Consensus 604 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 683 (888)
.++|+..+.||+|+||+||+|+... .||||+++..... ....+.|.+|++++++++|||||+++|++.. ...++||
T Consensus 7 ~~~~~~~~~lG~G~fg~Vy~~~~~~--~vAvK~~~~~~~~-~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~ 82 (276)
T d1uwha_ 7 DGQITVGQRIGSGSFGTVYKGKWHG--DVAVKMLNVTAPT-PQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVT 82 (276)
T ss_dssp TTCCCCCSEEEECSSCEEEEEESSS--EEEEEECCCSSCC-TTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEE
T ss_pred CCCEEEEEEEEECCCCEEEEEEECC--EEEEEEEECCCCC-HHHHHHHHHHHHHHHHCCCCCEEEEEEEEEC-CEEEEEE
T ss_conf 4518998898307885899999999--8999999734699-8999999999999984799878645679715-5899999
Q ss_pred ECCCCCCHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCCEEECCCCCCCCCCCC
Q ss_conf 30799998788430399999999988999999999988730245772523888897585799982670233432259999
Q 002721 684 NYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSK 763 (888)
Q Consensus 684 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~ 763 (888)
||+++|+|.+++..... .+++..+..|+.|||+||+|||+++|+||||||+|||++.++.+||+|||+++......
T Consensus 83 Ey~~~g~L~~~l~~~~~----~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~ 158 (276)
T d1uwha_ 83 QWCEGSSLYHHLHIIET----KFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWS 158 (276)
T ss_dssp ECCCEEEHHHHHHTSCC----CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC-----
T ss_pred ECCCCCCHHHHHHHCCC----CCCHHHHHHHHHHHHHHHHHHHCCCEECCCCCHHHEEECCCCCEEECCCCCEEECCCCC
T ss_conf 65899888999852357----89999999999999999888750999516147899798189978875002213335567
Q ss_pred CCCCCCCCCCCCCEECCCCCCCC---CCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCC
Q ss_conf 95200133454432163333557---858644305478999998819999877778863131211236789999410133
Q 002721 764 GTASISAVAGSFGYIPPEYAYTM---QVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQILD 840 (888)
Q Consensus 764 ~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~DVwSlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~i~d 840 (888)
.........||+.|+|||++.+. .++.++|||||||++|||+||+.||........ .......... .
T Consensus 159 ~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~-~~~~~~~~~~---------~ 228 (276)
T d1uwha_ 159 GSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ-IIFMVGRGYL---------S 228 (276)
T ss_dssp -------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH-HHHHHHHTSC---------C
T ss_pred CCCCCCCCCCCCCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHH-HHHHHHCCCC---------C
T ss_conf 76312566557431799999505689999531516359999999978899899896999-9999965888---------9
Q ss_pred CCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHC
Q ss_conf 333667858299999999999402378999999998999999986419
Q 002721 841 ARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEMLQEIKQN 888 (888)
Q Consensus 841 ~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~eil~~L~~~~~~ 888 (888)
+..... .......+.+++.+||+.+|++||||+|+++.|+.+.++
T Consensus 229 p~~~~~---~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~Le~l~~~ 273 (276)
T d1uwha_ 229 PDLSKV---RSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARS 273 (276)
T ss_dssp CCGGGS---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHT
T ss_pred CCCHHC---CCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHC
T ss_conf 860003---655549999999997588976892999999999999970
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=0 Score=378.02 Aligned_cols=261 Identities=18% Similarity=0.331 Sum_probs=209.8
Q ss_pred HHHCCCCCEEEECCCCEEEEEEECC-C---CEEEEEEEECCCHHHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEECCEE
Q ss_conf 8714786625426644299998179-9---68999993126714568799999999998503799325443578728952
Q 002721 604 KATMKDSNMIYCGTFSTVYKAVMPS-G---LILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVA 679 (888)
Q Consensus 604 ~~~~~~~~~lg~G~~g~Vy~~~~~~-~---~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~ 679 (888)
.++|+..++||+|+||+||+|.... + ..||+|.+...... ...+.|.+|++++++++|||||+++|++..++..
T Consensus 25 ~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~ 102 (299)
T d1jpaa_ 25 ISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYTE--KQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPV 102 (299)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSSCCH--HHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSC
T ss_pred HHHCEEEEEEEECCCEEEEEEEEECCCCEEEEEEEEEECCCCCH--HHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEE
T ss_conf 00427856980278829999999579978899999997844598--9999999999999857998886189999628877
Q ss_pred EEEEECCCCCCHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCCEEECCCCCCCC
Q ss_conf 99983079999878843039999999998899999999998873024577252388889758579998267023343225
Q 002721 680 LLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLL 759 (888)
Q Consensus 680 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~ 759 (888)
++|||||++|+|.+++..... .++|.++..|+.|||.||.|||+.+|+||||||+|||++.++.+||+|||+++..
T Consensus 103 ~iv~Ey~~~g~L~~~~~~~~~----~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~ 178 (299)
T d1jpaa_ 103 MIITEFMENGSLDSFLRQNDG----QFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFL 178 (299)
T ss_dssp EEEEECCTTEEHHHHHHTTTT----CSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCC------
T ss_pred EEEEEECCCCCCEEEECCCCC----CCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCEEEECCCCCEEECCCCCCEEC
T ss_conf 999972279853002104567----9999999999999999889885279835761504489889991998884431575
Q ss_pred CCCCCCCC---CCCCCCCCCEECCCCCCCCCCCCCCCCHHHHHHHHHHHH-CCCCCCCCCCCCCCHHHHCCCCCCCCCCC
Q ss_conf 99999520---013345443216333355785864430547899999881-99998777788631312112367899994
Q 002721 760 DPSKGTAS---ISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILT-TRLPVEEDFGEGVDLVKWVHGAPARGETP 835 (888)
Q Consensus 760 ~~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlG~il~ellt-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~ 835 (888)
........ .....||+.|+|||++.+..++.++|||||||++|||+| |+.||.+.... ++...+......
T Consensus 179 ~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~--~~~~~i~~~~~~---- 252 (299)
T d1jpaa_ 179 EDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQ--DVINAIEQDYRL---- 252 (299)
T ss_dssp -----------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--HHHHHHHTTCCC----
T ss_pred CCCCCCCEEEECCCCCCCCCCCCHHHHHCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHH--HHHHHHHCCCCC----
T ss_conf 67777653650256668830038788836997861214453578999986799999999999--999999737889----
Q ss_pred CCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHC
Q ss_conf 10133333667858299999999999402378999999998999999986419
Q 002721 836 EQILDARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEMLQEIKQN 888 (888)
Q Consensus 836 ~~i~d~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~eil~~L~~~~~~ 888 (888)
+........+.+++.+||+.+|++||||+|+++.|+++.+|
T Consensus 253 ------------~~~~~~~~~l~~li~~cl~~~P~~RPs~~ei~~~L~~~l~~ 293 (299)
T d1jpaa_ 253 ------------PPPMDCPSALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRN 293 (299)
T ss_dssp ------------CCCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHS
T ss_pred ------------CCCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHCC
T ss_conf ------------99742269999999997587976892999999999998418
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=378.02 Aligned_cols=258 Identities=19% Similarity=0.289 Sum_probs=209.3
Q ss_pred HHCCCCCEEEECCCCEEEEEEECCCCEEEEEEEECCCHHHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEECCEEEEEEE
Q ss_conf 71478662542664429999817996899999312671456879999999999850379932544357872895299983
Q 002721 605 ATMKDSNMIYCGTFSTVYKAVMPSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVALLLHN 684 (888)
Q Consensus 605 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 684 (888)
.+|+..+.||+|+||+||+|.+.++..||||+++..... .++|.+|++++++++|||||+++|++...+..++|||
T Consensus 5 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~~----~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E 80 (263)
T d1sm2a_ 5 SELTFVQEIGSGQFGLVHLGYWLNKDKVAIKTIREGAMS----EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFE 80 (263)
T ss_dssp SCEEEEEEEECCSSCCEEEEEETTTEEEEEEECCSSSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEE
T ss_pred HHCEEEEEEEECCCEEEEEEEECCCCEEEEEEECCCCCC----HHHHHHHHHHHHHCCCCCCCCCCCEECCCCCEEEEEE
T ss_conf 995888898208882999999889999999998788676----8999999999996689975653524315993379998
Q ss_pred CCCCCCHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCCEEECCCCCCCCCCCCC
Q ss_conf 07999987884303999999999889999999999887302457725238888975857999826702334322599999
Q 002721 685 YLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSKG 764 (888)
Q Consensus 685 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~ 764 (888)
|+++|+|.+++..... .+++..+..|+.|||.||+|+|+.+|+||||||+|||++.++.+||+|||+++.......
T Consensus 81 ~~~~g~L~~~l~~~~~----~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~ 156 (263)
T d1sm2a_ 81 FMEHGCLSDYLRTQRG----LFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY 156 (263)
T ss_dssp CCTTCBHHHHHHTTTT----CCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEECGGGCEEECSCC----------
T ss_pred ECCCCCHHHHHHCCCC----CCCHHHHHHHHHHHHHHHHHHHCCCEEECCCCHHHEEECCCCCEEECCCCHHEECCCCCC
T ss_conf 3699918997520134----788999999999999987765316431044315326666887768655321002368873
Q ss_pred CCCCCCCCCCCCEECCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCCCCC
Q ss_conf 52001334544321633335578586443054789999988199998777788631312112367899994101333336
Q 002721 765 TASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQILDARLS 844 (888)
Q Consensus 765 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~i~d~~~~ 844 (888)
. ......||..|+|||++.+..++.++|||||||++|||+|+..|+...... .+....+...... .
T Consensus 157 ~-~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~-~~~~~~i~~~~~~-------~----- 222 (263)
T d1sm2a_ 157 T-SSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN-SEVVEDISTGFRL-------Y----- 222 (263)
T ss_dssp ---------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCH-HHHHHHHHHTCCC-------C-----
T ss_pred E-EECCEECCCCCCCHHHHCCCCCCCHHHHCCHHHHHHHHHHCCCCCCCCCCH-HHHHHHHHHCCCC-------C-----
T ss_conf 3-504300176667857860799984033210599999998789888778999-9999999806888-------9-----
Q ss_pred CCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHC
Q ss_conf 67858299999999999402378999999998999999986419
Q 002721 845 TVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEMLQEIKQN 888 (888)
Q Consensus 845 ~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~eil~~L~~~~~~ 888 (888)
......+++.+++.+||+.+|++||||+|+++.|+++.++
T Consensus 223 ----~p~~~~~~l~~li~~cl~~~p~~Rps~~~il~~L~~i~es 262 (263)
T d1sm2a_ 223 ----KPRLASTHVYQIMNHCWKERPEDRPAFSRLLRQLAEIAES 262 (263)
T ss_dssp ----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHH
T ss_pred ----CCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHHC
T ss_conf ----9543679999999997657976891999999999999857
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=372.27 Aligned_cols=248 Identities=23% Similarity=0.302 Sum_probs=206.0
Q ss_pred HHCCCCCEEEECCCCEEEEEEEC-CCCEEEEEEEECCCHHHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEECCEEEEEE
Q ss_conf 71478662542664429999817-99689999931267145687999999999985037993254435787289529998
Q 002721 605 ATMKDSNMIYCGTFSTVYKAVMP-SGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVALLLH 683 (888)
Q Consensus 605 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 683 (888)
++|++.+.||+|+||+||+|+.. +++.||+|++.+...........+.+|+++++.++|||||++++++.+++..++||
T Consensus 6 ~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivm 85 (263)
T d2j4za1 6 EDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLIL 85 (263)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEE
T ss_conf 37699889851778589999998999499999981688567689999999999998568888885999999899989998
Q ss_pred ECCCCCCHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCCEEECCCCCCCCCCCC
Q ss_conf 30799998788430399999999988999999999988730245772523888897585799982670233432259999
Q 002721 684 NYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSK 763 (888)
Q Consensus 684 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~ 763 (888)
||+++|+|.+++.... .+++..+..++.||+.||+|||+.+|+||||||+|||++.++.+|++|||+++......
T Consensus 86 Ey~~~g~L~~~l~~~~-----~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~ 160 (263)
T d2j4za1 86 EYAPLGTVYRELQKLS-----KFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR 160 (263)
T ss_dssp ECCTTCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCC
T ss_pred EECCCCCHHHHHHHCC-----CCCHHHHHHHHHHHHHHHHHHHHCCEEEEEECCCCCEECCCCCEEECCCCEEEECCCCC
T ss_conf 5047985898875048-----99999999999999999999998894652202344146689987115556335448885
Q ss_pred CCCCCCCCCCCCCEECCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCCCC
Q ss_conf 95200133454432163333557858644305478999998819999877778863131211236789999410133333
Q 002721 764 GTASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQILDARL 843 (888)
Q Consensus 764 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~i~d~~~ 843 (888)
.....||+.|+|||++.+..++.++||||+||++|||++|+.||...... +....... ...
T Consensus 161 ----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~--~~~~~i~~-------------~~~ 221 (263)
T d2j4za1 161 ----RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ--ETYKRISR-------------VEF 221 (263)
T ss_dssp ----CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHH--HHHHHHHT-------------TCC
T ss_pred ----CCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHH--HHHHHHHC-------------CCC
T ss_conf ----23557887634999975899893144046759999983299998889999--99999971-------------899
Q ss_pred CCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf 6678582999999999994023789999999989999
Q 002721 844 STVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVE 880 (888)
Q Consensus 844 ~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~eil~ 880 (888)
. ......+++.+++.+||+.||++|||++|+++
T Consensus 222 ~----~p~~~s~~~~~li~~~L~~dp~~R~t~~eil~ 254 (263)
T d2j4za1 222 T----FPDFVTEGARDLISRLLKHNPSQRPMLREVLE 254 (263)
T ss_dssp C----CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred C----CCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf 9----98668999999999976479768909999971
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=376.05 Aligned_cols=267 Identities=21% Similarity=0.284 Sum_probs=206.6
Q ss_pred HHHCCCCCEEEECCCCEEEEEEEC-CCCEEEEEEEECCCHHHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEECCEEEEE
Q ss_conf 871478662542664429999817-9968999993126714568799999999998503799325443578728952999
Q 002721 604 KATMKDSNMIYCGTFSTVYKAVMP-SGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVALLL 682 (888)
Q Consensus 604 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv 682 (888)
.++|+..+.||+|+||+||+|+.. +|..||+|+++..... .....+.+|+.+++.++|||||++++++.+....++|
T Consensus 5 ~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iV 82 (322)
T d1s9ja_ 5 DDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEIKP--AIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISIC 82 (322)
T ss_dssp GGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCCCT--THHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCCCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCH--HHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEE
T ss_conf 56888978971277809999999899969999998754097--8999999999999867999999499999989999999
Q ss_pred EECCCCCCHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHCCC-CCEEECCCCCCCEEECCCCCCEEECCCCCCCCCC
Q ss_conf 830799998788430399999999988999999999988730245-7725238888975857999826702334322599
Q 002721 683 HNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHH-VAIIHLDISSGNVLLDADFKPLLGEIEISKLLDP 761 (888)
Q Consensus 683 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~ 761 (888)
|||+++|+|.+++.+.. .+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+|+....
T Consensus 83 mEy~~gg~L~~~l~~~~-----~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~ 157 (322)
T d1s9ja_ 83 MEHMDGGSLDQVLKKAG-----RIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLID 157 (322)
T ss_dssp EECCTTEEHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHH
T ss_pred EECCCCCCHHHHHHHCC-----CCCHHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEECCCCCEEEEECCCCCCCCC
T ss_conf 97679986899874249-----9999999999999999999999859997144577994687899899954877625678
Q ss_pred CCCCCCCCCCCCCCCEECCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHCCCCCCCCCCC------
Q ss_conf 99952001334544321633335578586443054789999988199998777788631312112367899994------
Q 002721 762 SKGTASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETP------ 835 (888)
Q Consensus 762 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~------ 835 (888)
.. ....+||..|+|||++.+..|+.++||||+||++|||++|+.||........+..............+
T Consensus 158 ~~----~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (322)
T d1s9ja_ 158 SM----ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTP 233 (322)
T ss_dssp HT----C---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC------------------
T ss_pred CC----CCCCCCCCCCCCCHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCC
T ss_conf 86----21113771411946875899894888998999999999888998998878999999887517754577421233
Q ss_pred -----------------CCCCCCCCCCCC--CCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf -----------------101333336678--5829999999999940237899999999899999
Q 002721 836 -----------------EQILDARLSTVS--FGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEM 881 (888)
Q Consensus 836 -----------------~~i~d~~~~~~~--~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~eil~~ 881 (888)
....+....... ........++.+++.+|++.||++|||++|+++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~ta~e~L~H 298 (322)
T d1s9ja_ 234 GRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVH 298 (322)
T ss_dssp ------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHC
T ss_conf 32211112223541347788766502687667644489999999999868994679089999609
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=373.67 Aligned_cols=263 Identities=19% Similarity=0.271 Sum_probs=210.3
Q ss_pred HHHHCCCCCEEEECCCCEEEEEEECC-C-----CEEEEEEEECCCHHHHHHHHHHHHHHHHHHCC-CCCCEEEEEEEEEE
Q ss_conf 98714786625426644299998179-9-----68999993126714568799999999998503-79932544357872
Q 002721 603 VKATMKDSNMIYCGTFSTVYKAVMPS-G-----LILSVKRLKSMDRTIIHHQNKMIRELEKLSKL-CHDNLVRPIGFVIY 675 (888)
Q Consensus 603 ~~~~~~~~~~lg~G~~g~Vy~~~~~~-~-----~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~g~~~~ 675 (888)
..++|++.+.||+|+||+||+|+... + ..||+|.+...... .....+.+|+.++.++ +|||||+++|++..
T Consensus 35 ~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~ 112 (325)
T d1rjba_ 35 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKADS--SEREALMSELKMMTQLGSHENIVNLLGACTL 112 (325)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CHHHEEEEEEEEECCCEEEEEEEECCCCCCCCEEEEEEEEECCCCCH--HHHHHHHHHHHHHHHHCCCCCEEEEEEEEEE
T ss_conf 78993970198307881999999857885542049999996633587--8999999999999971589968687788862
Q ss_pred CCEEEEEEECCCCCCHHHHHHCCCCC------------------CCCCCCHHHHHHHHHHHHHHHHHCCCCCEEECCCCC
Q ss_conf 89529998307999987884303999------------------999999889999999999887302457725238888
Q 002721 676 EDVALLLHNYLPNGTLAQLLHESTKQ------------------PDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISS 737 (888)
Q Consensus 676 ~~~~~lv~e~~~~gsL~~~l~~~~~~------------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~dlk~ 737 (888)
.+..++||||+++|+|.++++..... ....+++..++.++.||+.||+|||+.+|+||||||
T Consensus 113 ~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlKp 192 (325)
T d1rjba_ 113 SGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAA 192 (325)
T ss_dssp SSSCEEEEECCTTCBHHHHHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSG
T ss_pred CCEEEEEEECCCCCCHHHHHHHCCCCCCCHHHHHCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCH
T ss_conf 99589999727999599999862577751022100001222001257789999999999999999999739905052703
Q ss_pred CCEEECCCCCCEEECCCCCCCCCCCCCCCCCCCCCCCCCEECCCCCCCCCCCCCCCCHHHHHHHHHHHH-CCCCCCCCCC
Q ss_conf 975857999826702334322599999520013345443216333355785864430547899999881-9999877778
Q 002721 738 GNVLLDADFKPLLGEIEISKLLDPSKGTASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILT-TRLPVEEDFG 816 (888)
Q Consensus 738 ~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlG~il~ellt-g~~p~~~~~~ 816 (888)
+||+++.++.+||+|||+|+...............||+.|+|||++.+..++.++|||||||++|||+| |+.||.....
T Consensus 193 ~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~ 272 (325)
T d1rjba_ 193 RNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV 272 (325)
T ss_dssp GGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred HCCCCCCCCEEEEEECCCCCCCCCCCCEEEECCCCCCCCCCCHHHHCCCCCCCCEECCCHHHHHHHHHHCCCCCCCCCCH
T ss_conf 21443459828985142222045778615623435787657838872799996330300039999998389999999898
Q ss_pred CCCCHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHH
Q ss_conf 86313121123678999941013333366785829999999999940237899999999899999998
Q 002721 817 EGVDLVKWVHGAPARGETPEQILDARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEMLQE 884 (888)
Q Consensus 817 ~~~~l~~~~~~~~~~~~~~~~i~d~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~eil~~L~~ 884 (888)
. ..+...+...... . .+.....++.+++.+||+.+|++||||+||++.|..
T Consensus 273 ~-~~~~~~~~~~~~~----~------------~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~L~~ 323 (325)
T d1rjba_ 273 D-ANFYKLIQNGFKM----D------------QPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLGC 323 (325)
T ss_dssp S-HHHHHHHHTTCCC----C------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred H-HHHHHHHHCCCCC----C------------CCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHC
T ss_conf 9-9999998569989----9------------887678999999999758896689399999999748
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=375.39 Aligned_cols=258 Identities=19% Similarity=0.307 Sum_probs=206.8
Q ss_pred HHHHCCCCCEEEECCCCEEEEEEECCCCEEEEEEEECCCHHHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEECCEEEEE
Q ss_conf 98714786625426644299998179968999993126714568799999999998503799325443578728952999
Q 002721 603 VKATMKDSNMIYCGTFSTVYKAVMPSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVALLL 682 (888)
Q Consensus 603 ~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv 682 (888)
..++|++.+.||+|+||+||+|.++++..||||+++..... .+.|.+|++++++++|||||+++|++.. +..++|
T Consensus 11 ~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~~~~~~~~----~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv 85 (272)
T d1qpca_ 11 PRETLKLVERLGAGQFGEVWMGYYNGHTKVAVKSLKQGSMS----PDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYII 85 (272)
T ss_dssp CGGGEEEEEEEEEETTEEEEEEEETTTEEEEEEEECTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEE
T ss_pred CHHHEEEEEEEECCCCCEEEEEEECCCCEEEEEEECCCCCC----HHHHHHHHHHHHHCCCCCEEEEEEEECC-CCEEEE
T ss_conf 88993886798107982899999999999999998647688----8999999999986799988578731045-976999
Q ss_pred EECCCCCCHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCCEEECCCCCCCCCCC
Q ss_conf 83079999878843039999999998899999999998873024577252388889758579998267023343225999
Q 002721 683 HNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPS 762 (888)
Q Consensus 683 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~ 762 (888)
|||+++|+|.+++...... .+++..+++|+.||++||.|||+.+|+||||||+|||+++++.+||+|||+++.....
T Consensus 86 ~Ey~~~g~L~~~~~~~~~~---~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~ 162 (272)
T d1qpca_ 86 TEYMENGSLVDFLKTPSGI---KLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDN 162 (272)
T ss_dssp EECCTTCBHHHHTTSHHHH---TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSS
T ss_pred EEECCCCCHHHHHHHCCCC---CCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHEEEECCCCEEECCCCCEEECCCC
T ss_conf 9957898288887514789---8878899999999999999997489546756422515620244042341014773588
Q ss_pred CCCCCCCCCCCCCCEECCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCCC
Q ss_conf 99520013345443216333355785864430547899999881999987777886313121123678999941013333
Q 002721 763 KGTASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQILDAR 842 (888)
Q Consensus 763 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~i~d~~ 842 (888)
.. .......|++.|+|||++.+..++.++|||||||++|||+||..|+...... .+....+...... .
T Consensus 163 ~~-~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~-~~~~~~i~~~~~~-~--------- 230 (272)
T d1qpca_ 163 EY-TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN-PEVIQNLERGYRM-V--------- 230 (272)
T ss_dssp CE-ECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCH-HHHHHHHHTTCCC-C---------
T ss_pred CC-CCCCCCCCCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCH-HHHHHHHHHCCCC-C---------
T ss_conf 64-4203567744445828983799982456452579999999689888888899-9999999706888-8---------
Q ss_pred CCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHH
Q ss_conf 36678582999999999994023789999999989999999864
Q 002721 843 LSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEMLQEIK 886 (888)
Q Consensus 843 ~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~eil~~L~~~~ 886 (888)
.......++.+++.+||+.+|++||||+++++.|+.+-
T Consensus 231 ------~p~~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~f 268 (272)
T d1qpca_ 231 ------RPDNCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFF 268 (272)
T ss_dssp ------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ------CCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHH
T ss_conf ------96557199999999975889768939999999861132
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=0 Score=373.80 Aligned_cols=259 Identities=18% Similarity=0.292 Sum_probs=211.0
Q ss_pred HHHCCCCCEEEECCCCEEEEEEEC-CCCEEEEEEEECCCHHHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEECCEEEEE
Q ss_conf 871478662542664429999817-9968999993126714568799999999998503799325443578728952999
Q 002721 604 KATMKDSNMIYCGTFSTVYKAVMP-SGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVALLL 682 (888)
Q Consensus 604 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv 682 (888)
.++|+..+.||+|+||+||+|.+. ++..||||+++.... ..+++.+|++++++++|||||+++|++.+++..++|
T Consensus 16 ~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~----~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv 91 (287)
T d1opja_ 16 RTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYII 91 (287)
T ss_dssp GGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTCS----CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEE
T ss_pred HHHEEEEEEEEECCCEEEEEEEECCCCEEEEEEEECCCCC----HHHHHHHHHHHHHHCCCCCEECCCCCEEECCEEEEE
T ss_conf 7993986598208880899999999996999999777610----399999999999867999882677527457854787
Q ss_pred EECCCCCCHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCCEEECCCCCCCCCCC
Q ss_conf 83079999878843039999999998899999999998873024577252388889758579998267023343225999
Q 002721 683 HNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPS 762 (888)
Q Consensus 683 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~ 762 (888)
|||+++|+|.+++...... .+++..+..|+.|||.||+|||+.+|+||||||+|||++.++.+||+|||+++.....
T Consensus 92 ~E~~~~g~l~~~l~~~~~~---~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~ 168 (287)
T d1opja_ 92 TEFMTYGNLLDYLRECNRQ---EVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGD 168 (287)
T ss_dssp EECCTTCBHHHHHHHSCTT---TSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSS
T ss_pred EECCCCCCHHHHHHHCCCC---CHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCEEEECCCCCEEECCCCCEEECCCC
T ss_conf 6314676067775303554---1579999999999999788898789305760457689989992898324454653788
Q ss_pred CCCCCCCCCCCCCCEECCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCCC
Q ss_conf 99520013345443216333355785864430547899999881999987777886313121123678999941013333
Q 002721 763 KGTASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQILDAR 842 (888)
Q Consensus 763 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~i~d~~ 842 (888)
... ......|+..|+|||++.+..++.++|||||||++|||++|..|+....... .....+.... .+.
T Consensus 169 ~~~-~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~-~~~~~i~~~~----~~~------ 236 (287)
T d1opja_ 169 TYT-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS-QVYELLEKDY----RME------ 236 (287)
T ss_dssp SSE-EETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHH-HHHHHHHTTC----CCC------
T ss_pred CCE-EECCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHH-HHHHHHHCCC----CCC------
T ss_conf 722-1035566546669278727999810430217899999986799887742599-9999985588----888------
Q ss_pred CCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHH
Q ss_conf 366785829999999999940237899999999899999998641
Q 002721 843 LSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEMLQEIKQ 887 (888)
Q Consensus 843 ~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~eil~~L~~~~~ 887 (888)
.......++.+++.+||+.||++||||+|+++.|+.+.+
T Consensus 237 ------~~~~~~~~l~~li~~cl~~dP~~Rps~~ei~~~L~~~~~ 275 (287)
T d1opja_ 237 ------RPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQ 275 (287)
T ss_dssp ------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTS
T ss_pred ------CCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHH
T ss_conf ------874330999999999757797689399999999999987
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=371.84 Aligned_cols=253 Identities=19% Similarity=0.281 Sum_probs=205.7
Q ss_pred HHCCCCCEEEECCCCEEEEEEEC-CCCEEEEEEEECCCHHHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEECCEEEEEE
Q ss_conf 71478662542664429999817-99689999931267145687999999999985037993254435787289529998
Q 002721 605 ATMKDSNMIYCGTFSTVYKAVMP-SGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVALLLH 683 (888)
Q Consensus 605 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 683 (888)
++|++.+.||+|+||+||+|+.. +++.||+|++...... ...+.+.+|++++++++||||+++++++.+++..|+||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~--~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivm 82 (271)
T d1nvra_ 5 EDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAV--DCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFL 82 (271)
T ss_dssp TEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCC--HHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCEEEEEE
T ss_conf 4608998972174809999999999979999998456641--27999999999998579988846965404674367988
Q ss_pred ECCCCCCHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCCEEECCCCCCCCCCCC
Q ss_conf 30799998788430399999999988999999999988730245772523888897585799982670233432259999
Q 002721 684 NYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSK 763 (888)
Q Consensus 684 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~ 763 (888)
||+++|+|.+++.... .+++..+..++.||+.||+|||+.+|+||||||+|||+++++.+||+|||+|+......
T Consensus 83 Ey~~gg~L~~~l~~~~-----~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~ 157 (271)
T d1nvra_ 83 EYCSGGELFDRIEPDI-----GMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 157 (271)
T ss_dssp ECCTTEEGGGGSBTTT-----BCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETT
T ss_pred ECCCCCCHHHHHHCCC-----CCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHEEECCCCCEEECCCHHHEEECCCC
T ss_conf 6458980899975379-----99999999999999999999997598357546899788789987983231422404688
Q ss_pred CCCCCCCCCCCCCEECCCCCCCCCC-CCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCCC
Q ss_conf 9520013345443216333355785-864430547899999881999987777886313121123678999941013333
Q 002721 764 GTASISAVAGSFGYIPPEYAYTMQV-TAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQILDAR 842 (888)
Q Consensus 764 ~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DVwSlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~i~d~~ 842 (888)
........+||+.|+|||++.+..+ +.++||||+||++|||+||+.||....................
T Consensus 158 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~~~~~~~~----------- 226 (271)
T d1nvra_ 158 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYL----------- 226 (271)
T ss_dssp EECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHHHTTCTTS-----------
T ss_pred CCCCCCCEEECCCCCCHHHHCCCCCCCCCEEEEHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHCCCCCC-----------
T ss_conf 653111325574742872861899999710161737999999829978888985999999986388878-----------
Q ss_pred CCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf 36678582999999999994023789999999989999
Q 002721 843 LSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVE 880 (888)
Q Consensus 843 ~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~eil~ 880 (888)
..+.....++.+++.+||+.||++|||++|+++
T Consensus 227 -----~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~ 259 (271)
T d1nvra_ 227 -----NPWKKIDSAPLALLHKILVENPSARITIPDIKK 259 (271)
T ss_dssp -----TTGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred -----CCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf -----864469999999999976799668909999961
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=367.57 Aligned_cols=260 Identities=18% Similarity=0.352 Sum_probs=208.4
Q ss_pred HHCCCCCEEEECCCCEEEEEEECCC-----CEEEEEEEECCCHHHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEECCEE
Q ss_conf 7147866254266442999981799-----68999993126714568799999999998503799325443578728952
Q 002721 605 ATMKDSNMIYCGTFSTVYKAVMPSG-----LILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVA 679 (888)
Q Consensus 605 ~~~~~~~~lg~G~~g~Vy~~~~~~~-----~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~ 679 (888)
.+|+..++||+|+||+||+|.+..+ ..||||++...... .....|.+|++++++++|||||+++|++......
T Consensus 7 ~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~~~~--~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~ 84 (283)
T d1mqba_ 7 SCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGYTE--KQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPM 84 (283)
T ss_dssp TTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTCCH--HHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSE
T ss_pred HHEEEEEEEEECCCEEEEEEEEECCCCEEEEEEEEEEECCCCCH--HHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCE
T ss_conf 99686159811779099999996899878799999998844596--8999999999999856898783236778338803
Q ss_pred EEEEECCCCCCHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCCEEECCCCCCCC
Q ss_conf 99983079999878843039999999998899999999998873024577252388889758579998267023343225
Q 002721 680 LLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLL 759 (888)
Q Consensus 680 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~ 759 (888)
++||||++++++.+.+..... .++|.++..++.||+.||+|||+.+|+||||||+|||++.++.+||+|||+++..
T Consensus 85 ~~v~e~~~~~~l~~~~~~~~~----~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~ 160 (283)
T d1mqba_ 85 MIITEYMENGALDKFLREKDG----EFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVL 160 (283)
T ss_dssp EEEEECCTTEEHHHHHHHTTT----CSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC----
T ss_pred EEEEEECCCCCCHHHHHCCCC----CCCHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCEEEECCCCEEEECCCCHHHCC
T ss_conf 899972135740222102345----4208999999999998541212123425765644278889984998455103003
Q ss_pred CCCCCC-CCCCCCCCCCCEECCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCC
Q ss_conf 999995-2001334544321633335578586443054789999988199998777788631312112367899994101
Q 002721 760 DPSKGT-ASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQI 838 (888)
Q Consensus 760 ~~~~~~-~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~i 838 (888)
...... .......||..|+|||++.+..++.++|||||||++|||++|..|+...... .+....+.....
T Consensus 161 ~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~~-~~~~~~i~~~~~-------- 231 (283)
T d1mqba_ 161 EDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSN-HEVMKAINDGFR-------- 231 (283)
T ss_dssp -------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH-HHHHHHHHTTCC--------
T ss_pred CCCCCCCEEECCCCCCCCCCCHHHHCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCH-HHHHHHHHCCCC--------
T ss_conf 57876526742677773434888870499997355634489899999679886556899-999999863578--------
Q ss_pred CCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHH
Q ss_conf 3333366785829999999999940237899999999899999998641
Q 002721 839 LDARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEMLQEIKQ 887 (888)
Q Consensus 839 ~d~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~eil~~L~~~~~ 887 (888)
.. .....+.++.+++.+||+.+|++||||.|+++.|+++.+
T Consensus 232 -----~~---~~~~~~~~l~~li~~cl~~~p~~RPt~~eil~~L~~l~~ 272 (283)
T d1mqba_ 232 -----LP---TPMDCPSAIYQLMMQCWQQERARRPKFADIVSILDKLIR 272 (283)
T ss_dssp -----CC---CCTTCBHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred -----CC---CCHHHHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHH
T ss_conf -----99---850457999999999776797689399999999999866
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=371.96 Aligned_cols=252 Identities=18% Similarity=0.204 Sum_probs=207.9
Q ss_pred HHCCCCCEEEECCCCEEEEEEEC-CCCEEEEEEEECCCHHHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEECCEEEEEE
Q ss_conf 71478662542664429999817-99689999931267145687999999999985037993254435787289529998
Q 002721 605 ATMKDSNMIYCGTFSTVYKAVMP-SGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVALLLH 683 (888)
Q Consensus 605 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 683 (888)
++|++.+.||+|+||+||+|+.. +++.||+|++.+...........+.+|++++++++||||+++++++.+++..|+||
T Consensus 8 ~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivm 87 (288)
T d1uu3a_ 8 EDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGL 87 (288)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEEE
T ss_conf 87789889850879099999998999799999986577557778999999999998768888617999999899889999
Q ss_pred ECCCCCCHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCCEEECCCCCCCCCCCC
Q ss_conf 30799998788430399999999988999999999988730245772523888897585799982670233432259999
Q 002721 684 NYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSK 763 (888)
Q Consensus 684 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~ 763 (888)
||+++|+|.+++...+ .+++..+..++.|++.||+|||+.+|+||||||+|||+++++.+|++|||+++......
T Consensus 88 Ey~~gg~L~~~~~~~~-----~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~ 162 (288)
T d1uu3a_ 88 SYAKNGELLKYIRKIG-----SFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES 162 (288)
T ss_dssp CCCTTEEHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC---
T ss_pred ECCCCCCHHHHHHCCC-----CCCHHHHHHHHHHHHHHHHHHCCCCEECCCCCCCCCCCCCCCEEEECCCCCCEECCCCC
T ss_conf 7048987777653159-----99999999999999999976216508847677412366888538860321024225677
Q ss_pred CCCCCCCCCCCCCEECCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCCCC
Q ss_conf 95200133454432163333557858644305478999998819999877778863131211236789999410133333
Q 002721 764 GTASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQILDARL 843 (888)
Q Consensus 764 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~i~d~~~ 843 (888)
.........||+.|+|||++.+..++.++||||+||++|||+||+.||...... .+.... .....
T Consensus 163 ~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~--~~~~~i-------------~~~~~ 227 (288)
T d1uu3a_ 163 KQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEY--LIFQKI-------------IKLEY 227 (288)
T ss_dssp -------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHH-------------HTTCC
T ss_pred CCCCCCCCCCCCCCCCCEEECCCCCCCCCCEEHHHHHHHHHHHCCCCCCCCCHH--HHHHHH-------------HCCCC
T ss_conf 643335556775525844002689896662304569999980388998995999--999999-------------71899
Q ss_pred CCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf 6678582999999999994023789999999989999
Q 002721 844 STVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVE 880 (888)
Q Consensus 844 ~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~eil~ 880 (888)
. ......+++.+++.+||+.||++|||++|++.
T Consensus 228 ~----~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~ 260 (288)
T d1uu3a_ 228 D----FPEKFFPKARDLVEKLLVLDATKRLGCEEMEG 260 (288)
T ss_dssp C----CCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTC
T ss_pred C----CCCCCCHHHHHHHHHHCCCCHHHCCCHHHHCC
T ss_conf 9----98547999999999985579768919789737
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=365.37 Aligned_cols=250 Identities=20% Similarity=0.267 Sum_probs=204.7
Q ss_pred HHHCCCCCEEEECCCCEEEEEEE-CCCCEEEEEEEECCCHHHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEECCEEEEE
Q ss_conf 87147866254266442999981-79968999993126714568799999999998503799325443578728952999
Q 002721 604 KATMKDSNMIYCGTFSTVYKAVM-PSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVALLL 682 (888)
Q Consensus 604 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv 682 (888)
..+|+..+.||+|+||+||+|.. .+|..||+|+++..... ..+.+.+|+++++.++|||||++++++..++..|+|
T Consensus 19 ~~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~~---~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv 95 (293)
T d1yhwa1 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQP---KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVV 95 (293)
T ss_dssp TTTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGCS---CHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEE
T ss_pred CCCCEEEEEEECCCCCEEEEEEECCCCCEEEEEEEECCCCH---HHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEE
T ss_conf 10538878981285829999999899989999998430172---799999999999867999880585779889998999
Q ss_pred EECCCCCCHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCCEEECCCCCCCCCCC
Q ss_conf 83079999878843039999999998899999999998873024577252388889758579998267023343225999
Q 002721 683 HNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPS 762 (888)
Q Consensus 683 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~ 762 (888)
|||+++|+|.+++... .+++.++..++.||+.||+|||+.+|+||||||+|||++.++.+|++|||+++.....
T Consensus 96 mEy~~gg~L~~~~~~~------~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~ 169 (293)
T d1yhwa1 96 MEYLAGGSLTDVVTET------CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPE 169 (293)
T ss_dssp EECCTTCBHHHHHHHS------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCST
T ss_pred EEECCCCCHHHHHHCC------CCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHEEECCCCCEEECCCHHHEEECCC
T ss_conf 9703798089886415------9999999999999999999999879722677688868878996864251564132136
Q ss_pred CCCCCCCCCCCCCCEECCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCCC
Q ss_conf 99520013345443216333355785864430547899999881999987777886313121123678999941013333
Q 002721 763 KGTASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQILDAR 842 (888)
Q Consensus 763 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~i~d~~ 842 (888)
.. ......||+.|+|||++.+..++.++||||+||++|||+||+.||....... .+..........
T Consensus 170 ~~--~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~-~~~~~~~~~~~~----------- 235 (293)
T d1yhwa1 170 QS--KRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR-ALYLIATNGTPE----------- 235 (293)
T ss_dssp TC--CBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-HHHHHHHHCSCC-----------
T ss_pred CC--CCCCCCCCCCCCCHHHHCCCCCCCHHCEEHHHHHHHHHHHCCCCCCCCCHHH-HHHHHHHCCCCC-----------
T ss_conf 66--4444444777368266447998801203137299999804889989979999-999998579998-----------
Q ss_pred CCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf 36678582999999999994023789999999989999
Q 002721 843 LSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVE 880 (888)
Q Consensus 843 ~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~eil~ 880 (888)
+ ..+......+.+++.+||+.||++|||++|+++
T Consensus 236 ~----~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 269 (293)
T d1yhwa1 236 L----QNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQ 269 (293)
T ss_dssp C----SSGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTT
T ss_pred C----CCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf 8----885537999999999986699668909999964
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=367.87 Aligned_cols=257 Identities=20% Similarity=0.281 Sum_probs=204.9
Q ss_pred HHCCCCC-EEEECCCCEEEEEEEC---CCCEEEEEEEECCCHHHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEECCEEE
Q ss_conf 7147866-2542664429999817---99689999931267145687999999999985037993254435787289529
Q 002721 605 ATMKDSN-MIYCGTFSTVYKAVMP---SGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVAL 680 (888)
Q Consensus 605 ~~~~~~~-~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~ 680 (888)
+++...+ +||+|+||+||+|.+. ++..||||+++..... ...+.|.+|++++++++|||||+++|++.. +..|
T Consensus 8 ~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~~~~--~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~ 84 (285)
T d1u59a_ 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGTEK--ADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALM 84 (285)
T ss_dssp GGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSSCCH--HHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEE
T ss_pred CCEEECCCEEECCCCEEEEEEEEECCCCCEEEEEEEECHHCCH--HHHHHHHHHHHHHHHCCCCCEEEEEEEECC-CEEE
T ss_conf 4718878487306080999999960897689999998820397--899999999999986799888068656036-8079
Q ss_pred EEEECCCCCCHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCCEEECCCCCCCCC
Q ss_conf 99830799998788430399999999988999999999988730245772523888897585799982670233432259
Q 002721 681 LLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLD 760 (888)
Q Consensus 681 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~ 760 (888)
+||||+++|+|.+++..... .+++..+..++.|||.||+|||+.+|+||||||+||+++.++.+|++|||+++...
T Consensus 85 lvmE~~~~g~L~~~l~~~~~----~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~ 160 (285)
T d1u59a_ 85 LVMEMAGGGPLHKFLVGKRE----EIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALG 160 (285)
T ss_dssp EEEECCTTEEHHHHHTTCTT----TSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECT
T ss_pred EEEEECCCCCHHHHHHCCCC----CCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEECCCCCEEECCCHHHHCCC
T ss_conf 99980789968997521256----99999999999999998789986881057676466045468854203313421155
Q ss_pred CCCCCC-CCCCCCCCCCEECCCCCCCCCCCCCCCCHHHHHHHHHHHH-CCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCC
Q ss_conf 999952-0013345443216333355785864430547899999881-99998777788631312112367899994101
Q 002721 761 PSKGTA-SISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILT-TRLPVEEDFGEGVDLVKWVHGAPARGETPEQI 838 (888)
Q Consensus 761 ~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlG~il~ellt-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~i 838 (888)
...... ......||+.|+|||++.+..++.++|||||||++|||+| |+.||...... +....+.. +..+.
T Consensus 161 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~--~~~~~i~~----~~~~~-- 232 (285)
T d1u59a_ 161 ADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP--EVMAFIEQ----GKRME-- 232 (285)
T ss_dssp TCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH--HHHHHHHT----TCCCC--
T ss_pred CCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCCCHHHCCHHHHHHHHHCCCCCCCCCCHH--HHHHHHHC----CCCCC--
T ss_conf 43432113562113743358688727999954123220178999993899999997999--99999981----89999--
Q ss_pred CCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHH
Q ss_conf 333336678582999999999994023789999999989999999864
Q 002721 839 LDARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEMLQEIK 886 (888)
Q Consensus 839 ~d~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~eil~~L~~~~ 886 (888)
.....+.++.+++.+||+.+|++||||.++++.|+...
T Consensus 233 ----------~p~~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~ 270 (285)
T d1u59a_ 233 ----------CPPECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACY 270 (285)
T ss_dssp ----------CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred ----------CCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHH
T ss_conf ----------99767899999999975779768909999999999999
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=367.19 Aligned_cols=249 Identities=21% Similarity=0.290 Sum_probs=202.7
Q ss_pred HHHCCCCCEEEECCCCEEEEEEE-CCCCEEEEEEEECCCHHHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEECCEEEEE
Q ss_conf 87147866254266442999981-79968999993126714568799999999998503799325443578728952999
Q 002721 604 KATMKDSNMIYCGTFSTVYKAVM-PSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVALLL 682 (888)
Q Consensus 604 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv 682 (888)
...|+..+.||+|+||+||+|+. .++..||||++...........+.+.+|+++++.++|||||++++++.+++..|+|
T Consensus 14 ~~~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv 93 (309)
T d1u5ra_ 14 EKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLV 93 (309)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEE
T ss_pred HHHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCEEEEE
T ss_conf 78567627970188809999999899939999998444435889999999999999977899982389999989988999
Q ss_pred EECCCCCCHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCCEEECCCCCCCCCCC
Q ss_conf 83079999878843039999999998899999999998873024577252388889758579998267023343225999
Q 002721 683 HNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPS 762 (888)
Q Consensus 683 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~ 762 (888)
||||++|++..++.... .+++..+..++.||+.||.|||+.+|+||||||+|||++.++.+||+|||+++.....
T Consensus 94 ~E~~~~g~l~~~~~~~~-----~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~~ 168 (309)
T d1u5ra_ 94 MEYCLGSASDLLEVHKK-----PLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA 168 (309)
T ss_dssp EECCSEEHHHHHHHHTS-----CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB
T ss_pred EEECCCCCHHHHHHHCC-----CCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCCCEEEECCCCCEEEEECCCCCCCCCC
T ss_conf 98069994578997379-----9999999999999999999998689766678842179879997898443653346778
Q ss_pred CCCCCCCCCCCCCCEECCCCCCC---CCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCC
Q ss_conf 99520013345443216333355---785864430547899999881999987777886313121123678999941013
Q 002721 763 KGTASISAVAGSFGYIPPEYAYT---MQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQIL 839 (888)
Q Consensus 763 ~~~~~~~~~~gt~~y~aPE~~~~---~~~~~~~DVwSlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~i~ 839 (888)
....||+.|+|||++.+ ..|+.++|||||||++|||++|+.||....... .+........
T Consensus 169 ------~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~-~~~~i~~~~~---------- 231 (309)
T d1u5ra_ 169 ------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS-ALYHIAQNES---------- 231 (309)
T ss_dssp ------CCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHH-HHHHHHHSCC----------
T ss_pred ------CCCCCCCCCCCHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHH-HHHHHHHCCC----------
T ss_conf ------73134766368899834678886721454558999999987889999979999-9999982899----------
Q ss_pred CCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf 33336678582999999999994023789999999989999
Q 002721 840 DARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVE 880 (888)
Q Consensus 840 d~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~eil~ 880 (888)
+.. ......+.+.+++.+||+.||++|||++|+++
T Consensus 232 -~~~-----~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~ 266 (309)
T d1u5ra_ 232 -PAL-----QSGHWSEYFRNFVDSCLQKIPQDRPTSEVLLK 266 (309)
T ss_dssp -CCC-----SCTTSCHHHHHHHHHHTCSSGGGSCCHHHHTT
T ss_pred -CCC-----CCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHH
T ss_conf -988-----87888999999999977379657918999971
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=368.30 Aligned_cols=253 Identities=20% Similarity=0.254 Sum_probs=205.1
Q ss_pred HHHCCCCCEEEECCCCEEEEEEEC-CCCEEEEEEEECCCHHHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEECCEEEEE
Q ss_conf 871478662542664429999817-9968999993126714568799999999998503799325443578728952999
Q 002721 604 KATMKDSNMIYCGTFSTVYKAVMP-SGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVALLL 682 (888)
Q Consensus 604 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv 682 (888)
++.|++.+.||+|+||+||+|+.. +++.||+|++....... ....+.+|+.+++.++|||||++++++.+++..|+|
T Consensus 8 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~--~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv 85 (307)
T d1a06a_ 8 RDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALEG--KEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLI 85 (307)
T ss_dssp GGTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC------------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEE
T ss_pred CCCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECHHHHHH--HHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEE
T ss_conf 666699889940658399999999999899999981577312--899999999999867998999198999989988898
Q ss_pred EECCCCCCHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEEC---CCCCCEEECCCCCCCC
Q ss_conf 8307999987884303999999999889999999999887302457725238888975857---9998267023343225
Q 002721 683 HNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLD---ADFKPLLGEIEISKLL 759 (888)
Q Consensus 683 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~dlk~~NIll~---~~~~~kl~Dfg~~~~~ 759 (888)
|||+++|+|.+++.... .+++..+..++.||+.||+|||+.+|+||||||+||++. +++.+|++|||+++..
T Consensus 86 mE~~~gg~L~~~l~~~~-----~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~ 160 (307)
T d1a06a_ 86 MQLVSGGELFDRIVEKG-----FYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKME 160 (307)
T ss_dssp ECCCCSCBHHHHHHTCS-----CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC------
T ss_pred EECCCCCCHHHHHHCCC-----CCCHHHHHHHHHHHHHHHHHHHHCEEEEEEECCCCEEECCCCCCCEEEEECCCEEEEC
T ss_conf 85268984888653036-----7887899999999999987524130556870463001104688824998315435872
Q ss_pred CCCCCCCCCCCCCCCCCEECCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCC
Q ss_conf 99999520013345443216333355785864430547899999881999987777886313121123678999941013
Q 002721 760 DPSKGTASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQIL 839 (888)
Q Consensus 760 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~i~ 839 (888)
.... .....+||+.|+|||++.+..++.++||||+||++|||++|+.||....... ......
T Consensus 161 ~~~~---~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~--~~~~i~------------- 222 (307)
T d1a06a_ 161 DPGS---VLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAK--LFEQIL------------- 222 (307)
T ss_dssp ---------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH--HHHHHH-------------
T ss_pred CCCC---EEEEEEECCCCCCCHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHH--HHHHHH-------------
T ss_conf 5897---0440032842259188737999807873451599999985979999989999--999986-------------
Q ss_pred CCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 333366785829999999999940237899999999899999
Q 002721 840 DARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEM 881 (888)
Q Consensus 840 d~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~eil~~ 881 (888)
........+......+++.+++.+||+.||++|||++|+++.
T Consensus 223 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 264 (307)
T d1a06a_ 223 KAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQH 264 (307)
T ss_dssp TTCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHS
T ss_pred CCCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 168777876666789999999999760897579189998629
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=0 Score=365.63 Aligned_cols=252 Identities=15% Similarity=0.234 Sum_probs=204.4
Q ss_pred HHCCCCCEEEECCCCEEEEEEEC-CCCEEEEEEEECCCHHHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEECCEEEEEE
Q ss_conf 71478662542664429999817-99689999931267145687999999999985037993254435787289529998
Q 002721 605 ATMKDSNMIYCGTFSTVYKAVMP-SGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVALLLH 683 (888)
Q Consensus 605 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 683 (888)
++|++.+.||+|+||.||+|+.. +|..||+|++...... ..+.+.+|+.++++++|||||++++++.+++..|+||
T Consensus 26 ~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~~~---~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 102 (350)
T d1koaa2 26 DHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHES---DKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIY 102 (350)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCSHH---HHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEE
T ss_pred CCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCCHH---HHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEEE
T ss_conf 5758988984076819999998899989999998452431---6999999999998679979992999999899999999
Q ss_pred ECCCCCCHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEEC--CCCCCEEECCCCCCCCCC
Q ss_conf 307999987884303999999999889999999999887302457725238888975857--999826702334322599
Q 002721 684 NYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLD--ADFKPLLGEIEISKLLDP 761 (888)
Q Consensus 684 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~dlk~~NIll~--~~~~~kl~Dfg~~~~~~~ 761 (888)
|||++|+|.+++..... .+++..+..|+.||+.||+|||+.+|+||||||+|||++ .++.+||+|||+++....
T Consensus 103 E~~~gg~L~~~l~~~~~----~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~ 178 (350)
T d1koaa2 103 EFMSGGELFEKVADEHN----KMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDP 178 (350)
T ss_dssp CCCCSCBHHHHHTCTTS----CBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCT
T ss_pred ECCCCCCHHHHHHHHCC----CCCHHHHHHHHHHHHHHHHHHHHCCCEEEEECHHHEEECCCCCCEEEEEECCHHEECCC
T ss_conf 85799889999976237----89999999999999999999975697600015467364168898699954521044256
Q ss_pred CCCCCCCCCCCCCCCEECCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCC
Q ss_conf 99952001334544321633335578586443054789999988199998777788631312112367899994101333
Q 002721 762 SKGTASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQILDA 841 (888)
Q Consensus 762 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~i~d~ 841 (888)
... .....||+.|+|||++.+..++.++||||+||++|||++|+.||...... +........
T Consensus 179 ~~~---~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~--~~~~~i~~~------------- 240 (350)
T d1koaa2 179 KQS---VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD--ETLRNVKSC------------- 240 (350)
T ss_dssp TSC---EEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHHT-------------
T ss_pred CCC---CCEECCCCCCCCHHHHCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCHH--HHHHHHHHC-------------
T ss_conf 543---20006862421889975899872676554659999998598998997999--999999847-------------
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 3366785829999999999940237899999999899999
Q 002721 842 RLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEM 881 (888)
Q Consensus 842 ~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~eil~~ 881 (888)
..............++.+++.+||+.||++|||++|+++.
T Consensus 241 ~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~h 280 (350)
T d1koaa2 241 DWNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEH 280 (350)
T ss_dssp CCCSCCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHS
T ss_pred CCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 8898942235899999999999756896679089998629
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=365.88 Aligned_cols=265 Identities=23% Similarity=0.351 Sum_probs=212.5
Q ss_pred HHHHCCCCCEEEECCCCEEEEEEEC------CCCEEEEEEEECCCHHHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEEC
Q ss_conf 9871478662542664429999817------9968999993126714568799999999998503799325443578728
Q 002721 603 VKATMKDSNMIYCGTFSTVYKAVMP------SGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYE 676 (888)
Q Consensus 603 ~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~ 676 (888)
.+++|+..+.||+|+||+||+|+.. ++..||||+++..... .....|.+|+++++.++||||+++++++...
T Consensus 11 p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~--~~~~~~~~E~~il~~l~h~niv~~~~~~~~~ 88 (301)
T d1lufa_ 11 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEASA--DMQADFQREAALMAEFDNPNIVKLLGVCAVG 88 (301)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTCCH--HHHHHHHHHHHHHHTCCCTTBCCEEEEECSS
T ss_pred CHHHCEEEEEEEECCCEEEEEEEECCCCCCCCCEEEEEEEECHHCCH--HHHHHHHHHHHHHHHCCCCCCCCCEEEECCC
T ss_conf 98893886798207883999999888765778829999998821085--7999999999999966899765524666059
Q ss_pred CEEEEEEECCCCCCHHHHHHCCCC-------------------CCCCCCCHHHHHHHHHHHHHHHHHCCCCCEEECCCCC
Q ss_conf 952999830799998788430399-------------------9999999889999999999887302457725238888
Q 002721 677 DVALLLHNYLPNGTLAQLLHESTK-------------------QPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISS 737 (888)
Q Consensus 677 ~~~~lv~e~~~~gsL~~~l~~~~~-------------------~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~dlk~ 737 (888)
...++++||+++|+|.+++..... .....+++..++.|+.|++.||+|||+.+++||||||
T Consensus 89 ~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlKp 168 (301)
T d1lufa_ 89 KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLAT 168 (301)
T ss_dssp SSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG
T ss_pred CCEEEEEEECCCCCHHHHHHHCCCCCCCCCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCEEEEEECC
T ss_conf 80389998158992999998527554210000111001210346788989999999999999985541357868548840
Q ss_pred CCEEECCCCCCEEECCCCCCCCCCCCCCCCCCCCCCCCCEECCCCCCCCCCCCCCCCHHHHHHHHHHHHCCC-CCCCCCC
Q ss_conf 975857999826702334322599999520013345443216333355785864430547899999881999-9877778
Q 002721 738 GNVLLDADFKPLLGEIEISKLLDPSKGTASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILTTRL-PVEEDFG 816 (888)
Q Consensus 738 ~NIll~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlG~il~elltg~~-p~~~~~~ 816 (888)
+|||++.++.+||+|||+++...............|++.|+|||++.+..++.++|||||||++|||++|.. ||.....
T Consensus 169 ~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~ 248 (301)
T d1lufa_ 169 RNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAH 248 (301)
T ss_dssp GGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH
T ss_pred CCEEECCCCCEEECCCHHHEECCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCHHHHHCCCHHHHHHHHCCCCCCCCCCCH
T ss_conf 11689899928983314421136776411157777676767989972688980563025236299998068999999899
Q ss_pred CCCCHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHH
Q ss_conf 86313121123678999941013333366785829999999999940237899999999899999998641
Q 002721 817 EGVDLVKWVHGAPARGETPEQILDARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEMLQEIKQ 887 (888)
Q Consensus 817 ~~~~l~~~~~~~~~~~~~~~~i~d~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~eil~~L~~~~~ 887 (888)
. +....+. +..... .....+.++.+++.+||+.+|++||||.||++.|+++.+
T Consensus 249 ~--e~~~~v~-------------~~~~~~---~p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~~L~~i~~ 301 (301)
T d1lufa_ 249 E--EVIYYVR-------------DGNILA---CPENCPLELYNLMRLCWSKLPADRPSFCSIHRILQRMCE 301 (301)
T ss_dssp H--HHHHHHH-------------TTCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHTTC
T ss_pred H--HHHHHHH-------------CCCCCC---CCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHCC
T ss_conf 9--9999997-------------399788---873252999999999748896579399999999998429
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=0 Score=363.57 Aligned_cols=251 Identities=16% Similarity=0.179 Sum_probs=204.5
Q ss_pred HHCCCCCEEEECCCCEEEEEEE-CCCCEEEEEEEECCCHHHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEECCEEEEEE
Q ss_conf 7147866254266442999981-799689999931267145687999999999985037993254435787289529998
Q 002721 605 ATMKDSNMIYCGTFSTVYKAVM-PSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVALLLH 683 (888)
Q Consensus 605 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 683 (888)
+.|++.+.||+|+||+||+|.. .+|..||+|++...... ....+.+|+.++++++|||||++++++.+++..|+||
T Consensus 29 d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~~---~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivm 105 (352)
T d1koba_ 29 DYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPYPL---DKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLIL 105 (352)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSHH---HHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEE
T ss_pred CCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCCHH---HHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEEEEEE
T ss_conf 0359989993177829999999899979999998872646---7999999999998679979891999999899999999
Q ss_pred ECCCCCCHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEEC--CCCCCEEECCCCCCCCCC
Q ss_conf 307999987884303999999999889999999999887302457725238888975857--999826702334322599
Q 002721 684 NYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLD--ADFKPLLGEIEISKLLDP 761 (888)
Q Consensus 684 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~dlk~~NIll~--~~~~~kl~Dfg~~~~~~~ 761 (888)
|||++|+|.+++..... .+++..+..|+.||+.||+|||+.+|+||||||+|||++ .++.+||+|||+++....
T Consensus 106 E~~~gg~L~~~~~~~~~----~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~ 181 (352)
T d1koba_ 106 EFLSGGELFDRIAAEDY----KMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP 181 (352)
T ss_dssp ECCCCCBHHHHTTCTTC----CBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCT
T ss_pred ECCCCCHHHHHHHHCCC----CCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCCCCCCCCCCCEEEEEECCCCEECCC
T ss_conf 82899808888986389----98999999999999999999997792651314455311346788489952563034378
Q ss_pred CCCCCCCCCCCCCCCEECCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCC
Q ss_conf 99952001334544321633335578586443054789999988199998777788631312112367899994101333
Q 002721 762 SKGTASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQILDA 841 (888)
Q Consensus 762 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~i~d~ 841 (888)
... .....|++.|+|||++.+..++.++||||+||++|||+||+.||....... .+..........
T Consensus 182 ~~~---~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~-~~~~i~~~~~~~---------- 247 (352)
T d1koba_ 182 DEI---VKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE-TLQNVKRCDWEF---------- 247 (352)
T ss_dssp TSC---EEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHH-HHHHHHHCCCCC----------
T ss_pred CCC---EEECCCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCHHH-HHHHHHHCCCCC----------
T ss_conf 872---010047645348999747998976333898999999996889989979999-999998478898----------
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf 336678582999999999994023789999999989999
Q 002721 842 RLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVE 880 (888)
Q Consensus 842 ~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~eil~ 880 (888)
....+.....++.+++.+||+.||++|||++|+++
T Consensus 248 ----~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 282 (352)
T d1koba_ 248 ----DEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALE 282 (352)
T ss_dssp ----CSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHT
T ss_pred ----CCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf ----93002479999999999975699668918999960
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=360.55 Aligned_cols=251 Identities=19% Similarity=0.240 Sum_probs=201.7
Q ss_pred CEEEECCCCEEEEEEEC---CCCEEEEEEEECCCHHHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEECCEEEEEEECCC
Q ss_conf 62542664429999817---996899999312671456879999999999850379932544357872895299983079
Q 002721 611 NMIYCGTFSTVYKAVMP---SGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVALLLHNYLP 687 (888)
Q Consensus 611 ~~lg~G~~g~Vy~~~~~---~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~~ 687 (888)
++||+|+||+||+|.+. .++.||+|+++... ......+.+.+|++++++++|||||+++|+|.. +..++||||++
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~ 90 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA-NDPALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAE 90 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCT
T ss_pred CCCCCCCCEEEEEEEECCCCCCEEEEEEEECHHH-CCHHHHHHHHHHHHHHHHCCCCCCCEEEEEECC-CCEEEEEECCC
T ss_conf 7834587829999998169738599999988010-898999999999999986799898527777505-97799997478
Q ss_pred CCCHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCCEEECCCCCCCCCCCCCCC-
Q ss_conf 9998788430399999999988999999999988730245772523888897585799982670233432259999952-
Q 002721 688 NGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSKGTA- 766 (888)
Q Consensus 688 ~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~- 766 (888)
+|+|.++++... .+++..+..|+.||+.||+|||+.+|+||||||+|||++.++.+|++|||+++.........
T Consensus 91 ~g~L~~~l~~~~-----~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~ 165 (277)
T d1xbba_ 91 LGPLNKYLQQNR-----HVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYK 165 (277)
T ss_dssp TEEHHHHHHHCT-----TCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEE
T ss_pred CCCHHHHHHHCC-----CCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHCCCCCCCCCCCCHHHHHHCCCCCCCCC
T ss_conf 896899975225-----789999999999999997668747955677761131023567512341345331343234432
Q ss_pred CCCCCCCCCCEECCCCCCCCCCCCCCCCHHHHHHHHHHHH-CCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCCCCCC
Q ss_conf 0013345443216333355785864430547899999881-999987777886313121123678999941013333366
Q 002721 767 SISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILT-TRLPVEEDFGEGVDLVKWVHGAPARGETPEQILDARLST 845 (888)
Q Consensus 767 ~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlG~il~ellt-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~i~d~~~~~ 845 (888)
......||+.|+|||.+.+..++.++|||||||++|||+| |+.||...... +....+... ..+.
T Consensus 166 ~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~--~~~~~i~~~----~~~~--------- 230 (277)
T d1xbba_ 166 AQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS--EVTAMLEKG----ERMG--------- 230 (277)
T ss_dssp C----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH--HHHHHHHTT----CCCC---------
T ss_pred CCCCCCCCCEECCCHHHCCCCCCCHHHHCCCHHHHHHHHHCCCCCCCCCCHH--HHHHHHHCC----CCCC---------
T ss_conf 2445677842039166537999843443034031328965899999998999--999999828----9999---------
Q ss_pred CCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHH
Q ss_conf 78582999999999994023789999999989999999864
Q 002721 846 VSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEMLQEIK 886 (888)
Q Consensus 846 ~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~eil~~L~~~~ 886 (888)
.....+.++.+++.+||+.+|++||||+++++.|+..-
T Consensus 231 ---~p~~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~ 268 (277)
T d1xbba_ 231 ---CPAGCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYY 268 (277)
T ss_dssp ---CCTTCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHH
T ss_pred ---CCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHCHH
T ss_conf ---98656799999999975889768909899999852887
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=364.79 Aligned_cols=254 Identities=17% Similarity=0.292 Sum_probs=209.5
Q ss_pred HHCCCCCEEEECCCCEEEEEEECCCCEEEEEEEECCCHHHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEECCEEEEEEE
Q ss_conf 71478662542664429999817996899999312671456879999999999850379932544357872895299983
Q 002721 605 ATMKDSNMIYCGTFSTVYKAVMPSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVALLLHN 684 (888)
Q Consensus 605 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 684 (888)
++|+..+.||+|+||+||+|+++++..||||+++..... .++|.+|+.++++++||||++++|++.++...++|||
T Consensus 4 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~l~~~~~~----~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~E 79 (258)
T d1k2pa_ 4 KDLTFLKELGTGQFGVVKYGKWRGQYDVAIKMIKEGSMS----EDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITE 79 (258)
T ss_dssp CCCCCCCCCCEETTEEEEEEEETTTEEEEEEEEESSSSC----HHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEE
T ss_pred HHCEEEEEEECCCCEEEEEEEECCCCEEEEEEECCCCCC----HHHHHHHHHHHHHCCCCCEEEEEEEEEECCCEEEEEE
T ss_conf 997996898207883999999889989999998747577----8999999999996689860158899850781699997
Q ss_pred CCCCCCHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCCEEECCCCCCCCCCCCC
Q ss_conf 07999987884303999999999889999999999887302457725238888975857999826702334322599999
Q 002721 685 YLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSKG 764 (888)
Q Consensus 685 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~ 764 (888)
|+++|++.+++..... .+++..+.+++.|+++||+|||+.+|+||||||+||+++.++.+||+|||+++.......
T Consensus 80 y~~~g~l~~~~~~~~~----~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~ 155 (258)
T d1k2pa_ 80 YMANGCLLNYLREMRH----RFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY 155 (258)
T ss_dssp CCTTEEHHHHHHSGGG----CCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSC
T ss_pred CCCCCCHHHHHHCCCC----CCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCEEEEECCCCCEEECCCHHHEECCCCCC
T ss_conf 0489938886410246----776899999999999999987546843466541358876998479886144202357872
Q ss_pred CCCCCCCCCCCCEECCCCCCCCCCCCCCCCHHHHHHHHHHHH-CCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCCCC
Q ss_conf 520013345443216333355785864430547899999881-9999877778863131211236789999410133333
Q 002721 765 TASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILT-TRLPVEEDFGEGVDLVKWVHGAPARGETPEQILDARL 843 (888)
Q Consensus 765 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlG~il~ellt-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~i~d~~~ 843 (888)
. ......||..|+|||.+.+..++.++||||||+++|||+| |+.||....... ....+.... . ..
T Consensus 156 ~-~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~--~~~~i~~~~-~------~~---- 221 (258)
T d1k2pa_ 156 T-SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE--TAEHIAQGL-R------LY---- 221 (258)
T ss_dssp C-CCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHH--HHHHHHTTC-C------CC----
T ss_pred E-EECCCCCCCCCCCCHHHCCCCCCCCEEECCCCHHHHHHHHCCCCCCCCCCHHH--HHHHHHHCC-C------CC----
T ss_conf 2-52465788775780786379988521033643246739755999988999999--999998079-7------89----
Q ss_pred CCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHH
Q ss_conf 667858299999999999402378999999998999999986
Q 002721 844 STVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEMLQEI 885 (888)
Q Consensus 844 ~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~eil~~L~~~ 885 (888)
.+.....++.+++.+||+.+|++|||++++++.|.++
T Consensus 222 -----~p~~~~~~l~~li~~cl~~dP~~RPt~~eil~~L~di 258 (258)
T d1k2pa_ 222 -----RPHLASEKVYTIMYSCWHEKADERPTFKILLSNILDV 258 (258)
T ss_dssp -----CCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHCC
T ss_pred -----CCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHCC
T ss_conf -----9654659999999997668976893999999874188
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=365.08 Aligned_cols=251 Identities=19% Similarity=0.252 Sum_probs=202.1
Q ss_pred HHCCCCCEEEECCCCEEEEEEEC-CCCEEEEEEEECCCHHHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEECCEEEEEE
Q ss_conf 71478662542664429999817-99689999931267145687999999999985037993254435787289529998
Q 002721 605 ATMKDSNMIYCGTFSTVYKAVMP-SGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVALLLH 683 (888)
Q Consensus 605 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 683 (888)
+.|++.+.||+|+||+||+|+.. ++..||+|++...... ..+.+.+|+++++.++|||||++++++.+++..++||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~---~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvm 88 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTKSEE---ELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILI 88 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECSSSG---GGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CCEEEEEEEEECCCCEEEEEEECCCCEEEEEEEECCCCHH---HHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEE
T ss_conf 3759847993077819999999999939999998728999---9999999999998679999884988980099589999
Q ss_pred ECCCCCCHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCCEEECCCCCCCCCCCC
Q ss_conf 30799998788430399999999988999999999988730245772523888897585799982670233432259999
Q 002721 684 NYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSK 763 (888)
Q Consensus 684 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~ 763 (888)
||+++|+|.+++..... .+++.++..++.||+.||.|||+.+|+||||||+|||++.++.+||+|||+++.....
T Consensus 89 Ey~~~g~L~~~~~~~~~----~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~- 163 (288)
T d2jfla1 89 EFCAGGAVDAVMLELER----PLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT- 163 (288)
T ss_dssp ECCTTEEHHHHHHHHTS----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHH-
T ss_pred ECCCCCCHHHHHHHCCC----CCCHHHHHHHHHHHHHHHHHHHHCCEEEEECCHHHEEECCCCCEEEEECHHHHCCCCC-
T ss_conf 62799818899986289----9999999999999999999999889887140700314878999899716123035778-
Q ss_pred CCCCCCCCCCCCCEECCCCCC-----CCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCC
Q ss_conf 952001334544321633335-----578586443054789999988199998777788631312112367899994101
Q 002721 764 GTASISAVAGSFGYIPPEYAY-----TMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQI 838 (888)
Q Consensus 764 ~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~DVwSlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~i 838 (888)
........||+.|+|||++. +..|+.++||||+||++|||+||+.||........ +.......+..
T Consensus 164 -~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~-~~~i~~~~~~~------- 234 (288)
T d2jfla1 164 -IQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRV-LLKIAKSEPPT------- 234 (288)
T ss_dssp -HHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGH-HHHHHHSCCCC-------
T ss_pred -CCCCCCCCCCCCCCCHHHHHHCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCHHHH-HHHHHCCCCCC-------
T ss_conf -641001025626479999832025788888066578789999998208899999899999-99997079987-------
Q ss_pred CCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf 333336678582999999999994023789999999989999
Q 002721 839 LDARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVE 880 (888)
Q Consensus 839 ~d~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~eil~ 880 (888)
+ ........++.+++.+||+.||++|||++|+++
T Consensus 235 ----~----~~~~~~s~~~~~li~~~L~~dp~~R~t~~ell~ 268 (288)
T d2jfla1 235 ----L----AQPSRWSSNFKDFLKKCLEKNVDARWTTSQLLQ 268 (288)
T ss_dssp ----C----SSGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTT
T ss_pred ----C----CCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf ----7----765669999999999976699668919999962
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=359.89 Aligned_cols=250 Identities=19% Similarity=0.166 Sum_probs=205.9
Q ss_pred HHCCCCCEEEECCCCEEEEEEE-CCCCEEEEEEEECCCHHHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEECCEEEEEE
Q ss_conf 7147866254266442999981-799689999931267145687999999999985037993254435787289529998
Q 002721 605 ATMKDSNMIYCGTFSTVYKAVM-PSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVALLLH 683 (888)
Q Consensus 605 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 683 (888)
++|++.+.||+|+||+||+|+. .+++.||+|++++...........+.+|+.+++.++||||+++++++.+.+..|+||
T Consensus 5 ~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ 84 (337)
T d1o6la_ 5 NDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVM 84 (337)
T ss_dssp GGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEE
T ss_pred HHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCCCCCE
T ss_conf 74289889831768499999998999899999981565449799999999999998679998877876403564211100
Q ss_pred ECCCCCCHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCCEEECCCCCCCCCCCC
Q ss_conf 30799998788430399999999988999999999988730245772523888897585799982670233432259999
Q 002721 684 NYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSK 763 (888)
Q Consensus 684 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~ 763 (888)
||+++|+|.+++.... .+++.....++.||+.||+|||+.+|+||||||+|||++.++.+||+|||+++......
T Consensus 85 ey~~gg~L~~~~~~~~-----~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~ 159 (337)
T d1o6la_ 85 EYANGGELFFHLSRER-----VFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG 159 (337)
T ss_dssp ECCTTCBHHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT
T ss_pred ECCCCCCHHHHHHCCC-----CCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHEEECCCCCEEEEECCCCCCCCCCC
T ss_conf 0357986055553256-----77599999999999652113431596224647778476589988882056520035678
Q ss_pred CCCCCCCCCCCCCEECCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCCCC
Q ss_conf 95200133454432163333557858644305478999998819999877778863131211236789999410133333
Q 002721 764 GTASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQILDARL 843 (888)
Q Consensus 764 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~i~d~~~ 843 (888)
. .....+||+.|+|||++.+..|+.++||||+||++|||++|+.||....... +.... .....
T Consensus 160 ~--~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~--~~~~i-------------~~~~~ 222 (337)
T d1o6la_ 160 A--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHER--LFELI-------------LMEEI 222 (337)
T ss_dssp C--CBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHH-------------HHCCC
T ss_pred C--CCCCCEECHHHHHHHHCCCCCCCHHHCCCCHHHHHHHHHHCCCCCCCCCHHH--HHHHH-------------HCCCC
T ss_conf 6--2055100889966665048988833310223067889987899999969999--99998-------------52899
Q ss_pred CCCCCCCHHHHHHHHHHHHHCCCCCCCCCCC-----HHHHHH
Q ss_conf 6678582999999999994023789999999-----989999
Q 002721 844 STVSFGWRKEMLTALKVALLCTDSTPAKRPK-----MKKVVE 880 (888)
Q Consensus 844 ~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs-----~~eil~ 880 (888)
. .+....+++.+++.+|+++||++||+ ++|+++
T Consensus 223 ~----~p~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~ 260 (337)
T d1o6la_ 223 R----FPRTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVME 260 (337)
T ss_dssp C----CCTTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHT
T ss_pred C----CCCCCCHHHHHHHHHHCCCCCHHHCCCCCCCHHHHHC
T ss_conf 8----9866899999999866638934422565234999972
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=369.03 Aligned_cols=255 Identities=20% Similarity=0.278 Sum_probs=204.0
Q ss_pred HHHCCCCCEEEECCCCEEEEEEEC-CCCEEEEEEEECCCHHHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEE--CCEEE
Q ss_conf 871478662542664429999817-996899999312671456879999999999850379932544357872--89529
Q 002721 604 KATMKDSNMIYCGTFSTVYKAVMP-SGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIY--EDVAL 680 (888)
Q Consensus 604 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~--~~~~~ 680 (888)
.++|++.+.||+|+||+||+|+.. +|+.||+|.+...... ....+.+.+|++++++++|||||++++++.+ ....|
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ 81 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSMT-EAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLY 81 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTSC-HHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEE
T ss_pred CHHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCC-HHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEE
T ss_conf 33379967983088919999999999979999998746579-79999999999999977899982489999917899899
Q ss_pred EEEECCCCCCHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCC-----EEECCCCCCCEEECCCCCCEEECCCC
Q ss_conf 9983079999878843039999999998899999999998873024577-----25238888975857999826702334
Q 002721 681 LLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVA-----IIHLDISSGNVLLDADFKPLLGEIEI 755 (888)
Q Consensus 681 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~-----ivH~dlk~~NIll~~~~~~kl~Dfg~ 755 (888)
+||||+++|+|.+++....... ..+++..++.++.|++.||+|||+.+ |+||||||+|||++.++.+||+|||+
T Consensus 82 ivmEy~~~g~L~~~i~~~~~~~-~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~ 160 (269)
T d2java1 82 IVMEYCEGGDLASVITKGTKER-QYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGL 160 (269)
T ss_dssp EEEECCTTEEHHHHHHHHHHHT-CCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHH
T ss_pred EEEECCCCCCHHHHHHHCCCCC-CCCCHHHHHHHHHHHHHHHHHHHHHCCCCCCEEECCCCHHHCCCCCCCCEEEEECCC
T ss_conf 9995689993899998515457-899999999999999999999997167788788586765425747888579800100
Q ss_pred CCCCCCCCCCCCCCCCCCCCCEECCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHCCCCCCCCCCC
Q ss_conf 32259999952001334544321633335578586443054789999988199998777788631312112367899994
Q 002721 756 SKLLDPSKGTASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETP 835 (888)
Q Consensus 756 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~ 835 (888)
++........ .....||+.|+|||++.+..++.++|||||||++|||+||+.||...... ++....
T Consensus 161 a~~~~~~~~~--~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~--~~~~~i---------- 226 (269)
T d2java1 161 ARILNHDTSF--AKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK--ELAGKI---------- 226 (269)
T ss_dssp HHHC-------------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH--HHHHHH----------
T ss_pred EEECCCCCCC--CCCCCCCCCCCCHHHHCCCCCCHHHHHHHHCHHHHHHHHCCCCCCCCCHH--HHHHHH----------
T ss_conf 0322457775--56677882327999983999993898875278999980188998998999--999999----------
Q ss_pred CCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf 101333336678582999999999994023789999999989999
Q 002721 836 EQILDARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVE 880 (888)
Q Consensus 836 ~~i~d~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~eil~ 880 (888)
........+ .....++.+++.+||+.||++|||++|+++
T Consensus 227 ---~~~~~~~~~---~~~s~~l~~li~~~L~~dp~~Rps~~ell~ 265 (269)
T d2java1 227 ---REGKFRRIP---YRYSDELNEIITRMLNLKDYHRPSVEEILE 265 (269)
T ss_dssp ---HHTCCCCCC---TTSCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ---HCCCCCCCC---CCCCHHHHHHHHHHCCCCHHHCCCHHHHHH
T ss_conf ---718998897---435999999999976799557918999972
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=359.34 Aligned_cols=258 Identities=17% Similarity=0.286 Sum_probs=206.5
Q ss_pred HHCCCCCEEEECCCCEEEEEEEC-CCC----EEEEEEEECCCHHHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEECCEE
Q ss_conf 71478662542664429999817-996----8999993126714568799999999998503799325443578728952
Q 002721 605 ATMKDSNMIYCGTFSTVYKAVMP-SGL----ILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVA 679 (888)
Q Consensus 605 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~----~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~ 679 (888)
.+|+..++||+|+||+||+|.+. +|+ .||+|+++.... ....+.+.+|+.++++++|||||+++|+|.++ ..
T Consensus 9 ~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~ 85 (317)
T d1xkka_ 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATS--PKANKEILDEAYVMASVDNPHVCRLLGICLTS-TV 85 (317)
T ss_dssp TTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC------CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SE
T ss_pred HHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEEEECCCCC--HHHHHHHHHHHHHHHHCCCCCEEEEEEEEECC-CE
T ss_conf 9997831982089929999999589988989999999651349--79999999999999867998881589999619-83
Q ss_pred EEEEECCCCCCHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCCEEECCCCCCCC
Q ss_conf 99983079999878843039999999998899999999998873024577252388889758579998267023343225
Q 002721 680 LLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLL 759 (888)
Q Consensus 680 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~ 759 (888)
++++||+++|+|.+++..... .+++..++.++.|||.||+|||+++|+||||||+||+++.++.+||+|||+++..
T Consensus 86 ~~v~e~~~~~~l~~~~~~~~~----~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~ 161 (317)
T d1xkka_ 86 QLITQLMPFGCLLDYVREHKD----NIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLL 161 (317)
T ss_dssp EEEEECCTTCBHHHHHHHTSS----SCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHT
T ss_pred EEEEEECCCCCCCCCCCCCCC----CCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCHHHCCEECCCCCEEEECCCCCEEC
T ss_conf 699984268740101113345----7999999999999999999998769504762120311679987586025522233
Q ss_pred CCCCCCCCCCCCCCCCCEECCCCCCCCCCCCCCCCHHHHHHHHHHHH-CCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCC
Q ss_conf 99999520013345443216333355785864430547899999881-99998777788631312112367899994101
Q 002721 760 DPSKGTASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILT-TRLPVEEDFGEGVDLVKWVHGAPARGETPEQI 838 (888)
Q Consensus 760 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlG~il~ellt-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~i 838 (888)
.............||..|+|||++.+..++.++|||||||++|||+| |..||....... +...+.... .+
T Consensus 162 ~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~--~~~~i~~~~----~~--- 232 (317)
T d1xkka_ 162 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE--ISSILEKGE----RL--- 232 (317)
T ss_dssp TTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGG--HHHHHHHTC----CC---
T ss_pred CCCCCCCCCCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCHHH--HHHHHHCCC----CC---
T ss_conf 544453223651058644670887469998356544079999999977999999999899--999997599----89---
Q ss_pred CCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHH
Q ss_conf 3333366785829999999999940237899999999899999998641
Q 002721 839 LDARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEMLQEIKQ 887 (888)
Q Consensus 839 ~d~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~eil~~L~~~~~ 887 (888)
+........+.+++.+||+.+|++|||+.|+++.|+.+..
T Consensus 233 ---------~~p~~~~~~~~~li~~cl~~dP~~RPs~~eil~~l~~~~~ 272 (317)
T d1xkka_ 233 ---------PQPPICTIDVYMIMVKCWMIDADSRPKFRELIIEFSKMAR 272 (317)
T ss_dssp ---------CCCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---------CCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHH
T ss_conf ---------9985568999999998478993469199999999999875
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=362.69 Aligned_cols=257 Identities=18% Similarity=0.294 Sum_probs=208.2
Q ss_pred HHHCCCCCEEEECCCCEEEEEEECCCCEEEEEEEECCCHHHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEECCEEEEEE
Q ss_conf 87147866254266442999981799689999931267145687999999999985037993254435787289529998
Q 002721 604 KATMKDSNMIYCGTFSTVYKAVMPSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVALLLH 683 (888)
Q Consensus 604 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 683 (888)
.++|++.+.||+|+||+||+|.+.++..||+|+++..... .+.|.+|+.++++++|||||+++|++. ++..++||
T Consensus 16 ~~~~~i~~~iG~G~fg~Vy~~~~~~~~~vAiK~l~~~~~~----~~~~~~E~~~l~~l~h~nIv~~~g~~~-~~~~~lv~ 90 (285)
T d1fmka3 16 RESLRLEVKLGQGCFGEVWMGTWNGTTRVAIKTLKPGTMS----PEAFLQEAQVMKKLRHEKLVQLYAVVS-EEPIYIVT 90 (285)
T ss_dssp GGGEEEEEEEEECSSCEEEEEEETTTEEEEEEECCTTSSC----HHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEE
T ss_pred HHHEEEEEEEEECCCEEEEEEEECCCCEEEEEEECCCCCC----HHHHHHHHHHHHHCCCCCEEEEEEEEE-CCCEEEEE
T ss_conf 7997984699307980999999999999999998804488----899999999998666678868999982-39759999
Q ss_pred ECCCCCCHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCCEEECCCCCCCCCCCC
Q ss_conf 30799998788430399999999988999999999988730245772523888897585799982670233432259999
Q 002721 684 NYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSK 763 (888)
Q Consensus 684 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~ 763 (888)
||+++|++.+++...... .++|.+++.++.|||.||+|||+.+|+||||||+|||++.++++||+|||+++......
T Consensus 91 Ey~~~g~l~~~~~~~~~~---~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~ 167 (285)
T d1fmka3 91 EYMSKGSLLDFLKGETGK---YLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE 167 (285)
T ss_dssp CCCTTCBHHHHHSHHHHT---TCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC------
T ss_pred EECCCCCHHHHHHHCCCC---CCHHHHHHHHHHHHHHHHHHHHHHHEECCCCCCEEEEECCCCCEEECCCCHHHHCCCCC
T ss_conf 944799435420000355---30599999999999999998754114335312307999899929984425554256887
Q ss_pred CCCCCCCCCCCCCEECCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCCCC
Q ss_conf 95200133454432163333557858644305478999998819999877778863131211236789999410133333
Q 002721 764 GTASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQILDARL 843 (888)
Q Consensus 764 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~i~d~~~ 843 (888)
.. ......|+..|+|||++.+..++.++||||||+++|||+||..|+........ ....+......
T Consensus 168 ~~-~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~-~~~~i~~~~~~------------ 233 (285)
T d1fmka3 168 YT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNRE-VLDQVERGYRM------------ 233 (285)
T ss_dssp ---------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHH-HHHHHHTTCCC------------
T ss_pred CE-EECCCCCCCCCCCHHHHHCCCCCCHHHHHCCHHHHHHHHHCCCCCCCCCCHHH-HHHHHHHCCCC------------
T ss_conf 33-52454556654580898379989177413235899999868999998888999-99999826899------------
Q ss_pred CCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHH
Q ss_conf 6678582999999999994023789999999989999999864
Q 002721 844 STVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEMLQEIK 886 (888)
Q Consensus 844 ~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~eil~~L~~~~ 886 (888)
+......+++.+++.+||+.+|++||||++|++.|+...
T Consensus 234 ----~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~ 272 (285)
T d1fmka3 234 ----PCPPECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYF 272 (285)
T ss_dssp ----CCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTT
T ss_pred ----CCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHH
T ss_conf ----998323799999999975669758919999999876662
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=0 Score=357.38 Aligned_cols=251 Identities=16% Similarity=0.126 Sum_probs=198.0
Q ss_pred HHCCCCCEEEECCCCEEEEEEEC-CCCEEEEEEEECCCHHHHHHHHHHH---HHHHHHHCCCCCCEEEEEEEEEECCEEE
Q ss_conf 71478662542664429999817-9968999993126714568799999---9999985037993254435787289529
Q 002721 605 ATMKDSNMIYCGTFSTVYKAVMP-SGLILSVKRLKSMDRTIIHHQNKMI---RELEKLSKLCHDNLVRPIGFVIYEDVAL 680 (888)
Q Consensus 605 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~---~e~~~l~~l~h~niv~l~g~~~~~~~~~ 680 (888)
++|++.+.||+|+||.||+|+.. +|..||+|++.+...........+. +++.+++.++|||||++++++...+..|
T Consensus 4 ddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ 83 (364)
T d1omwa3 4 NDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLS 83 (364)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEE
T ss_pred HHCEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHCCHHHHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEECCEEE
T ss_conf 76851018842889099999999999799999984587542667999999999999985089985889999999899889
Q ss_pred EEEECCCCCCHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCCEEECCCCCCCCC
Q ss_conf 99830799998788430399999999988999999999988730245772523888897585799982670233432259
Q 002721 681 LLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLD 760 (888)
Q Consensus 681 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~ 760 (888)
+||||+++|+|.+++.... .+++..+..++.||+.||.|||+.+|+||||||+|||++.++.+||+|||+|+...
T Consensus 84 ivmE~~~gg~L~~~l~~~~-----~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~ 158 (364)
T d1omwa3 84 FILDLMNGGDLHYHLSQHG-----VFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFS 158 (364)
T ss_dssp EEECCCCSCBHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEECS
T ss_pred EEEEECCCCCHHHHHHHCC-----CCCHHHHHHHHHHHHHHHHHHHHCCCCCEEECCCEEEECCCCCEEEEEECEEEECC
T ss_conf 9999148983899987325-----53278999999999999999997796220444221678588967982201023337
Q ss_pred CCCCCCCCCCCCCCCCEECCCCCCC-CCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCC
Q ss_conf 9999520013345443216333355-785864430547899999881999987777886313121123678999941013
Q 002721 761 PSKGTASISAVAGSFGYIPPEYAYT-MQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQIL 839 (888)
Q Consensus 761 ~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DVwSlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~i~ 839 (888)
... .....||+.|+|||++.. ..|+.++||||+||++|||+||+.||........... .......
T Consensus 159 ~~~----~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~--~~~~~~~-------- 224 (364)
T d1omwa3 159 KKK----PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEI--DRMTLTM-------- 224 (364)
T ss_dssp SSC----CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHH--HHHSSSC--------
T ss_pred CCC----CCCCCCCCCCCHHHHHHCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCHHHHHHH--HHHCCCC--------
T ss_conf 886----43311345542168760389998441046778999999859998888998999999--9860468--------
Q ss_pred CCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCC-----HHHHHH
Q ss_conf 33336678582999999999994023789999999-----989999
Q 002721 840 DARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPK-----MKKVVE 880 (888)
Q Consensus 840 d~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs-----~~eil~ 880 (888)
. ...+....+++.+++.+||+.||++||| ++|+++
T Consensus 225 --~----~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~ 264 (364)
T d1omwa3 225 --A----VELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKE 264 (364)
T ss_dssp --C----CCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHT
T ss_pred --C----CCCCCCCCHHHHHHHHHHCCCCHHHHCCCCCCCHHHHHC
T ss_conf --8----878877899999999998566988808874357999974
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=354.14 Aligned_cols=257 Identities=19% Similarity=0.326 Sum_probs=204.5
Q ss_pred CCCCEEEECCCCEEEEEEECC----CCEEEEEEEECCCHHHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEEC-CEEEEE
Q ss_conf 786625426644299998179----968999993126714568799999999998503799325443578728-952999
Q 002721 608 KDSNMIYCGTFSTVYKAVMPS----GLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYE-DVALLL 682 (888)
Q Consensus 608 ~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~-~~~~lv 682 (888)
...++||+|+||+||+|.+.+ ...||||+++.... ......|.+|++++++++||||++++|++... ...++|
T Consensus 30 ~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv 107 (311)
T d1r0pa_ 30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRITD--IGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVV 107 (311)
T ss_dssp EEEEEEEEETTEEEEEEEECC----CEEEEEEEECCCCC--HHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEE
T ss_pred CCCEEEEECCCEEEEEEEEECCCCEEEEEEEEEECCCCC--HHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEEE
T ss_conf 266698136880999999977998799999999884369--789999999999998678999867867898069943899
Q ss_pred EECCCCCCHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCCEEECCCCCCCCCCC
Q ss_conf 83079999878843039999999998899999999998873024577252388889758579998267023343225999
Q 002721 683 HNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPS 762 (888)
Q Consensus 683 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~ 762 (888)
||||++|+|.+++..... ..++..+++++.|+|.||.|+|+.+|+||||||+|||+++++.+||+|||+++.....
T Consensus 108 ~E~~~~g~l~~~~~~~~~----~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~ 183 (311)
T d1r0pa_ 108 LPYMKHGDLRNFIRNETH----NPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDK 183 (311)
T ss_dssp EECCTTCBHHHHHHCTTC----CCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTT
T ss_pred EEEEECCCHHHHHCCCCC----CCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHEEECCCCCEEEECCCCHHHCCCC
T ss_conf 987406741442101345----4048999999999887652003367625776687576779998899106523225566
Q ss_pred CCC--CCCCCCCCCCCEECCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCC
Q ss_conf 995--200133454432163333557858644305478999998819999877778863131211236789999410133
Q 002721 763 KGT--ASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQILD 840 (888)
Q Consensus 763 ~~~--~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~i~d 840 (888)
... .......||..|+|||.+.+..++.++||||||+++|||+||+.||...... .+....+.... .+. .
T Consensus 184 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~-~~~~~~i~~g~----~~~---~ 255 (311)
T d1r0pa_ 184 EFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT-FDITVYLLQGR----RLL---Q 255 (311)
T ss_dssp TCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC-------CHHHHHTTC----CCC---C
T ss_pred CCCCCEECCCCCCCCCCCCHHHHHCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCCH-HHHHHHHHCCC----CCC---C
T ss_conf 555310025655564556768874379997457466199999999789999888999-99999998089----889---9
Q ss_pred CCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHH
Q ss_conf 33366785829999999999940237899999999899999998641
Q 002721 841 ARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEMLQEIKQ 887 (888)
Q Consensus 841 ~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~eil~~L~~~~~ 887 (888)
.......+.+++.+||+.||++||+|.||++.|+++..
T Consensus 256 ---------p~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~L~~i~~ 293 (311)
T d1r0pa_ 256 ---------PEYCPDPLYEVMLKCWHPKAEMRPSFSELVSRISAIFS 293 (311)
T ss_dssp ---------CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ---------CCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHH
T ss_conf ---------64475999999999768897689399999999999997
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=354.89 Aligned_cols=247 Identities=22% Similarity=0.311 Sum_probs=195.6
Q ss_pred CCCCCEEEECCCCEEEEEEEC-CCCEEEEEEEECCCHHHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEE----CCEEEE
Q ss_conf 478662542664429999817-996899999312671456879999999999850379932544357872----895299
Q 002721 607 MKDSNMIYCGTFSTVYKAVMP-SGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIY----EDVALL 681 (888)
Q Consensus 607 ~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~----~~~~~l 681 (888)
|+...+||+|+||+||+|... ++..||+|.+...... ....+.+.+|++++++++|||||++++++.. ....++
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~i 89 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKLT-KSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVL 89 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGSC-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEE
T ss_pred EEEEEEEECCCCCEEEEEEECCCCEEEEEEEECHHHCC-HHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCCCEEEE
T ss_conf 88516970082849999999999959999998512279-89999999999999857999850699998403345888999
Q ss_pred EEECCCCCCHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCC--EEECCCCCCCEEEC-CCCCCEEECCCCCCC
Q ss_conf 983079999878843039999999998899999999998873024577--25238888975857-999826702334322
Q 002721 682 LHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVA--IIHLDISSGNVLLD-ADFKPLLGEIEISKL 758 (888)
Q Consensus 682 v~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~--ivH~dlk~~NIll~-~~~~~kl~Dfg~~~~ 758 (888)
||||+++|+|.+++.... .+++..+..++.||+.||+|||+.+ |+||||||+|||++ +++.+||+|||+++.
T Consensus 90 vmE~~~~g~L~~~l~~~~-----~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~ 164 (270)
T d1t4ha_ 90 VTELMTSGTLKTYLKRFK-----VMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATL 164 (270)
T ss_dssp EEECCCSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGG
T ss_pred EEECCCCCCHHHHHHCCC-----CCCHHHHHHHHHHHHHHHHHHHHCCCCEEECCCCHHHCEEECCCCCEEEEECCCCEE
T ss_conf 995789894899975135-----546999999999999999999978997996876743511667999889800576542
Q ss_pred CCCCCCCCCCCCCCCCCCEECCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCC
Q ss_conf 59999952001334544321633335578586443054789999988199998777788631312112367899994101
Q 002721 759 LDPSKGTASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQI 838 (888)
Q Consensus 759 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~i 838 (888)
..... .....||+.|+|||++.+ .++.++||||+||++|||++|+.||.+..... .+...+... ..+.
T Consensus 165 ~~~~~----~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~-~~~~~i~~~----~~~~-- 232 (270)
T d1t4ha_ 165 KRASF----AKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAA-QIYRRVTSG----VKPA-- 232 (270)
T ss_dssp CCTTS----BEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHH-HHHHHHTTT----CCCG--
T ss_pred CCCCC----CCCCCCCCCCCCHHHHCC-CCCCCCCHHHHHHHHHHHHHCCCCCCCCCCHH-HHHHHHHCC----CCCC--
T ss_conf 36876----677553813008988478-99986711007999999987889998765599-999999738----9986--
Q ss_pred CCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf 333336678582999999999994023789999999989999
Q 002721 839 LDARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVE 880 (888)
Q Consensus 839 ~d~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~eil~ 880 (888)
.. .....+++.+++.+||++||++|||++|+++
T Consensus 233 ---~~------~~~~~~~~~~li~~~l~~dp~~R~s~~ell~ 265 (270)
T d1t4ha_ 233 ---SF------DKVAIPEVKEIIEGCIRQNKDERYSIKDLLN 265 (270)
T ss_dssp ---GG------GGCCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred ---CC------CCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf ---56------7557899999999976379758929999967
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=358.52 Aligned_cols=254 Identities=17% Similarity=0.217 Sum_probs=204.4
Q ss_pred HHHCCCCCEEEECCCCEEEEEEEC-CCCEEEEEEEECCCHHH---HHHHHHHHHHHHHHHCCCCCCEEEEEEEEEECCEE
Q ss_conf 871478662542664429999817-99689999931267145---68799999999998503799325443578728952
Q 002721 604 KATMKDSNMIYCGTFSTVYKAVMP-SGLILSVKRLKSMDRTI---IHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVA 679 (888)
Q Consensus 604 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~---~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~ 679 (888)
.++|++.+.||+|+||+||+|+.. +|..||+|++++..... ....+.+.+|+++++.++|||||++++++.+....
T Consensus 9 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 9 DDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEE
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCEE
T ss_conf 56779827981178959999999999989999998756632134068999999999999867998999388999979989
Q ss_pred EEEEECCCCCCHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCC----CCEEECCCC
Q ss_conf 9998307999987884303999999999889999999999887302457725238888975857999----826702334
Q 002721 680 LLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADF----KPLLGEIEI 755 (888)
Q Consensus 680 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~dlk~~NIll~~~~----~~kl~Dfg~ 755 (888)
|+|||||++|+|.+++.... .+++..+..++.|++.||+|||+.+|+||||||+||+++.++ .+|++|||+
T Consensus 89 ~iv~E~~~gg~L~~~i~~~~-----~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~ 163 (293)
T d1jksa_ 89 ILILELVAGGELFDFLAEKE-----SLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGL 163 (293)
T ss_dssp EEEEECCCSCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTT
T ss_pred EEEEECCCCCCCCCHHCCCC-----CCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCEEEEECCCCCCCCEEECCHHH
T ss_conf 99998677864310010356-----4215578999999999987666254221133301279825898666469643344
Q ss_pred CCCCCCCCCCCCCCCCCCCCCEECCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHCCCCCCCCCCC
Q ss_conf 32259999952001334544321633335578586443054789999988199998777788631312112367899994
Q 002721 756 SKLLDPSKGTASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETP 835 (888)
Q Consensus 756 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~ 835 (888)
+........ .....|++.|+|||++.+..++.++||||+||++|||++|+.||....... ......... . ...
T Consensus 164 a~~~~~~~~---~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~--~~~~i~~~~-~-~~~ 236 (293)
T d1jksa_ 164 AHKIDFGNE---FKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQE--TLANVSAVN-Y-EFE 236 (293)
T ss_dssp CEECTTSCB---CSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH--HHHHHHTTC-C-CCC
T ss_pred HHHCCCCCC---CCCCCCCCCCCCHHHHCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCHHH--HHHHHHHCC-C-CCC
T ss_conf 210577763---122477774309999818999976652214099999970889988999999--999998168-8-887
Q ss_pred CCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf 101333336678582999999999994023789999999989999
Q 002721 836 EQILDARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVE 880 (888)
Q Consensus 836 ~~i~d~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~eil~ 880 (888)
. . ........+.+++.+||+.||++|||++|+++
T Consensus 237 ~----~-------~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~ 270 (293)
T d1jksa_ 237 D----E-------YFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQ 270 (293)
T ss_dssp H----H-------HHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred C----H-------HCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf 0----1-------04788999999999986389668919999961
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=0 Score=356.44 Aligned_cols=247 Identities=21% Similarity=0.205 Sum_probs=203.4
Q ss_pred HHCCCCCEEEECCCCEEEEEEEC-CCCEEEEEEEECCCHHHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEECCEEEEEE
Q ss_conf 71478662542664429999817-99689999931267145687999999999985037993254435787289529998
Q 002721 605 ATMKDSNMIYCGTFSTVYKAVMP-SGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVALLLH 683 (888)
Q Consensus 605 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 683 (888)
.+|++.+.||+|+||+||+|+.. +|+.||+|++++.........+.+.+|+.+++.++|||||++++++.+.+..|+||
T Consensus 4 ~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivm 83 (316)
T d1fota_ 4 QDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIM 83 (316)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEE
T ss_pred HHEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCHHHEEEEEEECCEEEEEE
T ss_conf 47088889720768089999998999799999984577548899999999999998636967533035685288005676
Q ss_pred ECCCCCCHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCCEEECCCCCCCCCCCC
Q ss_conf 30799998788430399999999988999999999988730245772523888897585799982670233432259999
Q 002721 684 NYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSK 763 (888)
Q Consensus 684 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~ 763 (888)
||+++|++.+++.... .+++.....++.||+.||+|||+.+|+||||||+|||++.++.+||+|||+++......
T Consensus 84 E~~~gg~l~~~~~~~~-----~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~~ 158 (316)
T d1fota_ 84 DYIEGGELFSLLRKSQ-----RFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT 158 (316)
T ss_dssp CCCCSCBHHHHHHHTS-----SCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSCB
T ss_pred EECCCCCCCCCCCCCC-----CCCCCHHHHHHHHHHHHHHHHCCCCEECCCCCCHHEEECCCCCEEEECCCCCEEECCCC
T ss_conf 5037863223432222-----11100799999999876554124767705568105038689988983175216712456
Q ss_pred CCCCCCCCCCCCCEECCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCCCC
Q ss_conf 95200133454432163333557858644305478999998819999877778863131211236789999410133333
Q 002721 764 GTASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQILDARL 843 (888)
Q Consensus 764 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~i~d~~~ 843 (888)
...+||+.|+|||++.+..|+.++||||+||++|||+||+.||....... .... +.....
T Consensus 159 -----~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~--~~~~-------------i~~~~~ 218 (316)
T d1fota_ 159 -----YTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMK--TYEK-------------ILNAEL 218 (316)
T ss_dssp -----CCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHH--HHHH-------------HHHCCC
T ss_pred -----CCCCCCCCCCCHHHHCCCCCCCHHHCCCCCHHHHHHHHCCCCCCCCCHHH--HHHH-------------HHCCCC
T ss_conf -----43457634359999838999804304653336899975989999969999--9999-------------970898
Q ss_pred CCCCCCCHHHHHHHHHHHHHCCCCCCCCCC-----CHHHHHH
Q ss_conf 667858299999999999402378999999-----9989999
Q 002721 844 STVSFGWRKEMLTALKVALLCTDSTPAKRP-----KMKKVVE 880 (888)
Q Consensus 844 ~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RP-----s~~eil~ 880 (888)
. ......+++.+++.+|++.+|++|| |++++++
T Consensus 219 ~----~p~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~ 256 (316)
T d1fota_ 219 R----FPPFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKN 256 (316)
T ss_dssp C----CCTTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHT
T ss_pred C----CCCCCCHHHHHHHHHHHHHCHHHCCCCCHHHHHHHHC
T ss_conf 8----9977899999999999544997666431021999981
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=356.11 Aligned_cols=272 Identities=20% Similarity=0.232 Sum_probs=202.3
Q ss_pred HHCCCCCEEEECCCCEEEEEEECCCCEEEEEEEECCCHHHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEECC----EEE
Q ss_conf 7147866254266442999981799689999931267145687999999999985037993254435787289----529
Q 002721 605 ATMKDSNMIYCGTFSTVYKAVMPSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYED----VAL 680 (888)
Q Consensus 605 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~----~~~ 680 (888)
++|...+.||+|+||+||+|++ +|..||||+++..... ......|+..+..++||||++++|++.+.+ ..+
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~-~g~~vAvK~~~~~~~~----~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~ 77 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW-RGEEVAVKIFSSREER----SWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLW 77 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE-TTEEEEEEEECGGGHH----HHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEE
T ss_pred CEEEEEEEEEECCCEEEEEEEE-CCEEEEEEEECCCCHH----HHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCCEEEE
T ss_conf 6899988982078819999999-9989999998720046----7999999999962799868326889983798604899
Q ss_pred EEEECCCCCCHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHCCC--------CCEEECCCCCCCEEECCCCCCEEEC
Q ss_conf 99830799998788430399999999988999999999988730245--------7725238888975857999826702
Q 002721 681 LLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHH--------VAIIHLDISSGNVLLDADFKPLLGE 752 (888)
Q Consensus 681 lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~--------~~ivH~dlk~~NIll~~~~~~kl~D 752 (888)
+||||+++|+|.+++++. .++|..+++++.|+|.||+|+|+ ++|+||||||+|||++.++.+||+|
T Consensus 78 lv~Ey~~~g~L~~~l~~~------~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~D 151 (303)
T d1vjya_ 78 LVSDYHEHGSLFDYLNRY------TVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIAD 151 (303)
T ss_dssp EEEECCTTCBHHHHHHHC------CBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECC
T ss_pred EEEECCCCCCHHHHHHCC------CCCHHHHHHHHHHHHHHHHHHHHHHHHHCCCCCEECCCCCCCCEEECCCCCEEEEE
T ss_conf 999646698989998658------99989999999999999999887665204689866153173135786887768876
Q ss_pred CCCCCCCCCCCCCC--CCCCCCCCCCEECCCCCCCC------CCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCHHHH
Q ss_conf 33432259999952--00133454432163333557------85864430547899999881999987777886313121
Q 002721 753 IEISKLLDPSKGTA--SISAVAGSFGYIPPEYAYTM------QVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKW 824 (888)
Q Consensus 753 fg~~~~~~~~~~~~--~~~~~~gt~~y~aPE~~~~~------~~~~~~DVwSlG~il~elltg~~p~~~~~~~~~~l~~~ 824 (888)
||+++......... ......||+.|+|||++.+. .++.++|||||||++|||+||..|+.............
T Consensus 152 FGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~ 231 (303)
T d1vjya_ 152 LGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDL 231 (303)
T ss_dssp CTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTT
T ss_pred CCCCCCCCCCCCCEECCCCCEECCCCCCCHHHCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCCCCCHHHC
T ss_conf 38662346777620013552503547678221056545467776750122015999999962899887663112410122
Q ss_pred CCCCCCCCCCCCCCCCCCCCC---CCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHH
Q ss_conf 123678999941013333366---785829999999999940237899999999899999998641
Q 002721 825 VHGAPARGETPEQILDARLST---VSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEMLQEIKQ 887 (888)
Q Consensus 825 ~~~~~~~~~~~~~i~d~~~~~---~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~eil~~L~~~~~ 887 (888)
...............+..... ......+....+.+++.+||+.||++||||.|+++.|+++.+
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rps~~ei~~~L~~i~~ 297 (303)
T d1vjya_ 232 VPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARLTALRIKKTLSQLSQ 297 (303)
T ss_dssp SCSSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSCCHHHHHHHHHHHHH
T ss_pred CCCCCHHHHHHHHHHCCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHH
T ss_conf 556430999999875024688877655776899999999999760698589599999999998888
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=0 Score=356.05 Aligned_cols=247 Identities=15% Similarity=0.132 Sum_probs=204.2
Q ss_pred HHCCCCCEEEECCCCEEEEEEEC-CCCEEEEEEEECCCHHHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEECCEEEEEE
Q ss_conf 71478662542664429999817-99689999931267145687999999999985037993254435787289529998
Q 002721 605 ATMKDSNMIYCGTFSTVYKAVMP-SGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVALLLH 683 (888)
Q Consensus 605 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 683 (888)
++|++.+.||+|+||+||+|+.. +|..||+|++.+...........+.+|+++++.++|||||++++++......++|+
T Consensus 41 d~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~ 120 (350)
T d1rdqe_ 41 DQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVM 120 (350)
T ss_dssp GGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCCCCCCCCC
T ss_conf 37089889611768089999998999899999982677458899999999999999748772740344443222223222
Q ss_pred ECCCCCCHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCCEEECCCCCCCCCCCC
Q ss_conf 30799998788430399999999988999999999988730245772523888897585799982670233432259999
Q 002721 684 NYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSK 763 (888)
Q Consensus 684 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~ 763 (888)
||+++|+|.+++.... .+++..+..++.||+.||.|||+.+|+||||||+|||++.++.+||+|||+++.....
T Consensus 121 e~~~~g~l~~~l~~~~-----~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~- 194 (350)
T d1rdqe_ 121 EYVAGGEMFSHLRRIG-----RFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR- 194 (350)
T ss_dssp ECCTTCBHHHHHHHHC-----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC-
T ss_pred CCCCCCCHHHHHHHCC-----CCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHCCCCCCCCEEEEECEEEEECCCC-
T ss_conf 2334662266675158-----9899999999999999899998599861767999936077897886101033322566-
Q ss_pred CCCCCCCCCCCCCEECCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCCCC
Q ss_conf 95200133454432163333557858644305478999998819999877778863131211236789999410133333
Q 002721 764 GTASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQILDARL 843 (888)
Q Consensus 764 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~i~d~~~ 843 (888)
.....||+.|+|||++.+..++.++||||+||++|||+||+.||...... ..... +.....
T Consensus 195 ----~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~--~~~~~-------------i~~~~~ 255 (350)
T d1rdqe_ 195 ----TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPI--QIYEK-------------IVSGKV 255 (350)
T ss_dssp ----BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHH-------------HHHCCC
T ss_pred ----CCCCCCCCCCCCHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCHH--HHHHH-------------HHCCCC
T ss_conf ----64336763567889971799885331145007899997588998995999--99999-------------861798
Q ss_pred CCCCCCCHHHHHHHHHHHHHCCCCCCCCCC-----CHHHHHH
Q ss_conf 667858299999999999402378999999-----9989999
Q 002721 844 STVSFGWRKEMLTALKVALLCTDSTPAKRP-----KMKKVVE 880 (888)
Q Consensus 844 ~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RP-----s~~eil~ 880 (888)
. ......+++.+++.+|++.||.+|+ |++++++
T Consensus 256 ~----~p~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~ 293 (350)
T d1rdqe_ 256 R----FPSHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKN 293 (350)
T ss_dssp C----CCTTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHT
T ss_pred C----CCCCCCHHHHHHHHHHHHHCHHHCCCCCCCCHHHHHC
T ss_conf 8----9766899999999998340998606553454999971
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=354.56 Aligned_cols=266 Identities=19% Similarity=0.257 Sum_probs=207.8
Q ss_pred HHHHCCCCCEEEECCCCEEEEEEEC------CCCEEEEEEEECCCHHHHHHHHHHHHHHHHHHCC-CCCCEEEEEEEEEE
Q ss_conf 9871478662542664429999817------9968999993126714568799999999998503-79932544357872
Q 002721 603 VKATMKDSNMIYCGTFSTVYKAVMP------SGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKL-CHDNLVRPIGFVIY 675 (888)
Q Consensus 603 ~~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~g~~~~ 675 (888)
..++|+..+.||+|+||+||+|... +++.||+|+++..... .....+.+|...+.++ +|+||+.+++++..
T Consensus 11 ~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~--~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~ 88 (299)
T d1ywna1 11 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATH--SEHRALMSELKILIHIGHHLNVVNLLGACTK 88 (299)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC----CH--HHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CHHHEEEEEEEEECCCEEEEEEEECCCCCCCCCEEEEEEEECCCCCC--HHHHHHHHHHHHHHHHCCCCEEEEEEEEECC
T ss_conf 67997984498416783999999867775557839999998600171--7899999999998861499849974115404
Q ss_pred CC-EEEEEEECCCCCCHHHHHHCCCCC-----------CCCCCCHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEEC
Q ss_conf 89-529998307999987884303999-----------999999889999999999887302457725238888975857
Q 002721 676 ED-VALLLHNYLPNGTLAQLLHESTKQ-----------PDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLD 743 (888)
Q Consensus 676 ~~-~~~lv~e~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~dlk~~NIll~ 743 (888)
.+ ..++|||||++|+|.++++..... ....+++.++..++.||+.||+|||+.+|+||||||+|||++
T Consensus 89 ~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl~ 168 (299)
T d1ywna1 89 PGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS 168 (299)
T ss_dssp TTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC
T ss_pred CCCEEEEEEEECCCCCHHHHHHHCCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEC
T ss_conf 79757999984589929999985366666532220233214689999999999999999988737971786773106577
Q ss_pred CCCCCEEECCCCCCCCCCCCCCCCCCCCCCCCCEECCCCCCCCCCCCCCCCHHHHHHHHHHHHCCC-CCCCCCCCCCCHH
Q ss_conf 999826702334322599999520013345443216333355785864430547899999881999-9877778863131
Q 002721 744 ADFKPLLGEIEISKLLDPSKGTASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILTTRL-PVEEDFGEGVDLV 822 (888)
Q Consensus 744 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlG~il~elltg~~-p~~~~~~~~~~l~ 822 (888)
.++.+||+|||+++...............||+.|+|||++.+..++.++|||||||++|||+||.. ||...... ..+.
T Consensus 169 ~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~-~~~~ 247 (299)
T d1ywna1 169 EKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID-EEFC 247 (299)
T ss_dssp GGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCCS-HHHH
T ss_pred CCCCEEECCCCCHHHCCCCCCCCCCCCEEECCCCCCHHHHHCCCCCCCCCEEEHHHHHHHHHHCCCCCCCCCCHH-HHHH
T ss_conf 998289845752001135665222475166721020368646889966322136789999986889999899989-9999
Q ss_pred HHCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHH
Q ss_conf 21123678999941013333366785829999999999940237899999999899999998641
Q 002721 823 KWVHGAPARGETPEQILDARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEMLQEIKQ 887 (888)
Q Consensus 823 ~~~~~~~~~~~~~~~i~d~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~eil~~L~~~~~ 887 (888)
..+...... . ......+++.+++.+||+.||++||||+|+++.|+++.+
T Consensus 248 ~~~~~~~~~-~---------------~~~~~~~~l~~li~~cl~~dP~~Rpt~~eil~~L~~ilq 296 (299)
T d1ywna1 248 RRLKEGTRM-R---------------APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEHLGNLLQ 296 (299)
T ss_dssp HHHHHTCCC-C---------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred HHHHCCCCC-C---------------CCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHH
T ss_conf 999638988-8---------------886578999999999767796679199999999979986
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=352.46 Aligned_cols=266 Identities=21% Similarity=0.319 Sum_probs=213.1
Q ss_pred HHHHCCCCCEEEECCCCEEEEEEE------CCCCEEEEEEEECCCHHHHHHHHHHHHHHHHHHCC-CCCCEEEEEEEEEE
Q ss_conf 987147866254266442999981------79968999993126714568799999999998503-79932544357872
Q 002721 603 VKATMKDSNMIYCGTFSTVYKAVM------PSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKL-CHDNLVRPIGFVIY 675 (888)
Q Consensus 603 ~~~~~~~~~~lg~G~~g~Vy~~~~------~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~g~~~~ 675 (888)
..++|+..+.||+|+||.||+|++ .++..||||+++..... .....+.+|+.+++.+ +|||||+++|++..
T Consensus 21 ~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~~~--~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~ 98 (311)
T d1t46a_ 21 PRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSAHL--TEREALMSELKVLSYLGNHMNIVNLLGACTI 98 (311)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTCCH--HHHHHHHHHHHHHHHHCCCTTBCCEEEEECS
T ss_pred CHHHEEEEEEEEECCCEEEEEEEEECCCCCCCCEEEEEEEECCCCCH--HHHHHHHHHHHHHHHCCCCCCEEEEEEEEEE
T ss_conf 78996985498206882999999806644778869999998742487--7999999999998762699988789989831
Q ss_pred CCEEEEEEECCCCCCHHHHHHCCCCC-------------CCCCCCHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEE
Q ss_conf 89529998307999987884303999-------------99999988999999999988730245772523888897585
Q 002721 676 EDVALLLHNYLPNGTLAQLLHESTKQ-------------PDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLL 742 (888)
Q Consensus 676 ~~~~~lv~e~~~~gsL~~~l~~~~~~-------------~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~dlk~~NIll 742 (888)
....++||||+++|+|.++++..... ....+++..+..++.||+.||+|||+.+++||||||+||++
T Consensus 99 ~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl~ 178 (311)
T d1t46a_ 99 GGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILL 178 (311)
T ss_dssp SSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred CCEEEEEEECCCCCCHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCCCCC
T ss_conf 99789999737998799999853566544444533222334588999999999999999998875792666241021000
Q ss_pred CCCCCCEEECCCCCCCCCCCCCCCCCCCCCCCCCEECCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCHH
Q ss_conf 79998267023343225999995200133454432163333557858644305478999998819999877778863131
Q 002721 743 DADFKPLLGEIEISKLLDPSKGTASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLV 822 (888)
Q Consensus 743 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlG~il~elltg~~p~~~~~~~~~~l~ 822 (888)
+.++.+|++|||.++...............||+.|+|||++.+..++.++||||||+++|||+|+..|+.........+.
T Consensus 179 ~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~~ 258 (311)
T d1t46a_ 179 THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFY 258 (311)
T ss_dssp ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHH
T ss_pred CCCCCCCCCCCCHHEECCCCCCCEEEEECCCCHHHCCHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHH
T ss_conf 02575210234010233678861586201359687677886179999740010258999999858998877899899999
Q ss_pred HHCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHH
Q ss_conf 2112367899994101333336678582999999999994023789999999989999999864
Q 002721 823 KWVHGAPARGETPEQILDARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEMLQEIK 886 (888)
Q Consensus 823 ~~~~~~~~~~~~~~~i~d~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~eil~~L~~~~ 886 (888)
+.+.... ... ........+.+++.+||+.||++||||.+++++|+++.
T Consensus 259 ~~i~~~~--------------~~~--~~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~~L~~~i 306 (311)
T d1t46a_ 259 KMIKEGF--------------RML--SPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLIEKQI 306 (311)
T ss_dssp HHHHHTC--------------CCC--CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHCCC--------------CCC--CCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHH
T ss_conf 9986689--------------889--85436599999999975779657929999999998765
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=356.75 Aligned_cols=258 Identities=21% Similarity=0.300 Sum_probs=206.8
Q ss_pred HHHCCCCCEEEECCCCEEEEEEECC----CCEEEEEEEECCCHHHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEECCEE
Q ss_conf 8714786625426644299998179----968999993126714568799999999998503799325443578728952
Q 002721 604 KATMKDSNMIYCGTFSTVYKAVMPS----GLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVA 679 (888)
Q Consensus 604 ~~~~~~~~~lg~G~~g~Vy~~~~~~----~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~ 679 (888)
.++|+..+.||+|+||.||+|.+.. +..||+|.++.... ......+.+|++++++++||||++++|++. ++..
T Consensus 6 ~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~~~--~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~ 82 (273)
T d1mp8a_ 6 RERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTS--DSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPV 82 (273)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTTTS--HHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSC
T ss_pred HHHEEEEEEEEECCCCEEEEEEEECCCCEEEEEEEEEECCCCC--HHHHHHHHHHHHHHHHCCCCCEEEEEEEEE-CCEE
T ss_conf 8996987799307882999999936996449999999365668--799999999999998689999856988995-3747
Q ss_pred EEEEECCCCCCHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCCEEECCCCCCCC
Q ss_conf 99983079999878843039999999998899999999998873024577252388889758579998267023343225
Q 002721 680 LLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLL 759 (888)
Q Consensus 680 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~ 759 (888)
++||||+++|++.+++..... .+++..+..++.||+.||.|||+.+++||||||+||+++.++.+|++|||+++..
T Consensus 83 ~iv~E~~~~g~l~~~~~~~~~----~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~ 158 (273)
T d1mp8a_ 83 WIIMELCTLGELRSFLQVRKY----SLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM 158 (273)
T ss_dssp EEEEECCTTEEHHHHHHHTTT----TSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEETTEEEECC-------
T ss_pred EEEEEECCCCCHHHHHHCCCC----CCCHHHHHHHHHHHHHHHHHHCCCCEECCCCCHHHEEECCCCCEEECCCHHHEEC
T ss_conf 999984069807765422478----9999999999999987752302267441410265532067896787650342133
Q ss_pred CCCCCCCCCCCCCCCCCEECCCCCCCCCCCCCCCCHHHHHHHHHHHH-CCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCC
Q ss_conf 99999520013345443216333355785864430547899999881-99998777788631312112367899994101
Q 002721 760 DPSKGTASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILT-TRLPVEEDFGEGVDLVKWVHGAPARGETPEQI 838 (888)
Q Consensus 760 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlG~il~ellt-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~i 838 (888)
...... ......||+.|+|||++.+..++.++|||||||++|||+| |..||...... ++...+... ..+
T Consensus 159 ~~~~~~-~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~--~~~~~i~~~----~~~--- 228 (273)
T d1mp8a_ 159 EDSTYY-KASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN--DVIGRIENG----ERL--- 228 (273)
T ss_dssp -------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG--GHHHHHHTT----CCC---
T ss_pred CCCCCE-ECCCEECCCCCCHHHHHCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCCCCHH--HHHHHHHCC----CCC---
T ss_conf 677623-3054005831032667516998874524442478999982699998889999--999999818----999---
Q ss_pred CCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHH
Q ss_conf 3333366785829999999999940237899999999899999998641
Q 002721 839 LDARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEMLQEIKQ 887 (888)
Q Consensus 839 ~d~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~eil~~L~~~~~ 887 (888)
. .+......+.+++.+||+.+|++|||+.|+++.|+++.+
T Consensus 229 ------~---~~~~~~~~~~~li~~cl~~dp~~Rps~~ei~~~L~~i~~ 268 (273)
T d1mp8a_ 229 ------P---MPPNCPPTLYSLMTKCWAYDPSRRPRFTELKAQLSTILE 268 (273)
T ss_dssp ------C---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ------C---CCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHH
T ss_conf ------8---987779999999999768797689299999999999977
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=350.47 Aligned_cols=252 Identities=16% Similarity=0.196 Sum_probs=198.9
Q ss_pred HHCCCC-CEEEECCCCEEEEEEE-CCCCEEEEEEEECCCHHHHHHHHHHHHHHHHHHCC-CCCCEEEEEEEEEE----CC
Q ss_conf 714786-6254266442999981-79968999993126714568799999999998503-79932544357872----89
Q 002721 605 ATMKDS-NMIYCGTFSTVYKAVM-PSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKL-CHDNLVRPIGFVIY----ED 677 (888)
Q Consensus 605 ~~~~~~-~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~g~~~~----~~ 677 (888)
++|.+. +.||+|+||+||+|+. .+++.||+|+++.. ..+.+|+.++.++ +|||||++++++.+ +.
T Consensus 11 ~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~--------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~ 82 (335)
T d2ozaa1 11 DDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYAGRK 82 (335)
T ss_dssp GTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEE
T ss_pred CCEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECCC--------HHHHHHHHHHHHHCCCCCCCEEEEEEEECCCCCC
T ss_conf 48798107965454869999998899989999998974--------7799999999986699997829899950346897
Q ss_pred EEEEEEECCCCCCHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECC---CCCCEEECCC
Q ss_conf 5299983079999878843039999999998899999999998873024577252388889758579---9982670233
Q 002721 678 VALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDA---DFKPLLGEIE 754 (888)
Q Consensus 678 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~dlk~~NIll~~---~~~~kl~Dfg 754 (888)
..|+|||||++|+|.+++...... .+++.++..|+.||+.||+|||+.+|+||||||+|||++. ++.+|++|||
T Consensus 83 ~~~ivmEy~~gg~L~~~i~~~~~~---~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG 159 (335)
T d2ozaa1 83 CLLIVMECLDGGELFSRIQDRGDQ---AFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFG 159 (335)
T ss_dssp EEEEEEECCCSEEHHHHHHSCSCC---CEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCT
T ss_pred EEEEEEECCCCCCHHHHHHHCCCC---CCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
T ss_conf 899999778998499999862787---75799999999999999999997698644410022011355556631135455
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCEECCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHCCCCCCCCCC
Q ss_conf 43225999995200133454432163333557858644305478999998819999877778863131211236789999
Q 002721 755 ISKLLDPSKGTASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGET 834 (888)
Q Consensus 755 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~ 834 (888)
+++....... .....||+.|+|||++.+..|+.++||||+||++|||+||+.||........ .. ..
T Consensus 160 ~a~~~~~~~~---~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~~~--~~---------~~ 225 (335)
T d2ozaa1 160 FAKETTSHNS---LTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI--SP---------GM 225 (335)
T ss_dssp TCEECCCCCC---CCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC-----------------
T ss_pred EEEECCCCCC---CCCCCCCCCCCCCHHHCCCCCCHHHHHHHHCHHHHHHHHCCCCCCCCCHHHH--HH---------HH
T ss_conf 1233368886---4322677563792777489888888887645167788658899889887788--99---------99
Q ss_pred CCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 41013333366785829999999999940237899999999899999
Q 002721 835 PEQILDARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEM 881 (888)
Q Consensus 835 ~~~i~d~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~eil~~ 881 (888)
...+...........+....+++.+++.+|++.||++|||+.|+++.
T Consensus 226 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~h 272 (335)
T d2ozaa1 226 KTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNH 272 (335)
T ss_dssp --CCCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHHCCCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 99985388888985434699999999999756996579099999709
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=0 Score=354.97 Aligned_cols=264 Identities=22% Similarity=0.238 Sum_probs=211.9
Q ss_pred HHHCCCCCEEEECCCCEEEEEEE-CCCCEEEEEEEECCCHHHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEECC----E
Q ss_conf 87147866254266442999981-799689999931267145687999999999985037993254435787289----5
Q 002721 604 KATMKDSNMIYCGTFSTVYKAVM-PSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYED----V 678 (888)
Q Consensus 604 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~----~ 678 (888)
.++|++.+.||+|+||+||+|+. .+++.||+|+++............+.+|+++++.++||||+++++++...+ .
T Consensus 6 ~drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 6 SDRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEE
T ss_pred CCEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCCCCCCCEEEECCCCCCE
T ss_conf 62069868996089929999999999989999998556646989999999999999856999887311435432688766
Q ss_pred EEEEEECCCCCCHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCCEEECCCCCCC
Q ss_conf 29998307999987884303999999999889999999999887302457725238888975857999826702334322
Q 002721 679 ALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKL 758 (888)
Q Consensus 679 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~ 758 (888)
.|+||||+++++|.+++.... .+++.++..++.||+.||+|||+.+|+||||||+||+++.++..+++|||.+..
T Consensus 86 ~~lvmE~~~g~~L~~~~~~~~-----~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~ 160 (277)
T d1o6ya_ 86 PYIVMEYVDGVTLRDIVHTEG-----PMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARA 160 (277)
T ss_dssp EEEEEECCCEEEHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTSCEEECCCTTCEE
T ss_pred EEEEEECCCCCEEHHHHCCCC-----CCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCEEEHHHHHHH
T ss_conf 999997788987101120358-----999999999999999999999857952763467556657543201003444322
Q ss_pred CCCCCC-CCCCCCCCCCCCEECCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCC
Q ss_conf 599999-5200133454432163333557858644305478999998819999877778863131211236789999410
Q 002721 759 LDPSKG-TASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQ 837 (888)
Q Consensus 759 ~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 837 (888)
...... ........||+.|+|||++.+..+++++||||+||++|||+||+.||........ ........+ .+..
T Consensus 161 ~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~-~~~~~~~~~----~~~~ 235 (277)
T d1o6ya_ 161 IADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSV-AYQHVREDP----IPPS 235 (277)
T ss_dssp CC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHCCC----CCGG
T ss_pred HCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCEECCCCHHHHHHHHHCCCCCCCCCHHHH-HHHHHHCCC----CCCC
T ss_conf 12354433334642576243699998399999663202652899999769799899699999-999984699----9971
Q ss_pred CCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCC-CHHHHHHHHHHHHH
Q ss_conf 133333667858299999999999402378999999-99899999998641
Q 002721 838 ILDARLSTVSFGWRKEMLTALKVALLCTDSTPAKRP-KMKKVVEMLQEIKQ 887 (888)
Q Consensus 838 i~d~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RP-s~~eil~~L~~~~~ 887 (888)
. ......+++.+++.+|+++||++|| |+++++..|.+++.
T Consensus 236 ~----------~~~~~s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~r~~n 276 (277)
T d1o6ya_ 236 A----------RHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN 276 (277)
T ss_dssp G----------TSSSCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHC
T ss_pred H----------HCCCCCHHHHHHHHHHCCCCHHHCHHHHHHHHHHHHHHHC
T ss_conf 0----------0347899999999998667976777399999999999758
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=349.48 Aligned_cols=263 Identities=22% Similarity=0.281 Sum_probs=211.5
Q ss_pred HHHCCCCCEEEECCCCEEEEEEECC--------CCEEEEEEEECCCHHHHHHHHHHHHHHHHHHCC-CCCCEEEEEEEEE
Q ss_conf 8714786625426644299998179--------968999993126714568799999999998503-7993254435787
Q 002721 604 KATMKDSNMIYCGTFSTVYKAVMPS--------GLILSVKRLKSMDRTIIHHQNKMIRELEKLSKL-CHDNLVRPIGFVI 674 (888)
Q Consensus 604 ~~~~~~~~~lg~G~~g~Vy~~~~~~--------~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~g~~~ 674 (888)
.++|.+.+.||+|+||.||+|+... +..||+|+++..... ....++.+|...+.++ +|||||+++|++.
T Consensus 12 ~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~~--~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~ 89 (299)
T d1fgka_ 12 RDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDATE--KDLSDLISEMEMMKMIGKHKNIINLLGACT 89 (299)
T ss_dssp GGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTTCCH--HHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred HHHEEEEEEEEECCCCEEEEEEECCCCCCCCCCCEEEEEEEECCCCCH--HHHHHHHHHHHHHHHHCCCCEEEECCCCCC
T ss_conf 899697009851678289999985787555667549999998811286--889999999999998139996973465220
Q ss_pred ECCEEEEEEECCCCCCHHHHHHCCCCC-----------CCCCCCHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEEC
Q ss_conf 289529998307999987884303999-----------999999889999999999887302457725238888975857
Q 002721 675 YEDVALLLHNYLPNGTLAQLLHESTKQ-----------PDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLD 743 (888)
Q Consensus 675 ~~~~~~lv~e~~~~gsL~~~l~~~~~~-----------~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~dlk~~NIll~ 743 (888)
++...++||||+++|+|.+++...... ....+++.++++++.||+.||+|||+.+|+||||||+|||++
T Consensus 90 ~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiKp~NiLl~ 169 (299)
T d1fgka_ 90 QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT 169 (299)
T ss_dssp SSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEC
T ss_pred CCCEEEEEEECCCCCCHHHHHHHHCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEEEECCCCEEEC
T ss_conf 18868999973699909999986067764322233457434679999999999999999876637978630221022454
Q ss_pred CCCCCEEECCCCCCCCCCCCCCCCCCCCCCCCCEECCCCCCCCCCCCCCCCHHHHHHHHHHHH-CCCCCCCCCCCCCCHH
Q ss_conf 999826702334322599999520013345443216333355785864430547899999881-9999877778863131
Q 002721 744 ADFKPLLGEIEISKLLDPSKGTASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILT-TRLPVEEDFGEGVDLV 822 (888)
Q Consensus 744 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlG~il~ellt-g~~p~~~~~~~~~~l~ 822 (888)
.++.+|++|||+++...............+++.|+|||.+.+..|+.++||||||+++|||++ |..||...... +..
T Consensus 170 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~--~~~ 247 (299)
T d1fgka_ 170 EDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE--ELF 247 (299)
T ss_dssp TTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH--HHH
T ss_pred CCCCEEECCCHHHCCCCCCCCCCCCCCCCCCHHHHHHHHHCCCCCCCHHHHHHHHHHHHHHCCCCCCCCCCCCHH--HHH
T ss_conf 789767622111011355555431466788846632667517988825554775888887401798989999999--999
Q ss_pred HHCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHH
Q ss_conf 2112367899994101333336678582999999999994023789999999989999999864
Q 002721 823 KWVHGAPARGETPEQILDARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEMLQEIK 886 (888)
Q Consensus 823 ~~~~~~~~~~~~~~~i~d~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~eil~~L~~~~ 886 (888)
..+.... .+. .......++.+++.+||+.+|++||||.|+++.|+++.
T Consensus 248 ~~i~~~~----~~~------------~p~~~~~~l~~li~~cl~~dP~~Rps~~eil~~L~~i~ 295 (299)
T d1fgka_ 248 KLLKEGH----RMD------------KPSNCTNELYMMMRDCWHAVPSQRPTFKQLVEDLDRIV 295 (299)
T ss_dssp HHHHTTC----CCC------------CCSSCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHCCC----CCC------------CCCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHH
T ss_conf 9997288----889------------87435299999999976679767939999999998886
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=357.02 Aligned_cols=261 Identities=22% Similarity=0.289 Sum_probs=208.7
Q ss_pred HHHCCCCCEEEECCCCEEEEEEEC--CC--CEEEEEEEECCCHHHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEECCEE
Q ss_conf 871478662542664429999817--99--68999993126714568799999999998503799325443578728952
Q 002721 604 KATMKDSNMIYCGTFSTVYKAVMP--SG--LILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVA 679 (888)
Q Consensus 604 ~~~~~~~~~lg~G~~g~Vy~~~~~--~~--~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~ 679 (888)
.++|++.+.||+|+||+||+|+.. ++ ..||+|.+++.........+.|.+|+.++++++||||++++|++.+ ...
T Consensus 7 ~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~ 85 (273)
T d1u46a_ 7 EKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPM 85 (273)
T ss_dssp GGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSC
T ss_pred HHHEEEEEEEECCCCEEEEEEEEECCCCCEEEEEEEEECHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEE-CCH
T ss_conf 4891997898038883999999988999079999999983555798999999999999986899998789877740-100
Q ss_pred EEEEECCCCCCHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCCEEECCCCCCCC
Q ss_conf 99983079999878843039999999998899999999998873024577252388889758579998267023343225
Q 002721 680 LLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLL 759 (888)
Q Consensus 680 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~ 759 (888)
++||||+++|++.+++..... .+++..+..++.|||.||.|||+++|+||||||+||+++.++.+|++|||+++..
T Consensus 86 ~lv~e~~~~~~l~~~~~~~~~----~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~ 161 (273)
T d1u46a_ 86 KMVTELAPLGSLLDRLRKHQG----HFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRAL 161 (273)
T ss_dssp EEEEECCTTCBHHHHHHHHGG----GSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEEETTEEEECCCTTCEEC
T ss_pred HEEEEEECCCCHHHHHHCCCC----CCCHHHHHHHHHHHHHHHHHHHHCCEEEEEECHHHHCCCCCCCEEECCCHHHHHC
T ss_conf 114654238612544421268----9999999999999999998752178752056688815655654332561155530
Q ss_pred CCCCCCCC-CCCCCCCCCEECCCCCCCCCCCCCCCCHHHHHHHHHHHH-CCCCCCCCCCCCCCHHHHCCCCCCCCCCCCC
Q ss_conf 99999520-013345443216333355785864430547899999881-9999877778863131211236789999410
Q 002721 760 DPSKGTAS-ISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILT-TRLPVEEDFGEGVDLVKWVHGAPARGETPEQ 837 (888)
Q Consensus 760 ~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlG~il~ellt-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~ 837 (888)
........ .....|+..|+|||.+.+..++.++||||||+++|||+| |+.||...... +....+.... ..+.
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~--~~~~~i~~~~---~~~~- 235 (273)
T d1u46a_ 162 PQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS--QILHKIDKEG---ERLP- 235 (273)
T ss_dssp CC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH--HHHHHHHTSC---CCCC-
T ss_pred CCCCCCCEECCCCCCCCCCCCHHHHHCCCCCCCHHHHHHHHHHHHHHHCCCCCCCCCCHH--HHHHHHHHCC---CCCC-
T ss_conf 358875265476325731079999837999942156614899999996899999996999--9999998479---9999-
Q ss_pred CCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHH
Q ss_conf 1333336678582999999999994023789999999989999999864
Q 002721 838 ILDARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEMLQEIK 886 (888)
Q Consensus 838 i~d~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~eil~~L~~~~ 886 (888)
.....+..+.+++.+||+.+|++||||.++.+.|++..
T Consensus 236 -----------~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~~~L~~~~ 273 (273)
T d1u46a_ 236 -----------RPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLLEAQ 273 (273)
T ss_dssp -----------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHC
T ss_pred -----------CCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHCC
T ss_conf -----------85445399999999976889667929999999999649
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=355.77 Aligned_cols=251 Identities=22% Similarity=0.304 Sum_probs=204.5
Q ss_pred HHCCCCCEEEECCCCEEEEEEECCCCEEEEEEEECCCHHHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEEC-CEEEEEE
Q ss_conf 714786625426644299998179968999993126714568799999999998503799325443578728-9529998
Q 002721 605 ATMKDSNMIYCGTFSTVYKAVMPSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYE-DVALLLH 683 (888)
Q Consensus 605 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~-~~~~lv~ 683 (888)
++|+..+.||+|+||.||+|.+ .|..||||+++.... .+.+.+|++++++++||||++++|++.++ +..++||
T Consensus 7 ~~~~~~~~lG~G~fg~Vy~~~~-~~~~vAvK~i~~~~~-----~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ 80 (262)
T d1byga_ 7 KELKLLQTIGKGEFGDVMLGDY-RGNKVAVKCIKNDAT-----AQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVT 80 (262)
T ss_dssp GGEEEEEEEEECSSCEEEEEEE-TTEEEEEEECCCCC-------HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEE
T ss_pred HHEEEEEEEECCCCEEEEEEEE-CCEEEEEEEECCHHH-----HHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCEEEEE
T ss_conf 9948857982079808999999-990999999885777-----9999999999986789898549878872389289999
Q ss_pred ECCCCCCHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCCEEECCCCCCCCCCCC
Q ss_conf 30799998788430399999999988999999999988730245772523888897585799982670233432259999
Q 002721 684 NYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSK 763 (888)
Q Consensus 684 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~ 763 (888)
||+++|+|.+++...... .++|..+++|+.||+.||.|||+.+|+||||||+||+++.++.+|++|||+++......
T Consensus 81 ey~~~g~L~~~l~~~~~~---~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~~ 157 (262)
T d1byga_ 81 EYMAKGSLVDYLRSRGRS---VLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ 157 (262)
T ss_dssp CCCTTEEHHHHHHHHHHH---HCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC--------
T ss_pred ECCCCCCHHHHHHHCCCC---CCCHHHHHHHHHHHHHHCCCCCCCCEECCCCCHHHHEECCCCCEEECCCCCCEECCCCC
T ss_conf 636999899998745788---88999999999999852321133765536665676014689977632456003447877
Q ss_pred CCCCCCCCCCCCCEECCCCCCCCCCCCCCCCHHHHHHHHHHHH-CCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCCC
Q ss_conf 9520013345443216333355785864430547899999881-999987777886313121123678999941013333
Q 002721 764 GTASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILT-TRLPVEEDFGEGVDLVKWVHGAPARGETPEQILDAR 842 (888)
Q Consensus 764 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlG~il~ellt-g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~i~d~~ 842 (888)
....++..|+|||++.+..+++++||||||+++|||+| |+.||..... .+....+... ..+.
T Consensus 158 -----~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~--~~~~~~i~~~----~~~~------ 220 (262)
T d1byga_ 158 -----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL--KDVVPRVEKG----YKMD------ 220 (262)
T ss_dssp ---------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCG--GGHHHHHTTT----CCCC------
T ss_pred -----CCCCCCCCCCCHHHHHCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCH--HHHHHHHHCC----CCCC------
T ss_conf -----6556664677817872798885887775799999999789999999999--9999999808----9999------
Q ss_pred CCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHH
Q ss_conf 366785829999999999940237899999999899999998641
Q 002721 843 LSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEMLQEIKQ 887 (888)
Q Consensus 843 ~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~eil~~L~~~~~ 887 (888)
......+++.+++.+||+.||++||||.++++.|++++.
T Consensus 221 ------~~~~~~~~~~~li~~cl~~dP~~Rps~~~l~~~L~~i~~ 259 (262)
T d1byga_ 221 ------APDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQLEHIKT 259 (262)
T ss_dssp ------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ------CCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHH
T ss_conf ------976579999999999756697689399999999999986
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=350.68 Aligned_cols=260 Identities=22% Similarity=0.292 Sum_probs=205.4
Q ss_pred HHCCCCCEEEECCCCEEEEEEEC-CCC--EEEEEEEECCCHHHHHHHHHHHHHHHHHHCC-CCCCEEEEEEEEEECCEEE
Q ss_conf 71478662542664429999817-996--8999993126714568799999999998503-7993254435787289529
Q 002721 605 ATMKDSNMIYCGTFSTVYKAVMP-SGL--ILSVKRLKSMDRTIIHHQNKMIRELEKLSKL-CHDNLVRPIGFVIYEDVAL 680 (888)
Q Consensus 605 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~--~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l-~h~niv~l~g~~~~~~~~~ 680 (888)
++|+..+.||+|+||+||+|.+. ++. .||||++...... ...+.+.+|+++++++ +|||||+++|++...+..+
T Consensus 10 ~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~ 87 (309)
T d1fvra_ 10 NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASK--DDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLY 87 (309)
T ss_dssp GGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEE
T ss_pred HHCEEEEEEEECCCCEEEEEEECCCCEEEEEEEEEECCCCCH--HHHHHHHHHHHHHHHCCCCCCEEEEEEEEECCCEEE
T ss_conf 996887798207882899999989996999999997823385--799999999999986228998836788884187369
Q ss_pred EEEECCCCCCHHHHHHCCC-----------CCCCCCCCHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCCE
Q ss_conf 9983079999878843039-----------99999999889999999999887302457725238888975857999826
Q 002721 681 LLHNYLPNGTLAQLLHEST-----------KQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPL 749 (888)
Q Consensus 681 lv~e~~~~gsL~~~l~~~~-----------~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~dlk~~NIll~~~~~~k 749 (888)
+||||+++|+|.++++... ......+++..+.+++.|||.||.|+|+.+++||||||+|||++.++.+|
T Consensus 88 iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~~~k 167 (309)
T d1fvra_ 88 LAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAK 167 (309)
T ss_dssp EEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEE
T ss_pred EEEEECCCCCHHHHHHHCCCCCCCHHHHCCCCCCCCCCHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEECCCCCEE
T ss_conf 99980289869999864035555512310123457899999999999999998766308954555052048986887638
Q ss_pred EECCCCCCCCCCCCCCCCCCCCCCCCCEECCCCCCCCCCCCCCCCHHHHHHHHHHHHCCC-CCCCCCCCCCCHHHHCCCC
Q ss_conf 702334322599999520013345443216333355785864430547899999881999-9877778863131211236
Q 002721 750 LGEIEISKLLDPSKGTASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILTTRL-PVEEDFGEGVDLVKWVHGA 828 (888)
Q Consensus 750 l~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlG~il~elltg~~-p~~~~~~~~~~l~~~~~~~ 828 (888)
|+|||+++....... .....||..|+|||.+.+..++.++|||||||++|||++|.. ||.... ..++...+...
T Consensus 168 l~DfG~a~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~--~~~~~~~i~~~ 242 (309)
T d1fvra_ 168 IADFGLSRGQEVYVK---KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT--CAELYEKLPQG 242 (309)
T ss_dssp ECCTTCEESSCEECC---C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC--HHHHHHHGGGT
T ss_pred ECCCCCCCCCCCCCC---CCCEECCCCCCCHHHHCCCCCCCCCEEEHHHHHHHHHHHCCCCCCCCCC--HHHHHHHHHHC
T ss_conf 743443224442234---5530137755553875269999622153138899999836899999999--99999999826
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHH
Q ss_conf 78999941013333366785829999999999940237899999999899999998641
Q 002721 829 PARGETPEQILDARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEMLQEIKQ 887 (888)
Q Consensus 829 ~~~~~~~~~i~d~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~eil~~L~~~~~ 887 (888)
..+. .+....+++.+++.+||+.+|++||||+|+++.|+++.+
T Consensus 243 ----~~~~------------~~~~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~i~~ 285 (309)
T d1fvra_ 243 ----YRLE------------KPLNCDDEVYDLMRQCWREKPYERPSFAQILVSLNRMLE 285 (309)
T ss_dssp ----CCCC------------CCTTBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred ----CCCC------------CCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHHH
T ss_conf ----8888------------876678999999999767896689499999999999986
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=353.27 Aligned_cols=250 Identities=21% Similarity=0.231 Sum_probs=201.3
Q ss_pred HHCCCCCEEEECCCCEEEEEEEC-CCCEEEEEEEECCCHHHHHHHHHHHHHHHHHH-CCCCCCEEEEEEEEEECCEEEEE
Q ss_conf 71478662542664429999817-99689999931267145687999999999985-03799325443578728952999
Q 002721 605 ATMKDSNMIYCGTFSTVYKAVMP-SGLILSVKRLKSMDRTIIHHQNKMIRELEKLS-KLCHDNLVRPIGFVIYEDVALLL 682 (888)
Q Consensus 605 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~-~l~h~niv~l~g~~~~~~~~~lv 682 (888)
++|.+.+.||+|+||+||+|+.. +++.||+|++++...........+.+|..++. .++|||||++++++.+++..|+|
T Consensus 2 ddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yiv 81 (320)
T d1xjda_ 2 EDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFV 81 (320)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEE
T ss_pred CCEEEEEEEECCCCCEEEEEEECCCCCEEEEEEECHHHCCCHHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCEEEE
T ss_conf 97188658940878289999999999899999980555338489999999999999847999687898897049831677
Q ss_pred EECCCCCCHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCCEEECCCCCCCCCCC
Q ss_conf 83079999878843039999999998899999999998873024577252388889758579998267023343225999
Q 002721 683 HNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPS 762 (888)
Q Consensus 683 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~ 762 (888)
|||+++|+|.+++.... .+++.++..++.||+.||+|||+.+|+||||||+|||+++++.+|++|||+++.....
T Consensus 82 mEy~~~g~L~~~i~~~~-----~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~ 156 (320)
T d1xjda_ 82 MEYLNGGDLMYHIQSCH-----KFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLG 156 (320)
T ss_dssp EECCTTCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCT
T ss_pred EEECCCCCHHHHHHCCC-----CCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCCEEECCCCCEECCCCCHHHHCCCC
T ss_conf 75037980899864047-----8999999999999999999998689340347654044448996301555302323566
Q ss_pred CCCCCCCCCCCCCCEECCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCCC
Q ss_conf 99520013345443216333355785864430547899999881999987777886313121123678999941013333
Q 002721 763 KGTASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQILDAR 842 (888)
Q Consensus 763 ~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~i~d~~ 842 (888)
.. ......||+.|+|||++.+..++.++||||+||++|||+||+.||...... ++...... ..
T Consensus 157 ~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~--~~~~~i~~-------------~~ 219 (320)
T d1xjda_ 157 DA--KTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE--ELFHSIRM-------------DN 219 (320)
T ss_dssp TC--CBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH--HHHHHHHH-------------CC
T ss_pred CC--CCCCCCCCCCCCCHHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHH--HHHHHHHC-------------CC
T ss_conf 53--345457877768999982799883232011227898987388999998999--99999971-------------89
Q ss_pred CCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHH-HHHH
Q ss_conf 3667858299999999999402378999999998-9999
Q 002721 843 LSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMK-KVVE 880 (888)
Q Consensus 843 ~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~-eil~ 880 (888)
. ........++.+++.+||+.||++||++. ++++
T Consensus 220 ~----~~p~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~ 254 (320)
T d1xjda_ 220 P----FYPRWLEKEAKDLLVKLFVREPEKRLGVRGDIRQ 254 (320)
T ss_dssp C----CCCTTSCHHHHHHHHHHSCSSGGGSBTTBSCGGG
T ss_pred C----CCCCCCCHHHHHHHHHHCCCCCCCCCCHHHHHHH
T ss_conf 9----8975679999999999654489878388999980
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=351.31 Aligned_cols=264 Identities=18% Similarity=0.305 Sum_probs=210.1
Q ss_pred HHHCCCCCEEEECCCCEEEEEEEC------CCCEEEEEEEECCCHHHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEECC
Q ss_conf 871478662542664429999817------99689999931267145687999999999985037993254435787289
Q 002721 604 KATMKDSNMIYCGTFSTVYKAVMP------SGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYED 677 (888)
Q Consensus 604 ~~~~~~~~~lg~G~~g~Vy~~~~~------~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~ 677 (888)
.++|+..+.||+|+||+||+|.+. ++..||||+++..... .....+.+|+.++++++||||++++|++....
T Consensus 19 ~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~~~~--~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~ 96 (308)
T d1p4oa_ 19 REKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAASM--RERIEFLNEASVMKEFNCHHVVRLLGVVSQGQ 96 (308)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTSCH--HHHHHHHHHHHHGGGCCCTTBCCEEEEECSSS
T ss_pred HHHEEEEEEEEECCCEEEEEEEECCCCCCCCCCEEEEEEECCCCCH--HHHHHHHHHHHHHHHCCCCCEEEEEEEEECCC
T ss_conf 8991883598207881899999878644778968999998701286--89999999999999769998841254784288
Q ss_pred EEEEEEECCCCCCHHHHHHCCC-----CCCCCCCCHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCCEEEC
Q ss_conf 5299983079999878843039-----99999999889999999999887302457725238888975857999826702
Q 002721 678 VALLLHNYLPNGTLAQLLHEST-----KQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGE 752 (888)
Q Consensus 678 ~~~lv~e~~~~gsL~~~l~~~~-----~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~dlk~~NIll~~~~~~kl~D 752 (888)
..++||||+++|+|.+++.... ......+++..+.+++.|+|.||.|||+.+|+||||||+|||+++++++||+|
T Consensus 97 ~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~~NiLld~~~~~Kl~D 176 (308)
T d1p4oa_ 97 PTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGD 176 (308)
T ss_dssp SCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEEECC
T ss_pred CEEEEEEECCCCCHHHHHHHCCCCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECEECCCCEEECCCCEEEEEE
T ss_conf 10677760489988999875033211344468879999999999999999987647965432867754035996499942
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCEECCCCCCCCCCCCCCCCHHHHHHHHHHHHCC-CCCCCCCCCCCCHHHHCCCCCCC
Q ss_conf 33432259999952001334544321633335578586443054789999988199-99877778863131211236789
Q 002721 753 IEISKLLDPSKGTASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILTTR-LPVEEDFGEGVDLVKWVHGAPAR 831 (888)
Q Consensus 753 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlG~il~elltg~-~p~~~~~~~~~~l~~~~~~~~~~ 831 (888)
||+++...............|++.|+|||.+.+..++.++||||||+++|||+||. .||...... +....
T Consensus 177 FGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~~--~~~~~------- 247 (308)
T d1p4oa_ 177 FGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNE--QVLRF------- 247 (308)
T ss_dssp TTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCHH--HHHHH-------
T ss_pred CCCCEECCCCCCEEECCCEECCCCCCCHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCHH--HHHHH-------
T ss_conf 454202357763031340231632378888736998833344437899999996899999998999--99999-------
Q ss_pred CCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHH
Q ss_conf 99941013333366785829999999999940237899999999899999998641
Q 002721 832 GETPEQILDARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEMLQEIKQ 887 (888)
Q Consensus 832 ~~~~~~i~d~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~eil~~L~~~~~ 887 (888)
+.+...... .......+.+++.+||+.+|++||||+++++.|++..+
T Consensus 248 ------i~~~~~~~~---p~~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~ 294 (308)
T d1p4oa_ 248 ------VMEGGLLDK---PDNCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEME 294 (308)
T ss_dssp ------HHTTCCCCC---CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSC
T ss_pred ------HHHCCCCCC---CCCCHHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHCC
T ss_conf ------980888888---63353999999999757796589399999999787617
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=350.35 Aligned_cols=250 Identities=16% Similarity=0.187 Sum_probs=202.1
Q ss_pred HHCCCCCEEEECCCCEEEEEEEC-CCCEEEEEEEECCCHHHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEECCEEEEEE
Q ss_conf 71478662542664429999817-99689999931267145687999999999985037993254435787289529998
Q 002721 605 ATMKDSNMIYCGTFSTVYKAVMP-SGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVALLLH 683 (888)
Q Consensus 605 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 683 (888)
++|++.+.||+|+||+||+|... +++.||+|.++.... ....+.+|+++++.++|||||++++++.+++..|+||
T Consensus 5 ~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~~----~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvm 80 (321)
T d1tkia_ 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGT----DQVLVKKEISILNIARHRNILHLHESFESMEELVMIF 80 (321)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCTH----HHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEE
T ss_pred CCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCCC----CHHHHHHHHHHHHHCCCCCCCEEEEEEEECCEEEEEE
T ss_conf 105887898317783999999989996999999757866----5999999999998579979890989998899889999
Q ss_pred ECCCCCCHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCC--CCCEEECCCCCCCCCC
Q ss_conf 30799998788430399999999988999999999988730245772523888897585799--9826702334322599
Q 002721 684 NYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDAD--FKPLLGEIEISKLLDP 761 (888)
Q Consensus 684 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~dlk~~NIll~~~--~~~kl~Dfg~~~~~~~ 761 (888)
|||++|+|.+++..... .+++.++..|+.||+.||+|||+.+|+||||||+|||++.+ ..+|++|||+++....
T Consensus 81 E~~~gg~L~~~i~~~~~----~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~ 156 (321)
T d1tkia_ 81 EFISGLDIFERINTSAF----ELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKP 156 (321)
T ss_dssp CCCCCCBHHHHHTSSSC----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCT
T ss_pred ECCCCCCHHHHHHHCCC----CCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCEEEEECCCCHHHCCCC
T ss_conf 53899808899875389----99999999999999999999987699751355444344378851899764411100346
Q ss_pred CCCCCCCCCCCCCCCEECCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCC
Q ss_conf 99952001334544321633335578586443054789999988199998777788631312112367899994101333
Q 002721 762 SKGTASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPEQILDA 841 (888)
Q Consensus 762 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~i~d~ 841 (888)
.. ......+++.|+|||...+..++.++||||+||++|||++|+.||....... ... .+...
T Consensus 157 ~~---~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~--~~~-------------~i~~~ 218 (321)
T d1tkia_ 157 GD---NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQ--IIE-------------NIMNA 218 (321)
T ss_dssp TC---EEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHH--HHH-------------HHHHT
T ss_pred CC---CCCCCCCCCCCCCCHHCCCCCCCCHHHCCCHHHHHHHHHHCCCCCCCCCHHH--HHH-------------HHHHC
T ss_conf 77---5321223322234021048777840113027999999982899999989999--999-------------99838
Q ss_pred CCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf 336678582999999999994023789999999989999
Q 002721 842 RLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVE 880 (888)
Q Consensus 842 ~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~eil~ 880 (888)
........+.....++.+++.+|++.||++|||++|+++
T Consensus 219 ~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~ 257 (321)
T d1tkia_ 219 EYTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQ 257 (321)
T ss_dssp CCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHH
T ss_pred CCCCCHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf 999880223678999999999986699668909999963
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=0 Score=346.27 Aligned_cols=254 Identities=20% Similarity=0.253 Sum_probs=204.2
Q ss_pred HHCCCCCEEEECCCCEEEEEEE-CCCCEEEEEEEECCCHH------HHHHHHHHHHHHHHHHCCC-CCCEEEEEEEEEEC
Q ss_conf 7147866254266442999981-79968999993126714------5687999999999985037-99325443578728
Q 002721 605 ATMKDSNMIYCGTFSTVYKAVM-PSGLILSVKRLKSMDRT------IIHHQNKMIRELEKLSKLC-HDNLVRPIGFVIYE 676 (888)
Q Consensus 605 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~------~~~~~~~~~~e~~~l~~l~-h~niv~l~g~~~~~ 676 (888)
++|+..+.||+|+||+||+|+. .+++.||+|++.+.... .....+.+.+|+.++++++ ||||+++++++.++
T Consensus 3 ~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~ 82 (277)
T d1phka_ 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETN 82 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECS
T ss_pred CCCEECEEEECCCCEEEEEEEECCCCCEEEEEEEECCCCCCHHHHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEECCCC
T ss_conf 63888528841768499999999999899999996244641147888999999999999999850799747997621467
Q ss_pred CEEEEEEECCCCCCHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCCEEECCCCC
Q ss_conf 95299983079999878843039999999998899999999998873024577252388889758579998267023343
Q 002721 677 DVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEIS 756 (888)
Q Consensus 677 ~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~ 756 (888)
+..|+||||+++|+|.++++... .+++.++..++.||+.||+|||+.+|+||||||+||+++.++.+||+|||++
T Consensus 83 ~~~~ivmE~~~~g~L~~~l~~~~-----~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a 157 (277)
T d1phka_ 83 TFFFLVFDLMKKGELFDYLTEKV-----TLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFS 157 (277)
T ss_dssp SEEEEEEECCTTCBHHHHHHHHS-----SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTC
T ss_pred CCEEEEEECCCCCHHHHHHHHCC-----CCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCEEEECCCCCEEECCCHHE
T ss_conf 60599997689866899998659-----9999999999999999999998759943234625489868998387124031
Q ss_pred CCCCCCCCCCCCCCCCCCCCEECCCCCCC------CCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHCCCCCC
Q ss_conf 22599999520013345443216333355------785864430547899999881999987777886313121123678
Q 002721 757 KLLDPSKGTASISAVAGSFGYIPPEYAYT------MQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPA 830 (888)
Q Consensus 757 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~DVwSlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~~ 830 (888)
+....... .....||..|+|||.+.+ ..++.++||||+||++|||+||+.||........ ......+...
T Consensus 158 ~~~~~~~~---~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~~~-~~~i~~~~~~ 233 (277)
T d1phka_ 158 CQLDPGEK---LREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLM-LRMIMSGNYQ 233 (277)
T ss_dssp EECCTTCC---BCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH-HHHHHHTCCC
T ss_pred EECCCCCC---EEEEECCCCCCCHHHHHCCCCCCCCCCCCHHEECCCCHHHHHHCCCCCCCCCCCHHHH-HHHHHHCCCC
T ss_conf 67268872---1345246788898886053445678899233185656023103228889889999999-9999818988
Q ss_pred CCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 999941013333366785829999999999940237899999999899999
Q 002721 831 RGETPEQILDARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEM 881 (888)
Q Consensus 831 ~~~~~~~i~d~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~eil~~ 881 (888)
..........+++.+++.+||+++|++|||++|+++.
T Consensus 234 --------------~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h 270 (277)
T d1phka_ 234 --------------FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAH 270 (277)
T ss_dssp --------------CCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTS
T ss_pred --------------CCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf --------------8985434689999999999765896689199999739
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=337.31 Aligned_cols=269 Identities=19% Similarity=0.251 Sum_probs=200.1
Q ss_pred HHCCCCCEEEECCCCEEEEEEE-CCCCEEEEEEEECCCHHHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEECCEEEEEE
Q ss_conf 7147866254266442999981-799689999931267145687999999999985037993254435787289529998
Q 002721 605 ATMKDSNMIYCGTFSTVYKAVM-PSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVALLLH 683 (888)
Q Consensus 605 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 683 (888)
++|+..+.||+|+||+||+|+. .+++.||+|+++... ........+.+|++++++++|||||++++++.++...|+||
T Consensus 2 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~ 80 (298)
T d1gz8a_ 2 ENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDT-ETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVF 80 (298)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC--------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEE
T ss_pred CCCEECCEEECCCCEEEEEEEECCCCCEEEEEEEEHHH-CCHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCCCCEEEEE
T ss_conf 99776517723768099999999999799999980222-57589999999999998679983887445332243203788
Q ss_pred ECCCCCCHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCCEEECCCCCCCCCCCC
Q ss_conf 30799998788430399999999988999999999988730245772523888897585799982670233432259999
Q 002721 684 NYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSK 763 (888)
Q Consensus 684 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~ 763 (888)
||+.+ ++.+++...... .+++..+..++.||+.||+|||+.+|+||||||+|||++.++.+|++|||.++......
T Consensus 81 e~~~~-~~~~~~~~~~~~---~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~ 156 (298)
T d1gz8a_ 81 EFLHQ-DLKKFMDASALT---GIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV 156 (298)
T ss_dssp ECCSE-EHHHHHHHTTTT---CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS
T ss_pred EECCC-CHHHHHHHHCCC---CCCHHHHHHHHHHHHHHHHHHHCCCEECCCCCCHHEEECCCCCCEECCCCCCEECCCCC
T ss_conf 62377-445554420256---88889999999999999998652889921357114011346762103578613436886
Q ss_pred CCCCCCCCCCCCCEECCCCCCCCC-CCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHCCCC--CCCCCCCCCCCC
Q ss_conf 952001334544321633335578-58644305478999998819999877778863131211236--789999410133
Q 002721 764 GTASISAVAGSFGYIPPEYAYTMQ-VTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGA--PARGETPEQILD 840 (888)
Q Consensus 764 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DVwSlG~il~elltg~~p~~~~~~~~~~l~~~~~~~--~~~~~~~~~i~d 840 (888)
.......|++.|+|||...... ++.++||||+||++|||++|+.||....... .+....... +...........
T Consensus 157 --~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~~ 233 (298)
T d1gz8a_ 157 --RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEID-QLFRIFRTLGTPDEVVWPGVTSM 233 (298)
T ss_dssp --BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCCCCTTTSTTGGGS
T ss_pred --CCCEEECCCCEEEEHHHHCCCCCCCCCCCCCCCCHHHHHHHHCCCCCCCCCHHH-HHHHHHHHCCCCCHHHCCCCCCC
T ss_conf --410010365215411221366577742210333313427966879989889999-99999983289833314442224
Q ss_pred CC----CCCC-CCCC----HHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 33----3667-8582----9999999999940237899999999899999
Q 002721 841 AR----LSTV-SFGW----RKEMLTALKVALLCTDSTPAKRPKMKKVVEM 881 (888)
Q Consensus 841 ~~----~~~~-~~~~----~~~~~~~~~l~~~Cl~~~p~~RPs~~eil~~ 881 (888)
+. .... .... .....++.+++.+|++.||++|||++|+++.
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~~ell~H 283 (298)
T d1gz8a_ 234 PDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAKAALAH 283 (298)
T ss_dssp TTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCHHHHHTS
T ss_pred CCCCCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 21243454322220444166789999999999763995579189999678
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=336.38 Aligned_cols=263 Identities=18% Similarity=0.195 Sum_probs=195.0
Q ss_pred CCEEEECCCCEEEEEEEC-CCCEEEEEEEECCCHHH--HHHHHHHHHHHHHHHCCCCCCEEEEEEEEEECCEEEEEEECC
Q ss_conf 662542664429999817-99689999931267145--687999999999985037993254435787289529998307
Q 002721 610 SNMIYCGTFSTVYKAVMP-SGLILSVKRLKSMDRTI--IHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVALLLHNYL 686 (888)
Q Consensus 610 ~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~--~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~e~~ 686 (888)
.++||+|+||+||+|+.. +|+.||+|+++...... ......+.+|+.+++.++|||||++++++..++..|+||||+
T Consensus 3 l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~ 82 (299)
T d1ua2a_ 3 LDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFM 82 (299)
T ss_dssp EEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECC
T ss_pred CEEECCCCCEEEEEEEECCCCCEEEEEEEEHHHHHHHHHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCEEEHHHHH
T ss_conf 63851272829999999999969999998420212456799999999999998679999868985422587402204553
Q ss_pred CCCCHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCCEEECCCCCCCCCCCCCCC
Q ss_conf 99998788430399999999988999999999988730245772523888897585799982670233432259999952
Q 002721 687 PNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSKGTA 766 (888)
Q Consensus 687 ~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~~~ 766 (888)
+++++........ .+++..+..++.||+.||+|||+.+|+||||||+|||++.++.+||+|||.++........
T Consensus 83 ~~~~~~~~~~~~~-----~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~- 156 (299)
T d1ua2a_ 83 ETDLEVIIKDNSL-----VLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRA- 156 (299)
T ss_dssp SEEHHHHHTTCCS-----SCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCC-
T ss_pred CCHHHHHHHHCCC-----CCCHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEEECCCCCCCCCCCCCCCCCCCCCCC-
T ss_conf 4507765541266-----7789999999999999998863163550357762588537784114657610005787554-
Q ss_pred CCCCCCCCCCEECCCCCCCC-CCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHCC--CCCCCCCCCCCC---CC
Q ss_conf 00133454432163333557-8586443054789999988199998777788631312112--367899994101---33
Q 002721 767 SISAVAGSFGYIPPEYAYTM-QVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVH--GAPARGETPEQI---LD 840 (888)
Q Consensus 767 ~~~~~~gt~~y~aPE~~~~~-~~~~~~DVwSlG~il~elltg~~p~~~~~~~~~~l~~~~~--~~~~~~~~~~~i---~d 840 (888)
....+||..|+|||++.+. .++.++||||+||++|||+||+.||....... .+..... +.+......... ..
T Consensus 157 -~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~-~l~~i~~~~~~~~~~~~~~~~~~~~~ 234 (299)
T d1ua2a_ 157 -YTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLD-QLTRIFETLGTPTEEQWPDMCSLPDY 234 (299)
T ss_dssp -CCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHHHCCCCTTTSSSTTSSTTC
T ss_pred -CCCEECCHHHCCHHHHCCCCCCCHHHHHHHCCHHHHHHHHCCCCCCCCCHHH-HHHHHHHHCCCCCHHHCCCHHCCCHH
T ss_conf -3302047333639997267788805643630428999985969999999999-99999985189972545210002134
Q ss_pred CCCCCCCCCCH-----HHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf 33366785829-----99999999994023789999999989999
Q 002721 841 ARLSTVSFGWR-----KEMLTALKVALLCTDSTPAKRPKMKKVVE 880 (888)
Q Consensus 841 ~~~~~~~~~~~-----~~~~~~~~l~~~Cl~~~p~~RPs~~eil~ 880 (888)
........... ....++.+++.+|++.||++|||++|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~ 279 (299)
T d1ua2a_ 235 VTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 279 (299)
T ss_dssp CCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred HHHCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf 430347898867856568999999999976389456908999967
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=0 Score=327.83 Aligned_cols=267 Identities=16% Similarity=0.203 Sum_probs=200.6
Q ss_pred HHCCCCCEEEECCCCEEEEEEECCCCEEEEEEEECCCHHHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEECCEEEEEEE
Q ss_conf 71478662542664429999817996899999312671456879999999999850379932544357872895299983
Q 002721 605 ATMKDSNMIYCGTFSTVYKAVMPSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVALLLHN 684 (888)
Q Consensus 605 ~~~~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~e 684 (888)
++|+..+.||+|+||+||+|+.++++.||+|+++.... .......+.+|+.++++++||||+++++++...+..++++|
T Consensus 2 ~~Y~~~~~iG~G~fg~Vy~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e 80 (286)
T d1ob3a_ 2 EKYHGLEKIGEGTYGVVYKAQNNYGETFALKKIRLEKE-DEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFE 80 (286)
T ss_dssp CSEEEEEEEEEETTEEEEEEEETTSCEEEEEEECCSSG-GGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEE
T ss_pred CCCEECCEEECCCCCEEEEEEECCCCEEEEEEEEHHHC-CHHHHHHHHHHHHHHHHCCCCCEEEEEEECCCCCCEEEEEE
T ss_conf 99634318722778189999968999999999812326-85899999999999986799868766012046773158997
Q ss_pred CCCCCCHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCCEEECCCCCCCCCCCCC
Q ss_conf 07999987884303999999999889999999999887302457725238888975857999826702334322599999
Q 002721 685 YLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSKG 764 (888)
Q Consensus 685 ~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~~ 764 (888)
++.++.+..+..... .+++..+..++.||+.||+|||+.+|+||||||+|||++.++.+|++|||.+........
T Consensus 81 ~~~~~~~~~~~~~~~-----~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~ 155 (286)
T d1ob3a_ 81 HLDQDLKKLLDVCEG-----GLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR 155 (286)
T ss_dssp CCSEEHHHHHHTSTT-----CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC---
T ss_pred EEHHHHHHHHHHHCC-----CCCHHHHHHHHHHHHHHHHHHCCCCEEECCCCCCEEEECCCCCEEECCCCCCEECCCCCC
T ss_conf 400456789986047-----751445689999999999986057488267877505686899787323664301146765
Q ss_pred CCCCCCCCCCCCEECCCCCCCC-CCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHCC--CCCCCCCCCCCCC--
Q ss_conf 5200133454432163333557-8586443054789999988199998777788631312112--3678999941013--
Q 002721 765 TASISAVAGSFGYIPPEYAYTM-QVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVH--GAPARGETPEQIL-- 839 (888)
Q Consensus 765 ~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DVwSlG~il~elltg~~p~~~~~~~~~~l~~~~~--~~~~~~~~~~~i~-- 839 (888)
......+++.|+|||.+.+. .++.++||||+||++|||++|+.||....... .+.+... +.+..........
T Consensus 156 --~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~~~ 232 (286)
T d1ob3a_ 156 --KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEAD-QLMRIFRILGTPNSKNWPNVTELP 232 (286)
T ss_dssp --------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCCCCTTTSTTGGGST
T ss_pred --CCCEECCCCHHHHHHHHHCCCCCCCCEEEHHCCCHHHHHHHCCCCCCCCCHHH-HHHHHHHHHCCCCHHHCCCHHHHH
T ss_conf --41010243110137887178888841002111758999977979989889899-999999863899711042123332
Q ss_pred --CCCCCC-----CCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf --333366-----78582999999999994023789999999989999
Q 002721 840 --DARLST-----VSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVE 880 (888)
Q Consensus 840 --d~~~~~-----~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~eil~ 880 (888)
...... .........+.+.+++.+|++.||++|||++|+++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ell~ 280 (286)
T d1ob3a_ 233 KYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQALE 280 (286)
T ss_dssp TCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHHHT
T ss_pred HCCCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf 214333335676466651258999999999986689668909999856
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=330.87 Aligned_cols=269 Identities=19% Similarity=0.242 Sum_probs=193.0
Q ss_pred HHHCCCCCEEEECCCCEEEEEEEC-C-CCEEEEEEEECCCHHHHHHHHHHHHHHHHHHCC---CCCCEEEEEEEEEE---
Q ss_conf 871478662542664429999817-9-968999993126714568799999999998503---79932544357872---
Q 002721 604 KATMKDSNMIYCGTFSTVYKAVMP-S-GLILSVKRLKSMDRTIIHHQNKMIRELEKLSKL---CHDNLVRPIGFVIY--- 675 (888)
Q Consensus 604 ~~~~~~~~~lg~G~~g~Vy~~~~~-~-~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l---~h~niv~l~g~~~~--- 675 (888)
.++|++.+.||+|+||+||+|+.. + ++.||+|+++...... .....+.+|+.+++.+ +||||+++++++..
T Consensus 6 ~~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~~-~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~ 84 (305)
T d1blxa_ 6 DQQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE-GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT 84 (305)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTT-SCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC
T ss_pred CCCEEEEEEEECCCCEEEEEEEEECCCCEEEEEEEEEHHHCCC-HHHHHHHHHHHHHHHHHHCCCCCCCEEEEEECCCCC
T ss_conf 5897988899215586999999988899899999980232451-679999999999998742589880236632214666
Q ss_pred --CCEEEEEEECCCCCCHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCCEEECC
Q ss_conf --895299983079999878843039999999998899999999998873024577252388889758579998267023
Q 002721 676 --EDVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEI 753 (888)
Q Consensus 676 --~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~dlk~~NIll~~~~~~kl~Df 753 (888)
....++++||++++.+......... .+++..+..++.|++.||+|||+.+|+||||||+|||++.++.+|++||
T Consensus 85 ~~~~~~~~~~e~~~~~~~~~~~~~~~~----~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~df 160 (305)
T d1blxa_ 85 DRETKLTLVFEHVDQDLTTYLDKVPEP----GVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADF 160 (305)
T ss_dssp SSEEEEEEEEECCSCBHHHHHHHSCTT----CSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSC
T ss_pred CCCCEEEEEEEECCCCCHHHHHHCCCC----CCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCCCEEEECCCCCEEECCH
T ss_conf 667469999974058714444430378----9998999999999999999997588983579862789858997542100
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCEECCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHCC--CCCCC
Q ss_conf 3432259999952001334544321633335578586443054789999988199998777788631312112--36789
Q 002721 754 EISKLLDPSKGTASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVH--GAPAR 831 (888)
Q Consensus 754 g~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlG~il~elltg~~p~~~~~~~~~~l~~~~~--~~~~~ 831 (888)
|.++..... .......||+.|+|||++.+..|+.++||||+||++|||+||+.||....... .+..... +.+..
T Consensus 161 g~~~~~~~~---~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~-~~~~i~~~~~~~~~ 236 (305)
T d1blxa_ 161 GLARIYSFQ---MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD-QLGKILDVIGLPGE 236 (305)
T ss_dssp CSCCCCCGG---GGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH-HHHHHHHHHCCCCG
T ss_pred HHHHHHCCC---CCCCCCCCCHHHCCCCHHCCCCCCHHEHHHCHHHHHHHHHHCCCCCCCCCHHH-HHHHHHHHHCCCCH
T ss_conf 010110023---45777654851148310017988811100032899999987879989989899-99999984079961
Q ss_pred -----C-CCCCCCCCCCC-CCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf -----9-99410133333-66785829999999999940237899999999899999
Q 002721 832 -----G-ETPEQILDARL-STVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEM 881 (888)
Q Consensus 832 -----~-~~~~~i~d~~~-~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~eil~~ 881 (888)
. ........... ...........+.+.+++.+|++.||++|||++|+++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~sa~e~L~H 293 (305)
T d1blxa_ 237 EDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSH 293 (305)
T ss_dssp GGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HCCCCCCCCHHHHHCCCCCCCHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 105321111033302234564544044589999999999874896679189999669
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=332.58 Aligned_cols=242 Identities=18% Similarity=0.293 Sum_probs=194.1
Q ss_pred HHCCCCCEEEECCCCEEEEEEEC-CCCEEEEEEEECCCHHHH---HHHHHHHHHHHHHHCCC--CCCEEEEEEEEEECCE
Q ss_conf 71478662542664429999817-996899999312671456---87999999999985037--9932544357872895
Q 002721 605 ATMKDSNMIYCGTFSTVYKAVMP-SGLILSVKRLKSMDRTII---HHQNKMIRELEKLSKLC--HDNLVRPIGFVIYEDV 678 (888)
Q Consensus 605 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~---~~~~~~~~e~~~l~~l~--h~niv~l~g~~~~~~~ 678 (888)
.+|++.+.||+|+||+||+|+.. ++..||+|++.+...... .....+.+|+.++++++ |||||++++++...+.
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~ 83 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 83 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CEEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCEEEEEEEECCE
T ss_conf 83799679840878399999999999799999985688443345567999999999999743589881279999830996
Q ss_pred EEEEEECCCC-CCHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCC-CCCEEECCCCC
Q ss_conf 2999830799-998788430399999999988999999999988730245772523888897585799-98267023343
Q 002721 679 ALLLHNYLPN-GTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDAD-FKPLLGEIEIS 756 (888)
Q Consensus 679 ~~lv~e~~~~-gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~dlk~~NIll~~~-~~~kl~Dfg~~ 756 (888)
.++||||+++ +++.+++.... .+++..+..++.||+.||+|||+.+|+||||||+|||++.+ +.+|++|||++
T Consensus 84 ~~lv~e~~~~~~~l~~~~~~~~-----~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a 158 (273)
T d1xwsa_ 84 FVLILERPEPVQDLFDFITERG-----ALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSG 158 (273)
T ss_dssp EEEEEECCSSEEEHHHHHHHHC-----SCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTC
T ss_pred EEEEEEECCCCCHHHHHHHCCC-----CCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEEECCCCEEEECCCCCC
T ss_conf 8999983368622899986158-----99999999999999999999987797556676111477447884897754653
Q ss_pred CCCCCCCCCCCCCCCCCCCCEECCCCCCCCCC-CCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHCCCCCCCCCCC
Q ss_conf 22599999520013345443216333355785-86443054789999988199998777788631312112367899994
Q 002721 757 KLLDPSKGTASISAVAGSFGYIPPEYAYTMQV-TAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETP 835 (888)
Q Consensus 757 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~-~~~~DVwSlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~ 835 (888)
+...... .....||+.|+|||++.+..+ +.++||||+||++|||+||+.||..... .. .....
T Consensus 159 ~~~~~~~----~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~----i~---~~~~~----- 222 (273)
T d1xwsa_ 159 ALLKDTV----YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE----II---RGQVF----- 222 (273)
T ss_dssp EECCSSC----BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHHH----HH---HCCCC-----
T ss_pred EECCCCC----CCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCEEEEHHHHHCCCCCCCCHH----HH---HCCCC-----
T ss_conf 5324445----56656587747999984899788653325540345367568899887367----76---15447-----
Q ss_pred CCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf 101333336678582999999999994023789999999989999
Q 002721 836 EQILDARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVE 880 (888)
Q Consensus 836 ~~i~d~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~eil~ 880 (888)
..+ ....++.+++.+||+.||++|||++|+++
T Consensus 223 ---~~~----------~~s~~~~~li~~~L~~dp~~R~s~~eil~ 254 (273)
T d1xwsa_ 223 ---FRQ----------RVSSECQHLIRWCLALRPSDRPTFEEIQN 254 (273)
T ss_dssp ---CSS----------CCCHHHHHHHHHHTCSSGGGSCCHHHHHT
T ss_pred ---CCC----------CCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf ---787----------79999999999976089758939999853
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=325.82 Aligned_cols=261 Identities=25% Similarity=0.234 Sum_probs=190.4
Q ss_pred HCCCCCEEEECCCCEEEEEEEC-CCCEEEEEEEECCCHHHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEEC------CE
Q ss_conf 1478662542664429999817-9968999993126714568799999999998503799325443578728------95
Q 002721 606 TMKDSNMIYCGTFSTVYKAVMP-SGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYE------DV 678 (888)
Q Consensus 606 ~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~------~~ 678 (888)
+|+..++||+|+||+||+|+.. +++.||+|++..... ...+|++++++++||||+++++++... .+
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-------~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~ 93 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKR-------FKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY 93 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSS-------SCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCE
T ss_pred CCEEEEEEEECCCEEEEEEEECCCCCEEEEEEECCCCH-------HHHHHHHHHHHCCCCCCCCEEEEEEECCCCCCCEE
T ss_conf 76751698217683999999999997999999881606-------89999999986689898738789974476577318
Q ss_pred EEEEEECCCCCCHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCC-CCEEECCCCCC
Q ss_conf 29998307999987884303999999999889999999999887302457725238888975857999-82670233432
Q 002721 679 ALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADF-KPLLGEIEISK 757 (888)
Q Consensus 679 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~dlk~~NIll~~~~-~~kl~Dfg~~~ 757 (888)
.++||||++++.+......... ...+++.++..++.||+.||+|||+.+|+||||||+|||++.++ .+||+|||+++
T Consensus 94 ~~lv~Ey~~~~~~~~l~~~~~~--~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~ 171 (350)
T d1q5ka_ 94 LNLVLDYVPETVYRVARHYSRA--KQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK 171 (350)
T ss_dssp EEEEEECCSEEHHHHHHHHHHT--TCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCE
T ss_pred EEEEEECCCCCCHHHHHHHHHC--CCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCEEEEECCCCCEEEECCCCHH
T ss_conf 9999841688607888863103--68999999999999999999999866876457886037873589711673366054
Q ss_pred CCCCCCCCCCCCCCCCCCCEECCCCCCC-CCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHCCC---------
Q ss_conf 2599999520013345443216333355-785864430547899999881999987777886313121123---------
Q 002721 758 LLDPSKGTASISAVAGSFGYIPPEYAYT-MQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHG--------- 827 (888)
Q Consensus 758 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~DVwSlG~il~elltg~~p~~~~~~~~~~l~~~~~~--------- 827 (888)
....... .....|+..|+|||.+.+ ..++.++||||+||++|||++|+.||....... .+......
T Consensus 172 ~~~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~-~l~~i~~~~g~~~~~~~ 247 (350)
T d1q5ka_ 172 QLVRGEP---NVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVD-QLVEIIKVLGTPTREQI 247 (350)
T ss_dssp ECCTTSC---CCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHH-HHHHHHHHHCCCCHHHH
T ss_pred HCCCCCC---CCCCCCCCCCCCHHHHHCCCCCCCCEEECCCCEEEEEHHHCCCCCCCCCHHH-HHHHHHHHHCCCHHHHH
T ss_conf 4047765---3200255555682776404688821000246527785502879989879999-99999997489817765
Q ss_pred ---CCCC-CCCCCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf ---6789-99941013333366785829999999999940237899999999899999
Q 002721 828 ---APAR-GETPEQILDARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEM 881 (888)
Q Consensus 828 ---~~~~-~~~~~~i~d~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~eil~~ 881 (888)
.... .............. .......+++.+++.+|++.||++|||++|+++.
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~--~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~H 303 (350)
T d1q5ka_ 248 REMNPNYTEFKFPQIKAHPWTK--VFRPRTPPEAIALCSRLLEYTPTARLTPLEACAH 303 (350)
T ss_dssp HHHCC---CCCCCCCCCCCGGG--TSCTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTS
T ss_pred HHHCCCHHHCCCCCCCCCCHHH--HCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 4306210110355445674444--3156899999999999765895579299999669
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=321.21 Aligned_cols=261 Identities=15% Similarity=0.233 Sum_probs=197.9
Q ss_pred HHHCCCCCEEEECCCCEEEEEEEC-CCCEEEEEEEECCCHHHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEECC-----
Q ss_conf 871478662542664429999817-99689999931267145687999999999985037993254435787289-----
Q 002721 604 KATMKDSNMIYCGTFSTVYKAVMP-SGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYED----- 677 (888)
Q Consensus 604 ~~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~----- 677 (888)
.++|+..+.||+|+||+||+|... +|+.||+|+++... ......+.+.+|+++++.++|||||++++++...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~-~~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~ 95 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDF 95 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTT-SSHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTC
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHH-CCHHHHHHHHHHHHHHHHCCCCCEEEEEEEECCCCCCCCC
T ss_conf 771899889801778199999999999899999985222-5969999999999999866898754799986357655554
Q ss_pred -EEEEEEECCCCCCHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCCEEECCCCC
Q ss_conf -5299983079999878843039999999998899999999998873024577252388889758579998267023343
Q 002721 678 -VALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEIS 756 (888)
Q Consensus 678 -~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~ 756 (888)
..++||||+ +.++....+.. .+++..+..++.||+.||+|||+.+|+||||||+|||++.++.+|++|||.+
T Consensus 96 ~~~~lv~e~~-~~~l~~~~~~~------~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a 168 (346)
T d1cm8a_ 96 TDFYLVMPFM-GTDLGKLMKHE------KLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLA 168 (346)
T ss_dssp CCCEEEEECC-SEEHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTC
T ss_pred CEEEEEEECC-CCCHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCHHHCCCCCCCCCCCCCCE
T ss_conf 1599998405-52189998740------2269999999999999999987378764566851111210012211343102
Q ss_pred CCCCCCCCCCCCCCCCCCCCEECCCCCCCC-CCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHCCCCCCCC---
Q ss_conf 225999995200133454432163333557-8586443054789999988199998777788631312112367899---
Q 002721 757 KLLDPSKGTASISAVAGSFGYIPPEYAYTM-QVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARG--- 832 (888)
Q Consensus 757 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~DVwSlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~~~~--- 832 (888)
+..... .....|+..|+|||.+.+. .++.++||||+||++|||++|+.||....... .+...........
T Consensus 169 ~~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~-~~~~~~~~~~~~~~~~ 242 (346)
T d1cm8a_ 169 RQADSE-----MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLD-QLKEIMKVTGTPPAEF 242 (346)
T ss_dssp EECCSS-----CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHH-HHHHHHHHHCCCCHHH
T ss_pred ECCCCC-----CCCCCCCCCCCCHHHHCCCCCCCCCCHHHCCHHHHHHHHHCCCCCCCCCHHH-HHHHHHHCCCCCCHHH
T ss_conf 206876-----3102455333588998178789965010300389999997869988897689-9999985037884888
Q ss_pred ----CC---------CCCCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf ----99---------41013333366785829999999999940237899999999899999
Q 002721 833 ----ET---------PEQILDARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEM 881 (888)
Q Consensus 833 ----~~---------~~~i~d~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~eil~~ 881 (888)
.. ........+... .....+.+.+++.+|+..||++|||++|+++.
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~s~~~~dli~~mL~~dP~~R~ta~eiL~H 301 (346)
T d1cm8a_ 243 VQRLQSDEAKNYMKGLPELEKKDFASI---LTNASPLAVNLLEKMLVLDAEQRVTAGEALAH 301 (346)
T ss_dssp HHTCSCHHHHHHHHHSCCCCCCCGGGT---CTTCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHHHCCHHHHHHHCCCCCCCCCCHHHH---CCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 865300034433115786665566775---56899999999999772995579299999639
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=323.54 Aligned_cols=269 Identities=16% Similarity=0.238 Sum_probs=197.1
Q ss_pred HHCCCCCEEEECCCCEEEEEEE-CCCCEEEEEEEECCCHHHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEECC----EE
Q ss_conf 7147866254266442999981-799689999931267145687999999999985037993254435787289----52
Q 002721 605 ATMKDSNMIYCGTFSTVYKAVM-PSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYED----VA 679 (888)
Q Consensus 605 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~----~~ 679 (888)
.+|+..+.||+|+||+||+|.. .+|+.||||++.+.... ...+.+.+|+++++.++||||+++++++.... ..
T Consensus 8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~--~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~ 85 (345)
T d1pmea_ 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFEHQ--TYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKD 85 (345)
T ss_dssp TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTTCH--HHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCC
T ss_pred CCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEEHHCCH--HHHHHHHHHHHHHHHCCCCCCCCEEEEEEECCCCCCCE
T ss_conf 9859978994064809999999999949999998031095--89999999999999768989885888995056455414
Q ss_pred EEEEECCCCCCHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCCEEECCCCCCCC
Q ss_conf 99983079999878843039999999998899999999998873024577252388889758579998267023343225
Q 002721 680 LLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLL 759 (888)
Q Consensus 680 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~ 759 (888)
+++++|+.+|+|.+++... .+++..+..++.|++.||+|||+.+|+||||||+|||++.++.+||+|||+++..
T Consensus 86 ~~l~~~~~~g~L~~~l~~~------~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~ 159 (345)
T d1pmea_ 86 VYLVTHLMGADLYKLLKTQ------HLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVA 159 (345)
T ss_dssp EEEEEECCCEEHHHHHHHC------CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC
T ss_pred EEEEEEECCCCHHHHHHCC------CCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCEEEECCCCCEEECCCCCEEEC
T ss_conf 9999962598656644058------9999999999999999999999789867778764378879997787545705650
Q ss_pred CCCCCCC-CCCCCCCCCCEECCCCCC-CCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCC-HHHHCCCCCCCC----
Q ss_conf 9999952-001334544321633335-578586443054789999988199998777788631-312112367899----
Q 002721 760 DPSKGTA-SISAVAGSFGYIPPEYAY-TMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVD-LVKWVHGAPARG---- 832 (888)
Q Consensus 760 ~~~~~~~-~~~~~~gt~~y~aPE~~~-~~~~~~~~DVwSlG~il~elltg~~p~~~~~~~~~~-l~~~~~~~~~~~---- 832 (888)
....... ......|+..|+|||++. +..++.++||||+||++|||++|+.||......... ........+...
T Consensus 160 ~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~ 239 (345)
T d1pmea_ 160 DPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNC 239 (345)
T ss_dssp CGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHT
T ss_pred CCCCCCCEEECCCCCCCEECHHHHHHCCCCCCCHHHHHCCCCEEHHHHHCCCCCCCCCHHHHHHHHHHHCCCCCHHHHHH
T ss_conf 47776410101102652000387860478887410100467013377669799788888999998765206997566423
Q ss_pred CCCCCC---CCCCCCCCCCCCH----HHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 994101---3333366785829----999999999940237899999999899999
Q 002721 833 ETPEQI---LDARLSTVSFGWR----KEMLTALKVALLCTDSTPAKRPKMKKVVEM 881 (888)
Q Consensus 833 ~~~~~i---~d~~~~~~~~~~~----~~~~~~~~l~~~Cl~~~p~~RPs~~eil~~ 881 (888)
...... ...........+. ....++.+++.+|++.||++|||++|+++.
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~ta~e~L~h 295 (345)
T d1pmea_ 240 IINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAH 295 (345)
T ss_dssp CCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHHHHHCCCCCCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 43322220244677557787778378999999999999764895679089998619
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=323.37 Aligned_cols=271 Identities=17% Similarity=0.209 Sum_probs=197.0
Q ss_pred HHCCCCCEEEECCCCEEEEEEE-CCCCEEEEEEEECCCHHHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEEC-------
Q ss_conf 7147866254266442999981-79968999993126714568799999999998503799325443578728-------
Q 002721 605 ATMKDSNMIYCGTFSTVYKAVM-PSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYE------- 676 (888)
Q Consensus 605 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~------- 676 (888)
++|++.+.||+|+||+||+|+. .+|+.||||++...... ......+.+|+++++.++|||++++++++...
T Consensus 10 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~-~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~ 88 (318)
T d3blha1 10 SKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENEK-EGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRC 88 (318)
T ss_dssp GGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----CT-TSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC--------
T ss_pred CCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHHCC-HHHHHHHHHHHHHHHHHCCCCCCCEEEEEECCCCCCCCC
T ss_conf 7988999972274829999999899979999998422246-378999999999999835999660676540246544445
Q ss_pred -CEEEEEEECCCCCCHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCCEEECCCC
Q ss_conf -9529998307999987884303999999999889999999999887302457725238888975857999826702334
Q 002721 677 -DVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEI 755 (888)
Q Consensus 677 -~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~dlk~~NIll~~~~~~kl~Dfg~ 755 (888)
...++||||++++.+........ .++...+..++.|++.||.|||+.+|+||||||+|||++.++.+|++|||+
T Consensus 89 ~~~~~iv~e~~~~~~~~~~~~~~~-----~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~ 163 (318)
T d3blha1 89 KGSIYLVFDFCEHDLAGLLSNVLV-----KFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGL 163 (318)
T ss_dssp --CEEEEEECCCEEHHHHHTCTTC-----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTT
T ss_pred CCEEEEEEECCCCCCCCHHHHCCC-----CCCCHHHHHHHHHHHHHHHHHCCCCEEECCCCCHHEEECCCCCEEEEECCE
T ss_conf 763899985357874101222034-----433089999999999999885229988567672220366899687631350
Q ss_pred CCCCCCCCCC--CCCCCCCCCCCEECCCCCCCC-CCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCC-CHHHHCCCCCCC
Q ss_conf 3225999995--200133454432163333557-858644305478999998819999877778863-131211236789
Q 002721 756 SKLLDPSKGT--ASISAVAGSFGYIPPEYAYTM-QVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGV-DLVKWVHGAPAR 831 (888)
Q Consensus 756 ~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~-~~~~~~DVwSlG~il~elltg~~p~~~~~~~~~-~l~~~~~~~~~~ 831 (888)
++........ .......||..|+|||.+.+. .++.++||||+||++|||++|+.||........ .......+....
T Consensus 164 ~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~ 243 (318)
T d3blha1 164 ARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITP 243 (318)
T ss_dssp CEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCT
T ss_pred EEECCCCCCCCCCCCCCEECCHHHHHHHHHCCCCCCCCHHHCCCCCCEEEEHHHCCCCCCCCCHHHHHHHHHHHCCCCCH
T ss_conf 02235544432113566024978742899707999891787006786466174487998998999999999984189982
Q ss_pred CC---CCCCCCCCC---CCCCCCCCHH------HHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf 99---941013333---3667858299------99999999940237899999999899999
Q 002721 832 GE---TPEQILDAR---LSTVSFGWRK------EMLTALKVALLCTDSTPAKRPKMKKVVEM 881 (888)
Q Consensus 832 ~~---~~~~i~d~~---~~~~~~~~~~------~~~~~~~l~~~Cl~~~p~~RPs~~eil~~ 881 (888)
.. ......... .........+ ..+.+.+++.+|++.||++|||++|+++.
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~H 305 (318)
T d3blha1 244 EVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNH 305 (318)
T ss_dssp TTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHS
T ss_pred HHCCCCCHHHHHHHHCCCCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 55344320344433201334455503340444599899999999873896589099999749
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=318.96 Aligned_cols=268 Identities=18% Similarity=0.226 Sum_probs=202.3
Q ss_pred HHCCCCCEEEECCCCEEEEEEE-CCCCEEEEEEEECCCHHHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEECCEEEEEE
Q ss_conf 7147866254266442999981-799689999931267145687999999999985037993254435787289529998
Q 002721 605 ATMKDSNMIYCGTFSTVYKAVM-PSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYEDVALLLH 683 (888)
Q Consensus 605 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~~~~~lv~ 683 (888)
++|+..+.||+|+||+||+|+. .++..||||+++... ........+.+|+.+++.++||||+++++++......++|+
T Consensus 2 ~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~ 80 (292)
T d1unla_ 2 QKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDD-DDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVF 80 (292)
T ss_dssp CSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSC-SSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEE
T ss_pred CCCEEEEEEECCCCEEEEEEEECCCCCEEEEEEEEHHH-CCHHHHHHHHHHHHHHHHCCCCCEEEECCCCCCCCCEEEEE
T ss_conf 99786269712868199999999999699999980321-78689999999999998567578882135444443115886
Q ss_pred ECCCCCCHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCCEEECCCCCCCCCCCC
Q ss_conf 30799998788430399999999988999999999988730245772523888897585799982670233432259999
Q 002721 684 NYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKLLDPSK 763 (888)
Q Consensus 684 e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~~~~~ 763 (888)
+++.++++..++.... .+++..+..++.|++.||+|||+.+|+||||||+|||++.++.+|++|||.++......
T Consensus 81 ~~~~~~~l~~~~~~~~-----~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~ 155 (292)
T d1unla_ 81 EFCDQDLKKYFDSCNG-----DLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV 155 (292)
T ss_dssp ECCSEEHHHHHHHTTT-----CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCC
T ss_pred EECCCCCCCCCCCCCC-----CCCHHHHHHHHHHHHHHHHHHHCCCEEEECCCCCCCCCCCCCCEEEEECCHHHCCCCCC
T ss_conf 3023322211212356-----54036789999999999877433998600146761211337826652046011046887
Q ss_pred CCCCCCCCCCCCCEECCCCCCCCC-CCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCHHHH--CCCCCCCCCCCC--CC
Q ss_conf 952001334544321633335578-5864430547899999881999987777886313121--123678999941--01
Q 002721 764 GTASISAVAGSFGYIPPEYAYTMQ-VTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKW--VHGAPARGETPE--QI 838 (888)
Q Consensus 764 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DVwSlG~il~elltg~~p~~~~~~~~~~l~~~--~~~~~~~~~~~~--~i 838 (888)
.. .....++..|+|||.+.+.. ++.++||||+||++|||++|+.||.........+... ....+....... ..
T Consensus 156 ~~--~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 233 (292)
T d1unla_ 156 RC--YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKL 233 (292)
T ss_dssp SC--CCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGS
T ss_pred CC--CEEECCCCCHHHHHHHCCCCCCCCHHHCCCCCHHHHHHHHCCCCCCCCCCHHHHHHHHHHHCCCCCHHHHHHHHHC
T ss_conf 51--0010344310146675069888804440265418899851899998899999999999861189973551344322
Q ss_pred CC-------CCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf 33-------3336678582999999999994023789999999989999
Q 002721 839 LD-------ARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVE 880 (888)
Q Consensus 839 ~d-------~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~eil~ 880 (888)
.+ ................+.+++.+|++.||.+|||++|+++
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~e~L~ 282 (292)
T d1unla_ 234 PDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQ 282 (292)
T ss_dssp TTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHTT
T ss_pred CCCCCCCCCCCCCHHHHCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf 2113344454431043306568999999999986499668909999964
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=325.28 Aligned_cols=255 Identities=19% Similarity=0.181 Sum_probs=199.7
Q ss_pred HHCCCCCEEEECCCCEEEEEEE----CCCCEEEEEEEECCCHH-HHHHHHHHHHHHHHHHCCCC-CCEEEEEEEEEECCE
Q ss_conf 7147866254266442999981----79968999993126714-56879999999999850379-932544357872895
Q 002721 605 ATMKDSNMIYCGTFSTVYKAVM----PSGLILSVKRLKSMDRT-IIHHQNKMIRELEKLSKLCH-DNLVRPIGFVIYEDV 678 (888)
Q Consensus 605 ~~~~~~~~lg~G~~g~Vy~~~~----~~~~~vavK~~~~~~~~-~~~~~~~~~~e~~~l~~l~h-~niv~l~g~~~~~~~ 678 (888)
++|++.+.||+|+||+||+|+. .+|+.||+|.+++.... .....+.+.+|++++++++| |||+++++++.....
T Consensus 24 ~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~ 103 (322)
T d1vzoa_ 24 ENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETK 103 (322)
T ss_dssp GGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTE
T ss_pred HCEEEEEEEECCCCEEEEEEEECCCCCCCCEEEEEEEEHHHHCCCHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCC
T ss_conf 02599989832878399999987658879489999983677210168999999999999864679839996200024873
Q ss_pred EEEEEECCCCCCHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCCEEECCCCCCC
Q ss_conf 29998307999987884303999999999889999999999887302457725238888975857999826702334322
Q 002721 679 ALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKL 758 (888)
Q Consensus 679 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~ 758 (888)
.++++||+++|+|.+++.... .+.......++.|++.|++|+|+.+|+||||||+||+++.++.+||+|||+++.
T Consensus 104 ~~~v~e~~~~~~L~~~i~~~~-----~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~ 178 (322)
T d1vzoa_ 104 LHLILDYINGGELFTHLSQRE-----RFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKE 178 (322)
T ss_dssp EEEEECCCCSCBHHHHHHHHS-----CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEE
T ss_pred EEEEEECCCCCHHHHHHHHCC-----CCCHHHHHHHHHHHHHHHHHHHCCCEEECCCCCCCEEECCCCCEEEEECCCHHH
T ss_conf 001231234117999987304-----543788888899999999885149989654773201246999888741320222
Q ss_pred CCCCCCCCCCCCCCCCCCEECCCCCCCC--CCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHCCCCCCCCCCCC
Q ss_conf 5999995200133454432163333557--85864430547899999881999987777886313121123678999941
Q 002721 759 LDPSKGTASISAVAGSFGYIPPEYAYTM--QVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGETPE 836 (888)
Q Consensus 759 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~DVwSlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~~~ 836 (888)
+...... ......|++.|+|||.+.+. .++.++||||+||++|||+||+.||........ ..
T Consensus 179 ~~~~~~~-~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~~---------------~~ 242 (322)
T d1vzoa_ 179 FVADETE-RAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNS---------------QA 242 (322)
T ss_dssp CCGGGGG-GGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCCC---------------HH
T ss_pred HCCCCCC-CCCCCCCCCCCCHHHHHHCCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCCCHHHH---------------HH
T ss_conf 0344443-2212223333310687605776887132517777999999768999888877779---------------99
Q ss_pred CCCCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCC-----HHHHHH
Q ss_conf 01333336678582999999999994023789999999-----989999
Q 002721 837 QILDARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPK-----MKKVVE 880 (888)
Q Consensus 837 ~i~d~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs-----~~eil~ 880 (888)
.+.................++.+++.+||+++|++||| ++|+++
T Consensus 243 ~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~ 291 (322)
T d1vzoa_ 243 EISRRILKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKE 291 (322)
T ss_dssp HHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHT
T ss_pred HHHHHCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCCCCCCHHHHHC
T ss_conf 9998335689988654799999999997445898819997450999974
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=0 Score=318.32 Aligned_cols=260 Identities=18% Similarity=0.207 Sum_probs=195.8
Q ss_pred HHHCCCCCEEEECCCCEEEEEEE-CCCCEEEEEEEECCCHHHHHHHHHHHHHHHHHHCCC-CCCEEEEEEEEEEC--CEE
Q ss_conf 87147866254266442999981-799689999931267145687999999999985037-99325443578728--952
Q 002721 604 KATMKDSNMIYCGTFSTVYKAVM-PSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLC-HDNLVRPIGFVIYE--DVA 679 (888)
Q Consensus 604 ~~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~g~~~~~--~~~ 679 (888)
.++|++.+.||+|+||+||+|+. .+++.||+|+++.... +.+.+|+++++.+. ||||+++++++... ...
T Consensus 34 ~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~------~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~ 107 (328)
T d3bqca1 34 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPVKK------KKIKREIKILENLRGGPNIITLADIVKDPVSRTP 107 (328)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSSCH------HHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSE
T ss_pred CCCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHH------HHHHHHHHHHHHCCCCCCCCEEEEEEEECCCCCE
T ss_conf 8671897898317481999999889997999999888999------9999999999851579987679999981687712
Q ss_pred EEEEECCCCCCHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCC-CCEEECCCCCCC
Q ss_conf 9998307999987884303999999999889999999999887302457725238888975857999-826702334322
Q 002721 680 LLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADF-KPLLGEIEISKL 758 (888)
Q Consensus 680 ~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~dlk~~NIll~~~~-~~kl~Dfg~~~~ 758 (888)
++||||+++++|.+..+ .+++..+..++.||+.||+|||+.+|+||||||+|||++.++ .+|++|||++..
T Consensus 108 ~~v~e~~~~~~L~~~~~--------~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~ 179 (328)
T d3bqca1 108 ALVFEHVNNTDFKQLYQ--------TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEF 179 (328)
T ss_dssp EEEEECCCSCBGGGTTT--------SCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEE
T ss_pred EEEEEECCCCCHHHHHC--------CCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCEEECCCCCEEEECCCCCCEE
T ss_conf 68886317985899746--------8999999999999999998876433443456441237748998366415654266
Q ss_pred CCCCCCCCCCCCCCCCCCEECCCCCCCCC-CCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCHHH------------HC
Q ss_conf 59999952001334544321633335578-586443054789999988199998777788631312------------11
Q 002721 759 LDPSKGTASISAVAGSFGYIPPEYAYTMQ-VTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVK------------WV 825 (888)
Q Consensus 759 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DVwSlG~il~elltg~~p~~~~~~~~~~l~~------------~~ 825 (888)
...... .....+|..|+|||.+.+.. ++.++||||+||++|||++|+.||............ +.
T Consensus 180 ~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~ 256 (328)
T d3bqca1 180 YHPGQE---YNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYI 256 (328)
T ss_dssp CCTTCC---CCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHH
T ss_pred CCCCCC---CCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHCCCHHHHHH
T ss_conf 468874---44322486424761026888888452323354555876048899988760189999999987884155555
Q ss_pred CCCCCC-CCCCCCCCC----CCCC--CCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf 236789-999410133----3336--678582999999999994023789999999989999
Q 002721 826 HGAPAR-GETPEQILD----ARLS--TVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVE 880 (888)
Q Consensus 826 ~~~~~~-~~~~~~i~d----~~~~--~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~eil~ 880 (888)
...... ......... .... ..........+++.+++.+|++.||++|||++|+++
T Consensus 257 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~e~L~ 318 (328)
T d3bqca1 257 DKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAME 318 (328)
T ss_dssp HHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HHCCCCCCCCCCHHCCCCCCCCHHHCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf 42254447430000033343311211552112448999999999986699568908999964
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=316.79 Aligned_cols=265 Identities=16% Similarity=0.181 Sum_probs=200.5
Q ss_pred HHCCCCCEEEECCCCEEEEEEEC-CCCEEEEEEEECCCHHHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEEC------C
Q ss_conf 71478662542664429999817-9968999993126714568799999999998503799325443578728------9
Q 002721 605 ATMKDSNMIYCGTFSTVYKAVMP-SGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYE------D 677 (888)
Q Consensus 605 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~------~ 677 (888)
++|++.++||+|+||+||+|... +|..||||+++.... .......+.+|+.+++.++||||+++++++... .
T Consensus 17 ~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~ 95 (355)
T d2b1pa1 17 KRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQ 95 (355)
T ss_dssp TTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTTS-SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCC
T ss_pred CCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECHHHC-CHHHHHHHHHHHHHHHHCCCCCEEEEEEEEECCCCCCCCC
T ss_conf 775998896217585999999999998999999882336-9799999999999998648987648998970256434576
Q ss_pred EEEEEEECCCCCCHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCCEEECCCCCC
Q ss_conf 52999830799998788430399999999988999999999988730245772523888897585799982670233432
Q 002721 678 VALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISK 757 (888)
Q Consensus 678 ~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~ 757 (888)
..|+||||+.++ +.+.+.. .+++..+..++.||+.||.|||+.||+||||||+|||++.++.++++|||.++
T Consensus 96 ~~~iv~Ey~~~~-l~~~~~~-------~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~Nil~~~~~~~kl~df~~~~ 167 (355)
T d2b1pa1 96 DVYLVMELMDAN-LCQVIQM-------ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR 167 (355)
T ss_dssp EEEEEEECCSEE-HHHHHTS-------CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECCCCC--
T ss_pred EEEEEEECCCHH-HHHHHHC-------CCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCEEEECHHHHH
T ss_conf 269998414467-7876503-------89999999999999999988652211245677632113654431320102321
Q ss_pred CCCCCCCCCCCCCCCCCCCEECCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCC--CH--------------
Q ss_conf 25999995200133454432163333557858644305478999998819999877778863--13--------------
Q 002721 758 LLDPSKGTASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGV--DL-------------- 821 (888)
Q Consensus 758 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlG~il~elltg~~p~~~~~~~~~--~l-------------- 821 (888)
...... ......+|..|+|||++.+..+++++||||+||++|||++|+.||........ ..
T Consensus 168 ~~~~~~---~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~ 244 (355)
T d2b1pa1 168 TAGTSF---MMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKK 244 (355)
T ss_dssp ----------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTT
T ss_pred CCCCCC---CCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCHHHHHHHCCCCCCCCCHHHHHHHHHHHCCCCCHHHHHH
T ss_conf 146665---53322146555581331477778774333566257898659899888977889999997205898799987
Q ss_pred -----HHHCCCCCCCC-CCCCCCC-CCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHH
Q ss_conf -----12112367899-9941013-333366785829999999999940237899999999899999
Q 002721 822 -----VKWVHGAPARG-ETPEQIL-DARLSTVSFGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEM 881 (888)
Q Consensus 822 -----~~~~~~~~~~~-~~~~~i~-d~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~eil~~ 881 (888)
........... ....... +................+.+++.+|++.||++|||++|+++.
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~ta~elL~H 311 (355)
T d2b1pa1 245 LQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQH 311 (355)
T ss_dssp SCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSCCHHHHHTS
T ss_pred HHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHCC
T ss_conf 6566777764175435666421264333543210133379999999999876994579089999669
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=0 Score=316.75 Aligned_cols=260 Identities=13% Similarity=0.135 Sum_probs=196.3
Q ss_pred HHCCCCCEEEECCCCEEEEEEE-CCCCEEEEEEEECCCHHHHHHHHHHHHHHHHHHCCCCCCEEEE-EEEEEECCEEEEE
Q ss_conf 7147866254266442999981-7996899999312671456879999999999850379932544-3578728952999
Q 002721 605 ATMKDSNMIYCGTFSTVYKAVM-PSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRP-IGFVIYEDVALLL 682 (888)
Q Consensus 605 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l-~g~~~~~~~~~lv 682 (888)
++|++.+.||+|+||+||+|+. .+++.||||.+...... ..+.+|+++++.++|++++.. .++....+..++|
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-----~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~iv 81 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV 81 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS-----CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEE
T ss_pred CEEEEEEEEEECCCCEEEEEEECCCCCEEEEEEECHHCCC-----HHHHHHHHHHHHCCCCCCCCEEEEEEECCCEEEEE
T ss_conf 8899968985078809999999889989999997210058-----88999999999703899601799999519877899
Q ss_pred EECCCCCCHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEEC---CCCCCEEECCCCCCCC
Q ss_conf 8307999987884303999999999889999999999887302457725238888975857---9998267023343225
Q 002721 683 HNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLD---ADFKPLLGEIEISKLL 759 (888)
Q Consensus 683 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~dlk~~NIll~---~~~~~kl~Dfg~~~~~ 759 (888)
|||+. +++.+.+..... .+++..+..++.|++.||+|||+.+|+||||||+|||++ .+..+|++|||+++..
T Consensus 82 me~~~-~~l~~~~~~~~~----~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~ 156 (299)
T d1ckia_ 82 MELLG-PSLEDLFNFCSR----KFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 156 (299)
T ss_dssp EECCC-CBHHHHHHHTTT----CCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEEC
T ss_pred EEECC-CCHHHHHHHCCC----CCCHHHHHHHHHHHHHHHHHHHHCCEEECCCCHHHCCCCCCCCCCEEEEECCCCCEEC
T ss_conf 98738-713332443068----8768999999999999999999799442667876606433577761565046751342
Q ss_pred CCCCCC-----CCCCCCCCCCCEECCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHCCCCCCCCCC
Q ss_conf 999995-----200133454432163333557858644305478999998819999877778863131211236789999
Q 002721 760 DPSKGT-----ASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARGET 834 (888)
Q Consensus 760 ~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~~~~~~ 834 (888)
...... .......||+.|+|||...+..++.++|||||||++|||+||+.||...........
T Consensus 157 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~~~~~~------------ 224 (299)
T d1ckia_ 157 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQK------------ 224 (299)
T ss_dssp BCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC-------------------
T ss_pred CCCCCCCCEECCCCCCCCCCCCCCCHHHHHCCCCCCHHHEEECCHHHHHHHHCCCCCCCCCHHHHHHH------------
T ss_conf 55445541000135776787353299999189989832188617789999849876655305779999------------
Q ss_pred CCCCCCCCCCCCC-CCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHH
Q ss_conf 4101333336678-582999999999994023789999999989999999864
Q 002721 835 PEQILDARLSTVS-FGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEMLQEIK 886 (888)
Q Consensus 835 ~~~i~d~~~~~~~-~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~eil~~L~~~~ 886 (888)
............. ......+.++.+++..||+.+|++||+++++.+.|+.+.
T Consensus 225 ~~~~~~~~~~~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~ 277 (299)
T d1ckia_ 225 YERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLF 277 (299)
T ss_dssp HHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHH
T ss_pred HHHHHCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHHHHHHHH
T ss_conf 99852356789835753478899999999984399557919999999999999
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=0 Score=313.48 Aligned_cols=260 Identities=13% Similarity=0.086 Sum_probs=202.2
Q ss_pred HHCCCCCEEEECCCCEEEEEEEC-CCCEEEEEEEECCCHHHHHHHHHHHHHHHHHHCCCC-CCEEEEEEEEEECCEEEEE
Q ss_conf 71478662542664429999817-996899999312671456879999999999850379-9325443578728952999
Q 002721 605 ATMKDSNMIYCGTFSTVYKAVMP-SGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCH-DNLVRPIGFVIYEDVALLL 682 (888)
Q Consensus 605 ~~~~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h-~niv~l~g~~~~~~~~~lv 682 (888)
++|++.+.||+|+||+||+|+.. +++.||+|.+...... ..+.+|++.++.+.| ++++.+++++..+...++|
T Consensus 5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-----~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~v 79 (293)
T d1csna_ 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA-----PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLV 79 (293)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS-----CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEE
T ss_pred CCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCCCCC-----HHHHHHHHHHHHHCCCCCCCEEEEEEECCCCCEEE
T ss_conf 8069979984178829999999889979999997502582-----99999999999964899987799996018811799
Q ss_pred EECCCCCCHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECC-----CCCCEEECCCCCC
Q ss_conf 83079999878843039999999998899999999998873024577252388889758579-----9982670233432
Q 002721 683 HNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDA-----DFKPLLGEIEISK 757 (888)
Q Consensus 683 ~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~dlk~~NIll~~-----~~~~kl~Dfg~~~ 757 (888)
|||+ +++|.+++..... .+++.++..++.|++.||+|||+.+|+||||||+||+++. ++.+|++|||+++
T Consensus 80 me~~-~~~l~~~~~~~~~----~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~ 154 (293)
T d1csna_ 80 IDLL-GPSLEDLLDLCGR----KFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 154 (293)
T ss_dssp EECC-CCBHHHHHHHTTT----CCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCE
T ss_pred EEEC-CCCHHHHHHHHCC----CHHHHHHHHHHHHHHHHHHHHHHCCCEECCCCCCCEEECCCCCCCCCCEEECCCCEEE
T ss_conf 9964-8887999975203----1106899999999999999999779662667713152347543447956872366057
Q ss_pred CCCCCCCC-----CCCCCCCCCCCEECCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHCCCCCCCC
Q ss_conf 25999995-----2001334544321633335578586443054789999988199998777788631312112367899
Q 002721 758 LLDPSKGT-----ASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARG 832 (888)
Q Consensus 758 ~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~~~~ 832 (888)
........ .......||+.|+|||.+.+..++.++||||+|+++|||+||+.||...........
T Consensus 155 ~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~---------- 224 (293)
T d1csna_ 155 FYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAATNKQK---------- 224 (293)
T ss_dssp ESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCSCCHHHH----------
T ss_pred ECCCCCCCCCEEECCCCCEEECHHHCCHHHHCCCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHHHH----------
T ss_conf 7146766541110246762775102679896488888699989831999999869876788530219999----------
Q ss_pred CCCCCCCCCCCCCCC-CCCHHHHHHHHHHHHHCCCCCCCCCCCHHHHHHHHHHHH
Q ss_conf 994101333336678-582999999999994023789999999989999999864
Q 002721 833 ETPEQILDARLSTVS-FGWRKEMLTALKVALLCTDSTPAKRPKMKKVVEMLQEIK 886 (888)
Q Consensus 833 ~~~~~i~d~~~~~~~-~~~~~~~~~~~~l~~~Cl~~~p~~RPs~~eil~~L~~~~ 886 (888)
...+......... ......++++.+++..|++.+|++||+++.+.+.|+++.
T Consensus 225 --~~~i~~~~~~~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~ 277 (293)
T d1csna_ 225 --YERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVL 277 (293)
T ss_dssp --HHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHH
T ss_pred --HHHHHHCCCCCCHHHHCCCCCHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHHH
T ss_conf --99997056799958965799899999999984399300859999999999999
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=100.00 E-value=0 Score=319.78 Aligned_cols=291 Identities=31% Similarity=0.482 Sum_probs=174.3
Q ss_pred CCCCCCHHHHHHHHHHCC----CCCCCCCCCCCC--CCEEEEECCCCC--EEEEEECCCCCCCCCCCCCCCCCCCCEEEC
Q ss_conf 269999999999752125----899999999999--820037509999--199999399986334334458999989948
Q 002721 22 FAQLNDEPTLLAINKELI----VPGWGVNGTNFC--NWKGIDCDLNQA--FVVKLDLSRLQLRGNITLVSELKALKRLDL 93 (888)
Q Consensus 22 ~~~~~~~~~l~~~~~~~~----~~~w~~~~~~~c--~w~gv~c~~~~~--~v~~l~l~~~~l~~~~~~~~~l~~L~~L~L 93 (888)
.|.++|++||++||+++. +++|. .++||| .|+||+|+...+ ||+.+|++++++.|.
T Consensus 2 ~c~~~e~~aLl~~k~~~~~~~~l~sW~-~~~d~C~~~w~gv~C~~~~~~~~v~~L~L~~~~l~g~--------------- 65 (313)
T d1ogqa_ 2 LCNPQDKQALLQIKKDLGNPTTLSSWL-PTTDCCNRTWLGVLCDTDTQTYRVNNLDLSGLNLPKP--------------- 65 (313)
T ss_dssp CSCHHHHHHHHHHHHHTTCCGGGTTCC-TTSCTTTTCSTTEEECCSSSCCCEEEEEEECCCCSSC---------------
T ss_pred CCCHHHHHHHHHHHHHCCCCCCCCCCC-CCCCCCCCCCCCEEEECCCCCEEEEEEECCCCCCCCC---------------
T ss_conf 989899999999999779998677889-9999988948896974899947988998989988888---------------
Q ss_pred CCCCCCCCCCCCCCCCCCCCEEECCC-CCCCCCCCCCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCCEEEECCCCCCC
Q ss_conf 99957435998988999998987767-98999888878899751499928984556668433466532389942787789
Q 002721 94 SNNAFSGTIPSAFGNLSELEFLDLSL-NKFGGVIPRELGSLKDLRFFNISNNVLVGEIPDELKSLEKLEDFQVSSNKLNG 172 (888)
Q Consensus 94 ~~n~l~~~~p~~~~~l~~L~~L~Ls~-N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~ 172 (888)
..+|.++++|++|++|+|++ |+++|.+|..|+.+++|++|+|++|++.+..+..+..+.+|+.++++.|.+.+
T Consensus 66 ------~~lp~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~l~~N~~~~ 139 (313)
T d1ogqa_ 66 ------YPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLDFSYNALSG 139 (313)
T ss_dssp ------EECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEECCSSEEES
T ss_pred ------CCCCHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCC
T ss_conf ------87984784675335202026543330024311454200110203564344332222201110011112245555
Q ss_pred CCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCC-CCEEECCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCHHHHC
Q ss_conf 988432334445178524556458778777872346-5201015558897888855788864698227567899101201
Q 002721 173 SIPFWVGNLTNLRVFTAYENQLVGEIPDNLGSVSEL-ELLNLHSNQLEGPIPKSIFASGKLEVLVLTQNRLTGDIPELVG 251 (888)
Q Consensus 173 ~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L-~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~ 251 (888)
.+|..+.++++++.+++++|.+++.+|+.+..+..+ +.++++.|++++..|..+..+.. ..++++.+...+..|..+.
T Consensus 140 ~~p~~l~~l~~L~~l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~-~~l~l~~~~~~~~~~~~~~ 218 (313)
T d1ogqa_ 140 TLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNL-AFVDLSRNMLEGDASVLFG 218 (313)
T ss_dssp CCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCC-SEEECCSSEEEECCGGGCC
T ss_pred CCCHHHCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCCCCCCCCCCCCCC
T ss_conf 685122067400000023553356203121443112323102246435332433222222-2333333433222222222
Q ss_pred CCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEEEECCCCCCCCCCCCCCCCCCCEEEEECCCCCCCCCCCCCCCCCCCEE
Q ss_conf 68766604413884654358765457875199821368999889234688978689952376633489443577774177
Q 002721 252 HCKSLSNIRIGNNDLVGVIPRAIGNVSGLTYFEADNNNLSGEIVPEFSQCSNLTLLNLASNGFTGVIPPELGQLINLQEL 331 (888)
Q Consensus 252 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L 331 (888)
.+++++.+++++|.+.+.+| .+..+++|++|++++|++++.+|..|..+++|+.|+|++|+|+|.+|. ++.+.+|+.+
T Consensus 219 ~~~~l~~l~~~~~~l~~~~~-~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~-~~~L~~L~~l 296 (313)
T d1ogqa_ 219 SDKNTQKIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQ-GGNLQRFDVS 296 (313)
T ss_dssp TTSCCSEEECCSSEECCBGG-GCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCC-STTGGGSCGG
T ss_pred CCCCCCCCCCCCCCCCCCCC-CCCCCCCCCCCCCCCCEECCCCCHHHHCCCCCCEEECCCCCCCCCCCC-CCCCCCCCHH
T ss_conf 22221112222222222222-222455444444765706660876884799999897958835166898-6667998978
Q ss_pred EECCCC
Q ss_conf 701441
Q 002721 332 ILYENS 337 (888)
Q Consensus 332 ~L~~N~ 337 (888)
++++|+
T Consensus 297 ~l~~N~ 302 (313)
T d1ogqa_ 297 AYANNK 302 (313)
T ss_dssp GTCSSS
T ss_pred HHCCCC
T ss_conf 868895
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=0 Score=313.63 Aligned_cols=263 Identities=17% Similarity=0.205 Sum_probs=195.2
Q ss_pred HHCCCCCEEEECCCCEEEEEEE-CCCCEEEEEEEECCCHHHHHHHHHHHHHHHHHHCCCCCCEEEEEEEEEEC-----CE
Q ss_conf 7147866254266442999981-79968999993126714568799999999998503799325443578728-----95
Q 002721 605 ATMKDSNMIYCGTFSTVYKAVM-PSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDNLVRPIGFVIYE-----DV 678 (888)
Q Consensus 605 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~niv~l~g~~~~~-----~~ 678 (888)
++|+..+.||+|+||+||+|+. .+|+.||+|++++... .....+.+.+|+++++.++|||+|++++++... ..
T Consensus 18 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~ 96 (348)
T d2gfsa1 18 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFN 96 (348)
T ss_dssp TTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTTS-SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCC
T ss_pred CCEEEEEEEECCCCEEEEEEEECCCCCEEEEEEECCHHC-CHHHHHHHHHHHHHHHHCCCCCEEEEEEEEEECCCCCCCC
T ss_conf 871888898317883999999999997999999882002-8689999999999998668987425999996346456686
Q ss_pred EEEEEECCCCCCHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCCEEECCCCCCC
Q ss_conf 29998307999987884303999999999889999999999887302457725238888975857999826702334322
Q 002721 679 ALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGEIEISKL 758 (888)
Q Consensus 679 ~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~ 758 (888)
.+++++|+.+|+|.+++... .+++..+..++.||+.||+|||+.+|+||||||+|||++.++.+|++|||.+..
T Consensus 97 ~~~i~~~~~gg~L~~~~~~~------~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~ 170 (348)
T d2gfsa1 97 DVYLVTHLMGADLNNIVKCQ------KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARH 170 (348)
T ss_dssp CCEEEEECCSEEHHHHHTTC------CCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCC----C
T ss_pred EEEEEEEECCCCHHHHCCCC------CCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCHHCC
T ss_conf 49999962588623200224------530999999999999999999738876516677633455432200132100012
Q ss_pred CCCCCCCCCCCCCCCCCCEECCCCCCCCC-CCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCCCHHHHCCCCCCCC-----
Q ss_conf 59999952001334544321633335578-586443054789999988199998777788631312112367899-----
Q 002721 759 LDPSKGTASISAVAGSFGYIPPEYAYTMQ-VTAPGNVYSYGVVLLEILTTRLPVEEDFGEGVDLVKWVHGAPARG----- 832 (888)
Q Consensus 759 ~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DVwSlG~il~elltg~~p~~~~~~~~~~l~~~~~~~~~~~----- 832 (888)
... ......|+..|+|||...+.. ++.++||||+||++|||++|+.||........ ............
T Consensus 171 ~~~-----~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~-~~~i~~~~~~~~~~~~~ 244 (348)
T d2gfsa1 171 TDD-----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ-LKLILRLVGTPGAELLK 244 (348)
T ss_dssp CTG-----GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHH-HHHHHHHHCCCCHHHHT
T ss_pred CCC-----CCCCCCCCCCCCCCHHHCCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCHHHH-HHHHHHHCCCCCHHHHH
T ss_conf 575-----444434543555835533775678551243205899999768899788988999-99999730799757732
Q ss_pred -CCCC---CCCCCCCCCCCCCC----HHHHHHHHHHHHHCCCCCCCCCCCHHHHHH
Q ss_conf -9941---01333336678582----999999999994023789999999989999
Q 002721 833 -ETPE---QILDARLSTVSFGW----RKEMLTALKVALLCTDSTPAKRPKMKKVVE 880 (888)
Q Consensus 833 -~~~~---~i~d~~~~~~~~~~----~~~~~~~~~l~~~Cl~~~p~~RPs~~eil~ 880 (888)
.... .............. .....++.+++.+|++.||++|||++|+++
T Consensus 245 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~ta~elL~ 300 (348)
T d2gfsa1 245 KISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRITAAQALA 300 (348)
T ss_dssp TCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHT
T ss_pred HCCCHHHHHHHHHCCCCCCCCHHHHCCCCCHHHHHHHHHHCCCCHHHCCCHHHHHC
T ss_conf 00102445444303557875556626789999999999977588345938999855
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=0 Score=282.11 Aligned_cols=265 Identities=16% Similarity=0.155 Sum_probs=188.4
Q ss_pred HHCCCCCEEEECCCCEEEEEEE-CCCCEEEEEEEECCCHHHHHHHHHHHHHHHHHHCCC-----------CCCEEEEEEE
Q ss_conf 7147866254266442999981-799689999931267145687999999999985037-----------9932544357
Q 002721 605 ATMKDSNMIYCGTFSTVYKAVM-PSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLC-----------HDNLVRPIGF 672 (888)
Q Consensus 605 ~~~~~~~~lg~G~~g~Vy~~~~-~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-----------h~niv~l~g~ 672 (888)
.+|++.++||+|+||+||+|+. .+|+.||||+++.... ....+.+|+.+++.+. |+||++++++
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~----~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~ 88 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV----YTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDH 88 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHH----HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEE
T ss_pred CCEEEEEEEEECCCEEEEEEEECCCCCEEEEEEEECCCC----CHHHHHHHHHHHHHHCCHHHHHHHHCCCCCEEEEEEE
T ss_conf 857998997507781899999999997999999834313----3689999999999840145555542276764789987
Q ss_pred EEEC--CEEEEEEECCCCCCH-HHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHCCC-CCEEECCCCCCCEEECCCCC-
Q ss_conf 8728--952999830799998-788430399999999988999999999988730245-77252388889758579998-
Q 002721 673 VIYE--DVALLLHNYLPNGTL-AQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHH-VAIIHLDISSGNVLLDADFK- 747 (888)
Q Consensus 673 ~~~~--~~~~lv~e~~~~gsL-~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~-~~ivH~dlk~~NIll~~~~~- 747 (888)
+... ...+++++++..+.. ......... ..+++..+..++.||+.||+|||+ .+|+||||||+|||++.++.
T Consensus 89 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~ 165 (362)
T d1q8ya_ 89 FNHKGPNGVHVVMVFEVLGENLLALIKKYEH---RGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSP 165 (362)
T ss_dssp EEEEETTEEEEEEEECCCCEEHHHHHHHTTT---SCCCHHHHHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETT
T ss_pred EEECCCCCEEEEEEECCCCCCCCCCCCCCCC---CCCCHHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHEEEECCCCC
T ss_conf 6312565202343200035420000012234---6786899999999999998887640586465677057056305765
Q ss_pred -----CEEECCCCCCCCCCCCCCCCCCCCCCCCCEECCCCCCCCCCCCCCCCHHHHHHHHHHHHCCCCCCCCCCCCC---
Q ss_conf -----267023343225999995200133454432163333557858644305478999998819999877778863---
Q 002721 748 -----PLLGEIEISKLLDPSKGTASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVLLEILTTRLPVEEDFGEGV--- 819 (888)
Q Consensus 748 -----~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlG~il~elltg~~p~~~~~~~~~--- 819 (888)
++++|||.+....... ....|++.|+|||+..+..++.++||||+||+++||++|+.||........
T Consensus 166 ~~~~~~kl~dfg~s~~~~~~~-----~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~ 240 (362)
T d1q8ya_ 166 ENLIQIKIADLGNACWYDEHY-----TNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYTKD 240 (362)
T ss_dssp TTEEEEEECCCTTCEETTBCC-----CSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC---------CH
T ss_pred CCCCEEEEEECCCCCCCCCCC-----CCCCCCCCCCCHHHCCCCCCCCCCCCCCHHHHHHHHHHCCCCCCCCCCCCCCCH
T ss_conf 644305675314421234454-----223665210571321466777643201237899999878899898755432102
Q ss_pred --CHHHHCC--CCC---------------CCCCCCCCCC-------CCCCCCCCCCCHHHHHHHHHHHHHCCCCCCCCCC
Q ss_conf --1312112--367---------------8999941013-------3333667858299999999999402378999999
Q 002721 820 --DLVKWVH--GAP---------------ARGETPEQIL-------DARLSTVSFGWRKEMLTALKVALLCTDSTPAKRP 873 (888)
Q Consensus 820 --~l~~~~~--~~~---------------~~~~~~~~i~-------d~~~~~~~~~~~~~~~~~~~l~~~Cl~~~p~~RP 873 (888)
.+..... +.. ........+. ................++.+++.+|+..||.+||
T Consensus 241 ~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rp 320 (362)
T d1q8ya_ 241 DDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRA 320 (362)
T ss_dssp HHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCB
T ss_pred HHHHHHHHHHHCCCCHHHHHCCCCCCCCCCCCHHHHCCCCCCCCCHHHHCCCCCCCCCCCCHHHHHHHHHHCCCCHHHCC
T ss_conf 68999999983799878862453220001320122024323577644421000156743589999999998779945790
Q ss_pred CHHHHHHH
Q ss_conf 99899999
Q 002721 874 KMKKVVEM 881 (888)
Q Consensus 874 s~~eil~~ 881 (888)
|++|+++.
T Consensus 321 ta~e~L~H 328 (362)
T d1q8ya_ 321 DAGGLVNH 328 (362)
T ss_dssp CHHHHHTC
T ss_pred CHHHHHCC
T ss_conf 89999669
|
| >d1ogqa_ c.10.2.8 (A:) Polygalacturonase inhibiting protein PGIP {Kidney bean (Phaseolus vulgaris) [TaxId: 3885]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Polygalacturonase inhibiting protein PGIP domain: Polygalacturonase inhibiting protein PGIP species: Kidney bean (Phaseolus vulgaris) [TaxId: 3885]
Probab=100.00 E-value=6.7e-44 Score=253.75 Aligned_cols=258 Identities=30% Similarity=0.475 Sum_probs=170.2
Q ss_pred CCEEECCCCCCCC--CCCCCCCCCCCCCEEEEEC-CCCCCCCCCCCCCCCCCCEEEEECCCCCCCCCCCCCCCCCCCEEE
Q ss_conf 6604413884654--3587654578751998213-689998892346889786899523766334894435777741777
Q 002721 256 LSNIRIGNNDLVG--VIPRAIGNVSGLTYFEADN-NNLSGEIVPEFSQCSNLTLLNLASNGFTGVIPPELGQLINLQELI 332 (888)
Q Consensus 256 L~~L~L~~N~l~~--~~p~~~~~l~~L~~L~L~~-N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~ 332 (888)
++.|+|++|.+.+ .+|..++++++|++|++++ |.+.|.+|..|.++++|++|+|++|++.+..+..+..+..|+.++
T Consensus 52 v~~L~L~~~~l~g~~~lp~~l~~L~~L~~L~Ls~~N~l~g~iP~~i~~L~~L~~L~Ls~N~l~~~~~~~~~~~~~L~~l~ 131 (313)
T d1ogqa_ 52 VNNLDLSGLNLPKPYPIPSSLANLPYLNFLYIGGINNLVGPIPPAIAKLTQLHYLYITHTNVSGAIPDFLSQIKTLVTLD 131 (313)
T ss_dssp EEEEEEECCCCSSCEECCGGGGGCTTCSEEEEEEETTEESCCCGGGGGCTTCSEEEEEEECCEEECCGGGGGCTTCCEEE
T ss_pred EEEEECCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCHHHHCCCC
T ss_conf 88998989988888879847846753352020265433300243114542001102035643443322222011100111
Q ss_pred ECCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCCCHHCCCCCC-CEECCCCCCCCCCCCCCCCCCCCCEEEEEECCCCC
Q ss_conf 01441237676110025741099825885888887000044675-36205677564236888424456408983054154
Q 002721 333 LYENSLFGEIPKSILACKNLNKLDLSNNRFNGTIPNAICDMSRL-QYLLLGQNSLKGEIPHEIGNCMKLLQLHIGSNYLT 411 (888)
Q Consensus 333 L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~L-~~L~L~~N~l~~~~p~~~~~l~~L~~L~l~~N~l~ 411 (888)
+++|.+.+.+|..+..++.++.+++++|.+.+.+|..+..+..+ +.+++++|++++..|..+..+..+ .++++.+...
T Consensus 132 l~~N~~~~~~p~~l~~l~~L~~l~l~~n~l~~~ip~~~~~l~~l~~~l~~~~n~l~~~~~~~~~~l~~~-~l~l~~~~~~ 210 (313)
T d1ogqa_ 132 FSYNALSGTLPPSISSLPNLVGITFDGNRISGAIPDSYGSFSKLFTSMTISRNRLTGKIPPTFANLNLA-FVDLSRNMLE 210 (313)
T ss_dssp CCSSEEESCCCGGGGGCTTCCEEECCSSCCEEECCGGGGCCCTTCCEEECCSSEEEEECCGGGGGCCCS-EEECCSSEEE
T ss_pred CCCCCCCCCCCHHHCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC-CCCCCCCCCC
T ss_conf 122455556851220674000000235533562031214431123231022464353324332222222-3333334332
Q ss_pred CCCCCCCCCCCCHHHHHHCCCCCCCCCCCCCCCCCCCCCEEEEECCCCCCCCCHHHCCCCCCEEEECCCCCCCCCCCCCC
Q ss_conf 56998633322102343146731343698232499996499920784556886000036645099863884845589999
Q 002721 412 GSIPPEIGHIRNLQIALNLSFNHLHGSLPPELGKLDKLVSFDVSNNQLSGTIPSALKGMLSLIEVNFSNNLLTGPVPSFV 491 (888)
Q Consensus 412 ~~~p~~~~~l~~L~~~L~ls~N~l~~~~p~~~~~l~~L~~LdLs~N~l~~~~p~~~~~l~~L~~l~ls~N~l~~~~p~~~ 491 (888)
+.+|..+..+..++ .+++++|.+.+.+| .++.+++|+.|||++|+++|.+|..+..+++|++|++++|+++|.+|++.
T Consensus 211 ~~~~~~~~~~~~l~-~l~~~~~~l~~~~~-~~~~~~~L~~L~Ls~N~l~g~iP~~l~~L~~L~~L~Ls~N~l~g~iP~~~ 288 (313)
T d1ogqa_ 211 GDASVLFGSDKNTQ-KIHLAKNSLAFDLG-KVGLSKNLNGLDLRNNRIYGTLPQGLTQLKFLHSLNVSFNNLCGEIPQGG 288 (313)
T ss_dssp ECCGGGCCTTSCCS-EEECCSSEECCBGG-GCCCCTTCCEEECCSSCCEECCCGGGGGCTTCCEEECCSSEEEEECCCST
T ss_pred CCCCCCCCCCCCCC-CCCCCCCCCCCCCC-CCCCCCCCCCCCCCCCEECCCCCHHHHCCCCCCEEECCCCCCCCCCCCCC
T ss_conf 22222222222211-12222222222222-22245544444476570666087688479999989795883516689866
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCC
Q ss_conf 89889997556798887878878889
Q 002721 492 PFQKSPNSSFFGNKGLCGEPLSFSCG 517 (888)
Q Consensus 492 ~~~~~~~~~~~~n~~lc~~~~~~~~~ 517 (888)
.+.......+.+|+.+||.|++ .|+
T Consensus 289 ~L~~L~~l~l~~N~~l~g~plp-~c~ 313 (313)
T d1ogqa_ 289 NLQRFDVSAYANNKCLCGSPLP-ACT 313 (313)
T ss_dssp TGGGSCGGGTCSSSEEESTTSS-CCC
T ss_pred CCCCCCHHHHCCCCCCCCCCCC-CCC
T ss_conf 6799897886889500198988-989
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=100.00 E-value=1.8e-40 Score=235.08 Aligned_cols=344 Identities=21% Similarity=0.299 Sum_probs=177.6
Q ss_pred CCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCCE
Q ss_conf 58999989948999574359989889999989877679899988887889975149992898455666843346653238
Q 002721 83 SELKALKRLDLSNNAFSGTIPSAFGNLSELEFLDLSLNKFGGVIPRELGSLKDLRFFNISNNVLVGEIPDELKSLEKLED 162 (888)
Q Consensus 83 ~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~ 162 (888)
.++.+|+.|++++++++. + ..+..+++|++|+|++|+|++..+ ++.+++|++|++++|.+.+.. .+..+++|+.
T Consensus 41 ~~l~~l~~L~l~~~~I~~-l-~gl~~L~nL~~L~Ls~N~l~~l~~--l~~L~~L~~L~L~~n~i~~i~--~l~~l~~L~~ 114 (384)
T d2omza2 41 TDLDQVTTLQADRLGIKS-I-DGVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIADIT--PLANLTNLTG 114 (384)
T ss_dssp HHHTTCCEEECCSSCCCC-C-TTGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCCCCG--GGTTCTTCCE
T ss_pred HHHCCCCEEECCCCCCCC-C-CCCCCCCCCCEEECCCCCCCCCCC--CCCCCCCCCCCCCCCCCCCCC--CCCCCCCCCC
T ss_conf 895787899899989877-6-242458999989681881798863--347711010301343332222--1112334333
Q ss_pred EEECCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCEEEECCCCC
Q ss_conf 99427877899884323344451785245564587787778723465201015558897888855788864698227567
Q 002721 163 FQVSSNKLNGSIPFWVGNLTNLRVFTAYENQLVGEIPDNLGSVSELELLNLHSNQLEGPIPKSIFASGKLEVLVLTQNRL 242 (888)
Q Consensus 163 L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l 242 (888)
|++++|.+++..+ ......+..+....|.+....+.................. ...+.............|..
T Consensus 115 L~~~~~~~~~~~~--~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~ 187 (384)
T d2omza2 115 LTLFNNQITDIDP--LKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTD-----LKPLANLTTLERLDISSNKV 187 (384)
T ss_dssp EECCSSCCCCCGG--GTTCTTCSEEEEEEEEECCCGGGTTCTTCSEEEEEESCCC-----CGGGTTCTTCCEEECCSSCC
T ss_pred CCCCCCCCCCCCC--CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCH-----HHHHCCCCCCCCCCCCCCCC
T ss_conf 4433222222222--2222222112134663131002322221122222123220-----11112454211011222433
Q ss_pred CCCCHHHHCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEEEECCCCCCCCCCCCCCCCCCCEEEEECCCCCCCCCCCC
Q ss_conf 89910120168766604413884654358765457875199821368999889234688978689952376633489443
Q 002721 243 TGDIPELVGHCKSLSNIRIGNNDLVGVIPRAIGNVSGLTYFEADNNNLSGEIVPEFSQCSNLTLLNLASNGFTGVIPPEL 322 (888)
Q Consensus 243 ~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~ 322 (888)
. ....+..++++..+++++|.+++..| +... ++|+.|++++|.++.. +.+
T Consensus 188 ~--~~~~~~~l~~~~~l~l~~n~i~~~~~--~~~~------------------------~~L~~L~l~~n~l~~~--~~l 237 (384)
T d2omza2 188 S--DISVLAKLTNLESLIATNNQISDITP--LGIL------------------------TNLDELSLNGNQLKDI--GTL 237 (384)
T ss_dssp C--CCGGGGGCTTCSEEECCSSCCCCCGG--GGGC------------------------TTCCEEECCSSCCCCC--GGG
T ss_pred C--CCCCCCCCCCCCEEECCCCCCCCCCC--CCCC------------------------CCCCEEECCCCCCCCC--CHH
T ss_conf 3--21100223532333035774478786--4445------------------------7787888877777896--134
Q ss_pred CCCCCCCEEEECCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCCCHHCCCCCCCEECCCCCCCCCCCCCCCCCCCCCEE
Q ss_conf 57777417770144123767611002574109982588588888700004467536205677564236888424456408
Q 002721 323 GQLINLQELILYENSLFGEIPKSILACKNLNKLDLSNNRFNGTIPNAICDMSRLQYLLLGQNSLKGEIPHEIGNCMKLLQ 402 (888)
Q Consensus 323 ~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~L~~ 402 (888)
..+++|+.+++++|.+.+..+ +..+++|+.+++++|++.+.. .+..++.++.+++..|.+.+ ...+..+++++.
T Consensus 238 ~~l~~L~~L~l~~n~l~~~~~--~~~~~~L~~L~l~~~~l~~~~--~~~~~~~l~~l~~~~n~l~~--~~~~~~~~~l~~ 311 (384)
T d2omza2 238 ASLTNLTDLDLANNQISNLAP--LSGLTKLTELKLGANQISNIS--PLAGLTALTNLELNENQLED--ISPISNLKNLTY 311 (384)
T ss_dssp GGCTTCSEEECCSSCCCCCGG--GTTCTTCSEEECCSSCCCCCG--GGTTCTTCSEEECCSSCCSC--CGGGGGCTTCSE
T ss_pred HCCCCCCHHCCCCCCCCCCCC--CCCCCCCCEEECCCCCCCCCC--CCCCCCCCCCCCCCCCCCCC--CCCCCHHCCCCE
T ss_conf 325653410044674478775--355466877545674457877--32356522223323233333--221000024676
Q ss_pred EEEECCCCCCCCCCCCCCCCCHHHHHHCCCCCCCCCCCCCCCCCCCCCEEEEECCCCCCCCCHHHCCCCCCEEEECCCCC
Q ss_conf 98305415456998633322102343146731343698232499996499920784556886000036645099863884
Q 002721 403 LHIGSNYLTGSIPPEIGHIRNLQIALNLSFNHLHGSLPPELGKLDKLVSFDVSNNQLSGTIPSALKGMLSLIEVNFSNNL 482 (888)
Q Consensus 403 L~l~~N~l~~~~p~~~~~l~~L~~~L~ls~N~l~~~~p~~~~~l~~L~~LdLs~N~l~~~~p~~~~~l~~L~~l~ls~N~ 482 (888)
+++++|.+++.. .+..+++|+ .|++++|++++ ++ .++.+++|+.|++++|++++..| +.++++|+.|++++|.
T Consensus 312 L~ls~n~l~~l~--~l~~l~~L~-~L~L~~n~l~~-l~-~l~~l~~L~~L~l~~N~l~~l~~--l~~l~~L~~L~L~~Na 384 (384)
T d2omza2 312 LTLYFNNISDIS--PVSSLTKLQ-RLFFANNKVSD-VS-SLANLTNINWLSAGHNQISDLTP--LANLTRITQLGLNDQA 384 (384)
T ss_dssp EECCSSCCSCCG--GGGGCTTCC-EEECCSSCCCC-CG-GGGGCTTCCEEECCSSCCCBCGG--GTTCTTCSEEECCCEE
T ss_pred EECCCCCCCCCC--CCCCCCCCC-EEECCCCCCCC-CH-HHCCCCCCCEEECCCCCCCCCHH--HCCCCCCCEEECCCCC
T ss_conf 777788778984--536689889-89898998999-74-67089999989897995899800--0039999996397895
|
| >d2omza2 c.10.2.1 (A:33-416) Internalin A {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin A species: Listeria monocytogenes [TaxId: 1639]
Probab=100.00 E-value=1.5e-40 Score=235.48 Aligned_cols=340 Identities=25% Similarity=0.360 Sum_probs=227.0
Q ss_pred EEEEEECCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCEEEECCC
Q ss_conf 19999939998633433445899998994899957435998988999998987767989998888788997514999289
Q 002721 64 FVVKLDLSRLQLRGNITLVSELKALKRLDLSNNAFSGTIPSAFGNLSELEFLDLSLNKFGGVIPRELGSLKDLRFFNISN 143 (888)
Q Consensus 64 ~v~~l~l~~~~l~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~ 143 (888)
.++.++++++++.. ++-+..+++|++|+|++|++++. | .|+++++|++|++++|++.+..+ ++.+++|+.|++++
T Consensus 45 ~l~~L~l~~~~I~~-l~gl~~L~nL~~L~Ls~N~l~~l-~-~l~~L~~L~~L~L~~n~i~~i~~--l~~l~~L~~L~~~~ 119 (384)
T d2omza2 45 QVTTLQADRLGIKS-IDGVEYLNNLTQINFSNNQLTDI-T-PLKNLTKLVDILMNNNQIADITP--LANLTNLTGLTLFN 119 (384)
T ss_dssp TCCEEECCSSCCCC-CTTGGGCTTCCEEECCSSCCCCC-G-GGTTCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCS
T ss_pred CCCEEECCCCCCCC-CCCCCCCCCCCEEECCCCCCCCC-C-CCCCCCCCCCCCCCCCCCCCCCC--CCCCCCCCCCCCCC
T ss_conf 87899899989877-62424589999896818817988-6-33477110103013433322221--11233433344332
Q ss_pred CCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCC
Q ss_conf 84556668433466532389942787789988432334445178524556458778777872346520101555889788
Q 002721 144 NVLVGEIPDELKSLEKLEDFQVSSNKLNGSIPFWVGNLTNLRVFTAYENQLVGEIPDNLGSVSELELLNLHSNQLEGPIP 223 (888)
Q Consensus 144 N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p 223 (888)
|.+++..+ ......+..+....|.+....+.................. ...+.............|... ..
T Consensus 120 ~~~~~~~~--~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~--~~ 190 (384)
T d2omza2 120 NQITDIDP--LKNLTNLNRLELSSNTISDISALSGLTSLQQLSFGNQVTD-----LKPLANLTTLERLDISSNKVS--DI 190 (384)
T ss_dssp SCCCCCGG--GTTCTTCSEEEEEEEEECCCGGGTTCTTCSEEEEEESCCC-----CGGGTTCTTCCEEECCSSCCC--CC
T ss_pred CCCCCCCC--CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCH-----HHHHCCCCCCCCCCCCCCCCC--CC
T ss_conf 22222222--2222222112134663131002322221122222123220-----111124542110112224333--21
Q ss_pred CCCCCCCCCCEEEECCCCCCCCCHHHHCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEEEECCCCCCCCCCCCCCCCC
Q ss_conf 88557888646982275678991012016876660441388465435876545787519982136899988923468897
Q 002721 224 KSIFASGKLEVLVLTQNRLTGDIPELVGHCKSLSNIRIGNNDLVGVIPRAIGNVSGLTYFEADNNNLSGEIVPEFSQCSN 303 (888)
Q Consensus 224 ~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~ 303 (888)
.....+++++.+++++|.+++..+ +..+++|+.|++++|.++.. ..+..+++|+.+++++|.+++.. .+..+++
T Consensus 191 ~~~~~l~~~~~l~l~~n~i~~~~~--~~~~~~L~~L~l~~n~l~~~--~~l~~l~~L~~L~l~~n~l~~~~--~~~~~~~ 264 (384)
T d2omza2 191 SVLAKLTNLESLIATNNQISDITP--LGILTNLDELSLNGNQLKDI--GTLASLTNLTDLDLANNQISNLA--PLSGLTK 264 (384)
T ss_dssp GGGGGCTTCSEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCC--GGGGGCTTCSEEECCSSCCCCCG--GGTTCTT
T ss_pred CCCCCCCCCCEEECCCCCCCCCCC--CCCCCCCCEEECCCCCCCCC--CHHHCCCCCCHHCCCCCCCCCCC--CCCCCCC
T ss_conf 100223532333035774478786--44457787888877777896--13432565341004467447877--5355466
Q ss_pred CCEEEEECCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCCCHHCCCCCCCEECCCC
Q ss_conf 86899523766334894435777741777014412376761100257410998258858888870000446753620567
Q 002721 304 LTLLNLASNGFTGVIPPELGQLINLQELILYENSLFGEIPKSILACKNLNKLDLSNNRFNGTIPNAICDMSRLQYLLLGQ 383 (888)
Q Consensus 304 L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~~~~L~~L~L~~ 383 (888)
|+.|++++|.+++.. .+..++.++.+.++.|.+.+ ++ .+..+++++.+++++|++++.. .+..+++|+.|++++
T Consensus 265 L~~L~l~~~~l~~~~--~~~~~~~l~~l~~~~n~l~~-~~-~~~~~~~l~~L~ls~n~l~~l~--~l~~l~~L~~L~L~~ 338 (384)
T d2omza2 265 LTELKLGANQISNIS--PLAGLTALTNLELNENQLED-IS-PISNLKNLTYLTLYFNNISDIS--PVSSLTKLQRLFFAN 338 (384)
T ss_dssp CSEEECCSSCCCCCG--GGTTCTTCSEEECCSSCCSC-CG-GGGGCTTCSEEECCSSCCSCCG--GGGGCTTCCEEECCS
T ss_pred CCEEECCCCCCCCCC--CCCCCCCCCCCCCCCCCCCC-CC-CCCHHCCCCEEECCCCCCCCCC--CCCCCCCCCEEECCC
T ss_conf 877545674457877--32356522223323233333-22-1000024676777788778984--536689889898989
Q ss_pred CCCCCCCCCCCCCCCCCEEEEEECCCCCCCCCCCCCCCCCHHHHHHCCCCCCCCCCCCCCCCCCCCCEEEEECCC
Q ss_conf 756423688842445640898305415456998633322102343146731343698232499996499920784
Q 002721 384 NSLKGEIPHEIGNCMKLLQLHIGSNYLTGSIPPEIGHIRNLQIALNLSFNHLHGSLPPELGKLDKLVSFDVSNNQ 458 (888)
Q Consensus 384 N~l~~~~p~~~~~l~~L~~L~l~~N~l~~~~p~~~~~l~~L~~~L~ls~N~l~~~~p~~~~~l~~L~~LdLs~N~ 458 (888)
|++++ ++ .+..+++|+.|++++|+++ +.+| +.++++|+.|++++|.
T Consensus 339 n~l~~-l~-~l~~l~~L~~L~l~~N~l~-------------------------~l~~--l~~l~~L~~L~L~~Na 384 (384)
T d2omza2 339 NKVSD-VS-SLANLTNINWLSAGHNQIS-------------------------DLTP--LANLTRITQLGLNDQA 384 (384)
T ss_dssp SCCCC-CG-GGGGCTTCCEEECCSSCCC-------------------------BCGG--GTTCTTCSEEECCCEE
T ss_pred CCCCC-CH-HHCCCCCCCEEECCCCCCC-------------------------CCHH--HCCCCCCCEEECCCCC
T ss_conf 98999-74-6708999998989799589-------------------------9800--0039999996397895
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=4.9e-37 Score=216.23 Aligned_cols=245 Identities=21% Similarity=0.292 Sum_probs=127.9
Q ss_pred CCCEEEEECCCCCEEEEEECCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCC
Q ss_conf 98200375099991999993999863343344589999899489995743599898899999898776798999888878
Q 002721 51 CNWKGIDCDLNQAFVVKLDLSRLQLRGNITLVSELKALKRLDLSNNAFSGTIPSAFGNLSELEFLDLSLNKFGGVIPREL 130 (888)
Q Consensus 51 c~w~gv~c~~~~~~v~~l~l~~~~l~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~ 130 (888)
|.|++|+|.. .+++..+..+ .+.+++|+|++|+|+...+.+|.++++|++|++++|.+....|..|
T Consensus 10 c~~~~~~C~~------------~~L~~lP~~l--~~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f 75 (305)
T d1xkua_ 10 CHLRVVQCSD------------LGLEKVPKDL--PPDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAF 75 (305)
T ss_dssp EETTEEECTT------------SCCCSCCCSC--CTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTT
T ss_pred ECCCEEEECC------------CCCCCCCCCC--CCCCCEEECCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCHHHH
T ss_conf 5599998559------------9988519888--9997989784991898696576046565231123443445235665
Q ss_pred CCCCCCEEEECCCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCEEECCCCCCC--CCCCCCCCCCCCC
Q ss_conf 89975149992898455666843346653238994278778998843233444517852455645--8778777872346
Q 002721 131 GSLKDLRFFNISNNVLVGEIPDELKSLEKLEDFQVSSNKLNGSIPFWVGNLTNLRVFTAYENQLV--GEIPDNLGSVSEL 208 (888)
Q Consensus 131 ~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~--~~~p~~~~~l~~L 208 (888)
..+++|+.|++++|+++ .+|..+ ...+..|+++.|.+.+..+..+.....+..+....|... ...+..+..+++|
T Consensus 76 ~~l~~L~~L~l~~n~l~-~l~~~~--~~~l~~L~~~~n~l~~l~~~~~~~~~~~~~l~~~~n~~~~~~~~~~~~~~l~~L 152 (305)
T d1xkua_ 76 APLVKLERLYLSKNQLK-ELPEKM--PKTLQELRVHENEITKVRKSVFNGLNQMIVVELGTNPLKSSGIENGAFQGMKKL 152 (305)
T ss_dssp TTCTTCCEEECCSSCCS-BCCSSC--CTTCCEEECCSSCCCBBCHHHHTTCTTCCEEECCSSCCCGGGBCTTGGGGCTTC
T ss_pred HCCCCCCEECCCCCCCC-CCCCCH--HHHHHHHHCCCCCHHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
T ss_conf 27985578315687567-676400--111323210246102344445401331100001233333467776422345656
Q ss_pred CCEEECCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCHHHHCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEEEECC
Q ss_conf 52010155588978888557888646982275678991012016876660441388465435876545787519982136
Q 002721 209 ELLNLHSNQLEGPIPKSIFASGKLEVLVLTQNRLTGDIPELVGHCKSLSNIRIGNNDLVGVIPRAIGNVSGLTYFEADNN 288 (888)
Q Consensus 209 ~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N 288 (888)
+.+++++|.++. +|..+ .++|+.|++++|..+...+..|.+++.++.|++++|.+.+..+..+.++++|++|+|++|
T Consensus 153 ~~l~l~~n~l~~-l~~~~--~~~L~~L~l~~n~~~~~~~~~~~~~~~l~~L~~s~n~l~~~~~~~~~~l~~L~~L~L~~N 229 (305)
T d1xkua_ 153 SYIRIADTNITT-IPQGL--PPSLTELHLDGNKITKVDAASLKGLNNLAKLGLSFNSISAVDNGSLANTPHLRELHLNNN 229 (305)
T ss_dssp CEEECCSSCCCS-CCSSC--CTTCSEEECTTSCCCEECTGGGTTCTTCCEEECCSSCCCEECTTTGGGSTTCCEEECCSS
T ss_pred CCCCCCCCCCCC-CCCCC--CCCCCEEECCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEEECCCC
T ss_conf 712034677451-67101--776678989788677888267641341330154455332223454334433224302554
Q ss_pred CCCCCCCCCCCCCCCCCEEEEECCCCCC
Q ss_conf 8999889234688978689952376633
Q 002721 289 NLSGEIVPEFSQCSNLTLLNLASNGFTG 316 (888)
Q Consensus 289 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~ 316 (888)
.++.+ |..|..+++|+.|+|++|+|+.
T Consensus 230 ~L~~l-p~~l~~l~~L~~L~Ls~N~i~~ 256 (305)
T d1xkua_ 230 KLVKV-PGGLADHKYIQVVYLHNNNISA 256 (305)
T ss_dssp CCSSC-CTTTTTCSSCCEEECCSSCCCC
T ss_pred CCCCC-CCCCCCCCCCCEEECCCCCCCC
T ss_conf 00246-3110334678989898986576
|
| >d1xkua_ c.10.2.7 (A:) Decorin {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Decorin species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=9.2e-36 Score=209.27 Aligned_cols=103 Identities=24% Similarity=0.363 Sum_probs=58.5
Q ss_pred CCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCCEEEECC
Q ss_conf 98994899957435998988999998987767989998888788997514999289845566684334665323899427
Q 002721 88 LKRLDLSNNAFSGTIPSAFGNLSELEFLDLSLNKFGGVIPRELGSLKDLRFFNISNNVLVGEIPDELKSLEKLEDFQVSS 167 (888)
Q Consensus 88 L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~ 167 (888)
.+.+|-++++++ .+|..+. +++++|+|++|+|+.+.+..|..+++|++|++++|.+....|..|.++++|+.|++++
T Consensus 12 ~~~~~C~~~~L~-~lP~~l~--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~l~~n~~~~i~~~~f~~l~~L~~L~l~~ 88 (305)
T d1xkua_ 12 LRVVQCSDLGLE-KVPKDLP--PDTALLDLQNNKITEIKDGDFKNLKNLHTLILINNKISKISPGAFAPLVKLERLYLSK 88 (305)
T ss_dssp TTEEECTTSCCC-SCCCSCC--TTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred CCEEEECCCCCC-CCCCCCC--CCCCEEECCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCHHHHHCCCCCCEECCCC
T ss_conf 999985599988-5198889--9979897849918986965760465652311234434452356652798557831568
Q ss_pred CCCCCCCCCCCCCCCCCCEEECCCCCCCC
Q ss_conf 87789988432334445178524556458
Q 002721 168 NKLNGSIPFWVGNLTNLRVFTAYENQLVG 196 (888)
Q Consensus 168 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 196 (888)
|+++. +|..+ ...+..|.+.+|.+.+
T Consensus 89 n~l~~-l~~~~--~~~l~~L~~~~n~l~~ 114 (305)
T d1xkua_ 89 NQLKE-LPEKM--PKTLQELRVHENEITK 114 (305)
T ss_dssp SCCSB-CCSSC--CTTCCEEECCSSCCCB
T ss_pred CCCCC-CCCCH--HHHHHHHHCCCCCHHH
T ss_conf 75676-76400--1113232102461023
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-36 Score=212.69 Aligned_cols=220 Identities=20% Similarity=0.224 Sum_probs=118.3
Q ss_pred CCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCCEEEEC-CCCCC
Q ss_conf 89995743599898899999898776798999888878899751499928984556668433466532389942-78778
Q 002721 93 LSNNAFSGTIPSAFGNLSELEFLDLSLNKFGGVIPRELGSLKDLRFFNISNNVLVGEIPDELKSLEKLEDFQVS-SNKLN 171 (888)
Q Consensus 93 L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls-~N~l~ 171 (888)
.++++++ .+|..+. +.+++|+|++|+|+.+.+..|.++++|++|++++|.+....+..+..+..++.+... .|.++
T Consensus 18 c~~~~L~-~iP~~ip--~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~~~~~ 94 (284)
T d1ozna_ 18 CPQQGLQ-AVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLR 94 (284)
T ss_dssp CCSSCCS-SCCTTCC--TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCC
T ss_pred CCCCCCC-CCCCCCC--CCCCEEECCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
T ss_conf 4799989-4497889--998889774881798797786414213000013445433211121222222222222102235
Q ss_pred CCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCHHHHC
Q ss_conf 99884323344451785245564587787778723465201015558897888855788864698227567899101201
Q 002721 172 GSIPFWVGNLTNLRVFTAYENQLVGEIPDNLGSVSELELLNLHSNQLEGPIPKSIFASGKLEVLVLTQNRLTGDIPELVG 251 (888)
Q Consensus 172 ~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~ 251 (888)
...+.+|.++++|++|++++|.+....+..+....+|+.+++++|++++..+..+...++|+.|++++|+++...+..|.
T Consensus 95 ~l~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~ 174 (284)
T d1ozna_ 95 SVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFR 174 (284)
T ss_dssp CCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTT
T ss_pred CCCCHHHCCCCCCCEEECCCCCCCCCCCCCCCHHCCCCHHHHCCCCCCCCCHHHHCCCCCHHHCCCCCCCCCCCCHHHHC
T ss_conf 44620101010277875688544320135332000121102001431445805740434050223141765662566654
Q ss_pred CCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEEEECCCCCCCCCCCCCCCCCCCEEEEECCCCC
Q ss_conf 6876660441388465435876545787519982136899988923468897868995237663
Q 002721 252 HCKSLSNIRIGNNDLVGVIPRAIGNVSGLTYFEADNNNLSGEIVPEFSQCSNLTLLNLASNGFT 315 (888)
Q Consensus 252 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~ 315 (888)
++++|+.+++++|++++..|..|..+++|++|++++|.+.+..+..|..+++|+.|++++|.+.
T Consensus 175 ~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~ 238 (284)
T d1ozna_ 175 GLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWV 238 (284)
T ss_dssp TCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEE
T ss_pred CCCCCCHHHHHHCCCCCCCHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCEEEECCCCCC
T ss_conf 6563413142114346628167665320002333335221000002355465688981199887
|
| >d1ozna_ c.10.2.7 (A:) Reticulon 4 receptor (Nogo-66 receptor, Ngr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Reticulon 4 receptor (Nogo-66 receptor, Ngr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-35 Score=208.17 Aligned_cols=222 Identities=20% Similarity=0.228 Sum_probs=119.2
Q ss_pred ECCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCEEEECC-CCCCC
Q ss_conf 93999863343344589999899489995743599898899999898776798999888878899751499928-98455
Q 002721 69 DLSRLQLRGNITLVSELKALKRLDLSNNAFSGTIPSAFGNLSELEFLDLSLNKFGGVIPRELGSLKDLRFFNIS-NNVLV 147 (888)
Q Consensus 69 ~l~~~~l~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls-~N~l~ 147 (888)
++++.+++..+..+. ..+++|+|++|+|++..+.+|.++++|++|++++|++..+.+..+..+..+..++.. .|.++
T Consensus 17 ~c~~~~L~~iP~~ip--~~~~~L~Ls~N~i~~i~~~~f~~l~~L~~L~ls~n~l~~i~~~~~~~~~~~~~l~~~~~~~~~ 94 (284)
T d1ozna_ 17 SCPQQGLQAVPVGIP--AASQRIFLHGNRISHVPAASFRACRNLTILWLHSNVLARIDAAAFTGLALLEQLDLSDNAQLR 94 (284)
T ss_dssp ECCSSCCSSCCTTCC--TTCSEEECTTSCCCEECTTTTTTCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSCTTCC
T ss_pred ECCCCCCCCCCCCCC--CCCCEEECCCCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
T ss_conf 847999894497889--998889774881798797786414213000013445433211121222222222222102235
Q ss_pred CCCCCCCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCC
Q ss_conf 66684334665323899427877899884323344451785245564587787778723465201015558897888855
Q 002721 148 GEIPDELKSLEKLEDFQVSSNKLNGSIPFWVGNLTNLRVFTAYENQLVGEIPDNLGSVSELELLNLHSNQLEGPIPKSIF 227 (888)
Q Consensus 148 ~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~ 227 (888)
...+..|.++++|+.|++++|.+....+..+...++|+.+++++|++++..+..|..+++|+.|++++|++++..+..+.
T Consensus 95 ~l~~~~~~~l~~L~~L~l~~n~~~~~~~~~~~~~~~L~~l~l~~N~l~~i~~~~f~~~~~L~~L~l~~N~l~~l~~~~f~ 174 (284)
T d1ozna_ 95 SVDPATFHGLGRLHTLHLDRCGLQELGPGLFRGLAALQYLYLQDNALQALPDDTFRDLGNLTHLFLHGNRISSVPERAFR 174 (284)
T ss_dssp CCCTTTTTTCTTCCEEECTTSCCCCCCTTTTTTCTTCCEEECCSSCCCCCCTTTTTTCTTCCEEECCSSCCCEECTTTTT
T ss_pred CCCCHHHCCCCCCCEEECCCCCCCCCCCCCCCHHCCCCHHHHCCCCCCCCCHHHHCCCCCHHHCCCCCCCCCCCCHHHHC
T ss_conf 44620101010277875688544320135332000121102001431445805740434050223141765662566654
Q ss_pred CCCCCCEEEECCCCCCCCCHHHHCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEEEECCCCCC
Q ss_conf 78886469822756789910120168766604413884654358765457875199821368999
Q 002721 228 ASGKLEVLVLTQNRLTGDIPELVGHCKSLSNIRIGNNDLVGVIPRAIGNVSGLTYFEADNNNLSG 292 (888)
Q Consensus 228 ~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 292 (888)
.+++|+.+++++|++++..|..|.++++|++|++++|.+.+..+..|..+.+|++|++++|.+..
T Consensus 175 ~l~~L~~l~l~~N~l~~i~~~~f~~l~~L~~L~l~~N~i~~~~~~~~~~~~~L~~L~l~~N~l~C 239 (284)
T d1ozna_ 175 GLHSLDRLLLHQNRVAHVHPHAFRDLGRLMTLYLFANNLSALPTEALAPLRALQYLRLNDNPWVC 239 (284)
T ss_dssp TCTTCCEEECCSSCCCEECTTTTTTCTTCCEEECCSSCCSCCCHHHHTTCTTCCEEECCSSCEEC
T ss_pred CCCCCCHHHHHHCCCCCCCHHHHHHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCEEEECCCCCCC
T ss_conf 65634131421143466281676653200023333352210000023554656889811998878
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7e-32 Score=188.02 Aligned_cols=102 Identities=20% Similarity=0.254 Sum_probs=47.1
Q ss_pred CCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCCEEEECC
Q ss_conf 98994899957435998988999998987767989998888788997514999289845566684334665323899427
Q 002721 88 LKRLDLSNNAFSGTIPSAFGNLSELEFLDLSLNKFGGVIPRELGSLKDLRFFNISNNVLVGEIPDELKSLEKLEDFQVSS 167 (888)
Q Consensus 88 L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~ 167 (888)
+...+.++++++ .+|..+. +++++|+|++|+|+++.+..|..+++|++|+|++|+|+ .+| .+..+++|+.|++++
T Consensus 12 ~~~v~C~~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~-~l~-~~~~l~~L~~L~Ls~ 86 (266)
T d1p9ag_ 12 HLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT-KLQ-VDGTLPVLGTLDLSH 86 (266)
T ss_dssp CCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCC-EEE-CCSCCTTCCEEECCS
T ss_pred CEEEECCCCCCC-EECCCCC--CCCCEEECCCCCCCCCCHHHHHCCCCCCCCCCCCCCCC-CCC-CCCCCCCCCCCCCCC
T ss_conf 869980699988-6196757--68898988499289859778634565522135665444-431-111122321111122
Q ss_pred CCCCCCCCCCCCCCCCCCEEECCCCCCC
Q ss_conf 8778998843233444517852455645
Q 002721 168 NKLNGSIPFWVGNLTNLRVFTAYENQLV 195 (888)
Q Consensus 168 N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 195 (888)
|+++. .+..+.++++|+.|++++|.+.
T Consensus 87 N~l~~-~~~~~~~l~~L~~L~l~~~~~~ 113 (266)
T d1p9ag_ 87 NQLQS-LPLLGQTLPALTVLDVSFNRLT 113 (266)
T ss_dssp SCCSS-CCCCTTTCTTCCEEECCSSCCC
T ss_pred CCCCC-CCCCCCCCCCCCCCCCCCCCCC
T ss_conf 22211-1112122222222222223110
|
| >d1p9ag_ c.10.2.7 (G:) von Willebrand factor binding domain of glycoprotein Ib alpha {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: von Willebrand factor binding domain of glycoprotein Ib alpha species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-31 Score=185.94 Aligned_cols=60 Identities=17% Similarity=0.269 Sum_probs=26.8
Q ss_pred CCCCCEEECCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCCEEEECCCCCC
Q ss_conf 999989877679899988887889975149992898455666843346653238994278778
Q 002721 109 LSELEFLDLSLNKFGGVIPRELGSLKDLRFFNISNNVLVGEIPDELKSLEKLEDFQVSSNKLN 171 (888)
Q Consensus 109 l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~ 171 (888)
...+.+++.++++++ .+|..+. +++++|+|++|+|++..+..|.++++|+.|+|++|+++
T Consensus 9 ~~~~~~v~C~~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~l~~~~f~~l~~L~~L~L~~N~l~ 68 (266)
T d1p9ag_ 9 VASHLEVNCDKRNLT-ALPPDLP--KDTTILHLSENLLYTFSLATLMPYTRLTQLNLDRAELT 68 (266)
T ss_dssp STTCCEEECTTSCCS-SCCSCCC--TTCCEEECTTSCCSEEEGGGGTTCTTCCEEECTTSCCC
T ss_pred CCCCEEEECCCCCCC-EECCCCC--CCCCEEECCCCCCCCCCHHHHHCCCCCCCCCCCCCCCC
T ss_conf 689869980699988-6196757--68898988499289859778634565522135665444
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.96 E-value=1.1e-26 Score=159.62 Aligned_cols=137 Identities=28% Similarity=0.333 Sum_probs=77.3
Q ss_pred CCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCCEEEEC
Q ss_conf 99899489995743599898899999898776798999888878899751499928984556668433466532389942
Q 002721 87 ALKRLDLSNNAFSGTIPSAFGNLSELEFLDLSLNKFGGVIPRELGSLKDLRFFNISNNVLVGEIPDELKSLEKLEDFQVS 166 (888)
Q Consensus 87 ~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls 166 (888)
+++.|||++|+++ .+|.. .++|++|+|++|+|+ .+|.. +.+|+.|++++|+++ .+++. .+.|+.|+++
T Consensus 39 ~l~~LdLs~~~L~-~lp~~---~~~L~~L~Ls~N~l~-~lp~~---~~~L~~L~l~~n~l~-~l~~l---p~~L~~L~L~ 106 (353)
T d1jl5a_ 39 QAHELELNNLGLS-SLPEL---PPHLESLVASCNSLT-ELPEL---PQSLKSLLVDNNNLK-ALSDL---PPLLEYLGVS 106 (353)
T ss_dssp TCSEEECTTSCCS-CCCSC---CTTCSEEECCSSCCS-SCCCC---CTTCCEEECCSSCCS-CCCSC---CTTCCEEECC
T ss_pred CCCEEEECCCCCC-CCCCC---CCCCCEEECCCCCCC-CCCCC---HHHHHHHHHHHCCCC-HHHHH---CCCCCCCCCC
T ss_conf 9989993799988-78898---789888989999796-33620---332033266551432-03210---2211111334
Q ss_pred CCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCEEEECCCCCC
Q ss_conf 78778998843233444517852455645877877787234652010155588978888557888646982275678
Q 002721 167 SNKLNGSIPFWVGNLTNLRVFTAYENQLVGEIPDNLGSVSELELLNLHSNQLEGPIPKSIFASGKLEVLVLTQNRLT 243 (888)
Q Consensus 167 ~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 243 (888)
+|.++ .+|. +..+++|+.|++++|.+.. .+.. ...+..+.+..+... ....+..++.++.++++.|.+.
T Consensus 107 ~n~l~-~lp~-~~~l~~L~~L~l~~~~~~~-~~~~---~~~l~~l~~~~~~~~--~~~~l~~l~~l~~L~l~~n~~~ 175 (353)
T d1jl5a_ 107 NNQLE-KLPE-LQNSSFLKIIDVDNNSLKK-LPDL---PPSLEFIAAGNNQLE--ELPELQNLPFLTAIYADNNSLK 175 (353)
T ss_dssp SSCCS-SCCC-CTTCTTCCEEECCSSCCSC-CCCC---CTTCCEEECCSSCCS--SCCCCTTCTTCCEEECCSSCCS
T ss_pred CCCCC-CCCC-HHHHCCCEEECCCCCCCCC-CCCC---CCCCCCHHHCCCCCC--CCCCCCCCCCCEECCCCCCCCC
T ss_conf 55432-2210-0110131231135651001-3223---333210000122222--3332000122200111233443
|
| >d1jl5a_ c.10.2.6 (A:) Leucine rich effector protein YopM {Yersinia pestis [TaxId: 632]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Leucine rich effector protein YopM domain: Leucine rich effector protein YopM species: Yersinia pestis [TaxId: 632]
Probab=99.96 E-value=2.7e-26 Score=157.43 Aligned_cols=136 Identities=24% Similarity=0.264 Sum_probs=62.2
Q ss_pred EEEEECCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCEEEECCCC
Q ss_conf 99999399986334334458999989948999574359989889999989877679899988887889975149992898
Q 002721 65 VVKLDLSRLQLRGNITLVSELKALKRLDLSNNAFSGTIPSAFGNLSELEFLDLSLNKFGGVIPRELGSLKDLRFFNISNN 144 (888)
Q Consensus 65 v~~l~l~~~~l~~~~~~~~~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N 144 (888)
+..||+++++++..++ .+.+|++|+|++|+|+ .+|..+ .+|+.|++++|+++. ++.. .+.|++|++++|
T Consensus 40 l~~LdLs~~~L~~lp~---~~~~L~~L~Ls~N~l~-~lp~~~---~~L~~L~l~~n~l~~-l~~l---p~~L~~L~L~~n 108 (353)
T d1jl5a_ 40 AHELELNNLGLSSLPE---LPPHLESLVASCNSLT-ELPELP---QSLKSLLVDNNNLKA-LSDL---PPLLEYLGVSNN 108 (353)
T ss_dssp CSEEECTTSCCSCCCS---CCTTCSEEECCSSCCS-SCCCCC---TTCCEEECCSSCCSC-CCSC---CTTCCEEECCSS
T ss_pred CCEEEECCCCCCCCCC---CCCCCCEEECCCCCCC-CCCCCH---HHHHHHHHHHCCCCH-HHHH---CCCCCCCCCCCC
T ss_conf 9899937999887889---8789888989999796-336203---320332665514320-3210---221111133455
Q ss_pred CCCCCCCCCCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCEEECCCCCC
Q ss_conf 455666843346653238994278778998843233444517852455645877877787234652010155588
Q 002721 145 VLVGEIPDELKSLEKLEDFQVSSNKLNGSIPFWVGNLTNLRVFTAYENQLVGEIPDNLGSVSELELLNLHSNQLE 219 (888)
Q Consensus 145 ~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~ 219 (888)
.+. .+|. +..+++|+.|++++|.+... +.. ...+..+.+..+... ....+..++.++.++++.|.+.
T Consensus 109 ~l~-~lp~-~~~l~~L~~L~l~~~~~~~~-~~~---~~~l~~l~~~~~~~~--~~~~l~~l~~l~~L~l~~n~~~ 175 (353)
T d1jl5a_ 109 QLE-KLPE-LQNSSFLKIIDVDNNSLKKL-PDL---PPSLEFIAAGNNQLE--ELPELQNLPFLTAIYADNNSLK 175 (353)
T ss_dssp CCS-SCCC-CTTCTTCCEEECCSSCCSCC-CCC---CTTCCEEECCSSCCS--SCCCCTTCTTCCEEECCSSCCS
T ss_pred CCC-CCCC-HHHHCCCEEECCCCCCCCCC-CCC---CCCCCCHHHCCCCCC--CCCCCCCCCCCEECCCCCCCCC
T ss_conf 432-2210-01101312311356510013-223---333210000122222--3332000122200111233443
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.95 E-value=3.2e-28 Score=167.99 Aligned_cols=172 Identities=15% Similarity=0.034 Sum_probs=120.3
Q ss_pred CCCCEEEECCCCEEEEEEECCCCEEEEEEEECCCH---------------HHHHHHHHHHHHHHHHHCCCCCCEEEEEEE
Q ss_conf 78662542664429999817996899999312671---------------456879999999999850379932544357
Q 002721 608 KDSNMIYCGTFSTVYKAVMPSGLILSVKRLKSMDR---------------TIIHHQNKMIRELEKLSKLCHDNLVRPIGF 672 (888)
Q Consensus 608 ~~~~~lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~---------------~~~~~~~~~~~e~~~l~~l~h~niv~l~g~ 672 (888)
.+.+.||+|+||+||+|...+|..||+|.++.... ..........+|...+.++.|.+++..+++
T Consensus 3 ~vg~~IG~G~~g~Vy~a~~~~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~v~~~~~~ 82 (191)
T d1zara2 3 AIGKLMGEGKESAVFNCYSEKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAW 82 (191)
T ss_dssp EEEEEEEECSSEEEEEEEETTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEE
T ss_pred HHCCEEEECCCEEEEEEECCCCCEEEEEEEECCCCHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHCCCCCCCEEEEE
T ss_conf 22778024856599999979999999999860443466655656300088899999977899999998169991449986
Q ss_pred EEECCEEEEEEECCCCCCHHHHHHCCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCEEECCCCCCCEEECCCCCCEEEC
Q ss_conf 87289529998307999987884303999999999889999999999887302457725238888975857999826702
Q 002721 673 VIYEDVALLLHNYLPNGTLAQLLHESTKQPDYRPDWPTRLSIAIGVAEGLAFLHHVAIIHLDISSGNVLLDADFKPLLGE 752 (888)
Q Consensus 673 ~~~~~~~~lv~e~~~~gsL~~~l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH~~~ivH~dlk~~NIll~~~~~~kl~D 752 (888)
. ..+++|||+++....+ ++......++.|++.+++|||+.+|+||||||+|||++++ .++++|
T Consensus 83 ~----~~~lvme~~~~~~~~~------------l~~~~~~~i~~ql~~~l~~lH~~giiHrDiKP~NILv~~~-~~~liD 145 (191)
T d1zara2 83 E----GNAVLMELIDAKELYR------------VRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEE-GIWIID 145 (191)
T ss_dssp E----TTEEEEECCCCEEGGG------------CCCSCHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEEETT-EEEECC
T ss_pred C----CCEEEEEEECCCCCCC------------HHHHHHHHHHHHHHHHHHHHHHCCEEECCCCHHHEEEECC-CEEEEE
T ss_conf 2----8889999504565420------------0157899999999999999826888983689036114289-899987
Q ss_pred CCCCCCCCCCCCCCCCCCCCCCCCEECCCCCCCCCCCCCCCCHHHHHHH
Q ss_conf 3343225999995200133454432163333557858644305478999
Q 002721 753 IEISKLLDPSKGTASISAVAGSFGYIPPEYAYTMQVTAPGNVYSYGVVL 801 (888)
Q Consensus 753 fg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DVwSlG~il 801 (888)
||.|...............+.. ..++ ....|+.++|+||..--+
T Consensus 146 FG~a~~~~~~~~~~~l~rd~~~----~~~~-f~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 146 FPQSVEVGEEGWREILERDVRN----IITY-FSRTYRTEKDINSAIDRI 189 (191)
T ss_dssp CTTCEETTSTTHHHHHHHHHHH----HHHH-HHHHHCCCCCHHHHHHHH
T ss_pred CCCCCCCCCCCCHHHHHHHHHH----HHHH-HCCCCCCCCCHHHHHHHH
T ss_conf 7884308998709999877999----9999-757899844689999987
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.94 E-value=7e-26 Score=155.22 Aligned_cols=86 Identities=23% Similarity=0.251 Sum_probs=37.2
Q ss_pred CCCCEEECCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCC-CCCCCCCCCCCEEEECC-CCCCCCCCCCCCCCCCCCEE
Q ss_conf 99989877679899988887889975149992898455666-84334665323899427-87789988432334445178
Q 002721 110 SELEFLDLSLNKFGGVIPRELGSLKDLRFFNISNNVLVGEI-PDELKSLEKLEDFQVSS-NKLNGSIPFWVGNLTNLRVF 187 (888)
Q Consensus 110 ~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~L~ls~-N~l~~~~p~~~~~l~~L~~L 187 (888)
+++++|+|++|+|+.+.+..|.++++|++|++++|.+...+ +..|.+++.++.+.+.. |.+....+..|.++++|+.+
T Consensus 29 ~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~~n~l~~~~~~~~~~l~~L~~l 108 (242)
T d1xwdc1 29 RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYL 108 (242)
T ss_dssp SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEECCTTCCEECTTSEECCTTCCEE
T ss_pred CCCCEEECCCCCCCCCCHHHHHCCCHHHHHHHCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
T ss_conf 98899987699189649668614643232110221124201001122222222211111234322222212222222222
Q ss_pred ECCCCCCC
Q ss_conf 52455645
Q 002721 188 TAYENQLV 195 (888)
Q Consensus 188 ~L~~N~l~ 195 (888)
++++|.+.
T Consensus 109 ~l~~~~l~ 116 (242)
T d1xwdc1 109 LISNTGIK 116 (242)
T ss_dssp EEESCCCC
T ss_pred CCCHHHHC
T ss_conf 34211112
|
| >d1xwdc1 c.10.2.7 (C:18-259) Follicle-stimulating hormone receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Follicle-stimulating hormone receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.94 E-value=1.1e-25 Score=154.17 Aligned_cols=199 Identities=17% Similarity=0.178 Sum_probs=121.5
Q ss_pred CCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCC-CCCCCCCCCCEEEECC-CCCCCCCCCCCCCCCCCCCEE
Q ss_conf 99989948999574359989889999989877679899988-8878899751499928-984556668433466532389
Q 002721 86 KALKRLDLSNNAFSGTIPSAFGNLSELEFLDLSLNKFGGVI-PRELGSLKDLRFFNIS-NNVLVGEIPDELKSLEKLEDF 163 (888)
Q Consensus 86 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~L~Ls-~N~l~~~~p~~~~~l~~L~~L 163 (888)
..+++|+|++|.++...+..|.++++|++|++++|.+...+ +..|..+++++.+++. .|.+....+..|..+++|+.+
T Consensus 29 ~~l~~L~Ls~n~i~~l~~~~f~~l~~L~~L~ls~n~~~~~i~~~~f~~l~~l~~l~~~~~n~l~~~~~~~~~~l~~L~~l 108 (242)
T d1xwdc1 29 RNAIELRFVLTKLRVIQKGAFSGFGDLEKIEISQNDVLEVIEADVFSNLPKLHEIRIEKANNLLYINPEAFQNLPNLQYL 108 (242)
T ss_dssp SCCSEEEEESCCCCEECTTTTTTCTTCCEEEEESCTTCCEECSSSEESCTTCCEEEEECCTTCCEECTTSEECCTTCCEE
T ss_pred CCCCEEECCCCCCCCCCHHHHHCCCHHHHHHHCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
T ss_conf 98899987699189649668614643232110221124201001122222222211111234322222212222222222
Q ss_pred EECCCCCCCCCCC-CCCCCCCCCEEECCCCCCCCCCCCCCCCCC-CCCCEEECCCCCCCCCCCCCCCCCCCCEE-EECCC
Q ss_conf 9427877899884-323344451785245564587787778723-46520101555889788885578886469-82275
Q 002721 164 QVSSNKLNGSIPF-WVGNLTNLRVFTAYENQLVGEIPDNLGSVS-ELELLNLHSNQLEGPIPKSIFASGKLEVL-VLTQN 240 (888)
Q Consensus 164 ~ls~N~l~~~~p~-~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~-~L~~L~L~~N~l~~~~p~~~~~l~~L~~L-~L~~N 240 (888)
++++|.+....+. .+..+..+..+...++.+....+..|.+++ .++.|++++|+++. ++...+...++..+ ++++|
T Consensus 109 ~l~~~~l~~~~~~~~~~~l~~l~~~~~~n~~l~~i~~~~~~~~~~~l~~L~l~~n~l~~-i~~~~~~~~~l~~~~~l~~n 187 (242)
T d1xwdc1 109 LISNTGIKHLPDVHKIHSLQKVLLDIQDNINIHTIERNSFVGLSFESVILWLNKNGIQE-IHNCAFNGTQLDELNLSDNN 187 (242)
T ss_dssp EEESCCCCSCCCCTTTCBSSCEEEEEESCTTCCEECTTSSTTSBSSCEEEECCSSCCCE-ECTTTTTTCCEEEEECTTCT
T ss_pred CCCHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCEEEECCCCCCCC-CCCCCCCCHHHHCCCCCCCC
T ss_conf 34211112554333222111122222221211122222222223310012200123333-22222220111012123543
Q ss_pred CCCCCCHHHHCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEEE
Q ss_conf 678991012016876660441388465435876545787519982
Q 002721 241 RLTGDIPELVGHCKSLSNIRIGNNDLVGVIPRAIGNVSGLTYFEA 285 (888)
Q Consensus 241 ~l~~~~~~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L 285 (888)
+++.+.+..|.++++|++|++++|+++...+..|.+++.|+++++
T Consensus 188 ~l~~l~~~~f~~l~~L~~L~Ls~N~l~~l~~~~~~~l~~L~~l~~ 232 (242)
T d1xwdc1 188 NLEELPNDVFHGASGPVILDISRTRIHSLPSYGLENLKKLRARST 232 (242)
T ss_dssp TCCCCCTTTTTTSCCCSEEECTTSCCCCCCSSSCTTCCEEESSSE
T ss_pred CCCCCCHHHHCCCCCCCEEECCCCCCCCCCHHHHCCCCCCCCCCC
T ss_conf 246424788668999998989799289459779737713414767
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.93 E-value=1.1e-30 Score=181.41 Aligned_cols=108 Identities=23% Similarity=0.344 Sum_probs=59.3
Q ss_pred EEEEEECCCCCCCCCC--CCCCCCCCCCEEECCCCCCCC----CCCCCCCCCCCCCEEECCCCCCCCC----CCCCCC-C
Q ss_conf 1999993999863343--344589999899489995743----5998988999998987767989998----888788-9
Q 002721 64 FVVKLDLSRLQLRGNI--TLVSELKALKRLDLSNNAFSG----TIPSAFGNLSELEFLDLSLNKFGGV----IPRELG-S 132 (888)
Q Consensus 64 ~v~~l~l~~~~l~~~~--~~~~~l~~L~~L~L~~n~l~~----~~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~-~ 132 (888)
.+..+|++++++.+.. ..+..+++++.|+|++|+++. .+...+..+++|++|||++|.|+.. +...+. .
T Consensus 3 ~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~ 82 (460)
T d1z7xw1 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTP 82 (460)
T ss_dssp EEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCST
T ss_pred CCCEEEEECCCCCHHHHHHHHHHCCCCCEEEECCCCCCHHHHHHHHHHHHCCCCCCEEECCCCCCCHHHHHHHHHHHHCC
T ss_conf 87779820895886899999976779999982899998899999999985399988897959859728999999998437
Q ss_pred CCCCEEEECCCCCCCCC----CCCCCCCCCCCCEEEECCCCCC
Q ss_conf 97514999289845566----6843346653238994278778
Q 002721 133 LKDLRFFNISNNVLVGE----IPDELKSLEKLEDFQVSSNKLN 171 (888)
Q Consensus 133 l~~L~~L~Ls~N~l~~~----~p~~~~~l~~L~~L~ls~N~l~ 171 (888)
..+|+.|+|++|.++.. ++..+..+++|+.|++++|.++
T Consensus 83 ~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~ 125 (460)
T d1z7xw1 83 SCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLG 125 (460)
T ss_dssp TCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCH
T ss_pred CCCCCEEECCCCCCCCCCCCCCCCHHHCCCCCCCCCCCCCCCH
T ss_conf 8877887788877543221012110000343200244433202
|
| >d1h6ua2 c.10.2.1 (A:36-262) Internalin H {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin H species: Listeria monocytogenes [TaxId: 1639]
Probab=99.92 E-value=1.4e-24 Score=148.15 Aligned_cols=202 Identities=19% Similarity=0.335 Sum_probs=0.0
Q ss_pred ECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCCEEEECCCCCC
Q ss_conf 48999574359989889999989877679899988887889975149992898455666843346653238994278778
Q 002721 92 DLSNNAFSGTIPSAFGNLSELEFLDLSLNKFGGVIPRELGSLKDLRFFNISNNVLVGEIPDELKSLEKLEDFQVSSNKLN 171 (888)
Q Consensus 92 ~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~ 171 (888)
+++.+.+++.. .+..+.+|+.|++++|+|+.. ..+..+++|++|++++|++++..| +..+++|+.+++++|.++
T Consensus 25 ~l~~~~~~d~~--~~~~l~~L~~L~l~~~~i~~l--~~l~~l~~L~~L~ls~n~i~~~~~--l~~l~~l~~l~~~~n~~~ 98 (227)
T d1h6ua2 25 AAGKSNVTDTV--TQADLDGITTLSAFGTGVTTI--EGVQYLNNLIGLELKDNQITDLAP--LKNLTKITELELSGNPLK 98 (227)
T ss_dssp HTTCSSTTSEE--CHHHHHTCCEEECTTSCCCCC--TTGGGCTTCCEEECCSSCCCCCGG--GTTCCSCCEEECCSCCCS
T ss_pred HHCCCCCCCCC--CHHHCCCCCEEECCCCCCCCC--HHHHCCCCCCEEECCCCEEECCCC--CCCCCCCCCCCCCCCCCC
T ss_conf 84888767757--987848868997779999766--457448888376357853202543--112334320121112222
Q ss_pred CCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCHHHHC
Q ss_conf 99884323344451785245564587787778723465201015558897888855788864698227567899101201
Q 002721 172 GSIPFWVGNLTNLRVFTAYENQLVGEIPDNLGSVSELELLNLHSNQLEGPIPKSIFASGKLEVLVLTQNRLTGDIPELVG 251 (888)
Q Consensus 172 ~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~ 251 (888)
... .+.++++|+.+.++.+...+..+ +...+.+..+.++.+.+....+ +...++|+.|++++|.++...+ +.
T Consensus 99 ~i~--~l~~l~~L~~l~l~~~~~~~~~~--~~~~~~~~~l~~~~~~~~~~~~--~~~~~~L~~L~l~~n~~~~~~~--l~ 170 (227)
T d1h6ua2 99 NVS--AIAGLQSIKTLDLTSTQITDVTP--LAGLSNLQVLYLDLNQITNISP--LAGLTNLQYLSIGNAQVSDLTP--LA 170 (227)
T ss_dssp CCG--GGTTCTTCCEEECTTSCCCCCGG--GTTCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECCSSCCCCCGG--GT
T ss_pred CCC--CCCCCCCCCCCCCCCCCCCCCCH--HCCCCCHHHHHCHHHHHCHHHH--HCCCCCCCCCCCCCCCCCCCHH--HC
T ss_conf 222--22222222122122244331100--0002301222000000000000--0102111002333333331001--05
Q ss_pred CCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEEEECCCCCCCCCCCCCCCCCCCEEEEEC
Q ss_conf 687666044138846543587654578751998213689998892346889786899523
Q 002721 252 HCKSLSNIRIGNNDLVGVIPRAIGNVSGLTYFEADNNNLSGEIVPEFSQCSNLTLLNLAS 311 (888)
Q Consensus 252 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~~l~~L~~L~L~~ 311 (888)
++++|+.|++++|++++..+ ++.+++|++|++++|+++++.+ +..+++|+.|++++
T Consensus 171 ~l~~L~~L~Ls~n~l~~l~~--l~~l~~L~~L~Ls~N~lt~i~~--l~~l~~L~~L~lsn 226 (227)
T d1h6ua2 171 NLSKLTTLKADDNKISDISP--LASLPNLIEVHLKNNQISDVSP--LANTSNLFIVTLTN 226 (227)
T ss_dssp TCTTCCEEECCSSCCCCCGG--GGGCTTCCEEECTTSCCCBCGG--GTTCTTCCEEEEEE
T ss_pred CCCCCEECCCCCCCCCCCHH--HCCCCCCCEEECCCCCCCCCCC--CCCCCCCCEEEEEC
T ss_conf 64633564458884177853--4479999989795996899802--03699989897129
|
| >d1z7xw1 c.10.1.1 (W:1-460) Ribonuclease inhibitor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Ribonuclease inhibitor species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.92 E-value=2.8e-30 Score=179.27 Aligned_cols=379 Identities=18% Similarity=0.171 Sum_probs=166.4
Q ss_pred CCCEEECCCCCCCCCC-CCCCCCCCCCCEEECCCCCCCC----CCCCCCCCCCCCEEEECCCCCCCCC----CCCCCC-C
Q ss_conf 9989948999574359-9898899999898776798999----8888788997514999289845566----684334-6
Q 002721 87 ALKRLDLSNNAFSGTI-PSAFGNLSELEFLDLSLNKFGG----VIPRELGSLKDLRFFNISNNVLVGE----IPDELK-S 156 (888)
Q Consensus 87 ~L~~L~L~~n~l~~~~-p~~~~~l~~L~~L~Ls~N~l~~----~~p~~~~~l~~L~~L~Ls~N~l~~~----~p~~~~-~ 156 (888)
+|+.||++.|++++.. ..-+..++++++|+|++|.|+. .+...+...++|+.|+|++|.|+.. +...+. .
T Consensus 3 ~l~~ld~~~~~i~~~~~~~l~~~l~~l~~L~L~~~~i~~~~~~~l~~~L~~~~~L~~LdLs~N~i~~~~~~~l~~~l~~~ 82 (460)
T d1z7xw1 3 DIQSLDIQCEELSDARWAELLPLLQQCQVVRLDDCGLTEARCKDISSALRVNPALAELNLRSNELGDVGVHCVLQGLQTP 82 (460)
T ss_dssp EEEEEEEESCCCCHHHHHHHHHHHTTCSEEEEESSCCCHHHHHHHHHHHHTCTTCCEEECTTCCCHHHHHHHHHHTTCST
T ss_pred CCCEEEEECCCCCHHHHHHHHHHCCCCCEEEECCCCCCHHHHHHHHHHHHCCCCCCEEECCCCCCCHHHHHHHHHHHHCC
T ss_conf 87779820895886899999976779999982899998899999999985399988897959859728999999998437
Q ss_pred CCCCCEEEECCCCCCCC----CCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCC
Q ss_conf 65323899427877899----88432334445178524556458778777872346520101555889788885578886
Q 002721 157 LEKLEDFQVSSNKLNGS----IPFWVGNLTNLRVFTAYENQLVGEIPDNLGSVSELELLNLHSNQLEGPIPKSIFASGKL 232 (888)
Q Consensus 157 l~~L~~L~ls~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L 232 (888)
..+|+.|++++|.+++. ++..+..+++|+.|++++|.++......+.. .+.. .....
T Consensus 83 ~~~L~~L~L~~n~it~~~~~~l~~~l~~~~~L~~L~L~~N~i~~~~~~~l~~--~l~~-----------------~~~~~ 143 (460)
T d1z7xw1 83 SCKIQKLSLQNCCLTGAGCGVLSSTLRTLPTLQELHLSDNLLGDAGLQLLCE--GLLD-----------------PQCRL 143 (460)
T ss_dssp TCCCCEEECTTSCCBGGGHHHHHHHTTSCTTCCEEECCSSBCHHHHHHHHHH--HHTS-----------------TTCCC
T ss_pred CCCCCEEECCCCCCCCCCCCCCCCHHHCCCCCCCCCCCCCCCHHHHHHHHHH--CCCC-----------------CCCCC
T ss_conf 8877887788877543221012110000343200244433202345555443--0135-----------------54333
Q ss_pred CEEEECCCCCCCCC----HHHHCCCCCCCEEECCCCCCCCCC----CCCC-CCCCCCCEEEEECCCCCCCCC----CCCC
Q ss_conf 46982275678991----012016876660441388465435----8765-457875199821368999889----2346
Q 002721 233 EVLVLTQNRLTGDI----PELVGHCKSLSNIRIGNNDLVGVI----PRAI-GNVSGLTYFEADNNNLSGEIV----PEFS 299 (888)
Q Consensus 233 ~~L~L~~N~l~~~~----~~~~~~l~~L~~L~L~~N~l~~~~----p~~~-~~l~~L~~L~L~~N~l~~~~~----~~~~ 299 (888)
.........+.... ...+.....++.++++++...... ...+ ........+++..+.+..... ..+.
T Consensus 144 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ls~~~~~~~~~~~~~~~l~~~~~~~~~l~~~~~~~~~~~~~~~~~~l~ 223 (460)
T d1z7xw1 144 EKLQLEYCSLSAASCEPLASVLRAKPDFKELTVSNNDINEAGVRVLCQGLKDSPCQLEALKLESCGVTSDNCRDLCGIVA 223 (460)
T ss_dssp CEEECTTSCCBGGGHHHHHHHHHHCTTCCEEECCSSBCHHHHHHHHHHHHHHSCCCCCEEECTTSCCBTTHHHHHHHHHH
T ss_pred CCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHCCCCCCC
T ss_conf 22222232220011001122233332222233222212455554323433211221001241124542101101223322
Q ss_pred CCCCCCEEEEECCCCCCC-----CCCCCCCCCCCCEEEECCCCCCCCC----CCCCCCCCCCEEEECCCCCCCCCCCCHH
Q ss_conf 889786899523766334-----8944357777417770144123767----6110025741099825885888887000
Q 002721 300 QCSNLTLLNLASNGFTGV-----IPPELGQLINLQELILYENSLFGEI----PKSILACKNLNKLDLSNNRFNGTIPNAI 370 (888)
Q Consensus 300 ~l~~L~~L~L~~N~l~~~-----~p~~~~~l~~L~~L~L~~N~l~~~~----p~~~~~l~~L~~L~L~~N~l~~~~p~~~ 370 (888)
..+.++.+++.+|.+... .+........++.+++++|.+.... ...+...+.++.+++++|.+.......+
T Consensus 224 ~~~~~~~l~~~~n~~~~~~~~~~~~~~~~~~~~l~~l~l~~n~i~~~~~~~~~~~l~~~~~l~~l~l~~n~i~~~~~~~l 303 (460)
T d1z7xw1 224 SKASLRELALGSNKLGDVGMAELCPGLLHPSSRLRTLWIWECGITAKGCGDLCRVLRAKESLKELSLAGNELGDEGARLL 303 (460)
T ss_dssp HCTTCCEEECCSSBCHHHHHHHHHHHHTSTTCCCCEEECTTSCCCHHHHHHHHHHHHHCTTCCEEECTTCCCHHHHHHHH
T ss_pred CCCCCCCCCHHHCCCCCCCCCHHHCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHH
T ss_conf 22221001002112233442011000111111100001345433212334332211123433344444333224564211
Q ss_pred -----CCCCCCCEECCCCCCCCCCCCCC----CCCCCCCEEEEEECCCCCCC----CCCCCC-CCCCHHHHHHCCCCCCC
Q ss_conf -----04467536205677564236888----42445640898305415456----998633-32210234314673134
Q 002721 371 -----CDMSRLQYLLLGQNSLKGEIPHE----IGNCMKLLQLHIGSNYLTGS----IPPEIG-HIRNLQIALNLSFNHLH 436 (888)
Q Consensus 371 -----~~~~~L~~L~L~~N~l~~~~p~~----~~~l~~L~~L~l~~N~l~~~----~p~~~~-~l~~L~~~L~ls~N~l~ 436 (888)
.....|+.+++++|.+....... +...++|+.|++++|.++.. ++..+. ....|+ .|++++|.++
T Consensus 304 ~~~l~~~~~~L~~l~l~~~~l~~~~~~~l~~~~~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~-~L~Ls~n~i~ 382 (460)
T d1z7xw1 304 CETLLEPGCQLESLWVKSCSFTAACCSHFSSVLAQNRFLLELQISNNRLEDAGVRELCQGLGQPGSVLR-VLWLADCDVS 382 (460)
T ss_dssp HHHHTSTTCCCCEEECTTSCCBGGGHHHHHHHHHHCSSCCEEECCSSBCHHHHHHHHHHHHTSTTCCCC-EEECTTSCCC
T ss_pred HCCCCCCCCCCCCCCCCCCCHHHHHHHHCCCCCCCCCCHHHHHEEEECCCCCCCCHHHHHHHCCCCCCC-EEECCCCCCC
T ss_conf 101233344433332333410233443213322110111132012101357664001112204567778-8989799797
Q ss_pred CC----CCCCCCCCCCCCEEEEECCCCCCCCCHHH----C-CCCCCEEEECCCCCCCC
Q ss_conf 36----98232499996499920784556886000----0-36645099863884845
Q 002721 437 GS----LPPELGKLDKLVSFDVSNNQLSGTIPSAL----K-GMLSLIEVNFSNNLLTG 485 (888)
Q Consensus 437 ~~----~p~~~~~l~~L~~LdLs~N~l~~~~p~~~----~-~l~~L~~l~ls~N~l~~ 485 (888)
.. +...+...++|+.||+++|.++......+ . ....|+.+++++|.+..
T Consensus 383 ~~~~~~l~~~l~~~~~L~~L~Ls~N~i~~~g~~~l~~~l~~~~~~L~~l~l~~~~~~~ 440 (460)
T d1z7xw1 383 DSSCSSLAATLLANHSLRELDLSNNCLGDAGILQLVESVRQPGCLLEQLVLYDIYWSE 440 (460)
T ss_dssp HHHHHHHHHHHHHCCCCCEEECCSSSCCHHHHHHHHHHHTSTTCCCCEEECTTCCCCH
T ss_pred HHHHHHHHHHHHCCCCCCEEECCCCCCCHHHHHHHHHHHHHCCCCCCEEECCCCCCCH
T ss_conf 5999999999962998898989999698799999999997478866789898987898
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.91 E-value=1.8e-24 Score=147.43 Aligned_cols=127 Identities=17% Similarity=0.236 Sum_probs=67.6
Q ss_pred EECCCCCCCCCCCCCCCCCCCCEEECCCCCCCCC-CCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCEEEECCCCCC
Q ss_conf 9939998633433445899998994899957435-998988999998987767989998888788997514999289845
Q 002721 68 LDLSRLQLRGNITLVSELKALKRLDLSNNAFSGT-IPSAFGNLSELEFLDLSLNKFGGVIPRELGSLKDLRFFNISNNVL 146 (888)
Q Consensus 68 l~l~~~~l~~~~~~~~~l~~L~~L~L~~n~l~~~-~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l 146 (888)
+++++++++..+..+. .++++|+|++|.|++. .+..|.++++|+.|+|++|++....+..|..+++|++|+|++|+|
T Consensus 13 v~Cs~~~L~~iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~N~l 90 (192)
T d1w8aa_ 13 VDCTGRGLKEIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGENKI 90 (192)
T ss_dssp EECTTSCCSSCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCSCCC
T ss_pred EEEECCCCCCCCCCCC--CCCCEEEECCCCCCCCCCCCCCCCCCEEEEEECCCCCCCCCCCCCCCCCCCCCEEEECCCCC
T ss_conf 9970899670298989--78788984898775530200257876272130136322121212221122221010035534
Q ss_pred CCCCCCCCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCEEECCCCCCCC
Q ss_conf 56668433466532389942787789988432334445178524556458
Q 002721 147 VGEIPDELKSLEKLEDFQVSSNKLNGSIPFWVGNLTNLRVFTAYENQLVG 196 (888)
Q Consensus 147 ~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 196 (888)
+...|+.|.++++|+.|+|++|+|++..+.+|.++++|++++|++|.+..
T Consensus 91 ~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~ 140 (192)
T d1w8aa_ 91 KEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNC 140 (192)
T ss_dssp CEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCC
T ss_pred CCCCHHHHHCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCCC
T ss_conf 43497998079746552457745353597785687533420003644343
|
| >d1w8aa_ c.10.2.7 (A:) Slit {Fruit fly (Drosophila melanogaster) [TaxId: 7227]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: Slit species: Fruit fly (Drosophila melanogaster) [TaxId: 7227]
Probab=99.91 E-value=9.9e-25 Score=148.92 Aligned_cols=129 Identities=22% Similarity=0.348 Sum_probs=81.6
Q ss_pred CEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCC-CCCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCCEEEECC
Q ss_conf 89948999574359989889999989877679899988-88788997514999289845566684334665323899427
Q 002721 89 KRLDLSNNAFSGTIPSAFGNLSELEFLDLSLNKFGGVI-PRELGSLKDLRFFNISNNVLVGEIPDELKSLEKLEDFQVSS 167 (888)
Q Consensus 89 ~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~-p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~ 167 (888)
+.++.++++++ .+|..+. +++++|+|++|+|++.+ +..|..+++|+.|+|++|.+....+..|..+++|+.|+|++
T Consensus 11 ~~v~Cs~~~L~-~iP~~lp--~~l~~L~Ls~N~i~~~~~~~~f~~l~~L~~L~L~~N~i~~~~~~~~~~~~~L~~L~Ls~ 87 (192)
T d1w8aa_ 11 TTVDCTGRGLK-EIPRDIP--LHTTELLLNDNELGRISSDGLFGRLPHLVKLELKRNQLTGIEPNAFEGASHIQELQLGE 87 (192)
T ss_dssp TEEECTTSCCS-SCCSCCC--TTCSEEECCSCCCCSBCCSCSGGGCTTCCEEECCSSCCCCBCTTTTTTCTTCCEEECCS
T ss_pred CEEEEECCCCC-CCCCCCC--CCCCEEEECCCCCCCCCCCCCCCCCCEEEEEECCCCCCCCCCCCCCCCCCCCCEEEECC
T ss_conf 99997089967-0298989--78788984898775530200257876272130136322121212221122221010035
Q ss_pred CCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCEEECCCCCCC
Q ss_conf 87789988432334445178524556458778777872346520101555889
Q 002721 168 NKLNGSIPFWVGNLTNLRVFTAYENQLVGEIPDNLGSVSELELLNLHSNQLEG 220 (888)
Q Consensus 168 N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~ 220 (888)
|+++...+.+|.++++|+.|+|++|+|++..++.|..+++|++|+|++|.+..
T Consensus 88 N~l~~l~~~~F~~l~~L~~L~L~~N~l~~i~~~~f~~l~~L~~l~L~~N~~~~ 140 (192)
T d1w8aa_ 88 NKIKEISNKMFLGLHQLKTLNLYDNQISCVMPGSFEHLNSLTSLNLASNPFNC 140 (192)
T ss_dssp CCCCEECSSSSTTCTTCCEEECCSSCCCEECTTSSTTCTTCCEEECTTCCBCC
T ss_pred CCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCHHHHCCCCCCCCCCCCCCCCCC
T ss_conf 53443497998079746552457745353597785687533420003644343
|
| >d1h6ta2 c.10.2.1 (A:31-240) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.89 E-value=5.2e-23 Score=139.52 Aligned_cols=180 Identities=18% Similarity=0.285 Sum_probs=0.0
Q ss_pred ECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCCEEEECCCCCC
Q ss_conf 48999574359989889999989877679899988887889975149992898455666843346653238994278778
Q 002721 92 DLSNNAFSGTIPSAFGNLSELEFLDLSLNKFGGVIPRELGSLKDLRFFNISNNVLVGEIPDELKSLEKLEDFQVSSNKLN 171 (888)
Q Consensus 92 ~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~ 171 (888)
++..+.+.+.++. ..+.+|+.|++++|.++...+ +..+++|++|+|++|++++..+ +..+++|+.|++++|+++
T Consensus 30 ~l~~~~~~~~~~~--~~L~~L~~L~l~~~~i~~l~~--l~~l~~L~~L~L~~n~i~~l~~--~~~l~~L~~L~l~~n~i~ 103 (210)
T d1h6ta2 30 NLKKKSVTDAVTQ--NELNSIDQIIANNSDIKSVQG--IQYLPNVTKLFLNGNKLTDIKP--LANLKNLGWLFLDENKVK 103 (210)
T ss_dssp HTTCSCTTSEECH--HHHHTCCEEECTTSCCCCCTT--GGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCC
T ss_pred HHCCCCCCCCCCH--HHHCCCCEEECCCCCCCCCHH--HHHCCCCCEEECCCCCCCCCCC--CCCCCCCCCCCCCCCCCC
T ss_conf 8575765775188--795484589782798887444--7648998987698960258601--135862120143333321
Q ss_pred CCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCHHHHC
Q ss_conf 99884323344451785245564587787778723465201015558897888855788864698227567899101201
Q 002721 172 GSIPFWVGNLTNLRVFTAYENQLVGEIPDNLGSVSELELLNLHSNQLEGPIPKSIFASGKLEVLVLTQNRLTGDIPELVG 251 (888)
Q Consensus 172 ~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~~~ 251 (888)
.++ .+.++++|+.|++++|.+.. ...+..++.++.++++.|.++ .+..+..+++|+.+++++|++++..+ +.
T Consensus 104 -~l~-~l~~l~~L~~L~l~~~~~~~--~~~l~~l~~l~~l~~~~n~l~--~~~~~~~l~~L~~l~l~~n~l~~i~~--l~ 175 (210)
T d1h6ta2 104 -DLS-SLKDLKKLKSLSLEHNGISD--INGLVHLPQLESLYLGNNKIT--DITVLSRLTKLDTLSLEDNQISDIVP--LA 175 (210)
T ss_dssp -CGG-GGTTCTTCCEEECTTSCCCC--CGGGGGCTTCCEEECCSSCCC--CCGGGGGCTTCSEEECCSSCCCCCGG--GT
T ss_pred -CCC-CCCCCCCCCCCCCCCCCCCC--CCCCCCCCCCCCCCCCCCCCC--CCCCCCCCCCCCCCCCCCCCCCCCCC--CC
T ss_conf -222-12122211122345653221--122011111222112223334--54310001332100134643025645--36
Q ss_pred CCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEEEEC
Q ss_conf 687666044138846543587654578751998213
Q 002721 252 HCKSLSNIRIGNNDLVGVIPRAIGNVSGLTYFEADN 287 (888)
Q Consensus 252 ~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~ 287 (888)
++++|+.|++++|+++.+. .+..+++|++|++++
T Consensus 176 ~l~~L~~L~Ls~N~i~~l~--~l~~l~~L~~L~Ls~ 209 (210)
T d1h6ta2 176 GLTKLQNLYLSKNHISDLR--ALAGLKNLDVLELFS 209 (210)
T ss_dssp TCTTCCEEECCSSCCCBCG--GGTTCTTCSEEEEEE
T ss_pred CCCCCCEEECCCCCCCCCH--HHCCCCCCCEEECCC
T ss_conf 7898999989799899872--116999989997118
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.89 E-value=2e-22 Score=136.31 Aligned_cols=10 Identities=10% Similarity=-0.084 Sum_probs=3.1
Q ss_pred CCEEECCCCC
Q ss_conf 9898776798
Q 002721 112 LEFLDLSLNK 121 (888)
Q Consensus 112 L~~L~Ls~N~ 121 (888)
+++|++++|.
T Consensus 42 l~~L~l~~~~ 51 (199)
T d2omxa2 42 VTTLQADRLG 51 (199)
T ss_dssp CCEEECTTSC
T ss_pred CCEEECCCCC
T ss_conf 7899899999
|
| >d2omxa2 c.10.2.1 (A:37-235) Internalin B {Listeria monocytogenes [TaxId: 1639]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Internalin LRR domain domain: Internalin B species: Listeria monocytogenes [TaxId: 1639]
Probab=99.89 E-value=1.1e-22 Score=137.72 Aligned_cols=80 Identities=21% Similarity=0.348 Sum_probs=30.6
Q ss_pred CCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCCEEEE
Q ss_conf 99989948999574359989889999989877679899988887889975149992898455666843346653238994
Q 002721 86 KALKRLDLSNNAFSGTIPSAFGNLSELEFLDLSLNKFGGVIPRELGSLKDLRFFNISNNVLVGEIPDELKSLEKLEDFQV 165 (888)
Q Consensus 86 ~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~l 165 (888)
.++++|++++|+++. ++ .+..+++|++|++++|++++..| ++.+++|++|++++|.+. .++ .+.+++.|+.|++
T Consensus 40 ~~l~~L~l~~~~i~~-l~-~l~~l~nL~~L~Ls~N~l~~~~~--l~~l~~L~~L~l~~n~~~-~~~-~l~~l~~L~~L~l 113 (199)
T d2omxa2 40 DQVTTLQADRLGIKS-ID-GVEYLNNLTQINFSNNQLTDITP--LKNLTKLVDILMNNNQIA-DIT-PLANLTNLTGLTL 113 (199)
T ss_dssp TTCCEEECTTSCCCC-CT-TGGGCTTCCEEECCSSCCCCCGG--GTTCTTCCEEECCSSCCC-CCG-GGTTCTTCSEEEC
T ss_pred CCCCEEECCCCCCCC-CC-CCCCCCCCCCCCCCCCCCCCCCC--CCCCCCCCCCCCCCCCCC-CCC-CCCCCCCCCCCCC
T ss_conf 687899899999977-52-02137886757545655667640--167752231111222222-221-1111223222111
Q ss_pred CCCCCC
Q ss_conf 278778
Q 002721 166 SSNKLN 171 (888)
Q Consensus 166 s~N~l~ 171 (888)
++|.+.
T Consensus 114 ~~~~~~ 119 (199)
T d2omxa2 114 FNNQIT 119 (199)
T ss_dssp CSSCCC
T ss_pred CCCCCC
T ss_conf 222222
|
| >d2ca6a1 c.10.1.2 (A:2-345) Rna1p (RanGAP1), N-terminal domain {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Rna1p (RanGAP1), N-terminal domain domain: Rna1p (RanGAP1), N-terminal domain species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=99.79 E-value=2.6e-22 Score=135.67 Aligned_cols=13 Identities=31% Similarity=0.478 Sum_probs=4.7
Q ss_pred CCCCEEEECCCCC
Q ss_conf 5323899427877
Q 002721 158 EKLEDFQVSSNKL 170 (888)
Q Consensus 158 ~~L~~L~ls~N~l 170 (888)
++|+.|++++|.+
T Consensus 93 ~~L~~L~L~~n~i 105 (344)
T d2ca6a1 93 PKLHTVRLSDNAF 105 (344)
T ss_dssp TTCCEEECCSCCC
T ss_pred CCCCCCCCCCCCC
T ss_conf 7756330000134
|
| >d2astb2 c.10.1.3 (B:2136-2419) Cyclin A/CDK2-associated p19, Skp2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: Cyclin A/CDK2-associated p19, Skp2 domain: Cyclin A/CDK2-associated p19, Skp2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.79 E-value=8.9e-21 Score=127.28 Aligned_cols=258 Identities=17% Similarity=0.151 Sum_probs=0.0
Q ss_pred EEEECCCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCEEECCCCCCCCC-CCCCCCCCCCCCCEEECC
Q ss_conf 4999289845566684334665323899427877899884323344451785245564587-787778723465201015
Q 002721 137 RFFNISNNVLVGEIPDELKSLEKLEDFQVSSNKLNGSIPFWVGNLTNLRVFTAYENQLVGE-IPDNLGSVSELELLNLHS 215 (888)
Q Consensus 137 ~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~-~p~~~~~l~~L~~L~L~~ 215 (888)
+.+||+++.+.......+... .+..+.++...+. ..........+|+.|+++++.++.. +...+..+++|++|+|++
T Consensus 3 ~~lDLs~~~l~~~~l~~l~~~-~~~~lrl~~~~~~-~~~~~~~~~~~L~~LdLs~~~i~~~~l~~l~~~c~~L~~L~L~~ 80 (284)
T d2astb2 3 QTLDLTGKNLHPDVTGRLLSQ-GVIAFRCPRSFMD-QPLAEHFSPFRVQHMDLSNSVIEVSTLHGILSQCSKLQNLSLEG 80 (284)
T ss_dssp SEEECTTCBCCHHHHHHHHHT-TCSEEECTTCEEC-SCCCSCCCCBCCCEEECTTCEECHHHHHHHHTTBCCCSEEECTT
T ss_pred CEEECCCCCCCCHHHHHHHHC-CCEEEECCCCCCC-CCHHHHCCCCCCCEEECCCCCCCHHHHHHHHHHCCCCCCCCCCC
T ss_conf 779789997881479998745-5427465233345-52244256787887889898457779999997487765145234
Q ss_pred CCCCCCCCCCCCCCCCCCEEEECC-CCCC-CCCHHHHCCCCCCCEEECCCCCC---CCCCCCCCCCCCCCCEEEEE--CC
Q ss_conf 558897888855788864698227-5678-99101201687666044138846---54358765457875199821--36
Q 002721 216 NQLEGPIPKSIFASGKLEVLVLTQ-NRLT-GDIPELVGHCKSLSNIRIGNNDL---VGVIPRAIGNVSGLTYFEAD--NN 288 (888)
Q Consensus 216 N~l~~~~p~~~~~l~~L~~L~L~~-N~l~-~~~~~~~~~l~~L~~L~L~~N~l---~~~~p~~~~~l~~L~~L~L~--~N 288 (888)
+.++...+..+..+++|+.|++++ +.++ ......+.++++|++|+++++.. .+.........+.|+.|+++ .+
T Consensus 81 ~~l~~~~~~~l~~~~~L~~L~Ls~c~~itd~~l~~l~~~~~~L~~L~ls~c~~~~~~~~~~~~~~~~~~L~~L~l~~~~~ 160 (284)
T d2astb2 81 LRLSDPIVNTLAKNSNLVRLNLSGCSGFSEFALQTLLSSCSRLDELNLSWCFDFTEKHVQVAVAHVSETITQLNLSGYRK 160 (284)
T ss_dssp CBCCHHHHHHHTTCTTCSEEECTTCBSCCHHHHHHHHHHCTTCCEEECCCCTTCCHHHHHHHHHHSCTTCCEEECCSCGG
T ss_pred CCCCCHHHHHHHCCCCCCCCCCCCCCCCCCCCCCHHHHHHHHCCCCCCCCCCCCCCCCCHHHHCCCCCCCCHHHHCCCCC
T ss_conf 67986789998518997571510013412355403657887435652245332333220001000111110122135542
Q ss_pred CCCCCCCCCC-CCCCCCCEEEEEC-CCCCCCCCCCCCCCCCCCEEEECC-CCCCCCCCCCCCCCCCCEEEECCCCCCCCC
Q ss_conf 8999889234-6889786899523-766334894435777741777014-412376761100257410998258858888
Q 002721 289 NLSGEIVPEF-SQCSNLTLLNLAS-NGFTGVIPPELGQLINLQELILYE-NSLFGEIPKSILACKNLNKLDLSNNRFNGT 365 (888)
Q Consensus 289 ~l~~~~~~~~-~~l~~L~~L~L~~-N~l~~~~p~~~~~l~~L~~L~L~~-N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~ 365 (888)
.++......+ ..+++|+.|++++ +.+++.....+..+++|++|++++ +.+.+.....+..+++|+.|+++++--.+.
T Consensus 161 ~i~~~~l~~l~~~~~~L~~L~L~~~~~itd~~~~~l~~~~~L~~L~L~~C~~i~~~~l~~L~~~~~L~~L~l~~~~~d~~ 240 (284)
T d2astb2 161 NLQKSDLSTLVRRCPNLVHLDLSDSVMLKNDCFQEFFQLNYLQHLSLSRCYDIIPETLLELGEIPTLKTLQVFGIVPDGT 240 (284)
T ss_dssp GSCHHHHHHHHHHCTTCSEEECTTCTTCCGGGGGGGGGCTTCCEEECTTCTTCCGGGGGGGGGCTTCCEEECTTSSCTTC
T ss_pred CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCHHHHHHCCCCCCCEEECCCCCCCCHHHHHHHHCCCCCCEEEEECCCCHHH
T ss_conf 44444343423232221235532234778303333213576877989999978737899972699989896448889899
Q ss_pred CCCHHCCCCCCCEECCCCCCCCCCCCCCCCCCCC
Q ss_conf 8700004467536205677564236888424456
Q 002721 366 IPNAICDMSRLQYLLLGQNSLKGEIPHEIGNCMK 399 (888)
Q Consensus 366 ~p~~~~~~~~L~~L~L~~N~l~~~~p~~~~~l~~ 399 (888)
+......++.|+. ..+.++...+..+++...
T Consensus 241 l~~l~~~lp~L~i---~~~~ls~~~~~~~~~~~~ 271 (284)
T d2astb2 241 LQLLKEALPHLQI---NCSHFTTIARPTIGNKKN 271 (284)
T ss_dssp HHHHHHHSTTSEE---SCCCSCCTTCSSCSSTTC
T ss_pred HHHHHHHCCCCCC---CCCCCCCCCCCCCCCCCC
T ss_conf 9999976843661---686587777885476664
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.75 E-value=1.3e-18 Score=115.40 Aligned_cols=39 Identities=23% Similarity=0.132 Sum_probs=13.4
Q ss_pred CCCCCCEEECCCCCCCCCCCCCCCCCCCCEEEECCCCCCC
Q ss_conf 9999989877679899988887889975149992898455
Q 002721 108 NLSELEFLDLSLNKFGGVIPRELGSLKDLRFFNISNNVLV 147 (888)
Q Consensus 108 ~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~ 147 (888)
+..++++|+|++|+|+. ++..+..+++|+.|+|++|.|+
T Consensus 16 n~~~lr~L~L~~n~I~~-i~~~~~~l~~L~~L~Ls~N~i~ 54 (162)
T d1a9na_ 16 NAVRDRELDLRGYKIPV-IENLGATLDQFDAIDFSDNEIR 54 (162)
T ss_dssp CTTSCEEEECTTSCCCS-CCCGGGGTTCCSEEECCSSCCC
T ss_pred CCCCCCEEECCCCCCCC-CCCCCCCCCCCCEEECCCCCCC
T ss_conf 85748489788997886-5762004145998989799787
|
| >d1a9na_ c.10.2.4 (A:) Splicesomal U2A' protein {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: U2A'-like domain: Splicesomal U2A' protein species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.74 E-value=1.2e-18 Score=115.72 Aligned_cols=85 Identities=19% Similarity=0.226 Sum_probs=33.2
Q ss_pred CCCCCCEEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCCEE
Q ss_conf 89999899489995743599898899999898776798999888878899751499928984556668433466532389
Q 002721 84 ELKALKRLDLSNNAFSGTIPSAFGNLSELEFLDLSLNKFGGVIPRELGSLKDLRFFNISNNVLVGEIPDELKSLEKLEDF 163 (888)
Q Consensus 84 ~l~~L~~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L 163 (888)
+...++.|+|++|+|+ .++..+..+++|++|+|++|+|+.. +.|..+++|++|++++|+++...+..+..+++|+.|
T Consensus 16 n~~~lr~L~L~~n~I~-~i~~~~~~l~~L~~L~Ls~N~i~~l--~~~~~l~~L~~L~ls~N~i~~l~~~~~~~l~~L~~L 92 (162)
T d1a9na_ 16 NAVRDRELDLRGYKIP-VIENLGATLDQFDAIDFSDNEIRKL--DGFPLLRRLKTLLVNNNRICRIGEGLDQALPDLTEL 92 (162)
T ss_dssp CTTSCEEEECTTSCCC-SCCCGGGGTTCCSEEECCSSCCCEE--CCCCCCSSCCEEECCSSCCCEECSCHHHHCTTCCEE
T ss_pred CCCCCCEEECCCCCCC-CCCCCCCCCCCCCEEECCCCCCCCC--CCCCCCCCHHHHHCCCCCCCCCCCCCCCCCCCCCCC
T ss_conf 8574848978899788-6576200414599898979978764--774457613064310213457776322334534434
Q ss_pred EECCCCCC
Q ss_conf 94278778
Q 002721 164 QVSSNKLN 171 (888)
Q Consensus 164 ~ls~N~l~ 171 (888)
++++|+++
T Consensus 93 ~L~~N~i~ 100 (162)
T d1a9na_ 93 ILTNNSLV 100 (162)
T ss_dssp ECCSCCCC
T ss_pred EECCCCCC
T ss_conf 20300016
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.70 E-value=5.2e-17 Score=106.68 Aligned_cols=77 Identities=25% Similarity=0.449 Sum_probs=28.5
Q ss_pred EEECCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCCEEEECCCC
Q ss_conf 99489995743599898899999898776798999888878899751499928984556668433466532389942787
Q 002721 90 RLDLSNNAFSGTIPSAFGNLSELEFLDLSLNKFGGVIPRELGSLKDLRFFNISNNVLVGEIPDELKSLEKLEDFQVSSNK 169 (888)
Q Consensus 90 ~L~L~~n~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~ 169 (888)
.|+|++|+++ .++ .+..+++|++|++++|+|+ .+|..|+.+++|+.|++++|.+++ +| .+..+++|+.|++++|+
T Consensus 2 ~L~Ls~n~l~-~l~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~~-l~-~~~~l~~L~~L~l~~N~ 76 (124)
T d1dcea3 2 VLHLAHKDLT-VLC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALEN-VD-GVANLPRLQELLLCNNR 76 (124)
T ss_dssp EEECTTSCCS-SCC-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCCC-CG-GGTTCSSCCEEECCSSC
T ss_pred EEECCCCCCC-CCC-CCCCCCCCCEEECCCCCCC-CCHHHHHHHHCCCCCCCCCCCCCC-CC-CCCCCCCCCEEECCCCC
T ss_conf 8986899898-871-0105898898979787168-652156554313545324321123-57-41233555768888986
Q ss_pred CC
Q ss_conf 78
Q 002721 170 LN 171 (888)
Q Consensus 170 l~ 171 (888)
++
T Consensus 77 i~ 78 (124)
T d1dcea3 77 LQ 78 (124)
T ss_dssp CC
T ss_pred CC
T ss_conf 58
|
| >d1dcea3 c.10.2.2 (A:444-567) Rab geranylgeranyltransferase alpha-subunit, C-terminal domain {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain domain: Rab geranylgeranyltransferase alpha-subunit, C-terminal domain species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=99.69 E-value=3.7e-17 Score=107.48 Aligned_cols=55 Identities=29% Similarity=0.366 Sum_probs=22.3
Q ss_pred EEECCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCCEEEECCCCCC
Q ss_conf 9877679899988887889975149992898455666843346653238994278778
Q 002721 114 FLDLSLNKFGGVIPRELGSLKDLRFFNISNNVLVGEIPDELKSLEKLEDFQVSSNKLN 171 (888)
Q Consensus 114 ~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~ 171 (888)
+|+|++|+|+. ++ .+..+++|++|++++|+|+ .+|+.+..+++|+.|++++|.++
T Consensus 2 ~L~Ls~n~l~~-l~-~l~~l~~L~~L~ls~N~l~-~lp~~~~~l~~L~~L~l~~N~i~ 56 (124)
T d1dcea3 2 VLHLAHKDLTV-LC-HLEQLLLVTHLDLSHNRLR-ALPPALAALRCLEVLQASDNALE 56 (124)
T ss_dssp EEECTTSCCSS-CC-CGGGGTTCCEEECCSSCCC-CCCGGGGGCTTCCEEECCSSCCC
T ss_pred EEECCCCCCCC-CC-CCCCCCCCCEEECCCCCCC-CCHHHHHHHHCCCCCCCCCCCCC
T ss_conf 89868998988-71-0105898898979787168-65215655431354532432112
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.66 E-value=4e-16 Score=101.85 Aligned_cols=69 Identities=22% Similarity=0.221 Sum_probs=28.6
Q ss_pred CCCCCCCCCCCEEECCCC-CCCCCCCCCCCCCCCCEEEECCCCCCCCCCCCCCCCCCCCCEEEECCCCCC
Q ss_conf 989889999989877679-899988887889975149992898455666843346653238994278778
Q 002721 103 PSAFGNLSELEFLDLSLN-KFGGVIPRELGSLKDLRFFNISNNVLVGEIPDELKSLEKLEDFQVSSNKLN 171 (888)
Q Consensus 103 p~~~~~l~~L~~L~Ls~N-~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~ls~N~l~ 171 (888)
|..+..+++|++|++++| .++.+.+.+|.++++|+.|+|++|+|+...+..|..+++|+.|+|++|+++
T Consensus 24 p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~N~l~ 93 (156)
T d2ifga3 24 LHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALE 93 (156)
T ss_dssp TTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSCCS
T ss_pred CCCCCCCCCCCEEECCCCCCCCCCCCHHHCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCEECCCCCCC
T ss_conf 6002576565743168986644369212256666672162021247742011124554333322678785
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.65 E-value=1.4e-18 Score=115.32 Aligned_cols=13 Identities=31% Similarity=0.358 Sum_probs=4.0
Q ss_pred CCCCEEECCCCCC
Q ss_conf 9998987767989
Q 002721 110 SELEFLDLSLNKF 122 (888)
Q Consensus 110 ~~L~~L~Ls~N~l 122 (888)
++|++|+|++|+|
T Consensus 48 ~~L~~L~Ls~n~I 60 (198)
T d1m9la_ 48 KACKHLALSTNNI 60 (198)
T ss_dssp TTCCEEECSEEEE
T ss_pred CCCCEEECCCCCC
T ss_conf 0461519944689
|
| >d2ifga3 c.10.2.7 (A:36-191) High affinity nerve growth factor receptor, N-terminal domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: Ngr ectodomain-like domain: High affinity nerve growth factor receptor, N-terminal domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.65 E-value=7.1e-16 Score=100.49 Aligned_cols=98 Identities=18% Similarity=0.137 Sum_probs=65.4
Q ss_pred CCCCCCCCCCCCCCCCCEEECCCC-CCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCCCC
Q ss_conf 986334334458999989948999-5743599898899999898776798999888878899751499928984556668
Q 002721 73 LQLRGNITLVSELKALKRLDLSNN-AFSGTIPSAFGNLSELEFLDLSLNKFGGVIPRELGSLKDLRFFNISNNVLVGEIP 151 (888)
Q Consensus 73 ~~l~~~~~~~~~l~~L~~L~L~~n-~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p~~~~~l~~L~~L~Ls~N~l~~~~p 151 (888)
.++...+..+..+++|+.|++++| .++...+.+|.++++|+.|+|++|+|+.+.+.+|..+++|++|+|++|+|+...+
T Consensus 18 ~~~~~~p~~l~~l~~l~~L~l~~n~~l~~i~~~~f~~l~~L~~L~Ls~N~l~~i~~~~f~~l~~L~~L~Ls~N~l~~l~~ 97 (156)
T d2ifga3 18 DGALDSLHHLPGAENLTELYIENQQHLQHLELRDLRGLGELRNLTIVKSGLRFVAPDAFHFTPRLSRLNLSFNALESLSW 97 (156)
T ss_dssp SCCCTTTTTSCSCSCCSEEECCSCSSCCEECGGGSCSCCCCSEEECCSSCCCEECTTGGGSCSCCCEEECCSSCCSCCCS
T ss_pred CCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCHHHCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCEECCCCCCCCCCH
T ss_conf 99765860025765657431689866443692122566666721620212477420111245543333226787851574
Q ss_pred CCCCCCCCCCEEEECCCCCC
Q ss_conf 43346653238994278778
Q 002721 152 DELKSLEKLEDFQVSSNKLN 171 (888)
Q Consensus 152 ~~~~~l~~L~~L~ls~N~l~ 171 (888)
..|. ..+|+.|+|++|.+.
T Consensus 98 ~~~~-~~~l~~L~L~~Np~~ 116 (156)
T d2ifga3 98 KTVQ-GLSLQELVLSGNPLH 116 (156)
T ss_dssp TTTC-SCCCCEEECCSSCCC
T ss_pred HHHC-CCCCCCCCCCCCCCC
T ss_conf 5633-532124335798633
|
| >d1m9la_ c.10.3.1 (A:) Outer arm dynein light chain 1 {Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: Outer arm dynein light chain 1 family: Outer arm dynein light chain 1 domain: Outer arm dynein light chain 1 species: Green algae (Chlamydomonas reinhardtii) [TaxId: 3055]
Probab=99.65 E-value=6.3e-19 Score=117.18 Aligned_cols=14 Identities=29% Similarity=0.467 Sum_probs=4.5
Q ss_pred CCCCEEEECCCCCC
Q ss_conf 97514999289845
Q 002721 133 LKDLRFFNISNNVL 146 (888)
Q Consensus 133 l~~L~~L~Ls~N~l 146 (888)
+++|+.|+|++|+|
T Consensus 47 L~~L~~L~Ls~n~I 60 (198)
T d1m9la_ 47 LKACKHLALSTNNI 60 (198)
T ss_dssp TTTCCEEECSEEEE
T ss_pred CCCCCEEECCCCCC
T ss_conf 60461519944689
|
| >d1koha1 c.10.2.3 (A:201-362) mRNA export factor tap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: L domain-like family: mRNA export factor tap domain: mRNA export factor tap species: Human (Homo sapiens) [TaxId: 9606]
Probab=98.81 E-value=9.1e-11 Score=72.52 Aligned_cols=122 Identities=17% Similarity=0.050 Sum_probs=0.0
Q ss_pred CCCCEEECCCCCCCCCCCCCCCCCCCCCCEEECCCCCCCCCCCCCCCCCCCCEEEECCCCCCCCC--HHHHCCCCCCCEE
Q ss_conf 44517852455645877877787234652010155588978888557888646982275678991--0120168766604
Q 002721 182 TNLRVFTAYENQLVGEIPDNLGSVSELELLNLHSNQLEGPIPKSIFASGKLEVLVLTQNRLTGDI--PELVGHCKSLSNI 259 (888)
Q Consensus 182 ~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~--~~~~~~l~~L~~L 259 (888)
.+.+.|+++++... ..+..+..+..++...|... .++.....+++|++|+|++|+|+... +..+..+++|+.|
T Consensus 22 ~~~~~Ldls~l~~~----~~l~~~~~~~~l~~~~~~~~-~l~~~~~~~~~L~~L~Ls~N~i~~l~~~~~~~~~l~~L~~L 96 (162)
T d1koha1 22 GSQQALDLKGLRSD----PDLVAQNIDVVLNRRSSMAA-TLRIIEENIPELLSLNLSNNRLYRLDDMSSIVQKAPNLKIL 96 (162)
T ss_dssp SSSCCBCCCCCSSC----TTTTTTTCCCCTTSHHHHHH-HHHHHHHHCTTCCCCCCCSSCCCCCSGGGTHHHHSTTCCCC
T ss_pred HHHCEEECCCCCCC----CHHHHCCCHHHCCHHHHHHH-HHHHHHHHCCCCCEEECCCCCCCCCCHHHHHHHHCCCCCCC
T ss_conf 33086534359898----21554664011225556766-60788974878788637776666773158898658856100
Q ss_pred ECCCCCCCCCCCCCCCCCCCCCEEEEECCCCCCCCCCC-------CCCCCCCCEEE
Q ss_conf 41388465435876545787519982136899988923-------46889786899
Q 002721 260 RIGNNDLVGVIPRAIGNVSGLTYFEADNNNLSGEIVPE-------FSQCSNLTLLN 308 (888)
Q Consensus 260 ~L~~N~l~~~~p~~~~~l~~L~~L~L~~N~l~~~~~~~-------~~~l~~L~~L~ 308 (888)
+|++|.++...+-.+.....|+.+++++|.+....... +..+|+|+.||
T Consensus 97 ~Ls~N~i~~l~~l~~l~~~~L~~L~L~~Npl~~~~~~~~~y~~~i~~~~P~L~~LD 152 (162)
T d1koha1 97 NLSGNELKSERELDKIKGLKLEELWLDGNSLSDTFRDQSTYISAIRERFPKLLRLD 152 (162)
T ss_dssp CCTTSCCCCGGGHHHHTTCCCSSCCCTTSTTSSSSSSHHHHHHHHHTTSTTCCEET
T ss_pred CCCCCCCCCCHHHHHHHCCCCCEEECCCCCCCCCCCCCHHHHHHHHHHCCCCCEEC
T ss_conf 04357213423442220331042664899767676661569999999889978799
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.80 E-value=2.5e-08 Score=59.19 Aligned_cols=129 Identities=16% Similarity=0.075 Sum_probs=79.2
Q ss_pred CCCCEEEEEEECCCCEEEEEEEECCCHHHHHHHHHHHHHHHHHHCCC-CCCEEEEEEEEEECCEEEEEEECCCCCCHHHH
Q ss_conf 66442999981799689999931267145687999999999985037-99325443578728952999830799998788
Q 002721 616 GTFSTVYKAVMPSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLC-HDNLVRPIGFVIYEDVALLLHNYLPNGTLAQL 694 (888)
Q Consensus 616 G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~g~~~~~~~~~lv~e~~~~gsL~~~ 694 (888)
+..+.||+... ++..+.+|+......... ..+.+|...+..+. +-.+.+++.+...++..++||+++++.++.+.
T Consensus 25 ~s~~~v~rv~~-~~~~~vlk~~~~~~~~~~---~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~G~~~~~~ 100 (263)
T d1j7la_ 25 MSPAKVYKLVG-ENENLYLKMTDSRYKGTT---YDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEE 100 (263)
T ss_dssp CSSSEEEEEEC-SSCEEEEEEECGGGTTST---TCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHH
T ss_pred CCCCCEEEEEE-CCCEEEEEECCCCCCCCH---HHHHHHHHHHHHHHCCCCCCCEEEEEECCCCEEEEEEECCCCCCCCC
T ss_conf 98771899990-898699998488765325---56999999999876069987289997508964999986043343543
Q ss_pred HHCCCCCCCCCCCHHHHHHHHHHHHHHHHHCC------------------------------------------------
Q ss_conf 43039999999998899999999998873024------------------------------------------------
Q 002721 695 LHESTKQPDYRPDWPTRLSIAIGVAEGLAFLH------------------------------------------------ 726 (888)
Q Consensus 695 l~~~~~~~~~~l~~~~~~~i~~~ia~~L~~LH------------------------------------------------ 726 (888)
..... . ...++.++++.++.||
T Consensus 101 ~~~~~-------~---~~~~~~~l~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 170 (263)
T d1j7la_ 101 YEDEQ-------S---PEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPREL 170 (263)
T ss_dssp TTTCS-------C---HHHHHHHHHHHHHHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSHHHH
T ss_pred CCCCC-------C---HHHHHHHHHHHHHHHHCCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCHHHHHH
T ss_conf 34402-------6---9999998999999985568421435764465655577899877655554303323200579999
Q ss_pred -----------CCCEEECCCCCCCEEECCCCCCEEECCCCCCC
Q ss_conf -----------57725238888975857999826702334322
Q 002721 727 -----------HVAIIHLDISSGNVLLDADFKPLLGEIEISKL 758 (888)
Q Consensus 727 -----------~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~ 758 (888)
...++|+|+.+.||+++++....+.||+.+..
T Consensus 171 ~~~l~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 171 YDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp HHHHHHSCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHCCCCCCCEEEEEECCCCCEEECCCCEEEEEECHHCCC
T ss_conf 9999844986781789860047642364996599960231441
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=98.54 E-value=2.1e-07 Score=54.11 Aligned_cols=140 Identities=15% Similarity=0.085 Sum_probs=79.8
Q ss_pred EEECCC-CEEEEEEECCCCEEEEEEEECCCHHHHHHHHHHHHHHHHHHCCC--CCCEEEEEEEEEECCEEEEEEECCCCC
Q ss_conf 542664-42999981799689999931267145687999999999985037--993254435787289529998307999
Q 002721 613 IYCGTF-STVYKAVMPSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLC--HDNLVRPIGFVIYEDVALLLHNYLPNG 689 (888)
Q Consensus 613 lg~G~~-g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~--h~niv~l~g~~~~~~~~~lv~e~~~~g 689 (888)
+..|.. +.||+....++..+++|........ .+..|...++.+. .-.+.+++++...++..++||+++++.
T Consensus 18 ~~~G~s~~~v~r~~~~~~~~~vlK~~~~~~~~------~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~ 91 (255)
T d1nd4a_ 18 QTIGCSDAAVFRLSAQGRPVLFVKTDLSGALN------ELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQ 91 (255)
T ss_dssp CSCTTSSCEEEEEECTTSCCEEEEEECSCTTS------CHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSE
T ss_pred CCCCCCCCEEEEEEECCCCEEEEEECCCCCHH------HHHHHHHHHHHHHHCCCCCCCEEEECCCCCCEEEEEEEEECC
T ss_conf 67865477589999389878999958966776------899999999999865999886132224566159998744135
Q ss_pred CHHHH-----------------HHCCCCC-CCCCCCHHHHHH---------------------------HHHHHHHHHHH
Q ss_conf 98788-----------------4303999-999999889999---------------------------99999988730
Q 002721 690 TLAQL-----------------LHESTKQ-PDYRPDWPTRLS---------------------------IAIGVAEGLAF 724 (888)
Q Consensus 690 sL~~~-----------------l~~~~~~-~~~~l~~~~~~~---------------------------i~~~ia~~L~~ 724 (888)
++.+. ++..... ......+..... ....+...+..
T Consensus 92 ~~~~~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 171 (255)
T d1nd4a_ 92 DLLSSHLAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPD 171 (255)
T ss_dssp ETTTSCCCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCS
T ss_pred CCCCCCCCHHHHHHHHHHHHHHHCCCCHHHCCCCCCCHHHHHHHHHHHHHHHHCCCCCCCHHHHHHHHHHHHHHHHHCCC
T ss_conf 54322126899999999999987368854488755412468899999987541101134011213799999999871876
Q ss_pred CCCCCEEECCCCCCCEEECCCCCCEEECCCCCCC
Q ss_conf 2457725238888975857999826702334322
Q 002721 725 LHHVAIIHLDISSGNVLLDADFKPLLGEIEISKL 758 (888)
Q Consensus 725 LH~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~ 758 (888)
.....++|+|+.+.||+++++..+.+.||+.+..
T Consensus 172 ~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 172 GEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 205 (255)
T ss_dssp SCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred CCCCEEEECCCCCCCEEEECCCEEEEEECHHCCC
T ss_conf 5795678678887635773796589998533265
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=98.32 E-value=3.9e-06 Score=47.17 Aligned_cols=79 Identities=14% Similarity=0.077 Sum_probs=47.1
Q ss_pred CCEEEECCCCEEEEEEECC-CCEEEEEEEECCCHHH----HHHHHHHHHHHHHHHCCC-C--CCEEEEEEEEEECCEEEE
Q ss_conf 6625426644299998179-9689999931267145----687999999999985037-9--932544357872895299
Q 002721 610 SNMIYCGTFSTVYKAVMPS-GLILSVKRLKSMDRTI----IHHQNKMIRELEKLSKLC-H--DNLVRPIGFVIYEDVALL 681 (888)
Q Consensus 610 ~~~lg~G~~g~Vy~~~~~~-~~~vavK~~~~~~~~~----~~~~~~~~~e~~~l~~l~-h--~niv~l~g~~~~~~~~~l 681 (888)
.+.+|.|....||++...+ +..+++|.-....... .........|.+.++.+. + ..+++++.+ +.+..++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEECCCCEEEEEEEEECCCCEEEEEECCCCHHCCCCCCCCCCHHHHHHHHHHHHHHHHHCCCCCCEEEEE--CCCCCEE
T ss_conf 99807985276899995799848999617713034677788877899999999998650579885528998--5988779
Q ss_pred EEECCCCCC
Q ss_conf 983079999
Q 002721 682 LHNYLPNGT 690 (888)
Q Consensus 682 v~e~~~~gs 690 (888)
|||++++..
T Consensus 109 vmE~L~~~~ 117 (392)
T d2pula1 109 VMEDLSHLK 117 (392)
T ss_dssp EECCCTTSE
T ss_pred EEECCCCCC
T ss_conf 871357765
|
| >d1pgva_ c.10.1.1 (A:) Tropomodulin C-terminal domain {nematode (Caenorhabditis elegans) [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: nematode (Caenorhabditis elegans) [TaxId: 6239]
Probab=97.95 E-value=6.3e-07 Score=51.53 Aligned_cols=111 Identities=14% Similarity=0.146 Sum_probs=0.0
Q ss_pred CCCCCCCEEECCC-CCCCCC----CCCCCCCCCCCCEEECCCCCCC----CCCCCCCCCCCCCEEEECCCCCCCC----C
Q ss_conf 5899998994899-957435----9989889999989877679899----9888878899751499928984556----6
Q 002721 83 SELKALKRLDLSN-NAFSGT----IPSAFGNLSELEFLDLSLNKFG----GVIPRELGSLKDLRFFNISNNVLVG----E 149 (888)
Q Consensus 83 ~~l~~L~~L~L~~-n~l~~~----~p~~~~~l~~L~~L~Ls~N~l~----~~~p~~~~~l~~L~~L~Ls~N~l~~----~ 149 (888)
.+.++|+.|+|++ +.+... +-..+...+.|++|+|++|.+. ..+...+...+.|+.|+|++|.++. .
T Consensus 12 ~n~~~L~~L~L~~~~~i~~~~~~~l~~~L~~n~~L~~L~Ls~n~l~~~~~~~la~~L~~n~~L~~L~L~~n~i~~~g~~~ 91 (167)
T d1pgva_ 12 EDDTDLKEVNINNMKRVSKERIRSLIEAACNSKHIEKFSLANTAISDSEARGLIELIETSPSLRVLNVESNFLTPELLAR 91 (167)
T ss_dssp TTCSSCCEEECTTCCSSCHHHHHHHHHHHTTCSCCCEEECTTSCCBHHHHTTHHHHHHHCSSCCEEECCSSBCCHHHHHH
T ss_pred HCCCCCCEEEECCCCCCCHHHHHHHHHHHHHCCCCCEEECCCCCCCHHHHHHHHHHHHHCCCCCCEEEEHHHCCHHHHHH
T ss_conf 28999819782799998989999999997637764540120156215679887531000234330033010214599999
Q ss_pred CCCCCCCCCCCCEEEECCCCCCCC-------CCCCCCCCCCCCEEECCCCC
Q ss_conf 684334665323899427877899-------88432334445178524556
Q 002721 150 IPDELKSLEKLEDFQVSSNKLNGS-------IPFWVGNLTNLRVFTAYENQ 193 (888)
Q Consensus 150 ~p~~~~~l~~L~~L~ls~N~l~~~-------~p~~~~~l~~L~~L~L~~N~ 193 (888)
+...+...+.|++|++++|++... +...+..-++|+.|+++.+.
T Consensus 92 l~~aL~~n~sL~~L~l~~n~~~~~g~~~~~~l~~~L~~n~sL~~l~l~~~~ 142 (167)
T d1pgva_ 92 LLRSTLVTQSIVEFKADNQRQSVLGNQVEMDMMMAIEENESLLRVGISFAS 142 (167)
T ss_dssp HHHHTTTTCCCSEEECCCCSSCCCCHHHHHHHHHHHHHCSSCCEEECCCCC
T ss_pred HHHHHHHCCCCCEEECCCCCCCCCCHHHHHHHHHHHHHCCCCCEEECCCCC
T ss_conf 999998489389877887768886579999999999729985386486888
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=97.84 E-value=0.00014 Score=38.68 Aligned_cols=136 Identities=14% Similarity=0.124 Sum_probs=72.6
Q ss_pred CCEEEEEEECCCCEEEEEEEECCCHHHHHHHHHHHHHHHHHHCCCCCC--E---EEEE--EEEEECCEEEEEEECCCCCC
Q ss_conf 442999981799689999931267145687999999999985037993--2---5443--57872895299983079999
Q 002721 618 FSTVYKAVMPSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCHDN--L---VRPI--GFVIYEDVALLLHNYLPNGT 690 (888)
Q Consensus 618 ~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~n--i---v~l~--g~~~~~~~~~lv~e~~~~gs 690 (888)
--.||++...+|..+++|.......+. +++..|...+..+.... + +..- ......+..+.++++++|..
T Consensus 35 EN~vy~v~~~dg~~~VlK~~rp~~~s~----~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~G~~ 110 (325)
T d1zyla1 35 ENRVYQFQDEDRRRFVVKFYRPERWTA----DQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVGGRQ 110 (325)
T ss_dssp SSEEEEECCTTCCCEEEEEECTTTSCH----HHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCCCEE
T ss_pred CCEEEEEECCCCCEEEEEEECCCCCCH----HHHHHHHHHHHHHHHCCCCCCCCEECCCCEEEEEEEEEEEEEEECCCCC
T ss_conf 202699983899979999847877889----9999999999999855998787520689805665347999986527768
Q ss_pred H-----HHH---------HHC----CCCCCCCCCCHH----------------------HHHHHHHHHHHHHHHC-C---
Q ss_conf 8-----788---------430----399999999988----------------------9999999999887302-4---
Q 002721 691 L-----AQL---------LHE----STKQPDYRPDWP----------------------TRLSIAIGVAEGLAFL-H--- 726 (888)
Q Consensus 691 L-----~~~---------l~~----~~~~~~~~l~~~----------------------~~~~i~~~ia~~L~~L-H--- 726 (888)
+ .++ ++. .........++. .....+..+...+.-. .
T Consensus 111 ~~~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~ 190 (325)
T d1zyla1 111 FEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWREDF 190 (325)
T ss_dssp CCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCCSCS
T ss_pred CCCCCHHHHHHHHHHHHHHHHHCCCCCCCCCCCCCHHHHHHHHHHHHHHCCCCCHHHHHHHHHHHHHHHHHHHHHCCCCC
T ss_conf 89999999999899999988630357865567789788766568999874769988989999999999999998454568
Q ss_pred CCCEEECCCCCCCEEECCCCCCEEECCCCCCCC
Q ss_conf 577252388889758579998267023343225
Q 002721 727 HVAIIHLDISSGNVLLDADFKPLLGEIEISKLL 759 (888)
Q Consensus 727 ~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~~ 759 (888)
..+++|+|+.+.|||++++ ..+.||+-+...
T Consensus 191 p~~liHgDlh~~NvL~~~~--~~~IDFdd~~~g 221 (325)
T d1zyla1 191 TVLRLHGDCHAGNILWRDG--PMFVDLDDARNG 221 (325)
T ss_dssp CCEECCSSCSGGGEEESSS--EEECCCTTCCEE
T ss_pred CCEEECCCCCCCCEEEECC--CEEEECHHCCCC
T ss_conf 7120247888042878389--358865201468
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=97.61 E-value=0.00028 Score=37.04 Aligned_cols=72 Identities=14% Similarity=0.095 Sum_probs=42.9
Q ss_pred CEEEECCCCEEEEEEECCC--------CEEEEEEEECCCHHHHHHHHHHHHHHHHHHCCC-CCCEEEEEEEEEECCEEEE
Q ss_conf 6254266442999981799--------689999931267145687999999999985037-9932544357872895299
Q 002721 611 NMIYCGTFSTVYKAVMPSG--------LILSVKRLKSMDRTIIHHQNKMIRELEKLSKLC-HDNLVRPIGFVIYEDVALL 681 (888)
Q Consensus 611 ~~lg~G~~g~Vy~~~~~~~--------~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~-h~niv~l~g~~~~~~~~~l 681 (888)
+.++.|-.-.+|++...++ ..|.+++.. .... .. ...+|..+++.+. +.-..++++++.. .+
T Consensus 48 ~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g-~~~~-~i---dr~~E~~i~~~ls~~gl~Pkll~~~~~----g~ 118 (395)
T d1nw1a_ 48 SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYF-NPET-ES---HLVAESVIFTLLSERHLGPKLYGIFSG----GR 118 (395)
T ss_dssp EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEEC-SCCC-HH---HHHHHHHHHHHHHHTTSSSCEEEEETT----EE
T ss_pred EECCCCCCCCEEEEEECCCCCCCCCCCCCEEEEECC-CCCH-HH---HHHHHHHHHHHHHHCCCCCEEEEECCC----CE
T ss_conf 991785334348999688775445789817999659-9611-65---899999999999757999808998189----56
Q ss_pred EEECCCCCCH
Q ss_conf 9830799998
Q 002721 682 LHNYLPNGTL 691 (888)
Q Consensus 682 v~e~~~~gsL 691 (888)
|+||+++..+
T Consensus 119 I~efi~g~~l 128 (395)
T d1nw1a_ 119 LEEYIPSRPL 128 (395)
T ss_dssp EECCCCEEEC
T ss_pred EEEEECCCCC
T ss_conf 9997345548
|
| >d1io0a_ c.10.1.1 (A:) Tropomodulin C-terminal domain {Chicken (Gallus gallus) [TaxId: 9031]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a/b) fold: Leucine-rich repeat, LRR (right-handed beta-alpha superhelix) superfamily: RNI-like family: 28-residue LRR domain: Tropomodulin C-terminal domain species: Chicken (Gallus gallus) [TaxId: 9031]
Probab=97.04 E-value=3.1e-05 Score=42.31 Aligned_cols=111 Identities=12% Similarity=0.063 Sum_probs=0.0
Q ss_pred CCCCCCCEEEECC-CCCCCCCHHHHC----CCCCCCEEECCCCCCCCC----CCCCCCCCCCCCEEEEECCCCCCCCC--
Q ss_conf 5788864698227-567899101201----687666044138846543----58765457875199821368999889--
Q 002721 227 FASGKLEVLVLTQ-NRLTGDIPELVG----HCKSLSNIRIGNNDLVGV----IPRAIGNVSGLTYFEADNNNLSGEIV-- 295 (888)
Q Consensus 227 ~~l~~L~~L~L~~-N~l~~~~~~~~~----~l~~L~~L~L~~N~l~~~----~p~~~~~l~~L~~L~L~~N~l~~~~~-- 295 (888)
.+.++|+.|+|++ +.++...-..+. ..+.|++|++++|.+... +-..+...+.++.++++.|.+.....
T Consensus 14 ~~~~~L~~L~L~~~~~i~~~~~~~l~~al~~n~~L~~L~Ls~n~l~~~~~~~L~~~l~~~~~l~~l~l~~~~~~~~g~~~ 93 (166)
T d1io0a_ 14 NNDPDLEEVNLNNIMNIPVPTLKACAEALKTNTYVKKFSIVGTRSNDPVAFALAEMLKVNNTLKSLNVESNFISGSGILA 93 (166)
T ss_dssp TTCTTCCEEECTTCTTCCHHHHHHHHHHHTTCCSCCEEECTTSCCCHHHHHHHHHHHHHCSSCCEEECCSSCCCHHHHHH
T ss_pred HCCCCCCEEECCCCCCCCHHHHHHHHHHHHCCCCCCEEECCCCCCCHHHHHHHHHHHHHCCCCHHHHHCCCCCCCHHHHH
T ss_conf 55999868876899998989999999888419825743015896117789999987752122101210254322014788
Q ss_pred --CCCCCCCCCCE--EEEECCCCCC----CCCCCCCCCCCCCEEEECCCC
Q ss_conf --23468897868--9952376633----489443577774177701441
Q 002721 296 --PEFSQCSNLTL--LNLASNGFTG----VIPPELGQLINLQELILYENS 337 (888)
Q Consensus 296 --~~~~~l~~L~~--L~L~~N~l~~----~~p~~~~~l~~L~~L~L~~N~ 337 (888)
..+...++|+. |++++|.+.. .+...+...++|+.|+++.+.
T Consensus 94 l~~~l~~~~~L~~l~L~l~~n~i~~~~~~~La~~L~~n~~L~~L~l~~~~ 143 (166)
T d1io0a_ 94 LVEALQSNTSLIELRIDNQSQPLGNNVEMEIANMLEKNTTLLKFGYHFTQ 143 (166)
T ss_dssp HHHGGGGCSSCCEEECCCCSSCCCHHHHHHHHHHHHHCSSCCEEECCCSS
T ss_pred HHHHHHHCCCCCEEEECCCCCCCCHHHHHHHHHHHHHCCCCCEEECCCCC
T ss_conf 99999848652477321677867679999999999849984788581898
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.49 E-value=0.012 Score=28.15 Aligned_cols=140 Identities=14% Similarity=0.001 Sum_probs=68.3
Q ss_pred EEECCCCEEEEEEECCCCEEEEEEEECCCHHHHHHHHHHHHHHHHHHCCCC-----CCEEEE-EE--EEEECCEEEEEEE
Q ss_conf 542664429999817996899999312671456879999999999850379-----932544-35--7872895299983
Q 002721 613 IYCGTFSTVYKAVMPSGLILSVKRLKSMDRTIIHHQNKMIRELEKLSKLCH-----DNLVRP-IG--FVIYEDVALLLHN 684 (888)
Q Consensus 613 lg~G~~g~Vy~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h-----~niv~l-~g--~~~~~~~~~lv~e 684 (888)
|..|.--+.|+....+|+ +++|+....... +.+..|++.+..+.. |..++. -| +.........++.
T Consensus 26 i~~G~~N~ny~v~t~~g~-yVLri~~~~~~~-----~~l~~~~~~l~~L~~~g~pvp~pi~~~~g~~~~~~~~~~~~~~~ 99 (316)
T d2ppqa1 26 IAEGVENSNFLLHTTKDP-LILTLYEKRVEK-----NDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGELSGRPAALIS 99 (316)
T ss_dssp ECC---EEEEEEEESSCC-EEEEEECC---C-----CHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEETTEEEEEEE
T ss_pred CCCCCCCCEEEEEECCCC-EEEEECCCCCCH-----HHHHHHHHHHHHHHHCCCCCCCCCEECCCCCCEEEECCCCEEEE
T ss_conf 788852673899978972-899980789998-----89999999987543025554556410489762134125502453
Q ss_pred CCCCCCHHH--------------HHHCC----CCCCCCCCCH------------------HHHHHHHHHHHHHHHHCC--
Q ss_conf 079999878--------------84303----9999999998------------------899999999998873024--
Q 002721 685 YLPNGTLAQ--------------LLHES----TKQPDYRPDW------------------PTRLSIAIGVAEGLAFLH-- 726 (888)
Q Consensus 685 ~~~~gsL~~--------------~l~~~----~~~~~~~l~~------------------~~~~~i~~~ia~~L~~LH-- 726 (888)
+.++..... .++.. .......... ......+..+...+...+
T Consensus 100 ~~~g~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~ 179 (316)
T d2ppqa1 100 FLEGMWLRKPEAKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPEIDYLAAHWPK 179 (316)
T ss_dssp CCCCBCCSSCCHHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHHHHHHHHHCCC
T ss_pred ECCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCCHHHCCHHHHHHHHHHHHCCHHHHHHHHHHHHHHHCCCCC
T ss_conf 11465533320467888889987645444320245310111012002456777765311412799999998764204855
Q ss_pred --CCCEEECCCCCCCEEECCCCCCEEECCCCCCC
Q ss_conf --57725238888975857999826702334322
Q 002721 727 --HVAIIHLDISSGNVLLDADFKPLLGEIEISKL 758 (888)
Q Consensus 727 --~~~ivH~dlk~~NIll~~~~~~kl~Dfg~~~~ 758 (888)
..+++|+|+.+.||+++++...-+.||+.+..
T Consensus 180 ~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 180 DLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 213 (316)
T ss_dssp SSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred CCCCCCCCCCCCHHHHHCCCCCCEEEECCCCCCC
T ss_conf 4545033378636564020454126742221236
|